PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wilson, CH; Gamper, I; Perfetto, A; Auw, J; Littlewood, TD; Evan, GI				Wilson, C. H.; Gamper, I.; Perfetto, A.; Auw, J.; Littlewood, T. D.; Evan, G. I.			The kinetics of ER fusion protein activation in vivo	ONCOGENE			English	Article							RECOMBINATION; TAMOXIFEN; MOUSE; TISSUES; VITRO; CELLS; MICE; CRE; MYC	Reversibly switchable proteins are powerful tools with which to explore protein function in vitro and in vivo. For example, the activity of many proteins fused to the hormone-binding domain of the modified oestrogen receptor (ERTAM) can be regulated by provision or removal of 4-hydroxytamoxifen (4-OHT). Despite the widespread use of ERTAM fusions in vivo, inadequate data are available as to the most efficacious routes for systemic tamoxifen delivery. In this study, we have used two well-characterized ERTAM fusion proteins, both reversibly activated by 4-OHT, to compare the effectiveness and kinetics of 4-OHT delivery in mice in vivo by either tamoxifen in food or by intraperitoneal injection. Our data indicate that dietary tamoxifen offers an effective, facile and ethically preferable means for long-term activation of ERTAM fusion proteins in vivo.	[Wilson, C. H.; Gamper, I.; Perfetto, A.; Auw, J.; Littlewood, T. D.; Evan, G. I.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Evan, GI (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	gie20@cam.ac.uk		Wilson, Catherine/0000-0002-5333-0295	CRUK [A12077]; ERC [294851]; Cancer Research UK [12077, 13061] Funding Source: researchfish	CRUK(Cancer Research UK); ERC(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	We thank Debbie Burkhart for her advice with experimental procedures and the support staff within the biomedical facility of the Gurdon Institute. We thank Cyprotex Discovery Limited for LC/MS analysis. This work is supported by CRUK (Programme Grant A12077) and the ERC (Advanced Investigator Award 294851).	Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Ellisor D, 2010, MOL CELL NEUROSCI, V45, P132, DOI 10.1016/j.mcn.2010.06.004; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	11	21	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 2	2014	33	40					4877	4880		10.1038/onc.2014.78	http://dx.doi.org/10.1038/onc.2014.78			4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0EH	24662815	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000343240100009
J	Chiaradia, A; Forero, MG; McInnes, JC; Ramirez, F				Chiaradia, Andre; Forero, Manuela G.; McInnes, Julie C.; Ramirez, Francisco			Searching for the True Diet of Marine Predators: Incorporating Bayesian Priors into Stable Isotope Mixing Models	PLOS ONE			English	Article							PENGUINS EUDYPTULA-MINOR; AVIAN BLOOD; FOOD; SEABIRDS; DNA; SEGREGATION; UNCERTAINTY; MANAGEMENT; FISHERIES; VICTORIA	Reconstructing the diet of top marine predators is of great significance in several key areas of applied ecology, requiring accurate estimation of their true diet. However, from conventional stomach content analysis to recent stable isotope and DNA analyses, no one method is bias or error free. Here, we evaluated the accuracy of recent methods to estimate the actual proportion of a controlled diet fed to a top-predator seabird, the Little penguin (Eudyptula minor). We combined published DNA data of penguins scats with blood plasma delta N-15 and delta C-13 values to reconstruct the diet of individual penguins fed experimentally. Mismatch between controlled (true) ingested diet and dietary estimates obtained through the separately use of stable isotope and DNA data suggested some degree of differences in prey assimilation (stable isotope) and digestion rates (DNA analysis). In contrast, combined posterior isotope mixing model with DNA Bayesian priors provided the closest match to the true diet. We provided the first evidence suggesting that the combined use of these complementary techniques may provide better estimates of the actual diet of top marine predators-a powerful tool in applied ecology in the search for the true consumed diet.	[Chiaradia, Andre; McInnes, Julie C.] Phillip Isl Nat Pk, Dept Res, Cowes, Vic, Australia; [Forero, Manuela G.; Ramirez, Francisco] Estn Biol Donana, Appl Marine Ecol Grp, Dept Conservat Biol, E-41013 Seville, Andalucia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Chiaradia, A (corresponding author), Phillip Isl Nat Pk, Dept Res, Cowes, Vic, Australia.	achiaradia@penguins.org.au	Chiaradia, Andre/AAG-4928-2022; Chiaradia, Andre/AFK-6634-2022; Ramírez, Francisco/I-3553-2014	Chiaradia, Andre/0000-0002-6178-4211; Chiaradia, Andre/0000-0002-6178-4211; Ramírez, Francisco/0000-0001-9670-486X; McInnes, Julie/0000-0001-8902-5199	Penguin Foundation; Junta Andalucia, Spain; European Union Research Fund; Ministerio de Educacion y Ciencia de Espana	Penguin Foundation; Junta Andalucia, Spain; European Union Research Fund; Ministerio de Educacion y Ciencia de Espana(Spanish Government)	Several grants received to support this collaborative research: Penguin Foundation, Junta Andalucia, Spain, European Union Research Fund and Ministerio de Educacion y Ciencia de Espana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; Bearhop S, 2000, AUK, V117, P504, DOI 10.1642/0004-8038(2000)117[0504:IOLAUA]2.0.CO;2; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bowen WD, 2013, MAR MAMMAL SCI, V29, P719, DOI 10.1111/j.1748-7692.2012.00604.x; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; CAIRNS DK, 1992, CONDOR, V94, P811, DOI 10.2307/1369279; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; Chiaradia A, 2003, EMU, V103, P43, DOI 10.1071/MU02020; Chiaradia A, 2012, AUSTRAL ECOL, V37, P610, DOI 10.1111/j.1442-9993.2011.02323.x; Chiaradia A, 2010, ICES J MAR SCI, V67, P1710, DOI 10.1093/icesjms/fsq067; CULLEN JM, 1992, EMU, V91, P318, DOI 10.1071/MU9910318; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DUFFY D C, 1986, Colonial Waterbirds, V9, P1, DOI 10.2307/1521138; Forero MG, 2005, MAR ECOL PROG SER, V296, P107, DOI 10.3354/meps296107; Forero MG, 2002, MAR ECOL PROG SER, V234, P289, DOI 10.3354/meps234289; Fossi MC, 2012, MAR ENVIRON RES, V77, P156, DOI 10.1016/j.marenvres.2012.03.003; Franco-Trecu V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080019; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Furness RW, 2002, ICES J MAR SCI, V59, P261, DOI 10.1006/jmsc.2001.1155; Hardy CM, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04411.x; HOBSON KA, 1995, CONDOR, V97, P752, DOI 10.2307/1369183; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Iverson SJ, 2007, MAR ECOL PROG SER, V352, P235, DOI 10.3354/meps07073; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; Kotz S., 2000, DIRICHLET INVERTED D; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Maloy AP, 2013, MAR BIOL, V160, P479, DOI 10.1007/s00227-012-2105-4; Montevecchi W.A., 1988, BIOL OCEANOGR, V5, P153; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Morissette L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043966; Ogle K, 2013, ECOLOGICAL APPL, DOI [10.1890/12-1970.1, DOI 10.1890/12-1970.1]; Parnell A, 2011, STABLE ISOTOPE ANAL; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; R Development Core Team, 2009, R FDN STAT COMP; Ramos R, 2009, MAR ECOL PROG SER, V377, P289, DOI 10.3354/meps07792; Ropert-Coudert Y, 2009, P ROY SOC B-BIOL SCI, V276, P4105, DOI 10.1098/rspb.2009.1399; SCHWARCZ HP, 1991, J ARCHAEOL SCI, V18, P261, DOI 10.1016/0305-4403(91)90065-W; Sydeman WJ, 1997, CONDOR, V99, P327, DOI 10.2307/1369938; Thomas AC, 2014, MOL ECOL, V23, P3706, DOI 10.1111/mec.12523; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	50	41	43	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92665	10.1371/journal.pone.0092665	http://dx.doi.org/10.1371/journal.pone.0092665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667296	Green Submitted, gold, Green Published			2022-12-25	WOS:000333675600062
J	Gonzalez, BA; Orozco-terWengel, P; von Borries, R; Johnson, WE; Franklin, WL; Marin, JC				Gonzalez, Benito A.; Orozco-terWengel, Pablo; von Borries, Rainer; Johnson, Warren E.; Franklin, William L.; Marin, Juan C.			Maintenance of Genetic Diversity in an Introduced Island Population of Guanacos after Seven Decades and Two Severe Demographic Bottlenecks: Implications for Camelid Conservation	PLOS ONE			English	Article							LAMA-GUANICOE; MICROSATELLITE MARKERS; NUMBER; MANAGEMENT; SOFTWARE; DIFFERENTIATION; ARTIODACTYLA; ARGENTINA; MUTATION; PROGRAM	Fifteen guanacos were introduced to Staats Island in the Falklands/Malvinas archipelago from Patagonia in the 1930s. Twenty five years later, the population was culled from 300 to 10-20 individuals, but quickly rebounded to a population of almost 400 animals that today retain the genetic signature of the founding event and later bottleneck. The goals of this study were to (i) make a genetic assessment of this island population through comparisons with mainland populations and simulations, and (ii) assess the likely source-population of the introduced guanacos. Genetic variation was estimated from 513 bp of mitochondrial DNA sequence and 15 microsatellite loci among 154 guanacos collected from eight localities, including the adjacent mainland and the islands of Tierra del Fuego and Staats Island. Of the 23 haplotypes observed among our samples, the Staats Island population only contained three haplotypes, all of which were shared with the coastal Monte Leon population in southern Patagonia. Mitochondrial DNA and microsatellite variations on Staats Island were comparable to most mainland populations and greater than those observed on Tierra del Fuego. Patterns of genetic structure suggest that the Staats Island guanaco population was founded with animals from southern Patagonia (as opposed to northern Patagonia or Tierra del Fuego), but that effective reductions in population size lasted only a few generations and that surviving animals were a random sample of the pre-bottleneck genetic variation.	[Gonzalez, Benito A.] Univ Chile, Fac Ciencias Forestales & Conservac Nat, Lab Ecol Vida Silvestre, Santiago, Chile; [Orozco-terWengel, Pablo] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [von Borries, Rainer] Univ Chile, Fac Med, Santiago 7, Chile; [Johnson, Warren E.] Smithsonian Inst, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Franklin, William L.] Iowa State Univ, Dept Nat Resource Ecol & Management, Ames, IA USA; [Marin, Juan C.] Univ Bio Bio, Fac Ciencias, Lab Genom & Biodiversidad, Chillan, Chile	Universidad de Chile; Cardiff University; Universidad de Chile; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Iowa State University; Universidad del Bio-Bio	Marin, JC (corresponding author), Univ Bio Bio, Fac Ciencias, Lab Genom & Biodiversidad, Chillan, Chile.	jcmarin@ubiobio.cl	González, Benito/H-5189-2013; Orozco-terWengel, Pablo Andres/D-1527-2011; González, Benito/I-9570-2014; Johnson, Warren/D-4149-2016	Orozco-terWengel, Pablo Andres/0000-0002-7951-4148; González, Benito/0000-0001-8201-8789; Johnson, Warren/0000-0002-5954-186X; Gonzalez, Benito/0000-0002-0039-5722	Falkland Research Expeditions; Hidden Corners Inc.; Turner Foundation; University of South Florida; Comision Nacional de Investigacion, Ciencia y Tecnologia (CONICYT) [3050046]	Falkland Research Expeditions; Hidden Corners Inc.; Turner Foundation; University of South Florida; Comision Nacional de Investigacion, Ciencia y Tecnologia (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was partially funded by Falkland Research Expeditions, Hidden Corners Inc., Turner Foundation, University of South Florida, and the Comision Nacional de Investigacion, Ciencia y Tecnologia (CONICYT, Post-Doctoral grants No 3050046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi B, 2008, IUCN 2010 IUCN RED L; Baldi Ricardo, 1997, Mastozoologia Neotropical, V4, P5; Barri FR, 2011, ACTA ETHOL, V14, P103, DOI 10.1007/s10211-011-0098-5; Bas M. F., 2000, Ciencia e Investigacion Agraria, V27, P51; Beheregaray LB, 2003, CONSERV GENET, V4, P31, DOI 10.1023/A:1021864214375; BELKHIR K, 2005, GENETIX 4 05 LOGICIE; Bonhomme M, 2008, MOL ECOL, V17, P1009, DOI 10.1111/j.1365-294X.2007.03645.x; Busch JD, 2007, MOL ECOL, V16, P2450, DOI 10.1111/j.1365-294X.2007.03283.x; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Cornuet JM, 1996, GENETICS, V144, P2001; Cunazza C., 1995, TECNICAS MANEJO GUAN, P27; de la Tour G. D., 1954, Oryx, V2, P273; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; EBENHARD T, 1995, TRENDS ECOL EVOL, V10, P438, DOI 10.1016/S0169-5347(00)89176-4; Estevez J, 2001, INT J OSTEOARCHAEOL, V11, P24, DOI 10.1002/oa.543; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flores CE, 2012, RANGELAND J, V34, P439, DOI 10.1071/RJ12040; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Franklin W.L., 1983, Special Publication American Society of Mammalogists, P573; Franklin W. L., 1982, MAMMALIAN BIOL S AM, P457; Franklin W.L., 2005, FALKLAND ISLANDS J, V8, P21; Franklin W.L., 2005, INT CAMELID Q, V4, P7; Franklin William, 2011, HDB MAMMALS WORLD HO, V2, P206, DOI DOI 10.1002/ZOO.21021; Franklin WL, 2005, J BIOGEOGR, V32, P661, DOI 10.1111/j.1365-2699.2004.01220.x; Franklin WL, 2004, REPORT GUANACO RES E; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Georoff TA, 2010, J ZOO WILDLIFE MED, V41, P255, DOI 10.1638/2009-0203R.1; Gonzalez BA, 2010, AMBIENTE FORESTAL, V9, P26; Gonzalez BA, 2006, MAMMAL REV, V36, P157, DOI 10.1111/j.1365-2907.2006.00084.x; Goudet J., 2005, FSTAT VERSION 2 9 4; Hampton JO, 2004, J APPL ECOL, V41, P735, DOI 10.1111/j.0021-8901.2004.00936.x; Hare MP, 2002, EVOLUTION, V56, P804; Hartl D., 1989, PRINCIPLES POPULATIO; HEDRICK PW, 1992, ECOL APPL, V2, P30, DOI 10.2307/1941887; IRIARTE JA, 1986, BIOL CONSERV, V38, P243; Jaksic F.M., 2004, HIST NATURAL PARQUE, P93; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Kuo CH, 2003, MOL ECOL NOTES, V3, P669, DOI 10.1046/j.1471-8286.2003.00532.x; Lang KDM, 1996, ANIM GENET, V27, P293, DOI 10.1111/j.1365-2052.1996.tb00502.x; Le Page SL, 2000, MOL ECOL, V9, P753, DOI 10.1046/j.1365-294x.2000.00922.x; Lichtenstein G, 2013, J LAT AM GEOGR, V12, P187, DOI 10.1353/lag.2013.0002; Manceau V, 1999, ANIM CONSERV, V2, P33, DOI 10.1111/j.1469-1795.1999.tb00046.x; MARES MA, 1984, BIOSCIENCE, V34, P580, DOI 10.2307/1309601; Marin JC, 2007, REV CHIL HIST NAT, V80, P120; Marin JC, 2008, J MAMMAL, V89, P269, DOI 10.1644/06-MAMM-A-385R.1; Marin JC, 2013, MOL ECOL, V22, P463, DOI 10.1111/mec.12111; Marshall TC, 1999, ANIM CONSERV, V2, P269, DOI 10.1111/j.1469-1795.1999.tb00073.x; Massoia E., 1993, MAMIFEROS SILVESTRES; Mate ML, 2005, ANIM GENET, V36, P316, DOI 10.1111/j.1365-2052.2005.01307.x; McCulloch R., 1997, PATAGONIA NATURAL HI, P12; Montes Carolina, 2000, Mastozoologia Neotropical, V7, P23; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Park SDE, 2001, THESIS U DUBLIN; Penedo MCT, 1998, ANIM GENET, V29, P411; Penedo MCT, 1999, ANIM GENET, V30, P166, DOI 10.1046/j.1365-2052.1999.00382-8.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Raedeke K., 1978, CONAF PUBLICACION TE, V4; RALLS K, 1986, TRENDS ECOL EVOL, V1, P19, DOI 10.1016/0169-5347(86)90062-5; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Saba Sergio L., 1994, Mastozoologia Neotropical, V1, P113; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sarno RJ, 2000, MOL ECOL, V9, P1922, DOI 10.1046/j.1365-294x.2000.01077-3.x; Sarno RJ, 1996, J AM VET MED ASSOC, V208, P408; Sarno RJ, 2001, ANIM CONSERV, V4, P93, DOI 10.1017/S1367943001001123; Sigg DP, 2006, CONSERV GENET, V7, P577, DOI 10.1007/s10592-005-9096-3; Snyder NFR, 1996, CONSERV BIOL, V10, P338, DOI 10.1046/j.1523-1739.1996.10020338.x; Strange IJ, 1992, FIELD GUIDE WILDLIFE; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WHEELER JC, 1995, BIOL J LINN SOC, V54, P271, DOI 10.1016/0024-4066(95)90021-7; Wilson GA, 2005, CONSERV GENET, V6, P905, DOI 10.1007/s10592-005-9077-6; Young JK, 2004, J MAMMAL, V85, P72, DOI 10.1644/1545-1542(2004)085<0072:TFOMGI>2.0.CO;2	78	7	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91714	10.1371/journal.pone.0091714	http://dx.doi.org/10.1371/journal.pone.0091714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663026	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000333459900027
J	Hernandez-Rodriguez, Y; Masuo, S; Johnson, D; Orlando, R; Smith, A; Couto-Rodriguez, M; Momany, M				Hernandez-Rodriguez, Yainitza; Masuo, Shunsuke; Johnson, Darryl; Orlando, Ron; Smith, Amy; Couto-Rodriguez, Mara; Momany, Michelle			Distinct Septin Heteropolymers Co-Exist during Multicellular Development in the Filamentous Fungus Aspergillus nidulans	PLOS ONE			English	Article							ROLES; EMERGENCE; CYTOSKELETON; YEAST; ORGANIZATION; COMPONENT; REVEALS; GTPASES; FAMILY; ACTIN	Septins are important components of the cytoskeleton that are highly conserved in eukaryotes and play major roles in cytokinesis, patterning, and many developmental processes. Septins form heteropolymers which assemble into higher-order structures including rings, filaments, and gauzes. In contrast to actin filaments and microtubules, the molecular mechanism by which septins assemble is not well-understood. Here, we report that in the filamentous fungus Aspergillus nidulans, four core septins form heteropolymeric complexes. AspE, a fifth septin lacking in unicellular yeasts, interacts with only one of the core septins, and only during multicellular growth. AspE is required for proper localization of three of the core septins, and requires this same subset of core septins for its own unique cortical localization. The DaspE mutant lacks developmentally-specific septin higher-order structures and shows reduced spore production and slow growth with low temperatures and osmotic stress. Our results show that at least two distinct septin heteropolymer populations co-exist in A. nidulans, and that while AspE is not a subunit of either heteropolymer, it is required for assembly of septin higher-order structures found in multicellular development.	[Hernandez-Rodriguez, Yainitza; Masuo, Shunsuke; Smith, Amy; Couto-Rodriguez, Mara; Momany, Michelle] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Johnson, Darryl; Orlando, Ron] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Momany, M (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	momany@plantbio.uga.edu	Momany, Michelle/L-2327-2016	Masuo, Shunsuke/0000-0002-0454-3315; Couto-Rodriguez, Mara/0000-0002-9799-0068; Momany, Michelle/0000-0001-7110-063X; Hernandez Rodriguez, Yainitza/0000-0001-8219-6235	NSF from the Developmental Systems Cluster [IOS1051730]; Japan Society for the Promotion of Sciences; NIH Integrated Technology Resource for Biomedical Glycomics [P41RR018502]; Institutional Program for Young Researcher Overseas Visits; Direct For Biological Sciences [1051730] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER	NSF from the Developmental Systems Cluster; Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH Integrated Technology Resource for Biomedical Glycomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Program for Young Researcher Overseas Visits; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NSF Grant IOS1051730 from the Developmental Systems Cluster (to MM), the Institutional Program for Young Researcher Overseas Visits by the Japan Society for the Promotion of Sciences (to SM) and the NIH Integrated Technology Resource for Biomedical Glycomics Grant P41RR018502 (to RO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berepiki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063843; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Cao LH, 2007, FEBS LETT, V581, P5526, DOI 10.1016/j.febslet.2007.10.032; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; Garcia G, 2011, J CELL BIOL, V195, P993, DOI 10.1083/jcb.201107123; Gilden J, 2010, CYTOSKELETON, V67, P477, DOI 10.1002/cm.20461; Gilden JK, 2012, J CELL BIOL, V196, P103, DOI 10.1083/jcb.201105127; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Hall PA, 2012, J PATHOL, V226, P287, DOI 10.1002/path.3024; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Hernandez-Rodriguez Y, 2012, CURR OPIN MICROBIOL; Hernandez-Rodriguez Y, 2012, EUKARYOT CELL, V11, P311, DOI 10.1128/EC.05164-11; Juvvadi PR, 2013, BIOCHEM BIOPH RES CO, V431, P547, DOI 10.1016/j.bbrc.2013.01.020; Juvvadi PR, 2011, BIOCHEM BIOPH RES CO, V405, P238, DOI 10.1016/j.bbrc.2011.01.017; Kim MS, 2012, J BIOL CHEM, V287, P30406, DOI 10.1074/jbc.M112.387464; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Lindsey R, 2010, EUKARYOT CELL, V9, P155, DOI 10.1128/EC.00269-09; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; McMurray MA, 2011, DEV CELL, V20, P540, DOI 10.1016/j.devcel.2011.02.004; Meseroll RA, 2012, MOL BIOL CELL; Momany M, 2001, GENETICS, V157, P969; Momany M, 2000, MICROBIOL-UK, V146, P3279, DOI 10.1099/00221287-146-12-3279; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Nishihama R, 2011, BIOL CHEM, V392, P681, DOI 10.1515/BC.2011.086; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Powell DW, 2004, MOL CELL BIOL, V24, P7249, DOI 10.1128/MCB.24.16.7249-7259.2004; Sellin ME, 2011, MOL BIOL CELL, V22, P3152, DOI 10.1091/mbc.E11-03-0253; Shin KS, 2009, EUKARYOT CELL, V8, P738, DOI 10.1128/EC.00368-08; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Spiliotis ET, 2012, TRAFFIC, V13, P195, DOI 10.1111/j.1600-0854.2011.01268.x; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Yamazaki T, 2013, PLANT J, V74, P605, DOI 10.1111/tpj.12147; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n; Zybailov BL, 2007, MOL BIOSYST, V3, P354, DOI 10.1039/b701483j	38	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92819	10.1371/journal.pone.0092819	http://dx.doi.org/10.1371/journal.pone.0092819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664283	Green Submitted, gold, Green Published			2022-12-25	WOS:000333459900119
J	Leibovitch, EC; Brunetto, GS; Caruso, B; Fenton, K; Ohayon, J; Reich, DS; Jacobson, S				Leibovitch, Emily C.; Brunetto, Giovanna S.; Caruso, Breanna; Fenton, Kaylan; Ohayon, Joan; Reich, Daniel S.; Jacobson, Steven			Coinfection of Human Herpesviruses 6A (HHV-6A) and HHV-6B as Demonstrated by Novel Digital Droplet PCR Assay	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; POLYMERASE-CHAIN-REACTION; CENTRAL-NERVOUS-SYSTEM; REAL-TIME PCR; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; HEALTHY-ADULTS; HUMAN-HERPESVIRUS-6 VARIANT; ACTIVE REPLICATION; DNA	The human herpesviruses HHV-6A and HHV-6B have been associated with various neurologic disorders partly due to the detection of elevated viral DNA levels in patients compared to controls. However the reported frequency of these viruses varies widely, likely reflecting differences in PCR methodologies used for detection. Digital droplet PCR (ddPCR) is a third generation PCR technology that enables the absolute quantification of target DNA molecules. Mounting evidence of the biological differences between HHV-6A and HHV-6B has led to their recent reclassification as separate species. As it is now especially relevant to investigate each virus, our objectives were to first design a multiplex HHV-6A and HHV-6B ddPCR assay and then to investigate the incidence of HHV-6A and HHV-6B coinfection in samples from healthy donors and patients with MS, a disease in which HHV-6 is thought to play a role. In our assessment of healthy donors, we observed a heretofore-underappreciated high frequency of coinfection in PBMC and serum, and found that our assay precisely detects both HHV6A and HHV-6B chromosomally integrated virus, which has important implications in clinical settings. Interestingly, upon comparing the saliva from MS patients and healthy donors, we detected a significantly elevated frequency of coinfection in MS saliva; increased detection of HHV-6A in MS patients is consistent with other studies suggesting that this viral species (thought to be more neurotropic than HHV-6B) is more prevalent among MS patients compared to healthy donors. As the biology and disease associations between these two viral species differ, identifying and quantifying both species of HHV-6 may provide clinically relevant information, as well as enhance our understanding of the roles of each in health and disease.	[Leibovitch, Emily C.; Brunetto, Giovanna S.; Caruso, Breanna; Fenton, Kaylan; Ohayon, Joan; Reich, Daniel S.; Jacobson, Steven] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; [Leibovitch, Emily C.] George Washington Univ, Sch Med & Hlth Sci, Inst Biomed Sci, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); George Washington University	Jacobson, S (corresponding author), NINDS, Neuroimmunol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	jacobsons@ninds.nih.gov	Reich, Daniel S./E-5701-2010	Reich, Daniel S./0000-0002-2628-4334; Caruso, Breanna/0000-0001-6163-1023; Caruso, Breanna/0000-0002-1519-8131; Manzano, Giovanna/0000-0002-9991-9222	NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002817, ZIANS002204] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the intramural research program of NINDS, and the funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors thank Sandy Chiang, John Chuckalovcak and Dr. Bo Song from Bio-Rad laboratories for technical support. No funding was received from Bio-Rad.	Aberle SW, 1996, J CLIN MICROBIOL, V34, P3223, DOI 10.1128/JCM.34.12.3223-3225.1996; Achour A, 2007, J CLIN VIROL, V38, P280, DOI 10.1016/j.jcv.2006.12.019; Ahlqvist J, 2005, J NEUROVIROL, V11, P384, DOI 10.1080/13550280591002379; Ahram M, 2009, ACTA NEUROL SCAND, V120, P430, DOI 10.1111/j.1600-0404.2009.01187.x; Akhyani N, 2000, J INFECT DIS, V182, P1321, DOI 10.1086/315893; Alvarez-Lafuente R, 2010, EUR J NEUROL, V17, P129, DOI 10.1111/j.1468-1331.2009.02758.x; Alvarez-Lafuente R, 2006, J CLIN VIROL, V37, pS24, DOI 10.1016/S1386-6532(06)70007-5; [Anonymous], 2012, VIRUS TAXONOMY; Arbuckle JH, 2010, P NATL ACAD SCI USA, V107, P5563, DOI 10.1073/pnas.0913586107; Ashshi AM, 2003, J INFECTION, V47, P59, DOI 10.1016/S0163-4453(03)00057-4; Bates M, 2009, J MED VIROL, V81, P779, DOI 10.1002/jmv.21455; Berti R, 2002, J NEUROVIROL, V8, P250, DOI 10.1080/13550280290049615-1; Boutolleau D, 2006, J CLIN VIROL, V35, P257, DOI 10.1016/j.jcv.2005.08.002; Carricart SE, 2002, MEDICINA-BUENOS AIRE, V62, P9; Caserta MT, 2004, J PEDIATR-US, V145, P478, DOI 10.1016/j.jpeds.2004.06.016; Cassina G, 2013, J VIROL METHODS, V189, P172, DOI 10.1016/j.jviromet.2013.01.018; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; CONE RW, 1993, J CLIN MICROBIOL, V31, P1262, DOI 10.1128/JCM.31.5.1262-1267.1993; Csoma E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-403; CUENDE JI, 1994, J MED VIROL, V43, P115, DOI 10.1002/jmv.1890430203; De Bolle L, 2005, J MED VIROL, V75, P76, DOI 10.1002/jmv.20240; DEWHURST S, 1993, J CLIN MICROBIOL, V31, P416, DOI 10.1128/JCM.31.2.416-418.1993; Dominguez G, 1999, J VIROL, V73, P8040, DOI 10.1128/JVI.73.10.8040-8052.1999; Donati D, 2005, J VIROL, V79, P9439, DOI 10.1128/JVI.79.15.9439-9448.2005; Flamand L, 2008, J CLIN MICROBIOL, V46, P2700, DOI 10.1128/JCM.00370-08; Fotheringham Julie, 2005, Herpes, V12, P4; FOX JD, 1990, LANCET, V336, P590, DOI 10.1016/0140-6736(90)93392-3; Gautheret-Dejean A, 2009, J CLIN VIROL, V46, P33, DOI 10.1016/j.jcv.2009.05.020; Harberts E, 2011, P NATL ACAD SCI USA, V108, P13734, DOI 10.1073/pnas.1105143108; Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12; Henrich TJ, 2012, J VIROL METHODS, V186, P68, DOI 10.1016/j.jviromet.2012.08.019; Hidaka Y, 1997, CLIN INFECT DIS, V24, P1022, DOI 10.1093/clinids/24.5.1022; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; HUANG LM, 1992, J MED VIROL, V38, P7, DOI 10.1002/jmv.1890380103; Hudnall SD, 2008, TRANSFUSION, V48, P1180, DOI 10.1111/j.1537-2995.2008.01685.x; JARRETT RF, 1990, J MED VIROL, V32, P73, DOI 10.1002/jmv.1890320113; Jaworska J, 2010, P NATL ACAD SCI USA, V107, P8369, DOI 10.1073/pnas.0909951107; Kelley K, 2013, J CLIN MICROBIOL; Kim JS, 2000, EUR NEUROL, V43, P170, DOI 10.1159/000008158; Lautenschlager I, 2012, TRANSPL INT, V25, P493, DOI 10.1111/j.1432-2277.2012.01443.x; Lee TH, 2001, TRANSFUSION, V41, P276, DOI 10.1046/j.1537-2995.2001.41020276.x; LEVY JA, 1990, LANCET, V335, P1047, DOI 10.1016/0140-6736(90)92628-U; Magalhaes IM, 2010, MEM I OSWALDO CRUZ, V105, P925, DOI 10.1590/S0074-02762010000700015; Morissette G, 2010, J VIROL, V84, P12100, DOI 10.1128/JVI.01169-10; Muta T, 2009, BONE MARROW TRANSPL, V43, P583, DOI 10.1038/bmt.2008.359; Osiowy C, 1998, J CLIN MICROBIOL, V36, P68, DOI 10.1128/JCM.36.1.68-72.1998; Pellett PE, 2012, REV MED VIROL, V22, P144, DOI 10.1002/rmv.715; Pereira CM, 2004, ARCH ORAL BIOL, V49, P1043, DOI 10.1016/j.archoralbio.2004.06.002; Razonable RR, 2002, J INFECT DIS, V185, P110, DOI 10.1086/324772; SANDHOFF T, 1991, MED MICROBIOL IMMUN, V180, P127; Shimazu Y, 2013, TRANSPL INFECT DIS, V15, P195, DOI 10.1111/tid.12049; Soldan SS, 2000, ANN NEUROL, V47, P306, DOI 10.1002/1531-8249(200003)47:3<306::AID-ANA5>3.0.CO;2-A; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Theodore WH, 2008, EPILEPSIA, V49, P1828, DOI 10.1111/j.1528-1167.2008.01699.x; Vinnard C, 2009, LIVER TRANSPLANT, V15, P1242, DOI 10.1002/lt.21816; Ward KN, 2005, J CLIN VIROL, V32, P183, DOI 10.1016/j.jcv.2004.11.008; Yao K, 2010, J MED VIROL, V82, P1669, DOI 10.1002/jmv.21861; Yao K, 2009, ANN NEUROL, V65, P257, DOI 10.1002/ana.21611; Yoshikawa T, 2000, J MED VIROL, V62, P52, DOI 10.1002/1096-9071(200009)62:1&lt;52::AID-JMV9&gt;3.0.CO;2-5; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207	61	43	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92328	10.1371/journal.pone.0092328	http://dx.doi.org/10.1371/journal.pone.0092328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663487	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900051
J	Batstone, RT; Laurich, JR; Salvo, F; Dufour, SC				Batstone, Rebecca T.; Laurich, Jason R.; Salvo, Flora; Dufour, Suzanne C.			Divergent Chemosymbiosis-Related Characters in Thyasira cf. gouldi (Bivalvia: Thyasiridae)	PLOS ONE			English	Article							EDULIS SPECIES COMPLEX; MOLECULAR PHYLOGENY; EVOLUTIONARY RELATIONSHIPS; SYMBIOTIC BACTERIA; SOUTHWEST ENGLAND; CLAMS MOLLUSCA; RIBOSOMAL-RNA; COLD SEEP; VESICOMYIDAE; GASTROPODA	Within the marine bivalve family Thyasiridae, some species have bacterial chemosymbionts associated with gill epithelial cells while other species are asymbiotic. Although the abundance of symbionts in a particular thyasirid species may vary, the structure of their gills (i.e., their frontal-abfrontal thickening) does not. We examined gill structure in a species tentatively identified as Thyasira gouldi from a Northwest Atlantic fjord (Bonne Bay, Newfoundland) and found remarkable differences among specimens. Some individuals had thickened gill filaments with abundant symbionts, while others had thin filaments and lacked symbionts. We could differentiate symbiotic and asymbiotic specimens based on the size and outline of their shell as well as 18S rRNA, 28S rRNA and CO1 sequences. The wide morphological, genetic and symbiosis-related disparity described herein suggests that chemosymbiosis may influence host divergence, and that Thyasira gouldi forms a cryptic species complex.	[Batstone, Rebecca T.; Laurich, Jason R.; Salvo, Flora; Dufour, Suzanne C.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada	Memorial University Newfoundland	Dufour, SC (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	sdufour@mun.ca		Salvo, Flora/0000-0002-5275-2170; Batstone, Rebecca/0000-0002-2530-8998	Natural Sciences and Engineering Research Council of Canada; Newfoundland and Labrador Research and Development Corporation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Newfoundland and Labrador Research and Development Corporation	This project was funded by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant: SCD and Undergraduate Student Research Award: JRL), and Newfoundland and Labrador Research and Development Corporation (Ignite R&D Grant: SCD and Ocean Industries Student Research Award: RTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blacknell W.M., 1974, Thalassia Jugosl, V10, P23; Brissac T, 2011, MAR ECOL-EVOL PERSP, V32, P198, DOI 10.1111/j.1439-0485.2010.00413.x; Cannuel R, 2009, BIOL BULL-US, V217, P173, DOI 10.1086/BBLv217n2p173; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheesman SE, 2011, P NATL ACAD SCI USA, V108, P4570, DOI 10.1073/pnas.1000072107; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Coan EV, 2000, SANTA BARBARA MUSEUM; Conan Gerard Y., 1996, P INT S BIOL MAN EC P INT S BIOL MAN EC, P59; CRAMPTON JS, 1995, LETHAIA, V28, P179, DOI 10.1111/j.1502-3931.1995.tb01611.x; DANDO PR, 1993, MAR ECOL PROG SER, V92, P151, DOI 10.3354/meps092151; DANDO PR, 1986, J MAR BIOL ASSOC UK, V66, P915, DOI 10.1017/S0025315400048529; Dando PR, 2004, MAR ECOL PROG SER, V280, P181, DOI 10.3354/meps280181; Delgado-Gonzalo R, 2012, IEEE T IMAGE PROCESS, V21, P1258, DOI 10.1109/TIP.2011.2169975; Distel DL, 2011, MOL PHYLOGENET EVOL, V61, P245, DOI 10.1016/j.ympev.2011.05.019; DISTEL DL, 1992, J BACTERIOL, V174, P6317, DOI 10.1128/JB.174.19.6317-6320.1992; Dufour SC, 2005, BIOL BULL-US, V208, P200, DOI 10.2307/3593152; Dufour SC, 2003, NATURE, V426, P65, DOI 10.1038/nature02095; Dufour SC, 2006, MAR ECOL PROG SER, V320, P185, DOI 10.3354/meps320185; Duperron S, 2012, BIOGEOSCIENCES DISCU, V9, P16815, DOI DOI 10.5194/BGD-9-16815-2012; Fujiwara Y, 2001, MAR ECOL PROG SER, V214, P151, DOI 10.3354/meps214151; Gardner JPA, 1996, MAR BIOL, V125, P385, DOI 10.1007/BF00346319; GARDNER JPA, 1994, BIOCHEM SYST ECOL, V22, P1, DOI 10.1016/0305-1978(94)90109-0; Goffredi SK, 2002, MAR ECOL PROG SER, V225, P227, DOI 10.3354/meps225227; Goffredi SK, 2003, MAR BIOL, V142, P311, DOI 10.1007/s00227-002-0941-3; Gould A.A., 1870, REPORT INVERTEBRATA, P524; Gould A.A., 1841, REPORT INVERTEBRATA, DOI [10.5962/bhl.title.17646, DOI 10.5962/BHL.TITLE.17646]; Gros O, 1998, INVERTEBR REPROD DEV, V34, P219, DOI 10.1080/07924259.1998.9652656; Gros O, 1996, APPL ENVIRON MICROB, V62, P2324, DOI 10.1128/AEM.62.7.2324-2330.1996; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Layton K, 2012, THESIS U GUELPH CANA; Le Pennec M, 1988, J SHELLFISH RES, V7, P483; Littlewood DTJ, 2000, MOL PHYLOGENET EVOL, V16, P449, DOI 10.1006/mpev.2000.0802; Mikkelsen PM, 2011, AM MALACOL BULL, V29, P217, DOI 10.4003/006.029.0212; MONTGOMERY MK, 1994, DEVELOPMENT, V120, P1719; Neumann D, 2003, BIOL BULL-US, V205, P73, DOI 10.2307/1543447; Nussbaumer AD, 2006, NATURE, V441, P345, DOI 10.1038/nature04793; Ockelmann K.W, 1958, MEDD GRONL, V122, P1; Oliver PG, 2002, STUDIES MARINE BIODI; PAYNE CM, 1991, PHILOS T ROY SOC B, V334, P481, DOI 10.1098/rstb.1991.0128; SOUTHWARD EC, 1986, J MAR BIOL ASSOC UK, V66, P889, DOI 10.1017/S0025315400048517; Steiner G, 2000, GEOL SOC SPEC PUBL, V177, P11, DOI 10.1144/GSL.SP.2000.177.01.02; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JD, 2005, SYST BIODIVERS, V3, P281, DOI 10.1017/S1477200005001672; Taylor JD, 2007, J MAR BIOL ASSOC UK, V87, P565, DOI 10.1017/S0025315407054409; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VRIJENHOEK RC, 1994, DEEP-SEA RES PT I, V41, P1171, DOI 10.1016/0967-0637(94)90039-6; Williams ST, 2004, J MOLLUS STUD, V70, P187, DOI 10.1093/mollus/70.2.187; Williams ST, 2003, MOL PHYLOGENET EVOL, V28, P60, DOI 10.1016/S1055-7903(03)00038-1; Winnepenninckx BMH, 1998, J MOL EVOL, V47, P586, DOI 10.1007/PL00006415; Wlodarska-Kowalczuk M, 2007, POLAR RES, V26, P48, DOI 10.1111/j.1751-8369.2007.00003.x	53	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92856	10.1371/journal.pone.0092856	http://dx.doi.org/10.1371/journal.pone.0092856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658402	gold, Green Published, Green Submitted			2022-12-25	WOS:000333355300136
J	Colares, VS; Titan, SMDO; Pereira, ADC; Malafronte, P; Cardena, MM; Santos, S; Santos, PC; Fridman, C; Barros, RT; Woronik, V				Colares, Vinicius Sardao; Titan, Silvia Maria de Oliveira; Pereira, Alexandre da Costa; Malafronte, Patricia; Cardena, Mari M.; Santos, Sidney; Santos, Paulo C.; Fridman, Cintia; Barros, Rui Toledo; Woronik, Viktoria			MYH9 and APOL1 Gene Polymorphisms and the Risk of CKD in Patients with Lupus Nephritis from an Admixture Population	PLOS ONE			English	Article							STAGE RENAL-DISEASE; KIDNEY-DISEASE; AFRICAN; ERYTHEMATOSUS; VARIANTS; PREDNISONE; EXPRESSION; ANCESTRY	MYH9 polymorphisms have been described to be associated with the risk of CKD in non-diabetic nephropathy, HIV nephropathy and FSGS. Predominating in black descendants, MHY9 genetic variants could partially explain the excess risk of CKD associated with African ancestry. However, recent data suggests that APOL1 gene co-segregate with MYH9, and could be the gene truly associated with CKD risk. In this study, we evaluated the role of MYH9 and APOL1 gene polymorphisms in the risk of CKD in Brazilian patients with lupus nephritis (LN). A retrospective analysis of 196 LN patients was done. MYH9 rs4821480, rs2032487, rs4821481 and rs3752462, APOL 1rs73885319, rs16996616, rs60910145, rs71785313, and APOL3 rs11089781 gene polymorphisms were determined. Genetic ancestry was ascertained both by autossomal ancestry and mitochondrial haplogroup. Primary outcome was defined as doubling of serum creatinine (DC) or end stage renal disease (ESRD). Sixty-two patients presented the PO. In our population, MYH9 and APOL1 were not in LD. None APOL polymorphism was associated with the PO, whereas rs3752462 MYH9 polymorphism showed a positive association (HR3.72, 95% CI 1.47-9.38, p = 0.005). When we analyzed the MYH9 E1 haplotype, the GCCT carriers (1 or 2 alelles present in 29.7% in the PO group vs. 18.5% in controls) showed a significant association to the risk of PO, even after adjustments for baseline estimated creatinine clearance and autossomal ancestry (HR 2.0, 95% CI 1.2-3.4, p = 0.01). Our results show that in our population MYH9, but not APOL1, gene polymorphisms confer an increased risk of CKD in LN patients, independently of race.	[Colares, Vinicius Sardao; Titan, Silvia Maria de Oliveira; Malafronte, Patricia; Barros, Rui Toledo; Woronik, Viktoria] Univ Sao Paulo, Sch Med, Hosp Clin, Div Nephrol, Sao Paulo, Brazil; [Pereira, Alexandre da Costa; Santos, Paulo C.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Mol Cardiol Lab, Sao Paulo, Brazil; [Cardena, Mari M.; Fridman, Cintia] Univ Sao Paulo, Sch Med, Dept Legal Med Eth & Occupat Hlth, Sao Paulo, Brazil; [Santos, Sidney] Fed Univ Para, Lab Human Genet & Med, BR-66059 Belem, Para, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Para	Woronik, V (corresponding author), Univ Sao Paulo, Sch Med, Hosp Clin, Div Nephrol, Sao Paulo, Brazil.	viktoriaw@usp.br	Fridman, Cintia/G-1837-2012; Fridman, Cintia/E-2657-2013; Woronik, Viktoria/AAY-4763-2020; Pereira, Alexandre/HHN-1038-2022; Santos, Paulo CJL/D-1367-2012	Fridman, Cintia/0000-0003-2430-4888; Woronik, Viktoria/0000-0002-8318-142X	FAPESP	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support: FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon GS, 1999, LUPUS, V8, P197, DOI 10.1191/096120399678847704; AUSTIN HA, 1986, NEW ENGL J MED, V314, P614, DOI 10.1056/NEJM198603063141004; Behar DM, 2006, AM J KIDNEY DIS, V47, P88, DOI 10.1053/j.ajkd.2005.09.023; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bostrom MA, 2010, CLIN J AM SOC NEPHRO, V5, P1107, DOI 10.2215/CJN.08721209; Buhaescu I, 2007, SEMIN ARTHRITIS RHEU, V36, P224, DOI 10.1016/j.semarthrit.2006.09.002; Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005; Chen Z, 2012, J AM SOC NEPHROL, V23, p136A; Churg J., 1995, RENAL DIS CLASSIFICA, V2nd ed; Estrella MM, 2012, J AM SOC NEPHROL, V23, p248A; Franceschini N, 2010, HUM GENET, V127, P295, DOI 10.1007/s00439-009-0769-8; Freedman BI, 2010, AM J NEPHROL, V32, P66, DOI 10.1159/000314688; Freedman BI, 2009, KIDNEY INT, V75, P736, DOI 10.1038/ki.2008.701; Genovese G, 2013, NAT REV NEPHROL, V9, P240, DOI 10.1038/nrneph.2013.34; Genovese G, 2010, KIDNEY INT, V78, P698, DOI 10.1038/ki.2010.251; Hays T, 2012, AIDS, V26, P797, DOI 10.1097/QAD.0b013e328351f6cf; Hoy WE, 2012, J AM SOC NEPHROL, V23, p77A; Johnstone DB, 2011, MOL CELL BIOL, V31, P2162, DOI 10.1128/MCB.05234-11; Kanji Z, 2011, J AM SOC NEPHROL, V22, P2091, DOI 10.1681/ASN.2010121234; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Larsen CP, 2013, J AM SOC NEPHROL, V24, P722, DOI 10.1681/ASN.2012121180; LEVEY AS, 1992, ANN INTERN MED, V116, P114, DOI 10.7326/0003-4819-116-2-114; Lin CP, 2012, GENES IMMUN, V13, P232, DOI 10.1038/gene.2011.82; Matsha TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052529; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Muller T, 2011, KIDNEY INT, V80, P1055, DOI 10.1038/ki.2011.256; O'Toole JF, 2012, J AM SOC NEPHROL, V23, p323A; Papeta N, 2011, J AM SOC NEPHROL, V22, P1991, DOI 10.1681/ASN.2011040434; Sanchez E, 2012, ARTHRITIS RHEUM-US, V64, P3687, DOI 10.1002/art.34650; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853	35	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e87716	10.1371/journal.pone.0087716	http://dx.doi.org/10.1371/journal.pone.0087716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658608	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300002
J	Gonzalez-Feliciano, JA; Hernandez-Perez, M; Estrella, LA; Colon-Lopez, DD; Lopez, A; Martinez, M; Mauras-Rivera, KR; Lasalde, C; Martinez, D; Araujo-Perez, F; Gonzalez, CI				Gonzalez-Feliciano, Jose A.; Hernandez-Perez, Marimar; Estrella, Luis A.; Colon-Lopez, Daisy D.; Lopez, Armando; Martinez, Marina; Mauras-Rivera, Kirla R.; Lasalde, Clarivel; Martinez, Daviana; Araujo-Perez, Felix; Gonzalez, Carlos I.			The Role of HuR in the Post-Transcriptional Regulation of Interleukin-3 in T Cells	PLOS ONE			English	Article							BINDING PROTEIN HUR; MESSENGER-RNA TURNOVER; AU-RICH ELEMENT; STABILIZING FACTOR HUR; ELAV-LIKE PROTEIN; TRANSLATIONAL CONTROL; HNRNP D; IL-3; EXPRESSION; GENE	Human Interleukin-3 (IL-3) is a lymphokine member of a class of transiently expressed mRNAs harboring Adenosine/Uridine-Rich Elements (ARE) in their 3' untranslated regions (3'-UTRs). The regulatory effects of AREs are often mediated by specific ARE-binding proteins (ARE-BPs). In this report, we show that the human IL-3 3'-UTR plays a post-transcriptional regulation role in two human transformed cell lines. More specifically, we demonstrate that the hIL-3 3'-UTR represses the translation of a luciferase reporter both in HeLa and Jurkat T-cells. These results also revealed that the hIL-3 3'-UTR-mediated translational repression is exerted by an 83 nt region comprised mainly by AREs and some non-ARE sequences. Moreover, electrophoretic mobility shift assays (EMSAs) and UV-crosslinking analysis show that this hIL-3 ARE-rich region recruits five specific protein complexes, including the ARE-BPs HuR and TIA-1. HuR binding to this ARE-rich region appears to be spatially modulated during T-cell activation. Together, these results suggest that HuR recognizes the ARE-rich region and plays a role in the IL-3 3'-UTR-mediated post-transcriptional control in T-cells.	[Gonzalez-Feliciano, Jose A.; Estrella, Luis A.; Colon-Lopez, Daisy D.; Lopez, Armando; Mauras-Rivera, Kirla R.; Lasalde, Clarivel; Martinez, Daviana; Araujo-Perez, Felix; Gonzalez, Carlos I.] Univ Puerto Rico Rio Piedras, Coll Nat Sci, Dept Biol, San Juan, PR 00931 USA; [Hernandez-Perez, Marimar; Martinez, Marina; Gonzalez, Carlos I.] Univ Puerto Rico Med Sci, Dept Biochem, San Juan, PR USA; [Gonzalez, Carlos I.] Mol Sci Res Bldg, San Juan, PR USA	University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Gonzalez, CI (corresponding author), Univ Puerto Rico Rio Piedras, Coll Nat Sci, Dept Biol, San Juan, PR 00931 USA.	cigonzal@gmail.com	López, Daisy Colón/L-7978-2019; Martínez Filgueira, Marina/GZG-8145-2022; Colón-López, Daisy/E-9715-2019; Gonzalez, Carlos/V-7628-2019	López, Daisy Colón/0000-0002-3920-310X; Colón-López, Daisy/0000-0002-3920-310X; 	National Institutes of Health [GM008102-3052, KO1 HL-04355-05, U54 CA96297, FIPI, PES-UPR, PR-LSAMP, 2R25GM61151]; National Center for Research Resources, a component of the National Institutes of Health [P20 RR 016174]; NATIONAL CANCER INSTITUTE [U54CA096297] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U13RR016174] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL004355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, R25GM061151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health to CIG (GM008102-3052, KO1 HL-04355-05, U54 CA96297, FIPI, PES-UPR), and JGF (PR-LSAMP and RISE Award 2R25GM61151). This publication was made possible by Grant P20 RR 016174 from the National Center for Research Resources, a component of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Atasoy U, 1998, J CELL SCI, V111, P3145; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Benjamin D, 2006, MOL BIOSYST, V2, P561, DOI 10.1039/b609448a; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; BURGER H, 1990, BLOOD, V76, P2229; Casolaro V, 2008, J ALLERGY CLIN IMMUN, V121, P853, DOI 10.1016/j.jaci.2007.12.1166; Chang N, 2010, MOL CELL BIOL, V30, P3875, DOI 10.1128/MCB.00169-10; Chen XN, 2008, AM J PSYCHIAT, V165, P13, DOI 10.1176/appi.ajp.2007.07121868; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070; Dentelli P, 2011, ONCOGENE, V30, P4930, DOI 10.1038/onc.2011.204; Dickson AM, 2012, J BIOL CHEM, V287, P36229, DOI 10.1074/jbc.M112.371203; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Dorsey JF, 2002, LEUKEMIA, V16, P1589, DOI 10.1038/sj.leu.2402678; DORSSERS L, 1987, GENE, V55, P115, DOI 10.1016/0378-1119(87)90254-X; Ernst J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007469; Espel E, 2005, SEMIN CELL DEV BIOL, V16, P59, DOI 10.1016/j.semcdb.2004.11.008; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Giuliani N, 2006, BLOOD, V107, P841, DOI 10.1182/blood-2005-07-2719; GUBA SC, 1989, J CLIN INVEST, V84, P1701, DOI 10.1172/JCI114352; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Kandasamy K, 2005, J BIOL CHEM, V280, P1931, DOI 10.1074/jbc.M405937200; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Lee JW, 2004, BLOOD, V103, P2308, DOI 10.1182/blood-2003-06-1992; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; LOPEZ AF, 1988, BLOOD, V72, P1797; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Ming XF, 2001, MOL CELL BIOL, V21, P5778, DOI 10.1128/MCB.21.17.5778-5789.2001; Morris KR, 2008, J INTERF CYTOK RES, V28, P435, DOI 10.1089/jir.2007.0051; Mou Z, 2012, FEBS LETT; Mukherjee D, 2004, ANAL RNA EXONUCLEOCY, P195; NIEMEYER CM, 1989, BLOOD, V73, P945; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; OTSUKA T, 1988, J IMMUNOL, V140, P2288; Raghavan A, 2001, J BIOL CHEM, V276, P47958, DOI 10.1074/jbc.M109511200; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; Rodrigues L, 2006, J CLIN LAB ANAL, V20, P75, DOI 10.1002/jcla.20104; RYAN GR, 1991, BLOOD, V77, P1195; Seko Y, 2004, J BIOL CHEM, V279, P33359, DOI 10.1074/jbc.M312306200; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; STOECKLIN G, 1994, J BIOL CHEM, V269, P28591; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Vo DT, 2012, MOL CANCER RES, V10, P143, DOI 10.1158/1541-7786.MCR-11-0208; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; Wang XY, 1998, LEUKEMIA, V12, P520, DOI 10.1038/sj.leu.2400975; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; Yarovinsky TO, 2006, J IMMUNOL, V177, P4426, DOI 10.4049/jimmunol.177.7.4426; YMER S, 1985, NATURE, V317, P255, DOI 10.1038/317255a0; Zeoli A, 2008, BLOOD, V112, P350, DOI 10.1182/blood-2007-12-128215; Zou TT, 2006, J BIOL CHEM, V281, P19387, DOI 10.1074/jbc.M602344200	59	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92457	10.1371/journal.pone.0092457	http://dx.doi.org/10.1371/journal.pone.0092457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658545	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300084
J	Ma, JL; Wang, XJ; Wang, YT; Zhao, YX; Gao, M; Li, XQ				Ma, Jinling; Wang, Xiujie; Wang, Yutang; Zhao, Yuexiang; Gao, Meng; Li, Xiaoqian			The Relationship between Glycated Hemoglobin and Complexity of Coronary Artery Lesions among Older Patients with Diabetes Mellitus	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; 1-YEAR CLINICAL-OUTCOMES; SIROLIMUS-ELUTING STENT; PREDICTS ALL-CAUSE; SYNTAX SCORE; CARDIOVASCULAR-DISEASE; GLYCOSYLATED HEMOGLOBIN; INTERVENTION; MORTALITY; RISK	Objectives: Glycated hemoglobin (HbA1c) is associated with an increased risk of cardiovascular disease. The aim of this study was to examine the relationship between HbA1c levels and the complexity of coronary artery lesions among the older patients with diabetes mellitus (DM). Methods: This retrospective study enrolled a total of 3805 consecutive type 2 DM patients aged 60 years and older who underwent their first elective coronary angiography and had their HbA1c levels measured at the Chinese PLA General Hospital between December 2005 and December 2012. The complexity of the coronary artery lesions was evaluated using the Syntax score, and the subjects were divided into three groups according to their HbA1c levels. Logistic regression and Pearson correlation were used to analyze the association between the measured HbA1c levels and Syntax score. Results: The mean age was 72.3 +/- 10.6 years. The higher HbA1c levels were significantly associated with higher Syntax score (p<0.001). The unadjusted correlation coefficient of HbA1c levels and the Syntax score was 0. 371 (p<0.001). In addition, the higher HbA1c categories were able to independently predict patients with intermediate or high Syntax score (Syntax score >= 23) after adjustment for age, sex, hypertension, smoking, dyslipidemia and creatinine levels in the logistic regression analysis. Conclusion: HbA1c is significantly associated with the complexity of coronary lesions among older patients with DM. A higher HbA1c value is an independent predictor of the prevalence of complex coronary lesions. Further prospective multicentre studies are needed to confirm this finding.	[Ma, Jinling; Wang, Yutang; Zhao, Yuexiang; Gao, Meng; Li, Xiaoqian] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China; [Wang, Xiujie] Zhaoyuan Peoples Hosp, Dept Radiol, Shandong, Peoples R China	Chinese People's Liberation Army General Hospital	Wang, YT (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China.	wangyutang301@163.com						Brewer N, 2008, DIABETES CARE, V31, P1144, DOI 10.2337/dc07-2374; Capodanno D, 2012, INT J CARDIOL, V159, P165, DOI 10.1016/j.ijcard.2012.01.049; Capodanno D, 2009, CIRC-CARDIOVASC INTE, V2, P302, DOI 10.1161/CIRCINTERVENTIONS.108.847137; Fillipon NML, 2012, CLIN CARDIOL, V35, P565, DOI 10.1002/clc.22028; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P645, DOI 10.1016/j.jcin.2011.02.018; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P432, DOI 10.1016/j.jcin.2011.01.008; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P66, DOI 10.1016/j.jcin.2010.09.017; Gerstein HC, 2008, ARCH INTERN MED, V168, P1699, DOI 10.1001/archinte.168.15.1699; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Ikeda N, 2012, J ATHEROSCLER THROMB, V19, P1066, DOI 10.5551/jat.13722; Khaw KT, 2006, CURR OPIN LIPIDOL, V17, P637, DOI 10.1097/MOL.0b013e3280106b95; Lazzeri C, 2011, INT J CARDIOL, V151, P250, DOI 10.1016/j.ijcard.2011.06.077; Levitan EB, 2008, DIABETOLOGIA, V51, P267, DOI 10.1007/s00125-007-0882-y; Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi199; Martins RA, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-13; McNeely MJ, 2009, DIABETES CARE, V32, P1727, DOI 10.2337/dc09-0074; Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nishimura R, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-58; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pacilli A, 2013, ATHEROSCLEROSIS, V228, P247, DOI 10.1016/j.atherosclerosis.2013.02.010; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pradhan AD, 2007, AM J MED, V120, P720, DOI 10.1016/j.amjmed.2007.03.022; Rizza S, 2010, ATHEROSCLEROSIS, V212, P316, DOI 10.1016/j.atherosclerosis.2010.05.017; Rohlfing C, 2002, CLIN CHEM, V48, P1116; Saely CH, 2008, ATHEROSCLEROSIS, V199, P317, DOI 10.1016/j.atherosclerosis.2007.11.020; Saleh N, 2012, DIABETOLOGIA, V55, P2109, DOI 10.1007/s00125-012-2565-6; Sarwar N, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000278; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Serruys PW, 2010, J AM COLL CARDIOL, V55, P1093, DOI 10.1016/j.jacc.2009.11.049; Serruys PW, 2009, EUROINTERVENTION, V5, P50, DOI 10.4244/EIJV5I1A9; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Sianos Georgios, 2005, EuroIntervention, V1, P219; Silbernagel G, 2012, ATHEROSCLEROSIS, V221, P551, DOI 10.1016/j.atherosclerosis.2012.01.011; Silbernagel G, 2011, DIABETES CARE, V34, P1355, DOI 10.2337/dc10-2010; Singla A, 2012, J INTERV CARDIOL, V25, P262, DOI 10.1111/j.1540-8183.2011.00715.x; Valgimigli M, 2007, AM J CARDIOL, V99, P1072, DOI 10.1016/j.amjcard.2006.11.062; van Gaal WJ, 2009, INT J CARDIOL, V135, P60, DOI 10.1016/j.ijcard.2008.03.033; Wykrzykowska JJ, 2010, J AM COLL CARDIOL, V56, P272, DOI 10.1016/j.jacc.2010.03.044; Yun CH, 2009, ATHEROSCLEROSIS, V205, P481, DOI 10.1016/j.atherosclerosis.2009.01.015; Zhang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042551; Zhao M, 2013, INT J CARDIOL, V168, P3273, DOI 10.1016/j.ijcard.2013.04.136	46	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91972	10.1371/journal.pone.0091972	http://dx.doi.org/10.1371/journal.pone.0091972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658008	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300047
J	Martelli, D; Artoni, F; Monaco, V; Sabatini, AM; Micera, S				Martelli, Dario; Artoni, Fiorenzo; Monaco, Vito; Sabatini, Angelo Maria; Micera, Silvestro			Pre-Impact Fall Detection: Optimal Sensor Positioning Based on a Machine Learning Paradigm	PLOS ONE			English	Article							NEURONAL COORDINATION; RISK-FACTORS; MECHANISMS; PREVALENCE; PREVENTION; LOCOMOTION; RESPONSES; RECOVERY; SYSTEM	The aim of this study was to identify the best subset of body segments that provides for a rapid and reliable detection of the transition from steady walking to a slipping event. Fifteen healthy young subjects managed unexpected perturbations during walking. Whole-body 3D kinematics was recorded and a machine learning algorithm was developed to detect perturbation events. In particular, the linear acceleration of all the body segments was parsed by Independent Component Analysis and a Neural Network was used to classify walking from unexpected perturbations. The Mean Detection Time (MDT) was 3516123 ms with an Accuracy of 95.4%. The procedure was repeated with data related to different subsets of all body segments whose variability appeared strongly influenced by the perturbation-induced dynamic modifications. Accordingly, feet and hands accounted for most data information and the performance of the algorithm were slightly reduced using their combination. Results support the hypothesis that, in the framework of the proposed approach, the information conveyed by all the body segments is redundant to achieve effective fall detection, and suitable performance can be obtained by simply observing the kinematics of upper and lower distal extremities. Future studies are required to assess the extent to which such results can be reproduced in older adults and in different experimental conditions.	[Martelli, Dario; Artoni, Fiorenzo; Monaco, Vito; Sabatini, Angelo Maria; Micera, Silvestro] Scuola Superiore Santanna, BioRobot Inst, Pisa, Italy; [Micera, Silvestro] Swiss Fed Inst Technol Lausanne EPFL, Ctr Neuroprosthet, Translat Neural Engn Lab, Lausanne, Switzerland	Scuola Superiore Sant'Anna; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Monaco, V (corresponding author), Scuola Superiore Santanna, BioRobot Inst, Pisa, Italy.	v.monaco@sssup.it	Micera, Silvestro/AAD-6630-2021; Artoni, Fiorenzo/ABB-9343-2020; artoni, firoenzo/K-8948-2016; MONACO, Vito/AAD-6610-2021	Artoni, Fiorenzo/0000-0002-0967-6643; artoni, firoenzo/0000-0002-0967-6643; Martelli, Dario/0000-0002-1903-5372	Italian Ministry of Education and Research (MIUR); EC [GA 341 225929, ICT 287894, CIP-ICT-PSP-2011-5-297225]	Italian Ministry of Education and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); EC(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Italian Ministry of Education and Research (MIUR) through the relevant interest national project (PRIN) "A quantitative and multi factorial approach for estimating and preventing the risk of falls in the elderly people'' and by the following FP7 EC projects: CLONS "CLOsed-loop Neural prostheses for vestibular disorders'' (GA 341 225929); CYBERLEGs "The CYBERnetic LowEr-Limb CoGnitive Ortho-prosthesis'' (ICT 287894); I-DONT-FALL "Integrated prevention and Detection sOlutioNs Tailored to the population and Risk Factors associated with FALLs'' (CIP-ICT-PSP-2011-5-297225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Mostafa Y. S., 2012, AMLBOOK; Aziz O, 2011, IEEE T NEUR SYS REH, V19, P670, DOI 10.1109/TNSRE.2011.2162250; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; BERGER W, 1984, J PHYSIOL-LONDON, V357, P109, DOI 10.1113/jphysiol.1984.sp015492; Bourke AK, 2008, MED ENG PHYS, V30, P937, DOI 10.1016/j.medengphy.2007.12.003; Bourke AK, 2008, MED ENG PHYS, V30, P84, DOI 10.1016/j.medengphy.2006.12.001; Colombo R, 2008, NEUROREHAB NEURAL RE, V22, P50, DOI 10.1177/1545968307303401; Davidson ME, 2004, SYSTEM PROTECTION FA; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; DIETZ V, 1987, J PHYSIOL-LONDON, V386, P149, DOI 10.1113/jphysiol.1987.sp016527; Dietz V, 2001, EUR J NEUROSCI, V14, P1906, DOI 10.1046/j.0953-816x.2001.01813.x; ENG JJ, 1994, EXP BRAIN RES, V102, P339; Grip H, 2003, IEEE T INF TECHNOL B, V7, P412, DOI 10.1109/TITB.2003.821322; Kangas M, 2008, GAIT POSTURE, V28, P285, DOI 10.1016/j.gaitpost.2008.01.003; Liu J, 2009, GAIT POSTURE, V30, P276, DOI 10.1016/j.gaitpost.2009.04.005; Lockhart TE, 2005, HUM FACTORS, V47, P708, DOI 10.1518/001872005775571014; Lockhart TE, 2006, FALL SENSING SYSTEMS; Lockhart TE, 2008, J ELECTROMYOGR KINES, V18, P205, DOI 10.1016/j.jelekin.2007.06.006; Luciani LB, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-51; Maki BE, 1996, J BIOMECH, V29, P343, DOI 10.1016/0021-9290(95)00053-4; Marigold DS, 2009, NEUROSCIENTIST, V15, P36, DOI 10.1177/1073858408322674; Martelli D., 2013, IEEE T BIOMED ENG; Masud T, 2001, AGE AGEING, V30, P3, DOI 10.1093/ageing/30.suppl_4.3; Miller WC, 2001, ARCH PHYS MED REHAB, V82, P1031, DOI 10.1053/apmr.2001.24295; Nyan MN, 2008, J BIOMECH, V41, P2297, DOI 10.1016/j.jbiomech.2008.03.042; Nyan MN, 2006, MED ENG PHYS, V28, P842, DOI 10.1016/j.medengphy.2005.11.008; Nyan MN, 2008, J BIOMECH, V41, P3475, DOI 10.1016/j.jbiomech.2008.08.009; Stolze H, 2004, J NEUROL, V251, P79, DOI 10.1007/s00415-004-0276-8; Vaughan CL, 2005, GAIT POSTURE, V21, P350, DOI 10.1016/j.gaitpost.2004.01.011; Wu G, 2000, J BIOMECH, V33, P1497, DOI 10.1016/S0021-9290(00)00117-2; Wu G, 2008, IEEE T NEUR SYS REH, V16, P178, DOI 10.1109/TNSRE.2007.916282; Zatsiorsky VM, 1990, CONT PROBLEMS BIOMEC, P272; Zhang F, 2011, IEEE T NEUR SYS REH, V19, P567, DOI 10.1109/TNSRE.2011.2161888; Zhao G, SENSORS BASEL, V12, P15338	35	17	17	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92037	10.1371/journal.pone.0092037	http://dx.doi.org/10.1371/journal.pone.0092037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658093	gold, Green Published, Green Submitted			2022-12-25	WOS:000333355300050
J	Rahman, MA; Sundaram, K; Mitra, S; Gavrilin, MA; Wewers, MD				Rahman, Mohd. Akhlakur; Sundaram, Kruthika; Mitra, Srabani; Gavrilin, Mikhail A.; Wewers, Mark D.			Receptor Interacting Protein-2 Plays a Critical Role in Human Lung Epithelial Cells Survival in Response to Fas-Induced Cell-Death	PLOS ONE			English	Article							CARD15/NOD2 MUTATIONAL ANALYSIS; DOMAIN-CONTAINING PROTEIN; MEDIATED APOPTOSIS; TYROSINE KINASE; IN-VIVO; PHOSPHORYLATION; LIGAND; SUSCEPTIBILITY; INFLAMMASOME; ACTIVATION	Lung epithelial cell death is critical to the lung injury that occurs in the acute respiratory distress syndrome. It is known that FasL plays a prominent role in this lung cell death pathway and may work in part through activation of the receptor interacting protein-2 (RIP2). RIP2 is serine/threonine kinase with a C-terminal caspase activation and recruitment domain (CARD). This CARD contains a highly conserved, predicted tyrosine phosphorylation site. Thus, involvement of tyrosine phosphorylation in the CARD domain of RIP2 may play a critical role in Fas-mediated apoptosis in the human lung immune system. To test this hypothesis, human lung epithelial cells (BEAS-2B) were induced to undergo cell death in response to the Fas agonist antibody CH11 with and without manipulation of endogenous RIP2 concentrations. We show that CH11 increases lung epithelial cell death in a dose-dependent manner as determined by LDH release and nuclear condensation. Fas-induced LDH release was inhibited by RIP2 knock-down. Reduced levels of RIP2 in BEAS-2B cells after treatment with RIP2 siRNA were confirmed by immunoblot. Overexpression of RIP2 in BEAS-2B cells synergized with Fas ligand-induced LDH release in a dose-dependent manner. Finally, mutation of the tyrosine phosphorylation site in CARD of RIP2 protected BEAS-2B cells from Fas ligand induced cell death. Thus RIP2's CARD tyrosine phosphorylation may represent a new therapeutic target to promote the survival of human lung epithelial cells in disorders that lead to acute lung injury and ARDS.	[Rahman, Mohd. Akhlakur; Sundaram, Kruthika; Mitra, Srabani; Gavrilin, Mikhail A.; Wewers, Mark D.] Ohio State Univ, Dept Internal Med, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst,Div Pulm Al, Columbus, OH 43210 USA	Ohio State University	Wewers, MD (corresponding author), Ohio State Univ, Dept Internal Med, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst,Div Pulm Al, Columbus, OH 43210 USA.	wewers.2@osu.edu	Wewers, Mark/AAB-6202-2021; Sundaram, Kruthika/J-4010-2019	Sundaram, Kruthika/0000-0003-0510-424X; Gavrilin, Mikhail/0000-0003-2003-768X	NIH [HL089440, HL076278]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076278, R01HL089440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by NIH HL089440 and HL076278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaziz DHA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00018; Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Arostegui JI, 2007, ARTHRITIS RHEUM-US, V56, P3805, DOI 10.1002/art.22966; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Coulter KR, 2002, AM J RESP CELL MOL, V26, P58, DOI 10.1165/ajrcmb.26.1.4285; Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Hall MW, 2007, PEDIATR RES, V62, P597, DOI 10.1203/PDR.0b013e3181559774; Han DKM, 1997, P NATL ACAD SCI USA, V94, P11333, DOI 10.1073/pnas.94.21.11333; Hsu SC, 1999, EUR J IMMUNOL, V29, P2948, DOI 10.1002/(SICI)1521-4141(199909)29:09<2948::AID-IMMU2948>3.0.CO;2-0; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; King K, 2006, HUM MUTAT, V27, P44, DOI 10.1002/humu.20264; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lai YM, 2007, AM J PHYSIOL-LUNG C, V293, pL393, DOI 10.1152/ajplung.00392.2006; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Matute-Bello G, 1999, J IMMUNOL, V163, P2217; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Simon HU, 1998, BLOOD, V92, P547, DOI 10.1182/blood.V92.2.547.414k02_547_557; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; Sugimura M, 2003, CLIN GENET, V63, P160, DOI 10.1046/j.0009-9163.2002.00174.x; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Zakharova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009900	38	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92731	10.1371/journal.pone.0092731	http://dx.doi.org/10.1371/journal.pone.0092731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658576	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300124
J	Satake, A; Schmidt, AM; Nomura, S; Kambayashi, T				Satake, Atsushi; Schmidt, Amanda M.; Nomura, Shosaku; Kambayashi, Taku			Inhibition of Calcineurin Abrogates While Inhibition of mTOR Promotes Regulatory T Cell Expansion and Graft-Versus-Host Disease Protection by IL-2 in Allogeneic Bone Marrow Transplantation	PLOS ONE			English	Article							DENDRITIC CELLS; INTERLEUKIN-2; CD4(+); MAINTENANCE; HOMEOSTASIS; TOLERANCE; RAPAMYCIN; MODEL	Regulatory T cells (Treg)s attenuate excessive immune responses, making their expansion beneficial in immune-mediated diseases including allogeneic bone marrow transplantation (BMT)-associated graft-versus-host disease (GVHD). We have recently reported that Treg expansion does not require phospholipase C gamma activation when IL-2 is provided. As such, the combination of IL-2 and a calcineurin inhibitor (Cyclosporine A; CsA) expands Tregs while inhibiting Tconv proliferation and protects against a mouse model of multiple sclerosis. However, CsA inhibits Treg proliferation in the presence of a TCR stimulus, suggesting that CsA may negatively impact Treg proliferation when they receive strong allogeneic MHC-mediated TCR signals. In this study, we show that CsA inhibits Treg proliferation and inducible Treg generation in allogeneic but not in syngeneic BMT when IL-2 is provided. In contrast to CsA, the mTOR inhibitor (Rapamycin) almost completely suppressed IL-2- mediated Treg proliferation. However, CsA and Rapamycin inhibited Treg proliferation to a similar extent when TCR stimulation was provided. Furthermore, Rapamycin promoted Treg expansion and inducible Treg generation in allogeneic BMT recipients treated with IL-2. Consistent with these observations, CsA abrogated while Rapamycin promoted the protective effect of IL-2 on allogeneic BMT-induced GVHD. These results suggest that while CsA permits IL-2-induced Treg proliferation in the syngeneic setting (absence of strong TCR signals), CsA in combination with IL-2 may be detrimental for Treg proliferation in an allogeneic setting. Thus, in allogeneic settings, an mTOR inhibitor such as Rapamycin is a better choice for adjunct therapy with IL-2 in expansion of Tregs and protection against allogeneic BMT-induced GVHD.	[Satake, Atsushi; Schmidt, Amanda M.; Kambayashi, Taku] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Satake, Atsushi; Nomura, Shosaku] Kansai Med Univ, Dept Internal Med 1, Osaka, Japan	University of Pennsylvania; Pennsylvania Medicine; Kansai Medical University	Kambayashi, T (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	taku.kambayashi@uphs.upenn.edu			National Blood Foundation; University of Pennsylvania; National Institutes of Health [R01HL111501, R01HL107589]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111501, R01HL107589] Funding Source: NIH RePORTER	National Blood Foundation; University of Pennsylvania; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Blood Foundation, the University of Pennsylvania internal funds, and the National Institutes of Health (R01HL111501, R01HL107589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beres AJ, 2012, J IMMUNOL, V189, P464, DOI 10.4049/jimmunol.1200886; Bhandoola A, 2002, IMMUNITY, V17, P425, DOI 10.1016/S1074-7613(02)00417-X; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Matsuoka K, 2010, J CLIN INVEST, V120, P1479, DOI 10.1172/JCI41072; Robb RJ, 2012, BLOOD, V119, P5898, DOI 10.1182/blood-2011-12-396119; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakoda Y, 2007, BLOOD, V109, P1756, DOI 10.1182/blood-2006-08-042853; Satake A, 2013, J AUTOIMMUN, V44, P13, DOI 10.1016/j.jaut.2013.06.009; Sawamukai N, 2012, BLOOD, V119, P5575, DOI 10.1182/blood-2011-07-367987; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Swee LK, 2009, BLOOD, V113, P6277, DOI 10.1182/blood-2008-06-161026; Wang Y, 2011, J IMMUNOL, V186, P2809, DOI 10.4049/jimmunol.0903805; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zeiser R, 2006, BLOOD, V108, P390, DOI 10.1182/blood-2006-01-0329; Zou T, 2011, TRANSFUSION, V51, p160S, DOI 10.1111/j.1537-2995.2011.03379.x; Zou T, 2010, J IMMUNOL, V185, P2790, DOI 10.4049/jimmunol.0903740	27	25	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92888	10.1371/journal.pone.0092888	http://dx.doi.org/10.1371/journal.pone.0092888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658577	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300140
J	Ze, YG; Sheng, L; Zhao, XY; Hong, J; Ze, X; Yu, XH; Pan, XY; Lin, A; Zhao, Y; Zhang, C; Zhou, QP; Wang, L; Hong, FS				Ze, Yuguan; Sheng, Lei; Zhao, Xiaoyang; Hong, Jie; Ze, Xiao; Yu, Xiaohong; Pan, Xiaoyu; Lin, Anan; Zhao, Yue; Zhang, Chi; Zhou, Qiuping; Wang, Ling; Hong, Fashui			TiO2 Nanoparticles Induced Hippocampal Neuroinflammation in Mice	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; NF-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; MOLECULAR-MECHANISM; SIGNALING PATHWAYS; QUANTITATIVE PCR; IMMUNE-RESPONSES; PARTICLES; MEMORY; TRANSLOCATION	Titanium dioxide nanoparticles (TiO2 NPs) have been used in various medical and industrial areas. However, the impacts of these nanoparticles on neuroinflammation in the brain are poorly understood. In this study, mice were exposed to 2.5, 5, or 10 mg/kg body weight TiO2 NPs for 90 consecutive days, and the TLRs/TNF-alpha/NF-kappa B signaling pathway associated with the hippocampal neuroinflammation was investigated. Our findings showed titanium accumulation in the hippocampus, neuroinflammation and impairment of spatial memory in mice following exposure to TiO2 NPs. Furthermore, TiO2 NPs significantly activated the expression of Toll-like receptors (TLR2, TLR4), tumor necrosis factor-alpha, nucleic I kappa B kinase, NF-kappa B-inducible kinase, nucleic factor-kappa B, NF-kappa B2(p52), RelA(p65), and significantly suppressed the expression of I kappa B and interleukin-2. These findings suggest that neuroinflammation may be involved in TiO2 NP-induced alterations of cytokine expression in mouse hippocampus. Therefore, more attention should be focused on the application of TiO2 NPs in the food industry and their long-term exposure effects, especially in the human central nervous system.	[Ze, Yuguan; Sheng, Lei; Zhao, Xiaoyang; Hong, Jie; Ze, Xiao; Yu, Xiaohong; Pan, Xiaoyu; Lin, Anan; Zhao, Yue; Zhang, Chi; Zhou, Qiuping; Wang, Ling; Hong, Fashui] Soochow Univ, Coll Med, Suzhou, Peoples R China; [Hong, Fashui] Soochow Univ, Jiangsu Prov Key Lab Stem Cell Res, Suzhou, Peoples R China; [Hong, Fashui] Minist Sci & Technol & Jiangsu Prov, Cultivat Base State Key Lab Stem Cell & Biomat Bu, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Hong, FS (corresponding author), Soochow Univ, Coll Med, Suzhou, Peoples R China.	Hongfsh_cn@sina.com	Pan, Xiaoyu/ABE-1764-2021	Pan, Xiaoyu/0000-0002-5184-222X	National Natural Science Foundation of China [81273036, 30901218]; Priority Academic Program Development of Jiangsu Higher Education Institutions, National New Ideas Foundation of Student of China [111028534]; National Bringing New Ideas Foundation of Student of China [57315427, 57315927]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions, National New Ideas Foundation of Student of China; National Bringing New Ideas Foundation of Student of China	This work was supported by the National Natural Science Foundation of China (grant No. 81273036, 30901218), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, National New Ideas Foundation of Student of China (grant No. 111028534), and the National Bringing New Ideas Foundation of Student of China (grant No. 57315427, 57315927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwa Y, 2001, P NATL ACAD SCI USA, V98, P14033, DOI 10.1073/pnas.241503698; Bachevalier J, 1999, BIOL PSYCHIAT, V46, P329, DOI 10.1016/S0006-3223(99)00123-7; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Chen GY, 2012, BIOMATERIALS, V33, P6559, DOI 10.1016/j.biomaterials.2012.05.064; Chen P, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/015008; Chen P, 2011, SENSORS-BASEL, V11, P7219, DOI 10.3390/s110707219; Clark RE, 2000, J NEUROSCI, V20, P8853; Cui YL, 2011, J BIOMED MATER RES A, V96A, P221, DOI 10.1002/jbm.a.32976; Dellu F, 2000, NEUROBIOL LEARN MEM, V73, P31, DOI 10.1006/nlme.1999.3919; Duan YM, 2010, BIOMATERIALS, V31, P894, DOI 10.1016/j.biomaterials.2009.10.003; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; Fan HK, 2004, SHOCK, V22, P57, DOI 10.1097/01.shk.0000129759.58490.d6; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015; Hu RP, 2011, J HAZARD MATER, V191, P32, DOI 10.1016/j.jhazmat.2011.04.027; Hu RP, 2010, BIOMATERIALS, V31, P8043, DOI 10.1016/j.biomaterials.2010.07.011; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Ke LD, 2000, MOL CELL PROBE, V14, P127, DOI 10.1006/mcpr.2000.0288; Kreyling WG, 2002, J TOXICOL ENV HEAL A, V65, P1513, DOI 10.1080/00984100290071649; Lalancette-Hebert M, 2009, BRAIN, V132, P940, DOI 10.1093/brain/awn345; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockman PR, 2004, J DRUG TARGET, V12, P635, DOI 10.1080/10611860400015936; Ma LL, 2010, BIOMATERIALS, V31, P99, DOI 10.1016/j.biomaterials.2009.09.028; Ma LL, 2009, NANOSCALE RES LETT, V4, P1275, DOI 10.1007/s11671-009-9393-8; Mano SS, 2013, INT J MOL SCI, V14, P13154, DOI 10.3390/ijms140713154; MASUR J, 1971, PSYCHOPHARMACOLOGIA, V19, P388, DOI 10.1007/BF00404383; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Oberdorster C, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-8; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Peters A, 2006, PART FIBRE TOXICOL, V8, P3; Shin JA, 2010, NEUROSCIENCE, V165, P445, DOI 10.1016/j.neuroscience.2009.10.057; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Tin-Tin-Win-Shwe, 2006, TOXICOL LETT, V163, P153, DOI 10.1016/j.toxlet.2005.10.006; Tin-Tin-Win-Shwe, 2008, TOXICOL APPL PHARM, V226, P192, DOI 10.1016/j.taap.2007.09.009; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Wang JX, 2008, TOXICOLOGY, V254, P82, DOI 10.1016/j.tox.2008.09.014; Wang JX, 2008, TOXICOL LETT, V183, P72, DOI 10.1016/j.toxlet.2008.10.001; Wu JH, 2009, TOXICOL LETT, V191, P1, DOI 10.1016/j.toxlet.2009.05.020; Yang P, 2002, MATER LETT, V57, P794, DOI 10.1016/S0167-577X(02)00875-3; Ze YG, 2014, J HAZARD MATER, V264, P219, DOI 10.1016/j.jhazmat.2013.10.072; Ze YG, 2014, J BIOMED MATER RES A, V102, P470, DOI 10.1002/jbm.a.34705; Ze YG, 2013, CHEMOSPHERE, V92, P1183, DOI 10.1016/j.chemosphere.2013.01.094	45	80	82	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92230	10.1371/journal.pone.0092230	http://dx.doi.org/10.1371/journal.pone.0092230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658543	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300062
J	Bell, JJ; Smith, D; Hannan, D; Haris, A; Jompa, J; Thomas, L				Bell, James J.; Smith, David; Hannan, Danielle; Haris, Abdul; Jompa, Jamaludin; Thomas, Luke			Resilience to Disturbance Despite Limited Dispersal and Self-Recruitment in Tropical Barrel Sponges: Implications for Conservation and Management	PLOS ONE			English	Article							POPULATION-STRUCTURE; XESTOSPONGIA-MUTA; CORAL-REEFS; ASSIGNMENT TESTS; CLIMATE-CHANGE; GENE FLOW; MARINE; PORIFERA; PROGRAM; CONNECTIVITY	While estimates of connectivity are important for effective management, few such estimates are available for reef invertebrates other than for corals. Barrel sponges are one of the largest and most conspicuous members of the coral reef fauna across the Indo-Pacific and given their large size, longevity and ability to process large volumes of water, they have a major role in reef functioning. Here we used a panel of microsatellite markers to characterise the genetic structure of two barrel sponge species, Xestospongia testudinaria and a currently undescribed Xestospongia species. We sampled across seven populations in the Wakatobi Marine National Park, SE Sulawesi (Indonesia) spanning a spatial scale of approximately 2 to 70 km, and present the first estimates of demographic connectivity for coral reef sponges. Genetic analyses showed high levels of genetic differentiation between all populations for both species, but contrasting patterns of genetic structuring for the two species. Autocorrelation analyses showed the likely dispersal distances of both species to be in the order of 60 and 140 m for Xestopongia sp. and Xestospongia testudinaria, respectively, which was supported by assignment tests that showed high levels of self-recruitment (>80%). We also found consistently high inbreeding coefficients across all populations for both species. Our study highlights the potential susceptibility of barrel sponges to environmental perturbations because they are generally long-lived, slow growing, have small population sizes and are likely to be reliant on self-recruitment. Surprisingly, despite these features we actually found the highest abundance of both barrel sponge species (although they were generally smaller) at a site that has been severely impacted by humans over the last fifty years. This suggests that barrel sponges exhibit environmental adaptation to declining environmental quality and has important implications for the management and conservation of these important reef species.	[Bell, James J.; Hannan, Danielle] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Smith, David] Univ Essex, Coral Reef Res Unit, Colchester CO4 3SQ, Essex, England; [Haris, Abdul; Jompa, Jamaludin] Hasanuddin Univ, Res & Dev Ctr Marine Coastal & Small Isl, Makassar, Indonesia; [Thomas, Luke] Univ Western Australia, Sch Plant Biol, Oceans Inst, Nedlands, WA 6009, Australia	Victoria University Wellington; University of Essex; Universitas Hasanuddin; University of Western Australia	Bell, JJ (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	james.bell@vuw.ac.nz	Jompa, Jamaluddin/AAD-9280-2021; haris, abdul/GPG-0863-2022	Jompa, Jamaluddin/0000-0001-9740-333X; haris, abdul/0000-0001-7535-4514; Bell, James/0000-0001-9996-945X; Smith, David/0000-0003-1886-8193	Victoria University of Wellington Research Fund	Victoria University of Wellington Research Fund	This work was funded by the Victoria University of Wellington Research Fund. The funders has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison GW, 2003, ECOL APPL, V13, pS8; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bell JJ, 2007, MAR ECOL PROG SER, V339, P73, DOI 10.3354/meps339073; Bell JJ, 2014, CONSERV GENET RESOUR, V6, P105, DOI 10.1007/s12686-013-0015-5; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Bell JJ, 2005, P ROY SOC B-BIOL SCI, V272, P1067, DOI 10.1098/rspb.2005.3051; Bell JJ, 2004, J MAR BIOL ASSOC UK, V84, P581, DOI 10.1017/S0025315404009580h; Berry O, 2004, MOL ECOL, V13, P551, DOI 10.1046/j.1365-294X.2004.2081.x; Blanquer A, 2009, MAR ECOL PROG SER, V380, P95, DOI 10.3354/meps07931; Burke L., 2011, REEFS RISK REVISITED; Clifton J, 2010, ENVIRON SCI ENG TECH, P1; Cullen LC, 2010, ENVIRON SCI ENG TECH, P171; Duran S, 2004, MOL ECOL, V13, P511, DOI 10.1046/j.1365-294X.2004.2080.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FROMONT J, 1994, BIOCHEM SYST ECOL, V22, P735, DOI 10.1016/0305-1978(94)90059-0; FROMONT J, 1991, Beagle, V8, P73; FROMONT J, 1994, CORAL REEFS, V13, P119, DOI 10.1007/BF00300772; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; Horne JB, 2013, J HERED, V104, P532, DOI 10.1093/jhered/est021; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Knapp ISS, 2013, MAR POLLUT BULL, V66, P209, DOI 10.1016/j.marpolbul.2012.08.017; Lopez-Legentil S, 2009, CORAL REEFS, V28, P157, DOI 10.1007/s00338-008-0430-3; Lopez-Legentil S, 2008, MOL ECOL, V17, P1840, DOI 10.1111/j.1365-294X.2008.03667.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; McMellor S, 2010, ENVIRON SCI ENG TECH, P11; McMurray SE, 2008, MAR BIOL, V155, P159, DOI 10.1007/s00227-008-1014-z; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Powell AL, 2013, THESIS VICTORIA U WE; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saenz-Agudelo P, 2009, MOL ECOL, V18, P1765, DOI 10.1111/j.1365-294X.2009.04109.x; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Swierts T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074396; Underwood JN, 2009, ECOL APPL, V19, P18, DOI 10.1890/07-1461.1; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whalan S, 2005, MAR BIOL, V146, P425, DOI 10.1007/s00227-004-1466-8; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1943, GENETICS, V28, P114; Wulff J, 2001, B MAR SCI, V69, P831	59	30	30	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91635	10.1371/journal.pone.0091635	http://dx.doi.org/10.1371/journal.pone.0091635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651687	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000333352800044
J	Dubot-Peres, A; Tan, CYQ; de Chesse, R; Sibounheuang, B; Vongsouvath, M; Phommasone, K; Bessaud, M; Gazin, C; Thirion, L; Phetsouvanh, R; Newton, PN; de Lamballerie, X				Dubot-Peres, Audrey; Tan, Charlene Y. Q.; de Chesse, Reine; Sibounheuang, Bountoy; Vongsouvath, Manivanh; Phommasone, Koukeo; Bessaud, Mael; Gazin, Celine; Thirion, Laurence; Phetsouvanh, Rattanaphone; Newton, Paul N.; de Lamballerie, Xavier			SYBR Green Real-Time PCR for the Detection of All Enterovirus-A71 Genogroups	PLOS ONE			English	Article							ACUTE FLACCID PARALYSIS; MOUTH-DISEASE; RT-PCR; CLINICAL SPECIMENS; 71 INFECTION; MOLECULAR EPIDEMIOLOGY; HAND; FOOT; OUTBREAK; TAIWAN	Enterovirus A71 (EV-A71) has recently become an important public health threat, especially in South-East Asia, where it has caused massive outbreaks of Hand, Foot and Mouth disease every year, resulting in significant mortality. Rapid detection of EV-A71 early in outbreaks would facilitate implementation of prevention and control measures to limit spread. Real-time RTPCR is the technique of choice for the rapid diagnosis of EV-A71 infection and several systems have been developed to detect circulating strains. Although eight genogroups have been described globally, none of these PCR techniques detect all eight. We describe, for the first time, a SYBR Green real-time RT-PCR system validated to detect all 8 EV-A71 genogroups. This tool could permit the early detection and shift in genogroup circulation and the standardization of HFMD virological diagnosis, facilitating networking of laboratories working on EV-A71 in different regions.	[Dubot-Peres, Audrey; Tan, Charlene Y. Q.; de Chesse, Reine; Bessaud, Mael; Thirion, Laurence; de Lamballerie, Xavier] Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, Unite Mixte Rech Emergence Pathol Virales D 190, Marseille, France; [Dubot-Peres, Audrey; Sibounheuang, Bountoy; Vongsouvath, Manivanh; Phommasone, Koukeo; Phetsouvanh, Rattanaphone; Newton, Paul N.] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hospital Wellcome Trust Res Un, Viangchan, Laos; [Dubot-Peres, Audrey; Sibounheuang, Bountoy; Phommasone, Koukeo; Phetsouvanh, Rattanaphone; Newton, Paul N.] Univ Oxford, Churchill Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Gazin, Celine; de Lamballerie, Xavier] Univ Hosp, AP HM Timone, Inst Infect Dis & Trop Med, Lab Clin Microbiol, Marseille, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of Oxford; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Dubot-Peres, A (corresponding author), Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, Unite Mixte Rech Emergence Pathol Virales D 190, Marseille, France.	audrey@tropmedres.ac	Bessaud, Maël/J-3961-2019	Bessaud, Maël/0000-0001-6758-9591; Laurence, THIRION/0000-0003-4301-2944; Newton, Paul/0000-0002-4608-6431	Wellcome Trust of Great Britain; Institut of Research for Development; Assistance Publique-Hopitaux de Marseille; Aix-Marseille University	Wellcome Trust of Great Britain(Wellcome Trust); Institut of Research for Development; Assistance Publique-Hopitaux de Marseille; Aix-Marseille University	Funded by the Wellcome Trust of Great Britain, Institut of Research for Development, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Bessaud M, 2014, PLOS ONE IN PRESS; Bessaud M, 2012, J CLIN MICROBIOL, V50, P1650, DOI 10.1128/JCM.06657-11; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Brown BA, 2000, J CLIN VIROL, V16, P107, DOI 10.1016/S1386-6532(00)00065-2; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Cardosa MJ, 1999, LANCET, V354, P987, DOI 10.1016/S0140-6736(98)11032-2; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6; Chang LJ, 2008, J FORMOS MED ASSOC, V107, P589, DOI 10.1016/S0929-6646(08)60175-8; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Deshpande JM, 2003, CURR SCI INDIA, V84, P1350; Fan XL, 2013, VIRUS GENES, V46, P1, DOI 10.1007/s11262-012-0814-x; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Huang FL, 2002, CLIN INFECT DIS, V34, P1020, DOI 10.1086/339445; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; Jiang BF, 2012, J MED VIROL, V84, P1803, DOI 10.1002/jmv.23391; Komatsu H, 1999, PEDIATR NEUROL, V20, P17, DOI 10.1016/S0887-8994(98)00087-3; Lee MH, 2011, J MICROBIOL IMMUNOL, V44, P178, DOI 10.1016/j.jmii.2011.01.018; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Nguyen TTT, 2010, J VIROL METHODS, V170, P134, DOI 10.1016/j.jviromet.2010.09.017; Ni HX, 2012, J CLIN VIROL, V54, P342, DOI 10.1016/j.jcv.2012.04.021; Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Rao CD, 2012, EMERG INFECT DIS, V18, P1833, DOI 10.3201/eid1811.111457; Sadeuh-Mba SA, 2013, J CLIN MICROBIOL, V51, P759, DOI 10.1128/JCM.02119-12; Singh S, 2002, J CLIN MICROBIOL, V40, P2823, DOI 10.1128/JCM.40.8.2823-2827.2002; Tan EL, 2006, MOL CELL PROBE, V20, P135, DOI 10.1016/j.mcp.2005.11.003; Tan EL, 2008, DIAGN MICR INFEC DIS, V61, P294, DOI 10.1016/j.diagmicrobio.2008.02.009; Tan EL, 2008, J CLIN VIROL, V42, P203, DOI 10.1016/j.jcv.2008.01.001; Tsao KC, 2002, J VIROL METHODS, V102, P9, DOI 10.1016/S0166-0934(01)00376-7; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Xiao XL, 2009, ARCH VIROL, V154, P121, DOI 10.1007/s00705-008-0266-8; Yan JJ, 2001, J MED VIROL, V65, P331, DOI 10.1002/jmv.2038; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	43	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e89963	10.1371/journal.pone.0089963	http://dx.doi.org/10.1371/journal.pone.0089963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651608	gold, Green Published, Green Submitted			2022-12-25	WOS:000333352800006
J	Ma, L; Ballantyne, C; Brautbar, A; Keinan, A				Ma, Li; Ballantyne, Christie; Brautbar, Ariel; Keinan, Alon			Analysis of Multiple Association Studies Provides Evidence of an Expression QTL Hub in Gene-Gene Interaction Network Affecting HDL Cholesterol Levels	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; MISSING HERITABILITY; COMBINATION THERAPY; FENOFIBRIC ACID; LOCI; EPISTASIS; VARIANTS; RISK; ATHEROSCLEROSIS; INDIVIDUALS	Epistasis has been suggested to underlie part of the missing heritability in genome-wide association studies. In this study, we first report an analysis of gene-gene interactions affecting HDL cholesterol (HDL-C) levels in a candidate gene study of 2,091 individuals with mixed dyslipidemia from a clinical trial. Two additional studies, the Atherosclerosis Risk in Communities study (ARIC; n = 9,713) and the Multi-Ethnic Study of Atherosclerosis (MESA; n = 2,685), were considered for replication. We identified a gene-gene interaction between rs1532085 and rs12980554 (P = 7.1x10(-7)) in their effect on HDL-C levels, which is significant after Bonferroni correction (P-c = 0.017) for the number of SNP pairs tested. The interaction successfully replicated in the ARIC study (P = 7.0x10(-4); P-c = 0.02). Rs1532085, an expression QTL (eQTL) of LIPC, is one of the two SNPs involved in another, well-replicated gene-gene interaction underlying HDL-C levels. To further investigate the role of this eQTL SNP in gene-gene interactions affecting HDL-C, we tested in the ARIC study for interaction between this SNP and any other SNP genome-wide. We found the eQTL to be involved in a few suggestive interactions, one of which significantly replicated in MESA. Importantly, these gene-gene interactions, involving only rs1532085, explain an additional 1.4% variation of HDL-C, on top of the 0.65% explained by rs1532085 alone. LIPC plays a key role in the lipid metabolism pathway and it, and rs1532085 in particular, has been associated with HDL-C and other lipid levels. Collectively, we discovered several novel gene-gene interactions, all involving an eQTL of LIPC, thus suggesting a hub role of LIPC in the gene-gene interaction network that regulates HDL-C levels, which in turn raises the hypothesis that LIPC's contribution is largely via interactions with other lipid metabolism related genes.	[Ma, Li; Keinan, Alon] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Ballantyne, Christie; Brautbar, Ariel] Baylor Coll Med, Dept Med, Sect Cardiovasc Res, Houston, TX 77030 USA; [Brautbar, Ariel] Marshfield Clin Fdn Med Res & Educ, Dept Med Genet, Marshfield, WI USA	Cornell University; Baylor College of Medicine; Marshfield Clinic	Brautbar, A (corresponding author), Baylor Coll Med, Dept Med, Sect Cardiovasc Res, Houston, TX 77030 USA.	brautbar@bcm.edu; ak735@cornell.edu	Ballantyne, Christie/A-6599-2008; ma, li/C-1585-2014	Keinan, Alon/0000-0002-9760-1122; Ballantyne, Christie/0000-0002-6432-1730	National Institutes of Health [R01HG006849]; Ellison Medical Foundation; Alfred P. Sloan Research Fellowship; Edward Mallinckrodt, Jr. Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); Edward Mallinckrodt, Jr. Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by National Institutes of Health Grant (R01HG006849). A.K. was also supported by The Ellison Medical Foundation, an Alfred P. Sloan Research Fellowship, and the Edward Mallinckrodt, Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Brautbar A, 2012, J LIPID RES, V53, P556, DOI 10.1194/jlr.M020404; Brautbar A, 2011, ATHEROSCLEROSIS, V219, P737, DOI 10.1016/j.atherosclerosis.2011.08.015; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Folkersen L, 2010, CIRC-CARDIOVASC GENE, V3, P365, DOI 10.1161/CIRCGENETICS.110.948935; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-364; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Lu CQ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-407; Ma L, 2012, J LIPID RES; Ma L, 2012, PLOS GENETICS, V8; Ma L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-55; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maxwell TJ, 2013, GENETICS; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raue U, 2012, J APPL PHYSIOL, V112, P1625, DOI 10.1152/japplphysiol.00435.2011; Ritchie MD, 2011, ANN HUM GENET, V75, P172, DOI 10.1111/j.1469-1809.2010.00630.x; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Santamarina-Fojo S, 1998, CURR OPIN LIPIDOL, V9, P211, DOI 10.1097/00041433-199806000-00005; Sun Y, 2012, HUM GENET, P1; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Toedter G, 2011, AM J GASTROENTEROL, V106, P1272, DOI 10.1038/ajg.2011.83; Turner SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019586; van Raalte DH, 2004, PHARM RES-DORDR, V21, P1531, DOI 10.1023/B:PHAM.0000041444.06122.8d; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wei W-H, 2012, EUROPEAN J HUMAN GEN; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	49	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92469	10.1371/journal.pone.0092469	http://dx.doi.org/10.1371/journal.pone.0092469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651390	Green Submitted, gold, Green Published			2022-12-25	WOS:000333352800115
J	Norling, R; Buron, BMD; Therkildsen, MH; Henriksen, BM; von Buchwald, C; Nielsen, MB				Norling, Rikke; Buron, Birgitte Marie Due; Therkildsen, Marianne Hamilton; Henriksen, Birthe Merete; von Buchwald, Christian; Nielsen, Michael Bachmann			Staging of Cervical Lymph Nodes in Oral Squamous Cell Carcinoma: Adding Ultrasound in Clinically Lymph Node Negative Patients May Improve Diagnostic Work-Up	PLOS ONE			English	Article							NECK DISSECTION; ASPIRATION-CYTOLOGY; IMAGING METHODS; IN-VITRO; HEAD; SONOGRAPHY; CT; GUIDELINES; CAVITY; LYMPHADENOPATHY	Introduction: Clinical staging of patients with oral squamous cell carcinoma (OSCC) is crucial for the choice of treatment. Computed tomography (CT) and/or magnetic resonance imaging (MRI) are typically recommended and used for staging of the cervical lymph nodes (LNs). Although ultrasonography (US) is a non-expensive, accessible and non-ionising imaging modality this method is not consistently used. This study aimed to investigate if addition of US of patients classified as clinically LN negative (cN0) by CT and/or MRI, increases the detection of LN metastases. Also, we aimed to identify which of the sonographic characteristics: echogenicity, border, shape, appearance of hilum and nodal blood-flow pattern best detect metastases in this patient group. Method: Fifty-one patients with OSCC classified as cN0 by CT/MRI were consecutively included and prospectively examined with US prior to sentinel node biopsy or selective neck dissection. Localisation, size and sonographic characteristics were registered for each LN and compared with the pathological findings. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated for different size measurements and sonographic characteristics. Results: We found that short axial diameter was the best size criterion for detection of metastases. However, the sonographic characteristics were better predictors than size and the presence at least four of the sonographic characteristics: hypo-echoic or heterogeneous appearance; irregular border; spherical shape; absence of nodal hilum; and peripheral nodal blood-flow resulted in a sensitivity of 43.8; specificity 91.4; PPV 70.0; and NPV 78.0. The number of patients with occult metastases decreased from 16 out of 51 (31%) to nine out of 51 (18%). Three patients (6%) were over-staged by US. Conclusion: The addition of US to the clinical work-up of patients with cN0 OSCC increases the detection of metastases, thus US potentially reduces the number of patients requiring a secondary neck surgery after sentinel node biopsy.	[Norling, Rikke; Buron, Birgitte Marie Due; Henriksen, Birthe Merete; Nielsen, Michael Bachmann] Copenhagen Univ Hosp, Rigshosp, Dept Radiol, Copenhagen, Denmark; [Therkildsen, Marianne Hamilton] Copenhagen Univ Hosp, Rigshosp, Dept Pathol, Copenhagen, Denmark; [von Buchwald, Christian] Copenhagen Univ Hosp, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Norling, R (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Radiol, Copenhagen, Denmark.	Rikke.Norling@dadlnet.dk	von Buchwald, Christian/D-5336-2016; Nielsen, Michael Bachmann/U-2749-2018	von Buchwald, Christian/0000-0001-6753-8129; Nielsen, Michael Bachmann/0000-0002-9380-1688				AJCC, 2010, CANC STAGING MANUAL; Akoglu E, 2005, J OTOLARYNGOL, V34, P384, DOI 10.2310/7070.2005.34605; [Anonymous], 2009, TNM CLASSIFICATION M; Atula T, 1997, ACTA OTO-LARYNGOL, P223; Bhatia KSS, 2012, ULTRASOUND MED BIOL, V38, P195, DOI 10.1016/j.ultrasmedbio.2011.10.024; Bilde A, 2006, ACTA ONCOL, V45, P294, DOI 10.1080/02841860600592998; Christensen AF, 2006, ULTRASCHALL MED, V27, P360, DOI 10.1055/s-2005-858966; Cosgrove D, 2013, ULTRASCHALL MED, V34, P238, DOI 10.1055/s-0033-1335375; Danmarks statistik, 2013, FOLK; Devaney KO, 2007, AM J OTOLARYNG, V28, P271, DOI 10.1016/j.amjoto.2006.09.017; Dietrich CF, 2012, ULTRASCHALL MED, V33, P411, DOI 10.1055/s-0032-1325384; DSHHO, 2013, BEH OR PLAN KARC NAT; Gregoire V, 2003, RADIOTHER ONCOL, V69, P227, DOI 10.1016/j.radonc.2003.09.011; Gritzmann N, 2005, ULTRASCHALL MED, V26, P185, DOI 10.1055/s-2005-858271; Lai YS, 2013, LARYNGOSCOPE; Liao LJ, 2010, HEAD NECK-J SCI SPEC, V32, P594, DOI 10.1002/hed.21225; MAMELLE G, 1994, AM J SURG, V168, P494, DOI 10.1016/S0002-9610(05)80109-6; Mancuso AA, 2011, HEAD NECK RADIOLOGY; Nguyen A, 2013, LARYNGOSCOPE; NIELSEN MB, 1993, AM J ROENTGENOL, V161, P57, DOI 10.2214/ajr.161.1.8517321; Norling R, 2013, ACTA OTO-LARYNGOL, V133, P965, DOI 10.3109/00016489.2013.799290; Norling R, 2012, ACTA ONCOL, V51, P355, DOI 10.3109/0284186X.2011.640346; Piscaglia F, 2012, ULTRASCHALL MED, V33, P33, DOI 10.1055/s-0031-1281676; Rettenbacher T, 2010, ULTRASCHALL MED, V31, P344, DOI 10.1055/s-0029-1245584; Robbins KT, 2008, ARCH OTOLARYNGOL, V134, P536, DOI 10.1001/archotol.134.5.536; Schroeder U, 2008, ANN OTO RHINOL LARYN, V117, P854, DOI 10.1177/000348940811701111; Shoaib T, 1999, HEAD NECK-J SCI SPEC, V21, P728, DOI 10.1002/(SICI)1097-0347(199912)21:8<728::AID-HED8>3.0.CO;2-P; Stoeckli SJ, 2012, HEAD NECK-J SCI SPEC, V34, P469, DOI 10.1002/hed.21764; Stuckensen T, 2000, J CRANIO MAXILL SURG, V28, P319, DOI 10.1054/jcms.2000.0172; Sundhedsstyrelsen, 2012, PAKK HOV HALS KRAEFT; Thompson CF, 2013, EUR ARCH OTO-RHINO-L, V270, P2115, DOI 10.1007/s00405-012-2320-0; Trojanowska A, 2011, EUR J RADIOL; van den Brekel MWM, 1998, AM J NEURORADIOL, V19, P695; vandenBrekel MWM, 1996, LARYNGOSCOPE, V106, P987, DOI 10.1097/00005537-199608000-00014; VANDENBREKEL MWM, 1993, EUR ARCH OTO-RHINO-L, V250, P11, DOI 10.1007/BF00176941; Wendl CM, 2012, CLIN HEMORHEOL MICRO, V52, P153, DOI 10.3233/CH-2012-1593; Wensing BM, 2010, ORAL ONCOL, V46, P87, DOI 10.1016/j.oraloncology.2009.11.015; Wu CH, 2000, HEAD NECK-J SCI SPEC, V22, P223, DOI 10.1002/(SICI)1097-0347(200005)22:3<223::AID-HED3>3.0.CO;2-D; Yoon DY, 2009, EUR RADIOL, V19, P634, DOI 10.1007/s00330-008-1192-6	39	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90360	10.1371/journal.pone.0090360	http://dx.doi.org/10.1371/journal.pone.0090360			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651159	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800016
J	Oghabian, A; Kilpinen, S; Hautaniemi, S; Czeizler, E				Oghabian, Ali; Kilpinen, Sami; Hautaniemi, Sampsa; Czeizler, Elena			Biclustering Methods: Biological Relevance and Application in Gene Expression Analysis	PLOS ONE			English	Article							MICROARRAY DATA; ALGORITHMS	DNA microarray technologies are used extensively to profile the expression levels of thousands of genes under various conditions, yielding extremely large data-matrices. Thus, analyzing this information and extracting biologically relevant knowledge becomes a considerable challenge. A classical approach for tackling this challenge is to use clustering (also known as one-way clustering) methods where genes (or respectively samples) are grouped together based on the similarity of their expression profiles across the set of all samples (or respectively genes). An alternative approach is to develop biclustering methods to identify local patterns in the data. These methods extract subgroups of genes that are co-expressed across only a subset of samples and may feature important biological or medical implications. In this study we evaluate 13 biclustering and 2 clustering (k-means and hierarchical) methods. We use several approaches to compare their performance on two real gene expression data sets. For this purpose we apply four evaluation measures in our analysis: (1) we examine how well the considered (bi)clustering methods differentiate various sample types; (2) we evaluate how well the groups of genes discovered by the (bi)clustering methods are annotated with similar Gene Ontology categories; (3) we evaluate the capability of the methods to differentiate genes that are known to be specific to the particular sample types we study and (4) we compare the running time of the algorithms. In the end, we conclude that as long as the samples are well defined and annotated, the contamination of the samples is limited, and the samples are well replicated, biclustering methods such as Plaid and SAMBA are useful for discovering relevant subsets of genes and samples.	[Oghabian, Ali] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Kilpinen, Sami] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Hautaniemi, Sampsa] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Hautaniemi, Sampsa] Univ Helsinki, Genome Scale Biol Res Program, Helsinki, Finland; [Czeizler, Elena] Aalto Univ, Dept Comp Sci & Engn, Espoo, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Aalto University	Czeizler, E (corresponding author), Aalto Univ, Dept Comp Sci & Engn, Espoo, Finland.	elena.czeizler@aalto.fi	Hautaniemi, Sampsa/A-3122-2009; Hautaniemi, Sampsa/CAG-0362-2022	Hautaniemi, Sampsa/0000-0002-7749-2694; Hautaniemi, Sampsa/0000-0002-7749-2694; Kilpinen, Sami/0000-0003-3444-2539; Czeizler, Elena/0000-0003-4250-3979	Academy of Finland [125826]; Biocentrum Helsinki	Academy of Finland(Academy of Finland); Biocentrum Helsinki	These authors report the following sources of support or funding: Academy of Finland (project 125826, Center of Excellence in Cancer Genetics Research) (SH) and Biocentrum Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad W., 2007, VLDB WORKSH DAT MIN; Andreopoulos B, 2009, BRIEFINGS BIOINFORMA; [Anonymous], [No title captured]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Autio R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S24; Ayadi W, 2009, BIODATA MIN, V2, DOI 10.1186/1756-0381-2-9; Baldi P, 2004, HDB COMPUTATIONAL MO; Barkow S, 2006, BIOINFORMATICS, V22, P1282, DOI 10.1093/bioinformatics/btl099; Ben-Dor A, 2003, J COMPUT BIOL, V10, P373, DOI 10.1089/10665270360688075; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Busygin S, 2002, P 2 SIAM INT C DAT M; Busygin S, 2008, COMPUT OPER RES, V35, P2964, DOI 10.1016/j.cor.2007.01.005; Caldas J, 2010, LECT N BIOINFORMAT, V6044, P65, DOI 10.1007/978-3-642-12683-3_5; Caldas J, 2008, MACHINE LEARN SIGN P, P291, DOI 10.1109/MLSP.2008.4685495; Califano A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P75; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; den Bulcke TV, 2009, THESIS KATHOLIEKE U; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eren K, 2013, BRIEF BIOINFORM, V14, P279, DOI 10.1093/bib/bbs032; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Gu JJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S4; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2004, BIOINFORMATICS; Kaiser S, 2008, TECHNICAL REPORT; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Lazzeroni L, 2002, STAT SINICA, V12, P61; Li Haifeng, 2006, Journal of Bioinformatics and Computational Biology, V4, P911, DOI 10.1142/S021972000600217X; Li L, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-8; Liu JZ, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P436; Liu JZ, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P187; Liu X, 2008, BMC BIOINFORMATICS, V9; Liu XW, 2007, BIOINFORMATICS, V23, P50, DOI 10.1093/bioinformatics/btl560; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Murali T M, 2003, Pac Symp Biocomput, P77; Nikkila J, 2002, NEURAL NETWORKS, V15, P953, DOI 10.1016/S0893-6080(02)00070-9; Okada Yoshifumi, 2007, IAENG International Journal of Computer Science, V34, P119; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Reiss DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-280; Santamaria R, 2007, LECT NOTES COMPUT SC, V4881, P780; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Sheng Q, 2003, BIOINFORMATICS, V19; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sorensen T, 1957, BIOL SKR, V5, P1, DOI DOI 10.1016/J.NEUROIMAGE.2006.09.051; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tang C, 2002, BIOINF BIOENG C 2001, P41; Teng L, 2008, J SIGNAL PROCESS SYS, V50, P267, DOI 10.1007/s11265-007-0121-2; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Wang H., 2002, P 2002 ACM SIGMOD IN, P394, DOI DOI 10.1145/564691.564737; Wang YK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-102; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wu Chang-Jiun, 2004, Genome Inform, V15, P239; Wu CJ, 2005, NUCLEIC ACIDS RES, V33, pW596, DOI 10.1093/nar/gki469; Xiao J, 2008, J COMPUT BIOL, V15, P1275, DOI 10.1089/cmb.2007.0219; Yang J, 2005, INT J ARTIF INTELL T, V14, P771, DOI 10.1142/S0218213005002387; Yoon S, 2005, IEEE ACM T COMPUT BI, V2, P339, DOI 10.1109/TCBB.2005.55	64	74	75	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90801	10.1371/journal.pone.0090801	http://dx.doi.org/10.1371/journal.pone.0090801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651574	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800025
J	van Rijn, VM; Mooij, SH; Mollers, M; Snijders, PJF; Speksnijder, AGCL; King, AJ; de Vries, HJC; van Eeden, A; van der Klis, FRM; de Melker, HE; van der Sande, MAB; van der Loeff, MFS				van Rijn, Vera M.; Mooij, Sofie H.; Mollers, Madelief; Snijders, Peter J. F.; Speksnijder, Arjen G. C. L.; King, Audrey J.; de Vries, Henry J. C.; van Eeden, Arne; van der Klis, Fiona R. M.; de Melker, Hester E.; van der Sande, Marianne A. B.; van der Loeff, Maarten F. Schim			Anal, Penile, and Oral High-Risk HPV Infections and HPV Seropositivity in HIV-Positive and HIV-Negative Men Who Have Sex with Men	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; VIRUS-LIKE PARTICLES; AGE-SPECIFIC PREVALENCE; NATURAL-HISTORY; CAPSID ANTIBODIES; CANCER INCIDENCE; HOMOSEXUAL-MEN; UNITED-STATES; TYPE-16; WOMEN	The effects of single or multiple concordant HPV infections at various anatomical sites on type-specific HPV seropositivity are currently unknown. In this cross-sectional study we assessed whether high-risk HPV infections at various anatomical sites (i.e., anal canal, penile shaft, and oral cavity), as well as concordant infections at multiple anatomical sites, were associated with type-specific seropositivity in HIV-positive and HIV-negative MSM. MSM aged >= 18 years were recruited in Amsterdam, the Netherlands (2010-2011). Baseline anal, penile, and oral samples were analyzed for HPV DNA and genotyped using a highly sensitive PCR and reverse line blot assay. Virus-like particle (VLP) based multiplex immunoassay was used to asses HPV-specific serum antibodies against L1 VLPs. The associations between HPV infections and type-specific seropositivity of seven high-risk HPV types (7-hrHPV: types 16, 18, 31, 33, 45, 52, 58) were estimated using logistic regression analyses with generalized estimating equations. We found that 86% of 306 HIV-positive MSM and 62% of 441 HIV-negative MSM were seropositive for at least one 7-hrHPV type. 69% of HIV-positive and 41% of HIV-negative MSM were infected with at least one 7-hrHPV type at the anus, penis, or oral cavity. In multivariable analyses, 7-hrHPV seropositivity was associated with type-specific anal (and not penile) 7-hrHPV infection, and did not significantly increase with a higher number of infected anatomical sites. Oral 7-hrHPV infection showed a positive, albeit non-significant, association with seropositivity. In conclusion, seropositivity among MSM appears to be largely associated with anal HPV infection, irrespective of additionally infected anatomical sites.	[van Rijn, Vera M.; Mollers, Madelief; King, Audrey J.; de Vries, Henry J. C.; van der Klis, Fiona R. M.; de Melker, Hester E.; van der Sande, Marianne A. B.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Mooij, Sofie H.; Speksnijder, Arjen G. C. L.; de Vries, Henry J. C.; van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam, Amsterdam, Netherlands; [Snijders, Peter J. F.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Mooij, Sofie H.; van der Loeff, Maarten F. Schim] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [van Eeden, Arne] Jan van Goyen Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [van der Sande, Marianne A. B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Public Health Service Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	Mooij, SH (corresponding author), Publ Hlth Serv Amsterdam, Amsterdam, Netherlands.	somooij@ggd.amsterdam.nl	Speksnijder, Arjen/M-3406-2017; de Vries, Henry/K-5963-2012	Speksnijder, Arjen/0000-0002-1966-7265; de Vries, Henry/0000-0001-9784-547X; van der Sande, Marianne AB/0000-0002-4778-6739	Aids Fonds [2009029]; Public Health Service of Amsterdam; RIVM; Netherlands National Institute for Public Health and the Environment	Aids Fonds; Public Health Service of Amsterdam; RIVM; Netherlands National Institute for Public Health and the Environment	This study was funded through a grant from the Aids Fonds (grant number 2009029) and additional funding from the Public Health Service of Amsterdam and the RIVM. The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Public Health Service of Amsterdam, the Academic Medical Center of the University of Amsterdam, Sanquin Blood Supply Foundation, and the University Medical Center Utrecht, are part of the Netherlands HIV Monitoring Foundation and financially supported by the Netherlands National Institute for Public Health and the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Geijersstam V, 1998, J INFECT DIS, V177, P1710, DOI 10.1086/517428; Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; Carter JJ, 1996, J INFECT DIS, V174, P927, DOI 10.1093/infdis/174.5.927; Carter JJ, 2000, J INFECT DIS, V181, P1911, DOI 10.1086/315498; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; de Gruijl TD, 1999, J GEN VIROL, V80, P399, DOI 10.1099/0022-1317-80-2-399; Edelstein ZR, 2011, J INFECT DIS, V204, P209, DOI 10.1093/infdis/jir242; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Hagensee ME, 1997, J INFECT DIS, V176, P625, DOI 10.1086/514082; Heiligenberg M, 2013, J INFECT DIS, V208, P1081, DOI 10.1093/infdis/jit295; Ho GYF, 2004, CANCER EPIDEM BIOMAR, V13, P110, DOI 10.1158/1055-9965.EPI-03-0191; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kreimer AR, 2004, SEX TRANSM DIS, V31, P247, DOI 10.1097/01.OLQ.0000118425.49522.2C; Lu BB, 2012, CANCER EPIDEM BIOMAR, V21, P1542, DOI 10.1158/1055-9965.EPI-12-0483; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Mooij SH, 2013, CANCER EPIDEM BIOMAR, V22, P1698, DOI 10.1158/1055-9965.EPI-13-0460; Mooij SH, 2013, AIDS, V27, P2117, DOI 10.1097/QAD.0b013e328362395c; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Paaso AE, 2011, J GEN VIROL, V92, P2034, DOI 10.1099/vir.0.032011-0; Phanuphak N, 2013, JAIDS-J ACQ IMM DEF, V63, P472, DOI 10.1097/QAI.0b013e3182918a5a; Poynten IM, 2012, SEX TRANSM DIS, V39, P726, DOI 10.1097/OLQ.0b013e31825d5cb8; Scherpenisse M, 2012, VACCINE, V30, P6686, DOI 10.1016/j.vaccine.2012.08.068; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Silverberg MJ, 2006, CLIN VACCINE IMMUNOL, V13, P511, DOI 10.1128/CVI.13.4.511-519.2006; Sirera G, 2006, AIDS, V20, P1201, DOI 10.1097/01.aids.0000226963.10342.f4; Slavinsky J, 2001, INT J STD AIDS, V12, P516, DOI 10.1258/0956462011923615; Smith JS, 2011, J ADOLESCENT HEALTH, V48, P540, DOI 10.1016/j.jadohealth.2011.03.010; Svare EI, 1997, J INFECT DIS, V176, P876, DOI 10.1086/516505; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; van Aar F, 2013, AIDS, V27, P2921, DOI 10.1097/01.aids.0000432541.67409.3c; Vriend HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060696; WIDEROFF L, 1995, J INFECT DIS, V172, P1425, DOI 10.1093/infdis/172.6.1425; Xue XN, 2010, CANCER EPIDEM BIOMAR, V19, P159, DOI 10.1158/1055-9965.EPI-09-0546	39	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92208	10.1371/journal.pone.0092208	http://dx.doi.org/10.1371/journal.pone.0092208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651691	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800084
J	Goncalves-Souza, T; Diniz, JAF; Romero, GQ				Goncalves-Souza, Thiago; Felizola Diniz-Filho, Jose Alexandre; Romero, Gustavo Quevedo			Disentangling the Phylogenetic and Ecological Components of Spider Phenotypic Variation	PLOS ONE			English	Article							BODY-SIZE; HABITAT USE; EVOLUTION; PERFORMANCE; STRATEGIES; PATTERNS; LIFE; MASS	An understanding of how the degree of phylogenetic relatedness influences the ecological similarity among species is crucial to inferring the mechanisms governing the assembly of communities. We evaluated the relative importance of spider phylogenetic relationships and ecological niche (plant morphological variables) to the variation in spider body size and shape by comparing spiders at different scales: (i) between bromeliads and dicot plants (i. e., habitat scale) and (ii) among bromeliads with distinct architectural features (i. e., microhabitat scale). We partitioned the interspecific variation in body size and shape into phylogenetic (that express trait values as expected by phylogenetic relationships among species) and ecological components (that express trait values independent of phylogenetic relationships). At the habitat scale, bromeliad spiders were larger and flatter than spiders associated with the surrounding dicots. At this scale, plant morphology sorted out close related spiders. Our results showed that spider flatness is phylogenetically clustered at the habitat scale, whereas it is phylogenetically overdispersed at the microhabitat scale, although phylogenic signal is present in both scales. Taken together, these results suggest that whereas at the habitat scale selective colonization affect spider body size and shape, at fine scales both selective colonization and adaptive evolution determine spider body shape. By partitioning the phylogenetic and ecological components of phenotypic variation, we were able to disentangle the evolutionary history of distinct spider traits and show that plant architecture plays a role in the evolution of spider body size and shape. We also discussed the relevance in considering multiple scales when studying phylogenetic community structure.	[Goncalves-Souza, Thiago] Univ Estadual Paulista, Programa Posgrad Biol Anim, Dept Zool & Bot, Sao Jose Do Rio Preto, SP, Brazil; [Felizola Diniz-Filho, Jose Alexandre] Univ Fed Goias, Dept Ecol, Inst Ciencias Biol, Goiania, Go, Brazil; [Romero, Gustavo Quevedo] Univ Estadual Campinas, Dept Biol Anim, Inst Biol, Campinas, SP, Brazil	Universidade Estadual Paulista; Universidade Federal de Goias; Universidade de Sao Paulo; Universidade Estadual de Campinas	Goncalves-Souza, T (corresponding author), Univ Estadual Campinas, Dept Biol Anim, Inst Biol, Campinas, SP, Brazil.	tgoncalves.souza@gmail.com	Souza, Thiago Gonçalves/E-3813-2012; Diniz-Filho, José Alexandre Felizola/D-9405-2013; Romero, Gustavo Q/N-1896-2019; Romero, Gustavo Q/H-8974-2012	Souza, Thiago Gonçalves/0000-0001-8471-7479; Diniz-Filho, José Alexandre Felizola/0000-0002-0967-9684; Romero, Gustavo Q/0000-0003-3736-4759; Romero, Gustavo Q/0000-0003-3736-4759	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP; Conselho Nacional de Pesquisa/CNPq productivity fellowships	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa/CNPq productivity fellowships	GQR and TGS were funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP. JAFDF and GQR have been supported by Conselho Nacional de Pesquisa/CNPq productivity fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Atkinson David, 2007, P33, DOI 10.1017/CBO9780511611223.004; BENZING DH, 2000, BROMELIACEAE PROFILE; Bro-Jorgensen J, 2008, OIKOS, V117, P729, DOI 10.1111/j.0030-1299.2008.16069.x; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Desdevises Y, 2003, EVOLUTION, V57, P2647; Dias Sidclay Calaça, 2004, Rev. Bras. Zool., V21, P789, DOI 10.1590/S0101-81752004000400011; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Diniz JAF, 2012, ECOGRAPHY, V35, P239, DOI 10.1111/j.1600-0587.2011.06949.x; Diniz JAF, 2012, EVOLUTION, V66, P1079, DOI 10.1111/j.1558-5646.2011.01499.x; Diniz JAF, 2009, J BIOGEOGR, V36, P2222, DOI 10.1111/j.1365-2699.2009.02163.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Goncalves-Souza T, 2011, AUSTRAL ECOL, V36, P476, DOI 10.1111/j.1442-9993.2010.02177.x; Goodman BA, 2008, BIOL J LINN SOC, V94, P399, DOI 10.1111/j.1095-8312.2008.00988.x; Goodman BA, 2008, ECOLOGY, V89, P3462, DOI 10.1890/07-2093.1; Hare KM, 2009, HERPETOLOGICA, V65, P227, DOI 10.1655/08-032R2.1; HEDGES S B, 1989, Caribbean Journal of Science, V25, P123; Kelt DA, 1998, BIODIVERSITY DYNAMICS, P109; LIGHTON JRB, 1995, PHYSIOL ZOOL, V68, P43, DOI 10.1086/physzool.68.1.30163917; Moya-Larano J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001841; NORBERG RA, 1994, P ROY SOC B-BIOL SCI, V257, P227, DOI 10.1098/rspb.1994.0119; Piccoli GCO, 2011, HIST NATURAL ARANHA; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Polo V, 1999, J ANIM ECOL, V68, P324, DOI 10.1046/j.1365-2656.1999.00282.x; Remmel T, 2009, J ANIM ECOL, V78, P973, DOI 10.1111/j.1365-2656.2009.01566.x; Romero GQ, 2010, J ANIM ECOL, V79, P1122, DOI 10.1111/j.1365-2656.2010.01716.x; Romero GQ, 2008, ECOLOGY, V89, P3105, DOI 10.1890/08-0267.1; Sillett T. Scott, 1997, Ornithological Monographs, V48, P733; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Staggemeier VG, 2010, J ECOL, V98, P1409, DOI 10.1111/j.1365-2745.2010.01717.x; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Thomaz LD, 1997, BRENTWOOD BAY ME 193, P3; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; Wendt T, 2008, PLANT SYST EVOL, V275, P31, DOI 10.1007/s00606-008-0054-7	35	15	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89314	10.1371/journal.pone.0089314	http://dx.doi.org/10.1371/journal.pone.0089314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24651264	gold, Green Submitted, Green Published			2022-12-25	WOS:000331711900123
J	Wen, Z; Liu, H; Li, M; Li, B; Gao, W; Shao, Q; Fan, B; Zhao, F; Wang, Q; Xie, Q; Yang, Y; Yu, J; Qu, X				Wen, Z.; Liu, H.; Li, M.; Li, B.; Gao, W.; Shao, Q.; Fan, B.; Zhao, F.; Wang, Q.; Xie, Q.; Yang, Y.; Yu, J.; Qu, X.			Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration	ONCOGENE			English	Article							NECROSIS-FACTOR-ALPHA; ISCHEMIC TISSUES; GENE-EXPRESSION; GROWTH-FACTOR; MOUSE MODEL; PROGRESSION; CARCINOMA; PATHWAYS; LIPOXYGENASE; MATRILYSIN	5-lipoxygenase (5-LOX), a member of the lipoxygenase gene family, is a key enzyme assisting in the conversion of arachidonic acid to 5-HETE and leukotrienes. Tumor-associated macrophages (TAMs) have a critical role in the progression and metastasis of many tumors, including ovarian tumors. Moreover, TAMs are often found in a high density in the hypoxic areas of tumors. However, the relevant mechanisms have not been studied explicitly until now. In this study, we found that the expression of 5-LOX strongly correlated with the density of TAMs in hypoxic areas of human ovarian tumor tissues. In cultured ovarian cancer cells, 5-LOX metabolites were increased under hypoxic conditons. Increased 5-LOX metabolites from hypoxic ovarian cancer cells promoted migration and invasion of macrophages, which was further demonstrated to be mediated by the upregulation of matrix metalloproteinase (MMP)-7 expression through the p38 pathway. Besides, we also showed that 5-LOX metabolites enhanced the release of tumor necrosis factor (TNF-alpha) and heparin-binding epidermal growth factor-like growth factor through upregulation of MMP-7. Furthermore, in animal models, Zileuton (a selective and specific 5-LOX inhibitor) reduced the MMP-7 expression and the number of macrophages infiltrating in the xenograft. Our findings suggest for the first time that increased metabolites of 5-LOX from hypoxic ovarian cancer cells promote TAM infiltration. These results of this study have immediate translational implications for the therapeutic exploitation of TAMs.	[Wen, Z.; Liu, H.; Gao, W.; Shao, Q.; Wang, Q.; Xie, Q.; Yang, Y.; Qu, X.] Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan 250100, Peoples R China; [Wen, Z.; Liu, H.; Gao, W.; Shao, Q.; Wang, Q.; Xie, Q.; Yang, Y.; Qu, X.] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250100, Peoples R China; [Li, M.; Li, B.; Fan, B.; Zhao, F.; Yu, J.] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan 250117, Shandong, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Yu, J (corresponding author), Shandong Canc Hosp & Inst, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China.	jinmingyusd@126.com; xunqusd@126.com		Qu, Xun/0000-0002-2521-3761	National Natural Science Foundation of China [31270971, 81072406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Colin D Funk, Department of Physiology and Biochemistry, Queen's University for providing us with essential material and a technical guide. This study was supported by National Natural Science Foundation of China (Nos. 31270971, 81072406).	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bingham BA, 2013, CLIN NUCL MED, V38, pE140, DOI 10.1097/RLU.0b013e318263869d; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bonizzi G, 1999, MOL CELL BIOL, V19, P1950; Brigatte P, 2011, AMINO ACIDS, V40, P101, DOI 10.1007/s00726-010-0512-8; Burke B, 2003, AM J PATHOL, V163, P1233, DOI 10.1016/S0002-9440(10)63483-9; Camp RL, 1999, CANCER, V86, P2259, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2; Chang MC, 2012, BIOCHEM J, V442, P293, DOI 10.1042/BJ20110282; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Chu J, 2011, AM J PATHOL, V178, P1762, DOI 10.1016/j.ajpath.2010.12.032; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Dunsmore SE, 1998, J CLIN INVEST, V102, P1321, DOI 10.1172/JCI1516; Freedman RS, 2007, CLIN CANCER RES, V13, P5736, DOI 10.1158/1078-0432.CCR-07-0583; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; Horiuchi A, 2012, INT J CANCER, V131, P1755, DOI 10.1002/ijc.27448; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Johnson N, 2011, NAT MED, V17, P875, DOI 10.1038/nm.2377; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kioi M, 2003, ONCOGENE, V22, P8662, DOI 10.1038/sj.onc.1207181; Kummer NT, 2012, J CELL BIOCHEM, V113, P1998, DOI 10.1002/jcb.24069; Lee SK, 2012, INT J CANCER, V131, pE190, DOI 10.1002/ijc.27381; Lewis JS, 2000, J PATHOL, V192, P150, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Maniecki MB, 2012, INT J CANCER, V131, P2320, DOI 10.1002/ijc.27506; Megias J, 2007, BRIT J PHARMACOL, V150, P977, DOI 10.1038/sj.bjp.0707184; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Murdoch C, 2005, INT J CANCER, V117, P701, DOI 10.1002/ijc.21422; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Negus RPM, 1997, AM J PATHOL, V150, P1723; Negus RPM, 1998, J LEUKOCYTE BIOL, V63, P758, DOI 10.1002/jlb.63.6.758; Phuangsab A, 2001, CANCER LETT, V172, P27, DOI 10.1016/S0304-3835(01)00617-6; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Reinartz S, 2014, INT J CANCER, V134, P32, DOI 10.1002/ijc.28335; Rocconi RP, 2008, REPROD SCI, V15, P321, DOI 10.1177/1933719108316390; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Ruhrberg C, 2010, NAT MED, V16, P861, DOI 10.1038/nm0810-861; Schroder A, 2013, J UROLOGY, V189, P2377, DOI 10.1016/j.juro.2012.12.110; Sitia G, 2004, J CLIN INVEST, V113, P1158, DOI 10.1172/JCI200421087; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wen ZH, 2013, ONCOGENE, V32, P160, DOI 10.1038/onc.2012.47; Yamaguchi Tatsuyuki, 1995, Life Sciences, V56, P379; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702	54	61	63	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2015	34	10					1241	1252		10.1038/onc.2014.85	http://dx.doi.org/10.1038/onc.2014.85			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC9JX	24662827				2022-12-25	WOS:000350687100004
J	Chen, H; Zheng, X; Chen, YG; Li, M; Liu, K; Li, X				Chen, Hong; Zheng, Xiong; Chen, Yinguang; Li, Mu; Liu, Kun; Li, Xiang			Influence of Copper Nanoparticles on the Physical-Chemical Properties of Activated Sludge	PLOS ONE			English	Article							BIOLOGICAL PHOSPHORUS REMOVAL; EXTRACELLULAR POLYMERIC SUBSTANCES; WASTE-WATER; SILVER NANOPARTICLES; TITANIUM-DIOXIDE; SHOCK LOAD; STABILITY; SURFACE; FLOCS; BIOFLOCCULATION	The physical-chemical properties of activated sludge, such as flocculating ability, hydrophobicity, surface charge, settleability, dewaterability and bacteria extracellular polymer substances (EPS), play vital roles in the normal operation of wastewater treatment plants (WWTPs). The nanoparticles released from commercial products will enter WWTPs and can induce potential adverse effects on activated sludge. This paper focused on the effects of copper nanoparticles (CuNPs) on these specific physical-chemical properties of activated sludge. It was found that most of these properties were unaffected by the exposure to lower CuNPs concentration (5 ppm), but different observation were made at higher CuNPs concentrations (30 and 50 ppm). At the higher CuNPs concentrations, the sludge surface charge increased and the hydrophobicity decreased, which were attributed to more Cu2+ ions released from the CuNPs. The carbohydrate content of EPS was enhanced to defense the toxicity of CuNPs. The flocculating ability was found to be deteriorated due to the increased cell surface charge, the decreased hydrophobicity, and the damaged cell membrane. The worsened flocculating ability made the sludge flocs more dispersed, which further increased the toxicity of the CuNPs by increasing the availability of the CuNPs to the bacteria present in the sludge. Further investigation indicated that the phosphorus removal efficiency decreased at higher CuNPs concentrations, which was consistent with the deteriorated physical-chemical properties of activated sludge. It seems that the physical-chemical properties can be used as an indicator for determining CuNPs toxicity to the bacteria in activated sludge. This work is important because bacteria toxicity effects to the activated sludge caused by nanoparticles may lead to the deteriorated treatment efficiency of wastewater treatment, and it is therefore necessary to find an easy way to indicate this toxicity.	[Chen, Hong; Zheng, Xiong; Chen, Yinguang; Li, Mu; Liu, Kun; Li, Xiang] Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China	Tongji University	Chen, YG (corresponding author), Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.	yinguangchen@tongji.edu.cn	Zheng, Xiong/Q-4336-2016	Zheng, Xiong/0000-0002-5327-1248; li, xiang/0000-0001-7110-8316; li, xiang/0000-0001-7409-8109	National Science Foundation of China;  [51278354]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This manuscript was financially supported by the National Science Foundation of China. The relevant grant number is 51278354, and the funder's website is http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Biggs CA, 2000, WATER RES, V34, P2542, DOI 10.1016/S0043-1354(99)00431-5; Brumfiel G, 2006, NATURE, V440, P262, DOI 10.1038/440262a; BRUUS JH, 1992, WATER RES, V26, P1597, DOI 10.1016/0043-1354(92)90159-2; CABANISS SE, 1992, ENVIRON SCI TECHNOL, V26, P1133, DOI 10.1021/es50002a018; Chen H, 2013, RSC ADV, V3, P9835, DOI 10.1039/c3ra40989a; Chen YG, 2012, J HAZARD MATER, V239, P88, DOI 10.1016/j.jhazmat.2012.07.049; Duan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058640; Ganesh R, 2010, ENVIRON SCI TECHNOL, V44, P7808, DOI 10.1021/es101355k; Henze M., 1995, WASTEWATER TREATMENT, DOI 10.1007/978-3-662-04806-1; Hoa PT, 2003, WATER SA, V29, P437; Jin B, 2003, CHEM ENG J, V95, P221, DOI 10.1016/S1385-8947(03)00108-6; Jorand F, 1998, WATER SCI TECHNOL, V37, P307, DOI 10.2166/wst.1998.0652; Joshi PM, 2009, ENVIRON SCI TECHNOL, V43, P5884, DOI 10.1021/es900063b; Kaegi R, 2011, ENVIRON SCI TECHNOL, V45, P3902, DOI 10.1021/es1041892; Keiding K, 2001, WATER SCI TECHNOL, V43, P17, DOI 10.2166/wst.2001.0330; Kim B, 2010, ENVIRON SCI TECHNOL, V44, P7509, DOI 10.1021/es101565j; Li XY, 2007, WATER RES, V41, P1022, DOI 10.1016/j.watres.2006.06.037; Liang ZH, 2010, WATER RES, V44, P5432, DOI 10.1016/j.watres.2010.06.060; Liao BQ, 2001, WATER RES, V35, P339, DOI 10.1016/S0043-1354(00)00277-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madoni P, 1999, WATER RES, V33, P2459, DOI 10.1016/S0043-1354(98)00455-2; Mikkelsen LH, 2002, WATER RES, V36, P2451, DOI 10.1016/S0043-1354(01)00477-8; Mu H, 2012, ENVIRON SCI TECHNOL, V46, P5997, DOI 10.1021/es300616a; Oehmen A, 2007, WATER RES, V41, P2271, DOI 10.1016/j.watres.2007.02.030; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8; Sani RK, 2001, APPL ENVIRON MICROB, V67, P4765, DOI 10.1128/AEM.67.10.4765-4772.2001; Serafim LS, 2004, BIOTECHNOL BIOENG, V87, P145, DOI 10.1002/bit.20085; Sheng GP, 2006, WATER RES, V40, P1233, DOI 10.1016/j.watres.2006.01.023; Shin H.S., 2000, BIOTECHNOL BIOPROCES, V5, P460, DOI DOI 10.1007/BF02931948; The Project on Emerging Nanotechnologies, NAN EN CONS PROD CON; Tong JA, 2007, ENVIRON SCI TECHNOL, V41, P7126, DOI 10.1021/es071002n; URBAIN V, 1993, WATER RES, V27, P829, DOI 10.1016/0043-1354(93)90147-A; Wilen BM, 2003, WATER RES, V37, P2127, DOI 10.1016/S0043-1354(02)00629-2; Wolterbeek HT, 2005, ASSAY DRUG DEV TECHN, V3, P675, DOI 10.1089/adt.2005.3.675; Wu FC, 2001, GEOCHEM J, V35, P333, DOI 10.2343/geochemj.35.333; Xiong Zheng YC, 2011, ENV SCI TECHNOL; Yan Q, 2008, APPL BIOCHEM BIOTECH, V150, P259, DOI 10.1007/s12010-008-8176-5; Yang XN, 2013, WATER RES, V47, P3947, DOI 10.1016/j.watres.2013.01.056; Zheng X, 2012, ENVIRON SCI TECHNOL, V46, P7182, DOI 10.1021/es300777b; Zheng X, 2011, ENVIRON SCI TECHNOL, V45, P7284, DOI 10.1021/es2008598; Zheng XO, 2011, ENVIRON SCI TECHNOL, V45, P2826, DOI 10.1021/es2000744; ZITA A, 1994, APPL ENVIRON MICROB, V60, P3041, DOI 10.1128/AEM.60.9.3041-3048.1994	43	30	30	4	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92871	10.1371/journal.pone.0092871	http://dx.doi.org/10.1371/journal.pone.0092871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663333	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900126
J	Mukherjee, A; Larson, EA; Klein, RF; Rotwein, P				Mukherjee, Aditi; Larson, Emily A.; Klein, Robert F.; Rotwein, Peter			Distinct Actions of Akt1 on Skeletal Architecture and Function	PLOS ONE			English	Article							MICE LACKING; OSTEOBLAST DIFFERENTIATION; CELL-SURVIVAL; PHOSPHATIDYLINOSITOL 3-KINASE; GLUCOSE-HOMEOSTASIS; BONE; GROWTH; KINASE; OSTEOCLAST; INSULIN	Skeletal integrity is dependent on the coordinated actions of bone-forming osteoblasts and bone-resorbing osteoclasts, which recognize and respond to multiple environmental inputs. Here we have studied the roles in bone development and growth of Akt1 and Akt2, two closely related signaling proteins, by evaluating mice lacking either of these enzymes. Global deficiency of Akt1 but not Akt2 caused a reduction in whole body and femoral bone mineral density, in femoral cortical thickness and volume, and in trabecular thickness in both males and females when measured at 20-weeks of age, which was reflected in diminished femoral resistance to fracture. Haplo-deficiency of Akt1 in male mice also decreased femoral cortical and trabecular skeletal parameters, and reduced bone strength. Cell-based studies showed that genetic Akt1 deficiency diminished the rate of proliferation of osteoblast progenitors and impaired osteoclast differentiation in primary culture but that loss of Akt2 did not. Our results demonstrate differential effects of Akt1 and Akt2 on skeletal maturation and architecture through actions on both osteoblast and osteoclast precursors.	[Mukherjee, Aditi; Rotwein, Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Larson, Emily A.; Klein, Robert F.] Oregon Hlth & Sci Univ, Dept Med, Bone & Mineral Res Unit, Portland, OR 97201 USA; [Klein, Robert F.] Oregon Hlth & Sci Univ, Portland Vet Affairs Med Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; VA Portland Health Care System	Rotwein, P (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	NIH [R01 DK42748]; VA Medical Research Service; OHSU Medical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Medical Research Service(US Department of Veterans Affairs); OHSU Medical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported in part by NIH grant R01 DK42748 (to P. R.), by the VA Medical Research Service (R. F. K.), and by an OHSU Medical Research Foundation new investigator grant (to A. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amer Y, 2000, J BIOL CHEM, V275, P27307; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brandi ML, 2009, RHEUMATOLOGY, V48, pIV3, DOI 10.1093/rheumatology/kep273; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Ferrari S, 2008, BEST PRACT RES CL EN, V22, P723, DOI 10.1016/j.beem.2008.08.007; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Henriksen K, 2011, ENDOCR REV, V32, P31, DOI 10.1210/er.2010-0006; Karaguzel G, 2010, REV ENDOCR METAB DIS, V11, P237, DOI 10.1007/s11154-010-9154-0; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Khosla S, 2007, NEW ENGL J MED, V356, P2293, DOI 10.1056/NEJMcp070341; Klein R. F., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P287; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; McGonnell Imelda M, 2012, Front Endocrinol (Lausanne), V3, P88, DOI 10.3389/fendo.2012.00088; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P1238, DOI 10.1210/me.2008-0001; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P206, DOI 10.1210/me.2007-0336; Mukherjee A, 2012, J BONE MINER RES, V27, P1345, DOI 10.1002/jbmr.1590; Mukherjee A, 2012, MOL CELL BIOL, V32, P490, DOI 10.1128/MCB.06361-11; Mukherjee A, 2009, J CELL SCI, V122, P716, DOI 10.1242/jcs.042770; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Ohlsson Claes, 2012, Bonekey Rep, V1, P2, DOI 10.1038/bonekey.2012.3; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; Oury F, 2012, ANN NY ACAD SCI, V1260, P1, DOI 10.1111/j.1749-6632.2011.06360.x; Patil CK, 2013, CELL, V154, P481, DOI 10.1016/j.cell.2013.07.022; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Somerville JN, 2004, CALCIFIED TISSUE INT, V74, P469, DOI 10.1007/s00223-003-0101-x; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Toker A, 2011, ADV ENZYME REGUL, V52, P78; Tu QS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.152405; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1925, DOI 10.1016/j.bbamcr.2011.08.014; Xiong Q, 2009, GENOMICS, V93, P401, DOI 10.1016/j.ygeno.2008.12.008; Xu XH, 2010, ENDOCR REV, V31, P447, DOI 10.1210/er.2009-0032; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	50	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93040	10.1371/journal.pone.0093040	http://dx.doi.org/10.1371/journal.pone.0093040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663486	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900147
J	Soong, RS; Song, LW; Trieu, J; Lee, SY; He, LM; Tsai, YC; Wu, TC; Hung, CF				Soong, Ruey-Shyang; Song, Liwen; Trieu, Janson; Lee, Sung Yong; He, Liangmei; Tsai, Ya-Chea; Wu, T. -C.; Hung, Chien-Fu			Direct T Cell Activation via CD40 Ligand Generates High Avidity CD8(+) T Cells Capable of Breaking Immunological Tolerance for the Control of Tumors	PLOS ONE			English	Article							INTRACELLULAR TARGETING STRATEGIES; DENDRITIC CELLS; DNA VACCINES; GENE-EXPRESSION; CANCER; MEMORY; LYMPHOCYTES; INDUCTION; ANTIGEN; IMMUNOTHERAPY	CD40 and CD40 ligand (CD40L) are costimulatory molecules that play a pivotal role in the proinflammatory immune response. Primarily expressed by activated CD4(+) T cells, CD40L binds to CD40 on antigen presenting cells (APCs), thereby inducing APC activation. APCs, in turn, prime cytotoxic T lymphocytes (CTLs). Here, two tumor-associated antigen (TAA) animal models, p53-based and GP100-based, were utilized to examine the ability of CD40-CD40L to improve antigenspecific CTL-mediated antitumor immune responses. Although p53 and GP100 are self-antigens that generate low affinity antigen-specific CD8(+) T cells, studies have shown that their functional avidity can be improved with CD40L-expressing APCs. Therefore, in the current study, we immunized mice with a DNA construct encoding a TAA in conjunction with another construct encoding CD40L via intramuscular injection followed by electroporation. We observed a significant increase in the antigen-specific CTL-mediated immune responses as well as the potent antitumor effects in both models. Antibody depletion experiments demonstrated that CD8(+) T cells play a crucial role in eliciting antitumor effects in vaccinated mice. Furthermore, we showed that in vitro stimulation with irradiated tumor cells expressing both TAA and CD40L improved the functional avidity of antigen-specific CD8(+) T cells. Thus, our data show that vaccination with TAA/CD40L DNA can induce potent antitumor effects against TAA-expressing tumors through the generation of better functioning antigen-specific CD8(+) T cells. Our study serves as an important foundation for future clinical translation.	[Soong, Ruey-Shyang; Song, Liwen; Lee, Sung Yong; He, Liangmei; Tsai, Ya-Chea; Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Wu, T. -C.] Johns Hopkins Med Inst, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; [Wu, T. -C.] Johns Hopkins Med Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Soong, Ruey-Shyang] Chang Gung Mem Hosp Keelung, Dept Gen Surg, Keelung, Taiwan; [Soong, Ruey-Shyang] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Song, Liwen] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Song, Liwen] Shanghai Inst Planned Parenthood Res, Dept Pharmacol & Toxicol, Shanghai, Peoples R China; [Song, Liwen] Tongji Univ, Dept Obstet & Gynecol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Trieu, Janson] Johns Hopkins Univ, Baltimore, MD USA; [Lee, Sung Yong] Korea Univ, Dept Internal Med, Med Ctr, Seoul, South Korea	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Chang Gung Memorial Hospital; Chang Gung University; Fudan University; Tongji University; Johns Hopkins University; Korea University; Korea University Medicine (KU Medicine)	Wu, TC (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	wutc@jhmi.edu; chung2@jhmi.edu		LEE, SUNG YONG/0000-0002-8693-5792; Song, Liwen/0000-0002-5013-2007	National Institutes of Health/National Cancer Institute Cervical Cancer SPORE [P50CA098252, 2R01CA114425-06]; Chang Gung Memorial Hospital, Keelung, Taiwan [CMRPG2C0371]; NATIONAL CANCER INSTITUTE [P50CA098252, R01CA114425] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute Cervical Cancer SPORE; Chang Gung Memorial Hospital, Keelung, Taiwan(Chang Gung Memorial Hospital); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health/National Cancer Institute Cervical Cancer SPORE P50CA098252 and 2R01CA114425-06 grants and by CMRPG2C0371 from Chang Gung Memorial Hospital, Keelung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Best SR, 2009, VACCINE, V27, P5450, DOI 10.1016/j.vaccine.2009.07.005; Boise LH, 1997, P NATL ACAD SCI USA, V94, P3759, DOI 10.1073/pnas.94.8.3759; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Chang CL, 2007, GENE THER, V14, P1189, DOI 10.1038/sj.gt.3302974; Cheng WF, 2001, J CLIN INVEST, V108, P669, DOI 10.1172/JCI200112346; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Cho HI, 2009, CANCER RES, V69, P9012, DOI 10.1158/0008-5472.CAN-09-2019; Dahl AM, 1996, J IMMUNOL, V157, P239; de Gruijl TD, 2002, J IMMUNOL, V169, P5322, DOI 10.4049/jimmunol.169.9.5322; DeBenedette MA, 2008, J IMMUNOL, V181, P5296, DOI 10.4049/jimmunol.181.8.5296; Disis ML, 2009, LANCET, V373, P673, DOI 10.1016/S0140-6736(09)60404-9; Forero-Torres A, 2013, LEUKEMIA LYMPHOMA, V54, P277, DOI 10.3109/10428194.2012.710328; FOX BA, 1990, J BIOL RESP MODIF, V9, P499; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Hangalapura BN, 2012, J GENE MED, V14, P416, DOI 10.1002/jgm.1648; Hangalapura BN, 2010, J IMMUNOTHER, V33, P706, DOI 10.1097/CJI.0b013e3181eccbd4; Hung CF, 2007, GENE THER, V14, P921, DOI 10.1038/sj.gt.3302913; Ishizaki H, 2010, J IMMUNOTHER, V33, P609, DOI 10.1097/CJI.0b013e3181e032c6; Ji HX, 1999, HUM GENE THER, V10, P2727, DOI 10.1089/10430349950016474; Johnson S, 2009, IMMUNITY, V30, P218, DOI 10.1016/j.immuni.2008.11.015; Jones DS, 2008, J IMMUNOL, V181, P1760, DOI 10.4049/jimmunol.181.3.1760; Kang TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035141; Kato K, 1998, J CLIN INVEST, V101, P1133, DOI 10.1172/JCI1472; Khong A, 2012, INT REV IMMUNOL, V31, P246, DOI 10.3109/08830185.2012.698338; Kim TW, 2005, HUM GENE THER, V16, P26, DOI 10.1089/hum.2005.16.26; Kim TW, 2003, J IMMUNOL, V171, P2970, DOI 10.4049/jimmunol.171.6.2970; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Lee CH, 2006, MOL CANCER THER, V5, P2592, DOI 10.1158/1535-7163.MCT-06-0310; Lin KY, 1996, CANCER RES, V56, P21; Loskog Angelica, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P23; Machado-Silva A, 2010, SEMIN CANCER BIOL, V20, P57, DOI 10.1016/j.semcancer.2010.02.005; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Nemunaitis J, 2011, HEAD NECK-J SCI SPEC, V33, P131, DOI 10.1002/hed.21364; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Pedersen SR, 2013, J IMMUNOL, V191, P3955, DOI 10.4049/jimmunol.1300555; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Rizzuto GA, 2009, J EXP MED, V206, P849, DOI 10.1084/jem.20081382; Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008; Seah SGK, 2013, J LEUKOCYTE BIOL, V93, P145, DOI 10.1189/jlb.0612266; Soong RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056912; Suttles J, 2009, SEMIN IMMUNOL, V21, P257, DOI 10.1016/j.smim.2009.05.011; Suzuki I, 1998, J EXP MED, V187, P123, DOI 10.1084/jem.187.1.123; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Vierboom MPM, 2000, CANCER RES, V60, P5508; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059	50	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93162	10.1371/journal.pone.0093162	http://dx.doi.org/10.1371/journal.pone.0093162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664420	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900160
J	Matsumoto, A; Mizuno, M; Hamada, N; Nozaki, Y; Jimbo, EF; Momoi, MY; Nagata, K; Yamagata, T				Matsumoto, Ayumi; Mizuno, Makoto; Hamada, Nanako; Nozaki, Yasuyuki; Jimbo, Eriko F.; Momoi, Mariko Y.; Nagata, Koh-ichi; Yamagata, Takanori			LIN7A Depletion Disrupts Cerebral Cortex Development, Contributing to Intellectual Disability in 12q21-Deletion Syndrome	PLOS ONE			English	Article							FACIO-CUTANEOUS SYNDROME; NEURONAL MIGRATION; INTERSTITIAL DELETION; MENTAL-RETARDATION; CANDIDATE REGION; BRAIN; PROTEIN; ELECTROPORATION; IDENTIFICATION; DOUBLECORTIN	Interstitial deletion of 12q21 has been reported in four cases, which share several common clinical features, including intellectual disability (ID), low-set ears, and minor cardiac abnormalities. Comparative genomic hybridization (CGH) analysis using the Agilent Human Genome CGH 180K array was performed with the genomic DNA from a two-year-old Japanese boy with these symptoms, as well as hypoplasia of the corpus callosum. Consequently, a 14 Mb deletion at 12q21.2-q21.33 (nt. 77 203 574-91 264 613 bp), which includes 72 genes, was detected. Of these, we focused on LIN7A, which encodes a scaffold protein that is important for synaptic function, as a possible responsible gene for ID, and we analyzed its role in cerebral cortex development. Western blotting analyses revealed that Lin-7A is expressed on embryonic day (E) 13.5, and gradually increases in the mouse brain during the embryonic stage. Biochemical fractionation resulted in the enrichment of Lin-7A in the presynaptic fraction. Suppression of Lin-7A expression by RNAi, using in utero electroporation on E14.5, delayed neuronal migration on postnatal day (P) 2, and Lin-7A-deficient neurons remained in the lower zone of the cortical plate and the intermediate zone. In addition, when Lin-7A was silenced in cortical neurons in one hemisphere, axonal growth in the contralateral hemisphere was delayed; development of these neurons was disrupted such that one half did not extend into the contralateral hemisphere after leaving the corpus callosum. Taken together, LIN7A is a candidate gene responsible for 12q21-deletion syndrome, and abnormal neuronal migration and interhemispheric axon development may contribute to ID and corpus callosum hypoplasia, respectively.	[Matsumoto, Ayumi; Nozaki, Yasuyuki; Jimbo, Eriko F.; Momoi, Mariko Y.; Yamagata, Takanori] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan; [Mizuno, Makoto; Hamada, Nanako; Nagata, Koh-ichi] Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, Kasugai, Aichi, Japan	Jichi Medical University	Yamagata, T (corresponding author), Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan.	takanori@jichi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23390275]; MEXT; Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the grant from Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 23390275), MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2011-2015 (Cooperative Basic and Clinical Research on Circadian Medicine). And also Grants-in-Aid for Scientific Research on Priority Area, Challenging Exploratory Research and Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and a grant from Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Brady AF, 1999, J MED GENET, V36, P939; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Corbo JC, 2002, J NEUROSCI, V22, P7548; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Humeau Y, 2009, J NEUROCHEM, V109, P1, DOI 10.1111/j.1471-4159.2009.05881.x; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Inaguma Y, 2014, EMBO MOL ME IN PRESS; Ito H, 2009, J NEUROCHEM, V108, P867, DOI 10.1111/j.1471-4159.2008.05849.x; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Klein OD, 2005, AM J MED GENET A, V138A, P349, DOI 10.1002/ajmg.a.30867; Lanktree M, 2008, AM J MED GENET B, V147B, P945, DOI 10.1002/ajmg.b.30723; Misawa H, 2001, J BIOL CHEM, V276, P9264, DOI 10.1074/jbc.M009334200; Mizutani Y, 2013, BIOL CHEM, V394, P281, DOI 10.1515/hsz-2012-0258; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Nishimura YV, 2012, MED MOL MORPHOL, V45, P1, DOI 10.1007/s00795-011-0557-0; Rauen KA, 2000, AM J MED GENET, V93, P219, DOI 10.1002/1096-8628(20000731)93:3<219::AID-AJMG12>3.0.CO;2-5; Rauen KA, 2002, AM J MED GENET, V110, P51, DOI 10.1002/ajmg.10478; Reiner O, 2009, MOL NEUROBIOL, V40, P1, DOI 10.1007/s12035-009-8065-0; Shinawi M, 2011, AM J MED GENET A, V155A, P1272, DOI 10.1002/ajmg.a.33878; Shinoda T, 2010, MOL BIOL CELL, V21, P1324, DOI 10.1091/mbc.E09-10-0869; Sudo K, 2006, NEUROSCI RES, V56, P347, DOI 10.1016/j.neures.2006.08.003; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; WISE SP, 1975, BRAIN RES, V90, P139, DOI 10.1016/0006-8993(75)90688-5; Zheng CY, 2011, NEUROSCIENTIST, V17, P493, DOI 10.1177/1073858410386384; Zhou J, 2013, P NATL ACAD SCI USA, V110, pE2714, DOI 10.1073/pnas.1310233110; Zucker B, 2010, J NEUROPATH EXP NEUR, V69, P880, DOI 10.1097/NEN.0b013e3181ed7a41	30	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92695	10.1371/journal.pone.0092695	http://dx.doi.org/10.1371/journal.pone.0092695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658322	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300117
J	Taha, MS; Nouri, K; Milroy, LG; Moll, JM; Herrmann, C; Brunsveld, L; Piekorz, RP; Ahmadian, MR				Taha, Mohamed S.; Nouri, Kazem; Milroy, Lech G.; Moll, Jens M.; Herrmann, Christian; Brunsveld, Luc; Piekorz, Roland P.; Ahmadian, Mohammad R.			Subcellular Fractionation and Localization Studies Reveal a Direct Interaction of the Fragile X Mental Retardation Protein (FMRP) with Nucleolin	PLOS ONE			English	Article							MESSENGER-RNA; INTRACELLULAR-LOCALIZATION; BINDING PROTEINS; CELL-CYCLE; IDENTIFICATION; NUCLEAR; POLYRIBOSOMES; ASSOCIATION; MITOCHONDRIA; TRANSLATION	Fragile X mental Retardation Protein (FMRP) is a well-known regulator of local translation of its mRNA targets in neurons. However, despite its ubiquitous expression, the role of FMRP remains ill-defined in other cell types. In this study we investigated the subcellular distribution of FMRP and its protein complexes in HeLa cells using confocal imaging as well as detergent-free fractionation and size exclusion protocols. We found FMRP localized exclusively to solid compartments, including cytosolic heavy and light membranes, mitochondria, nuclear membrane and nucleoli. Interestingly, FMRP was associated with nucleolin in both a high molecular weight ribosomal and translation-associated complex (>= 6 MDa) in the cytosol, and a low molecular weight complex (similar to 200 kDa) in the nucleoli. Consistently, we identified two functional nucleolar localization signals (NoLSs) in FMRP that are responsible for a strong nucleolar colocalization of the C-terminus of FMRP with nucleolin, and a direct interaction of the N-terminus of FMRP with the arginine-glycine-glycine (RGG) domain of nucleolin. Taken together, we propose a novel mechanism by which a transient nucleolar localization of FMRP underlies a strong nucleocytoplasmic translocation, most likely in a complex with nucleolin and possibly ribosomes, in order to regulate translation of its target mRNAs.	[Taha, Mohamed S.; Nouri, Kazem; Moll, Jens M.; Piekorz, Roland P.; Ahmadian, Mohammad R.] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Milroy, Lech G.; Brunsveld, Luc] Tech Univ Eindhoven, Biol Chem Lab, NL-5600 MB Eindhoven, Netherlands; [Milroy, Lech G.; Brunsveld, Luc] Tech Univ Eindhoven, Inst Complex Mol Syst, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Herrmann, Christian] Ruhr Univ Bochum, Dept Phys Chem 1, Bochum, Germany	Heinrich Heine University Dusseldorf; Eindhoven University of Technology; Eindhoven University of Technology; Ruhr University Bochum	Ahmadian, MR (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	taha, mohamed/W-8321-2019	Nouri, Kazem/0000-0001-7787-1304; Taha, Mohamed/0000-0002-7121-9283; Brunsveld, Luc/0000-0001-5675-511X	German Academic Exchange Service (DAAD); International Graduate School of Protein Science and Technology (iGRASP); Strategic Research Fund (SFF) of the Heinrich-Heine University Dusseldorf [F-2012/79-6]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); International Graduate School of Protein Science and Technology (iGRASP); Strategic Research Fund (SFF) of the Heinrich-Heine University Dusseldorf	This work was supported in part by the German Academic Exchange Service (DAAD), the International Graduate School of Protein Science and Technology (iGRASP) and by the Strategic Research Fund (SFF) of the Heinrich-Heine University Dusseldorf (Grant F-2012/79-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Adams-Cioaba MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013559; Adinolfi S, 2003, BIOCHEMISTRY-US, V42, P10437, DOI 10.1021/bi034909g; Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Bardoni B, 2003, EXP CELL RES, V289, P95, DOI 10.1016/S0014-4827(03)00222-2; Bardoni B, 2003, HUM MOL GENET, V12, P1689, DOI 10.1093/hmg/ddg181; Bardoni B, 1997, NEUROBIOL DIS, V4, P329, DOI 10.1006/nbdi.1997.0142; Bardoni B, 2001, BRAIN RES BULL, V56, P375, DOI 10.1016/S0361-9230(01)00647-5; Bardoni Barbara, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010751; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Blackwell E, 2010, HUM MOL GENET, V19, P1314, DOI 10.1093/hmg/ddq007; Brackett DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058296; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Callebaut C, 1996, VIROLOGY, V218, P181, DOI 10.1006/viro.1996.0178; Callebaut C, 1998, J BIOL CHEM, V273, P21988, DOI 10.1074/jbc.273.34.21988; Callebaut C, 1997, J BIOL CHEM, V272, P7159, DOI 10.1074/jbc.272.11.7159; Caudle WM, 2009, NEUROSCI LETT, V459, P11, DOI 10.1016/j.neulet.2009.04.060; Ceman S, 1999, MOL CELL BIOL, V19, P7925; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Ceman S, 2000, BIOCHEM BIOPH RES CO, V279, P904, DOI 10.1006/bbrc.2000.4035; Collins SC, 2010, AM J MED GENET A, V152A, P2512, DOI 10.1002/ajmg.a.33626; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Darnell JC, 2013, NAT NEUROSCI; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davidovic L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003367; Dolzhanskaya N, 2006, J CELL SCI, V119, P1933, DOI 10.1242/jcs.02882; Dury AY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003890; Eberth Alexander, 2009, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1409s43; El Fatimy R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039338; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Galva C, 2012, J CELL SCI, V125, P6137, DOI 10.1242/jcs.114959; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Hoogeveen AT, 2002, MICROSC RES TECHNIQ, V57, P148, DOI 10.1002/jemt.10064; Huang L, 2011, J BIOL CHEM, V286, P24219, DOI 10.1074/jbc.M111.240259; Iacoangeli A, 2013, TRENDS BIOCHEM SCI, V38, P47, DOI 10.1016/j.tibs.2012.11.001; Jackson RS, 2007, CELL CYCLE, V6, P95, DOI 10.4161/cc.6.1.3665; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Kaplan ES, 2012, J NEUROCHEM, V123, P613, DOI 10.1111/j.1471-4159.2012.07936.x; Kim M, 2012, CURR PROTEIN PEPT SC, V13, P358, DOI 10.2174/138920312801619420; Kim M, 2009, MOL CELL BIOL, V29, P214, DOI 10.1128/MCB.01377-08; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; McLennan Y, 2011, CURR GENOMICS, V12, P216, DOI 10.2174/138920211795677886; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Ross-Inta C, 2010, BIOCHEM J, V429, P545, DOI 10.1042/BJ20091960; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Seidler NW, 2013, ADV EXP MED BIOL, V985, P61, DOI 10.1007/978-94-007-4716-6_3; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Sidorov MS, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-15; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; Tajrishi Marjan M, 2011, Commun Integr Biol, V4, P267, DOI 10.4161/cib.4.3.14884; Tamanini F, 1996, HUM MOL GENET, V5, P809, DOI 10.1093/hmg/5.6.809; Tamanini F, 2000, HUM MOL GENET, V9, P1487, DOI 10.1093/hmg/9.10.1487; Tamanini F, 1999, BIOCHEM J, V343, P517, DOI 10.1042/0264-6021:3430517; Tamanini F, 1999, HUM MOL GENET, V8, P863, DOI 10.1093/hmg/8.5.863; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552; Wang T, 2012, CURR OPIN GENET DEV, V22, P256, DOI 10.1016/j.gde.2012.02.002; Willemsen R, 1996, BIOCHEM BIOPH RES CO, V225, P27, DOI 10.1006/bbrc.1996.1126; Wojcik F, 2012, J ORG CHEM, V77, P4226, DOI 10.1021/jo202561k; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yao AY, 2011, HUM MOL GENET, V20, P51, DOI 10.1093/hmg/ddq431	76	41	46	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91465	10.1371/journal.pone.0091465	http://dx.doi.org/10.1371/journal.pone.0091465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658146	gold, Green Published			2022-12-25	WOS:000333355300033
J	Zhao, TJ; Sun, Q; del Rincon, SV; Lovato, A; Marques, M; Witcher, M				Zhao, Tiejun; Sun, Qiang; del Rincon, Sonia V.; Lovato, Amanda; Marques, Maud; Witcher, Michael			Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo	PLOS ONE			English	Article							DNA-DAMAGE; TANNIC-ACID; CYCLIN D1; TGFBI; CHECKPOINT; EXPRESSION; PACLITAXEL; CHK2; ASSOCIATION; METASTASIS	Triple-negative breast cancers are associated with poor clinical outcomes and new therapeutic strategies are clearly needed. Gallotannin (Gltn) has been previously demonstrated to have potent anti-tumor properties against cholangiocarcinoma in mice, but little is known regarding its capacity to suppress tumor outgrowth in breast cancer models. We tested Gltn for potential growth inhibitory properties against a variety of breast cancer cell lines in vitro. In particular, triple-negative breast cancer cells display higher levels of sensitivity to Gltn. The loss of proliferative capacity in Gltn exposed cells is associated with slowed cell cycle progression and S phase arrest, dependent on Chk2 phosphorylation and further characterized by changes to proliferation related genes, such as cyclin D1 (CcnD1) as determined by Nanostring technology. Importantly, Gltn administered orally or via intraperitoneal (IP) injections greatly reduced tumor outgrowth of triple-negative breast cells from mammary fat pads without signs of toxicity. In conclusion, these data strongly suggest that Gltn represents a novel approach to treat triple-negative breast carcinomas.	[Witcher, Michael] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University	Witcher, M (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	michael.witcher@mcgill.ca			Quebec Breast Cancer Foundation; Canadian Institute of Health Research; Weekend to End Womena(sic)(TM)s Cancer grants; Canadian Institute for Health research	Quebec Breast Cancer Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Weekend to End Womena(sic)(TM)s Cancer grants; Canadian Institute for Health research(Canadian Institutes of Health Research (CIHR))	This work was supported by Quebec Breast Cancer Foundation, Canadian Institute of Health Research and Weekend to End Womena(sic)(TM) s Cancer grants to M. W. A. L. was supported by student fellowships from the Canadian Institute for Health research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Ahmed AA, 2011, CANCER RES, V71, P5806, DOI 10.1158/0008-5472.CAN-11-0025; Al-Halabi R, 2011, CANCER BIOL THER, V12, P59, DOI 10.4161/cbt.12.1.15715; ATHAR M, 1989, CANCER RES, V49, P5784; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beeharry N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040342; BICHEL J, 1968, ACTA PHARMACOL TOX, V26, P41; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Casanova F, 2012, J CELL BIOCHEM, V113, P2586, DOI 10.1002/jcb.24134; Daenen LGM, 2011, CANCER RES, V71, P6976, DOI 10.1158/0008-5472.CAN-11-0627; de Lange J, 2012, CELL DEATH DIFFER, V19, P980, DOI 10.1038/cdd.2011.182; Duan JM, 2007, MOL CANCER THER, V6, P37, DOI 10.1158/1535-7163.MCT-05-0285; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Fathers C, 2012, CELL CYCLE, V11, P990, DOI 10.4161/cc.11.5.19482; Galanina N, 2011, CANCER J, V17, P96, DOI 10.1097/PPO.0b013e318212dee3; Gorogh T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-12; Han TD, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-183; Ibanez de Caceres I, 2010, ONCOGENE, V29, P1681, DOI 10.1038/onc.2009.454; Irigoyen M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-130; Joe AK, 2002, CLIN CANCER RES, V8, P893; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Juvekar A, 2012, CANCER DISCOV, V2, P1048, DOI 10.1158/2159-8290.CD-11-0336; Kurian AW, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2780; Lee HJ, 2011, CARCINOGENESIS, V32, P804, DOI 10.1093/carcin/bgr015; Li BY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-239; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Marienfeld C, 2003, HEPATOLOGY, V37, P1097, DOI 10.1053/jhep.2003.50192; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ng CP, 2004, J BIOL CHEM, V279, P8808, DOI 10.1074/jbc.M312215200; Pan Y, 2009, CANCER BIOL THER, V8, P1559, DOI 10.4161/cbt.8.16.8955; Ramnath N, 2005, CANCER CHEMOTH PHARM, V56, P447, DOI 10.1007/s00280-004-0951-6; Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040; Segurado M, 2009, BIOL CELL, V101, P617, DOI 10.1042/BC20090053; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Sharpe R, 2011, CLIN CANCER RES, V17, P5275, DOI 10.1158/1078-0432.CCR-10-2727; Son HN, 2013, BBA-MOL CELL RES, V1833, P2378, DOI 10.1016/j.bbamcr.2013.06.012; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Touvier M, 2013, BREAST CANCER RES TR, V137, P225, DOI 10.1007/s10549-012-2323-y; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; Tyagi A, 2011, CLIN CANCER RES, V17, P5402, DOI 10.1158/1078-0432.CCR-11-1072; Vassileva V, 2008, MOL CANCER THER, V7, P630, DOI 10.1158/1535-7163.MCT-07-2117; Velasco-Velazquez MA, 2011, FUTURE ONCOL, V7, P753, DOI [10.2217/FON.11.56, 10.2217/fon.11.56]; Wang J, 2004, J BIOL CHEM, V279, P39584, DOI 10.1074/jbc.M400015200; Wang LC, 2005, J BIOL CHEM, V280, P7634, DOI 10.1074/jbc.M413384200; Wang N, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-6; Wen GY, 2011, INT J ONCOL, V39, P1001, DOI 10.3892/ijo.2011.1097; Wu AH, 2011, MOL NUTR FOOD RES, V55, P921, DOI 10.1002/mnfr.201100006; Yamauchi K, 2008, CANCER RES, V68, P516, DOI 10.1158/0008-5472.CAN-07-3063; Zeng L, 2013, EXP CELL RES, V319, P2282, DOI 10.1016/j.yexcr.2013.06.011; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648	51	16	16	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92853	10.1371/journal.pone.0092853	http://dx.doi.org/10.1371/journal.pone.0092853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658335	Green Submitted, gold, Green Published			2022-12-25	WOS:000333355300134
J	Burger, EA; Sy, S; Nygard, M; Kristiansen, IS; Kim, JJ				Burger, Emily A.; Sy, Stephen; Nygard, Mari; Kristiansen, Ivar S.; Kim, Jane J.			Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS-VACCINATION; QUALITY-OF-LIFE; CERVICAL-CANCER; GENITAL WARTS; YOUNG-WOMEN; TRANSMISSION; HEALTH; IMPACT; VACCINES; STATES	Background: Increasingly, countries have introduced female vaccination against human papillomavirus (HPV), causally linked to several cancers and genital warts, but few have recommended vaccination of boys. Declining vaccine prices and strong evidence of vaccine impact on reducing HPV-related conditions in both women and men prompt countries to reevaluate whether HPV vaccination of boys is warranted. Methods: A previously-published dynamic model of HPV transmission was empirically calibrated to Norway. Reductions in the incidence of HPV, including both direct and indirect benefits, were applied to a natural history model of cervical cancer, and to incidence-based models for other non-cervical HPV-related diseases. We calculated the health outcomes and costs of the different HPV-related conditions under a gender-neutral vaccination program compared to a female-only program. Results: Vaccine price had a decisive impact on results. For example, assuming 71% coverage, high vaccine efficacy and a reasonable vaccine tender price of $75 per dose, we found vaccinating both girls and boys fell below a commonly cited cost-effectiveness threshold in Norway ($83,000/quality-adjusted life year (QALY) gained) when including vaccine benefit for all HPV-related diseases. However, at the current market price, including boys would not be considered 'good value for money.' For settings with a lower cost-effectiveness threshold ($30,000/QALY), it would not be considered cost-effective to expand the current program to include boys, unless the vaccine price was less than $36/dose. Increasing vaccination coverage to 90% among girls was more effective and less costly than the benefits achieved by vaccinating both genders with 71% coverage. Conclusions: At the anticipated tender price, expanding the HPV vaccination program to boys may be cost-effective and may warrant a change in the current female-only vaccination policy in Norway. However, increasing coverage in girls is uniformly more effective and cost-effective than expanding vaccination coverage to boys and should be considered a priority.	[Burger, Emily A.; Kristiansen, Ivar S.] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway; [Sy, Stephen; Kim, Jane J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci Boston, Cambridge, MA 02138 USA; [Nygard, Mari] Norway Dept Res, Canc Registry, Oslo, Norway	University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health	Burger, EA (corresponding author), Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway.	emily.burger@medisin.uio.no		Nygard, Mari/0000-0002-4100-4855	Norwegian Cancer Society [634201-2012]; U.S. National Cancer Institute of the National Institutes of Health [U54CA164336, R01CA160744]; NATIONAL CANCER INSTITUTE [R01CA160744, U54CA164336] Funding Source: NIH RePORTER	Norwegian Cancer Society(Norwegian Cancer Society); U.S. National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	EAB is supported in part by the Norwegian Cancer Society [634201-2012]; JJK is supported by the U.S. National Cancer Institute of the National Institutes of Health [U54CA164336, R01CA160744]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2032; [Anonymous], [No title captured]; Bishai D, 2000, ARCH OTOLARYNGOL, V126, P935, DOI 10.1001/archotol.126.8.935; Bogaards JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001147; Brill D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f924; Brisson M, 2011, J INFECT DIS, V204, P372, DOI 10.1093/infdis/jir285; Brown DR, 1999, J CLIN MICROBIOL, V37, P3316, DOI 10.1128/JCM.37.10.3316-3322.1999; Burger EA, 2012, BRIT J CANCER, V106, P1571, DOI 10.1038/bjc.2012.94; Cancer Registry of Norway, 2009, CANC NORW 2009 SPEC; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Conway EL, 2012, SEX TRANSM INFECT, V88, P517, DOI 10.1136/sextrans-2011-050161; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Elbasha EH, 2010, VACCINE, V28, P6858, DOI 10.1016/j.vaccine.2010.08.030; Federal Reserve, HIST RAT NORW KRON; French KM, 2007, BRIT J CANCER, V96, P514, DOI 10.1038/sj.bjc.6603575; Health Protection Agency, NUMB RAT AN WARTS DI; Hernandez BY, 2008, EMERG INFECT DIS, V14, P888, DOI 10.3201/eid1406.070616; Insinga RP, 2007, VACCINE, V26, P128, DOI 10.1016/j.vaccine.2007.10.056; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; Kim JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3884; Klee M, 2000, GYNECOL ONCOL, V76, P14, DOI 10.1006/gyno.1999.5642; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Larsen TK, 2007, CANC NORWAY 2006 CAN; Leval A, 2013, JNCI-J NATL CANCER I, V105, P469, DOI 10.1093/jnci/djt032; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Mork J, 2012, MD AND GAP C 2012; Mork J, 2010, CANCER CAUSE CONTROL, V21, P1397, DOI 10.1007/s10552-010-9567-9; Norwegian Directorate of Health, 2012, EC EV HEALTHC GUID; Norwegian Directorate of Health, 2007, HLTH EFF SOC AN; Norwegian Institute of Public Health, 2012, ANN REP HPV VACC CHI; Norwegian Medicines Agency, 2010, PHARM ASS IP YERV TR; Norwegian Ministry of Health, PRIOR NEW REV GUID P; Olsen J, 2010, INT J TECHNOL ASSESS, V26, P183, DOI 10.1017/S0266462310000085; Omland T, 2012, LARYNGOSCOPE, V122, P1595, DOI 10.1002/lary.23327; Pedersen W, 2003, J NORWEGIAN MED SOC, V21, P3006; Rannestad T, 2008, PSYCHOL HEALTH, V23, P219; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Seto K, 2012, DRUGS, V72, P715, DOI 10.2165/11599470-000000000-00000; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; Tjalma WA, 2013, INT J CANCER, V132, P854, DOI 10.1002/ijc.27713; Traeen B, 2003, REPORT SEXUAL BEHAV; Woodhall SC, 2011, SEX TRANSM INFECT, V87, P458, DOI 10.1136/sextrans-2011-050073; World Health Organization. ICO (Institut Catala d'Oncologia), INF CTR HUM PAP VIR; Zechmeister I, 2009, VACCINE, V27, P5133, DOI 10.1016/j.vaccine.2009.06.039	48	70	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e89974	10.1371/journal.pone.0089974	http://dx.doi.org/10.1371/journal.pone.0089974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651645	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800007
J	Nishimura, AL; Shum, C; Scotter, EL; Abdelgany, A; Sardone, V; Wright, J; Lee, YB; Chen, HJ; Bilican, B; Carrasco, M; Maniatis, T; Chandran, S; Rogelj, B; Gallo, JM; Shaw, CE				Nishimura, Agnes L.; Shum, Carole; Scotter, Emma L.; Abdelgany, Amr; Sardone, Valentina; Wright, Jamie; Lee, Youn-Bok; Chen, Han-Jou; Bilican, Bilada; Carrasco, Monica; Maniatis, Tom; Chandran, Siddharthan; Rogelj, Boris; Gallo, Jean-Marc; Shaw, Christopher E.			Allele-Specific Knockdown of ALS-Associated Mutant TDP-43 in Neural Stem Cells Derived from Induced Pluripotent Stem Cells	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; RNA INTERFERENCE; MUTATIONS; PROGRESSION; SOD1; EXPRESSION; NUCLEAR; MODEL; FUS	TDP-43 is found in cytoplasmic inclusions in 95% of amyotrophic lateral sclerosis (ALS) and 60% of frontotemporal lobar degeneration (FTLD). Approximately 4% of familial ALS is caused by mutations in TDP-43. The majority of these mutations are found in the glycine-rich domain, including the variant M337V, which is one of the most common mutations in TDP-43. In order to investigate the use of allele-specific RNA interference (RNAi) as a potential therapeutic tool, we designed and screened a set of siRNAs that specifically target TDP-43(M337V) mutation. Two siRNA specifically silenced the M337V mutation in HEK293T cells transfected with GFP-TDP-43(wt) or GFP-TDP-43(M337V) or TDP-43 C-terminal fragments counterparts. C-terminal TDP-43 transfected cells show an increase of cytosolic inclusions, which are decreased after allele-specific siRNA in M337V cells. We then investigated the effects of one of these allele-specific siRNAs in induced pluripotent stem cells (iPSCs) derived from an ALS patient carrying the M337V mutation. These lines showed a two-fold increase in cytosolic TDP-43 compared to the control. Following transfection with the allele-specific siRNA, cytosolic TDP-43 was reduced by 30% compared to cells transfected with a scrambled siRNA. We conclude that RNA interference can be used to selectively target the TDP-43(M337V) allele in mammalian and patient cells, thus demonstrating the potential for using RNA interference as a therapeutic tool for ALS.	[Nishimura, Agnes L.; Shum, Carole; Scotter, Emma L.; Abdelgany, Amr; Wright, Jamie; Lee, Youn-Bok; Chen, Han-Jou; Gallo, Jean-Marc; Shaw, Christopher E.] Kings Coll London, Dept Clin Neurosci, London, England; [Sardone, Valentina] Univ Pavia, Dept Publ Hlth Neurosci Expt & Forens Med, I-27100 Pavia, Italy; [Bilican, Bilada; Chandran, Siddharthan] Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Bilican, Bilada; Chandran, Siddharthan] Univ Edinburgh, Ctr Neurodegenerat, Edinburgh, Midlothian, Scotland; [Carrasco, Monica; Maniatis, Tom] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Rogelj, Boris] Jozef Stefan Inst, Dept Biotechnol, Ljubljana, Slovenia	University of London; King's College London; University of Pavia; University of Edinburgh; University of Edinburgh; Columbia University; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Shaw, CE (corresponding author), Kings Coll London, Dept Clin Neurosci, London, England.	Christopher.Shaw@kcl.ac.uk	Rogelj, Boris/G-9252-2011; Scotter, Emma/C-4833-2012; Nishimura, Agnes L/B-2905-2011	Rogelj, Boris/0000-0003-3898-1943; Scotter, Emma/0000-0003-4064-3599; Gallo, Jean-Marc/0000-0003-0214-4545; Lee, Younbok/0000-0002-0479-9361; Nishimura, Agnes/0000-0001-5295-797X; Shaw, Christopher/0000-0003-0251-0146	Motor Neurone Disease Association UK; Wellcome Trust; Medical Research Council UK; Psychiatry Research Trust of the Institute of Psychiatry	Motor Neurone Disease Association UK; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Psychiatry Research Trust of the Institute of Psychiatry	This work was supported by grants from the Motor Neurone Disease Association UK, The Wellcome Trust, Medical Research Council UK, and The Psychiatry Research Trust of the Institute of Psychiatry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgany A, 2003, HUM MOL GENET, V12, P2637, DOI 10.1093/hmg/ddg280; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950; de Ynigo-Mojado L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021352; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fiszer A, 2011, NUCLEIC ACIDS RES, V39, P5578, DOI 10.1093/nar/gkr156; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Maxwell MM, 2004, P NATL ACAD SCI USA, V101, P3178, DOI 10.1073/pnas.0308726100; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Rodriguez-Lebron E, 2009, MOL THER, V17, P1563, DOI 10.1038/mt.2009.123; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Scotter EL, 2008, J NEUROSCI METH, V171, P174, DOI 10.1016/j.jneumeth.2008.02.007; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tamaoka A, 2010, INTERNAL MED, V49, P331, DOI 10.2169/internalmedicine.49.2915; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Towne C, 2008, MOL THER, V16, P1018, DOI 10.1038/mt.2008.73; Tsai CP, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.009; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu YF, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-73; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Zhang Y, 2009, J NEUROCHEM, V108, P82, DOI 10.1111/j.1471-4159.2008.05734.x	39	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91269	10.1371/journal.pone.0091269	http://dx.doi.org/10.1371/journal.pone.0091269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651281	gold, Green Published, Green Submitted			2022-12-25	WOS:000333352800035
J	Rico, E; Oliva, C; Gutierrez, KJ; Alzate, JF; Genes, CM; Moreno, D; Casanova, E; Gigante, A; Perez-Perez, MJ; Camarasa, MJ; Clos, J; Gago, F; Jimenez-Ruiz, A				Rico, Eva; Oliva, Cristina; Jesus Gutierrez, Kilian; Fernando Alzate, Juan; Mario Genes, Carlos; Moreno, David; Casanova, Elena; Gigante, Alba; Perez-Perez, Maria-Jesus; Camarasa, Maria-Jose; Clos, Joachim; Gago, Federico; Jimenez-Ruiz, Antonio			Leishmania infantum EndoG Is an Endo/Exo-Nuclease Essential for Parasite Survival	PLOS ONE			English	Article							MITOCHONDRIAL ENDONUCLEASE-G; PROGRAMMED CELL-DEATH; PURIFICATION; APOPTOSIS	EndoG, a member of the DNA/RNA non-specific beta beta alpha-metal family of nucleases, has been demonstrated to be present in many organisms, including Trypanosomatids. This nuclease participates in the apoptotic program in these parasites by migrating from the mitochondrion to the nucleus, where it takes part in the degradation of genomic DNA that characterizes this process. We now demonstrate that Leishmania infantum EndoG (LiEndoG) is an endo-exonuclease that has a preferential 59 exonuclease activity on linear DNA. Regardless of its role during apoptotic cell death, this enzyme seems to be necessary during normal development of the parasites as indicated by the reduced growth rates observed in LiEndoG hemi-knockouts and their poor infectivity in differentiated THP-1 cells. The pro-life role of this protein is also corroborated by the higher survival rates of parasites that over-express this protein after treatment with the LiEndoG inhibitor Lei49. Taken together, our results demonstrate that this enzyme plays essential roles in both survival and death of Leishmania parasites.	[Rico, Eva; Oliva, Cristina; Jesus Gutierrez, Kilian; Mario Genes, Carlos; Moreno, David; Jimenez-Ruiz, Antonio] Univ Alcala de Henares, CSIC, Dept Biol Sistemas, Unidad Asociada, Madrid, Spain; [Fernando Alzate, Juan] Univ Antioquia, Fac Med, Dept Microbiol & Parasitol, Medellin, Colombia; [Casanova, Elena; Gigante, Alba; Perez-Perez, Maria-Jesus; Camarasa, Maria-Jose] IQM CSIC, Madrid, Spain; [Clos, Joachim] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Gago, Federico] CSIC, Unidad Asociada, Dept Ciencias Biomed, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Alcala; Universidad de Antioquia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); Bernhard Nocht Institut fur Tropenmedizin; Consejo Superior de Investigaciones Cientificas (CSIC)	Jimenez-Ruiz, A (corresponding author), Univ Alcala de Henares, CSIC, Dept Biol Sistemas, Unidad Asociada, Madrid, Spain.	antonio.jimenez@uah.es	Jimenez-Ruiz, Antonio/K-2991-2014; Oliva, Cristina/AAI-9548-2020; Alzate, Juan F./AFD-6646-2022; Camarasa, María-José/N-8845-2019; Perez-Perez, Maria-Jesus/O-4580-2014; Camarasa, María-José/B-6340-2015; Gago, Federico/H-1004-2015; Gago, Federico/AAS-3992-2020; Moreno, David/J-2969-2012	Jimenez-Ruiz, Antonio/0000-0001-8238-3081; Alzate, Juan F./0000-0003-2578-4609; Camarasa, María-José/0000-0002-4978-6468; Perez-Perez, Maria-Jesus/0000-0003-1336-7760; Camarasa, María-José/0000-0002-4978-6468; Gago, Federico/0000-0002-3071-4878; Gago, Federico/0000-0002-3071-4878; Moreno, David/0000-0002-7017-4095; Gigante, Alba/0000-0003-2606-665X; Genes, Carlos/0000-0001-5449-3355	Spanish MEC/MICINN [SAF2009-13914-C02]; Comunidad de Madrid [S-2010/BMD-2457]; Junta de Comunidades de Castilla la Mancha [POII10-0180-7897]	Spanish MEC/MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Junta de Comunidades de Castilla la Mancha(Junta de Comunidades de Castilla-La Mancha)	Sources of funding: Spanish MEC/MICINN Project SAF2009-13914-C02; Comunidad de Madrid Project BIPEDD-2-CM ref S-2010/BMD-2457; Junta de Comunidades de Castilla la Mancha Project POII10-0180-7897. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzate JF, 2006, APOPTOSIS, V11, P161, DOI 10.1007/s10495-006-4570-z; BERNARDI A, 1975, EUR J BIOCHEM, V52, P451, DOI 10.1111/j.1432-1033.1975.tb04013.x; BERNARDI G, 1973, NATURE-NEW BIOL, V246, P36, DOI 10.1038/newbio246036a0; Bosedasgupta S, 2008, CELL DEATH DIFFER; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Casanova E, 2013, CHEMMEDCHEM, V8, P1161, DOI 10.1002/cmdc.201300129; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; CUMMINGS OW, 1987, J BIOL CHEM, V262, P2005; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; DAKE E, 1988, J BIOL CHEM, V263, P7691; FRASER MJ, 1989, J BIOL CHEM, V264, P13093; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Loll B, 2009, NUCLEIC ACIDS RES, V37, P7312, DOI 10.1093/nar/gkp770; Low RL, 2003, MITOCHONDRION, V2, P225, DOI 10.1016/S1567-7249(02)00104-6; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Plano D, 2011, EUR J MED CHEM, V46, P3315, DOI 10.1016/j.ejmech.2011.04.054; Quijada L, 2003, MOL BIOCHEM PARASIT, V130, P139, DOI 10.1016/S0166-6851(03)00159-2; Rico E, 2009, MOL BIOCHEM PARASIT, V163, P28, DOI 10.1016/j.molbiopara.2008.09.007; RUIZCARRILLO A, 1987, EMBO J, V6, P401, DOI 10.1002/j.1460-2075.1987.tb04769.x; Schafer P, 2004, J MOL BIOL, V338, P217, DOI 10.1016/j.jmb.2004.02.069; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Yokoyama WM, 2006, CURR PROTOC IMMUNOL; ZASSENHAUS HP, 1994, CURR GENET, V25, P142, DOI 10.1007/BF00309540	23	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89526	10.1371/journal.pone.0089526	http://dx.doi.org/10.1371/journal.pone.0089526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24651293	Green Published, Green Submitted, gold			2022-12-25	WOS:000332389000052
J	Presslauer, S; Milosavljevic, D; Huebl, W; Parigger, S; Schneider-Koch, G; Bruecke, T				Presslauer, Stefan; Milosavljevic, Dejan; Huebl, Wolfgang; Parigger, Silvia; Schneider-Koch, Gabriele; Bruecke, Thomas			Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS	PLOS ONE			English	Article							CEREBROSPINAL-FLUID ANALYSIS; MULTIPLE-SCLEROSIS; OLIGOCLONAL BANDS; DIFFERENTIAL-DIAGNOSIS; IMMUNE-RESPONSE; CSF; IGG; CRITERIA; ABSENCE	Background: Quantification of kappa free light chains (KFLC) in cerebrospinal fluid shows high diagnostic sensitivity in multiple sclerosis and clinically isolated syndrome patients. However, a clearly defined threshold value is still missing and a possible prognostic value of the KFLC levels in these patients remains undefined. Methods: Results of KFLC quantification in 420 controls were used to set an upper limit of normal KFLC concentration in CSF under different blood-CSF-barrier conditions. Additionally, KFLC values of MS and CIS patients were assessed and results were evaluated with reference to the patients corresponding disease courses. Results: The calculated upper limit of normal KFLC-concentration covers 98% of these control patients. Using this cut-off, plasma cell activity in CSF can be detected in 97% of MS patients and in 97% of CIS patients. However, there is no evidence that the extent of KFLC elevation provides prognostic value in MS and CIS patients in this study. Conclusion: KFLC determination should become a first line screen in the diagnostic algorithms of MS and CIS. The extent of elevation of intrathecal KFLC has no prognostic value on the disease course in MS and CIS patients.	[Presslauer, Stefan; Parigger, Silvia; Schneider-Koch, Gabriele; Bruecke, Thomas] Wilhelminenspital Stadt Wien, Dept Neurol, Vienna, Austria; [Milosavljevic, Dejan; Huebl, Wolfgang] Wilhelminenspital Stadt Wien, Dept Lab Med, Vienna, Austria	Wilhelminenspital; Wilhelminenspital	Presslauer, S (corresponding author), Wilhelminenspital Stadt Wien, Dept Neurol, Vienna, Austria.	presslauer@gmx.at						Annunziata P, 2006, J NEUROL SCI, V244, P97, DOI 10.1016/j.jns.2006.01.004; Desplat-Jego S, 2005, J CLIN IMMUNOL, V25, P338, DOI 10.1007/s10875-005-5371-9; Dobson R, 2013, J NEUROL NEUROSUR PS, V84, P909, DOI 10.1136/jnnp-2012-304695; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; Goffette S, 2004, J NEUROL NEUROSUR PS, V75, P308, DOI 10.1136/jnnp.2003.010710; Gout O, 2011, MULT SCLER, V17, P164, DOI 10.1177/1352458510385506; Imrell K, 2006, NEUROLOGY, V67, P1062, DOI 10.1212/01.wnl.0000237343.93389.35; Joseph FG, 2009, J NEUROL NEUROSUR PS, V80, P292, DOI 10.1136/jnnp.2008.150896; Ignacio RJ, 2010, J NEUROL, V257, P1188, DOI 10.1007/s00415-010-5490-y; Kaplan B, 2010, J NEUROIMMUNOL, V229, P263, DOI 10.1016/j.jneuroim.2010.09.002; Katzmann JA, 2002, CLIN CHEM, V48, P1437; Krakauer M, 1998, ACTA NEUROL SCAND, V98, P161, DOI 10.1111/j.1600-0404.1998.tb07287.x; LEFVERT AK, 1985, ANN NEUROL, V17, P13, DOI 10.1002/ana.410170105; Link H, 2006, J NEUROIMMUNOL, V180, P17, DOI 10.1016/j.jneuroim.2006.07.006; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MCLEAN BN, 1990, BRAIN, V113, P1269, DOI 10.1093/brain/113.5.1269; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Presslauer S, 2008, J NEUROL, V255, P1508, DOI 10.1007/s00415-008-0954-z; Reiber H, 1998, MULT SCLER, V4, P111, DOI 10.1177/135245859800400304; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Rinker John R 2nd, 2006, Neurology, V67, P1288, DOI 10.1212/01.wnl.0000238107.31364.21; Rudick R A, 1995, Mult Scler, V1, P150; RUDICK RA, 1989, NEUROLOGY, V39, P964, DOI 10.1212/WNL.39.7.964; Schaffler N, 2011, ACTA NEUROL SCAND, V124, P151, DOI 10.1111/j.1600-0404.2010.01454.x; Siritho S, 2009, J NEUROL SCI, V279, P21, DOI 10.1016/j.jns.2008.12.029; STENDAHLBRODIN L, 1980, J NEUROL NEUROSUR PS, V43, P102, DOI 10.1136/jnnp.43.2.102; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Tintore M, 2013, ECTRIMS 2013 OCT 03; Villar LM, 2005, ARCH NEUROL-CHICAGO, V62, P574, DOI 10.1001/archneur.62.4.574; Villar LM, 2012, CLIN CHIM ACTA, V413, P1813, DOI 10.1016/j.cca.2012.07.007; Zeman AZJ, 1996, J NEUROL NEUROSUR PS, V60, P27, DOI 10.1136/jnnp.60.1.27; Zipoli V, 2009, MULT SCLER J, V15, P472, DOI 10.1177/1352458508100502	34	56	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89945	10.1371/journal.pone.0089945	http://dx.doi.org/10.1371/journal.pone.0089945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24651567	Green Submitted, gold, Green Published			2022-12-25	WOS:000332385900102
J	Huang, Z; Choi, BK; Mujoo, K; Fan, X; Fa, M; Mukherjee, S; Owiti, N; Zhang, N; An, Z				Huang, Z.; Choi, B-K; Mujoo, K.; Fan, X.; Fa, M.; Mukherjee, S.; Owiti, N.; Zhang, N.; An, Z.			The E3 ubiquitin ligase NEDD4 negatively regulates HER3/ErbB3 level and signaling	ONCOGENE			English	Article							EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASES; BREAST-CANCER; PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT ACTIVATION; PROSTATE-CANCER; ERBB RECEPTORS; BINDING-SITE; HER3; DEGRADATION	HER3/ErbB3, a member of the epidermal growth factor receptor (EGFR) family, has a pivotal role in cancer and is emerging as a therapeutic antibody target. In this study, we identified NEDD4 (neural precursor cell expressed, developmentally downregulated 4) as a novel interaction partner and ubiquitin E3 ligase of human HER3. Using molecular and biochemical approaches, we demonstrated that the C-terminal tail of HER3 interacted with the WW domains of NEDD4 and the interaction was independent of neuregulin-1. Short hairpin RNA knockdown of NEDD4 elevated HER3 levels and resulted in increased HER3 signaling and cancer cell proliferation in vitro and in vivo. A similar inverse relationship between HER3 and NEDD4 levels was observed in prostate cancer tumor tissues. More importantly, the upregulated HER3 expression by NEDD4 knockdown sensitized cancer cells for growth inhibition by an anti-HER3 antibody. Taken together, our results suggest that low NEDD4 levels may predict activation of HER3 signaling and efficacies of anti-HER3 antibody therapies.	[Huang, Z.; Choi, B-K; Mujoo, K.; Fan, X.; Fa, M.; Mukherjee, S.; Owiti, N.; Zhang, N.; An, Z.] Univ Texas Houston, Texas Therapeut Inst, Brown Fdn Inst Mol Med, Hlth Sci Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Zhang, N (corresponding author), Univ Texas Houston, Texas Therapeut Inst, Brown Fdn Inst Mol Med, Hlth Sci Ctr, Houston, TX 77030 USA.	Ningyan.zhang@uth.tmc.edu; Zhiqiang.an@uth.tmc.edu	Mujoo, Kalpana/S-9933-2019	Mujoo, Kalpana/0000-0002-4275-1051; Owiti, Norah/0000-0002-5061-7434; Zhang, Ningyan/0000-0002-4348-2180; An, Zhiqiang/0000-0001-9309-2335	Texas Emerging Technology Fund; Johnson and Johnson; Welch Foundation [AU00024]	Texas Emerging Technology Fund; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Welch Foundation(The Welch Foundation)	We thank Dr Hui Deng for help on cell cultures; Professor Renping Zhou and Dr Kendra Carmon for critical comments on the manuscript; Dr Stephen Hewitt of NIH/ NCI for providing the prostate cancer clinical samples; and Dr Rabih Said for interpretation of immunohistochemistry experiments. The work was partially funded by grants from the Texas Emerging Technology Fund, Johnson and Johnson, and the Welch Foundation grant no. AU00024 to ZA.	Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Baselga J, 2010, ANN ONCOL, V21, P36, DOI 10.1093/annonc/mdq421; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bouyain S, 2007, PROTEIN SCI, V16, P654, DOI 10.1110/ps.062700307; Carraway KL, 2010, SEMIN CELL DEV BIOL, V21, P936, DOI 10.1016/j.semcdb.2010.09.006; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Chaib H, 2001, NEOPLASIA, V3, P43, DOI 10.1038/sj.neo.7900126; Choi BK, 2012, CANCER MED-US, V1, P28, DOI 10.1002/cam4.10; Choi BK, 2012, PROTEIN CELL, V3, P781, DOI 10.1007/s13238-012-2065-y; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Dornan D, 2004, CANCER RES, V64, P7226, DOI 10.1158/0008-5472.CAN-04-2601; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Feng SM, 2009, MOL CELL BIOL, V29, P892, DOI 10.1128/MCB.00595-08; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Huang QQ, 2010, J BIOL CHEM, V285, P42130, DOI 10.1074/jbc.M110.143412; Huang X, 2000, NATURE, P7634; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Koumakpayi IH, 2006, CLIN CANCER RES, V12, P2730, DOI 10.1158/1078-0432.CCR-05-2242; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li Z, 2006, CARCINOGENESIS, V27, P1054, DOI 10.1093/carcin/bgi324; Lipkowitz S, 2003, BREAST CANCER RES, V5, P8, DOI 10.1186/bcr541; Lyne JC, 1997, CANCER J SCI AM, V3, P21; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Menendez JA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1773; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Omerovic J, 2007, FASEB J, V21, P2849, DOI 10.1096/fj.06-7925com; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Sweeney C, 2004, BRIT J CANCER, V90, P289, DOI 10.1038/sj.bjc.6601500; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tsang RY, 2012, BRIT J CANCER, V106, P6, DOI 10.1038/bjc.2011.516; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Vijapurkar U, 1998, J BIOL CHEM, V273, P20996, DOI 10.1074/jbc.273.33.20996; Waterman H, 1999, EMBO J, V18, P3348, DOI 10.1093/emboj/18.12.3348; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Zeng FH, 2009, FASEB J, V23, P1935, DOI 10.1096/fj.08-121947	56	45	46	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 26	2015	34	9					1105	1115		10.1038/onc.2014.56	http://dx.doi.org/10.1038/onc.2014.56			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RY	24662824				2022-12-25	WOS:000350122100004
J	Walker, SR; Liu, S; Xiang, M; Nicolais, M; Hatzi, K; Giannopoulou, E; Elemento, O; Cerchietti, L; Melnick, A; Frank, DA				Walker, S. R.; Liu, S.; Xiang, M.; Nicolais, M.; Hatzi, K.; Giannopoulou, E.; Elemento, O.; Cerchietti, L.; Melnick, A.; Frank, D. A.			The transcriptional modulator BCL6 as a molecular target for breast cancer therapy	ONCOGENE			English	Article							B-CELL LYMPHOMAS; HUMAN TUMORS; BTB DOMAIN; CHIP-SEQ; IN-VITRO; EXPRESSION; STAT5; DIFFERENTIATION; IDENTIFICATION; COREPRESSOR	Inappropriate expression or activation of transcription factors can drive patterns of gene expression, leading to the malignant behavior of breast cancer cells. We have found that the transcriptional repressor BCL6 is highly expressed in breast cancer cell lines, and its locus is amplified in about half of primary breast cancers. To understand how BCL6 regulates gene expression in breast cancer cells, we used chromatin immunoprecipitation followed by deep sequencing to identify the BCL6 binding sites on a genomic scale. This revealed that BCL6 regulates a unique cohort of genes in breast cancer cell lines compared with B-cell lymphomas. Furthermore, BCL6 expression promotes the survival of breast cancer cells, and targeting BCL6 with a peptidomimetic inhibitor leads to apoptosis of these cells. Finally, combining a BCL6 inhibitor and a signal transducer and activator of transcription3 inhibitor provided enhanced cell killing in triple-negative breast cancer cell lines, suggesting that combination therapy may be particularly useful. Thus, targeting BCL6 alone or in conjunction with other signaling pathways may be a useful therapeutic strategy for treating breast cancer.	[Walker, S. R.; Liu, S.; Xiang, M.; Nicolais, M.; Frank, D. A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Walker, S. R.; Liu, S.; Frank, D. A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Walker, S. R.; Liu, S.; Frank, D. A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hatzi, K.; Cerchietti, L.; Melnick, A.] Weill Cornell Med Coll, Dept Med & Pharmacol, New York, NY USA; [Giannopoulou, E.; Elemento, O.] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsa, New York, NY USA; [Giannopoulou, E.; Elemento, O.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Cornell University; Cornell University; Cornell University	Frank, DA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave,M522B, Boston, MA 02215 USA.	david_frank@dfci.harvard.edu	Melnick, Ari/AAA-5763-2020; Giannopoulou, Evgenia/K-9576-2019	Cerchietti, Leandro/0000-0003-0608-1350	BCRF-AACR grant for Translational Breast Cancer Research; National Cancer Institute [R01-CA160979]; Susan G Komen for the Cure; Brent Leahey Fund; Friends of the Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA104348, R01CA160979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	BCRF-AACR grant for Translational Breast Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Brent Leahey Fund; Friends of the Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a BCRF-AACR grant for Translational Breast Cancer Research, and grants from the National Cancer Institute (R01-CA160979), Susan G Komen for the Cure, the Brent Leahey Fund and Friends of the Dana-Farber Cancer Institute.	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Alvarez JV, 2005, CANCER RES, V65, P5054, DOI 10.1158/0008-5472.CAN-04-4281; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bos R, 2003, ONCOGENE, V22, P8948, DOI 10.1038/sj.onc.1206995; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Cerchietti LC, 2009, BLOOD, V113, P3397, DOI 10.1182/blood-2008-07-168773; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; DiRenzo J, 2002, CANCER RES, V62, P89; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Ghetu AF, 2008, MOL CELL, V29, P384, DOI 10.1016/j.molcel.2007.12.026; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lasho TL, 2008, LEUKEMIA, V22, P1790, DOI 10.1038/leu.2008.56; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Logarajah S, 2003, ONCOGENE, V22, P5572, DOI 10.1038/sj.onc.1206689; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mendez LM, 2008, MOL CELL BIOL, V28, P2175, DOI 10.1128/MCB.01400-07; Nelson EA, 2004, J BIOL CHEM, V279, P54724, DOI 10.1074/jbc.M408464200; Nelson EA, 2008, BLOOD, V112, P5095, DOI 10.1182/blood-2007-12-129718; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Parekh S, 2007, BLOOD, V110, P2067, DOI 10.1182/blood-2007-01-069575; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Polo JM, 2008, BLOOD, V112, P644, DOI 10.1182/blood-2008-01-131813; Polo JM, 2007, P NATL ACAD SCI USA, V104, P3207, DOI 10.1073/pnas.0611399104; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Walker SR, 2007, ONCOGENE, V26, P224, DOI 10.1038/sj.onc.1209775; Walker SR, 2013, MOL CELL BIOL, V33, P2879, DOI 10.1128/MCB.01620-12; Walker SR, 2009, MOL CANCER RES, V7, P966, DOI 10.1158/1541-7786.MCR-08-0238; Wang X, 2002, P NATL ACAD SCI USA, V99, P15018, DOI 10.1073/pnas.232581199; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	38	46	48	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 26	2015	34	9					1073	1082		10.1038/onc.2014.61	http://dx.doi.org/10.1038/onc.2014.61			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RY	24662818	Green Accepted, Green Submitted			2022-12-25	WOS:000350122100001
J	Chen, WT; Wu, YL; Chen, T; Cheng, CS; Chan, HL; Chou, HC; Chen, YW; Yin, HS				Chen, Wen-Ting; Wu, Yi-Le; Chen, Ting; Cheng, Chao-Sheng; Chan, Hong-Lin; Chou, Hsiu-Chuan; Chen, Yi-Wen; Yin, Hsien-Sheng			Proteomics Analysis of the DF-1 Chicken Fibroblasts Infected with Avian Reovirus Strain S1133	PLOS ONE			English	Article							BURSAL DISEASE VIRUS; VIRAL ARTHRITIS-TENOSYNOVITIS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; APOPTOSIS INDUCTION; NONSTRUCTURAL PROTEIN; SIGNALING PATHWAYS; CULTURED-CELLS; HOST-CELLS; SIGMA-C; ACTIVATION	Background: Avian reovirus (ARV) is a member of the Orthoreovirus genus in the Reoviridae family. It is the etiological agent of several diseases, among which viral arthritis and malabsorption syndrome are the most commercially important, causing considerable economic losses in the poultry industry. Although a small but increasing number of reports have characterized some aspects of ARV infection, global changes in protein expression in ARV-infected host cells have not been examined. The current study used a proteomics approach to obtain a comprehensive view of changes in protein levels in host cells upon infection by ARV. Methodology and Principal Findings: The proteomics profiles of DF-1 chicken fibroblast cells infected with ARV strain S1133 were analyzed by two-dimensional differential-image gel electrophoresis. The majority of protein expression changes (>= 1.5 fold, p<0.05) occurred at 72 h post-infection. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry identified 51 proteins with differential expression levels, including 25 that were upregulated during ARV infection and 26 that were downregulated. These proteins were divided into eight groups according to biological function: signal transduction, stress response, RNA processing, the ubiquitin-proteasome pathway, lipid metabolism, carbohydrate metabolism, energy metabolism, and cytoskeleton organization. They were further examined by immunoblotting to validate the observed alterations in protein expression. Conclusion/Significance: This is the first report of a time-course proteomic analysis of ARV-infected host cells. Notably, all identified proteins involved in signal transduction, RNA processing, and the ubiquitin-proteasome pathway were downregulated in infected cells, whereas proteins involved in DNA synthesis, apoptosis, and energy production pathways were upregulated. In addition, other differentially expressed proteins were linked with the cytoskeleton, metabolism, redox regulation, and stress response. These proteomics data provide valuable information about host cell responses to ARV infection and will facilitate further studies of the molecular mechanisms underlying ARV pathogenesis.	[Chen, Wen-Ting; Wu, Yi-Le; Chen, Ting; Cheng, Chao-Sheng; Chan, Hong-Lin; Chen, Yi-Wen; Yin, Hsien-Sheng] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Chen, Wen-Ting; Wu, Yi-Le; Chen, Ting; Cheng, Chao-Sheng; Chan, Hong-Lin; Chen, Yi-Wen; Yin, Hsien-Sheng] Natl Tsing Hua Univ, Coll Life Sci, Hsinchu, Taiwan; [Chou, Hsiu-Chuan] Natl Hsinchu Univ Educ, Dept Appl Sci, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Yin, HS (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	hstin@mx.nthu.edu.tw	Chen, Ting/GOE-6981-2022	Chen, Ting/0000-0001-8055-3104	National Science Council, Taiwan (NSC) [NSC-101-2627-B-007-003-]	National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	The authors acknowledge the support of the National Science Council, Taiwan (NSC grant number NSC-101-2627-B-007-003-). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baciu PC, 2000, J CELL SCI, V113, P315; Benavente J, 2006, CURR TOP MICROBIOL, V309, P67; Benavente J, 2007, VIRUS RES, V123, P105, DOI 10.1016/j.virusres.2006.09.005; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bodelon G, 2001, VIROLOGY, V290, P181, DOI 10.1006/viro.2001.1159; Bodelon G, 2002, J BIOL CHEM, V277, P17789, DOI 10.1074/jbc.M202018200; Calvo PG, 2005, J MOL BIOL, V354, P137, DOI 10.1016/j.jmb.2005.09.034; CASELLA JF, 1986, J BIOL CHEM, V261, P915; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chang LY, 2006, J MED VIROL, V78, P1105, DOI 10.1002/jmv.20669; Chen YW, 2011, FUNCT INTEGR GENOMIC, V11, P225, DOI 10.1007/s10142-011-0210-y; Chen YI, 2008, J VIROL METHODS, V151, P95, DOI 10.1016/j.jviromet.2008.03.016; Chi PI, 2013, J BIOL CHEM, V288, P3571, DOI 10.1074/jbc.M112.390245; Chulu JLC, 2007, BIOCHEM BIOPH RES CO, V356, P529, DOI 10.1016/j.bbrc.2007.02.164; Chulu JLC, 2010, J VIROL, V84, P7683, DOI 10.1128/JVI.02604-09; De BP, 1996, J BIOL CHEM, V271, P24728, DOI 10.1074/jbc.271.40.24728; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Falke D, 1997, TRENDS MICROBIOL, V5, P306, DOI 10.1016/S0966-842X(97)82226-3; Gachet Y, 1999, J CELL SCI, V112, P1257; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Grande A, 2000, VIROLOGY, V274, P367, DOI 10.1006/viro.2000.0473; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Huang WR, 2011, J BIOL CHEM, V286, P30780, DOI 10.1074/jbc.M111.257154; Jamaluddin M, 2010, J VIROL, V84, P9533, DOI 10.1128/JVI.01005-10; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Li ZH, 2012, J VIROL, V86, P1328, DOI 10.1128/JVI.06104-11; Lin PY, 2011, ARCH VIROL, V156, P1917, DOI 10.1007/s00705-011-1063-3; Lin PY, 2010, VIROLOGY, V400, P104, DOI 10.1016/j.virol.2010.01.024; Lin PY, 2009, VIROLOGY, V385, P323, DOI 10.1016/j.virol.2008.12.028; Lin ST, 2013, MOL BIOSYST, V9, P447, DOI 10.1039/c2mb25367d; MORERO RD, 1985, BIOCHEMISTRY-US, V24, P1904, DOI 10.1021/bi00329a015; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; O'Hara D, 2001, J VIROL, V75, P5027, DOI 10.1128/JVI.75.11.5027-5035.2001; Ohman T, 2010, J PROTEOME RES, V9, P1549, DOI 10.1021/pr901040u; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; RAU WE, 1980, AVIAN DIS, V24, P648, DOI 10.2307/1589802; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; Salsman J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000016; Santamaria E, 2009, MOL CELL PROTEOMICS, V8, P805, DOI 10.1074/mcp.M800202-MCP200; Schultz DE, 1996, J BIOL CHEM, V271, P14134, DOI 10.1074/jbc.271.24.14134; Shih WL, 2004, VIROLOGY, V321, P65, DOI 10.1016/j.virol.2003.12.004; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; SORGATO MC, 1993, CRIT REV BIOCHEM MOL, V28, P127; Sun JF, 2008, J PROTEOME RES, V7, P5263, DOI 10.1021/pr800546m; Sun Z, 2010, J CELL PHYSIOL, V223, P798, DOI 10.1002/jcp.22100; Thio CLP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061444; Tonge R, 2001, PROTEOMICS, V1, P377; VANDERHEIDE L, 1977, AVIAN PATHOL, V6, P271, DOI 10.1080/03079457708418237; Walsh B, 2009, REDOX REP, V14, P275, DOI 10.1179/135100009X12525712409652; Wang HC, 2007, DEV COMP IMMUNOL, V31, P672, DOI 10.1016/j.dci.2006.11.001; Wang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002507; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; WU WY, 1994, J VIROL METHODS, V48, P119, DOI 10.1016/0166-0934(94)90094-9; Wu YP, 2012, PROTEOMICS, V12, P1844, DOI 10.1002/pmic.201100479; Wu YF, 2007, VET IMMUNOL IMMUNOP, V116, P37, DOI 10.1016/j.vetimm.2006.12.010; Yang SH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-40; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25; Zhe JP, 2012, J PROTEOMICS, V75, P1732, DOI 10.1016/j.jprot.2011.12.012; Zheng XJ, 2008, MOL CELL PROTEOMICS, V7, P612, DOI 10.1074/mcp.M700396-MCP200; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	67	24	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92154	10.1371/journal.pone.0092154	http://dx.doi.org/10.1371/journal.pone.0092154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667214	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600022
J	Bendali, A; Agnes, C; Meffert, S; Forster, V; Bongrain, A; Arnault, JC; Sahel, JA; Offenhausser, A; Bergonzo, P; Picaud, S				Bendali, Amel; Agnes, Charles; Meffert, Simone; Forster, Valerie; Bongrain, Alexandre; Arnault, Jean-Charles; Sahel, Jose-Alain; Offenhaeusser, Andreas; Bergonzo, Philippe; Picaud, Serge			Distinctive Glial and Neuronal Interfacing on Nanocrystalline Diamond	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; FILMS; PROSTHESIS; ELECTRODES; LAMININ; ADSORPTION; STABILITY; SURFACES; SPECTRA; CULTURE	Direct electrode/neuron interfacing is a key challenge to achieve high resolution of neuronal stimulation required for visual prostheses. Neuronal interfacing on biomaterials commonly requires the presence of glial cells and/or protein coating. Nanocrystalline diamond is a highly mechanically stable biomaterial with a remarkably large potential window for the electrical stimulation of tissues. Using adult retinal cell cultures from rats, we found that glial cells and retinal neurons grew equally well on glass and nanocrystalline diamond. The use of a protein coating increased cell survival, particularly for glial cells. However, bipolar neurons appeared to grow even in direct contact with bare diamond. We investigated whether the presence of glial cells contributed to this direct neuron/diamond interface, by using purified adult retinal ganglion cells to seed diamond and glass surfaces with and without protein coatings. Surprisingly, these fully differentiated spiking neurons survived better on nanocrystalline diamond without any protein coating. This greater survival was indicated by larger cell numbers and the presence of longer neurites. When a protein pattern was drawn on diamond, neurons did not grow preferentially on the coated area, by contrast to their behavior on a patterned glass. This study highlights the interesting biocompatibility properties of nanocrystalline diamond, allowing direct neuronal interfacing, whereas a protein coating was required for glial cell growth.	[Bendali, Amel; Forster, Valerie; Sahel, Jose-Alain; Picaud, Serge] INSERM, U968, Inst Vis, Paris, France; [Bendali, Amel; Forster, Valerie; Sahel, Jose-Alain; Picaud, Serge] Sorbonne Univ, Univ Paris 06, UMR S968, Inst Vis, Paris, France; [Bendali, Amel; Forster, Valerie; Sahel, Jose-Alain; Picaud, Serge] CNRS, UMR7210, Inst Vis, Paris, France; [Agnes, Charles; Bongrain, Alexandre; Arnault, Jean-Charles; Bergonzo, Philippe] CEA LIST, Diamond Sensors Lab, Gif Sur Yvette, France; [Meffert, Simone; Offenhaeusser, Andreas] Forschungszentrum Julich, Inst Bio & Nanosyst Bioelect IBN2, D-52425 Julich, Germany; [Sahel, Jose-Alain] Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France; [Sahel, Jose-Alain; Picaud, Serge] Fdn Ophtalmol Adolphe de Rothschild, Paris, France; [Sahel, Jose-Alain] UCL, Inst Ophthalmol, London, England; [Sahel, Jose-Alain] French Acad Sci, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Research Center Julich; CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; University of London; University College London	Picaud, S (corresponding author), INSERM, U968, Inst Vis, Paris, France.	serge.picaud@inserm.fr	Bergonzo, Philippe/A-6567-2015; Bergonzo, P/AFT-4220-2022; Sahel, Jose-Alain/F-3172-2017; Arnault, Jean-Charles/AAN-2948-2021; Picaud, Serge/H-4012-2014; Offenhäusser, Andreas/E-7990-2012	Bergonzo, Philippe/0000-0002-0647-9134; Sahel, Jose-Alain/0000-0002-4831-1153; Picaud, Serge/0000-0002-0548-5145; Offenhäusser, Andreas/0000-0001-6143-2702	INSERM; UPMC (Paris VI); Fondation Ophtalmologique A. de Rothschild (Paris); Agence Nationale pour la Recherche (MEDINAS project) [ANR-07-TECSAN-014]; Fondation Fighting Blindness; Fondation pour la Recherche Medicale; sixth European framework (DREAMS) [FP6-NMP-2006-676033345]; sixth European framework (NEUROCARE) [FP7-NMP-280433]; IMPLANTS project from ITMO-TecSan; Federation des Aveugles de France; IRRP; city of Paris; Regional Council of Ile-de-France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC (Paris VI); Fondation Ophtalmologique A. de Rothschild (Paris); Agence Nationale pour la Recherche (MEDINAS project)(French National Research Agency (ANR)); Fondation Fighting Blindness; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); sixth European framework (DREAMS); sixth European framework (NEUROCARE); IMPLANTS project from ITMO-TecSan; Federation des Aveugles de France; IRRP; city of Paris(Region Ile-de-France); Regional Council of Ile-de-France(Region Ile-de-France)	This work was supported by INSERM, UPMC (Paris VI), the Fondation Ophtalmologique A. de Rothschild (Paris), Agence Nationale pour la Recherche (MEDINAS project, ANR-07-TECSAN-014), Fondation Fighting Blindness, Fondation pour la Recherche Medicale, the sixth European framework (DREAMS, project FP6-NMP-2006-676033345; NEUROCARE, project FP7-NMP-280433), IMPLANTS project from ITMO-TecSan, Federation des Aveugles de France, IRRP, the city of Paris, the Regional Council of Ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariano P, 2009, BIOSENS BIOELECTRON, V24, P2046, DOI 10.1016/j.bios.2008.10.017; Aumailley M, 2013, CELL ADHES MIGR, V7, P48, DOI 10.4161/cam.22826; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Bates CA, 1997, DEV BIOL, V181, P91, DOI 10.1006/dbio.1996.8438; Briggs D., 1992, HIGH RESOLUTION XPS; Butterwick A, 2009, EXP EYE RES, V88, P22, DOI 10.1016/j.exer.2008.09.018; Chang JC, 2001, BIOSENS BIOELECTRON, V16, P527, DOI 10.1016/S0956-5663(01)00166-X; Chang WC, 2008, LANGMUIR, V24, P13048, DOI 10.1021/la8021479; Chen YC, 2010, BIOMATERIALS, V31, P5575, DOI 10.1016/j.biomaterials.2010.03.061; Chen YC, 2009, BIOMATERIALS, V30, P3428, DOI 10.1016/j.biomaterials.2009.03.058; Djilas M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046020; Dobelle WH, 2000, ASAIO J, V46, P3, DOI 10.1097/00002480-200001000-00002; Fuchs C, 2005, INVEST OPHTH VIS SCI, V46, P2983, DOI 10.1167/iovs.04-1177; Gao WL, 2010, APPL SURF SCI, V257, P538, DOI 10.1016/j.apsusc.2010.07.029; Ghodbane S, 2010, DIAM RELAT MATER, V19, P630, DOI 10.1016/j.diamond.2010.01.014; GI RS, 1995, JPN J APPL PHYS 1, V34, P5550, DOI 10.1143/JJAP.34.5550; Granger MC, 2000, ANAL CHEM, V72, P3793, DOI 10.1021/ac0000675; Graupner R, 1998, PHYS REV B, V57, P12397, DOI 10.1103/PhysRevB.57.12397; Gupta S, 2008, J APPL PHYS, V104, DOI 10.1063/1.2990058; Hadjinicolaou AE, 2012, BIOMATERIALS, V33, P5812, DOI 10.1016/j.biomaterials.2012.04.063; Humayun MS, 2012, OPHTHALMOLOGY, V119, P779, DOI 10.1016/j.ophtha.2011.09.028; Kiran R, 2012, SENSORS-BASEL, V12, P7669, DOI 10.3390/s120607669; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lions M, 2009, PHYS STATUS SOLIDI-R, V3, P205, DOI 10.1002/pssr.200903128; Liu BF, 2006, COLLOID SURFACE B, V53, P175, DOI 10.1016/j.colsurfb.2006.08.018; Maynard EM, 2000, J NEUROSCI METH, V97, P93, DOI 10.1016/S0165-0270(00)00159-X; Mehes E, 2005, GLIA, V49, P492, DOI 10.1002/glia.20135; Romano C, 2007, PROG RETIN EYE RES, V26, P379, DOI 10.1016/j.preteyeres.2007.03.001; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Ruiz-Taylor LA, 2001, LANGMUIR, V17, P7313, DOI 10.1021/la010620t; Snidero E, 2003, J APPL PHYS, V93, P2700, DOI 10.1063/1.1539922; Specht CG, 2004, BIOMATERIALS, V25, P4073, DOI 10.1016/j.biomaterials.2003.11.006; Thalhammer A, 2010, BIOMATERIALS, V31, P2097, DOI 10.1016/j.biomaterials.2009.11.109; Vanhove E, 2007, PHYS STATUS SOLIDI A, V204, P2931, DOI 10.1002/pssa.200776340; Vanhove E, 2009, PHYS STATUS SOLIDI A, V206, P2063, DOI 10.1002/pssa.200982235; Wei M, 2009, CHEM COMMUN, P3624, DOI 10.1039/b903284c; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	37	30	30	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92562	10.1371/journal.pone.0092562	http://dx.doi.org/10.1371/journal.pone.0092562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664111	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900075
J	Gaignier, F; Schenten, V; Bittencourt, MD; Gauquelin-Koch, G; Frippiat, JP; Legrand-Frossi, C				Gaignier, Fanny; Schenten, Veronique; Bittencourt, Marcelo De Carvalho; Gauquelin-Koch, Guillemette; Frippiat, Jean-Pol; Legrand-Frossi, Christine			Three Weeks of Murine Hindlimb Unloading Induces Shifts from B to T and from Th to Tc Splenic Lymphocytes in Absence of Stress and Differentially Reduces Cell-Specific Mitogenic Responses	PLOS ONE			English	Article							AMPHIBIAN PLEURODELES-WALTL; IMMUNE-SYSTEM; SPACE-FLIGHT; SIMULATED WEIGHTLESSNESS; SPACEFLIGHT CONDITIONS; GENE-EXPRESSION; RODENT MODEL; IMMUNOLOGICAL RESPONSES; APPLIED PHYSIOLOGY; DURATION MISSIONS	Extended space missions are known to induce stress and immune dysregulation. Hindlimb unloading is a ground-based model used to reproduce most spaceflight conditions. The aim of this study was to better characterize the consequences of prolonged exposure to hindlimb unloading on murine splenic lymphocyte sub-populations. To ensure that the observed changes were not due to tail restraint but to the antiorthostatic position, three groups of mice were used: control (C), orthostatic restrained (R) and hindlimb unloaded (HU). After 21 days of exposure, no difference in serum corticosterone levels nor in thymus and spleen weights were observed between HU mice and their counterparts, revealing a low state of stress. Interestingly, flow cytometric analyses showed that B cells were drastically reduced in HU mouse spleens by 59% and, while the T cells number did not change, the Th/Tc ratio was decreased. Finally, the use of a fluorescent dye monitoring lymphoproliferation demonstrated that lymphocyte response to mitogen was reduced in Th and Tc populations and to a greater extent in B cells. Thus, we showed for the first time that, even if restraint has its own effects on the animals and their splenic lymphocytes, the prolonged antiorthostatic position leads, despite the absence of stress, to an inversion of the B/T ratio in the spleen. Furthermore, the lymphoproliferative response was impaired with a strong impact on B cells. Altogether, these results suggest that B cells are more affected by hindlimb unloading than T cells which may explain the high susceptibility to pathogens, such as gram-negative bacteria, described in animal models and astronauts.	[Gaignier, Fanny; Schenten, Veronique; Frippiat, Jean-Pol; Legrand-Frossi, Christine] Lorraine Univ, EA7300, Stress Immun Pathogens Lab, Vandoeuvre Les Nancy, France; [Bittencourt, Marcelo De Carvalho] Lorraine Univ, UMR7039, Res Ctr Automat Control Nancy, Vandoeuvre Les Nancy, France; [Gauquelin-Koch, Guillemette] French Natl Space Agcy, Paris, France	Universite de Lorraine; Universite de Lorraine	Legrand-Frossi, C (corresponding author), Lorraine Univ, EA7300, Stress Immun Pathogens Lab, Vandoeuvre Les Nancy, France.	christine.frossi@univ-lorraine.fr	De Carvalho Bittencourt, Marcelo/E-9316-2012	De Carvalho Bittencourt, Marcelo/0000-0002-2698-2458; Frippiat, Jean-Pol/0000-0002-4027-6269	French National Space Agency (CNES); National Research Agency (ANR); French Ministry of Higher Education and Research; Region Lorraine; Lorraine-University; CNES	French National Space Agency (CNES)(Centre National D'etudes Spatiales); National Research Agency (ANR)(French National Research Agency (ANR)); French Ministry of Higher Education and Research; Region Lorraine(Region Grand-Est); Lorraine-University; CNES(Centre National D'etudes Spatiales)	This work was supported by the French National Space Agency (CNES), the National Research Agency (ANR), the French Ministry of Higher Education and Research, the Region Lorraine and the Lorraine-University. V. S. was supported by a CNES post-doctoral fellowship. F. G. was supported by CNES and the Region Lorraine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles H, 2005, NEUROIMMUNOMODULAT, V12, P173, DOI 10.1159/000084850; Aviles H, 2004, J APPL PHYSIOL, V97, P1437, DOI 10.1152/japplphysiol.00259.2004; Aviles H, 2003, J APPL PHYSIOL, V95, P73, DOI 10.1152/japplphysiol.00968.2002; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Bascove M, 2011, FASEB J, V25, P2947, DOI 10.1096/fj.11-185215; Bascove M, 2010, MOL IMMUNOL, V47, P1640, DOI 10.1016/j.molimm.2010.01.005; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; Belay T, 2002, J ALLERGY CLIN IMMUN, V110, P262, DOI 10.1067/mai.2002.126459; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; CAREN LD, 1980, AVIAT SPACE ENVIR MD, V51, P251; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; Chapes SK, 1999, J APPL PHYSIOL, V86, P2065, DOI 10.1152/jappl.1999.86.6.2065; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; Chouker A, 2020, STRESS CHALLENGES IM, DOI [10.1007/978-3-030-16996-1_8, DOI 10.1007/978-3-030-16996-1_8]; Cogoli A, 1997, Adv Space Biol Med, V6, P33, DOI 10.1016/S1569-2574(08)60077-5; COGOLI A, 1993, J LEUKOCYTE BIOL, V54, P259, DOI 10.1002/jlb.54.3.259; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; DRACOTT BN, 1979, IMMUNOLOGY, V38, P429; DURNOVA GN, 1976, AVIAT SPACE ENVIR MD, V47, P588; Erofeeva LM, 2003, B EXP BIOL MED+, V135, P190, DOI 10.1023/A:1023840419469; Felix K, 2004, MOL CELL BIOCHEM, V266, P79, DOI 10.1023/B:MCBI.0000049136.55611.dd; Frippiat JP, 2013, MOL IMMUNOL, V56, P434, DOI 10.1016/j.molimm.2013.06.011; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Gridley DS, 2003, J APPL PHYSIOL, V94, P2095, DOI 10.1152/japplphysiol.01053.2002; Grigorenko D E, 2012, Morfologiia, V142, P67; GROVE DS, 1995, EXP CELL RES, V219, P102, DOI 10.1006/excr.1995.1210; Gueguinou N, 2012, PSYCHONEUROENDOCRINO, V37, P137, DOI 10.1016/j.psyneuen.2011.05.015; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Huin-Schohn C, 2013, FASEB J, V27, P333, DOI 10.1096/fj.12-217547; ILYIN EA, 1980, KOSM BIOL AVIAK MED+, V14, P79; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; LESNYAK AT, 1993, J LEUKOCYTE BIOL, V54, P214, DOI 10.1002/jlb.54.3.214; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MANDEL AD, 1977, AVIAT SPACE ENVIR MD, V48, P1051; Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295; Morey E R, 1979, Physiologist, V22, pS23; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; NASH PV, 1991, EXP CELL RES, V195, P353, DOI 10.1016/0014-4827(91)90384-7; NASH PV, 1992, J APPL PHYSIOL, V73, pS186; O'Donnell PM, 2009, STRESS, V12, P82, DOI 10.1080/10253890802049269; Pecaut MJ, 2004, J APPL PHYSIOL, V97, P29, DOI 10.1152/japplphysiol.01304.2003; Pecaut MJ, 2003, J APPL PHYSIOL, V94, P2085, DOI 10.1152/japplphysiol.01052.2002; Pecaut MJ, 2000, AM J PHYSIOL-REG I, V279, pR2072, DOI 10.1152/ajpregu.2000.279.6.R2072; Rykova M P, 2006, Aviakosm Ekolog Med, V40, P19; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; Sonnenfeld G, 2002, MED SCI SPORT EXER, V34, P2021, DOI 10.1097/00005768-200212000-00024; SONNENFELD G, 1993, J LEUKOCYTE BIOL, V54, P253, DOI 10.1002/jlb.54.3.253; SONNENFELD G, 1992, J APPL PHYSIOL, V73, pS191, DOI 10.1152/jappl.1992.73.2.S191; SONNENFELD G, 1982, J INTERFERON RES, V2, P467, DOI 10.1089/jir.1982.2.467; STEFFEN JM, 1987, AVIAT SPACE ENVIR MD, V58, P996; TAYLOR GR, 1986, AVIAT SPACE ENVIR MD, V57, P213; TAYLOR GR, 1992, J LEUKOCYTE BIOL, V51, P129, DOI 10.1002/jlb.51.2.129; TAYLOR GR, 1993, J LEUKOCYTE BIOL, V54, P202, DOI 10.1002/jlb.54.3.202; Tsvirkun D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039923; VOSS EW, 1984, SCIENCE, V225, P214, DOI 10.1126/science.6729476; Wang KX, 2007, P NATL ACAD SCI USA, V104, P14777, DOI 10.1073/pnas.0703236104; Wei LX, 2003, CELL RES, V13, P465, DOI 10.1038/sj.cr.7290189; WRONSKI TJ, 1987, AVIAT SPACE ENVIR MD, V58, P63; Wronski TJ, 1998, J APPL PHYSIOL, V85, P279, DOI 10.1152/jappl.1998.85.1.279; Yamauchi K, 2002, J APPL PHYSIOL, V93, P161, DOI 10.1152/japplphysiol.01084.2001; Yuwaki Keiichi, 2004, Biol Sci Space, V18, P175; Zhang H, 1999, Space Med Med Eng (Beijing), V12, P423	65	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92664	10.1371/journal.pone.0092664	http://dx.doi.org/10.1371/journal.pone.0092664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664102	gold, Green Submitted, Green Published			2022-12-25	WOS:000333459900093
J	Weiner, AKM; Weinkauf, MFG; Kurasawa, A; Darling, KF; Kucera, M; Grimm, GW				Weiner, Agnes K. M.; Weinkauf, Manuel F. G.; Kurasawa, Atsushi; Darling, Kate F.; Kucera, Michal; Grimm, Guido W.			Phylogeography of the Tropical Planktonic Foraminifera Lineage Globigerinella Reveals Isolation Inconsistent with Passive Dispersal by Ocean Currents	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; REPRODUCTIVE ISOLATION; CRYPTIC SPECIATION; MOLECULAR EVIDENCE; DIVERSITY; DIVERSIFICATION; DIFFERENTIATION; AEQUILATERALIS; BIOGEOGRAPHY; PERFORMANCE	Morphologically defined species of marine plankton often harbor a considerable level of cryptic diversity. Since many morphospecies show cosmopolitan distribution, an understanding of biogeographic and evolutionary processes at the level of genetic diversity requires global sampling. We use a database of 387 single-specimen sequences of the SSU rDNA of the planktonic foraminifera Globigerinella as a model to assess the biogeographic and phylogenetic distributions of cryptic diversity in marine microplankton on a global scale. Our data confirm the existence of multiple, well isolated genetic lineages. An analysis of their abundance and distribution indicates that our sampling is likely to approximate the actual total diversity. Unexpectedly, we observe an uneven allocation of cryptic diversity among the phylogenetic lineages. We show that this pattern is neither an artifact of sampling intensity nor a function of lineage age. Instead, we argue that it reflects an ongoing speciation process in one of the three major lineages. Surprisingly, four of the six genetic types in the hyperdiverse lineage are biogeographically restricted to the Indopacific. Their mutual co-occurrence and their hierarchical phylogenetic structure provide no evidence for an origin through sudden habitat fragmentation and their limitation to the Indopacific challenges the view of a global gene flow within the warm-water provinces. This phenomenon shows that passive dispersal is not sufficient to describe the distribution of plankton diversity. Rather, these organisms show differentiated distribution patterns shaped by species interactions and reflecting phylogenetic contingency with unique histories of diversification rates.	[Weiner, Agnes K. M.; Weinkauf, Manuel F. G.; Kucera, Michal] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Kurasawa, Atsushi] Japanese Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa, Japan; [Darling, Kate F.] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Darling, Kate F.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Grimm, Guido W.] Swedish Museum Nat Hist, Dept Palaeobiol, S-10405 Stockholm, Sweden	University of Bremen; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Edinburgh; University of Edinburgh; Swedish Museum of Natural History	Weiner, AKM (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany.	aweiner@marum.de	Weinkauf, Manuel/AAL-5704-2020; Kucera, Michal/ABH-6065-2020; Kucera, Michal/B-9277-2009; Kucera, Michal/AAE-8115-2020	Kucera, Michal/0000-0002-7817-9018; Kucera, Michal/0000-0002-7817-9018; Weinkauf, Manuel F. G./0000-0002-4640-9659; Grimm, Guido/0000-0003-0674-3553; Weiner, Agnes K. M./0000-0002-9917-5235	Deutsche Forschungsgemeinschaf [KU 2259/19]; Natural Environment Research Council of the UK [NER/J/S/2000/00860, NE/ D009707/1]; Swedish Research Council [2008-3726]; Natural Environment Research Council [NER/J/S/2000/00860] Funding Source: researchfish	Deutsche Forschungsgemeinschaf(German Research Foundation (DFG)); Natural Environment Research Council of the UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Deutsche Forschungsgemeinschaft (grant KU 2259/19), the Natural Environment Research Council of the UK (grants NER/J/S/2000/00860 and NE/ D009707/1) and the Swedish Research Council (project no. 2008-3726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algar AC, 2013, GLOBAL ECOL BIOGEOGR, V22, P391, DOI 10.1111/geb.12003; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Andre A, 2013, PALEOBIOLOGY, V39, P21, DOI 10.1666/0094-8373-39.1.21; Aurahs R, 2009, BIOINFORM BIOL INSIG, V3, P155; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Aze T, 2011, BIOL REV, V86, P900, DOI 10.1111/j.1469-185X.2011.00178.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beal LM, 2011, NATURE, V472, P429, DOI 10.1038/nature09983; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BIJMA J, 1990, J FORAMIN RES, V20, P95, DOI 10.2113/gsjfr.20.2.95; Bijma J, 1998, MAR MICROPALEONTOL, V35, P141, DOI 10.1016/S0377-8398(98)00017-6; Blanco-Bercial L, 2011, J EXP MAR BIOL ECOL, V404, P108, DOI 10.1016/j.jembe.2011.05.011; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Darling KF, 2007, P NATL ACAD SCI USA, V104, P5002, DOI 10.1073/pnas.0700520104; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; de Vargas C, 2002, MAR MICROPALEONTOL, V45, P101, DOI 10.1016/S0377-8398(02)00037-3; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; DMODIFIER LETTER PRIMEOrbigny A.D., 1839, HIST PHYS POLITIQUE, P82; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FABER WW, 1988, J FORAMIN RES, V18, P334, DOI 10.2113/gsjfr.18.4.334; FABER WW, 1989, J FORAMIN RES, V19, P185, DOI 10.2113/gsjfr.19.3.185; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goker M, 2010, EVOL BIOINFORM, V6, P97; Goetze E, 2011, INTEGR COMP BIOL, V51, P580, DOI 10.1093/icb/icr104; Grimm GW, 2007, MAR MICROPALEONTOL, V62, P75, DOI 10.1016/j.marmicro.2006.07.005; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Holzmann M, 1996, J FORAMIN RES, V26, P264, DOI 10.2113/gsjfr.26.3.264; Huber BT, 1997, PALEOBIOLOGY, V23, P33, DOI 10.1017/S0094837300016638; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kennett J.P., 1983, NEOGENE PLANKTONIC F; Kucera M, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P409; Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006; Maddison WP, 2011, MESQUITE MODULAR SYS; McPeek MA, 2007, AM NAT, V169, pE97, DOI 10.1086/512135; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Morard R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026665; Morard R, 2009, MAR MICROPALEONTOL, V71, P148, DOI 10.1016/j.marmicro.2009.03.001; Morisita M., 1959, MEM FS KYUSHU U    E, V3, P65, DOI DOI 10.18960/SEITAI.11.6_252_4; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Paradis E, 2005, EVOLUTION, V59, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2012, EVOLUTION, V66, P288, DOI 10.1111/j.1558-5646.2011.01429.x; Parket F. L., 1962, Micropaleontology, V8, P219, DOI 10.2307/1484745; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Pillet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032373; QUENOUILLE MH, 1949, J ROY STAT SOC B, V11, P68; Quillevere F, 2013, PALAEOGEOGR IN PRESS, DOI DOI 10.1016/J.PALAE0.2011.1003.1013; R Development Core Team, 2011, R LANG ENV STAT COMP; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rambaut A, 2009, TREE FIGURE DRAWING; Schlitzer R, 2014, OCEAN DATA VIEW; Seears HA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-54; Sexton PF, 2008, GEOLOGY, V36, P899, DOI 10.1130/G25232A.1; Slapeta J, 2006, MOL BIOL EVOL, V23, P23, DOI 10.1093/molbev/msj001; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Stamatakis A., 2006, P IPDPS RHOD GREEC; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Weiner A, 2012, MOL ECOL, V21, P4063, DOI 10.1111/j.1365-294X.2012.05686.x; WILLIAMS ERNEST E., 1965, BREVIORA MUS COMP ZOOL HARVARD UNIV, V227, P1; Wuyts J, 2002, NUCLEIC ACIDS RES, V30, P183, DOI 10.1093/nar/30.1.183	65	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92148	10.1371/journal.pone.0092148	http://dx.doi.org/10.1371/journal.pone.0092148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663038	Green Submitted, gold, Green Published			2022-12-25	WOS:000333459900044
J	Carter, R; Mouralidarane, A; Soeda, J; Ray, S; Pombo, J; Saraswati, R; Novelli, M; Fusai, G; Rappa, F; Saracino, C; Pazienza, V; Poston, L; Taylor, PD; Vinciguerra, M; Oben, JA				Carter, Rebeca; Mouralidarane, Angelina; Soeda, Junpei; Ray, Shuvra; Pombo, Joaquim; Saraswati, Ruma; Novelli, Marco; Fusai, Giuseppe; Rappa, Francesca; Saracino, Chiara; Pazienza, Valerio; Poston, Lucilla; Taylor, Paul D.; Vinciguerra, Manlio; Oben, Jude A.			Non-Alcoholic Fatty Pancreas Disease Pathogenesis: A Role for Developmental Programming and Altered Circadian Rhythms	PLOS ONE			English	Article							BODY-MASS INDEX; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; OFFSPRING HYPERPHAGIA; METABOLIC SYNDROME; CANCER; MODEL; METAANALYSIS; ADIPOSITY; PREGNANCY	Objectives: Emerging evidence suggests that maternal obesity (MO) predisposes offspring to obesity and the recently described non-alcoholic fatty pancreas disease (NAFPD) but involved mechanisms remain unclear. Using a pathophysiologically relevant murine model, we here investigated a role for the biological clock -molecular core circadian genes (CCG) in the generation of NAFPD. Design: Female C57BL6 mice were fed an obesogenic diet (OD) or standard chow (SC) for 6 weeks, prior to pregnancy and throughout gestation and lactation: resulting offspring were subsequently weaned onto either OD (Ob_Ob and Con_Ob) or standard chow (Ob_Con and Con_Con) for 6 months. Biochemical, pro-inflammatory and pro-fibrogenic markers associated with NAFPD were then evaluated and CCG mRNA expression in the pancreas determined. Results: Offspring of obese dams weaned on to OD (Ob_Ob) had significantly increased (p<0.05): bodyweight, pancreatic triglycerides, macrovesicular pancreatic fatty-infiltration, and pancreatic mRNA expression of TNF-alpha, IL-6, alpha-SMA, TGF-beta and increased collagen compared to offspring of control dams weaned on to control chow (Con_Con). Analyses of CCG expression demonstrated a phase shift in CLOCK (-4.818, p<0.01), REV-ERB-alpha (-1.4, p<0.05) and Per2 (3.27, p<0.05) in association with decreased amplitude in BMAL-1 (-0.914, p<0.05) and PER2 (1.18, p<0.005) in Ob_Ob compared to Con_Con. 2-way ANOVA revealed significant interaction between MO and post-weaning OD in expression of CLOCK (p<0.005), PER1 (p<0.005) and PER2 (p<0.05) whilst MO alone influenced the observed rhythmic variance in expression of all 5 measured CCG. Conclusions: Fetal and neonatal exposure to a maternal obesogenic environment interacts with a post-natal hyper-calorific environment to induce offspring NAFPD through mechanisms involving perturbations in CCG expression.	[Carter, Rebeca; Mouralidarane, Angelina; Soeda, Junpei; Ray, Shuvra; Vinciguerra, Manlio; Oben, Jude A.] UCL, Royal Free Hosp, Inst Liver & Digest Hlth, London, England; [Ray, Shuvra; Oben, Jude A.] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London, England; [Pombo, Joaquim; Saraswati, Ruma; Poston, Lucilla; Taylor, Paul D.] Kings Coll London, Div Womens Hlth, London WC2R 2LS, England; [Pombo, Joaquim; Saraswati, Ruma; Poston, Lucilla] Kings Hlth Partners, London, England; [Saraswati, Ruma; Novelli, Marco] UCL, Dept Pathol, London, England; [Fusai, Giuseppe] UCL, Royal Free Hosp, Hepatobiliary & Liver Transplant Unit, London, England; [Rappa, Francesca] Univ Palermo, Sect Human Anat, Dept Expt Biomed & Clin Neurosci, Palermo, Italy; [Rappa, Francesca; Vinciguerra, Manlio] Euromediterranean Inst Sci & Technol IEMEST, Palermo, Italy; [Pazienza, Valerio; Vinciguerra, Manlio] IRCCS Casa Sollievo Sofferenza, Gastroenterol Unit, Dept Med Sci, San Giovanni Rotondo, Italy	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Palermo; IRCCS Casa Sollievo Della Sofferenza	Oben, JA (corresponding author), UCL, Royal Free Hosp, Inst Liver & Digest Hlth, London, England.	j.oben@ucl.ac.uk	OBEN, JUDE A/K-4331-2013; Francesca, Rappa/ADW-8431-2022; Soeda, Junpei/AAC-4816-2020; Pazienza, Valerio/K-5073-2012; Vinciguerra, Manlio/N-1309-2015	Pazienza, Valerio/0000-0002-3492-1153; Vinciguerra, Manlio/0000-0002-1768-3894; Poston, Lucilla/0000-0003-1100-2821; Taylor, Paul David/0000-0002-4740-4307; Oben, Jude/0000-0003-3350-8356; Soeda, Junpei/0000-0003-3753-0999; rappa, francesca/0000-0001-6610-5268	Wellcome Trust; MFAG - AIRC; Italian Ministry of Health [RC1303GA49]; Biotechnology and Biological Sciences Research Council [BB/H008845/1] Funding Source: researchfish; BBSRC [BB/H008845/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MFAG - AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JAO is supported by the Wellcome Trust. MV is supported by a MFAG - AIRC grant. VP is supported by a grant of the Italian Ministry of Health (RC1303GA49). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; Benegiamo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060527; Bracci PM, 2012, MOL CARCINOGEN, V51, P53, DOI 10.1002/mc.20778; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Deblon N, 2012, BRIT J PHARMACOL, V165, P2325, DOI 10.1111/j.1476-5381.2011.01716.x; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Grabiec K, 2012, POSTEP HIG MED DOSW, V66, P1, DOI 10.5604/973505; Hinde K, 2010, AM J PRIMATOL, V72, P522, DOI 10.1002/ajp.20806; Hurt Ryan T, 2011, JPEN J Parenter Enteral Nutr, V35, p4S, DOI 10.1177/0148607111415110; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005; Lamia KA, 2010, NATURE, V466, P571, DOI 10.1038/466571a; Larsson SC, 2007, INT J CANCER, V120, P1993, DOI 10.1002/ijc.22535; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Mathur Abhishek, 2007, HPB (Oxford), V9, P312, DOI 10.1080/13651820701504157; Matthews PA, 2011, J PHYSIOL-LONDON, V589, P3969, DOI 10.1113/jphysiol.2011.212324; Mazzoccoli G, 2012, CHRONOBIOL INT, V29, P227, DOI 10.3109/07420528.2012.658127; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Norman JE, 2011, P NUTR SOC, V70, P450, DOI 10.1017/S0029665111003077; Oben JA, 2010, BIOCHEM BIOPH RES CO, V394, P24, DOI 10.1016/j.bbrc.2010.02.057; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Organization WH, 2012, OB OV; Orozco-Solis R, 2011, INT J OBESITY, V35, P990, DOI 10.1038/ijo.2010.223; Orozco-Solis R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013537; Patel AV, 2005, CANCER EPIDEM BIOMAR, V14, P459, DOI 10.1158/1055-9965.EPI-04-0583; Peaston AE, 2006, MAMM GENOME, V17, P365, DOI 10.1007/s00335-005-0180-2; Pitt Henry A, 2007, HPB (Oxford), V9, P92, DOI 10.1080/13651820701286177; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Smits MM, 2011, NAT REV GASTRO HEPAT, V8, P169, DOI 10.1038/nrgastro.2011.4; Suter M, 2011, FASEB J, V25, P714, DOI 10.1096/fj.10-172080; Tevy MF, 2013, TRENDS ENDOCRIN MET, V24, P229, DOI 10.1016/j.tem.2012.12.002; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Varcoe TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053800; Veyrat-Durebex C, 2009, AM J PHYSIOL-ENDOC M, V296, pE1120, DOI 10.1152/ajpendo.90592.2008; Vinciguerra M, 2013, CLIN EXP MED; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169	42	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89505	10.1371/journal.pone.0089505	http://dx.doi.org/10.1371/journal.pone.0089505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24657938	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300006
J	Gong, XW; Li, JB; Lu, QC; Liang, PJ; Zhang, PM				Gong, Xin-Wei; Li, Jing-Bo; Lu, Qin-Chi; Liang, Pei-Ji; Zhang, Pu-Ming			Effective Connectivity of Hippocampal Neural Network and Its Alteration in Mg2+-Free Epilepsy Model	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; PARTIAL DIRECTED COHERENCE; EPILEPTIFORM DISCHARGES; BRAIN NETWORKS; ORGANIZATION; TOPOLOGY; SEIZURE; LOCALIZATION; PROPAGATION; DYNAMICS	Understanding the connectivity of the brain neural network and its evolution in epileptiform discharges is meaningful in the epilepsy researches and treatments. In the present study, epileptiform discharges were induced in rat hippocampal slices perfused with Mg2+-free artificial cerebrospinal fluid. The effective connectivity of the hippocampal neural network was studied by comparing the normal and epileptiform discharges recorded by a microelectrode array. The neural network connectivity was constructed by using partial directed coherence and analyzed by graph theory. The transition of the hippocampal network topology from control to epileptiform discharges was demonstrated. Firstly, differences existed in both the averaged in- and out-degree between nodes in the pyramidal cell layer and the granule cell layer, which indicated an information flow from the pyramidal cell layer to the granule cell layer during epileptiform discharges, whereas no consistent information flow was observed in control. Secondly, the neural network showed different small-worldness in the early, middle and late stages of the epileptiform discharges, whereas the control network did not show the small-world property. Thirdly, the network connectivity began to change earlier than the appearance of epileptiform discharges and lasted several seconds after the epileptiform discharges disappeared. These results revealed the important network bases underlying the transition from normal to epileptiform discharges in hippocampal slices. Additionally, this work indicated that the network analysis might provide a useful tool to evaluate the neural network and help to improve the prediction of seizures.	[Gong, Xin-Wei; Liang, Pei-Ji; Zhang, Pu-Ming] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Li, Jing-Bo; Lu, Qin-Chi] Shanghai Jiao Tong Univ, Ren Ji Hosp, Dept Neurol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, PM (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	pmzhang@sjtu.edu.cn			Key Basic Research Project of Science and Technology Commission of Shanghai [13DJ1400303]; Natural Science Foundation of Shanghai [12ZR1413800]; Shanghai Jiao Tong University Fund for Interdisciplinary Research for Medical Applications [YG2012ZD08]; Seed Fund of Ren Ji Hospital [RJZZ13-005]	Key Basic Research Project of Science and Technology Commission of Shanghai; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Jiao Tong University Fund for Interdisciplinary Research for Medical Applications; Seed Fund of Ren Ji Hospital	This work was supported by the Key Basic Research Project of Science and Technology Commission of Shanghai (13DJ1400303), the Natural Science Foundation of Shanghai (12ZR1413800), the Shanghai Jiao Tong University Fund for Interdisciplinary Research for Medical Applications (YG2012ZD08), and the Seed Fund of Ren Ji Hospital (RJZZ13-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andersen P., 2007, HIPPOCAMPUS BOOK; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bartolomei F, 2013, CLIN NEUROPHYSIOL; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bertram EH, 2013, EXP NEUROL, V244, P67, DOI 10.1016/j.expneurol.2012.01.028; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Daniel S, 2012, SPECTRAL GRAPH THEOR, P495; Ding L, 2007, NEUROIMAGE, V34, P575, DOI 10.1016/j.neuroimage.2006.09.042; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Dolan KT, 2001, PHYS REV E, V64; Douw L, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00174; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Gandica Y, 2010, PHYSICA A, V389, P4172, DOI 10.1016/j.physa.2010.05.043; Gong XW, 2010, PROG BIOCHEM BIOPHYS, V37, P1240, DOI 10.3724/SP.J.1206.2010.00065; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Hill AJ, 2010, J NEUROSCI METH, V185, P246, DOI 10.1016/j.jneumeth.2009.10.007; Kass RE, 2003, NETWORK-COMP NEURAL, V14, P5, DOI 10.1088/0954-898X/14/1/301; Korzeniewska A, 1997, J NEUROSCI METH, V73, P49, DOI 10.1016/S0165-0270(96)02212-1; Kramer MA, 2008, EPILEPSY RES, V79, P173, DOI 10.1016/j.eplepsyres.2008.02.002; Kramer MA, 2012, NEUROSCIENTIST, V18, P360, DOI 10.1177/1073858411422754; [李静波 Li Jingbo], 2012, [生物物理学报, Acta Biophysica Sinica], V28, P119; Liao W., 2010, PLOS ONE, V5; Liu JS, 2013, NEUROSCI BULL, V29, P28, DOI 10.1007/s12264-013-1304-4; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; MORF M, 1978, IEEE T GEOSCI REMOTE, V16, P85, DOI 10.1109/TGE.1978.294569; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Sameshima K, 1999, J NEUROSCI METH, V94, P93, DOI 10.1016/S0165-0270(99)00128-4; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Steidl EM, 2006, BRAIN RES, V1096, P70, DOI 10.1016/j.brainres.2006.04.034; Tassi L, 2009, EPILEPTIC DISORD, V11, P281, DOI 10.1684/epd.2009.0279; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; WESTERHOFF CHA, 1995, PFLUG ARCH EUR J PHY, V430, P238, DOI 10.1007/BF00374655; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Wilke C, 2010, EPILEPSIA, V51, P564, DOI 10.1111/j.1528-1167.2009.02329.x; Wu HH, 2006, LECT NOTES COMPUT SC, V3973, P573; Yang F, 2010, NEURAL REGEN RES, V5, P1548, DOI 10.3969/j.issn.1673-5374.2010.20.004; Zhang W, 2012, J NEUROSCI, V32, P1183, DOI 10.1523/JNEUROSCI.5342-11.2012; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	52	27	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92961	10.1371/journal.pone.0092961	http://dx.doi.org/10.1371/journal.pone.0092961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658094	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300148
J	Grewal, DS; Chou, J; Rollins, SD; Fawzi, AA				Grewal, Dilraj S.; Chou, Jonathan; Rollins, Stuart D.; Fawzi, Amani A.			A Pilot Quantitative Study of Topographic Correlation between Reticular Pseudodrusen and the Choroidal Vasculature Using En Face Optical Coherence Tomography	PLOS ONE			English	Article							SUBRETINAL DRUSENOID DEPOSITS; MACULAR DEGENERATION; HIGH-PENETRATION; PREVALENCE; COMPLEMENT; CHORIOCAPILLARIS; ASSOCIATION; HYPOTHESIS; IMAGE; RPE	Purpose: To analyze the topographic correlation between reticular pseudodrusen (RPD) visualized on infrared reflectance (IR) and choroidal vasculature using en-face volumetric spectral-domain optical coherence tomography (SD-OCT). Methods: A masked observer marked individual RPD on IR images using ImageJ (NIH, Bethesda, MD). Using the macular volume scan (Cirrus, Carl Zeiss Meditec Inc, Dublin, CA), the RPE slab function was used to generate a C-scan of the most superficial choroidal vasculature. An independent masked grader created a topographic binary map of the choroidal vasculature by thresholding the en-face image, which was overlaid onto the IR map of RPD. For each IR image, ImageJ was used to generate a random set of dots as "control lesions''. Results: 17 eyes of 11 patients (78 +/- 13.7 years) with RPD were analyzed. The average number of RPD lesions identified on IR images was 414 +/- 71.5, of which 49.6 +/- 4.3% were located overlying the choroidal vasculature, compared to 45.4 +/- 4.0% in controls (p = 0.014). 50.4 +/- 4.3% of lesions overlay the choroidal stroma, of which 76.5 +/- 3.1% were <= 3 pixels from the choroidal vessels. The percentage of RPD lesions located within <= 3 pixels from the choroidal vasculature was significantly greater than the percentage located >= 7 pixels away. (p<0.0001). Compared to controls (71.6 +/- 3.8%), RPD were more likely to be located <= 3 pixels away from choroidal vessels (p = 0.014). In contrast, control lesions were more likely to be >= 7 pixels away from choroidal vessels than RPD (9.1 +/- 1.9% vs. 4.8 +/- 1.2%, respectively, p = 0.002). Conclusions: Our analysis shows that RPD lesions follow the underlying choroidal vasculature. Approximately half the RPD directly overlay the choroidal vessels and the majority of the remaining lesions were <= 3 pixels (<= 30microns) from the vessel edge, supporting the hypothesis that RPD maybe related to pathologic changes at the choroidal level.	[Grewal, Dilraj S.; Chou, Jonathan; Rollins, Stuart D.; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	afawzimd@gmail.com	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558; Grewal, Dilraj/0000-0002-2229-5343	Research to Prevent Blindness (RPB, NY); RPB student research grant;  [NIH-EY021470]; NATIONAL EYE INSTITUTE [R01EY021470] Funding Source: NIH RePORTER	Research to Prevent Blindness (RPB, NY)(Research to Prevent Blindness (RPB)); RPB student research grant; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by NIH-EY021470 (AAF), unrestricted funds to the Department of Ophthalmology from Research to Prevent Blindness (RPB, NY), and RPB student research grant (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alten F, 2013, INVESTIGATIVE OPHTHA; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Arnold JJ, 1997, AM J OPHTHALMOL, V124, P344, DOI 10.1016/S0002-9394(14)70826-8; ARNOLD JJ, 1995, RETINA-J RET VIT DIS, V15, P183, DOI 10.1097/00006982-199515030-00001; Cohen SY, 2007, BRIT J OPHTHALMOL, V91, P354, DOI 10.1136/bjo.2006.101022; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; FRIEDMAN E, 1963, ARCH OPHTHALMOL-CHIC, V69, P220; Gehrs KM, 2010, ARCH OPHTHALMOL-CHIC, V128, P349, DOI 10.1001/archophthalmol.2010.18; Hageman GS, 1999, MOL VIS, V5; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Jaillon F, 2011, BIOMED OPT EXPRESS, V2, P1147, DOI 10.1364/BOE.2.001147; Klein R, 2008, AM J OPHTHALMOL, V145, P317, DOI 10.1016/j.ajo.2007.09.008; Kortvely E, 2010, INVEST OPHTH VIS SCI, V51, P79, DOI 10.1167/iovs.09-3850; Leng T, 2009, RETINA-J RET VIT DIS, V29, P988, DOI 10.1097/IAE.0b013e3181ae7113; Lengyel I, 2004, INVEST OPHTH VIS SCI, V45, P2886, DOI 10.1167/iovs.03-1083; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; MIMOUN G, 1990, J FR OPHTALMOL, V13, P511; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Puche N, 2013, RETINA-J RET VIT DIS, V33, P998, DOI 10.1097/IAE.0b013e31827b6483; Pumariega NM, 2011, OPHTHALMOLOGY, V118, P1619, DOI 10.1016/j.ophtha.2011.01.029; Querques G, 2013, RETINA; Querques G, 2011, RETINA-J RET VIT DIS, V31, P518, DOI 10.1097/IAE.0b013e3181f04974; Querques G, 2012, INVEST OPHTH VIS SCI, V53, P1258, DOI 10.1167/iovs.11-8907; Rudolf M, 2008, EXP EYE RES, V87, P402, DOI 10.1016/j.exer.2008.07.010; Sarks J, 2011, BRIT J OPHTHALMOL, V95, P979, DOI 10.1136/bjo.2010.194977; Sarks SH, 1999, BRIT J OPHTHALMOL, V83, P358, DOI 10.1136/bjo.83.3.358; Schmitz-Valckenberg S, 2011, INVEST OPHTH VIS SCI, V52, P5009, DOI 10.1167/iovs.11-7235; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwartz DM, 2013, OPHTHALMOLOGY; Smith RT, 2011, ARCH OPHTHALMOL-CHIC, V129, P1061, DOI 10.1001/archophthalmol.2011.212; Smith RT, 2009, AM J OPHTHALMOL, V148, P733, DOI 10.1016/j.ajo.2009.06.028; Sohrab M, 2013, MED HYPOTHESIS DISCO, V2, P69; Sohrab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048631; Sohrab MA, 2011, INVEST OPHTH VIS SCI, V52, P5743, DOI 10.1167/iovs.10-6942; Spaide RF, 2010, RETINA-J RET VIT DIS, V30, P1441, DOI 10.1097/IAE.0b013e3181ee5ce8; Ueda-Arakawa N, 2013, AM J OPHTHALMOL, V155, P260, DOI 10.1016/j.ajo.2012.08.011; Yasuno Y, 2009, INVEST OPHTH VIS SCI, V50, P405, DOI 10.1167/iovs.08-2272; Zweifel SA, 2011, RETINA-J RET VIT DIS, V31, P229, DOI 10.1097/IAE.0b013e3181f049bd; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P1775, DOI 10.1016/j.ophtha.2010.01.027; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	41	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92841	10.1371/journal.pone.0092841	http://dx.doi.org/10.1371/journal.pone.0092841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658298	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300133
J	Sharma, A; Huard, C; Vernochet, C; Ziemek, D; Knowlton, KM; Tyminski, E; Paradis, T; Zhang, Y; Jones, JEC; von Schack, D; Brown, CT; Milos, PM; Coyle, AJ; Tremblay, F; Martinez, RV				Sharma, Ankur; Huard, Christine; Vernochet, Cecile; Ziemek, Daniel; Knowlton, Kelly M.; Tyminski, Edyta; Paradis, Theresa; Zhang, Ying; Jones, Jessica E. C.; von Schack, David; Brown, Christopher T.; Milos, Patrice M.; Coyle, Anthony J.; Tremblay, Frederic; Martinez, Robert V.			Brown Fat Determination and Development from Muscle Precursor Cells by Novel Action of Bone Morphogenetic Protein 6	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ADIPOSE-TISSUE DEVELOPMENT; ADIPOCYTE DIFFERENTIATION; REGULATED EXPRESSION; INSULIN-RESISTANCE; WHITE ADIPOCYTES; C2C12 CELLS; PPAR-GAMMA; ADIPOGENESIS; MICE	Brown adipose tissue (BAT) plays a pivotal role in promoting energy expenditure by the virtue of uncoupling protein-1 (UCP-1) that differentiates BAT from its energy storing white adipose tissue (WAT) counterpart. The clinical implication of "classical" BAT (originates from Myf5 positive myoblastic lineage) or the "beige" fat (originates through trans-differentiation of WAT) activation in improving metabolic parameters is now becoming apparent. However, the inducers and endogenous molecular determinants that govern the lineage commitment and differentiation of classical BAT remain obscure. We report here that in the absence of any forced gene expression, stimulation with bone morphogenetic protein 6 (BMP6) induces brown fat differentiation from skeletal muscle precursor cells of murine and human origins. Through a comprehensive transcriptional profiling approach, we have discovered that two days of BMP6 stimulation in C2C12 myoblast cells is sufficient to induce genes characteristic of brown preadipocytes. This developmental switch is modulated in part by newly identified regulators, Optineurin (Optn) and Cyclooxygenase-2 (Cox2). Furthermore, pathway analyses using the Causal Reasoning Engine (CRE) identified additional potential causal drivers of this BMP6 induced commitment switch. Subsequent analyses to decipher key pathway that facilitates terminal differentiation of these BMP6 primed cells identified a key role for Insulin Like Growth Factor-1 Receptor (IGF-1R). Collectively these data highlight a therapeutically innovative role for BMP6 by providing a means to enhance the amount of myogenic lineage derived brown fat.	[Sharma, Ankur; Huard, Christine; Knowlton, Kelly M.; Tyminski, Edyta; Milos, Patrice M.; Coyle, Anthony J.; Tremblay, Frederic; Martinez, Robert V.] Pfizer Inc, Ctr Therapeut Innovat, Boston, MA 02115 USA; [Vernochet, Cecile; Jones, Jessica E. C.] Pfizer Inc, CVMED, Cambridge, MA USA; [Ziemek, Daniel] Pfizer Inc, Computat Sci Ctr Emphasis, Cambridge, MA USA; [Paradis, Theresa; Zhang, Ying; von Schack, David] Pfizer Inc, BioTherapeut Clin Res, Cambridge, MA USA; [Brown, Christopher T.] Pfizer Inc, Global BioTherapeut Technol, Cambridge, MA USA	Pfizer; Pfizer; Pfizer; Pfizer; Pfizer	Martinez, RV (corresponding author), Pfizer Inc, Ctr Therapeut Innovat, Boston, MA 02115 USA.	Robert.Martinez@Pfizer.com		Jones, Jessica/0000-0003-2539-5697	Pfizer	Pfizer(Pfizer)	This work was funded, supported and performed using Pfizer resources. The funder did support all authors in the form of salaries, while the research was conducted AND was involved in granting permission and authorizing the publication.	Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639; Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; Alexander DL, 1998, J CELL SCI, V111, P3311; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Bernot D, 2010, J BIOL CHEM, V285, P6508, DOI 10.1074/jbc.M109.078444; Boucher J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1905; Boucher J, 2010, J BIOL CHEM, V285, P17235, DOI 10.1074/jbc.M110.118620; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Chang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030637; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Cristancho AG, 2011, P NATL ACAD SCI USA, V108, P16271, DOI 10.1073/pnas.1109409108; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Cypess AM, 2013, NAT MED; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; Entingh-Pearsall A, 2004, J BIOL CHEM, V279, P38016, DOI 10.1074/jbc.M313201200; Fajas L, 2003, J LIPID RES, V44, P1652, DOI 10.1194/jlr.M300248-JLR200; Fournier B, 2012, MOL CELL BIOL, V32, P2871, DOI 10.1128/MCB.06575-11; Fuentealba L, 1999, J BIOL CHEM, V274, P37876, DOI 10.1074/jbc.274.53.37876; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; Fux C, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh001; Ghoshal S, 2011, J BIOL CHEM, V286, P889, DOI 10.1074/jbc.M110.139139; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hsieh PS, 2009, OBESITY, V17, P1150, DOI 10.1038/oby.2008.674; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; John-Aryankalayil M, 2009, MOL CANCER THER, V8, P261, DOI 10.1158/1535-7163.MCT-08-0928; Kachaner D, 2012, CELL CYCLE, V11, P2808, DOI 10.4161/cc.20946; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kim DH, 2013, J LIPID RES, V54, P786, DOI 10.1194/jlr.M033894; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED; Lindon C, 1998, J CELL BIOL, V140, P111, DOI 10.1083/jcb.140.1.111; Liu P, 2009, GENE, V433, P72, DOI 10.1016/j.gene.2008.12.010; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Mancini A, 2007, ONCOGENE, V26, P1020, DOI 10.1038/sj.onc.1209853; Maruyama H, 2012, GERIATR GERONTOL INT; Meng QF, 2012, MOL BIOL REP, V39, P5867, DOI 10.1007/s11033-011-1397-7; Nath M, 2011, CELL TISSUE RES, V344, P435, DOI 10.1007/s00441-011-1165-y; Nishio M, 2012, CELL METAB, V16, P394, DOI 10.1016/j.cmet.2012.08.001; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Petersen RK, 2003, J LIPID RES, V44, P2320, DOI 10.1194/jlr.M300192-JLR200; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; RAJAKUMARI S, 2013, CELL METAB; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Schulz TJ, 2013, BIOCHEM J, V453, P167, DOI 10.1042/BJ20130457; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Strader AD, 2004, J CLIN INVEST, V114, P1354, DOI 10.1172/JCI200420631; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vukicevic S, 2009, CYTOKINE GROWTH F R, V20, P441, DOI 10.1016/j.cytogfr.2009.10.020; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004	69	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92608	10.1371/journal.pone.0092608	http://dx.doi.org/10.1371/journal.pone.0092608			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658703	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300105
J	Subudhi, AW; Bourdillon, N; Bucher, J; Davis, C; Elliott, JE; Eutermoster, M; Evero, O; Fan, JL; Houten, SJV; Julian, CG; Kark, J; Kark, S; Kayser, B; Kern, JP; Kim, SE; Lathan, C; Laurie, SS; Lovering, AT; Paterson, R; Polaner, DM; Ryan, BJ; Spira, JL; Tsao, JW; Wachsmuth, NB; Roach, RC				Subudhi, Andrew W.; Bourdillon, Nicolas; Bucher, Jenna; Davis, Christopher; Elliott, Jonathan E.; Eutermoster, Morgan; Evero, Oghenero; Fan, Jui-Lin; Jameson-Van Houten, Sonja; Julian, Colleen G.; Kark, Jonathan; Kark, Sherri; Kayser, Bengt; Kern, Julia P.; Kim, See Eun; Lathan, Corinna; Laurie, Steven S.; Lovering, Andrew T.; Paterson, Ryan; Polaner, David M.; Ryan, Benjamin J.; Spira, James L.; Tsao, Jack W.; Wachsmuth, Nadine B.; Roach, Robert C.			AltitudeOmics: The Integrative Physiology of Human Acclimatization to Hypobaric Hypoxia and Its Retention upon Reascent	PLOS ONE			English	Article							OPERATION EVEREST-II; PULMONARY GAS-EXCHANGE; ACUTE MOUNTAIN-SICKNESS; PLASMA-VOLUME EXPANSION; COGNITIVE PERFORMANCE; SIMULATED ASCENT; OXYGEN-TRANSPORT; EXERCISE; VO(2MAX); NEOCYTOLYSIS	An understanding of human responses to hypoxia is important for the health of millions of people worldwide who visit, live, or work in the hypoxic environment encountered at high altitudes. In spite of dozens of studies over the last 100 years, the basic mechanisms controlling acclimatization to hypoxia remain largely unknown. The AltitudeOmics project aimed to bridge this gap. Our goals were 1) to describe a phenotype for successful acclimatization and assess its retention and 2) use these findings as a foundation for companion mechanistic studies. Our approach was to characterize acclimatization by measuring changes in arterial oxygenation and hemoglobin concentration [Hb], acute mountain sickness (AMS), cognitive function, and exercise performance in 21 subjects as they acclimatized to 5260 m over 16 days. We then focused on the retention of acclimatization by having subjects reascend to 5260 m after either 7 (n = 14) or 21 (n = 7) days at 1525 m. At 16 days at 5260 m we observed: 1) increases in arterial oxygenation and [Hb] (compared to acute hypoxia: PaO2 rose 964 mmHg to 45 +/- 4 while PaCO2 dropped a further 6 +/- 3 mmHg to 21 +/- 3, and [Hb] rose 1.8 +/- 0.7 g/dL to 16 +/- 2 g/dL; 2) no AMS; 3) improved cognitive function; and 4) improved exercise performance by 8 +/- 8% (all changes p<0.01). Upon reascent, we observed retention of arterial oxygenation but not [Hb], protection from AMS, retention of exercise performance, less retention of cognitive function; and noted that some of these effects lasted for 21 days. Taken together, these findings reveal new information about retention of acclimatization, and can be used as a physiological foundation to explore the molecular mechanisms of acclimatization and its retention.	[Subudhi, Andrew W.; Davis, Christopher; Eutermoster, Morgan; Evero, Oghenero; Jameson-Van Houten, Sonja; Julian, Colleen G.; Kark, Jonathan; Kark, Sherri; Paterson, Ryan; Roach, Robert C.] Univ Colorado, Altitude Res Ctr, Dept Emergency Med, Aurora, CO 80045 USA; [Subudhi, Andrew W.] Univ Colorado, Dept Biol, Colorado Springs, CO 80907 USA; [Bourdillon, Nicolas; Fan, Jui-Lin; Kayser, Bengt] Univ Lausanne, Fac Biol & Med, Inst Sports Sci, Lausanne, Switzerland; [Bourdillon, Nicolas; Fan, Jui-Lin] Univ Lausanne, Fac Biol & Med, Dept Physiol, Lausanne, Switzerland; [Bucher, Jenna; Elliott, Jonathan E.; Kern, Julia P.; Kim, See Eun; Laurie, Steven S.; Lovering, Andrew T.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [Fan, Jui-Lin] Univ Lausanne, Leman Doctoral Sch Neurosci, Lausanne, Switzerland; [Lathan, Corinna] AnthroTronix Inc, Silver Spring, MD USA; [Polaner, David M.] Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO USA; [Polaner, David M.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Polaner, David M.] Childrens Hosp Colorado, Aurora, CO USA; [Ryan, Benjamin J.] Univ Colorado, Dept Integrat Physiol, Boulder, CO USA; [Spira, James L.] Univ Hawaii, US Dept Vet Affairs, Pacific Islands Hlth Care Syst, Natl Ctr PTSD, Honolulu, HI 96822 USA; [Spira, James L.] Univ Hawaii, John A Burns Sch Med, Dept Psychiat, Honolulu, HI 96822 USA; [Tsao, Jack W.] US Navy Bur Med & Surg, Wounded Ill & Injured Directorate M9, Falls Church, VA USA; [Wachsmuth, Nadine B.] Univ Bayreuth, Dept Sports Med Sports Physiol, Bayreuth, Germany	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado at Colorado Springs; University of Lausanne; University of Lausanne; University of Oregon; University of Lausanne; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Boulder; University of Hawaii System; US Department of Veterans Affairs; University of Hawaii System; University of Bayreuth	Roach, RC (corresponding author), Univ Colorado, Altitude Res Ctr, Dept Emergency Med, Anschutz Med Campus, Aurora, CO 80045 USA.	Robert.Roach@ucdenver.edu	Kayser, Bengt/M-8643-2013; Polaner, David M/AAX-2514-2021; Lovering, Andrew/AAV-4419-2021; Roach, Robert/F-4729-2011	Kayser, Bengt/0000-0002-9776-7501; Polaner, David M/0000-0001-8716-6289; Lovering, Andrew/0000-0001-7826-4290; Fan, Jui-Lin/0000-0002-4413-5615; Ryan, Benjamin/0000-0001-5848-6988; Elliott, Jonathan/0000-0002-6992-6851; Wachsmuth, Nadine B./0000-0002-6321-3594; Roach, Robert/0000-0002-7998-8976; Subudhi, Andrew/0000-0001-9719-7660	United States Department of Defense [W81XWH-11-2-0040 TATRC, W81XWH-10-2-0114]; National Institutes of Health (NIH)/National Center for Advancing Translational Sciences Colorado CTSI [UL1 TR000154]; Cardiopulmonary & Respiratory Physiology Laboratory, University of Oregon; Altitude Research Center; Charles S. Houston Endowed Professorship, Department of Emergency Medicine, School of Medicine, University of Colorado Denver; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154, UL1TR001082] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); National Institutes of Health (NIH)/National Center for Advancing Translational Sciences Colorado CTSI; Cardiopulmonary & Respiratory Physiology Laboratory, University of Oregon; Altitude Research Center; Charles S. Houston Endowed Professorship, Department of Emergency Medicine, School of Medicine, University of Colorado Denver; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The overall AltitudeOmics study was funded, in part, by grants from the United States Department of Defense (W81XWH-11-2-0040 TATRC to RCR and W81XWH-10-2-0114 to ATL). The project was also supported, in part, by National Institutes of Health (NIH)/National Center for Advancing Translational Sciences Colorado CTSI Grant Number UL1 TR000154. Contents are the author's sole responsibility and do not necessarily represent official NIH views. Major additional support came from the Cardiopulmonary & Respiratory Physiology Laboratory, University of Oregon; the Altitude Research Center and the Charles S. Houston Endowed Professorship, Department of Emergency Medicine, School of Medicine, University of Colorado Denver. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfrey CP, 1997, LANCET, V349, P1389, DOI 10.1016/S0140-6736(96)09208-2; Amann M, 2013, J APPL PHYSIOL, V115, P634, DOI 10.1152/japplphysiol.00606.2013; Barcroft J, 1923, PHILOS T R SOC LON B, V211, P351, DOI 10.1098/rstb.1923.0008; BEBOUT DE, 1989, J APPL PHYSIOL, V67, P2286, DOI 10.1152/jappl.1989.67.6.2286; Beidleman BA, 1997, MED SCI SPORT EXER, V29, P1588, DOI 10.1097/00005768-199712000-00007; Calbet JAL, 2004, AM J PHYSIOL-HEART C, V287, pH1214, DOI 10.1152/ajpheart.00840.2003; Calbet JAL, 2003, J PHYSIOL-LONDON, V551, P379, DOI 10.1113/jphysiol.2003.045112; Calbet JAL, 2003, AM J PHYSIOL-REG I, V284, pR304, DOI 10.1152/ajpregu.00156.2002; Calbet JAL, 2003, AM J PHYSIOL-REG I, V284, pR291, DOI 10.1152/ajpregu.00155.2002; Calbet JAL, 2008, APPL PHYSIOL NUTR ME, V33, P593, DOI 10.1139/H08-010; Cauchy E, 2002, AVIAT SPACE ENVIR MD, V73, P1224; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dodd JW, 2010, EUR RESPIR J, V35, P913, DOI 10.1183/09031936.00125109; Fan JL, 2013, J APPL PHYSIOL, DOI [10.1152/japplphysiol.00704.2013, DOI 10.1152/JAPPLPHYSI0L.00704.2013)]; Fulco CS, 2005, J APPL PHYSIOL, V99, P867, DOI 10.1152/japplphysiol.00019.2005; Fulco CS, 2002, AVIAT SPACE ENVIR MD, V73, P758; Gerard A B, 2000, High Alt Med Biol, V1, P51, DOI 10.1089/152702900320685; Goodall S, 2014, ACTA PHYSL, DOI [10.1111/apha.12241, DOI 10.1111/APHA.12241)]; GROVES BM, 1987, J APPL PHYSIOL, V63, P521, DOI 10.1152/jappl.1987.63.2.521; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hill A.V., 1910, J PHYSL, V40, pi, DOI DOI 10.1113/JPHYSIOL.1910.SP191040SUPPLTOC; HORNBEIN TF, 1989, NEW ENGL J MED, V321, P1714, DOI 10.1056/NEJM198912213212505; HORSTMAN D, 1980, J APPL PHYSIOL, V49, P311, DOI 10.1152/jappl.1980.49.2.311; HOUSTON CS, 1987, J APPL PHYSIOL, V63, P877, DOI 10.1152/jappl.1987.63.2.877; Houston CS, 2005, GOING HIGHER OXYGEN; Hultgren H, 1997, HIGH ALTITUDE MED; Janocha AJ, 2011, NEW ENGL J MED, V365, P1942, DOI 10.1056/NEJMc1107887; Julian CG, 2011, J APPL PHYSIOL, V111, P392, DOI 10.1152/japplphysiol.00391.2011; KELMAN GR, 1966, J APPL PHYSIOL, V21, P1375, DOI 10.1152/jappl.1966.21.4.1375; KENNEDY RS, 1989, AVIAT SPACE ENVIR MD, V60, P99; KIDA M, 1993, J APPL PHYSIOL, V74, P1735, DOI 10.1152/jappl.1993.74.4.1735; KNAPIK J, 1989, MIL MED, V154, P326; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Latshang TD, 2011, SCANDINAVIAN J MED S; Leifflen D, 1997, AVIAT SPACE ENVIR MD, V68, P993; Luft U, 1942, LUFTFAHRTMEDIZEN, V7, P205; Lundby C, 2007, SCAND J MED SCI SPOR, V17, P281, DOI 10.1111/j.1600-0838.2006.00530.x; Lundby C, 2006, SCAND J MED SCI SPOR, V16, P35, DOI 10.1111/j.1600-0838.2004.00434.x; Lundby C, 2004, AM J PHYSIOL-REG I, V287, pR1202, DOI 10.1152/ajpregu.00725.2003; LYONS TP, 1995, AVIAT SPACE ENVIR MD, V66, P957; MAHER JT, 1974, J APPL PHYSIOL, V37, P895, DOI 10.1152/jappl.1974.37.6.895; MERINO CF, 1950, BLOOD, V5, P1; Messner R, 1989, CRYSTAL HORIZON EVER; MOORE RJ, 1992, CHANGES SOLDIER NUTR; Muza SR, 1995, ACTA ANDINA, V4, P109; Muza SR, 2010, HIGH ALT MED BIOL, V11, P87, DOI 10.1089/ham.2010.1006; NAKHOSTINE N, 1993, AM J PHYSIOL, V265, pH1289, DOI 10.1152/ajpheart.1993.265.4.H1289; Pavlicek V, 2005, AVIAT SPACE ENVIR MD, V76, P28; REEVES JT, 1987, J APPL PHYSIOL, V63, P531, DOI 10.1152/jappl.1987.63.2.531; REGARD M, 1991, AVIAT SPACE ENVIR MD, V62, P291; REYNAFARJE C, 1959, BLOOD, V14, P433, DOI 10.1182/blood.V14.4.433.433; Rice L, 2005, CELL PHYSIOL BIOCHEM, V15, P245, DOI 10.1159/000087234; Richalet JP, 2012, AM J RESP CRIT CARE, V185, P192, DOI 10.1164/rccm.201108-1396OC; Robach P, 2000, J APPL PHYSIOL, V89, P29; Robach P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002996; SAMPSON JB, 1980, AVIAT SPACE ENVIR MD, V51, P872; Schneider M, 2002, MED SCI SPORT EXER, V34, P1886, DOI 10.1097/00005768-200212000-00005; SCHOENE RB, 1990, MED SCI SPORT EXER, V22, P804, DOI 10.1249/00005768-199012000-00012; Schuler B, 2007, SCAND J MED SCI SPOR, V17, P588, DOI 10.1111/j.1600-0838.2006.00611.x; SEVERINGHAUS JW, 1966, J APPL PHYSIOL, V21, P1108, DOI 10.1152/jappl.1966.21.3.1108; SINGH I, 1969, NEW ENGL J MED, V280, P175, DOI 10.1056/NEJM196901232800402; STAMPER DA, 1970, PERCEPT MOTOR SKILL, V31, P247, DOI 10.2466/pms.1970.31.1.247; Subudhi AW, 2008, AM J PHYSIOL-HEART C, V294, pH164, DOI 10.1152/ajpheart.01104.2007; Subudhi AW, 2011, J APPL PHYSIOL, V110, P1219, DOI 10.1152/japplphysiol.01393.2010; Subudhi AW, 2013, J APPL PHYSIOL, DOI [10.1152/japplphysiol.00880.2013, DOI 10.1152/JAPPLPHYSI0L.00880.2013)]; Subudhi AW, 2013, EXP PHYSIOL, DOI [10.1113/expphysiol.2013.075184, DOI 10.1113/EXPPHYSI0L.2013.075184)]; SUTTON JR, 1988, J APPL PHYSIOL, V64, P1309, DOI 10.1152/jappl.1988.64.4.1309; Thorne DR, 2006, BEHAV RES METHODS, V38, P569, DOI 10.3758/BF03193886; Wagner PD, 2002, J APPL PHYSIOL, V92, P1393, DOI 10.1152/japplphysiol.00093.2001; WAGNER PD, 1987, J APPL PHYSIOL, V63, P2348, DOI 10.1152/jappl.1987.63.6.2348; WOLFEL EE, 1991, J APPL PHYSIOL, V70, P1129, DOI 10.1152/jappl.1991.70.3.1129; Wu TY, 2009, HIGH ALT MED BIOL, V10, P221, DOI 10.1089/ham.2009.1012; Young AJ, 1996, J APPL PHYSIOL, V81, P252, DOI 10.1152/jappl.1996.81.1.252	74	60	64	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92191	10.1371/journal.pone.0092191	http://dx.doi.org/10.1371/journal.pone.0092191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658407	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300059
J	Chen, DP; Ma, YY; Wang, XQ; Yu, SQ; Li, L; Dai, B; Mao, ZG; Sun, LJ; Xu, CG; Rong, S; Tang, MJ; Zhao, HB; Liu, HC; Serra, AL; Graf, N; Liu, SY; Wuthrich, RP; Mei, CL				Chen, Dongping; Ma, Yiyi; Wang, Xueqi; Yu, Shengqiang; Li, Lin; Dai, Bing; Mao, Zhiguo; Sun, Lijun; Xu, Chenggang; Rong, Shu; Tang, Mengjun; Zhao, Hongbo; Liu, Hongchao; Serra, Andreas L.; Graf, Nicole; Liu, Shiyuan; Wuethrich, Rudolf P.; Mei, Changlin			Clinical Characteristics and Disease Predictors of a Large Chinese Cohort of Patients with Autosomal Dominant Polycystic Kidney Disease	PLOS ONE			English	Article							STAGE RENAL-DISEASE; SINGLE-CENTER; VOLUME; PROGRESSION; ADPKD; IDENTIFICATION; EXPERIENCE; RISK; PKD1	Objective: Autosomal dominant polycystic kidney disease (ADPKD) is a relentlessly progressing form of chronic kidney disease for which there is no cure. The aim of this study was to characterize Chinese patients with ADPKD and to identify the factors which predict cyst growth and renal functional deterioration. Methods: To analyze disease predicting factors we performed a prospective longitudinal observational study in a cohort of 541 Chinese patients with ADPKD and an eGFR >= 30 ml/min/1.73 m(2). Patients were followed clinically and radiologically with sequential abdominal magnetic resonance imaging (MRI). Clinical characteristics and laboratory data were related to changes in estimated glomerular filtration rate (eGFR) and total kidney volume (TKV). A linear regression model was developed to analyze the factors which determine eGFR and TKV changes. Results: The age range of this unselected cohort ranged from 4 to 77 years. Median follow-up time was 14.3 +/- 10.6 months. Although inter-individual differences in eGFR and TKV were large, there was a consistent link between these two parameters. Baseline log(10)-transformed TKV and urinary protein/creatinine ratio were identified as the major predictors for a faster eGFR decline and were associated with a higher TKV growth rate. Interestingly, a lower thrombocyte count correlated significantly with lower eGFR (r = 0.222) and higher TKV (r = 0.134). Conclusions: This large cohort of Chinese patients with ADPKD provides unique epidemiological data for comparison with other cohorts of different ethnicity. In Chinese patients we identified a lower thrombocyte count as a significant predictor of disease progression. These results are important for the design of future clinical trials to retard polycystic kidney disease progression.	[Chen, Dongping; Ma, Yiyi; Wang, Xueqi; Yu, Shengqiang; Li, Lin; Dai, Bing; Mao, Zhiguo; Sun, Lijun; Xu, Chenggang; Rong, Shu; Tang, Mengjun; Mei, Changlin] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Nephrol, Kidney Inst, Shanghai, Peoples R China; [Zhao, Hongbo; Liu, Hongchao; Liu, Shiyuan] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Radiol, Shanghai, Peoples R China; [Serra, Andreas L.; Wuethrich, Rudolf P.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Graf, Nicole] Graf Biostat, Winterthur, Switzerland	Naval Medical University; Naval Medical University; University of Zurich; University Zurich Hospital	Wuthrich, RP (corresponding author), Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland.	wuethrich@usz.ch; chlmei1954@126.com	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X; Ma, yiyi/0000-0002-0772-957X	Institutional Partnership Grant from the Sino Swiss Science & Technology Cooperation (SSSTC) Program; National High Technology Reseach Development (863) Project of China [2007AA02Z3Z1]; National Natural Science Foundation of China [30570867, 30771016, 30971368]; National Natural Science Foundation of China for Young Scientists [81000281, 81100482]; Shanghai Key Clinical Disciplines Construction Project; Key Scientific and Technological Project of Shanghai Committee of Science and Technology [11431920800]	Institutional Partnership Grant from the Sino Swiss Science & Technology Cooperation (SSSTC) Program; National High Technology Reseach Development (863) Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China for Young Scientists(National Natural Science Foundation of China (NSFC)); Shanghai Key Clinical Disciplines Construction Project; Key Scientific and Technological Project of Shanghai Committee of Science and Technology	This work was supported by an Institutional Partnership Grant from the Sino Swiss Science & Technology Cooperation (SSSTC) Program, National High Technology Reseach Development (863) Project of China (2007AA02Z3Z1), National Natural Science Foundation of China (30570867, 30771016, 30971368), National Natural Science Foundation of China for Young Scientists (81000281, 81100482), Shanghai Key Clinical Disciplines Construction Project, Key Scientific and Technological Project of Shanghai Committee of Science and Technology (11431920800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audrezet MP, 2012, HUM MUTAT, V33, P1239, DOI 10.1002/humu.22103; BATH PMW, 1995, PLATELETS, V6, P336, DOI 10.3109/09537109509078468; Chapman AB, 2003, KIDNEY INT, V64, P1035, DOI 10.1046/j.1523-1755.2003.00185.x; CHAPMAN AB, 1994, J AM SOC NEPHROL, V5, P1349; Chapman AB, 2012, CLIN J AM SOC NEPHRO, V7, P479, DOI 10.2215/CJN.09500911; Choukroun G, 1995, J AM SOC NEPHROL, V6, P1634; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; FRANZ KA, 1983, KIDNEY INT, V23, P526, DOI 10.1038/ki.1983.51; Grantham J, 2008, KIDNEY INT, V73, P108, DOI 10.1038/sj.ki.5002624; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Helal I, 2013, NEPHROL DIAL TRANSPL, V28, P380, DOI 10.1093/ndt/gfs417; Johnson AM, 1997, J AM SOC NEPHROL, V8, P1560; King BF, 2000, J AM SOC NEPHROL, V11, P1505, DOI 10.1681/ASN.V1181505; Kistler AD, 2009, KIDNEY INT, V75, P235, DOI 10.1038/ki.2008.558; Meijer E, 2010, AM J KIDNEY DIS, V56, P883, DOI 10.1053/j.ajkd.2010.06.023; Neumann HPH, 2013, NEPHROL DIAL TRANSPL, V28, P1472, DOI 10.1093/ndt/gfs551; Orskov B, 2012, NEPHROL DIAL TRANSPL, V27, P1607, DOI 10.1093/ndt/gfr467; Ozkok A, 2013, CLIN EXP NEPHROL, V17, P345, DOI 10.1007/s10157-012-0706-3; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Rossetti S, 2012, J AM SOC NEPHROL, V23, P915, DOI 10.1681/ASN.2011101032; SIMON HB, 1955, JAMA-J AM MED ASSOC, V159, P657, DOI 10.1001/jama.1955.02960240023006; Sise C, 2000, KIDNEY INT, V58, P2492, DOI 10.1046/j.1523-1755.2000.00433.x; Thong KM, 2013, QJM-INT J MED, V106, P639, DOI 10.1093/qjmed/hct082; Tokiwa S, 2011, CLIN EXP NEPHROL, V15, P539, DOI 10.1007/s10157-011-0428-y; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2011, CLIN J AM SOC NEPHRO, V6, P640, DOI 10.2215/CJN.03250410; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161	28	23	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92232	10.1371/journal.pone.0092232	http://dx.doi.org/10.1371/journal.pone.0092232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651850	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000333352800087
J	Meggyes, M; Miko, E; Polgar, B; Bogar, B; Farkas, B; Illes, Z; Szereday, L				Meggyes, Matyas; Miko, Eva; Polgar, Beata; Bogar, Barbara; Farkas, Balint; Illes, Zsolt; Szereday, Laszlo			Peripheral Blood TIM-3 Positive NK and CD8+T Cells throughout Pregnancy: TIM-3/Galectin-9 Interaction and Its Possible Role during Pregnancy	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; T-HELPER TYPE-1; INNATE IMMUNE CELLS; GALECTIN-9; TOLERANCE; AUTOIMMUNE; LIGAND; INTERFACE; INDUCTION; RESPONSES	Problem: The T-cell immunoglobulin and mucin domain (TIM) family is a relatively newly described group of molecules with a conserved structure and important immunological functions. Identification of Galectin-9 as a ligand for TIM-3 has established the Galectin-9/TIM-3 pathway as an important negative regulator of Th1 immunity and tolerance induction. Data about the TIM-3/Gal-9 pathway in the pathogenesis of human diseases is emerging, but their possible role during human pregnancy is not precisely known. The aim of our study was to investigate the number, phenotype and functional activity of TIM-3+ peripheral blood mononuclear cells during healthy human pregnancy. Methods of Study: 57 healthy pregnant women [first trimester (n = 16); second trimester (n = 19); third trimester (n = 22)] and 30 non-pregnant controls were enrolled in the study. We measured the surface expression of TIM-3 by cytotoxic T cells, NK cells and NK cell subsets as well as Galectin-9 expression by regulatory T cells by flow cytometry. We analyzed the cytokine production and cytotoxicity of TIM3+ and TIM3-CD8 T and NK cells obtained from non-pregnant and healthy pregnant women at different stages of pregnancy by flow cytometry. Serum Galectin-9 levels were measured by ELISA. Results: Our results show that the numbers of peripheral NK and cytotoxic T cells and their TIM-3 expression do not change between the first, second and third trimesters of pregnancy. Compared to non-pregnant individuals, regulatory T cells show higher level of Galectin-9 expression as pregnancy proceeds, which is in line with the level of Galectin-9 in the patients sera. Cytotoxic T cells, NK cells and NK cell subsets expressing TIM-3 molecule show altered cytokine production and cytotoxicity during pregnancy compared to non-pregnant individuals. Conclusion: Our results indicate that Galectin-9 expressing regulatory T cells, TIM-3+ cytotoxic T cells and NK cells could play an important role in the maintenance of healthy pregnancy.	[Meggyes, Matyas; Miko, Eva; Polgar, Beata; Bogar, Barbara; Szereday, Laszlo] Univ Pecs, Ctr Clin, Dept Med Microbiol & Immunol, Pecs, Hungary; [Meggyes, Matyas; Miko, Eva; Polgar, Beata; Szereday, Laszlo] Janos Szentagothai Res Ctr, Pecs, Hungary; [Farkas, Balint] Univ Pecs, Ctr Clin, Dept Obstet & Gynaecol, Pecs, Hungary; [Illes, Zsolt] Odense Univ Hosp, Dept Neurol, DK-5000 Odense, Denmark; [Illes, Zsolt] Univ Southern Denmark, Inst Clin Res, Odense, Denmark	University of Pecs; University of Pecs; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Szereday, L (corresponding author), Univ Pecs, Ctr Clin, Dept Med Microbiol & Immunol, Pecs, Hungary.	szereday.laszlo@pte.hu	Szereday, Laszlo/AAR-5741-2021; Liu, FU-TONG/A-5749-2019; Farkas, Balint/AAF-9137-2019	Szereday, Laszlo/0000-0002-1208-2969; Liu, FU-TONG/0000-0002-3354-1001; Farkas, Balint/0000-0003-0638-2057; Illes, Zsolt/0000-0001-9655-0450	Hungarian National Research Fund [OTKA K104960]; Pecs University Research Fund [PTE-AOK-KA-2013/21, 34039/KA-OTKA/11-19, 11-14]; Social Renewal Operational Programme [TAMOP-4.2.1. B-10/2/KONV-2010-0002, TAMOP-4.2.2/B-10/1-2010-0029, TAMOP-4.2.2.A-11/1/KONV-2012-0053, TAMOP 4.2.4. A/2-11-1-2012-0001]; Hungarian Academy of Sciences	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Pecs University Research Fund; Social Renewal Operational Programme; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by grants from Hungarian National Research Fund (OTKA K104960), Pecs University Research Fund (PTE-AOK-KA-2013/21, 34039/KA-OTKA/11-19 and 11-14), Social Renewal Operational Programme (TAMOP-4.2.1.B-10/2/KONV-2010-0002, TAMOP-4.2.2/B-10/1-2010-0029, TAMOP-4.2.2.A-11/1/KONV-2012-0053. and TAMOP 4.2.4. A/2-11-1-2012-0001) and the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences to L. Szereday. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blidner AG, 2013, AM J REPROD IMMUNOL, V69, P369, DOI 10.1111/aji.12090; Borzychowski AM, 2005, EUR J IMMUNOL, V35, P3054, DOI 10.1002/eji.200425929; Chabtini L, 2013, J IMMUNOL, V190, P88, DOI 10.4049/jimmunol.1202176; Chaouat G, 2007, SEMIN IMMUNOPATHOL, V29, P95, DOI 10.1007/s00281-007-0069-0; de Weyer PSV, 2006, BIOCHEM BIOPH RES CO, V351, P571, DOI 10.1016/j.bbrc.2006.10.079; Golden-Mason L, 2013, J VIROL, V87, P4835, DOI 10.1128/JVI.01085-12; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Kwak-Kim J, 2008, AM J REPROD IMMUNOL, V59, P388, DOI 10.1111/j.1600-0897.2008.00596.x; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; LIN H, 1993, J IMMUNOL, V151, P4562; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Miko E, 2010, REPROD BIOMED ONLINE, V21, P750, DOI 10.1016/j.rbmo.2010.07.012; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Naka EL, 2009, INT IMMUNOPHARMACOL, V9, P658, DOI 10.1016/j.intimp.2008.11.013; Oomizu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048574; Popovici RM, 2005, J CLIN ENDOCR METAB, V90, P6170, DOI 10.1210/jc.2004-2529; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sacks GP, 2003, CLIN EXP IMMUNOL, V131, P490, DOI 10.1046/j.1365-2249.2003.02082.x; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Shimizu Y, 2008, ENDOCR J, V55, P879, DOI 10.1507/endocrj.K08E-111; Southcombe J, 2010, J REPROD IMMUNOL, V87, P52, DOI 10.1016/j.jri.2010.07.003; Than NG, 2012, TRENDS ENDOCRIN MET, V23, P23, DOI 10.1016/j.tem.2011.09.003; von Wolff M, 2005, MOL HUM REPROD, V11, P189, DOI 10.1093/molehr/gah144; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; Zhao J, 2009, J IMMUNOL, V182, P6618, DOI 10.4049/jimmunol.0803876; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	30	55	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92371	10.1371/journal.pone.0092371	http://dx.doi.org/10.1371/journal.pone.0092371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651720	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000333352800104
J	Sanches, TLM; Cunha, LD; Silva, GK; Guedes, PMM; Silva, JS; Zamboni, DS				Sanches, Tiago L. M.; Cunha, Larissa D.; Silva, Grace K.; Guedes, Paulo M. M.; Silva, Joao Santana; Zamboni, Dario S.			The Use of a Heterogeneously Controlled Mouse Population Reveals a Significant Correlation of Acute Phase Parasitemia with Mortality in Chagas Disease	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; IFN-GAMMA; REDUCES PARASITEMIA; GENETIC-CONTROL; RESISTANT MICE; SUSCEPTIBILITY; HOST; STRAINS; INTERLEUKIN-12; PATHOLOGY	Chagas disease develops upon infection with the protozoan parasite Trypanosoma cruzi and undergoes an acute phase characterized by massive parasite replication and the presence of parasites in the blood. This condition is known as acute phase parasitemia. This initial stage may result in a cure, in the development of the chronic stages of the disease or in the death of the infected host. Despite intensive investigation related to the characterization of the acute and chronic phases of the disease, the cause-effect relationship of acute phase parasitemia to the outcome of the disease is still poorly understood. In this study, we artificially generated a heterogeneously controlled mouse population by intercrossing F1 mice obtained from a parental breeding of highly susceptible A/J with highly resistant C57BL/6 mouse strains. This F2 population was infected and used to assess the correlation of acute phase parasitemia with the longevity of the animals. We used nonparametric statistical analyses and found a significant association between parasitemia and mortality. If males and females were evaluated separately, we found that the former were more susceptible to death, although parasitemia was similar in males and females. In females, we found a strong negative correlation between parasitemia and longevity. In males, however, additional factors independent of parasitemia may favor mouse mortality during the development of the disease. The correlations of acute phase parasitemia with mortality reported in this study may facilitate an appropriate prognostic approach to the disease in humans. Moreover, these results illustrate the complexity of the mammalian genetic traits that regulate host resistance during Chagas disease.	[Sanches, Tiago L. M.; Cunha, Larissa D.; Zamboni, Dario S.] Univ Sao Paulo, Med Sch Ribeirao Preto, FMRP USP, Dept Cell Biol, Sao Paulo, Brazil; [Silva, Grace K.; Guedes, Paulo M. M.; Silva, Joao Santana] Univ Sao Paulo, Med Sch Ribeirao Preto, FMRP USP, Dept Biochem & Immunol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Zamboni, DS (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, FMRP USP, Dept Cell Biol, Sao Paulo, Brazil.	dszamboni@fmrp.usp.br	Silva, Joao/A-4484-2008; Zamboni, Dario S/D-3024-2012; Cunha, Larissa D/I-4204-2012; Guedes, Paulo/Y-2546-2018; Silva, Grace/E-7673-2012	Silva, Joao/0000-0002-3410-3927; Zamboni, Dario S/0000-0002-7856-7512; Silva, Grace/0000-0001-6417-4243; Dias da Cunha, Larissa/0000-0002-1290-0263; Matta Guedes, Paulo Marcos/0000-0002-4564-6791	Instituto Nacional de Ciencia e Tecnologia em Vacinas (INCTV/CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/50959-4, 2013/08216-2]; Fundacao de Amparo ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); FAPESP	Instituto Nacional de Ciencia e Tecnologia em Vacinas (INCTV/CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Instituto Nacional de Ciencia e Tecnologia em Vacinas (INCTV/CNPq), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Grants 2010/50959-4 and 2013/08216-2) and Fundacao de Amparo ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA). TLMS, GKS and LDC are supported by fellowships from FAPESP. DSZ and JSS are CNPq Research Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsohn IA, 1996, EXP PARASITOL, V84, P231, DOI 10.1006/expr.1996.0109; Aleixo Denise Lessa, 2012, BMC Res Notes, V5, P352, DOI 10.1186/1756-0500-5-352; Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; Andersson J, 2003, IMMUNOL LETT, V86, P207, DOI 10.1016/S0165-2478(03)00019-1; Andrade LO, 2002, EXP PARASITOL, V100, P269, DOI 10.1016/S0014-4894(02)00024-3; Andrade Sonia G., 1997, Revista da Sociedade Brasileira de Medicina Tropical, V30, P27, DOI 10.1590/S0037-86821997000100006; [Anonymous], 2012, WHO TECHN REP SER; Arantes JM, 2007, EXP PARASITOL, V117, P43, DOI 10.1016/j.exppara.2007.03.006; Arantes JM, 2011, EXP PARASITOL, V128, P401, DOI 10.1016/j.exppara.2011.05.011; Barretto A C, 1993, Arq Bras Cardiol, V60, P225; Chessler ADC, 2011, INFECT IMMUN, V79, P2112, DOI 10.1128/IAI.01176-10; Clapcott SJ, 2000, PARASITE IMMUNOL, V22, P259, DOI 10.1046/j.1365-3024.2000.00308.x; Coura JR, 2012, REV SOC BRAS MED TRO, V45, P286, DOI 10.1590/S0037-86822012000300002; Coura JR, 2010, ACTA TROP, V115, P5, DOI 10.1016/j.actatropica.2010.03.008; da Costa SCG, 2002, HISTOL HISTOPATHOL, V17, P837, DOI 10.14670/HH-17.837; Da Silva APG, 2003, IMMUNOLOGY, V108, P230, DOI 10.1046/j.1365-2567.2003.01571.x; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Engman DM, 2002, ACTA TROP, V81, P123, DOI 10.1016/S0001-706X(01)00202-9; ESPINOSA R, 1985, INT J CARDIOL, V8, P45, DOI 10.1016/0167-5273(85)90262-1; Garzoni LR, 2004, INT J ANTIMICROB AG, V23, P286, DOI 10.1016/j.ijantimicag.2003.07.019; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Graefe SEB, 2003, GENES IMMUN, V4, P321, DOI 10.1038/sj.gene.6363972; Graefe SEB, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000057; Guedes PMM, 2010, BRIT J PHARMACOL, V160, P270, DOI 10.1111/j.1476-5381.2009.00576.x; Kayama H, 2010, MICROBES INFECT, V12, P511, DOI 10.1016/j.micinf.2010.03.005; Laroque A, 2012, GENES IMMUN, V13, P155, DOI 10.1038/gene.2011.67; Macedo Andra M, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004118; Marinho CRF, 2009, MICROBES INFECT, V11, P1037, DOI 10.1016/j.micinf.2009.07.011; Marinho CRF, 2004, INFECT IMMUN, V72, P2350, DOI 10.1128/IAI.72.4.2350-2357.2004; Martins GA, 2004, MICROBES INFECT, V6, P1133, DOI 10.1016/j.micinf.2004.07.002; MINOPRIO P, 1991, INT IMMUNOL, V3, P427, DOI 10.1093/intimm/3.5.427; MINOPRIO P, 1993, J IMMUNOL, V151, P4200; Nagajyothi F, 2012, PARASITOL RES, V110, P2491, DOI 10.1007/s00436-011-2790-9; Nava-Castro K, 2012, ANN NY ACAD SCI, V1262, P16, DOI 10.1111/j.1749-6632.2012.06632.x; Paiva CN, 2009, J LEUKOCYTE BIOL, V86, P1239, DOI 10.1189/jlb.0309187; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; RIVERAVANDERPAS MT, 1983, ACTA TROP, V40, P5; Roberts CW, 2001, CLIN MICROBIOL REV, V14, P476, DOI 10.1128/CMR.14.3.476-488.2001; Roberts LJ, 1999, EUR J IMMUNOL, V29, P3047, DOI 10.1002/(SICI)1521-4141(199909)29:09&lt;3047::AID-IMMU3047&gt;3.0.CO;2-L; Rodrigues CM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000846; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Silva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053766; Silva GK, 2010, J IMMUNOL, V184, P1148, DOI 10.4049/jimmunol.0902254; TANOWITZ HB, 1992, CLIN MICROBIOL REV, V5, P400, DOI 10.1128/CMR.5.4.400-419.1992; Vago AR, 2000, AM J PATHOL, V156, P1805, DOI 10.1016/S0002-9440(10)65052-3; Valdez RH, 2012, ANTIMICROB AGENTS CH, V56, P507, DOI 10.1128/AAC.05575-11; Vasconcelos RHT, 2012, CYTOKINE, V59, P203, DOI 10.1016/j.cyto.2012.04.035; Wallace A, 2001, BIOL RES, V34, P83; WRIGHTSMAN R, 1982, INFECT IMMUN, V36, P637, DOI 10.1128/IAI.36.2.637-644.1982; Yoshida N, 2008, PARASITOL INT, V57, P105, DOI 10.1016/j.parint.2007.12.008	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91640	10.1371/journal.pone.0091640	http://dx.doi.org/10.1371/journal.pone.0091640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651711	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800045
J	Ward, JD; Mullaney, B; Schiller, BJ; He, LD; Petnic, SE; Couillault, C; Pujol, N; Bernal, TU; Van Gilst, MR; Ashrafi, K; Ewbank, JJ; Yamamoto, KR				Ward, Jordan D.; Mullaney, Brendan; Schiller, Benjamin J.; He, Le D.; Petnic, Sarah E.; Couillault, Carole; Pujol, Nathalie; Bernal, Teresita U.; Van Gilst, Marc R.; Ashrafi, Kaveh; Ewbank, Jonathan J.; Yamamoto, Keith R.			Defects in the C. elegans acyl-CoA Synthase, acs-3, and Nuclear Hormone Receptor, nhr-25, Cause Sensitivity to Distinct, but Overlapping Stresses	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE EXPRESSION; CAENORHABDITIS-ELEGANS; CUTICLE SURFACE; INNATE IMMUNITY; DEVELOPMENTAL AGE; OSMOTIC-STRESS; SOMATIC GONAD; PROTEIN; GENES; EPIDERMIS	Metazoan transcription factors control distinct networks of genes in specific tissues, yet understanding how these networks are integrated into physiology, development, and homeostasis remains challenging. Inactivation of the nuclear hormone receptor nhr-25 ameliorates developmental and metabolic phenotypes associated with loss of function of an acyl-CoA synthetase gene, acs-3. ACS-3 activity prevents aberrantly high NHR-25 activity. Here, we investigated this relationship further by examining gene expression patterns following acs-3 and nhr-25 inactivation. Unexpectedly, we found that the acs-3 mutation or nhr-25 RNAi resulted in similar transcriptomes with enrichment in innate immunity and stress response gene expression. Mutants of either gene exhibited distinct sensitivities to pathogens and environmental stresses. Only nhr-25 was required for wild-type levels of resistance to the bacterial pathogen P. aeruginosa and only acs-3 was required for wild-type levels of resistance to osmotic stress and the oxidative stress generator, juglone. Inactivation of either acs-3 or nhr-25 compromised lifespan and resistance to the fungal pathogen D. coniospora. Double mutants exhibited more severe defects in the lifespan and P. aeruginosa assays, but were similar to the single mutants in other assays. Finally, acs-3 mutants displayed defects in their epidermal surface barrier, potentially accounting for the observed sensitivities. Together, these data indicate that inactivation of either acs-3 or nhr-25 causes stress sensitivity and increased expression of innate immunity/stress genes, most likely by different mechanisms. Elevated expression of these immune/stress genes appears to abrogate the transcriptional signatures relevant to metabolism and development.	[Ward, Jordan D.; Schiller, Benjamin J.; Petnic, Sarah E.; Bernal, Teresita U.; Yamamoto, Keith R.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Mullaney, Brendan; Ashrafi, Kaveh] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [He, Le D.; Couillault, Carole; Pujol, Nathalie; Ewbank, Jonathan J.] UM2 Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France; [He, Le D.; Couillault, Carole; Pujol, Nathalie; Ewbank, Jonathan J.] INSERM, F-13258 Marseille, France; [He, Le D.; Couillault, Carole; Pujol, Nathalie; Ewbank, Jonathan J.] CNRS, UMR7280, Marseille, France; [Van Gilst, Marc R.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Fred Hutchinson Cancer Center	Ward, JD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	jordan.ward@ucsf.edu	Ward, Jordan/H-3444-2019; Pujol, Nathalie/K-3880-2012; Ewbank, Jonathan J/G-4948-2010	Ward, Jordan/0000-0001-9870-8936; Pujol, Nathalie/0000-0001-8889-3197; Ewbank, Jonathan J/0000-0002-1257-6862	Terry Fox Foundation [700046]; Canadian Institutes of Health Research [234765]; NIH [CA20535]; NSF [MCB-1157767]; National Institute of Environmental Health Sciences [ES021412-01]; Program in Breakthrough Biomedical Research; INSERM; CNRS; French ANR; Direct For Biological Sciences [1157767] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R37CA020535, R01CA020535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021412] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Terry Fox Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Program in Breakthrough Biomedical Research; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); French ANR(French National Research Agency (ANR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	JDW was supported by postdoctoral fellowships from the Terry Fox Foundation (award #700046) and the Canadian Institutes of Health Research (award #234765). Research support was from the NIH (CA20535) and NSF (MCB-1157767) to KRY, the National Institute of Environmental Health Sciences (ES021412-01) and the Program in Breakthrough Biomedical Research to KA. JE is funded by institutional grants from INSERM and the CNRS, and program grants from the French ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; Asahina M, 2000, GENES CELLS, V5, P711, DOI 10.1046/j.1365-2443.2000.00361.x; Asahina M, 2006, DEV CELL, V11, P203, DOI 10.1016/j.devcel.2006.06.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; BLAXTER ML, 1992, PARASITOL TODAY, V8, P243, DOI 10.1016/0169-4758(92)90126-M; BLAXTER ML, 1993, J BIOL CHEM, V268, P6600; BLUM J, 1983, ARCH BIOCHEM BIOPHYS, V222, P35, DOI 10.1016/0003-9861(83)90499-X; BRENNER S, 1974, GENETICS, V77, P71; Cezairliyan B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003101; Chen Z, 2004, MOL CELL BIOL, V24, P7345, DOI 10.1128/MCB.24.17.7345-7358.2004; Chisholm AD, 2012, WIRES DEV BIOL, V1, P879, DOI 10.1002/wdev.77; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Dierking K, 2011, CELL HOST MICROBE, V9, P425, DOI 10.1016/j.chom.2011.04.011; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gissendanner CR, 2000, DEV BIOL, V221, P259, DOI 10.1006/dbio.2000.9679; Gomez F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-300; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Hada K, 2010, DEV BIOL, V344, P1100, DOI 10.1016/j.ydbio.2010.05.508; Hansen M, 2007, WESTERN HUM REV, V61, P6; Hartwig K, 2009, GENES NUTR, V4, P59, DOI 10.1007/s12263-009-0113-x; Hayes GD, 2006, DEVELOPMENT, V133, P4631, DOI 10.1242/dev.02655; HIMMELHOCH S, 1979, J NEMATOL, V11, P358; HIMMELHOCH S, 1983, EXP PARASITOL, V55, P299, DOI 10.1016/0014-4894(83)90026-7; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; JANSSON HB, 1986, J NEMATOL, V18, P570; Kage-Nakadai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008857; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lamitina ST, 2004, AM J PHYSIOL-CELL PH, V286, pC785, DOI 10.1152/ajpcell.00381.2003; Lee KZ, 2010, VIRULENCE, V1, P113, DOI 10.4161/viru.1.3.10974; Li Y, 2011, BMB REP, V44, P285, DOI 10.5483/BMBRep.2011.44.4.285; Meli VS, 2010, MOL BIOL CELL, V21, P1648, DOI 10.1091/mbc.E08-07-0708; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; Monsalve GC, 2011, CURR BIOL, V21, P2033, DOI 10.1016/j.cub.2011.10.054; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; Mullaney BC, 2010, CELL METAB, V12, P398, DOI 10.1016/j.cmet.2010.08.013; Partridge FA, 2008, DEV BIOL, V317, P549, DOI 10.1016/j.ydbio.2008.02.060; Pathare PP, 2012, PLOS GENET, V8, P333, DOI 10.1371/journal.pgen.1002645; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Silhankova M, 2005, J CELL SCI, V118, P223, DOI 10.1242/jcs.01609; Simeckova K, 2007, FOLIA BIOL-PRAGUE, V53, P85; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Sutphin George L, 2009, J Vis Exp, DOI 10.3791/1152; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Taubert S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000021; Taubert S, 2011, MOL CELL ENDOCRINOL, V334, P49, DOI 10.1016/j.mce.2010.04.021; Tong A, 2009, P NATL ACAD SCI USA, V106, P1457, DOI 10.1073/pnas.0809339106; Ward JD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003992; Wheeler JM, 2006, GENETICS, V174, P1327, DOI 10.1534/genetics.106.059089; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Ziegler K, 2009, CELL HOST MICROBE, V5, P341, DOI 10.1016/j.chom.2009.03.006; ZUCKERMAN BM, 1979, EXP PARASITOL, V47, P419, DOI 10.1016/0014-4894(79)90095-X; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	67	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92552	10.1371/journal.pone.0092552	http://dx.doi.org/10.1371/journal.pone.0092552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651852	Green Published, gold			2022-12-25	WOS:000333352800127
J	Kim, B; Wang, S; Lee, JM; Jeong, Y; Ahn, T; Son, DS; Park, HW; Yoo, HS; Song, YJ; Lee, E; Oh, YM; Lee, SB; Choi, J; Murray, JC; Zhou, Y; Song, PH; Kim, KA; Weiner, LM				Kim, B.; Wang, S.; Lee, J. M.; Jeong, Y.; Ahn, T.; Son, D-S; Park, H. W.; Yoo, H-s; Song, Y-J; Lee, E.; Oh, Y. M.; Lee, S. B.; Choi, J.; Murray, J. C.; Zhou, Y.; Song, P. H.; Kim, K-A; Weiner, L. M.			Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; TYROSINE KINASE; HEPATOCYTE GROWTH; C-MET; GEFITINIB RESISTANCE; ACTIVATING MUTATIONS; MEDIATES RESISTANCE; SIGNALING PATHWAY; DRUG-RESISTANCE	Met is a receptor tyrosine kinase that promotes cancer progression. In addition, Met has been implicated in resistance of tumors to various targeted therapies such as epidermal growth factor receptor inhibitors in lung cancers, and has been prioritized as a key molecular target for cancer therapy. However, the underlying mechanism of resistance to Met-targeting drugs is poorly understood. Here, we describe screening of 1310 genes to search for key regulators related to drug resistance to an anti-Met therapeutic antibody (SAIT301) by using a small interfering RNA-based synthetic lethal screening method. We found that knockdown of 69 genes in Met-amplified MKN45 cells sensitized the antitumor activity of SAIT301. Pathway analysis of these 69 genes implicated fibroblast growth factor receptor (FGFR) as a key regulator for antiproliferative effects of Met-targeting drugs. Inhibition of FGFR3 increased target cell apoptosis through the suppression of Bcl-xL expression, followed by reduced cancer cell growth in the presence of Met-targeting drugs. Treatment of cells with the FGFR inhibitors substantially restored the efficacy of SAIT301 in SAIT301-resistant cells and enhanced the efficacy in SAIT301-sensitive cells. In addition to FGFR3, integrin beta 3 is another potential target for combination treatment with SAIT301. Suppression of integrin beta 3 decreased AKT phosphorylation in SAIT301-resistant cells and restored SAIT301 responsiveness in HCC1954 cells, which are resistant to SAIT301. Gene expression analysis using CCLE database shows that cancer cells with high levels of FGFR and integrin beta 3 are resistant to crizotinib treatment, suggesting that FGFR and integrin beta 3 could be used as predictive markers for Met-targeted therapy and provide a potential therapeutic option to overcome acquired and innate resistance for the Met-targeting drugs.	[Kim, B.; Lee, J. M.; Jeong, Y.; Ahn, T.; Son, D-S; Park, H. W.; Yoo, H-s; Song, Y-J; Lee, E.; Oh, Y. M.; Lee, S. B.; Choi, J.; Song, P. H.; Kim, K-A] SAIT, BioTherapeut Lab, Yongin 446712, Gyeonggi Do, South Korea; [Wang, S.; Murray, J. C.; Weiner, L. M.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA; [Zhou, Y.] Fox Chase Canc Ctr, Biostat & Bioinformat Fac, Philadelphia, PA 19111 USA	Samsung; Georgetown University; Fox Chase Cancer Center	Kim, KA (corresponding author), SAIT, BioTherapeut Lab, 95 Samsung2 Ro, Yongin 446712, Gyeonggi Do, South Korea.	ka10.kim@samsung.com	Murray, Joseph C/J-8916-2014; Lee, Ji Min/ABE-7494-2021; Jeong, Yunju/GRS-0008-2022	Murray, Joseph C/0000-0001-6159-7814; Lee, Ji Min/0000-0003-2978-2440; Wang, Shangzi/0000-0002-8936-6572	NCI [CA51008, CA50633]; Lombardi Comprehensive Cancer Center's Genomics and Epigenomics Shared Resource; NATIONAL CANCER INSTITUTE [P30CA051008, T32CA009686, R01CA050633] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lombardi Comprehensive Cancer Center's Genomics and Epigenomics Shared Resource; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	LMW, SW and JCM are supported in part by NCI Grants CA51008 and CA50633. We thank Sandra A Jablonski, Wei Xu and Kyutaeg Lee for technical assistance. We are grateful for the support of the Lombardi Comprehensive Cancer Center's Genomics and Epigenomics Shared Resource.	Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Bachleitner-Hofmann T, 2008, MOL CANCER THER, V7, P3499, DOI 10.1158/1535-7163.MCT-08-0374; Basilico C, 2013, CLIN CANCER RES, V19, P2381, DOI 10.1158/1078-0432.CCR-12-3459; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Burke PA, 2002, CANCER RES, V62, P4263; Cecchi F, 2012, EXPERT OPIN THER TAR, V16, P553, DOI 10.1517/14728222.2012.680957; Cepero V, 2010, CANCER RES, V70, P7580, DOI 10.1158/0008-5472.CAN-10-0436; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Corso S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-121; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fong JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078398; Garcia S, 2007, HUM PATHOL, V38, P830, DOI 10.1016/j.humpath.2006.11.015; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Harbinski F, 2012, CANCER DISCOV, V2, P948, DOI 10.1158/2159-8290.CD-12-0237; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Huang C, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2936; Iida Mari, 2013, Cancer Biol Ther, V14, P481, DOI 10.4161/cbt.24342; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Ju LX, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-15; Kentsis A, 2012, NAT MED, V18, P1118, DOI 10.1038/nm.2819; Landi L, 2013, CURR OPIN ONCOL, V25, P130, DOI 10.1097/CCO.0b013e32835daf37; Langsenlehner U, 2006, BREAST CANCER RES TR, V97, P67, DOI 10.1007/s10549-005-9089-4; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lee JM, 2014, ONCOGENE, V33, P34, DOI 10.1038/onc.2012.551; Lee NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039653; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Lesniak D, 2009, CANCER RES, V69, P8620, DOI 10.1158/0008-5472.CAN-09-1591; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Morse DL, 2010, BIOCHEM PHARMACOL, V80, P731, DOI 10.1016/j.bcp.2010.04.011; Nagilla M, 2012, ADV THER, V29, P925, DOI 10.1007/s12325-012-0060-6; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Ou SHI, 2011, J THORAC ONCOL, V6, P942, DOI 10.1097/JTO.0b013e31821528d3; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Scagliotti GV, 2013, CANCER TREAT REV, V39, P793, DOI 10.1016/j.ctrv.2013.02.001; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Singleton KR, 2013, MOL PHARMACOL, V83, P882, DOI 10.1124/mol.112.084111; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Surati M, 2011, EXPERT OPIN BIOL TH, V11, P1655, DOI 10.1517/14712598.2011.626762; Tiedt R, 2011, CANCER RES, V71, P5255, DOI 10.1158/0008-5472.CAN-10-4433; Tuck AB, 2000, J CELL BIOCHEM, V78, P465, DOI 10.1002/1097-4644(20000901)78:3<465::AID-JCB11>3.0.CO;2-C; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vogler M, 2010, CLIN CANCER RES, V16, P4217, DOI 10.1158/1078-0432.CCR-10-0777; Wickramasinghe D, 2005, CELL CYCLE, V4, P683, DOI 10.4161/cc.4.5.1688; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Yadav V, 2012, J BIOL CHEM, V287, P28087, DOI 10.1074/jbc.M112.377218; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Zhang Y, 2010, IDRUGS, V13, P112; Zhang YW, 2010, CANCER RES, V70, P6880, DOI 10.1158/0008-5472.CAN-10-0898; Zhu LJ, 2005, MOL CANCER THER, V4, P787, DOI 10.1158/1535-7163.MCT-04-0330	51	23	24	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 26	2015	34	9					1083	1093		10.1038/onc.2014.51	http://dx.doi.org/10.1038/onc.2014.51			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RY	24662823	Green Accepted			2022-12-25	WOS:000350122100002
J	Wong, PP; Yeoh, CC; Ahmad, AS; Chelala, C; Gillett, C; Speirs, V; Jones, JL; Hurst, HC				Wong, P-P; Yeoh, C. C.; Ahmad, A. S.; Chelala, C.; Gillett, C.; Speirs, V.; Jones, J. L.; Hurst, H. C.			Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer	ONCOGENE			English	Article							P53-DEPENDENT APOPTOSIS; CANCER/TESTIS ANTIGENS; TUMOR-CELLS; MECHANISMS; PROTEIN; EXPRESSION; REPRESSION; COMPLEXES; DISCOVERY; ARREST	The antiestrogen tamoxifen is a well-tolerated, effective treatment for estrogen receptor-alpha-positive (ER+) breast cancer, but development of resistance eventually limits its use. Here we show that expression of MAGEA2, and related members of this cancertestis antigen family, is upregulated in tamoxifen-resistant tumor cells. Expression of MAGEA2 in tumor lines grown in vitro or as xenografts led to continued proliferation in the presence of tamoxifen. At the molecular level, we demonstrate that MAGEA2 protein localizes to the nucleus and forms complexes with p53 and ER alpha, resulting in repression of the p53 pathway but increased ER-dependent signaling. In a series of ER+, tamoxifen-treated breast cancer patients, we show a highly significant (P = 0.006) association between MAGEA (melanoma-associated antigen) expression and reduced overall survival, confirming the clinical significance of our observations.	[Wong, P-P; Yeoh, C. C.; Jones, J. L.; Hurst, H. C.] Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Biol, London EC1M 6BQ, England; [Ahmad, A. S.] Queen Mary Univ London, Barts Canc Inst, Ctr Epidemiol Math & Stat, London EC1M 6BQ, England; [Chelala, C.] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London EC1M 6BQ, England; [Gillett, C.] Kings Coll London, Guys Hosp, Breast Pathol Res Grp, London, England; [Speirs, V.] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Leeds	Wong, PP (corresponding author), Queen Mary Univ London, John Vane Sci Ctr, Ctr Tumour Biol, Barts Canc Inst, Charterhouse Sq, London EC1M 6BQ, England.	p.p.wong@qmul.ac.uk; hchurst@btinternet.com	Speirs, Valerie/ABE-7377-2021	Speirs, Valerie/0000-0002-0602-4666; Wong, Ping Pui/0000-0003-1592-4823; chelala, claude/0000-0002-2488-0669; Jones, J Louise/0000-0003-3880-3274	Cancer Research UK; Barts and the London Charity; Cancer Research UK [12008] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Barts and the London Charity; Cancer Research UK(Cancer Research UK)	We are grateful to our colleagues Andrew Clear, Keyur Trivedi and Abeer Shaaban for technical assistance with the TMA for the BLT and Leeds cases, respectively, Dr Yaohe Wang for help with scoring the Immunohistochemistry study, Ian Hart and Steven Robinson for invaluable advice and help with the xenograft study and to Richard Grose for useful comments on the manuscript. We thank Tracey Chapman for expert handling of the Affymetrix arrays and Simak Ali, Dennis McCance and Hinrich Gronemeyer for the generous provision of reagents. This work was funded by Cancer Research UK and Barts and the London Charity.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Atanackovic D, 2008, P NATL ACAD SCI USA, V105, P1650, DOI 10.1073/pnas.0707140104; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Butt AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1779; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Clarke N, 2004, EMBO J, V23, P3051, DOI 10.1038/sj.emboj.7600302; DAUVOIS S, 1993, J CELL SCI, V106, P1377; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Fentiman IS, 2003, EUR J CANCER, V39, P309, DOI 10.1016/S0959-8049(02)00673-1; Fentiman IS, 2003, EUR J CANCER, V39, P300, DOI 10.1016/S0959-8049(02)00672-X; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Hughes-Davies L, 2009, BRIT J CANCER, V101, P875, DOI 10.1038/sj.bjc.6605231; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Laios I, 2003, J STEROID BIOCHEM, V87, P207, DOI 10.1016/j.jsbmb.2003.09.011; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; MAAS RA, 1995, CANCER LETT, V97, P107, DOI 10.1016/0304-3835(95)03959-Z; Maraqa L, 2008, CLIN CANCER RES, V14, P405, DOI 10.1158/1078-0432.CCR-07-1363; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Markou A, 2011, CLIN CHEM, V57, P421, DOI 10.1373/clinchem.2010.154328; McDonnell DP, 2010, CURR OPIN PHARMACOL, V10, P620, DOI 10.1016/j.coph.2010.09.007; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nardiello T, 2011, CLIN CANCER RES, V17, P4309, DOI 10.1158/1078-0432.CCR-10-1820; SHEIKH MS, 1994, ONCOGENE, V9, P3407; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Toillon RA, 2002, BREAST CANCER RES TR, V71, P269, DOI 10.1023/A:1014422101452; VANDENEYNDE B, 1995, J EXP MED, V182, P689, DOI 10.1084/jem.182.3.689; Williams CMJ, 2009, EMBO J, V28, P3591, DOI 10.1038/emboj.2009.290; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478	35	27	27	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 11	2014	33	37					4579	4588		10.1038/onc.2014.45	http://dx.doi.org/10.1038/onc.2014.45			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3UZ	24662835	Green Published, hybrid			2022-12-25	WOS:000342004800005
J	Klinkhammer, BM; Kramann, R; Mallau, M; Makowska, A; van Roeyen, CR; Rong, S; Buecher, EB; Boor, P; Kovacova, K; Zok, S; Denecke, B; Stuettgen, E; Otten, S; Floege, J; Kunter, U				Klinkhammer, Barbara Mara; Kramann, Rafael; Mallau, Monika; Makowska, Anna; van Roeyen, Claudia Renate; Rong, Song; Buecher, Eva Bettina; Boor, Peter; Kovacova, Katarina; Zok, Stephanie; Denecke, Bernd; Stuettgen, Esther; Otten, Simon; Floege, Juergen; Kunter, Uta			Mesenchymal Stem Cells from Rats with Chronic Kidney Disease Exhibit Premature Senescence and Loss of Regenerative Potential	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CHRONIC-RENAL-FAILURE; ADIPOSE-TISSUE; STROMAL CELLS; EXPRESSION; DIFFERENTIATION; FIBROSIS; GROWTH; PROLIFERATION; CAPACITY	Mesenchymal stem cell (MSC) transplantation has the potential for organ repair. Nevertheless, some factors might lessen the regenerative potential of MSCs, e. g. donor age or systemic disease. It is thus important to carefully assess the patient's suitability for autologous MSC transplantation. Here we investigated the effects of chronic kidney disease (CKD) on MSC function. We isolated bone marrow MSCs from remnant kidney rats (RK) with CKD (CKD-RK-MSC) and found signs of premature senescence: spontaneous adipogenesis, reduced proliferation capacity, active senescence-associated-beta-galactosidase, accumulation of actin and a modulated secretion profile. The functionality of CKD-RK-MSCs in vivo was tested in rats with acute anti-Thy1.1-nephritis, where healthy MSCs have been shown to be beneficial. Rats received healthy MSCs, CKD-RK-MSC or medium by injection into the left renal artery. Kidneys receiving healthy MSCs exhibited accelerated healing of glomerular lesions, whereas CKD-RK-MSC or medium exerted no benefit. The negative influence of advanced CKD/uremia on MSCs was confirmed in a second model of CKD, adenine nephropathy (AD). MSCs from rats with adenine nephropathy (CKD-AD-MSC) also exhibited cellular modifications and functional deficits in vivo. We conclude that CKD leads to a sustained loss of in vitro and in vivo functionality in MSCs, possibly due to premature cellular senescence. Considering autologous MSC therapy in human renal disease, studies identifying uremia-associated mechanisms that account for altered MSC function are urgently needed.	[Klinkhammer, Barbara Mara; Kramann, Rafael; Mallau, Monika; Makowska, Anna; van Roeyen, Claudia Renate; Rong, Song; Buecher, Eva Bettina; Boor, Peter; Kovacova, Katarina; Zok, Stephanie; Stuettgen, Esther; Otten, Simon; Floege, Juergen; Kunter, Uta] RWTH Aachen Univ Hosp, Div Nephrol & Immunol, Aachen, Germany; [Boor, Peter] RWTH Aachen Univ Hosp, Inst Pathol, Aachen, Germany; [Boor, Peter] Comenius Univ, Inst Mol Biomed, Bratislava, Slovakia; [Denecke, Bernd] RWTH Aachen Univ Hosp, Interdisciplinary Ctr Clin Res, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Comenius University Bratislava; RWTH Aachen University; RWTH Aachen University Hospital	Kunter, U (corresponding author), RWTH Aachen Univ Hosp, Div Nephrol & Immunol, Aachen, Germany.	ukunter@ukaachen.de	Klinkhammer, Barbara Mara/AAB-3524-2019; Boor, Peter/C-7707-2011; Kramann, Rafael/K-7995-2013	Klinkhammer, Barbara Mara/0000-0002-1566-7129; Boor, Peter/0000-0001-9921-4284; Kramann, Rafael/0000-0003-4048-6351	European Community [HEALTH-F5-2008-223007 STAR-TREK]; German Research Foundation (Deutsche Forschungsgemeinschaft [SFB TRR57 P19, RO4036/1]; Medical Faculty of the RWTH Aachen (START grant)	European Community(European Commission); German Research Foundation (Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty of the RWTH Aachen (START grant)	European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement no HEALTH-F5-2008-223007 STAR-TREK; German Research Foundation (Deutsche Forschungsgemeinschaft, SFB TRR57 P19 and RO4036/1); Medical Faculty of the RWTH Aachen (START grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma H, 2011, J SURG RES, V168, pE51, DOI 10.1016/j.jss.2010.06.022; Ball SG, 2012, STEM CELLS; Betjes MGH, 2011, KIDNEY INT, V80, P209, DOI 10.1038/ki.2011.110; Boor P, 2007, J AM SOC NEPHROL, V18, P1508, DOI 10.1681/ASN.2006121343; Boor P, 2011, KIDNEY INT, V80, P1182, DOI 10.1038/ki.2011.254; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Buemi M, 2010, J NEPHROL, V23, P328; Cavaglieri RC, 2009, TRANSPL P, V41, P947, DOI 10.1016/j.transproceed.2009.01.072; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Choi S, 2009, STEM CELLS DEV, V18, P521, DOI 10.1089/scd.2008.0097; de Groot K, 2005, TRANSPLANTATION, V79, P941, DOI 10.1097/00007890-200504270-00012; de Groot K, 2004, KIDNEY INT, V66, P641, DOI 10.1111/j.1523-1755.2004.00784.x; Di Bonzo LV, 2008, GUT, V57, P223, DOI 10.1136/gut.2006.111617; Drewa T, 2008, TRANSPL P, V40, P1668, DOI 10.1016/j.transproceed.2008.03.141; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Eitner F, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134910; GRAHAM GJ, 1990, NATURE, V344, P442, DOI 10.1038/344442a0; Hanssen L, 2011, J IMMUNOL, V187, P298, DOI 10.4049/jimmunol.1100382; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007; Kisseberth WC, 1999, DEV BIOL, V214, P128, DOI 10.1006/dbio.1999.9417; Kramann R, 2011, ARTERIOSCL THROM VAS, V31, pE45, DOI 10.1161/ATVBAHA.111.228601; Krtolica A, 2003, Adv Gerontol, V11, P109; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815; Kunter U, 2011, KIDNEY INT SUPPL, V1, P68, DOI 10.1038/kisup.2011.16; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; Lee SR, REN FAIL, V32, P840; Li B, 2006, KIDNEY INT, V69, P323, DOI 10.1038/sj.ki.5000083; Li ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020526; Liu Y, 2003, CARDIOVASC RES, V58, P460, DOI 10.1016/S0008-6363(03)00265-7; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Montzka K, 2010, CYTOTHERAPY, V12, P870, DOI 10.3109/14653249.2010.501789; Nakanishi C, 2011, CIRC J, V75, P2260, DOI 10.1253/circj.CJ-11-0246; Neven E, 2011, CIRC RES, V108, P249, DOI 10.1161/CIRCRESAHA.110.225904; Ninichuk V, 2006, KIDNEY INT, V70, P121, DOI 10.1038/sj.ki.5001521; Noh H, 2012, NEPHROL DIAL TRANSPL; Ohnishi S, 2007, FEBS LETT, V581, P3961, DOI 10.1016/j.febslet.2007.07.028; Ostendorf T, 1999, J CLIN INVEST, V104, P913, DOI 10.1172/JCI6740; Ostendorf T, 2003, J AM SOC NEPHROL, V14, P2237, DOI 10.1097/01.ASN.0000083393.00959.02; Roemeling-van Rhijn M, 2012, KIDNEY INT, V82, P748, DOI 10.1038/ki.2012.187; Salazar KD, 2009, AM J PHYSIOL-LUNG C, V297, pL1002, DOI 10.1152/ajplung.90347.2008; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Sugawara J, 2005, J CLIN ENDOCR METAB, V90, P5329, DOI 10.1210/jc.2005-0532; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274; van Koppen A, CELL TRANSPLANT; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Yang HC, 2011, J AM SOC NEPHROL; Yuen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009543	52	62	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92115	10.1371/journal.pone.0092115	http://dx.doi.org/10.1371/journal.pone.0092115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667162	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600020
J	Chung, MC; Dean, S; Marakasova, ES; Nwabueze, AO; van Hoek, ML				Chung, Myung-Chul; Dean, Scott; Marakasova, Ekaterina S.; Nwabueze, Albert O.; van Hoek, Monique L.			Chitinases Are Negative Regulators of Francisella novicida Biofilms	PLOS ONE			English	Article							TULARENSIS SUBSP NOVICIDA; SURFACE-CHARGE; BACTERIAL BIOFILMS; PORE SENSORS; IN-VITRO; VIRULENCE; CELLS; HYDROPHOBICITY; MECHANISMS; ATTACHMENT	Biofilms, multicellular communities of bacteria, may be an environmental survival and transmission mechanism of Francisella tularensis. Chitinases of F. tularensis ssp. novicida (Fn) have been suggested to regulate biofilm formation on chitin surfaces. However, the underlying mechanisms of how chitinases may regulate biofilm formation are not fully determined. We hypothesized that Fn chitinase modulates bacterial surface properties resulting in the alteration of biofilm formation. We analyzed biofilm formation under diverse conditions using chitinase mutants and their counterpart parental strain. Substratum surface charges affected biofilm formation and initial attachments. Biophysical analysis of bacterial surfaces confirmed that the chi mutants had a net negative-charge. Lectin binding assays suggest that chitinase cleavage of its substrates could have exposed the concanavalin A-binding epitope. Fn biofilm was sensitive to chitinase, proteinase and DNase, suggesting that Fn biofilm contains exopolysaccharides, proteins and extracellular DNA. Exogenous chitinase increased the drug susceptibility of Fn biofilms to gentamicin while decreasing the amount of biofilm. In addition, chitinase modulated bacterial adhesion and invasion of A549 and J774A.1 cells as well as intracellular bacterial replication. Our results support a key role of the chitinase(s) in biofilm formation through modulation of the bacterial surface properties. Our findings position chitinase as a potential anti-biofilm enzyme in Francisella species.	[Chung, Myung-Chul] George Mason Univ, Sch Syst Biol, Manassas, VA 20110 USA; George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA	George Mason University; George Mason University	Chung, MC (corresponding author), George Mason Univ, Sch Syst Biol, Manassas, VA 20110 USA.	mchung3@gmu.edu	Marakasova, Ekaterina/K-3470-2014; Dean, Scott/ABB-6978-2020; van Hoek, Monique/E-1629-2011	van Hoek, Monique/0000-0003-1679-4899; Marakasova, Ekaterina/0000-0002-6505-4726	DOD Defense Threat Reduction Agency (DTRA) [421 HDTRA1-12-C0039]	DOD Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This research was supported by the DOD Defense Threat Reduction Agency (DTRA; grant No. 421 HDTRA1-12-C0039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; BellonFontaine MN, 1996, COLLOID SURFACE B, V7, P47, DOI 10.1016/0927-7765(96)01272-6; Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2; Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838; Chandler JC, 2011, J BACTERIOL, V193, P3265, DOI 10.1128/JB.00093-11; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dahiya N, 2006, APPL MICROBIOL BIOT, V71, P773, DOI 10.1007/s00253-005-0183-7; Durham-Colleran MW, 2010, MICROB ECOL, V59, P457, DOI 10.1007/s00248-009-9586-9; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Johnsen AR, 2000, APPL ENVIRON MICROB, V66, P3487, DOI 10.1128/AEM.66.8.3487-3491.2000; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Kozak D, 2012, ACS NANO, V6, P6990, DOI 10.1021/nn3020322; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Liu JR, 2007, BIOTECHNIQUES, V43, P487, DOI 10.2144/000112574; Mahajan UV, 2011, FEMS MICROBIOL ECOL, V78, P520, DOI 10.1111/j.1574-6941.2011.01182.x; Margolis JJ, 2010, APPL ENVIRON MICROB, V76, P596, DOI 10.1128/AEM.02037-09; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Melillo A, 2006, FEMS MICROBIOL LETT, V263, P102, DOI 10.1111/j.1574-6968.2006.00413.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Orgad O, 2011, BIOFOULING, V27, P787, DOI 10.1080/08927014.2011.603145; Palmer JS, 2010, J IND MICROBIOL BIOT, V37, P1111, DOI 10.1007/s10295-010-0758-x; Pantoom S, 2011, J BIOL CHEM, V286, P24312, DOI 10.1074/jbc.M110.183376; Rahman MM, 2008, WORLD J MICROB BIOT, V24, P1593, DOI 10.1007/s11274-007-9650-x; Reif KE, 2011, INFECT IMMUN, V79, P4941, DOI 10.1128/IAI.05676-11; Skillman LC, 1999, J APPL MICROBIOL, V85, p13S, DOI 10.1111/j.1365-2672.1998.tb05278.x; Sowerby SJ, 2007, SENSOR ACTUAT B-CHEM, V123, P325, DOI 10.1016/j.snb.2006.08.031; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Thethi K, 1997, CELL BIOCHEM FUNCT, V15, P35, DOI 10.1002/(SICI)1099-0844(199703)15:1<35::AID-CBF717>3.0.CO;2-S; Valle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002843; van Hoek ML, 2013, VIRULENCE, V4, P833, DOI 10.4161/viru.27023; Verhoeven AB, 2010, BIOL BULL-US, V219, P178, DOI 10.1086/BBLv219n2p178; Vogel R, 2012, ANAL CHEM, V84, P3125, DOI 10.1021/ac2030915; Vogel R, 2011, ANAL CHEM, V83, P3499, DOI 10.1021/ac200195n; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Zogaj X, 2012, INFECT IMMUN, V80, P4239, DOI 10.1128/IAI.00702-12	43	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93119	10.1371/journal.pone.0093119	http://dx.doi.org/10.1371/journal.pone.0093119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664176	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900154
J	Krishnan, A; Almen, MS; Fredriksson, R; Schioth, HB				Krishnan, Arunkumar; Almen, Markus Sallman; Fredriksson, Robert; Schioth, Helgi B.			Insights into the Origin of Nematode Chemosensory GPCRs: Putative Orthologs of the Srw Family Are Found across Several Phyla of Protostomes	PLOS ONE			English	Article							RECEPTOR GENE REPERTOIRES; PHEROMONE RECEPTORS; ODORANT RECEPTORS; GENOME REVEALS; EVOLUTION; MAFFT	Nematode chemosensory GPCRs in Caenorhabditis elegans (NemChRs) are classified into 19 gene families, and are initially thought to have split from the ancestral Rhodopsin family of GPCRs. However, earlier studies have shown that among all 19 NemChR gene families, only the srw family has a clear sequence relationship to the ancestral Rhodopsin GPCR family. Yet, the phylogenetic relationships between the srw family of NemChRs and the Rhodopsin subfamilies are not fully understood. Also, a widespread search was not previously performed to check for the presence of putative srw family-like sequences or the other 18 NemChR families in several new protostome species outside the nematode lineage. In this study, we have investigated for the presence of 19 NemChR families across 26 eukaryotic species, covering basal eukaryotic branches and provide the first evidence that the srw family of NemChRs is indeed present across several phyla of protostomes. We could identify 29 putative orthologs of the srw family in insects (15 genes), molluscs (11 genes) and Schistosoma mansoni (3 genes). Furthermore, using HMM-HMM profile based comparisons and phylogenetic analysis we show that among all Rhodopsin subfamilies, the peptide and SOG (somatostatin/opioid/galanin) subfamilies are phylogenetically the closest relatives to the srw family of NemChRs. Taken together, we demonstrate that the srw family split from the large Rhodopsin family, possibly from the peptide and/or SOG subfamilies, well before the split of the nematode lineage, somewhere close to the divergence of the common ancestor of protostomes. Our analysis also suggests that the srsx family of NemChRs shares a clear sequence homology with the Rhodopsin subfamilies, as well as with few of the vertebrate olfactory receptors. Overall, this study provides further insights into the evolutionary events that shaped the GPCR chemosensory system in protostome species.	[Krishnan, Arunkumar; Almen, Markus Sallman; Fredriksson, Robert; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Schioth, HB (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	helgi.schioth@neuro.uu.se	Schioth, Helgi/AAQ-7239-2020	Sallman Almen, Markus/0000-0001-9591-9228; Krishnan, Arunkumar/0000-0002-9677-9092; Fredriksson, Robert/0000-0002-2810-3226	Swedish Research Council; Ahlens Foundation; Tore Nilssons foundation; byggmastare Engquist foundation; Swedish Brain Research Foundation; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF13OC0005723] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ahlens Foundation; Tore Nilssons foundation; byggmastare Engquist foundation; Swedish Brain Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Swedish Research Council, the Ahlens Foundation, Tore Nilssons foundation, byggmastare Engquist foundation, the Swedish Brain Research Foundation and the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Churcher AM, 2011, GENOME BIOL EVOL, V3, P36, DOI 10.1093/gbe/evq079; Churcher AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-242; Cummins SF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-28; Dong D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-12; Dryer L, 1999, TRENDS PHARMACOL SCI, V20, P413, DOI 10.1016/S0165-6147(99)01381-4; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gaillard I, 2004, CELL MOL LIFE SCI, V61, P456, DOI 10.1007/s00018-003-3273-7; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hashiguchi Y, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-76; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Johnstone KA, 2009, MOL BIOL EVOL, V26, P1117, DOI 10.1093/molbev/msp027; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Libants S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-180; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nordstrom KJV, 2011, MOL BIOL EVOL, V28, P2471, DOI 10.1093/molbev/msr061; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Raible F, 2006, DEV BIOL, V300, P461, DOI 10.1016/j.ydbio.2006.08.070; Robertson Hugh M, 2006, WormBook, P1; Rouquier S, 2007, MUTAT RES-FUND MOL M, V616, P95, DOI 10.1016/j.mrfmmm.2006.11.012; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	36	15	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93048	10.1371/journal.pone.0093048	http://dx.doi.org/10.1371/journal.pone.0093048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663674	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900148
J	Muraoka, T; Adachi, K; Chowdhury, R; Kinbara, K				Muraoka, Takahiro; Adachi, Kota; Chowdhury, Rainy; Kinbara, Kazushi			Transetherification on Polyols by Intra- and Intermolecular Nucleophilic Substitutions	PLOS ONE			English	Article							MODULAR SYNTHESIS; POLYMER; PENTAERYTHRITOL; BIOACTIVITY; CHEMISTRY; TRIVALENT; DESIGN; PEG	Transetherification on polyols involving intra-and intermolecular nucleophilic substitutions is reported. Di- or trialkoxide formation of propane-1,3-diol or 2-(hydroxymethyl)propane-1,3-diol derivatives by NaH triggers the reaction via oxetanes formation, where the order to add NaH and a polyol significantly influences the yields of products. It was demonstrated that the protective group on the pentaerythritol skeleton is apparently transferred to the hydrophilic and hydrophobic chain molecules bearing a leaving group in one-step, and a protective group conversion from tosyl to benzyl was successful using a benzyl-appending triol to afford a desired product in 67% yield.	[Muraoka, Takahiro; Adachi, Kota; Chowdhury, Rainy; Kinbara, Kazushi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 980, Japan; [Muraoka, Takahiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Kinbara, K (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 980, Japan.	kinbara@tagen.tohoku.ac.jp	Muraoka, Takahiro/C-6262-2017; Kinbara, Kazushi/E-6347-2017	Muraoka, Takahiro/0000-0001-6744-048X; Kinbara, Kazushi/0000-0002-5945-9612	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23115003]; Management Expenses Grants for National Universities Corporations; Japan Society for the Promotion of Science (JSPS) [21675003, 24655112]; Hattori Hokokai Foundation; Asahi Group Foundation; Grants-in-Aid for Scientific Research [21675003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Management Expenses Grants for National Universities Corporations; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hattori Hokokai Foundation; Asahi Group Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Scientific Research on Innovative Areas "Spying minority in biological phenomena (No.3306)'' (23115003 to KK) and the Management Expenses Grants for National Universities Corporations, by Japan Society for the Promotion of Science (JSPS), Grant-in-Aids for Young Scientists S (21675003 to KK) and Grant-in-Aids for Challenging Exploratory Research (24655112 to TM), by the Hattori Hokokai Foundation (to TM), and by the Asahi Group Foundation (to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER RH, 1960, J ORG CHEM, V25, P1496, DOI 10.1021/jo01079a009; BAKER RH, 1948, J AM CHEM SOC, V70, P3857, DOI 10.1021/ja01191a094; Boden N, 1997, TETRAHEDRON, V53, P10939, DOI 10.1016/S0040-4020(97)00698-4; Boekhoven J, 2013, NAT CHEM, V5, P433, DOI 10.1038/nchem.1617; Burns CJ, 1999, SYNTHETIC COMMUN, V29, P2337, DOI 10.1080/00397919908086236; Caras-Quintero D, 2004, CHEM COMMUN, P926, DOI 10.1039/b400965g; Cordonier CEJ, 2005, J ORG CHEM, V70, P3425, DOI 10.1021/jo0500232; Coric I, 2013, ANGEW CHEM INT EDIT, V52, P3490, DOI 10.1002/anie.201209983; Fishman A, 2003, J ORG CHEM, V68, P9843, DOI 10.1021/jo034868u; Garcia-Bernabe A, 2004, CHEM-EUR J, V10, P2822, DOI 10.1002/chem.200305305; Gehin C, 2013, J AM CHEM SOC, V135, P9295, DOI 10.1021/ja404153m; Gouin SG, 2009, CHEMMEDCHEM, V4, P749, DOI 10.1002/cmdc.200900034; Huang Z, 2012, SCIENCE, V337, P1521, DOI 10.1126/science.1224741; Jayakannan M, 2001, MACROMOL RAPID COMM, V22, P1463, DOI 10.1002/1521-3927(20011201)22:18<1463::AID-MARC1463>3.0.CO;2-F; Kihara N, 2009, ORG LETT, V11, P1313, DOI 10.1021/ol900095d; Kondo K, 2013, ANGEW CHEM INT EDIT, V52, P2308, DOI 10.1002/anie.201208643; Kubota Y, 2003, B CHEM SOC JPN, V76, P805, DOI 10.1246/bcsj.76.805; Li L, 2013, ANGEW CHEM INT EDIT, V52, P424, DOI 10.1002/anie.201205940; Li XF, 2012, J ORG CHEM, V77, P8206, DOI 10.1021/jo301573e; Li XF, 2012, MACROMOLECULES, V45, P1447, DOI 10.1021/ma201599p; Liu Y, 2013, J AM CHEM SOC, V135, P4765, DOI 10.1021/ja3122608; Lohmeijer BGG, 2006, ORG LETT, V8, P4683, DOI 10.1021/ol0614166; Muraoka T, 2013, ANGEW CHEM INT EDIT, V52, P2430, DOI 10.1002/anie.201206563; Natarajan A, 2007, CHEM COMMUN, P695, DOI 10.1039/b611636a; NOUGUIER RM, 1985, J ORG CHEM, V50, P3296, DOI 10.1021/jo00218a010; Novakova V, 2011, EUR J ORG CHEM, V2011, P5879, DOI 10.1002/ejoc.201100689; PADIAS AB, 1987, J ORG CHEM, V52, P5305, DOI 10.1021/jo00233a002; Papp I, 2008, CHEM COMMUN, P5851, DOI 10.1039/b813414f; Percec V, 2013, J AM CHEM SOC, V135, P9055, DOI 10.1021/ja403323y; Sarmah MP, 2005, TETRAHEDRON, V61, P4437, DOI 10.1016/j.tet.2005.02.073; Shah STA, 2009, J ORG CHEM, V74, P2179, DOI 10.1021/jo802494t; Stanoeva E, 2004, TETRAHEDRON, V60, P5077, DOI 10.1016/j.tet.2004.04.046; Sun RY, 2013, J AM CHEM SOC, V135, P5990, DOI 10.1021/ja4016952; Sur S, 2012, ACS NANO, V6, P10776, DOI 10.1021/nn304101x; Thompson DS, 2000, MACROMOLECULES, V33, P6412, DOI 10.1021/ma990845z; Touaibia M, 2007, CHEM COMMUN, P380, DOI 10.1039/b612471b; Ueno T, 2010, SOFT MATTER, V6, P6072, DOI 10.1039/c0sm00788a; Wang YM, 2009, BIOMACROMOLECULES, V10, P617, DOI 10.1021/bm801333s; Williamson A., 1850, LONDON EDINBURGH DUB, V37, P350; Wuts PGM, 2007, GREENES PROTECTIVE G, P273; Yao F, 2010, MACROMOLECULES, V43, P9761, DOI 10.1021/ma102039n; Yeh MC, 2013, ANGEW CHEM INT EDIT, V52, P1031, DOI 10.1002/anie.201207708; Zha ZH, 2011, J MED CHEM, V54, P8085, DOI 10.1021/jm2009106; Zhao YJ, 2009, J APPL POLYM SCI, V111, P1638, DOI 10.1002/app.29140	44	1	1	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91912	10.1371/journal.pone.0091912	http://dx.doi.org/10.1371/journal.pone.0091912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663293	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900031
J	Bae, SE; Wright, IK; Wyse, C; Samson-Desvignes, N; Le Blanc, P; Laroche, S; Hazlerigg, DG; Johnston, JD				Bae, Sung-Eun; Wright, Ian K.; Wyse, Cathy; Samson-Desvignes, Nathalie; Le Blanc, Pascale; Laroche, Serge; Hazlerigg, David G.; Johnston, Jonathan D.			Regulation of Pituitary MT1 Melatonin Receptor Expression by Gonadotrophin-Releasing Hormone (GnRH) and Early Growth Response Factor-1 (Egr-1): In Vivo and In Vitro Studies	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; LUTEINIZING-HORMONE; PARS TUBERALIS; MULTIPLE PITUITARY; MESSENGER-RNA; HUMAN PUBERTY; TRANSCRIPTION; MICE; INHIBITION; LINEAGE	Melatonin receptor expression exhibits profound developmental changes through poorly understood mechanisms. In mammals, a current model suggests that pubertal reactivation of gonadotrophin-releasing hormone (GnRH) secretion down-regulates MT1 melatonin receptors in pituitary gonadotroph cells, via the induction of early growth response factor-1 (EGR-1). Here we have examined this model by testing the hypotheses that inhibition of Mt1 expression by GnRH occurs directly in gonadotroph cells, can be reversed in adulthood by blockade of GnRH receptors, and requires EGR-1. We first confirmed the endogenous expression of Mt1 mRNA in the alpha T3-1 gonadotroph cell line. Stimulation of these cells with a GnRH agonist resulted in a rapid increase of Egr-1 mRNA expression, which peaked after 30-60 minutes, and a more prolonged elevation of nuclear EGR-1 immunoreactivity. Moreover, the GnRH agonist significantly decreased Mt1 mRNA. We then treated adult male rats with the GnRH antagonist cetrorelix or saline. After 4 weeks of daily injections, cetrorelix significantly reduced serum LH concentration and testis weight, with histological analysis confirming absence of spermatogenesis. Despite the successful inhibition of GnRH signalling, pituitary Mt1 expression was unchanged. Next we studied the proximal region of the rat Mt1 promoter. Consistent with previous work, over-expression of the transcription factor PITX-1 increased Mt1-luciferase reporter activity; this effect was dependent on the presence of consensus PITX-1 promoter binding regions. Over-expression of EGR-1 inhibited PITX-1-stimulated activity, even following mutation of the consensus EGR-1 binding site. Finally, we studied Egr1(-/-) mice and observed no difference in pituitary Mt1 expression between Egr1(-/-) and wild-type litter mates. This work demonstrates that GnRH receptor activation directly down-regulates Mt1 expression in gonadotroph cells. However, pituitary Mt1 expression in adults is unaltered by blockade of GnRH signalling or absence of EGR-1. Our data therefore suggest that melatonin receptor regulation by GnRH is not reversible in adulthood and doesn't require EGR-1.	[Bae, Sung-Eun; Wright, Ian K.; Johnston, Jonathan D.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Wyse, Cathy; Hazlerigg, David G.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Wyse, Cathy] Univ Glasgow, Sch Vet Med, Glasgow, Lanark, Scotland; [Samson-Desvignes, Nathalie; Le Blanc, Pascale; Laroche, Serge] Univ Paris 11, CNRS, Ctr Neurosci Paris Sud, Orsay, France; [Hazlerigg, David G.] Univ Tromso, Fac Biosci Fisheries & Econ, Dept Arctic & Marine Biol, Tromso, Norway	University of Surrey; University of Aberdeen; University of Glasgow; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UiT The Arctic University of Tromso	Johnston, JD (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England.	j.johnston@surrey.ac.uk	Johnston, Jonathan D/H-6363-2011; Johnston, Jonathan/AAS-6969-2021	Johnston, Jonathan D/0000-0001-8083-9794; Desvignes, Nathalie/0000-0002-4243-0733	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F020309/1]; BBSRC [BB/F020309/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F020309/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC; grant BB/F020309/1; http://www.bbsrc.ac.uk/home/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett P, 1996, MOL ENDOCRINOL, V10, P892, DOI 10.1210/me.10.7.892; Crowley SJ, 2012, DEV PSYCHOBIOL, V54, P468, DOI 10.1002/dev.20605; Davis FC, 1997, J BIOL RHYTHM, V12, P498, DOI 10.1177/074873049701200603; de Holanda FS, 2011, GYNECOL ENDOCRINOL, V27, P519, DOI 10.3109/09513590.2010.501888; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Fortin J, 2010, CELL SIGNAL, V22, P936, DOI 10.1016/j.cellsig.2010.01.019; Hansson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046001; HORN F, 1991, MOL ENDOCRINOL, V5, P347, DOI 10.1210/mend-5-3-347; Ishii H, 2009, NEUROENDOCRINOLOGY, V90, P251, DOI 10.1159/000231993; Johnston JD, 2006, J NEUROENDOCRINOL, V18, P50, DOI 10.1111/j.1365-2826.2005.01389.x; Johnston JD, 2006, ENDOCRINOLOGY, V147, P959, DOI 10.1210/en.2005-1100; Johnston JD, 2003, J NEUROENDOCRINOL, V15, P405, DOI 10.1046/j.1365-2826.2003.00972.x; Johnston JD, 2003, P NATL ACAD SCI USA, V100, P2831, DOI 10.1073/pnas.0436184100; Johnston JD, 2007, MOL CELL ENDOCRINOL, V268, P59, DOI 10.1016/j.mce.2007.01.015; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Liu J, 2001, INT J ONCOL, V18, P863; MARTIN JE, 1979, ENDOCRINOLOGY, V105, P1007, DOI 10.1210/endo-105-4-1007; MARTIN JE, 1976, SCIENCE, V191, P301, DOI 10.1126/science.1108199; MARTIN JE, 1980, NEUROENDOCRINOLOGY, V31, P13, DOI 10.1159/000123044; Otway DT, 2009, CHRONOBIOL INT, V26, P1340, DOI 10.3109/07420520903412368; REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947; Reiter RJ, 2010, PROG BRAIN RES, V181, P127, DOI 10.1016/S0079-6123(08)81008-4; SILMAN RE, 1979, NATURE, V282, P301, DOI 10.1038/282301a0; Srinivasan V, 2009, GYNECOL ENDOCRINOL, V25, P779, DOI 10.3109/09513590903159649; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Torres-Farfan C, 2011, ENDOCRINOLOGY, V152, P1891, DOI 10.1210/en.2010-1260; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tourtellotte WG, 2000, MOL CELL BIOL, V20, P5261, DOI 10.1128/MCB.20.14.5261-5268.2000; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; van Geijlswijk IM, 2011, PSYCHOPHARMACOLOGY, V216, P111, DOI 10.1007/s00213-011-2202-y; Vanecek J, 1999, REV REPROD, V4, P67, DOI 10.1530/revreprod/4.2.67; Veyrac A, 2013, P NATL ACAD SCI USA, V110, P7062, DOI 10.1073/pnas.1220558110; Wagner GC, 2007, EUR J NEUROSCI, V25, P485, DOI 10.1111/j.1460-9568.2006.05291.x; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597; Zeman M, 2009, J HYPERTENS, V27, pS21, DOI 10.1097/01.hjh.0000358833.41181.f6; Zhang F, 2003, J BIOL CHEM, V278, P44246, DOI 10.1074/jbc.M305564200	36	12	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90056	10.1371/journal.pone.0090056	http://dx.doi.org/10.1371/journal.pone.0090056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658054	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000333355300010
J	Bonneh, YS; Donner, TH; Cooperman, A; Heeger, DJ; Sagi, D				Bonneh, Yoram S.; Donner, Tobias H.; Cooperman, Alexander; Heeger, David J.; Sagi, Dov			Motion-Induced Blindness and Troxler Fading: Common and Different Mechanisms	PLOS ONE			English	Article							BINOCULAR-RIVALRY; FILLING-IN; ADAPTATION; SCOTOMAS; MOVEMENT; DYNAMICS; STIMULI; REVEALS	Extended stabilization of gaze leads to disappearance of dim visual targets presented peripherally. This phenomenon, known as Troxler fading, is thought to result from neuronal adaptation. Intense targets also disappear intermittently when surrounded by a moving pattern (the "mask''), a phenomenon known as motion-induced blindness (MIB). The similar phenomenology and dynamics of these disappearances may suggest that also MIB is, likewise, solely due to adaptation, which may be amplified by the presence of the mask. Here we directly compared the dependence of both phenomena on target contrast. Observers reported the disappearance and reappearance of a target of varying intensity (contrast levels: 8%-80%). MIB was induced by adding a mask that moved at one of various different speeds. The results revealed a lawful effect of contrast in both MIB and Troxler fading, but with opposite trends. Increasing target contrast increased (doubled) the rate of disappearance events for MIB, but decreased the disappearance rate to half in Troxler fading. The target mean invisible period decreased equally strongly with target contrast in MIB and in Troxler fading. The results suggest that both MIB and Troxler are equally affected by contrast adaptation, but that the rate of MIB is governed by an additional mechanism, possibly involving antagonistic processes between neuronal populations processing target and mask. Our results link MIB to other bi-stable visual phenomena that involve neuronal competition (such as binocular rivalry), which exhibit an analogous dependency on the strength of the competing stimulus components.	[Bonneh, Yoram S.] Univ Haifa, Dept Human Biol, IL-31999 Haifa, Israel; [Bonneh, Yoram S.; Cooperman, Alexander; Sagi, Dov] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Donner, Tobias H.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Donner, Tobias H.] Univ Amsterdam, Ctr Cognit Sci, Amsterdam, Netherlands; [Donner, Tobias H.] Charite, Bernstein Ctr Computat Neurosci, D-13353 Berlin, Germany; [Donner, Tobias H.; Heeger, David J.] NYU, Dept Psychol, New York, NY 10003 USA; [Donner, Tobias H.; Heeger, David J.] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of Haifa; Weizmann Institute of Science; University of Amsterdam; University of Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; New York University; New York University	Bonneh, YS (corresponding author), Univ Haifa, Dept Human Biol, IL-31999 Haifa, Israel.	yoram.bonneh@gmail.com	Sagi, Dov/A-5454-2008	Sagi, Dov/0000-0002-8446-9230; Bonneh, Yoram/0000-0003-1091-639X; Donner, Tobias H./0000-0002-7559-6019	US-Israel Binational Science Foundation; Weizmann-New York University Demonstration Fund in Neuroscience; German Academy of Science Leopoldina [BMBF-LPD 9901/8-136]; NIH [ROI-EY016752]; NATIONAL EYE INSTITUTE [R01EY016752] Funding Source: NIH RePORTER	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Weizmann-New York University Demonstration Fund in Neuroscience; German Academy of Science Leopoldina; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the US-Israel Binational Science Foundation (D. S. and D.J.H.), The Weizmann-New York University Demonstration Fund in Neuroscience (D.J.H. and D. S.), German Academy of Science Leopoldina (BMBF-LPD 9901/8-136, T. H. D.), and NIH (ROI-EY016752, D.J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bonneh Y, 2003, J VISION, V3, P221; Bonneh YS, 2010, J VISION, V10, DOI 10.1167/10.14.22; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; Brascamp JW, 2006, J VISION, V6, P1244, DOI 10.1167/6.11.8; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; BURBECK CA, 1984, J OPT SOC AM A, V1, P216, DOI 10.1364/JOSAA.1.000216; Caetta F, 2009, INTERACTIONS SENSORI; Caetta F, 2007, J VISION, V7, DOI 10.1167/7.7.4; Donner TH, 2008, J NEUROSCI, V28, P10298, DOI 10.1523/JNEUROSCI.2371-08.2008; Donner TH, 2013, J NEUROSCI, V33, P2188, DOI 10.1523/JNEUROSCI.3388-12.2013; Gigante G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000430; Gorea A, 2009, J VISION, V9, DOI 10.1167/9.6.16; Graf EW, 2002, VISION RES, V42, P2731, DOI 10.1016/S0042-6989(02)00390-5; Hofstoetter C, 2004, CONSCIOUS COGN, V13, P691, DOI 10.1016/j.concog.2004.06.007; Hsu LC, 2004, VISION RES, V44, P2857, DOI 10.1016/j.visres.2003.10.029; Hsu LC, 2006, VISION RES, V46, P1973, DOI 10.1016/j.visres.2005.11.004; HUNZELMANN N, 1984, VISION RES, V24, P1765, DOI 10.1016/0042-6989(84)90007-5; Kang MS, 2010, J VISION, V10, DOI 10.1167/10.11.3; Kim CY, 2005, TRENDS COGN SCI, V9, P381, DOI 10.1016/j.tics.2005.06.012; Klink PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003473; Koch C., 2007, QUEST CONSCIOUSNESS; Libedinsky C, 2009, J VISION, V9, DOI 10.1167/9.1.14; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Mitroff SR, 2005, VISION RES, V45, P961, DOI 10.1016/j.visres.2004.09.044; Montaser-Kouhsari L, 2004, PERCEPTION, V33, P249, DOI 10.1068/p5174; New JJ, 2008, PSYCHOL SCI, V19, P653, DOI 10.1111/j.1467-9280.2008.02139.x; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; Simons D, 2006, J VISION, V6, P1093, DOI 10.1167/6.10.9; Sturzel F, 2001, VISION RES, V41, P2969, DOI 10.1016/S0042-6989(01)00172-9; Troxler D, 1804, OPHTHALMOLOGISCHES B, P51; Wallis TSA, 2009, CURR BIOL, V19, P325, DOI 10.1016/j.cub.2008.12.053; Weil RS, 2011, BRAIN RES REV, V67, P40, DOI 10.1016/j.brainresrev.2010.10.004; Welchman AE, 2001, VISION RES, V41, P2107, DOI 10.1016/S0042-6989(01)00087-6; Wilke M, 2003, NEURON, V39, P1043, DOI 10.1016/j.neuron.2003.08.003	38	19	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92894	10.1371/journal.pone.0092894	http://dx.doi.org/10.1371/journal.pone.0092894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658600	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300141
J	Cousin, MA; Ebbert, JO; Wiinamaki, AR; Urban, MD; Argue, DP; Ekker, SC; Klee, EW				Cousin, Margot A.; Ebbert, Jon O.; Wiinamaki, Amanda R.; Urban, Mark D.; Argue, David P.; Ekker, Stephen C.; Klee, Eric W.			Larval Zebrafish Model for FDA-Approved Drug Repositioning for Tobacco Dependence Treatment	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; RECEPTOR PARTIAL AGONIST; ORAL TOPIRAMATE; MEDICATION DEVELOPMENT; INDUCED REINSTATEMENT; DOPAMINE SYSTEM; NICOTINE; ALCOHOL; COCAINE; APOMORPHINE	Cigarette smoking remains the most preventable cause of death and excess health care costs in the United States, and is a leading cause of death among alcoholics. Long-term tobacco abstinence rates are low, and pharmacotherapeutic options are limited. Repositioning medications approved by the U. S. Food and Drug Administration (FDA) may efficiently provide clinicians with new treatment options. We developed a drug-repositioning paradigm using larval zebrafish locomotion and established predictive clinical validity using FDA-approved smoking cessation therapeutics. We evaluated 39 physician-vetted medications for nicotine-induced locomotor activation blockade. We further evaluated candidate medications for altered ethanol response, as well as in combination with varenicline for nicotine-response attenuation. Six medications specifically inhibited the nicotine response. Among this set, apomorphine and topiramate blocked both nicotine and ethanol responses. Both positively interact with varenicline in the Bliss Independence test, indicating potential synergistic interactions suggesting these are candidates for translation into Phase II clinical trials for smoking cessation.	[Cousin, Margot A.; Ebbert, Jon O.; Wiinamaki, Amanda R.; Urban, Mark D.; Argue, David P.; Ekker, Stephen C.; Klee, Eric W.] Mayo Clin, Mayo Addict Res Ctr, Rochester, MN 55905 USA; [Cousin, Margot A.; Ekker, Stephen C.; Klee, Eric W.] Mayo Clin, Ctr Clin & Translat Sci, Rochester, MN USA; [Ebbert, Jon O.] Mayo Clin, Nicotine Dependence Ctr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Klee, EW (corresponding author), Mayo Clin, Mayo Addict Res Ctr, Rochester, MN 55905 USA.	klee.eric@mayo.edu	Cousin, Margot/AAD-4591-2019	Cousin, Margot/0000-0002-6119-9346; Ekker, Stephen/0000-0003-0726-4212	Eagles Foundation; Mayo Foundation; Mayo Clinic Cancer Center; Mayo Clinic CTSA [UL1TR000135]; National Institutes of Health (NIH) [DA034475, DA14546, KL2 TR000136]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000136, UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA034475, R01DA014546] Funding Source: NIH RePORTER	Eagles Foundation; Mayo Foundation; Mayo Clinic Cancer Center; Mayo Clinic CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Eagles Foundation, Mayo Foundation, Mayo Clinic Cancer Center, Mayo Clinic CTSA UL1TR000135, National Institutes of Health (NIH) DA034475 to MAC, DA14546 to SCE, and KL2 TR000136 to EWK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; BACOPOULOS NG, 1979, PSYCHOPHARMACOLOGY, V60, P195, DOI 10.1007/BF00432293; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Bang PI, 2002, J NEUROSCI METH, V118, P177, DOI 10.1016/S0165-0270(02)00118-8; BEIL H, 1977, BRIT J ADDICT, V72, P129; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Bernardi RE, 2009, LEARN MEMORY, V16, P777, DOI 10.1101/lm.1648509; Best JD, 2008, NEUROPSYCHOPHARMACOL, V33, P1206, DOI 10.1038/sj.npp.1301489; Brennan CH, 2011, REV NEUROSCIENCE, V22, P37, DOI 10.1515/RNS.2011.006; Brunerova L, 2012, PSYCHIAT RES, V198, P297, DOI 10.1016/j.psychres.2011.09.022; Buckley CE, 2010, NEUROPHARMACOLOGY, V59, P149, DOI 10.1016/j.neuropharm.2010.04.014; Cachat J, 2010, BEHAV BRAIN RES, V208, P371, DOI 10.1016/j.bbr.2009.12.004; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P599, DOI 10.1080/10408440802026315; Carey RJ, 2004, BRAIN RES, V1019, P134, DOI 10.1016/j.brainres.2004.05.091; Cecchi M, 2007, NEUROPSYCHOPHARMACOL, V32, P589, DOI 10.1038/sj.npp.1301140; Charlet K, 2013, CURR TOP BEHAV NEURO, V13, P461, DOI 10.1007/7854_2011_130; CLARKE PBS, 1983, BRIT J PHARMACOL, V78, P329, DOI 10.1111/j.1476-5381.1983.tb09398.x; Ebbert JO, 2014, JAMA-J AM MED ASSOC, V311, P155, DOI 10.1001/jama.2013.283185; Ebbert JO, 2009, NICOTINE TOB RES, V11, P234, DOI 10.1093/ntr/ntn031; Faessel HM, 2010, CLIN PHARMACOKINET, V49, P799, DOI 10.2165/11537850-000000000-00000; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; FIORE MC, 2000, TREATING TOBACCO USE; Goldoni M, 2007, TOXICOL IN VITRO, V21, P759, DOI 10.1016/j.tiv.2007.03.003; Gonzalez Lorie A, 2009, Mol Cell Pharmacol, V1, P180; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; Hajak G, 2003, ADDICTION, V98, P1371, DOI 10.1046/j.1360-0443.2003.00491.x; HALVORSEN KAL, 1978, INT J ADDICT, V13, P475, DOI 10.3109/10826087809045262; Hurt RD, 1996, JAMA-J AM MED ASSOC, V275, P1097, DOI 10.1001/jama.275.14.1097; Irons TD, 2013, PHARMACOL BIOCHEM BE, V103, P792, DOI 10.1016/j.pbb.2012.12.010; JENSEN SB, 1977, BRIT J ADDICT, V72, P325; Jerlhag E, 2011, DRUG ALCOHOL DEPEN, V117, P126, DOI 10.1016/j.drugalcdep.2011.01.010; Johnson BA, 2005, ARCH INTERN MED, V165, P1600, DOI 10.1001/archinte.165.14.1600; Johnson BA, 2004, ARCH GEN PSYCHIAT, V61, P905, DOI 10.1001/archpsyc.61.9.905; Johnson BA, 2003, LANCET, V361, P1677, DOI 10.1016/S0140-6736(03)13370-3; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kayir H, 2009, SYNAPSE, V63, P15, DOI 10.1002/syn.20576; Kedikian X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069453; Kenna George A, 2009, Curr Drug Abuse Rev, V2, P135; Khazaal Y, 2006, PSYCHIAT CLIN NEUROS, V60, P384, DOI 10.1111/j.1440-1819.2006.01518.x; Kily LJM, 2008, J EXP BIOL, V211, P1623, DOI 10.1242/jeb.014399; Klee EW, 2012, HUM GENET, V131, P977, DOI 10.1007/s00439-011-1128-0; Klee EW, 2011, NICOTINE TOB RES, V13, P301, DOI 10.1093/ntr/ntr010; Kokel D, 2012, TRENDS BIOTECHNOL, V30, P421, DOI 10.1016/j.tibtech.2012.05.001; Kokel David, 2008, Briefings in Functional Genomics & Proteomics, V7, P483, DOI 10.1093/bfgp/eln040; Lerman C, 2007, NAT REV DRUG DISCOV, V6, P746, DOI 10.1038/nrd2361; Lobina Carla, 2011, Front Psychiatry, V2, P76, DOI 10.3389/fpsyt.2011.00076; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; Mantsch JR, 2010, NEUROPSYCHOPHARMACOL, V35, P2165, DOI 10.1038/npp.2010.86; Mathur P, 2010, NEUROBIOL DIS, V40, P66, DOI 10.1016/j.nbd.2010.05.016; McKee SA, 2009, ADDICT BIOL, V14, P99, DOI 10.1111/j.1369-1600.2008.00135.x; MEREU G, 1987, EUR J PHARMACOL, V141, P395, DOI 10.1016/0014-2999(87)90556-5; Miller N, 2013, BEHAV BRAIN RES, V240, P192, DOI 10.1016/j.bbr.2012.11.033; Morgan G, 2010, AM J HEALTH BEHAV, V34, P267, DOI 10.5993/AJHB.34.3.2; Neelkantan N, 2013, ACS CHEM NEUROSCI, V4, P1137, DOI 10.1021/cn400090q; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Obach RS, 2006, DRUG METAB DISPOS, V34, P121, DOI 10.1124/dmd.105.006767; Ou HC, 2009, JARO-J ASSOC RES OTO, V10, P191, DOI 10.1007/s10162-009-0158-y; Parker MO, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00065; Petzold AM, 2009, P NATL ACAD SCI USA, V106, P18662, DOI 10.1073/pnas.0908247106; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Radke AK, 2012, NEUROPSYCHOPHARMACOL, V37, P2405, DOI 10.1038/npp.2012.97; Rauhut AS, 2003, PSYCHOPHARMACOLOGY, V169, P1, DOI 10.1007/s00213-003-1450-x; Regan KS, 2011, J EXP BIOL, V214, P2560, DOI 10.1242/jeb.056333; Rovira M, 2011, P NATL ACAD SCI USA, V108, P19264, DOI 10.1073/pnas.1113081108; Rudoy CA, 2007, PROG NEURO-PSYCHOPH, V31, P1119, DOI 10.1016/j.pnpbp.2007.04.005; Rudoy CA, 2009, NEUROPSYCHOPHARMACOL, V34, P1135, DOI 10.1038/npp.2008.102; Shakarchi K, 2013, J EXP BIOL, V216, P869, DOI 10.1242/jeb.079657; Shen RY, 2007, BIOL PSYCHIAT, V61, P93, DOI 10.1016/j.biopsych.2006.03.018; Soderpalm B, 2013, CURR TOP BEHAV NEURO, V13, P127, DOI 10.1007/7854_2011_170; Sparks JA, 1999, PSYCHOPHARMACOLOGY, V141, P145, DOI 10.1007/s002130050818; Stewart A, 2011, REV NEUROSCIENCE, V22, P95, DOI 10.1515/RNS.2011.011; STROMBOM U, 1977, PSYCHOPHARMACOLOGY, V51, P293, DOI 10.1007/BF00431639; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Vranjkovic O, 2012, J PHARMACOL EXP THER, V342, P541, DOI 10.1124/jpet.112.193615; Wafford KA, 2005, CURR OPIN PHARMACOL, V5, P47, DOI 10.1016/j.coph.2004.08.006; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Zacny JP, 2012, DRUG ALCOHOL DEPEN, V120, P229, DOI 10.1016/j.drugalcdep.2011.07.006; Zarrindast MR, 2010, NEUROSCI LETT, V475, P156, DOI 10.1016/j.neulet.2010.03.069; Zhao T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048911	82	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90467	10.1371/journal.pone.0090467	http://dx.doi.org/10.1371/journal.pone.0090467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658307	gold, Green Submitted, Green Published			2022-12-25	WOS:000333355300017
J	Kiessling, S; Sollars, PJ; Pickard, GE				Kiessling, Silke; Sollars, Patricia J.; Pickard, Gary E.			Light Stimulates the Mouse Adrenal through a Retinohypothalamic Pathway Independent of an Effect on the Clock in the Suprachiasmatic Nucleus	PLOS ONE			English	Article							ACUTE REGULATORY PROTEIN; CIRCADIAN CLOCK; GENE-EXPRESSION; DEFICIENT MICE; GOLDEN-HAMSTER; TIME; RAT; GLUCOCORTICOIDS; MPER2; TRACT	The brain's master circadian pacemaker resides within the hypothalamic suprachiasmatic nucleus (SCN). SCN clock neurons are entrained to the day/night cycle via the retinohypothalamic tract and the SCN provides temporal information to the central nervous system and to peripheral organs that function as secondary oscillators. The SCN clock-cell network is thought to be the hypothalamic link between the retina and descending autonomic circuits to peripheral organs such as the adrenal gland, thereby entraining those organs to the day/night cycle. However, there are at least three different routes or mechanisms by which retinal signals transmitted to the hypothalamus may be conveyed to peripheral organs: 1) via retinal input to SCN clock neurons; 2) via retinal input to non-clock neurons in the SCN; or 3) via retinal input to hypothalamic regions neighboring the SCN. It is very well documented that light-induced responses of the SCN clock (i.e., clock gene expression, neural activity, and behavioral phase shifts) occur primarily during the subjective night. Thus to determine the role of the SCN clock in transmitting photic signals to descending autonomic circuits, we compared the phase dependency of light-evoked responses in the SCN and a peripheral oscillator, the adrenal gland. We observed light-evoked clock gene expression in the mouse adrenal throughout the subjective day and subjective night. Light also induced adrenal corticosterone secretion during both the subjective day and subjective night. The irradiance threshold for light-evoked adrenal responses was greater during the subjective day compared to the subjective night. These results suggest that retinohypothalamic signals may be relayed to the adrenal clock during the subjective day by a retinal pathway or cellular mechanism that is independent of an effect of light on the SCN neural clock network and thus may be important for the temporal integration of physiology and metabolism.	[Kiessling, Silke; Sollars, Patricia J.; Pickard, Gary E.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA; [Kiessling, Silke] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Pickard, Gary E.] Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; McGill University; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center	Pickard, GE (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.	gpickard2@unl.edu	Kiessling, Silke/AAZ-3854-2020	Kiessling, Silke/0000-0002-6293-6328	NIH [R01NS077003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077003] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grant R01NS077003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Malek ZA, 2001, CELL MOL LIFE SCI, V58, P434, DOI 10.1007/PL00000868; Abizaid A, 2004, EUR J NEUROSCI, V20, P2767, DOI 10.1111/j.1460-9568.2004.03737.x; Abraham D, 2006, J BIOL RHYTHM, V21, P169, DOI 10.1177/0748730406288040; Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bae K, 2007, J BIOL RHYTHM, V22, P85, DOI 10.1177/0748730406296718; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bittman EL, 2003, AM J PHYSIOL-REG I, V285, pR561, DOI 10.1152/ajpregu.00783.2002; BLOCK GD, 1993, INT REV CYTOL, V146, P83, DOI 10.1016/S0074-7696(08)60381-2; BORNSTEIN SR, 1990, ENDOCRINOLOGY, V127, P900, DOI 10.1210/endo-127-2-900; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; Buijs RM, 1999, EUR J NEUROSCI, V11, P1535, DOI 10.1046/j.1460-9568.1999.00575.x; Canteras NS, 2011, BRAIN RES REV, V65, P150, DOI 10.1016/j.brainresrev.2010.09.006; CASCIO CS, 1987, BRAIN RES, V423, P173, DOI 10.1016/0006-8993(87)90837-7; Diekman CO, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003196; Dragich JM, 2010, EUR J NEUROSCI, V31, P864, DOI 10.1111/j.1460-9568.2010.07119.x; EADE NR, 1958, BRIT J PHARM CHEMOTH, V13, P390; Engeland WC, 2005, ENDOCRINE, V28, P325, DOI 10.1385/ENDO:28:3:325; Gooley Joshua J., 2003, Journal of Neuroscience, V23, P7093; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; HENDRICKSON AE, 1972, Z ZELLFORSCH MIK ANA, V135, P1, DOI 10.1007/BF00307084; HOLLAND WC, 1956, BRIT J PHARM CHEMOTH, V11, P449, DOI 10.1111/j.1476-5381.1956.tb00015.x; Irwin RP, 2007, J NEUROSCI, V27, P11748, DOI 10.1523/JNEUROSCI.1840-07.2007; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Jakubcakova V, 2007, NEURON, V54, P831, DOI 10.1016/j.neuron.2007.04.031; JOHNSON RF, 1988, BRAIN RES, V462, P301, DOI 10.1016/0006-8993(88)90558-6; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kino T, 2011, ENDOCR DEV, V20, P116, DOI 10.1159/000321232; KLEIN DC, 1979, BRAIN RES, V174, P245, DOI 10.1016/0006-8993(79)90848-5; LEVINE JD, 1991, J COMP NEUROL, V306, P344, DOI 10.1002/cne.903060210; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Loh DH, 2008, NEUROENDOCRINOLOGY, V88, P246, DOI 10.1159/000140676; Meijer JH, 1998, J NEUROSCI, V18, P9078; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; Mohawk JA, 2007, PHYSIOL BEHAV, V92, P800, DOI 10.1016/j.physbeh.2007.06.009; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Morin LP, 2013, EXP NEUROL, V243, P4, DOI 10.1016/j.expneurol.2012.06.026; Mutoh T, 2003, J PHYSIOL-LONDON, V547, P317, DOI 10.1113/jphysiol.2002.028001; Nakamura TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028726; NIIJIMA A, 1993, PHYSIOL BEHAV, V54, P555, DOI 10.1016/0031-9384(93)90249-F; NIIJIMA A, 1992, J AUTONOM NERV SYST, V40, P155, DOI 10.1016/0165-1838(92)90026-D; Oishi K, 2002, MOL BRAIN RES, V109, P11, DOI 10.1016/S0169-328X(02)00457-6; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Ota T, 2012, MOL CELL ENDOCRINOL, V349, P30, DOI 10.1016/j.mce.2011.08.010; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Pendergast JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030254; Pendergast JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008552; Pezuk P, 2012, ENDOCRINOLOGY, V153, P4775, DOI 10.1210/en.2012-1486; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICKARD GE, 1982, J COMP NEUROL, V211, P65, DOI 10.1002/cne.902110107; PICKARD GE, 1981, J COMP NEUROL, V196, P155, DOI 10.1002/cne.901960111; Pickard GE, 2008, THE SENSES VISION, P537; Pittendrigh CS., 1981, HDB BEHAV NEUROBIOLO, V4, P94; Ruan GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038985; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Schrader JA, 2010, NEUROSCIENCE, V171, P513, DOI 10.1016/j.neuroscience.2010.08.057; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Sujino M, 2012, ENDOCRINOLOGY, V153, P2277, DOI 10.1210/en.2011-1794; van der Veen DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047692; Yan L, 1999, NEUROSCIENCE, V94, P141, DOI 10.1016/S0306-4522(99)00223-7; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng B, 1999, CELL, V105, P683	71	48	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92959	10.1371/journal.pone.0092959	http://dx.doi.org/10.1371/journal.pone.0092959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658072	Green Published, gold			2022-12-25	WOS:000333355300147
J	Liu, AR; Chen, S; Cai, SX; Dong, L; Liu, L; Yang, Y; Guo, FM; Lu, XM; He, HL; Chen, QH; Hu, SL; Qiu, HB				Liu, Airan; Chen, Song; Cai, Shixia; Dong, Liang; Liu, Le; Yang, Yi; Guo, Fengmei; Lu, Xiaomin; He, Hongli; Chen, Qihong; Hu, Shuling; Qiu, Haibo			Wnt5a through Noncanonical Wnt/JNK or Wnt/PKC Signaling Contributes to the Differentiation of Mesenchymal Stem Cells into Type II Alveolar Epithelial Cells In Vitro	PLOS ONE			English	Article							INDUCED LUNG INJURY; PROGENITOR CELLS; PROMOTES PROLIFERATION; MYOCARDIAL-INFARCTION; TRANSCRIPTION FACTORS; DEPENDENT PATHWAY; IMPROVES SURVIVAL; OXIDATIVE STRESS; STROMAL CELLS; MIGRATION	The differentiation of mesenchymal stem cells (MSCs) into type II alveolar epithelial (AT II) cells is critical for reepithelization and recovery in acute respiratory distress syndrome (ARDS), and Wnt signaling was considered to be the underlying mechanisms. In our previous study, we found that canonical Wnt pathway promoted the differentiation of MSCs into AT II cells, however the role of the noncanonical Wnt pathway in this process is unclear. It was disclosed in this study that noncanonical Wnt signaling in mouse bone marrow-derived MSCs (mMSCs) was activated during the differentiation of mMSCs into AT II cells in a modified co-culture system with murine lung epithelial-12 cells and small airway growth media. The levels of surfactant protein (SP) C, SPB and SPD, the specific markers of AT II cells, increased in mMSCs when Wnt5a was added to activate noncanonical Wnt signaling, while pretreatment with JNK or PKC inhibitors reversed the promotion of Wnt5a. The differentiation rate of mMSCs also depends on their abilities to accumulate and survive in inflammatory tissue. We found that the Wnt5a supplement promoted the vertical and horizontal migration of mMSCs, ameliorated the cell death and the reduction of Bcl-2/Bax induced by H2O2. The effect of Wnt5a on the migration of mMSCs and their survival after H2O2 exposure were partially inhibited with PKC or JNK blockers. In conclusion, Wnt5a through Wnt/JNK signaling alone or both Wnt/JNK and Wnt/PKC signaling promoted the differentiation of mMSCs into AT II cells and the migration of mMSCs; through Wnt/PKC signaling, Wnt5a increased the survival of mMSCs after H2O2 exposure in vitro.	[Liu, Airan; Cai, Shixia; Dong, Liang; Liu, Le; Yang, Yi; Guo, Fengmei; Lu, Xiaomin; He, Hongli; Chen, Qihong; Hu, Shuling; Qiu, Haibo] Southeast Univ, Zhongda Hosp, Sch Med, Dept Crit Care Med, Nanjing, Jiangsu, Peoples R China; [Chen, Song] China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China	Southeast University - China; China Pharmaceutical University	Qiu, HB (corresponding author), Southeast Univ, Zhongda Hosp, Sch Med, Dept Crit Care Med, Nanjing, Jiangsu, Peoples R China.	haiboq2000@gmail.com	Qiu, Haibo/AAS-9047-2021; Chen, QH/GXH-3158-2022	Qiu, Haibo/0000-0001-8589-4717; 	national natural science foundation of China [81070049, 81300060, 81170057, Bk2010399, BK2011600]; Ministry of Education China [2010009212006]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education China(Ministry of Education, China)	This work was co-financed by three national natural science foundations of China (No. 81070049, 81300060, 81170057 URL:http://isisn.nsfc.gov.cn/egrantweb/), two natural science foundations of the Jiangsu province (No. Bk2010399, BK2011600 URL: http://210.73.128.90/XMSB/Eve_Login.jsp) and the new teacher fund for doctor station sponsored by the Ministry of Education China (No. 2010009212006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartis D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057393; Berger MJ, 2006, CYTOTHERAPY, V8, P480, DOI 10.1080/14653240600941549; Bergwitz C, 2001, BBA-MOL CELL RES, V1538, P129, DOI 10.1016/S0167-4889(00)00123-3; Bluwstein A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.15; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Caelles C, 1997, GENE DEV, V11, P3351, DOI 10.1101/gad.11.24.3351; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Cheng CW, 2008, BIOCHEM BIOPH RES CO, V365, P285, DOI 10.1016/j.bbrc.2007.10.166; Copland IB, 2009, STEM CELLS, V27, P467, DOI 10.1634/stemcells.2008-0520; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Flaherty MP, 2008, CIRCULATION, V117, P2241, DOI 10.1161/CIRCULATIONAHA.107.741066; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hara T, 1998, BIOCHEM BIOPH RES CO, V244, P41, DOI 10.1006/bbrc.1998.8210; He ZS, 2011, STEM CELLS DEV, V20, P1771, DOI 10.1089/scd.2010.0380; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jin Z, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-480; Karow M, 2009, J CELL MOL MED, V13, P2506, DOI 10.1111/j.1582-4934.2008.00619.x; Koyanagi M, 2005, J BIOL CHEM, V280, P16838, DOI 10.1074/jbc.M500323200; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Lang WH, 2004, CELL SIGNAL, V16, P457, DOI 10.1016/j.cellsig.2003.09.002; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Liebermann DA, 1998, INT J ONCOL, V12, P685; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu AR, 2013, J CELL PHYSIOL, V228, P1270, DOI 10.1002/jcp.24282; Loscertales M, 2008, DEVELOPMENT, V135, P1365, DOI 10.1242/dev.010504; Ma N, 2011, CELL BIOL INT, V35, P1261, DOI 10.1042/CBI20110026; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Matthay Michael A, 2005, Proc Am Thorac Soc, V2, P206, DOI 10.1513/pats.200501-009AC; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Muller-Ehmsen J, 2006, J MOL CELL CARDIOL, V41, P876, DOI 10.1016/j.yjmcc.2006.07.023; Onizuka T, 2012, J MOL CELL CARDIOL, V52, P650, DOI 10.1016/j.yjmcc.2011.11.010; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061; Rackley CR, 2012, J CLIN INVEST, V122, P2724, DOI 10.1172/JCI60519; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Ring L, 2014, CELL SIGNAL, V26, P260, DOI 10.1016/j.cellsig.2013.11.021; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Serikov VB, 2007, ANAT REC, V290, P1033, DOI 10.1002/ar.20574; Shang YC, 2007, ACTA PHARMACOL SIN, V28, P1761, DOI 10.1111/j.1745-7254.2007.00671.x; Shi MD, 2013, CELL BIOCHEM BIOPHYS, V66, P161, DOI 10.1007/s12013-012-9465-8; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wang LM, 2002, NEPHRON, V91, P142, DOI 10.1159/000057616; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Ward PA, 2010, ANN NY ACAD SCI, V1203, P53, DOI 10.1111/j.1749-6632.2010.05552.x; Yamada M, 2004, J IMMUNOL, V172, P1266, DOI 10.4049/jimmunol.172.2.1266; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yang YJ, 2008, EUR HEART J, V29, P1578, DOI 10.1093/eurheartj/ehn167; Yoon SO, 2001, FASEB J, V15, P111, DOI 10.1096/fj.01-0398fje; Yu JM, 2006, MOL CELL BIOCHEM, V288, P17, DOI 10.1007/s11010-005-9113-3; Yuzugullu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-90; Zhang JY, 2008, CELL MOL LIFE SCI, V65, P1435, DOI 10.1007/s00018-008-8047-9; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhao F, 2008, TRANSPL P, V40, P1700, DOI 10.1016/j.transproceed.2008.01.080; Zhao Y, 2010, MOL CARCINOGEN, V49, P760, DOI 10.1002/mc.20651; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823; Zhuang Y, 2009, CHINESE MED J-PEKING, V122, P183, DOI 10.3760/cma.j.issn.0366-6999.2009.02.014	67	34	39	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90229	10.1371/journal.pone.0090229	http://dx.doi.org/10.1371/journal.pone.0090229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658098	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300012
J	Kong, YY; Wang, DF; Shi, L; Hui, SCN; Chu, WCW				Kong, Youyong; Wang, Defeng; Shi, Lin; Hui, Steve C. N.; Chu, Winnie C. W.			Adaptive Distance Metric Learning for Diffusion Tensor Image Segmentation	PLOS ONE			English	Article							LEVEL SET METHOD; DTI SEGMENTATION; THALAMIC NUCLEI; BRAIN; CONNECTIVITY; TRACTOGRAPHY; MRI; INFORMATION; MAPS	High quality segmentation of diffusion tensor images (DTI) is of key interest in biomedical research and clinical application. In previous studies, most efforts have been made to construct predefined metrics for different DTI segmentation tasks. These methods require adequate prior knowledge and tuning parameters. To overcome these disadvantages, we proposed to automatically learn an adaptive distance metric by a graph based semi-supervised learning model for DTI segmentation. An original discriminative distance vector was first formulated by combining both geometry and orientation distances derived from diffusion tensors. The kernel metric over the original distance and labels of all voxels were then simultaneously optimized in a graph based semi-supervised learning approach. Finally, the optimization task was efficiently solved with an iterative gradient descent method to achieve the optimal solution. With our approach, an adaptive distance metric could be available for each specific segmentation task. Experiments on synthetic and real brain DTI datasets were performed to demonstrate the effectiveness and robustness of the proposed distance metric learning approach. The performance of our approach was compared with three classical metrics in the graph based semi-supervised learning framework.	[Kong, Youyong; Wang, Defeng; Shi, Lin; Hui, Steve C. N.; Chu, Winnie C. W.] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [Kong, Youyong; Wang, Defeng; Shi, Lin; Hui, Steve C. N.; Chu, Winnie C. W.] Chinese Univ Hong Kong, Res Ctr Med Image Comp, Shatin, Hong Kong, Peoples R China; [Wang, Defeng; Chu, Winnie C. W.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Wang, Defeng] Chinese Univ Hong Kong, Dept Biomed Engn, Shatin, Hong Kong, Peoples R China; [Wang, Defeng] Chinese Univ Hong Kong, Shun Hing Inst Adv Engn, Shatin, Hong Kong, Peoples R China; [Shi, Lin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Wang, DF (corresponding author), Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.	dfwang@cuhk.edu.hk; winniechu@cuhk.edu.hk	Chu, Winnie CW/F-8449-2014; Shi, Lin/K-5241-2014; Hui, Steve CN/Q-3715-2016; Hui, Steve/AAF-6195-2021	Chu, Winnie CW/0000-0003-4962-4132; Shi, Lin/0000-0003-2318-4669; Hui, Steve CN/0000-0002-1523-4040; Hui, Steve/0000-0002-1523-4040	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 411811, 475711, 416712, 473012, 462611, SEG_CUHK02]; National Natural Science Foundation of China [81271653, 81201157]; Shenzhen Science and Technology Innovation Committee [JCYJ20120619152326449, JC201005250030A]; Shun Hing Institute of Advanced Engineering [BME-p2-13/BME-CUHK]; Chinese University of Hong Kong; Fondation Yves Cotrel pour la Recherche en Pathologie Rechidienne-Institut de France	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Innovation Committee; Shun Hing Institute of Advanced Engineering; Chinese University of Hong Kong(Chinese University of Hong Kong); Fondation Yves Cotrel pour la Recherche en Pathologie Rechidienne-Institut de France	The work described in this paper was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No.: CUHK 411811, 475711, 416712, 473012, 462611, SEG_CUHK02), grants from the National Natural Science Foundation of China (Project No. 81271653 and 81201157), grants from Shenzhen Science and Technology Innovation Committee (Project No. JCYJ20120619152326449 and JC201005250030A), a grant from BME-p2-13/BME-CUHK of the Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong, and a grant from Fondation Yves Cotrel pour la Recherche en Pathologie Rechidienne-Institut de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbeek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081895; Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; Awate SP, 2007, IEEE T MED IMAGING, V26, P1525, DOI 10.1109/TMI.2007.907301; Bao LJ, 2009, PHYS MED BIOL, V54, P1435, DOI 10.1088/0031-9155/54/6/004; Barbieri S, 2012, NEUROIMAGE, V60, P1025, DOI 10.1016/j.neuroimage.2012.01.076; Barbieri S, 2011, NEUROIMAGE, V55, P532, DOI 10.1016/j.neuroimage.2010.12.069; Boggs PT, 1996, ANN OPER RES, V62, P419, DOI 10.1007/BF02206825; Choe AS, 2012, NMR BIOMED, V25, P900, DOI 10.1002/nbm.1810; de Luis-Garcia R, 2013, IEEE ENG MED BIO, P503, DOI 10.1109/EMBC.2013.6609547; Deng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063385; Deng Y, 2013, IEEE T NEUR NET LEAR, V24, P383, DOI 10.1109/TNNLS.2012.2235082; Deng Y, 2012, IEEE J-STSP, V6, P566, DOI 10.1109/JSTSP.2012.2195472; Deng Y, 2011, IEEE T IMAGE PROCESS, V20, P2329, DOI 10.1109/TIP.2011.2109729; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gahm JK, 2013, I S BIOMED IMAGING, P504; Gao YR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082782, 10.1371/journal.pone.0075065]; Gu YF, 2013, IEEE J-STARS, V6, P1109, DOI 10.1109/JSTARS.2013.2243112; Guggenberger R, 2013, EUR J RADIOL, V82, pE590, DOI 10.1016/j.ejrad.2013.05.011; Guo WH, 2008, PHILOS T R SOC A, V366, P2279, DOI 10.1098/rsta.2008.0042; Han D, 2009, IEEE ENG MED BIO, P5653, DOI 10.1109/IEMBS.2009.5333767; Hao X, 2014, MED IMAGE ANAL, V18, P161, DOI 10.1016/j.media.2013.10.007; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Jbabdi S, 2012, MAGN RESON MED, V68, P1846, DOI 10.1002/mrm.24204; Jia YQ, 2008, IEEE IMAGE PROC, P3204, DOI 10.1109/ICIP.2008.4712477; Jiang N, 2011, IEEE T IMAGE PROCESS, V20, P2288, DOI 10.1109/TIP.2011.2114895; Jin R, 2009, PROC CVPR IEEE, P896, DOI 10.1109/CVPRW.2009.5206684; Jonasson L, 2007, SIGNAL PROCESS, V87, P309, DOI 10.1016/j.sigpro.2005.12.017; Jou RJ, 2011, AM J NEURORADIOL, V32, P1607, DOI 10.3174/ajnr.A2558; Kim KI, 2005, IEEE T PATTERN ANAL, V27, P1351, DOI 10.1109/TPAMI.2005.181; Kong Y, 2011, 3D DIFFUSION TENSOR, P1602; Kong Y, 2014, AM J NEUROR IN PRESS; Lemaire JJ, 2007, NEUROIMAGE, V37, pS109, DOI 10.1016/j.neuroimage.2007.05.055; Li CM, 2011, IEEE T IMAGE PROCESS, V20, P2007, DOI 10.1109/TIP.2011.2146190; Liu B, 2010, IEEE T SYST MAN CY B, V40, P973, DOI 10.1109/TSMCB.2009.2034632; Liu TM, 2007, NEUROIMAGE, V38, P114, DOI 10.1016/j.neuroimage.2007.07.002; Malcolm J, 2007, IEEE I CONF COMP VIS, P2726; Mang SC, 2012, MAGN RESON MED, V67, P118, DOI 10.1002/mrm.22996; Morgan VL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006660; Rathore RKS, 2011, MAGN RESON IMAGING, V29, P1088, DOI 10.1016/j.mri.2011.04.014; Sajjadi SA, 2013, BRAIN, V136, P2253, DOI 10.1093/brain/awt118; Saygin ZM, 2011, NEUROIMAGE, V56, P1353, DOI 10.1016/j.neuroimage.2011.03.006; Schmithorst VJ, 2007, BEHAV BRAIN SCI, V30, P169, DOI 10.1017/S0140525X0700129X; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Unrath A, 2008, NEUROSCI LETT, V434, P322, DOI 10.1016/j.neulet.2008.02.013; Wang DF, 2012, J NEUROSCI METH, V209, P371, DOI 10.1016/j.jneumeth.2012.06.026; Wang Q, 2010, AM J NEURORADIOL, V31, P516, DOI 10.3174/ajnr.A1862; Wang ZZ, 2005, IEEE T MED IMAGING, V24, P1267, DOI 10.1109/TMI.2005.854516; Weldeselassie YT, 2007, SPIE MED IMAGING, V6512; Wiegell MR, 2003, NEUROIMAGE, V19, P391, DOI 10.1016/S1053-8119(03)00044-2; Wiltshire K, 2010, CAN J NEUROL SCI, V37, P595, DOI 10.1017/S0317167100010751; Wu YC, 2011, NEUROIMAGE, V54, P1840, DOI 10.1016/j.neuroimage.2010.09.067; Xiang SM, 2008, PATTERN RECOGN, V41, P3600, DOI 10.1016/j.patcog.2008.05.018; Yang L, 2010, IEEE T PATTERN ANAL, V32, P30, DOI 10.1109/TPAMI.2008.273; Yang W, 2012, MED PHYS, V39, P6929, DOI 10.1118/1.4754305; Yap PT, 2010, IEEE T MED IMAGING, V29, P1192, DOI 10.1109/TMI.2010.2043680; Yassa MA, 2010, P NATL ACAD SCI USA, V107, P12687, DOI 10.1073/pnas.1002113107; Yeung DY, 2007, IEEE T NEURAL NETWOR, V18, P141, DOI 10.1109/TNN.2006.883723; Zhou DY, 2004, ADV NEUR IN, V16, P321; Ziyan U, 2006, LECT NOTES COMPUT SC, V4191, P807	59	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92069	10.1371/journal.pone.0092069	http://dx.doi.org/10.1371/journal.pone.0092069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651858	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800067
J	Liu, LL; Qu, JQ; Zhou, XL; Liu, XF; Zhang, ZB; Wang, XM; Liu, T; Liu, GM				Liu, Longlong; Qu, Jieqiong; Zhou, Xilong; Liu, Xuefeng; Zhang, Zhaobao; Wang, Xumin; Liu, Tao; Liu, Guiming			Discovery of a Strongly-Interrelated Gene Network in Corals under Constant Darkness by Correlation Analysis after Wavelet Transform on Complex Network Model	PLOS ONE			English	Article							EXPRESSION PROFILES; REEF; DYNAMICS	Coral reefs occupy a relatively small portion of sea area, yet serve as a crucial source of biodiversity by establishing harmonious ecosystems with marine plants and animals. Previous researches mainly focused on screening several key genes induced by stress. Here we proposed a novel method-correlation analysis after wavelet transform of complex network model, to explore the effect of light on gene expression in the coral Acropora millepora based on microarray data. In this method, wavelet transform and the conception of complex network were adopted, and 50 key genes with large differences were finally captured, including both annotated genes and novel genes without accurate annotation. These results shed light on our understanding of coral's response toward light changes and the genome-wide interaction among genes under the control of biorhythm, and hence help us to better protect the coral reef ecosystems. Further studies are needed to explore how functional connections are related to structural connections, and how connectivity arises from the interactions within and between different systems. The method introduced in this study for analyzing microarray data will allow researchers to explore genome-wide interaction network with their own dataset and understand the relevant biological processes.	[Liu, Longlong; Qu, Jieqiong; Zhou, Xilong; Liu, Xuefeng; Liu, Tao] Ocean Univ China, Qingdao, Shandong, Peoples R China; [Wang, Xumin; Liu, Guiming] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Zhang, Zhaobao] Shandong Univ Tradit Chinese Med, Coll Pharm, Jinan, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Shandong University of Traditional Chinese Medicine	Liu, GM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	liugm@big.ac.cn	Qu, Jieqiong/AAA-4288-2019; wang, xumin/HII-8627-2022	Qu, Jieqiong/0000-0003-0915-1342; Zhang, Zhaobao/0000-0003-2422-9566	Chinese National Natural Science Funds [40906097]	Chinese National Natural Science Funds(National Natural Science Foundation of China (NSFC))	This research was supported by the Chinese National Natural Science Funds (grant no. 40906097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Aronson RB, 2000, LIMNOL OCEANOGR, V45, P251, DOI 10.4319/lo.2000.45.1.0251; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Besser J, 2007, GENE EXPR PATTERNS, V7, P511, DOI 10.1016/j.modgep.2006.10.007; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Deuker L, 2009, NEUROIMAGE, V47, P1460, DOI 10.1016/j.neuroimage.2009.05.035; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; Fukamachi S, 2007, J MOL EVOL, V65, P359, DOI 10.1007/s00239-007-9035-7; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Gui LM, 2013, DEV CELL, V25, P43, DOI 10.1016/j.devcel.2013.02.008; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Ke BX, 2012, P NATL ACAD SCI USA, V109, P6165, DOI 10.1073/pnas.1113987109; Kim S, 2000, J BIOMED OPT, V5, P411, DOI 10.1117/1.1289142; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Mercado-Pimentel ME, 2007, DEV BIOL, V304, P420, DOI 10.1016/j.ydbio.2006.12.038; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mueller RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-492; Neigel J, 2007, CORAL REEFS, V26, P487, DOI 10.1007/s00338-007-0248-4; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-435; Shono H, 2000, COMPUT BIOL MED, V30, P237, DOI 10.1016/S0010-4825(00)00010-X; SPUDICH JL, 1980, J CELL BIOL, V85, P136, DOI 10.1083/jcb.85.1.136; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Wang S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r126; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Zeng S, 2002, GENE, V294, P45, DOI 10.1016/S0378-1119(02)00791-6	36	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92434	10.1371/journal.pone.0092434	http://dx.doi.org/10.1371/journal.pone.0092434			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651851	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800106
J	Post, S; Heijink, IH; Petersen, AH; de Bruin, HG; van Oosterhout, AJM; Nawijn, MC				Post, Sijranke; Heijink, Irene H.; Petersen, Arjen H.; de Bruin, Harold G.; van Oosterhout, Antoon J. M.; Nawijn, Martijn C.			Protease-Activated Receptor-2 Activation Contributes to House Dust Mite-Induced IgE Responses in Mice	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; NF-KAPPA-B; BRONCHIAL EPITHELIAL-CELLS; DEPENDENT ACTIVATION; GERMAN-COCKROACH; INHALED ANTIGEN; ASTHMA; SENSITIZATION; EXPRESSION; EXPOSURE	Aeroallergens such as house dust mite (HDM), cockroach, and grass or tree pollen are innocuous substances that can induce allergic sensitization upon inhalation. The serine proteases present in these allergens are thought to activate the protease-activated receptor (PAR)-2, on the airway epithelium, thereby potentially inducing allergic sensitization at the expense of inhalation tolerance. We hypothesized that the proteolytic activity of allergens may play an important factor in the allergenicity to house dust mite and is essential to overcome airway tolerance. Here, we aimed to investigate the role of PAR-2 activation in allergic sensitization and HDM-induced allergic airway inflammation. In our study, Par-2 deficient mice were treated with two different HDM extracts containing high and low serine protease activities twice a week for a period of 5 weeks. We determined airway inflammation through quantification of percentages of mononuclear cells, eosinophils and neutrophils in the bronchial alveolar lavage fluid and measured total IgE and HDM-specific IgE and IgG1 levels in serum. Furthermore, Th2 and pro-inflammatory cytokines including IL-5, IL-13, Eotaxin-1, IL-17, KC, Chemokine (C-C motif) ligand 17 (CCL17) and thymic stromal lymphopoietin (TSLP), were measured in lung tissue homogenates. We observed that independent of the serine protease content, HDM was able to induce elevated levels of eosinophils and neutrophils in the airways of both wild-type (WT) and Par-2 deficient mice. Furthermore, we show that induction of pro-inflammatory cytokines by HDM exposure is independent of Par-2 activation. In contrast, serine protease activity of HDM does contribute to enhanced levels of total IgE, but not HDM-specific IgE. We conclude that, while Par-2 activation contributes to the development of IgE responses, it is largely dispensable for the HDM-induced induction of pro-inflammatory cytokines and airway inflammation in an experimental mouse model of HDM-driven allergic airway disease.	[Post, Sijranke; Heijink, Irene H.; Petersen, Arjen H.; de Bruin, Harold G.; van Oosterhout, Antoon J. M.; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Lab Allergol & Pulm Dis, Groningen, Netherlands; [Post, Sijranke; Heijink, Irene H.; de Bruin, Harold G.; van Oosterhout, Antoon J. M.; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Heijink, Irene H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Nawijn, MC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Lab Allergol & Pulm Dis, Groningen, Netherlands.	m.c.nawijn@umcg.nl		Nawijn, Martijn/0000-0003-3372-6521	Dutch Lung Foundation [NAF 3.2.07.019]; Foundation Dutch Asthma Control [SAB2011/016]	Dutch Lung Foundation; Foundation Dutch Asthma Control	This study was supported by grants from the Dutch Lung Foundation (NAF 3.2.07.019) and the Foundation Dutch Asthma Control (Stichting Astma bestrijding SAB2011/016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Alcorn JF, 2010, AM J PHYSIOL-LUNG C, V298, pL57, DOI 10.1152/ajplung.00037.2009; Arizmendi NG, 2011, ALLERGY ASTHMA CL IM, V7, DOI 10.1186/1710-1492-7-22; Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Barlow JL, 2011, CLIN EXP ALLERGY, V41, P1447, DOI 10.1111/j.1365-2222.2011.03806.x; Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Cocks TM, 1999, NATURE, V398, P156, DOI 10.1038/18223; Day SB, 2012, J INNATE IMMUN, V4, P100, DOI 10.1159/000329132; Ebeling C, 2005, J ALLERGY CLIN IMMUN, V115, P623, DOI 10.1016/j.jaci.2004.11.042; Ebeling C, 2007, J IMMUNOL, V179, P2910, DOI 10.4049/jimmunol.179.5.2910; Gough L, 2003, CLIN EXP ALLERGY, V33, P1159, DOI 10.1046/j.1365-2222.2003.01716.x; Gregory LG, 2009, CLIN EXP ALLERGY, V39, P1597, DOI 10.1111/j.1365-2222.2009.03302.x; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Heijink IH, 2007, J IMMUNOL, V178, P7678, DOI 10.4049/jimmunol.178.12.7678; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; HOLT PG, 1981, IMMUNOLOGY, V42, P409; Jeon SK, 2008, J INVEST DERMATOL, V128, P1930, DOI 10.1038/jid.2008.13; Kauffman H. F., 2006, CLIN MOL ALLERGY, V4, P1; Knight DA, 2001, J ALLERGY CLIN IMMUN, V108, P797, DOI 10.1067/mai.2001.119025; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lewkowich IP, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-122; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Nelson RP, 1996, J ALLERGY CLIN IMMUN, V98, P258, DOI 10.1016/S0091-6749(96)70148-3; Osterlund C, 2009, CLIN EXP ALLERGY, V39, P1199, DOI 10.1111/j.1365-2222.2009.03284.x; Page K, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-62; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; Rallabhandi P, 2008, J BIOL CHEM, V283, P24314, DOI 10.1074/jbc.M804800200; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Tully JE, 2013, J IMMUNOL, V191, P5811, DOI 10.4049/jimmunol.1301329; Vieira RP, 2011, AM J RESP CRIT CARE, V184, P215, DOI 10.1164/rccm.201011-1762OC; Walsh ER, 2008, J EXP MED, V205, P1285, DOI 10.1084/jem.20071836; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183	36	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91206	10.1371/journal.pone.0091206	http://dx.doi.org/10.1371/journal.pone.0091206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651123	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800033
J	Wang, C; Grohme, MA; Mali, B; Schill, RO; Frohme, M				Wang, Chong; Grohme, Markus A.; Mali, Brahim; Schill, Ralph O.; Frohme, Marcus			Towards Decrypting Cryptobiosis-Analyzing Anhydrobiosis in the Tardigrade Milnesium tardigradum Using Transcriptome Sequencing	PLOS ONE			English	Article							DESICCATION TOLERANCE; HEAT-SHOCK; MOLECULAR-MECHANISMS; CRYSTALLIN PROTEIN; GENE-EXPRESSION; MESSENGER-RNA; DNA; TREHALOSE; RESISTANCE; INDUCTION	Background: Many tardigrade species are capable of anhydrobiosis; however, mechanisms underlying their extreme desiccation resistance remain elusive. This study attempts to quantify the anhydrobiotic transcriptome of the limnoterrestrial tardigrade Milnesium tardigradum. Results: A prerequisite for differential gene expression analysis was the generation of a reference hybrid transcriptome atlas by assembly of Sanger, 454 and Illumina sequence data. The final assembly yielded 79,064 contigs (>100 bp) after removal of ribosomal RNAs. Around 50% of them could be annotated by SwissProt and NCBI non-redundant protein sequences. Analysis using CEGMA predicted 232 (93.5%) out of the 248 highly conserved eukaryotic genes in the assembly. We used this reference transcriptome for mapping and quantifying the expression of transcripts regulated under anhdydrobiosis in a time-series during dehydration and rehydration. 834 of the transcripts were found to be differentially expressed in a single stage (dehydration/inactive tun/rehydration) and 184 were overlapping in two stages while 74 were differentially expressed in all three stages. We have found interesting patterns of differentially expressed transcripts that are in concordance with a common hypothesis of metabolic shutdown during anhydrobiosis. This included down-regulation of several proteins of the DNA replication and translational machinery and protein degradation. Among others, heat shock proteins Hsp27 and Hsp30c were up-regulated in response to dehydration and rehydration. In addition, we observed up-regulation of ployubiquitin-B upon rehydration together with a higher expression level of several DNA repair proteins during rehydration than in the dehydration stage. Conclusions: Most of the transcripts identified to be differentially expressed had distinct cellular function. Our data suggest a concerted molecular adaptation in M. tardigradum that permits extreme forms of ametabolic states such as anhydrobiosis. It is temping to surmise that the desiccation tolerance of tradigrades can be achieved by a constitutive cellular protection system, probably in conjunction with other mechanisms such as rehydration-induced cellular repair.	[Wang, Chong; Grohme, Markus A.; Mali, Brahim; Frohme, Marcus] Tech Univ Appl Sci Wildau, Wildau, Germany; [Schill, Ralph O.] Univ Stuttgart, Inst Biol, D-70174 Stuttgart, Germany	University of Applied Sciences Wildau; University of Stuttgart	Wang, C (corresponding author), Tech Univ Appl Sci Wildau, Wildau, Germany.	cwang@th-wildau.de	Frohme, Marcus/HCH-4031-2022; Grohme, Markus/ABH-4373-2020	Grohme, Markus/0000-0002-4250-5600	German Federal Ministry of Education and Research, BMBF, as part of FUNCRYPTA [FKY 0313838E]	German Federal Ministry of Education and Research, BMBF, as part of FUNCRYPTA	This work was supported by the German Federal Ministry of Education and Research, BMBF, as part of FUNCRYPTA (FKY 0313838E). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-69; Altiero T, 2012, J LIMNOL, V71, P211, DOI 10.4081/jlimnol.2012.e22; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barker MS, 2010, EVOL BIOINFORM, V6, P143, DOI 10.4137/EBO.S5861; Beisser D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-72; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bewley J. D., 1992, Water and life: comparative analysis of water relationships at the organismic, cellular and molecular level., P141; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Browne JA, 2004, EUKARYOT CELL, V3, P966, DOI 10.1128/EC.3.4.966-975.2004; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Clegg JS, 2005, INTEGR COMP BIOL, V45, P715, DOI 10.1093/icb/45.5.715; Cornette R, 2010, J BIOL CHEM, V285, P35889, DOI 10.1074/jbc.M110.150623; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Eyres I, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-148; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Forster F, 2012, BIOINFORM BIOL INSIG, V6, P69, DOI 10.4137/BBI.S9150; Forster F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-469; Gagyi-Palffy Andrea, 2011, ELBA Bioflux, V3, P13; Gechev TS, 2013, CELL MOL LIFE SCI, V70, P689, DOI 10.1007/s00018-012-1155-6; Ghisolfi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043628; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Goyal K, 2005, INTEGR COMP BIOL, V45, P702, DOI 10.1093/icb/45.5.702; Grohme MA, 2011, J ZOOL SYST EVOL RES, V49, P127, DOI 10.1111/j.1439-0469.2010.00610.x; Gusev O, 2011, CELL STRESS CHAPERON, V16, P81, DOI 10.1007/s12192-010-0223-9; Hayward SAL, 2004, J EXP BIOL, V207, P963, DOI 10.1242/jeb.00842; Heikkila JJ, 2004, J CELL BIOCHEM, V93, P672, DOI 10.1002/jcb.20237; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Hengherr S, 2009, PHYSIOL BIOCHEM ZOOL, V82, P749, DOI 10.1086/605954; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Garcia AH, 2011, J BIOSCIENCES, V36, P939, DOI 10.1007/s12038-011-9107-0; Higo A, 2007, MICROBIOL-SGM, V153, P3685, DOI 10.1099/mic.0.2007/009233-0; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Humann JL, 2009, APPL ENVIRON MICROB, V75, P446, DOI 10.1128/AEM.02207-08; Jonsson I., 2014, OPEN ZOOL J, V3, P1, DOI [10.2174/1874336601003010001, DOI 10.2174/1874336601003010001]; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Katoh H, 2004, MICROB ECOL, V47, P164, DOI 10.1007/s00248-003-1043-6; KOSTER KL, 1988, PLANT PHYSIOL, V88, P829, DOI 10.1104/pp.88.3.829; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7; Leek JT, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-150; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li ZY, 2012, BRIEF FUNCT GENOMICS, V11, P25, DOI 10.1093/bfgp/elr035; Liang P, 1997, J BIOL CHEM, V272, P19051, DOI 10.1074/jbc.272.30.19051; Liang P, 1997, EUR J BIOCHEM, V243, P225, DOI 10.1111/j.1432-1033.1997.0225a.x; Liu XN, 2003, AM J BOT, V90, P526, DOI 10.3732/ajb.90.4.526; Lopez MD, 2008, RNA, V14, P1, DOI 10.1261/rna.782308; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; MacManes MD, 2013, PEERJ, V1, DOI 10.7717/peerj.113; Malde K, 2006, BIOINFORMATICS, V22, P2232, DOI 10.1093/bioinformatics/btl368; Mali B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-168; MANNIRONI C, 1989, NUCLEIC ACIDS RES, V17, P9113, DOI 10.1093/nar/17.22.9113; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Martinez-Barnetche J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-207; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mizrahi T, 2010, CELL STRESS CHAPERON, V15, P351, DOI 10.1007/s12192-009-0150-9; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-673; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Niedringhaus TP, 2011, ANAL CHEM, V83, P4327, DOI 10.1021/ac2010857; O'Mahony PJ, 1999, PLANT MOL BIOL, V41, P657, DOI 10.1023/A:1006330623364; Ono F, 2008, J PHYS CHEM SOLIDS, V69, P2297, DOI 10.1016/j.jpcs.2008.04.019; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rebecchi L, 2007, ISJ-INVERT SURVIV J, V4, P65; Rebecchi L, 2009, J EXP BIOL, V212, P4033, DOI 10.1242/jeb.033266; Ren XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051188; Reuner A, 2010, CELL STRESS CHAPERON, V15, P423, DOI 10.1007/s12192-009-0158-1; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Salmela L, 2010, BIOINFORMATICS, V26, P1284, DOI 10.1093/bioinformatics/btq151; Schill RO, 2004, J EXP BIOL, V207, P1607, DOI 10.1242/jeb.00935; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Shirkey B, 2003, NUCLEIC ACIDS RES, V31, P2995, DOI 10.1093/nar/gkg404; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Singh J, 2005, APPL ENVIRON MICROB, V71, P8752, DOI 10.1128/AEM.71.12.8752-8763.2005; Tunnacliffe A, 2005, HYDROBIOLOGIA, V546, P315, DOI 10.1007/s10750-005-4239-6; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Tyson Trevor, 2012, BMC Research Notes, V5, P68, DOI 10.1186/1756-0500-5-68; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019; Willsie JK, 2001, J EXP BIOL, V204, P2339; Wolkers WF, 2002, COMP BIOCHEM PHYS A, V131, P535, DOI 10.1016/S1095-6433(01)00505-0; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044209; Yang XA, 2010, BIOINFORMATICS, V26, P2526, DOI 10.1093/bioinformatics/btq468; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	100	34	35	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92663	10.1371/journal.pone.0092663	http://dx.doi.org/10.1371/journal.pone.0092663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651535	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800139
J	Liu, Z; Zhan, Y; Tu, Y; Chen, K; Liu, Z; Wu, C				Liu, Z.; Zhan, Y.; Tu, Y.; Chen, K.; Liu, Z.; Wu, C.			PDZ and LIM domain protein 1(PDLIM1)/CLP36 promotes breast cancer cell migration, invasion and metastasis through interaction with alpha-actinin	ONCOGENE			English	Article							RHO-GTPASES; GENE AMPLIFICATION; STRESS FIBERS; ADHESION; CLP36; ALPHA-ACTININ-1; MOTILITY; ACTIVATION; EXPRESSION; MIGFILIN	Increased CLP36 expression has been found to be closely associated with breast cancer progression. However, whether and how it contributes to malignant behavior of breast cancer cells were not known. We show here that CLP36 is critical for promoting breast cancer cell migration and invasion in vitro and metastasis in vivo, whereas it is dispensable for breast cell proliferation and anchorage-independent growth in vitro and tumor growth in vivo. CLP36 interacted with both alpha-actinin-1 and -4 in breast cancer cells. Depletion of either alpha-actinin-1 or -4 inhibited breast cancer cell migration. Furthermore, mutations inhibiting the a-actinin-binding activity abolished the ability of CLP36 to promote breast cancer cell migration. Finally, depletion of CLP36 or disruption of the CLP36-alpha-actinin complex in breast cancer cells substantially inhibited Cdc42 activation, cell polarization and migration. Our results identify CLP36 as an important regulator of breast cancer cell migration and metastasis, and shed light on how increased CLP36 expression contributes to the progression of breast cancer.	[Liu, Z.; Tu, Y.; Chen, K.; Wu, C.] Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15261 USA; [Zhan, Y.; Liu, Z.] Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Wu, C.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, C (corresponding author), Univ Pittsburgh, Dept Pathol, Sch Med, 3550 Terrace St,707B Scaife Hall, Pittsburgh, PA 15261 USA.	carywu@pitt.edu			NIH [GM65188]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grant GM65188 to CW.	Bauer K, 2000, BLOOD, V96, P4236; Bouzahzah B, 2001, MOL MED, V7, P816, DOI 10.1007/BF03401974; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Klaavuniemi T, 2004, J BIOL CHEM, V279, P26402, DOI 10.1074/jbc.M401871200; Liu ZM, 2011, J BIOL CHEM, V286, P30795, DOI 10.1074/jbc.M111.255984; Miyazaki K, 2012, EXP CELL RES, V318, P1716, DOI 10.1016/j.yexcr.2012.05.006; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Pichot CS, 2010, CANCER RES, V70, P8347, DOI 10.1158/0008-5472.CAN-09-4149; Pitteri SJ, 2011, CANCER RES, V71, P5090, DOI 10.1158/0008-5472.CAN-11-0568; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; Shi XH, 2008, MOL CANCER RES, V6, P715, DOI 10.1158/1541-7786.MCR-07-2026; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Tamura N, 2007, BIOCHEM BIOPH RES CO, V364, P589, DOI 10.1016/j.bbrc.2007.10.064; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Uehara N, 2008, MOL CANCER RES, V6, P186, DOI 10.1158/1541-7786.MCR-07-0254; Vallenius T, 2004, EXP CELL RES, V293, P117, DOI 10.1016/j.yexcr.2003.09.004; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; Velthuis AJWT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000189; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Zhang YJ, 2006, J BIOL CHEM, V281, P12397, DOI 10.1074/jbc.M512107200	30	31	33	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2015	34	10					1300	1311		10.1038/onc.2014.64	http://dx.doi.org/10.1038/onc.2014.64			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC9JX	24662836	Green Accepted			2022-12-25	WOS:000350687100010
J	Okumoto, K; Noda, H; Fujiki, Y				Okumoto, Kanji; Noda, Hiromi; Fujiki, Yukio			Distinct Modes of Ubiquitination of Peroxisome-targeting Signal Type 1 ( PTS1) Receptor Pex5p Regulate PTS1 Protein Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Peroxisomes; Protein Targeting; Ubiquitin; Ubiquitin Ligase; Ubiquitination; Pex5p; RING Peroxins; Peroxisome Biogenesis	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; DEFICIENT ZELLWEGER-SYNDROME; OVARY CELL MUTANTS; BIOGENESIS DISORDERS; MEMBRANE-PROTEIN; FUNCTIONAL COMPLEMENTATION; 3-KETOACYL-COA THIOLASE; CONSERVED CYSTEINE; CYCLING RECEPTOR; MATRIX PROTEINS	Background: Pex5p translocates the cargo proteins into peroxisomes. Results: Mammalian RING peroxins, the Pex10pPex12p complex, catalyze Lys-linked, multiple monoubiquitination of Pex5p, assuring efficient export of Pex5p from peroxisomes. Conclusion: Distinct Lys- and Cys-linked modes of Pex5p ubiquitination control Pex5p-mediated matrix protein import. Significance: This work provides the first evidence of a functional role of mammalian RING peroxins in Pex5p ubiquitination. Peroxisome targeting signal type-1 (PTS1) receptor, Pex5p, is a key player in peroxisomal matrix protein import. Pex5p recognizes PTS1 cargoes in the cytosol, targets peroxisomes, translocates across the membrane, unloads the cargoes, and shuttles back to the cytosol. Ubiquitination of Pex5p at a conserved cysteine is required for the exit from peroxisomes. However, any potential ubiquitin ligase (E3) remains unidentified in mammals. Here, we establish an in vitro ubiquitination assay system and demonstrate that RING finger Pex10p functions as an E3 with an E2, UbcH5C. The E3 activity of Pex10p is essential for its peroxisome-restoring activity, being enhanced by another RING peroxin, Pex12p. The Pex10pPex12p complex catalyzes monoubiquitination of Pex5p at one of multiple lysine residues in vitro, following the dissociation of Pex5p from Pex14p and the PTS1 cargo. Several lines of evidence with lysine-to-arginine mutants of Pex5p demonstrate that Pex10p RING E3-mediated ubiquitination of Pex5p is required for its efficient export from peroxisomes to the cytosol and peroxisomal matrix protein import. RING peroxins are required for both modes of Pex5p ubiquitination, thus playing a pivotal role in Pex5p shuttling.	[Okumoto, Kanji; Noda, Hiromi; Fujiki, Yukio] Kyushu Univ, Grad Sch, Dept Biol, Fac Sci, Fukuoka 8128581, Japan; [Okumoto, Kanji] Kyushu Univ, Grad Sch, Grad Sch Syst Life Sci, Fukuoka 8128581, Japan	Kyushu University; Kyushu University	Fujiki, Y (corresponding author), Kyushu Univ, Grad Sch, Dept Biol, Fac Sci,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	yfujiki@kyudai.jp			Global Centers of Excellence Program; Ministry of Education, Culture, Sports, Science, and Technology of Japan; SORST grant from the Science and Technology Agency of Japan; CREST grant from the Science and Technology Agency of Japan; Takeda Science Foundation; Japanese Foundation for Applied Enzymology;  [19058011];  [20370039];  [24247038];  [25112518];  [1977087];  [21770117];  [24770130]; Grants-in-Aid for Scientific Research [24770130] Funding Source: KAKEN	Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SORST grant from the Science and Technology Agency of Japan; CREST grant from the Science and Technology Agency of Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Foundation for Applied Enzymology; ; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research 19058011, 20370039, 24247038, and 25112518 (to Y. F.) and 1977087, 21770117, and 24770130 (to K. O.), the Global Centers of Excellence Program, and Grants for Excellent Graduate Schools from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; SORST and CREST grants (to Y. F.) from the Science and Technology Agency of Japan; and grants (to Y. F.) from the Takeda Science Foundation and the Japanese Foundation for Applied Enzymology.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Akiyama N, 2002, BIOCHEM BIOPH RES CO, V293, P1523, DOI 10.1016/S0006-291X(02)00419-9; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Chang CC, 1999, J CELL BIOL, V147, P761, DOI 10.1083/jcb.147.4.761; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; El Magraoui F, 2013, TRAFFIC, V14, P1290, DOI 10.1111/tra.12120; El Magraoui F, 2012, FEBS J, V279, P2060, DOI 10.1111/j.1742-4658.2012.08591.x; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Fukuda S, 1996, AM J HUM GENET, V59, P1210; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Harano T, 1999, J BIOCHEM-TOKYO, V125, P1168, DOI 10.1093/oxfordjournals.jbchem.a022400; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hazra PP, 2002, TRAFFIC, V3, P560, DOI 10.1034/j.1600-0854.2002.30806.x; Hensel A, 2011, J BIOL CHEM, V286, P43495, DOI 10.1074/jbc.M111.286104; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Itoh R, 2006, J BIOL CHEM, V281, P10196, DOI 10.1074/jbc.M600158200; Kaur N, 2013, J INTEGR PLANT BIOL, V55, P108, DOI 10.1111/jipb.12014; Kiel JAKW, 2005, BBA-MOL CELL RES, V1745, P176, DOI 10.1016/j.bbamcr.2005.01.004; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Lazarow PB, 2003, CURR OPIN CELL BIOL, V15, P489, DOI 10.1016/S0955-0674(03)00082-6; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; Liu XQ, 2013, J BIOL CHEM, V288, P7230, DOI 10.1074/jbc.M112.424911; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Matsumoto N, 2003, AM J HUM GENET, V73, P233, DOI 10.1086/377004; MIURA S, 1992, J BIOL CHEM, V267, P14405; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Miyata N, 2012, TRAFFIC, V13, P168, DOI 10.1111/j.1600-0854.2011.01298.x; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Noguchi M, 2013, GENES CELLS, V18, P476, DOI 10.1111/gtc.12051; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Okumoto K, 1997, NAT GENET, V17, P265, DOI 10.1038/ng1197-265; Okumoto K, 1998, HUM MOL GENET, V7, P1399, DOI 10.1093/hmg/7.9.1399; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, FEBS LETT, V581, P2811, DOI 10.1016/j.febslet.2007.04.001; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; Shimozawa N, 1999, BIOCHEM BIOPH RES CO, V262, P504, DOI 10.1006/bbrc.1999.1232; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; Toyama R, 1999, HUM MOL GENET, V8, P1673, DOI 10.1093/hmg/8.9.1673; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Warren DS, 1998, AM J HUM GENET, V63, P347, DOI 10.1086/301963; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Williams C, 2008, BIOCHEM BIOPH RES CO, V374, P620, DOI 10.1016/j.bbrc.2008.07.054; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200	76	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14089	14108		10.1074/jbc.M113.527937	http://dx.doi.org/10.1074/jbc.M113.527937			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24662292	Green Published, hybrid			2022-12-25	WOS:000335984600038
J	Codeluppi, S; Fernandez-Zafra, T; Sandor, K; Kjell, J; Liu, QS; Abrams, M; Olson, L; Gray, NS; Svensson, CI; Uhlen, P				Codeluppi, Simone; Fernandez-Zafra, Teresa; Sandor, Katalin; Kjell, Jacob; Liu, Qingsong; Abrams, Mathew; Olson, Lars; Gray, Nathanael S.; Svensson, Camilla I.; Uhlen, Per			Interleukin-6 Secretion by Astrocytes Is Dynamically Regulated by PI3K-mTOR-Calcium Signaling	PLOS ONE			English	Article							SPINAL-CORD-INJURY; GENE-EXPRESSION; MESSENGER-RNA; IMMUNE-RESPONSES; SMOOTH-MUSCLE; REGENERATION; RAPAMYCIN; RECEPTOR; RELEASE; PATHWAY	After contusion spinal cord injury (SCI), astrocytes become reactive and form a glial scar. While this reduces spreading of the damage by containing the area of injury, it inhibits regeneration. One strategy to improve the recovery after SCI is therefore to reduce the inhibitory effect of the scar, once the acute phase of the injury has passed. The pleiotropic cytokine interleukin-6 (IL-6) is secreted immediately after injury and regulates scar formation; however, little is known about the role of IL-6 in the sub-acute phases of SCI. Interestingly, IL-6 also promotes axon regeneration, and therefore its induction in reactive astrocytes may improve regeneration after SCI. We found that IL-6 is expressed by astrocytes and neurons one week post-injury and then declines. Using primary cultures of rat astrocytes we delineated the molecular mechanisms that regulate IL-6 expression and secretion. IL-6 expression requires activation of p38 and depends on NF-kappa B transcriptional activity. Activation of these pathways in astrocytes occurs when the PI3K-mTOR-AKT pathway is inhibited. Furthermore, we found that an increase in cytosolic calcium concentration was necessary for IL-6 secretion. To induce IL-6 secretion in astrocytes, we used torin2 and rapamycin to block the PI3K-mTOR pathway and increase cytosolic calcium, respectively. Treating injured animals with torin2 and rapamycin for two weeks, starting two weeks after injury when the scar has been formed, lead to a modest effect on mechanical hypersensitivity, limited to the period of treatment. These data, taken together, suggest that treatment with torin2 and rapamycin induces IL-6 secretion by astrocytes and may contribute to the reduction of mechanical hypersensitivity after SCI.	[Codeluppi, Simone; Fernandez-Zafra, Teresa; Uhlen, Per] Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden; [Sandor, Katalin; Svensson, Camilla I.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Kjell, Jacob; Abrams, Mathew; Olson, Lars] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Liu, Qingsong; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Liu, Qingsong; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Codeluppi, S (corresponding author), Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden.	simone.codeluppi@ki.se	Kjell, Jacob/HDN-4979-2022; Liu, Qingsong/AFS-0714-2022; 刘, 青松/AEM-1932-2022; codeluppi, simone/I-4143-2012; svensson, camilla/C-9511-2014	Liu, Qingsong/0000-0002-7829-2547; 刘, 青松/0000-0002-7829-2547; codeluppi, simone/0000-0002-7053-0520; Uhlen, Per/0000-0003-1446-1062; svensson, camilla/0000-0001-7980-4631; Kjell, Jacob/0000-0002-8335-0780	Wenner-Gren foundation; Svenska Sallskapet for Medicinsk Forskning; Becas Talentia; Hjarnfonden; Swedish Research Council; Linnaeus Center in Developmental Biology for Regenerative Medicine; Knut and Alice Wallenberg Foundation; Royal Swedish Academy of Sciences; Wings for Life; Vinnova; Karolinska Distinguished Professor Award; Karolinska StratNeuro program	Wenner-Gren foundation; Svenska Sallskapet for Medicinsk Forskning; Becas Talentia; Hjarnfonden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Linnaeus Center in Developmental Biology for Regenerative Medicine; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Royal Swedish Academy of Sciences; Wings for Life; Vinnova(Vinnova); Karolinska Distinguished Professor Award; Karolinska StratNeuro program	This work was supported by: Wenner-Gren foundation (SC, KS), Svenska Sallskapet for Medicinsk Forskning (SC), Becas Talentia (TFZ), Hjarnfonden (SC, PU), Swedish Research Council (CS, PU, LO), Linnaeus Center in Developmental Biology for Regenerative Medicine (PU), the Knut and Alice Wallenberg Foundation Grant to Center of Live Imaging of Cells at Karolinska Institutet (PU), the Royal Swedish Academy of Sciences (PU), Wings for Life (LO, MA), Vinnova (LO), Karolinska Distinguished Professor Award (LO), Karolinska StratNeuro program (LO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BENVENISTE EN, 1990, J NEUROIMMUNOL, V30, P201, DOI 10.1016/0165-5728(90)90104-U; Blum S, 2001, J BIOL CHEM, V276, P33428, DOI 10.1074/jbc.M105474200; Boyle DL, 2003, ARTHRITIS RES THER, V5, pR352, DOI 10.1186/ar1004; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Codeluppi S, 2011, J NEUROSCI METH, V197, P118, DOI 10.1016/j.jneumeth.2011.02.011; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Ducreux S, 2004, J BIOL CHEM, V279, P43838, DOI 10.1074/jbc.M403612200; Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200; Guha M, 2002, J BIOL CHEM; Guptarak J, 2013, PAIN; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Jeong HJ, 2002, CELL SIGNAL, V14, P633, DOI 10.1016/S0898-6568(02)00005-0; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Keller Evan T., 1996, Frontiers in Bioscience (online), V1, pD340; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v; Ljosa V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000603; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MacMillan D, 2005, J CELL SCI, V118, P5443, DOI 10.1242/jcs.02657; MacMillan D, 2009, BRIT J PHARMACOL, V158, P1112, DOI 10.1111/j.1476-5381.2009.00369.x; Matyash M, 2001, FASEB J; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Okada S, 2009, IEEE INTELEC     OCT, P1; Okada S., 2008, INFLAMM REGEN, V28, P440, DOI [10.2492/inflammregen.28.440, DOI 10.2492/INFLAMMREGEN.28.440]; Onifer SM, 2007, ILAR J, V48, P385, DOI 10.1093/ilar.48.4.385; Parpura V, 2010, NEUROCHEM INT, V57, P451, DOI 10.1016/j.neuint.2010.02.007; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwartz M, 1999, TRENDS NEUROSCI, V22, P295, DOI 10.1016/S0166-2236(99)01405-8; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Snyder SH, 1998, NEURON, V21, P283, DOI 10.1016/S0896-6273(00)80538-3; Stammers AT, 2012, J NEUROSCI RES, V90, P782, DOI 10.1002/jnr.22820; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Sun J, 2011, J BIOL CHEM, V286, P6791, DOI 10.1074/jbc.M110.172882; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Weichhart T, 2011, BLOOD, V117, P4273, DOI 10.1182/blood-2010-09-310888; Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001; Yang P, 2012, EXP NEUROL, V236, P19, DOI 10.1016/j.expneurol.2012.03.019; Zhao W, 2008, J BIOL CHEM, V283, P1778, DOI 10.1074/jbc.M707573200; Zhu XL, 1999, CYTOKINE, V11, P696, DOI 10.1006/cyto.1998.0479	56	27	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92649	10.1371/journal.pone.0092649	http://dx.doi.org/10.1371/journal.pone.0092649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667246	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600061
J	El-Khoury, R; Panayotis, N; Matagne, V; Ghata, A; Villard, L; Roux, JC				El-Khoury, Rita; Panayotis, Nicolas; Matagne, Valerie; Ghata, Adeline; Villard, Laurent; Roux, Jean-Christophe			GABA and Glutamate Pathways Are Spatially and Developmentally Affected in the Brain of Mecp2-Deficient Mice	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; SYNAPTIC CIRCUIT ABNORMALITIES; 2/3 PYRAMIDAL NEURONS; RETT-SYNDROME; MOUSE MODEL; HIPPOCAMPAL SLICES; MECP2-NULL MOUSE; DECARBOXYLASE; RAT; NEUROTRANSMISSION	Proper brain functioning requires a fine-tuning between excitatory and inhibitory neurotransmission, a balance maintained through the regulation and release of glutamate and GABA. Rett syndrome (RTT) is a rare genetic disorder caused by mutations in the methyl-CpG binding protein 2 (MECP2) gene affecting the postnatal brain development. Dysfunctions in the GABAergic and glutamatergic systems have been implicated in the neuropathology of RTT and a disruption of the balance between excitation and inhibition, together with a perturbation of the electrophysiological properties of GABA and glutamate neurons, were reported in the brain of the Mecp2-deficient mouse. However, to date, the extent and the nature of the GABA/glutamate deficit affecting the Mecp2-deficient mouse brain are unclear. In order to better characterize these deficits, we simultaneously analyzed the GABA and glutamate levels in Mecp2-deficient mice at 2 different ages (P35 and P55) and in several brain areas. We used a multilevel approach including the quantification of GABA and glutamate levels, as well as the quantification of the mRNA and protein expression levels of key genes involved in the GABAergic and glutamatergic pathways. Our results show that Mecp2-deficient mice displayed regional- and age-dependent variations in the GABA pathway and, to a lesser extent, in the glutamate pathway. The implication of the GABA pathway in the RTT neuropathology was further confirmed using an in vivo treatment with a GABA reuptake inhibitor that significantly improved the lifespan of Mecp2-deficient mice. Our results confirm that RTT mouse present a deficit in the GABAergic pathway and suggest that GABAergic modulators could be interesting therapeutic agents for this severe neurological disorder.	[El-Khoury, Rita; Panayotis, Nicolas; Matagne, Valerie; Ghata, Adeline; Villard, Laurent; Roux, Jean-Christophe] Aix Marseille Univ, GMGF, Marseille, France; [El-Khoury, Rita; Panayotis, Nicolas; Matagne, Valerie; Ghata, Adeline; Villard, Laurent; Roux, Jean-Christophe] INSERM, UMR S 910, F-13258 Marseille, France; [Panayotis, Nicolas] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Weizmann Institute of Science	Roux, JC (corresponding author), Aix Marseille Univ, GMGF, Marseille, France.	jean-christophe.roux@univ-amu.fr	Roux, Jean-Christophe/S-2563-2016; Panayotis, Nicolas/N-3412-2019; Villard, Laurent/E-3941-2016; Panayotis, Nicolas/E-6734-2015	Roux, Jean-Christophe/0000-0002-9721-8844; Panayotis, Nicolas/0000-0002-6204-6771; Villard, Laurent/0000-0001-6657-5008; Panayotis, Nicolas/0000-0002-6204-6771; EL KHOURY, RITA/0000-0002-5132-5038	Inserm; Aix-Marseille University; region Provence-Alpes-Cote d'Azur; AFSR (Association Francaise du Syndrome de Rett); ANR Rett cure; UE Initial Training Network [238242]; INSERM-Region Provence-Alpes-Cote d'Azur; French Muscular Dystrophy Association (AFM-Telethon)	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Aix-Marseille University; region Provence-Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'Azur); AFSR (Association Francaise du Syndrome de Rett); ANR Rett cure(French National Research Agency (ANR)); UE Initial Training Network; INSERM-Region Provence-Alpes-Cote d'Azur(Institut National de la Sante et de la Recherche Medicale (Inserm)Region Provence-Alpes-Cote d'Azur); French Muscular Dystrophy Association (AFM-Telethon)	This work was funded by Inserm, Aix-Marseille University, the region Provence-Alpes-Cote d'Azur, AFSR (Association Francaise du Syndrome de Rett) and was supported in part by funding from the ANR Rett cure. Rita El-Khoury was supported by the UE Initial Training Network Project no238242 "DISCHROM", Dr Nicolas Panayotis was supported by an INSERM-Region Provence-Alpes-Cote d'Azur PhD fellowship and Valerie Matagne was supported by the French Muscular Dystrophy Association (AFM-Telethon). The different funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala APL, 2010, P NATL ACAD SCI USA, V107, P18208, DOI 10.1073/pnas.1012104107; Akbarian S, 2001, NEUROBIOL DIS, V8, P784, DOI 10.1006/nbdi.2001.0420; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Buddhala C, 2009, NEUROCHEM INT, V55, P9, DOI 10.1016/j.neuint.2009.01.020; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; CHANG YC, 1988, J NEUROSCI, V8, P2123; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chatton JY, 2003, P NATL ACAD SCI USA, V100, P12456, DOI 10.1073/pnas.2132096100; COENEN AML, 1995, EPILEPSY RES, V21, P89, DOI 10.1016/0920-1211(95)00015-3; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Fischer M, 2009, J NEUROPHYSIOL, V101, P1016, DOI 10.1152/jn.91124.2008; Guerrini R, 2012, EPILEPSIA, V53, P2067, DOI 10.1111/j.1528-1167.2012.03656.x; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Ide S, 2005, NEUROSCI LETT, V386, P14, DOI 10.1016/j.neulet.2005.05.056; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kline DD, 2010, J NEUROSCI, V30, P5303, DOI 10.1523/JNEUROSCI.5503-09.2010; Kron M, 2012, J NEUROSCI, V32, P13860, DOI 10.1523/JNEUROSCI.2159-12.2012; Kullmann DM, 2011, CURR OPIN NEUROBIOL, V21, P709, DOI 10.1016/j.conb.2011.05.006; Lang M, 2013, HUM MOL GENET, V22, P358, DOI 10.1093/hmg/dds433; Lee M, 2011, GLIA, V59, P1600, DOI 10.1002/glia.21202; Lerner A, 2012, BRAIN, V135, P1926, DOI 10.1093/brain/aws104; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madsen KK, 2010, PHARMACOL THERAPEUT, V125, P394, DOI 10.1016/j.pharmthera.2009.11.007; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Mathews GC, 2003, J NEUROSCI, V23, P2040; McDonald LM, 2008, PSYCHOPHARMACOLOGY, V197, P591, DOI 10.1007/s00213-008-1077-z; Medrihan L, 2008, J NEUROPHYSIOL, V99, P112, DOI 10.1152/jn.00826.2007; Mel Bartlett W, 2004, Sci STKE, V2004, pPE44; Minh VCN, 2012, J NEUROSCI, V32, P10021, DOI 10.1523/JNEUROSCI.1316-12.2012; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Nelson ED, 2011, J NEUROPHYSIOL, V106, P193, DOI 10.1152/jn.00751.2010; Obata K, 1999, NEUROSCIENCE, V93, P1475, DOI 10.1016/S0306-4522(99)00274-2; Okabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035354; Palkovits N, 1988, MAPS GUIDE MICRODISS; Panayotis N, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-47; Panayotis N, 2011, NEUROBIOL DIS, V41, P385, DOI 10.1016/j.nbd.2010.10.006; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pratte M, 2011, BEHAV BRAIN RES, V216, P313, DOI 10.1016/j.bbr.2010.08.011; Ricceri L, 2008, BEHAV PHARMACOL, V19, P501, DOI 10.1097/FBP.0b013e32830c3645; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Roux JC, 2003, J NEURAL TRANSM, V110, P51, DOI 10.1007/s00702-002-0767-7; Roux JC, 2012, NEUROBIOL DIS, V45, P786, DOI 10.1016/j.nbd.2011.11.002; Roux JC, 2010, J NEUROSCI RES, V88, P1500, DOI 10.1002/jnr.22312; Roux JC, 2010, BEHAV GENET, V40, P59, DOI 10.1007/s10519-009-9303-y; Roux JC, 2008, NEUROSCI LETT, V447, P82, DOI 10.1016/j.neulet.2008.09.045; Rowley NM, 2012, NEUROCHEM INT, V61, P546, DOI 10.1016/j.neuint.2012.02.013; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Santos M, 2010, NEUROSCIENCE, V170, P453, DOI 10.1016/j.neuroscience.2010.07.010; Sauvinet V, 2003, ELECTROPHORESIS, V24, P3187, DOI 10.1002/elps.200305565; Schousboe A, 2006, CURR TOP MED CHEM, V6, P929, DOI 10.2174/156802606777323719; SHERIF F, 1991, J NEURAL TRANSM-GEN, V84, P95, DOI 10.1007/BF01249113; Sloviter RS, 1996, J COMP NEUROL, V373, P593; Stanley BG, 2011, PHYSIOL BEHAV, V104, P40, DOI 10.1016/j.physbeh.2011.04.046; Stettner GM, 2007, J PHYSIOL-LONDON, V579, P863, DOI 10.1113/jphysiol.2006.119966; Taneja P, 2009, J NEUROSCI, V29, P12187, DOI 10.1523/JNEUROSCI.3156-09.2009; Thoeringer CK, 2010, J PSYCHOPHARMACOL, V24, P733, DOI 10.1177/0269881109103091; Viemari JC, 2005, J NEUROSCI, V25, P11521, DOI 10.1523/JNEUROSCI.4373-05.2005; Viola A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000157; Wood L, 2010, NEUROBIOL DIS, V38, P281, DOI 10.1016/j.nbd.2010.01.018; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389; Zhang ZW, 2010, J NEUROPHYSIOL, V103, P2470, DOI 10.1152/jn.00601.2009	73	40	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92169	10.1371/journal.pone.0092169	http://dx.doi.org/10.1371/journal.pone.0092169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667344	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600025
J	Alvarez, Y; Esteban-Torres, M; Cortes-Cabrera, A; Gago, F; Acebron, I; Benavente, R; Mardo, K; de las Rivas, B; Munoz, R; Mancheno, JM				Alvarez, Yanaisis; Esteban-Torres, Maria; Cortes-Cabrera, Alvaro; Gago, Federico; Acebron, Ivan; Benavente, Rocio; Mardo, Karin; de las Rivas, Blanca; Munoz, Rosario; Mancheno, Jose M.			Esterase LpEst1 from Lactobacillus plantarum: A Novel and Atypical Member of the alpha beta Hydrolase Superfamily of Enzymes	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; CRYSTAL-STRUCTURE; BACTERIAL HOMOLOG; FOLD ENZYMES; CARBOXYLESTERASE; PROTEINS; ACETYLCHOLINESTERASE; PURIFICATION; SUBFAMILY	The genome of the lactic acid bacterium Lactobacillus plantarum WCFS1 reveals the presence of a rich repertoire of esterases and lipases highlighting their important role in cellular metabolism. Among them is the carboxylesterase LpEst1 a bacterial enzyme related to the mammalian hormone-sensitive lipase, which is known to play a central role in energy homeostasis. In this study, the crystal structure of LpEst1 has been determined at 2.05 angstrom resolution; it exhibits an alpha beta-hydrolase fold, consisting of a central beta-sheet surrounded by alpha-helices, endowed with novel topological features. The structure reveals a dimeric assembly not comparable with any other enzyme from the bacterial hormone-sensitive lipase family, probably echoing the specific structural features of the participating subunits. Biophysical studies including analytical gel filtration and ultracentrifugation support the dimeric nature of LpEst1. Structural and mutational analyses of the substrate-binding pocket and active site together with biochemical studies provided insights for understanding the substrate profile of LpEst1 and suggested for the first time the conserved Asp173, which is adjacent to the nucleophile, as a key element in the stabilization of the loop where the oxyanion hole resides.	[Alvarez, Yanaisis; Acebron, Ivan; Benavente, Rocio; Mancheno, Jose M.] CSIC, Dept Crystallog & Struct Biol, Inst Phys Chem Rocasolano, Madrid, Spain; [Alvarez, Yanaisis] CITMA, Ctr Adv Studies Cuba, Havana, Cuba; [Esteban-Torres, Maria; de las Rivas, Blanca; Munoz, Rosario] CSIC, Lab Bacterial Biotechnol, Inst Food Sci & Technol & Nutr ICTAN, Madrid, Spain; [Cortes-Cabrera, Alvaro; Gago, Federico] Univ Alcala, Sch Med & Hlth Sci, Dept Biomed Sci, Madrid, Spain; [Mardo, Karin] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); Universidad de Alcala; University of Tartu	Mancheno, JM (corresponding author), CSIC, Dept Crystallog & Struct Biol, Inst Phys Chem Rocasolano, Madrid, Spain.	xjosemi@iqfr.csic.es	Esteban-Torres, Maria/AAA-8621-2020; Muñoz, Rosario/H-8597-2012; Ernits, Karin/F-5511-2019; Esteban-Torres, María/AAT-6046-2020; Gago, Federico/H-1004-2015; Gago, Federico/AAS-3992-2020; Ernits, Karin/X-4427-2019; Mancheno, Jose/K-4984-2014; de las Rivas, Blanca/K-3899-2014; Cortes Cabrera, Alvaro/B-3748-2016	Muñoz, Rosario/0000-0003-4170-9713; Ernits, Karin/0000-0003-1072-4945; Esteban-Torres, María/0000-0001-8433-5729; Gago, Federico/0000-0002-3071-4878; Gago, Federico/0000-0002-3071-4878; Ernits, Karin/0000-0003-1072-4945; Mancheno, Jose/0000-0001-6943-3291; de las Rivas, Blanca/0000-0002-8357-5226; Cortes Cabrera, Alvaro/0000-0003-4635-6267; Acebron, Ivan/0000-0003-0397-1550	Ministerio de Economia y Competitividad [BFU2010-17929/BMC]; Factoria de Cristalizacion (Consolider-Ingenio) [AGL2011-22745, FUN-C-FOOD Consolider 25506]	Ministerio de Economia y Competitividad(Spanish Government); Factoria de Cristalizacion (Consolider-Ingenio)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Ministerio de Economia y Competitividad (BFU2010-17929/BMC) and the Factoria de Cristalizacion (Consolider-Ingenio-2007) (to Jose M. Mancheno), and AGL2011-22745 and FUN-C-FOOD Consolider 25506 (to Rosario Munoz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alvarez Y, 2011, ACTA CRYSTALLOGR F, V67, P1436, DOI 10.1107/S1744309111036682; Angkawidjaja C, 2012, FEBS J, V279, P3071, DOI 10.1111/j.1742-4658.2012.08687.x; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Benavente R, 2013, FEBS J, V280, P6658, DOI 10.1111/febs.12569; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; Byun JS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-47; Case D.A., 2012, AMBER; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole JL, 2009, HETEROANALYSIS; Cabrera AC, 2012, J CHEM INF MODEL, V52, P2300, DOI 10.1021/ci300194a; de las Rivas B, 2007, BIOTECHNOL PROGR, V23, P680, DOI 10.1021/bp060318g; De Simone G, 2000, J MOL BIOL, V303, P761, DOI 10.1006/jmbi.2000.4195; De Simone G, 2001, J MOL BIOL, V314, P507, DOI 10.1006/jmbi.2001.5152; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fenster KM, 2003, J DAIRY SCI, V86, P1118, DOI 10.3168/jds.S0022-0302(03)73694-7; Fojan P, 2000, BIOCHIMIE, V82, P1033, DOI 10.1016/S0300-9084(00)01188-3; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gobbetti M, 1996, J FOOD BIOCHEM, V20, P227, DOI 10.1111/j.1745-4514.1996.tb00553.x; Gobbetti M, 1997, J DAIRY SCI, V80, P3099, DOI 10.3168/jds.S0022-0302(97)76280-5; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Hasan F, 2009, BIOTECHNOL ADV, V27, P782, DOI 10.1016/j.biotechadv.2009.06.001; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; HEMILA H, 1994, BBA-LIPID LIPID MET, V1210, P249, DOI 10.1016/0005-2760(94)90129-5; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hotelier T, 2004, NUCLEIC ACIDS RES, V32, pD145, DOI 10.1093/nar/gkh141; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klett J, 2012, J CHEM THEORY COMPUT, V8, P3395, DOI 10.1021/ct300497z; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue TM, 1992, BIOCH POLYM SCI; Liu AMF, 2001, TETRAHEDRON-ASYMMETR, V12, P545, DOI 10.1016/S0957-4166(01)00072-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morreale A, 2007, PROTEINS, V67, P606, DOI 10.1002/prot.21269; Nam KH, 2009, BIOCHEM BIOPH RES CO, V379, P553, DOI 10.1016/j.bbrc.2008.12.085; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Ngo TD, 2013, ACTA CRYSTALLOGR D, V69, P1726, DOI 10.1107/S0907444913013425; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Palm GJ, 2011, APPL MICROBIOL BIOT, V91, P1061, DOI 10.1007/s00253-011-3337-9; Powell HR, 2011, ACTA CRYSTALLOGR D, VD69, P1195; Redinbo MR, 2005, DRUG DISCOV TODAY, V10, P313, DOI 10.1016/S1359-6446(05)03383-0; Reis P, 2009, ADV COLLOID INTERFAC, V147-48, P237, DOI 10.1016/j.cis.2008.06.001; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Toone Eric J, 2011, Adv Enzymol Relat Areas Mol Biol, V78, pix; Wei YY, 1999, NAT STRUCT BIOL, V6, P340; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhu XY, 2003, J BIOL CHEM, V278, P2008, DOI 10.1074/jbc.M210103200	57	18	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92257	10.1371/journal.pone.0092257	http://dx.doi.org/10.1371/journal.pone.0092257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663330	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900048
J	Kobayashi, Y; Sanno, Y; Sakai, A; Sawabu, Y; Tsutsumi, M; Goto, M; Kitahata, H; Nakata, S; Kumamoto, J; Denda, M; Nagayama, M				Kobayashi, Yasuaki; Sanno, Yumi; Sakai, Akihiko; Sawabu, Yusuke; Tsutsumi, Moe; Goto, Makiko; Kitahata, Hiroyuki; Nakata, Satoshi; Kumamoto, Junichi; Denda, Mitsuhiro; Nagayama, Masaharu			Mathematical Modeling of Calcium Waves Induced by Mechanical Stimulation in Keratinocytes	PLOS ONE			English	Article							INTRACELLULAR CALCIUM; OSCILLATIONS; PROPAGATION; MUTATIONS; EPIDERMIS; BARRIER; PUMP	Recent studies have shown that the behavior of calcium in the epidermis is closely related to the conditions of the skin, especially the differentiation of the epidermal keratinocytes and the permeability barrier function, and therefore a correct understanding of the calcium dynamics is important in explaining epidermal homeostasis. Here we report on experimental observations of in vitro calcium waves in keratinocytes induced by mechanical stimulation, and present a mathematical model that can describe the experimentally observed wave behavior that includes finite-range wave propagation and a ring-shaped pattern. A mechanism of the ring formation hypothesized by our model may be related to similar calcium propagation patterns observed during the wound healing process in the epidermis. We discuss a possible extension of our model that may serve as a tool for investigating the mechanisms of various skin diseases.	[Kobayashi, Yasuaki; Sawabu, Yusuke; Nagayama, Masaharu] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan; [Kobayashi, Yasuaki; Kumamoto, Junichi; Denda, Mitsuhiro; Nagayama, Masaharu] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Sanno, Yumi; Sakai, Akihiko] Kanazawa Univ, Grad Sch Sci & Technol, Kanazawa, Ishikawa, Japan; [Tsutsumi, Moe; Goto, Makiko; Kumamoto, Junichi; Denda, Mitsuhiro] Shiseido Co Ltd, Shiseido Res Ctr, Yokohama, Kanagawa, Japan; [Kitahata, Hiroyuki] Chiba Univ, Dept Phys, Grad Sch Sci, Chiba 260, Japan; [Nakata, Satoshi] Hiroshima Univ, Grad Sch Sci, Higashihiroshima 724, Japan	Hokkaido University; Japan Science & Technology Agency (JST); Kanazawa University; Shiseido Company, Limited; Chiba University; Hiroshima University	Nagayama, M (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan.	nagayama@es.hokudai.ac.jp	Kitahata, Hiroyuki/E-8635-2015; Nakata, Satoshi/T-4225-2017; Kitahata, Hiroyuki/AGZ-4066-2022; Nagayama, Masaharu/D-6759-2012	Kitahata, Hiroyuki/0000-0003-3453-9883; Nakata, Satoshi/0000-0002-7290-1508; Kitahata, Hiroyuki/0000-0003-3453-9883; Tsutsumi, Moe/0000-0001-9953-7219; Kobayashi, Yasuaki/0000-0003-4966-963X	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21340023]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (B)(21340023) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATRI A, 1993, BIOPHYS J, V65, P1727, DOI 10.1016/S0006-3495(93)81191-3; Burnstock G, 2000, J PHARMACOL EXP THER, V295, P862; Denda M, 2000, BIOCHEM BIOPH RES CO, V272, P134, DOI 10.1006/bbrc.2000.2739; Denda M, 2003, J INVEST DERMATOL, V121, P1557, DOI 10.1111/j.1523-1747.2003.12619.x; Denda M, 2007, SKIN RES TECHNOL, V13, P195, DOI 10.1111/j.1600-0846.2007.00210.x; DUPONT G, 1991, CELL CALCIUM, V12, P73, DOI 10.1016/0143-4160(91)90010-C; Edwards JR, 2010, J THEOR BIOL, V263, P45, DOI 10.1016/j.jtbi.2009.12.002; Elias P.M., 2006, SKIN BARRIER, P1; Elias PM, 2002, J INVEST DERMATOL, V119, P1128, DOI 10.1046/j.1523-1747.2002.19512.x; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Forslind B, 1999, ACTA DERM-VENEREOL, V79, P12; GIRARD S, 1992, BIOPHYS J, V61, P509, DOI 10.1016/S0006-3495(92)81855-6; GOLDBETER A, 1990, P NATL ACAD SCI USA, V87, P1461, DOI 10.1073/pnas.87.4.1461; Goto M, 2010, J CELL PHYSIOL, V224, P229, DOI 10.1002/jcp.22121; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Keener J., 1998, MATH PHYSL; KEENER JP, 1987, SIAM J APPL MATH, V47, P556, DOI 10.1137/0147038; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Li P, 2009, PHYSICA D, V238, P992, DOI 10.1016/j.physd.2008.12.008; Mauro T, 1998, J INVEST DERMATOL, V111, P1198, DOI 10.1046/j.1523-1747.1998.00421.x; MENON GK, 1994, BRIT J DERMATOL, V130, P139, DOI 10.1111/j.1365-2133.1994.tb02892.x; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; SNEYD J, 1993, B MATH BIOL, V55, P315; SNEYD J, 1995, AM J PHYSIOL-CELL PH, V268, pC1537, DOI 10.1152/ajpcell.1995.268.6.C1537; Tsutsumi M, 2013, EXP DERMATOL, V22, P367, DOI 10.1111/exd.12136; Tsutsumi M, 2010, SKIN RES TECHNOL, V16, P146, DOI 10.1111/j.1600-0846.2009.00420.x; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Warren NJ, 2010, EXP PHYSIOL, V95, P232, DOI 10.1113/expphysiol.2009.049585	31	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92650	10.1371/journal.pone.0092650	http://dx.doi.org/10.1371/journal.pone.0092650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663805	Green Published, gold			2022-12-25	WOS:000333459900091
J	Lionetti, L; Mollica, MP; Donizzetti, I; Gifuni, G; Sica, R; Pignalosa, A; Cavaliere, G; Gaita, M; De Filippo, C; Zorzano, A; Putti, R				Lionetti, Lilla; Mollica, Maria Pina; Donizzetti, Immacolata; Gifuni, Giorgio; Sica, Raffaella; Pignalosa, Angelica; Cavaliere, Gina; Gaita, Marcello; De Filippo, Chiara; Zorzano, Antonio; Putti, Rosalba			High-Lard and High-Fish-Oil Diets Differ in Their Effects on Function and Dynamic Behaviour of Rat Hepatic Mitochondria (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							POLYUNSATURATED FATTY-ACIDS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; FLUORESCENT-PROBE; PROTON LEAK; MEMBRANE; GLUCOSE; LIVER; DYSFUNCTION; CHAIN	Background: Mitochondria are dynamic organelles that frequently undergo fission and fusion processes, and imbalances in these processes may be involved in obesity and insulin resistance. Aims: The present work had the following aims: (a) to evaluate whether the mitochondrial dysfunction present in the hepatic steatosis induced by a high-fat diet is associated with changes in mitochondrial dynamics and morphology; (b) to evaluate whether effects on the above parameters differ between high-lard and high-fish-oil diets, as it has been suggested that fish oil may have anti-obesity and anti-steatotic effects by stimulating fatty acids utilisation. Methods: The development of hepatic steatosis and insulin resistance was monitored in rats fed a high-lard or high-fish-oil diet. Immunohistochemical and electronic microscopic observations were performed on liver sections. In isolated liver mitochondria, assessments of fatty acids oxidation rate, proton conductance and oxidative stress (by measuring H2O2 release and aconitase activity) were performed. Western blot and immunohistochemical analyses were performed to evaluate the presence of proteins involved in mitochondrial dynamics (i.e., fusion and fission processes). To investigate the fusion process, mitofusin 2 and autosomal dominant optic atrophy-1 (OPA1) were analysed. To investigate the fission process, the presence of dynamin-related protein 1 (Drp1) and fission 1 protein (Fis1) was assessed. Results: High-lard feeding elicited greater hepatic lipid accumulation, insulin resistance with associated mitochondrial dysfunction, greater oxidative stress and a shift towards mitochondrial fission processes (versus high-fish-oil feeding, which had an anti-steatotic effect associated with increased mitochondrial fusion processes). Conclusions: Different types of high-fat diets differ in their effect on mitochondrial function and dynamic behaviour, leading to different cellular adaptations to over-feeding.	[Lionetti, Lilla; Mollica, Maria Pina; Donizzetti, Immacolata; Gifuni, Giorgio; Sica, Raffaella; Pignalosa, Angelica; Cavaliere, Gina; Gaita, Marcello; De Filippo, Chiara; Putti, Rosalba] Univ Naples Federico II, Dept Biol, Naples, Italy; [Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain	University of Naples Federico II; University of Barcelona	Putti, R (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	rosalba.putti@unina.it	Lionetti, Lilla/AAM-1756-2021; Zorzano, Antonio/R-5479-2018	Lionetti, Lilla/0000-0002-4059-8030; Mollica, Maria Pina/0000-0003-2726-7779				AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564; Armstrong MB, 2001, AM J PHYSIOL-ENDOC M, V281, pE1197, DOI 10.1152/ajpendo.2001.281.6.E1197; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Buono S, 2007, COMP BIOCHEM PHYS C, V145, P306, DOI 10.1016/j.cbpc.2006.12.016; Caldwell SH, 2009, HEPATOLOGY, V49, P1888, DOI 10.1002/hep.22851; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Civitarese AE, 2008, ENDOCRINOLOGY, V149, P950, DOI 10.1210/en.2007-1444; COLONNA R, 1973, EUR J BIOCHEM, V34, P577, DOI 10.1111/j.1432-1033.1973.tb02798.x; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; de Lange P, 2011, DIABETES, V60, P2730, DOI 10.2337/db11-0207; Dobbins RL, 2002, DIABETES, V51, P1825, DOI 10.2337/diabetes.51.6.1825; Estabrook RW, 1967, METHOD ENZYMOL, V10, P4711; Fan YY, 2011, CANCER PREV RES, V4, P1267, DOI 10.1158/1940-6207.CAPR-10-0368; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Holmstrom MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE731, DOI 10.1152/ajpendo.00159.2011; Holness MJ, 2004, DIABETES, V53, pS166, DOI 10.2337/diabetes.53.2007.S166; Holness MJ, 2003, ENDOCRINOLOGY, V144, P3958, DOI 10.1210/en.2003-0479; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Iossa S, 2001, FEBS LETT, V505, P53, DOI 10.1016/S0014-5793(01)02772-7; Jezek P, 2002, INT J BIOCHEM CELL B, V34, P1190, DOI 10.1016/S1357-2725(02)00061-4; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Johnson-Delaney C, 1996, EXOTIC ANIMAL COMPAN; Kohn D. F., 2002, Laboratory animal medicine, P121; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lionetti L, 2007, INT J OBESITY, V31, P1596, DOI 10.1038/sj.ijo.0803636; Lionetti L, 2004, CELL MOL LIFE SCI, V61, P1366, DOI 10.1007/s00018-004-4073-4; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; LIVERINI G, 1991, COMP BIOCHEM PHYS B, V98, P583, DOI 10.1016/0305-0491(91)90258-F; Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Mollica MP, 2009, J HEPATOL, V51, P363, DOI 10.1016/j.jhep.2009.03.023; Nakatani T, 2003, J LIPID RES, V44, P369, DOI 10.1194/jlr.M200289-JLR200; NEDERGAARD J, 1983, EUR J BIOCHEM, V133, P185, DOI 10.1111/j.1432-1033.1983.tb07446.x; NISHIHIRA T, 1986, HEPATOLOGY, V6, P220, DOI 10.1002/hep.1840060211; Nunnari J, 2002, METHOD ENZYMOL, V351, P381; Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004; Poussin C, 2011, DIABETES, V60, P2216, DOI 10.2337/db11-0338; Putti R, 1996, GEN COMP ENDOCR, V103, P249, DOI 10.1006/gcen.1996.0119; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; Stillwell W, 1997, LIPIDS, V32, P497, DOI 10.1007/s11745-997-0064-6; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Xin I, 2011, NUTR METAB CARDIOVAS, V21, pB1; Xin YN, 2008, MED HYPOTHESES, V71, P820, DOI 10.1016/j.mehy.2008.07.008; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhang Y, 2011, METABOLISM, V60, P767, DOI 10.1016/j.metabol.2010.07.026	61	102	104	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92753	10.1371/journal.pone.0092753	http://dx.doi.org/10.1371/journal.pone.0092753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663492	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900109
J	Liu, R; Liu, X; Zee, PC; Hou, LF; Zheng, Z; Wei, YX; Du, J				Liu, Rong; Liu, Xin; Zee, Phyllis C.; Hou, Lifang; Zheng, Zheng; Wei, Yongxiang; Du, Jie			Association between Sleep Quality and C-Reactive Protein: Results from National Health and Nutrition Examination Survey, 2005-2008	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RESTLESS LEGS SYNDROME; RISK-FACTOR; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; YOUNG-ADULTS; DURATION; INFLAMMATION; OBESITY; BIOMARKERS	Objective: Our objective was to explore the association between poor sleep quality and hs_CRP in an adult U.S. population. Methods: This study focused on 9,317 participants in the National Health and Nutrition Examination Survey (NHANES) from 2005-2008 who were aged 20-85 years, completed a sleep disorder questionnaire, and had available information on serum hs_CRP. Sleep quality was classified into three categories (good, moderate, poor) based on the responses of participants to the NHANES sleep disorder questionnaire. High CRP was defined as hs-CRP > 1 md/dL. Linear regression model was applied to investigate the association between poor sleep quality and log-transformed hs_CRP. And logistic regression model was fitted to evaluate the association between sleep quality and the risk of high CRP. Results: Females were more likely to report poor sleep quality than males (26% vs. 19%, p<0.0001). Each sleep disorder was significantly associated with increased hs_CRP and correlative to other sleep disorders. In fully-adjusted linear regression model, poor sleep quality was significantly associated with elevated hs_CRP (log transformed) among the overall sample and in females only (beta = 0.10, se = 0.03, p<0.01 and beta = 0.13, se = 0.04, p<0.01, respectively). In fully-adjusted logistics regression model, poor sleep quality was linked with risk of high CRP(OR: 1.42, 95% CI: 1.15-1.76 in overall sample and OR: 1.59, 95%CI: 1.18-2.14 in females, respectively). Conclusion: We found that poor sleep quality was independently associated with elevated hs_CRP in females but not in males in a U.S. adult population.	[Liu, Rong; Du, Jie] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Minist Educ, Beijing An Zhen Hosp,Key Lab Remodeling Related C, Beijing, Peoples R China; [Liu, Rong; Liu, Xin] Northwestern Univ, Feinberg Sch Med, Mary Ann & J Milburn Smith Child Hlth Res Program, Dept Pediat, Chicago, IL 60611 USA; [Liu, Rong; Liu, Xin] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Liu, Rong; Liu, Xin] Childrens Hosp Chicago Res Ctr, Chicago, IL USA; [Zee, Phyllis C.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Zee, Phyllis C.] Northwestern Univ, Feinberg Sch Med, Sleep Med Ctr, Chicago, IL 60611 USA; [Hou, Lifang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Zheng, Zheng] Capital Med Univ, Beijing Xuan Wu Hosp, Beijing Inst Geriatr, Dept Neurobiol, Beijing, Peoples R China; [Wei, Yongxiang] Capital Med Univ, Beijing An Zhen Hosp, Dept Otorhinolaryngol, Beijing, Peoples R China	Capital Medical University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Capital Medical University; Capital Medical University	Liu, R (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Minist Educ, Beijing An Zhen Hosp,Key Lab Remodeling Related C, Beijing, Peoples R China.	rongliu606@gmail.com; jdu@bcm.edu	Zee, Phyllis C/GPF-3704-2022		Beijing collaborative innovative research center for cardiovascular diseases [PXM2013_014226_07_000088]	Beijing collaborative innovative research center for cardiovascular diseases	Funding provided by Beijing collaborative innovative research center for cardiovascular diseases (PXM2013_014226_07_000088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agras WS, 2004, J PEDIATR-US, V145, P20, DOI 10.1016/j.jpeds.2004.03.023; Albert MA, 2006, CIRCULATION, V114, pE67, DOI 10.1161/CIRCULATIONAHA.106.613570; APPELS A, 1987, ACTIV NERV SUPER, V29, P147; Bansil P, 2011, J CLIN HYPERTENS, V13, P739, DOI 10.1111/j.1751-7176.2011.00500.x; CDC, 2013, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2013, NHANES AN COURS; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; Dowd JB, 2011, ANN EPIDEMIOL, V21, P799, DOI 10.1016/j.annepidem.2011.07.004; Ford ES, 2003, CLIN CHEM, V49, P1353, DOI 10.1373/49.8.1353; Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289; Grandner MA, 2013, SLEEP, V36, P769, DOI 10.5665/sleep.2646; Hasler G, 2004, SLEEP, V27, P661, DOI 10.1093/sleep/27.4.661; Ishida K, 2009, CHEST, V136, P125, DOI 10.1378/chest.08-1431; Jackowska M, 2013, PSYCHONEUROENDOCRINO, V38, P1484, DOI 10.1016/j.psyneuen.2012.12.015; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Laugsand LE, 2012, PSYCHOSOM MED, V74, P543, DOI 10.1097/PSY.0b013e31825904eb; Li YP, 2012, CIRCULATION, V126, P1689, DOI 10.1161/CIRCULATIONAHA.112.112698; Matthews KA, 2010, SLEEP, V33, P1649, DOI 10.1093/sleep/33.12.1649; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Miller MA, 2009, SLEEP, V32, P857; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Mollicone DJ, 2008, ACTA ASTRONAUT, V63, P833, DOI 10.1016/j.actaastro.2007.12.005; Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x; Pasceri V, 2000, CIRCULATION, V102, P2165; Patel SR, 2006, AM J EPIDEMIOL, V164, P947, DOI 10.1093/aje/kwj280; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Plaisance EP, 2006, SPORTS MED, V36, P443, DOI 10.2165/00007256-200636050-00006; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Rifai N, 1999, CLIN CHEM, V45, P2136; Schwartz SW, 1998, ANN EPIDEMIOL, V8, P384, DOI 10.1016/S1047-2797(97)00238-X; Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2008, INT J PEDIATR OBES, V3, P27, DOI 10.1080/17477160802404681; Taheri S, 2007, SLEEP, V30, P991, DOI 10.1093/sleep/30.8.991; Trotti LM, 2012, BRAIN BEHAV IMMUN, V26, P1239, DOI 10.1016/j.bbi.2012.06.003; Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603; Vozoris NT, 2012, SLEEP MED, V13, P637, DOI 10.1016/j.sleep.2012.01.004	41	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92607	10.1371/journal.pone.0092607	http://dx.doi.org/10.1371/journal.pone.0092607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663098	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900084
J	Pongsiri, A; Ponlawat, A; Thaisomboonsuk, B; Jarman, RG; Scott, TW; Lambrechts, L				Pongsiri, Arissara; Ponlawat, Alongkot; Thaisomboonsuk, Butsaya; Jarman, Richard G.; Scott, Thomas W.; Lambrechts, Louis			Differential Susceptibility of Two Field Aedes aegypti Populations to a Low Infectious Dose of Dengue Virus	PLOS ONE			English	Article							FRENCH-POLYNESIA; DISEASE SEVERITY; VIREMIA; THAILAND; TRANSMISSION; CHILDREN; VILLAGES; STRAINS; BURDEN	Background: The infectious dose required to infect mosquito vectors when they take a blood meal from a viremic person is a critical parameter underlying the probability of dengue virus (DENV) transmission. Because experimental vector competence studies typically examine the proportion of mosquitoes that become infected at intermediate or high DENV infectious doses in the blood meal, the minimum blood meal titer required to infect mosquitoes is poorly documented. Understanding the factors influencing the lower infectiousness threshold is epidemiologically significant because it determines the transmission potential of humans with a low DENV viremia, possibly including inapparent infections, and during the onset and resolution of the viremic period of acutely infected individuals. Methodology/Principal Findings: We compared the susceptibility of two field-derived Aedes aegypti populations from Kamphaeng Phet, Thailand when they were orally exposed to low titers of six DENV-2 isolates derived from the serum of naturally infected humans living in the same region. The infectious dose, time-point post-blood feeding, viral isolate and mosquito population, were significant predictors of the proportion of mosquitoes that became infected. Importantly, the dose-response profile differed significantly between the two Ae. aegypti populations. Although both mosquito populations had a similar 50% oral infectious dose (OID50), the slope of the dose-response was shallower in one population, resulting in a markedly higher susceptibility at low blood meal titers. Conclusions/Significance: Our results indicate that mosquitoes in nature vary in their infectious dose-response to DENV. Thus, different mosquito populations have a differential ability to acquire DENV infection at low viremia levels. Future studies on human-to-mosquito DENV transmission should not be limited to OID50 values, but rather they should be expanded to account for the shape of the dose-response profile across a range of virus titers.	[Pongsiri, Arissara; Ponlawat, Alongkot] Armed Forces Res Inst Med Sci, Dept Entomol, Bangkok 10400, Thailand; [Thaisomboonsuk, Butsaya; Jarman, Richard G.] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand; [Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Scott, Thomas W.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Lambrechts, Louis] Inst Pasteur, CNRS, Dept Genomes & Genet, Insect Virus Interact Grp,Unite Rech Associee 301, Paris, France	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lambrechts, L (corresponding author), Inst Pasteur, CNRS, Dept Genomes & Genet, Insect Virus Interact Grp,Unite Rech Associee 301, Paris, France.	louis.lambrechts@pasteur.fr	Lambrechts, Louis/A-2057-2010	Lambrechts, Louis/0000-0001-5958-2138	United States National Institutes of Health [R01 GM083224]; United States Military Infectious Diseases Research Program; French Agence Nationale de la Recherche [ANR-09-RPDOC-007-01]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]; Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, United States National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083224] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Military Infectious Diseases Research Program; French Agence Nationale de la Recherche(French National Research Agency (ANR)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases(French National Research Agency (ANR)); Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, United States National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was primarily supported by grant R01 GM083224 from the United States National Institutes of Health and by the United States Military Infectious Diseases Research Program. L. L. received funding from the French Agence Nationale de la Recherche (grant ANR-09-RPDOC-007-01) and from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (grant ANR-10-LABX-62-IBEID). T. W. S. received support from the Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security, and Fogarty International Center, United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769; Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9; Bosio CF, 2005, AM J TROP MED HYG, V72, P434, DOI 10.4269/ajtmh.2005.72.434; Choy MM, 2013, AM J TROP MED HYG, V89, P1001, DOI 10.4269/ajtmh.13-0100; Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975; Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621; GUBLER DJ, 1981, AM J TROP MED HYG, V30, P1094, DOI 10.4269/ajtmh.1981.30.1094; GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581; GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623; GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045; Hanley Kathryn A., 2008, BMC Ecology, V8, P1, DOI 10.1186/1472-6785-8-1; Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07; Lambrechts L, 2012, MEM I OSWALDO CRUZ, V107, P1080, DOI 10.1590/S0074-02762012000800022; Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Murgue B, 2000, J MED VIROL, V60, P432, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;432::AID-JMV11&gt;3.0.CO;2-7; Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110; Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; SILER J. F., 1926, PHILIPPINE JOUR SCI, V29, P1; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; SIMMONS JAMES STEVENS, 1931, PHILIPPINE JOUR SCI, V44, P1; Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357	30	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92971	10.1371/journal.pone.0092971	http://dx.doi.org/10.1371/journal.pone.0092971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664142	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900135
J	Prokop, JW; Schmidt, C; Gasper, D; Duff, RJ; Milsted, A; Ohkubo, T; Ball, HC; Shawkey, MD; Mays, HL; Cogburn, LA; Londraville, RL				Prokop, Jeremy W.; Schmidt, Cameron; Gasper, Donald; Duff, Robert J.; Milsted, Amy; Ohkubo, Takeshi; Ball, Hope C.; Shawkey, Matthew D.; Mays, Herman L., Jr.; Cogburn, Larry A.; Londraville, Richard L.			Discovery of the Elusive Leptin in Birds: Identification of Several 'Missing Links' in the Evolution of Leptin and Its Receptor	PLOS ONE			English	Article							I-TASSER; OB GENE; PROTEIN; EXPRESSION; GENERATION; REVEALS; INSIGHT; CLONING; WEIGHT; GENOME	Leptin is a pleiotropic protein best known for regulation of appetite and fat storage in mammals. While many leptin orthologs have been identified among vertebrates, an authentic leptin in birds has remained elusive and controversial. Here we identify leptin sequence from the Peregrine falcon, Falco peregrinus (pfleptin), and identify sequences from two other birds (mallard and zebra finch), and 'missing' vertebrates (elephant shark, alligator, Indian python, Chinese soft-shelled turtle, and coelacanth). The pattern of genes surrounding leptin (snd1, rbm28) is syntenic between the falcon and mammalian genomes. Phylogenetic analysis of all known leptin protein sequences improves our understanding of leptin's evolution. Structural modeling of leptin orthologs highlights a highly conserved hydrophobic core in the four-helix cytokine packing domain. A docked model of leptin with the leptin receptor for Peregrine falcon reveals several conserved amino acids important for the interaction and possible coevolution of leptin with its receptor. We also show for the first time, an authentic avian leptin sequence that activates the JAK-STAT signaling pathway. These newly identified sequences, structures, and tools for avian leptin and its receptor will allow elucidation of the function of these proteins in feral and domestic birds.	[Prokop, Jeremy W.; Schmidt, Cameron; Gasper, Donald; Duff, Robert J.; Milsted, Amy; Ball, Hope C.; Shawkey, Matthew D.; Londraville, Richard L.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Prokop, Jeremy W.] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Ohkubo, Takeshi] Ibaraki Univ, Coll Agr, Amimachi, Ibaraki, Japan; [Mays, Herman L., Jr.] Cincinnati Museum Ctr, Geier Collect & Res Ctr, Cincinnati, OH USA; [Cogburn, Larry A.] Univ Delaware, Newark, DE 19716 USA	University System of Ohio; University of Akron; Medical College of Wisconsin; Ibaraki University; University of Delaware	Cogburn, LA (corresponding author), Univ Delaware, Newark, DE 19716 USA.	londraville@uakron.edu	Prokop, Jeremy/AAG-4931-2019	Prokop, Jeremy/0000-0002-1818-9695; Shawkey, Matthew/0000-0002-5131-8209; Mays, Herman/0000-0003-1104-5100; Cogburn, Larry/0000-0003-0977-7580; Londraville, Richard/0000-0002-9438-7976	American Heart Association [11PRE7380033]; Ohio Board of regents; NIH [2R15DK079282-02]; University of Akron; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK079282] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Ohio Board of regents; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Akron; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	JWP was funded by American Heart Association award 11PRE7380033; JWP/CS/HCB by the Ohio Board of regents, and RLL by NIH 2R15DK079282-02. The project was started from funding provided by The University of Akron to JWP/CS/DG/HCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2008, J ENDOCRINOL, V197, P335, DOI 10.1677/JOE-08-0098; Adachi H, 2012, J POULT SCI, V49, P46, DOI 10.2141/jpsa.011085; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Byerly MS, 2009, AM J PHYSIOL-REG I, V296, pR1180, DOI 10.1152/ajpregu.90813.2008; Carpenter B, 2012, STRUCTURE, V20, P487, DOI 10.1016/j.str.2012.01.019; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Copeland DL, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00026; Crespi EJ, 2006, P NATL ACAD SCI USA, V103, P10092, DOI 10.1073/pnas.0507519103; Dagil R, 2012, STRUCTURE, V20, P270, DOI 10.1016/j.str.2011.12.010; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Doyon C, 2001, GEN COMP ENDOCR, V124, P188, DOI 10.1006/gcen.2001.7701; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Friedman-Einat M, 1999, GEN COMP ENDOCR, V115, P354, DOI 10.1006/gcen.1999.7322; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Haniu M, 1998, J BIOL CHEM, V273, P28691, DOI 10.1074/jbc.273.44.28691; Hen G, 2008, J ENDOCRINOL, V197, P325, DOI 10.1677/JOE-08-0065; Horev G, 2000, MOL CELL ENDOCRINOL, V162, P95, DOI 10.1016/S0303-7207(00)00205-7; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Huising MO, 2006, ENDOCRINOLOGY, V147, P5786, DOI 10.1210/en.2006-0824; Johnson RM, 2000, J EXP ZOOL, V286, P718, DOI 10.1002/(SICI)1097-010X(20000601)286:7&lt;718::AID-JEZ6&gt;3.0.CO;2-I; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Liu Q, 2012, GEN COMP ENDOCR, V178, P562, DOI 10.1016/j.ygcen.2012.07.011; Mancour LV, 2012, MOL CELL, V48, P655, DOI 10.1016/j.molcel.2012.09.003; Mariano G, 2013, PEPTIDES, V48, P59, DOI 10.1016/j.peptides.2013.07.026; Niewiarowski PH, 2000, J EXP BIOL, V203, P295; Ohkubo T, 2007, GEN COMP ENDOCR, V151, P269, DOI 10.1016/j.ygcen.2007.01.021; Ohkubo T, 2008, J POULT SCI, V45, P233, DOI 10.2141/jpsa.45.233; Pitel F, 2000, ANIM GENET, V31, P281, DOI 10.1046/j.1365-2052.2000.00610.x; Pitel F, 2010, GEN COMP ENDOCR, V167, P1, DOI 10.1016/j.ygcen.2009.10.006; Prokop JW, 2012, PEPTIDES, V38, P326, DOI 10.1016/j.peptides.2012.10.002; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Resnyk CW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-557; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sharp PJ, 2008, GEN COMP ENDOCR, V158, P2, DOI 10.1016/j.ygcen.2008.05.018; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	43	49	52	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92751	10.1371/journal.pone.0092751	http://dx.doi.org/10.1371/journal.pone.0092751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663438	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900108
J	Sharma, R; Sahoo, A; Devendran, R; Jain, M				Sharma, Raghvendra; Sahoo, Annapurna; Devendran, Ragunathan; Jain, Mukesh			Over-Expression of a Rice Tau Class Glutathione S-Transferase Gene Improves Tolerance to Salinity and Oxidative Stresses in Arabidopsis	PLOS ONE			English	Article							ABIOTIC STRESS; PROFILING REVEALS; AUXIN; PLANT; OVEREXPRESSION; PEROXIDASE; RESISTANCE; RESPONSES; CATALASE; GROWTH	Glutathione S-transferases (GSTs) are multifunctional proteins encoded by large gene family in plants, which play important role in cellular detoxification of several endobiotic and xenobiotic compounds. Previously, we suggested the diverse roles of rice GST gene family members in plant development and various stress responses based on their differential expression. In this study, we report the functional characterization of a rice tau class GST gene, OsGSTU4. OsGSTU4 fusion protein was found to be localized in nucleus and cytoplasm. The over-expression of OsGSTU4 in E. coli resulted in better growth and higher GST activity under various stress conditions. Further, we raised over-expression transgenic Arabidopsis plants to reveal its in planta function. These transgenic lines showed reduced sensitivity towards plant hormones, auxin and abscisic acid. Various analyses revealed improved tolerance in transgenic Arabidopsis plants towards salinity and oxidative stresses, which may be attributed to the lower accumulation of reactive oxygen species and enhanced GST activity. In addition, microarray analysis revealed up-regulation of several genes involved in stress responses and cellular detoxification processes in the transgenic plants as compared to wild-type. These results suggest that OsGSTU4 can be used as a good candidate for the generation of stress-tolerant crop plants.	[Sharma, Raghvendra; Sahoo, Annapurna; Devendran, Ragunathan; Jain, Mukesh] Natl Inst Plant Genome Res, Funct & Appl Genom Lab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Jain, M (corresponding author), Natl Inst Plant Genome Res, Funct & Appl Genom Lab, Aruna Asaf Ali Marg, New Delhi, India.	mjain@nipgr.ac.in	Jain, Mukesh/AAP-5816-2021; Devendran, Ragunathan/AAV-6684-2021; Sharma, Raghvendra/M-3400-2013	Jain, Mukesh/0000-0002-7622-1083; Devendran, Ragunathan/0000-0002-0822-1655; Sharma, Raghvendra/0000-0002-7612-6932	Department of Biotechnology, Government of India [BT/BI/12/040/2005, BT/02/IYBA/2010]; NIPGR	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); NIPGR	This work was financially supported by the Department of Biotechnology, Government of India, under Innovative Young Biotechnologists Award scheme (grant numbers BT/BI/12/040/2005 and BT/02/IYBA/2010) and core grant from NIPGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2002, PLANT SCI, V12, P1939; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Anderson JV, 2004, PHYSIOL PLANTARUM, V120, P421, DOI 10.1111/j.0031-9317.2004.00249.x; Bashandy T, 2010, PLANT CELL, V22, P376, DOI 10.1105/tpc.109.071225; BERHANE K, 1994, P NATL ACAD SCI USA, V91, P1480, DOI 10.1073/pnas.91.4.1480; Bianchi MW, 2002, PHYSIOL PLANTARUM, V116, P96, DOI 10.1034/j.1399-3054.2002.1160112.x; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Chen IC, 2007, PLANT PHYSIOL, V143, P1189, DOI 10.1104/pp.106.094185; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Edwards R, 2005, METHOD ENZYMOL, V401, P169, DOI 10.1016/S0076-6879(05)01011-6; Edwards R., 2000, HERBICIDES THEIR MEC, P33; EZAKI B, 1995, PHYSIOL PLANTARUM, V93, P11, DOI 10.1034/j.1399-3054.1995.930103.x; Ezaki B, 2004, PLANT PHYSIOL, V134, P1672, DOI 10.1104/pp.103.037135; Gazarian IG, 1998, BIOCHEM J, V333, P223, DOI 10.1042/bj3330223; George S, 2010, J PLANT PHYSIOL, V167, P311, DOI 10.1016/j.jplph.2009.09.004; Habig W H, 1981, Methods Enzymol, V77, P398; HARTUNG W, 1988, PLANT PHYSIOL, V86, P908, DOI 10.1104/pp.86.3.908; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Jain M, 2006, FEBS J, V273, P5245, DOI 10.1111/j.1742-4658.2006.05518.x; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Ji W, 2010, BIOTECHNOL LETT, V32, P1173, DOI 10.1007/s10529-010-0269-x; Iglesias MJ, 2011, PLANT SIGNAL BEHAV, V6, P452, DOI 10.4161/psb.6.3.14676; Kapoor S, 2002, PLANT CELL, V14, P2353, DOI 10.1105/tpc.003061; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Loyall L, 2000, PLANT CELL, V12, P1939, DOI 10.1105/tpc.12.10.1939; McGonigle B, 2000, PLANT PHYSIOL, V124, P1105, DOI 10.1104/pp.124.3.1105; Moons A, 2003, FEBS LETT, V553, P427, DOI 10.1016/S0014-5793(03)01077-9; Pasternak T, 2005, J EXP BOT, V56, P1991, DOI 10.1093/jxb/eri196; Pearson WR, 2005, METHOD ENZYMOL, V401, P186, DOI 10.1016/S0076-6879(05)01012-8; Potters G, 2009, PLANT CELL ENVIRON, V32, P158, DOI 10.1111/j.1365-3040.2008.01908.x; PRICE AH, 1994, PLANT CELL, V6, P1301, DOI 10.1105/tpc.6.9.1301; Qi YC, 2010, RUSS J PLANT PHYSL+, V57, P233, DOI 10.1134/S102144371002010X; Roxas VP, 1997, NAT BIOTECHNOL, V15, P988, DOI 10.1038/nbt1097-988; Sharma R, 2013, PLANTA, V238, P871, DOI 10.1007/s00425-013-1940-y; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Song YL, 2009, PLANTA, V229, P577, DOI 10.1007/s00425-008-0853-7; Soranzo N, 2004, MOL GENET GENOMICS, V271, P511, DOI 10.1007/s00438-004-1006-8; TAKAHASHI Y, 1992, P NATL ACAD SCI USA, V89, P56, DOI 10.1073/pnas.89.1.56; Takesawa T, 2002, MOL BREEDING, V9, P93, DOI 10.1023/A:1026718308155; Thom R, 2002, BIOCHEMISTRY-US, V41, P7008, DOI 10.1021/bi015964x; Tsuchiya T, 2004, GENE, V335, P141, DOI 10.1016/j.gene.2004.03.020; Ueki S, 2009, NAT PROTOC, V4, P71, DOI 10.1038/nprot.2008.217; Vollenweider S, 2000, PLANT J, V24, P467, DOI 10.1046/j.1365-313x.2000.00897.x; Wagner U, 2002, PLANT MOL BIOL, V49, P515, DOI 10.1023/A:1015557300450; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Wright STC, 1978, PHYTOHORMONES RELATE, P495; Xu FX, 2002, PLANT PHYSIOL, V130, P362, DOI 10.1104/pp.004796; Yu T, 2003, J PLANT PHYSIOL, V160, P1305, DOI 10.1078/0176-1617-01205; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zhao Feng-Yun, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P231; Zhao FY, 2006, PLANT CELL TISS ORG, V86, P349, DOI 10.1007/s11240-006-9133-z; ZHOU JM, 1993, PLANT MOL BIOL, V22, P517, DOI 10.1007/BF00015980	61	98	103	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92900	10.1371/journal.pone.0092900	http://dx.doi.org/10.1371/journal.pone.0092900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663444	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900128
J	Valdez, G; Heyer, MP; Feng, GP; Sanes, JR				Valdez, Gregorio; Heyer, Mary P.; Feng, Guoping; Sanes, Joshua R.			The Role of Muscle microRNAs in Repairing the Neuromuscular Junction	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; MESSENGER-RNA LEVELS; RAT NERVOUS-SYSTEM; SKELETAL-MUSCLE; NONCODING RNA; MOUSE; MICE; EXPRESSION; DIFFERENTIATION; MIR-206	microRNAs have been implicated in mediating key aspects of skeletal muscle development and responses to diseases and injury. Recently, we demonstrated that a synaptically enriched microRNA, miR-206, functions to promote maintenance and repair of the neuromuscular junction (NMJ); in mutant mice lacking miR-206, reinnervation is impaired following nerve injury and loss of NMJs is accelerated in a mouse model of amyotrophic lateral sclerosis (ALS). Here, we asked whether other microRNAs play similar roles. One attractive candidate is miR-133b because it is in the same transcript that encodes miR-206. Like miR-206, miR-133b is concentrated near NMJs and induced after denervation. In miR-133b null mice, however, NMJ development is unaltered, reinnervation proceeds normally following nerve injury, and disease progression is unaffected in the SOD1(G93A) mouse model of ALS. To determine if miR-206 compensates for the loss of miR-133b, we generated mice lacking both microRNAs. The phenotype of these double mutants resembled that of miR-206 single mutants. Finally, we used conditional mutants of Dicer, an enzyme required for the maturation of most microRNAs, to generate mice in which microRNAs were depleted from skeletal muscle fibers postnatally, thus circumventing a requirement for microRNAs in embryonic muscle development. Reinnervation of muscle fibers following injury was impaired in these mice, but the defect was similar in magnitude to that observed in miR-206 mutants. Together, these results suggest that miR-206 is the major microRNA that regulates repair of the NMJ following nerve injury.	[Valdez, Gregorio; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Valdez, Gregorio; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Valdez, Gregorio] Virginia Tech, Virginia Tech Carilion Res Inst, Roanoke, VA USA; [Heyer, Mary P.; Feng, Guoping] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Heyer, Mary P.] Scripps Res Inst Florida, Dept Mol Therapeut, Jupiter, FL USA; [Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Harvard University; Harvard University; Virginia Polytechnic Institute & State University; Duke University; Scripps Research Institute; Massachusetts Institute of Technology (MIT)	Valdez, G (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	gvaldez1@vtc.vt.edu	Feng, Guoping/Y-2827-2019		NIH [R01AG032322]; NINDS/NIH; Ruth K. Broad Foundation Fellowship; NINDS NRSA; NIH/NINDS; Poitras Center for Affective Disorders Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032322] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ruth K. Broad Foundation Fellowship; NINDS NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Poitras Center for Affective Disorders Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant R01AG032322 from the NIH to JRS and GV was supported by a NRSA Postdoctoral Fellowship from NINDS/NIH. MPH was supported by a Ruth K. Broad Foundation Fellowship and a NINDS NRSA. GF was supported by NIH/NINDS and by The Poitras Center for Affective Disorders Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; BaliceGordon RJ, 1997, MUSCLE NERVE, pS83; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; CARDASIS CA, 1987, MUSCLE NERVE, V10, P200, DOI 10.1002/mus.880100303; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chakkalakal JV, 2012, GENESIS, V50, P50, DOI 10.1002/dvg.20794; Chen JF, 2005, NAT GENET; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; FAHIM MA, 1982, J NEUROCYTOL, V11, P641, DOI 10.1007/BF01262429; FAHIM MA, 1983, J NEUROCYTOL, V12, P13, DOI 10.1007/BF01148085; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; GOLDMAN D, 1988, NEURON, V1, P329, DOI 10.1016/0896-6273(88)90081-5; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Heyer MP, 2012, J NEUROSCI, V32, P10887, DOI 10.1523/JNEUROSCI.1732-12.2012; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; MERLIE JP, 1984, J CELL BIOL, V99, P332, DOI 10.1083/jcb.99.1.332; MOSCOSO LM, 1995, MOL CELL NEUROSCI, V6, P80, DOI 10.1006/mcne.1995.1008; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Punga AR, 2012, CURR OPIN PHARMACOL, V12, P340, DOI 10.1016/j.coph.2012.02.002; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHMITT TL, 1991, HISTOCHEMISTRY, V96, P459, DOI 10.1007/BF00267071; SOLBACH S, 1991, ANAT EMBRYOL, V184, P103, DOI 10.1007/BF00942742; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; VAUGHAN DW, 1992, J COMP NEUROL, V323, P219, DOI 10.1002/cne.903230207; VELLECA MA, 1994, MOL CELL BIOL, V14, P7095, DOI 10.1128/MCB.14.11.7095; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711	51	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93140	10.1371/journal.pone.0093140	http://dx.doi.org/10.1371/journal.pone.0093140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664281	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900157
J	Barnwell, E; Padmaraju, V; Baranello, R; Pacheco-Quinto, J; Crosson, C; Ablonczy, Z; Eckman, E; Eckman, CB; Ramakrishnan, V; Greig, NH; Pappolla, MA; Sambamurti, K				Barnwell, Eliza; Padmaraju, Vasudevaraju; Baranello, Robert; Pacheco-Quinto, Javier; Crosson, Craig; Ablonczy, Zsolt; Eckman, Elizabeth; Eckman, Christopher B.; Ramakrishnan, Viswanathan; Greig, Nigel H.; Pappolla, Miguel A.; Sambamurti, Kumar			Evidence of a Novel Mechanism for Partial gamma-Secretase Inhibition Induced Paradoxical Increase in Secreted Amyloid beta Protein	PLOS ONE			English	Article							ENDOTHELIN-CONVERTING ENZYME; CARBOXYL-TERMINAL FRAGMENTS; TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; A-BETA; PRECURSOR PROTEIN; CELL-SURFACE; THERAPEUTIC TARGETS; BACE PROMOTER; APP	BACE1 (beta-secretase) and alpha-secretase cleave the Alzheimer's amyloid beta protein (A beta) precursor (APP) to C-terminal fragments of 99 aa (CTF beta) and 83 aa (CTF alpha), respectively, which are further cleaved by gamma-secretase to eventually secrete A beta and A alpha (a.k.a. P3) that terminate predominantly at residues 40 and 42. A number of gamma-secretase inhibitors (GSIs), such as N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT), have been developed with the goal of reducing A beta to treat Alzheimer's disease (AD). Although most studies show that DAPT inhibits A beta in a dose-dependent manner several studies have also detected a biphasic effect with an unexpected increase at low doses of DAPT in cell cultures, animal models and clinical trials. In this article, we confirm the increase in A beta 40 and A beta 42 in SH-SY5Y human neuroblastoma cells treated with low doses of DAPT and identify one of the mechanisms for this paradox. We studied the pathway by first demonstrating that stimulation of A beta, a product of gamma-secretase, was accompanied by a parallel increase of its substrate CTF beta, thereby demonstrating that the inhibitor was not anomalously stimulating enzyme activity at low levels. Secondly, we have demonstrated that inhibition of an A beta degrading activity, endothelin converting enzyme (ECE), yielded more A beta, but Abolished the DAPT-induced stimulation. Finally, we have demonstrated that A alpha, which is generated in the secretory pathway before endocytosis, is not subject to the DAPT-mediated stimulation. We therefore conclude that impairment of gamma-secretase can paradoxically increase A beta by transiently skirting A beta degradation in the endosome. This study adds to the growing body of literature suggesting that preserving gamma-secretase activity, rather than inhibiting it, is important for prevention of neurodegeneration.	[Barnwell, Eliza; Padmaraju, Vasudevaraju; Baranello, Robert; Sambamurti, Kumar] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Pacheco-Quinto, Javier; Eckman, Elizabeth; Eckman, Christopher B.] MidAtlantic Neonatol Associates & Atlant Hlth Sy, Biomed Res Inst New Jersey, Morristown, NJ USA; [Crosson, Craig; Ablonczy, Zsolt] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Ramakrishnan, Viswanathan] Med Univ S Carolina, Dept Biostat, Charleston, SC 29425 USA; [Greig, Nigel H.] Natl Inst Aging, Intramural Res Program, Translat Gerontol Branch, Drug Design & Dev Sect, Baltimore, MD USA; [Pappolla, Miguel A.] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Texas System; University of Texas Medical Branch Galveston	Sambamurti, K (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	sambak@musc.edu	Eckman, Elizabeth/AAL-7316-2021; Padmaraju, Vasudevaraju/ABH-3160-2021; Sambamurti, Kumar/A-1620-2012; Pappolla, Miguel/ABE-4966-2021	Sambamurti, Kumar/0000-0001-9507-9214; PADMARAJU, VASUDEVARAJU/0000-0002-1676-9610; Eckman, Elizabeth/0000-0002-5391-4960	Alzheimer's Association [IIRG 10-173-180]; NIH [AG046200, EY019065, NS073512]; Research to Prevent Blindness; Intramural NIA; NATIONAL EYE INSTITUTE [R01EY019065, R01EY021368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG046200, ZIAAG000311] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Intramural NIA; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Alzheimer's Association IIRG 10-173-180 and NIH AG046200 to KS, EY019065 to ZA, NIH NS073512 to EE, an unrestricted grant of Research to Prevent Blindness to the Department of Ophthalmology at MUSC and Intramural NIA to NHG supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablonczy Z, 2009, J BIOL CHEM, V284, P30177, DOI 10.1074/jbc.M109.032391; Bailey JA, 2011, GENE, V488, P13, DOI 10.1016/j.gene.2011.06.017; Barthet G, 2012, PROG NEUROBIOL, V98, P166, DOI 10.1016/j.pneurobio.2012.05.006; Barthet G, 2011, FASEB J, V25, P2937, DOI 10.1096/fj.11-183806; Brodney MA, 2011, BIOORG MED CHEM LETT, V21, P2637, DOI 10.1016/j.bmcl.2010.12.118; Burton CR, 2008, J BIOL CHEM, V283, P22992, DOI 10.1074/jbc.M804175200; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021164; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; Chen FS, 2000, J BIOL CHEM, V275, P36794, DOI 10.1074/jbc.M006986200; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Confaloni A, 2005, MOL BRAIN RES, V136, P12, DOI 10.1016/j.molbrainres.2004.12.022; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; Cummings J, 2010, BIOL PSYCHIAT, V68, P876, DOI 10.1016/j.biopsych.2010.09.020; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gandhi S, 2004, J MOL NEUROSCI, V24, P137, DOI 10.1385/JMN:24:1:137; Ge YW, 2004, FASEB J, V18, P1037, DOI 10.1096/fj.03-1379fje; Goate A, 2012, J NEUROCHEM, V120, P3, DOI 10.1111/j.1471-4159.2011.07575.x; Golde TE, 2001, TRENDS MOL MED, V7, P264, DOI 10.1016/S1471-4914(01)02064-0; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 2005, BIOCHEM SOC T, V33, P578, DOI 10.1042/BST0330578; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Herskowitz JH, 2012, MOL BIOL CELL, V23, P2645, DOI 10.1091/mbc.E12-01-0014; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kelleher RJ, 2010, SCIENCE, V330, P1055, DOI 10.1126/science.1198668; Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012; Lahiri Debomoy K., 2006, Current Alzheimer Research, V3, P475, DOI 10.2174/156720506779025224; Lane RF, 2013, J NEUROSCI, V33, P7099, DOI 10.1523/JNEUROSCI.5270-12.2013; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; Levy N, 2001, ENDOCRINOLOGY, V142, P5254, DOI 10.1210/en.142.12.5254; Maloney B, 2011, GENE, V488, P1, DOI 10.1016/j.gene.2011.06.004; Marlow L, 2003, BIOCHEM BIOPH RES CO, V305, P502, DOI 10.1016/S0006-291X(03)00797-6; Mitsuda N, 2006, LIFE SCI, V78, P2444, DOI 10.1016/j.lfs.2005.10.007; Mori K, 2010, PSYCHOGERIATRICS, V10, P117, DOI 10.1111/j.1479-8301.2010.00330.x; Morihara T, 2000, MOL BRAIN RES, V85, P85, DOI 10.1016/S0169-328X(00)00229-1; Niva C, 2013, EUR J CLIN PHARMACOL, V69, P1247, DOI 10.1007/s00228-012-1459-3; Pacheco-Quinto J, 2013, J BIOL CHEM, V288, P5606, DOI 10.1074/jbc.M112.422964; Pettersson M, 2013, EXPERT OPIN THER PAT, V23, P1349, DOI 10.1517/13543776.2013.821465; Pinnix I, 2001, FASEB J, V15, P1810, DOI 10.1096/fj.00-0891fje; Pinnix I, 2013, AM J GERIAT PSYCHIAT, V21, P474, DOI 10.1016/j.jagp.2013.02.009; Prakasam A, 2010, J ALZHEIMERS DIS, V20, P1243, DOI 10.3233/JAD-2010-100210; Refolo LM, 1999, J NEUROCHEM, V73, P2383, DOI 10.1046/j.1471-4159.1999.0732383.x; REFOLO LM, 1995, J NEUROSCI RES, V40, P694, DOI 10.1002/jnr.490400515; Robakis NK, 2011, NEUROBIOL AGING, V32, P372, DOI 10.1016/j.neurobiolaging.2010.05.022; Robakis NK, 2010, NEURODEGENER DIS, V7, P32, DOI 10.1159/000266476; ROBAKIS NK, 1987, LANCET, V1, P384; Sambamurti K, 1999, J BIOL CHEM, V274, P26810, DOI 10.1074/jbc.274.38.26810; Sambamurti K, 2004, FASEB J, V18, P1034, DOI 10.1096/fj.03-1378fje; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; SAMBAMURTI K, 1992, ANN NY ACAD SCI, V674, P118, DOI 10.1111/j.1749-6632.1992.tb27481.x; Sambamurti K, 2011, J NEUROCHEM, V117, P359, DOI 10.1111/j.1471-4159.2011.07213.x; Sambamurti Kumar, 2006, Current Alzheimer Research, V3, P81, DOI 10.2174/156720506775697142; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Svedruzic ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050759; Udayar V, 2013, CELL REP, V5, P1536, DOI 10.1016/j.celrep.2013.12.005; Vidal R, 2012, FASEB J, V26, P2899, DOI 10.1096/fj.12-205542; Vieira SI, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-40; Walker KR, 2012, J NEUROSCI, V32, P10423, DOI 10.1523/JNEUROSCI.5491-11.2012; Wolfe MS, 2013, BBA-BIOMEMBRANES, V1828, P2886, DOI 10.1016/j.bbamem.2013.04.015; Xia WM, 2012, J ALZHEIMERS DIS, V31, P685, DOI 10.3233/JAD-2012-120751; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Xu XM, 2009, J ALZHEIMERS DIS, V16, P211, DOI 10.3233/JAD-2009-0957; Yanagisawa H, 2000, J CLIN INVEST, V105, P1373, DOI 10.1172/JCI7447; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1; Zahs KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00028; Zhou Y, 2008, FASEB J, V22, P47, DOI 10.1096/fj.07-8175com; Zhu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045033	80	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91531	10.1371/journal.pone.0091531	http://dx.doi.org/10.1371/journal.pone.0091531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658363	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300037
J	Bilic, I; Jaskulska, B; Souillard, R; Liebhart, D; Hess, M				Bilic, Ivana; Jaskulska, Barbara; Souillard, Rozenn; Liebhart, Dieter; Hess, Michael			Multi-Locus Typing of Histomonas meleagridis Isolates Demonstrates the Existence of Two Different Genotypes	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; 5.8S RIBOSOMAL-RNA; DIENTAMOEBA-FRAGILIS; UNITED-STATES; TETRATRICHOMONAS-GALLINARUM; MOLECULAR CHARACTERIZATION; TRICHOMONADID PROTOZOA; PARTIAL SEQUENCE; STOOL SPECIMENS; REGIONS	Histomonas meleagridis is the aetiological agent of histomonosis or "blackhead disease". Histomonosis is of special importance today, because there is no effective treatment to prevent its occurrence with considerable losses for the poultry industry. Despite its importance only a few molecular studies have yet been performed to investigate the degree of genetic diversity between different isolates of this parasite. In the present study a collection of well defined samples, previously shown positive for the DNA of H. meleagridis, was used to investigate genetic relatedness of the parasite. Samples originated from 25 turkey flocks collected in France between 2007 and 2010. Additionally, diagnostic samples, collected at our Clinic in Vienna, from different European countries and Azerbaijan, during 2010 to 2013 were included in the analyses. For the analysis three different genetic loci were analyzed: 18S rRNA, alpha-actinin1 and rpb1 genes. To amplify partial sequences of alpha-actinin1 and rpb1 genes, primers specifically targeting H. meleagridis were designed. Following PCR, the sequences of 18S rRNA, alpha-actinin1 and rpb1 loci were analyzed. Phylogenetic analyses demonstrated separation of H. meleagridis isolates in two different clusters. The majority of isolates grouped within the cluster 1 and originated from different European countries. The cluster 2 was rare and predominantly found in samples originating from France. Considering that the genetic variability of clusters can be seen as two distinct genetic types we propose the term genotype instead of cluster.	[Bilic, Ivana; Jaskulska, Barbara; Liebhart, Dieter; Hess, Michael] Univ Vet Med Vienna, Dept Farm Animals & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria; [Souillard, Rozenn] European Univ Brittany, French Agcy Food Environm & Occupat Hlth Safety A, Unit Epidemiol & Welf poultry, F-22440 Ploufragan, France; [Souillard, Rozenn] Rabbit Ploufragan Plouzane Lab, F-22440 Ploufragan, France	University of Veterinary Medicine Vienna	Bilic, I (corresponding author), Univ Vet Med Vienna, Dept Farm Animals & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria.	ivana.bilic@vetmeduni.ac.at	Liebhart, Dieter/P-3765-2019	Liebhart, Dieter/0000-0003-2412-1248; Bilic, Ivana/0000-0003-3296-5117; Hess, Michael/0000-0002-6991-0120	French Turkey Producers Association; Bretagne Region; Pays de Loire Region; France Agrimer; Vetmeduni Vienna, Austria; Anses	French Turkey Producers Association; Bretagne Region(Region Bretagne); Pays de Loire Region; France Agrimer; Vetmeduni Vienna, Austria; Anses	The French study was supported financially by the French Turkey Producers Association, Bretagne and Pays de Loire Regions, France Agrimer and Anses. All other additional funds for consumables were obtained from the Vetmeduni Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart A, 2008, J CLIN MICROBIOL, V46, P3270, DOI 10.1128/JCM.00680-08; Cepicka I, 2010, PROTIST, V161, P400, DOI 10.1016/j.protis.2009.11.005; Esquenet C, 2003, AVIAN PATHOL, V32, P305, DOI 10.1080/0307945031000097903; Felleisen RSJ, 1997, PARASITOLOGY, V115, P111, DOI 10.1017/S0031182097001212; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gerbod D, 2001, J EUKARYOT MICROBIOL, V48, P498, DOI 10.1111/j.1550-7408.2001.tb00185.x; Gerhold RW, 2011, J PARASITOL, V97, P354, DOI 10.1645/GE-2618.1; Gerhold RW, 2008, J PARASITOL, V94, P1335, DOI 10.1645/GE-1585.1; Grabensteiner E, 2010, VET PARASITOL, V172, P53, DOI 10.1016/j.vetpar.2010.04.015; Hauck R, 2010, AVIAN DIS, V54, P1021, DOI 10.1637/9261-012910-Reg.1; Hauck R, 2010, J PARASITOL, V96, P396, DOI 10.1645/GE-2267.1; Hauck R, 2009, PARASITOL RES, V104, P1183, DOI 10.1007/s00436-008-1309-5; Hess M, 2006, PARASITOLOGY, V133, P547, DOI 10.1017/S0031182006000758; Kleina P, 2004, INT J PARASITOL, V34, P963, DOI 10.1016/j.ijpara.2004.04.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lollis L, 2011, J PARASITOL, V97, P610, DOI 10.1645/GE-2648.1; Malik SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020774; Mantini C, 2009, PARASITOL RES, V106, P163, DOI 10.1007/s00436-009-1643-2; McDougald LR, 2005, AVIAN DIS, V49, P462, DOI 10.1637/7420-081005R.1; Munsch M, 2009, PARASITOL RES, V104, P1137, DOI 10.1007/s00436-008-1299-3; Noda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029938; Peek R, 2004, J CLIN MICROBIOL, V42, P631, DOI 10.1128/JCM.42.2.631-635.2004; Stark D, 2005, INT J PARASITOL, V35, P57, DOI 10.1016/j.ijpara.2004.09.003; Tyzzer E. E., 1920, Journal of Parasitology Urbana, V6, DOI 10.2307/3271065; van der Heijden HMJF, 2006, AVIAN PATHOL, V35, P330, DOI 10.1080/03079450600815499; Walker RL, 2003, J VET DIAGN INVEST, V15, P14, DOI 10.1177/104063870301500104; Windsor JJ, 2006, J EUKARYOT MICROBIOL, V53, P188, DOI 10.1111/j.1550-7408.2006.00092.x	27	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92438	10.1371/journal.pone.0092438	http://dx.doi.org/10.1371/journal.pone.0092438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658534	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300083
J	David, MA; Jones, KH; Inzana, JA; Zuscik, MJ; Awad, HA; Mooney, RA				David, Michael A.; Jones, Khyrie H.; Inzana, Jason A.; Zuscik, Michael J.; Awad, Hani A.; Mooney, Robert A.			Tendon Repair Is Compromised in a High Fat Diet-Induced Mouse Model of Obesity and Type 2 Diabetes	PLOS ONE			English	Article							FLEXOR; CELLS; TENDINOPATHY; ADHESIONS; COLLAGEN; BIOLOGY; INJURY	Introduction: The obesity epidemic has resulted in a large increase in type 2 diabetes (T2D). While some secondary complications of T2D are well recognized and their cellular and molecular mechanisms are defined, the impact of T2D on the musculoskeletal system is less understood. Clinical evidence suggests that tendon strength and repair are compromised. Here, a mouse model of obesity and T2D recapitulates the deleterious effects of this condition on tendon repair. Methods: Male C57BL/6J mice at 5 weeks of age were placed on a high fat (HF)(60% kcal) or low fat (10% kcal) diet for 12 weeks. The flexor digitorum longus (FDL) tendon was then injured by puncturing it with a beveled needle. Progression of FDL tendon healing was assessed through biomechanical and histological analysis at 0, 7, 14 and 28 days post-injury. Results: HF-fed mice displayed increased body weight and elevated fasting glucose levels, both consistent with T2D. No differences in biomechanical properties of the uninjured FDL tendon were observed after 12 weeks on HF versus lean diets, but decreased maximum force in uninjured tendons from HF-fed mice was observed at 24 weeks. Following puncture injury, tendons from HF-fed mice displayed impaired biomechanical properties at day 28 post injury. In support of defective repair in the HF-fed mice, histological examination of the injury site showed a smaller area of repair and lower cell content in the repair area of HF-fed mice. Insulin receptors were expressed in most cells at the injury site regardless of diet. Discussion: The HF-diet mouse model of obesity and T2D reproduces the impaired tendon healing that is observed in this patient population. The exact mechanism is unknown, but we hypothesize that a cellular defect, perhaps involving insulin resistance, leads to decreased proliferation or recruitment to the injury site, and ultimately contributes to defective tendon healing.	[David, Michael A.; Jones, Khyrie H.; Mooney, Robert A.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [David, Michael A.; Inzana, Jason A.; Awad, Hani A.] Univ Rochester, Dept Biomed Engn, Rochester, NY USA; [Zuscik, Michael J.; Awad, Hani A.; Mooney, Robert A.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Mooney, RA (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA.	Robert_Mooney@urmc.rochester.edu	Awad, Hani A/G-6976-2014; Mostafa, Taymour/H-6834-2019	Awad, Hani A/0000-0003-2197-2610; Mostafa, Taymour/0000-0003-3627-0662; Zuscik, Michael/0000-0003-0461-8708; Inzana, Jason/0000-0002-5221-273X	NIH [P50 AR054041]; AO Trauma Research Fund; NIAMS/NIH [P30 AR061307, R01AR056696]; NSF [2012116002]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056696, P50AR054041, P30AR061307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AO Trauma Research Fund; NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the following: NIH P50 AR054041, AO Trauma Research Fund, NIAMS/NIH P30 AR061307, NIAMS/NIH R01AR056696, and NSF graduate research fellowship 2012116002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2013, RHEUMATOLOGY, V52, P599, DOI 10.1093/rheumatology/kes395; Akturk M, 2007, EXP CLIN ENDOCR DIAB, V115, P92, DOI 10.1055/s-2007-955097; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Aydeniz A, 2008, J INT MED RES, V36, P505, DOI 10.1177/147323000803600315; Bedi A, 2010, J SHOULDER ELB SURG, V19, P978, DOI 10.1016/j.jse.2009.11.045; Bloomgarden ZT, 2000, DIABETES CARE, V23, P118, DOI 10.2337/diacare.23.1.118; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Branford OA, 2008, PLAST RECONSTR SURG, V121, P781, DOI 10.1097/01.prs.0000299373.25294.65; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chbinou N, 2004, AM J PHYSIOL-REG I, V286, pR952, DOI 10.1152/ajpregu.00536.2003; Chen AL, 2003, J SHOULDER ELB SURG, V12, P416, DOI 10.1016/S1058-2746(03)00172-1; Chuen FS, 2004, J HISTOCHEM CYTOCHEM, V52, P1151, DOI 10.1369/jhc.3A6232.2004; Clement ND, 2010, J BONE JOINT SURG BR, V92B, P1112, DOI 10.1302/0301-620X.92B8.23571; DiDomenico LA, 2008, J FOOT ANKLE SURG, V47, P463, DOI 10.1053/j.jfas.2008.05.007; Elfar JC, 2008, J BONE JOINT SURG AM, V90A, P1644, DOI 10.2106/JBJS.G.00557; Gaida JE, 2008, DISABIL REHABIL, V30, P1555, DOI 10.1080/09638280701786864; GARNER WL, 1989, PLAST RECONSTR SURG, V83, P875, DOI 10.1097/00006534-198905000-00018; GELBERMAN RH, 1986, J HAND SURG-AM, V11A, P106, DOI 10.1016/S0363-5023(86)80115-0; Hasslund S, 2008, J ORTHOP RES, V26, P824, DOI 10.1002/jor.20531; Huang ES, 2009, DIABETES CARE, V32, P2225, DOI 10.2337/dc09-0459; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; Loiselle AE, 2009, J ORTHOP RES, V27, P833, DOI 10.1002/jor.20769; Palmes D, 2002, J ORTHOPAED RES, V20, P939, DOI 10.1016/S0736-0266(02)00032-3; Ramchurn N, 2009, EUR J INTERN MED, V20, P718, DOI 10.1016/j.ejim.2009.08.001; Ramirez LC, 1998, J DIABETES COMPLICAT, V12, P337, DOI 10.1016/S1056-8727(98)00024-5; Reddy GK, 2004, EXP DIABESITY RES, V5, P143, DOI 10.1080/15438600490277860; Rosenbloom AL, 1996, ENDOCRIN METAB CLIN, V25, P473, DOI 10.1016/S0889-8529(05)70335-2; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; TANAKA S, 1988, J MOL BIOL, V203, P495, DOI 10.1016/0022-2836(88)90015-0; Taylor R, 2012, DIABETES, V61, P778, DOI 10.2337/db12-0073; VLASSARA H, 1994, LAB INVEST, V70, P138; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122; WOJCIAK B, 1993, CLIN EXP IMMUNOL, V93, P108; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	37	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91234	10.1371/journal.pone.0091234	http://dx.doi.org/10.1371/journal.pone.0091234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658034	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300028
J	Hao, LP; Lu, F; Wu, Q; Shao, LM; He, PJ				Hao, Liping; Lu, Fan; Wu, Qing; Shao, Liming; He, Pinjing			High Concentrations of Methyl Fluoride Affect the Bacterial Community in a Thermophilic Methanogenic Sludge	PLOS ONE			English	Article							RICE FIELD SOIL; ISOTOPE FRACTIONATION; ACETOCLASTIC METHANOGENESIS; SP NOV.; ACETATE; INHIBITION; DIVERSITY; QUANTIFICATION; OXIDATION; PATHWAYS	To precisely control the application of methyl fluoride (CH3F) for analysis of methanogenic pathways, the influence of 0-10% CH3F on bacterial and archaeal communities in a thermophilic methanogenic sludge was investigated. The results suggested that CH3F acts specifically on acetoclastic methanogenesis. The inhibitory effect stabilized at an initial concentration of 3-5%, with around 90% of the total methanogenic activity being suppressed, and a characteristic of hydrogenotrophic pathway in isotope fractionation was demonstrated under this condition. However, extended exposure (12 days) to high concentrations of CH3F (>3%) altered the bacterial community structure significantly, resulting in increased diversity and decreased evenness, which can be related to acetate oxidation and CH3F degradation. Bacterial clone library analysis showed that syntrophic acetate oxidizing bacteria Thermacetogenium phaeum were highly enriched under the suppression of 10% CH3F. However, the methanogenic community did not change obviously. Thus, excessive usage of CH3F over the long term can change the composition of the bacterial community. Therefore, data from studies involving the use of CH3F as an acetoclast inhibitor should be interpreted with care. Conversely, CH3F has been suggested as a factor to stimulate the enrichment of syntrophic acetate oxidizing bacteria.	[Hao, Liping; Lu, Fan; Wu, Qing] Tongji Univ, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China; [Lu, Fan; Shao, Liming; He, Pinjing] Tongji Univ, Inst Waste Treatment & Reclamat, Shanghai 200092, Peoples R China; [Shao, Liming; He, Pinjing] Minist Housing & Urban Rural Dev PR China MOHURD, Ctr Technol Res & Training Household Waste Small, Shanghai, Peoples R China	Tongji University; Tongji University	Lu, F (corresponding author), Tongji Univ, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.	lvfan.rhodea@tongji.edu.cn; solidwaste@tongji.edu.cn	He, Pinjing/O-6215-2019; Lü, Fan/F-4812-2013; Hao, Liping/GLN-4379-2022	Lü, Fan/0000-0002-8496-3941; 	National Basic Research Program of China (973 Program) [2012CB719801]; National Science Foundation of China [51378375, 51178327, 21177096]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was sponsored by National Basic Research Program of China (973 Program, No. 2012CB719801) and National Science Foundation of China (51378375; 51178327; 21177096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk M, 2002, INT J SYST EVOL MICR, V52, P1361, DOI [10.1099/ijs.0.02165-0, 10.1099/00207713-52-4-1361]; Bodelier PLE, 1999, APPL ENVIRON MICROB, V65, P1826; Chau JF, 2011, ENVIRON FORENSICS, V12, P333, DOI 10.1080/15275922.2011.622348; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Conrad R, 2005, ORG GEOCHEM, V36, P739, DOI 10.1016/j.orggeochem.2004.09.006; Conrad R, 2002, CHEMOSPHERE, V47, P797, DOI 10.1016/S0045-6535(02)00120-0; Conrad R, 1999, FEMS MICROBIOL ECOL, V30, P47, DOI 10.1111/j.1574-6941.1999.tb00634.x; Conrad R, 2010, LIMNOL OCEANOGR, V55, P689, DOI 10.4319/lo.2009.55.2.0689; Daebeler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053656; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fotidis IA, 2013, BIORESOURCE TECHNOL, V146, P57, DOI 10.1016/j.biortech.2013.07.041; Frenzel P, 1996, FEMS MICROBIOL ECOL, V21, P25; Hao LP, 2011, CHEMOSPHERE, V84, P1194, DOI 10.1016/j.chemosphere.2011.06.045; Hao LP, 2011, ENVIRON SCI TECHNOL, V45, P508, DOI 10.1021/es102228v; Hao LP, 2013, J ENVIRON SCI, V25, P857, DOI 10.1016/S1001-0742(12)60203-4; Hao LP, 2013, BIORESOURCE TECHNOL, V140, P319, DOI 10.1016/j.biortech.2013.04.113; Hattori S, 2008, MICROBES ENVIRON, V23, P118, DOI 10.1264/jsme2.23.118; Janssen PH, 1997, APPL ENVIRON MICROB, V63, P4552, DOI 10.1128/AEM.63.11.4552-4557.1997; Kamagata Y, 1989, RECENT ADV MICROBIAL, P459; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Liu FH, 2010, ENVIRON MICROBIOL, V12, P2341, DOI 10.1111/j.1462-2920.2010.02289.x; Liu JJ, 2011, APPL MICROBIOL BIOT, V91, P1659, DOI 10.1007/s00253-011-3354-8; OREMLAND RS, 1992, APPL ENVIRON MICROB, V58, P2983, DOI 10.1128/AEM.58.9.2983-2992.1992; Penger J, 2012, APPL ENVIRON MICROB, V78, P7596, DOI 10.1128/AEM.01773-12; Penning H, 2006, APPL ENVIRON MICROB, V72, P178, DOI 10.1128/AEM.72.1.178-184.2006; Penning H, 2007, ORG GEOCHEM, V38, P2058, DOI 10.1016/j.orggeochem.2007.08.004; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Schnurer A, 1996, INT J SYST BACTERIOL, V46, P1145, DOI 10.1099/00207713-46-4-1145; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; TIWARI SC, 1993, BIOL FERT SOILS, V16, P131, DOI 10.1007/BF00369414; Westerholm M., 2012, BIOGAS PRODUCTION SY; Westerholm M, 2011, SYST APPL MICROBIOL, V34, P260, DOI 10.1016/j.syapm.2010.11.018; Westerholm M, 2010, FEMS MICROBIOL LETT, V309, P100, DOI 10.1111/j.1574-6968.2010.02023.x; Wittebolle L, 2008, APPL ENVIRON MICROB, V74, P286, DOI 10.1128/AEM.01006-07; Ye Ningfang, 2007, Chinese Journal of Applied and Environmental Biology, V13, P238; Zhang XL, 2005, J MICROBIOL METH, V60, P1, DOI 10.1016/j.mimet.2004.08.015	36	1	2	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92604	10.1371/journal.pone.0092604	http://dx.doi.org/10.1371/journal.pone.0092604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658656	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300104
J	Pei, N; Jie, FL; Luo, J; Wan, RQ; Zhang, YL; Chen, XL; Liang, ZB; Du, HY; Li, A; Chen, BH; Zhang, Y; Sumners, C; Li, JL; Gu, WW; Li, HW				Pei, Nana; Jie, Feilong; Luo, Jie; Wan, Renqiang; Zhang, Yanling; Chen, Xinglu; Liang, Zhibing; Du, Hongyan; Li, Andrew; Chen, Baihong; Zhang, Yi; Sumners, Colin; Li, Jinlong; Gu, Weiwang; Li, Hongwei			Gene Expression Profiling Associated with Angiotensin II Type 2 Receptor-Induced Apoptosis in Human Prostate Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRAIL-INDUCED APOPTOSIS; MEDIATED APOPTOSIS; LIGAND TRAIL; DEATH; INHIBITION; FAMILY; HRK; PROLIFERATION; GROWTH	Increased expression of angiotensin II type 2 receptor (AT2R) induces apoptosis in numerous tumor cell lines, with either Angiotensin II-dependent or Angiotensin II-independent regulation, but its molecular mechanism remains poorly understood. Here, we used PCR Array analysis to determine the gene and microRNA expression profiles in human prostate cancer cell lines transduced with AT2R recombinant adenovirus. Our results demonstrated that AT2R over expression leads to up-regulation of 6 apoptosis-related genes (TRAIL-R2, BAG3, BNIPI, HRK, Gadd45a, TP53BP2), 2 cytokine genes (IL6 and IL8) and 1 microRNA, and down-regulation of 1 apoptosis-related gene TNFSF10 and 2 cytokine genes (BMP6, BMP7) in transduced DU145 cells. HRK was identified as an up-regulated gene in AT2R-transduced PC-3 cells by real-time RT-PCR. Next, we utilized siRNAs to silence the up-regulated genes to further determine their roles on AT2R overexpression mediated apoptosis. The results showed downregulation of Gadd45a reduced the apoptotic effect by similar to 30% in DU145 cells, downregulation of HRK reduced AT2R-mediated apoptosis by more than 50% in PC-3 cells, while downregulation of TRAIL-R2 enhanced AT2R-mediated apoptosis more than 4 times in DU145 cells. We also found that the effects on AT2R-mediated apoptosis caused by downregulation of Gadd45a, TRAIL-R2 and HRK were independent in activation of p38 MAPK, p44/42 MAPK and p53. Taken together, our results demonstrated that TRAIL-R2, Gadd45a and HRK may be novel target genes for further study of the mechanism of AT2R-mediated apoptosis in prostate cancer cells.	[Pei, Nana; Jie, Feilong; Luo, Jie; Zhang, Yanling; Chen, Xinglu; Liang, Zhibing; Du, Hongyan; Chen, Baihong; Li, Jinlong; Li, Hongwei] Southern Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China; [Wan, Renqiang] Guangdong No 2 Prov Peoples Hosp, Dept Otolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China; [Li, Andrew] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Zhang, Yi] Univ Florida, Dept Pharmacol, Gainesville, FL 32610 USA; [Sumners, Colin] Univ Florida, Dept Physiol & Funct Gen, Gainesville, FL USA; [Gu, Weiwang] Southern Med Univ, Inst Comparat Med, Guangzhou, Guangdong, Peoples R China; [Gu, Weiwang] Southern Med Univ, Ctr Lab Animals, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Southern Medical University - China; Southern Medical University - China	Li, JL (corresponding author), Southern Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China.	lijinlong75@126.com; guww100@163.com; hongwei1@yahoo.com		Sumners, Colin/0000-0002-9689-2255	National Natural Science Foundation of China [81072113]; National 863 High Technique Development Projects of China [2012AA02A403]; State Key Laboratory of Pathogen and Biosecurity Program [SKLPBS1103]; Chinese government [2011A091000022, 2010B060500001, 2011B060300028, 2011B060300014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 High Technique Development Projects of China(National High Technology Research and Development Program of China); State Key Laboratory of Pathogen and Biosecurity Program; Chinese government	This work was supported by National Natural Science Foundation of China Grant 81072113 (H.L.), National 863 High Technique Development Projects of China Grant 2012AA02A403 (H.L.), State Key Laboratory of Pathogen and Biosecurity Program SKLPBS1103 (H.L.), as well as by awards 2011A091000022, 2010B060500001, 2011B060300028 and 2011B060300014 to W. G. from the Chinese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedecs K, 1997, BIOCHEM J, V325, P449, DOI 10.1042/bj3250449; Bhaskaran M, 2003, AM J PHYSIOL-RENAL, V284, pF955, DOI 10.1152/ajprenal.00246.2002; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chow L, 2008, PROSTATE, V68, P651, DOI 10.1002/pros.20738; Crawford ED, 2009, UROLOGY, V73, P4, DOI 10.1016/j.urology.2009.03.001; Cretu Alexandra, 2009, Cancer Ther, V7, P268; Cui TX, 2002, MOL ENDOCRINOL, V16, P2113, DOI 10.1210/me.2001-0284; Ding GH, 2002, AM J PHYSIOL-RENAL, V283, pF173, DOI 10.1152/ajprenal.00240.2001; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; FORNACE AJ, 1992, ANN NY ACAD SCI, V663, P139, DOI 10.1111/j.1749-6632.1992.tb38657.x; Ghosh AP, 2009, J NEUROPATH EXP NEUR, V68, P747, DOI 10.1097/NEN.0b013e3181a9d524; GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395; Greene MI, 2000, ONCOGENE REV, V19, P2984; Griffith TS, 2000, J IMMUNOL, V165, P2886, DOI 10.4049/jimmunol.165.5.2886; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; Haselmann V, 2014, GASTROENTEROLOGY, V146, P278, DOI 10.1053/j.gastro.2013.10.009; Horiuchi M, 1997, J BIOL CHEM, V272, P19022, DOI 10.1074/jbc.272.30.19022; Inoue K, 2000, CANCER RES, V60, P2290; Kalinec GM, 2005, P NATL ACAD SCI USA, V102, P16019, DOI 10.1073/pnas.0508053102; Kawabata A, 2012, CANCER RES, V72, P2057, DOI 10.1158/0008-5472.CAN-11-3634; Keane MM, 1999, CANCER RES, V59, P734; Klose A, 2011, NEOPLASIA, V13, P276, DOI 10.1593/neo.101540; Koyama S, 2002, J CANCER RES CLIN, V128, P73, DOI 10.1007/s004320100292; Li HW, 2009, MOL CANCER THER, V8, P3255, DOI 10.1158/1535-7163.MCT-09-0237; Li HW, 2005, BIOCHEM BIOPH RES CO, V336, P29, DOI 10.1016/j.bbrc.2005.08.035; Liebermann DA, 1998, ONCOGENE, V17, P3319, DOI 10.1038/sj.onc.1202574; Liebermann DA, 2011, CELL CYCLE, V10, P3428, DOI 10.4161/cc.10.20.17528; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Marcus JS, 2003, GLIA, V41, P152, DOI 10.1002/glia.10168; MATSUSHIMA K, 1992, CHEM IMMUNOL, V51, P236; Miura S, 2005, J BIOL CHEM, V280, P18237, DOI 10.1074/jbc.M500639200; Miura SI, 2000, EMBO J, V19, P4026, DOI 10.1093/emboj/19.15.4026; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Nakamura M, 2005, ACTA NEUROPATHOL, V110, P402, DOI 10.1007/s00401-005-1065-x; Nakamura M, 2008, ONCOGENE, V27, pS105, DOI 10.1038/onc.2009.48; Nimmanapalli R, 2001, CANCER RES, V61, P759; Nouet S, 2004, J BIOL CHEM, V279, P28989, DOI 10.1074/jbc.M403880200; Palacios C, 2013, CURR PHARM DES; Qiu Y, 1998, NATURE, V393, P83, DOI 10.1038/30012; Sanz C, 2002, HAEMATOLOGICA, V87, P903; Shenoy UV, 1999, ENDOCRINOLOGY, V140, P500, DOI 10.1210/en.140.1.500; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; Szliszka E, 2012, INT J MOL SCI, V13, P15343, DOI 10.3390/ijms131115343; Szliszka E, 2013, UROL ONCOL-SEMIN ORI, V31, P331, DOI 10.1016/j.urolonc.2011.01.019; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Wach S, 2001, ONCOGENE, V20, P7761, DOI 10.1038/sj.onc.1204962; Wakabayashi T, 2002, NEUROSCI LETT, V318, P77, DOI 10.1016/S0304-3940(01)02487-9; Wang M, 2008, J PATHOL, V215, P13, DOI 10.1002/path.2333; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yamada T, 1996, P NATL ACAD SCI USA, V93, P156, DOI 10.1073/pnas.93.1.156; Yang F, 2013, J BIOL CHEM, V288, P6552, DOI 10.1074/jbc.M112.418335; Young JE, 2009, J NEUROSCI, V29, P1987, DOI 10.1523/JNEUROSCI.4072-08.2009; Zhang XD, 1999, CANCER RES, V59, P2747	60	11	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92253	10.1371/journal.pone.0092253	http://dx.doi.org/10.1371/journal.pone.0092253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658029	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300067
J	Thompson, MC; Wheeler, KK; Shi, JX; Smith, GA; Xiang, HY				Thompson, Meghan C.; Wheeler, Krista K.; Shi, Junxin; Smith, Gary A.; Xiang, Huiyun			An Evaluation of Comparability between NEISS and ICD-9-CM Injury Coding	PLOS ONE			English	Article							SURVEILLANCE SYSTEM	Objective: To evaluate the National Electronic Injury Surveillance System's (NEISS) comparability with a data source that uses ICD-9-CM coding. Methods: A sample of NEISS cases from a children's hospital in 2008 was selected, and cases were linked with their original medical record. Medical records were reviewed and an ICD-9-CM code was assigned to each case. Cases in the NEISS sample that were non-injuries by ICD-9-CM standards were identified. A bridging matrix between the NEISS and ICD-9-CM injury coding systems, by type of injury classification, was proposed and evaluated. Results: Of the 2,890 cases reviewed, 13.32% (n = 385) were non-injuries according to the ICD-9-CM diagnosis. Using the proposed matrix, the comparability of the NEISS with ICD-9-CM coding was favorable among injury cases (k = 0.87, 95% CI: 0.85-0.88). The distribution of injury types among the entire sample was similar for the two systems, with percentage differences >= 1% for only open wounds or amputation, poisoning, and other or unspecified injury types. Conclusions: There is potential for conducting comparable injury research using NEISS and ICD-9-CM data. Due to the inclusion of some non-injuries in the NEISS and some differences in type of injury definitions between NEISS and ICD-9-CM coding, best practice for studies using NEISS data obtained from the CPSC should include manual review of case narratives. Use of the standardized injury and injury type definitions presented in this study will facilitate more accurate comparisons in injury research.	[Thompson, Meghan C.; Wheeler, Krista K.; Shi, Junxin; Smith, Gary A.; Xiang, Huiyun] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA; [Thompson, Meghan C.; Smith, Gary A.; Xiang, Huiyun] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Xiang, HY (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA.	Huiyun.Xiang@nationwidechildrens.org	Xiang, Huiyun/E-4335-2011	Thompson, Meghan/0000-0003-1462-4802	National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, United States Department of Health and Human Services [1R49CE000241-01]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE000241] Funding Source: NIH RePORTER	National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, United States Department of Health and Human Services; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was funded by the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, United States Department of Health and Human Services (Grant No.: 1R49CE000241-01). The views expressed here are solely the responsibility of the authors and do not necessarily reflect the official views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; [Anonymous], 2009, ACC ICD 9 CM COD 5 0; [Anonymous], 2013, ICD 10; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Buck CJ, 2009, 2009 ICD 9 CM, V1; Centers for Disease Control and Prevention, 2003, WEB BAS INJ STAT QUE; CHRISTOFFEL KK, 1992, PEDIATRICS, V89, P1027; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Division of Hazard and Injury Systems U.S. Consumer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; German R R, 2001, MMWR Recomm Rep, V50, P1; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Halpin J, 2009, INJURY PREV, V15, P328, DOI 10.1136/ip.2009.021691; Harris VA, 2011, PEDIATRICS, V128, P455, DOI 10.1542/peds.2010-2687; Holder Y, 2001, INJURY SURVEILLANCE; Horan JM, 2003, EPIDEMIOL REV, V25, P24, DOI 10.1093/epirev/mxg010; Israeli Center for Trauma and Emergency Medicine Research Gertner Institute Sheba Medical Center, BAR INJ DIAGN MATR C BAR INJ DIAGN MATR C; Jhung MA, 2007, MED CARE, V45, pS96, DOI 10.1097/MLR.0b013e318041f737; Lawrence BA., 2011, MED WORK LOSS COST E; Lawrence BA, 2000, INJURY CONTROL SAFET, V7, P97; McDonald A K, 1996, Inj Prev, V2, P77, DOI 10.1136/ip.2.1.77; Miller TR., 1995, DATABOOK NONFATAL IN; Quinlan KP, 1999, ANN EMERG MED, V34, P637, DOI 10.1016/S0196-0644(99)70166-6; Schroeder T, 2013, STATISTICIAN; Spicer R.S., 2010, FINAL REPORT NATL HI; U.S. Consumer Product Safety Commission, 2012, NEISS COD MAN ALL TR; U.S. Consumer Product Safety Commission, 2012, NEISS COD MAN; United States Department of Health and Human Services Centers for Disease Control and Prevention National Center for Injury Prevention and Control and United States Consumer Product Safety Commission, 2009, NAT EL INJ SURV SYST; Weiss H B, 1996, Inj Prev, V2, P61, DOI 10.1136/ip.2.1.61; Xiang H, 2006, INJURY PREV, V12, P8, DOI 10.1136/ip.2005.010033; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034	31	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92052	10.1371/journal.pone.0092052	http://dx.doi.org/10.1371/journal.pone.0092052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658100	gold, Green Published			2022-12-25	WOS:000333355300051
J	Wang, TN; Huang, MS; Lin, MC; Duh, TH; Lee, CH; Wang, CC; Chen, PH; Chiang, SL; Sheu, CC; Chen, VCH; Wu, CC; Ferri, CP; Stewart, R; Ko, YC				Wang, Tsu-Nai; Huang, Ming-Shyan; Lin, Meng-Chih; Duh, Tsai-Hui; Lee, Chih-Hung; Wang, Chin-Chou; Chen, Ping-Ho; Chiang, Shang-Lun; Sheu, Chau-Chyun; Chen, Vincent Chin-Hung; Wu, Chao-Chien; Ferri, Cleusa P.; Stewart, Robert; Ko, Ying-Chin			Betel Chewing and Arecoline Affects Eotaxin-1, Asthma and Lung Function	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; ORAL-CANCER; ACTIVATOR PROTEIN-1; GUINEA-PIGS; RISK-FACTOR; KAPPA-B; NUT; FIBROBLASTS; EXPRESSION; TAIWAN	Background: Betel nut is commonly used in many countries. Despite evidence suggesting an association with asthma, few studies have investigated the connection between betel nut use and asthma; thus, the underlying mechanism for the association with asthma is also unclear. The aim of this study was to investigate the association between betel chewing and asthma as well as the associations of plasma arecoline (a biomarker for exposure) and eotaxin-1 (a potential mediator) with asthma and lung function. Methods: We recruited 600 hospital-based asthmatic patients and 1200 age- and gender-matched community controls in southern Taiwan. To clarify the mechanism of action for eotaxin-1 in the association between betel chewing and asthma, we also designed an in vitro experiment to study the functional associations between arecoline exposure and eotaxin-1 levels. Results: A significant association was found between asthma and current betel chewing (adjusted odds ratio 2.05, 95% CI = 1.12-3.76), which was independent of potential confounders but was attenuated following adjustment for eotaxin-1. Arecoline and eotaxin-1 levels were positively correlated (Spearman r = 0.303, p = 0.02), while arecoline and arecaidine were negatively correlated with lung function. Functionally, arecoline alone does not induce eotaxin-1 release in vitro from dermal and gingival fibroblasts. However, in the presence of IL-4 and TNF-alpha, arecoline at 100 mg/ml induced more eotaxin-1 release than arecoline at 0 mu g/ml (2700 +/- 98 pg/ml vs 1850 +/- 142 pg/ml, p = 0.01 in dermal fibroblast cells, and 1489 +/- 78 pg/ml vs 1044 +/- 95 pg/ml, p = 0.03 in gingival fibroblast cells, respectively). Conclusion: Betel chewing is associated with asthma in this population, with arecoline induction of eotaxin-1 supported as a plausible causal pathway.	[Wang, Tsu-Nai] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan; [Wang, Tsu-Nai; Huang, Ming-Shyan; Duh, Tsai-Hui; Chen, Ping-Ho] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Huang, Ming-Shyan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Internal Med,Div Pulm & Crit Care Med & Geri, Kaohsiung, Taiwan; [Lin, Meng-Chih; Wu, Chao-Chien] Chang Gung Univ, Chang Gung Mem Hospital, Coll Med, Med Ctr,Dept Med,Div Pulm & Critical Care Med, Kaohsiung, Taiwan; [Duh, Tsai-Hui] Kaohsiung Med Univ, Dept Med & Appl Chem, Kaohsiung, Taiwan; [Lee, Chih-Hung] Kaohsiung Chang Gung Mem Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Lee, Chih-Hung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chen, Ping-Ho] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung, Taiwan; [Chiang, Shang-Lun; Ko, Ying-Chin] China Med Univ Hosp, Environment Omics Dis Res Ctr, Taichung, Taiwan; [Chiang, Shang-Lun; Ko, Ying-Chin] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sheu, Chau-Chyun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Fac Med,Dept Internal Med,Div Pulm & Crit Care Me, Kaohsiung, Taiwan; [Chen, Vincent Chin-Hung] Chung Shan Med Univ, Chung Shan Med Univ Hosp, Sch Med, Inst Med,Dept Psychiat, Taichung, Taiwan; [Ferri, Cleusa P.] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Chen, Vincent Chin-Hung; Stewart, Robert] Kings Coll London, Inst Psychiat, London, England	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Universidade Federal de Sao Paulo (UNIFESP); University of London; King's College London	Wu, CC (corresponding author), Chang Gung Univ, Chang Gung Mem Hospital, Coll Med, Med Ctr,Dept Med,Div Pulm & Critical Care Med, Kaohsiung, Taiwan.	my47104710@gmail.com; ycko0406@gmail.com	Sheu, Chau-Chyun/AAC-7244-2020; Ferri, Cleusa Pinheiro/B-2922-2010; Stewart, Robert/B-1667-2010; Lee, Chih-Hung/AAJ-5551-2020	Sheu, Chau-Chyun/0000-0002-7979-3749; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Stewart, Robert/0000-0002-4435-6397; Lee, Chih-Hung/0000-0001-9804-3874; Wang, Tsu-Nai/0000-0002-0278-289X	National Health Research Institutes [NHRI-CN-PD9611P]; National Science Council, Taiwan [NSC96-2314-B-037-040-MY3, NSC100-2314-B-037-025-MY3]; National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust; King's College London	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London(General Electric)	This work was supported by grants NHRI-CN-PD9611P from the National Health Research Institutes, NSC96-2314-B-037-040-MY3 and NSC100-2314-B-037-025-MY3 from National Science Council, Taiwan. RS is part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakraborty P, 2009, INT ARCH ALLERGY IMM, V149, P305, DOI 10.1159/000205576; Chen CL, 2002, J TOXICOL ENV HEAL A, V65, P327, DOI 10.1080/15287390252800909; Chiang SL, 2007, TOXICOL SCI, V100, P66, DOI 10.1093/toxsci/kfm201; GINA, 1995, NAT I HLTH BETH NAT, V95-3659; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; Henderson WR, 2002, J IMMUNOL, V169, P5294, DOI 10.4049/jimmunol.169.9.5294; IARC, 1985, IARC MONOGR EVAL CAR, V37, P145; KIYINGI KS, 1991, PAPUA NEW GUINEA MED, V34, P117; KO YC, 1992, J ORAL PATHOL MED, V21, P261, DOI 10.1111/j.1600-0714.1992.tb01007.x; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; LADENIUS ARC, 1993, EUR J PHARMACOL, V235, P127; Lamkhioued B, 1997, J IMMUNOL, V159, P4593; Lu HH, 2010, AUTOPHAGY, V6, P725, DOI 10.4161/auto.6.6.12423; Manna SK, 2006, BIOCHEM PHARMACOL, V71, P1602, DOI 10.1016/j.bcp.2006.02.014; Min MG, 2007, J IMMUNOL, V178, P5321, DOI 10.4049/jimmunol.178.8.5321; Miyamasu M, 1999, CYTOKINE, V11, P751, DOI 10.1006/cyto.1999.0487; Moerloose KB, 2005, AM J RESP CRIT CARE, V172, P168, DOI 10.1164/rccm.200409-1174OC; Nelson BS, 1999, ANN EMERG MED, V34, P238, DOI 10.1016/S0196-0644(99)70239-8; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; PICKWELL SM, 1994, WESTERN J MED, V160, P326; ROTHENBERG ME, 1995, P NATL ACAD SCI USA, V92, P8960, DOI 10.1073/pnas.92.19.8960; Sabatini F, 2002, IMMUNOL LETT, V84, P173, DOI 10.1016/S0165-2478(02)00183-9; TAYLOR RFH, 1992, LANCET, V339, P1134, DOI 10.1016/0140-6736(92)90732-I; Teran LM, 1999, AM J RESP CELL MOL, V20, P777, DOI 10.1165/ajrcmb.20.4.3508; TIMBERLAKE CM, 1992, PAPUA NEW GUINEA MED, V35, P186; Trivedy C, 1999, BMJ-BRIT MED J, V318, P1287; VANOOSTERHOUT AJM, 1993, AM REV RESPIR DIS, V147, P548, DOI 10.1164/ajrccm/147.3.548; Vayssier M, 1998, AM J PHYSIOL-LUNG C, V275, pL771, DOI 10.1152/ajplung.1998.275.4.L771; Wang TN, 2010, AM J RESP CRIT CARE, V182, P1369, DOI 10.1164/rccm.200906-0969OC; Warnakulasuriya S, 2002, BMJ-BRIT MED J, V324, P799, DOI 10.1136/bmj.324.7341.799; Wu IC, 2010, J ANAL TOXICOL, V34, P325, DOI 10.1093/jat/34.6.325	31	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91889	10.1371/journal.pone.0091889	http://dx.doi.org/10.1371/journal.pone.0091889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658613	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300043
J	Allen, RJ; Soares, MA; Haberman, ID; Szpalski, C; Schachar, J; Lin, CD; Nguyen, PD; Saadeh, PB; Warren, SM				Allen, Robert J., Jr.; Soares, Marc A.; Haberman, Ilyse D.; Szpalski, Caroline; Schachar, Jeffrey; Lin, Clarence D.; Nguyen, Phuong D.; Saadeh, Pierre B.; Warren, Stephen M.			Combination Therapy Accelerates Diabetic Wound Closure	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; QUALITY-OF-LIFE; GROWTH-FACTOR; MYOCARDIAL-INFARCTION; MOBILIZATION; STEM; NEOVASCULARIZATION; COMPLICATIONS; CXCR4; VASCULOGENESIS	Background: Non-healing foot ulcers are the most common cause of non-traumatic amputation and hospitalization amongst diabetics in the developed world. Impaired wound neovascularization perpetuates a cycle of dysfunctional tissue repair and regeneration. Evidence implicates defective mobilization of marrow-derived progenitor cells (PCs) as a fundamental cause of impaired diabetic neovascularization. Currently, there are no FDA-approved therapies to address this defect. Here we report an endogenous PC strategy to improve diabetic wound neovascularization and closure through a combination therapy of AMD3100, which mobilizes marrow-derived PCs by competitively binding to the cell surface CXCR4 receptor, and PDGF-BB, which is a protein known to enhance cell growth, progenitor cell migration and angiogenesis. Methods and Results: Wounded mice were assigned to 1 of 5 experimental arms (n = 8/arm): saline treated wild-type, saline treated diabetic, AMD3100 treated diabetic, PDGF-BB treated diabetic, and AMD3100/PDGF-BB treated diabetic. Circulating PC number and wound vascularity were analyzed for each group (n = 8/group). Cellular function was assessed in the presence of AMD3100. Using a validated preclinical model of type II diabetic wound healing, we show that AMD3100 therapy (10 mg/kg; i.p. daily) alone can rescue diabetes-specific defects in PC mobilization, but cannot restore normal wound neovascularization. Through further investigation, we demonstrate an acquired trafficking-defect within AMD3100-treated diabetic PCs that can be rescued by PDGF-BB (2 mg; topical) supplementation within the wound environment. Finally, we determine that combination therapy restores diabetic wound neovascularization and accelerates time to wound closure by 40%. Conclusions: Combination AMD3100 and PDGF-BB therapy synergistically improves BM PC mobilization and trafficking, resulting in significantly improved diabetic wound closure and neovascularization. The success of this endogenous, cell-based strategy to improve diabetic wound healing using FDA-approved therapies is inherently translatable.	[Allen, Robert J., Jr.; Soares, Marc A.; Haberman, Ilyse D.; Szpalski, Caroline; Schachar, Jeffrey; Lin, Clarence D.; Nguyen, Phuong D.; Saadeh, Pierre B.; Warren, Stephen M.] NYU, Inst Reconstruct Plast Surg, Langone Med Ctr, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Warren, SM (corresponding author), NYU, Inst Reconstruct Plast Surg, Langone Med Ctr, New York, NY 10016 USA.	stephen.warren.md@gmail.com		Haberman, Ilyse/0000-0002-3289-4788; Saadeh, Pierre/0000-0001-9818-8598	NIMHD NIH HHS [L60 MD003100] Funding Source: Medline	NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Armstrong DG, 2008, J FOOT ANKLE SURG, V47, P278, DOI 10.1053/j.jfas.2008.02.015; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bernardi S, 2012, EXP DIABETES RES, DOI 10.1155/2012/872504; Boutoille D, 2008, FOOT ANKLE INT, V29, P1074, DOI 10.3113/FAI.2008.1074; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Capla JM, 2007, PLAST RECONSTR SURG, V119, P59, DOI 10.1097/01.prs.0000244830.16906.3f; Cashen Amanda F, 2007, Future Oncol, V3, P19, DOI 10.2217/14796694.3.1.19; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan RK, 2006, J BURN CARE RES, V27, P202, DOI 10.1097/01.BCR.0000202898.11277.58; Cheng CF, 2011, J CLIN INVEST, V121, P4348, DOI 10.1172/JCI46475; Cross KJ, 2003, SURG CLIN N AM, V83, P531, DOI 10.1016/S0039-6109(02)00202-5; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Davidson EH, 2011, PLAST RECONSTR SURG, V128, P406, DOI 10.1097/PRS.0b013e31821e6e2e; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fiorina P, 2010, CELL TRANSPLANT, V19, P1369, DOI 10.3727/096368910X514288; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Jarajapu YPR, 2010, CIRC RES, V106, P854, DOI 10.1161/CIRCRESAHA.109.213140; Kao HK, 2011, ANN SURG, V254, P1066, DOI 10.1097/SLA.0b013e3182251559; KOLLURU GK, 2012, INT J VASC MED, DOI DOI 10.1155/2012/918267; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Lee E, 2010, INVEST OPHTH VIS SCI, V51, P3666, DOI 10.1167/iovs.09-3802; Lin CD, 2008, PLAST RECONSTR SURG, V122, P1341, DOI 10.1097/PRS.0b013e318188217b; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Miyajima S, 2006, DIABETES RES CLIN PR, V71, P272, DOI 10.1016/j.diabres.2005.07.005; Nagai MK, 2002, EXPERT OPIN BIOL TH, V2, P211, DOI 10.1517/14712598.2.2.211; Nishimura Y, 2012, J INVEST DERMATOL, V132, P711, DOI 10.1038/jid.2011.356; Petersen M, 2003, DIABETES CARE, V26, P917; Robson MC, 1998, AM J SURG, V176, p80S, DOI 10.1016/S0002-9610(98)00186-X; Roncalli J, 2011, J AM COLL CARDIOL, V57, P2444, DOI 10.1016/j.jacc.2010.11.069; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Schwartz A, 2004, CYTOM PART B-CLIN CY, V57B, P1, DOI 10.1002/cyto.b.10066; Sciaccaluga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073426; Suriano R, 2008, CANCER RES, V68, P6038, DOI 10.1158/0008-5472.CAN-08-1009; Tanaka R, 2014, CELL TRANSPLANT, V23, P167, DOI 10.3727/096368912X658007; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Tepper OM, 2010, DIABETES, V59, P1974, DOI 10.2337/db09-0185; Theiss HD, 2011, STEM CELL RES, V7, P244, DOI 10.1016/j.scr.2011.05.003; Wang XX, 2011, PLAST RECONSTR SURG, V128, P395, DOI 10.1097/PRS.0b013e31821e6e10	46	22	22	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92667	10.1371/journal.pone.0092667	http://dx.doi.org/10.1371/journal.pone.0092667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651576	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800140
J	Barciszewska, AM; Nowak, S; Naskret-Barciszewska, MZ				Barciszewska, Anna-Maria; Nowak, Stanislaw; Naskret-Barciszewska, Miroslawa Z.			The Degree of Global DNA Hypomethylation in Peripheral Blood Correlates with That in Matched Tumor Tissues in Several Neoplasia	PLOS ONE			English	Article							METHYLATION; DEMETHYLATION; CANCER; CLASSIFICATION; EPIGENOME; BIOLOGY; CELLS	There are no good blood and serum biomarkers for detection, follow up, or prognosis of brain tumors. However, they are needed for more detailed tumor classification, better prognosis estimation and selection of an efficient therapeutic strategy. The aim of this study was to use the epigenetic changes in DNA of peripheral blood samples as a molecular marker to diagnose brain tumors as well as other diseases. We have applied a very precise thin-layer chromatography (TLC) analysis of the global amount of 5-methylcytosine (m(5)C) in DNA from brain tumors, colon and breast cancer tissues and peripheral blood samples of the same patients. The m(5)C level in tissue DNA from different brain tumor types, expressed as R coefficient, changes within the range of 0.2-1.6 and overlaps with R of that of blood samples. It negatively correlates with the WHO malignancy grade. The global DNA hypomethylation quantitative measure in blood, demonstrates a big potential for development of non-invasive applications for detection of a low and a high grade brain tumors. We have also used this approach to analyze patients with breast and colon cancers. In all these cases the m(5)C amount in DNA cancer tissue match with data of blood. This study is the first to demonstrate the potential role of global m(5)C content in blood DNA for early detection of brain tumors and others diseases. So, genomic DNA hypomethylation is a promising marker for prognosis of various neoplasms as well as other pathologies.	[Barciszewska, Anna-Maria; Nowak, Stanislaw] Poznan Univ Med Sci, Dept Neurosurg & Neurotraumatol, Poznan, Poland; [Naskret-Barciszewska, Miroslawa Z.] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	Poznan University of Medical Sciences; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Barciszewska, AM (corresponding author), Poznan Univ Med Sci, Dept Neurosurg & Neurotraumatol, Poznan, Poland.	abarcisz@man.poznan.pl	Barciszewska, Anna-Maria/J-5978-2018	Barciszewska, Anna-Maria/0000-0002-7179-1474	Polish Ministry of Science and Higher Education [N N401 066338, N N403 219637]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported within the Polish Ministry of Science and Higher Education projects Nr N N401 066338 to AMB and MZNB and Nr N N403 219637 to AMB, SN and MZNB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli R, 2011, FREE RADICAL BIO MED, V50, P254, DOI 10.1016/j.freeradbiomed.2010.11.009; Barciszewska AM, 2007, IUBMB LIFE, V59, P765, DOI 10.1080/15216540701697412; Barciszewska AM, 2009, THERAPEUTIC RIBONUCLEIC ACIDS IN BRAIN TUMORS, P141, DOI 10.1007/978-3-642-00475-9_7; Barciszewska MZ, 2007, BIOGERONTOLOGY, V8, P673, DOI 10.1007/s10522-007-9109-3; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Fouse SD, 2010, EPIGENOMICS-UK, V2, P105, DOI 10.2217/EPI.09.35; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Fueyo J, 2011, ARCH NEUROL-CHICAGO, V68, P303, DOI 10.1001/archneurol.2010.293; Gong ZZ, 2011, CELL RES, V21, P1649, DOI 10.1038/cr.2011.140; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Iwamoto K, 2011, GENOME RES, V21, P688, DOI 10.1101/gr.112755.110; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Klug M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r63; Langevin SM, 2012, EPIGENETICS-US, V7, P291, DOI 10.4161/epi.7.3.19134; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nagarajan RP, 2009, SEMIN CANCER BIOL, V19, P188, DOI 10.1016/j.semcancer.2009.02.005; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; Niedzwiecki MM, 2013, EPIGENETICS-US, V8, P730, DOI 10.4161/epi.25012; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Rajendran G, 2011, J NEURO-ONCOL, V104, P483, DOI 10.1007/s11060-010-0520-2; Smolarek I, 2010, MED SCI MONITOR, V16, pCR149; Stieber D, 2011, EXPERT OPIN THER TAR, V15, P1227, DOI 10.1517/14728222.2011.588211; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Ullah MF, 2009, CANCER TREAT REV, V35, P193, DOI 10.1016/j.ctrv.2008.10.004; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Volle CB, 2012, BIOCHEMISTRY-US, V51, P52, DOI 10.1021/bi201552s; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zukiel R, 2004, MOL CANCER RES, V2, P196	33	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92599	10.1371/journal.pone.0092599	http://dx.doi.org/10.1371/journal.pone.0092599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651295	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800132
J	Buti, E; Mesquita, D; Araujo, SJ				Buti, Elisenda; Mesquita, Duarte; Araujo, Sofia J.			Hedgehog Is a Positive Regulator of FGF Signalling during Embryonic Tracheal Cell Migration	PLOS ONE			English	Article							SONIC HEDGEHOG; FEEDBACK LOOP; BRANCHING MORPHOGENESIS; TRANSCRIPTION FACTORS; DROSOPHILA SEGMENT; GENE-EXPRESSION; GROWTH; EGR; BRANCHLESS; HOMOLOG	Cell migration is a widespread and complex process that is crucial for morphogenesis and for the underlying invasion and metastasis of human cancers. During migration, cells are steered toward target sites by guidance molecules that induce cell direction and movement through complex intracellular mechanisms. The spatio-temporal regulation of the expression of these guidance molecules is of extreme importance for both normal morphogenesis and human disease. One way to achieve this precise regulation is by combinatorial inputs of different transcription factors. Here we used Drosophila melanogaster mutants with migration defects in the ganglionic branches of the tracheal system to further clarify guidance regulation during cell migration. By studying the cellular consequences of overactivated Hh signalling, using ptc mutants, we found that Hh positively regulates Bnl/FGF levels during embryonic stages. Our results show that Hh modulates cell migration non-autonomously in the tissues surrounding the action of its activity. We further demonstrate that the Hh signalling pathway regulates bnl expression via Stripe (Sr), a zinc-finger transcription factor with homology to the Early Growth Response (EGR) family of vertebrate transcription factors. We propose that Hh modulates embryonic cell migration by participating in the spatio-temporal regulation of bnl expression in a permissive mode. By doing so, we provide a molecular link between the activation of Hh signalling and increased chemotactic responses during cell migration.	[Buti, Elisenda; Mesquita, Duarte; Araujo, Sofia J.] CSIC, IBMB, Inst Mol Biol Barcelona, Dept Dev Biol, Barcelona, Spain; [Buti, Elisenda; Mesquita, Duarte; Araujo, Sofia J.] Inst Res Biomed IRB Barcelona, Cell & Dev Biol Programme, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Araujo, SJ (corresponding author), CSIC, IBMB, Inst Mol Biol Barcelona, Dept Dev Biol, Barcelona, Spain.	sarbmc@ibmb.csic.es	Araújo, Sofia J/J-5681-2014	Araújo, Sofia J/0000-0002-4749-8913	Spanish Ministerio de Ciencia y Innovacion [RYC-2007-00417, BFU-2006-01935, BFU-2009-07629]; FPI fellowship; Leonardo da Vinci fellowship; Spanish Ministerio de Ciencia y Innovacion	Spanish Ministerio de Ciencia y Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPI fellowship(Spanish Government); Leonardo da Vinci fellowship; Spanish Ministerio de Ciencia y Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the Spanish Ministerio de Ciencia y Innovacion (RYC-2007-00417, BFU-2006-01935, BFU-2009-07629). E. B. was supported by a FPI fellowship and D. M. by a Leonardo da Vinci fellowship. S.J.A. holds a Ramon y Cajal Researcher position granted by the Spanish Ministerio de Ciencia y Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFOLTER M, 1994, DEVELOPMENT, V120, P3105; AFFOLTER M, 1994, DEVELOPMENT, V120, P743; Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Araujo SJ, 2011, J CELL SCI; Araujo SJ, 2007, DEVELOPMENT, V134, P3665, DOI 10.1242/dev.007328; Aza-Blanc P, 1999, TRENDS GENET, V15, P458, DOI 10.1016/S0168-9525(99)01869-7; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Barrett AL, 2008, DEV BIOL, V317, P234, DOI 10.1016/j.ydbio.2008.02.025; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Biehs B, 2010, DEVELOPMENT, V137, P3887, DOI 10.1242/dev.055871; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; BRAND AH, 1993, DEVELOPMENT, V118, P401; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Campos-Ortega AJ, 1985, EMBRYONIC DEV DROSOP, P10; Casali A, 2004, NATURE, V431, P76, DOI 10.1038/nature02835; Caussinus E, 2008, CURR BIOL, V18, P1727, DOI 10.1016/j.cub.2008.10.062; Chen CK, 1998, DEVELOPMENT, V125, P4959; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Choy SW, 2012, VITAM HORM, V88, P1, DOI 10.1016/B978-0-12-394622-5.00001-8; Christiansen AE, 2013, CELL DEATH DIFFER, V20, P302, DOI 10.1038/cdd.2012.126; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Dorfman R, 2002, DEV BIOL, V252, P119, DOI 10.1006/dbio.2002.0836; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Englund C, 1999, DEVELOPMENT, V126, P1505; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Frommer G, 1996, EMBO J, V15, P1642, DOI 10.1002/j.1460-2075.1996.tb00509.x; Geisbrecht ER, 2013, DEV DYN; Gervais L, 2011, DEVELOPMENT, V138, P1269, DOI 10.1242/dev.059188; Ghabrial AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002087; Glazer L, 2001, DEVELOPMENT, V128, P1599; Guillemin K, 1996, DEVELOPMENT, V122, P1353; HIDALGO A, 1990, DEVELOPMENT, V110, P291; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Imam F, 1999, GENETICS; Ingham PW, 2011, NATURE REV GENETICS; Kato K, 2004, DEVELOPMENT, V131, P5253, DOI 10.1242/dev.01404; Khaliullina H, 2009, DEVELOPMENT; Klambt C, 1992, GENES DEV; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; LEE JC, 1995, P NATL ACAD SCI USA, V92, P10344, DOI 10.1073/pnas.92.22.10344; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; Lin CW, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003423; Merabet S, 2005, EMBO REP, V6, P762, DOI 10.1038/sj.embor.7400462; Miyake A, 2005, DEV BIOL, V288, P259, DOI 10.1016/j.ydbio.2005.09.042; Nussbaumer U, 2000, MECH DEVELOP, V96, P27, DOI 10.1016/S0925-4773(00)00373-7; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Piepenburg O, 2000, MOL CELL, V6, P203, DOI 10.1016/S1097-2765(00)00022-8; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; SUKHATME VP, 1990, J AM SOC NEPHROL, V1, P859; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; Vincent S, 1997, DEVELOPMENT, V124, P2741; Vorbruggen G, 1997, P NATL ACAD SCI USA, V94, P8606, DOI 10.1073/pnas.94.16.8606; Zhan YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014134; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	66	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92682	10.1371/journal.pone.0092682	http://dx.doi.org/10.1371/journal.pone.0092682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651658	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800142
J	Cardoso, JCR; Felix, RC; Power, DM				Cardoso, Joao C. R.; Felix, Rute C.; Power, Deborah M.			Nematode and Arthropod Genomes Provide New Insights into the Evolution of Class 2 B1 GPCRs	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CYCLASE-ACTIVATING POLYPEPTIDE; HORMONE-RELEASING-HORMONE; PARATHYROID-HORMONE; FUNCTIONAL-CHARACTERIZATION; CAENORHABDITIS-ELEGANS; PHYLOGENETIC ANALYSIS; DIURETIC HORMONES; SECRETIN RECEPTOR; FAMILY	Nematodes and arthropods are the most speciose animal groups and possess Class 2 B1 G-protein coupled receptors (GPCRs). Existing models of invertebrate Class 2 B1 GPCR evolution are mainly centered on Caenorhabditis elegans and Drosophila melanogaster and a few other nematode and arthropod representatives. The present study reevaluates the evolution of metazoan Class 2 B1 GPCRs and orthologues by exploring the receptors in several nematode and arthropod genomes and comparing them to the human receptors. Three novel receptor phylogenetic clusters were identified and designated cluster A, cluster B and PDF-R-related cluster. Clusters A and B were identified in several nematode and arthropod genomes but were absent from D. melanogaster and Culicidae genomes, whereas the majority of the members of the PDF-R-related cluster were from nematodes. Cluster A receptors were nematode and arthropod-specific but shared a conserved gene environment with human receptor loci. Cluster B members were orthologous to human GCGR, PTHR and Secretin members with which they probably shared a common origin. PDF-R and PDF-R related clusters were present in representatives of both nematodes and arthropods. The results of comparative analysis of GPCR evolution and diversity in protostomes confirm previous notions that C. elegans and D. melanogaster genomes are not good representatives of nematode and arthropod phyla. We hypothesize that at least four ancestral Class 2 B1 genes emerged early in the metazoan radiation, which after the protostome-deuterostome split underwent distinct selective pressures that resulted in duplication and deletion events that originated the current Class 2 B1 GPCRs in nematode and arthropod genomes.	[Cardoso, Joao C. R.; Felix, Rute C.; Power, Deborah M.] Ctr Marine Sci, Faro, Portugal		Cardoso, JCR (corresponding author), Ctr Marine Sci, Faro, Portugal.	jccardo@ualg.pt	Félix, Rute/AAC-2912-2020; Power, Deborah M/D-3333-2011; Félix, Rute C/M-6164-2013; dos Reis Cardoso, Joao Carlos/M-4151-2013	Félix, Rute/0000-0002-4144-3452; Power, Deborah M/0000-0003-1366-0246; Félix, Rute C/0000-0002-4144-3452; dos Reis Cardoso, Joao Carlos/0000-0001-7890-0170	Portuguese Foundation for Science and Technology (FCT) [PTDC/BIA-BCM/114395/2009]; European Regional Development Fund through COMPETE; FCT [PEst-C/MAR/LA0015/2011, SFRH/BPD/89811/2012]; auxiliary research contract FCT Pluriannual funds	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Regional Development Fund through COMPETE; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); auxiliary research contract FCT Pluriannual funds	This work was supported by the Portuguese Foundation for Science and Technology (FCT) project PTDC/BIA-BCM/114395/2009, by the European Regional Development Fund through COMPETE and FCT under the project "PEst-C/MAR/LA0015/2011." RCF is in receipt of an FCT grant (SFRH/BPD/89811/2012) and JCRC is supported by auxiliary research contract FCT Pluriannual funds attributed to CCMAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti G, 2006, J BIOL CHEM, V281, P24193, DOI 10.1074/jbc.M603528200; Asmann YW, 2000, MOL PHARMACOL, V58, P911, DOI 10.1124/mol.58.5.911; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P325; Cabrero P, 2002, J EXP BIOL, V205, P3799; Cardoso JCR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-108; Cardoso Joao C R, 2012, Front Endocrinol (Lausanne), V3, P157, DOI 10.3389/fendo.2012.00157; Cardoso JCR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-135; Coast GM, 2002, ADV INSECT PHYSIOL, V29, P279, DOI 10.1016/S0065-2806(02)29004-9; Coghlan Avril, 2005, P1; Couvineau A, 2012, CURR DRUG TARGETS, V13, P103, DOI 10.2174/138945012798868434; DeAlmeida VI, 1998, MOL ENDOCRINOL, V12, P750, DOI 10.1210/me.12.5.750; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Dobolyi Arpad, 2012, Front Endocrinol (Lausanne), V3, P121, DOI 10.3389/fendo.2012.00121; Dong MQ, 2002, RECEPTOR CHANNEL, V8, P189, DOI 10.1080/10606820213686; Donnelly D, 1997, FEBS LETT, V409, P431, DOI 10.1016/S0014-5793(97)00546-2; Drozdowski L, 2009, WORLD J GASTROENTERO, V15, P385, DOI 10.3748/wjg.15.385; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Frooninckx Lotte, 2012, Front Endocrinol (Lausanne), V3, P167, DOI 10.3389/fendo.2012.00167; Furuya K, 2000, P NATL ACAD SCI USA, V97, P6469, DOI 10.1073/pnas.97.12.6469; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Harmar AJ, 2001, GENOME BIOL, V2; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hector CE, 2009, J EXP BIOL, V212, P3142, DOI 10.1242/jeb.033175; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hwang JI, 2013, MOL BIOL EVOL; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; Janssen Donny, 2013, Front Endocrinol (Lausanne), V4, P28, DOI 10.3389/fendo.2013.00028; Janssen T, 2008, J BIOL CHEM, V283, P15241, DOI 10.1074/jbc.M709060200; Jee C, 2013, GENES BRAIN BEHAV, V12, P250, DOI 10.1111/j.1601-183X.2012.00829.x; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Johnson EC, 2004, J EXP BIOL, V207, P743, DOI 10.1242/jeb.00818; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Kokkoris Stelios, 2012, Front Endocrinol (Lausanne), V3, P135, DOI 10.3389/fendo.2012.00135; Korner Meike, 2012, Front Endocrinol (Lausanne), V3, P158, DOI 10.3389/fendo.2012.00158; Laburthe M, 1996, ANN NY ACAD SCI, V805, P94; Laburthe M, 2002, RECEPTOR CHANNEL, V8, P137, DOI 10.1080/10606820290005191; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; Lam IPY, 2008, INT REV CYTOL, V265, P159, DOI 10.1016/S0074-7696(07)65004-9; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Li CJ, 2013, GENE, V519, P1, DOI 10.1016/j.gene.2013.01.061; Li YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028269; Meelkop E, 2011, PROG NEUROBIOL, V93, P125, DOI 10.1016/j.pneurobio.2010.10.004; Meelkop E, 2012, MOL CELL ENDOCRINOL, V361, P232, DOI 10.1016/j.mce.2012.05.001; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Mertens I, 2007, PEPTIDES, V28, P1775, DOI 10.1016/j.peptides.2007.05.005; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Naot D, 2008, BONE, V43, P813, DOI 10.1016/j.bone.2008.07.003; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nery LEM, 1997, COMP BIOCHEM PHYS A, V118, P1135, DOI 10.1016/S0300-9629(97)00045-5; Ng SYL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044691; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Pinheiro PLC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-110; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rota-Stabelli O, 2013, CURR BIOL, V23, P392, DOI 10.1016/j.cub.2013.01.026; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savard J, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-7; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Skaer NJV, 2002, J EXP BIOL, V205, P1869; Sommer RJ, 2011, ANNU REV GENET, V45, P1, DOI 10.1146/annurev-genet-110410-132417; Taghert PH, 2003, ADV GENET, V49, P1, DOI 10.1016/S0065-2660(03)01001-0; Talsma AD, 2012, P NATL ACAD SCI USA, V109, P12177, DOI 10.1073/pnas.1200247109; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Witherspoon DJ, 2003, J MOL EVOL, V56, P751, DOI 10.1007/s00239-002-2450-x; Wyder S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r242; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zamanian M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-596; Zandawala M, 2012, INSECT BIOCHEM MOLEC, V42, P816, DOI 10.1016/j.ibmb.2012.06.006	86	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92220	10.1371/journal.pone.0092220	http://dx.doi.org/10.1371/journal.pone.0092220			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651821	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800086
J	Charney, ND; Castorino, JJ; Dobro, MJ; Steely, SL				Charney, Noah D.; Castorino, John J.; Dobro, Megan J.; Steely, Sarah L.			Embryo Development inside Female Salamander (Ambystoma jeffersonianum-laterale) Prior to Egg Laying	PLOS ONE			English	Article							SPERM STORAGE; UNISEXUAL SALAMANDERS; RETENTION; EVOLUTION; AMPHIBIANS; PEDOMORPHOSIS; PLASTICITY; VIVIPARITY; ADVANTAGE	The length of embryo retention prior to oviposition is a critical evolutionary trait. In all oviparous salamanders, which include the vast majority of species in the order, fertilization is thought to occur at the time of egg laying. Embryos then enter the first cleavage stage several hours after being deposited. This pattern holds for previously studied individuals in the Ambystoma jeffersonianum-laterale complex. Here, we document an instance in which a female Ambystoma jeffersonianum-laterale was carrying embryos internally that had already reached stage 10 of development. Development likely began several days prior to the start of migration to the breeding pond. This is the first such record for any egg-laying salamander, and suggests a degree of plasticity in the timing of fertilization and development not previously recognized. Further work is needed to ascertain the prevalence, mechanics, and evolutionary significance of this phenomenon.	[Charney, Noah D.; Castorino, John J.; Dobro, Megan J.; Steely, Sarah L.] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA		Charney, ND (corresponding author), Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA.	noah@alumni.amherst.edu		Dobro, Megan/0000-0002-6464-3932				Andrews RM, 1997, J ZOOL, V243, P579, DOI 10.1111/j.1469-7998.1997.tb02803.x; [Anonymous], 1998, SALAMANDERS US CANAD; Bogart JP, 2007, GENOME, V50, P119, DOI 10.1139/G06-152; Boisseau C, 1975, P94; Briegleb W., 1962, Zeitschrift fuer Morphologie und Oekologie der Tiere, V51, P271, DOI 10.1007/BF00407657; Bruce RC, 2003, REPROD BIOL PHYLOGEN, V1; Buckley D, 2007, EVOL DEV, V9, P105, DOI 10.1111/j.1525-142X.2006.00141.x; Buskirk JV, 2009, ECOL MONOGR, V79, P681; Charney ND, 2013, J HERPETOLO IN PRESS; Charney ND, 2012, EVOLUTION, V66, P1387, DOI 10.1111/j.1558-5646.2011.01523.x; Clarke SF, 1879, DEV AMBLYSTOMA PUNCT, V1, P105; Denoel M, 2005, BIOL REV, V80, P663, DOI 10.1017/S1464793105006858; Duellman W. E., 1986, BIOL AMPHIBIANS; Exbrayat J. M., 2006, REPROD BIOL PHYLOGEN, V5; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Greven H., 2003, REPROD BIOL PHYLOGEN, V1; Harrison R.G, 1969, ORG DEV EMBRYO, V1, P44; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Kupfer A, 2006, ZOOL ANZ, V244, P223, DOI 10.1016/j.jcz.2005.12.001; Larson A, 2003, REPROD BIOL PHYLOGEN, V1; Laurin M, 1999, ANN SCI NAT ZOOL, V20, P99, DOI 10.1016/S0003-4339(00)86974-9; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; POLLACK HN, 1993, GLOBAL PLANET CHANGE, V7, P173, DOI 10.1016/0921-8181(93)90048-S; SCHRECKENBERG GM, 1975, DEV BIOL, V42, P391, DOI 10.1016/0012-1606(75)90343-7; SEVER DM, 1995, J MORPHOL, V223, P35, DOI 10.1002/jmor.1052230106; Sever DM, 1998, J EXP ZOOL, V282, P460, DOI 10.1002/(SICI)1097-010X(199811/12)282:4/5<460::AID-JEZ5>3.0.CO;2-O; Sever DM, 2003, REPROD BIOL PHYLOGEN, V2; Tennessen JA, 2003, MOL ECOL, V12, P1567, DOI 10.1046/j.1365-294X.2003.01830.x; TOMPA AS, 1979, J MOLLUS STUD, V45, P155, DOI 10.1093/oxfordjournals.mollus.a065489; Wake MH, 1998, J EXP ZOOL, V282, P477; WAKE MH, 1993, J EXP ZOOL, V266, P394, DOI 10.1002/jez.1402660507; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P111, DOI 10.1093/icb/icr046; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037	33	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91919	10.1371/journal.pone.0091919	http://dx.doi.org/10.1371/journal.pone.0091919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651275	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800054
J	Fulcher, BD; Phillips, AJK; Postnova, S; Robinson, PA				Fulcher, Ben D.; Phillips, Andrew J. K.; Postnova, Svetlana; Robinson, Peter A.			A Physiologically Based Model of Orexinergic Stabilization of Sleep and Wake	PLOS ONE			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; COERULEUS-NORADRENERGIC SYSTEM; VENTROLATERAL PREOPTIC NUCLEUS; ASCENDING AROUSAL SYSTEM; CIRCADIAN-RHYTHMS; QUANTITATIVE MODEL; ACTIVE NEURONS; HYPOCRETIN/OREXIN NEURONS; NARCOLEPSY-CATAPLEXY; MATHEMATICAL-MODEL	The orexinergic neurons of the lateral hypothalamus (Orx) are essential for regulating sleep-wake dynamics, and their loss causes narcolepsy, a disorder characterized by severe instability of sleep and wake states. However, the mechanisms through which Orx stabilize sleep and wake are not well understood. In this work, an explanation of the stabilizing effects of Orx is presented using a quantitative model of important physiological connections between Orx and the sleep-wake switch. In addition to Orx and the sleep-wake switch, which is composed of mutually inhibitory wake-active monoaminergic neurons in brainstem and hypothalamus (MA) and the sleep-active ventrolateral preoptic neurons of the hypothalamus (VLPO), the model also includes the circadian and homeostatic sleep drives. It is shown that Orx stabilizes prolonged waking episodes via its excitatory input to MA and by relaying a circadian input to MA, thus sustaining MA firing activity during the circadian day. During sleep, both Orx and MA are inhibited by the VLPO, and the subsequent reduction in Orx input to the MA indirectly stabilizes sustained sleep episodes. Simulating a loss of Orx, the model produces dynamics resembling narcolepsy, including frequent transitions between states, reduced waking arousal levels, and a normal daily amount of total sleep. The model predicts a change in sleep timing with differences in orexin levels, with higher orexin levels delaying the normal sleep episode, suggesting that individual differences in Orx signaling may contribute to chronotype. Dynamics resembling sleep inertia also emerge from the model as a gradual sleep-to-wake transition on a timescale that varies with that of Orx dynamics. The quantitative, physiologically based model developed in this work thus provides a new explanation of how Orx stabilizes prolonged episodes of sleep and wake, and makes a range of experimentally testable predictions, including a role for Orx in chronotype and sleep inertia.	[Fulcher, Ben D.; Postnova, Svetlana; Robinson, Peter A.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Phillips, Andrew J. K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Sleep Med, Boston, MA 02115 USA; [Postnova, Svetlana; Robinson, Peter A.] Univ Sydney, Ctr Integrated Res & Understanding Sleep, Sydney, NSW 2006, Australia; [Postnova, Svetlana; Robinson, Peter A.] Univ Sydney, Brain Dynam Ctr, Sydney, NSW 2006, Australia; [Robinson, Peter A.] Univ Sydney, Cooperat Res Ctr Alertness Safety & Prod, Sydney, NSW 2006, Australia	University of Sydney; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Sydney; University of Sydney; University of Sydney	Fulcher, BD (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	ben.d.fulcher@gmail.com	Fulcher, Ben/H-8733-2019	Fulcher, Ben/0000-0002-3003-4055; Robinson, Peter/0000-0002-5050-9804; Postnova, Svetlana/0000-0002-1224-0779; Phillips, Andrew/0000-0003-1156-7056	Australian Research Council; National Health and Medical Research Council, Westmead Millennium Institute; National Space Biomedical Research Institute through NASA NCC [9-58]	Australian Research Council(Australian Research Council); National Health and Medical Research Council, Westmead Millennium Institute; National Space Biomedical Research Institute through NASA NCC	This work was supported by the Australian Research Council, the National Health and Medical Research Council, Westmead Millennium Institute, and the National Space Biomedical Research Institute through NASA NCC 9-58. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1995, ARCH ITAL BIOL, V134, P109; ACHERMANN P, 1994, BIOL CYBERN, V71, P115, DOI 10.1007/BF00197314; Akerstedt T, 2002, SLEEP MED REV, V6, P267, DOI 10.1053/smrv.2001.0202; Alexandre C, 2013, CURR OPIN NEUROBIOL, V23, P752, DOI 10.1016/j.conb.2013.04.008; Anaclet C, 2012, J NEUROSCI, V32, P17970, DOI 10.1523/JNEUROSCI.0620-12.2012; Andlauer O, 2012, SLEEP, V35, P1247, DOI 10.5665/sleep.2080; Aran A, 2010, SLEEP, V33, P1457, DOI 10.1093/sleep/33.11.1457; ASTONJONES G, 1991, PROG BRAIN RES, V88, P501; Behn CGD, 2008, J NEUROPHYSIOL, V99, P3090, DOI 10.1152/jn.01243.2007; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BROUGHTON R, 1986, SLEEP, V9, P205, DOI 10.1093/sleep/9.1.205; Burgess CR, 2012, J NEUROSCI, V32, P12305, DOI 10.1523/JNEUROSCI.2630-12.2012; Carrier J, 1997, J SLEEP RES, V6, P230, DOI 10.1111/j.1365-2869.1997.00230.x; Carter ME, 2012, P NATL ACAD SCI USA, V109, pE2635, DOI 10.1073/pnas.1202526109; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chou TC, 2003, J NEUROSCI, V23, P10691; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; DANTZ B, 1994, ELECTROEN CLIN NEURO, V90, P24, DOI 10.1016/0013-4694(94)90110-4; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dworak M, 2007, NEUROSCIENCE, V150, P789, DOI 10.1016/j.neuroscience.2007.09.062; Eriksson KS, 2001, J NEUROSCI, V21, P9273, DOI 10.1523/JNEUROSCI.21-23-09273.2001; Freeman WJ, 1975, MASS ACTION NERVOUS; Fulcher BD, 2010, J THEOR BIOL, V264, P407, DOI 10.1016/j.jtbi.2010.02.028; Fulcher BD, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051920; Gallopin T, 2004, SLEEP, V27, P19; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Grivel J, 2005, J NEUROSCI, V25, P4127, DOI 10.1523/JNEUROSCI.0666-05.2005; Gundel A., 2007, SOMNOLOGIE SCHLAFFOR, V11, P148, DOI [10.1007/s11818-007-0312-x, DOI 10.1007/S11818-007-0312-X]; Horvath TL, 1999, J COMP NEUROL, V415, P145; Hungs M, 2001, BIOESSAYS, V23, P397, DOI 10.1002/bies.1058; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; Jewett ME, 1999, SLEEP, V22, P171, DOI 10.1093/sleep/22.2.171; John J, 2004, NEURON, V42, P619, DOI 10.1016/S0896-6273(04)00247-8; JONES BE, 2000, PRINCIPLES PRACTICE, P134; KAITIN KI, 1986, SLEEP, V9, P116, DOI 10.1093/sleep/9.1.116; Kantor S, 2009, SLEEP, V32, P1127, DOI 10.1093/sleep/32.9.1127; Kessler BA, 2011, NEUROSCIENCE, V178, P82, DOI 10.1016/j.neuroscience.2011.01.031; Kloeden PE, 2010, NUMERICAL SOLUTION S, V23; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Kukkonen JP, 2002, AM J PHYSIOL-CELL PH, V283, pC1567, DOI 10.1152/ajpcell.00055.2002; Kumar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042059; Lazarus M, 2013, CURR OPIN NEUROBIOL, V23, P780, DOI 10.1016/j.conb.2013.02.001; Liu RJ, 2002, J NEUROSCI, V22, P9453; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Mallis MM, 2004, AVIAT SPACE ENVIR MD, V75, pA4; Mieda M, 2004, J NEUROSCI, V24, P10493, DOI 10.1523/JNEUROSCI.3171-04.2004; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Morairty S, 2004, NEUROSCIENCE, V123, P451, DOI 10.1016/j.neuroscience.2003.08.066; Nobili L, 1996, NEUROPHYSIOL CLIN, V26, P51, DOI 10.1016/0987-7053(96)81534-6; Ohno K, 2008, FRONT NEUROENDOCRIN, V29, P70, DOI 10.1016/j.yfrne.2007.08.001; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Phillips AJK, 2007, J BIOL RHYTHM, V22, P167, DOI 10.1177/0748730406297512; Phillips AJK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003213; Phillips AJK, 2013, J THEOR BIOL, V319, P75, DOI 10.1016/j.jtbi.2012.11.029; Phillips AJK, 2010, J BIOL RHYTHM, V25, P217, DOI 10.1177/0748730410369208; Phillips AJK, 2008, J THEOR BIOL, V255, P413, DOI 10.1016/j.jtbi.2008.08.022; Phillips AJK, 2011, J BIOL RHYTHM, V26, P441, DOI 10.1177/0748730411414163; Phillips AJK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000826; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Postnova S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053379; Postnova S, 2009, J BIOL RHYTHM, V24, P523, DOI 10.1177/0748730409346655; Puckeridge M, 2011, J THEOR BIOL, V273, P44, DOI 10.1016/j.jtbi.2010.12.018; Rempe MJ, 2010, J MATH BIOL, V60, P615, DOI 10.1007/s00285-009-0276-5; Robinson PA, 1997, PHYS REV E, V56, P826, DOI 10.1103/PhysRevE.56.826; Robinson PA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041924; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Scammell TE, 2005, NAT NEUROSCI, V8, P1286, DOI 10.1038/nn1005-1286; Scammell TE, 2003, ANN NEUROL, V53, P154, DOI 10.1002/ana.10444; Selbach O, 2006, CHRONOBIOL INT, V23, P63, DOI 10.1080/07420520500545961; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Sun H, 2013, SLEEP, V36, P259, DOI 10.5665/sleep.2386; Takahashi K, 2008, NEUROSCIENCE, V153, P860, DOI 10.1016/j.neuroscience.2008.02.058; Tamakawa Y, 2006, J NEUROPHYSIOL, V95, P2055, DOI 10.1152/jn.00575.2005; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; Thakkar MM, 2008, NEUROSCIENCE, V153, P875, DOI 10.1016/j.neuroscience.2008.01.017; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2009, SLEEP, V32, P993, DOI 10.1093/sleep/32.8.993; WEBSTER RA, 2002, NEUROTRANSMITTERS DR; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859	97	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91982	10.1371/journal.pone.0091982	http://dx.doi.org/10.1371/journal.pone.0091982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651580	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800061
J	Liu, C; Li, XX; Gao, W; Liu, W; Liu, DS				Liu, Cui; Li, Xing-Xia; Gao, Wei; Liu, Wen; Liu, De-Shan			Progranulin-Derived Atsttrin Directly Binds to TNFRSF25 (DR3) and Inhibits TNF-Like Ligand 1A (TL1A) Activity	PLOS ONE			English	Article							NECROSIS-FACTOR TNF; T-CELL; GROWTH-FACTOR; DEATH RECEPTOR; FAMILY; SUPERFAMILY; MOUSE; THERAPIES; CYTOKINE; IMMUNITY	Atsttrin, a progranulin (PGRN)-derived molecule composed of three TNFR-binding domains of PGRN, binds to TNF receptors (TNFR) and is therapeutic against inflammatory arthritis. Here we screened the associations of Atsttrin and other members in TNFR subfamily, which led to the discovery of TNFRSF25 (DR3) as an additional Atsttrin-interacting member in TNFR family. Similar to TNFR1 and TNFR2, DR3 also directly bound to Atsttrin. The first three cysteine-rich domains (CRD) in the extracellular portion of DR3 were required for this interaction. Atsttrin inhibited the interaction between DR3 and its TNF-Like Ligand 1A (TL1A). In addition, Atsttrin inhibited TL1A-stimulated target gene expressions and neutralized TL1A-enhanced osteoclastogenesis in vitro. Furthermore, Atsttrin ameliorated the pathology in dextran sulfate sodium induced colitis. Taken together, these findings not only provide the new insights into Atsttrin's therapeutic action in inflammatory arthritis, but may also present Atsttrin as a novel biological agent for treating various types of diseases associated with TL1A/DR3 pathway.	[Liu, Cui; Li, Xing-Xia] Shandong Univ, Qilu Hosp, Dept Pediat Surg, Jinan 250100, Peoples R China; [Gao, Wei] Shandong Univ, Qilu Hosp, Dept Nursing, Jinan 250100, Peoples R China; [Liu, Wen] Taishan Med Univ, Dept Biotechnol, Tai An, Shandong, Peoples R China; [Liu, De-Shan] Shandong Univ, Dept Tradit Chinese Med, Qilu Hosp, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Liu, DS (corresponding author), Shandong Univ, Dept Tradit Chinese Med, Qilu Hosp, Jinan 250100, Peoples R China.	dsliu168@gmail.com			National Natural Science Foundation of China [81173250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 81173250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; Borysenko CW, 2005, BIOCHEM BIOPH RES CO, V328, P794, DOI 10.1016/j.bbrc.2005.01.017; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Buchan SL, 2012, EUR J IMMUNOL, V42, P580, DOI 10.1002/eji.201041950; Bull MJ, 2008, J EXP MED, V205, P2457, DOI 10.1084/jem.20072378; Cavallini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060136; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; Chen X, 2013, J NEUROSCI, V33, P9202, DOI 10.1523/JNEUROSCI.5336-12.2013; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Croft M, 2012, TRENDS IMMUNOL, V33, P144, DOI 10.1016/j.it.2011.10.004; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Egashira Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-105; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Furst DE, 2010, CLIN EXP RHEUMATOL, V28, pS5; Guo ZL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/540794; Haritunians T, 2010, INFLAMM BOWEL DIS, V16, P1830, DOI 10.1002/ibd.21293; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; Hwang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076679; Jian JL, 2013, FEBS LETT, V587, P3428, DOI 10.1016/j.febslet.2013.09.024; Jian JL, 2013, J LEUKOCYTE BIOL, V93, P199, DOI 10.1189/jlb.0812429; Kawase R, 2013, CARDIOVASC RES, V100, P125, DOI 10.1093/cvr/cvt178; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kim S, 2005, J IMMUNOL METHODS, V298, P1, DOI 10.1016/j.jim.2004.12.019; Latiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022688; Lee SE, 2010, DERMATOL SIN, V28, P1; Liu CJ, 2012, PHARMACOL THERAPEUT, V133, P124, DOI 10.1016/j.pharmthera.2011.10.003; Liu CJ, 2011, FEBS LETT, V585, P3675, DOI 10.1016/j.febslet.2011.04.065; Magis C, 2012, TRENDS BIOCHEM SCI, V37, P353, DOI 10.1016/j.tibs.2012.06.002; McLaren JE, 2010, J IMMUNOL, V184, P5827, DOI 10.4049/jimmunol.0903782; Meylan F, 2011, MUCOSAL IMMUNOL, V4, P172, DOI 10.1038/mi.2010.67; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Meylan F, 2011, IMMUNOL REV, V244, P188, DOI 10.1111/j.1600-065X.2011.01068.x; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Newman SJ, 2000, BRAIN RES, V857, P131, DOI 10.1016/S0006-8993(99)02417-8; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Prehn JL, 2007, J IMMUNOL, V178, P4033, DOI 10.4049/jimmunol.178.7.4033; Rasheed Z, 2008, CURR RHEUMATOL REV, V4, P246, DOI 10.2174/157339708786263915; Screaton GR, 1997, P NATL ACAD SCI USA, V94, P4615, DOI 10.1073/pnas.94.9.4615; Sfikakis PP, 2011, CLIN IMMUNOL, V141, P231, DOI 10.1016/j.clim.2011.09.005; Shih DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016090; Slebioda TJ, 2011, EUR J IMMUNOL, V41, P2606, DOI 10.1002/eji.201141477; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tan KB, 1997, GENE, V204, P35, DOI 10.1016/S0378-1119(97)00509-X; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Thurner L, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4406; Tremelling M, 2008, INFLAMM BOWEL DIS, V14, P733, DOI 10.1002/ibd.20399; Twohig JP, 2010, J NEUROSCI, V30, P3782, DOI 10.1523/JNEUROSCI.1928-09.2010; Vezina A, 2014, CANCER LETT, V345, P100, DOI 10.1016/j.canlet.2013.11.021; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645; Zhao YP, 2013, FEBS LETT, V587, P1805, DOI 10.1016/j.febslet.2013.04.037; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	54	46	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92743	10.1371/journal.pone.0092743	http://dx.doi.org/10.1371/journal.pone.0092743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651300	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800152
J	Qi, Y; Duhachek-Muggy, S; Li, H; Zolkiewska, A				Qi, Yue; Duhachek-Muggy, Sara; Li, Hui; Zolkiewska, Anna			Phenotypic Diversity of Breast Cancer-Related Mutations in Metalloproteinase-Disintegrin ADAM12	PLOS ONE			English	Article							I-TASSER; HB-EGF; CARCINOMAS; EXPRESSION; INCREASES; MIGRATION; SERVER; NOTCH	Six different somatic missense mutations in the human ADAM12 gene have been identified so far in breast cancer. Five of these mutations involve highly conserved residues in the extracellular domain of the transmembrane ADAM12-L protein. Two of these extracellular mutations, D301H and G479E, have been previously characterized in the context of mouse ADAM12. Three other mutations, T596A, R612Q, and G668A, have been reported more recently, and their effects on ADAM12-L protein structure/function are not known. Here, we show that ADAM12-L bearing the G668A mutation is largely retained in the endoplasmic reticulum in its nascent, full-length form, with an intact N-terminal pro-domain. The T596A and R612Q mutants are efficiently trafficked to the cell surface and proteolytically processed to remove their pro-domains. However, the T596A mutant shows decreased catalytic activity at the cell surface, while the R612Q mutant is fully active and comparable to the wild-type ADAM12-L. The D301H and G479E mutants, consistent with the corresponding D299H and G477E mutants of mouse ADAM12 described earlier, are not proteolytically processed and do not exhibit catalytic activity at the cell surface. Among all six breast cancer-associated mutations in ADAM12-L, mutations that preserve the activity R612Q and L792F - occur in triple-negative breast cancers, while loss-of-function mutations - D301H, G479E, T596A, and G668A - are found in non-triple negative cancers. This apparent association between the catalytic activity of the mutants and the type of breast cancer supports a previously postulated role of an active ADAM12-L in the triple negative breast cancer disease.	[Qi, Yue; Duhachek-Muggy, Sara; Li, Hui; Zolkiewska, Anna] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA	Kansas State University	Zolkiewska, A (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	zolkiea@ksu.edu		Li, Hui/0000-0002-4114-8349	NIH [R15CA151065, R01CA172222]; Terry C. Johnson Center for Basic Cancer Research at KSU; NATIONAL CANCER INSTITUTE [R15CA151065, R01CA172222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry C. Johnson Center for Basic Cancer Research at KSU; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants R15CA151065 and R01CA172222, and Innovative Research Award from Terry C. Johnson Center for Basic Cancer Research at KSU. This is contribution 13-310-J from Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Creighton CJ, 2012, BIOL-TARGETS THER, V6, P289, DOI 10.2147/BTT.S29923; Diaz B, 2013, J CELL BIOL, V201, P279, DOI 10.1083/jcb.201209151; Dillon LW, 2013, HUM MOL GENET, V22, P1443, DOI 10.1093/hmg/dds561; Dyczynska E, 2008, INT J CANCER, V122, P2634, DOI 10.1002/ijc.23405; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Frohlich C, 2013, BIOCHEM J, V452, P97, DOI 10.1042/BJ20121558; Harsha A, 2008, J MOL MED, V86, P961, DOI 10.1007/s00109-008-0353-z; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Huang J, 2005, MOL BIOL CELL, V16, P4982, DOI 10.1091/mbc.E05-03-0258; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Li H, 2013, BREAST CANCER RES TR, V139, P691, DOI 10.1007/s10549-013-2602-2; Li H, 2012, BREAST CANCER RES TR, V135, P759, DOI 10.1007/s10549-012-2220-4; Liu HL, 2009, J BIOL CHEM, V284, P29077, DOI 10.1074/jbc.M109.014258; Mitsui Y, 2006, CANCER RES, V66, P9913, DOI 10.1158/0008-5472.CAN-06-0377; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Rao VH, 2012, ONCOGENE, V31, P2888, DOI 10.1038/onc.2011.460; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Roy R, 2011, J BIOL CHEM, V286, P20758, DOI 10.1074/jbc.M110.216036; Roy R, 2012, BREAST CANCER RES TR, V131, P731, DOI 10.1007/s10549-011-1431-4; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stautz D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037628; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	37	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92536	10.1371/journal.pone.0092536	http://dx.doi.org/10.1371/journal.pone.0092536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651654	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800123
J	Sano, M; Sasaki, T; Hirakawa, S; Sakabe, J; Ogawa, M; Baba, S; Zaima, N; Tanaka, H; Inuzuka, K; Yamamoto, N; Setou, M; Sato, K; Konno, H; Unno, N				Sano, Masaki; Sasaki, Takeshi; Hirakawa, Satoshi; Sakabe, Junichi; Ogawa, Mikako; Baba, Satoshi; Zaima, Nobuhiro; Tanaka, Hiroki; Inuzuka, Kazunori; Yamamoto, Naoto; Setou, Mitsutoshi; Sato, Kohji; Konno, Hiroyuki; Unno, Naoki			Lymphangiogenesis and Angiogenesis in Abdominal Aortic Aneurysm	PLOS ONE			English	Article							MACROPHAGE RECRUITMENT; MICROVESSEL DENSITY; BREAST-CANCER; UP-REGULATION; ATHEROSCLEROSIS; INFLAMMATION; PATHOGENESIS; PODOPLANIN; TUMORS; CELLS	The pathogenesis of abdominal aortic aneurysm (AAA) is characterized to be inflammation-associated degeneration of vascular wall. Neovascularization is regularly found in human AAA and considered to play critical roles in the development and rupture of AAA. However, little is known about lymphangiogenesis in AAA. The purpose of this study was to demonstrate both angiogenesis and lymphangiogenesis in AAA. Abdominal aortic tissue was harvested either from autopsy (control group) and during open-repair surgery for AAA (AAA group). Adventitial lymphatic vasa vasorum was observed in both groups, but seemed to be no significant morphological changes in AAA. Immunohistochemical studies identified infiltration of lymphatic vessel endothelial hyaluronan receptor (LYVE) -1, vascular endothelial growth factor (VEGF)-C, and matrix metalloproteinase (MMP)-9-positive macrophages and podoplanin and Prox-1-positive microvessels in the intima/media in AAA wall, where hypoxia-inducible factors (HIF)-1 alpha was expressed. VEGF-C and MMP-9 were not expressed in macrophages infiltrating in the adventitia. Intraoperative indocyanine green fluorescence lymphography revealed lymph stasis in intima/medial in AAA. Fluorescence microscopy of the collected samples also confirmed the accumulation of lymph in the intima/media but not in adventitia. These results demonstrate that infiltration of macrophages in intima/media is associated with lymphangiogenesis and angiogenesis in AAA. Lymph-drainage appeared to be insufficient in the AAA wall.	[Sano, Masaki; Tanaka, Hiroki; Inuzuka, Kazunori; Yamamoto, Naoto; Unno, Naoki] Med Photon Res Ctr, Appl Med Photon Lab, Div Vasc Surg, Hamamatsu, Shizuoka, Japan; [Sasaki, Takeshi; Sato, Kohji] Med Photon Res Ctr, Appl Med Photon Lab, Dept Anat & Neurosci, Hamamatsu, Shizuoka, Japan; [Hirakawa, Satoshi; Sakabe, Junichi] Med Photon Res Ctr, Appl Med Photon Lab, Dept Dermatol, Hamamatsu, Shizuoka, Japan; [Ogawa, Mikako] Med Photon Res Ctr, Appl Med Photon Lab, Dept Mol Imaging, Hamamatsu, Shizuoka, Japan; [Baba, Satoshi] Hamamatsu Univ Sch Med, Dept Diagnost Pathol, Hamamatsu, Shizuoka 4313192, Japan; [Zaima, Nobuhiro; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Sano, Masaki; Tanaka, Hiroki; Inuzuka, Kazunori; Yamamoto, Naoto; Konno, Hiroyuki; Unno, Naoki] Hamamatsu Univ Sch Med, Dept Surg 2, Hamamatsu, Shizuoka 4313192, Japan; [Zaima, Nobuhiro] Kinki Univ, Dept Appl Biol Chem, Osaka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Kindai University (Kinki University)	Unno, N (corresponding author), Med Photon Res Ctr, Appl Med Photon Lab, Div Vasc Surg, Hamamatsu, Shizuoka, Japan.	unno@hama-med.ac.jp		Sakabe, Jun-Ichi/0000-0002-8237-0472	Japan Society for the Promotion of Science (JSPS) [22591400]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101090, R01GM088847] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24689049, 23390289] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported partly by a Grant-in-Aid for Scientific Research (C) (22591400) (to N.U.) from Japan Society for the Promotion of Science (JSPS) for purchasing reagents or analysis tools. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Choi I, 2013, ANGIOGENESIS, V16, P29, DOI 10.1007/s10456-012-9297-6; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Danese S, 2006, GASTROENTEROLOGY, V130, P2060, DOI 10.1053/j.gastro.2006.03.054; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Drozdz K, 2012, LYMPHOLOGY, V45, P26; Fenyo IM, 2013, IMMUNOBIOLOGY, V218, P1376, DOI 10.1016/j.imbio.2013.06.005; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; Hatakeyama K, 2012, THROMB RES; HOLMES DR, 1995, J VASC SURG, V21, P761, DOI 10.1016/S0741-5214(05)80007-2; James JM, 2013, DEVELOPMENT, V140, P3903, DOI 10.1242/dev.095026; Kajimoto K, 2009, ATHEROSCLEROSIS, V206, P505, DOI 10.1016/j.atherosclerosis.2009.03.028; Kaneko H, 2011, CARDIOVASC RES, V91, P358, DOI 10.1093/cvr/cvr080; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Miwa K, 2005, GENE THER, V12, P1109, DOI 10.1038/sj.gt.3302496; Nakayama Y, 2007, ANTICANCER RES, V27, P619; Ordonez NG, 2012, ADV ANAT PATHOL, V19, P281, DOI 10.1097/PAP.0b013e3182691c2a; Rizas KD, 2009, CARDIOL REV, V17, P201, DOI 10.1097/CRD.0b013e3181b04698; ROSS R, 1976, NEW ENGL J MED, V295, P420, DOI 10.1056/NEJM197608192950805; ROSS R, 1976, NEW ENGL J MED, V295, P369, DOI 10.1056/NEJM197608122950707; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoppmann SF, 2001, ANTICANCER RES, V21, P2351; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sharma R, 2008, ANN NY ACAD SCI, V1131, P13, DOI 10.1196/annals.1413.002; Shi VY, 2012, MICROCIRCULATION, V19, P567, DOI 10.1111/j.1549-8719.2012.00189.x; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Sugaya M, 2012, J INVEST DERMATOL, V132, P667, DOI 10.1038/jid.2011.349; Suzuki Y, 2012, KIDNEY INT, V81, P865, DOI 10.1038/ki.2011.464; Swedenborg J, 2011, ARTERIOSCL THROM VAS, V31, P734, DOI 10.1161/ATVBAHA.110.213157; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tanaka H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057398; Thairu N, 2011, ANGIOGENESIS, V14, P223, DOI 10.1007/s10456-011-9208-2; Unno N, 2008, EUR J VASC ENDOVASC, V36, P230, DOI 10.1016/j.ejvs.2008.04.013; Unno N, 2013, SURG TODAY; Vermeulen PB, 1996, EUR J CANCER, V32A, P2474, DOI 10.1016/S0959-8049(96)00379-6; Vijaynagar B, 2013, EUR J CLIN INVEST, V43, P758, DOI 10.1111/eci.12103; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WOLPE SD, 1988, J EXP MED, V167, P570, DOI 10.1084/jem.167.2.570; Xu XS, 2009, INT J CARDIOL, V134, P426, DOI 10.1016/j.ijcard.2007.12.098; Zampell JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049940; Zampell JC, 2012, PLAST RECONSTR SURG, V129, P825, DOI 10.1097/PRS.0b013e3182450b2d; Zhou Q, 2011, ARTHRITIS RHEUM-US, V63, P2318, DOI 10.1002/art.30421	52	34	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e89830	10.1371/journal.pone.0089830	http://dx.doi.org/10.1371/journal.pone.0089830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651519	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800005
J	Shigemizu, D; Abe, T; Morizono, T; Johnson, TA; Boroevich, KA; Hirakawa, Y; Ninomiya, T; Kiyohara, Y; Kubo, M; Nakamura, Y; Maeda, S; Tsunoda, T				Shigemizu, Daichi; Abe, Testuo; Morizono, Takashi; Johnson, Todd A.; Boroevich, Keith A.; Hirakawa, Yoichiro; Ninomiya, Toshiharu; Kiyohara, Yutaka; Kubo, Michiaki; Nakamura, Yusuke; Maeda, Shiro; Tsunoda, Tatsuhiko			The Construction of Risk Prediction Models Using GWAS Data and Its Application to a Type 2 Diabetes Prospective Cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISM; DETECTING GENE-GENE; POPULATION; SUSCEPTIBILITY; REGRESSION; MELLITUS; IMPACT; TESTS	Recent genome-wide association studies (GWAS) have identified several novel single nucleotide polymorphisms (SNPs) associated with type 2 diabetes (T2D). Various models using clinical and/or genetic risk factors have been developed for T2D risk prediction. However, analysis considering algorithms for genetic risk factor detection and regression methods for model construction in combination with interactions of risk factors has not been investigated. Here, using genotype data of 7,360 Japanese individuals, we investigated risk prediction models, considering the algorithms, regression methods and interactions. The best model identified was based on a Bayes factor approach and the lasso method. Using nine SNPs and clinical factors, this method achieved an area under a receiver operating characteristic curve (AUC) of 0.8057 on an independent test set. With the addition of a pair of interaction factors, the model was further improved (p-value 0.0011, AUC 0.8085). Application of our model to prospective cohort data showed significantly better outcome in disease-free survival, according to the log-rank trend test comparing Kaplan-Meier survival curves (p value2.09 x 10(-11)). While the major contribution was from clinical factors rather than the genetic factors, consideration of genetic risk factors contributed to an observable, though small, increase in predictive ability. This is the first report to apply risk prediction models constructed from GWAS data to a T2D prospective cohort. Our study shows our model to be effective in prospective prediction and has the potential to contribute to practical clinical use in T2D.	[Shigemizu, Daichi; Abe, Testuo; Morizono, Takashi; Johnson, Todd A.; Boroevich, Keith A.; Tsunoda, Tatsuhiko] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Hirakawa, Yoichiro; Ninomiya, Toshiharu; Kiyohara, Yutaka] Kyushu Univ, Dept Environm Med, Grad Sch Med Sci, Fukuoka 812, Japan; [Ninomiya, Toshiharu] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Maeda, Shiro] RIKEN, Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan	RIKEN; Kyushu University; Kyushu University; RIKEN; University of Tokyo; RIKEN	Tsunoda, T (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan.	tsunoda@src.riken.jp	Tsunoda, Tatsuhiko/K-2061-2014; Kubo, Michiaki/N-7947-2015; Johnson, Todd Andrew/ABG-4704-2021; Johnson, Todd/Q-9944-2019	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Johnson, Todd Andrew/0000-0003-3377-6692; Johnson, Todd/0000-0003-3377-6692; Boroevich, Keith/0000-0001-7095-7332	Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Banerji B, 1990, Ann Soc Belg Med Trop, V70 Suppl 1, P15; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Cule E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-372; Doi Y, 2012, DIABETIC MED, V29, P107, DOI 10.1111/j.1464-5491.2011.03376.x; Doi Y, 2008, J CLIN ENDOCR METAB, V93, P3425, DOI 10.1210/jc.2007-2819; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gulcher J, 2009, NEW ENGL J MED, V360, P1360; Horikawa Y, 2008, J CLIN ENDOCR METAB, V93, P3136, DOI 10.1210/jc.2008-0452; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Jia HX, 2011, ARCH MED RES, V42, P361, DOI 10.1016/j.arcmed.2011.08.001; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kooperberg C, 2010, GENET EPIDEMIOL, V34, P643, DOI 10.1002/gepi.20509; Larkin M, 2001, LANCET, V358, P565, DOI 10.1016/S0140-6736(01)05751-8; Lu Qing, 2009, BMC Proc, V3 Suppl 7, pS49; Lukacs K, 2012, DIABETOLOGIA, V55, P689, DOI 10.1007/s00125-011-2378-z; Ma LJ, 2010, DIABETES, V59, P2837, DOI 10.2337/db09-1604; McCarthy MI, 2011, DIABETIC MED, V28, P132, DOI 10.1111/j.1464-5491.2010.03194.x; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; OHMURA T, 1993, DIABETOLOGIA, V36, P1198, DOI 10.1007/BF00401066; Ohshige T, 2010, DIABETES CARE, V33, P842, DOI 10.2337/dc09-1933; Pan W, 2011, HUM HERED, V72, P98, DOI 10.1159/000330632; Park SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S13; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sparso T, 2009, DIABETOLOGIA, V52, P1308, DOI 10.1007/s00125-009-1362-3; Team RDC, 2009, R LANG ENV STAT COMP; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wei Z, 2013, AM J HUM GENET; Willems SM, 2011, CURR DIABETES REP, V11, P511, DOI 10.1007/s11892-011-0235-6; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; ZOU H, 2005, J R STAT SOC B, V67	42	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92549	10.1371/journal.pone.0092549	http://dx.doi.org/10.1371/journal.pone.0092549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651836	gold, Green Submitted, Green Published			2022-12-25	WOS:000333352800126
J	Wierenga, C; Bischoff-Grethe, A; Melrose, AJ; Grenesko-Stevens, E; Irvine, Z; Wagner, A; Simmons, A; Matthews, S; Yau, WYW; Fennema-Notestine, C; Kaye, WH				Wierenga, Christina; Bischoff-Grethe, Amanda; Melrose, A. James; Grenesko-Stevens, Emily; Irvine, Zoe; Wagner, Angela; Simmons, Alan; Matthews, Scott; Yau, Wai-Ying Wendy; Fennema-Notestine, Christine; Kaye, Walter H.			Altered BOLD Response during Inhibitory and Error Processing in Adolescents with Anorexia Nervosa	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL FLEXIBILITY; SET-SHIFTING ABILITY; ANTERIOR CINGULATE; EATING-DISORDERS; BRAIN ACTIVATION; NO-GO; TASK; MODEL; CHILDHOOD; RECOVERY	Background: Individuals with anorexia nervosa (AN) are often cognitively rigid and behaviorally over-controlled. We previously showed that adult females recovered from AN relative to healthy comparison females had less prefrontal activation during an inhibition task, which suggested a functional brain correlate of altered inhibitory processing in individuals recovered from AN. However, the degree to which these functional brain alterations are related to disease state and whether error processing is altered in AN individuals is unknown. Methodology/Principal Findings: In the current study, ill adolescent AN females (n = 11) and matched healthy comparison adolescents (CA) with no history of an eating disorder (n = 12) performed a validated stop signal task (SST) during functional magnetic resonance imaging (fMRI) to explore differences in error and inhibitory processing. The groups did not differ on sociodemographic variables or on SST performance. During inhibitory processing, a significant group x difficulty (hard, easy) interaction was detected in the right dorsal anterior cingulate cortex (ACC), right middle frontal gyrus (MFG), and left posterior cingulate cortex (PCC), which was characterized by less activation in AN compared to CA participants during hard trials. During error processing, a significant group x accuracy (successful inhibit, failed inhibit) interaction in bilateral MFG and right PCC was observed, which was characterized by less activation in AN compared to CA participants during error (i.e., failed inhibit) trials. Conclusion/Significance: Consistent with our prior findings in recovered AN, ill AN adolescents, relative to CA, showed less inhibition-related activation within the dorsal ACC, MFG and PCC as inhibitory demand increased. In addition, ill AN adolescents, relative to CA, also showed reduced activation to errors in the bilateral MFG and left PCC. These findings suggest that altered prefrontal and cingulate activation during inhibitory and error processing may represent a behavioral characteristic in AN that is independent of the state of recovery.	[Wierenga, Christina; Bischoff-Grethe, Amanda; Melrose, A. James; Grenesko-Stevens, Emily; Irvine, Zoe; Wagner, Angela; Simmons, Alan; Matthews, Scott; Yau, Wai-Ying Wendy; Fennema-Notestine, Christine; Kaye, Walter H.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Simmons, Alan; Matthews, Scott] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Fennema-Notestine, Christine] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Bischoff-Grethe, A (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	agrethe@ucsd.edu	Wierenga, Christina/N-3019-2017; Simmons, Alan N/A-9815-2008	Wierenga, Christina/0000-0002-4843-1809; Simmons, Alan N/0000-0003-3963-2112; Fennema-Notestine, Christine/0000-0002-6527-6361	National Institutes of Health [R21-MH086017, R01-MH042984-17A1, R01-MH042984-18S1]; Price Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH042984, R21MH086017, R01MH092793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Price Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by National Institutes of Health grants R21-MH086017, R01-MH042984-17A1, R01-MH042984-18S1, and the Price Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2012, COG NEUROPSYCHI 0717; Anguera JA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00649; Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Attia E, 2005, BIOL PSYCHIAT, V57, P674, DOI 10.1016/j.biopsych.2004.11.045; Badgaiyan RD, 1998, NEUROIMAGE, V7, P255, DOI 10.1006/nimg.1998.0326; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; BEATON GH, 1979, AM J CLIN NUTR, V32, P2546, DOI 10.1093/ajcn/32.12.2546; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Boutelle KN, 1998, OBES RES, V6, P219, DOI 10.1002/j.1550-8528.1998.tb00340.x; Brooks SJ, 2012, CONSCIOUS COGN, V21, P751, DOI 10.1016/j.concog.2012.02.006; Brooks SJ, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-76; Buhren K, 2012, J NEURAL TRANSM, V119, P1047, DOI 10.1007/s00702-012-0821-z; Bulik CM, 2007, INT J EAT DISORDER, V40, P310, DOI 10.1002/eat.20367; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Casey BJ, 2011, J RES ADOLESCENCE, V21, P21, DOI 10.1111/j.1532-7795.2010.00712.x; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dietz WH, 1998, PEDIATRICS, V101, P518; Dixon LB, 2006, J NUTR, V136, P3054, DOI 10.1093/jn/136.12.3054; Ferro AM, 2005, INT J EAT DISORDER, V38, P323, DOI 10.1002/eat.20203; First M. D., 1996, USERS GUIDE STRUCTUR; Fitzpatrick KK, 2012, INT J EAT DISORDER, V45, P909, DOI 10.1002/eat.22027; Frank GK, 2005, BIOL PSYCHIAT, V58, P908, DOI 10.1016/j.biopsych.2005.05.003; Friederich HC, 2011, CURR TOP BEHAV NEURO, V6, P111, DOI 10.1007/7854_2010_83; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Halmi KA, 2012, INT J EAT DISORDER, V45, P800, DOI 10.1002/eat.22019; Harnishfeger KK, 1996, J EXP CHILD PSYCHOL, V62, P292, DOI 10.1006/jecp.1996.0032; Heaton KH, 2003, WISCONSIN CARD SORTI; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; HERZOG DB, 1992, J CLIN PSYCHIAT, V53, P147; Holliday J, 2005, AM J PSYCHIAT, V162, P2269, DOI 10.1176/appi.ajp.162.12.2269; Jenkinson M., 2004, 10 INT C FUNCT MAPP; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Jimerson DC, 1996, PSYCHIAT CLIN N AM, V19, P739, DOI 10.1016/S0193-953X(05)70378-6; Kaye WH, 2013, BIOL PSYCHIAT, V73, P836, DOI 10.1016/j.biopsych.2013.01.002; Kaye WH, 2013, TRENDS NEUROSCI, V36, P110, DOI 10.1016/j.tins.2013.01.003; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Keel PK, 1999, ARCH GEN PSYCHIAT, V56, P63, DOI 10.1001/archpsyc.56.1.63; Klein DA, 2003, INT REV PSYCHIATR, V15, P205, DOI 10.1080/0954026031000136839; Knutson B, 2007, ANN NY ACAD SCI, V1104, P54, DOI 10.1196/annals.1390.020; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Kullman S, 2013, SOC COGN AFFECT NEUR; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lampard AM, 2011, EAT BEHAV, V12, P90, DOI 10.1016/j.eatbeh.2010.11.004; Lock J, 2005, INT J EAT DISORDER, V37, pS64, DOI 10.1002/eat.20122; Lock J, 2011, AM J PSYCHIAT, V168, P55, DOI 10.1176/appi.ajp.2010.10010056; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Marsh R, 2006, HUM BRAIN MAPP, V27, P848, DOI 10.1002/hbm.20225; Marsh R, 2011, AM J PSYCHIAT, V168, P1210, DOI 10.1176/appi.ajp.2011.11010094; Matthews SC, 2005, NEUROREPORT, V16, P755, DOI 10.1097/00001756-200505120-00020; McAnarney ER, 2011, J ADOLESCENT HEALTH, V49, P99, DOI 10.1016/j.jadohealth.2010.11.259; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Nakazato M, 2009, PSYCHOL MED, V39, P1029, DOI 10.1017/S0033291708004108; Nakazato M, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-29; National Institute for Health and Clinical Excellence (NICE), 2004, COR INT TREATM MAN A; Oberndorfer TA, 2011, INT J EAT DISORDER, V44, P1, DOI 10.1002/eat.20750; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Pieters GLM, 2007, BRAIN COGNITION, V63, P42, DOI 10.1016/j.bandc.2006.07.009; Pinheiro J, 2016, NLME LINEAR NONLINEA, DOI DOI 10.1016/S0006-3207(01)00201-4; Roberts ME, 2007, PSYCHOL MED, V37, P1075, DOI 10.1017/S0033291707009877; Robertson G, 2006, WIDE RANGE ACHIEVEME; Sarrar L, 2011, PSYCHONEUROENDOCRINO, V36, P1396, DOI 10.1016/j.psyneuen.2011.03.014; Sato Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061108; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Shott ME, 2012, NEUROPSYCHOLOGY, V26, P191, DOI 10.1037/a0026771; Stedal K, 2012, EUR EAT DISORD REV, V20, P175, DOI 10.1002/erv.1160; Steinglass JE, 2006, J INT NEUROPSYCH SOC, V12, P431, DOI 10.1017/S1355617706060528; Steinglass JE, 2012, J INT NEUROPSYCH SOC, V18, P773, DOI 10.1017/S1355617712000446; Suskauer SJ, 2008, J AM ACAD CHILD PSY, V47, P1141, DOI 10.1097/CHI.0b013e3181825b1f; Tchanturia K, 2004, J PSYCHIATR RES, V38, P545, DOI 10.1016/j.jpsychires.2004.03.001; Tchanturia K, 2002, Eat Weight Disord, V7, P312; Tchanturia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028331; Vogt BA, 2005, J COMP NEUROL, V485, P218, DOI 10.1002/cne.20512; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Wagner A, 2006, INT J EAT DISORDER, V39, P276, DOI 10.1002/eat.20251; Walton ME, 2003, J NEUROSCI, V23, P6475; Wartenburger I, 2009, NEUROIMAGE, V48, P291, DOI 10.1016/j.neuroimage.2009.06.025; Watanabe J, 2002, NEUROIMAGE, V17, P1207, DOI 10.1006/nimg.2002.1198; Wecshler D, 1999, WECHSLER ABBREVIATED; Woolley J, 2008, BRIT J PSYCHIAT, V192, P25, DOI 10.1192/bjp.bp.107.036558; Yang TT, 2009, NEUROREPORT, V20, P440, DOI 10.1097/WNR.0b013e3283262e10; Yucel M, 2003, J PSYCHIATR NEUROSCI, V28, P350; Zastrow A, 2009, AM J PSYCHIAT, V166, P608, DOI 10.1176/appi.ajp.2008.08050775; Zheng D, 2008, J COGNITIVE NEUROSCI, V20, P1434, DOI 10.1162/jocn.2008.20100	88	51	51	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92017	10.1371/journal.pone.0092017	http://dx.doi.org/10.1371/journal.pone.0092017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651705	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800064
J	Yucebas, SC; Son, YA				Yucebas, Sait Can; Son, Yesim Aydin			A Prostate Cancer Model Build by a Novel SVM-ID3 Hybrid Feature Selection Method Using Both Genotyping and Phenotype Data from dbGaP	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUPPORT VECTOR MACHINES; BODY-MASS INDEX; RISK; CLASSIFICATION; METAANALYSIS; DIAGNOSIS; GENETICS; DENSITY; ANTIGEN	Through Genome Wide Association Studies (GWAS) many Single Nucleotide Polymorphism (SNP)-complex disease relations can be investigated. The output of GWAS can be high in amount and high dimensional, also relations between SNPs, phenotypes and diseases are most likely to be nonlinear. In order to handle high volume-high dimensional data and to be able to find the nonlinear relations we have utilized data mining approaches and a hybrid feature selection model of support vector machine and decision tree has been designed. The designed model is tested on prostate cancer data and for the first time combined genotype and phenotype information is used to increase the diagnostic performance. We were able to select phenotypic features such as ethnicity and body mass index, and SNPs those map to specific genes such as CRR9, TERT. The performance results of the proposed hybrid model, on prostate cancer dataset, with 90.92% of sensitivity and 0.91 of area under ROC curve, shows the potential of the approach for prediction and early detection of the prostate cancer.	[Yucebas, Sait Can; Son, Yesim Aydin] Middle E Tech Univ, Grad Sch Informat, Dept Med Informat, TR-06531 Ankara, Turkey; [Son, Yesim Aydin] Middle E Tech Univ, Grad Sch Informat, Bioinformat Grad Program, TR-06531 Ankara, Turkey	Middle East Technical University; Middle East Technical University	Son, YA (corresponding author), Middle E Tech Univ, Grad Sch Informat, Dept Med Informat, TR-06531 Ankara, Turkey.	yesim.aydinson@gmail.com	SON, Yesim AYDIN/F-5879-2011; Son, Yesim Aydin/AAF-8696-2019; Yucebas, Sait/O-7341-2019	SON, Yesim AYDIN/0000-0002-8118-4272; Son, Yesim Aydin/0000-0002-8118-4272; Yucebas, Sait Can/0000-0002-1030-3545	NATIONAL CANCER INSTITUTE [RC2CA148085, U01CA136792, U01CA098758, R37CA054281, P01CA033619, R01CA063464] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004726] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA63464, R37CA54281, P01CA33619, RC2 CA148085, U01CA136792, U01CA98758] Funding Source: Medline; NHGRI NIH HHS [U01HG004726, U01HG004789-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Aguiar V., 2010, SOFT COMPUTING METHO, P219; Aksoy Y, 2003, ANN CLIN LAB SCI, V33, P320; Anunciacao O, 2010, ADV INTEL SOFT COMPU, V74, P43, DOI 10.1007/978-3-642-13214-8_6; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BRETTON PR, 1994, CANCER, V74, P2991, DOI 10.1002/1097-0142(19941201)74:11<2991::AID-CNCR2820741116>3.0.CO;2-R; Caplan A, 2002, AM J CLIN PATHOL, V117, P104, DOI DOI 10.1309/C4UN-12LK-43HP-JXY3; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Frohlich H, 2005, IEEE IJCNN, P1431; Gerstenblith MR, 2010, PIGM CELL MELANOMA R, V23, P587, DOI 10.1111/j.1755-148X.2010.00730.x; Giovannucci E, 2003, J NATL CANCER I, V95, P1240, DOI 10.1093/jnci/djg009; Graczyk M, 2009, LECT NOTES ARTIF INT, V5796, P800; He JY, 2006, IEEE T NANOBIOSCI, V5, P46, DOI 10.1109/TNB.2005.864021; HIATT RA, 1994, CANCER CAUSE CONTROL, V5, P66, DOI 10.1007/BF01830728; Hoffman Richard M, 2002, BMC Fam Pract, V3, P19, DOI 10.1186/1471-2296-3-19; Hoffman RM, 2001, JNCI-J NATL CANCER I, V93, P388, DOI 10.1093/jnci/93.5.388; Huang J, 2004, P NATL ACAD SCI USA, V101, P10529, DOI 10.1073/pnas.0403794101; Huang LC, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-81; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kleinmann N, 2012, NAT REV UROL, V9, P258, DOI 10.1038/nrurol.2012.56; Lee JC, 2011, BRIEF FUNCT GENOMICS, V10, P71, DOI 10.1093/bfgp/elr009; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Listgarten J, 2004, CLIN CANCER RES, V10, P2725, DOI 10.1158/1078-0432.CCR-1115-03; Mooney MA, 2012, IEEE ACM T COMPUT BI, V9, P899, DOI 10.1109/TCBB.2011.145; Mourad R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-16; Musani SK, 2007, HUM HERED, V63, P67, DOI 10.1159/000099179; OESTERLING JE, 1991, J UROLOGY, V145, P907, DOI 10.1016/S0022-5347(17)38491-4; Reddy MVPL, 2011, GENES IMMUN, V12, P208, DOI 10.1038/gene.2010.70; Ritchie MD, 2007, APPL SOFT COMPUT, V7, P471, DOI 10.1016/j.asoc.2006.01.013; Rokach L, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P165, DOI 10.1007/0-387-25465-X_9; Scholkopf B., 2004, MIT PRESS SERIES COM; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tsuji S, 2010, HUM MOL GENET, V19, pR65, DOI 10.1093/hmg/ddq162; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; Wu KP, 2009, PATTERN RECOGN, V42, P710, DOI 10.1016/j.patcog.2008.08.030; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	41	9	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91404	10.1371/journal.pone.0091404	http://dx.doi.org/10.1371/journal.pone.0091404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651484	Green Published, gold			2022-12-25	WOS:000333352800040
J	Feuerborn, A; Mathow, D; Srivastava, PK; Gretz, N; Grone, HJ				Feuerborn, A.; Mathow, D.; Srivastava, P. K.; Gretz, N.; Groene, H-J			Basonuclin-1 modulates epithelial plasticity and TGF-beta 1-induced loss of epithelial cell integrity	ONCOGENE			English	Article							BREAST-CANCER CELLS; TGF-BETA; MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR; E-CADHERIN; GENE-EXPRESSION; GROWTH; METASTASIS; SUPPRESSOR; PROTEINS	Transforming growth factor-alpha 1 (TGF-beta 1) is a multifunctional cytokine and critically involved in the progression of a variety of cancers. TGF-beta 1 signaling can impair tumor development by its anti-proliferative and pro-apoptotic features. In contrast, it may actively promote tumor progression and cancer cell dissemination by inducing a gradual switch from epithelial towards mesenchymal-like cell features (EMT-like), including decreased intercellular adhesion. Here, we show that expression of the transcription factor Basonuclin-1 (Bnc1) modulates TGF-beta 1-induced epithelial dedifferentiation of mammary epithelial cells. RNAi-mediated repression of Bnc1 resulted in enhanced intercellular adhesion and strongly impaired TGF-beta 1-dependent sheet disintegration and cell scattering. In contrast, forced expression of Bnc1 modifies plasma membrane/cytoskeletal dynamics and seemingly interferes with the initiation of sustainable cell-cell contacts. Follow-up analyses revealed that Bnc1 affects the expression of numerous TGF-beta 1-responsive genes including distinct EMT-related transcription factors, some of which modulate the expression of Bnc1 themselves. These results suggest that Bnc1 is part of a transcription factor network related to epithelial plasticity with reciprocal feedback-loop connections on which Smad-factors integrate TGF-beta 1 signaling. Our study demonstrates that Bnc1 regulates epithelial plasticity of mammary epithelial cells and influences outcome of TGF-beta 1 signaling.	[Feuerborn, A.; Mathow, D.; Groene, H-J] German Canc Res Ctr, Dept Cellular & Mol Pathol, Heidelberg, Germany; [Srivastava, P. K.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci, London, England; [Gretz, N.] Heidelberg Univ, Med Res Ctr ZMF, Fac Med, Dept Med Res, Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Imperial College London; Ruprecht Karls University Heidelberg	Feuerborn, A (corresponding author), German Canc Res Ctr, Dept Cellular & Mol Pathol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	alexander.feuerborn@path.ox.ac.uk; h.-j.groene@dkfz.de			DFG [SFB-938]	DFG(German Research Foundation (DFG))	We kindly acknowledge Peter ten Dijke, David Danielpour, Sebastian Diecke and Roderick Beijersbergen for generously providing cells and plasmids. Support by the DKFZ Light Microscopy Facility is gratefully acknowledged. We thank Maria Muciek for excellent assistance with regard to microarray expression profiling and Ann Na Tan for excellent technical support. This study was supported by a grant of the DFG (SFB-938) to HJG.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Aigner K, 2007, FEBS LETT, V581, P1617, DOI 10.1016/j.febslet.2007.03.026; Boldrup L, 2012, EUR J CANCER, V48, P1401, DOI 10.1016/j.ejca.2011.06.032; Brena RM, 2006, PLOS MED, V3, P2184, DOI 10.1371/journal.pmed.0030479; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; Cui CH, 2004, CANCER RES, V64, P5651, DOI 10.1158/0008-5472.CAN-04-0801; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Feuerborn A, 2011, J CELL PHYSIOL, V226, P710, DOI 10.1002/jcp.22385; Feuerborn A, 2011, CELL CYCLE, V10, P2454, DOI 10.4161/cc.10.15.16306; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gervasi M, 2012, J CELL BIOL, V196, P589, DOI 10.1083/jcb.201109045; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Guo LX, 2011, AM J PATHOL, V178, P2357, DOI 10.1016/j.ajpath.2011.01.047; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kenzelmann M, 2007, P NATL ACAD SCI USA, V104, P6164, DOI 10.1073/pnas.0610439104; Koinuma D, 2009, CANCER SCI, V100, P2133, DOI 10.1111/j.1349-7006.2009.01299.x; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kumper S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011801; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loerke D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002677; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahoney MG, 1998, BIOL REPROD, V59, P388, DOI 10.1095/biolreprod59.2.388; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Morikawa M, 2013, ONCOGENE, V32, P1609, DOI 10.1038/onc.2012.191; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; Nakahata S, 2010, ONCOGENE, V29, P4157, DOI 10.1038/onc.2010.172; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Papantonis A, 2012, EMBO J, V31, P4404, DOI 10.1038/emboj.2012.288; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Sundqvist A, 2013, ONCOGENE, V32, P3606, DOI 10.1038/onc.2012.370; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tang YN, 2011, CELL RES, V21, P316, DOI 10.1038/cr.2010.126; Tseng H, 1999, DIFFERENTIATION, V65, P221, DOI 10.1046/j.1432-0436.1999.6540221.x; Tseng H, 1998, FRONT BIOSCI, V3, pD985; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vanhoutteghem A, 2011, BIOCHIMIE, V93, P127, DOI 10.1016/j.biochi.2010.09.010; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Wang JW, 2006, BIOCHEM BIOPH RES CO, V348, P1261, DOI 10.1016/j.bbrc.2006.07.198; Xie L, 2003, BREAST CANCER RES, V5, pR187, DOI 10.1186/bcr640; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825; Zhang SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000902; Zhang XH, 2012, GENESIS, V50, P517, DOI 10.1002/dvg.22014; Zhang XH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001087	62	6	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 26	2015	34	9					1185	1195		10.1038/onc.2014.54	http://dx.doi.org/10.1038/onc.2014.54			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RY	24662832				2022-12-25	WOS:000350122100011
J	Hosoda, F; Arai, Y; Okada, N; Shimizu, H; Miyamoto, M; Kitagawa, N; Katai, H; Taniguchi, H; Yanagihara, K; Imoto, I; Inazawa, J; Ohki, M; Shibata, T				Hosoda, F.; Arai, Y.; Okada, N.; Shimizu, H.; Miyamoto, M.; Kitagawa, N.; Katai, H.; Taniguchi, H.; Yanagihara, K.; Imoto, I.; Inazawa, J.; Ohki, M.; Shibata, T.			Integrated genomic and functional analyses reveal glyoxalase I as a novel metabolic oncogene in human gastric cancer	ONCOGENE			English	Article							DNA COPY NUMBER; TUMOR-SUPPRESSOR; GENE-EXPRESSION; POTENTIAL TARGET; UP-REGULATION; IDENTIFICATION; METHYLGLYOXAL; AMPLIFICATION; PROTEIN; OVEREXPRESSION	Chromosomal abnormalities are good guideposts when hunting for cancer-related genes. We analyzed copy number alterations of 163 primary gastric cancers using array-based comparative genomic hybridization and simultaneously performed a genome-wide integrated analysis of copy number and gene expression using microarray data for 58 tumors. We showed that chromosome 6p21 amplification frequently occurred secondary to ERBB2 amplification, was associated with poorer prognosis and caused overexpression of half of the genes mapped. A comprehensive small interfering RNA knockdown of 58 genes overexpressed in tumors identified 32 genes that reduced gastric cancer cell growth. Enforced expression of 16 of these genes promoted cell growth in vitro, and six genes showing more than two-fold activity conferred tumor-forming ability in vivo. Among these six candidates, GLO1, encoding a detoxifying enzyme glyoxalase I (GLO1), exhibited the strongest tumor-forming activity. Coexpression of other genes with GLO1 enhanced growth-stimulating activity. A GLO1 inhibitor, S-p-bromobenzyl glutathione cyclopentyl diester, inhibited the growth of two-thirds of 24 gastric cancer cell lines examined. The efficacy was found to be associated with the mRNA expression ratio of GLO1 to GLO2, encoding glyoxalase II (GLO2), another constituent of the glyoxalase system. GLO1 downregulation affected cell growth through inactivating central carbon metabolism and reduced the transcriptional activities of nuclear factor kappa B and activator protein-1. Our study demonstrates that GLO1 is a novel metabolic oncogene of the 6p21 amplicon, which promotes tumor growth and aberrant transcriptional signals via regulating cellular metabolic activities for energy production and could be a potential therapeutic target in gastric cancer.	[Hosoda, F.; Arai, Y.; Okada, N.; Shimizu, H.; Miyamoto, M.; Kitagawa, N.; Ohki, M.; Shibata, T.] Natl Canc Ctr, Div Canc Genom, Tokyo 1040045, Japan; [Katai, H.] Natl Canc Ctr, Div Gastr Surg, Tokyo, Japan; [Taniguchi, H.] Natl Canc Ctr, Div Clin Lab, Tokyo, Japan; [Yanagihara, K.] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Translat Res, Chiba, Japan; [Imoto, I.; Inazawa, J.] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Imoto, I.] Univ Tokushima, Dept Human Genet & Publ Hlth, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU); Tokushima University	Shibata, T (corresponding author), Natl Canc Ctr, Div Canc Genom, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tashibat@ncc.go.jp	Shibata, Tatsuhiro/ABA-8234-2020; Imoto, Issei/AAD-5799-2020; Shibata, Tatsuhiro/AAO-1278-2021		Ministry of Health, Labor and Welfare, Japan; New Energy and Industrial Technology Development Organization (NEDO), Japan; National Institute of Biomedical Innovation (NiBio), Japan; Foundation for Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research [22134002, 26293304] Funding Source: KAKEN	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation (NiBio), Japan(National Institute of Biomedical Innovation); Foundation for Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Setsuo Hirohashi for generous support and encouragement; Yukihiro Nakanishi for advice on histological classification of gastric tumors; Tokuki Sakiyama and Go Maeno for helping with the analysis of the aCGH data; Jun Yasuda for advice on the RNA interference techniques; Yu Nakamura, Michiyo Fukushima, Satomi Uryu and Yasuko Kuwabara for providing considerable contributions to the sample preparation of BAC DNA and patients' DNA and array hybridization; and Sayaka Kadoguchi and Kenjiro Kami for advice on metabolome analysis. This research was supported in part by a Grant-in-Aid for the Comprehensive 10-Year-Strategy for Cancer Control and from the Ministry of Health, Labor and Welfare, Japan, a grant from the New Energy and Industrial Technology Development Organization (NEDO), Japan and a grant from the National Institute of Biomedical Innovation (NiBio), Japan. MM and NK were recipients of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research in Japan.	Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Antognelli C, 2013, INT J BIOCHEM CELL B, V45, P836, DOI 10.1016/j.biocel.2013.01.003; Antognelli C, 2013, PROSTATE, V73, P121, DOI 10.1002/pros.22547; Bair WB, 2010, MELANOMA RES, V20, P85, DOI 10.1097/CMR.0b013e3283364903; Chen J, 2009, AM J PATHOL, V175, P400, DOI 10.2353/ajpath.2009.080972; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; de Hemptinne V, 2009, MOL CELL BIOCHEM, V325, P169, DOI 10.1007/s11010-009-0031-7; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Ghiorghi YK, 2007, J BIOL CHEM, V282, P8150, DOI 10.1074/jbc.M610648200; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Hansen F, 2012, METAB BRAIN DIS, V27, P531, DOI 10.1007/s11011-012-9329-3; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Kasugai Y, 2005, CLIN CANCER RES, V11, P8265, DOI 10.1158/1078-0432.CCR-05-1028; Kim DJ, 2010, P NATL ACAD SCI USA, V107, P21418, DOI 10.1073/pnas.1010153107; Kim SS, 2007, CANCER RES, V67, P9616, DOI 10.1158/0008-5472.CAN-07-0644; Kuiper RP, 2003, HUM MOL GENET, V12, P1661, DOI 10.1093/hmg/ddg178; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lewis BC, 2000, CANCER RES, V60, P6178; Lochhead P, 2008, BRIT MED BULL, V85, P87, DOI 10.1093/bmb/ldn007; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Myllykangas S, 2008, INT J CANCER, V123, P817, DOI 10.1002/ijc.23574; Nakamura Y, 2009, INT J CANCER, V125, P1859, DOI 10.1002/ijc.24538; Obama K, 2006, CLIN CANCER RES, V12, P70, DOI 10.1158/1078-0432.CCR-05-0588; ORAY B, 1982, METHOD ENZYMOL, V90, P542; RANGANATHAN S, 1995, BIOCHEM J, V309, P127, DOI 10.1042/bj3090127; Ranganathan S, 1999, GENE, V240, P149, DOI 10.1016/S0378-1119(99)00420-5; Sakamoto H, 2001, CLIN CANCER RES, V7, P2513; Santarius T, 2010, GENE CHROMOSOME CANC, V49, P711, DOI 10.1002/gcc.20784; Santos GC, 2007, J CLIN PATHOL, V60, P1, DOI 10.1136/jcp.2005.034389; Takada H, 2005, ONCOGENE, V24, P8051, DOI 10.1038/sj.onc.1208952; Tamura G, 2006, WORLD J GASTROENTERO, V12, P192, DOI 10.3748/wjg.v12.i2.192; Tanami H, 2005, LAB INVEST, V85, P1118, DOI 10.1038/labinvest.3700312; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Tsukamoto Y, 2008, J PATHOL, V216, P471, DOI 10.1002/path.2424; Varela-Rey M, 2009, HEPATOLOGY, V50, P443, DOI 10.1002/hep.23033; Vauhkonen H, 2006, CANCER GENET CYTOGEN, V167, P150, DOI 10.1016/j.cancergencyto.2005.11.014; Xue MZ, 2012, BIOCHEM J, V443, P213, DOI 10.1042/BJ20111648; Yagi T, 2003, BLOOD, V102, P1849, DOI 10.1182/blood-2003-02-0578; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Yang S, 2007, GENOMICS, V89, P451, DOI 10.1016/j.ygeno.2006.12.001	45	39	39	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 26	2015	34	9					1196	1206		10.1038/onc.2014.57	http://dx.doi.org/10.1038/onc.2014.57			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RY	24662817				2022-12-25	WOS:000350122100012
J	Doyle, JR; Krishnaji, ST; Zhu, GL; Xu, ZZ; Heller, D; Ji, RR; Levy, BD; Kumar, K; Kopin, AS				Doyle, Jamie R.; Krishnaji, Subrahmanian T.; Zhu, Guangli; Xu, Zhen-Zhong; Heller, Daniel; Ji, Ru-Rong; Levy, Bruce D.; Kumar, Krishna; Kopin, Alan S.			Development of a Membrane-anchored Chemerin Receptor Agonist as a Novel Modulator of Allergic Airway Inflammation and Neuropathic Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergy; Drug Screening; G Protein-coupled Receptors (GPCR); Inflammation; Pharmacology; CMKLR1; ChemR23; Lipidated Peptides; Membrane-tethered Ligands	RESOLVIN E1; TETHERED LIGANDS; PEPTIDES; ACID; SUBSTITUTION; SPECIFICITY; ACTIVATION; RESOLUTION; ASTHMA; CELLS	Background: The chemerin-CMKLR1 axis modulates inflammation; ligands for CMKLR1 have short half-lives. Results: We have utilized a novel technology to develop a long-acting, high potency membrane-anchored CMKLR1 agonist. Conclusion: This ligand decreases allergic airway inflammation and neuropathic pain in mice. Significance: Our approach can be applied to develop other candidate therapeutics targeting peptide hormone receptors implicated as modulators of disease. The chemerin receptor (CMKLR1) is a G protein-coupled receptor found on select immune, epithelial, and dorsal root ganglion/spinal cord neuronal cells. CMKLR1 is primarily coupled to the inhibitory G protein, G(i), and has been shown to modulate the resolution of inflammation and neuropathic pain. CMKLR1 is activated by both lipid and peptide agonists, resolvin E1 and chemerin, respectively. Notably, these ligands have short half-lives. To expedite the development of long acting, stable chemerin analogs as candidate therapeutics, we used membrane-tethered ligand technology. Membrane-tethered ligands are recombinant proteins comprised of an extracellular peptide ligand, a linker sequence, and an anchoring transmembrane domain. Using this technology, we established that a 9-amino acid-tethered chemerin fragment (amino acids 149-157) activates both mouse and human CMKLR1 with efficacy exceeding that of the full-length peptide (amino acids 21-157). To enable in vivo delivery of a corresponding soluble membrane anchored ligand, we generated lipidated analogs of the 9-amino acid fragment. Pharmacological assessment revealed high potency and wash resistance (an index of membrane anchoring). When tested in vivo, a chemerin SMAL decreased allergic airway inflammation and attenuated neuropathic pain in mice. This compound provides a prototype membrane-anchored peptide for the treatment of inflammatory disease. A parallel approach may be applied to developing therapeutics targeting other peptide hormone G protein-coupled receptors.	[Doyle, Jamie R.; Heller, Daniel; Kopin, Alan S.] Tufts Med Ctr, Mol Pharmacol Res Ctr, Boston, MA 02111 USA; [Doyle, Jamie R.; Heller, Daniel; Kopin, Alan S.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Krishnaji, Subrahmanian T.; Kumar, Krishna] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Zhu, Guangli; Levy, Bruce D.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pulm & Crit Care Med, Boston, MA 02115 USA; [Xu, Zhen-Zhong; Ji, Ru-Rong] Duke Univ, Med Ctr, Sensory Plast Lab, Dept Anesthesiol, Durham, NC 27710 USA; [Xu, Zhen-Zhong; Ji, Ru-Rong] Duke Univ, Med Ctr, Sensory Plast Lab, Dept Neurobiol, Durham, NC 27710 USA	Tufts Medical Center; Tufts Medical Center; Tufts University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Duke University; Duke University	Kopin, AS (corresponding author), 800 Washington St,POB 7703, Boston, MA 02111 USA.	akopin@tuftsmedicalcenter.org	Kumar, Krishna/B-3151-2009; Ji, Ru-Rong/L-7070-2017	Kumar, Krishna/0000-0002-0548-5014; Ji, Ru-Rong/0000-0002-9355-3688; Tarakkad Krishnaji, Subrahmanian/0000-0001-8950-6072; Heller-Trulli, Daniel/0000-0003-0549-0646; Xu, Zhen-Zhong/0000-0001-6578-211X	National Institutes of Health [R01-DK072497, T32-HL069770, R01-HL068669, P01-GM095467, R01-GM65500, R01-CA125033, R01-NS67686]; NATIONAL CANCER INSTITUTE [R01CA125033] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122531, T32HL069770, R01HL068669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065500, P01GM095467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK072497 (to A. S. K.), T32-HL069770 (to J. R. D.), R01-HL068669 and P01-GM095467 (to B. D. L.), R01-GM65500 and R01-CA125033 (to K. K.), and R01-NS67686 (to R. R. J.).	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bellucci F, 2002, BRIT J PHARMACOL, V135, P266, DOI 10.1038/sj.bjp.0704443; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Choi C, 2009, CURR BIOL, V19, P1167, DOI 10.1016/j.cub.2009.06.029; Chou KC, 1999, PROTEINS, V34, P137, DOI 10.1002/(SICI)1097-0134(19990101)34:1<137::AID-PROT11>3.3.CO;2-F; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Doyle JR, 2013, J LIPID RES, V54, P823, DOI 10.1194/jlr.M034660; Du XY, 2009, ACTA BIOCH BIOPH SIN, V41, P973, DOI 10.1093/abbs/gmp091; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029; Fortin JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024693; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Harwood BN, 2013, MOL PHARMACOL, V83, P814, DOI 10.1124/mol.112.081570; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Ishida T, 2010, INFLAMM BOWEL DIS, V16, P87, DOI 10.1002/ibd.21029; Jacobsen EA, 2007, CURR ALLERGY ASTHM R, V7, P18, DOI 10.1007/s11882-007-0026-y; Ji RR, 2011, TRENDS NEUROSCI, V34, P599, DOI 10.1016/j.tins.2011.08.005; Kostenis E, 2005, J PHARMACOL EXP THER, V313, P78, DOI 10.1124/jpet.104.080424; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Pennington M W, 1994, Methods Mol Biol, V35, P41; POWELL MF, 1993, PHARMACEUT RES, V10, P1268, DOI 10.1023/A:1018953309913; ROMANO R, 1993, BIOCHIM BIOPHYS ACTA, V1145, P235, DOI 10.1016/0005-2736(93)90294-A; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Shimamura K, 2009, PEPTIDES, V30, P1529, DOI 10.1016/j.peptides.2009.05.030; Summerhill Susan, 2008, Journal of Pharmacological and Toxicological Methods, V58, P189, DOI 10.1016/j.vascn.2008.06.003; Wegmann M, 2011, AM J RESP CELL MOL, V45, P667, DOI 10.1165/rcmb.2011-0013TR; Weinstock MT, 2012, BIOPOLYMERS, V98, P431, DOI 10.1002/bip.22073; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Xu ZZ, 2013, ANN NEUROL, V74, P490, DOI 10.1002/ana.23928; Xu ZZ, 2013, J NEUROIMMUNE PHARM, V8, P37, DOI 10.1007/s11481-012-9394-8; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yoshimura T, 2011, EXP CELL RES, V317, P674, DOI 10.1016/j.yexcr.2010.10.023; Zhang L, 2012, CURR MED CHEM, V19, P1602; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006	40	23	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13385	13396		10.1074/jbc.M113.522680	http://dx.doi.org/10.1074/jbc.M113.522680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24659779	hybrid, Green Published			2022-12-25	WOS:000335522800037
J	Yamashita, Y; Kadokura, Y; Sotta, N; Fujiwara, T; Takigawa, I; Satake, A; Onouchi, H; Naito, S				Yamashita, Yui; Kadokura, Yoshitomo; Sotta, Naoyuki; Fujiwara, Toru; Takigawa, Ichigaku; Satake, Akiko; Onouchi, Hitoshi; Naito, Satoshi			Ribosomes in a Stacked Array	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MRNA decay; Ribosome function; Ribosomes; Translation; Translation regulation; peptidyl-tRNA; puromycin reaction; ribosome stacking; translation arrest	PEPTIDYL TRANSFERASE CENTER; MESSENGER-RNA DEGRADATION; DOUBLE-ROW POLYRIBOSOMES; GAMMA-SYNTHASE GENE; PROLYL-TRANSFER-RNA; NASCENT PEPTIDE; A-SITE; POSTTRANSCRIPTIONAL AUTOREGULATION; TRANSLATION ELONGATION; NEUROSPORA-CRASSA	Background:S-Adenosyl-l-methionine arrests ribosomes on CGS1 mRNA at the pre-translocation step, and ribosomes stack behind it. Results: Puromycin reactivity of stacked ribosomes was intermediate between ribosomes at the pre- and post-translocation steps. Conclusion: Ribosomes are stacked at nine-codon intervals, and the majority are stalled at an early step of translocation. Significance: This study is the first report of ribosomal states in a stacked array. Expression of CGS1, which codes for an enzyme of methionine biosynthesis, is feedback-regulated by mRNA degradation in response to S-adenosyl-l-methionine (AdoMet). In vitro studies revealed that AdoMet induces translation arrest at Ser-94, upon which several ribosomes stack behind the arrested one, and mRNA degradation occurs at multiple sites that presumably correspond to individual ribosomes in a stacked array. Despite the significant contribution of stacked ribosomes to inducing mRNA degradation, little is known about the ribosomes in the stacked array. Here, we assigned the peptidyl-tRNA species of the stacked second and third ribosomes to their respective codons and showed that they are arranged at nine-codon intervals behind the Ser-94 codon, indicating tight stacking. Puromycin reacts with peptidyl-tRNA in the P-site, releasing the nascent peptide as peptidyl-puromycin. This reaction is used to monitor the activity of the peptidyltransferase center (PTC) in arrested ribosomes. Puromycin reaction of peptidyl-tRNA on the AdoMet-arrested ribosome, which is stalled at the pre-translocation step, was slow. This limited reactivity can be attributed to the peptidyl-tRNA occupying the A-site at this step rather than to suppression of PTC activity. In contrast, puromycin reactions of peptidyl-tRNA with the stacked second and third ribosomes were slow but were not as slow as pre-translocation step ribosomes. We propose that the anticodon end of peptidyl-tRNA resides in the A-site of the stacked ribosomes and that the stacked ribosomes are stalled at an early step of translocation, possibly at the P/E hybrid state.	[Yamashita, Yui; Kadokura, Yoshitomo; Naito, Satoshi] Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan; [Sotta, Naoyuki; Fujiwara, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Takigawa, Ichigaku] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido 0010021, Japan; [Satake, Akiko] Hokkaido Univ, Grad Sch Environm Sci, Biosphere Dept, Sapporo, Hokkaido 0600810, Japan; [Onouchi, Hitoshi; Naito, Satoshi] Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; University of Tokyo; Hokkaido University; Hokkaido University; Hokkaido University	Naito, S (corresponding author), Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan.	naito@abs.agr.hokudai.ac.jp	Takigawa, Ichigaku/B-3823-2012; Sotta, Naoyuki/AAH-7816-2020	Takigawa, Ichigaku/0000-0001-5633-995X; Sotta, Naoyuki/0000-0001-5558-5155	Japan Society for the Promotion of Science [23-1971]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22119006]; Japan Science and Technology Agency [PJ34085001]; Grants-in-Aid for Scientific Research [22119011, 22119006] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science Fellows 23-1971 (to Y. Y.) from the Japan Society for the Promotion of Science; by a Grant-in-Aid for Scientific Research on Innovative Areas 22119006 (to S. N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Core Research for Evolutionary Science and Technology (CREST) Grant PJ34085001 (to H. O.) from the Japan Science and Technology Agency.	Afonina ZA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P445, DOI 10.1134/S0006297913050027; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanchard SC, 2010, CHEM BIOL, V17, P633, DOI 10.1016/j.chembiol.2010.06.003; Brandt F, 2010, MOL CELL, V39, P560, DOI 10.1016/j.molcel.2010.08.003; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Budkevich T, 2011, MOL CELL, V44, P214, DOI 10.1016/j.molcel.2011.07.040; Chiba S, 2012, MOL CELL, V47, P863, DOI 10.1016/j.molcel.2012.06.034; Chiba Y, 1999, SCIENCE, V286, P1371, DOI 10.1126/science.286.5443.1371; Chiba Y, 2003, P NATL ACAD SCI USA, V100, P10225, DOI 10.1073/pnas.1831512100; Cruz-Vera LR, 2006, P NATL ACAD SCI USA, V103, P3598, DOI 10.1073/pnas.0600082103; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Fang P, 2002, FUNGAL GENET BIOL, V36, P167, DOI 10.1016/S1087-1845(02)00014-2; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2012, CURR OPIN STRUC BIOL, V22, P778, DOI 10.1016/j.sbi.2012.08.001; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Haraguchi Y, 2008, PLANT CELL PHYSIOL, V49, P314, DOI 10.1093/pcp/pcn005; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Kopeina GS, 2008, NUCLEIC ACIDS RES, V36, P2476, DOI 10.1093/nar/gkm1177; MARTIN KA, 1983, DEV BIOL, V98, P338, DOI 10.1016/0012-1606(83)90364-0; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Ominato K, 2002, J BIOL CHEM, V277, P36380, DOI 10.1074/jbc.M204645200; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; Onoue N, 2011, J BIOL CHEM, V286, P14903, DOI 10.1074/jbc.M110.211656; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; Pogulis R J, 1996, Methods Mol Biol, V57, P167; Ramu H, 2011, MOL CELL, V41, P321, DOI 10.1016/j.molcel.2010.12.031; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; SEMENKOV Y, 1992, FEBS LETT, V296, P207, DOI 10.1016/0014-5793(92)80380-Y; Sharma D, 2004, RNA, V10, P102, DOI 10.1261/rna.5148704; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; Wei JJ, 2012, MOL CELL BIOL, V32, P2396, DOI 10.1128/MCB.00136-12; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	46	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12693	12704		10.1074/jbc.M113.526616	http://dx.doi.org/10.1074/jbc.M113.526616			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24652291	Green Published, hybrid			2022-12-25	WOS:000335581400041
J	Azad, GK; Singh, V; Tomar, RS				Azad, Gajendra Kumar; Singh, Vikash; Tomar, Raghuvir S.			Assessment of the Biological Pathways Targeted by Isocyanate Using N-Succinimidyl N-Methylcarbamate in Budding Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE INHIBITOR; HUMAN RAD52 PROTEIN; OXIDATIVE STRESS; DNA-DAMAGE; GLUTATHIONE PEROXIDASES; CHROMATIN; ADDUCTS; EBSELEN; BHOPAL; GAS	Isocyanates, a group of low molecular weight aromatic and aliphatic compounds possesses the functional isocyanate group. They are highly toxic in nature hence; we used N-succinimidyl N-methylcarbamate (NSNM), a surrogate chemical containing a functional isocyanate group to understand the mode of action of this class of compounds. We employed budding yeast Saccharomyces cerevisiae as a model organism to study the pathways targeted by NSNM. Our screening with yeast mutants revealed that it affects chromatin, DNA damage response, protein-ubiquitylation and chaperones, oxidative stress, TOR pathway and DNA repair processes. We also show that NSNM acts as an epigenetic modifier as its treatment causes reduction in global histone acetylation and formation of histone adducts. Cells treated with NSNM exhibited increase in mitochondrial membrane potential as well as intracellular ROS levels and the effects were rescued by addition of reduced glutathione to the medium. We also report that deletion of SOD1 and SOD2, the superoxide dismutase in Saccharomyces cerevisiae displayed hypersensitivity to NSNM. Furthermore, NSNM treatment causes rapid depletion of total glutathione and reduced glutathione. We also demonstrated that NSNM induces degradation of Sml1, a ribonucleotide reductase inhibitor involved in regulating dNTPs production. In summary, we define the various biological pathways targeted by isocyanates.	[Azad, Gajendra Kumar; Singh, Vikash; Tomar, Raghuvir S.] Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Tomar, RS (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal, India.	rst@iiserb.ac.in	Azad, Gajendra/K-3381-2014; Azad, Gajendra Kumar/AAC-7014-2019; Singh, Vikash/HCI-9902-2022	Azad, Gajendra/0000-0003-0338-3265; Singh, Vikash/0000-0002-5325-1386; Azad, Gajendra Kumar/0000-0001-5478-526X	Council of Scientific and Industrial Research (CSIR); Department of Biotechnology (DBT), Govt. of India; Department of Science & Technology (DST), Govt. of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India); Department of Science & Technology (DST), Govt. of India(Department of Science & Technology (India))	Council of Scientific and Industrial Research (CSIR) is acknowledged for fellowship support to GKA. This work was financially supported by the Department of Biotechnology (DBT) and Department of Science & Technology (DST), Govt. of India to RST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreson BL, 2010, NUCLEIC ACIDS RES, V38, P6490, DOI 10.1093/nar/gkq552; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Azad GK, 2012, BIOCHEM PHARMACOL, V83, P296, DOI 10.1016/j.bcp.2011.10.011; Azad GK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059003; Azad GK, 2014, FEBS OPEN BIO; Azad GK, 2014, MOL BIOL REP; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Balkrishna SJ, 2014, ORG BIOMOL CHEM, V12, P1215, DOI 10.1039/c4ob00027g; Balkrishna SJ, 2010, ORG LETT, V12, P5394, DOI 10.1021/ol102027j; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Baumann RP, 2005, ONCOL RES, V15, P313, DOI 10.3727/096504005776404553; Beyerbach A, 2006, CHEM RES TOXICOL, V19, P1611, DOI 10.1021/tx0600853; BHARUCHA EP, 1987, INDIAN J MED RES, V86, P59; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Chen DQ, 2013, J BIOL CHEM, V288, P21678, DOI 10.1074/jbc.M113.476630; DANIEL CS, 1987, INDIAN J MED RES, V86, P83; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Devasagayam TPA, 2009, INDIAN J BIOCHEM BIO, V46, P5; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Edwards TM, 2007, ENVIRON HEALTH PERSP, V115, P1264, DOI 10.1289/ehp.9951; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Fisseler-Eckhoff A, 2011, INT J ENV RES PUB HE, V8, P3672, DOI 10.3390/ijerph8093672; Golla U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064798; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Johnston M, 1996, CURR BIOL, V6, P500, DOI 10.1016/S0960-9822(02)00526-2; KANHERE S, 1987, INDIAN J MED RES, V86, P77; Koharyova M, 2008, GEN PHYSIOL BIOPHYS, V27, P71; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Lushchak V, 2010, BIOCHEMISTRY-MOSCOW+, V75, P281, DOI 10.1134/S0006297910030041; Mandal P, 2012, BIOCHEM BIOPH RES CO, V421, P261, DOI 10.1016/j.bbrc.2012.03.149; MARTINEZ J, 1982, J MED CHEM, V25, P178, DOI 10.1021/jm00344a017; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mishra PK, 2009, GENET MOL RES, V8, P129, DOI 10.4238/vol8-1gmr544; Mishra PK, 2008, J BIOCHEM MOL TOXIC, V22, P429, DOI 10.1002/jbt.20260; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Parsons CA, 2000, EMBO J, V19, P4175, DOI 10.1093/emboj/19.15.4175; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; SEGAL A, 1989, CHEM-BIOL INTERACT, V69, P359, DOI 10.1016/0009-2797(89)90122-1; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Singh V, 2014, FEBS LETT; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; TAMURA N, 1992, MUTAT RES, V283, P97, DOI 10.1016/0165-7992(92)90140-D; Tang HMV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000697; Tosatto SCE, 2008, ANTIOXID REDOX SIGN, V10, P1515, DOI 10.1089/ars.2008.2055; Wu B, 2011, CHEM-EUR J, V17, P3562, DOI 10.1002/chem.201100298; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299	53	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92993	10.1371/journal.pone.0092993	http://dx.doi.org/10.1371/journal.pone.0092993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664350	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900140
J	Brzostek, A; Szulc, I; Klink, M; Brzezinska, M; Sulowska, Z; Dziadek, J				Brzostek, Anna; Szulc, Izabela; Klink, Magdalena; Brzezinska, Marta; Sulowska, Zofia; Dziadek, Jaroslaw			Either Non-Homologous Ends Joining or Homologous Recombination Is Required to Repair Double-Strand Breaks in the Genome of Macrophage-Internalized Mycobacterium tuberculosis	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; GENETIC REQUIREMENTS; RECA PROTEIN; SURVIVAL; PATHWAYS; PATHOGENESIS; MUTANT; DAMAGE; MECHANISMS	The intracellular pathogen Mycobacterium tuberculosis (Mtb) is constantly exposed to a multitude of hostile conditions and is confronted by a variety of potentially DNA-damaging assaults in vivo, primarily from host-generated antimicrobial toxic radicals. Exposure to reactive nitrogen species and/or reactive oxygen species causes different types of DNA damage, including oxidation, depurination, methylation and deamination, that can result in single-or double-strand breaks (DSBs). These breaks affect the integrity of the whole genome and, when left unrepaired, can lead to cell death. Here, we investigated the role of the DSB repair pathways, homologous recombination (HR) and non-homologous ends joining (NHEJ), in the survival of Mtb inside macrophages. To this end, we constructed Mtb strains defective for HR (Delta recA), NHEJ [Delta(ku,ligD)], or both DSB repair systems [Delta(ku,ligD,recA)]. Experiments using these strains revealed that either HR or NHEJ is sufficient for the survival and propagation of tubercle bacilli inside macrophages. Inhibition of nitric oxide or superoxide anion production with L-NIL or apocynin, respectively, enabled the Delta(ku,ligD,recA) mutant strain lacking both systems to survive intracellularly. Complementation of the Delta(ku,ligD,recA) mutant with an intact recA or ku-ligD rescued the ability of Mtb to propagate inside macrophages.	[Brzostek, Anna; Szulc, Izabela; Klink, Magdalena; Brzezinska, Marta; Sulowska, Zofia; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, Lodz, Poland	Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Dziadek, J (corresponding author), Polish Acad Sci, Inst Med Biol, Lodz, Poland.	jdziadek@cbm.pan.pl	Klink, Magdalena/U-1953-2019	Dziadek, Jaroslaw/0000-0003-1427-884X; Szulc-Kielbik, Izabela/0000-0003-1290-697X; Klink, Magdalena/0000-0002-9870-7391	European Regional Development Fund [POIG.01.01.02-10-107/09]	European Regional Development Fund(European Commission)	This research was financed by a grant from the European Regional Development Fund (POIG.01.01.02-10-107/09) under the Operational Programme Innovative Economy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Aranda J, 2011, J BACTERIOL, V193, P3740, DOI 10.1128/JB.00389-11; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; Brzezinska M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-43; Brzostek A, 2007, FEMS MICROBIOL LETT, V275, P106, DOI 10.1111/j.1574-6968.2007.00865.x; Brzostek A, 2013, J STEROID BIOCHEM, V134, P1, DOI 10.1016/j.jsbmb.2012.09.028; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; BUCHMEIER NA, 1993, MOL MICROBIOL, V7, P933, DOI 10.1111/j.1365-2958.1993.tb01184.x; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Cadet J, 2012, CANCER LETT, V327, P5, DOI 10.1016/j.canlet.2012.04.005; Carpenter EP, 2007, EMBO J, V26, P1363, DOI 10.1038/sj.emboj.7601593; Cuccui J, 2007, INFECT IMMUN, V75, P1186, DOI 10.1128/IAI.01240-06; Darwin KH, 2005, INFECT IMMUN, V73, P4581, DOI 10.1128/IAI.73.8.4581-4587.2005; Davies BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001295; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Dziadek J, 2002, J BACTERIOL, V184, P3848, DOI 10.1128/JB.184.14.3848-3855.2002; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Fletcher HM, 1997, INFECT IMMUN, V65, P4592, DOI 10.1128/IAI.65.11.4592-4597.1997; Fu LM, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/23054; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Gorna AE, 2010, CLIN SCI, V119, P187, DOI 10.1042/CS20100041; Gupta R, 2011, MOL MICROBIOL, V79, P316, DOI 10.1111/j.1365-2958.2010.07463.x; Houghton J, 2012, J BACTERIOL, V194, P2916, DOI 10.1128/JB.06654-11; Korycka-Machala M, 2006, FEMS MICROBIOL LETT, V258, P83, DOI 10.1111/j.1574-6968.2006.00199.x; KOWALCZYKOWSKI SC, 1994, EXPERIENTIA, V50, P204, DOI 10.1007/BF01924003; KOWALCZYKOWSKI SC, 1991, BIOCHIMIE, V73, P289, DOI 10.1016/0300-9084(91)90216-N; Kurthkoti K, 2012, MECH AGEING DEV, V133, P138, DOI 10.1016/j.mad.2011.09.003; Mertens K, 2008, MOL MICROBIOL, V69, P1411, DOI 10.1111/j.1365-2958.2008.06373.x; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pitcher RS, 2007, ANNU REV MICROBIOL, V61, P259, DOI 10.1146/annurev.micro.61.080706.093354; Pitcher RS, 2007, DNA REPAIR, V6, P1271, DOI 10.1016/j.dnarep.2007.02.009; Pitcher RS, 2005, J MOL BIOL, V351, P531, DOI 10.1016/j.jmb.2005.06.038; Raja A, 2004, INDIAN J MED RES, V120, P213; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Richardson AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000451; Sander P, 2001, INFECT IMMUN, V69, P3562, DOI 10.1128/IAI.69.6.3562-3568.2001; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; Wojcik EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051064; Yang Chul-Su, 2009, Immune Netw, V9, P46, DOI 10.4110/in.2009.9.2.46; Yeager CM, 2001, APPL ENVIRON MICROB, V67, P5384, DOI 10.1128/AEM.67.12.5384-5391.2001	49	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92799	10.1371/journal.pone.0092799	http://dx.doi.org/10.1371/journal.pone.0092799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658131	Green Submitted, gold, Green Published			2022-12-25	WOS:000333355300130
J	Fiorillo, A; di Marino, D; Bertuccini, L; Via, A; Pozio, E; Camerini, S; Ilari, A; Lalle, M				Fiorillo, Annarita; di Marino, Daniele; Bertuccini, Lucia; Via, Allegra; Pozio, Edoardo; Camerini, Serena; Ilari, Andrea; Lalle, Marco			The Crystal Structure of Giardia duodenalis 14-3-3 in the Apo Form: When Protein Post-Translational Modifications Make the Difference	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ALPHA-SYNUCLEIN; BINDING; POLYGLYCINE; ISOFORMS	The 14-3-3s are a family of dimeric evolutionary conserved pSer/pThr binding proteins that play a key role in multiple biological processes by interacting with a plethora of client proteins. Giardia duodenalis is a flagellated protozoan that affects millions of people worldwide causing an acute and chronic diarrheal disease. The single giardial 14-3-3 isoform ( g14-3-3), unique in the 14-3-3 family, needs the constitutive phosphorylation of Thr214 and the polyglycylation of its C-terminus to be fully functional in vivo. Alteration of the phosphorylation and polyglycylation status affects the parasite differentiation into the cyst stage. To further investigate the role of these post-translational modifications, the crystal structure of the g14-3-3 was solved in the unmodified apo form. Oligomers of g14-3-3 were observed due to domain swapping events at the protein C-terminus. The formation of filaments was supported by TEM. Mutational analysis, in combination with native PAGE and chemical cross-linking, proved that polyglycylation prevents oligomerization. In silico phosphorylation and molecular dynamics simulations supported a structural role for the phosphorylation of Thr214 in promoting target binding. Our findings highlight unique structural features of g14-3-3 opening novel perspectives on the evolutionary history of this protein family and envisaging the possibility to develop anti-giardial drugs targeting g14-3-3.	[Fiorillo, Annarita] Univ Rome Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [Fiorillo, Annarita; Ilari, Andrea] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Fiorillo, Annarita; Ilari, Andrea] Univ Rome Sapienza, Inst Pasteur, Cenci Bolognetti Fdn, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [di Marino, Daniele; Via, Allegra] Univ Rome Sapienza, Dept Phys, Rome, Italy; [Bertuccini, Lucia] Ist Super Sanita, Dept Hlth & Technol, I-00161 Rome, Italy; [Pozio, Edoardo; Lalle, Marco] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy; [Camerini, Serena] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Lalle, M (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	marco.lalle@iss.it	Bertuccini, Lucia/AAI-6683-2021; Lalle, Marco/O-2287-2015; Di Marino, Daniele/AAB-9653-2019; Ilari, Andrea/AAC-7670-2022; Di Marino, Daniele/ABB-2333-2020; Via, Allegra/AAY-7435-2020; Camerini, Serena/A-4637-2017; Ilari, Andrea/T-5501-2017; BERTUCCINI, LUCIA/F-2102-2015	Bertuccini, Lucia/0000-0002-4278-2376; Lalle, Marco/0000-0001-5168-2150; Di Marino, Daniele/0000-0001-6961-3129; Ilari, Andrea/0000-0002-7754-399X; Camerini, Serena/0000-0001-6131-4335; Ilari, Andrea/0000-0002-7754-399X; 	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca [RBFR08F41U]; Istituto Superiore di Sanita [1APC/1303/2011]; Fondazione Istituto Italiano di Tecnologia (IIT); King Abdullah University of Science and Technology (KAUST) [KUK-I1-012-43]	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita; Fondazione Istituto Italiano di Tecnologia (IIT); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	This study has been partially supported by the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (FIRB grant RBFR08F41U), Istituto Superiore di Sanita (1APC/1303/2011), Fondazione Istituto Italiano di Tecnologia (IIT), (grant "Tecniche di Bioinformatica strutturale: Modellizzazione di proteine, docking e simulazione di dinamica molecolare), and the King Abdullah University of Science and Technology (KAUST, grant KUK-I1-012-43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; [Anonymous], [No title captured], DOI DOI 10.1016/B978-0-12-059820-5.50015-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brock TG, 2008, NEUROCHEM RES, V33, P801, DOI 10.1007/s11064-007-9498-3; Brokx SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014827; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Haladova K, 2012, J STRUCT BIOL, V179, P10, DOI 10.1016/j.jsb.2012.04.016; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim TD, 2004, BIOCHEM BIOPH RES CO, V324, P1352, DOI 10.1016/j.bbrc.2004.09.208; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; Lalle M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078090; Lalle M, 2012, J PROTEOME RES, V11, P2666, DOI 10.1021/pr3000199; Lalle M, 2011, J BIOL CHEM, V286, P4471, DOI 10.1074/jbc.M110.181511; Lalle M, 2010, INT J PARASITOL, V40, P201, DOI 10.1016/j.ijpara.2009.07.010; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; LOTZ B, 1974, J MOL BIOL, V87, P169, DOI 10.1016/0022-2836(74)90141-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Ohnishi S, 2006, J AM CHEM SOC, V128, P16338, DOI 10.1021/ja066008b; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Ottmann C, 2013, BIOORGAN MED CHEM, V21, P4058, DOI 10.1016/j.bmc.2012.11.028; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Rousseau F, 2012, ADV EXP MED BIOL, V747, P137, DOI 10.1007/978-1-4614-3229-6_9; Siles-Lucas MD, 2003, TRENDS PARASITOL, V19, P575, DOI 10.1016/j.pt.2003.10.003; Steinacker P, 2011, SEMIN CELL DEV BIOL, V22, P696, DOI 10.1016/j.semcdb.2011.08.005; Thompson RCA, 2012, ADV PARASIT, V78, P57, DOI 10.1016/B978-0-12-394303-3.00003-7; Thompson RCA, 2000, INT J PARASITOL, V30, P1259, DOI 10.1016/S0020-7519(00)00127-2; Tomassi Laura, 2008, BMC Biochemistry, V9, P21, DOI 10.1186/1471-2091-9-21; Veisova D, 2010, BIOCHEMISTRY-US, V49, P3853, DOI 10.1021/bi100273k; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Wan WY, 1999, J MOL BIOL, V286, P1651, DOI 10.1006/jmbi.1999.2551; Williams DM, 2011, BIOCHEM J, V437, P493, DOI 10.1042/BJ20102178; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	53	9	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92902	10.1371/journal.pone.0092902	http://dx.doi.org/10.1371/journal.pone.0092902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658679	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300143
J	Hernaus, D; van Winkel, R; Gronenschild, E; Habets, P; Kenis, G; Marcelis, M; van Os, J; Myin-Germeys, I; Collip, D				Hernaus, Dennis; van Winkel, Ruud; Gronenschild, Ed; Habets, Petra; Kenis, Gunter; Marcelis, Machteld; van Os, Jim; Myin-Germeys, Inez; Collip, Dina		Genetic Risk Outcome Psychosis GRO	Brain-Derived Neurotrophic Factor/FK506-Binding Protein 5 Genotype by Childhood Trauma Interactions Do Not Impact on Hippocampal Volume and Cognitive Performance	PLOS ONE			English	Article							EARLY-LIFE STRESS; FACTOR VAL66MET POLYMORPHISM; BDNF VAL(66)MET; FKBP5; PSYCHOSIS; GENE; ASSOCIATION; EXPOSURE; REACTIVITY; ADVERSITY	In the development of psychotic symptoms, environmental and genetic factors may both play a role. The reported association between childhood trauma and psychotic symptoms could therefore be moderated by single nucleotide polymorphisms (SNPs) associated with the stress response, such as FK506-binding protein 5 (FKBP5) and brain-derived neurotrophic factor (BDNF). Recent studies investigating childhood trauma by SNP interactions have inconsistently found the hippocampus to be a potential target underlying these interactions. Therefore, more detailed modelling of these effects, using appropriate covariates, is required. We examined whether BDNF/FKBP5 and childhood trauma interactions affected two proxies of hippocampal integrity: (i) hippocampal volume and (ii) cognitive performance on a block design (BD) and delayed auditory verbal task (AVLT). We also investigated whether the putative interaction was different for patients with a psychotic disorder (n = 89) compared to their non-psychotic siblings (n = 95), in order to elicit possible group-specific protective/vulnerability effects. SNPs were rs9296158, rs4713916, rs992105, rs3800373 (FKBP5) and rs6265 (BDNF). In the combined sample, no BDNF/FKBP5 by childhood trauma interactions were apparent for either outcome, and BDNF/FKBP5 by childhood trauma interactions were not different for patients and siblings. The omission of drug use and alcohol consumption sometimes yielded false positives, greatly affected explained error and influenced p-values. The consistent absence of any significant BDNF/FKBP5 by childhood trauma interactions on assessments of hippocampal integrity suggests that the effect of these interactions on psychotic symptoms is not mediated by hippocampal integrity. The importance of appropriate statistical designs and inclusion of relevant covariates should be carefully considered.	[Hernaus, Dennis; van Winkel, Ruud; Gronenschild, Ed; Habets, Petra; Kenis, Gunter; Marcelis, Machteld; van Os, Jim; Myin-Germeys, Inez; Collip, Dina] Maastricht Univ, Sch Mental Hlth & NeuroSci MHeNS, EURON, Dept Psychiat & Psychol,South Limburg Mental Hlth, Maastricht, Netherlands; [van Winkel, Ruud] Catholic Univ Louvain, Univ Psychiat Ctr, Kortenberg, Belgium; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Inst Psychiat, Dept Psychosis Studies, London, England	Maastricht University; Universite Catholique Louvain; University of London; King's College London	van Os, J (corresponding author), Maastricht Univ, Sch Mental Hlth & NeuroSci MHeNS, EURON, Dept Psychiat & Psychol,South Limburg Mental Hlth, Maastricht, Netherlands.	j.vanos@maastrichtuniversity.nl	Myin-Germeys, Inez/L-5106-2014; Habets, Petra/AAZ-1258-2021; van Os, Jim/C-2113-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019	Habets, Petra/0000-0001-9184-517X; van Os, Jim/0000-0002-7245-1586; Marcelis, Machteld/0000-0003-0045-9244; Hernaus, Dennis/0000-0002-8370-5756; Myin-Germeys, Inez/0000-0002-3731-4930	Geestkracht program of the Netherlands Organization for Scientific Research (NWO) (GROUP); European Community [HEALTH F2-2009-241909]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award; Dutch Medical Research Council (VENI and VIDI grant); European Research Council [ERC-2012-StG -309767]; Eli Lilly; BMS; Lundbeck; Organon; Janssen; GlaxoSmithKline; AstraZeneca; Pfizer; Servier; King Baudouin Foundation; Maastricht University	Geestkracht program of the Netherlands Organization for Scientific Research (NWO) (GROUP)(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award(NARSAD); Dutch Medical Research Council (VENI and VIDI grant); European Research Council(European Research Council (ERC)European Commission); Eli Lilly(Eli Lilly); BMS(Bristol-Myers Squibb); Lundbeck(Lundbeck Corporation); Organon; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Pfizer(Pfizer); Servier(Servier); King Baudouin Foundation; Maastricht University	This work was sponsored by the Geestkracht program of the Netherlands Organization for Scientific Research (NWO) (GROUP) and the European Community's Seventh Framework Programme under grant agreement HEALTH F2-2009-241909 (EU-GEI consortium). Furthermore, it was sponsored by a 2006 National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award and by the Dutch Medical Research Council (VENI and VIDI grant), and a European Research Council consolidator grant (ERC-2012-StG -309767) to I. Myin-Germeys. J. van Os is or has been an unrestricted research grant holder with, or his institution has received financial compensation as an independent symposium speaker from, Eli Lilly, BMS, Lundbeck, Organon, Janssen, GlaxoSmithKline, AstraZeneca, Pfizer, and Servier. M. Marcelis has received financial compensation as an independent symposium speaker from Eli Lilly and Janssen. G. Kenis has received financial compensation as an independent symposium speaker from Eli Lilly, Janssen and Servier. Ruud van Winkel is supported by the King Baudouin Foundation (Fund Dr. Gustave Delport). Dina Collip is supported by a Maastricht University post-doc Kootstra fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2009, PSYCHOL MED, V39, P1425, DOI 10.1017/S0033291709005248; Alemany S, 2011, BRIT J PSYCHIAT, V199, P38, DOI 10.1192/bjp.bp.110.083808; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Appel K, 2011, NEUROPSYCHOPHARMACOL, V36, P1982, DOI 10.1038/npp.2011.81; Baker LM, 2013, BRAIN IMAGING BEHAV, V7, P196, DOI 10.1007/s11682-012-9215-y; Banner H, 2011, EUR J NEUROSCI, V33, P968, DOI 10.1111/j.1460-9568.2010.07550.x; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Carballedo A, 2013, AM J MED GENET B, V162B, P183, DOI 10.1002/ajmg.b.32130; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; Collip D, 2013, BRIT J PSYCHIAT, V202, P261, DOI 10.1192/bjp.bp.112.115972; DEBELLIS MD, 1994, J CLIN ENDOCR METAB, V78, P249, DOI 10.1210/jc.78.2.249; den Hollander B, 2012, J NEUROL NEUROSUR PS, V83, P83, DOI 10.1136/jnnp.2010.228387; Fani N, 2013, JAMA PSYCHIAT, V70, P392, DOI 10.1001/2013.jamapsychiatry.210; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Geibprasert S, 2010, EUR RADIOL, V20, P1492, DOI 10.1007/s00330-009-1668-z; Gerritsen L, 2012, MOL PSYCHIATR, V17, P597, DOI 10.1038/mp.2011.51; Goodman J, 2013, J CHILD PSYCHOL PSYC; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; Habets P, 2012, PSYCHOL MED, V42, P1523, DOI 10.1017/S0033291711002728; Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531; Hoy K, 2012, SCHIZOPHRENIA BULL, V38, P1162, DOI 10.1093/schbul/sbr085; Kambeitz JP, 2012, NEUROSCI BIOBEHAV R, V36, P2165, DOI 10.1016/j.neubiorev.2012.07.002; Kelleher I, 2013, AM J PSYCHIAT, V170, P734, DOI 10.1176/appi.ajp.2012.12091169; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Klaassens ER, 2009, PROG NEURO-PSYCHOPH, V33, P889, DOI 10.1016/j.pnpbp.2009.04.011; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lorenzetti V, 2010, SUBST USE MISUSE, V45, P1787, DOI 10.3109/10826084.2010.482443; McGrath J, 2010, ARCH GEN PSYCHIAT, V67, P440, DOI 10.1001/archgenpsychiatry.2010.6; Miller S, 2013, J PSYCHIATR RES, V47, P252, DOI 10.1016/j.jpsychires.2012.10.015; Molendijk ML, 2012, AM J MED GENET B, V159B, P731, DOI 10.1002/ajmg.b.32078; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; Rosazza C, 2009, AM J NEURORADIOL, V30, P1134, DOI 10.3174/ajnr.A1518; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; Savitz J, 2007, BIOL PSYCHIAT, V62, P391, DOI 10.1016/j.biopsych.2006.10.017; Scharf SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016883; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; Strange BA, 2002, J NEUROSCI, V22, P523, DOI 10.1523/JNEUROSCI.22-02-00523.2002; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; UNO H, 1990, DEV BRAIN RES, V53, P157, DOI 10.1016/0165-3806(90)90002-G; Van Bokhoven P, 2011, EUR J NEUROSCI, V33, P1833, DOI 10.1111/j.1460-9568.2011.07668.x; van Winkel R, 2013, CAN J PSYCHIAT, V58, P44, DOI 10.1177/070674371305800109; White MG, 2012, GENES BRAIN BEHAV, V11, P869, DOI 10.1111/j.1601-183X.2012.00837.x; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Yucel M, 2008, ARCH GEN PSYCHIAT, V65, P694, DOI 10.1001/archpsyc.65.6.694	52	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92722	10.1371/journal.pone.0092722	http://dx.doi.org/10.1371/journal.pone.0092722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658422	gold, Green Published, Green Submitted			2022-12-25	WOS:000333355300120
J	Huang, LQ; Yu, ZH; Zhang, T; Zhao, XP; Huang, G				Huang, Liangqian; Yu, Zhenhai; Zhang, Teng; Zhao, Xiaoping; Huang, Gang			HSP40 Interacts with Pyruvate Kinase M2 and Regulates Glycolysis and Cell Proliferation in Tumor Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CANCER; PKM2; GROWTH; ISOFORM; TARGETS; HSP70; CYCLE; BETA; DNAJ	Pyruvate kinase M2 (PKM2) is predominantly expressed in cancers, which is considered as a key regulator of the Warburg effect. In this study, HSP40 was identified as a novel binding partner of PKM2. HSP40-PKM2 association destabilized PKM2 protein through HSC70. In the presence of HSP40, PKM2 protein level and PKM2-mediated PDK1 expression were down-regulated. Moreover, HSP40 was involved in regulating glucose metabolism on PKM2 dependent way and at the mean time had an effect on mitochondrial oxygen respiration. In line with inhibition effect of HSP40 on glycolysis, the growth of cancer cells was inhibited by HSP40. Our data provided a new regulation mechanism of PKM2, which suggested a new therapeutic target for cancer therapy.	[Huang, Liangqian; Huang, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Huang, Liangqian; Huang, Gang] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Huang, Liangqian; Zhang, Teng; Zhao, Xiaoping; Huang, Gang] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China; [Yu, Zhenhai; Huang, Gang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China.	huang2802@163.com			"973'' Project [2012CB932604]; New Drug Discovery Project [2012ZX09506-001-005]; Shanghai Leading Academic Discipline Project [S30203]; National Natural Science Foundation of China [81071180, 81001008, 81372195]; Shanghai Pujiang Program [13PJ1406000]; Science and Technology Commission of Shanghai Municipality [134119a5600]	"973'' Project(National Basic Research Program of China); New Drug Discovery Project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The study was supported by research grants from "973'' Project (No. 2012CB932604), New Drug Discovery Project (No. 2012ZX09506-001-005), Shanghai Leading Academic Discipline Project (No. S30203), National Natural Science Foundation of China (No. 81071180,81001008 & 81372195), Shanghai Pujiang Program (No. 13PJ1406000) and Science and Technology Commission of Shanghai Municipality (No. 134119a5600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Chen J, 2012, CANCER LETT, V316, P204, DOI 10.1016/j.canlet.2011.10.039; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Gao XL, 2013, J BIOL CHEM, V288, P15971, DOI 10.1074/jbc.M112.448753; Guo CX, 2013, BIOORG MED CHEM LETT, V23, P3358, DOI 10.1016/j.bmcl.2013.03.090; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Jo SR, 2012, J NEUROSCI, V32, P8491, DOI 10.1523/JNEUROSCI.6514-11.2012; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Mitra A, 2009, CLIN EXP METASTAS, V26, P559, DOI 10.1007/s10585-009-9255-x; Mitra A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1874; Newington JT, 2012, J BIOL CHEM, V287, P37245, DOI 10.1074/jbc.M112.366195; Ohtsuka K, 2000, INT J HYPERTHER, V16, P231, DOI 10.1080/026567300285259; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; QI M, 2013, BIOCHIM BIOPHYS ACTA, V1839, P62; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Soo ETL, 2008, IN VIVO, V22, P311; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Wang CC, 2006, CANCER RES, V66, P6756, DOI 10.1158/0008-5472.CAN-06-0185; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu SF, 2013, ACTA BIOCH BIOPH SIN, V45, P27, DOI 10.1093/abbs/gms106; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; YU L, 2012, ONCOLOGY LETT; Yu Z., 2013, J BIOL CHEM; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	37	27	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92949	10.1371/journal.pone.0092949	http://dx.doi.org/10.1371/journal.pone.0092949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658033	gold, Green Submitted, Green Published			2022-12-25	WOS:000333355300146
J	Lee, JY; Hong, WJ; Majeti, R; Stearns, T				Lee, Joanna Y.; Hong, Wan-Jen; Majeti, Ravindra; Stearns, Tim			Centrosome-Kinase Fusions Promote Oncogenic Signaling and Disrupt Centrosome Function in Myeloproliferative Neoplasms	PLOS ONE			English	Article							BCR-ABL ONCOPROTEIN; TYROSINE KINASE; T(6/8) TRANSLOCATION; PRIMARY CILIUM; STEM-CELLS; FOP; PROTEINS; DISORDER; DISEASE; GENE	Chromosomal translocations observed in myeloproliferative neoplasms (MPNs) frequently fuse genes that encode centrosome proteins and tyrosine kinases. This causes constitutive activation of the kinase resulting in aberrant, proliferative signaling. The function of centrosome proteins in these fusions is not well understood. Among others, kinase centrosome localization and constitutive kinase dimerization are possible consequences of centrosome protein-kinase fusions. To test the relative contributions of localization and dimerization on kinase signaling, we targeted inducibly dimerizable FGFR1 to the centrosome and other subcellular locations and generated a mutant of the FOP-FGFR1 MPN fusion defective in centrosome localization. Expression in mammalian cells followed by western blot analysis revealed a significant decrease in kinase signaling upon loss of FOP-FGFR1 centrosome localization. Kinase dimerization alone resulted in phosphorylation of the FGFR1 signaling target PLC gamma, however levels comparable to FOP-FGFR1 required subcellular targeting in addition to kinase dimerization. Expression of MPN fusion proteins also resulted in centrosome disruption in epithelial cells and transformed patient cells. Primary human MPN cells showed masses of modified tubulin that colocalized with centrin, Smoothened (Smo), IFT88, and Arl13b. This is distinct from acute myeloid leukemia (AML) cells, which are not associated with centrosome-kinase fusions and had normal centrosomes. Our results suggest that effective proliferative MPN signaling requires both subcellular localization and dimerization of MPN kinases, both of which may be provided by centrosome protein fusion partners. Furthermore, centrosome disruption may contribute to the MPN transformation phenotype.	[Lee, Joanna Y.; Stearns, Tim] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Sch Med, Inst Canc, Stanford, CA 94305 USA; [Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Stearns, Tim] Stanford Sch Med, Dept Genet, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	stearns@stanford.edu		Majeti, Ravindra/0000-0002-5814-0984; Stearns, Tim/0000-0002-0671-6582	NIH Cell and Molecular Biology Training Grant; ARCS Foundation Award; NIH Grant [GM52022]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052022] Funding Source: NIH RePORTER	NIH Cell and Molecular Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS Foundation Award; NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH Cell and Molecular Biology Training Grant to J.Y.L. (http://www.nigms.nih.gov/Training/InstPredoc/PredocTrainingDescription.htm), an ARCS Foundation Award to J.Y.L. (https://www.arcsfoundation.org), and NIH Grant GM52022 to T.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochtler T, 2012, LEUKEMIA, V26, P728, DOI 10.1038/leu.2011.283; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Cross NCP, 2008, ACTA HAEMATOL-BASEL, V119, P199, DOI 10.1159/000140631; de la Roche M, 2013, SCIENCE, V342, P1247, DOI 10.1126/science.1244689; Delaval B, 2005, LEUKEMIA, V19, P1739, DOI 10.1038/sj.leu.2403926; Delaval B, 2005, CANCER RES, V65, P7231, DOI 10.1158/0008-5472.CAN-04-4167; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Giehl M, 2005, LEUKEMIA, V19, P1192, DOI 10.1038/sj.leu.2403779; Gilliland DG, 2002, SEMIN HEMATOL, V39, P6, DOI 10.1053/shem.2002.36921; Gillingham AK, 2000, EMBO REP, V1, P524; Guasch G, 2004, BLOOD, V103, P309, DOI 10.1182/blood-2003-05-1690; Guasch G, 2001, MOL CELL BIOL, V21, P8129, DOI 10.1128/MCB.21.23.8129-8142.2001; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Kazmierczak B, 2010, IET SYST BIOL, V4, P348, DOI 10.1049/iet-syb.2010.0002; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Lee JY, 2013, PLOS ONE IN PRESS; Lelievre H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-30; Mahjoub MR, 2012, CURR BIOL, V22, P1628, DOI 10.1016/j.cub.2012.06.057; Matsuda M, 2001, J CELL BIOL, V153, P599, DOI 10.1083/jcb.153.3.599; MCWHIRTER JR, 1993, EMBO J, V12, P1533, DOI 10.1002/j.1460-2075.1993.tb05797.x; Michaud EJ, 2006, CANCER RES, V66, P6463, DOI 10.1158/0008-5472.CAN-06-0462; Mikolajka A, 2006, J MOL BIOL, V359, P863, DOI 10.1016/j.jmb.2006.03.070; NEGOESCU A, 1994, J HISTOCHEM CYTOCHEM, V42, P433, DOI 10.1177/42.3.7508473; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Popovici C, 1999, BLOOD, V93, P1381, DOI 10.1182/blood.V93.4.1381.404k30_1381_1389; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosnet O, 2007, HAEMATOLOGICA, V92, P728, DOI 10.3324/haematol.11387; Tefferi A, 2009, CANCER-AM CANCER SOC, V115, P3842, DOI 10.1002/cncr.24440; TOWLER DA, 1987, J BIOL CHEM, V262, P1030; Walz C, 2007, HAEMATOLOGICA, V92, P163, DOI 10.3324/haematol.10980; Xiao S, 2000, BLOOD, V96, P699; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zhao X, 2002, NAT STRUCT BIOL, V9, P117	42	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92641	10.1371/journal.pone.0092641	http://dx.doi.org/10.1371/journal.pone.0092641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658090	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300109
J	Riedel, G; Rudrich, U; Fekete-Drimusz, N; Manns, MP; Vondran, FWR; Bock, M				Riedel, Gesa; Ruedrich, Urda; Fekete-Drimusz, Nora; Manns, Michael P.; Vondran, Florian W. R.; Bock, Michael			An Extended Delta CT-Method Facilitating Normalisation with Multiple Reference Genes Suited for Quantitative RT-PCR Analyses of Human Hepatocyte-Like Cells	PLOS ONE			English	Article							HOUSEKEEPING GENE; DIFFERENTIATION; IDENTIFICATION; EXPRESSION; CULTURE; TARGET	Reference genes (RG) as sample internal controls for gene transcript level analyses by quantitative RT-PCR (RT-qPCR) must be stably expressed within the experimental range. A variety of in vitro cell culture settings with primary human hepatocytes, and Huh-7 and HepG2 cell lines, were used to determine candidate RG expression stability in RT-qPCR analyses. Employing GeNorm, BestKeeper and Normfinder algorithms, this study identifies PSMB6, MDH1 and some more RG as sufficiently unregulated, thus expressed at stable levels, in hepatocyte-like cells in vitro. Inclusion of multiple RG, quenching occasional regulations of single RG, greatly stabilises gene expression level calculations from RT-qPCR data. To further enhance validity and reproducibility of relative RT-qPCR quantifications, the Delta CT calculation can be extended (e-Delta CT) by replacing the CT of a single RG in Delta CT with an averaged CT-value from multiple RG. The use of two or three RG here identified suited for human hepatocyte-like cells - for normalisation with the straightforward e-Delta CT calculation, should improve reproducibility and robustness of comparative RT-qPCR-based gene expression analyses.	[Riedel, Gesa; Ruedrich, Urda; Fekete-Drimusz, Nora; Bock, Michael] Hannover Med Sch, REBIRTH Res Grp Hepat Cell Therapy, Hannover, Germany; [Riedel, Gesa; Ruedrich, Urda; Fekete-Drimusz, Nora; Manns, Michael P.; Bock, Michael] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Vondran, Florian W. R.] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Bock, M (corresponding author), Hannover Med Sch, REBIRTH Res Grp Hepat Cell Therapy, Hannover, Germany.	bock.michael@mh-hannover.de		Bock, Michael/0000-0001-9673-4903	REBIRTH-Cluster of Excellence (Deutsche Forschungsgemeinschaft); German Centre for Infection Research (DZIF, TTU Hepatitis); Else Kroner-Fresenius-Stiftung (FWRV) [2010_A49]	REBIRTH-Cluster of Excellence (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Centre for Infection Research (DZIF, TTU Hepatitis); Else Kroner-Fresenius-Stiftung (FWRV)	This work was funded by the REBIRTH-Cluster of Excellence (Deutsche Forschungsgemeinschaft), the German Centre for Infection Research (DZIF, TTU Hepatitis) and the Else Kroner-Fresenius-Stiftung (FWRV; 2010_A49). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Koyama T, 2009, TISSUE ENG PT A, V15, P1099, DOI 10.1089/ten.tea.2008.0242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sivaganesan M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-120; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Tostoes RM, 2012, HEPATOLOGY, V55, P1227, DOI 10.1002/hep.24760; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vondran FWR, 2008, ARTIF ORGANS, V32, P205, DOI 10.1111/j.1525-1594.2007.00524.x; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Yamashita Y, 2003, INT J CANCER, V103, P572, DOI 10.1002/ijc.10699; Yang Xianxian, 2012, BMC Res Notes, V5, P222, DOI 10.1186/1756-0500-5-222	20	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e93031	10.1371/journal.pone.0093031	http://dx.doi.org/10.1371/journal.pone.0093031			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658132	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300152
J	Di Gaetano, C; Fiorito, G; Ortu, MF; Rosa, F; Guarrera, S; Pardini, B; Cusi, D; Frau, F; Barlassina, C; Troffa, C; Argiolas, G; Zaninello, R; Fresu, G; Glorioso, N; Piazza, A; Matullo, G				Di Gaetano, Cornelia; Fiorito, Giovanni; Ortu, Maria Francesca; Rosa, Fabio; Guarrera, Simonetta; Pardini, Barbara; Cusi, Daniele; Frau, Francesca; Barlassina, Cristina; Troffa, Chiara; Argiolas, Giuseppe; Zaninello, Roberta; Fresu, Giovanni; Glorioso, Nicola; Piazza, Alberto; Matullo, Giuseppe			Sardinians Genetic Background Explained by Runs of Homozygosity and Genomic Regions under Positive Selection	PLOS ONE			English	Article							MEDITERRANEAN ISLANDS CORSICA; POPULATION; HISTORY; MTDNA; ASSOCIATION; PATTERNS; MODEL; AREA; SET	The peculiar position of Sardinia in the Mediterranean sea has rendered its population an interesting biogeographical isolate. The aim of this study was to investigate the genetic population structure, as well as to estimate Runs of Homozygosity and regions under positive selection, using about 1.2 million single nucleotide polymorphisms genotyped in 1077 Sardinian individuals. Using four different methods - fixation index, inflation factor, principal component analysis and ancestry estimation - we were able to highlight, as expected for a genetic isolate, the high internal homogeneity of the island. Sardinians showed a higher percentage of genome covered by RoHs>0.5 Mb (F-RoH%0.5) when compared to peninsular Italians, with the only exception of the area surrounding Alghero. We furthermore identified 9 genomic regions showing signs of positive selection and, we re-captured many previously inferred signals. Other regions harbor novel candidate genes for positive selection, like TMEM252, or regions containing long non coding RNA. With the present study we confirmed the high genetic homogeneity of Sardinia that may be explained by the shared ancestry combined with the action of evolutionary forces.	[Di Gaetano, Cornelia; Fiorito, Giovanni; Piazza, Alberto; Matullo, Giuseppe] Univ Turin, Dept Med Sci, Turin, Italy; [Di Gaetano, Cornelia; Fiorito, Giovanni; Rosa, Fabio; Guarrera, Simonetta; Pardini, Barbara; Piazza, Alberto; Matullo, Giuseppe] HuGeF Human Genet Fdn, Turin, Italy; [Ortu, Maria Francesca; Frau, Francesca; Troffa, Chiara; Argiolas, Giuseppe; Zaninello, Roberta; Fresu, Giovanni; Glorioso, Nicola] Univ Sassari, AOU, Hypertens & Related Dis Ctr, I-07100 Sassari, Italy; [Cusi, Daniele; Frau, Francesca; Barlassina, Cristina] Univ Milan, Dept Hlth Sci, Milan, Italy; [Cusi, Daniele; Frau, Francesca; Barlassina, Cristina] Filarete Fdn, Genom & Bioinformat Unit, Milan, Italy	University of Turin; University of Sassari; University of Milan	Di Gaetano, C (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	cornelia.digaetano@unito.it; giuseppe.matullo@unito.it	Matullo, Giuseppe/K-6383-2016; Pardini, Barbara/ABI-2295-2020; Guarrera, Simonetta/AAB-8482-2022; Di Gaetano, Cornelia/AAA-5477-2019; Rosa, Fabio/AGI-6840-2022; Pardini, Barbara/K-9451-2016	Matullo, Giuseppe/0000-0003-0674-7757; Pardini, Barbara/0000-0001-9571-4257; Di Gaetano, Cornelia/0000-0001-8938-7093; Rosa, Fabio/0000-0002-8335-4482; Pardini, Barbara/0000-0001-9571-4257; Barlassina, Cristina/0000-0001-7407-2697; Fiorito, Giovanni/0000-0002-7651-5452; Piazza, Alberto/0000-0002-2355-4183	Human Genetic Foundation (HuGeF); Compagnia di San Paolo of Turin; HYPERGENES project; Seventh Framework Programme [FP7 - HEALTH-F4-2007-201550]; InterOmics an Italian Flagship project; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Consiglio Nazionale delle Ricerche (CNR) [PB.05]	Human Genetic Foundation (HuGeF); Compagnia di San Paolo of Turin(Compagnia di San Paolo); HYPERGENES project; Seventh Framework Programme(European Commission); InterOmics an Italian Flagship project; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR))	The Human Genetic Foundation (HuGeF) and the Compagnia di San Paolo of Turin (to M.G.) were the main supporter of this project. This study used data from the following grants: HYPERGENES project (funded by the Seventh Framework Programme FP7 - HEALTH-F4-2007-201550) and InterOmics an Italian Flagship project (funded b 1 y Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) and Consiglio Nazionale delle Ricerche (CNR) Project PB.05 (to C.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Angius A, 2002, HUM GENET, V111, P9, DOI 10.1007/s00439-002-0753-z; BARBUJANI G, 1995, P NATL ACAD SCI USA, V92, P9171, DOI 10.1073/pnas.92.20.9171; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Calo C M, 1998, Anthropol Anz, V56, P227; Calo CM, 2003, COLLEGIUM ANTROPOL, V27, P105; Capelli C, 2006, ANN HUM GENET, V70, P207, DOI 10.1111/j.1529-8817.2005.00224.x; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; Caramelli D, 2007, HUM GENET, V122, P327, DOI 10.1007/s00439-007-0403-6; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Contini M., 1989, GEOLINGUISTIQUE, V4, P129; Contini M, 1979, B I PHONETIQUE GRENO, V8, P57; Contu D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001430; Contu L, 1998, TISSUE ANTIGENS, V52, P452, DOI 10.1111/j.1399-0039.1998.tb03072.x; D'Amore G, 2010, HOMO, V61, P385, DOI 10.1016/j.jchb.2010.09.002; Development Core Team R R, 2009, LANG ENV STAT COMP; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Gaetano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043759; Falchi A, 2006, J HUM GENET, V51, P9, DOI 10.1007/s10038-005-0324-y; Francalacci P, 2003, AM J PHYS ANTHROPOL, V121, P270, DOI 10.1002/ajpa.10265; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Fraumene C, 2006, MOL BIOL EVOL, V23, P2101, DOI 10.1093/molbev/msl084; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gilad Y, 2003, AM J HUM GENET, V73, P489, DOI 10.1086/378132; Gompert Z, 2011, GENETICS, V187, P903, DOI 10.1534/genetics.110.124693; Grimaldi MC, 2001, TISSUE ANTIGENS, V58, P281, DOI 10.1034/j.1399-0039.2001.580501.x; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; HUDSON RR, 1992, GENETICS, V132, P583; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Lampis R, 2000, HUM MOL GENET, V9, P2959, DOI 10.1093/hmg/9.20.2959; Malaspina P, 2000, ANN HUM GENET, V64, P395, DOI 10.1046/j.1469-1809.2000.6450395.x; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; MORAL P, 1994, AM J PHYS ANTHROPOL, V93, P441, DOI 10.1002/ajpa.1330930405; Morelli L, 2000, HUM BIOL, V72, P585; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; Pardo LM, 2012, EUR J HUM GENET, V20, P956, DOI 10.1038/ejhg.2012.22; PIAZZA A, 1988, ANN HUM GENET, V52, P203, DOI 10.1111/j.1469-1809.1988.tb01098.x; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Piras IS, 2012, EUR J HUM GENET; Pistis G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004654; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rendine S, 1997, ANN HUM GENET, V61, P411; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Salvi E, 2011, HYPERTENSION; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sutin AR, 2011, J BEHAV MED; Terracciano A, 2010, MOL PSYCHIATR, V15, P647, DOI 10.1038/mp.2008.113; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; VONA G, 1997, INT J ANTHR, V12, P71, DOI DOI 10.1007/BF02447890; VONA G, 1992, INT J ANTHR, V7, P25; Wagner M. L., 1941, HIST LAUTLEHRE SARDI; Zei G, 2003, EUR J HUM GENET, V11, P802, DOI 10.1038/sj.ejhg.5201040; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	60	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91237	10.1371/journal.pone.0091237	http://dx.doi.org/10.1371/journal.pone.0091237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651212	gold, Green Published			2022-12-25	WOS:000333352800034
J	Toshner, M; Dunmore, BJ; McKinney, EF; Southwood, M; Caruso, P; Upton, PD; Waters, JP; Ormiston, ML; Skepper, JN; Nash, G; Rana, AA; Morrell, NW				Toshner, Mark; Dunmore, Benjamin J.; McKinney, Eoin F.; Southwood, Mark; Caruso, Paola; Upton, Paul D.; Waters, John P.; Ormiston, Mark L.; Skepper, Jeremy N.; Nash, Gerard; Rana, Amer A.; Morrell, Nicholas W.			Transcript Analysis Reveals a Specific HOX Signature Associated with Positional Identity of Human Endothelial Cells	PLOS ONE			English	Article							GENE-EXPRESSION; EXTRACELLULAR-MATRIX; PROGENITOR CELLS; HOMEOBOX GENES; IN-VITRO; CANCER; DIFFERENTIATION; MORPHOGENESIS; COMMITMENT; DIVERSITY	The endothelial cell has a remarkable ability for sub-specialisation, adapted to the needs of a variety of vascular beds. The role of developmental programming versus the tissue contextual environment for this specialization is not well understood. Here we describe a hierarchy of expression of HOX genes associated with endothelial cell origin and location. In initial microarray studies, differential gene expression was examined in two endothelial cell lines: blood derived outgrowth endothelial cells (BOECs) and pulmonary artery endothelial cells. This suggested shared and differential patterns of HOX gene expression between the two endothelial lines. For example, this included a cluster on chromosome 2 of HOXD1, HOXD3, HOXD4, HOXD8 and HOXD9 that was expressed at a higher level in BOECs. Quantative PCR confirmed the higher expression of these HOXs in BOECs, a pattern that was shared by a variety of microvascular endothelial cell lines. Subsequently, we analysed publically available microarrays from a variety of adult cell and tissue types using the whole "HOX transcriptome" of all 39 HOX genes. Using hierarchical clustering analysis the HOX transcriptome was able to discriminate endothelial cells from 61 diverse human cell lines of various origins. In a separate publically available microarray dataset of 53 human endothelial cell lines, the HOX transcriptome additionally organized endothelial cells related to their organ or tissue of origin. Human tissue staining for HOXD8 and HOXD9 confirmed endothelial expression and also supported increased microvascular expression of these HOXs. Together these observations suggest a significant involvement of HOX genes in endothelial cell positional identity.	[Toshner, Mark; Dunmore, Benjamin J.; McKinney, Eoin F.; Caruso, Paola; Upton, Paul D.; Waters, John P.; Ormiston, Mark L.; Rana, Amer A.; Morrell, Nicholas W.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Toshner, Mark; Southwood, Mark] Papworth Hosp, Cambridge CB3 8RE, England; [Skepper, Jeremy N.] Univ Cambridge, Dept Neurosci & Physiol, Cambridge CB2 2QQ, England; [Nash, Gerard] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Papworth Hospital; University of Cambridge; University of Birmingham	Morrell, NW (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England.	nwm23@cam.ac.uk	wei, wei/HHR-8613-2022; Nash, Gerard B/E-4182-2010; Manganotti, Paolo/L-1763-2018	Nash, Gerard B/0000-0002-5935-2831; Manganotti, Paolo/0000-0001-5305-6268; Morrell, Nicholas/0000-0001-5700-9792; Toshner, Mark/0000-0002-3969-6143; Ormiston, Mark/0000-0003-0907-1940; McKinney, Eoin/0000-0003-3516-3072; southwood, mark/0000-0002-3493-9599	Academy of Medical Sciences; British Heart Foundation; Cambridge Cardiovascular Consortium; Cambridge National Institutes of Health Research Biomedical Research Centre; MRC [G0800784, MR/K020919/1, G1000847] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL5-Toshner] Funding Source: researchfish; British Heart Foundation [FS/13/19/29931, PG/12/54/29734, FS/12/39/29653, PG/11/10/28724, PG/10/35/28339, SP/12/12/29836, RG/13/4/30107] Funding Source: researchfish; Kidney Research UK [TF13/2010] Funding Source: researchfish; Medical Research Council [MR/K020919/1, G0800784, G1000847] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10174] Funding Source: researchfish	Academy of Medical Sciences(Academy of Medical Sciences (AMS)); British Heart Foundation(British Heart Foundation); Cambridge Cardiovascular Consortium; Cambridge National Institutes of Health Research Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); British Heart Foundation(British Heart Foundation); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by grants from the Academy of Medical Sciences and the British Heart Foundation, and supported by the Cambridge Cardiovascular Consortium and Cambridge National Institutes of Health Research Biomedical Research Centre. The authors would like to acknowledge the contribution of Phil Stone who organized the leucocyte migration assays, and sadly died during the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007; Amali AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058857; Belotti D, 1998, LAB INVEST, V78, P1291; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Diehl F, 2007, BLOOD, V109, P1472, DOI 10.1182/blood-2006-08-039651; Garry DJ, 2006, CELL, V127, P1101, DOI 10.1016/j.cell.2006.11.031; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Hansen SL, 2006, J CRANIOFAC SURG, V17, P767, DOI 10.1097/00001665-200607000-00031; Harada K, 2009, J CELL SCI, V122, P3923, DOI 10.1242/jcs.052324; Jeong MS, 2009, J MICROBIOL BIOTECHN, V19, P1557, DOI 10.4014/jmb.0905.05021; Kusuma S, 2012, FASEB J, V26, P4925, DOI 10.1096/fj.12-209296; Lee HJ, 2011, EXP LUNG RES, V37, P344, DOI 10.3109/01902148.2011.577267; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; MANOHAR CF, 1993, BIOCHEM MOL BIOL INT, V30, P733; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Murthi P, 2008, PLACENTA, V29, P624, DOI 10.1016/j.placenta.2008.04.006; Ormiston ML, 2012, CIRCULATION; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pitera JE, 2001, MECH DEVELOP, V109, P377, DOI 10.1016/S0925-4773(01)00530-5; RAINGER GE, 1995, AM J PHYSIOL-HEART C, V269, pH1398, DOI 10.1152/ajpheart.1995.269.4.H1398; REDLINE RW, 1992, GENOMICS, V13, P425, DOI 10.1016/0888-7543(92)90263-R; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rossig L, 2005, J EXP MED, V201, P1825, DOI 10.1084/jem.20042097; Storti P, 2011, LEUKEMIA, V25, P527, DOI 10.1038/leu.2010.270; Takahashi Y, 2004, EXP CELL RES, V293, P144, DOI 10.1016/j.yexcr.2003.09.024; Toshner M, 2009, AM J RESP CRIT CARE, V180, P780, DOI 10.1164/rccm.200810-1662OC; Wang H, 2006, CIRC RES, V98, P1331, DOI 10.1161/01.RES.0000220650.26555.1d; Wang KC, 2009, TRENDS CELL BIOL, V19, P268, DOI 10.1016/j.tcb.2009.03.007; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Winnik S, 2009, CARDIOVASC RES, V83, P558, DOI 10.1093/cvr/cvp133; Wu YX, 2003, MOL CELL BIOL, V23, P5680, DOI 10.1128/MCB.23.16.5680-5691.2003; Zhong JP, 2003, J CLIN INVEST, V112, P30, DOI 10.1172/JCI200317034; Zhu SK, 2013, CIRC RES, V112, P152, DOI 10.1161/CIRCRESAHA.112.280016; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	40	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91334	10.1371/journal.pone.0091334	http://dx.doi.org/10.1371/journal.pone.0091334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651450	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800038
J	Wu, CY; Wang, C; Guan, XC; Liu, YX; Li, DM; Zhou, XJ; Zhang, YN; Chen, X; Wang, JJ; Zen, K; Zhang, CY; Zhang, CN				Wu, Caiyun; Wang, Cheng; Guan, Xiaocui; Liu, Yuxiu; Li, Demin; Zhou, Xiaojun; Zhang, Yanni; Chen, Xi; Wang, Junjun; Zen, Ke; Zhang, Chen-Yu; Zhang, Chunni			Diagnostic and Prognostic Implications of a Serum miRNA Panel in Oesophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILE; CIRCULATING MICRORNAS; POTENTIAL BIOMARKER; CLINICAL IMPACT; CANCER; PLASMA	Background and Aim: Circulating microRNAs (miRNAs) are potential biomarkers for cancer detection; however, little is known about their prognostic impact on oesophageal squamous cell carcinoma (ESCC). The current study aims to uncover novel miRNAs for prognostic biomarkers in ESCC patients. Patients and Methods: We initially screened the expression of 754 serum miRNAs using TaqMan Low Density Array in two pooled samples respectively from 28 ESCC and 28 normal controls. Markedly upregulated miRNAs in ESCC and some miRNAs reported to be differently expressed in ESCC tissue were then validated individually by RT-qPCR in another 83 patients and 83 controls arranged in two phases. The changes of the selected miRNAs during the esophagectomy and their prognostic value were examined. Results: Seven serum miRNAs were found to be significantly higher in ESCC than in controls; namely, miR-25, miR-100, miR-193-3p, miR-194, miR-223, miR-337-5p and miR-483-5p (P<0.0001), and the area under the receiver-operating-characteristic (ROC) curve (AUC) for the seven-miRNA panel was 0.83 (95% CI 0.75-0.90). Most of these miRNAs declined markedly in postoperative samples versus preoperative samples (P<0.05). Moreover, high level of miR-25 was significantly correlated with shorter overall survival in patients (P = 0.027). Cox regression analysis identified lymph node metastasis, miR-25 and miR-100 as the independent risk factors for overall survival (hazard ratio (HR) 2.98 [1.36-6.55], P = 0.006; HR 3.84 [1.02-14.41], P = 0.029; HR 4.18 [1.21-14.50], P = 0.024, respectively). Conclusion: The seven serum miRNAs could potentially serve as novel biomarkers for ESCC; moreover, specific miRNAs such as miR-25 and miR-100 can predict poor survival in ESCC.	[Wu, Caiyun; Wang, Cheng; Guan, Xiaocui; Wang, Junjun; Zhang, Chunni] Nanjing Univ, Jinling Hosp, Sch Life Sci, Dept Clin Lab, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Cheng; Chen, Xi; Zen, Ke; Zhang, Chen-Yu; Zhang, Chunni] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Yuxiu] Nanjing Univ, Jinling Hosp, Sch Clin, Coll Med,Dept Sci Res Management, Nanjing 210008, Jiangsu, Peoples R China; [Li, Demin] Nanjing Univ, Jinling Hosp, Sch Clin, Coll Med,Dept Cardiothorac Surg, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Xiaojun] Nanjing Univ, Jinling Hosp, Sch Clin, Coll Med,Dept Pathol, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Yanni] Canc Hosp Xuzhou, Dept Med Oncol, Xuzhou, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University	Zen, K (corresponding author), Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	kzen@nju.edu.cn; cyzhang@nju.edu.cn; zchunni27@hotmail.com	Wang, Cheng/O-7206-2016	Wang, Cheng/0000-0002-1834-2119; Zhang, Chunni/0000-0002-7329-7162	National Basic Research Program of China (973 Program) [2014CB542300]; National Natural Science Foundation of China [81171661, 81301511, 81271904]; Natural Science Foundation of Jiangsu Province [BK2011013]; Medical Scientific Research Foundation of Nanjing Military Command [12Z28]; Research Special Fund for Public Welfare Industry of Health [201302018]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Medical Scientific Research Foundation of Nanjing Military Command; Research Special Fund for Public Welfare Industry of Health	This work was supported by grants from the National Basic Research Program of China (973 Program) (no. 2014CB542300), the National Natural Science Foundation of China (Nos. 81171661, 81301511 and 81271904), Natural Science Foundation of Jiangsu Province (no. BK2011013), Medical Scientific Research Foundation of Nanjing Military Command (no. 12Z28) and the Research Special Fund for Public Welfare Industry of Health (no. 201302018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosman F., 2010, WHO CLASSIFICATION T, V4th; Chabre O, 2013, ENDOCR-RELAT CANCER, V20, P579, DOI 10.1530/ERC-13-0051; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070914, 10.1371/journal.pone.0079652]; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gu J, 2013, CURR PHARM DESIGN, V19, P1292; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Hirajima S, 2013, BRIT J CANCER, V108, P1822, DOI 10.1038/bjc.2013.148; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Kurashige J, 2012, J SURG ONCOL, V106, P188, DOI 10.1002/jso.23064; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Luo Y, 2013, CLIN CHEM, V59, P658, DOI 10.1373/clinchem.2012.195297; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ruol A, 2008, ARCH SURG-CHICAGO, V144, P247; Selth LA, 2013, BRIT J CANCER, V109, P641, DOI 10.1038/bjc.2013.369; Sun J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0411-9; Takeshita N, 2013, BRIT J CANCER, V108, P644, DOI 10.1038/bjc.2013.8; Tanaka Y, 2013, CANCER-AM CANCER SOC, V119, P1159, DOI 10.1002/cncr.27895; Wang Y, 2013, J APPL TOXI IN PRESS; Xu XH, 2012, BIOCHEM BIOPH RES CO, V421, P640, DOI 10.1016/j.bbrc.2012.03.048; Yang CH, 2013, INT J CANCER, V132, P116, DOI 10.1002/ijc.27657; Yong FL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-280; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553; Zhang TF, 2013, MOL CARCINOGEN, V52, P581, DOI 10.1002/mc.21880; Zhang TF, 2011, CLIN SCI, V121, P437, DOI 10.1042/CS20110207	29	78	81	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92292	10.1371/journal.pone.0092292	http://dx.doi.org/10.1371/journal.pone.0092292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651474	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800097
J	Karamitros, CS; Konrad, M				Karamitros, Christos S.; Konrad, Manfred			Human 60-kDa Lysophospholipase Contains an N-terminal L-Asparaginase Domain That Is Allosterically Regulated by L-Asparagine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Enzyme Mutation; Enzyme Purification; Fluorescence; Leukemia; l-Asparaginases; Allostery; Conformational Stability; Differential Scanning Fluorometry; Human Lysophospholipase	GUANIDINE-HYDROCHLORIDE DENATURATION; ESCHERICHIA-COLI-ASPARAGINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SUBSTRATE HYDROLYSIS; COPURIFYING GROEL; MONOMERIC ENZYMES; HUMAN GLUCOKINASE; FUSION PROTEINS	Background: The 60-kDa human lysophospholipase comprises an N-terminal domain with predicted, yet uncharacterized l-asparaginase activity and a C-terminal ankyrin repeat-like domain. Results: The N-terminal domain, termed hASNase1, was identified as a functional structural unit possessing catalytic activity. Conclusion: hASNase1 is an allosterically regulated bacterial-type cytoplasmic l-asparaginase. Significance: Domains of multifunctional human proteins harbor homologs of prokaryotic enzymes displaying similar structural and kinetic features. The structural and functional characterization of human enzymes that are of potential medical and therapeutic interest is of prime significance for translational research. One of the most notable examples of a therapeutic enzyme is l-asparaginase, which has been established as an antileukemic protein drug for more than four decades. Up until now, only bacterial enzymes have been used in therapy despite a plethora of undesired side effects mainly attributed to the bacterial origins of these enzymes. Therefore, the replacement of the currently approved bacterial drugs by human homologs aiming at the elimination of adverse effects is of great importance. Recently, we structurally and biochemically characterized the enzyme human l-asparaginase 3 (hASNase3), which possesses l-asparaginase activity and belongs to the N-terminal nucleophile superfamily of enzymes. Inspired by the necessity for the development of a protein drug of human origin, in the present study, we focused on the characterization of another human l-asparaginase, termed hASNase1. This bacterial-type cytoplasmic l-asparaginase resides in the N-terminal subdomain of an overall 573-residue protein previously reported to function as a lysophospholipase. Our kinetic, mutagenesis, structural modeling, and fluorescence labeling data highlight allosteric features of hASNase1 that are similar to those of its Escherichia coli homolog, EcASNase1. Differential scanning fluorometry and urea denaturation experiments demonstrate the impact of particular mutations on the structural and functional integrity of the l-asparaginase domain and provide a direct comparison of sites critical for the conformational stability of the human and E. coli enzymes.	[Karamitros, Christos S.; Konrad, Manfred] Max Planck Inst Biophys Chem, Enzyme Biochem Grp, D-37077 Gottingen, Germany	Max Planck Society	Konrad, M (corresponding author), Max Planck Inst Biophys Chem, Enzyme Biochem Grp, D-37077 Gottingen, Germany.	mkonrad@gwdg.de			Max Planck Society; Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences	Max Planck Society(Max Planck Society); Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences	This work was supported by the Max Planck Society (to C. S. K. and M. K.) and the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (to C. S. K.).	ASSELIN BL, 1989, CANCER RES, V49, P4363; Balcao VM, 2001, BIOTECHNOL PROGR, V17, P537, DOI 10.1021/bp000163r; Bandyopadhyay D, 1997, MOL CELL BIOCHEM, V167, P73, DOI 10.1023/A:1006815504302; Baryshnikova EN, 2005, PROTEIN SCI, V14, P2658, DOI 10.1110/ps.051402705; Baskakov IV, 1999, PROTEIN SCI, V8, P1314, DOI 10.1110/ps.8.6.1314; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; Boivin S, 2013, PROTEIN EXPRES PURIF, V91, P192, DOI 10.1016/j.pep.2013.08.002; Borek D, 2004, EUR J BIOCHEM, V271, P3215, DOI 10.1111/j.1432-1033.2004.04254.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Cantor JR, 2009, BIOCHEMISTRY-US, V48, P11026, DOI 10.1021/bi901397h; Cardenas ML, 2013, FEBS LETT, V587, P2767, DOI 10.1016/j.febslet.2013.07.014; CARDENAS ML, 1984, EUR J BIOCHEM, V145, P163, DOI 10.1111/j.1432-1033.1984.tb08536.x; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Credali A, 2013, PLANT CELL PHYSIOL, V54, P107, DOI 10.1093/pcp/pcs156; Delano D.W., 2002, PYMOL MOL GRAPHICS S; DERST C, 1992, PROTEIN ENG, V5, P785, DOI 10.1093/protein/5.8.785; Dieterich DC, 2003, J NEUROCHEM, V85, P1117, DOI 10.1046/j.1471-4159.2003.01766.x; Duval M, 2002, BLOOD, V99, P2734, DOI 10.1182/blood.V99.8.2734; Ereno-Orbea J, 2013, P NATL ACAD SCI USA, V110, pE3790, DOI 10.1073/pnas.1313683110; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Grimsley G. R., 2013, CURR PROTOC PROTEIN, V71; Guan C, 1998, J BIOL CHEM, V273, P9695, DOI 10.1074/jbc.273.16.9695; HANSEN HA, 1994, APPL MICROBIOL BIOT, V41, P560, DOI 10.1007/BF00178489; Hejazi M, 2002, BIOCHEM J, V364, P129, DOI 10.1042/bj3640129; Huang ZM, 2014, NUCLEIC ACIDS RES, V42, pD510, DOI 10.1093/nar/gkt1247; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Karamitros CS, 2014, PROTEIN EXPRES PURIF, V93, P1, DOI 10.1016/j.pep.2013.10.007; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Li WZ, 2012, ACS CHEM BIOL, V7, P1840, DOI 10.1021/cb300232n; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; Lubkowski J, 1996, EUR J BIOCHEM, V241, P201, DOI 10.1111/j.1432-1033.1996.0201t.x; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Menniti M, 2010, CELL PHYSIOL BIOCHEM, V26, P587, DOI 10.1159/000322326; Michalska K, 2005, J BIOL CHEM, V280, P28484, DOI 10.1074/jbc.M504501200; Michalska K, 2006, ACTA BIOCHIM POL, V53, P627, DOI 10.18388/abp.2006_3291; Modesti M, 2011, METHODS MOL BIOL, V783, P101, DOI 10.1007/978-1-61779-282-3_6; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Nomme J, 2012, BIOCHEMISTRY-US, V51, P6816, DOI 10.1021/bi300870g; O'Brien JR, 2003, BIOCHEMISTRY-US, V42, P5547, DOI 10.1021/bi0341096; OINONEN C, 1995, NAT STRUCT BIOL, V2, P1102, DOI 10.1038/nsb1295-1102; Pace CN, 1999, PROTEIN SCI, V8, P1500, DOI 10.1110/ps.8.7.1500; Peroutka RJ, 2011, METHODS MOL BIOL, V705, P15, DOI 10.1007/978-1-61737-967-3_2; Pieters R, 2011, CANCER-AM CANCER SOC, V117, P238, DOI 10.1002/cncr.25489; Porter CM, 2012, BIOORG CHEM, V43, P44, DOI 10.1016/j.bioorg.2011.11.001; Rial DV, 2002, PROTEIN EXPRES PURIF, V25, P503, DOI 10.1016/S1046-5928(02)00024-4; RICARD J, 1974, EUR J BIOCHEM, V49, P195, DOI 10.1111/j.1432-1033.1974.tb03825.x; Rohman M, 2000, PROTEIN EXPRES PURIF, V20, P45, DOI 10.1006/prep.2000.1271; Saito S, 2008, BIOCHEM BIOPH RES CO, V377, P1168, DOI 10.1016/j.bbrc.2008.10.142; SHE HS, 1994, BIOCHEM J, V298, P23, DOI 10.1042/bj2980023; Shirley Bret A., 1995, V40, P177; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Srikhanta YN, 2013, BIOCHEM BIOPH RES CO, V436, P362, DOI 10.1016/j.bbrc.2013.05.066; Stecher A L, 1999, Pharm Acta Helv, V74, P1, DOI 10.1016/S0031-6865(99)00009-6; Su Y, 2013, CHEM BIOL, V20, P533, DOI 10.1016/j.chembiol.2013.03.006; Sugimoto H, 1998, J BIOL CHEM, V273, P12536, DOI 10.1074/jbc.273.20.12536; SWAIN AL, 1993, P NATL ACAD SCI USA, V90, P1474, DOI 10.1073/pnas.90.4.1474; Talla-Singh D, 2008, PROTEINS, V71, P1607, DOI 10.1002/prot.22016; Thain A, 1996, TRENDS GENET, V12, P209, DOI 10.1016/S0168-9525(96)90022-0; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Voronin D A, 2007, Tsitologiia, V49, P989; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weidle UH, 2009, ANTICANCER RES, V29, P951; WILLIS RC, 1975, J BACTERIOL, V123, P937, DOI 10.1128/JB.123.3.937-945.1975; Yun MK, 2007, J MOL BIOL, V369, P794, DOI 10.1016/j.jmb.2007.03.061; Zhang J, 2006, P NATL ACAD SCI USA, V103, P13368, DOI 10.1073/pnas.0605738103	69	29	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					12962	12975		10.1074/jbc.M113.545038	http://dx.doi.org/10.1074/jbc.M113.545038			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24657844	Green Published, hybrid			2022-12-25	WOS:000335522800002
J	Novgorodov, SA; Riley, CL; Yu, J; Borg, KT; Hannun, YA; Proia, RL; Kindy, MS; Gudz, TI				Novgorodov, Sergei A.; Riley, Christopher L.; Yu, Jin; Borg, Keith T.; Hannun, Yusuf A.; Proia, Richard L.; Kindy, Mark S.; Gudz, Tatyana I.			Essential Roles of Neutral Ceramidase and Sphingosine in Mitochondrial Dysfunction Due to Traumatic Brain Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain; Cell Death; Mitochondria; Respiratory Chain; Sphingolipid	CYTOCHROME-C-OXIDASE; SUBCELLULAR-LOCALIZATION; CHRONIC ACTIVATION; RESPIRATORY-CHAIN; MOLECULAR-CLONING; RAT-BRAIN; IN-VITRO; KINASE; SPHINGOSINE-1-PHOSPHATE; SPHINGOLIPIDS	Background: A cardinal feature of many neurological disorders is mitochondrial dysfunction. Results: Knocking down neutral ceramidase reduces mitochondrial sphingosine, preserves mitochondrial function, and improves brain function recovery after trauma. Conclusion: Activation of the sphingosine-generating pathway plays a significant role in promoting mitochondrial injury. Significance: This is the first direct evidence of endogenous sphingosine involvement in regulation of mitochondrial function. In addition to immediate brain damage, traumatic brain injury (TBI) initiates a cascade of pathophysiological events producing secondary injury. The biochemical and cellular mechanisms that comprise secondary injury are not entirely understood. Herein, we report a substantial deregulation of cerebral sphingolipid metabolism in a mouse model of TBI. Sphingolipid profile analysis demonstrated increases in sphingomyelin species and sphingosine concurrently with up-regulation of intermediates of de novo sphingolipid biosynthesis in the brain. Investigation of intracellular sites of sphingosine accumulation revealed an elevation of sphingosine in mitochondria due to the activation of neutral ceramidase (NCDase) and the reduced activity of sphingosine kinase 2 (SphK2). The lack of change in gene expression suggested that post-translational mechanisms are responsible for the shift in the activities of both enzymes. Immunoprecipitation studies revealed that SphK2 is complexed with NCDase and cytochrome oxidase (COX) subunit 1 in mitochondria and that brain injury hindered SphK2 association with the complex. Functional studies showed that sphingosine accumulation resulted in a decreased activity of COX, a rate-limiting enzyme of the mitochondrial electron transport chain. Knocking down NCDase reduced sphingosine accumulation in mitochondria and preserved COX activity after the brain injury. Also, NCDase knockdown improved brain function recovery and lessened brain contusion volume after trauma. These studies highlight a novel mechanism of secondary TBI involving a disturbance of sphingolipid-metabolizing enzymes in mitochondria and suggest a critical role for mitochondrial sphingosine in promoting brain injury after trauma.	[Riley, Christopher L.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Yu, Jin; Kindy, Mark S.; Gudz, Tatyana I.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Novgorodov, Sergei A.; Kindy, Mark S.; Gudz, Tatyana I.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Borg, Keith T.] Med Univ S Carolina, Dept Emergency Med, Charleston, SC 29425 USA; [Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gudz, TI (corresponding author), 114 Doughty St, Charleston, SC 29425 USA.	gudz@musc.edu	Proia, Richard L/A-7908-2012	Proia, Richard/0000-0003-0456-1270	National Institutes of Health [P30 GM103339]; Veterans Affairs Merit Awards [I01RX000206, I01BX001104, I01RX000331]; American Diabetes Association [7-12-IN-28]; NATIONAL CANCER INSTITUTE [R01CA172517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056016, ZIADK056014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, P30GM103339] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000206, I01RX000331, I01BX001104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Awards(US Department of Veterans Affairs); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant P30 GM103339 (to S. A. N.). This work was also supported by Veterans Affairs Merit Awards I01RX000206 (to T. I. G.), I01BX001104 (to T. I. G.), and I01RX000331 (to M. S. K.). The Lipidomics Core Facility at Medical University of South Carolina is supported in part by National Institutes of Health Grant P30 GM103339.; Supported in part by American Diabetes Association Innovation Grant 7-12-IN-28.	Arnold S, 2012, ADV EXP MED BIOL, V748, P305, DOI 10.1007/978-1-4614-3573-0_13; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Chan HS, 2013, BBA-MOL CELL BIOL L, V1831, P147, DOI 10.1016/j.bbalip.2012.07.005; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Clarke CJ, 2011, J BIOL CHEM, V286, P21565, DOI 10.1074/jbc.M110.193375; Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; El Bawab S, 1999, J BIOL CHEM, V274, P27948, DOI 10.1074/jbc.274.39.27948; El Bawab S, 2001, J BIOL CHEM, V276, P16758, DOI 10.1074/jbc.M009331200; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Franzen R, 2001, J BIOL CHEM, V276, P35382, DOI 10.1074/jbc.M102153200; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Galadari S, 2006, BIOCHEM J, V393, P687, DOI 10.1042/BJ20050682; Geoffroy K, 2004, J BIOL CHEM, V279, P34343, DOI 10.1074/jbc.M403273200; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; HARTL FU, 1986, CELL, V47, P939, DOI 10.1016/0092-8674(86)90809-3; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hwang YH, 2005, BIOCHEM BIOPH RES CO, V331, P37, DOI 10.1016/j.bbrc.2005.03.134; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; Novgorodov Sergei A, 2011, Int J Biochem Mol Biol, V2, P347; Novgorodov SA, 2011, J BIOL CHEM, V286, P25352, DOI 10.1074/jbc.M110.214866; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; Noygorodov SA, 2009, J CARDIOVASC PHARM, V53, P198, DOI 10.1097/FJC.0b013e31819b52d5; O'Neill SM, 2011, ARCH BIOCHEM BIOPHYS, V511, P31, DOI 10.1016/j.abb.2011.04.009; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Rotstein NP, 2010, J LIPID RES, V51, P1247, DOI 10.1194/jlr.R003442; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Spaethling JM, 2007, PROG BRAIN RES, V161, P27, DOI 10.1016/S0079-6123(06)61003-0; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Tani M, 1999, J BIOCHEM-TOKYO, V125, P746; Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wong-Riley MTT, 2012, ADV EXP MED BIOL, V748, P283, DOI 10.1007/978-1-4614-3573-0_12; Woodcock J, 2006, IUBMB LIFE, V58, P462, DOI 10.1080/15216540600871118; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Zhu Q, 2008, ACTA PHARMACOL SIN, V29, P593, DOI 10.1111/j.1745-7254.2008.00781.x; Zigdon H, 2013, J BIOL CHEM, V288, P4947, DOI 10.1074/jbc.M112.402719	64	30	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13142	13154		10.1074/jbc.M113.530311	http://dx.doi.org/10.1074/jbc.M113.530311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24659784	hybrid, Green Published			2022-12-25	WOS:000335522800016
J	Tudor, C; te Riet, J; Eich, C; Harkes, R; Smisdom, N; Wenger, JB; Ameloot, M; Holt, M; Kanger, JS; Figdor, CG; Cambi, A; Subramaniam, V				Tudor, Cicerone; te Riet, Joost; Eich, Christina; Harkes, Rolf; Smisdom, Nick; Wenger, Jessica Bouhuijzen; Ameloot, Marcel; Holt, Matthew; Kanger, Johannes S.; Figdor, Carl G.; Cambi, Alessandra; Subramaniam, Vinod			Syntenin-1 and Ezrin Proteins Link Activated Leukocyte Cell Adhesion Molecule to the Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Atomic Force Microscopy; Cell Adhesion; Cytoskeleton; Fluorescence Resonance Energy Transfer (FRET); ALCAM; FRET-FLIM; Single-cell Force Spectroscopy	IMMUNOLOGICAL SYNAPSE FORMATION; CUTTING EDGE; LIVING CELLS; KINASE-C; ALCAM; CD6; EXPRESSION; CLONING; ANTIGEN; CANCER	Background: The activated leukocyte cell adhesion molecule (ALCAM) is involved in immune responses and cancer metastasis. Results: ALCAM is linked to the actin cytoskeleton through a supramolecular complex, including ezrin and syntenin-1. Conclusion: ALCAM supramolecular complex engaged to CD6 stabilizes the immunological synapse. Significance: Insights into the immunological synapse at the dendritic cell side contribute to clarify immune regulation mechanisms. Activated leukocyte cell adhesion molecule (ALCAM) is a type I transmembrane protein member of the immunoglobulin superfamily of cell adhesion molecules. Involved in important pathophysiological processes such as the immune response, cancer metastasis, and neuronal development, ALCAM undergoes both homotypic interactions with other ALCAM molecules and heterotypic interactions with the surface receptor CD6 expressed at the T cell surface. Despite biochemical and biophysical evidence of a dynamic association between ALCAM and the actin cytoskeleton, no detailed information is available about how this association occurs at the molecular level. Here, we exploit a combination of complementary microscopy techniques, including FRET detected by fluorescence lifetime imaging microscopy and single-cell force spectroscopy, and we demonstrate the existence of a preformed ligand-independent supramolecular complex where ALCAM stably interacts with actin by binding to syntenin-1 and ezrin. Interaction with the ligand CD6 further enhances these multiple interactions. Altogether, our results propose a novel biophysical framework to understand the stabilizing role of the ALCAM supramolecular complex engaged to CD6 during dendritic cell-T cell interactions and provide novel information on the molecular players involved in the formation and signaling of the immunological synapse at the dendritic cell side.	[Tudor, Cicerone; Harkes, Rolf; Holt, Matthew; Kanger, Johannes S.; Cambi, Alessandra; Subramaniam, Vinod] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [Tudor, Cicerone; Harkes, Rolf; Holt, Matthew; Kanger, Johannes S.; Cambi, Alessandra; Subramaniam, Vinod] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Tudor, Cicerone; Wenger, Jessica Bouhuijzen] VIB Ctr Biol Dis, Lab Glia Biol, B-3000 Louvain, Belgium; [Tudor, Cicerone; Wenger, Jessica Bouhuijzen] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [te Riet, Joost; Eich, Christina; Figdor, Carl G.; Cambi, Alessandra] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, NL-6500 HB Nijmegen, Netherlands; [Smisdom, Nick; Ameloot, Marcel] Hasselt Univ, Biomed Res Inst, B-3590 Diepenbeek, Belgium; [Smisdom, Nick] Flemish Inst Technol Res, Environm Risk & Hlth Unit, B-2400 Mol, Belgium	University of Twente; University of Twente; Flanders Institute for Biotechnology (VIB); KU Leuven; Radboud University Nijmegen; Hasselt University; VITO	Cambi, A (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.	a.cambi@ncmls.ru.nl; subramaniam@amolf.nl	Holt, Matthew/AAJ-1813-2020; te Riet, Joost/L-1584-2015; Figdor, Carl G/A-4232-2010; Smisdom, Nick/U-7567-2019; Subramaniam, Vinod/B-4197-2010; Cambi, Alessandra/L-4242-2015	Holt, Matthew/0000-0002-8958-4027; te Riet, Joost/0000-0002-9093-010X; Figdor, Carl G/0000-0002-2366-9212; Smisdom, Nick/0000-0002-0495-2012; Subramaniam, Vinod/0000-0001-6712-7266; Eich, Christina/0000-0001-7839-0932; Harkes, Rolf/0000-0001-6592-654X; Cambi, Alessandra/0000-0003-1597-1582	Netherlands Organization for Scientific Research Medium Sized Investment Grant [91110007]	Netherlands Organization for Scientific Research Medium Sized Investment Grant	We thank all members of our laboratories for encouragement and constructive criticisms. We acknowledge Christian Blum for help with time-correlated single photon-counting fluorescence lifetime measurements. We thank Pascale Zimmermann for the plasmids for syntenin-1-GFP and syntenin-1-mCherry and Satyajit Mayor for the plasmids for ezrin-GFP and ezrin-RFP. We also thank Theodorus W. J. Gadella and Joachim Goedhart ( Molecular Cytology, University of Amsterdam) for the pmTurquoise2-N1 and mVenus (L68V)-mTurquoise2 plasmids. We thank Ruurd Torensma for providing the AZN-L50 antibody. The atomic force microscope was supported by Netherlands Organization for Scientific Research Medium Sized Investment Grant 91110007.	Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Bruder SP, 1998, J BONE MINER RES, V13, P655, DOI 10.1359/jbmr.1998.13.4.655; Bucherl C, 2010, METHODS MOL BIOL, V655, P389, DOI 10.1007/978-1-60761-765-5_26; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Buschow SI, 2010, J PROTEOME RES, V9, P1727, DOI 10.1021/pr9008546; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Cook GA, 2002, BLOOD, V100, P4502, DOI 10.1182/blood.V100.13.4502; Cortes F, 1999, BLOOD, V93, P826, DOI 10.1182/blood.V93.3.826.403k28_826_837; Emiliani V, 2003, APPL PHYS LETT, V83, P2471, DOI 10.1063/1.1604938; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Friedrichs J, 2010, NAT PROTOC, V5, P1353, DOI 10.1038/nprot.2010.89; Gallardo R, 2010, CHEMBIOCHEM, V11, P456, DOI 10.1002/cbic.200900616; Gilsanz A, 2013, CELL MOL LIFE SCI, V70, P475, DOI 10.1007/s00018-012-1132-0; Gimferrer I, 2005, J IMMUNOL, V175, P1406, DOI 10.4049/jimmunol.175.3.1406; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Gordon-Alonso M, 2012, MOL BIOL CELL, V23, P2253, DOI 10.1091/mbc.E11-12-1003; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hassan NJ, 2004, EUR J IMMUNOL, V34, P930, DOI 10.1002/eji.200424856; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hwangbo C, 2010, CANCER RES, V70, P1645, DOI 10.1158/0008-5472.CAN-09-2447; Ihnen M, 2010, BRIT J CANCER, V103, P1048, DOI 10.1038/sj.bjc.6605840; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; Kijima N, 2012, NEURO-ONCOLOGY, V14, P1254, DOI 10.1093/neuonc/nor202; King JA, 2004, BREAST CANCER RES, V6, pR478, DOI 10.1186/bcr815; Kuo WC, 2010, ONCOGENE, V29, P1374, DOI 10.1038/onc.2009.417; Lamers E, 2012, EUR CELLS MATER, V23, P182, DOI 10.22203/eCM.v023a14; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Levesque MC, 1998, ARTHRITIS RHEUM, V41, P2221, DOI 10.1002/1529-0131(199812)41:12<2221::AID-ART18>3.0.CO;2-I; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Lunter PC, 2005, CANCER RES, V65, P8801, DOI 10.1158/0008-5472.CAN-05-0378; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181; Nelissen JMDT, 2000, MOL BIOL CELL, V11, P2057, DOI 10.1091/mbc.11.6.2057; Nelissen JMDT, 2000, EXP HEMATOL, V28, P422, DOI 10.1016/S0301-472X(00)00127-2; Ohneda O, 2001, BLOOD, V98, P2134, DOI 10.1182/blood.V98.7.2134; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Riol-Blanco L, 2009, NAT IMMUNOL, V10, P753, DOI 10.1038/ni.1750; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Sala-Valdes M, 2012, J CELL SCI, V125, P1235, DOI 10.1242/jcs.094912; Schlachter S, 2009, OPT EXPRESS, V17, P1557, DOI 10.1364/OE.17.001557; Stephan JP, 1999, DEV BIOL, V212, P264, DOI 10.1006/dbio.1999.9348; TANAKA H, 1991, NEURON, V7, P535, DOI 10.1016/0896-6273(91)90366-8; te Riet J, 2007, J CELL SCI, V120, P3965, DOI 10.1242/jcs.004010; te Riet J, 2014, J CELL SCI, V127, P1595, DOI 10.1242/jcs.141077; te Riet J, 2011, ULTRAMICROSCOPY, V111, P1659, DOI 10.1016/j.ultramic.2011.09.012; Tomita K, 2003, UROONCOLOGY, V3, P121, DOI DOI 10.1080/15610950310001632322; Uchida N, 1997, BLOOD, V89, P2706, DOI 10.1182/blood.V89.8.2706; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P231; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zimmerman AW, 2006, BLOOD, V107, P3212, DOI 10.1182/blood-2005-09-3881; Zimmerman AW, 2004, J CELL SCI, V117, P2841, DOI 10.1242/jcs.01139	63	29	30	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13445	13460		10.1074/jbc.M113.546754	http://dx.doi.org/10.1074/jbc.M113.546754			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24662291	Green Published, hybrid			2022-12-25	WOS:000335522800042
J	Hirst, JA; Stevens, RJ; Farmer, AJ				Hirst, Jennifer A.; Stevens, Richard J.; Farmer, Andrew J.			Changes in HbA1c Level over a 12-Week Follow-up in Patients with Type 2 Diabetes following a Medication Change	PLOS ONE			English	Article							GLYCEMIC CONTROL; PLASMA-GLUCOSE; GLYCATED HEMOGLOBIN; ASSOCIATION; PREVALENCE; ADHERENCE; KINETICS; HBA(1C); IMPACT	Background: Current guidance about the interval needed before retesting HbA1c when monitoring for glycaemic control is based on expert opinion rather than well-powered studies. The aim of our work was to explore how fast HbA1c changes after a change in glucose-lowering medication. This has implications for whether routine HbA1c testing intervals before 12 weeks could inform diabetes medication adjustments. Methods: This 12-week cohort study recruited patients from 18 general practices in the United Kingdom with non-insulin treated diabetes who were initiating or changing dose of oral glucose-lowering medication. HbA1c was measured at baseline and 2, 4, 8 and 12 weeks after recruitment. HbA1c levels at earlier time intervals were correlated with 12-week HbA1c. A ROC curve analysis was used to identify the 8-week threshold above which medication adjustment may be clinically appropriate. Results: Ninety-three patients were recruited to the study. Seventy-nine patients with no change in medication and full 12week follow-up had the following baseline characteristics: mean +/- standard deviation age of 61.3 +/- 10.8 years, 34% were female and diabetes duration of 6.0 +/- 4.3 years. Mean HbA1c at baseline, 2, 4, 8 and 12 weeks was 8.7 +/- 1.5%, (72.0 +/- 16.8 mmol/mol) 8.6 +/- 1.6% (70.7 +/- 17.0 mmol/mol), 8.4 +/- 1.5% (68.7 +/- 15.9 mmol/mol), 8.2 +/- 1.4% (66.3 +/- 15.8 mmol/mol) and 8.1 +/- 1.4% (64.8 +/- 15.7 mmol/mol) respectively. At the end of the study 61% of patients had sub-optimal glycaemic control (HbA1c > 7.5% or 59 mmol/mol). The 8-week change correlated significantly with the 12-week change in HbA1c and an HbA1c above 8.2% (66 mmol/mol) at 8 weeks correctly classified all 28 patients who had not achieved glycaemic control by 12 weeks. Conclusions/interpretation: This is the first study designed with sufficient power to examine short-term changes in HbA1c. The 12-week change in HbA1c can be predicted 8 weeks after a medication change. Many participants who had not achieved glycaemic control after 12 weeks may have benefitted from an earlier review of their HbA1c and medication.	[Hirst, Jennifer A.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; Natl Inst Hlth Res Sch Primary Care Res, Oxford, England	University of Oxford	Hirst, JA (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England.	jennifer.hirst@phc.ox.ac.uk		Hirst, Jennifer/0000-0002-8416-2159; Stevens, Richard/0000-0002-9258-4060	UK's National Institute for Health Research (NIHR) School for Primary Care Research (SPCR); National Institute for Health Research (NIHR); NIHR Oxford Biomedical Research Centre; National Institute for Health Research [NF-SI-0512-10077] Funding Source: researchfish	UK's National Institute for Health Research (NIHR) School for Primary Care Research (SPCR); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by the UK's National Institute for Health Research (NIHR) School for Primary Care Research (SPCR). This article/paper/report presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. AF receives support from the NIHR Oxford Biomedical Research Centre and is an NIHR Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akan P, 2007, J EVAL CLIN PRACT, V13, P21, DOI 10.1111/j.1365-2753.2006.00641.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Berard LD, 2013, CAN J DIABETES, V37, pS35, DOI 10.1016/j.jcjd.2013.01.017; Bosi E, 2009, DIABETES OBES METAB, V11, P506, DOI 10.1111/j.1463-1326.2009.01040.x; BUNN HF, 1976, J CLIN INVEST, V57, P1652, DOI 10.1172/JCI108436; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Driskell OJ, 2012, CLIN CHEM, V58, P906, DOI 10.1373/clinchem.2011.176487; Kanavos P, 2012, DIABETES EXPENDITURE; Kennedy L, 2006, DIABETES CARE, V29, P1; Kilpatrick ES, 2008, J CLIN PATHOL, V61, P977, DOI 10.1136/jcp.2007.054304; Loh TP, 2011, DIABETES RES CLIN PR, V94, pE40, DOI 10.1016/j.diabres.2011.07.034; Lyon Andrew W, 2009, J Diabetes Sci Technol, V3, P411; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; MORTENSEN HB, 1983, CLIN CHIM ACTA, V134, P317, DOI 10.1016/0009-8981(83)90370-4; Muntner P, 2013, J CLIN HYPERTENS, V15, P112, DOI 10.1111/jch.12037; NGSP, 2014, LIST NGSP CERT METH; NICE, 2008, TYP 2 DIAB NAT CLIN, V66; Osterman-Golkar SM, 2006, J DIABETES COMPLICAT, V20, P285, DOI 10.1016/j.jdiacomp.2005.07.009; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Salvagno GL, 2007, CLIN CHEM LAB MED, V45, P1065, DOI 10.1515/CCLM.2007.195; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; TAHARA Y, 1993, DIABETES CARE, V16, P1313, DOI 10.2337/diacare.16.9.1313; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Tanis SP, 1996, J MED CHEM, V39, P5053, DOI 10.1021/jm9605694	24	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92458	10.1371/journal.pone.0092458	http://dx.doi.org/10.1371/journal.pone.0092458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667212	Green Published, gold			2022-12-25	WOS:000333675600041
J	Guo, XF; Zhu, XF; Yang, WC; Zhang, SH; Zhen, YS				Guo, Xiao-Fang; Zhu, Xiao-Fei; Yang, Wan-Cai; Zhang, Sheng-Hua; Zhen, Yong-Su			An EGFR/HER2-Bispecific and Enediyne-Energized Fusion Protein Shows High Efficacy against Esophageal Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MOUSE XENOGRAFT MODEL; SQUAMOUS-CELL CARCINOMA; PHASE-I TRIAL; RECOMBINANT IMMUNOTOXIN; EGFR; EXPRESSION; HER2; MALIGNANCIES; TRASTUZUMAB	Esophageal cancer is one of the most common cancers, and the 5-year survival rate is less than 10% due to lack of effective therapeutic agents. This study was to evaluate antitumor activity of Ec-LDP-Hr-AE, a recently developed bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor (EGFR) and epidermal growth factor receptor 2 (HER2), on esophageal cancer. The fusion protein Ec-LDP-Hr-AE consists of two oligopeptide ligands and an enediyne antibiotic lidamycin (LDM) for receptor binding and cell killing, respectively. The current study demonstrated that Ec-LDP-Hr had high affinity to bind to esophageal squamous cell carcinoma (ESCC) cells, and enediyne-energized fusion protein Ec-LDP-Hr-AE showed potent cytotoxicity to ESCC cells with differential expression of EGFR and HER2. Ec-LDP-Hr-AE could cause significant G2-M arrest in EC9706 and KYSE150 cells, and it also induced apoptosis in ESCC cells in a dosage-dependent manner. Western blot assays showed that Ec-LDP-Hr-AE promoted caspase-3 and caspase-7 activities as well as PARP cleavage. Moreover, Ec-LDP-Hr-AE inhibited cell proliferation via decreasing phosphorylation of EGFR and HER2, and further exerted inhibition of the activation of their downstream signaling molecules. In vivo, at a tolerated dose, Ec-LDP-Hr-AE inhibited tumor growth by 88% when it was administered to nude mice bearing human ESCC cell KYSE150 xenografts. These results indicated that Ec-LDP-Hr-AE exhibited potent anti-caner efficacy on ESCC, suggesting it could be a promising candidate for targeted therapy of esophageal cancer.	[Guo, Xiao-Fang] Xinxiang Med Univ, Dept Microbiol, Xinxiang, Peoples R China; [Zhu, Xiao-Fei] Xinxiang Med Univ, Sch Lab Med, Xinxiang, Peoples R China; [Yang, Wan-Cai] Xinxiang Med Univ, Dept Pathol, Xinxiang, Peoples R China; [Yang, Wan-Cai] Univ Illinois, Dept Pathol, Chicago, IL USA; [Zhang, Sheng-Hua; Zhen, Yong-Su] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Zhang, Sheng-Hua; Zhen, Yong-Su] Perking Union Med Coll, Beijing, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhen, YS (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	zhenys@public.bta.net.cn	Yang, Wancai/O-7655-2019; xiaofei, Zhu/AAH-2181-2019	Yang, Wancai/0000-0001-7437-9197; xiaofei, Zhu/0000-0001-6360-140X; Xiao-Fang, Guo/0000-0003-4005-7530	Natural Science Research Project of the Education Department of Henan Province, China [12B350004]; National Natural Science Foundation of China [81202447]; USCACA [USCACA-TIGM-001]	Natural Science Research Project of the Education Department of Henan Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); USCACA	This work is supported in part by the Natural Science Research Project of the Education Department of Henan Province, China (No. 12B350004 to XFG), National Natural Science Foundation of China (No. 81202447 to XFG, http://www.nsfc.gov.cn/Portal0/default152.htm), and a grant from the USCACA (No. USCACA-TIGM-001 to WCY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein DJ, 2012, INVEST NEW DRUG, V30, P1684, DOI 10.1007/s10637-011-9736-z; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Campbell NP, 2010, WORLD J GASTROENTERO, V16, P3793, DOI 10.3748/wjg.v16.i30.3793; Crosby T, 2013, LANCET ONCOL, V14, P627, DOI 10.1016/S1470-2045(13)70136-0; Fidias Panos, 2002, Clin Lung Cancer, V3, P219, DOI 10.3816/CLC.2002.n.006; FitzGerald DJ, 2011, CANCER RES, V71, P6300, DOI 10.1158/0008-5472.CAN-11-1374; Forde PM, 2013, J THORAC ONCOL, V8, P673, DOI 10.1097/JTO.0b013e31828b5172; Frankel AE, 2009, LEUKEMIA RES, V33, P1173, DOI 10.1016/j.leukres.2009.03.037; Garland L, 2005, J IMMUNOTHER, V28, P376, DOI 10.1097/01.cji.0000162782.86008.mL; Ge D, 2003, CLIN MED J CHINA, V10, P699; Gibault L, 2005, BRIT J CANCER, V93, P107, DOI 10.1038/sj.bjc.6602625; Guo XF, 2010, CLIN CANCER RES, V16, P2085, DOI 10.1158/1078-0432.CCR-09-2699; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Homs MYV, 2009, EXPERT OPIN EMERG DR, V14, P329, DOI 10.1517/14728210902976842; Hong TS, 2013, SEMIN RADIAT ONCOL, V23, P31, DOI 10.1016/j.semradonc.2012.09.004; Ilson DH, 2011, CANCER-AM CANCER SOC, V117, P1409, DOI 10.1002/cncr.25602; ITAKURA Y, 1994, CANCER, V74, P795, DOI 10.1002/1097-0142(19940801)74:3<795::AID-CNCR2820740303>3.0.CO;2-I; Kawaguchi Y, 2007, BRIT J CANCER, V97, P494, DOI 10.1038/sj.bjc.6603885; Kreitman RJ, 2005, J CLIN ONCOL, V23, P6719, DOI 10.1200/JCO.2005.11.437; Neuner Geoffrey, 2009, Gastrointest Cancer Res, V3, P57; Olsen E, 2001, J CLIN ONCOL, V19, P376, DOI 10.1200/JCO.2001.19.2.376; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; Reddy D, 2011, CURR TREAT OPTION ON, V12, P46, DOI 10.1007/s11864-011-0138-4; Reid A, 2007, EUR J CANCER, V43, P481, DOI 10.1016/j.ejca.2006.11.007; Rusnak DW, 2007, CELL PROLIFERAT, V40, P580, DOI 10.1111/j.1365-2184.2007.00455.x; Safran H, 2007, INT J RADIAT ONCOL, V67, P405, DOI 10.1016/j.ijrobp.2006.08.076; Shah MA, 2004, ANN SURG ONCOL, V11, P641, DOI 10.1245/ASO.2004.04.907; Stish BJ, 2007, CLIN CANCER RES, V13, P6486, DOI 10.1158/1078-0432.CCR-07-0938; Stish BJ, 2007, CLIN CANCER RES, V13, P3058, DOI 10.1158/1078-0432.CCR-06-2454; Todhunter DA, 2004, PROTEIN ENG DES SEL, V17, P157, DOI 10.1093/protein/gzh023; Vallera DA, 2005, CLIN CANCER RES, V11, P3879, DOI 10.1158/1078-0432.CCR-04-2290; Waldron NN, 2013, TARGET ONCOL; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wei QC, 2007, INT J ONCOL, V31, P493; Wiernik A, 2013, CLIN CANCER RES, V19, P3844, DOI 10.1158/1078-0432.CCR-13-0505; Zhang DW, 2008, MOL CANCER THER, V7, P1846, DOI 10.1158/1535-7163.MCT-08-0168	36	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92986	10.1371/journal.pone.0092986	http://dx.doi.org/10.1371/journal.pone.0092986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664246	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900138
J	Jeffree, RA; Markich, SJ; Twining, JR				Jeffree, Ross A.; Markich, Scott J.; Twining, John R.			Diminished Metal Accumulation in Riverine Fishes Exposed to Acid Mine Drainage over Five Decades	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; FRESH-WATER; COPPER-METABOLISM; ORGANIC-MATTER; FINNISS RIVER; SPECIATION; POLLUTION; CADMIUM; VARIABILITY; TOLERANCE	Bony bream (Nematalosa erebi) and black catfish (Neosilurus ater) were sampled from the fresh surface waters of the Finniss River in tropical northern Australia, along a metal pollution gradient draining the Rum Jungle copper/uranium mine, a contaminant source for over five decades. Paradoxically, populations of both fish species exposed to the highest concentrations of mine-related metals (cobalt, copper, lead, manganese, nickel, uranium and zinc) in surface water and sediment had the lowest tissue (bone, liver and muscle) concentrations of these metals. The degree of reduction in tissue concentrations of exposed populations was also specific to each metal and inversely related to its degree of environmental increase above background. Several explanations for diminished metal bioaccumulation in fishes from the contaminated region were evaluated. Geochemical speciation modeling of metal bioavailability in surface water showed no differences between the contaminated region and the control sites. Also, the macro-nutrient (calcium, magnesium and sodium) water concentrations, that may competitively inhibit metal uptake, were not elevated with trace metal contamination. Reduced exposure to contaminants due to avoidance behavior was unlikely due to the absence of refugial water bodies with the requisite metal concentrations lower than the control sites and very reduced connectivity at time of sampling. The most plausible interpretation of these results is that populations of both fish species have modified kinetics within their metal bioaccumulation physiology, via adaptation or tolerance responses, to reduce their body burdens of metals. This hypothesis is consistent with (i) reduced tissue concentrations of calcium, magnesium and sodium (macro-nutrients), in exposed populations of both species, (ii) experimental findings for other fish species from the Finniss River and other contaminated regions, and (iii) the number of generations exposed to likely selection pressure over 50 years.	[Jeffree, Ross A.] Univ Technol Sydney, Sch Environm C3, Sydney, NSW 2007, Australia; [Markich, Scott J.] Aquat Solut Int, Collaroy, NSW, Australia; [Twining, John R.] Austral Radioecol, Oyster Bay, NSW, Australia	University of Technology Sydney	Jeffree, RA (corresponding author), Univ Technol Sydney, Sch Environm C3, Sydney, NSW 2007, Australia.	ross.jeffree@uts.edu.au			Australian Nuclear Science and Technology Organisation	Australian Nuclear Science and Technology Organisation	This research was primarily supported by the Australian Nuclear Science and Technology Organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi JA, 2013, AQUAT TOXICOL, V130, P51, DOI 10.1016/j.aquatox.2013.01.001; ALLENGIL SM, 1995, SCI TOTAL ENVIRON, V160-61, P653, DOI 10.1016/0048-9697(95)93634-T; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Andres S, 2000, SCI TOTAL ENVIRON, V248, P11, DOI 10.1016/S0048-9697(99)00477-5; ANZECC (Australian and New Zealand Environment and Conservation Council), 2000, GUID FRESH MAR WAT Q; BARKER D, 2009, GUIDE ACCEPTABLE PRO; Bishop KA, 2001, ECOLOGICAL STUDIES F; Bryan SE, 2002, COMP BIOCHEM PHYS C, V133, P37, DOI 10.1016/S1532-0456(02)00083-2; Burger J, 2002, ENVIRON RES, V89, P85, DOI 10.1006/enrs.2002.4330; Chowdhury MJ, 2008, ENVIRON SCI TECHNOL, V42, P1359, DOI 10.1021/es071889n; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Edwards CA, 2002, THESIS U TECHNOLOGY; Farkas A., 2000, Lakes and Reservoirs Research and Management, V5, P271, DOI 10.1046/j.1440-1770.2000.00127.x; Gale SA, 2003, AQUAT TOXICOL, V62, P135, DOI 10.1016/S0166-445X(02)00081-4; Groenenberg JE, 2010, ENVIRON SCI TECHNOL, V44, P1340, DOI 10.1021/es902615w; Gustafsson JP, 2012, VISUAL MINTEQ V3 0 W; HOLM PE, 1995, WATER RES, V29, P803, DOI 10.1016/0043-1354(94)00205-L; Hydrobiology, 2013, HYDROBIOLOGY; JEFFREE RA, 1980, ECOL MONOGR, V50, P457, DOI 10.2307/1942653; Jeffree RA, 2001, ENVIRON SCI TECHNOL, V35, P2932, DOI 10.1021/es001719+; Jeffree RA, 2000, CONTAMINATED SITE RE, P51; Jeffree RA, 1975, RUM JUNGLE ENV STUDI; Kamunde C, 2002, J EXP BIOL, V205, P279; Kamunde CN, 2001, CAN J FISH AQUAT SCI, V58, P293, DOI 10.1139/cjfas-58-2-293; Klerks PL, 2002, ENVIRON POLLUT, V45, P173; Lenoir T, 2010, ENVIRON SCI TECHNOL, V44, P6221, DOI 10.1021/es1015313; Markich SJ, 1998, SCI TOTAL ENVIRON, V217, P201, DOI 10.1016/S0048-9697(98)00188-0; Markich SJ, 2002, ENVIRON SCI TECHNOL, V36, P821, DOI 10.1021/es011066c; Markich SJ, 2012, C112 ASI; Medeiros ES, 2014, ENV BIOL FI IN PRESS, V97; Minghetti M, 2010, AQUAT TOXICOL, V97, P23, DOI 10.1016/j.aquatox.2009.11.017; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pusey B., 2004, FRESHWATER FISHES NE; Rohlf FJ., 2011, BIOMETRY PRINCIPLES; Ryan B, 2005, 498 IR AUSTR GOV; Sjostedt CS, 2010, ENVIRON SCI TECHNOL, V44, P8587, DOI 10.1021/es102415r; Sternberg D, 2008, MAR FRESHWATER RES, V59, P137, DOI 10.1071/MF07125; Taweel A, 2011, AFR J BIOTECHNOL, V10, P11562; Thompson PA, 2005, ENVIRON MONIT ASSESS, V110, P71, DOI 10.1007/s10661-005-6291-0; Tipping E, 2011, ENVIRON CHEM, V8, P225, DOI 10.1071/EN11016; UNEP, 2010, CLEAR WAT FOC WAT QU; Velcheva Iliana G., 2006, Turkish Journal of Zoology, V30, P1; Vulkan R, 2000, ENVIRON SCI TECHNOL, V34, P5115, DOI 10.1021/es0000910; WEIS JS, 1989, BIOSCIENCE, V39, P89, DOI 10.2307/1310907; Wood C.M., 2012, FISH PHYSL A, V31A; Wood C.M., 2012, FISH PHYSL B, V31B; WRIGHT DA, 1986, J MAR BIOL ASSOC UK, V66, P83, DOI 10.1017/S0025315400039667; Xie LT, 2004, AQUAT TOXICOL, V66, P73, DOI 10.1016/j.aquatox.2003.08.003	48	5	5	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91371	10.1371/journal.pone.0091371	http://dx.doi.org/10.1371/journal.pone.0091371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663964	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900019
J	Koetschan, C; Kittelmann, S; Lu, JL; Al-Halbouni, D; Jarvis, GN; Muller, T; Wolf, M; Janssen, PH				Koetschan, Christian; Kittelmann, Sandra; Lu, Jingli; Al-Halbouni, Djamila; Jarvis, Graeme N.; Mueller, Tobias; Wolf, Matthias; Janssen, Peter H.			Internal Transcribed Spacer 1 Secondary Structure Analysis Reveals a Common Core throughout the Anaerobic Fungi (Neocallimastigomycota)	PLOS ONE			English	Article							SEQUENCE-STRUCTURE ANALYSIS; RNA SEQUENCE; ITS2; PHYLOGENY; RECONSTRUCTION; CHLOROPHYCEAE; DIVERSITY; TOOL; POPULATIONS; ALIGNMENT	The internal transcribed spacer (ITS) is a popular barcode marker for fungi and in particular the ITS1 has been widely used for the anaerobic fungi (phylum Neocallimastigomycota). A good number of validated reference sequences of isolates as well as a large number of environmental sequences are available in public databases. Its highly variable nature predisposes the ITS1 for low level phylogenetics; however, it complicates the establishment of reproducible alignments and the reconstruction of stable phylogenetic trees at higher taxonomic levels (genus and above). Here, we overcame these problems by proposing a common core secondary structure of the ITS1 of the anaerobic fungi employing a Hidden Markov Model-based ITS1 sequence annotation and a helix-wise folding approach. We integrated the additional structural information into phylogenetic analyses and present for the first time an automated sequence-structure-based taxonomy of the ITS1 of the anaerobic fungi. The methodology developed is transferable to the ITS1 of other fungal groups, and the robust taxonomy will facilitate and improve high-throughput anaerobic fungal community structure analysis of samples from various environments.	[Koetschan, Christian; Kittelmann, Sandra; Lu, Jingli; Janssen, Peter H.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand; [Mueller, Tobias; Wolf, Matthias] Univ Wurzburg, Bioctr, Dept Bioinformat, D-97070 Wurzburg, Germany; [Al-Halbouni, Djamila] ViaLactia Biosci Ltd, Auckland, New Zealand; [Al-Halbouni, Djamila] New Zealand Trade & Enterprise, Wellington, New Zealand	AgResearch - New Zealand; University of Wurzburg	Kittelmann, S (corresponding author), AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand.	sandra.kittelmann@agresearch.co.nz	Müller, Tobias/A-8952-2008; Wolf, Matthias/A-5580-2008	Wolf, Matthias/0000-0003-2004-1806; Kittelmann, Sandra/0000-0002-6019-9854; Janssen, Peter/0000-0002-1022-3502	Pastoral Greenhouse Gas Research Consortium (PGgRc); New Zealand Ministry for Primary Industries (MPI); Global Research Alliance on Agricultural Greenhouse Gases (GRA)	Pastoral Greenhouse Gas Research Consortium (PGgRc); New Zealand Ministry for Primary Industries (MPI); Global Research Alliance on Agricultural Greenhouse Gases (GRA)	This work was supported by and research was carried out under contract to the Pastoral Greenhouse Gas Research Consortium (PGgRc; www.pggrc.co.nz), and the New Zealand Ministry for Primary Industries (MPI; www.mpi.govt.nz) as part of its support for the Global Research Alliance on Agricultural Greenhouse Gases (GRA; www.globalresearchalliance.org). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The authors required the funders' approval to publish.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bates ST, 2013, STAND GENOMIC SCI, V8, P118, DOI 10.4056/sigs.3737409; Benson D, 2011, NUCLEIC ACIDS RES, V40, P48; Buchheim MA, 2012, ANN BOT-LONDON, V109, P109, DOI 10.1093/aob/mcr275; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 1998, PROTIST, V149, P135, DOI 10.1016/S1434-4610(98)70018-5; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Molina MD, 2011, LICHENOLOGIST, V43, P585, DOI 10.1017/S0024282911000521; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fliegerova K, 2010, FOLIA MICROBIOL, V55, P319, DOI 10.1007/s12223-010-0049-y; Friedrich J, 2005, BIOINFORMATICS, V21, P2108, DOI 10.1093/bioinformatics/bti289; Gottschling M, 2001, PLANT BIOLOGY, V3, P629, DOI 10.1055/s-2001-19371; Herrera J, 2011, MICROB ECOL, V61, P239, DOI 10.1007/s00248-010-9744-0; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hibbett DS, 2013, NAT REV MICROBIOL, V11, P129, DOI 10.1038/nrmicro2963; Hoshina R, 2010, MICROBES ENVIRON, V25, P313, DOI 10.1264/jsme2.ME10129; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Keller A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-4; Kittelmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036866; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Lamanna AC, 2011, J MOL BIOL, V405, P3, DOI 10.1016/j.jmb.2010.09.064; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letsch HO, 2010, MOL BIOL EVOL, V27, P2507, DOI 10.1093/molbev/msq140; Liggenstoffer AS, 2010, ISME J, V4, P1225, DOI 10.1038/ismej.2010.49; Markert SM, 2012, PLANT BIOLOGY, V14, P987, DOI 10.1111/j.1438-8677.2012.00576.x; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; McNeill J., 2006, V146, P1; Mello A, 2011, MYCOLOGIA, V103, P1184, DOI 10.3852/11-027; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; Muller T, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-20; Nicholson MJ, 2010, ANAEROBE, V16, P66, DOI 10.1016/j.anaerobe.2009.05.003; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; ORPIN CG, 1975, J GEN MICROBIOL, V91, P249, DOI 10.1099/00221287-91-2-249; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; RAMBAUT A, 2009, FIGTREE; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Shaw AJ, 2010, AM J BOT, V97, P1511, DOI 10.3732/ajb.1000055; Thornhill DJ, 2010, PROTIST, V161, P434, DOI 10.1016/j.protis.2009.11.004; Tuckwell DS, 2005, MICROBIOL-SGM, V151, P1557, DOI 10.1099/mic.0.27689-0; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Wolf M, 2008, BIOINFORMATICS, V24, P2401, DOI 10.1093/bioinformatics/btn453	48	60	64	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91928	10.1371/journal.pone.0091928	http://dx.doi.org/10.1371/journal.pone.0091928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663345	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900032
J	Kuzelova, K; Grebenova, D; Holoubek, A; Roselova, P; Obr, A				Kuzelova, Katerina; Grebenova, Dana; Holoubek, Ales; Roeselova, Pavla; Obr, Adam			Group I PAK Inhibitor IPA-3 Induces Cell Death and Affects Cell Adhesivity to Fibronectin in Human Hematopoietic Cells	PLOS ONE			English	Article							P21-ACTIVATED KINASE; PHOSPHORYLATION; ACTIVATION; OVEREXPRESSION; MODULATION; EXPRESSION; APOPTOSIS; MIGRATION; INVASION; PATHWAY	P21-activated kinases (PAKs) are involved in the regulation of multiple processes including cell proliferation, adhesion and migration. However, the current knowledge about their function is mainly based on results obtained in adherent cell types. We investigated the effect of group I PAK inhibition using the compound IPA-3 in a variety of human leukemic cell lines (JURL-MK1, MOLM-7, K562, CML-T1, HL-60, Karpas-299, Jurkat, HEL) as well as in primary blood cells. IPA-3 induced cell death with EC50 ranging from 5 to more than 20 mu M. Similar range was found for IPA-3-mediated dephosphorylation of a known PAK downstream effector, cofilin. The cell death was associated with caspase-3 activation, PARP cleavage and apoptotic DNA fragmentation. In parallel, 20 mM IPA-3 treatment induced rapid and marked decrease of the cell adhesivity to fibronectin. Per contra, partial reduction of PAK activity using lower dose IPA-3 or siRNA resulted in a slight increase in the cell adhesivity. The changes in the cell adhesivity were also studied using real-time microimpedance measurement and by interference reflection microscopy. Significant differences in the intracellular IPA-3 level among various cell lines were observed indicating that an active mechanism is involved in IPA-3 transport.	[Kuzelova, Katerina; Grebenova, Dana; Holoubek, Ales; Roeselova, Pavla; Obr, Adam] Inst Hematol & Blood Transfus, Dept Cellular Biochem, CR-12820 Prague, Czech Republic	Institute of Hematology Prague	Kuzelova, K (corresponding author), Inst Hematol & Blood Transfus, Dept Cellular Biochem, CR-12820 Prague, Czech Republic.	kuzel@uhkt.cz	Kuzelova, Katerina/ADE-8303-2022	Kuzelova, Katerina/0000-0002-9628-6255; Obr, Adam/0000-0003-0057-076X	Ministry of Health of the Czech Republic (Project for conceptual development of research organization) [00023736]; European Union [ERDF OPPK CZ.2.16/3.1.00/24001, CZ.2.16/3.1.00/28007]	Ministry of Health of the Czech Republic (Project for conceptual development of research organization); European Union(European Commission)	The work was supported by the Ministry of Health of the Czech Republic (Project for conceptual development of research organization No 00023736) and by European Union (grants ERDF OPPK CZ.2.16/3.1.00/24001 and CZ.2.16/3.1.00/28007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai A, 2005, CELL SIGNAL, V17, P497, DOI 10.1016/j.cellsig.2004.09.007; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Barr Valarie A, 2009, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0423s45; Bright MD, 2009, CELL SIGNAL, V21, P1738, DOI 10.1016/j.cellsig.2009.07.005; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dorrance AM, 2013, BLOOD, V121, P2474, DOI 10.1182/blood-2012-10-460709; Flaiz C, 2009, EXP NEUROL, V218, P137, DOI 10.1016/j.expneurol.2009.04.019; Grebenova D, 2012, J PROTEOMICS; Hoover WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042601; Kamai T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-164; Kichina JV, 2010, EXPERT OPIN THER TAR, V14, P703, DOI 10.1517/14728222.2010.492779; Kosoff R, 2013, J BIOL CHEM, V288, P974, DOI 10.1074/jbc.M112.422295; Kuzelova K, 2007, CYTOM PART A, V71A, P605, DOI 10.1002/cyto.a.20415; Kuzelova K, 2011, J CELL BIOCHEM, V112, P3334, DOI 10.1002/jcb.23263; Kuzelova K, 2010, J CELL BIOCHEM, V109, P184, DOI 10.1002/jcb.22397; Lee MY, 2011, FERTIL STERIL, V96, P508, DOI 10.1016/j.fertnstert.2011.05.082; Lee N, 1997, P NATL ACAD SCI USA, V94, P13642, DOI 10.1073/pnas.94.25.13642; Li TT, 2011, CARCINOGENESIS, V32, P659, DOI 10.1093/carcin/bgq271; Luo SQ, 2009, J CELL SCI, V122, P875, DOI 10.1242/jcs.050013; Marlin JW, 2011, MAMM GENOME, V22, P306, DOI 10.1007/s00335-011-9326-6; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; McCarty SK, 2010, ENDOCR-RELAT CANCER, V17, P989, DOI 10.1677/ERC-10-0168; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Obr A, 2013, CELL ADHES MIGR, V7, P275, DOI 10.4161/cam.24531; Ong CC, 2013, J NATL CANC I; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Parekh P, 2007, CELL BIOL INT, V31, P35, DOI 10.1016/j.cellbi.2006.09.005; Persico A, 2010, MOL BIOL CELL, V21, P3708, DOI 10.1091/mbc.E10-03-0243; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sato M, 2013, J GASTROENTEROL HEPA; Singhal R, 2012, ONCOTARGET, V3, P700, DOI 10.18632/oncotarget.587; Siu MKY, 2010, INT J CANCER, V127, P21, DOI 10.1002/ijc.25005; Stockton RA, 2004, J BIOL CHEM, V279, P46621, DOI 10.1074/jbc.M408877200; Tsuji-Takayama K, 1994, Hum Cell, V7, P167; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Viaud J, 2009, MOL CANCER THER, V8, P2559, DOI 10.1158/1535-7163.MCT-09-0102; Walsh K, 2013, CLIN CANCER RES, V19, P1106, DOI 10.1158/1078-0432.CCR-12-1060; Wang H, 2010, CELL SIGNAL, V22, P1022, DOI 10.1016/j.cellsig.2010.02.005; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wu R, 2010, INT J CANCER, V127, P2230, DOI 10.1002/ijc.25226; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104	44	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92560	10.1371/journal.pone.0092560	http://dx.doi.org/10.1371/journal.pone.0092560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664099	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900074
J	Nagatomo, Y; Meguro, T; Ito, H; Koide, K; Anzai, T; Fukuda, K; Ogawa, S; Yoshikawa, T				Nagatomo, Yuji; Meguro, Tomomi; Ito, Hiroyuki; Koide, Kimi; Anzai, Toshihisa; Fukuda, Keiichi; Ogawa, Satoshi; Yoshikawa, Tsutomu			Significance of AT(1) Receptor Independent Activation of Mineralocorticoid Receptor in Murine Diabetic Cardiomyopathy	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC DYSFUNCTION; CONVERTING ENZYME-INHIBITION; CONGESTIVE-HEART-FAILURE; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; CARDIAC-FUNCTION; NADPH OXIDASE; DOPPLER-ECHOCARDIOGRAPHY; HYPERTENSIVE-RATS; DEFICIENT MICE	Background: Diabetes mellitus (DM) has deleterious influence on cardiac performance independent of coronary artery disease and hypertension. The objective of the present study was to investigate the role of the renin-angiotensin-aldosterone system, especially angiotensin II type 1a receptor (AT(1a)R) and mineralocorticoid receptor (MR) signaling, in left ventricular (LV) dysfunction induced by diabetes mellitus (DM). Methods and Results: DM was induced by intraperitoneal injection of streptozotocin (200 mg/ kg BW) in wild-type (WT) or AT1aR knockout (KO) male mice, and they were bred during 6 or 12 weeks. Some KO mice were administered the MR antagonist eplerenone (100 mg/ kg body weight). At 6 weeks, LV diastolic function was impaired in WT-DM, but preserved in KO-DM. At that time point MR mRNA expression was upregulated, NADPH oxidase subunit (p47phox) and glutathione peroxidase (GPx1) mRNA expression were upregulated, the staining intensities of LV tissue for 4-hydroxy-2-nonenal was stronger in immunohistochemistry, the number of terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) positive cells was increased, Bcl-2 protein expression was significantly downregulated, and the expression of SERCA2a and phosphorylated phospholamban was depressed in WT-DM, while these changes were not seen in KO-DM. At 12 weeks, however, these changes were also noted in KO-DM. Eplerenone arrested those changes. The plasma aldosterone concentration was elevated in WT-DM but not in KO-DM at 6 weeks. It showed 3.7-fold elevation at 12 weeks even in KO-DM, which suggests "aldosterone breakthrough'' phenomenon. However, the aldosterone content in LV tissue was unchanged in KO-DM. Conclusions: DM induced diastolic dysfunction was observed even in KO at 12 weeks, which was ameliorated by minelarocorticoid receptor antagonist, eplerenone. AT(1)-independent MR activation in the LV might be responsible for the pathogenesis of diabetic cardiomyopathy.	[Nagatomo, Yuji; Ito, Hiroyuki; Koide, Kimi; Anzai, Toshihisa; Fukuda, Keiichi; Ogawa, Satoshi; Yoshikawa, Tsutomu] Keio Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 160, Japan; [Meguro, Tomomi] Int Univ Hlth & Welf, KAKEN Hosp, Dept Cardiol, Ichikawa, Japan	Keio University; International University of Health & Welfare	Meguro, T (corresponding author), Int Univ Hlth & Welf, KAKEN Hosp, Dept Cardiol, Ichikawa, Japan.	tmeguro@iuhw.ac.jp	Fukuda, Keiichi/L-3777-2013; Nagatomo, Yuji/AAQ-1590-2020; Anzai, Toshihisa/J-2179-2015; Nagatomo, Yuji/HDM-4151-2022	Nagatomo, Yuji/0000-0002-3430-4614; Anzai, Toshihisa/0000-0003-3319-4967; 	Japanese Ministry of Education, Culture, Sports, Science and Technology [17790500]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (No. 17790500; http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shafei AIM, 2002, J PHYSIOL-LONDON, V538, P555, DOI 10.1113/jphysiol.2001.012857; Baba A, 2006, INT J CARDIOL, V112, P15, DOI 10.1016/j.ijcard.2006.05.026; Candido R, 2002, CIRCULATION, V106, P246, DOI 10.1161/01.CIR.0000021122.63813.32; CASTREN M, 1995, J MOL ENDOCRINOL, V14, P285, DOI 10.1677/jme.0.0140285; Choi KM, 2002, AM J PHYSIOL-HEART C, V283, pH1398, DOI 10.1152/ajpheart.00313.2002; Delcayre C, 2002, J MOL CELL CARDIOL, V34, P1577, DOI 10.1006/jmcc.2002.2088; Edelmann F, 2013, JAMA-J AM MED ASSOC, V309, P781, DOI 10.1001/jama.2013.905; Gorcsan J, 1997, CIRCULATION, V95, P2423, DOI 10.1161/01.CIR.95.10.2423; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Guo ZX, 2007, AM J PHYSIOL-HEART C, V292, pH1728, DOI 10.1152/ajpheart.01328.2005; Hafezi-Moghadam A, 2002, NAT MED, V8, P473, DOI 10.1038/nm0502-473; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Joffe II, 1999, J AM COLL CARDIOL, V34, P2111, DOI 10.1016/S0735-1097(99)00436-2; Kajstura J, 2001, DIABETES, V50, P1414, DOI 10.2337/diabetes.50.6.1414; Kaneko H, 2011, CIRC J, V75, P2482, DOI 10.1253/circj.CJ-11-0182; Kanki H, 1999, LIFE SCI, V65, P2305, DOI 10.1016/S0024-3205(99)00497-X; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Katada J, 2005, CIRCULATION, V111, P2157, DOI 10.1161/01.CIR.0000163562.82134.8E; Le Menuet D, 2001, J BIOL CHEM, V276, P38911, DOI 10.1074/jbc.M103984200; Mano Y, 2011, CIRC J, V75, P1717, DOI 10.1253/circj.CJ-10-1199; Matsue Y, 2011, CIRC J, V75, P2833, DOI 10.1253/circj.CJ-11-0754; Matsushima S, 2006, AM J PHYSIOL-HEART C, V291, pH2237, DOI 10.1152/ajpheart.00427.2006; Meguro T, 1999, CIRC RES, V84, P735, DOI 10.1161/01.RES.84.6.735; Mizuno Y, 2001, CIRCULATION, V103, P72; Nagata K, 2006, HYPERTENSION, V47, P656, DOI 10.1161/01.HYP.0000203772.78696.67; Naruse M, 2002, HYPERTENSION, V40, P28, DOI 10.1161/01.HYP.0000022606.52221.2F; Noda K, 2012, J CARDIOVASC PHARM, V60, P140, DOI 10.1097/FJC.0b013e318258f8ce; O'Keefe JH, 2008, DIABETES OBES METAB, V10, P492, DOI 10.1111/j.1463-1326.2007.00730.x; Ogawa S, 2006, CLIN EXP PHARMACOL P, V33, P477, DOI 10.1111/j.1440-1681.2006.04390.x; Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1161/CIRCULATIONAHA.104.503706; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Qin FZ, 2007, FREE RADICAL BIO MED, V43, P271, DOI 10.1016/j.freeradbiomed.2007.04.021; Qin WN, 2003, CIRC RES, V93, P69, DOI 10.1161/01.RES.0000080521.15238.E5; Rossier MF, 2008, HYPERTENSION, V52, P721, DOI 10.1161/HYPERTENSIONAHA.108.114223; Sato A, 2001, J INT MED RES, V29, P13, DOI 10.1177/147323000102900103; Schannwell CM, 2002, CARDIOLOGY, V98, P33, DOI 10.1159/000064682; SECHI LA, 1994, DIABETES, V43, P1180, DOI 10.2337/diabetes.43.10.1180; Solomon SD, 2003, J AM COLL CARDIOL, V42, P1674, DOI 10.1016/j.jacc.2003.08.008; STAESSEN J, 1981, J ENDOCRINOL, V91, P457, DOI 10.1677/joe.0.0910457; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Takeda M, 2007, HYPERTENS RES, V30, P427, DOI 10.1291/hypres.30.427; Trost SU, 2002, DIABETES, V51, P1166, DOI 10.2337/diabetes.51.4.1166; Tsutsui H, 2007, HYPERTENS RES, V30, P439, DOI 10.1291/hypres.30.439; Wang H, 2008, J HYPERTENS, V26, P1453, DOI 10.1097/HJH.0b013e328300a232; Yamashita K, 2008, J CHROMATOGR A, V1200, P114, DOI 10.1016/j.chroma.2008.05.034; Yang GP, 2001, J MOL CELL CARDIOL, V33, P1505, DOI 10.1006/jmcc.2001.1413; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhang L, 2008, DIABETES, V57, P2158, DOI 10.2337/db08-0140	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93145	10.1371/journal.pone.0093145	http://dx.doi.org/10.1371/journal.pone.0093145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664319	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900158
J	Skocaj, M; Resnik, N; Grundner, M; Ota, K; Rojko, N; Hodnik, V; Anderluh, G; Sobota, A; Macek, P; Veranic, P; Sepcic, K				Skocaj, Matej; Resnik, Natasa; Grundner, Maja; Ota, Katja; Rojko, Nejc; Hodnik, Vesna; Anderluh, Gregor; Sobota, Andrzej; Macek, Peter; Veranic, Peter; Sepcic, Kristina			Tracking Cholesterol/Sphingomyelin-Rich Membrane Domains with the Ostreolysin A-mCherry Protein	PLOS ONE			English	Article							MUSHROOM PLEUROTUS-OSTREATUS; PORE-FORMING PROTEIN; LIPID RAFTS; EDIBLE MUSHROOM; CYTOLYTIC PROTEIN; PERFRINGOLYSIN-O; EQUINATOXIN-II; CHOLESTEROL; SPHINGOMYELIN; BINDING	Ostreolysin A (OlyA) is an similar to 15-kDa protein that has been shown to bind selectively to membranes rich in cholesterol and sphingomyelin. In this study, we investigated whether OlyA fluorescently tagged at the C-terminal with mCherry (OlyA-mCherry) labels cholesterol/sphingomyelin domains in artificial membrane systems and in membranes of Madin-Darby canine kidney (MDCK) epithelial cells. OlyA-mCherry showed similar lipid binding characteristics to non-tagged OlyA. OlyA-mCherry also stained cholesterol/sphingomyelin domains in the plasma membranes of both fixed and living MDCK cells, and in the living cells, this staining was abolished by pretreatment with either methyl-beta-cyclodextrin or sphingomyelinase. Double labelling of MDCK cells with OlyA-mCherry and the sphingomyelin-specific markers equinatoxin II-Alexa488 and GST-lysenin, the cholera toxin B subunit as a probe that binds to the ganglioside GM1, or the cholesterol-specific D4 domain of perfringolysin O fused with EGFP, showed different patterns of binding and distribution of OlyA-mCherry in comparison with these other proteins. Furthermore, we show that OlyA-mCherry is internalised in living MDCK cells, and within 90 min it reaches the juxtanuclear region via caveolin-1-positive structures. No binding to membranes could be seen when OlyA-mCherry was expressed in MDCK cells. Altogether, these data clearly indicate that OlyA-mCherry is a promising tool for labelling a distinct pool of cholesterol/sphingomyelin membrane domains in living and fixed cells, and for following these domains when they are apparently internalised by the cell.	[Skocaj, Matej; Ota, Katja; Rojko, Nejc; Hodnik, Vesna; Anderluh, Gregor; Macek, Peter; Sepcic, Kristina] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Resnik, Natasa; Veranic, Peter] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia; [Grundner, Maja] Univ Ljubljana, Fac Med, Inst Biophys, Ljubljana, Slovenia; [Anderluh, Gregor] Natl Inst Chem, Ljubljana, Slovenia; [Sobota, Andrzej] Nencki Inst Expt Biol, Warsaw, Poland	University of Ljubljana; University of Ljubljana; University of Ljubljana; National Institute of Chemistry - Slovenia; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Veranic, P (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia.	peter.veranic@mf.uni-lj.si; kristina.sepcic@bf.uni-lj.si	Maček, Peter/Y-9877-2019; Anderluh, Gregor/C-6905-2014; Sepcic, Kristina/S-5533-2018; skocaj, matej/AAD-2754-2022; Maček, Peter/U-4662-2017; Veranic, Peter/I-6276-2015	Maček, Peter/0000-0001-6470-7759; Anderluh, Gregor/0000-0002-9916-8465; Sepcic, Kristina/0000-0002-4023-5379; Maček, Peter/0000-0001-6470-7759; Veranic, Peter/0000-0003-1999-9988	Slovenian Research Agency [JI-4305, PI-0207]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency (http://www.arrs.gov.si/en/agencija), grants JI-4305 and PI-0207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2013, BIOCH BIOPH IN PRESS; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Angus AA, 2008, INFECT IMMUN, V76, P1992, DOI 10.1128/IAI.01221-07; [Anonymous], 1965, REG AN CELL LIN SE S; Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Berne S, 2005, BIOCHEMISTRY-US, V44, P11137, DOI 10.1021/bi051013y; Berne S, 2002, BBA-GEN SUBJECTS, V1570, P153, DOI 10.1016/S0304-4165(02)00190-3; Berne S, 2009, PROTEIN SCI, V18, P694, DOI 10.1002/pro.85; Besenicar M, 2006, CHEM PHYS LIPIDS, V141, P169, DOI 10.1016/j.chemphyslip.2006.02.010; Bhat HB, 2013, J LIPID RES, V54, P2933, DOI 10.1194/jlr.D041731; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chowdhury HH, 2008, TOXICON, V51, P1345, DOI 10.1016/j.toxicon.2008.03.010; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; Duggan J, 2008, EUR BIOPHYS J BIOPHY, V37, P1279, DOI 10.1007/s00249-008-0349-1; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; Hodnik V, 2010, METHODS MOL BIOL, V627, P201, DOI 10.1007/978-1-60761-670-2_13; Ishitsuka R, 2005, J BIOCHEM, V137, P249, DOI 10.1093/jb/mvi041; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Ishitsuka R., 2008, PROBES TAGS STUDY BI, P53; Keyel PA, 2011, J CELL SCI, V124, P2414, DOI 10.1242/jcs.076182; Kolanjiappan K, 2003, CLIN BIOCHEM, V36, P61, DOI 10.1016/S0009-9120(02)00421-6; Kulma M, 2010, BBA-BIOMEMBRANES, V1798, P471, DOI 10.1016/j.bbamem.2009.12.004; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Li HY, 2003, BLOOD, V101, P3628, DOI 10.1182/blood-2002-07-2283; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; London E, 2002, CURR OPIN STRUC BIOL, V12, P480, DOI 10.1016/S0959-440X(02)00351-2; McConnell HM, 2003, ANNU REV BIOPH BIOM, V32, P469, DOI 10.1146/annurev.biophys.32.110601.141704; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Ohno-Iwashita Y, 2010, SUBCELL BIOCHEM, V51, P597, DOI 10.1007/978-90-481-8622-8_22; Ota K, 2013, BIOCHIMIE, V95, P1855, DOI 10.1016/j.biochi.2013.06.012; Pletnev S, 2010, J AM CHEM SOC, V132, P2243, DOI 10.1021/ja908418r; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Resnik N, 2011, J BIOL CHEM, V286, P1499, DOI 10.1074/jbc.M110.189464; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Schlumberger S, 2014, FEBS LETT, V588, P35, DOI 10.1016/j.febslet.2013.10.038; Sepcic K, 2003, EUR J BIOCHEM, V270, P1199, DOI 10.1046/j.1432-1033.2003.03480.x; Shakor ABA, 2003, FEBS LETT, V542, P1, DOI 10.1016/S0014-5793(03)00330-2; Shibata T, 2010, TOXICON, V56, P1436, DOI 10.1016/j.toxicon.2010.08.010; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Shogomori H, 2001, J BIOL CHEM, V276, P9182, DOI 10.1074/jbc.M009414200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Skocaj M, 2013, CURR MED CHEM, V20, P491; Tomita T, 2004, J BIOL CHEM, V279, P26975, DOI 10.1074/jbc.M402676200; van Meer G, 2010, FEBS LETT, V584, P1800, DOI 10.1016/j.febslet.2009.10.020; van Zanten TS, 2010, P NATL ACAD SCI USA, V107, P15437, DOI 10.1073/pnas.1003876107; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798; Waugh MG, 2013, NAT PROTOC, V8, P2429, DOI 10.1038/nprot.2013.148; Yachi R, 2012, GENES CELLS, V17, P720, DOI 10.1111/j.1365-2443.2012.01621.x; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Zinchuk V, 2013, NATURE SCI REPORTS, V1356, P1	63	51	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92783	10.1371/journal.pone.0092783	http://dx.doi.org/10.1371/journal.pone.0092783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664106	Green Published, gold			2022-12-25	WOS:000333459900113
J	Fancsalszky, L; Monostori, E; Farkas, Z; Pourkarimi, E; Masoudi, N; Hargitai, B; Bosnar, MH; Dezeljin, M; Zsakai, A; Vellai, T; Mehta, A; Takacs-Vellai, K				Fancsalszky, Luca; Monostori, Eszter; Farkas, Zsolt; Pourkarimi, Ehsan; Masoudi, Neda; Hargitai, Balazs; Bosnar, Maja Herak; Dezeljin, Martina; Zsakai, Annamaria; Vellai, Tibor; Mehta, Anil; Takacs-Vellai, Krisztina			NDK-1, the Homolog of NM23-H1/H2 Regulates Cell Migration and Apoptotic Engulfment in C. elegans	PLOS ONE			English	Article							NUCLEOSIDE-DIPHOSPHATE KINASE; METASTASIS SUPPRESSOR NM23-H1; RNA INTERFERENCE; GENE NM23; AWD; DIFFERENTIATION; PHAGOCYTOSIS; EXPRESSION; CLEARANCE; INTEGRINS	Abnormal regulation of cell migration and altered rearrangement of cytoskeleton are characteristic of metastatic cells. The first described suppressor of metastatic processes is NM23-H1, which displays NDPK (nucleoside-diphosphate kinase) activity. To better understand the role of nm23 genes in cell migration, we investigated the function of NDK-1, the sole Caenorhabditis elegans homolog of group I NDPKs in distal tip cell (DTC) migration. Dorsal phase of DTC migration is regulated by integrin mediated signaling. We find that ndk-1 loss of function mutants show defects in this phase. Epistasis analysis using mutants of the alpha-integrin ina-1 and the downstream functioning motility-promoting signaling module (referred to as CED-10 pathway) placed NDK-1 downstream of CED-10/Rac. As DTC migration and engulfment of apoptotic corpses are analogous processes, both partially regulated by the CED-10 pathway, we investigated defects of apoptosis in ndk-1 mutants. Embryos and germ cells defective for NDK-1 showed an accumulation of apoptotic cell corpses. Furthermore, NDK-1::GFP is expressed in gonadal sheath cells, specialized cells for engulfment and clearence of apoptotic corpses in germ line, which indicates a role for NDK-1 in apoptotic corpse removal. In addition to the CED-10 pathway, engulfment in the worm is also mediated by the CED-1 pathway. abl-1/Abl and abi-1/Abi, which function in parallel to both CED-10/CED-1 pathways, also regulate engulfment and DTC migration. ndk-1(-); abi-1(-) double mutant embryos display an additive phenotype (e.g. enhanced number of apoptotic corpses) which suggests that ndk-1 acts in parallel to abi-1. Corpse number in ndk-1(-); ced-10(-) double mutants, however, is similar to ced-10(-) single mutants, suggesting that ndk-1 acts downstream of ced-10 during engulfment. In addition, NDK-1 shows a genetic interaction with DYN-1/dynamin, a downstream component of the CED-1 pathway. In summary, we propose that NDK-1/NDPK might represent a converging point of CED-10 and CED-1 pathways in the process of cytoskeleton rearrangement.	[Fancsalszky, Luca; Monostori, Eszter; Farkas, Zsolt; Pourkarimi, Ehsan; Masoudi, Neda; Hargitai, Balazs; Vellai, Tibor; Takacs-Vellai, Krisztina] Eotvos Lorand Univ, Dept Genet, Budapest, Hungary; [Bosnar, Maja Herak; Dezeljin, Martina] Rudjer Boskovic Inst, Div Mol Med, Mol Oncol Lab, Zagreb, Croatia; [Zsakai, Annamaria] Eotvos Lorand Univ, Dept Biol Anthropol, Budapest, Hungary; [Mehta, Anil] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland	Eotvos Lorand University; Rudjer Boskovic Institute; Eotvos Lorand University; University of Dundee	Takacs-Vellai, K (corresponding author), Eotvos Lorand Univ, Dept Genet, Budapest, Hungary.	takacsve@gmail.com	Farkas, Zsolt/AAF-9966-2020; Vellai, Tibor/AAG-2154-2020; Zsakai, Annamaria/AAE-8639-2020; Takacs-Vellai, Krisztina/AAF-9062-2020; Bosnar, Maja Herak/AAN-6122-2020	Farkas, Zsolt/0000-0001-8531-8912; Zsakai, Annamaria/0000-0001-8880-2056; Takacs-Vellai, Krisztina/0000-0002-4472-0363; Pourkarimi, Ehsan/0000-0001-9598-3465	OTKA Hungarian Scientific Research Fund [PD75477]; Wellcome Trust [069150]; OTKA grants [NK78012, K109349]; Janos Bolyai Scholarship of the Hungarian Academy of Sciences	OTKA Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Wellcome Trust(Wellcome TrustEuropean Commission); OTKA grants(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the OTKA Hungarian Scientific Research Fund PD75477 to K.T.-V. A.M. is supported by the Wellcome Trust [069150]. T.V. is supported by OTKA grants NK78012 and K109349. K.T.-V. is a grantee of the Janos Bolyai Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL of OTKA: http://www.otka.hu/en, URL of Janos Bolyai scholarship: http://mta.hu/cikkek/?node_id=22421, Wellcome Trust: http://www.wellcome.ac.uk/.	Annesley SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026024; Baillat G, 2002, J BIOL CHEM, V277, P18961, DOI 10.1074/jbc.M108818200; Besant PG, 2003, INT J BIOCHEM CELL B, V35, P297, DOI 10.1016/S1357-2725(02)00257-1; Blelloch R, 1999, CURR OPIN CELL BIOL, V11, P608, DOI 10.1016/S0955-0674(99)00028-9; Boissan M, 2010, CANCER RES, V70, P7710, DOI 10.1158/0008-5472.CAN-10-1887; BRENNER S, 1974, GENETICS, V77, P71; Choudhuri T, 2010, CANCER BIOL THER, V9, P1065, DOI 10.4161/cbt.9.12.11995; Cram EJ, 2006, J CELL SCI, V119, P4811, DOI 10.1242/jcs.03274; Dammai V, 2003, GENE DEV, V17, P2812, DOI 10.1101/gad.1096903; Desvignes T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-256; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fournier HN, 2003, J BIOENERG BIOMEMBR, V35, P81, DOI 10.1023/A:1023450008347; Gartner A., 2008, GERMLINE SURVIVAL AP; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu TY, 2010, CURR BIOL, V20, P477, DOI 10.1016/j.cub.2010.01.062; Hurwitz ME, 2009, PLOS BIOL, V7, P876, DOI 10.1371/journal.pbio.1000099; Kang Y, 2007, BIOCHEM BIOPH RES CO, V359, P76, DOI 10.1016/j.bbrc.2007.05.090; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Lee M, 2005, BBA-GEN SUBJECTS, V1723, P248, DOI 10.1016/j.bbagen.2005.01.003; Lee M, 2001, J BIOL CHEM, V276, P36404, DOI 10.1074/jbc.M105795200; Lehmann R, 2001, CURR OPIN GENET DEV, V11, P457, DOI 10.1016/S0959-437X(00)00217-3; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Ma DQ, 2004, J BIOL CHEM, V279, P18073, DOI 10.1074/jbc.M400185200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Marino N, 2011, N-S ARCH PHARMACOL, V384, P351, DOI 10.1007/s00210-011-0646-6; Masoudi N, 2013, DEVELOPMENT, V140, P3486, DOI 10.1242/dev.094011; Meighan CM, 2007, GENE DEV, V21, P1615, DOI 10.1101/gad.1534807; Miyamoto M, 2009, MOL CELL BIOCHEM, V329, P175, DOI 10.1007/s11010-009-0106-5; Montell DJ, 1999, DEVELOPMENT, V126, P3035; Nallamothu G, 2008, MOL CELL BIOL, V28, P1964, DOI 10.1128/MCB.01743-07; Nallamothu G, 2009, MOL CELL BIOCHEM, V329, P35, DOI 10.1007/s11010-009-0112-7; Negroni A, 2000, CELL DEATH DIFFER, V7, P843, DOI 10.1038/sj.cdd.4400720; Palmieri D, 2005, JNCI-J NATL CANCER I, V97, P632, DOI 10.1093/jnci/dji111; Perina D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-87; Postel EH, 1996, P NATL ACAD SCI USA, V93, P6892, DOI 10.1073/pnas.93.14.6892; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; She SY, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-93; Shen Q, 2013, DEVELOPMENT, V140, P3230, DOI 10.1242/dev.093732; Steeg PS, 2003, CANCER LETT, V190, P1, DOI 10.1016/S0304-3835(02)00499-8; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sun J, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008769, 10.1371/journal.pone.0011351]; Timmons Lisa, 2006, V351, P109; VENTURELLI D, 1995, P NATL ACAD SCI USA, V92, P7435, DOI 10.1073/pnas.92.16.7435; Volm M, 1998, CLIN EXP METASTAS, V16, P595, DOI 10.1023/A:1006588601683; Woolworth JA, 2009, MOL CELL BIOL, V29, P4679, DOI 10.1128/MCB.00297-09; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhang QB, 2011, INT J CANCER, V128, P40, DOI 10.1002/ijc.25307	52	18	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92687	10.1371/journal.pone.0092687	http://dx.doi.org/10.1371/journal.pone.0092687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658123	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000333355300113
J	Paino, T; Sarasquete, ME; Paiva, B; Krzeminski, P; San-Segundo, L; Corchete, LA; Redondo, A; Garayoa, M; Garcia-Sanz, R; Gutierrez, NC; Ocio, EM; San-Miguel, JF				Paino, Teresa; Sarasquete, Maria E.; Paiva, Bruno; Krzeminski, Patryk; San-Segundo, Laura; Corchete, Luis A.; Redondo, Alba; Garayoa, Mercedes; Garcia-Sanz, Ramon; Gutierrez, Norma C.; Ocio, Enrique M.; San-Miguel, Jesus F.			Phenotypic, Genomic and Functional Characterization Reveals No Differences between CD138(++) and CD138(low) Subpopulations in Multiple Myeloma Cell Lines	PLOS ONE			English	Article							CANCER STEM-CELLS; PLASMA-CELLS; BONE-MARROW; CLONOGENIC CELLS; DRUG-RESISTANCE; TUMOR-CELLS; PROGENITORS; LEUKEMIA; CAPACITY; GROWTH	Despite recent advances in the treatment of multiple myeloma (MM), it remains an incurable disease potentially due to the presence of resistant myeloma cancer stem cells (MM-CSC). Although the presence of clonogenic cells in MM was described three decades ago, the phenotype of MM-CSC is still controversial, especially with respect to the expression of syndecan-1 (CD138). Here, we demonstrate the presence of two subpopulations - CD138(++) (95-99%) and CD138(low) (1-5%) - in eight MM cell lines. To find out possible stem-cell-like features, we have phenotypically, genomic and functionally characterized the two subpopulations. Our results show that the minor CD138(low) subpopulation is morphologically identical to the CD138(++) fraction and does not represent a more immature B-cell compartment (with lack of CD19, CD20 and CD27 expression). Moreover, both subpopulations have similar gene expression and genomic profiles. Importantly, both CD138(++) and CD138(low) subpopulations have similar sensitivity to bortezomib, melphalan and doxorubicin. Finally, serial engraftment in CB17-SCID mice shows that CD138(++) as well as CD138(low) cells have self-renewal potential and they are phenotypically interconvertible. Overall, our results differ from previously published data in MM cell lines which attribute a B-cell phenotype to MM-CSC. Future characterization of clonal plasma cell subpopulations in MM patients' samples will guarantee the discovery of more reliable markers able to discriminate true clonogenic myeloma cells.	[Paino, Teresa; Krzeminski, Patryk; San-Segundo, Laura; Garayoa, Mercedes; Ocio, Enrique M.] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain; [Sarasquete, Maria E.; Corchete, Luis A.; Redondo, Alba; Garcia-Sanz, Ramon; Gutierrez, Norma C.; Ocio, Enrique M.] Hosp Univ Salamanca, Salamanca, Spain; [Paino, Teresa; Sarasquete, Maria E.; Krzeminski, Patryk; San-Segundo, Laura; Garayoa, Mercedes; Garcia-Sanz, Ramon; Gutierrez, Norma C.; Ocio, Enrique M.] Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain; [Paiva, Bruno; San-Miguel, Jesus F.] Univ Navarra Clin, CIMA, Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Navarra	Ocio, EM (corresponding author), Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain.	emocio@usal.es	San-Segundo, Laura/E-6441-2018; San-Miguel, Jesús F./V-8977-2018; Sánchez, Luis Antonio Corchete/D-1336-2018; Krzeminski, Patryk/AAH-3956-2021; Paiva, Bruno/AAB-8881-2021; Krzeminski, Patryk/J-3262-2016; Garcia-Sanz, Ramon/B-7986-2017; Garayoa, Mercedes/O-6039-2017; sarasquete, Maria E/U-8063-2018	San-Segundo, Laura/0000-0003-2391-5935; San-Miguel, Jesús F./0000-0002-9183-4857; Sánchez, Luis Antonio Corchete/0000-0003-4577-8599; Paiva, Bruno/0000-0003-1977-3815; Garcia-Sanz, Ramon/0000-0003-4120-2787; Garayoa, Mercedes/0000-0003-2194-2841; sarasquete, Maria E/0000-0001-7335-3657; Gutierrez, Norma/0000-0001-5834-9510; Ocio, Enrique M./0000-0002-5765-0085	Cooperative Research Thematic Network (RTICs) [RD06/0020/0006]; Junta de Castilla y Leon. Consejeria de Sanidad [GRS 391/B/09]; Ministerio de Ciencia e Innovacion [PS09/01897]; Fundacion Memoria D. Samuel Solorzano Barruso [FS/2-2010]; Asociacion Espanola Contra el Cancer (AECC) [GCB120981SAN]	Cooperative Research Thematic Network (RTICs); Junta de Castilla y Leon. Consejeria de Sanidad(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Memoria D. Samuel Solorzano Barruso; Asociacion Espanola Contra el Cancer (AECC)	This work was supported by the Cooperative Research Thematic Network (RTICs; RD06/0020/0006), the "Junta de Castilla y Leon. Consejeria de Sanidad" (GRS 391/B/09), the "Ministerio de Ciencia e Innovacion" (PS09/01897), the "Fundacion Memoria D. Samuel Solorzano Barruso" (FS/2-2010) and Asociacion Espanola Contra el Cancer (AECC)(GCB120981SAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharadwaj S, 2013, STEM CELLS, V31, P1840, DOI 10.1002/stem.1424; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boucher K, 2012, CLIN CANCER RES, V18, P6155, DOI 10.1158/1078-0432.CCR-12-0531; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Carvajal-Vergara X, 2005, BLOOD, V105, P4492, DOI 10.1182/blood-2004-08-2985; Chaidos A, 2013, BLOOD, V121, P318, DOI 10.1182/blood-2012-06-436220; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Chilosi M, 1999, MODERN PATHOL, V12, P1101; Chiron D, 2012, BRIT J HAEMATOL, V156, P679, DOI 10.1111/j.1365-2141.2011.08904.x; Christensen JH, 2012, HAEMATOL-HEMATOL J, V97, pE18, DOI 10.3324/haematol.2011.043125; Dick J E, 1996, Curr Opin Hematol, V3, P405; Fuhler GM, 2010, EXP CELL RES, V316, P1816, DOI 10.1016/j.yexcr.2010.03.013; Greenstein S, 2003, EXP HEMATOL, V31, P271, DOI 10.1016/S0301-472X(03)00023-7; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Guteerrez NC, 2005, LEUKEMIA, V19, P402, DOI 10.1038/sj.leu.2403625; HAMBURGER A, 1977, J CLIN INVEST, V60, P846, DOI 10.1172/JCI108839; Hosen N, 2012, LEUKEMIA, V26, P2135, DOI 10.1038/leu.2012.80; Jacak J, 2013, J BIOTECHNOL, V164, P525, DOI 10.1016/j.jbiotec.2013.01.027; Jakubikova J, 2011, BLOOD, V117, P4409, DOI 10.1182/blood-2010-02-267344; Jego G, 1999, BLOOD, V94, P701, DOI 10.1182/blood.V94.2.701.414k16_701_712; Jego G, 2001, BLOOD, V97, P1817, DOI 10.1182/blood.V97.6.1817; Kim D, 2012, LEUKEMIA, V26, P2530, DOI 10.1038/leu.2012.140; Kukreja A, 2006, J EXP MED, V203, P1859, DOI 10.1084/jem.20052136; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; Ma MH, 2003, CLIN CANCER RES, V9, P1136; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Ocio EM, 2009, BLOOD, V113, P3781, DOI 10.1182/blood-2008-09-177774; PAINO T, 2013, HAEMATOLOGICA, V97, P1110; Paino T, 2013, HAEMATOL-HEMATOL J, V98, DOI 10.3324/haematol.2012.077727; Paino T, 2012, HAEMATOL-HEMATOL J, V97, P1110, DOI 10.3324/haematol.2011.057372; Paiva B, 2011, LEUKEMIA, V25, P697, DOI 10.1038/leu.2010.320; Pilarski LM, 2000, BLOOD, V95, P1056, DOI 10.1182/blood.V95.3.1056.003k26_1056_1065; Reid S, 2010, INT J LAB HEMATOL, V32, pE190, DOI 10.1111/j.1751-553X.2010.01222.x; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; San-Miguel JF, 2011, HAEMATOL-HEMATOL J, V96, P1246, DOI 10.3324/haematol.2011.051169; Sanz-Rodriguez F, 1999, BRIT J HAEMATOL, V107, P825, DOI 10.1046/j.1365-2141.1999.01762.x; Spisek R, 2007, J EXP MED, V204, P831, DOI 10.1084/jem.20062387; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Van Valckenborgh E, 2012, LEUKEMIA, V26, P1436, DOI 10.1038/leu.2011.373; Wei A, 2003, J CLIN PATHOL, V56, P406, DOI 10.1136/jcp.56.6.406; Wijdenes J, 1996, BRIT J HAEMATOL, V94, P318, DOI 10.1046/j.1365-2141.1996.d01-1811.x; Wulf GG, 2001, BLOOD, V98, P1166, DOI 10.1182/blood.V98.4.1166; Yaccoby S, 2005, CLIN CANCER RES, V11, P7599, DOI 10.1158/1078-0432.CCR-05-0523; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	51	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92378	10.1371/journal.pone.0092378	http://dx.doi.org/10.1371/journal.pone.0092378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658332	gold, Green Submitted, Green Published			2022-12-25	WOS:000333355300078
J	Sugimoto, K; Senda, M; Kasai, D; Fukuda, M; Masai, E; Senda, T				Sugimoto, Keisuke; Senda, Miki; Kasai, Daisuke; Fukuda, Masao; Masai, Eiji; Senda, Toshiya			Molecular Mechanism of Strict Substrate Specificity of an Extradiol Dioxygenase, DesB, Derived from Sphingobium sp SYK-6	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; 2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE; CATABOLIC PATHWAYS; LIGNIN; CRYSTALLIZATION; LIGAB; GENE	DesB, which is derived from Sphingobium sp. SYK-6, is a type II extradiol dioxygenase that catalyzes a ring opening reaction of gallate. While typical extradiol dioxygenases show broad substrate specificity, DesB has strict substrate specificity for gallate. The substrate specificity of DesB seems to be required for the efficient growth of S. sp. SYK-6 using lignin-derived aromatic compounds. Since direct coordination of hydroxyl groups of the substrate to the non-heme iron in the active site is a critical step for the catalytic reaction of the extradiol dioxygenases, the mechanism of the substrate recognition and coordination of DesB was analyzed by biochemical and crystallographic methods. Our study demonstrated that the direct coordination between the non-heme iron and hydroxyl groups of the substrate requires a large shift of the Fe (II) ion in the active site. Mutational analysis revealed that His124 and His192 in the active site are essential to the catalytic reaction of DesB. His124, which interacts with OH (4) of the bound gallate, seems to contribute to proper positioning of the substrate in the active site. His192, which is located close to OH (3) of the gallate, is likely to serve as the catalytic base. Glu377' interacts with OH (5) of the gallate and seems to play a critical role in the substrate specificity. Our biochemical and structural study showed the substrate recognition and catalytic mechanisms of DesB.	[Sugimoto, Keisuke] Asahikawa Natl Coll Technol, Dept Chem Mat, Asahikawa, Hokkaido, Japan; [Senda, Miki; Senda, Toshiya] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Photon Factory, Struct Biol Res Ctr, Tsukuba, Ibaraki, Japan; [Kasai, Daisuke; Fukuda, Masao; Masai, Eiji] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 94021, Japan	High Energy Accelerator Research Organization (KEK); Nagaoka University of Technology	Senda, T (corresponding author), High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Photon Factory, Struct Biol Res Ctr, Tsukuba, Ibaraki, Japan.	toshiya.senda@kek.jp		Senda, Toshiya/0000-0002-5153-928X; Masai, Eiji/0000-0001-9194-7483	Ministry of Education, Science, and Culture, Japan [22121005]; New Energy and Industrial Technology Development Organization (NEDO) [P08005]	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (22121005 TS) from the Ministry of Education, Science, and Culture, Japan (http://www.mext.go.jp/english/). This work was also supported by the New Energy and Industrial Technology Development Organization (NEDO) (http://www.nedo.go.jp/english/index.html) (P08005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barry KP, 2013, BIOCHEMISTRY-US, V52, P6724, DOI 10.1021/bi400665t; Eltis LD, 1996, J BACTERIOL, V178, P5930, DOI 10.1128/jb.178.20.5930-5937.1996; Emerson JP, 2008, P NATL ACAD SCI USA, V105, P7347, DOI 10.1073/pnas.0711179105; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fielding AJ, 2011, J BIOL INORG CHEM, V16, P341, DOI 10.1007/s00775-010-0732-0; HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976; Jackson TA, 2004, ACCOUNTS CHEM RES, V37, P461, DOI 10.1021/ar030272h; Ju KS, 2011, MOL MICROBIOL, V82, P355, DOI 10.1111/j.1365-2958.2011.07817.x; Kasai D, 2005, J BACTERIOL, V187, P5067, DOI 10.1128/JB.187.15.5067-5074.2005; Kasai D, 2004, J BACTERIOL, V186, P4951, DOI 10.1128/JB.186.15.4951-4959.2004; KATAYAMA Y, 1988, FEBS LETT, V233, P129, DOI 10.1016/0014-5793(88)81369-3; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; Lipscomb JD, 2008, CURR OPIN STRUC BIOL, V18, P644, DOI 10.1016/j.sbi.2008.11.001; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Mendel S, 2004, BIOCHEMISTRY-US, V43, P13390, DOI 10.1021/bi048518t; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Sato N, 2002, J MOL BIOL, V321, P621, DOI 10.1016/S0022-2836(02)00673-3; Senda M, 2007, ACTA CRYSTALLOGR F, V63, P311, DOI 10.1107/S1744309107009992; Senda T, 1996, J MOL BIOL, V255, P735, DOI 10.1006/jmbi.1996.0060; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Sugimoto K, 1999, STRUCTURE, V7, P953, DOI 10.1016/S0969-2126(99)80122-1; Sugimoto K, 2009, ACTA CRYSTALLOGR F, V65, P1171, DOI 10.1107/S1744309109041086; Uragami Y, 2001, J INORG BIOCHEM, V83, P269, DOI 10.1016/S0162-0134(00)00172-0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaillancourt FH, 1998, J BIOL CHEM, V273, P34887, DOI 10.1074/jbc.273.52.34887; Vaillancourt FH, 2002, J AM CHEM SOC, V124, P2485, DOI 10.1021/ja0174682; Vance CK, 1998, J AM CHEM SOC, V120, P461, DOI 10.1021/ja972060j; Vetting MW, 2004, J BACTERIOL, V186, P1945, DOI 10.1128/JB.186.7.1945-1958.2004	30	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92249	10.1371/journal.pone.0092249	http://dx.doi.org/10.1371/journal.pone.0092249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24657997	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300066
J	Theysohn, JM; Kraff, O; Eilers, K; Andrade, D; Gerwig, M; Timmann, D; Schmitt, F; Ladd, ME; Ladd, SC; Bitz, AK				Theysohn, Jens M.; Kraff, Oliver; Eilers, Kristina; Andrade, Dorian; Gerwig, Marcus; Timmann, Dagmar; Schmitt, Franz; Ladd, Mark E.; Ladd, Susanne C.; Bitz, Andreas K.			Vestibular Effects of a 7 Tesla MRI Examination Compared to 1.5 T and 0 T in Healthy Volunteers	PLOS ONE			English	Article							STATIC MAGNETIC-FIELDS; STRAY FIELDS; CROSSOVER; EXPOSURE; VERTIGO; SYSTEMS; SAFETY	Ultra-high-field MRI (7 Tesla (T) and above) elicits more temporary side-effects compared to 1.5 T and 3 T, e. g. dizziness or "postural instability'' even after exiting the scanner. The current study aims to assess quantitatively vestibular performance before and after exposure to different MRI scenarios at 7 T, 1.5 T and 0 T. Sway path and body axis rotation (Unterberger's stepping test) were quantitatively recorded in a total of 46 volunteers before, 2 minutes after, and 15 minutes after different exposure scenarios: 7 T head MRI (n = 27), 7 T no RF (n = 22), 7 T only B-0 (n = 20), 7 T in & out B-0 (n = 20), 1.5 T no RF (n = 20), 0 T (n = 15). All exposure scenarios lasted 30 minutes except for brief one minute exposure in 7 T in & out B-0. Both measures were documented utilizing a 3D ultrasound system. During sway path evaluation, the experiment was repeated with eyes both open and closed. Sway paths for all long-lasting 7 T scenarios (normal, no RF, only B-0) with eyes closed were significantly prolonged 2 minutes after exiting the scanner, normalizing after 15 minutes. Brief exposure to 7 T B-0 or 30 minutes exposure to 1.5 T or 0 T did not show significant changes. End positions after Unterberger's stepping test were significantly changed counter-clockwise after all 7 T scenarios, including the brief in & out B-0 exposure. Shorter exposure resulted in a smaller alteration angle. In contrast to sway path, reversal of changes in body axis rotation was incomplete after 15 minutes. 1.5 T caused no rotational changes. The results show that exposure to the 7 Tesla static magnetic field causes only a temporary dysfunction or "over-compensation'' of the vestibular system not measurable at 1.5 or 0 Tesla. Radiofrequency fields, gradient switching, and orthostatic dysregulation do not seem to play a role.	[Theysohn, Jens M.; Kraff, Oliver; Eilers, Kristina; Andrade, Dorian; Ladd, Mark E.; Ladd, Susanne C.; Bitz, Andreas K.] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Theysohn, Jens M.; Kraff, Oliver; Eilers, Kristina; Andrade, Dorian; Ladd, Susanne C.] Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Gerwig, Marcus; Timmann, Dagmar] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Schmitt, Franz] Siemens Healthcare Sect, Erlangen, Germany; [Ladd, Mark E.; Bitz, Andreas K.] German Canc Res Ctr, Div Med Phys Radiol E020, Heidelberg, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Siemens AG; Helmholtz Association; German Cancer Research Center (DKFZ)	Theysohn, JM (corresponding author), Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.	jens.theysohn@uni-due.de	Kraff, Oliver/AAE-2238-2020	Kraff, Oliver/0000-0002-6006-8934; Ladd, Mark/0000-0002-4128-9440	University Duisburg-Essen; German Research Foundation (DFG)	University Duisburg-Essen; German Research Foundation (DFG)(German Research Foundation (DFG))	The authors kindly thank the University Duisburg-Essen and the German Research Foundation (DFG) for their assumption of publication costs of this article. The authors have no other support or funding to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakeres DW, 2005, PROG BIOPHYS MOL BIO, V87, P255, DOI 10.1016/j.pbiomolbio.2004.08.012; Chakeres DW, 2003, J MAGN RESON IMAGING, V18, P346, DOI 10.1002/jmri.10367; Chakeres DW, 2003, J MAGN RESON IMAGING, V18, P342, DOI 10.1002/jmri.10366; Davalos-Bichara M, 2013, NORMATIVE RESULTS HL; de Vocht F, 2007, BIOELECTROMAGNETICS, V28, P247, DOI 10.1002/bem.20311; Faraldo-Garcia A, 2012, EUR ARCH OTO-RHINO-L, V269, P673, DOI 10.1007/s00405-011-1707-7; *FDA, 2003, GUID IND FDA STAFF C; Fetter M., 2010, NEUROREHABILITATION, V383, P398; Glover PM, 2007, BIOELECTROMAGNETICS, V28, P349, DOI 10.1002/bem.20316; Heilmaier C, 2011, BIOELECTROMAGNETICS, V32, P610, DOI 10.1002/bem.20680; Heinrich A, 2013, RADIOLOGY, V266, P236, DOI 10.1148/radiol.12112172; IEC, 2010, MED EL EQ 2; Kangarlu A, 1999, MAGN RESON IMAGING, V17, P1407, DOI 10.1016/S0730-725X(99)00086-7; Kangarlu A, 2004, RADIOLOGE, V44, P19, DOI 10.1007/s00117-003-0993-5; Kangarlu A, 2000, CONCEPT MAGNETIC RES, V12, P321; MCROBBIE D, 1984, CLIN PHYS PHYSIOL M, V5, P67, DOI 10.1088/0143-0815/5/2/002; Mian OS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078748; MIRKA A, 1990, NEUROL CLIN, V8, P351, DOI 10.1016/S0733-8619(18)30360-8; Roberts DC, 2011, CURR BIOL, V21, P1635, DOI 10.1016/j.cub.2011.08.029; Robitaille PML, 1998, NMR BIOMED, V11, P263, DOI 10.1002/(SICI)1099-1492(199810)11:6<263::AID-NBM549>3.0.CO;2-0; Saunders R, 1983, NUCL MAGN RESON, P383; Schenck JF, 2005, PROG BIOPHYS MOL BIO, V87, P185, DOI 10.1016/j.pbiomolbio.2004.08.009; SCHENCK JF, 1992, MED PHYS, V19, P1089, DOI 10.1118/1.596827; Schenck JF, 2000, J MAGN RESON IMAGING, V12, P2, DOI 10.1002/1522-2586(200007)12:1<2::AID-JMRI2>3.0.CO;2-V; Schild H, 2005, ROFO-FORTSCHR RONTG, V177, P621, DOI 10.1055/s-2005-858048; TENFORDE TS, 1992, ANNU REV PUBL HEALTH, V13, P173, DOI 10.1146/annurev.publhealth.13.1.173; Theysohn JM, 2008, MAGN RESON MATER PHY, V21, P63, DOI 10.1007/s10334-007-0095-x; Thormann M, 2013, EUR J RADIOL, V82, P768, DOI 10.1016/j.ejrad.2011.08.001; van Nierop LE, 2013, MAGN RESON MED, V70, P232, DOI 10.1002/mrm.24454; Versluis MJ, 2013, J MAGN RESON IMAGING, V38, P722, DOI 10.1002/jmri.23904; Vogt FM, 2004, RADIOLOGY, V233, P548, DOI 10.1148/radiol.2332030428	31	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92104	10.1371/journal.pone.0092104	http://dx.doi.org/10.1371/journal.pone.0092104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658179	gold, Green Submitted, Green Published			2022-12-25	WOS:000333355300054
J	Chiang, WH; Huang, WC; Shen, MY; Wang, CH; Huang, YF; Lin, SC; Chern, CS; Chiu, HC				Chiang, Wen-Hsuan; Huang, Wen-Chia; Shen, Ming-Yin; Wang, Che-Hsu; Huang, Yi-Fong; Lin, Sung-Chyr; Chern, Chorng-Shyan; Chiu, Hsin-Cheng			Dual-Layered Nanogel-Coated Hollow Lipid/Polypeptide Conjugate Assemblies for Potential pH-Triggered Intracellular Drug Release	PLOS ONE			English	Article							POLYMER-CAGED NANOBINS; TRANSMEMBRANE CHANNELS; RAFT POLYMERIZATION; STRUCTURAL-CHANGES; DELIVERY PLATFORM; IN-VIVO; MICELLES; VESICLES; NANOPARTICLES; COPOLYMERS	To achieve effective intracellular anticancer drug delivery, the polymeric vesicles supplemented with the pH-responsive outlayered gels as a delivery system of doxorubicin (DOX) were developed from self-assembly of the lipid/polypeptide adduct, distearin grafted poly(gamma-glutamic acid) (poly(gamma-GA)), followed by sequential deposition of chitosan and poly(gamma-GA-co-gamma-glutamyl oxysuccinimide)-g-monomethoxy poly(ethylene glycol) in combination with in situ covalent cross-linking on assembly surfaces. The resultant gel-caged polymeric vesicles (GCPVs) showed superior performance in regulating drug release in response to the external pH change. Under typical physiological conditions (pH 7.4 and 37 degrees C) at which the gamma-GA/DOX ionic pairings remained mostly undisturbed, the dense outlayered gels of GCPVs significantly reduced the premature leakage of the uncomplexed payload. With the environmental pH being reduced from pH 7.4 to 4.7, the drug liberation was appreciably promoted by the massive disruption of the ionic gamma-GA/DOX complexes along with the significant swelling of nanogel layers upon the increased protonation of chitosan chain segments. After being internalized by HeLa cells via endocytosis, GCPVs exhibited cytotoxic effect comparable to free DOX achieved by rapidly releasing the payload in intracellular acidic endosomes and lysosomes. This strongly implies the great promise of such unique GCPVs as an intracellular drug delivery carrier for potential anticancer treatment.	[Chiang, Wen-Hsuan; Huang, Wen-Chia; Shen, Ming-Yin; Wang, Che-Hsu; Chiu, Hsin-Cheng] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Shen, Ming-Yin] Natl Taiwan Univ Hosp, Dept Surg, Hsinchu Branch, Hsinchu, Taiwan; [Huang, Yi-Fong; Lin, Sung-Chyr] Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan; [Chern, Chorng-Shyan] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei, Taiwan	National Tsing Hua University; National Taiwan University; National Taiwan University Hospital; National Chung Hsing University; National Taiwan University of Science & Technology	Chiu, HC (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	hscchiu@mx.nthu.edu.tw		Chiu, Hsin-Cheng/0000-0001-5509-2107; Chiang, Wen-Hsuan/0000-0002-2022-0858	National Tsing Hua University [102N2733E1, 101N2716E1]; National Taiwan Hospital-Hsinchu Branch [HCH-101-17, NTHU-HCH100-03]	National Tsing Hua University; National Taiwan Hospital-Hsinchu Branch	This work is financially supported by the National Tsing Hua University (102N2733E1 and 101N2716E1) and National Taiwan Hospital-Hsinchu Branch (HCH-101-17 and NTHU-HCH100-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmady ZS, 2012, ACS NANO, V6, P9335, DOI 10.1021/nn302148p; Bae HH, 2012, J MICROBIOL BIOTECHN, V22, P1782, DOI 10.4014/jmb.1208.08031; Blanazs A, 2009, MACROMOL RAPID COMM, V30, P267, DOI 10.1002/marc.200800713; Broz P, 2006, NANO LETT, V6, P2349, DOI 10.1021/nl0619305; Chen ZW, 2013, BIOMATERIALS, V34, P1364, DOI 10.1016/j.biomaterials.2012.10.060; Chiang WH, 2012, LANGMUIR, V28, P15056, DOI 10.1021/la302903v; Chiang WH, 2009, MACROMOLECULES, V42, P3611, DOI 10.1021/ma900263j; Chiu HC, 2008, ANGEW CHEM INT EDIT, V47, P1875, DOI 10.1002/anie.200704078; Cuomo F, 2010, LANGMUIR, V26, P10555, DOI 10.1021/la100584b; Dai J, 2011, ANGEW CHEM INT EDIT, V50, P9404, DOI 10.1002/anie.201103806; Dou HJ, 2003, ANGEW CHEM INT EDIT, V42, P1516, DOI 10.1002/anie.200250254; Du JZ, 2011, J AM CHEM SOC, V133, P17560, DOI 10.1021/ja207150n; ElBayoumi TA, 2010, METHODS MOL BIOL, V605, P1, DOI 10.1007/978-1-60327-360-2_1; Han SY, 2011, J MATER CHEM, V21, P7996, DOI 10.1039/c1jm10466g; Hsu YH, 2005, MACROMOLECULES, V38, P9757, DOI 10.1021/ma0512713; Hsu YH, 2006, LANGMUIR, V22, P6764, DOI 10.1021/la060229d; Huang WC, 2012, ADV FUNCT MATER, V22, P2267, DOI 10.1002/adfm.201103117; Huang YF, 2011, CHEM COMMUN, V47, P10978, DOI 10.1039/c1cc14793e; Jung SH, 2009, INT J PHARMACEUT, V382, P254, DOI 10.1016/j.ijpharm.2009.08.002; Lee HJ, 2010, CHEM COMMUN, V46, P377, DOI 10.1039/b913732g; Lee SM, 2010, ANGEW CHEM INT EDIT, V49, P9960, DOI 10.1002/anie.201004867; Lee SM, 2009, J AM CHEM SOC, V131, P9311, DOI 10.1021/ja9017336; Li J, 2012, BIOMATERIALS, V33, P2310, DOI 10.1016/j.biomaterials.2011.11.022; Li YL, 2009, ANGEW CHEM INT EDIT, V48, P9914, DOI 10.1002/anie.200904260; Manocha B, 2010, J NANOMATER, V2010, DOI 10.1155/2010/780171; Miyata K, 2011, REACT FUNCT POLYM, V71, P227, DOI 10.1016/j.reactfunctpolym.2010.10.009; Ning SH, 2011, SOFT MATTER, V7, P9394, DOI 10.1039/c1sm05814b; Osaka T, 2009, COLLOID SURFACE B, V71, P325, DOI 10.1016/j.colsurfb.2009.03.004; Park JH, 2008, PROG POLYM SCI, V33, P113, DOI 10.1016/j.progpolymsci.2007.09.003; Poon Z, 2011, ACS NANO, V5, P4284, DOI 10.1021/nn200876f; Rapoport N, 2007, PROG POLYM SCI, V32, P962, DOI 10.1016/j.progpolymsci.2007.05.009; Samad Abdus, 2007, Current Drug Delivery, V4, P297, DOI 10.2174/156720107782151269; Smith AE, 2010, MACROMOLECULES, V43, P1210, DOI 10.1021/ma902378k; Sun PJ, 2011, J CONTROL RELEASE, V155, P96, DOI 10.1016/j.jconrel.2010.11.005; Sun QQ, 2011, J MATER CHEM, V21, P15316, DOI 10.1039/c1jm12404h; Tang RP, 2011, J CONTROL RELEASE, V151, P18, DOI 10.1016/j.jconrel.2010.12.005; Wan WM, 2009, MACROMOLECULES, V42, P4950, DOI 10.1021/ma901014m; Wang DL, 2011, BIOMACROMOLECULES, V12, P1370, DOI 10.1021/bm200155t; Wang WW, 2012, ADV MATER, V24, P115, DOI 10.1002/adma.201104066; Zhang L, 2011, BIOMATERIALS, V32, P4604, DOI 10.1016/j.biomaterials.2011.02.064; Zhang WL, 2010, BIOMACROMOLECULES, V11, P1331, DOI 10.1021/bm100116g; Zheng C, 2011, MACROMOL BIOSCI, V11, P338, DOI 10.1002/mabi.201000333	42	18	19	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92268	10.1371/journal.pone.0092268	http://dx.doi.org/10.1371/journal.pone.0092268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651156	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800091
J	Drillon, G; Carbone, A; Fischer, G				Drillon, Guenola; Carbone, Alessandra; Fischer, Gilles			SynChro: A Fast and Easy Tool to Reconstruct and Visualize Synteny Blocks along Eukaryotic Chromosomes	PLOS ONE			English	Article							HOMOLOGY; ARABIDOPSIS; REGIONS; REARRANGEMENTS; ADHORE	Reconstructing synteny blocks is an essential step in comparative genomics studies. Different methods were already developed to answer various needs such as genome (re-)annotation, identification of duplicated regions and whole genome duplication events or estimation of rearrangement rates. We present SynChro, a tool that reconstructs synteny blocks between pairwise comparisons of multiple genomes. SynChro is based on a simple algorithm that computes Reciprocal Best-Hits (RBH) to reconstruct the backbones of the synteny blocks and then automatically completes these blocks with non-RBH syntenic homologs. This approach has two main advantages: (i) synteny block reconstruction is fast (feasible on a desk computer for large eukaryotic genomes such as human) and (ii) synteny block reconstruction is straightforward as all steps are integrated (no need to run Blast or TribeMCL prior to reconstruction) and there is only one parameter to set up, the synteny block stringency Delta. Benchmarks on three pairwise comparisons of genomes, representing three different levels of synteny conservation (Human/Mouse, Human/Zebra Finch and Human/Zebrafish) show that Synchro runs faster and performs at least as well as two other commonly used and more sophisticated tools (MCScanX and i-ADHoRe). In addition, SynChro provides the user with a rich set of graphical outputs including dotplots, chromosome paintings and detailed synteny maps to visualize synteny blocks with all homology relationships and synteny breakpoints with all included genetic features. SynChro is freely available under the BSD license at http://www.lcqb.upmc.fr/CHROnicle/SynChro.html.	[Drillon, Guenola; Carbone, Alessandra; Fischer, Gilles] Sorbonne Univ, Univ Paris 06, UMR 7238, Paris, France; [Drillon, Guenola; Carbone, Alessandra; Fischer, Gilles] CNRS, UMR7238, Paris, France; [Carbone, Alessandra] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Universitaire de France	Fischer, G (corresponding author), Sorbonne Univ, Univ Paris 06, UMR 7238, Paris, France.	Gilles.Fischer@upmc.fr	Fischer, Gilles/Q-4603-2019; Fischer, Gilles/G-6654-2016	Fischer, Gilles/0000-0001-5732-2682; Carbone, Alessandra/0000-0003-2098-5743	Agence Nationale de la Recherche ('GB-3G') [ANR-10-BLAN-1606-01]; CNRS	Agence Nationale de la Recherche ('GB-3G')(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Agence Nationale de la Recherche ('GB-3G', ANR-10-BLAN-1606-01, http://www.agence-nationale-recherche.fr/) and by an ATIP grant from the CNRS (http://www.cnrs.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cannon SB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r68; Dong XJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r86; Drillon G, 2013, J LOGIC COMPUT, V23, P815, DOI 10.1093/logcom/exr047; Drillon G, 2011, CR BIOL, V334, P629, DOI 10.1016/j.crvi.2011.05.011; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Hampson S, 2003, GENOME RES, V13, P999, DOI 10.1101/gr.814403; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; Ng MP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-192; Pan XK, 2005, BIOINFORMATICS, V21, P3461, DOI 10.1093/bioinformatics/bti555; Proost S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr955; Simillion C, 2004, GENOME RES, V14, P1095, DOI 10.1101/gr.2179004; Sinha AU, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-82; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Vandepoele K, 2002, GENOME RES, V12, P1792, DOI 10.1101/gr.400202; Wang XY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-447; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Xinghuo Z., 2008, P 11 INT C EXT DAT T, P656	22	56	56	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92621	10.1371/journal.pone.0092621	http://dx.doi.org/10.1371/journal.pone.0092621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651407	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800134
J	Khan, MH; Meghvansi, MK; Gupta, R; Veer, V; Singh, L; Kalita, MC				Khan, Mohammad Haneef; Meghvansi, Mukesh K.; Gupta, Rajeev; Veer, Vijay; Singh, Lokendra; Kalita, Mohan C.			Foliar Spray with Vermiwash Modifies the Arbuscular Mycorrhizal Dependency and Nutrient Stoichiometry of Bhut Jolokia (Capsicum assamicum)	PLOS ONE			English	Article							COMPOST TEA; NAGA CHILLI; GROWTH-RATE; PLANT; FUNGI; SOIL; RESPONSES; YIELD; L.; NUTRITION	Vermiwash (VW), a liquid extract obtained from vermicomposting beds, is used as an organic fertilizer for crop plants. The current study investigated the effect of a vermiwash foliar spray on the response of bhut jolokia (Capsicum assamicum) exposed to two different arbuscular mycorrhizal fungi (AMF: Rhizophagus irregularis, RI and G. mosseae, GM) in acidic soil under naturally ventilated greenhouse conditions. The VW spray significantly influenced the growth of plants receiving the dual treatment of AMF+VW. Plant growth was more prominent in the GM+VW treatment group than that in the RI+VW treatment group. The plant-AMF interactions in relation to growth and nutrient requirements were also significantly influenced by the application of VW. Interestingly, the VW treatment appeared to contribute more N to plants when compared to that under the AMF treatment, which led to changes in the C: N: P stoichiometry in plant shoots. Furthermore, the increased potassium dependency, as observed in the case of the dual treatments, suggests the significance of such treatments for improving crop conditions under salt stress. Overall, our study shows that the VW foliar spray modifies the response of a crop to inoculations of different AMF with regard to growth and nutrient utilization, which has implications for the selection of an efficient combination of nutrient source for improving crop growth.	[Khan, Mohammad Haneef; Meghvansi, Mukesh K.; Gupta, Rajeev; Veer, Vijay] Def Res & Dev Org, Def Res Lab, Tezpur, Assam, India; [Singh, Lokendra] Def Res & Dev Org, Directorate Gen Life Sci, New Delhi, India; [Kalita, Mohan C.] Gauhati Univ, Dept Biotechnol & Bioengn, Gauhati, Assam, India	Defence Research & Development Organisation (DRDO); Defence Research Laboratory (DRL); Defence Research & Development Organisation (DRDO); Gauhati University	Meghvansi, MK (corresponding author), Def Res & Dev Org, Def Res Lab, Post Bag 2, Tezpur, Assam, India.	mk_meghvansi@yahoo.co.in		Khan, Mohammad Haneef/0000-0001-9603-7593	Defence Research & Development Organisation (DRDO), New Delhi, India	Defence Research & Development Organisation (DRDO), New Delhi, India(Defence Research & Development Organisation (DRDO))	This study was funded by Defence Research & Development Organisation (DRDO), New Delhi, India from operating funds rather than grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Alloush GA, 2001, COMMUN SOIL SCI PLAN, V32, P231, DOI 10.1081/CSS-100103004; Ansari AA, 2010, AFR J AGR RES, V5, P1794; Arancon N. Q., 2007, BioCycle, V48, P51; Arthur GD, 2001, ENVIRON EXP BOT, V45, P55, DOI 10.1016/S0098-8472(00)00080-0; Chen MM, 2010, PLANT SOIL, V326, P21, DOI 10.1007/s11104-009-9982-4; Doubkova P, 2012, SOIL BIOL BIOCHEM, V44, P56, DOI 10.1016/j.soilbio.2011.09.011; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Garcia Martinez Ignacio, 2002, Crop Research (Hisar), V24, P323; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gosling P, 2006, AGR ECOSYST ENVIRON, V113, P17, DOI 10.1016/j.agee.2005.09.009; Guo W, 2013, APPL SOIL ECOL, V72, P85, DOI 10.1016/j.apsoil.2013.06.001; Hanway J.J., 1952, IOWA AGR, V57, P1, DOI DOI 10.12691/AJWR-7-1-5; Haytova D., 2013, Annual Review and Research in Biology, V3, P455; Hessen DO, 2007, FUNCT ECOL, V21, P956, DOI 10.1111/j.1365-2435.2007.01306.x; Holloway Peter J., 1993, Pesticide Science, V37, P203, DOI 10.1002/ps.2780370214; Ismail SA, 1997, VERMICOLOGY BIOL EAR; Jackson ML, 2005, SOIL CHEM ANAL ADV C; Johnson NC, 2010, NEW PHYTOL, V185, P631, DOI 10.1111/j.1469-8137.2009.03110.x; Jordan NR, 2000, WEED RES, V40, P397, DOI 10.1046/j.1365-3180.2000.00207.x; Khorshidi M., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V5, P1191; Kuepper G, 2003, FOLIAR FERTILIZATION; Kyle M, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.1; Leon-Anzueto E, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue6-fulltext-9; Medina A, 2010, J SOIL SCI PLANT NUT, V10, P354, DOI 10.4067/S0718-95162010000100009; Medina A, 2010, APPL SOIL ECOL, V44, P181, DOI 10.1016/j.apsoil.2009.12.004; Meghvansi MK, 2012, J CROP IMPROV, V26, P520, DOI 10.1080/15427528.2012.657293; Meghvansi MK, 2010, J ETHNOPHARMACOL, V132, P1, DOI 10.1016/j.jep.2010.08.034; Meghvansi MK, 2008, EUR J SOIL BIOL, V44, P316, DOI 10.1016/j.ejsobi.2008.03.003; Milleret R, 2009, PLANT SOIL, V316, P1, DOI 10.1007/s11104-008-9753-7; Muthukumar T, 2002, J AGRON CROP SCI, V188, P123, DOI 10.1046/j.1439-037X.2002.00544.x; Naidu Y, 2013, SCI HORTIC-AMSTERDAM, V159, P33, DOI 10.1016/j.scienta.2013.04.024; Peng S., 1992, International Rice Research Newsletter, V17, P19; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; PLENCHETTE C, 1983, PLANT SOIL, V70, P199, DOI 10.1007/BF02374780; Porras-Soriano A, 2009, J PLANT PHYSIOL, V166, P1350, DOI 10.1016/j.jplph.2009.02.010; Scheuerell S, 2002, COMPOST SCI UTIL, V10, P313; Schonherr J, 2000, PLANTA, V212, P112, DOI 10.1007/s004250000373; Sensoy S, 2007, SCI HORTIC-AMSTERDAM, V113, P92, DOI 10.1016/j.scienta.2007.01.023; Sharma P. K., 1980, Journal of the Indian Society of Soil Science, V28, P450; Siddiqui Y, 2008, CROP PROT, V27, P385, DOI 10.1016/j.cropro.2007.07.002; Siddiqui Y, 2011, SCI HORTIC-AMSTERDAM, V130, P289, DOI 10.1016/j.scienta.2011.05.043; Singh RK, 2011, AFR J MICROBIOL RES, V5, P5004, DOI 10.5897/AJMR11.628; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; STERNER RW, 1995, LINKING SPECIES & ECOSYSTEMS, P240; Tandon HLS., 1993, METHODS ANAL SOILS P; Thomas JMG, 2003, CROP SCI, V43, P1548, DOI 10.2135/cropsci2003.1548; van der Heijden MGA, 2002, ECOL STU AN, V157, P243; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Willis A, 2013, CRIT REV PLANT SCI, V32, P1, DOI 10.1080/07352689.2012.683375; Wilson GWT, 1998, AM J BOT, V85, P1732, DOI 10.2307/2446507; Zhang F, 2004, PLANT SOIL, V260, P89, DOI 10.1023/B:PLSO.0000030192.15621.20	58	24	24	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92318	10.1371/journal.pone.0092318	http://dx.doi.org/10.1371/journal.pone.0092318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651577	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800100
J	McMahon, CR; Howe, H; van den Hoff, J; Alderman, R; Brolsma, H; Hindell, MA				McMahon, Clive R.; Howe, Hamish; van den Hoff, John; Alderman, Rachael; Brolsma, Henk; Hindell, Mark A.			Satellites, the All-Seeing Eyes in the Sky: Counting Elephant Seals from Space	PLOS ONE			English	Article							BIODIVERSITY LOSS; MIROUNGA-LEONINA; SOUTHERN; TRENDS; TIME	Regular censuses are fundamental for the management of animal populations but, are logistically challenging for species living in remote regions. The advent of readily accessible, high resolution satellite images of earth mean that it is possible to resolve relatively small (0.6 m) objects, sufficient to discern large animals. To illustrate how these advances can be used to count animals in remote regions, individual elephant seals (Mirounga leonina) were counted using satellite imagery. We used an image taken on 10/10/2011 to count elephant seals (n = 1790 +/- 306 (95%CL)) on the isthmus of Macquarie Island, an estimate which overlapped with concurrent ground counts (n = 1991). The number of individuals per harem estimated using the two approaches were highly correlated, with a slope close to one and the estimated intercept also encompassing zero. This proof of concept opens the way for satellites to be used as a standard censusing technique for inaccessible and cryptically coloured species. Quantifying the population trends of higher order predators provides an especially informative and tractable indicator of ecosystem health.	[McMahon, Clive R.; Howe, Hamish; Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [van den Hoff, John; Brolsma, Henk] Australian Antarctic Div, Kingston, Tas, Australia; [Alderman, Rachael] Dept Primary Ind Water & Environm, Threatened Species & Marine Sect, Hobart, Tas, Australia	University of Tasmania; Australian Antarctic Division	McMahon, CR (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	clive.mcmahon@utas.edu.au	McMahon, Clive R/D-5713-2013	McMahon, Clive R/0000-0001-5241-8917; Hindell, Mark/0000-0002-7823-7185				Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Fretwell PT, 2009, GLOBAL ECOL BIOGEOGR, V18, P543, DOI 10.1111/j.1466-8238.2009.00467.x; Gutro R, 2005, SATELLITE DATA TRACK; HINDELL MA, 1987, J ZOOL, V213, P365, DOI 10.1111/j.1469-7998.1987.tb03712.x; Hindell MA, 2003, MARINE MAMMALS HUMAN; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Horning N., 2010, REMOTE SENSING ECOLO; Hughes BJ, 2011, WILDLIFE BIOL, V17, P210, DOI 10.2981/10-106; Laliberte AS, 2003, WILDLIFE SOC B, V31, P362; LaRue MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060568; LaRue MA, 2011, POLAR BIOL, V34, P1727, DOI 10.1007/s00300-011-1023-0; Lynch HJ, 2012, POLAR BIOL, V35, P963, DOI 10.1007/s00300-011-1138-3; McMahon CR, 2009, OECOLOGIA, V159, P69, DOI 10.1007/s00442-008-1205-9; McMahon CR, 2005, MAMMAL REV, V35, P82, DOI 10.1111/j.1365-2907.2005.00055.x; McMahon CR, 2004, BEHAV ECOL SOCIOBIOL, V55, P349, DOI 10.1007/s00265-003-0721-1; Naveen R, 2012, POLAR BIOL, V35, P1879, DOI 10.1007/s00300-012-1230-3; Platonov NG, 2013, BIOL BULL+, V40, P197, DOI 10.1134/S1062359013020106; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Trathan PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014738; van den Hoff J, 2007, POLAR BIOL, V30, P1275, DOI 10.1007/s00300-007-0288-9; Yang Z, 2012, EVALUATING HIGH RESO	22	50	54	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92613	10.1371/journal.pone.0092613	http://dx.doi.org/10.1371/journal.pone.0092613			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651378	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800133
J	Pohar, J; Pirher, N; Bencina, M; Mancek-Keber, M; Jerala, R				Pohar, Jelka; Pirher, Nina; Bencina, Mojca; Mancek-Keber, Mateja; Jerala, Roman			The Ectodomain of TLR3 Receptor Is Required for Its Plasma Membrane Translocation	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; NUCLEIC-ACID; INTRACELLULAR COMPARTMENTS; EPITHELIAL-CELLS; SENSING TLRS; CPG-DNA; LOCALIZATION; RECOGNITION; PROTEIN	Toll-like receptor 3 (TLR3) is a dsRNA sensing receptor that is localized in the cellular compartments but also at the plasma membrane. Overexpression of UNC93B1 promoted localization of TLR3, but not other nucleic acid sensing TLRs, to the plasma membrane. Here we show that UNC93B1 itself is localized at the plasma membrane. We investigated the role of different domains of TLR3 on cell signaling by preparing chimeric receptors between TLR3 and TLR9 where each of the transmembrane segments or cytosolic domains has been exchanged. While the ectodomain completely governs ligand specificity and the cytosolic TIR domain determines the engagement of the signaling adapters as well as the potentiation of receptor activation by UNC93B1, the ectodomain but not transmembrane segment or cytosolic domain determines plasma membrane localization of TLR3. Nevertheless, TLR3 receptor and ligand endocytosis as well as endosomal acidification are important for the robust signaling of TLR3.	[Pohar, Jelka; Pirher, Nina; Bencina, Mojca; Mancek-Keber, Mateja; Jerala, Roman] Natl Inst Chem, Ljubljana, Slovenia; [Bencina, Mojca; Mancek-Keber, Mateja; Jerala, Roman] EN FIST Ctr Excellence, Ljubljana, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana	Jerala, R (corresponding author), Natl Inst Chem, Hajdrihova 19, Ljubljana, Slovenia.	roman.jerala@ki.si		Pohar, Jelka/0000-0002-7616-164X	Slovenian Research Agency; International Centre for Genetic Engineering and Biotechnology (CRP-ICGEB) [CRP/SLO08-01]; EN-FIST Centre of Excellence; European Union	Slovenian Research Agency(Slovenian Research Agency - Slovenia); International Centre for Genetic Engineering and Biotechnology (CRP-ICGEB); EN-FIST Centre of Excellence; European Union(European Commission)	This work was supported by the project and program grant from the Slovenian Research Agency (http://www.arrs.gov.si/en/dobrodoslica.asp), International Centre for Genetic Engineering and Biotechnology (CRP-ICGEB research grant - project no. CRP/SLO08-01; http://www.icgeb.org/home.html) and EN-FIST Centre of Excellence (http://enfist.si/En/) financed in part by the European Union structural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrade WA, 2013, CELL HOST MICROBE, V13, P42, DOI 10.1016/j.chom.2012.12.003; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Chaturvedi A, 2009, TRAFFIC, V10, P621, DOI 10.1111/j.1600-0854.2009.00899.x; Chuang TH, 2002, J LEUKOCYTE BIOL, V71, P538; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Deane JA, 2006, J IMMUNOL, V177, P6573, DOI 10.4049/jimmunol.177.10.6573; Eaton-Bassiri A, 2004, INFECT IMMUN, V72, P7202, DOI 10.1128/IAI.72.12.7202-7211.2004; Ewaschuk JB, 2007, INFECT IMMUN, V75, P2572, DOI 10.1128/IAI.01662-06; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Itoh K, 2008, J IMMUNOL, V181, P5522, DOI 10.4049/jimmunol.181.8.5522; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kajita E, 2006, BIOCHEM BIOPH RES CO, V343, P578, DOI 10.1016/j.bbrc.2006.03.014; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim J, 2013, J IMMUNOL, V190, P5287, DOI 10.4049/jimmunol.1202767; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Pegu A, 2008, J IMMUNOL, V180, P3399, DOI 10.4049/jimmunol.180.5.3399; Pifer R, 2011, J BIOL CHEM, V286, P3307, DOI 10.1074/jbc.M110.171025; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Pohar J, 2013, J BIOL CHEM, V288, P442, DOI 10.1074/jbc.M112.413922; Qi RS, 2012, J BIOL CHEM, V287, P32617, DOI 10.1074/jbc.M112.387803; Qi RS, 2010, J BIOL CHEM, V285, P36635, DOI 10.1074/jbc.M110.144402; Singh D, 2013, J BIOL CHEM, V288, P8258, DOI 10.1074/jbc.M112.440883; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Ueta M, 2005, BIOCHEM BIOPH RES CO, V331, P285, DOI 10.1016/j.bbrc.2005.02.196; Watanabe A, 2011, J BIOL CHEM, V286, P10702, DOI 10.1074/jbc.M110.185793; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	53	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92391	10.1371/journal.pone.0092391	http://dx.doi.org/10.1371/journal.pone.0092391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651829	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800105
J	Qu, B; Gu, YH; Shen, J; Qin, JZ; Bao, JQ; Hu, Y; Zeng, WX; Dong, WZ				Qu, Bin; Gu, Yihua; Shen, Jian; Qin, Jinzhou; Bao, Jianqiang; Hu, Yuan; Zeng, Wenxian; Dong, Wuzi			Trehalose Maintains Vitality of Mouse Epididymal Epithelial Cells and Mediates Gene Transfer	PLOS ONE			English	Article							IN-VITRO; SPERM; MEMBRANE; CULTURE; CAPUT; COCULTURE; INJECTION; DELIVERY; FLUIDITY; LINE	In the present study, trehalose was utilized to improve primary culture of mouse epididymal epithelial cells in vitro, and to enhance naked DNA delivery in epididymis in vivo. During the six-day culture, the proliferation activity of the cells in the medium with addition of trehalose was higher than that of those cells cultured in absence of trehalose (p<0.01). To determine the optimal concentration for cell proliferation, a series of trehalose concentrations (0, 60, 120, 180 mM) were tested, and the result indicated that the cell in the medium with 120 mM trehalose showed the highest proliferation potential. The epididymis epithelial cells were cultured in the medium containing 120 mM trehalose upon 16th passage, and they continued expressing markers of epididymal epithelial cell, such as rE-RABP, AR and ER-beta. Our study also indicated that trehalose concentrations of 120-240 mM, especially 180 mM, could effectively enhance DNA delivery into the mouse epididymis epithelial cell in vitro. Moreover, trehalose could induce in vivo expression of exogenous DNA in epididymal epithelial cells and help to internalize plasmid into sperm, which did not influence motility of sperm when the mixture of trehalose (180 mM) and DNA was injected into epididymal lumen through efferent tubule. This study suggested that trehalose, as an effective and safer reagent, could be employed potentially to maintain vitality of mouse epididymal epthetial cells during long-term culture in vitro and to mediate in vitro and in vivo gene transfer.	[Qu, Bin; Shen, Jian; Qin, Jinzhou; Hu, Yuan; Zeng, Wenxian; Dong, Wuzi] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Gu, Yihua] Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China; [Bao, Jianqiang] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA	Northwest A&F University - China; Nevada System of Higher Education (NSHE); University of Nevada Reno	Dong, WZ (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	dongyangluyi@126.com	Bao, Jianqiang/T-7299-2019; Bao, Jianqiang/G-9184-2016; Zeng, Wen/GPS-8058-2022	Bao, Jianqiang/0000-0003-1248-2687; 	National Natural Science Foundation of China [C170104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. C170104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagla EME, 2003, BIOL REPROD, V69, P1245, DOI 10.1095/biolreprod.103.017889; Bassols J, 2004, THERIOGENOLOGY, V62, P929, DOI 10.1016/j.theriogenology.2003.12.015; Bongso A, 1996, HUM REPROD, V11, P1451; Britan A, 2004, MOL CELL ENDOCRINOL, V224, P41, DOI 10.1016/j.mce.2004.06.010; Chen YC, 1998, TISSUE CELL, V30, P1, DOI 10.1016/S0040-8166(98)80002-5; Companyo M, 2007, BBA-BIOMEMBRANES, V1768, P2246, DOI 10.1016/j.bbamem.2007.06.011; Du JY, 2009, BIOL REPROD, V80, P13, DOI 10.1095/biolreprod.108.068346; Dufresne J, 2005, ENDOCRINOLOGY, V146, P4710, DOI 10.1210/en.2004-1634; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Esponda P, 2011, ZYGOTE, V19, P287, DOI 10.1017/S0967199410000523; Gao X, 2007, AAPS J, V9, pE92, DOI 10.1208/aapsj0901009; Hall JC, 1997, BIOCHEM MOL BIOL INT, V42, P833, DOI 10.1080/15216549700203271; Hamzeh M, 2009, J ANDROL, V30, P200, DOI 10.2164/jandrol.108.006171; Hermo L., 2002, EPIDIDYMIS MOL CLIN, P81, DOI [10.1007/978-1-4615-0679-9_5, DOI 10.1007/978-1-4615-0679-9_5]; HIRATA T, 1994, SURGERY, V115, P102; Kaneko T, 2009, CRYOBIOLOGY, V59, P59, DOI 10.1016/j.cryobiol.2009.04.006; Kang Mo K, 2007, Methods Mol Biol, V371, P151; McGinnis LK, 2005, BIOL REPROD, V73, P627, DOI 10.1095/biolreprod.105.042291; MOORE HDM, 1986, J REPROD FERTIL, V78, P327, DOI 10.1530/jrf.0.0780327; Moore HDM, 1998, J REPROD FERTIL, P23; Oliver A. E., 2004, CELL PRESERV TECHNOL, V2, P35, DOI DOI 10.1089/153834404322708745; OLSON GE, 1983, J ANDROL, V4, P347; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sasnoor LM, 2005, TRANSPLANTATION, V80, P1251, DOI 10.1097/01.tp.0000169028.01327.90; Sato M, 2002, MOL REPROD DEV, V61, P49, DOI 10.1002/mrd.1130; Saxena A, 2012, BIOTECHNIQUES, V52, P381, DOI 10.2144/0000113878; Seki T, 2010, J BIOL CHEM, V285, P33252, DOI 10.1074/jbc.M110.146704; Tabuchi Y, 2005, BIOCHEM BIOPH RES CO, V329, P812, DOI 10.1016/j.bbrc.2005.02.066; Tang CH, 2009, J GENE MED, V11, P250, DOI 10.1002/jgm.1295; Tseng WC, 2007, J GENE MED, V9, P659, DOI 10.1002/jgm.1063; Wang Z, 2000, Shi Yan Sheng Wu Xue Bao, V33, P129; Woelders H, 1997, CRYOBIOLOGY, V35, P93, DOI 10.1006/cryo.1997.2028; Wolkers WF, 2003, BBA-BIOMEMBRANES, V1612, P154, DOI 10.1016/S0005-2736(03)00114-7; Yamashiro H, 2007, ANIM REPROD SCI, V102, P165, DOI 10.1016/j.anireprosci.2007.02.026; Zhao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054645; Zhao Y, 2011, CELL MOL LIFE SCI, V68, P697, DOI 10.1007/s00018-010-0478-4; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106	38	6	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92483	10.1371/journal.pone.0092483	http://dx.doi.org/10.1371/journal.pone.0092483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651491	gold, Green Published, Green Submitted			2022-12-25	WOS:000333352800118
J	Wang, CY; Huang, EYH; Huang, SC; Chung, BC				Wang, C-Y; Huang, E. Y-H; Huang, S-c; Chung, B-c			DNA-PK/Chk2 induces centrosome amplification during prolonged replication stress	ONCOGENE			English	Article							DNA-DAMAGE; S-PHASE; CELLS; ATM; KINASE; PHOSPHORYLATION; ACTIVATION; RADIATION; PK; OVERDUPLICATION	The antineoplastic drug hydroxyurea (HU), when used at subtoxic doses, induces prolonged replication stress and centrosome amplification. This causes genomic instability and increases the malignancy of the recurring tumor. The mechanism of centrosome amplification induced by prolonged replication stress, however, is still unclear. Here, we examined the involvement of ataxia telangiectasia, mutated (ATM), ataxia telangiectasia, mutated and Rad3-related (ATR) and DNA-dependent protein kinase (DNA-PK) and found that HU-induced centrosome amplification was inhibited by the depletion of DNA-PKcs, but not ATM and ATR. Inactivation of ATM/ATR in U2OS cells instead caused aneuploidy and cell death. We found DNA-PKcs depletion also abrogated ATM phosphorylation, indicating that ATM activation during prolonged replication stress depends on DNA-PK. Depletion of DNA-PK abrogated checkpoint kinase (Chk) 2 activation and partially reduced Chk1 activation. Chk2 depletion blocked HU-induced centrosome amplification, indicating a function of Chk2 in centrosome amplification. We further found that Chk2 was phosphorylated at Thr68 on the mother centriole at late G2 and mitosis when unstressed and on all amplified centrioles induced by HU. In summary, we have elucidated that DNA-PK/Chk2 signaling induces centrosome amplification upon long-term HU treatment, therefore increasing our insight into tumor recurrence after initial chemotherapy.	[Wang, C-Y; Huang, E. Y-H; Huang, S-c; Chung, B-c] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Wang, C-Y] Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan 70101, Taiwan	Academia Sinica - Taiwan; National Cheng Kung University	Chung, BC (corresponding author), Acad Sinica, Inst Mol Biol, 128 Acad Rd Sect 2, Taipei 115, Taiwan.	mbchung@sinica.edu.tw		Chung, Bon-chu/0000-0002-8612-0219	Academia Sinica [NHRI-EX102-10210SI, NSC102-2923-B-001-003-MY3, NSC102-2320-B-006-051]	Academia Sinica(Academia Sinica - Taiwan)	We would like to thank Ya-Min Lin for technical assistance in FACS analysis. This study was supported by grants from Academia Sinica, NHRI-EX102-10210SI and NSC102-2923-B-001-003-MY3 to B-cC and NSC102-2320-B-006-051 to C-YW.	An J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-32; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Ayene IS, 2005, MOL CANCER THER, V4, P529, DOI 10.1158/1535-7163.MCT-04-0130; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bennett RA, 2004, ONCOGENE, V23, P6823, DOI 10.1038/sj.onc.1207561; Bourke E, 2010, ONCOGENE, V29, P616, DOI 10.1038/onc.2009.340; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Golan A, 2010, CELL CYCLE, V9, P2647, DOI 10.4161/cc.9.13.12121; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Lee KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.212969; Liu QH, 2000, GENE DEV, V14, P1448; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Prosser SL, 2009, MOL CELL BIOL, V29, P1760, DOI 10.1128/MCB.01124-08; Rampakakis E, 2008, J CELL SCI, V121, P590, DOI 10.1242/jcs.021352; Robinson HMR, 2007, CELL CYCLE, V6, P982, DOI 10.4161/cc.6.8.4111; Sato N, 2000, ONCOGENE, V19, P5281, DOI 10.1038/sj.onc.1203902; Shang ZF, 2010, CANCER RES, V70, P3657, DOI 10.1158/0008-5472.CAN-09-3362; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Stehman FB, 1997, GYNECOL ONCOL, V66, P262, DOI 10.1006/gyno.1997.4761; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Stolz A, 2010, NAT CELL BIOL, V12, P492, DOI 10.1038/ncb2051; Tsvetkov L, 2003, J BIOL CHEM, V278, P8468, DOI 10.1074/jbc.M211202200; Wang CY, 2013, MOL CELL BIOL, V33, P476, DOI 10.1128/MCB.01064-12; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	31	27	28	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2015	34	10					1263	1269		10.1038/onc.2014.74	http://dx.doi.org/10.1038/onc.2014.74			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC9JX	24662822				2022-12-25	WOS:000350687100006
J	Goyer, K; Bertolo, A; Pepino, M; Magnan, P				Goyer, Katerine; Bertolo, Andrea; Pepino, Marc; Magnan, Pierre			Effects of Lake Warming on Behavioural Thermoregulatory Tactics in a Cold-Water Stenothermic Fish	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; LACUSTRINE BROOK CHARR; ECOLOGICAL DATA; SOCKEYE-SALMON; HABITAT USE; TEMPERATURE PREFERENCE; THERMAL TOLERANCE; NEIGHBOR MATRICES; RAINBOW-TROUT; BROWN TROUT	Despite some evidence of within-population phenotypic variation in fish thermal behaviour, the occurrence of alternative tactics of this behaviour is rarely explicitly considered when studying natural populations. Brook charr provide an example of within-population variability in behavioural thermoregulation as revealed by a recent study on a lacustrine population of this species. The objectives of the present study were (i) to determine the influence of natural variability in the lake's thermal profiles on the expression of thermoregulatory tactics, and (ii) to determine the vertical and horizontal movements of individuals at different periods of the day to better understand the spatio-temporal behaviour associated with each thermoregulatory tactic. During summer 2010, 30 adult brook charr were equipped with thermo-sensitive radio transmitters to monitor their selected temperatures and daily movements. These individuals exhibited the same four behavioural thermoregulatory tactics observed in 2003 and 2005, but the expression of two of these was weaker in 2010. This result was associated with lake warming, which constrained the expression of two thermoregulatory tactics: brook charr significantly decreased their selected temperatures and daily movements when the mean daily epilimnion temperature was above 22.4 degrees C. This study shows for the first time that the expression of behavioural thermoregulatory tactics is related to the lake's thermal regime and that the tactics are plastic through time.	[Goyer, Katerine; Bertolo, Andrea; Pepino, Marc; Magnan, Pierre] Univ Quebec Trois Rivieres, Ctr Rech Interact Bassins Versants Ecosyst Aquat, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Bertolo, A (corresponding author), Univ Quebec Trois Rivieres, Ctr Rech Interact Bassins Versants Ecosyst Aquat, Trois Rivieres, PQ GA9 5H7, Canada.	andrea.bertolo@uqtr.ca	Magnan, Pierre/U-9342-2019	Magnan, Pierre/0000-0003-3122-7163; Bertolo, Andrea/0000-0002-6018-816X	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair program; NSERC; Fonds de recherche du Quebec - Nature et technologies	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec - Nature et technologies	This research was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Research Chair program to P. Magnan. K. Goyer was supported by post-graduate fellowships from NSERC and the Fonds de recherche du Quebec - Nature et technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanara A, 2001, J ANIM ECOL, V70, P980, DOI 10.1046/j.0021-8790.2001.00550.x; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; Atkinson EJ, 2000, 61 MAYO FDN; Baird OE, 2003, T AM FISH SOC, V132, P1194, DOI 10.1577/T02-127; Belanger G, 2001, J FISH BIOL, V59, P987, DOI 10.1111/j.1095-8649.2001.tb00166.x; Bertolo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018603; Bicego KC, 2007, COMP BIOCHEM PHYS A, V147, P616, DOI 10.1016/j.cbpa.2006.06.032; Biro PA, 1998, T AM FISH SOC, V127, P212, DOI 10.1577/1548-8659(1998)127<0212:SCBTDS>2.0.CO;2; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Bourke P, 1999, EVOL ECOL, V13, P19, DOI 10.1023/A:1006530029418; Bourke P, 1996, J FISH BIOL, V49, P1174; Bourke P, 1997, J FISH BIOL, V51, P783, DOI 10.1111/j.1095-8649.1997.tb01999.x; Breau C, 2011, J ANIM ECOL, V80, P844, DOI 10.1111/j.1365-2656.2011.01828.x; BREIMAN L., 1984, CRC PRESS; BRETT JR, 1971, AM ZOOL, V11, P99; Bridger CJ, 2003, REV FISH SCI, V11, P13, DOI 10.1080/16226510390856510; CHERRY DS, 1975, J FISH RES BOARD CAN, V32, P485, DOI 10.1139/f75-059; CRAWSHAW LI, 1977, J FISH RES BOARD CAN, V34, P730, DOI 10.1139/f77-113; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dynes J, 1999, J FISH BIOL, V54, P955, DOI 10.1111/j.1095-8649.1999.tb00850.x; Fry FEJ, 1947, U TORONTO STUD BIOL, V55; Fry FEJ, 1947, RES LAB, V68, P1; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Hansson LA, 2009, P R SOC B, V276, P331, DOI 10.1098/rspb.2008.1088; Hayes DB, 1998, HEADWATERS: WATER RESOURCES AND SOIL CONSERVATION, P175; Hays GC, 2001, LIMNOL OCEANOGR, V46, P2050, DOI 10.4319/lo.2001.46.8.2050; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; Hrabik TR, 2006, CAN J FISH AQUAT SCI, V63, P2286, DOI 10.1139/F06-124; JAVAID MY, 1967, J FISH RES BOARD CAN, V24, P1515, DOI 10.1139/f67-125; Keefer ML, 2009, CAN J FISH AQUAT SCI, V66, P1734, DOI 10.1139/F09-131; Kobler A, 2009, OECOLOGIA, V161, P837, DOI 10.1007/s00442-009-1415-9; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 1998, NUMERICAL ECOLOGY, V24; MAGNAN P, 1988, CAN J FISH AQUAT SCI, V45, P999, DOI 10.1139/f88-123; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Magnuson JJ, 1997, HYDROL PROCESS, V11, P825; MATTHEWS KR, 1994, T AM FISH SOC, V123, P549, DOI 10.1577/1548-8659(1994)123<0549:CWFATH>2.3.CO;2; McDermid JL, 2012, T AM FISH SOC, V141, P1230, DOI 10.1080/00028487.2012.688917; Mehner T, 2011, J ANIM ECOL, V80, P761, DOI 10.1111/j.1365-2656.2011.01823.x; MOYLE PB, 2000, FISHES INTRO ICHTHYO; Music B., 2011, CRCM DIAGNOSTICS FUT; NEVERMAN D, 1994, OECOLOGIA, V98, P247, DOI 10.1007/BF00324211; Podrabsky JE, 2008, J COMP PHYSIOL A, V194, P385, DOI 10.1007/s00359-008-0313-7; Power G, 1980, CHARRS SALMONID FISH, P141; R Development Core Team, 2007, R LANG ENV STAT COMP; Rejwan C, 1999, ECOLOGY, V80, P341, DOI 10.1890/0012-9658(1999)080[0341:TRAOTN]2.0.CO;2; REYNOLDS WW, 1979, HYDROBIOLOGIA, V62, P79, DOI 10.1007/BF00012567; REYNOLDS WW, 1979, AM ZOOL, V19, P193; Richter A, 2005, REV FISH SCI, V13, P23, DOI 10.1080/10641260590885861; Robinson JM, 2010, T AM FISH SOC, V139, P685, DOI 10.1577/T08-185.1; Roscoe DW, 2010, ECOL FRESHW FISH, V19, P51, DOI 10.1111/j.1600-0633.2009.00388.x; Scheuerell MD, 2003, ECOLOGY, V84, P1713, DOI 10.1890/0012-9658(2003)084[1713:DVMBJS]2.0.CO;2; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; SNUCINS EJ, 1995, T AM FISH SOC, V124, P118, DOI 10.1577/1548-8659(1995)124<0118:CWAWEB>2.3.CO;2; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; van Dijk PLM, 2002, OECOLOGIA, V130, P496, DOI 10.1007/s00442-001-0830-3; Wehrly KE, 2007, T AM FISH SOC, V136, P365, DOI 10.1577/T06-163.1; Wetzel RG, 2001, LIMNOLOGY, Vthird, P331; Wismer D. A., 1987, SPECIAL PUBLICATION, V87; WURTSBAUGH WA, 1975, T AM FISH SOC, V104, P88, DOI 10.1577/1548-8659(1975)104<88:FADOUB>2.0.CO;2	64	28	31	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92514	10.1371/journal.pone.0092514	http://dx.doi.org/10.1371/journal.pone.0092514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663489	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900069
J	Lee, PH; Lin, HC; Huang, ASE; Wei, SH; Lai, MS; Lin, HH				Lee, Pin-Hui; Lin, Hui-Chen; Huang, Angela Song-En; Wei, Sung-Hsi; Lai, Mei-Shu; Lin, Hsien-Ho			Diabetes and Risk of Tuberculosis Relapse: Nationwide Nested Case-Control Study	PLOS ONE			English	Article							RECURRENT TUBERCULOSIS; PULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; MELLITUS; ASSOCIATION; MANAGEMENT; DIAGNOSIS; IMPACT; MICE	The aim of this study was to investigate the association between diabetes mellitus (DM) and tuberculosis (TB) relapse using the nationwide TB registry in Taiwan. We conducted a case-control study nested within a nationwide cohort of all incident cases of pulmonary TB that were notified during 2006-2007 and had completed anti-TB treatment. The relapse of TB was confirmed by bacteriological or pathological findings. For each relapse case, one control was selected from the study cohort matching by time since treatment completion. DM status was ascertained by medical chart review and cross-matching with the National Health Insurance claims database. A total of 305 cases of relapse were identified after a median follow-up of 3 years (relapse rate: 488 per 100,000 person-year; 95% confidence interval (CI): 434-546). Presence of DM during previous anti-TB treatment was 34.0% and 22.7% in cases and controls, respectively. After adjusting for other potential confounders, DM was associated with increased risk of TB relapse (adjusted odds ratio: 1.96, 95% CI: 1.22-3.15). Only one-third of the DM-TB patients in our study received glycaemic monitoring using HbA1c during anti-TB treatment. Presence of DM was independently associated with risk of TB relapse. TB programs should seriously consider rigorous glucose control in DM-TB patients.	[Lee, Pin-Hui; Lin, Hui-Chen; Huang, Angela Song-En; Wei, Sung-Hsi] Ctr Dis Control, Taipei, Taiwan; [Lee, Pin-Hui; Lai, Mei-Shu; Lin, Hsien-Ho] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Wei, Sung-Hsi] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Wei, Sung-Hsi] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Centers For Disease Control - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, HH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	hsienho@ntu.edu.tw		Lai, Mei-shu/0000-0001-6130-3468; LIN, HSIEN-HO/0000-0002-7481-6016	Centers for Disease Control, Taiwan [DOH100-DC-2043]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002043] Funding Source: NIH RePORTER	Centers for Disease Control, Taiwan; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the Centers for Disease Control, Taiwan [Grant DOH100-DC-2043]. The sponsors had no role in the study design or the collection, or analysis, or interpretation of data, or the writing of the article, or the decision to submit it for publication.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Bang D, 2010, INT J TUBERC LUNG D, V14, P447; Bloss E, 2012, INT J TUBERC LUNG D, V16, P462, DOI 10.5588/ijtld.11.0121; Chang TJ, 2012, J FORMOS MED ASSOC, V111, P605, DOI 10.1016/j.jfma.2012.09.011; Crofts JP, 2010, THORAX, V65, P310, DOI 10.1136/thx.2009.124677; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Lo HY, 2015, ASIA-PAC J PUBLIC HE, V27, pNP758, DOI 10.1177/1010539511429591; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sacks DB, 2011, DIABETES CARE, V34, P1419, DOI 10.2337/dc11-9997; Selassie AW, 2005, ANN EPIDEMIOL, V15, P519, DOI 10.1016/j.annepidem.2005.03.002; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stalenhoef JE, 2008, EUR J CLIN MICROBIOL, V27, P97, DOI 10.1007/s10096-007-0395-0; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Taiwan Bureau of National Health Insurance, 2012, NAT HLTH INS TAIW 20; Taiwan Centers for Disease Control, 2006, TREATM GUID TUB; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2009, TREATM TUB GUID NAT; World Health Organization International Union against Tuberculosis and Lung Disease, 2011, COLL FRAM CAR CONTR; Yamashiro S, 2005, CLIN EXP IMMUNOL, V139, P57, DOI 10.1111/j.1365-2249.2005.02677.x; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644	39	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92623	10.1371/journal.pone.0092623	http://dx.doi.org/10.1371/journal.pone.0092623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663327	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900086
J	Michaud, A; Lacroix-Pepin, N; Pelletier, M; Veilleux, A; Noel, S; Bouchard, C; Marceau, P; Fortier, MA; Tchernof, A				Michaud, Andreanne; Lacroix-Pepin, Nicolas; Pelletier, Melissa; Veilleux, Alain; Noel, Suzanne; Bouchard, Celine; Marceau, Picard; Fortier, Michel A.; Tchernof, Andre			Prostaglandin (PG) F2 Alpha Synthesis in Human Subcutaneous and Omental Adipose Tissue: Modulation by Inflammatory Cytokines and Role of the Human Aldose Reductase AKR1B1	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; 3T3-L1 CELLS; F-2 ALPHA; 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE; PREADIPOCYTE DIFFERENTIATION; BOVINE ENDOMETRIUM; PRIMARY CULTURE; DOWN-REGULATION; FAT-CELLS; SYNTHASE	Introduction: PGF(2 alpha) may be involved in the regulation of adipose tissue function. Objectives: 1) To examine PGF(2 alpha) release by primary preadipocytes, mature adipocytes and whole tissue explants from the subcutaneous and omental fat compartments; 2) To assess which PGF synthase is the most relevant in human adipose tissue. Methods: Fat samples were obtained by surgery in women. PGF(2 alpha) release by preadipocytes, adipocytes and explants under stimulation by TNF-alpha, IL-1 beta or both was measured. Messenger RNA expression levels of AKR1B1 and AKR1C3 were measured by RT-PCR in whole adipose tissue and cytokine-treated preadipocytes. The effect of AKR1B1 inhibitor ponalrestat on PGF(2 alpha) synthesis was investigated. Results: PGF(2 alpha) release was significantly induced in response to cytokines compared to control in omental (p = 0.01) and to a lesser extent in subcutaneous preadipocytes (p = 0.02). Messenger RNA of COX-2 was significantly higher in omental compared to subcutaneous preadipocytes in response to combined TNF-alpha and IL-1 beta (p = 0.01). Inflammatory cytokines increased AKR1B1 mRNA expression and protein levels (p <= 0.05), but failed to increase expression levels of AKR1C3 in cultured preadipocytes. Accordingly, ponalrestat blunted PGF(2 alpha) synthesis by preadipocytes in basal and stimulated conditions (p <= 0.05). Women with the highest PGF(2 alpha) release by omental adipocytes had a higher BMI (p = 0.05), waist circumference (p <= 0.05) and HOMAir index (p <= 0.005) as well as higher mRNA expression of AKR1B1 in omental (p < 0.10) and subcutaneous (p <= 0.05) adipose tissue compared to women with low omental adipocytes PGF(2 alpha) release. Positive correlations were observed between mRNA expression of AKR1B1 in both compartments and BMI, waist circumference as well as HOMAir index (p <= 0.05 for all). Conclusion: PGF(2 alpha) release by omental mature adipocytes is increased in abdominally obese women. Moreover, COX-2 expression and PGF(2 alpha) release is particularly responsive to inflammatory stimulation in omental preadipocytes. Yet, blockade of PGF synthase AKR1B1 inhibits most of the PGF(2 alpha) release.	[Michaud, Andreanne; Lacroix-Pepin, Nicolas; Pelletier, Melissa; Fortier, Michel A.; Tchernof, Andre] Univ Laval, Med Ctr, Quebec City, PQ, Canada; [Michaud, Andreanne; Veilleux, Alain; Tchernof, Andre] Univ Laval, Dept Nutr, Quebec City, PQ, Canada; [Noel, Suzanne; Bouchard, Celine] Univ Laval, Med Ctr, Gynecol Unit, Quebec City, PQ, Canada; [Marceau, Picard] Quebec Cardiol & Pulmonol Inst, Dept Surg, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Tchernof, A (corresponding author), Univ Laval, Med Ctr, Quebec City, PQ, Canada.	andre.tchernof@crchul.ulaval.ca	Veilleux, Alain/I-5028-2019	Veilleux, Alain/0000-0003-4078-1908; Bouchard, Celine/0000-0003-2258-058X; Michaud, Andreanne/0000-0003-2028-8307; Tchernof, Andre/0000-0002-2587-1000	Canadian Institutes of Health Research [MOP-64182]; Fonds de recherche du Quebec - Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	This study was supported by grant MOP-64182 (A. Tchernof) from the Canadian Institutes of Health Research. Andreanne Michaud was funded by Fonds de recherche du Quebec - Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprikian O, 2007, AM J PHYSIOL-REG I, V293, pR2006, DOI 10.1152/ajpregu.00382.2007; Asselin E, 1996, BIOL REPROD, V54, P371, DOI 10.1095/biolreprod54.2.371; AXELROD L, 1986, DIABETES, V35, P1004, DOI 10.2337/diabetes.35.9.1004; AXELROD L, 1983, PROSTAG OTH LIPID M, V25, P571, DOI 10.1016/0090-6980(83)90029-1; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Blouin K, 2003, J CLIN ENDOCR METAB, V88, P5944, DOI 10.1210/jc.2003-030535; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Borglum JD, 1999, PROSTAG OTH LIPID M, V57, P305, DOI 10.1016/S0090-6980(98)00082-3; Bresson E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00098; Bresson E, 2011, J CLIN ENDOCR METAB, V96, P210, DOI 10.1210/jc.2010-1589; Casimir DA, 1996, DIFFERENTIATION, V60, P203, DOI 10.1046/j.1432-0436.1996.6040203.x; Chapdelaine P, 2006, MOL HUM REPROD, V12, P309, DOI 10.1093/molehr/gal034; CHATZIPANTELI K, 1992, DIABETES, V41, P927, DOI 10.2337/diabetes.41.8.927; Chou WL, 2007, J BIOL CHEM, V282, P18162, DOI 10.1074/jbc.M702289200; CURTISPRIOR PB, 1979, EXPERIENTIA, V35, P911, DOI 10.1007/BF01955144; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dufort I, 1999, ENDOCRINOLOGY, V140, P568, DOI 10.1210/en.140.2.568; Fain JN, 2002, PROSTAG LEUKOTR ESS, V67, P467, DOI 10.1054/plef.2002.0430; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fain JN, 2008, METABOLISM, V57, P1005, DOI 10.1016/j.metabol.2008.02.019; Farb MG, 2013, OBESITY, V10; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Fujimori K, 2010, J BIOL CHEM, V285, P8880, DOI 10.1074/jbc.M109.077164; Hayaishi O, 1988, Prog Clin Biol Res, V274, P577; Hetu PO, 2007, OBESITY, V15, P60, DOI 10.1038/oby.2007.514; Kabututu Z, 2009, J BIOCHEM, V145, P161, DOI 10.1093/jb/mvn152; Liu L, 2007, J CELL BIOCHEM, V100, P161, DOI 10.1002/jcb.21044; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Madan AK, 2006, OBES SURG, V16, P1342, DOI 10.1381/096089206778663652; Madore E, 2003, J BIOL CHEM, V278, P11205, DOI 10.1074/jbc.M208318200; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867; Michaud A, 2012, METABOLISM, V61, P689, DOI 10.1016/j.metabol.2011.10.004; Miller CW, 1996, ENDOCRINOLOGY, V137, P5641, DOI 10.1210/en.137.12.5641; Nagata N, 2011, FEBS J, V278, P1288, DOI 10.1111/j.1742-4658.2011.08049.x; Nishimura K, 2006, BIOSCI BIOTECH BIOCH, V70, P2145, DOI 10.1271/bbb.60106; RICHELSEN B, 1987, BIOCHEM J, V247, P389, DOI 10.1042/bj2470389; RODBELL M, 1964, J BIOL CHEM, V239, P375; Serrero G, 1997, BIOCHEM BIOPH RES CO, V233, P200, DOI 10.1006/bbrc.1997.6433; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; SOCHOR M, 1988, BIOCHEM PHARMACOL, V37, P3349, DOI 10.1016/0006-2952(88)90649-1; Tsuboi H, 2004, BIOCHEM BIOPH RES CO, V322, P1066, DOI 10.1016/j.bbrc.2004.08.018; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; VASSAUX G, 1992, ENDOCRINOLOGY, V131, P2393, DOI 10.1210/en.131.5.2393; WATANABE K, 1985, J BIOL CHEM, V260, P7035; Watanabe K, 2002, PROSTAG OTH LIPID M, V68-9, P401, DOI 10.1016/S0090-6980(02)00044-8; Watanabe K, 2011, J BIOCHEM, V150, P593, DOI 10.1093/jb/mvr116; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Zhang Y, 2000, J MOL ENDOCRINOL, V25, P221, DOI 10.1677/jme.0.0250221	54	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90861	10.1371/journal.pone.0090861	http://dx.doi.org/10.1371/journal.pone.0090861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663124	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900011
J	Muller, M; Demeret, C				Muller, Mandy; Demeret, Caroline			CCHCR1 Interacts Specifically with the E2 Protein of Human Papillomavirus Type 16 on a Surface Overlapping BRD4 Binding	PLOS ONE			English	Article							TRANSACTIVATION DOMAIN; HUMAN KERATINOCYTES; CERVICAL-CANCER; CANDIDATE GENE; PSORS1 LOCUS; EXPRESSION; HCR; PSORIASIS; COMPLEX; CELLS	The Human Papillomavirus E2 proteins are key regulators of the viral life cycle, whose functions are commonly mediated through protein-protein interactions with the host cell proteome. We identified an interaction between E2 and a cellular protein called CCHCR1, which proved highly specific for the HPV16 genotype, the most prevalent in HPV-associated cancers. Further characterization of the interaction revealed that CCHCR1 binds the N-terminal alpha helices of HPV16 E2 N-terminal domain. On this domain, the CCHCR1 binding interface overlaps that of BRD4, a key mediator of E2 transcriptional activity. Consequently a physical competition occurs between the two proteins for the binding to HPV16 E2, and CCHCR1 interferes with BRD4-mediated enhancement of E2-dependent transcription. In addition, we showed that the interaction with CCHCR1 induced a massive redistribution of HPV16 E2, from a predominantly nuclear to a cytoplasmic localization in dot-like structures, where E2 perfectly co-localizes with CCHCR1. Such a cytoplasmic docking likely interferes with the nuclear functions of HPV16 E2. Upon co-expression of BRD4 and CCHCR1, E2 accumulates both in the nucleus and in the cytoplasm, indicating that for HPV16, both sub-cellular localization and transcriptional functions of E2 may depend on the proportion of both factors within the cell. We provided evidence of a strong induction of the keratinocyte differentiation marker K10 by HPV16 E2, and showed that this activation is compromised by the interaction with CCHCR1. The specific interaction described here could thus impact on the pathogenesis of HPV16. We propose that it could underlie some specific traits of HPV16 infection, such as an enhanced propensity to give rise to lesions evolving toward cancer.	[Muller, Mandy; Demeret, Caroline] Inst Pasteur, Unite Genet Papillomavirus & Canc Humain, Paris, France; [Muller, Mandy] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Demeret, C (corresponding author), Inst Pasteur, Unite Genet Mol Virus ARN, Paris, France.	caroline.demeret@pasteur.fr	Muller, Mandy/AAD-1126-2019	Muller, Mandy/0000-0002-0056-3589; Demeret, caroline/0000-0002-1103-6805	Institut Pasteur; M.E.N.R.T fellowship	Institut Pasteur(European Commission); M.E.N.R.T fellowship	This work was supported by funding from the Institut Pasteur. M. M. is a recipient of a M.E.N.R.T fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Antson AA, 2000, NATURE, V403, P805, DOI 10.1038/35001638; Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Asumalahti K, 2000, HUM MOL GENET, V9, P1533, DOI 10.1093/hmg/9.10.1533; Bellanger S, 2001, J VIROL, V75, P7244, DOI 10.1128/JVI.75.16.7244-7251.2001; Blachon S, 2005, J BIOL CHEM, V280, P36088, DOI 10.1074/jbc.M505138200; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Burns JE, 2010, VIROLOGY, V401, P314, DOI 10.1016/j.virol.2010.03.002; Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773; Corbi N, 2005, J CELL SCI, V118, P4253, DOI 10.1242/jcs.02545; D'Abramo C M, 2011, Open Virol J, V5, P80, DOI 10.2174/1874357901105010080; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Helfer CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077994; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Muller Mandy, 2012, Open Virol J, V6, P173, DOI 10.2174/1874357901206010173; Muller M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002761; Olejnik-Schmidt AK, 2008, ARCH VIROL, V153, P983, DOI 10.1007/s00705-008-0061-6; Pacholska-Bogalska J, 2012, INT J MOL MED, V29, P669, DOI 10.3892/ijmm.2012.877; Santin AD, 2005, VIROLOGY, V331, P269, DOI 10.1016/j.virol.2004.09.045; Schweiger MR, 2006, J VIROL, V80, P4276, DOI 10.1128/JVI.80.9.4276-4285.2006; Suomela S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006030; Tervaniemi MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049920; Tiala I, 2008, HUM MOL GENET, V17, P1043, DOI 10.1093/hmg/ddm377; Tiala I, 2007, J MOL MED, V85, P589, DOI 10.1007/s00109-006-0155-0; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wang Y, 2004, J BIOL CHEM, V279, P6976, DOI 10.1074/jbc.M311376200; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	30	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92581	10.1371/journal.pone.0092581	http://dx.doi.org/10.1371/journal.pone.0092581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664238	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900079
J	Li, JB; Jia, WS; Zhao, QS				Li, Junbo; Jia, Wenshuang; Zhao, Qingshun			Excessive Nitrite Affects Zebrafish Valvulogenesis through Yielding Too Much NO Signaling	PLOS ONE			English	Article							CARDIAC-VALVE FORMATION; OXIDE; HEART; EXPRESSION; PATHWAY; NITRATE	Sodium nitrite, a common food additive, exists widely not only in the environment but also in our body. Excessive nitrite causes toxicological effects on human health; however, whether it affects vertebrate heart valve development remains unknown. In vertebrates, developmental defects of cardiac valves usually lead to congenital heart disease. To understand the toxic effects of nitrite on valvulogenesis, we exposed zebrafish embryos with different concentrations of sodium nitrite. Our results showed that sodium nitrite caused developmental defects of zebrafish heart dose dependently. It affected zebrafish heart development starting from 36 hpf (hour post fertilization) when heart initiates looping process. Comprehensive analysis on the embryos at 24 hpf and 48 hpf showed that excessive nitrite did not affect blood circulation, vascular network, myocardium and endocardium development. But development of endocardial cells in atrioventricular canal (AVC) of the embryos at 48 hpf was disrupted by too much nitrite, leading to defective formation of primitive valve leaflets at 76 hpf. Consistently, excessive nitrite diminished expressions of valve progenitor markers including bmp4, has2, vcana and notch1b at 48 hpf. Furthermore, 39', 59'-cyclic guanosine monophosphate (cGMP), downstream of nitric oxide (NO) signaling, was increased its level significantly in the embryos exposed with excessive nitrite and microinjection of soluble guanylate cyclase inhibitor ODQ (1H-[1,2,4]Oxadiazolo[4,3-a] quinoxalin-1-one), an antagonist of NO signaling, into nitrite-exposed embryos could partly rescue the cardiac valve malformation. Taken together, our results show that excessive nitrite affects early valve leaflet formation by producing too much NO signaling.	[Li, Junbo; Jia, Wenshuang; Zhao, Qingshun] Nanjing Univ, Model Anim Res Ctr, Key Lab Model Anim Dis Study, Minist Educ, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Zhao, QS (corresponding author), Nanjing Univ, Model Anim Res Ctr, Key Lab Model Anim Dis Study, Minist Educ, Nanjing 210008, Jiangsu, Peoples R China.	qingshun@nju.edu.cn			Ministry of Science and Technology of China [2011CB943804]; National Natural Science Foundation of China [31271569]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China [2011CB943804] and the National Natural Science Foundation of China [31271569]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataya B, 2011, TRENDS CARDIOVAS MED, V21, P157, DOI 10.1016/j.tcm.2012.05.002; Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Balashova N, 2005, J BIOL CHEM, V280, P2186, DOI 10.1074/jbc.M411545200; Banjo T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2978; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; BRUNNER F, 1995, FEBS LETT, V376, P262, DOI 10.1016/0014-5793(95)01297-X; Bryan NS, 2008, FREE RADICAL BIO MED, V45, P468, DOI 10.1016/j.freeradbiomed.2008.04.040; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Bryan NS, 2011, NUTR HEALTH SER, P1, DOI 10.1007/978-1-60761-616-0; Chang ACY, 2011, DEV CELL, V21, P288, DOI 10.1016/j.devcel.2011.06.022; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.689; Fashena D, 1999, J COMP NEUROL, V406, P415, DOI 10.1002/(SICI)1096-9861(19990412)406:3<415::AID-CNE9>3.0.CO;2-2; Feng QP, 2002, CIRCULATION, V106, P873, DOI 10.1161/01.CIR.0000024114.82981.EA; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Gracia R, 2004, PHARMACOTHERAPY, V24, P1358, DOI 10.1592/phco.24.14.1358.43149; HADDAD EK, 1995, J EXP MED, V182, P1143, DOI 10.1084/jem.182.4.1143; Hunter L, 2011, BRIT J CLIN PHARMACO, V72, P18, DOI 10.1111/j.1365-2125.2011.03950.x; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC MONOGR EVAL CAR, V94, p[v, 1]; Jensen FB, 2003, COMP BIOCHEM PHYS A, V135, P9, DOI 10.1016/S1095-6433(02)00323-9; Jensen FB, 2007, J EXP BIOL, V210, P3387, DOI 10.1242/jeb.008748; Lagendijk AK, 2011, CIRC RES, V109, P649, DOI 10.1161/CIRCRESAHA.111.247635; Liang D, 2008, GENE EXPR PATTERNS, V8, P248, DOI 10.1016/j.gep.2007.12.007; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Madigan M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00174; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; McKnight GM, 1999, BRIT J NUTR, V81, P349, DOI 10.1017/S000711459900063X; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; Rastaldo R, 2007, LIFE SCI, V81, P779, DOI 10.1016/j.lfs.2007.07.019; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; Scherz PJ, 2008, DEVELOPMENT, V135, P1179, DOI 10.1242/dev.010694; Simmons AE, 2012, ZEBRAFISH, V9, P200, DOI 10.1089/zeb.2012.0746; Staudt D, 2012, ANNU REV GENET, V46, P397, DOI 10.1146/annurev-genet-110711-155646; U.S. EPA, 1991, FED REGISTER, V56, P3526; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; YUTZEY KE, 1994, DEVELOPMENT, V120, P871	42	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92728	10.1371/journal.pone.0092728	http://dx.doi.org/10.1371/journal.pone.0092728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658539	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300123
J	Perrineau, MM; Gross, J; Zelzion, E; Price, DC; Levitan, O; Boyd, J; Bhattacharya, D				Perrineau, Marie-Mathilde; Gross, Jeferson; Zelzion, Ehud; Price, Dana C.; Levitan, Orly; Boyd, Jeffrey; Bhattacharya, Debashish			Using Natural Selection to Explore the Adaptive Potential of Chlamydomonas reinhardtii	PLOS ONE			English	Article							ELECTRON-TRANSPORT; ESCHERICHIA-COLI; CIRCADIAN CLOCK; MUTATION-RATE; EXPRESSION; MECHANISM; EVOLUTION; REVEALS; REPAIR; ALGAE	Improving feedstock is critical to facilitate the commercial utilization of algae, in particular in open pond systems where, due to the presence of competitors and pests, high algal growth rates and stress tolerance are beneficial. Here we raised laboratory cultures of the model alga Chlamydomonas reinhardtii under serial dilution to explore the potential of crop improvement using natural selection. The alga was evolved for 1,880 generations in liquid medium under continuous light (EL population). At the end of the experiment, EL cells had a growth rate that was 35% greater than the progenitor population (PL). The removal of acetate from the medium demonstrated that EL growth enhancement largely relied on efficient usage of this organic carbon source. Genome re-sequencing uncovered 1,937 polymorphic DNA regions in the EL population with 149 single nucleotide polymorphisms resulting in amino acid substitutions. Transcriptome analysis showed, in the EL population, significant up regulation of genes involved in protein synthesis, the cell cycle and cellular respiration, whereas the DNA repair pathway and photosynthesis were down regulated. Like other algae, EL cells accumulated neutral lipids under nitrogen depletion. Our work demonstrates transcriptome and genome-wide impacts of natural selection on algal cells and points to a useful strategy for strain improvement.	[Perrineau, Marie-Mathilde; Gross, Jeferson; Zelzion, Ehud; Price, Dana C.; Bhattacharya, Debashish] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA; [Levitan, Orly; Bhattacharya, Debashish] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Boyd, Jeffrey] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Bhattacharya, D (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA.	bhattacharya@aesop.rutgers.edu	Perrineau, Marie-Mathilde/J-4459-2014	Perrineau, Marie-Mathilde/0000-0002-1772-7009; Boyd, Jeffrey/0000-0001-7721-3926; Levitan, Orly/0000-0001-5248-8501	Department of Energy [DE-EE0003373/001]; Rutgers University	Department of Energy(United States Department of Energy (DOE)); Rutgers University	This work was supported by a grant from the Department of Energy (DE-EE0003373/001) and by financial support from Rutgers University for the SEBS Genome Cooperative (http://dblab.rutgers.edu/genome_cooperative/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen SL, 2010, BIOESSAYS, V32, P1058, DOI 10.1002/bies.201000087; [Anonymous], 2007, PRINCIPLES PLANT GEN; Bailis JM, 2008, MOL CELL BIOL, V28, P1724, DOI 10.1128/MCB.01717-07; Bec B, 2008, LIMNOL OCEANOGR, V53, P863, DOI 10.4319/lo.2008.53.2.0863; Bell G, 2013, EVOLUTION, V67, P468, DOI 10.1111/j.1558-5646.2012.01782.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; Brueggeman AJ, 2012, PLANT CELL, V24, P1860, DOI 10.1105/tpc.111.093435; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Collins S, 2004, NATURE, V431, P566, DOI 10.1038/nature02945; Collins S, 2011, EVOL BIOL, V38, P3, DOI 10.1007/s11692-010-9106-3; Demirbas A, 2011, ENERG CONVERS MANAGE, V52, P163, DOI 10.1016/j.enconman.2010.06.055; Dittami SM, 2012, PLANT J, V71, P366, DOI 10.1111/j.1365-313X.2012.04982.x; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Fang W, 2012, PLANT CELL, V24, P1876, DOI 10.1105/tpc.112.097949; FETT JP, 1994, PLANT PHYSIOL, V106, P103, DOI 10.1104/pp.106.1.103; Gokhale A, 2009, J CELL BIOL, V186, P817, DOI 10.1083/jcb.200906168; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Govender T, 2012, BIORESOURCE TECHNOL, V114, P507, DOI 10.1016/j.biortech.2012.03.024; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Gu Zhenglong, 2009, Genome Biol, V10, P304, DOI 10.1186/gb-2009-10-3-304; Hannon M, 2010, BIOFUELS-UK, V1, P763, DOI 10.4155/BFS.10.44; Harris JM, 2013, WORKING PAPER; Heifetz PB, 2000, PLANT PHYSIOL, V122, P1439, DOI 10.1104/pp.122.4.1439; Huesemann MH, 2009, APPL BIOCHEM BIOTECH, V157, P507, DOI 10.1007/s12010-008-8298-9; Jeong BR, 2002, P NATL ACAD SCI USA, V99, P1076, DOI 10.1073/pnas.022392999; Johnson X, 2013, EUKARYOT CELL, V12, P776, DOI 10.1128/EC.00318-12; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Lee K., 2001, BIOTECHNOL BIOPROC E, V6, P194, DOI [DOI 10.1007/BF02932550, 10.1007/BF02932550]; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Liang DT, 1999, J CELL SCI, V112, P559; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohbeck KT, 2013, EVOLUTION, V67, P1892, DOI 10.1111/j.1558-5646.2012.01812.x; Luck M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.401604; Maki K, 2011, J BIOL CHEM, V286, P41701, DOI 10.1074/jbc.M111.285619; Maranon E, 2013, ECOL LETT, V16, P371, DOI 10.1111/ele.12052; Matsuo M, 1998, PLANT CELL PHYSIOL, V39, P263, DOI 10.1093/oxfordjournals.pcp.a029366; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Mittag M, 2005, PLANT PHYSIOL, V137, P399, DOI 10.1104/pp.104.052415; Ness RW, 2012, GENETICS, V192, P1447, DOI 10.1534/genetics.112.145078; Nishihama R, 2013, CURR OPIN PLANT BIOL, V16, P630, DOI 10.1016/j.pbi.2013.07.006; Niwa Y, 2013, P NATL ACAD SCI USA, V110, P13666, DOI 10.1073/pnas.1220004110; Page MD, 2012, PLANT CELL, V24, P2649, DOI 10.1105/tpc.112.098962; Reisdorph NA, 2004, PLANT PHYSIOL, V134, P1546, DOI 10.1104/pp.103.031930; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Russell GE, 1978, PLANT BREEDING PEST; Santosa V, 2013, J BIOL CHEM, V288, P6864, DOI 10.1074/jbc.M112.432393; Sheehan J., 1998, TP58024190 NREL; Snow AA, 2012, BIOSCIENCE, V62, P765, DOI 10.1525/bio.2012.62.8.9; Sung W, 2012, P NATL ACAD SCI USA, V109, P18488, DOI 10.1073/pnas.1216223109; Vlcek D, 2008, CURR GENET, V53, P1, DOI 10.1007/s00294-007-0163-9; Zhila NO, 2005, RUSS J PLANT PHYSL+, V52, P311, DOI 10.1007/s11183-005-0047-0	55	29	29	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92533	10.1371/journal.pone.0092533	http://dx.doi.org/10.1371/journal.pone.0092533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658261	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300094
J	Zeytuni, N; Uebe, R; Maes, M; Davidov, G; Baram, M; Raschdorf, O; Nadav-Tsubery, M; Kolusheva, S; Bitton, R; Goobes, G; Friedler, A; Miller, Y; Schuler, D; Zarivach, R				Zeytuni, Natalie; Uebe, Rene; Maes, Michal; Davidov, Geula; Baram, Michal; Raschdorf, Oliver; Nadav-Tsubery, Merav; Kolusheva, Sofiya; Bitton, Ronit; Goobes, Gil; Friedler, Assaf; Miller, Yifat; Schueler, Dirk; Zarivach, Raz			Cation Diffusion Facilitators Transport Initiation and Regulation Is Mediated by Cation Induced Conformational Changes of the Cytoplasmic Domain	PLOS ONE			English	Article							PARTICLE MESH EWALD; MAGNETOSPIRILLUM-GRYPHISWALDENSE; MAGNETOSOME FORMATION; PROTEIN; FAMILY; MEMBRANE; BINDING; HYPERMANGANESEMIA; POLYCYTHEMIA; HOMEOSTASIS	Cation diffusion facilitators (CDF) are part of a highly conserved protein family that maintains cellular divalent cation homeostasis in all domains of life. CDF's were shown to be involved in several human diseases, such as Type-II diabetes and neurodegenerative diseases. In this work, we employed a multi-disciplinary approach to study the activation mechanism of the CDF protein family. For this we used MamM, one of the main ion transporters of magnetosomes - bacterial organelles that enable magnetotactic bacteria to orientate along geomagnetic fields. Our results reveal that the cytosolic domain of MamM forms a stable dimer that undergoes distinct conformational changes upon divalent cation binding. MamM conformational change is associated with three metal binding sites that were identified and characterized. Altogether, our results provide a novel auto-regulation mode of action model in which the cytosolic domain's conformational changes upon ligand binding allows the priming of the CDF into its transport mode.	[Zeytuni, Natalie; Davidov, Geula; Zarivach, Raz] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Zeytuni, Natalie; Davidov, Geula; Zarivach, Raz] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Uebe, Rene; Raschdorf, Oliver; Schueler, Dirk] Univ Munich, Dept Biol 1, Martinsried, Germany; [Maes, Michal; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Baram, Michal] Ben Gurion Univ Negev, Dept Chem, Beer Sheva, Israel; [Baram, Michal; Kolusheva, Sofiya; Bitton, Ronit; Miller, Yifat] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel; [Nadav-Tsubery, Merav; Goobes, Gil] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel; [Bitton, Ronit; Miller, Yifat] Ben Gurion Univ Negev, Dept Chem Engn, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; University of Munich; Hebrew University of Jerusalem; Ben Gurion University; Ben Gurion University; Bar Ilan University; Ben Gurion University	Zarivach, R (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	zarivach@bgu.ac.il	Zeytuni, Natalie/AAP-7850-2021; ZARIVACH, RAZ/F-1671-2012	ZARIVACH, RAZ/0000-0001-6543-0296; Raschdorf, Oliver/0000-0003-1558-059X; Kolusheva, Sofiya/0000-0002-4406-2241; Davidov, Geula/0000-0001-5153-4940; Zeytuni, Natalie/0000-0002-5708-4095; Bitton, Ronit/0000-0001-9601-9926; Schuler, Dirk/0000-0002-2327-0762; Maes, Michal/0000-0002-7406-3982	GIF (German-Israeli Foundation for Scientific Research and Development); European Cooperation in Science and Technology (COST action) [CM0902]; Israeli Ministry of Science and Technology; Deutsche Forschungsgemeinschaft [SCHU 1080/13-1]; European Union [NMP4-SL-2010-245542-Bio2MaN4MRI]; European Research Council under the European Community/ERC [203413]; FP7-PEOPLE-2011-CIG [303741]	GIF (German-Israeli Foundation for Scientific Research and Development)(German-Israeli Foundation for Scientific Research and Development); European Cooperation in Science and Technology (COST action)(European Cooperation in Science and Technology (COST)); Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); European Research Council under the European Community/ERC(European Research Council (ERC)); FP7-PEOPLE-2011-CIG	This research was supported by grants from the GIF (German-Israeli Foundation for Scientific Research and Development), the European Cooperation in Science and Technology (COST action CM0902), the Israeli Ministry of Science and Technology, the Deutsche Forschungsgemeinschaft (grant SCHU 1080/13-1) and the FP7 of the European Union (collaborative grant NMP4-SL-2010-245542-Bio2MaN4MRI). AF is supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 203413. YM is supported by the FP7-PEOPLE-2011-CIG, research grant no. 303741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Anton A, 1999, J BACTERIOL, V181, P6876, DOI 10.1128/JB.181.22.6876-6881.1999; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barraud P, 2012, J BIOMOL NMR, V53, P93, DOI 10.1007/s10858-012-9625-6; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Coudray N, 2013, P NATL ACAD SCI US; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Etzion Y, 2008, J CARDIOVASC ELECTR, V19, P157, DOI 10.1111/j.1540-8167.2007.01008.x; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Fu RQ, 2004, J MAGN RESON, V168, P8, DOI 10.1016/j.jmr.2004.01.012; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guinier A, 1955, J POLYM SCI, V1, P268; Haney CJ, 2005, J IND MICROBIOL BIOT, V32, P215, DOI 10.1007/s10295-005-0224-3; Higuchi T, 2009, PROTEINS, V76, P768, DOI 10.1002/prot.22444; Jiang F, 2012, BIOMED ENVIRON SCI, V25, P23, DOI 10.3967/0895-3988.2012.01.004; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Katzmann E, 2010, MOL MICROBIOL, V77, P208, DOI 10.1111/j.1365-2958.2010.07202.x; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Mahoney MW, 2001, J CHEM PHYS, V115, P10758, DOI 10.1063/1.1418243; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Munkelt D, 2004, J BACTERIOL, V186, P8036, DOI 10.1128/JB.186.23.8036-8043.2004; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Patel AB, 2005, J MOL BIOL, V347, P803, DOI 10.1016/j.jmb.2005.01.069; Patrushev N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033211; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Persans MW, 2001, P NATL ACAD SCI USA, V98, P9995, DOI 10.1073/pnas.171039798; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Schuler D, 2004, ARCH MICROBIOL, V181, P1, DOI 10.1007/s00203-003-0631-7; SCHULER D, 1995, FEMS MICROBIOL LETT, V132, P139, DOI 10.1016/0378-1097(95)00300-T; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Uebe R, 2011, MOL MICROBIOL, V82, P818, DOI 10.1111/j.1365-2958.2011.07863.x; Uebe R, 2010, J BACTERIOL, V192, P4192, DOI 10.1128/JB.00319-10; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Zeytuni N, 2012, ACTA CRYSTALLOGR F, V68, P927, DOI 10.1107/S1744309112025638; Zeytuni N, 2011, P NATL ACAD SCI USA, V108, pE480, DOI 10.1073/pnas.1103367108	53	33	35	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92141	10.1371/journal.pone.0092141	http://dx.doi.org/10.1371/journal.pone.0092141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658343	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300057
J	Dessein, PH; Tsang, L; Norton, GR; Woodiwiss, AJ; Solomon, A				Dessein, Patrick H.; Tsang, Linda; Norton, Gavin R.; Woodiwiss, Angela J.; Solomon, Ahmed			Retinol Binding Protein 4 Concentrations Relate to Enhanced Atherosclerosis in Obese Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; ENDOTHELIAL ACTIVATION; METABOLIC-SYNDROME; CAUCASIAN WOMEN; AFRICAN BLACK; RETINOL-BINDING-PROTEIN-4; DISEASE; CLASSIFICATION; ADIPONECTIN	Background: Retinol binding protein 4 (RBP) enhances metabolic risk and atherogenesis. Whether RBP4 contributes to cardiovascular risk in rheumatoid arthritis (RA) is unknown. Methods: We assessed RBP4 concentrations and those of endothelial activation molecules including E-selectin, vascular cell adhesion molecule-1, intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 by ELISA, and the common carotid artery intima-media thickness (cIMT) and carotid artery plaque by ultrasound in 217 (112 black and 105 white) patients with RA. Relationships were identified in potential confounder and mediator adjusted mixed regression models. Results: RBP4 concentrations were associated with systolic and mean blood pressure, and those of glucose and E-selectin (partial R = -0.207 (p = 0.003), -0.195 (p = 0.006), -0.155 (p = 0.03) and -0.191 (p = 0.007), respectively in all patients); these RBP4-cardiovascular risk relations were mostly reproduced in patients with but not without adverse traditional or non-traditional cardiovascular risk profiles. RBP4 concentrations were not associated with atherosclerosis in all patients, but related independently to cIMT (partial R = 0.297, p = 0.03) and plaque (OR (95% CI) = 2.95 (1.31-6.68), p = 0.008) in those with generalized obesity, as well as with plaque in those with abdominal obesity (OR (95% CI) = 1.95 (1.12-3.42), p = 0.01). Conclusion: In the present study, RBP4 concentrations were inversely associated with metabolic risk and endothelial activation in RA. This requires further investigation. RBP4 concentrations were related to enhanced atherosclerosis in patients with generalized or/and abdominal obesity.	[Dessein, Patrick H.; Norton, Gavin R.; Woodiwiss, Angela J.] Univ Witwatersrand, Sch Physiol, Fac Hlth Sci, Cardiovasc Pathophysiol & Genom Res Unit, Johannesburg, South Africa; [Tsang, Linda] Milpk Hosp, Johannesburg, South Africa; [Solomon, Ahmed] Univ Witwatersrand, Charlotte Maxeke Johannesburg Acad Hosp, Fac Hlth Sci, Dept Rheumatol, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand	Dessein, PH (corresponding author), Univ Witwatersrand, Sch Physiol, Fac Hlth Sci, Cardiovasc Pathophysiol & Genom Res Unit, Johannesburg, South Africa.	Dessein@telkomsa.net	Dessein, Patrick/AAL-2986-2020	Norton, Gavin/0000-0001-6416-6104	South African Medical Research Council [MRC2008_DES]; National Research Foundation	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation	The study was supported by the South African Medical Research Council, grant number MRC2008_DES, and the National Research Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manauscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Balagopal P, 2007, J CLIN ENDOCR METAB, V92, P1971, DOI 10.1210/jc.2006-2712; Bobbert T, 2010, ATHEROSCLEROSIS, V213, P549, DOI 10.1016/j.atherosclerosis.2010.07.063; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; Corrales A, 2013, ANN RHEUM DIS, DOI [10.1136/annrheumdis-2012-203101, DOI 10.1136/ANNRHEUMDIS-2012-203101]]; Craig RL, 2007, MOL GENET METAB, V90, P338, DOI 10.1016/j.ymgme.2006.11.003; Crowson CS, 2011, ANN RHEUM DIS, V70, P719, DOI 10.1136/ard.2010.145482; Dessein PH, 2013, CLIN EXP RHEUMATOL, V31, P53; Dessein Patrick H, 2007, BMC Cardiovasc Disord, V7, P31, DOI 10.1186/1471-2261-7-31; Dessein PH, 2005, J RHEUMATOL, V32, P435; Dessein PH, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4308; Dessein PH, 2013, ANN RHEUM DIS, V72, P1743, DOI 10.1136/annrheumdis-2013-203911; Dessein PH, 2013, ANN RHEUM DIS, V72, P1586, DOI 10.1136/annrheumdis-2013-203587; Dessein PH, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/461849; Dessein PH, 2009, J RHEUMATOL, V36, P1357, DOI 10.3899/jrheum.090288; Dessein PH, 2006, J RHEUMATOL, V33, P201; Dessein PH, 2004, ANN RHEUM DIS, V63, P170, DOI 10.1089/105072504323150750; Dessein PH, 2005, ARTHRITIS RES THER, V7, pR634, DOI 10.1186/ar1717; Dessein PH, 2014, RHEUMATOL I IN PRESS; Dessein PH, 2014, ARTHRITIS R IN PRESS; Dessein PH, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/510243; Farjo KM, 2012, MOL CELL BIOL, V32, P5103, DOI 10.1128/MCB.00820-12; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Frommer KW, 2010, ARTHRITIS RHEUM-US, V62, P2886, DOI 10.1002/art.27616; Gabriel SE, 2012, CURR OPIN RHEUMATOL, V24, P171, DOI 10.1097/BOR.0b013e32834ff2fd; Garcia-Bermudez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077695; Genre F, 2014, ANN RHEUM DIS, V73, P941, DOI 10.1136/annrheumdis-2013-204484; Gepner AD, 2006, J AM SOC ECHOCARDIOG, V19, P223, DOI 10.1016/j.echo.2005.09.006; Graham TE, 2007, DIABETOLOGIA, V50, P814, DOI 10.1007/s00125-006-0557-0; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gulfe A, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-41; Hahn BH, 2010, LUPUS, V19, P913, DOI 10.1177/0961203310364397; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kotnik P, 2011, EUR J ENDOCRINOL, V165, P703, DOI 10.1530/EJE-11-0431; Kremers HM, 2008, ARTHRITIS RHEUM-US, V58, P2268, DOI 10.1002/art.23650; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Mallat Z, 2009, J CLIN ENDOCR METAB, V94, P255, DOI 10.1210/jc.2008-0253; Myasoedova E, 2011, J RHEUMATOL, V38, P983, DOI 10.3899/jrheum.101133; Sattar N, 2008, J CLIN ENDOCR METAB, V93, P3299, DOI 10.1210/jc.2008-1435; Sodergren A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3116; Solomon A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3784; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Steyn NP, 2008, PUBLIC HEALTH NUTR, V11, P307, DOI 10.1017/S136898000700033X; Takashima N, 2006, NEW ENGL J MED, V355, P1392; Tong KM, 2008, CELL SIGNAL, V20, P1478, DOI 10.1016/j.cellsig.2008.04.003; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; von Eynatten M, 2007, DIABETOLOGIA, V50, P1930, DOI 10.1007/s00125-007-0743-8; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	52	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92739	10.1371/journal.pone.0092739	http://dx.doi.org/10.1371/journal.pone.0092739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651174	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800150
J	Vidal, N; Zaldua, N; D'Anatro, A; Naya, DE				Vidal, Nicolas; Zaldua, Natalia; D'Anatro, Alejandro; Naya, Daniel E.			Are the Most Plastic Species the Most Abundant Ones? An Assessment Using a Fish Assemblage	PLOS ONE			English	Article							CLIMATE-CHANGE; PHENOTYPIC PLASTICITY; DIGESTIVE FLEXIBILITY; IMPACTS; MODELS; HYPOTHESIS; MORPHOLOGY; PHYSIOLOGY; EVOLUTION; COMMUNITY	Few studies have evaluated phenotypic plasticity at the community level, considering, for example, plastic responses in an entire species assemblage. In addition, none of these studies have addressed the relationship between phenotypic plasticity and community structure. Within this context, here we assessed the magnitude of seasonal changes in digestive traits (seasonal flexibility), and of changes during short-term fasting (flexibility during fasting), occurring in an entire fish assemblage, comprising ten species, four trophic levels, and a 37-fold range in body mass. In addition, we analyzed the relationship between estimates of digestive flexibility and three basic assemblage structure attributes, i.e., species trophic position, body size, and relative abundance. We found that: (1) Seasonal digestive flexibility was not related with species trophic position or with body size; (2) Digestive flexibility during fasting tended to be inversely correlated with body size, as expected from scaling relationships; (3) Digestive flexibility, both seasonal and during fasting, was positively correlated with species relative abundance. In conclusion, the present study identified two trends in digestive flexibility in relation to assemblage structure, which represents an encouraging departure point in the search of general patterns in phenotypic plasticity at the local community scale.	[Vidal, Nicolas; Zaldua, Natalia; D'Anatro, Alejandro; Naya, Daniel E.] Univ Republica, Fac Ciencias, Dept Ecol & Evoluc, Montevideo, Uruguay	Universidad de la Republica, Uruguay	Naya, DE (corresponding author), Univ Republica, Fac Ciencias, Dept Ecol & Evoluc, Montevideo, Uruguay.	dnaya@fcien.edu.uy			ANII (Uruguay); SDC (China-Denmark); PEDECIBA (Uruguay); CSIC (Uruguay)	ANII (Uruguay); SDC (China-Denmark); PEDECIBA (Uruguay); CSIC (Uruguay)	Funded by ANII (Uruguay) and SDC (China-Denmark) to NV, PEDECIBA (Uruguay) to NZ, ANII (Uruguay) to AD, and CSIC (Uruguay) to DEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Kirigin AJ, 2013, OECOLOGIA, V173, P745, DOI 10.1007/s00442-013-2682-z; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Clauss M, 2007, COMP BIOCHEM PHYS A, V148, P249, DOI 10.1016/j.cbpa.2007.05.024; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Firn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035870; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Gianoli E, 2012, BIOL J LINN SOC, V105, P1, DOI 10.1111/j.1095-8312.2011.01793.x; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Gurevitch J., 2001, ANAL ECOLOGICAL EXPT, P347; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; HUME ID, 1989, PHYSIOL ZOOL, V62, P1145, DOI 10.1086/physzool.62.6.30156206; Karasov WH, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P87; KARASOV WH, 1983, AM J PHYSIOL, V245, pG443, DOI 10.1152/ajpgi.1983.245.4.G443; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x; Konarzewski M, 2013, J COMP PHYSIOL B, V183, P27, DOI 10.1007/s00360-012-0698-z; Molina-Montenegro MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047620; Naya DE, 2008, AM NAT, V172, pE122, DOI 10.1086/590957; Naya DE, 2007, EVOL ECOL RES, V9, P1363; Peacor SD, 2012, P ROY SOC B-BIOL SCI, V279, P122, DOI 10.1098/rspb.2011.0606; Pennisi E, 2005, SCIENCE, V307, P1896, DOI 10.1126/science.307.5717.1896; Peterson AT, 2011, ECOLOGICAL NICHES GE; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Piersma T., 2010, FLEXIBLE PHENOTYPE B; Pigliucci M., 2001, SYN ECO EVO; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Richter-Boix A, 2006, EVOL ECOL RES, V8, P1139; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Starck JM, 2005, PHYSL ECOLOGICAL ADA; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Teixeira de Mello F., 2011, PECES AGUA DULCE URU; Teixeira-de Mello F, 2012, HYDROBIOLOGIA, V684, P143, DOI 10.1007/s10750-011-0979-7; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Touchon JC, 2011, J ANIM ECOL, V80, P79, DOI 10.1111/j.1365-2656.2010.01765.x; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; West-Eberhard Mary Jane, 2003, pi; WESTOBY M, 1995, J ECOL, V83, P531, DOI 10.2307/2261605; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Zaldua N, 2014, COMP BIOCHEM PHYS A, V169, P7, DOI 10.1016/j.cbpa.2013.12.006	45	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92446	10.1371/journal.pone.0092446	http://dx.doi.org/10.1371/journal.pone.0092446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651865	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800107
J	Wei, ZH; Chen, H; Zhang, C; Ye, BC				Wei, Zi-Han; Chen, Huan; Zhang, Chang; Ye, Bang-Ce			FRET-Based System for Probing Protein-Protein Interactions between sigma(R) and RsrA from Streptomyces Coelicolor in Response to the Redox Environment	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; DISULFIDE BOND FORMATION; NF-KAPPA-B; OXIDATIVE STRESS; FLUORESCENT PROTEINS; ORGANIC HYDROPEROXIDES; BACILLUS-SUBTILIS; LIVING CELLS; ZINC; IDENTIFICATION	Protein-protein interactions between sigma factor sigma(R) and its corresponding zinc-binding anti-sigma (ZAS) protein RsrA trigger the thioredoxin system for maintaining cellular redox homeostasis in S. coelicolor. RsrA bound to zinc associates with sigma(R), inhibiting its transcriptional activity in a reducing environment. During disulfide stress it forms intramolecular disulfide bonds, leading to zinc release and dissociation from sigma(R), which initiates transcription to produce reductase and thioredoxin. We designed a fluorescence resonance energy transfer (FRET) based system for monitoring protein-protein interactions between sigma(R) and RsrA to further understand how this redox switch regulates the thioredoxin system in S. coelicolor in response to its redox environment, especially various reactive oxygen species (ROS) derived from different metabolic pathways, and clarify the different response mechanisms between Zn-RsrA and apo-RsrA. By the use of the FRET approach described here, we showed that zinc protected thiols in RsrA and causes the sigma(R)-RsrA complex to form a more compact structure. This system was also utilized to detect changes in redox status induced by ROS and diamide in real time in E. coli cells.	[Wei, Zi-Han; Chen, Huan; Zhang, Chang; Ye, Bang-Ce] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	East China University of Science & Technology	Ye, BC (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	bcye@ecust.edu.cn			China NSF [21276079]; SRFDP [20120074110009]; Chinese Ministry of Education [313019]; Fundamental Research Funds for the Central Universities	China NSF(National Natural Science Foundation of China (NSFC)); SRFDP(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Chinese Ministry of Education(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the China NSF (21276079), SRFDP (no. 20120074110009), the Key Grant Project (no. 313019) of the Chinese Ministry of Education, and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, ACS CHEM BIOL, V1, P371, DOI 10.1021/cb600202f; Aslund F, 1999, CELL, V96, P751, DOI 10.1016/S0092-8674(00)80584-X; Bae JB, 2004, J MOL BIOL, V335, P425, DOI 10.1016/j.jmb.2003.10.065; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Bill A, 2011, J AM CHEM SOC, V133, P8372, DOI 10.1021/ja202513s; DiPilato LM, 2010, CURR OPIN CHEM BIOL, V14, P37, DOI 10.1016/j.cbpa.2009.10.012; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Ewald JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028245; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Gaballa A, 2002, MOL MICROBIOL, V45, P997, DOI 10.1046/j.1365-2958.2002.03068.x; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Herbig AF, 2001, MOL MICROBIOL, V41, P849, DOI 10.1046/j.1365-2958.2001.02543.x; Hoppe AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064760; Ibraheem A, 2010, CURR OPIN CHEM BIOL, V14, P30, DOI 10.1016/j.cbpa.2009.09.033; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Kim MS, 2009, MOL MICROBIOL, V73, P815, DOI 10.1111/j.1365-2958.2009.06824.x; Kolossov VL, 2008, EXP BIOL MED, V233, P238, DOI 10.3181/0707-RM-192; Li W, 2003, J MOL BIOL, V333, P461, DOI 10.1016/j.jmb.2003.08.038; Li W, 2002, J MOL BIOL, V323, P225, DOI 10.1016/S0022-2836(02)00948-8; Maret W, 2005, J TRACE ELEM MED BIO, V19, P7, DOI 10.1016/j.jtemb.2005.02.003; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; Najumudeen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066425; Oushiki D, 2010, J AM CHEM SOC, V132, P2795, DOI 10.1021/ja910090v; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Paget MSB, 2001, MOL MICROBIOL, V42, P1007, DOI 10.1046/j.1365-2958.2001.02675.x; Paige JS, 2012, SCIENCE, V335, P1194, DOI 10.1126/science.1218298; Park JH, 2008, MOL MICROBIOL, V68, P861, DOI 10.1111/j.1365-2958.2008.06191.x; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Shcherbakova D., 2012, ANGEW CHEM INT EDIT, V51, P2; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Whitby PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050588; White R, 2004, METHODS MOL BIOL NIT, P215; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Wilkins MR, 2007, PROTEOME RES CONCEPT, P169; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zdanowski K, 2006, BIOCHEMISTRY-US, V45, P8294, DOI 10.1021/bi060711v; Zhang C, 2014, BIOSENS BIOELECTRON, V54, P15, DOI 10.1016/j.bios.2013.10.038; Zhang C, 2013, BIOTECHNOL J, V8, P1280, DOI 10.1002/biot.201300001; Zhang C, 2013, APPL MICROBIOL BIOT, V97, P8307, DOI 10.1007/s00253-013-5121-5; Zhang YX, 2012, FREE RADICAL BIO MED, V53, P1531, DOI 10.1016/j.freeradbiomed.2012.07.010; Zhao BS, 2010, J AM CHEM SOC, V132, P17065, DOI 10.1021/ja1071114	47	6	6	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92330	10.1371/journal.pone.0092330	http://dx.doi.org/10.1371/journal.pone.0092330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651617	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800101
J	Clumeck, C; Garcia, SS; Bourguignon, M; Wens, V; Op de Beeck, M; Marty, B; Deconinck, N; Soncarrieu, MV; Goldman, S; Jousmaki, V; Van Bogaert, P; De Tiege, X				Clumeck, Catherine; Garcia, Sarah Suarez; Bourguignon, Mathieu; Wens, Vincent; Op de Beeck, Marc; Marty, Brice; Deconinck, Nicolas; Soncarrieu, Marie-Vincianne; Goldman, Serge; Jousmaki, Veikko; Van Bogaert, Patrick; De Tiege, Xavier			Preserved Coupling between the Reader's Voice and the Listener's Cortical Activity in Autism Spectrum Disorders	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; HIGH-FUNCTIONING AUTISM; SOCIAL-PERCEPTION; SPEECH-PERCEPTION; ASPERGER-SYNDROME; MIRROR NEURONS; CHILDREN; LANGUAGE; NETWORK; MIND	Purpose: Investigating the steadiness of the phase-coupling between the time-course of the reader's voice and brain signals of subjects with autism spectrum disorder (ASD) passively listening to connected speech using magnetoencephalography (MEG). In typically developed subjects, such coupling occurs at the right posterior temporal sulcus (pSTS) for frequencies below 1 Hz, and reflects the neural processing of sentence-level rhythmic prosody at the prelexical level. Methods: Cortical neuromagnetic signals were recorded with MEG (Elekta Oy, Finland) while seven right-handed and native French-speaking ASD subjects (six males, one female, range: 13-20 years) listened to live (Live) or recorded (Recorded) voices continuously reading a text in French for five minutes. Coherence was computed between the reader's voice time-course and ASD subjects' MEG signals. Coherent neural sources were subsequently reconstructed using a beamformer. Key findings: Significant coupling was found at 0.5 Hz in all ASD subjects in Live and in six subjects in Recorded. Coherent sources were located close to the right pSTS in both conditions. No significant difference was found in coherence levels between Live and Recorded, and between ASD subjects and ten typically developed subjects (right-handed, native French-speaking adults, 5 males, 5 females, age range: 21-38 years) included in a previous study. Significance: This study discloses a preserved coupling between the reader's voice and ASD subjects' cortical activity at the right pSTS. These findings support the existence of preserved neural processing of sentence-level rhythmic prosody in ASD. The preservation of early cortical processing of prosodic elements in verbal language might be exploited in therapeutic interventions in ASD.	[Clumeck, Catherine; Garcia, Sarah Suarez; Bourguignon, Mathieu; Wens, Vincent; Op de Beeck, Marc; Marty, Brice; Goldman, Serge; Van Bogaert, Patrick; De Tiege, Xavier] Univ Libre Bruxelles, UNI ULB Neurosci Inst, Lab Cartog Fonct Cerveau, Brussels, Belgium; [Clumeck, Catherine] Univ Libre Bruxelles, UNI ULB Neurosci Inst, Lab Rech Psychiat, Brussels, Belgium; [Deconinck, Nicolas; Soncarrieu, Marie-Vincianne] Hop Univ Enfants Reine Fabiola, Ctr Reference Troubles Envahissants Dev & Trouble, Brussels, Belgium; [Jousmaki, Veikko] Aalto Univ, Brain Res Unit, OV Lounasmaa Lab, Espoo, Finland; [Jousmaki, Veikko] Aalto Univ, MEG Core, Espoo, Finland	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Aalto University; Aalto University	De Tiege, X (corresponding author), Univ Libre Bruxelles, UNI ULB Neurosci Inst, Lab Cartog Fonct Cerveau, Brussels, Belgium.	xdetiege@ulb.ac.be	Jousmäki, Veikko/H-6008-2012; Bourguignon, Mathieu/I-6967-2012	Jousmäki, Veikko/0000-0003-1963-5834; Bourguignon, Mathieu/0000-0003-1694-5087; Marty, Brice/0000-0002-0522-8245; De Tiege, Xavier/0000-0003-0127-089X; Goldman, Serge/0000-0002-9917-8735	Fonds de la Recherche Scientifique (FRS-FNRS, Belgium); FRS-FNRS [J.0021.13]	Fonds de la Recherche Scientifique (FRS-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	Catherine Clumeck (Research Fellow) and Xavier De Tiege (Postdoctorate Clinical Master Specialist) benefit of a research grant form the Fonds de la Recherche Scientifique (FRS-FNRS, Belgium). This study was supported by a research grant from the FRS-FNRS (research project: J.0021.13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; [Anonymous], TEST LANGAGE ORAL CO; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Bourguignon M, 2013, NEUROIMAGE, V66, P500, DOI 10.1016/j.neuroimage.2012.10.038; Bourguignon M, 2013, HUM BRAIN MAPP, V34, P314, DOI 10.1002/hbm.21442; Bourguignon M, 2012, NEUROIMAGE, V59, P1684, DOI 10.1016/j.neuroimage.2011.09.022; Brandwein AB, 2013, CEREB CORTEX, V23, P1329, DOI [10.1093/cercor/bhs109, 10.1093/cercor/bht213]; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Cohen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061402; Collignon O, 2013, CORTEX, V49, P1704, DOI 10.1016/j.cortex.2012.06.001; Faes L, 2004, IEEE T BIO-MED ENG, V51, P1156, DOI 10.1109/TBME.2004.827271; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gepner B, 2009, NEUROSCI BIOBEHAV R, V33, P1227, DOI 10.1016/j.neubiorev.2009.06.006; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Golan O, 2008, J AUTISM DEV DISORD, V38, P1534, DOI 10.1007/s10803-007-0533-7; Groen WB, 2008, NEUROSCI BIOBEHAV R, V32, P1416, DOI 10.1016/j.neubiorev.2008.05.008; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Henson RN, 2009, NEUROIMAGE, V46, P168, DOI 10.1016/j.neuroimage.2009.01.062; Hesling I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011571; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Jarvinen-Pasley A, 2008, J AUTISM DEV DISORD, V38, P239, DOI 10.1007/s10803-007-0386-0; Kaland N, 2008, J AUTISM DEV DISORD, V38, P1112, DOI 10.1007/s10803-007-0496-8; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Lim HA, 2011, J MUSIC THER, V48, P532, DOI 10.1093/jmt/48.4.532; Lim HA, 2010, J MUSIC THER, V47, P2, DOI 10.1093/jmt/47.1.2; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; MILLER SB, 1979, J CLIN PSYCHIAT, V40, P201; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nishitani N, 2004, ANN NEUROL, V55, P558, DOI 10.1002/ana.20031; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peelle JE, 2013, CEREB CORTEX, V23, P1378, DOI 10.1093/cercor/bhs118; Piitulainen H, 2013, NEUROIMAGE, V72, P83, DOI 10.1016/j.neuroimage.2013.01.029; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Rapin I, 2003, BRAIN DEV-JPN, V25, P166, DOI 10.1016/S0387-7604(02)00191-2; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Samson F, 2006, J AUTISM DEV DISORD, V36, P65, DOI 10.1007/s10803-005-0043-4; Schroeder JH, 2010, RES AUTISM SPECT DIS, V4, P555, DOI 10.1016/j.rasd.2010.01.004; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Taulu S, 2005, IEEE T SIGNAL PROCES, V53, P3359, DOI 10.1109/TSP.2005.853302; von dem Hagen EAH, 2011, CEREB CORTEX, V21, P493, DOI 10.1093/cercor/bhq062; Wang AT, 2007, ARCH GEN PSYCHIAT, V64, P698, DOI 10.1001/archpsyc.64.6.698; Wechsler D, 1974, WECHSLER INTELLIGENC; Wechsler D., 1997, WECHSLER ADULT INTEL; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8; Wilson M, 2005, PSYCHON B REV, V12, P957, DOI 10.3758/BF03206432; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004	65	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92329	10.1371/journal.pone.0092329	http://dx.doi.org/10.1371/journal.pone.0092329			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663673	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900052
J	Ding, WG; Xie, Y; Toyoda, F; Matsuura, H				Ding, Wei-Guang; Xie, Yu; Toyoda, Futoshi; Matsuura, Hiroshi			Improved Functional Expression of Human Cardiac Kv1.5 Channels and Trafficking-Defective Mutants by Low Temperature Treatment	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; TRANSMEMBRANE CONDUCTANCE REGULATOR; ANCHORING PROTEIN SAP97; CELL-SURFACE EXPRESSION; N-LINKED GLYCOSYLATION; RECTIFIER K+ CURRENT; LONG QT SYNDROME; ATRIAL-FIBRILLATION; MOLECULAR-BASIS; POTASSIUM CHANNELS	We herein investigated the effect of low temperature exposure on the expression, degradation, localization and activity of human Kv1.5 (hKv1.5). In hKv1.5-expressing CHO cells, the currents were significantly increased when cultured at a reduced temperature (28 degrees C) compared to those observed at 37 degrees C. Western blot analysis indicated that the protein levels (both immature and mature proteins) of hKv1.5 were significantly elevated under the hypothermic condition. Treatment with a proteasome inhibitor, MG132, significantly increased the immature, but not the mature, hKv1.5 protein at 37 degrees C, however, there were no changes in either the immature or mature hKv1.5 proteins at low temperature following MG132 exposure. These observations suggest that the enhancement of the mature hKv1.5 protein at reduced temperature may not result from the inhibition of proteolysis. Moreover, the hKv1.5 fluorescence signal in the cells increased significantly on the cell surface at 28 degrees C versus those cultured at 37 degrees C. Importantly, the low temperature treatment markedly shifted the subcellular distribution of the mature hKv1.5, which showed considerable overlap with the trans-Golgi component. Experiments using tunicamycin, an inhibitor of N-glycosylation, indicated that the N-glycosylation of hKv1.5 is more effective at 28 degrees C than at 37 degrees C. Finally, the hypothermic treatment also rescued the protein expression and currents of trafficking-defective hKv1.5 mutants. These results indicate that low temperature exposure stabilizes the protein in the cellular organelles or on the plasma membrane, and modulates its maturation and trafficking, thus enhancing the currents of hKv1.5 and its trafficking defect mutants.	[Ding, Wei-Guang; Xie, Yu; Toyoda, Futoshi; Matsuura, Hiroshi] Shiga Univ Med Sci, Dept Physiol, Otsu, Shiga 52021, Japan	Shiga University of Medical Science	Ding, WG (corresponding author), Shiga Univ Med Sci, Dept Physiol, Otsu, Shiga 52021, Japan.	ding@belle.shiga-med.ac.jp			Japan Society for the Promotion of Science [22590206, 22590205]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in-Aid for Scientific Research (Nos. 22590206 to W-G. D. and Nos. 22590205 to H. M.) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Char J, 2008, AM J PHYSIOL-HEART C, V294, pH1851, DOI 10.1152/ajpheart.01045.2007; Al-Fageeh MB, 2006, BIOTECHNOL BIOENG, V93, P829, DOI 10.1002/bit.20789; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Beers MF, 1996, J BIOL CHEM, V271, P14361, DOI 10.1074/jbc.271.24.14361; Chen MX, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-93; Chen QA, 2010, AM J PHYSIOL-ENDOC M, V299, pE62, DOI 10.1152/ajpendo.00067.2010; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Decher N, 2004, J BIOL CHEM, V279, P394, DOI 10.1074/jbc.M307411200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Eldstrom J, 2006, FEBS LETT, V580, P6039, DOI 10.1016/j.febslet.2006.09.069; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Gong YZ, 2008, EUR J PHARMACOL, V600, P18, DOI 10.1016/j.ejphar.2008.10.010; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Kleizen B, 2000, EUR J CELL BIOL, V79, P544, DOI 10.1078/0171-9335-00078; Koshida S, 2009, EUR J PHARMACOL, V604, P93, DOI 10.1016/j.ejphar.2008.12.016; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Li HL, 2005, J MOL CELL CARDIOL, V39, P121, DOI 10.1016/j.yjmcc.2005.03.013; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; McEwen DP, 2007, J BIOL CHEM, V282, P29612, DOI 10.1074/jbc.M704402200; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Ravens U, 2008, EUROPACE, V10, P1133, DOI 10.1093/europace/eun193; Ravens U, 2011, CARDIOVASC RES, V89, P776, DOI 10.1093/cvr/cvq398; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schumacher SM, 2010, HEART RHYTHM, V7, P1309, DOI 10.1016/j.hrthm.2010.02.017; Schumacher SM, 2009, CIRC RES, V104, P1390, DOI 10.1161/CIRCRESAHA.108.192773; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Stump GL, 2005, J PHARMACOL EXP THER, V315, P1362, DOI 10.1124/jpet.105.092197; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Ting YK, 2011, BRIT J PHARMACOL, V162, P1832, DOI 10.1111/j.1476-5381.2011.01204.x; van der Heyden MAG, 2008, BRIT J PHARMACOL, V153, P406, DOI 10.1038/sj.bjp.0707618; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Wettwer E, 2004, CIRCULATION, V110, P2299, DOI 10.1161/01.CIR.0000145155.60288.71; Wu J, 2009, BRIT J PHARMACOL, V156, P377, DOI 10.1111/j.1476-5381.2008.00017.x; Yanagawa T, 2007, CANCER RES, V67, P8682, DOI 10.1158/0008-5472.CAN-07-1586; Yang YQ, 2009, J HUM GENET, V54, P277, DOI 10.1038/jhg.2009.26; Yang Z, 2008, CARDIOVASC RES, V78, P449, DOI 10.1093/cvr/cvn038; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	42	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92923	10.1371/journal.pone.0092923	http://dx.doi.org/10.1371/journal.pone.0092923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663680	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900130
J	Holder, PW; Armstrong, K; Van Hale, R; Millet, MA; Frew, R; Clough, TJ; Baker, JA				Holder, Peter W.; Armstrong, Karen; Van Hale, Robert; Millet, Marc-Alban; Frew, Russell; Clough, Timothy J.; Baker, Joel A.			Isotopes and Trace Elements as Natal Origin Markers of Helicoverpa armigera - An Experimental Model for Biosecurity Pests	PLOS ONE			English	Article							NEW-ZEALAND; STABLE-ISOTOPES; LEPIDOPTERA-NOCTUIDAE; MONARCH BUTTERFLIES; GEOGRAPHICAL ORIGIN; HUBNER LEPIDOPTERA; HYDROGEN ISOTOPES; MINERAL PROFILES; BIRD FEATHERS; STRONTIUM	Protecting a nation's primary production sector and natural estate is heavily dependent on the ability to determine the risk presented by incursions of exotic insect species. Identifying the geographic origin of such biosecurity breaches can be crucial in determining this risk and directing the appropriate operational responses and eradication campaigns, as well as ascertaining incursion pathways. Reading natural abundance biogeochemical markers using mass spectrometry is a powerful tool for tracing ecological pathways as well as provenance determination of commercial products and items of forensic interest. However, application of these methods to trace insects has been underutilised to date and our understanding in this field is still in a phase of basic development. In addition, biogeochemical markers have never been considered in the atypical situation of a biosecurity incursion, where sample sizes are often small, and of unknown geographic origin and plant host. These constraints effectively confound the interpretation of the one or two isotope geo-location markers systems that are currently used, which are therefore unlikely to achieve the level of provenance resolution required in biosecurity interceptions. Here, a novel approach is taken to evaluate the potential for provenance resolution of insect samples through multiple biogeochemical markers. The international pest, Helicoverpa armigera, has been used as a model species to assess the validity of using naturally occurring delta(2) H, Sr-87/Sr-86, Pb-207/Pb-206 and Pb-208/Pb-206 isotope ratios and trace element concentration signatures from single moth specimens for regional assignment to natal origin. None of the biogeochemical markers selected were individually able to separate moths from the different experimental regions (150-3000 km apart). Conversely, using multivariate analysis, the region of origin was correctly identified for approximately 75% of individual H. armigera samples. The geographic resolution demonstrated with this approach has considerable potential for biosecurity as well as other disciplines including forensics, ecology and pest management.	[Holder, Peter W.; Armstrong, Karen] Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand; [Van Hale, Robert; Frew, Russell] Univ Otago, Dept Chem, Dunedin, New Zealand; [Millet, Marc-Alban; Baker, Joel A.] Victoria Univ Wellington, Sch Geog Environm & Earth Sci, Wellington, New Zealand; [Clough, Timothy J.] Lincoln Univ, Dept Soil & Phys Sci, Canterbury, New Zealand	Lincoln University - New Zealand; University of Otago; Victoria University Wellington; Lincoln University - New Zealand	Holder, PW (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand.	peter.holder@lincoln.ac.nz	Clough, Timothy/Q-4982-2018; Holder, Peter/C-5224-2014; Frew, Russell/HDN-6138-2022; Frew, Russell/I-5591-2012; Armstrong, Karen/J-3460-2013	Clough, Timothy/0000-0002-5978-5274; Holder, Peter/0000-0003-2942-7289; Frew, Russell/0000-0002-6138-2116; Armstrong, Karen/0000-0003-4973-2651; Millet, Marc-Alban/0000-0003-2710-5374; Baker, Joel/0000-0001-6371-5060	New Zealand Tertiary Education Commission PhD scholarship; National Isotope Map of New Zealand Precipitation Cross Department Research Project grant [10749/2007]	New Zealand Tertiary Education Commission PhD scholarship; National Isotope Map of New Zealand Precipitation Cross Department Research Project grant	This work was funded by a New Zealand Tertiary Education Commission PhD scholarship and a National Isotope Map of New Zealand Precipitation Cross Department Research Project grant (10749/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney MR, 2008, ENTOMOL EXP APPL, V126, P46, DOI 10.1111/j.1570-7458.2007.00633.x; Adams CJ, 2004, NEW ZEAL J GEOL GEOP, V47, P201, DOI 10.1080/00288306.2004.9515048; Adams CJ, 2004, NEW ZEAL J GEOL GEOP, V47, P173, DOI 10.1080/00288306.2004.9515046; Anderson KA, 2005, J AGR FOOD CHEM, V53, P410, DOI 10.1021/jf048907u; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Baker J, 2004, CHEM GEOL, V211, P275, DOI 10.1016/j.chemgeo.2004.06.030; BARLEY ME, 1987, J VOLCANOL GEOTH RES, V32, P247, DOI 10.1016/0377-0273(87)90047-3; Barr NB, 2009, J ECON ENTOMOL, V102, P401, DOI 10.1603/029.102.0153; Baxter MJ, 2008, ARCHAEOMETRY, V50, P968, DOI 10.1111/j.1475-4754.2008.00427.x; Biosecurity-New-Zealand, 2011, PATHW AN REP 2010 11; Biosecurity-New-Zealand, 2006, PATHW AN REP 2005 06; Blum JD, 2000, BIOGEOCHEMISTRY, V49, P87, DOI 10.1023/A:1006390707989; Blum JD, 2001, OECOLOGIA, V126, P569, DOI 10.1007/s004420000550; BORTOLOTTI GR, 1988, J WILDLIFE MANAGE, V52, P736, DOI 10.2307/3800939; BOWDEN J, 1984, B ENTOMOL RES, V74, P207, DOI 10.1017/S0007485300011354; BOWDEN J, 1979, ECOL ENTOMOL, V4, P199, DOI 10.1111/j.1365-2311.1979.tb00576.x; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Brattstrom O, 2008, ECOGRAPHY, V31, P490, DOI 10.1111/j.0906-7590.2008.05267.x; Brevault T, 2008, B ENTOMOL RES, V98, P565, DOI 10.1017/S0007485308005877; Capo RC, 1998, GEODERMA, V82, P197, DOI 10.1016/S0016-7061(97)00102-X; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; COMMON IFB, 1953, AUST J ZOOL, V1, P319, DOI 10.1071/ZO9530319; DEMPSTER JP, 1986, ECOL ENTOMOL, V11, P51, DOI 10.1111/j.1365-2311.1986.tb00279.x; EDWARDS WR, 1984, J WILDLIFE MANAGE, V48, P853, DOI 10.2307/3801432; FAO, 2002, GUID PHYT CERT INT S; Farmer A, 2008, OECOLOGIA, V158, P183, DOI 10.1007/s00442-008-1143-6; Faure G., 2005, ISOTOPES PRINCIPLES, VThird; Feng HQ, 2010, ECOL MODEL, V221, P1819, DOI 10.1016/j.ecolmodel.2010.04.003; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Fitzpatrick BM, 2012, BIOL INVASIONS, V14, P245, DOI 10.1007/s10530-011-0064-1; Font L, 2007, J ANAL ATOM SPECTROM, V22, P513, DOI 10.1039/b616328a; Frei KM, 2011, APPL GEOCHEM, V26, P325, DOI 10.1016/j.apgeochem.2010.12.006; GOEDE AA, 1986, ENVIRON MONIT ASSESS, V7, P249, DOI 10.1007/BF00418017; Goldson SL, 2005, NEW ZEAL J AGR RES, V48, P401, DOI 10.1080/00288233.2005.9513673; Grocke DR, 2011, TOP GEOBIOL, V34, P105, DOI 10.1007/978-90-481-9684-5_5; GULSON BL, 1981, ENVIRON SCI TECHNOL, V15, P691, DOI 10.1021/es00088a008; Hill T, 2011, STAT METHODS APPL; Hobson KA, 2005, DIVERS DISTRIB, V11, P157, DOI 10.1111/j.1366-9516.2005.00149.x; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 1999, OECOLOGIA, V120, P397, DOI 10.1007/s004420050872; Hobson KA, 2012, METHODS ECOL EVOL, V3, P766, DOI 10.1111/j.2041-210X.2012.00202.x; Holder PW, 2013, ARHOPALUS FERUS CERA, DOI DOI 10.6084/M9.FIGSHARE.813315; Holder PW, 2013, THESIS LINCOLN U; Husheer T, 2005, STABLE ISOTOPE INVES; Kaimal B, 2009, J GEOCHEM EXPLOR, V102, P176, DOI 10.1016/j.gexplo.2009.02.008; Kamber BS, 2010, PALAEOGEOGR PALAEOCL, V298, P432, DOI 10.1016/j.palaeo.2010.06.024; Kelly S, 2005, TRENDS FOOD SCI TECH, V16, P555, DOI 10.1016/j.tifs.2005.08.008; Kelly S, 2002, EUR FOOD RES TECHNOL, V214, P72, DOI 10.1007/s002170100400; Lancaster J, 2001, LIMNOL OCEANOGR, V46, P723, DOI 10.4319/lo.2001.46.3.0723; Langin KM, 2007, OECOLOGIA, V152, P449, DOI 10.1007/s00442-007-0669-3; Lavandero B, 2004, INT J PEST MANAGE, V50, P147, DOI 10.1080/09670870410001731853; Longhurst RD, 2004, NEW ZEAL J AGR RES, V47, P23, DOI 10.1080/00288233.2004.9513567; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; McLean J.A., 1979, P369; MCLEAN JA, 1978, ENVIRON ENTOMOL, V7, P93, DOI 10.1093/ee/7.1.93; MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654; Montgomery J, 2007, APPL GEOCHEM, V22, P1502, DOI 10.1016/j.apgeochem.2007.02.009; Norris DR, 2007, CAN J ZOOL, V85, P579, DOI 10.1139/Z07-024; Notten MJM, 2008, APPL GEOCHEM, V23, P1581, DOI 10.1016/j.apgeochem.2008.01.010; Ouin A, 2011, RAPID COMMUN MASS SP, V25, P2793, DOI 10.1002/rcm.5127; Oulhote Y, 2011, TRAC-TREND ANAL CHEM, V30, P302, DOI 10.1016/j.trac.2010.10.015; Pimentel D, 2011, BIOLOGICAL INVASIONS: ECONOMIC AND ENVIRONMENTAL COSTS OF ALIEN PLANT, ANIMAL, AND MICROBE SPECIES, 2ND EDITION, P1, DOI 10.1201/b10938; PIN C, 1992, ANAL CHIM ACTA, V269, P249, DOI 10.1016/0003-2670(92)85409-Y; Pogue MG, 2004, ANN ENTOMOL SOC AM, V97, P1222, DOI 10.1603/0013-8746(2004)097[1222:ANSOHZ]2.0.CO;2; Revel-Rolland M, 2006, EARTH PLANET SC LETT, V249, P1, DOI 10.1016/j.epsl.2006.06.028; Rossmann A, 2001, FOOD REV INT, V17, P347, DOI 10.1081/FRI-100104704; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Sarbas B, 2012, GEOCHEMISTRY ROCKS O; Sauer PE, 2009, RAPID COMMUN MASS SP, V23, P949, DOI 10.1002/rcm.3954; Savin S., 1993, CLIMATE CHANGE CONTI, V78, P367, DOI 10.1029/GM078P0367; Schimmelmann A, 1999, GEOCHIM COSMOCHIM AC, V63, P3751, DOI 10.1016/S0016-7037(99)00221-5; Sellick MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004735; Spence KO, 2005, OECOLOGIA, V146, P89, DOI 10.1007/s00442-005-0170-9; Szep T, 2003, J AVIAN BIOL, V34, P307, DOI 10.1034/j.1600-048X.2003.03026.x; Timm C, 2009, J PETROL, V50, P989, DOI 10.1093/petrology/egp029; Timm NH, 2002, APPL MULTIVARIATE AN, DOI 10.1007/b98963; Torres-Dowdall J, 2010, CONDOR, V112, P490, DOI 10.1525/cond.2010.090166; TURNER RH, 1983, SCAN ELECTRON MICROS, P873; Wassenaar LI, 2006, RAPID COMMUN MASS SP, V20, P2505, DOI 10.1002/rcm.2626; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Wassenaar LI, 2010, 7 INT C APPL STABL I; Wunder MB, 2008, ECOL APPL, V18, P549, DOI 10.1890/07-0058.1	82	27	27	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92384	10.1371/journal.pone.0092384	http://dx.doi.org/10.1371/journal.pone.0092384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664236	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000333459900059
J	Kung, E; Coward, WR; Neill, DR; Malak, HA; Muhlemann, K; Kadioglu, A; Hilty, M; Hathaway, LJ				Kueng, Eliane; Coward, William R.; Neill, Daniel R.; Malak, Hesham A.; Muehlemann, Kathrin; Kadioglu, Aras; Hilty, Markus; Hathaway, Lucy J.			The Pneumococcal Polysaccharide Capsule and Pneumolysin Differentially Affect CXCL8 and IL-6 Release from Cells of the Upper and Lower Respiratory Tract	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; EPITHELIAL-CELLS; COLONIZATION; INNATE; GENES	The polysaccharide capsule and pneumolysin toxin are major virulence factors of the human bacterial pathogen Streptococcus pneumoniae. Colonization of the nasopharynx is asymptomatic but invasion of the lungs can result in invasive pneumonia. Here we show that the capsule suppresses the release of the pro-inflammatory cytokines CXCL8 (IL-8) and IL-6 from the human pharyngeal epithelial cell line Detroit 562. Release of both cytokines was much less from human bronchial epithelial cells (iHBEC) but levels were also affected by capsule. Pneumolysin stimulates CXCL8 release from both cell lines. Suppression of CXCL8 homologue (CXCL2/MIP-2) release by the capsule was also observed in vivo during intranasal colonization of mice but was only discernable in the absence of pneumolysin. When pneumococci were administered intranasally to mice in a model of long term, stable nasopharyngeal carriage, encapsulated S. pneumoniae remained in the nasopharynx whereas the nonencapsulated pneumococci disseminated into the lungs. Pneumococcal capsule plays a role not only in protection from phagocytosis but also in modulation of the pro-inflammatory immune response in the respiratory tract.	[Kueng, Eliane; Muehlemann, Kathrin; Hilty, Markus; Hathaway, Lucy J.] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Kueng, Eliane] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Coward, William R.] Nottingham Resp Biomed Res Unit, Nottingham, England; [Neill, Daniel R.; Malak, Hesham A.; Kadioglu, Aras] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Hilty, Markus] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Nottingham; University of Liverpool; University of Bern; University Hospital of Bern	Hathaway, LJ (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	lucy.hathaway@ifik.unibe.ch	Kummer, Juerg/B-3322-2011; Neill, Daniel/Q-6290-2019; Neill, Daniel/E-1403-2012; Hilty, Markus/H-9560-2019	Neill, Daniel/0000-0002-7911-8153; Neill, Daniel/0000-0002-7911-8153; Hilty, Markus/0000-0002-2418-6474; kadioglu, aras/0000-0003-1137-6321; Hathaway, Lucy Jane/0000-0002-5361-5397	Swiss National Science Foundation [31003A_133157/1]; Wellcome Trust	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Swiss National Science Foundation (31003A_133157/1) to KM and currently led by LJH. WRC receives funding from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A.K., 2016, CELL MOL IMMUNOL, V9th; Battig P, 2007, FEMS IMMUNOL MED MIC, V50, P324, DOI 10.1111/j.1574-695X.2007.00246.x; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; Dogan S, 2011, MICROBES INFECT, V13, P65, DOI 10.1016/j.micinf.2010.10.003; Engel H, 2013, ANTIMICROB AGENTS CH, V57, P2801, DOI 10.1128/AAC.00223-13; Gomez MI, 2008, PEDIATR PULM, V43, P11, DOI 10.1002/ppul.20735; Hathaway LJ, 2004, J BACTERIOL, V186, P3721, DOI 10.1128/JB.186.12.3721-3729.2004; Hathaway LJ, 2007, MICROBIOL-SGM, V153, P2465, DOI 10.1099/mic.0.2006/005066-0; Hathaway LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002574; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kronenberg A, 2006, J CLIN MICROBIOL, V44, P2032, DOI 10.1128/JCM.00275-06; Luer S, 2011, SUPPORT CARE CANCER, V19, P799, DOI 10.1007/s00520-010-0894-x; Marriott HM, 2012, INFECT IMMUN, V80, P1140, DOI 10.1128/IAI.05697-11; Mayer AK, 2007, ARCH IMMUNOL THER EX, V55, P353, DOI 10.1007/s00005-007-0041-7; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Meier PS, 2003, ANTIMICROB AGENTS CH, V47, P863, DOI 10.1128/AAC.47.3.863-868.2003; Ogunniyi AD, 2002, MICROBIOL-SGM, V148, P2045, DOI 10.1099/00221287-148-7-2045; Paterson GK, 2010, RESPIROLOGY, V15, P1057, DOI 10.1111/j.1440-1843.2010.01814.x; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rastogi D, 2001, Paediatr Respir Rev, V2, P245, DOI 10.1053/prrv.2001.0147; Ratner AJ, 2005, P NATL ACAD SCI USA, V102, P3429, DOI 10.1073/pnas.0500599102; Richards L, 2010, IMMUNOBIOLOGY, V215, P251, DOI 10.1016/j.imbio.2009.12.004; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; van Cuyck H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-241; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Yoon BN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/813610; Yuste J, 2005, J IMMUNOL, V175, P1813, DOI 10.4049/jimmunol.175.3.1813	33	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92355	10.1371/journal.pone.0092355	http://dx.doi.org/10.1371/journal.pone.0092355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664110	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900056
J	Yue, M; Zeng, L; Singh, A; Xu, YJ				Yue, Ming; Zeng, Li; Singh, Amanpreet; Xu, Yongjie			Rad4 Mainly Functions in Chk1-Mediated DNA Damage Checkpoint Pathway as a Scaffold Protein in the Fission Yeast Schizosaccharomyces pombe	PLOS ONE			English	Article							S-PHASE CHECKPOINT; STALLED REPLICATION FORKS; C-TERMINAL TAIL; KINASE CDS1; RAD3-RAD26 COMPLEX; BUDDING YEAST; MEC1 KINASE; ACTIVATION; PHOSPHORYLATION; DPB11	Rad4/Cut5 is a scaffold protein in the Chk1-mediated DNA damage checkpoint in S. pombe. However, whether it contains a robust ATR-activation domain (AAD) required for checkpoint signaling like its orthologs TopBP1 in humans and Dpb11 in budding yeast has been incompletely clear. To identify the putative AAD in Rad4, we carried out an extensive genetic screen looking for novel mutants with an enhanced sensitivity to replication stress or DNA damage in which the function of the AAD can be eliminated by the mutations. Two new mutations near the N-terminus were identified that caused significantly higher sensitivities to DNA damage or chronic replication stress than all previously reported mutants, suggesting that most of the checkpoint function of the protein is eliminated. However, these mutations did not affect the activation of Rad3 (ATR in humans) yet eliminated the scaffolding function of the protein required for the activation of Chk1. Several mutations were also identified in or near the recently reported AAD in the C-terminus of Rad4. However, all mutations in the C-terminus only slightly sensitized the cells to DNA damage. Interestingly, a mutant lacking the whole C-terminus was found resistant to DNA damage and replication stress almost like the wild type cells. Consistent with the resistance, all known Rad3 dependent phosphorylations of checkpoint proteins remained intact in the C-terminal deletion mutant, indicating that unlike that in Dpb11, the C-terminus of Rad4 does not contain a robust AAD. These results, together with those from the biochemical studies, show that Rad4 mainly functions as a scaffold protein in the Chk1, not the Cds1(CHK2 in humans), checkpoint pathway. It plays a minor role or is functionally redundant with an unknown factor in Rad3 activation.	[Yue, Ming; Singh, Amanpreet; Xu, Yongjie] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Zeng, Li] Zhengzhou Univ, Affiliated Hosp 1, Dept Pediat, Zhengzhou 450052, Peoples R China	University System of Ohio; Wright State University Dayton; Zhengzhou University	Xu, YJ (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	yong-jie.xu@wright.edu			Wright State University Boonshoft School of Medicine; Ohio Cancer Research Associates, Inc.	Wright State University Boonshoft School of Medicine; Ohio Cancer Research Associates, Inc.	This work was supported in part by the Emerging Science Seed Grant from Wright State University Boonshoft School of Medicine and a grant from Ohio Cancer Research Associates, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Bhaumik D, 1998, MOL BIOL CELL, V9, P2107, DOI 10.1091/mbc.9.8.2107; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Callegari AJ, 2007, CELL CYCLE, V6, P660, DOI 10.4161/cc.6.6.3984; Callegari AJ, 2006, P NATL ACAD SCI USA, V103, P15877, DOI 10.1073/pnas.0607343103; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Esashi F, 1999, MOL CELL, V4, P167, DOI 10.1016/S1097-2765(00)80364-0; FENECH M, 1991, NUCLEIC ACIDS RES, V19, P6737, DOI 10.1093/nar/19.24.6737; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Fukuura M, 2011, MOL BIOL CELL, V22, P2620, DOI 10.1091/mbc.E10-12-0995; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Furuya K, 2003, J CELL SCI, V116, P3847, DOI 10.1242/jcs.00790; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Harris S, 2003, J CELL SCI, V116, P3519, DOI 10.1242/jcs.00677; Hermand D, 2007, MOL CELL, V26, P553, DOI 10.1016/j.molcel.2007.04.014; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; Kai M, 2006, METHOD ENZYMOL, V409, P183, DOI 10.1016/S0076-6879(05)09011-7; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Limbo O, 2011, MOL CELL BIOL, V31, P573, DOI 10.1128/MCB.00994-10; Lin SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002801; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Majka J, 2004, J BIOL CHEM, V279, P20921, DOI 10.1074/jbc.M400898200; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Mochida S, 2004, EMBO J, V23, P418, DOI 10.1038/sj.emboj.7600018; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Navadgi-Patil VM, 2011, J BIOL CHEM, V286, P40999, DOI 10.1074/jbc.M111.283994; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; Ohouo PY, 2013, NATURE, V493, P120, DOI 10.1038/nature11658; Pfander B, 2011, EMBO J, V30, P4897, DOI 10.1038/emboj.2011.345; Qu M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002817; Sabatinos SA, 2012, MOL CELL BIOL, V32, P4986, DOI 10.1128/MCB.01060-12; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; SAKA Y, 1993, CELL, V74, P383, DOI 10.1016/0092-8674(93)90428-S; SAMEJIMA I, 1993, J CELL SCI, V105, P135; SCHUPBACH M, 1971, MUTAT RES, V11, P361; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stracker TH, 2008, MOL CELL, V31, P21, DOI 10.1016/j.molcel.2008.04.028; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka K, 2001, MOL CELL BIOL, V21, P3398, DOI 10.1128/MCB.21.10.3398-3404.2001; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Taricani L, 2006, MOL BIOL CELL, V17, P3456, DOI 10.1091/mbc.E06-01-0056; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Xu YJ, 2006, GENE DEV, V20, P990, DOI 10.1101/gad.1406706; Xu YJ, 2009, J BIOL CHEM, V284, P16016, DOI 10.1074/jbc.M900785200; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yue M, 2011, J BIOL CHEM, V286, P22864, DOI 10.1074/jbc.M111.236687; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou L, 2009, MOL CELL, V36, P734, DOI 10.1016/j.molcel.2009.11.026	66	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92936	10.1371/journal.pone.0092936	http://dx.doi.org/10.1371/journal.pone.0092936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663817	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900131
J	Contreras-Vallejos, E; Utreras, E; Borquez, DA; Prochazkova, M; Terse, A; Jaffe, H; Toledo, A; Arruti, C; Pant, HC; Kulkarni, AB; Gonzalez-Billault, C				Contreras-Vallejos, Erick; Utreras, Elias; Borquez, Daniel A.; Prochazkova, Michaela; Terse, Anita; Jaffe, Howard; Toledo, Andrea; Arruti, Cristina; Pant, Harish C.; Kulkarni, Ashok B.; Gonzalez-Billault, Christian			Searching for Novel Cdk5 Substrates in Brain by Comparative Phosphoproteomics of Wild Type and Cdk5(-/-) Mice	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; ACTIVATED PROTEIN-KINASE; MONOCLONAL-ANTIBODY; C SUBSTRATE; PHOSPHORYLATION; MARCKS; EXPRESSION; IDENTIFICATION; DOUBLECORTIN; NEURONS	Protein phosphorylation is the most common post-translational modification that regulates several pivotal functions in cells. Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/threonine kinase which is mostly active in the nervous system. It regulates several biological processes such as neuronal migration, cytoskeletal dynamics, axonal guidance and synaptic plasticity among others. In search for novel substrates of Cdk5 in the brain we performed quantitative phosphoproteomics analysis, isolating phosphoproteins from whole brain derived from E18.5 Cdk5(+/+) and Cdk5(-/-) embryos, using an Immobilized Metal-Ion Affinity Chromatography (IMAC), which specifically binds to phosphorylated proteins. The isolated phosphoproteins were eluted and isotopically labeled for relative and absolute quantitation (iTRAQ) and mass spectrometry identification. We found 40 proteins that showed decreased phosphorylation at Cdk5(-/-) brains. In addition, out of these 40 hypophosphorylated proteins we characterized two proteins, : MARCKS (Myristoylated Alanine-Rich protein Kinase C substrate) and Grin1 (G protein regulated inducer of neurite outgrowth 1). MARCKS is known to be phosphorylated by Cdk5 in chick neural cells while Grin1 has not been reported to be phosphorylated by Cdk5. When these proteins were overexpressed in N2A neuroblastoma cell line along with p35, serine phosphorylation in their Cdk5 motifs was found to be increased. In contrast, treatments with roscovitine, the Cdk5 inhibitor, resulted in an opposite effect on serine phosphorylation in N2A cells and primary hippocampal neurons transfected with MARCKS. In summary, the results presented here identify Grin 1 as novel Cdk5 substrate and confirm previously identified MARCKS as a a bona fide Cdk5 substrate.	[Contreras-Vallejos, Erick; Utreras, Elias; Borquez, Daniel A.; Gonzalez-Billault, Christian] Univ Chile, Dept Biol, Lab Cellular & Neuronal Dynam, Fac Sci, Santiago, Chile; [Prochazkova, Michaela; Terse, Anita; Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, NIH, Bethesda, MD 20892 USA; [Jaffe, Howard] NINDS, Prot & Peptide Facil, NIH, Bethesda, MD 20892 USA; [Toledo, Andrea; Arruti, Cristina] Univ Repub, Fac Ciencias, Dept Biol Celular & Mol, Secci Biol Celular,Lab Cultivo Tejidos, Montevideo, Uruguay; [Pant, Harish C.] NINDS, Neurochem Lab, NIH, Bethesda, MD 20892 USA	Universidad de Chile; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Universidad de la Republica, Uruguay; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Kulkarni, AB (corresponding author), Natl Inst Dent & Craniofacial Res, Funct Genom Sect, NIH, Bethesda, MD 20892 USA.	ak40m@nih.gov; chrgonza@uchile.cl	Utreras, Elias/I-1038-2013; Gonzalez-Billault, Christian/P-2393-2019; Gonzalez-Billault, Christian/K-9622-2013	Utreras, Elias/0000-0002-1004-0466; Gonzalez-Billault, Christian/0000-0003-0335-1482; Toledo, Andrea/0000-0002-8310-8636	Fondecyt [1095089, ACT1114, PAI 79100009, 11110136]; Divisions of Intramural Research, National Institute of Dental and Craniofacial Research; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America;  [CONICYT-24120958];  [MECESUP-UCH7013]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003104] Funding Source: NIH RePORTER	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Divisions of Intramural Research, National Institute of Dental and Craniofacial Research; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America; ; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by CONICYT-24120958 and MECESUP-UCH7013 (EC) Fondecyt 1095089 and ACT1114 (to CG-B), PAI 79100009 and Fondecyt 11110136 (EU), and the Divisions of Intramural Research, National Institute of Dental and Craniofacial Research (ABK) and the National Institute of Neurological Disorders and Stroke (HCP), National Institutes of Health, Bethesda, Maryland, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arif A, 2012, BIOCHEM PHARMACOL, V84, P985, DOI 10.1016/j.bcp.2012.06.027; Bernasconi F, 2006, NEUROSIGNALS, V15, P180, DOI 10.1159/000096734; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Borquez DA, 2013, GENOMICS, V101, P221, DOI 10.1016/j.ygeno.2013.01.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Chen LT, 1999, J BIOL CHEM, V274, P26931, DOI 10.1074/jbc.274.38.26931; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Connell-Crowley L, 2000, CURR BIOL, V10, P599, DOI 10.1016/S0960-9822(00)00487-5; Contreras-Vallejos E, 2012, CELL SIGNAL, V24, P44, DOI 10.1016/j.cellsig.2011.08.022; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dosemeci A, 2010, BIOCHEM BIOPH RES CO, V391, P78, DOI 10.1016/j.bbrc.2009.10.167; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gatlin JC, 2006, MOL BIOL CELL, V17, P5115, DOI 10.1091/mbc.E05-12-1183; Gillardon F, 2005, J CELL BIOCHEM, V95, P817, DOI 10.1002/jcb.20463; Gillardon F, 2005, PROTEOMICS, V5, P1299, DOI 10.1002/pmic.200400992; Gonzalez-Billault C, 2000, HISTOL HISTOPATHOL, V15, P1177, DOI 10.14670/HH-15.1177; Goswami T, 2012, PROTEOMICS, V12, P2185, DOI 10.1002/pmic.201200003; GRAFF JM, 1989, MOL ENDOCRINOL, V3, P1903, DOI 10.1210/mend-3-11-1903; Graham ME, 2004, BIOCHEM J, V381, P471, DOI 10.1042/BJ20040324; Hahn CM, 2005, NEUROSCIENCE, V134, P449, DOI 10.1016/j.neuroscience.2005.04.020; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hawash Ammar H., 2007, Biotechnology Journal, V2, P941, DOI 10.1002/biot.200700093; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Henriquez DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053123; Hernandez F, 2013, J ALZHEIMERS DIS, V33, pS141, DOI 10.3233/JAD-2012-129025; Horiuchi Y, 2006, GENES CELLS, V11, P1393, DOI 10.1111/j.1365-2443.2006.01027.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Iida N, 2004, METHOD ENZYMOL, V390, P475; Jimenez-Mateos EM, 2005, J NEUROSCI RES, V80, P350, DOI 10.1002/jnr.20453; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Liu CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S25; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Luttrell DK, 2003, ASSAY DRUG DEV TECHN, V1, P327, DOI 10.1089/15406580360545143; Manenti S, 1999, BIOCHEM J, V340, P775, DOI 10.1042/0264-6021:3400775; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Nakata H, 2005, MOL PHARMACOL, V67, P695, DOI 10.1124/mol.104.003913; Nordman JC, 2012, J CELL SCI, V125, P5502, DOI 10.1242/jcs.110379; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Palmer RH, 1996, FEBS LETT, V378, P281, DOI 10.1016/0014-5793(95)01454-3; Pant AC, 1997, BRAIN RES, V765, P259, DOI 10.1016/S0006-8993(97)00561-1; Pigino G, 1997, J CELL SCI, V110, P257; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Rudrabhatla P, 2010, FASEB J, V24, P4396, DOI 10.1096/fj.10-157859; Scarlett CO, 2003, DEV BRAIN RES, V144, P25, DOI 10.1016/S0165-3806(03)00155-x; Schnack C, 2008, PROTEOMICS, V8, P1980, DOI 10.1002/pmic.200701063; Sharma P, 2002, J BIOL CHEM, V277, P528, DOI 10.1074/jbc.M109324200; Solomonia RO, 2008, EXP BRAIN RES, V188, P323, DOI 10.1007/s00221-008-1428-3; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Sun KH, 2009, MOL BIOL CELL, V20, P4611, DOI 10.1091/mbc.E09-05-0433; Tanaka H, 2012, DEV BIOL, V370, P223, DOI 10.1016/j.ydbio.2012.07.032; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; TANIGUCHI H, 1994, J BIOL CHEM, V269, P18299; Terada M, 1998, J NEUROCHEM, V71, P2600; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Toledo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062863; Toledo A, 2009, BIOCHEM BIOPH RES CO, V383, P353, DOI 10.1016/j.bbrc.2009.04.029; Trivedi N, 2005, J CELL SCI, V118, P993, DOI 10.1242/jcs.01697; Tseng HC, 2005, CHEM BIOL, V12, P769, DOI 10.1016/j.chembiol.2005.05.012; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Utreras E, 2009, NEUROSCIENCE, V161, P978, DOI 10.1016/j.neuroscience.2009.04.002; Utreras E, 2012, J BIOL CHEM, V287, P16917, DOI 10.1074/jbc.M111.329979; Utreras Elias, 2009, Drug Discov Today Ther Strateg, V6, P105, DOI 10.1016/j.ddstr.2009.04.004; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; WU WCS, 1982, P NATL ACAD SCI-BIOL, V79, P5249, DOI 10.1073/pnas.79.17.5249; Zolessi FR, 2004, J PROTEOME RES, V3, P84, DOI 10.1021/pr034066f; Zolessi FR, 1999, BIOCHEM BIOPH RES CO, V257, P480, DOI 10.1006/bbrc.1999.0490; Zolessi FR, 2001, DEV BRAIN RES, V130, P257, DOI 10.1016/S0165-3806(01)00251-6	72	26	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90363	10.1371/journal.pone.0090363	http://dx.doi.org/10.1371/journal.pone.0090363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658276	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300016
J	Oberst, S; Baro, EN; Lai, JCS; Evans, TA				Oberst, Sebastian; Baro, Enrique Nava; Lai, Joseph C. S.; Evans, Theodore A.			Quantifying Ant Activity Using Vibration Measurements	PLOS ONE			English	Article							LEAF-CUTTING ANTS; IRIDOMYRMEX-PURPUREUS; MEAT ANTS; COMMUNICATION; STRIDULATION; RECRUITMENT; HYMENOPTERA; ABUNDANCE	Ant behaviour is of great interest due to their sociality. Ant behaviour is typically observed visually, however there are many circumstances where visual observation is not possible. It may be possible to assess ant behaviour using vibration signals produced by their physical movement. We demonstrate through a series of bioassays with different stimuli that the level of activity of meat ants (Iridomyrmex purpureus) can be quantified using vibrations, corresponding to observations with video. We found that ants exposed to physical shaking produced the highest average vibration amplitudes followed by ants with stones to drag, then ants with neighbours, illuminated ants and ants in darkness. In addition, we devised a novel method based on wavelet decomposition to separate the vibration signal owing to the initial ant behaviour from the substrate response, which will allow signals recorded from different substrates to be compared directly. Our results indicate the potential to use vibration signals to classify some ant behaviours in situations where visual observation could be difficult.	[Oberst, Sebastian; Baro, Enrique Nava; Lai, Joseph C. S.] Univ New S Wales, Sch Engn & Informat Technol, Acoust & Vibrat Unit, Canberra, ACT, Australia; [Baro, Enrique Nava] Univ Malaga, Escuela Tecn Super Ingn Telecomunicac, Dept Ingn Comunicac, E-29071 Malaga, Spain; [Evans, Theodore A.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	University of New South Wales Sydney; Universidad de Malaga; National University of Singapore	Oberst, S (corresponding author), Univ New S Wales, Sch Engn & Informat Technol, Acoust & Vibrat Unit, Canberra, ACT, Australia.	s.oberst@adfa.edu.au	Nava-Baro, Enrique/R-4589-2019; Evans, Theodore A/A-6020-2008; Oberst, Sebastian/AAQ-2854-2020	Nava-Baro, Enrique/0000-0001-7817-6442; Evans, Theodore A/0000-0002-0558-3036; Oberst, Sebastian/0000-0002-1388-2749; Lai, Joseph/0000-0002-8946-9993	Australian Research Council [DP110102564]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council's Discovery Project funding scheme (project number DP110102564, http://www.arc.gov.au/pdf/DP11_fundingrules.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay A, 2002, J ACOUST SOC AM, V111, P1525, DOI 10.1121/1.1456514; ANDERSEN AN, 1994, OECOLOGIA, V98, P15, DOI 10.1007/BF00326085; BAERENDS GP, 1959, ANNU REV ENTOMOL, V4, P207, DOI 10.1146/annurev.en.04.010159.001231; Balch T., 2001, Proceedings of the Fifth International Conference on Autonomous Agents, P521, DOI 10.1145/375735.376434; Baro EN, 2013, INT 2013 INNSBR AUST, P1; BARONIURBANI C, 1988, INSECT SOC, V35, P241, DOI 10.1007/BF02224057; GREAVES T, 1973, Journal of the Australian Entomological Society, V12, P284; GREENSLADE PJ, 1974, SOIL BIOL BIOCHEM, V6, P7, DOI 10.1016/0038-0717(74)90004-2; GREENSLADE PJM, 1987, AUST J ZOOL, V35, P259, DOI 10.1071/ZO9870259; Hickling R, 2000, J ACOUST SOC AM, V108, P1920, DOI 10.1121/1.1290515; Hogg RV., 1987, ENG STAT; Holldobler B, 1999, J COMP PHYSIOL A, V184, P129, DOI 10.1007/s003590050313; Holldobler B., 1990, pi; HUA Y, 1990, IEEE T ACOUST SPEECH, V38, P814, DOI 10.1109/29.56027; Keller L., 2009, LIVES ANTS; Lach L, 2010, ANT ECOLOGY, P1; Mankin RW, 2006, J ECON ENTOMOL, V99, P244, DOI 10.1603/0022-0493(2006)099[0244:GDOSTA]2.0.CO;2; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; Oster G.F., 1978, Monographs in Population Biology, pi; Percival D., 2000, CA ST PR MA; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; ROCES F, 1995, BEHAV ECOL SOCIOBIOL, V37, P297; ROCES F, 1993, NATURWISSENSCHAFTEN, V80, P521, DOI 10.1007/BF01140810; SPANGLER HG, 1967, SCIENCE, V155, P1687, DOI 10.1126/science.155.3770.1687; Spanos A., 1999, PROBABILITY THEORY S; Stephane M., 1999, WAVELET TOUR SIGNAL; TAUTZ J, 1995, SCIENCE, V267, P84, DOI 10.1126/science.267.5194.84; Ward-Fear G, 2010, J APPL ECOL, V47, P273, DOI 10.1111/j.1365-2664.2010.01773.x; Wheeler W. M., 1913, ANTS THEIR STRUCTURE	29	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90902	10.1371/journal.pone.0090902	http://dx.doi.org/10.1371/journal.pone.0090902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658467	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300022
J	Wu, HH; Yin, JB; Zhang, T; Cui, YY; Dong, YL; Chen, GZ; Wang, W				Wu, Huang-Hui; Yin, Jun-Bin; Zhang, Ting; Cui, Yuan-Yuan; Dong, Yu-Lin; Chen, Guo-Zhong; Wang, Wen			Inhibiting Spinal Neuron-Astrocytic Activation Correlates with Synergistic Analgesia of Dexmedetomidine and Ropivacaine	PLOS ONE			English	Article							NEUROPATHIC PAIN; NERVE LIGATION; MECHANICAL ALLODYNIA; CAUSES NEUROTOXICITY; GLIAL ACTIVATION; JNK ACTIVATION; RAT MODEL; KETAMINE; CELLS; CORD	Background: This study aims to identify that intrathecal (i.t.) injection of dexmedetomidine (Dex) and ropivacaine (Ropi) induces synergistic analgesia on chronic inflammatory pain and is accompanied with corresponding "neuron-astrocytic" alterations. Methods: Male, adult Sprague-Dawley rats were randomly divided into sham, control and i.t. medication groups. The analgesia profiles of i.t. Dex, Ropi, and their combination detected by Hargreaves heat test were investigated on the subcutaneous (s.c.) injection of complete Freund adjuvant (CFA) induced chronic pain in rat and their synergistic analgesia was confirmed by using isobolographic analysis. During consecutive daily administration, pain behavior was daily recorded, and immunohistochemical staining was applied to investigate the number of Fos-immunoreactive (Fos-ir) neurons on hour 2 and day 1, 3 and 7, and the expression of glial fibrillary acidic protein (GFAP) within the spinal dorsal horn (SDH) on day 1, 3, 5 and 7 after s.c. injection of CFA, respectively, and then Western blot to examine spinal GFAP and beta-actin levels on day 3 and 7. Results: i.t. Dex or Ropi displayed a short-term analgesia in a dose-dependent manner, and consecutive daily administrations of their combination showed synergistic analgesia and remarkably down-regulated neuronal and astrocytic activations indicated by decreases in the number of Fos-ir neurons and the GFAP expression within the SDH, respectively. Conclusion: i.t. co-delivery of Dex and Ropi shows synergistic analgesia on the chronic inflammatory pain, in which spinal "neuron-astrocytic activation" mechanism may play an important role.	[Wu, Huang-Hui; Chen, Guo-Zhong] Fuzhou Gen Hosp Nanjing Mil Reg, Dept Anesthesiol, Fuzhou, Peoples R China; [Yin, Jun-Bin; Zhang, Ting; Cui, Yuan-Yuan; Dong, Yu-Lin; Wang, Wen] Fourth Mil Med Univ, Preclin Sch Med, Dept Anat Histol & Embryol, Xian 710032, Peoples R China; [Yin, Jun-Bin; Zhang, Ting; Cui, Yuan-Yuan; Dong, Yu-Lin; Wang, Wen] Fourth Mil Med Univ, Preclin Sch Med, KK Leung Brain Res Ctr, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Chen, GZ (corresponding author), Fuzhou Gen Hosp Nanjing Mil Reg, Dept Anesthesiol, Fuzhou, Peoples R China.	cgzssq2000@sina.com; wangwen@fmmu.edu.cn			NSFC [31070976, 81271230]; Fourth Military Medical University	NSFC(National Natural Science Foundation of China (NSFC)); Fourth Military Medical University	This work is partly supported by the NSFC (31070976, 81271230) and intramural grant of the Fourth Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT FV, 1984, BRAIN RES, V295, P77, DOI 10.1016/0006-8993(84)90817-5; Al-Mustafa MM, 2009, SAUDI MED J, V30, P365; Bai L, 2012, PAIN PHYSICIAN, V15, P311; BOURGOIN S, 1993, NEUROPHARMACOLOGY, V32, P633, DOI 10.1016/0028-3908(93)90076-F; Bruzzone A, 2008, BRIT J PHARMACOL, V155, P494, DOI 10.1038/bjp.2008.278; Chichorro JG, 2004, BRIT J PHARMACOL, V141, P1175, DOI 10.1038/sj.bjp.0705724; Dadure C, 2012, PEDIATR ANESTH, V22, P93, DOI 10.1111/j.1460-9592.2011.03730.x; Gandhi Kishor, 2012, Anesthesiol Clin, V30, pe1; GOLDMAN JA, 1958, BRIT J ANAESTH, V30, P377, DOI 10.1093/bja/30.8.377; Grosu Irina, 2010, F1000 Med Rep, V2, P90, DOI 10.3410/M2-90; Guo BL, 2013, MITOCHONDRION, V13, P292, DOI 10.1016/j.mito.2013.03.007; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Gupta R, 2011, INDIAN J ANAESTH, V55, P347, DOI 10.4103/0019-5049.84841; Gupta Rajni, 2011, J Anaesthesiol Clin Pharmacol, V27, P339, DOI 10.4103/0970-9185.83678; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Harsten A, 2013, BRIT J ANAESTHESIA; HOLZ GG, 1989, J NEUROSCI, V9, P657; Huang R, 2000, BRAIN RES, V873, P297, DOI 10.1016/S0006-8993(00)02525-7; Ihmsen H, 2012, ANAESTHESIST, V61, P1059, DOI 10.1007/s00101-012-2114-1; Jones L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009234.pub2; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kanazi GE, 2006, ACTA ANAESTH SCAND, V50, P222, DOI 10.1111/j.1399-6576.2006.00919.x; Katsura H, 2008, GLIA, V56, P723, DOI 10.1002/glia.20648; Kimura M, 2012, NEUROSCI LETT, V529, P70, DOI 10.1016/j.neulet.2012.08.008; Li SS, 2013, CNS NEUROSCI THER, V19, P364, DOI 10.1111/cns.12100; Li XH, 2001, J PHARMACOL EXP THER, V299, P939; Liang LL, 2013, BRAIN RES, V1513, P17, DOI 10.1016/j.brainres.2013.04.003; Liu L, 2012, BRAIN RES, V1427, P1, DOI 10.1016/j.brainres.2011.08.019; Mei XP, 2011, NEUROSIGNALS, V19, P44, DOI 10.1159/000324293; Mei XP, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-6; Mei XP, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-50; Mei XP, 2009, J NEUROCHEM, V109, P1691, DOI 10.1111/j.1471-4159.2009.06087.x; Mohamed AA, 2012, PAIN PHYSICIAN, V15, P339; Mori K, 2002, NEUROPHARMACOLOGY, V43, P1026, DOI 10.1016/S0028-3908(02)00211-3; Nishimori M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005059.pub3; Oka M, 2006, BIOCHEM BIOPH RES CO, V341, P874, DOI 10.1016/j.bbrc.2006.01.039; Perrott DH, 2008, CURR OPIN ANESTHESIO, V21, P480, DOI 10.1097/ACO.0b013e3283063499; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sanders RD, 2010, ACTA ANAESTH SCAND, V54, P710, DOI 10.1111/j.1399-6576.2009.02177.x; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shukla Deepika, 2011, J Anaesthesiol Clin Pharmacol, V27, P495, DOI 10.4103/0970-9185.86594; Simmons SW, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003401.pub3; Sites BD, 2012, REGION ANESTH PAIN M, V37, P478, DOI 10.1097/AAP.0b013e31825cb3d6; Solanki SL, 2013, ANAESTH INTENS CARE, V41, P51, DOI 10.1177/0310057X1304100110; Stone LS, 1998, J NEUROSCI, V18, P5928; Sun YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076603; Sun ZH, 2012, ANAESTH INTENS CARE, V40, P825, DOI 10.1177/0310057X1204000427; Sun ZH, 2012, MOL MED REP, V6, P1455, DOI 10.3892/mmr.2012.1115; Suter MR, 2007, NEURON GLIA BIOL, V3, P255, DOI 10.1017/S1740925X08000100; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Thorlin T, 1998, NEUROPHARMACOLOGY, V37, P299, DOI 10.1016/S0028-3908(98)00026-4; Toda S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-2; Wang W, 2008, ANAT REC, V291, P513, DOI 10.1002/ar.20673; Wang W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006973; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Werdehausen R, 2009, BRIT J ANAESTH, V103, P711, DOI 10.1093/bja/aep236; Wirkner K, 2007, CEREB CORTEX, V17, P621, DOI 10.1093/cercor/bhk012; Xu B, 2010, CLIN EXP PHARMACOL P, V37, pe158, DOI 10.1111/j.1440-1681.2010.05426.x; Yan M, 2011, NEUROCHEM INT, V58, P549, DOI 10.1016/j.neuint.2011.01.013; Yaster M, 2011, ANESTHESIOLOGY, V114, P412, DOI 10.1097/ALN.0b013e318205df50; Yuan X, 2013, EUROPEAN J ANAESTHES; Zhang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055556; Zhong Z, 2009, ANAESTH INTENS CARE, V37, P929, DOI 10.1177/0310057X0903700612; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	66	14	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92374	10.1371/journal.pone.0092374	http://dx.doi.org/10.1371/journal.pone.0092374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658263	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300076
J	Bailey, AL; Lauck, M; Weiler, A; Sibley, SD; Dinis, JM; Bergman, Z; Nelson, CW; Correll, M; Gleicher, M; Hyeroba, D; Tumukunde, A; Weny, G; Chapman, C; Kuhn, JH; Hughes, AL; Friedrich, TC; Goldberg, TL; O'Connor, DH				Bailey, Adam L.; Lauck, Michael; Weiler, Andrea; Sibley, Samuel D.; Dinis, Jorge M.; Bergman, Zachary; Nelson, Chase W.; Correll, Michael; Gleicher, Michael; Hyeroba, David; Tumukunde, Alex; Weny, Geoffrey; Chapman, Colin; Kuhn, Jens H.; Hughes, Austin L.; Friedrich, Thomas C.; Goldberg, Tony L.; O'Connor, David H.			High Genetic Diversity and Adaptive Potential of Two Simian Hemorrhagic Fever Viruses in a Wild Primate Population	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-VIRUS; DEHYDROGENASE-ELEVATING VIRUS; N-LINKED GLYCOSYLATION; NEUTRALIZATION EPITOPE; ANTIBODY NEUTRALIZATION; MOLECULAR-BIOLOGY; GP5; IDENTIFICATION; GLYCOPROTEIN; EMERGENCE	Key biological properties such as high genetic diversity and high evolutionary rate enhance the potential of certain RNA viruses to adapt and emerge. Identifying viruses with these properties in their natural hosts could dramatically improve disease forecasting and surveillance. Recently, we discovered two novel members of the viral family Arteriviridae: simian hemorrhagic fever virus (SHFV)-krc1 and SHFV-krc2, infecting a single wild red colobus (Procolobus rufomitratus tephrosceles) in Kibale National Park, Uganda. Nearly nothing is known about the biological properties of SHFVs in nature, although the SHFV type strain, SHFV-LVR, has caused devastating outbreaks of viral hemorrhagic fever in captive macaques. Here we detected SHFV-krc1 and SHFV-krc2 in 40% and 47% of 60 wild red colobus tested, respectively. We found viral loads in excess of 10(6)-10(7) RNA copies per milliliter of blood plasma for each of these viruses. SHFV-krc1 and SHFV-krc2 also showed high genetic diversity at both the inter-and intra-host levels. Analyses of synonymous and non-synonymous nucleotide diversity across viral genomes revealed patterns suggestive of positive selection in SHFV open reading frames (ORF) 5 (SHFV-krc2 only) and 7 (SHFV-krc1 and SHFV-krc2). Thus, these viruses share several important properties with some of the most rapidly evolving, emergent RNA viruses.	[Bailey, Adam L.; Lauck, Michael; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Bailey, Adam L.; Lauck, Michael; Weiler, Andrea; Sibley, Samuel D.; Bergman, Zachary; Friedrich, Thomas C.; Goldberg, Tony L.; O'Connor, David H.] Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Weiler, Andrea; Sibley, Samuel D.; Dinis, Jorge M.; Bergman, Zachary; Friedrich, Thomas C.; Goldberg, Tony L.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Nelson, Chase W.; Hughes, Austin L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Correll, Michael; Gleicher, Michael] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA; [Hyeroba, David; Tumukunde, Alex; Weny, Geoffrey; Chapman, Colin] Makerere Univ, Kampala, Uganda; [Chapman, Colin] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin] McGill Univ, Sch Environm, Montreal, PQ, Canada; [Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Wisconsin System; University of Wisconsin Madison; Makerere University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	O'Connor, DH (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.	dhoconno@wisc.edu	Kuhn, Jens H./B-7615-2011; Chapman, Colin/S-1911-2019	Kuhn, Jens H./0000-0002-7800-6045; Chapman, Colin/0000-0002-8827-8140; Friedrich, Thomas/0000-0001-9831-6895; Nelson, Chase/0000-0001-6287-1598; o'connor, david/0000-0003-2139-470X; Sibley, Samuel/0000-0002-6754-3187; Bergman, Zachary/0000-0002-2924-2965	US Department of Health and Human Services [HHSN272200700016I]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077376, R01AI098420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081061, T32GM008692] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER; Div Of Information & Intelligent Systems [1162037] Funding Source: National Science Foundation	US Department of Health and Human Services; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Jens H. Kuhn is employed by a commercial company, Tunnell Government Services, Inc. Tunnell is a subcontractor to Battelle Memorial Institute, which is the primary contractor to NIH to run the NIH facility "Integrated Research Facility at Fort Detrick". As the authors pointed out in the disclaimer, Tunnell's involvement with Battelle, and Battelle's involvement with NIH is stipulated in US Department of Health and Human Services contract HHSN272200700016I. All work performed by Jens H. Kuhn (and all other Tunnell IRF employees) is property of the US government under the contract. Jens H. Kuhn therefore has no competing interests. The affiliation with Tunnell/Battelle does not alter Jens H. Kuhn's adherence to all PLOS ONE policies on sharing data and materials. To be completely clear, this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN AM, 1968, AM J TROP MED HYG, V17, P413, DOI 10.4269/ajtmh.1968.17.413; Ansari IH, 2006, J VIROL, V80, P3994, DOI 10.1128/JVI.80.8.3994-4004.2006; Apetrei C, 2004, FRONT BIOSCI-LANDMRK, V9, P225, DOI 10.2741/1154; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Balasuriya UBR, 1997, VIROLOGY, V232, P114, DOI 10.1006/viro.1997.8551; Borderia AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010319; BRIERLEY I, 1995, J GEN VIROL, V76, P1885, DOI 10.1099/0022-1317-76-8-1885; Chapman CA, 1996, INT J PRIMATOL, V17, P31, DOI 10.1007/BF02696157; Chen ZY, 2000, VIROLOGY, V266, P88, DOI 10.1006/viro.1999.0050; Chen ZY, 1999, J NEUROVIROL, V5, P200, DOI 10.3109/13550289909022003; de Lima M, 2009, VIROLOGY, V390, P31, DOI 10.1016/j.virol.2009.04.017; de Oliveira T, 2004, GENETICS, V167, P1047, DOI 10.1534/genetics.103.018135; Dokland T, 2010, VIRUS RES, V154, P86, DOI 10.1016/j.virusres.2010.07.029; Duran JP, 1997, VIRUS GENES, V14, P19, DOI 10.1023/A:1007931322271; Faaberg KS, 1997, VIROLOGY, V227, P245, DOI 10.1006/viro.1996.8310; Fang Y, 2012, P NATL ACAD SCI USA, V109, pE2920, DOI 10.1073/pnas.1211145109; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Goldberg TL, 2012, CONSERVATION MED APP; Gonin P, 1998, ARCH VIROL, V143, P1927, DOI 10.1007/s007050050430; GRAVELL M, 1986, P SOC EXP BIOL MED, V181, P112; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hedges JF, 1999, VIROLOGY, V264, P92, DOI 10.1006/viro.1999.9982; Hofmann K., 1993, BIOL CHEM HOPPE SEYL, V374; Holmes E., 2009, EVOLUTION EMERGENCE; Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505; Hughes AL, 2001, J VIROL, V75, P7966, DOI 10.1128/JVI.75.17.7966-7972.2001; Johnson RF, 2011, VIROLOGY, V421, P129, DOI 10.1016/j.virol.2011.09.016; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kimura MA, 1985, NEUTRAL THEORY MOL E; King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAPIN B. A., 1967, VOP VIRUSOL, V12, P168; Lauck M, 2013, J VIROL, V87, P688, DOI 10.1128/JVI.02433-12; Lauck M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019056; LONDON WT, 1977, NATURE, V268, P344, DOI 10.1038/268344a0; Lu ZC, 2012, VIROLOGY, V432, P99, DOI 10.1016/j.virol.2012.05.022; Mardassi H, 1998, J VIROL, V72, P6298, DOI 10.1128/JVI.72.8.6298-6306.1998; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ni JQ, 2012, J VET DIAGN INVEST, V24, P349, DOI 10.1177/1040638711434111; NOVELLA IS, 1995, P NATL ACAD SCI USA, V92, P5841, DOI 10.1073/pnas.92.13.5841; Ostrowski M, 2002, J VIROL, V76, P4241, DOI 10.1128/JVI.76.9.4241-4250.2002; PALMER AE, 1968, AM J TROP MED HYG, V17, P404, DOI 10.4269/ajtmh.1968.17.404; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plagemann PGW, 2004, VET IMMUNOL IMMUNOP, V102, P263, DOI 10.1016/j.vetimm.2004.09.011; Plagemann PGW, 2002, ARCH VIROL, V147, P2327, DOI 10.1007/s00705-002-0887-2; Plagemann PGW, 2001, VIROLOGY, V290, P11, DOI 10.1006/viro.2001.1139; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Struhsaker T, 2008, IUCN 2013 IUCN RED L; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAURASO NM, 1968, AM J TROP MED HYG, V17, P422, DOI 10.4269/ajtmh.1968.17.422; Tian DB, 2012, J VIROL, V86, P3701, DOI 10.1128/JVI.06836-11; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Van Breedam W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000730; van Marle G, 1999, P NATL ACAD SCI USA, V96, P12056, DOI 10.1073/pnas.96.21.12056; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Vu HLX, 2011, J VIROL, V85, P5555, DOI 10.1128/JVI.00189-11; Wasserman MD, 2013, INT J PRIMATOL, V34, P1020, DOI 10.1007/s10764-013-9711-y; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wieringa R, 2002, J VIROL, V76, P10829, DOI 10.1128/JVI.76.21.10829-10840.2002; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354; Wright CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	68	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90714	10.1371/journal.pone.0090714	http://dx.doi.org/10.1371/journal.pone.0090714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651479	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800021
J	Gao, YL; Reitz, SR; Wei, QB; Yu, WY; Zhang, Z; Lei, ZR				Gao, Yulin; Reitz, Stuart R.; Wei, Qingbo; Yu, Wenyan; Zhang, Zhi; Lei, Zhongren			Local Crop Planting Systems Enhance Insecticide-Mediated Displacement of Two Invasive Leafminer Fly	PLOS ONE			English	Article							DIGLYPHUS-ISAEA HYMENOPTERA; LIRIOMYZA-TRIFOLII DIPTERA; AGROMYZIDAE; SATIVAE; SUSCEPTIBILITY; HUIDOBRENSIS; EULOPHIDAE; PARASITISM; ABAMECTIN	Liriomyza sativae and L. trifolii are highly invasive leafminer pests of vegetable crops that have invaded southern China in recent years. Liriomyza sativae was the first of these species to invade China, but it is now being displaced by L. trifolii. The rate and extent of this displacement vary across southern China. In Hainan, monocultures of highly valuable cowpea are planted and treated extensively with insecticides in attempts to control leafminer damage. In Guangdong, cowpea fields are interspersed with other less valuable crops, such as towel gourd (Luffa cylindrica), which receive significantly fewer insecticide applications than cowpea. To determine how differences in cropping systems influence the Liriomyza species composition, we conducted field trials in 2011 and 2012 in Guangdong where both species were present. We replicated conditions in Hainan by planting cowpea monocultures that were isolated from other agricultural fields, and we replicated conditions in Guangdong by planting cowpea in a mixed crop environment with towel gourd planted in neighboring plots. We then compared leafminer populations in cowpea treated with the insecticide avermectin and untreated cowpea. We also monitored leafminer populations in the untreated towel gourd. Untreated cowpea and towel gourd had comparatively low proportions of L. trifolii, which remained relatively stable over the course of each season. Avermectin applications led to increases in the proportions of L. trifolii, and after three weekly applications populations were >95% L. trifolii in both crop systems. However, the rate of change and persistence of L. trifolii in the mixed crop system were less than in the monocrop. These results indicate that L. trifolii is much less susceptible to avermectin than is L. sativae. Further, L. sativae was able to persist in the untreated towel gourd, which probably enabled it to recolonize treated cowpea.	[Gao, Yulin; Wei, Qingbo; Yu, Wenyan; Zhang, Zhi; Lei, Zhongren] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Reitz, Stuart R.] Oregon State Univ, Dept Crop & Soil Sci, Ontario, OR USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Oregon State University	Gao, YL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	ylgao@ippcaas.cn; leizr@sina.com	Gao, Yu/HGE-1937-2022; Reitz, Stuart/AAC-4467-2019		National Key Basic Research Program [2009CB119004]; China Agriculture Research System [CARS-25-B-07]	National Key Basic Research Program(National Basic Research Program of China); China Agriculture Research System	This work was supported in part by the National Key Basic Research Program (973 Projects Grant 2009CB119004) and the China Agriculture Research System (CARS-25-B-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, BIOL INVASIONS, V10, P951, DOI 10.1007/s10530-007-9173-2; Chen XX, 2003, BIOCONTROL, V48, P515, DOI 10.1023/A:1025726813462; Gao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036622; Gao YL, 2011, J ECON ENTOMOL, V104, P1771, DOI 10.1603/EC11206; JOHNSON MW, 1987, J ECON ENTOMOL, V80, P56, DOI 10.1093/jee/80.1.56; KANG L, 1996, ECOLOGY SUSTAINABLE; Kaspi R, 2005, BIOL CONTROL, V35, P172, DOI 10.1016/j.biocontrol.2005.07.021; [雷仲仁 Lei Zhongren], 2007, [植物保护, Plant Protection], V33, P37; Lei ZR, 2005, BIOL MANAGEMENT INVA, P177; MASON GA, 1987, J ECON ENTOMOL, V80, P1262, DOI 10.1093/jee/80.6.1262; Mujica N, 2011, ENVIRON ENTOMOL, V40, P217, DOI 10.1603/EN10170; Musundire R, 2012, J ECON ENTOMOL, V105, P161, DOI 10.1603/EC10420; OATMAN E R, 1976, Journal of Economic Entomology, V69, P667, DOI 10.1093/jee/69.5.667; PALUMBO JC, 1994, J ECON ENTOMOL, V87, P1070, DOI 10.1093/jee/87.4.1070; PARRELLA M P, 1985, Journal of Agricultural Entomology, V2, P234; PARRELLA MP, 1987, ANNU REV ENTOMOL, V32, P201, DOI 10.1146/annurev.en.32.010187.001221; Purcell Mary F., 1995, Proceedings of the Hawaiian Entomological Society, V32, P45; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; Reitz SR, 2013, INSECTICIDES DEV SAF; Tokumaru S, 2005, JPN J APPL ENTOMOL Z, V49, P1, DOI 10.1303/jjaez.2005.1; Weintraub PG, 2001, CROP PROT, V20, P207, DOI 10.1016/S0261-2194(00)00128-9; Zehnder G. W., 1984, California Agriculture, V38, P7; ZEHNDER GW, 1984, ENVIRON ENTOMOL, V13, P492, DOI 10.1093/ee/13.2.492; Zhang WenJun, 2011, Proceedings of the International Academy of Ecology and Environmental Sciences, V1, P125; Zhong PingSheng, 2010, Guangxi Agricultural Sciences, V41, P338	25	14	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92625	10.1371/journal.pone.0092625	http://dx.doi.org/10.1371/journal.pone.0092625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651465	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800135
J	Kooistra, SM; Norgaard, LCR; Lees, MJ; Steinhauer, C; Johansen, JV; Helin, K				Kooistra, Susanne Marije; Norgaard, Lise Christine Rudkjaer; Lees, Michael James; Steinhauer, Cornelia; Johansen, Jens Vilstrup; Helin, Kristian			A Screen Identifies the Oncogenic Micro-RNA miR-378a-5p as a Negative Regulator of Oncogene-Induced Senescence	PLOS ONE			English	Article							DEMETHYLASE JMJD3 CONTRIBUTES; ORAL-CANCER CELLS; TUMOR-SUPPRESSOR; DOWN-REGULATION; CELLULAR SENESCENCE; CYCLE ARREST; EXPRESSION; GENE; PROLIFERATION; ANGIOGENESIS	Oncogene-induced senescence (OIS) can occur in response to hyperactive oncogenic signals and is believed to be a fail-safe mechanism protecting against tumorigenesis. To identify new factors involved in OIS, we performed a screen for microRNAs that can overcome or inhibit OIS in human diploid fibroblasts. This screen led to the identification of miR-378a-5p and in addition several other miRNAs that have previously been shown to play a role in senescence. We show that ectopic expression of miR-378a-5p reduces the expression of several senescence markers, including p16(INK4A) and senescence-associated beta-galactosidase. Moreover, cells with ectopic expression of miR-378a-5p retain proliferative capacity even in the presence of an activated Braf oncogene. Finally, we identified several miR-378a-5p targets in diploid fibroblasts that might explain the mechanism by which the microRNA can delay OIS. We speculate that miR-378a-5p might positively influence tumor formation by delaying OIS, which is consistent with a known pro-oncogenic function of this microRNA.	[Kooistra, Susanne Marije; Norgaard, Lise Christine Rudkjaer; Lees, Michael James; Steinhauer, Cornelia; Johansen, Jens Vilstrup; Helin, Kristian] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Kooistra, Susanne Marije; Norgaard, Lise Christine Rudkjaer; Lees, Michael James; Steinhauer, Cornelia; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Johansen, Jens Vilstrup] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Danish Stem Cell Ctr DanStem, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Helin, K (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark.	kristian.helin@bric.ku.dk	Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022	Helin, Kristian/0000-0003-1975-6097; Steinhauer, Cornelia/0000-0002-5390-4893; Vilstrup Johansen, Jens/0000-0001-7094-6801	Netherlands Organisation for Scientific Research (NWO); Danish National Advanced Technology Foundation; Novo Nordisk Foundation; Lundbeck Foundation; Excellence program of the University of Copenhagen	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Danish National Advanced Technology Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Excellence program of the University of Copenhagen	SMK was supported by a postdoctoral fellowship from the Netherlands Organisation for Scientific Research (NWO). The work in the Helin laboratory was supported by, the Danish National Advanced Technology Foundation, the Novo Nordisk Foundation, the Lundbeck Foundation, and the Excellence program of the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2012, AGEING RES REV, V11, P491, DOI 10.1016/j.arr.2012.01.003; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Bishop CL, 2010, MOL CELL, V40, P533, DOI 10.1016/j.molcel.2010.10.027; Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chandler H, 2013, CURR OPIN CELL BIOL, V25, P765, DOI 10.1016/j.ceb.2013.07.005; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen YJ, 2011, HEAD NECK-J SCI SPEC, V33, P257, DOI 10.1002/hed.21442; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Deng ZQ, 2013, J BIOL CHEM, V288, P319, DOI 10.1074/jbc.M112.418830; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Fang L, 2012, CELL CYCLE, V11, P4352, DOI 10.4161/cc.22670; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Gambaro K, 2013, MOL ONCOL, V7, P513, DOI 10.1016/j.molonc.2012.12.006; Gorospe M, 2011, TRENDS GENET, V27, P233, DOI 10.1016/j.tig.2011.03.005; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kang L, 2008, PATHOL INT, V58, P334, DOI 10.1111/j.1440-1827.2008.02233.x; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Li QC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048278; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Roychoudhury P, 2007, MOL CARCINOGEN, V46, P198, DOI 10.1002/mc.20265; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sharp TV, 2008, P NATL ACAD SCI USA, V105, P19932, DOI 10.1073/pnas.0805003105; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Wu QP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044579; Ying MY, 2011, STEM CELLS, V29, P20, DOI 10.1002/stem.561	44	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91034	10.1371/journal.pone.0091034	http://dx.doi.org/10.1371/journal.pone.0091034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651706	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800028
J	Lu, W; Tamura, T; Song, JN; Akutsu, T				Lu, Wei; Tamura, Takeyuki; Song, Jiangning; Akutsu, Tatsuya			Integer Programming-Based Method for Designing Synthetic Metabolic Networks by Minimum Reaction Insertion in a Boolean Model	PLOS ONE			English	Article							ESCHERICHIA-COLI; ROBUSTNESS; PREDICTION; PATHWAYS; TARGETS	In this paper, we consider the Minimum Reaction Insertion (MRI) problem for finding the minimum number of additional reactions from a reference metabolic network to a host metabolic network so that a target compound becomes producible in the revised host metabolic network in a Boolean model. Although a similar problem for larger networks is solvable in a flux balance analysis (FBA)-based model, the solution of the FBA-based model tends to include more reactions than that of the Boolean model. However, solving MRI using the Boolean model is computationally more expensive than using the FBA-based model since the Boolean model needs more integer variables. Therefore, in this study, to solve MRI for larger networks in the Boolean model, we have developed an efficient Integer Programming formalization method in which the number of integer variables is reduced by the notion of feedback vertex set and minimal valid assignment. As a result of computer experiments conducted using the data of metabolic networks of E. coli and reference networks downloaded from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, we have found that the developed method can appropriately solve MRI in the Boolean model and is applicable to large scale-networks for which an exhaustive search does not work. We have also compared the developed method with the existing connectivity-based methods and FBA-based methods, and show the difference between the solutions of our method and the existing methods. A theoretical analysis of MRI is also conducted, and the NP-completeness of MRI is proved in the Boolean model. Our developed software is available at "http://sunflower.kuicr.kyoto-u.ac.jp/similar to rogi/minRect/minRect.html."	[Lu, Wei; Tamura, Takeyuki; Akutsu, Tatsuya] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan; [Song, Jiangning] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin, Peoples R China	Kyoto University; Monash University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Tamura, T (corresponding author), Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan.	tamura@kuicr.kyoto-u.ac.jp; takutsu@kuicr.kyoto-u.ac.jp	Tamura, Takeyuki/ABI-2627-2020; Song, Jiangning/F-9787-2010	Song, Jiangning/0000-0001-8031-9086; Akutsu, Tatsuya/0000-0001-9763-797X	JSPS, Japan [25730005, 25250028, 22240009]; Chinese Academy of Sciences (CAS); Chinese Academy of Sciences Visiting Professorship for Senior International Scientists, China	JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Chinese Academy of Sciences Visiting Professorship for Senior International Scientists, China	TT was partially supported by JSPS, Japan (Grant-in-Aid for Young Scientists (B) 25730005 and Grant-in-Aid for Scientific Research (A) 25250028). JS is an Australian National Health and Medical Research Council (NHMRC) Peter Doherty Fellow and a recipient of the Hundred Talents Program of the Chinese Academy of Sciences (CAS). TA was partly supported by the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists, China, and Grant-in-Aid #22240009 from JSPS, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Ara K, 2007, BIOTECHNOL APPL BIOC, V46, P169, DOI 10.1042/BA20060111; Bro C, 2006, METAB ENG, V8, P102, DOI 10.1016/j.ymben.2005.09.007; Cho A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-35; de Boer AL, 2003, CURR OPIN CHEM BIOL, V7, P273, DOI 10.1016/S1367-5931(03)00023-1; Ellis LBM, 2006, NUCLEIC ACIDS RES, V34, pD517, DOI 10.1093/nar/gkj076; Gonzalez-Lergier J, 2005, J AM CHEM SOC, V127, P9930, DOI 10.1021/ja051586y; Handorf T, 2005, J MOL EVOL, V61, P498, DOI 10.1007/s00239-005-0027-1; Hatzimanikatis V, 2005, BIOINFORMATICS, V21, P1603, DOI 10.1093/bioinformatics/bti213; Haus UU, 2008, J COMPUT BIOL, V15, P259, DOI 10.1089/cmb.2007.0229; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Hou BK, 2003, J CHEM INF COMP SCI, V43, P1051, DOI 10.1021/ci034018f; Hou BK, 2004, J IND MICROBIOL BIOT, V31, P261, DOI 10.1007/s10295-004-0144-7; IBM, 2022, IBM ILOG CPLEX OPT; Jin GX, 2011, BIOINFORMATICS, V27, pI310, DOI 10.1093/bioinformatics/btr202; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KARMARKAR N, 1984, COMBINATORICA, V4, P373, DOI 10.1007/BF02579150; Lee D, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.027101; Lee JH, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-2; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Lemke N, 2004, BIOINFORMATICS, V20, P115, DOI 10.1093/bioinformatics/btg386; Li Z, 2009, IET SYST BIOL, V3, P523, DOI 10.1049/iet-syb.2008.0166; Mijts BN, 2003, CURR OPIN BIOTECH, V14, P597, DOI 10.1016/j.copbio.2003.09.009; Mizoguchi H, 2007, BIOTECHNOL APPL BIOC, V46, P157, DOI 10.1042/BA200650107; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Prather KLJ, 2008, CURR OPIN BIOTECH, V19, P468, DOI 10.1016/j.copbio.2008.07.009; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Schrijver A., 1998, THEORY LINEAR INTEGE; Smart AG, 2008, P NATL ACAD SCI USA, V105, P13223, DOI 10.1073/pnas.0803571105; Soh KC, 2010, TRENDS BIOTECHNOL, V28, P501, DOI 10.1016/j.tibtech.2010.07.002; Sridhar Padmavati, 2008, Pac Symp Biocomput, P291; Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285; Takemoto K, 2013, PHYSICA A, V392, P5525, DOI 10.1016/j.physa.2013.07.003; Tamura Takeyuki, 2010, International Journal of Knowledge Discovery in Bioinformatics, V1, P14, DOI 10.4018/jkdb.2010100202; Zhenping L, 2007, BIOINFORMATICS, V23, P1631, DOI 10.1093/bioinformatics/btm156	36	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92637	10.1371/journal.pone.0092637	http://dx.doi.org/10.1371/journal.pone.0092637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651476	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800136
J	Rasschaert, F; Telfer, B; Lessitala, F; Decroo, T; Remartinez, D; Biot, M; Candrinho, B; Mbofana, F; Van Damme, W				Rasschaert, Freya; Telfer, Barbara; Lessitala, Faustino; Decroo, Tom; Remartinez, Daniel; Biot, Marc; Candrinho, Baltazar; Mbofana, Francisco; Van Damme, Wim			A Qualitative Assessment of a Community Antiretroviral Therapy Group Model in Tete, Mozambique	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SELF-MANAGEMENT; PATIENT RETENTION; TREATMENT PROGRAM; HEALTH-SERVICES; HIV TREATMENT; CARE; ADHERENCE; COUNTRIES; PEOPLE	Background: To improve retention on ART, Medecins Sans Frontieres, the Ministry of Health and patients piloted a community-based antiretroviral distribution and adherence monitoring model through Community ART Groups (CAG) in Tete, Mozambique. By December 2012, almost 6000 patients on ART had formed groups of whom 95.7% were retained in care. We conducted a qualitative study to evaluate the relevance, dynamic and impact of the CAG model on patients, their communities and the healthcare system. Methods: Between October 2011 and May 2012, we conducted 16 focus group discussions and 24 in-depth interviews with the major stakeholders involved in the CAG model. Audio-recorded data were transcribed verbatim and analysed using a grounded theory approach. Results: Six key themes emerged from the data: 1) Barriers to access HIV care, 2) CAG functioning and actors involved, 3) Benefits for CAG members, 4) Impacts of CAG beyond the group members, 5) Setbacks, and 6) Acceptance and future expectations of the CAG model. The model provides cost and time savings, certainty of ART access and mutual peer support resulting in better adherence to treatment. Through the active role of patients, HIV information could be conveyed to the broader community, leading to an increased uptake of services and positive transformation of the identity of people living with HIV. Potential pitfalls included limited access to CAG for those most vulnerable to defaulting, some inequity to patients in individual ART care and a high dependency on counsellors. Conclusion: The CAG model resulted in active patient involvement and empowerment, and the creation of a supportive environment improving the ART retention. It also sparked a reorientation of healthcare services towards the community and strengthened community actions. Successful implementation and scalability requires (a) the acceptance of patients as partners in health, (b) adequate resources, and (c) a well-functioning monitoring and management system.	[Rasschaert, Freya; Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Telfer, Barbara; Lessitala, Faustino; Decroo, Tom] Med Sans Frontieres Tete, Tete, Mozambique; [Remartinez, Daniel] Med Sans Frontieres Maputo, Maputo, Mozambique; [Biot, Marc] Med Sans Frontieres Brussels, Brussels, Belgium; [Candrinho, Baltazar] Minist Hlth Tete, Tete, Mozambique; [Mbofana, Francisco] Minist Hlth Maputo, Maputo, Mozambique	Institute of Tropical Medicine (ITM)	Rasschaert, F (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	frasschaert@itg.be	Decroo, Tom/AAV-7208-2020; Van Damme, Wim/F-7404-2011	Decroo, Tom/0000-0002-1205-1484; Van Damme, Wim/0000-0002-6344-3007	MSF - Operational Centre Brussels	MSF - Operational Centre Brussels	The study was funded by proper funds (money collected through donations of the general population in mainly European countries) of the MSF - Operational Centre Brussels. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfani F, 2012, 6217 WPS WORLD BANK; [Anonymous], SOC SCI MED, V64, P1549; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bailey J, 2008, FAM PRACT, V25, P127, DOI 10.1093/fampra/cmn003; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Bernard HR, 2006, RES METHODS ANTHR QU, V4th; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Caluwaerts C, 2009, INT HEALTH, V1, P97, DOI 10.1016/j.inhe.2009.03.002; Curtis S, 2000, SOC SCI MED, V50, P1001, DOI 10.1016/S0277-9536(99)00350-0; Decroo T, 2013, INT STD RES IN PRESS; Decroo T, 2013, INT HEALTH, V5, P169, DOI 10.1093/inthealth/iht016; Decroo T, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/749718; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Decroo T, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-6; Foddy W. H., 1993, CONSTRUCTING QUESTIO, DOI 10.1017/CBO9780511518201; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Gifford AL, 2002, JAIDS-J ACQ IMM DEF, V31, pS163, DOI 10.1097/00126334-200212153-00016; Groh K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-650; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; HAYS RB, 1993, AIDS, V7, P425, DOI 10.1097/00002030-199303000-00019; Hennink M., 2011, QUALITATIVE RES METH; Hermann K, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-31; INS INE & ICF Macro, 2010, INQ NAC PREV RISC CO; Instituto Nacional de Estatistica de Mozambique, 2008, PREL REP MULT IND CL; Kipp W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040902; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Kober K, 2011, EXPERT PATIENTS AIDS; Lambdin BH, 2011, JAIDS-J ACQ IMM DEF, V57, pE33, DOI 10.1097/QAI.0b013e3182167e90; Lorig K, 2000, SELF MANAGEMENT ED C; Mak WWS, 2007, SOC SCI MED, V64, P1549, DOI 10.1016/j.socscimed.2006.12.003; Manjate F, 2009, NYAU COMO PRESERVACA; Maxwell J., 2004, QUALITATIVE RES DESI, DOI DOI 10.1177/1094428106290193; Ministry of Health Mozambique, 2012, PROGR TRAT ANT TARV; Ministry of Health of Mozambique, 2010, INQ NAC PREV RISC CO; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Posse M, 2009, AIDS PATIENT CARE ST, V23, P867, DOI 10.1089/apc.2009.0050; Rice E, 2009, AIDS BEHAV, V13, P1253, DOI 10.1007/s10461-009-9554-x; Rifkin S. B., 1986, Health Policy and Planning, V1, P240, DOI 10.1093/heapol/1.3.240; Ssali SN, 2010, AIDS PATIENT CARE ST, V24, P675, DOI 10.1089/apc.2010.0062; Swendeman D, 2009, AIDS CARE, V21, P1321, DOI 10.1080/09540120902803158; Thompson AGH, 2007, SOC SCI MED, V64, P1297, DOI 10.1016/j.socscimed.2006.11.002; Ulin P.R., 2005, QUAL METHODS PUBL HL, P71; Van Damme W, 2008, SOC SCI MED, V66, P2108, DOI 10.1016/j.socscimed.2008.01.043; van Olmen J, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-38; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; WHO UNAIDS UNICEF, 2012, GLOB HIV AIDS RESP E; World Health Organization, 2009, WHO COUNTR COOP STRA; Wouters E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-194	52	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91544	10.1371/journal.pone.0091544	http://dx.doi.org/10.1371/journal.pone.0091544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651523	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800042
J	Watanabe, K; Biesinger, J; Salmans, ML; Roberts, BS; Arthur, WT; Cleary, M; Andersen, B; Xie, XH; Dai, X				Watanabe, Kazuhide; Biesinger, Jacob; Salmans, Michael L.; Roberts, Brian S.; Arthur, William T.; Cleary, Michele; Andersen, Bogi; Xie, Xiaohui; Dai, Xing			Integrative ChIP-seq/Microarray Analysis Identifies a CTNNB1 Target Signature Enriched in Intestinal Stem Cells and Colon Cancer	PLOS ONE			English	Article							CHROMATIN OCCUPANCY; WNT; DNA; ACTIVATION; METHYLATION; PATHWAY; GENES; SET	Background: Deregulation of canonical Wnt/CTNNB1 (beta-catenin) pathway is one of the earliest events in the pathogenesis of colon cancer. Mutations in APC or CTNNB1 are highly frequent in colon cancer and cause aberrant stabilization of CTNNB1, which activates the transcription of Wnt target genes by binding to chromatin via the TCF/LEF transcription factors. Here we report an integrative analysis of genome-wide chromatin occupancy of CTNNB1 by chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-seq) and gene expression profiling by microarray analysis upon RNAi-mediated knockdown of CTNNB1 in colon cancer cells. Results: We observed 3629 CTNNB1 binding peaks across the genome and a significant correlation between CTNNB1 binding and knockdown-induced gene expression change. Our integrative analysis led to the discovery of a direct Wnt target signature composed of 162 genes. Gene ontology analysis of this signature revealed a significant enrichment of Wnt pathway genes, suggesting multiple feedback regulations of the pathway. We provide evidence that this gene signature partially overlaps with the Lgr(5+) intestinal stem cell signature, and is significantly enriched in normal intestinal stem cells as well as in clinical colorectal cancer samples. Interestingly, while the expression of the CTNNB1 target gene set does not correlate with survival, elevated expression of negative feedback regulators within the signature predicts better prognosis. Conclusion: Our data provide a genome-wide view of chromatin occupancy and gene regulation of Wnt/CTNNB1 signaling in colon cancer cells.	[Watanabe, Kazuhide; Salmans, Michael L.; Andersen, Bogi; Dai, Xing] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92717 USA; [Biesinger, Jacob; Xie, Xiaohui; Dai, Xing] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92717 USA; [Biesinger, Jacob; Xie, Xiaohui] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92717 USA; [Roberts, Brian S.; Arthur, William T.; Cleary, Michele] Merck & Co Inc, Rosetta Inpharmat LLC, Seattle, WA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Merck & Company	Dai, X (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92717 USA.	xdai@uci.edu	Watanabe, Kazuhide/C-9667-2017	Watanabe, Kazuhide/0000-0002-5331-0593; Dai, Xing/0000-0001-8134-1365; Xie, Xiaohui/0000-0002-5479-6345; Biesinger, W Jacob B/0000-0003-0172-525X	Susan G. Komen grant [KG110897]; U.S. Department of Defense BCRP Postdoctoral Fellowship [W81XWH-10-1-0383]; National Institutes of Health [R01HG006870]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044882] Funding Source: NIH RePORTER	Susan G. Komen grant(Susan G. Komen Breast Cancer Foundation); U.S. Department of Defense BCRP Postdoctoral Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding from Susan G. Komen grant KG110897 (XD), a U.S. Department of Defense BCRP Postdoctoral Fellowship (K.W. W81XWH-10-1-0383), and National Institutes of Health grant R01HG006870 (to XX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Biechele TL, 2009, COLD SPRING HARB PRO, V2009; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Flowers GP, 2012, DEVELOPMENT, V139, P2416, DOI 10.1242/dev.063206; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Hoverter NP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.139pe43; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Jessen S, 2008, BIOESSAYS, V30, P448, DOI 10.1002/bies.20757; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Karolchik D, 2011, CURR PROTOC HUM GENE; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; King TD, 2006, EXP CELL RES, V312, P3693, DOI 10.1016/j.yexcr.2006.08.010; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Lin GX, 2006, NAT BIOTECHNOL, V24, P1476, DOI 10.1038/nbt1206-1476; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mokry M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015092; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Munoz J, 2012, EMBO J; Najdi Rani, 2011, J Carcinog, V10, P5, DOI 10.4103/1477-3163.78111; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	52	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92317	10.1371/journal.pone.0092317	http://dx.doi.org/10.1371/journal.pone.0092317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651522	gold, Green Published			2022-12-25	WOS:000333352800099
J	Xiao, L; Hu, ZY; Dong, X; Tan, Z; Li, W; Tang, M; Chen, L; Yang, L; Tao, Y; Jiang, Y; Li, J; Yi, B; Li, B; Fan, S; You, S; Deng, X; Hu, F; Feng, L; Bode, AM; Dong, Z; Sun, LQ; Cao, Y				Xiao, L.; Hu, Z-Y; Dong, X.; Tan, Z.; Li, W.; Tang, M.; Chen, L.; Yang, L.; Tao, Y.; Jiang, Y.; Li, J.; Yi, B.; Li, B.; Fan, S.; You, S.; Deng, X.; Hu, F.; Feng, L.; Bode, A. M.; Dong, Z.; Sun, L-Q; Cao, Y.			Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy	ONCOGENE			English	Article							LATENT MEMBRANE-PROTEIN-1; TUMOR-SUPPRESSOR; CANCER; GROWTH; DYSREGULATION; TRANSCRIPTION; MITOCHONDRIA; MAINTENANCE; TRAFFICKING; METABOLISM	Our goal in this work was to illustrate the Epstein-Barr virus (EBV)-modulated global biochemical profile and provide a novel metabolism-related target to improve the therapeutic regimen of nasopharyngeal carcinoma (NPC). We used a metabolomics approach to investigate EBV-modulated metabolic changes, and found that the exogenous overexpression of the EBV-encoded latent membrane protein 1 (LMP1) significantly increased glycolysis. The deregulation of several glycolytic genes, including hexokinase 2 (HK2), was determined to be responsible for the reprogramming of LMP1-mediated glucose metabolism in NPC cells. The upregulation of HK2 elevated aerobic glycolysis and facilitated proliferation by blocking apoptosis. More importantly, HK2 was positively correlated with LMP1 in NPC biopsies, and high HK2 levels were significantly associated with poor overall survival of NPC patients following radiation therapy. Knockdown of HK2 effectively enhanced the sensitivity of LMP1-overexpressing NPC cells to irradiation. Finally, c-Myc was demonstrated to be required for LMP1-induced upregulation of HK2. The LMP1-mediated attenuation of the PI3-K/Akt-GSK3beta-FBW7 signaling axis resulted in the stabilization of c-Myc. These findings indicate a close relationship between EBV and glycolysis in NPC. Notably, LMP1 is the key regulator of the reprogramming of EBV-mediated glycolysis in NPC cells. Given the importance of EBV-mediated deregulation of glycolysis, anti-glycolytic therapy might represent a worthwhile avenue of exploration in the treatment of EBV-related cancers.	[Xiao, L.; Hu, Z-Y; Dong, X.; Tan, Z.; Li, W.; Tang, M.; Chen, L.; Yang, L.; Tao, Y.; Jiang, Y.; Li, J.; Cao, Y.] Cent S Univ, Xiangya Sch Med, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Xiao, L.; Hu, Z-Y; Dong, X.; Tan, Z.; Li, W.; Tang, M.; Chen, L.; Yang, L.; Tao, Y.; Jiang, Y.; Li, J.; Cao, Y.] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha, Hunan, Peoples R China; [Xiao, L.; Hu, Z-Y; Dong, X.; Tan, Z.; Li, W.; Tang, M.; Chen, L.; Yang, L.; Tao, Y.; Jiang, Y.; Li, J.; Cao, Y.] Minist Hlth, Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Hu, Z-Y] First Hosp Changsha City, Changsha, Hunan, Peoples R China; [Tang, M.; Hu, F.; Feng, L.] Cent S Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr, Changsha 410078, Hunan, Peoples R China; [Sun, L-Q] Cent S Univ, Xiangya Hosp, Ctr Mol Med, Changsha 410078, Hunan, Peoples R China; [Yi, B.] Cent S Univ, Xiangya Hosp, Clin Biochem Lab, Changsha 410078, Hunan, Peoples R China; [Li, B.] Cent S Univ, Xiangya Hosp, Dept Pathol, Changsha 410078, Hunan, Peoples R China; [Fan, S.] Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha 410078, Hunan, Peoples R China; [You, S.; Deng, X.] Emory Univ, Sch Med, Winship Canc Inst, Dept Radiat Oncol, Atlanta, GA USA; [You, S.] Cent S Univ, Xiangya Hosp 2, Dept Endocrinol, Changsha 410078, Hunan, Peoples R China; [Bode, A. M.; Dong, Z.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Emory University; Central South University; University of Minnesota System	Sun, LQ (corresponding author), Cent S Univ, Xiangya Hosp, Ctr Mol Med, Xiangya Rd 110, Changsha 410078, Hunan, Peoples R China.	lunquansun@csu.edu.cn; ycao98@vip.sina.com		Jiang, Yiqun/0000-0003-3262-9498	National Basic Research Program of China [2011CB504305]; National High Technology Research and Development Program of China [2012AA02A501]; National Natural Science Foundation of China (NSFC) [30930101, 81161120410]; China Postdoctoral Science Foundation funded project [2011M501300]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation)	We thank Dr Ryan Michalek, Dr Sheng Quan and Dr Lining Guo at Metabolon for metabolomics analysis. We also thank Dr Giovanni Melillo from Bristol-Myers Squibb for their critical comments and suggestions. This study was supported by National Basic Research Program of China, No. 2011CB504305; The National High Technology Research and Development Program of China, No. 2012AA02A501; National Natural Science Foundation of China (NSFC), No. 30930101 and 81161120410; and China Postdoctoral Science Foundation funded project, No. 2011M501300.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; Bhatt AP, 2012, P NATL ACAD SCI USA, V109, P11818, DOI 10.1073/pnas.1205995109; Chen JQ, 2012, BBA-REV CANCER, V1826, P370, DOI 10.1016/j.bbcan.2012.06.004; Darekar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042072; Dawson CW, 2012, SEMIN CANCER BIOL, V22, P144, DOI 10.1016/j.semcancer.2012.01.004; Delgado T, 2010, P NATL ACAD SCI USA, V107, P10696, DOI 10.1073/pnas.1004882107; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Gimenez-Cassina A, 2009, J BIOL CHEM, V284, P3001, DOI 10.1074/jbc.M808698200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu JY, 2005, CLIN CANCER RES, V11, P4658, DOI 10.1158/1078-0432.CCR-04-1798; Zheng H, 2007, CELL MOL IMMUNOL, V4, P185; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kohio HP, 2013, VIROLOGY, V444, P301, DOI 10.1016/j.virol.2013.06.026; Kondo S, 2006, CANCER RES, V66, P9870, DOI 10.1158/0008-5472.CAN-06-1679; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Liu WS, 2012, INT J RADIAT ONCOL, V82, P561, DOI 10.1016/j.ijrobp.2010.11.055; Lu ZX, 2008, CANCER LETT, V265, P226, DOI 10.1016/j.canlet.2008.02.019; Ma XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024647; Mainou BA, 2005, ONCOGENE, V24, P6917, DOI 10.1038/sj.onc.1208846; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Marquitz AR, 2012, P NATL ACAD SCI USA, V109, P9593, DOI 10.1073/pnas.1202910109; Meckes DG, 2013, J VIROL, V87, P1301, DOI 10.1128/JVI.02519-12; Noch E, 2012, MOL CANCER THER, V11, P14, DOI 10.1158/1535-7163.MCT-11-0517; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Shair KHY, 2007, PLOS PATHOG, V3, P1669, DOI 10.1371/journal.ppat.0030166; Shin HJ, 2011, J BIOL CHEM, V286, P29872, DOI 10.1074/jbc.M111.259978; Sommermann TG, 2011, CANCER RES, V71, P7291, DOI 10.1158/0008-5472.CAN-11-1715; Soni V, 2007, ADV EXP MED BIOL, V597, P173; Tang LQ, 2013, J CLIN ONCOL, V31, P2861, DOI 10.1200/JCO.2012.46.0816; Terrin L, 2008, J VIROL, V82, P10175, DOI 10.1128/JVI.00321-08; Vastag L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002124; Wakisaka N, 2004, MOL CELL BIOL, V24, P5223, DOI 10.1128/MCB.24.12.5223-5234.2004; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang HN, 2006, P NATL ACAD SCI USA, V103, P10397, DOI 10.1073/pnas.0604008103; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417	45	130	135	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 11	2014	33	37					4568	4578		10.1038/onc.2014.32	http://dx.doi.org/10.1038/onc.2014.32			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3UZ	24662831	Green Published, hybrid			2022-12-25	WOS:000342004800004
J	Grant, R; Nguyen, KY; Ravussin, A; Albarado, D; Youm, YH; Dixit, VD				Grant, Ryan; Nguyen, Kim Y.; Ravussin, Anthony; Albarado, Diana; Youm, Yun-Hee; Dixit, Vishwa Deep			Inactivation of C/ebp Homologous Protein-driven ImmuneMetabolic Interactions Exacerbate Obesity and Adipose Tissue Leukocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue Metabolism; Cell Metabolism; Energy Metabolism; Immunology; Inflammation; Insulin Resistance	ENDOPLASMIC-RETICULUM STRESS; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; ER STRESS; NLRP3 INFLAMMASOME; INSULIN-RESISTANCE; GLUCOSE-HOMEOSTASIS; CHEMICAL CHAPERONES; CELL-DEATH; CHOP; APOPTOSIS	Background: C/ebp homologous protein contributes to ER stress-induced inflammatory cytokine secretion and apoptosis. Results: Loss of Chop increases obesity, insulin resistance, and adipose tissue leukocytosis and inflammation. Conclusion: ER stress signaling through Chop is necessary for adaptation to a high fat diet. Significance: Although in obesity ER stress may impair metabolic health, inactivation of Chop promotes obesity-associated inflammation. Successful adaptation to periods of chronic caloric excess is a highly coordinated event that is critical to the survival and propagation of species. Transcription factor C/ebp homologous protein (Chop) is thought to be an important molecular mediator that integrates nutrient signals to endoplasmic reticulum (ER) stress and innate immune activation. Given that aberrant ER stress response is implicated in inducing metabolic inflammation and insulin resistance, we hypothesized that ER stress target gene Chop integrates immune and metabolic systems to adapt to chronic positive energy balance. Here we report that inactivation of Chop in mice fed a high fat diet led to significant increase in obesity caused by a reduction in energy expenditure without any change in food intake. Importantly, ablation of Chop does not induce metabolically healthy obesity, because Chop-deficient mice fed a high fat diet had increased hepatic steatosis with significantly higher insulin resistance. Quantification of adipose tissue leukocytosis revealed that elimination of Chop during obesity led to substantial increase in number of adipose tissue T and B lymphocytes. In addition, deficiency of Chop led to increase in total number of myeloid subpopulations like neutrophils and F4/80(+) adipose tissue macrophages without any alterations in the frequency of M1- or M2-like adipose tissue macrophages. Further investigation of inflammatory mechanisms revealed that ablation of Chop increases the sensitivity of macrophages to inflammasome-induced activation of IL- in macrophages. Our findings indicate that regulated expression of Chop during obesity is critical for adaptation to chronic caloric excess and maintenance of energy homeostasis via integration of metabolic and immune systems.	[Grant, Ryan; Albarado, Diana; Dixit, Vishwa Deep] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Nguyen, Kim Y.; Ravussin, Anthony; Youm, Yun-Hee; Dixit, Vishwa Deep] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Nguyen, Kim Y.; Ravussin, Anthony; Youm, Yun-Hee; Dixit, Vishwa Deep] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Yale University; Yale University	Dixit, VD (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, 310 Cedar St, New Haven, CT 06520 USA.	Vishwa.Dixit@yale.edu		Youm, Yun-Hee/0000-0002-8098-8527; Ravussin, Anthony/0000-0003-4237-3190; Grant, Ryan/0000-0002-8940-4196	National Institutes of Health [AG31797, AG043608, AI105097, DK090556]; T32 Training Grant [DK064584-10]; Pennington Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI105097, R01AI105097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090556, T32DK064584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043608, R01AG031797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 Training Grant; Pennington Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG31797, AG043608, AI105097, and DK090556 (to V. D. D.) and T32 Training Grant DK064584-10 (to R. W. G.). This work was also supported by the Pennington Foundation.	Allagnat F, 2012, CELL DEATH DIFFER, V19, P1836, DOI 10.1038/cdd.2012.67; Ariyama Y, 2007, OBESITY, V15, P1647, DOI 10.1038/oby.2007.197; Dixit VD, 2012, SEMIN IMMUNOL, V24, P321, DOI 10.1016/j.smim.2012.04.002; Dong J, 2007, AM J PHYSIOL-CELL PH, V292, pC209, DOI 10.1152/ajpcell.00157.2006; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Esposito V, 2013, AM J PHYSIOL-RENAL, V304, pF440, DOI 10.1152/ajprenal.00487.2011; Ferrante AW, 2013, J CLIN INVEST, V123, P4992, DOI 10.1172/JCI73658; Grant RW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00050; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Han J, 2013, DIABETOLOGIA, V56, P911, DOI 10.1007/s00125-012-2809-5; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Malhi H, 2013, J BIOL CHEM, V288, P18624, DOI 10.1074/jbc.M112.442954; Maris M, 2012, DIABETOLOGIA, V55, P1167, DOI 10.1007/s00125-011-2427-7; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Scull CM, 2011, ARTERIOSCL THROM VAS, V31, P2792, DOI 10.1161/ATVBAHA.111.224881; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	34	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14045	14055		10.1074/jbc.M113.545921	http://dx.doi.org/10.1074/jbc.M113.545921			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24662293	Green Published, hybrid			2022-12-25	WOS:000335984600034
J	Goosens, VJ; Monteferrante, CG; van Dijl, JM				Goosens, Vivianne J.; Monteferrante, Carmine G.; van Dijl, Jan Maarten			Co-factor Insertion and Disulfide Bond Requirements for Twin-arginine Translocase-dependent Export of the Bacillus subtilis Rieske Protein QcrA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; Cytochromes; Disulfide; Iron-Sulfur Protein; Protein Translocation; QcrA; Rieske Protein; TatAy; Twin-arginine Translocation	CYTOCHROME BC(1) COMPLEX; WATER-SOLUBLE FRAGMENT; GRAM-POSITIVE BACTERIA; LEADER-BINDING PROTEIN; IRON-SULFUR PROTEIN; ESCHERICHIA-COLI; SIGNAL PEPTIDE; TAT PATHWAY; MEMBRANE-PROTEINS; QUALITY-CONTROL	Background: The Rieske protein QcrA was recently shown to be exported by twin-arginine translocation (Tat) in Bacillus subtilis. Results: QcrA has disulfide bond and co-factor requirements for effective Tat-dependent translocation. Conclusion: A hierarchy exists between disulfide bonding and co-factor insertion in QcrA quality control and translocation. Significance: First studies on Tat-dependent translocation where oxidative folding and co-factor attachment were addressed in a single native molecule. The twin-arginine translocation (Tat) pathway can transport folded and co-factor-containing cargo proteins over bacterial cytoplasmic membranes. Functional Tat machinery components, a folded state of the cargo protein and correct co-factor insertion in the cargo protein are generally considered as prerequisites for successful translocation. The present studies were aimed at a dissection of these requirements with regard to the Rieske iron-sulfur protein QcrA of Bacillus subtilis. Notably, QcrA is a component of the cytochrome bc(1) complex, which is conserved from bacteria to man. Single amino acid substitutions were introduced into the Rieske domain of QcrA to prevent either co-factor binding or disulfide bond formation. Both types of mutations precluded QcrA translocation. Importantly, a proofreading hierarchy was uncovered, where a QcrA mutant defective in disulfide bonding was quickly degraded, whereas mutant QcrA proteins defective in co-factor binding accumulated in the cytoplasm and membrane. Altogether, these are the first studies on Tat-dependent protein translocation where both oxidative folding and co-factor attachment have been addressed in a single native molecule.	[Goosens, Vivianne J.; Monteferrante, Carmine G.; van Dijl, Jan Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands	University of Groningen	van Dijl, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Hanzepl 1,POB 30001, NL-9700 RB Groningen, Netherlands.	j.m.van.dijl01@umcg.nl		Goosens, Vivianne/0000-0002-7808-5185	CEU [PITN-GA-2008-215524, LSHG-CT-2006-037469, LSHG-CT-2006-244093]; transnational SysMO initiative through projects BACELL SysMO1 and -2; Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research (NWO-ALW)	CEU; transnational SysMO initiative through projects BACELL SysMO1 and -2; Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by CEU projects PITN-GA-2008-215524 (TranSys), LSHG-CT-2006-037469 and -244093 (to V. J. G. and J. M. v. D.), and the transnational SysMO initiative through projects BACELL SysMO1 and -2 with funding from the Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research (NWO-ALW).	Ahuja U, 2009, MOL MICROBIOL, V73, P1058, DOI 10.1111/j.1365-2958.2009.06833.x; Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Bachmann J, 2006, FEBS J, V273, P4817, DOI 10.1111/j.1742-4658.2006.05480.x; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bongers RS, 2005, APPL ENVIRON MICROB, V71, P8818, DOI 10.1128/AEM.71.12.8818-8824.2005; Bron S, 1998, J BIOTECHNOL, V64, P3, DOI 10.1016/S0168-1656(98)00099-6; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dalbey RE, 2012, MICROBIOL MOL BIOL R, V76, P311, DOI 10.1128/MMBR.05019-11; De Buck E, 2007, FEBS LETT, V581, P259, DOI 10.1016/j.febslet.2006.12.022; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Draskovic I, 2005, MOL MICROBIOL, V55, P881, DOI 10.1111/j.1365-2958.2004.04430.x; Dubois JYF, 2009, ANTIMICROB AGENTS CH, V53, P651, DOI 10.1128/AAC.01189-08; Eijlander RT, 2009, MICROBIOL-SGM, V155, P1776, DOI 10.1099/mic.0.027987-0; Erlendsson LS, 2003, J BIOL CHEM, V278, P17852, DOI 10.1074/jbc.M300103200; Freudl R, 2013, RES MICROBIOL, V164, P664, DOI 10.1016/j.resmic.2013.03.014; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; GASSON MJ, 1983, J BACTERIOL, V154, P1; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; Goosens VJ, 2013, ANTIOXID REDOX SIGN, V18, P1159, DOI 10.1089/ars.2012.4664; Goosens VJ, 2013, J PROTEOME RES, V12, P796, DOI 10.1021/pr300866f; Graumann P, 2012, BACILLUS: CELLULAR AND MOLECULAR BIOLOGY, SECOND EDITION, P1; Gubernator B, 2006, BBA-PROTEINS PROTEOM, V1764, P735, DOI 10.1016/j.bbapap.2005.12.013; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; Hochgrafe F, 2005, MOL MICROBIOL, V58, P409, DOI 10.1111/j.1365-2958.2005.04845.x; Hodson CTC, 2008, J BACTERIOL, V190, P4697, DOI 10.1128/JB.00145-08; Hopkins A, 2014, J BACTERIOL, V196, P50, DOI 10.1128/JB.00776-13; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Jongbloed JDH, 2002, J BIOL CHEM, V277, P44068, DOI 10.1074/jbc.M203191200; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Keller R, 2012, J CELL BIOL, V199, P303, DOI 10.1083/jcb.201204149; Kim JY, 2005, APPL ENVIRON MICROB, V71, P8451, DOI 10.1128/AEM.71.12.8451-8459.2005; Kolkman MAB, 2008, APPL ENVIRON MICROB, V74, P7507, DOI 10.1128/AEM.01401-08; Kouwen TRHM, 2007, MOL MICROBIOL, V64, P984, DOI 10.1111/j.1365-2958.2007.05707.x; Kouwen TRHM, 2009, PROTEOMICS, V9, P1018, DOI 10.1002/pmic.200800580; Kouwen TRHM, 2008, APPL ENVIRON MICROB, V74, P7536, DOI 10.1128/AEM.00894-08; Krishnappa L, 2013, J PROTEOME RES, V12, P4101, DOI 10.1021/pr400433h; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Link TA, 1996, EUR J BIOCHEM, V237, P71, DOI 10.1111/j.1432-1033.1996.0071n.x; Matos CFRO, 2008, EMBO J, V27, P2055, DOI 10.1038/emboj.2008.132; Maurer C, 2009, FEBS LETT, V583, P2849, DOI 10.1016/j.febslet.2009.07.038; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; Miethke M, 2013, BBA-MOL CELL RES, V1833, P2267, DOI 10.1016/j.bbamcr.2013.05.027; Molik S, 2001, J BIOL CHEM, V276, P42761, DOI 10.1074/jbc.M106690200; Monteferrante CG, 2012, J BIOL CHEM, V287, P29789, DOI 10.1074/jbc.M112.378190; Monteferrante CG, 2012, APPL ENVIRON MICROB, V78, P4999, DOI 10.1128/AEM.01108-12; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Oresnik IJ, 2001, MOL MICROBIOL, V40, P323, DOI 10.1046/j.1365-2958.2001.02391.x; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Papish AL, 2003, J BIOL CHEM, V278, P32501, DOI 10.1074/jbc.M301076200; Ribnicky B, 2007, J MOL BIOL, V369, P631, DOI 10.1016/j.jmb.2007.03.068; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Sambrook F., 1989, MOL CLONING LAB MANU; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Schiott T, 1997, J BACTERIOL, V179, P4523, DOI 10.1128/jb.179.14.4523-4529.1997; Schmidt CL, 2001, J BIOENERG BIOMEMBR, V33, P9, DOI 10.1023/A:1005616505962; Schneider D, 2005, BBA-BIOENERGETICS, V1710, P1, DOI 10.1016/j.bbabio.2005.09.003; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; van der Ploeg R, 2011, J BIOL CHEM, V286, P43759, DOI 10.1074/jbc.M111.243824; van der Ploeg R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018140; van Dijl JM, 2002, J BIOTECHNOL, V98, P243, DOI 10.1016/S0168-1656(02)00135-9; VANDIJL JM, 1991, J GEN MICROBIOL, V137, P2073, DOI 10.1099/00221287-137-9-2073; Vogtentanz G, 2007, PROTEIN EXPRES PURIF, V55, P40, DOI 10.1016/j.pep.2007.05.001; Whitaker N, 2012, J BIOL CHEM, V287, P11252, DOI 10.1074/jbc.M111.324525; Winstedt L, 2000, J BACTERIOL, V182, P6557, DOI 10.1128/JB.182.23.6557-6564.2000; YU J, 1995, J BACTERIOL, V177, P6751, DOI 10.1128/jb.177.23.6751-6760.1995	79	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13124	13131		10.1074/jbc.M113.529677	http://dx.doi.org/10.1074/jbc.M113.529677			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652282	hybrid, Green Published			2022-12-25	WOS:000335522800014
J	Gurunathan, S; Winkles, JA; Ghosh, S; Hayden, MS				Gurunathan, Sujatha; Winkles, Jeffrey A.; Ghosh, Sankar; Hayden, Matthew S.			Regulation of Fibroblast Growth Factor-inducible 14 ( Fn14) Expression Levels via Ligand-independent Lysosomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Receptor Endocytosis; Receptor Regulation; Trafficking; Tumor Necrosis Factor (TNF); Proteostasis; Fn14; Tweak	TNF RECEPTOR 1; FACTOR-KAPPA-B; WEAK INDUCER; TWEAK/FN14 PATHWAY; THERAPEUTIC TARGET; SUPERFAMILY MEMBER; ENDOTHELIAL-CELLS; PROGENITOR CELLS; DOWN-REGULATION; TUMOR-CELLS	Background: Fn14 is a highly inducible TNF superfamily cytokine receptor. Results: Fn14 undergoes rapid, ligand-independent internalization and degradation mediated by the extracellular domain of the receptor. Conclusion: Fn14 expression is regulated through transcription as described previously and through a novel post-translational mechanism. Significance: Receptor trafficking may play an important role in regulating receptor availability, cytokine responses, and ligand-independent signaling. Fibroblast growth factor-inducible 14 (Fn14) is a highly inducible cytokine receptor that engages multiple intracellular signaling pathways, including nuclear factor-B (NF-B) and mitogen-activated protein kinase (MAPK). Fn14 expression is regulated by several cytokines and growth factors, and Fn14 is transiently up-regulated after injury. In contrast, in states of chronic inflammatory disease and in some solid tumors, Fn14 is persistently up-regulated. However, the post-translational regulation of Fn14 expression has not been directly investigated. Thus, we examined Fn14 proteostasis in the presence and absence of the Fn14 ligand TNF-like weak inducer of apoptosis (TWEAK). Similar to other TNF receptor superfamily members, we found that TWEAK induces Fn14 internalization and degradation. Surprisingly, we also observed rapid, TWEAK-independent, constitutive Fn14 internalization and turnover. Fn14 levels are maintained in cell culture by ongoing synthesis and trafficking of the receptor, leading to subsequent down-regulation by lysosomal degradation. Unexpectedly, the extracellular domain of Fn14 is necessary and sufficient for constitutive turnover. Based on these findings, we propose a model in which constitutive down-regulation of Fn14 facilitates dynamic regulation of Fn14 protein levels and prevents spontaneous or inappropriate receptor signaling.	[Gurunathan, Sujatha; Ghosh, Sankar; Hayden, Matthew S.] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Gurunathan, Sujatha; Hayden, Matthew S.] Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; [Winkles, Jeffrey A.] Univ Maryland, Dept Surg, Ctr Vasc & Inflammatory Dis, Sch Med, Baltimore, MD 21201 USA; [Winkles, Jeffrey A.] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Sch Med, Baltimore, MD 21201 USA	Columbia University; Columbia University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Ghosh, S (corresponding author), Columbia Univ, Dept Microbiol & Immunol, 710W 168th St, New York, NY 10032 USA.	sg2715@columbia.edu		Hayden, Matthew/0000-0003-1670-6430	National Institutes of Health [P30 AR058886, R37 AI33443, R01 CA130967, R01 NS055126]; NATIONAL CANCER INSTITUTE [R01CA130967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058886, P30AR044535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 AR058886 (to M. S. H.), R37 AI33443 (to S. G.), and R01 CA130967 and R01 NS055126 (to J. A. W.). This work was also supported by institutional support from Columbia University.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Anolik J, 2003, EUR J IMMUNOL, V33, P2398, DOI 10.1002/eji.200323515; Asrani K, 2013, MOL CANCER RES, V11, P393, DOI 10.1158/1541-7786.MCR-12-0542; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; BRADLEY JR, 1993, J IMMUNOL, V150, P5544; Brown SAN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065248; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Chen JJ, 2007, ARTERIOSCL THROM VAS, V27, P2005, DOI 10.1161/ATVBAHA.107.145961; Chen YH, 2006, J PINEAL RES, V40, P40, DOI 10.1111/j.1600-079X.2005.00274.x; Desplat-Jego S, 2005, CLIN IMMUNOL, V117, P15, DOI 10.1016/j.clim.2005.06.005; Desplat-Jego S, 2002, J NEUROIMMUNOL, V133, P116, DOI 10.1016/S0165-5728(02)00368-5; Dohi T, 2012, J LEUKOCYTE BIOL, V92, P265, DOI 10.1189/jlb.0112042; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Felli N, 2005, J IMMUNOL, V175, P1464, DOI 10.4049/jimmunol.175.3.1464; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; HIGUCHI M, 1994, J IMMUNOL, V152, P3550; Hosokawa Y, 2006, CLIN EXP IMMUNOL, V146, P540, DOI 10.1111/j.1365-2249.2006.03233.x; Jakubowski A, 2002, J CELL SCI, V115, P267; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Justo P, 2006, KIDNEY INT, V70, P1750, DOI 10.1038/sj.ki.5001866; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kwon OH, 2012, CANCER LETT, V314, P73, DOI 10.1016/j.canlet.2011.09.016; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Michaelson JS, 2005, ONCOGENE, V24, P2613, DOI 10.1038/sj.onc.1208208; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Munoz-Garcia B, 2006, STROKE, V37, P2044, DOI 10.1161/01.STR.0000230648.00027.00; Nakayama M, 2002, J IMMUNOL, V168, P734, DOI 10.4049/jimmunol.168.2.734; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Philipp S, 2010, P NATL ACAD SCI USA, V107, P1112, DOI 10.1073/pnas.0908486107; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Potrovita I, 2004, J NEUROSCI, V24, P8237, DOI 10.1523/JNEUROSCI.1089-04.2004; Salzmann S, 2013, J BIOL CHEM, V288, P13455, DOI 10.1074/jbc.M112.435917; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; SEGLEN O, 1975, BIOCHEM BIOPH RES CO, V66, P44, DOI 10.1016/S0006-291X(75)80292-0; Serafini B, 2008, J NEUROPATH EXP NEUR, V67, P1137, DOI 10.1097/NEN.0b013e31818dab90; Tanabe K, 2003, J NEUROSCI, V23, P9675; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; TSUJIMOTO M, 1987, J BIOCHEM-TOKYO, V102, P1571, DOI 10.1093/oxfordjournals.jbchem.a122206; Tucker TA, 2008, EUR J IMMUNOL, V38, P864, DOI 10.1002/eji.200737828; van Kuijk AWR, 2010, ANN RHEUM DIS, V69, P301, DOI 10.1136/ard.2008.090548; Vince JE, 2006, CELL DEATH DIFFER, V13, P1842, DOI 10.1038/sj.cdd.4402027; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Watts GS, 2007, INT J CANCER, V121, P2132, DOI 10.1002/ijc.22898; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; YELLIN MJ, 1994, J IMMUNOL, V152, P598; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zavzavadjian JR, 2007, MOL CELL PROTEOMICS, V6, P413, DOI 10.1074/mcp.M600437-MCP200; Zhou H, 2013, CANCER RES, V73, P4439, DOI 10.1158/0008-5472.CAN-13-0187; Zhou H, 2013, J INVEST DERMATOL, V133, P1052, DOI 10.1038/jid.2012.402; Zhou H, 2011, MOL CANCER THER, V10, P1276, DOI 10.1158/1535-7163.MCT-11-0161	63	19	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					12976	12988		10.1074/jbc.M114.563478	http://dx.doi.org/10.1074/jbc.M114.563478			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652288	Green Published, hybrid			2022-12-25	WOS:000335522800003
J	Ayme, L; Baud, S; Dubreucq, B; Joffre, F; Chardot, T				Ayme, Laure; Baud, Sebastien; Dubreucq, Bertrand; Joffre, Florent; Chardot, Thierry			Function and Localization of the Arabidopsis thaliana Diacylglycerol Acyltransferase DGAT2 Expressed in Yeast	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; TRIACYLGLYCEROL SYNTHESIS; LIPID BODIES; HETEROLOGOUS EXPRESSION; KEY ENZYME; IDENTIFICATION; CLONING; FAMILY; PURIFICATION; BIOGENESIS	Diacylglycerol acyltransferases (DGATs) catalyze the final and only committed step of triacylglycerol synthesis. DGAT activity is rate limiting for triacylglycerol accumulation in mammals, plants and microbes. DGATs belong to three different evolutionary classes. In Arabidopsis thaliana, DGAT1, encoded by At2g19450, is the major DGAT enzyme involved in triacylglycerol accumulation in seeds. Until recently, the function of DGAT2 (At3g51520) has remained elusive. Previous attempts to characterize its enzymatic function by heterologous expression in yeast were unsuccessful. In the present report we demonstrate that expression of a codon-optimized version of the DGAT2 gene is able to restore neutral lipid accumulation in the Saccharomyces cerevisiae mutant strain (H1246), which is defective in triacylglycerol biosynthesis. Heterologous expression of codon-optimized DGAT2 and DGAT1 induced the biogenesis of subcellular lipid droplets containing triacylglycerols and squalene. Both DGAT proteins were found to be associated with these lipid droplets. The fatty acid composition was affected by the nature of the acyltransferase expressed. DGAT2 preferentially incorporated C16:1 fatty acids whereas DGAT1 displayed preference for C16: 0, strongly suggesting that these enzymes have contrasting substrate specificities.	[Ayme, Laure; Baud, Sebastien; Dubreucq, Bertrand; Chardot, Thierry] INRA, Inst Jean Pierre Bourgin, UMR1318, Saclay Plant Sci, F-78026 Versailles, France; [Ayme, Laure; Baud, Sebastien; Dubreucq, Bertrand; Chardot, Thierry] AgroParisTech, Inst Jean Pierre Bourgin, Saclay Plant Sci, Versailles, France; [Joffre, Florent] ITERG, Pessac, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Chardot, T (corresponding author), INRA, Inst Jean Pierre Bourgin, UMR1318, Saclay Plant Sci, F-78026 Versailles, France.	thierry.chardot@versailles.inra.fr	Baud, Sébastien/ABI-7606-2020; DUBREUCQ, Bertrand/AAY-9948-2020	Baud, Sébastien/0000-0002-5507-327X; DUBREUCQ, Bertrand/0000-0003-2661-5479; Chardot, Thierry/0000-0001-6689-6151; JOFFRE, Florent/0000-0002-5028-5302	DGA (Direction Generale de l'Armement)/DGAC (Direction Generale de l'Aviation Civile) [2012 93 0805]	DGA (Direction Generale de l'Armement)/DGAC (Direction Generale de l'Aviation Civile)	This work was done in the context of the program CAER supported by DGA (Direction Generale de l'Armement)/DGAC (Direction Generale de l'Aviation Civile) under the convention no 2012 93 0805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Beopoulos A, 2012, APPL MICROBIOL BIOT, V93, P1523, DOI 10.1007/s00253-011-3506-x; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Cahoon EB, 2007, CURR OPIN PLANT BIOL, V10, P236, DOI 10.1016/j.pbi.2007.04.005; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2002, DIABETES, V51, P3189, DOI 10.2337/diabetes.51.11.3189; Chiapello H, 1998, GENE, V209, pGC1, DOI 10.1016/S0378-1119(97)00671-9; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; FOLCH J, 1957, J BIOL CHEM, V226, P497; Froissard Marine, 2006, Biotechnology Journal, V1, P308, DOI 10.1002/biot.200500034; Froissard M, 2009, FEMS YEAST RES, V9, P428, DOI 10.1111/j.1567-1364.2009.00483.x; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; KATAVIC V, 1995, PLANT PHYSIOL, V108, P399, DOI 10.1104/pp.108.1.399; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; Kwiatkowska M, 2012, FOLIA HISTOCHEM CYTO, V50, P427, DOI [10.5603/19752, 10.5603/FHC.2012.0058]; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; LEHNER R, 1993, J BIOL CHEM, V268, P8781; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Hernandez ML, 2012, PLANT PHYSIOL, V160, P215, DOI 10.1104/pp.112.201541; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Miquel M., 1995, SEED DEV GERMINATION, P169; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; POCKLINGTON WD, 1985, PURE APPL CHEM, V57, P1515, DOI 10.1351/pac198557101515; Routaboul JM, 1999, PLANT PHYSIOL BIOCH, V37, P831, DOI 10.1016/S0981-9428(99)00115-1; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Spanova M, 2011, EUROPEAN J LIPID SCI, V113, P1299; Spanova M, 2012, BBA-MOL CELL BIOL L, V1821, P647, DOI 10.1016/j.bbalip.2012.01.015; Spanova M, 2010, J BIOL CHEM, V285, P6127, DOI 10.1074/jbc.M109.074229; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; Stobart K, 1997, PLANTA, V203, P58, DOI 10.1007/s004250050165; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Turchetto-Zolet AC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-263; Vindigni JD, 2013, BBA-BIOMEMBRANES, V1828, P1881, DOI 10.1016/j.bbamem.2013.04.009; Weselake Randall J., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-24; Weselake RJ, 2009, BIOTECHNOL ADV, V27, P866, DOI 10.1016/j.biotechadv.2009.07.001; Xu JY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-4; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yu WG, 2000, BLOOD, V95, P1078, DOI 10.1182/blood.V95.3.1078.003k16_1078_1085; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zhou XR, 2013, FEBS LETT, V587, P2371, DOI 10.1016/j.febslet.2013.06.003; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	56	41	44	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92237	10.1371/journal.pone.0092237	http://dx.doi.org/10.1371/journal.pone.0092237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663078	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900045
J	De Michele, C; Accatino, F				De Michele, Carlo; Accatino, Francesco			Tree Cover Bimodality in Savannas and Forests Emerging from the Switching between Two Fire Dynamics	PLOS ONE			English	Article							ALTERNATIVE STABLE STATES; POSITIVE FEEDBACKS; TROPICAL SAVANNA; AFRICAN SAVANNA; MATRIX MODEL; VEGETATION; ECOLOGY; DETERMINANTS; THRESHOLDS; RESILIENCE	Moist savannas and tropical forests share the same climatic conditions and occur side by side. Experimental evidences show that the tree cover of these ecosystems exhibits a bimodal frequency distribution. This is considered as a proof of savanna-forest bistability, predicted by dynamic vegetation models based on non-linear differential equations. Here, we propose a change of perspective about the bimodality of tree cover distribution. We show, using a simple matrix model of tree dynamics, how the bimodality of tree cover can emerge from the switching between two linear dynamics of trees, one in presence and one in absence of fire, with a feedback between fire and trees. As consequence, we find that the transitions between moist savannas and tropical forests, if sharp, are not necessarily catastrophic.	[De Michele, Carlo; Accatino, Francesco] Politecn Milan, Dept Civil & Environm Engn, I-20133 Milan, Italy	Polytechnic University of Milan	De Michele, C (corresponding author), Politecn Milan, Dept Civil & Environm Engn, I-20133 Milan, Italy.	carlo.demichele@polimi.it	ACCATINO, Francesco/AAQ-8022-2020; De Michele, Carlo/L-7503-2015	De Michele, Carlo/0000-0002-7098-4725	Ministry of Foreign Affairs	Ministry of Foreign Affairs(Ministry of Foreign Affairs and International Cooperation (Italy))	Funded by Ministry of Foreign Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accatino F, 2013, ECOL MODEL, V265, P170, DOI 10.1016/j.ecolmodel.2013.05.022; Accatino F, 2010, J THEOR BIOL, V267, P235, DOI 10.1016/j.jtbi.2010.08.012; Beckage B, 2011, ECOL MODEL, V222, P2227, DOI 10.1016/j.ecolmodel.2011.01.015; Beckage B, 2009, AM NAT, V174, P805, DOI 10.1086/648458; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.1890/1540-9295(2003)001[0376:ASSIE]2.0.CO;2; Bestelmeyer BT, 2013, ECOL LETT, V16, P339, DOI 10.1111/ele.12045; Boettiger C, 2013, NATURE, V493, P157, DOI 10.1038/493157a; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Buceta J, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.036216; Buckley YM, 2010, ECOL LETT, V13, P1182, DOI 10.1111/j.1461-0248.2010.01506.x; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Conlisk J, 1973, ECONOMICA, V11, P402; Costa O. L. V., 2006, DISCRETE TIME MARKOV; D'Odorico P, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027499; De Michele C, 2011, J THEOR BIOL, V289, P74, DOI 10.1016/j.jtbi.2011.08.014; Dogruel M, 1995, 383 P 1995 IEEE INT, V2, P1324; Favier C, 2012, GLOBAL ECOL BIOGEOGR, V21, P787, DOI 10.1111/j.1466-8238.2011.00725.x; Gavin DG, 2006, ECOLOGY, V87, P1722, DOI 10.1890/0012-9658(2006)87[1722:WCCOSF]2.0.CO;2; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; GURVITS L, 1995, LINEAR ALGEBRA APPL, V231, P47, DOI 10.1016/0024-3795(94)00010-7; Higgins SI, 2007, ECOLOGY, V88, P1119, DOI 10.1890/06-1664; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Hoffmann WA, 1999, ECOLOGY, V80, P1354, DOI 10.1890/0012-9658(1999)080[1354:FAPDOW]2.0.CO;2; Hoffmann WA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015424; Hoffmann WA, 2003, FUNCT ECOL, V17, P720, DOI 10.1111/j.1365-2435.2003.00796.x; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Rietkerk M, 1997, OIKOS, V79, P69, DOI 10.2307/3546091; Salguero-Gomez R, 2010, AM NAT, V176, P710, DOI 10.1086/657044; Salguero-Gomez R, 2010, J ECOL, V98, P250, DOI 10.1111/j.1365-2745.2009.01635.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scheffer M., 2009, CRITICAL TRANSITIONS; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Staver AC, 2009, ECOL APPL, V19, P1909, DOI 10.1890/08-1907.1; STUARTHILL GC, 1989, J APPL ECOL, V26, P285, DOI 10.2307/2403668; Van Nes EH, 2005, ECOL MODEL, V185, P153, DOI 10.1016/j.ecolmodel.2004.12.001; van Wilgen BW, 2009, S AFR J SCI, V105, P343; Van Wilgen B.W., 2003, KRUGER EXPERIENCE, P149; Ward D., 2005, African Journal of Range & Forage Science, V22, P101, DOI 10.2989/10220110509485867; Whitlock C., 2010, OPEN ECOL J, V3, P6	42	8	8	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91195	10.1371/journal.pone.0091195	http://dx.doi.org/10.1371/journal.pone.0091195			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663432	Green Published, gold			2022-12-25	WOS:000333459900015
J	Ouyang, B; Sun, XZ; Han, DY; Chen, SF; Yao, B; Gao, Y; Bian, J; Huang, YP; Zhang, YD; Wan, Z; Yang, B; Xiao, HP; Zhou, SY; Liu, GH; Zhang, YY; Deng, CH				Ouyang, Bin; Sun, Xiangzhou; Han, Dayu; Chen, Shenfu; Yao, Bing; Gao, Yong; Bian, Jun; Huang, Yanping; Zhang, Yadong; Wan, Zi; Yang, Bin; Xiao, Haipeng; Zhou Songyang; Liu, Guihua; Zhang, Yuanyuan; Deng, Chunhua			Human Urine-Derived Stem Cells Alone or Genetically-Modified with FGF2 Improve Type 2 Diabetic Erectile Dysfunction in a Rat Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; ANGIOGENESIS; EXPRESSION; DIFFERENTIATION; TRANSPLANTATION; MEN; RECONSTRUCTION; RECEPTORS; ISCHEMIA	Aim: The aim of this study was to determine the possibility of improving erectile dysfunction using cell therapy with either human urine-derived stem cells (USCs) or USCs genetically-modified with FGF2 in a type 2 diabetic rat model. Methods: Human USCs were collected from 3 healthy donors. USCs were transfected with FGF2 (USCs-FGF2). Sixty-five SD male rats were divided into five groups (G). A control group of normal rats (G1, n = 10), and four other test groups of type 2 diabetic erectile dysfunction rats: PBS as a negative control (G2, n = 10), USCs (G3, n = 15), lentivirus-FGF2 (G4, n = 15), and USCs-FGF2 (G5, n = 15). Diabetes was induced in the rats via a high fat diet for 28 days and a subsequent intraperitoneal injection of streptozotocin (35 mg/kg). Erectile dysfunction was screened with apomorphine (100 mg/kg). Cell injections in the test groups (G2-G5) occurred directly into the corpora cavernosa. The implanted cells were tracked at 7 days (n = 5 animals/G) and 28 days (n = 10 animals/G) post injection. Mean arterial pressure (MAP), intracavernosal pressure (ICP), expression of endothelial markers (CD31, VEGF and eNOS), smooth muscle markers (desmin and smoothelin), histological changes and erectile function were assessed for each group. Results: USCs expressed mesenchymal stem cell markers, and secreted a number of proangiogenic growth factors. USCs expressed endothelial cell markers (CD31 and vWF) after transfection with FGF2. Implanted USCs or USCs-FGF2 displayed a significantly raised ICP and ICP/MAP ratio (p<0.01) 28 days after intracavernous injection. Although few cell were detected within the implanted sites, histological and western blot analysis demonstrated an increased expression of endothelial and smooth muscle markers within the cavernous tissue following USC or USC-FGF2 injection. Conclusions: The paracrine effect of USCs or USCs-FGF2 induced improvement of erectile function in type 2 diabetic rats by recruiting resident cells and increasing the endothelial expression and contents of smooth muscle.	[Ouyang, Bin; Sun, Xiangzhou; Han, Dayu; Chen, Shenfu; Yao, Bing; Zhang, Yadong; Wan, Zi; Deng, Chunhua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Yong] Sun Yat Sen Univ, Affiliated Hosp 1, Reprod Med Ctr, Key Lab Reprod Med Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China; [Bian, Jun] Southern Med Univ, Affiliated Hosp 3, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Huang, Yanping] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai Inst Androl, Shanghai 200030, Peoples R China; [Yang, Bin] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Urol, Shanghai 200092, Peoples R China; [Yang, Bin; Liu, Guihua; Zhang, Yuanyuan] Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA; [Xiao, Haipeng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou Songyang] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Liu, Guihua] Sun Yat Sen Univ, Affiliated Hosp 6, Ctr Reprod Med, Dept Androl, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China; Shanghai Jiao Tong University; Tongji University; Wake Forest University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Baylor College of Medicine; Sun Yat Sen University	Liu, GH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Ctr Reprod Med, Dept Androl, Guangzhou 510275, Guangdong, Peoples R China.	lgh99707@163.com; yzhang@wakehealth.edu; dch0313@163.com	zhang, yuanyuan/GYA-4428-2022; guihua, liu/B-1060-2012	Huang, Yan-Ping/0000-0002-3301-2847	National Natural Science Foundation of China [81270696, 81302223]; Research Fund for the Doctoral Program of Higher Education of China [20130171120078]; Guangdong natural science fund [S2011010005282]; Guangdong province science & technology project [2011B031800115, 2011B032000003]; Science and Technology Planning Project of Guangzhou [201300000094]; Medical Scientific Research Foundation of Guangdong Province, China [B2013104]; International Program of Project 985, Sun Yat-Sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Guangdong natural science fund; Guangdong province science & technology project; Science and Technology Planning Project of Guangzhou; Medical Scientific Research Foundation of Guangdong Province, China; International Program of Project 985, Sun Yat-Sen University	This work was funded by the grant from the National Natural Science Foundation of China (81270696 and 81302223)(http://www.nsfc.gov.cn/Portal0/default152.htm), Research Fund for the Doctoral Program of Higher Education of China (20130171120078)(http://www.cutech.edu.cn), Guangdong natural science fund (S2011010005282) (http://gdsf.gdstc.gov.cn/), the Guangdong province science & technology project (2011B031800115, 2011B032000003)(http://pro.gdstc.gov.cn/stms/main.jsp), Science and Technology Planning Project of Guangzhou (201300000094) (Http://www.gzsi.gov.cn), Medical Scientific Research Foundation of Guangdong Province, China (B2013104)(http://www.gdwst.gov.cn/), and the International Program of Project 985, Sun Yat-Sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albersen M, 2011, UROLOGY; Asplin IR, 2001, BLOOD, V97, P3450, DOI 10.1182/blood.V97.11.3450; Bacon CG, 2002, DIABETES CARE, V25, P1458, DOI 10.2337/diacare.25.8.1458; Bahk JY, 2010, EXP CLIN TRANSPLANT, V8, P150; Bahramsoltani M, 2010, CLIN HEMORHEOL MICRO, V46, P189, DOI 10.3233/CH-2010-1345; Bharadwaj S, 2013, STEM CELLS; Bharadwaj S, 2011, TISSUE ENG PT A, V17, P2123, DOI [10.1089/ten.TEA.2010.0637, 10.1089/ten.tea.2010.0637]; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Bodin A, 2010, BIOMATERIALS, V31, P8889, DOI 10.1016/j.biomaterials.2010.07.108; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Fujii T, 2008, ATHEROSCLEROSIS, V200, P51, DOI 10.1016/j.atherosclerosis.2007.12.012; Garcia MM, 2010, J SEX MED, V7, P89, DOI 10.1111/j.1743-6109.2009.01541.x; Giugliano F, 2010, INT J IMPOT RES, V22, P204, DOI 10.1038/ijir.2010.1; Gou X, 2011, ASIAN J ANDROL, V13, P332, DOI 10.1038/aja.2010.116; Green PJ, 1996, BIOESSAYS, V18, P639, DOI 10.1002/bies.950180807; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; HEATON JPW, 1991, J UROLOGY, V145, P1099, DOI 10.1016/S0022-5347(17)38543-9; Huang YP, 2012, INT J IMPOT RES, V24, P247, DOI 10.1038/ijir.2012.26; Jesmin S, 2003, J MOL ENDOCRINOL, V31, P401, DOI 10.1677/jme.0.0310401; Kalter-Leibovici O, 2005, DIABETES CARE, V28, P1739, DOI 10.2337/diacare.28.7.1739; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Li WQ, 2010, CELL TRANSPLANT, V19, P1181, DOI 10.3727/096368910X504469; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Lin CS, 2012, STEM CELLS DEV, V21, P2770, DOI 10.1089/scd.2012.0176; Lin G, 2011, INT J IMPOT RES; Liu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072790; Liu GH, 2013, BIOMATERIALS, V34, P1311, DOI 10.1016/j.biomaterials.2012.10.038; Liu GH, 2010, J SEX MED, V7, P3868, DOI 10.1111/j.1743-6109.2010.01844.x; Malavige LS, 2009, J SEX MED, V6, P1232, DOI 10.1111/j.1743-6109.2008.01168.x; Masaki I, 2002, CIRC RES, V90, P966, DOI 10.1161/01.RES.0000019540.41697.60; Moreland RB, 2000, INT J IMPOT RES, V12, pS39, DOI 10.1038/sj.ijir.3900576; Ning HX, 2009, J SEX MED, V6, P967, DOI 10.1111/j.1743-6109.2008.01172.x; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Penson DF, 2003, DIABETES CARE, V26, P1093, DOI 10.2337/diacare.26.4.1093; Qiu X, 2011, J ANDROL; Qiu XF, 2011, J SEX MED, V8, P427, DOI 10.1111/j.1743-6109.2010.02118.x; Rinaldi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069954; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0; Sun XZ, 2011, CHINESE MED J-PEKING, V124, P3093, DOI 10.3760/cma.j.issn.0366-6999.2011.19.026; Szebenyi G, 1999, INT REV CYTOL, V185, P45; VLODAVSKY I, 1990, CANCER METAST REV, V9, P203, DOI 10.1007/BF00046361; Wu R.P., 2012, 3 ANN REG MED FDN C; Wu SF, 2011, J UROLOGY, V186, P640, DOI 10.1016/j.juro.2011.03.152; Wu SF, 2011, BIOMATERIALS, V32, P1317, DOI 10.1016/j.biomaterials.2010.10.006; Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023; Zhu XY, 2009, BIOCHEM BIOPH RES CO, V379, P1084, DOI 10.1016/j.bbrc.2009.01.019	47	83	95	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92825	10.1371/journal.pone.0092825	http://dx.doi.org/10.1371/journal.pone.0092825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663037	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900122
J	Zhang, Z; Ober, U; Erbe, M; Zhang, H; Gao, N; He, JL; Li, JQ; Simianer, H				Zhang, Zhe; Ober, Ulrike; Erbe, Malena; Zhang, Hao; Gao, Ning; He, Jinlong; Li, Jiaqi; Simianer, Henner			Improving the Accuracy of Whole Genome Prediction for Complex Traits Using the Results of Genome Wide Association Studies	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; GENETIC ARCHITECTURE; LINKAGE DISEQUILIBRIUM; QUANTITATIVE TRAITS; DAIRY-CATTLE; MILK-PRODUCTION; DATABASE TOOL; SELECTION; LOCI; INFORMATION	Utilizing the whole genomic variation of complex traits to predict the yet-to-be observed phenotypes or unobserved genetic values via whole genome prediction (WGP) and to infer the underlying genetic architecture via genome wide association study (GWAS) is an interesting and fast developing area in the context of human disease studies as well as in animal and plant breeding. Though thousands of significant loci for several species were detected via GWAS in the past decade, they were not used directly to improve WGP due to lack of proper models. Here, we propose a generalized way of building trait-specific genomic relationship matrices which can exploit GWAS results in WGP via a best linear unbiased prediction (BLUP) model for which we suggest the name BLUP|GA. Results from two illustrative examples show that using already existing GWAS results from public databases in BLUP|GA improved the accuracy of WGP for two out of the three model traits in a dairy cattle data set, and for nine out of the 11 traits in a rice diversity data set, compared to the reference methods GBLUP and BayesB. While BLUP|GA outperforms BayesB, its required computing time is comparable to GBLUP. Further simulation results suggest that accounting for publicly available GWAS results is potentially more useful for WGP utilizing smaller data sets and/or traits of low heritability, depending on the genetic architecture of the trait under consideration. To our knowledge, this is the first study incorporating public GWAS results formally into the standard GBLUP model and we think that the BLUP|GA approach deserves further investigations in animal breeding, plant breeding as well as human genetics.	[Zhang, Zhe; Zhang, Hao; Gao, Ning; He, Jinlong; Li, Jiaqi] South China Agr Univ, Coll Anim Sci, Natl Engn Res Ctr Breeding Swine Ind, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China; [Zhang, Zhe; Ober, Ulrike; Erbe, Malena; Simianer, Henner] Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, D-37073 Gottingen, Germany	South China Agricultural University; University of Gottingen	Li, JQ (corresponding author), South China Agr Univ, Coll Anim Sci, Natl Engn Res Ctr Breeding Swine Ind, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China.	jqli@scau.edu.cn; hsimian@gwdg.de	Simianer, Henner/A-6574-2015; Zhang, Zhe/AAG-9641-2019	Simianer, Henner/0000-0002-7551-3797; Zhang, Zhe/0000-0001-7338-7718	National Natural Science Foundation of China [31200925, 31371258]; earmarked fund for China Agriculture Research System [CARS-36]; Ph.D. Programs Foundation of Ministry of Education of China [20124404120001]; Guangdong Natural Science Foundation [S2012040007753]; Key Scientific and Technological Projects of Guangzhou [11A62100441]; German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding" [0315528C]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for China Agriculture Research System; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Key Scientific and Technological Projects of Guangzhou; German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding"	This work was supported by the National Natural Science Foundation of China (31200925, 31371258), the earmarked fund for China Agriculture Research System (CARS-36), the Ph.D. Programs Foundation (the Doctoral Fund) of Ministry of Education of China (20124404120001), the Guangdong Natural Science Foundation (S2012040007753), the Key Scientific and Technological Projects of Guangzhou (11A62100441). HS, UO and ME acknowledge the funding by the German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding" (Funding ID: 0315528C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2007, ANIM GENET, V38, P491, DOI 10.1111/j.1365-2052.2007.01642.x; Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Browning BL, 2007, GENET EPIDEMIOL, V31, P606; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Drinkwater NR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002975; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Flint J, 2012, NAT REV GENET, V13, P807, DOI 10.1038/nrg3335; Forni S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-1; GELDERMANN H, 1975, THEOR APPL GENET, V46, P319, DOI 10.1007/BF00281673; GEORGES M, 1995, GENETICS, V139, P907; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gonzalez-Recio O, 2008, GENETICS, V178, P2305, DOI 10.1534/genetics.107.084293; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Henderson C. R, 1984, APPL LINEAR MODELS A; HENDERSON CR, 1959, BIOMETRICS, V15, P192, DOI 10.2307/2527669; Hindorff LA, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ibanez-Escriche N, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-12; Jaiswal P, 2006, RICE GENETICS NEWSLE, V22, P9; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kapell DNRG, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-42; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Knott SA, 1996, THEOR APPL GENET, V93, P71, DOI 10.1007/BF00225729; Lawrence CJ, 2004, NUCLEIC ACIDS RES, V32, pD393, DOI 10.1093/nar/gkh011; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; LUND MS, 2010, 9 WORLD C GEN APPL L, P880; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Madsen P., 2006, WORLD C GENETICS APP; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meredith BK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-21; Meuwissen THE, 2001, GENETICS, V157, P1819; Muir WM, 2007, J ANIM BREED GENET, V124, P342, DOI 10.1111/j.1439-0388.2007.00700.x; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Phifer-Rixey M, 2012, MOL BIOL EVOL, V29, P2949, DOI 10.1093/molbev/mss105; Qanbari S, 2010, ANIM GENET, V41, P346, DOI 10.1111/j.1365-2052.2009.02011.x; Riedelsheimer C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-452; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Stranden I, 2009, J DAIRY SCI, V92, P2971, DOI 10.3168/jds.2008-1929; Stranden I, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-25; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Uimari P, 2011, J ANIM SCI, V89, P609, DOI 10.2527/jas.2010-3249; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Welsh CS, 2010, J ANIM SCI, V88, P1610, DOI 10.2527/jas.2009-2537; Wray NR, 2008, CURR OPIN GENET DEV, V18, P257, DOI 10.1016/j.gde.2008.07.006; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao W, 2006, NUCLEIC ACIDS RES, V34, pD752, DOI 10.1093/nar/gkj011; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	76	125	133	5	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93017	10.1371/journal.pone.0093017	http://dx.doi.org/10.1371/journal.pone.0093017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663104	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900143
J	Chang, CC; Sue, YM; Yang, NJ; Lee, YH; Juan, SH				Chang, Chih-Cheng; Sue, Yuh-Mou; Yang, Nian-Jie; Lee, Yi-Hsuan; Juan, Shu-Hui			3-Methylcholanthrene, an AhR Agonist, Caused Cell-Cycle Arrest by Histone Deacetylation through a RhoA-Dependent Recruitment of HDAC1 and pRb2 to E2F1 Complex	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; VASCULAR ENDOTHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; RETINOBLASTOMA PROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; MOLECULAR-MECHANISMS; TUMOR-SUPPRESSOR; DIOXIN RECEPTOR; EXPRESSION; TRANSCRIPTION	We previously showed that treating vascular endothelial cells with 3-methylcholanthrene (3MC) caused cell-cycle arrest in the Go/G1 phase; this resulted from the induction of p21 and p27 and a decreased level and activity of the cyclin-dependent kinase, Cdk2. We further investigated the molecular mechanisms that modulate cell-cycle regulatory proteins through the aryl-hydrocarbon receptor (AhR)/Ras homolog gene family, member A (RhoA) dependent epigenetic modification of histone. AhR/RhoA activation mediated by 3MC was essential for the upregulation of retinoblastoma 2 (pRb2) and histone deacetylase 1 (HDAC1), whereas their nuclear translocation was primarily modulated by RhoA activation. The combination of increased phosphatase and tensin homolog (PTEN) activity and decreased phosphatidylinositide 3-kinase (PI3K) activation by 3MC led to the inactivation of the Ras-cRaf pathway, which contributed to pRb2 hypophosphorylation. Increased HDAC1/pRb2 recruitment to the E2F1 complex decreased E2F1-transactivational activity and H3/H4 deacetylation, resulting in the downregulation of cell-cycle regulatory proteins (Cdk2/4 and Cyclin D3/E). Co-immunoprecipitation and electrophoretic mobility shift assay (EMSA) results showed that simvastatin prevented the 3MC-increased binding activities of E2F1 proteins in their promoter regions. Additionally, RhoA inhibitors (statins) reversed the effect of 3MC in inhibiting DNA synthesis by decreasing the nuclear translocation of pRb2/HDAC1, leading to a recovery of the levels of cell-cycle regulatory proteins. In summary, 3MC decreased cell proliferation by the epigenetic modification of histone through an AhR/RhoA-dependent mechanism that can be rescued by statins.	[Chang, Chih-Cheng; Yang, Nian-Jie; Juan, Shu-Hui] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan; [Chang, Chih-Cheng; Yang, Nian-Jie; Juan, Shu-Hui] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Sue, Yuh-Mou] Taipei Med Univ, Wan Fang Hosp, Dept Nephrol, Taipei, Taiwan; [Lee, Yi-Hsuan] Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Yang Ming Chiao Tung University	Juan, SH (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan.	juansh@tmu.edu.tw		Lee, Yi-Hsuan/0000-0002-3213-827X	National Science Council of Taiwan [NSC100-2320-B-038-016-MY2[2-2], NSC102-2320-B-038-030-MY3]; Taipei Medical University-associated Wan Fang Hospital [100TMU-WFH-06, 101TMU-WFH-09]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University-associated Wan Fang Hospital	This study was sponsored by grants from the National Science Council of Taiwan (NSC100-2320-B-038-016-MY2[2-2] and NSC102-2320-B-038-030-MY3) and the Taipei Medical University-associated Wan Fang Hospital (100TMU-WFH-06 and 101TMU-WFH-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; Chang CC, 2012, AM J PATHOL, V181, P211, DOI 10.1016/j.ajpath.2012.03.032; Chang CC, 2009, CELL MOL LIFE SCI, V66, P3193, DOI 10.1007/s00018-009-0102-7; Claudio PP, 2001, CANCER RES, V61, P462; Davis RK, 2008, DRUG NEWS PERSPECT, V21, P331, DOI 10.1358/dnp.2008.21.6.1246832; DeGregori J, 2006, MOL CELL BIOL, V26, P1165, DOI 10.1128/MCB.26.4.1165-1169.2006; DENISON MS, 1995, J BIOL CHEM, V270, P18175, DOI 10.1074/jbc.270.31.18175; Dudler T, 1996, J BIOL CHEM, V271, P11541, DOI 10.1074/jbc.271.19.11541; Elferink CJ, 2001, MOL PHARMACOL, V59, P664, DOI 10.1124/mol.59.4.664; Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444; Garrison PM, 2000, ARCH BIOCHEM BIOPHYS, V374, P161, DOI 10.1006/abbi.1999.1620; Ge NL, 1998, J BIOL CHEM, V273, P22708, DOI 10.1074/jbc.273.35.22708; Gomez-Duran A, 2008, J MOL BIOL, V380, P1, DOI 10.1016/j.jmb.2008.04.056; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; Juan SH, 2006, EUR J PHARMACOL, V530, P1, DOI 10.1016/j.ejphar.2005.11.023; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; LAM EWF, 1995, GENE, V160, P277, DOI 10.1016/0378-1119(95)00184-8; Latchney SE, 2011, STEM CELLS DEV, V20, P313, DOI 10.1089/scd.2009.0529; LEES E, 1995, CURR OPIN CELL BIOL, V7, P773, DOI 10.1016/0955-0674(95)80060-3; Lin H, 2008, J CELL PHYSIOL, V214, P434, DOI 10.1002/jcp.21214; Ma Q, 1997, J BIOL CHEM, V272, P8878; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Mulero-Navarro S, 2005, J BIOL CHEM, V280, P28731, DOI 10.1074/jbc.M504538200; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Pang PH, 2008, J CELL PHYSIOL, V215, P161, DOI 10.1002/jcp.21299; Paramio JM, 1999, ONCOGENE, V18, P7462, DOI 10.1038/sj.onc.1203151; Pierre S, 2011, BIOCHEM PHARMACOL, V81, P304, DOI 10.1016/j.bcp.2010.10.003; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Puga A, 2011, TOXICOL SCI, V120, P256, DOI 10.1093/toxsci/kfq393; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shih CM, 2004, EUR J PHARMACOL, V496, P41, DOI 10.1016/j.ejphar.2004.06.016; Wang S, 1998, MOL CELL BIOL, V18, P7487, DOI 10.1128/MCB.18.12.7487; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; Xu J, 2000, STROKE, V31, P1744, DOI 10.1161/01.STR.31.7.1744; Zhang HS, 2001, ONCOGENE, V20, P3134, DOI 10.1038/sj.onc.1204338	36	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92793	10.1371/journal.pone.0092793	http://dx.doi.org/10.1371/journal.pone.0092793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658119	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300129
J	Ma, R; Cui, Z; Hu, SY; Jia, XY; Yang, R; Zheng, X; Ao, J; Liu, G; Liao, YH; Zhao, MH				Ma, Rui; Cui, Zhao; Hu, Shui-Yi; Jia, Xiao-Yu; Yang, Rui; Zheng, Xin; Ao, Jie; Liu, Gang; Liao, Yun-Hua; Zhao, Ming-Hui			The Alternative Pathway of Complement Activation May Be Involved in the Renal Damage of Human Anti-Glomerular Basement Membrane Disease	PLOS ONE			English	Article							PROPERDIN BINDS; MICE; GLOMERULONEPHRITIS; NEPHRITIS; C3; CELLS; DEFICIENCY; ARTHRITIS; ANTIBODY; DEPOSIT	Linear deposition of IgG and complement 3 (C3) along glomerular basement membrane (GBM) is generally revealed in the kidneys of human anti-GBM disease. Our recent studies demonstrated the pathogenic role of complement activation in renal damage of this disease. However, the pathways of complement activation were still paradoxical. In this study, renal biopsy tissues from 10 patients with anti-GBM disease were used to investigate the pathways of complement activation by detecting the deposition of various complement components, including C1q, factor B, factor P (properdin), mannose-binding lectin (MBL), C3d, C4d and C5b-9, using immunohistochemistry and immunofluorescence. We found that C1q, factor B, properdin, C3d, C4d and C5b-9 were detected in all the glomeruli of our patients, along GBM with a linear and/or granular staining pattern. Furthermore, C1q, factor B and properdin co-localized well with C5b-9. The properdin also co-localized well with C3d. However, the deposition of MBL was diffusive in mesangium, GBM, Bowman's capsule and within crescents and was not co-localized with C5b-9 but partially co-localized with C4d. The intensity of factor B deposition (3.3 vs. 1.2, P<0.001) and C5b-9 deposition (3.2 vs. 1.6, P<0.001) was significantly stronger in the glomeruli with crescent formation, compared with the glomeruli without crescents. The complement system is overall activated via both the alternative pathway and classical pathway in the kidneys of human anti-GBM disease. The alternative pathway might play an important role in complement activation induced renal damage.	[Ma, Rui; Cui, Zhao; Hu, Shui-Yi; Jia, Xiao-Yu; Yang, Rui; Zheng, Xin; Ao, Jie; Liu, Gang; Zhao, Ming-Hui] Peking Univ, Hosp 1, Inst Nephrol,Key Lab Renal Dis, Dept Med,Renal Div,Minist Educ China,Key Lab Chro, Beijing 100871, Peoples R China; [Ma, Rui; Liao, Yun-Hua] Guangxi Med Univ, Affiliated Hosp 1, Dept Med, Div Renal, Nanning, Guangxi Zhuang, Peoples R China; [Zhao, Ming-Hui] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Ministry of Education, China; Peking University; Guangxi Medical University	Cui, Z (corresponding author), Peking Univ, Hosp 1, Inst Nephrol,Key Lab Renal Dis, Dept Med,Renal Div,Minist Educ China,Key Lab Chro, Beijing 100871, Peoples R China.	cuizhao@bjmu.edu.cn	Cui, Zhao/ABZ-9262-2022	Cui, Zhao/0000-0002-5837-1926	Chinese 973 project [2012CB517702]; Natural Science Fund of China [81321064]; National Natural Science Fund of China [81370801]	Chinese 973 project(National Basic Research Program of China); Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant of Chinese 973 project (No. 2012CB517702), a grant from Natural Science Fund of China to the Innovation Research Group (81321064) and a grant of National Natural Science Fund of China (81370801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cui Z, 2005, NEPHRON CLIN PRACT, V99, pC49, DOI 10.1159/000083133; Daha M, 1989, BEHRING I MITT, V84, P42; Elliott MK, 2004, KIDNEY INT, V65, P129, DOI 10.1111/j.1523-1755.2004.00371.x; Fischer EG, 2006, AM J CLIN PATHOL, V125, P445, DOI 10.1309/NPTP-4UKV-7JU3-ELMQ; Gaarkeuken H, 2008, AM J PHYSIOL-RENAL, V295, pF1397, DOI 10.1152/ajprenal.90313.2008; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Hebert MJ, 1998, NEPHROL DIAL TRANSPL, V13, P2799, DOI 10.1093/ndt/13.11.2799; Hietala MA, 2002, J IMMUNOL, V169, P454, DOI 10.4049/jimmunol.169.1.454; Hisano S, 2005, AM J KIDNEY DIS, V45, P295, DOI 10.1053/j.ajkd.2004.10.020; Hisano S, 2007, PATHOL INT, V57, P351, DOI 10.1111/j.1440-1827.2007.02107.x; Holers VM, 2002, J EXP MED, V195, P211, DOI 10.1084/jem.200116116; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kluth DC, 1999, J AM SOC NEPHROL, V10, P2446; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; Lerner RA, 1999, J AM SOC NEPHROL, V10, P1389; Ma R, 2013, J CLIN IMMUNOL, V33, P172, DOI 10.1007/s10875-012-9772-2; Otten MA, 2009, J IMMUNOL, V183, P3980, DOI 10.4049/jimmunol.0901301; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; SCHULZE M, 1993, AM J PATHOL, V142, P179; Segelmark M, 2003, NEPHRON CLIN PRACT, V94, pC59, DOI 10.1159/000072022; Sheerin NS, 1997, CLIN EXP IMMUNOL, V110, P403, DOI 10.1046/j.1365-2249.1997.4261438.x; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Trouw LA, 2004, J CLIN INVEST, V114, P679, DOI 10.1172/JCI200421075; Xing GQ, 2009, J CLIN IMMUNOL, V29, P282, DOI 10.1007/s10875-008-9268-2; Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613	28	27	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91250	10.1371/journal.pone.0091250	http://dx.doi.org/10.1371/journal.pone.0091250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658070	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300029
J	Ruan, M; Zhang, Z; Li, SY; Yan, M; Liu, SW; Yang, WJ; Wang, LZ; Zhang, CP				Ruan, Min; Zhang, Zun; Li, Siyi; Yan, Min; Liu, Shengwen; Yang, Wenjun; Wang, Lizheng; Zhang, Chenping			Activation of Toll-Like Receptor-9 Promotes Cellular Migration via Up-Regulating MMP-2 Expression in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							NF-KAPPA-B; MATRIX METALLOPROTEINASES; SIGNALING PATHWAYS; INNATE IMMUNITY; CANCER; INVASION; METASTASIS; SUPPRESSES; SITE	Purpose: Activation of Toll like receptors (TLRs) signaling has been implicated in promoting malignant cell invasion and metastatic potential. Previously we demonstrated that increased TLR-9 expression predicted poor survival in oral cancer patients. The objective of this study is to further investigate the roles and potential molecular mechanisms of TLR-9 signaling in human oral cancer cell invasion. Methods: Cell migration, invasion and protein expression were detected by wound healing assay, Transwell chambers model and western blot. The secretion and activity levels of metalloproteinases-2/9 were quantified by ELISA and Gelatin zymography. EMSA and ChIP assays were employed to detect the activity of AP-1signal pathway. TLR-9 siRNA transfection was used to regulate the expression and activity of TLR-9 in oral cancer cell line HB cells. Result: The results of both wound healing assay and in vitro Transwell assay revealed that activation of TLR-9 induced dose- and time-dependent migration and invasion of HB cells. An increased expression, secretion and activity of MMP-2 were observed upon the treatment of CpG-ODN. The TLR-9 signaling-mediated MMP-2 expression appeared to be a consequence of AP-1 activation, because that their DNA binding activity was enhanced by CpG-ODN treatment. All these influences were efficiently repressed by the knockdown of TLR-9 through siRNA or pretreatment of an AP-1 inhibitor. Conclusion: Activation of TLR-9 signaling could promote human oral cancer HB cells invasion with the induction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel anti-metastatic application for TLR-9 targeted therapy in oral cancer in the future.	[Ruan, Min; Li, Siyi; Yan, Min; Liu, Shengwen; Yang, Wenjun; Zhang, Chenping] Shanghai Jiao Tong Univ, Peoples Hosp 9, Coll Stomatol,Shanghai Key Lab Stomatol, Sch Med,Dept Oral & Maxillofacial Head & Neck On, Shanghai 200030, Peoples R China; [Zhang, Zun] Tongji Univ, Shanghai East Hosp, Dept Stomatol, Shanghai 200092, Peoples R China; [Wang, Lizheng] Shanghai Jiao Tong Univ, Peoples Hosp 9, Coll Stomatol, Sch Med,Dept Oral Pathol,Shanghai Key Lab Stomato, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Tongji University; Shanghai Jiao Tong University	Ruan, M (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Coll Stomatol,Shanghai Key Lab Stomatol, Sch Med,Dept Oral & Maxillofacial Head & Neck On, Shanghai 200030, Peoples R China.	doctorruanmin@hotmail.com		Ruan, Min/0000-0002-1789-7518	National Natural Science Foundation of China [81102049]; Natural Science Foundation of Shanghai [11ZR1420600]; Shanghai Leading Academic Discipline Project [S30206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This study was supported by Project of National Natural Science Foundation of China (Grant No. 81102049) (URL: http://www.nsfc.gov.cn/Portal0/default152.htm); the Natural Science Foundation of Shanghai (Grant No. 11ZR1420600) to MR (URL: http://www.stcsm.gov.cn/); and Shanghai Leading Academic Discipline Project (Project Number: S30206) to CZ (URL: http://www.shec.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Chen R, 2007, AM J REPROD IMMUNOL, V57, P93, DOI 10.1111/j.1600-0897.2006.00441.x; de Vicente JC, 2005, ORAL ONCOL, V41, P283, DOI 10.1016/j.oraloncology.2004.08.013; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ferlay J, 2010, IARC CANC BASE, V10; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Guo HY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-77; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hsieh YS, 2007, CARCINOGENESIS, V28, P977, DOI 10.1093/carcin/bgl221; Hua D, 2009, MOL IMMUNOL, V46, P2876, DOI 10.1016/j.molimm.2009.06.016; Ilvesaro JM, 2007, PROSTATE, V67, P774, DOI 10.1002/pros.20562; Katayama A, 2004, CLIN CANCER RES, V10, P634, DOI 10.1158/1078-0432.CCR-0864-02; Katomongkolgit R, 2008, ORAL ONCOL, V44, P587, DOI 10.1016/j.oraloncology.2007.08.005; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Killeen SD, 2009, BRIT J CANCER, V100, P1589, DOI 10.1038/sj.bjc.6604942; KUSUKAWA J, 1993, AM J CLIN PATHOL, V99, P18, DOI 10.1093/ajcp/99.1.18; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Myoung H, 2002, CANCER LETT, V185, P201, DOI 10.1016/S0304-3835(02)00281-1; O'Neill LAJ, 2002, CURR TOP MICROBIOL, V270, P47; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Ruan Min, 2008, Phytotherapy Research, V22, P407, DOI 10.1002/ptr.2340; Ruan M, 2012, CANCER SCI, V103, P1938, DOI 10.1111/j.1349-7006.2012.02394.x; Ruan M, 2011, ARCH ORAL BIOL, V56, P877, DOI 10.1016/j.archoralbio.2011.01.010; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Toualbi-Abed K, 2008, CARCINOGENESIS, V29, P536, DOI 10.1093/carcin/bgm293; Xie WJ, 2009, BIOCHEM BIOPH RES CO, V379, P1027, DOI 10.1016/j.bbrc.2009.01.009; Yang XC, 2013, EUR REV MED PHARMACO, V17, P1669; Zhong LP, 2008, ARCH ORAL BIOL, V53, P443, DOI 10.1016/j.archoralbio.2007.12.002	35	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92748	10.1371/journal.pone.0092748	http://dx.doi.org/10.1371/journal.pone.0092748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658023	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300126
J	Abdiche, YN; Miles, A; Eckman, J; Foletti, D; Van Blarcom, TJ; Yeung, YA; Pons, J; Rajpal, A				Abdiche, Yasmina Noubia; Miles, Adam; Eckman, Josh; Foletti, Davide; Van Blarcom, Thomas J.; Yeung, Yik Andy; Pons, Jaume; Rajpal, Arvind			High-Throughput Epitope Binning Assays on Label-Free Array-Based Biosensors Can Yield Exquisite Epitope Discrimination That Facilitates the Selection of Monoclonal Antibodies with Functional Activity	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; HUMAN HEMOGLOBIN; IDENTIFICATION; RECEPTOR; MIXTURE; PROTEON; DOMAIN	Here, we demonstrate how array-based label-free biosensors can be applied to the multiplexed interaction analysis of large panels of analyte/ligand pairs, such as the epitope binning of monoclonal antibodies (mAbs). In this application, the larger the number of mAbs that are analyzed for cross-blocking in a pairwise and combinatorial manner against their specific antigen, the higher the probability of discriminating their epitopes. Since cross-blocking of two mAbs is necessary but not sufficient for them to bind an identical epitope, high-resolution epitope binning analysis determined by high-throughput experiments can enable the identification of mAbs with similar but unique epitopes. We demonstrate that a mAb's epitope and functional activity are correlated, thereby strengthening the relevance of epitope binning data to the discovery of therapeutic mAbs. We evaluated two state-of-the-art label-free biosensors that enable the parallel analysis of 96 unique analyte/ligand interactions and nearly ten thousand total interactions per unattended run. The IBIS-MX96 is a microarray-based surface plasmon resonance imager (SPRi) integrated with continuous flow microspotting technology whereas the Octet-HTX is equipped with disposable fiber optic sensors that use biolayer interferometry (BLI) detection. We compared their throughput, versatility, ease of sample preparation, and sample consumption in the context of epitope binning assays. We conclude that the main advantages of the SPRi technology are its exceptionally low sample consumption, facile sample preparation, and unparalleled unattended throughput. In contrast, the BLI technology is highly flexible because it allows for the simultaneous interaction analysis of 96 independent analyte/ligand pairs, ad hoc sensor replacement and on-line reloading of an analyte- or ligand-array. Thus, the complementary use of these two platforms can expedite applications that are relevant to the discovery of therapeutic mAbs, depending upon the sample availability, and the number and diversity of the interactions being studied.	[Abdiche, Yasmina Noubia; Foletti, Davide; Van Blarcom, Thomas J.; Yeung, Yik Andy; Pons, Jaume; Rajpal, Arvind] Rinat Pfizer Inc, San Francisco, CA 94080 USA; [Miles, Adam; Eckman, Josh] Wasatch Microfluid, Salt Lake City, UT USA	Pfizer	Abdiche, YN (corresponding author), Rinat Pfizer Inc, San Francisco, CA 94080 USA.	yasmina.abdiche@pfizer.com			Rinat-Pfizer Inc.	Rinat-Pfizer Inc.(Pfizer)	The study was funded by Rinat-Pfizer Inc. The authors designed the experiments, collected and analyzed the data, and wrote the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche YN, 2012, J IMMUNOL METHODS, V382, P101, DOI 10.1016/j.jim.2012.05.010; Abdiche YN, 2011, ANAL BIOCHEM, V411, P139, DOI 10.1016/j.ab.2010.12.020; Abdiche YN, 2009, ANAL BIOCHEM, V386, P172, DOI 10.1016/j.ab.2008.11.038; Aldaz-Carroll L, 2005, VIROLOGY, V341, P59, DOI 10.1016/j.virol.2005.07.006; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Eddings MA, 2008, ANAL BIOCHEM, V382, P55, DOI 10.1016/j.ab.2008.07.031; El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2; Emde A, 2011, ONCOGENE, V30, P1631, DOI 10.1038/onc.2010.547; Gesellchen Frank, 2005, V305, P17; Jamnani FR, 2012, EXP CELL RES, V318, P1112, DOI 10.1016/j.yexcr.2012.03.004; Klein C, 2013, MABS-AUSTIN, V5, P22, DOI 10.4161/mabs.22771; Koefoed K, 2011, MABS-AUSTIN, V3, P584, DOI 10.4161/mabs.3.6.17955; Krummenacher C, 2000, J VIROL, V74, P10863, DOI 10.1128/JVI.74.23.10863-10872.2000; Markovitz RC, 2013, BLOOD, V121, P2785, DOI 10.1182/blood-2012-09-456582; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Rich RL, 2007, ANAL BIOCHEM, V361, P1, DOI 10.1016/j.ab.2006.10.040; Robak T, 2012, BLOOD, V120, P3670, DOI 10.1182/blood-2012-06-438804; Song HY, 2012, LANGMUIR, V28, P997, DOI 10.1021/la202734f; Spangler JB, 2012, J MOL BIOL, V422, P532, DOI 10.1016/j.jmb.2012.06.014; Sun GY, 2008, J CHROMATOGR B, V867, P1, DOI 10.1016/j.jchromb.2008.02.014; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06	22	73	77	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92451	10.1371/journal.pone.0092451	http://dx.doi.org/10.1371/journal.pone.0092451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651868	gold, Green Submitted, Green Published			2022-12-25	WOS:000333352800108
J	Sun, XD; Li, J; Dong, FN; Dong, JT				Sun, Xiaodong; Li, Jie; Dong, Frederick N.; Dong, Jin-Tang			Characterization of Nuclear Localization and SUMOylation of the ATBF1 Transcription Factor in Epithelial Cells	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; TUMOR-SUPPRESSOR; PROTEIN; BINDING; EXPRESSION; UBIQUITIN; MOTIF; GENE; PML; DIFFERENTIATION	ATBF1/ZFHX3 is a large transcription factor that functions in development, tumorigenesis and other biological processes. ATBF1 is normally localized in the nucleus, but is often mislocalized in the cytoplasm in cancer cells. The mechanism underlying the mislocalization of ATBF1 is unknown. In this study, we analyzed the nuclear localization of ATBF1, and found that ectopically expressed ATBF1 formed nuclear body (NB)-like dots in the nucleus, some of which indeed physically associated with promyelocytic leukemia (PML) NBs. We also defined a 3-amino acid motif, KRK2615-2617, as the nuclear localization signal (NLS) for ATBF1. Interestingly, diffusely distributed nuclear SUMO1 proteins were sequestered into ATBF1 dots, which could be related to ATBF1's physical association with PML NBs, known SUMOylation hotspots. Furthermore, ATBF1 itself was SUMOylated. ATBF1 SUMOylation occurred at more than 3 lysine residues including K-2349, K-2806 and K-3258 and was nuclear specific. Finally, the PIAS3 SUMO1 E3 ligase, which interacts with ATBF1 directly, diminished rather than enhanced ATBF1 SUMOylation, preventing the co-localization of ATBF1 with SUMO1 in the nucleus. These findings suggest that nuclear localization and SUMOylation are important for the transcription factor function of ATBF1, and that ATBF1 could cooperate with PML NBs to regulate protein SUMOylation in different biological processes.	[Sun, Xiaodong; Li, Jie; Dong, Frederick N.; Dong, Jin-Tang] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University	Dong, JT (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA.	j.dong@emory.edu	Li, Jie/K-8812-2015	Dong, Jin-Tang/0000-0003-2349-5782	National Cancer Institute, National Institutes of Health [R01CA121459]; NATIONAL CANCER INSTITUTE [R01CA121459] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R01CA121459 from the National Cancer Institute, National Institutes of Health, http://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Brand Peter, 2010, PMC Biophys, V3, P3, DOI 10.1186/1757-5036-3-3; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Cho YG, 2007, CLIN CANCER RES, V13, P4355, DOI 10.1158/1078-0432.CCR-07-0619; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Dahle O, 2004, EXP CELL RES, V297, P118, DOI 10.1016/j.yexcr.2004.03.014; Delaune A, 2008, J NEUROCHEM, V104, P89, DOI 10.1111/j.1471-4159.2007.05019.x; Dong XY, 2012, BIOCHEM J, V444, P581, DOI 10.1042/BJ20111890; Dong XY, 2010, J BIOL CHEM, V285, P32801, DOI 10.1074/jbc.M110.128330; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Ishii Y, 2003, J COMP NEUROL, V465, P57, DOI 10.1002/cne.10807; Jang MS, 2002, BIOCHEM BIOPH RES CO, V295, P495, DOI 10.1016/S0006-291X(02)00699-X; Jung CG, 2005, DEVELOPMENT, V132, P5137, DOI 10.1242/dev.02098; Jung CG, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-47; Kaspar P, 1999, J BIOL CHEM, V274, P14422, DOI 10.1074/jbc.274.20.14422; Kataoka H, 2000, BIOCHEM BIOPH RES CO, V267, P91, DOI 10.1006/bbrc.1999.1911; Kim CJ, 2008, HISTOPATHOLOGY, V52, P552, DOI 10.1111/j.1365-2559.2008.02980.x; Kim TS, 2010, DIS MODEL MECH, V3, P752, DOI 10.1242/dmm.004689; Kocer B, 2004, DIGEST DIS SCI, V49, P954, DOI 10.1023/B:DDAS.0000034554.96191.66; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Li M, 2013, BIOCHEM BIOPH RES CO, V430, P358, DOI 10.1016/j.bbrc.2012.11.009; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049841; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Mabuchi M, 2010, BIOCHEM BIOPH RES CO, V398, P321, DOI 10.1016/j.bbrc.2010.06.090; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MIURA Y, 1995, J BIOL CHEM, V270, P26840, DOI 10.1074/jbc.270.45.26840; Mori Y, 2007, INT J CANCER, V121, P241, DOI 10.1002/ijc.22654; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; Qi Y, 2008, P NATL ACAD SCI USA, V105, P2481, DOI 10.1073/pnas.0712196105; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sun XD, 2007, J CANCER RES CLIN, V133, P103, DOI 10.1007/s00432-006-0148-y; Sun XD, 2013, HEAD NECK-J SCI SPEC, V35, P1007, DOI 10.1002/hed.23077; Sun XD, 2012, GENESIS, V50, P819, DOI 10.1002/dvg.22041; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; Watanabe M, 1996, MOL BRAIN RES, V42, P344, DOI 10.1016/S0169-328X(96)00204-5; Xu JY, 2006, PROSTATE, V66, P1082, DOI 10.1002/pros.20430; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Zhang S, 2012, BIOCHEM BIOPH RES CO, V427, P537, DOI 10.1016/j.bbrc.2012.09.092; Zhang ZH, 2005, CLIN CANCER RES, V11, P193; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020	50	18	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92746	10.1371/journal.pone.0092746	http://dx.doi.org/10.1371/journal.pone.0092746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651376	gold, Green Submitted, Green Published			2022-12-25	WOS:000333352800153
J	Bickeboller, M; Tagscherer, KE; Kloor, M; Jansen, L; Chang-Claude, J; Brenner, H; Hoffmeister, M; Toth, C; Schirmacher, P; Roth, W; Blaker, H				Bickeboeller, M.; Tagscherer, K. E.; Kloor, M.; Jansen, L.; Chang-Claude, J.; Brenner, H.; Hoffmeister, M.; Toth, C.; Schirmacher, P.; Roth, W.; Blaeker, H.			Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival	ONCOGENE			English	Article							PROTEIN-KINASE-C; APOPTOSIS-INDUCING LIGAND; PROMINENT CELLULAR SUBSTRATE; MICROSATELLITE INSTABILITY; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; MELANOMA-CELLS; DIFFERENTIAL EXPRESSION; CALMODULIN-BINDING; EFFECTOR DOMAIN	The myristoylated alanine-rich C-kinase substrate (MARCKS) acts as a tumor suppressor in a variety of human neoplasms. In colorectal cancers (CRCs), MARCKS has been shown to be a preferential target of mutational inactivation in tumors following the microsatellite instability (MSI-H) pathway but little is known about its impact on intestinal carcinogenesis. To investigate the relevance of MARCKS inactivation in more detail, we analyzed 926 MSI-typed CRCs for MARCKS expression by immunohistochemistry and studied the functional consequences of MARCKS depletion in colorectal cancer cell lines. We found that loss of MARCKS expression was not restricted to MSI-H cancers but also occurred in microsatellite stable (MSS) tumors, where it was associated with an adverse outcome regarding overall survival, cancer-specific and disease-free survival (P = 0.002, P = 0.0018, P = 0.0001, respectively; univariate analysis). In MARCKS-positive MSS colon cancer cell lines (SW480 and SW707) small interfering RNA (siRNA)-mediated knockdown of MARCKS conferred resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. This was accompanied by the downregulation of the TRAIL receptors DR4 and DR5 at the cell surface and activation of AKT signaling. Inhibition of AKT signaling and transient overexpression of wild-type MARCKS, but not of MARCKS lacking the effector domain (ED), abolished the anti-apoptotic effect. In conclusion, our data show that inactivation of MARCKS is common in CRCs and is associated with adverse outcome in MSS cancers. The finding that MARCKS acts as a mediator of apoptosis in MSS CRC cells adds a novel tumor-suppressing function to the so far established roles of MARCKS in cell motility and proliferation and can explain the prognostic effect of MARCKS depletion in MSS CRC.	[Bickeboeller, M.; Tagscherer, K. E.; Roth, W.] German Canc Res Ctr, Div Mol Tumor Pathol, Heidelberg, Germany; [Bickeboeller, M.; Tagscherer, K. E.; Toth, C.; Schirmacher, P.; Roth, W.] Heidelberg Univ, Inst Pathol, Dept Gen Pathol, Heidelberg, Germany; [Kloor, M.] Heidelberg Univ, Inst Pathol, Dept Appl Tumor Biol, Heidelberg, Germany; [Jansen, L.; Brenner, H.; Hoffmeister, M.] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Chang-Claude, J.] German Canc Res Ctr, Unit Genet Epidemiol, Div Canc Epidemiol, Heidelberg, Germany; [Blaeker, H.] Univ Hosp Charite, Inst Pathol, Dept Gen Pathol, D-10117 Berlin, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Blaker, H (corresponding author), Univ Hosp Charite, Inst Pathol, Dept Gen Pathol, Campus Mitte,Charitepl 1, D-10117 Berlin, Germany.	hendrik.blaeker@charite.de	Brenner, Hermann/B-4627-2017; Hoffmeister, Michael/T-7187-2019; Hoffmeister, Michael/B-5745-2012; Brenner, Hermann/ABE-6383-2020; Hoffmeister, Michael/AAB-2321-2022; Tagscherer, Katrin/AAS-3809-2021; Jansen, Lina/D-7255-2016	Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Tagscherer, Katrin/0000-0002-0657-6399; Jansen, Lina/0000-0001-8004-4940	German Research Council (Deutsche Forschungsgemeinschaft) [BL554/3-2, BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 390 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; Interdisciplinary Research Program of the National Center for Tumor Diseases (NCT), Heidelberg, Germany	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Research Program of the National Center for Tumor Diseases (NCT), Heidelberg, Germany	We thank the study participants and the interviewers who collected the data. We also greatly appreciate the help of the hospitals, pathology departments and cooperating institutions in recruiting patients for this study and providing tumor samples. We thank Jutta Richter, Ute Handte-Daub, Bettina Walter, Barbara Schreiber and Marina Gernold for their excellent technical assistance. H Blaker has been supported by a grant from the German Research Council (Deutsche Forschungsgemeinschaft; grant number: BL554/3-2). The DACHS study was supported by grants from the German Research Council (Deutsche Forschungsgemeinschaft, grant numbers BR 1704/6-1, BR 1704/6-3, BR 1704/6-4 and CH 390 117/1-1), the German Federal Ministry of Education and Research (grant numbers 01KH0404 and 01ER0814), and the Interdisciplinary Research Program of the National Center for Tumor Diseases (NCT), Heidelberg, Germany.	ALBERT KA, 1987, P NATL ACAD SCI USA, V84, P7046, DOI 10.1073/pnas.84.20.7046; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brooks G, 1996, CARCINOGENESIS, V17, P683, DOI 10.1093/carcin/17.4.683; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Chen XY, 2010, CELL SIGNAL, V22, P1097, DOI 10.1016/j.cellsig.2010.03.003; Cho SJ, 2001, BIOCHEM BIOPH RES CO, V283, P273, DOI 10.1006/bbrc.2001.4773; Estrada-Bernal A, 2009, J CELL SCI, V122, P2300, DOI 10.1242/jcs.047860; Fassl A, 2012, ONCOGENE, V31, P4698, DOI 10.1038/onc.2011.615; Findeisen P, 2005, CANCER RES, V65, P8072, DOI 10.1158/0008-5472.CAN-04-4146; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; GRAFF JM, 1991, J BIOL CHEM, V266, P14390; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; GRAFF JM, 1989, J BIOL CHEM, V264, P11912; HARLAN DM, 1991, J BIOL CHEM, V266, P14399; Hoffmeister M, 2013, CANCER EPIDEM BIOMAR, V22, P2303, DOI 10.1158/1055-9965.EPI-13-0239; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Jarboe JS, 2012, CLIN CANCER RES, V18, P3030, DOI 10.1158/1078-0432.CCR-11-3091; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Jones SJ, 1999, J IMMUNOL, V162, P1042; JOSEPH CK, 1992, J BIOL CHEM, V267, P1327; Kim NG, 2002, ONCOGENE, V21, P5081, DOI 10.1038/sj.onc.1205703; Koh KH, 2005, LAB INVEST, V85, P1130, DOI 10.1038/labinvest.3700315; Kriegl L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051654; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Li YH, 2001, J BIOL CHEM, V276, P40982, DOI 10.1074/jbc.M105614200; Lilla C, 2006, CANCER EPIDEM BIOMAR, V15, P99, DOI 10.1158/1055-9965.EPI-05-0618; Michel S, 2010, MOL CARCINOGEN, V49, P175, DOI 10.1002/mc.20587; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Morash SC, 2005, NEUROCHEM RES, V30, P1353, DOI 10.1007/s11064-005-8220-6; Morton LA, 2013, ACS CHEM BIOL, V8, P218, DOI 10.1021/cb300429e; Myat MM, 1997, CURR BIOL, V7, P611, DOI 10.1016/S0960-9822(06)00262-4; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Peuhu E, 2010, ONCOGENE, V29, P898, DOI 10.1038/onc.2009.386; Rombouts K, 2013, CANCER LETT, V333, P244, DOI 10.1016/j.canlet.2013.01.040; ROSE SD, 1994, J NEUROCHEM, V63, P2314; Rudolph A, 2012, BRIT J CANCER, V107, P831, DOI 10.1038/bjc.2012.323; Schmitt M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp581; SEYKORA JT, 1991, P NATL ACAD SCI USA, V88, P2505, DOI 10.1073/pnas.88.6.2505; Shin N, 2011, INT J CANCER, V128, P2872, DOI 10.1002/ijc.25641; SIMEK SL, 1989, P NATL ACAD SCI USA, V86, P7410, DOI 10.1073/pnas.86.19.7410; Simova S, 2008, APOPTOSIS, V13, P423, DOI 10.1007/s10495-007-0171-8; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; Su R, 2010, NEUROSCI BULL, V26, P338, DOI 10.1007/s12264-010-0131-0; Sundaram M, 2004, BIOCHEM CELL BIOL, V82, P191, DOI 10.1139/o03-087; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Techasen A, 2010, CANCER SCI, V101, P658, DOI 10.1111/j.1349-7006.2009.01427.x; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; Woerner SM, 2005, ONCOGENE, V24, P2525, DOI 10.1038/sj.onc.1208456; WOLFMAN A, 1987, J BIOL CHEM, V262, P16546; Yamaguchi T, 2006, DIS COLON RECTUM, V49, P399, DOI 10.1007/s10350-005-0293-4; Zhang XD, 2000, J IMMUNOL, V164, P3961, DOI 10.4049/jimmunol.164.8.3961; Zhu YM, 2005, CANCER RES, V65, P4520, DOI 10.1158/0008-5472.CAN-04-4506	56	31	31	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 26	2015	34	9					1150	1159		10.1038/onc.2014.40	http://dx.doi.org/10.1038/onc.2014.40			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RY	24662837				2022-12-25	WOS:000350122100008
J	Lee, IH; Sohn, M; Lim, HJ; Yoon, S; Oh, H; Shin, S; Shin, JH; Oh, SH; Kim, J; Lee, DK; Noh, DY; Bae, DS; Seong, JK; Bae, YS				Lee, I. H.; Sohn, M.; Lim, H. J.; Yoon, S.; Oh, H.; Shin, S.; Shin, J. H.; Oh, S-H; Kim, J.; Lee, D. K.; Noh, D. Y.; Bae, D. S.; Seong, J. K.; Bae, Y. S.			Ahnak functions as a tumor suppressor via modulation of TGF beta/Smad signaling pathway	ONCOGENE			English	Article							MAMMARY-GLAND DEVELOPMENT; C-MYC; BETA; PROTEIN; IDENTIFICATION; TARGET; GENE; PHOSPHATASE; COMPLEX	We provide detailed mechanisms of Ahnak-mediated potentiation of transforming growth factor beta (TGF beta) signaling, which leads to a negative regulation of cell growth. We show that Smad3 interacts with Ahnak through MH2 domain and that Ahnak stimulates Smad3 localization into nucleus leading to potentiating TGF beta-induced transcriptional activity of R-Smad. Moreover, overexpression of Ahnak resulted in growth retardation and cell cycle arrest through downregulation of c-Myc and cyclin D1/D2. We describe results from analyses of Ahnak(-/-) mouse model expressing middle T antigen in a mammary gland-specific manner (MMTVTg/+ Ahnak(-/-)), which showed significantly progressed hyperplasia of mammary glands compared with MMTVTg/+ Ahnak(+/+). Finally, we screened multiple human breast cancer tissues and showed that the expression of Ahnak in cancer tissues is lower than that in control tissues by 50%. Taken together, these data indicate that Ahnak mediates a negative regulation of cell growth and acts as novel tumor suppressor through potentiation of TGF beta signaling.	[Lee, I. H.; Sohn, M.; Lim, H. J.; Yoon, S.; Oh, H.; Shin, S.; Kim, J.; Lee, D. K.; Bae, Y. S.] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Lee, I. H.; Sohn, M.; Lim, H. J.; Yoon, S.; Oh, H.; Shin, S.; Kim, J.; Lee, D. K.; Bae, Y. S.] Ewha Womans Univ, GT5 program, Seoul, South Korea; [Shin, J. H.; Seong, J. K.] Seoul Natl Univ, Coll Vet Med, Lab Dev Biol & Genom, Seoul 151742, South Korea; [Oh, S-H] Gachon Univ, Coll Pharm, Inchon, South Korea; [Noh, D. Y.] Seoul Natl Univ, Sch Med, Dept Surg, Seoul 151742, South Korea; [Bae, D. S.] Sungkyunkwan Univ, Samsung Hosp, Dept Obstet & Gynecol, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Seoul National University (SNU); Gachon University; Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center	Seong, JK (corresponding author), Seoul Natl Univ, Coll Vet Med, Lab Dev Biol & Genom, Seoul 151742, South Korea.	snumouse@snu.ac.kr; baeys@ewha.ac.kr	LEE, IN HYE/T-2714-2019	LEE, IN HYE/0000-0003-2334-3594; Seong, Je Kyung/0000-0003-1177-6958; Lee, Daekee/0000-0001-8130-2059	National Research Foundation of Korea (NRF) grant [2012R1A5A1048236]; Drug Target Validation program [20090093987]; Bio & Medical Technology Development Program [2012M3A9B4028785]; Redoxomics grant - Ministry of Science, ICT & Future Planning [2012M3A9C5048708]; Ewha Womans University Research Grant	National Research Foundation of Korea (NRF) grant; Drug Target Validation program; Bio & Medical Technology Development Program; Redoxomics grant - Ministry of Science, ICT & Future Planning; Ewha Womans University Research Grant	This work was supported by the National Research Foundation of Korea (NRF) grant (No. 2012R1A5A1048236), by the Drug Target Validation program (No. 20090093987), by the Bio & Medical Technology Development Program (No. 2012M3A9B4028785) and by Redoxomics grant (No. 2012M3A9C5048708) funded by Ministry of Science, ICT & Future Planning, and the Ewha Womans University Research Grant of 2013 (to I.H.L.).	Briones-Orta Marco A, 2011, Curr Mol Pharmacol, V4, P141; Conidi A, 2011, CYTOKINE GROWTH F R, V22, P287, DOI 10.1016/j.cytogfr.2011.11.006; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Florenes VA, 1996, ONCOGENE, V13, P2447; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; Gentil BJ, 2001, J BIOL CHEM, V276, P23253, DOI 10.1074/jbc.M010655200; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Haase H, 1999, FASEB J, V13, P2161, DOI 10.1096/fasebj.13.15.2161; HASHIMOTO T, 1995, EXP CELL RES, V217, P258, DOI 10.1006/excr.1995.1085; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hohaus A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0855com; Jackson R, 2013, VIROLOGY, V435, P425, DOI 10.1016/j.virol.2012.09.032; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Lee IH, 2004, J BIOL CHEM, V279, P26645, DOI 10.1074/jbc.M311525200; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Lim HJ, 2013, CARDIOVASC RES, V97, P302, DOI 10.1093/cvr/cvs311; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Morikawa M, 2013, ONCOGENE, V32, P1609, DOI 10.1038/onc.2012.191; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Scollen S, 2011, CANCER EPIDEM BIOMAR, V20, P1112, DOI 10.1158/1055-9965.EPI-11-0062; SEEDORF K, 1987, EMBO J, V6, P139, DOI 10.1002/j.1460-2075.1987.tb04731.x; Sekiya F, 1999, J BIOL CHEM, V274, P13900, DOI 10.1074/jbc.274.20.13900; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Sundqvist A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3066; Tarasewicz E, 2012, CELL CYCLE, V11, P2443, DOI 10.4161/cc.20546; Wang CG, 2011, CELL CYCLE, V10, P57, DOI 10.4161/cc.10.1.14449; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zuber J, 2000, NAT GENET, V24, P144, DOI 10.1038/72799	35	83	84	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 18	2014	33	38					4675	4684		10.1038/onc.2014.69	http://dx.doi.org/10.1038/onc.2014.69			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3VX	24662814	Green Published, hybrid			2022-12-25	WOS:000342007200006
J	Shah, VB; Aiken, C				Shah, Vaibhav B.; Aiken, Christopher			Gene Expression Analysis of a Panel of Cell Lines That Differentially Restrict HIV-1 CA Mutants Infection in a Cyclophilin A-Dependent Manner	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; OLD-WORLD MONKEY; CYCLOSPORINE-A; LIFE-CYCLE; TRIM5-ALPHA RESTRICTION; NONDIVIDING CELLS; LENTIVIRAL VECTOR; REPLICATION; GAG; PROTEIN	HIV-1 replication is dependent on binding of the viral capsid to the host protein cyclophilin A (CypA). Interference with cyclophilin A binding, either by mutations in the HIV-1 capsid protein (CA) or by the drug cyclosporine A (CsA), inhibits HIV-1 replication in cell culture. Resistance to CsA is conferred by A92E or G94D substitutions in CA. The mutant viruses are also dependent on CsA for their replication. Interestingly, infection of some cell lines by these mutants is enhanced by CsA, while infection of others is not affected by the drug. The cells are thus termed nonpermissive and permissive, respectively, for infection by CsA-dependent mutants. The mechanistic basis for the cell type dependence is not well understood, but has been hypothesized to result from a dominant-acting host factor that blocks HIV-1 infection by a mechanism that requires CypA binding to the viral capsid. In an effort to identify a CypA-dependent host restriction factor, we adopted a strategy involving comparative gene expression analysis in three permissive and three non-permissive cell types. We ranked the genes based on their relative overexpression in non-permissive cell types compared to the permissive cell types. Based on specific selection criteria, 26 candidate genes were selected and targeted using siRNA in nonpermissive (HeLa) cells. Depletion of none of the selected candidate genes led to the reversal of CsA-dependent phenotype of the A92E mutant. Our data suggest that none of the 26 genes tested is responsible for the dependence of the A92E mutant on CsA. Our study provides gene expression data that may be useful for future efforts to identify the putative CypA-dependent HIV-1 restriction factor and in studies of other cell-specific phenotypes.	[Shah, Vaibhav B.; Aiken, Christopher] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA	Vanderbilt University	Aiken, C (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.	chris.aiken@vanderbilt.edu	Aiken, Christopher/Y-9252-2019		National Institutes of Health [AI073137]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI073137 (CA) (www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberham C, 1996, J VIROL, V70, P3536, DOI 10.1128/JVI.70.6.3536-3544.1996; An P, 2007, PLOS PATHOG, V3, P849, DOI 10.1371/journal.ppat.0030088; Berthoux L, 2005, P NATL ACAD SCI USA, V102, P14849, DOI 10.1073/pnas.0505659102; Bleiber G, 2005, J VIROL, V79, P12674, DOI 10.1128/JVI.79.20.12674-12680.2005; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; De Iaco A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-11; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Di Nunzio F, 2013, VIROLOGY, V440, P8, DOI 10.1016/j.virol.2013.02.008; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gatanaga H, 2006, J BIOL CHEM, V281, P1241, DOI 10.1074/jbc.M505920200; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Gupta P, 2011, J MOL BIOL, V410, P681, DOI 10.1016/j.jmb.2011.03.022; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Henning MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003868; Ikeda Y, 2004, J VIROL, V78, P11816, DOI 10.1128/JVI.78.21.11816-11822.2004; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Keckesova Z, 2006, J VIROL, V80, P4683, DOI 10.1128/JVI.80.10.4683-4690.2006; Kiernan RE, 1998, J VIROL, V72, P4116, DOI 10.1128/JVI.72.5.4116-4126.1998; Kootstra NA, 2003, P NATL ACAD SCI USA, V100, P1298, DOI 10.1073/pnas.0337541100; LANDAU NR, 1992, J VIROL, V66, P5110, DOI 10.1128/JVI.66.8.5110-5113.1992; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Li Y, 2009, J VIROL, V83, P10951, DOI 10.1128/JVI.00682-09; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Misumi S, 2010, J BIOL CHEM, V285, P25185, DOI 10.1074/jbc.M110.114256; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; POPOVIC M, 1984, LANCET, V2, P1472; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Qi ML, 2008, J VIROL, V82, P12001, DOI 10.1128/JVI.01518-08; Rits MAN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003975; ROSENWIRTH B, 1994, ANTIMICROB AGENTS CH, V38, P1763, DOI 10.1128/AAC.38.8.1763; Sayah DM, 2004, J VIROL, V78, P12066, DOI 10.1128/JVI.78.21.12066-12070.2004; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Shah VB, 2013, J VIROL, V87, P422, DOI 10.1128/JVI.07177-11; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; Song C, 2007, J VIROL, V81, P11946, DOI 10.1128/JVI.00620-07; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2006, VIROLOGY, V351, P112, DOI 10.1016/j.virol.2006.03.015; Takemura T, 2013, J VIROL, V87, P4086, DOI 10.1128/JVI.01319-12; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Towers G, 2002, J VIROL, V76, P2548, DOI 10.1128/JVI.76.5.2548-2550.2002; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; WAINBERG MA, 1988, BLOOD, V72, P1904; Wehrly K, 1997, METHODS, V12, P288, DOI 10.1006/meth.1997.0481; WEISS A, 1984, J IMMUNOL, V133, P123; Yang RF, 2007, J VIROL, V81, P3749, DOI 10.1128/JVI.02634-06; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Yin L, 1998, J VIROL, V72, P6430, DOI 10.1128/JVI.72.8.6430-6436.1998; Ylinen LMJ, 2009, J VIROL, V83, P2044, DOI 10.1128/JVI.01876-08; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194	61	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92724	10.1371/journal.pone.0092724	http://dx.doi.org/10.1371/journal.pone.0092724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663101	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900103
J	Zhang, LJ; Chen, YY; Li, C; Lin, XJ; Cheng, XL; Li, T				Zhang, Lijuan; Chen, Yanyan; Li, Cheng; Lin, Xiaojie; Cheng, Xiaoli; Li, Tang			Protective Effects of Combined Intervention with Adenovirus Vector Mediated IL-10 and IGF-1 Genes on Endogenous Islet beta Cells in Nonobese Diabetes Mice with Onset of Type 1 Diabetes Mellitus	PLOS ONE			English	Article							AUTOIMMUNE-DISEASES; APOPTOSIS; MECHANISMS; EXPRESSION; PREVENTS; THERAPY; VIRUSES; MOUSE	Objective: To investigate the protective effects of combined intervention with adenovirus vector mediated interleukin 10 (IL-10) and insulin-like growth factor 1 (IGF-1) genes on islet beta cells in nonobese diabetes (NOD) mice with type 1 diabetes mellitus (T1D) at early stage. Methods: Twenty-four female NOD mice at onset of diabetes and aged 17-20 weeks old were randomly divided into four groups. Mouse 1, 2 and 3 groups were intraperitoneally injected 0.1 ml of Ad-mIGF-1, Ad-mIL-10, and combined Ad-mIGF-1 and Ad-mIL-10, respectively. Mouse 4 group were used as diabetes control. In addition, six age-and sex-matched nondiabetic NOD mice were intraperitoneally injected 0.1 ml of PBS and assigned 5 group as normal controls. All mice were weekly monitored for body weight, urine glucose and blood glycose, and sacrificed 3 weeks after injection. Their serum levels of IL-10, IGF-1, IFN-gamma, IL-4 and C-peptide were measured and the degree of insulitis and the local expression of IGF-1 and IL-10 gene were observed. Results: 1) IL-10 and IGF-1 levels in serum and pancreas were enhanced in 1, 2, and 3 groups; 2) serum INF-gamma level was decreased while serum IL-10 and IL-4 levels were increased in 1, 2 and 3 groups, and these alterations were more significant in 3 group than 1 and 2 groups (P<0.01); 3) C-peptide level was not enhanced in 1 group, but significantly increased in 2 and 3 groups, and these increases were more significant in the latter (P<0.01); 4) Three weeks later, the body mass of mice in 2 and 3 groups decreased significantly (P<0.05). Conclusion: The administration of adenovirus vector mediated IL-10 and/or IGF-1 gene showed limited immune regulatory and protective effects on islet beta-cells in NOD mice with T1D at early stage, and no significant reduction in insulitis, blood glucose and body weight.	[Zhang, Lijuan; Li, Cheng; Lin, Xiaojie; Li, Tang] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Pediat, Qingdao, Shandong, Peoples R China; [Chen, Yanyan] Peoples Hosp RiZhao, Dept Pediat, Rizhao, Shandong, Peoples R China; [Cheng, Xiaoli] Qingdao Sanat Shandong Prov, Dept Med Ctr, Qingdao, Shandong, Peoples R China	Qingdao University	Li, T (corresponding author), Qingdao Univ, Coll Med, Affiliated Hosp, Dept Pediat, Qingdao, Shandong, Peoples R China.	ljuanzhang1983@126.com	Zhang, Li/GWM-7501-2022		National Natural Science Foundation of China [81170762]; Shandong Province Natural Science Foundation [Y2008C50]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province)	This study is supported by the National Natural Science Foundation of China (81170762) and Shandong Province Natural Science Foundation (Y2008C50). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerblom HK, 2002, AM J MED GENET, V115, P18, DOI 10.1002/ajmg.10340; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Ansaria MJI, 2008, CLIN IMMUNOL, V126, P140, DOI 10.1016/j.clim.2007.07.019; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Atkinson MA, 2001, SEMINAR, P358; Bharhani MS, 2006, AM J PHYSIOL-GASTR L, V291, pG820, DOI 10.1152/ajpgi.00438.2005; Capoluongo E, 2006, EUR CYTOKINE NETW, V17, P167, DOI 10.1684/ecn.2006.0036; Casellas A, 2006, DIABETES, V55, P3246, DOI 10.2337/db06-0328; Chen W, 2004, ENDOCRINOLOGY, V145, P627, DOI 10.1210/en.2003-1274; Chen ZH, 2009, CHINESE MED J-PEKING, V122, P2159, DOI 10.3760/cma.j.issn.0366-6999.2009.18.016; Chen Zhi-hong, 2007, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V21, P188; Chen Zhihong, 2009, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V26, P1067; Denes B, 2010, DIABETES TECHNOL THE, V12, P649, DOI 10.1089/dia.2009.0116; Dunger DB, 2005, ENDOCR DEV, V9, P107, DOI 10.1159/000085761; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fiorina P, 2008, DIABETES, V57, P3013, DOI 10.2337/db08-0420; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; Hu CY, 2013, DIABETES, V62, P2849, DOI 10.2337/db12-1175; Jun HS, 2003, DIABETES-METAB RES, V19, P8, DOI 10.1002/dmrr.337; Jun HS, 2001, DIABETOLOGIA, V44, P271, DOI 10.1007/s001250051614; Kanagawa O, 2002, J IMMUNOL, V168, P6159, DOI 10.4049/jimmunol.168.12.6159; Leger J, 2006, J CLIN ENDOCR METAB, V91, P3947, DOI 10.1210/jc.2006-0711; Lehtihet M, 2008, CLIN SCI, V115, P167, DOI 10.1042/CS20070372; Makino S, 1980, Jikken Dobutsu, V29, P1; Moyer-Mileur LJ, 2008, J BONE MINER RES, V23, P1884, DOI 10.1359/JBMR.080713; Prud'homme GJ, 2000, J GENE MED, V2, P222; Rewers M, 1996, J AUTOIMMUN, V9, P405, DOI 10.1006/jaut.1996.0055; [石昌红 Shi Changhong], 2006, [中国免疫学杂志, Chinese Journal of Immunology], V22, P771; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Wang H, 2010, INT J IMMUNOLOGY, V37, P315; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Wong FS, 1999, CURR OPIN IMMUNOL, V11, P643, DOI 10.1016/S0952-7915(99)00031-X; Xie XW, 2010, J PRACTICAL PEDIAT C, V25, P555; Xu Ai-jing, 2010, Zhonghua Yi Xue Za Zhi, V90, P1711; Xu AJ, 2010, MOL CELL BIOCHEM, V344, P163, DOI 10.1007/s11010-010-0539-x; [徐爱晶 Xu Aijing], 2011, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V27, P158; Zhang YC, 2003, DIABETES, V52, P708, DOI 10.2337/diabetes.52.3.708; Zhou JH, 2001, J IMMUNOL, V167, P4436, DOI 10.4049/jimmunol.167.8.4436	39	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92616	10.1371/journal.pone.0092616	http://dx.doi.org/10.1371/journal.pone.0092616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663217	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900085
J	Diesch, J; Sanij, E; Gilan, O; Love, C; Tran, H; Fleming, NI; Ellul, J; Amalia, M; Haviv, I; Pearson, RB; Tulchinsky, E; Mariadason, JM; Sieber, OM; Hannan, RD; Dhillon, AS				Diesch, Jeannine; Sanij, Elaine; Gilan, Omer; Love, Christopher; Tran, Hoanh; Fleming, Nicholas I.; Ellul, Jason; Amalia, Marcia; Haviv, Izhak; Pearson, Richard B.; Tulchinsky, Eugene; Mariadason, John M.; Sieber, Oliver M.; Hannan, Ross D.; Dhillon, Amardeep S.			Widespread FRA1-Dependent Control of Mesenchymal Transdifferentiation Programs in Colorectal Cancer Cells	PLOS ONE			English	Article							FOS FAMILY-MEMBERS; BETA-CATENIN; DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTORS; FRA-1; TRANSITION; INVASION; RAS; METASTASIS; PHENOTYPE	Tumor invasion and metastasis involves complex remodeling of gene expression programs governing epithelial homeostasis. Mutational activation of the RAS-ERK is a frequent occurrence in many cancers and has been shown to drive overexpression of the AP-1 family transcription factor FRA1, a potent regulator of migration and invasion in a variety of tumor cell types. However, the nature of FRA1 transcriptional targets and the molecular pathways through which they promote tumor progression remain poorly understood. We found that FRA1 was strongly expressed in tumor cells at the invasive front of human colorectal cancers (CRCs), and that its depletion suppressed mesenchymal-like features in CRC cells in vitro. Genome-wide analysis of FRA1 chromatin occupancy and transcriptional regulation identified epithelial-mesenchymal transition (EMT)-related genes as a major class of direct FRA1 targets in CRC cells. Expression of the promesenchymal subset of these genes predicted adverse outcomes in CRC patients, and involved FRA-1-dependent regulation and cooperation with TGF beta signaling pathway. Our findings reveal an unexpectedly widespread and direct role for FRA1 in control of epithelial-mesenchymal plasticity in CRC cells, and suggest that FRA1 plays an important role in mediating cross talk between oncogenic RAS-ERK and TGF beta signaling networks during tumor progression.	[Diesch, Jeannine; Sanij, Elaine; Gilan, Omer; Ellul, Jason; Amalia, Marcia; Pearson, Richard B.; Hannan, Ross D.; Dhillon, Amardeep S.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic, Australia; [Gilan, Omer; Amalia, Marcia; Pearson, Richard B.; Hannan, Ross D.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Melbourne, Vic, Australia; [Sanij, Elaine; Pearson, Richard B.; Hannan, Ross D.; Dhillon, Amardeep S.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Sanij, Elaine; Dhillon, Amardeep S.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Love, Christopher; Fleming, Nicholas I.; Sieber, Oliver M.] Walter & Eliza Inst Med Res, Parkville, Vic, Australia; [Tran, Hoanh; Mariadason, John M.] Ludwig Inst Canc Res, Heidelberg, Vic, Australia; [Haviv, Izhak] Bar Ilan Univ, Fac Med, Tel Aviv, Israel; [Tulchinsky, Eugene] Univ Leicester, Sch Canc Studies & Mol Med, Leicester, Leics, England; [Hannan, Ross D.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Hannan, Ross D.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute; Ludwig Institute for Cancer Research; Bar Ilan University; University of Leicester; Monash University; University of Queensland	Dhillon, AS (corresponding author), Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic, Australia.	Amardeep.Dhillon@petermac.org	Tulchinsky, Eugene/ABD-7070-2021; Haviv, Izhak/E-3782-2015; Pearson, Richard Bruce/I-1451-2013; Sieber, Oliver/ABA-9211-2021; Diesch, Jeannine/J-8558-2017; Sieber, Oliver/M-9473-2015	Haviv, Izhak/0000-0002-0837-5005; Pearson, Richard Bruce/0000-0001-5919-5090; Sieber, Oliver/0000-0001-9480-0786; Diesch, Jeannine/0000-0002-4667-3468; Sieber, Oliver/0000-0001-9480-0786; Ellul, Jason/0000-0002-6046-5139; Mariadason, John/0000-0001-9123-7684; Sanij, Elaine/0000-0002-2063-7813; Hannan, Ross/0000-0002-2166-4493; Dhillon, Amardeep/0000-0002-6065-663X	National Health and Medical Research Council of Australia [1026228, 1044168]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by project grants 1026228 and 1044168 (to A. S. D.) and Senior Research Fellowships (to R. D. H., R. B. P. and J.M.M.) from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshaiah P, 2007, CANCER RES, V67, P6204, DOI 10.1158/0008-5472.CAN-06-4687; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen H, 2002, ONCOGENE, V21, P4843, DOI 10.1038/sj.onc.1205590; Andreolas C, 2008, INT J CANCER, V122, P1745, DOI 10.1002/ijc.23309; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Brabletz T, 2002, VIRCHOWS ARCH, V441, P1, DOI 10.1007/s00428-002-0642-9; Cejas P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008199; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Debinski W, 2005, MOL CANCER RES, V3, P237; Desmet CJ, 2013, P NATL ACAD SCI USA, V110, P5139, DOI 10.1073/pnas.1222085110; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Eger A, 2004, ONCOGENE, V23, P2672, DOI 10.1038/sj.onc.1207416; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilles C, 2003, CANCER RES, V63, P2658; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hlubek F, 2001, CANCER RES, V61, P8089; Hlubek F, 2004, INT J CANCER, V108, P321, DOI 10.1002/ijc.11522; Hlubek F, 2007, INT J CANCER, V121, P1941, DOI 10.1002/ijc.22916; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LeGolvan MP, 2010, J SURG ONCOL, V102, P898, DOI 10.1002/jso.21817; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Luo YP, 2010, ONCOGENE, V29, P662, DOI 10.1038/onc.2009.308; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Nash GM, 2010, ANN SURG ONCOL, V17, P572, DOI 10.1245/s10434-009-0605-3; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Pino MS, 2010, GASTROENTEROLOGY, V138, P1406, DOI 10.1053/j.gastro.2009.12.010; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; RETTIG WJ, 1986, CANCER RES, V46, P6406; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Sayan AE, 2012, ONCOGENE, V31, P1493, DOI 10.1038/onc.2011.336; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thompson EW, 2011, NAT MED, V17, P1048, DOI 10.1038/nm.2437; Tice DA, 2002, J BIOL CHEM, V277, P6118, DOI 10.1074/jbc.M111255200; Tkach V, 2003, ONCOGENE, V22, P5045, DOI 10.1038/sj.onc.1206570; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vial E, 2003, J CELL SCI, V116, P4957, DOI 10.1242/jcs.00812; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001; Zhang WH, 2005, AM J CLIN PATHOL, V124, P11, DOI 10.1309/T1H2Y2CHWY7PD2BN; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Zlobec I, 2010, ONCOTARGET, V1, P651, DOI 10.18632/oncotarget.199	64	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e88950	10.1371/journal.pone.0088950	http://dx.doi.org/10.1371/journal.pone.0088950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658684	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300004
J	Liu, RH; Jin, PP; Yu, LQ; Wang, Y; Han, LP; Shi, T; Li, X				Liu, Ruohai; Jin, Pengpeng; Yu, Liqun; Wang, Ying; Han, Liping; Shi, Tong; Li, Xu			Impaired Mitochondrial Dynamics and Bioenergetics in Diabetic Skeletal Muscle	PLOS ONE			English	Article							INSULIN-RESISTANCE; MITOFUSIN 2; FUSION; FISSION; TRANSMISSION; CONTRIBUTES; PGC-1-ALPHA; DYSFUNCTION; METABOLISM; ACTIVATION	In most cells, mitochondria are highly dynamic organelles that constantly fuse, divide and move. These processes allow mitochondria to redistribute in a cell and exchange contents among the mitochondrial population, and subsequently repair damaged mitochondria. However, most studies on mitochondrial dynamics have been performed on cultured cell lines and neurons, and little is known about whether mitochondria are dynamic organelles in vivo, especially in the highly specialized and differentiated adult skeletal muscle cells. Using mitochondrial matrix-targeted photoactivatable green fluorescent protein (mtPAGFP) and electroporation methods combined with confocal microscopy, we found that mitochondria are dynamic in skeletal muscle in vivo, which enables mitochondria exchange contents within the whole mitochondrial population through nanotunneling-mediated mitochondrial fusion. Mitochondrial network promotes rapid transfer of mtPAGFP within the cell. More importantly, the dynamic behavior was impaired in high-fat diet (HFD)-induced obese mice, accompanying with disturbed mitochondrial respiratory function and decreased ATP content in skeletal muscle. We further found that proteins controlling mitochondrial fusion MFN1 and MFN2 but not Opa1 were decreased and proteins governing mitochondrial fission Fis1 and Drp1 were increased in skeletal muscle of HFD-induced mice when compared to normal diet-fed mice. Altogether, we conclude that mitochondria are dynamic organelles in vivo in skeletal muscle, and it is essential in maintaining mitochondrial respiration and bioenergetics.	[Liu, Ruohai; Shi, Tong] Wenzhou Med Univ, Affiliated Hosp 2, Dept Anaesthesia, Wenzhou, Peoples R China; [Jin, Pengpeng; Yu, Liqun; Wang, Ying; Han, Liping; Li, Xu] Wenzhou Med Univ, Renji Coll, Dept Physiol, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Li, X (corresponding author), Wenzhou Med Univ, Renji Coll, Dept Physiol, Wenzhou, Peoples R China.	lixu0577@126.com			National Nature Science Foundation of China [81100138]; Wenzhou Science and Technology Bureau [Y20100212, Y20090230]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Science and Technology Bureau	This work was supported by grants from National Nature Science Foundation of China (No. 81100138) and Wenzhou Science and Technology Bureau (NO.Y20100212 and Y20090230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Caffin F, 2013, J PHYSIOL-LONDON, V591, P6017, DOI 10.1113/jphysiol.2013.263079; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen Le, 2011, Congest Heart Fail, V17, P257; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Eisenberg BR, 2010, COMPREHENSIVE PHYSL, P73; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Gan KX, 2013, WORLD J GASTROENTERO, V19, P1572, DOI 10.3748/wjg.v19.i10.1572; Garcia-Cazarin ML, 2011, JOVE-J VIS EXP, DOI 10.3791/2452; GOLDSPINK G, 1964, NATURE, V204, P1095, DOI 10.1038/2041095a0; Grandemange S, 2009, SEMIN CANCER BIOL, V19, P50, DOI 10.1016/j.semcancer.2008.12.001; Holloway GP, 2008, AM J PHYSIOL-ENDOC M, V294, pE1060, DOI 10.1152/ajpendo.00726.2007; Huang XH, 2013, P NATL ACAD SCI USA, V110, P2846, DOI 10.1073/pnas.1300741110; Hernandez-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Kanzaki Y, 2010, CIRCULATION, V121, P831, DOI 10.1161/CIR.0b013e3181d22e2d; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Liesa M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003613; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Matsumoto-Ida M, 2006, CIRCULATION, V114, P1497, DOI 10.1161/CIRCULATIONAHA.106.628834; OGATA T, 1985, CELL TISSUE RES, V242, P461; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Redpath CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069165; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Sciote J J, 2000, J Orthod, V27, P15, DOI 10.1093/ortho/27.1.15; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; SKULACHEV VP, 1990, J MEMBRANE BIOL, V114, P97, DOI 10.1007/BF01869092; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Vendelin M, 2005, AM J PHYSIOL-CELL PH, V288, pC757, DOI 10.1152/ajpcell.00281.2004; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yi JX, 2011, J BIOL CHEM, V286, P32436, DOI 10.1074/jbc.M110.217711; Zhao J, 2012, ONCOGENE; Zorzano A, 2010, BBA-BIOENERGETICS, V1797, P1028, DOI 10.1016/j.bbabio.2010.02.017; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004; Zorzano Antonio, 2009, Archives of Physiology and Biochemistry, V115, P1, DOI 10.1080/13813450802676335	44	91	95	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92810	10.1371/journal.pone.0092810	http://dx.doi.org/10.1371/journal.pone.0092810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658162	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300131
J	Bar-On, L; Aertbelien, E; Molenaers, G; Desloovere, K				Bar-On, Lynn; Aertbelien, Erwin; Molenaers, Guy; Desloovere, Kaat			Muscle Activation Patterns When Passively Stretching Spastic Lower Limb Muscles of Children with Cerebral Palsy	PLOS ONE			English	Article							TOXIN TYPE-A; REFLEX THRESHOLD; PATHOPHYSIOLOGY; RECOMMENDATIONS; RELIABILITY; MOVEMENT; PARESIS; ONSET; CATCH	The definition of spasticity as a velocity-dependent activation of the tonic stretch reflex during a stretch to a passive muscle is the most widely accepted. However, other mechanisms are also thought to contribute to pathological muscle activity and, in patients post-stroke and spinal cord injury can result in different activation patterns. In the lower-limbs of children with spastic cerebral palsy (CP) these distinct activation patterns have not yet been thoroughly explored. The aim of the study was to apply an instrumented assessment to quantify different muscle activation patterns in four lower-limb muscles of children with CP. Fifty-four children with CP were included (males/females n = 35/19; 10.8 +/- 3.8 yrs; bilateral/unilateral involvement n = 32/22; Gross Motor Functional Classification Score I-IV) of whom ten were retested to evaluate intra-rater reliability. With the subject relaxed, single-joint, sagittal-plane movements of the hip, knee, and ankle were performed to stretch the lower-limb muscles at three increasing velocities. Muscle activity and joint motion were synchronously recorded using inertial sensors and electromyography (EMG) from the adductors, medial hamstrings, rectus femoris, and gastrocnemius. Muscles were visually categorised into activation patterns using average, normalized root mean square EMG (RMS-EMG) compared across increasing position zones and velocities. Based on the visual categorisation, quantitative parameters were defined using stretch-reflex thresholds and normalized RMS-EMG. These parameters were compared between muscles with different activation patterns. All patterns were dominated by high velocity-dependent muscle activation, but in more than half, low velocity-dependent activation was also observed. Muscle activation patterns were found to be both muscle-and subject-specific (p<0.01). The intra-rater reliability of all quantitative parameters was moderate to good. Comparing RMS-EMG between incremental position zones during low velocity stretches was found to be the most sensitive in categorizing muscles into activation patterns (p<0.01). Future studies should investigate whether muscles with different patterns react differently to treatment.	[Bar-On, Lynn; Molenaers, Guy; Desloovere, Kaat] Univ Hosp Leuven, Clin Mot Anal Lab, Leuven, Belgium; [Bar-On, Lynn; Desloovere, Kaat] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Aertbelien, Erwin] Katholieke Univ Leuven, Dept Mech Engn, Leuven, Belgium; [Molenaers, Guy] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Molenaers, Guy] Univ Hosp Leuven, Dept Orthopaed, Leuven, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven	Bar-On, L (corresponding author), Univ Hosp Leuven, Clin Mot Anal Lab, Leuven, Belgium.	Lynn.1.bar-on@uzleuven.be	Aertbeliën, Erwin/L-5547-2018; Bar-On, Lynn/GLT-6281-2022; Desloovere, Kaat/F-3240-2014	Aertbeliën, Erwin/0000-0002-4514-0934; Bar-On, Lynn/0000-0003-4793-2860; Desloovere, Kaat/0000-0002-8507-5276	Doctoral Scholarships Committee for International Collaboration with non EER-countries (DBOF) of the University of Leuven, Belgium; Flemish agency for Innovation by Science and Technology (IWT-TBM) [060799]	Doctoral Scholarships Committee for International Collaboration with non EER-countries (DBOF) of the University of Leuven, Belgium; Flemish agency for Innovation by Science and Technology (IWT-TBM)	Lynn Bar-On is supported by a grant from the Doctoral Scholarships Committee for International Collaboration with non EER-countries (DBOF) of the University of Leuven, Belgium. This work was further supported by a grant for Applied Biomedical Research from the Flemish agency for Innovation by Science and Technology (IWT-TBM: grant number 060799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-On L, 2013, GAIT POSTURE, V38, P141, DOI 10.1016/j.gaitpost.2012.11.003; Bar-On L, 2014, ARCH PHYS MED REHAB, V95, P515, DOI 10.1016/j.apmr.2013.08.010; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Boyd RN, 1999, EUR J NEUROL, V6, pS23, DOI 10.1111/j.1468-1331.1999.tb00031.x; Burke D, 2013, NEUROLOGY, V80, pS20, DOI 10.1212/WNL.0b013e31827624a7; Calota A, 2008, CLIN NEUROPHYSIOL, V119, P2329, DOI 10.1016/j.clinph.2008.07.215; Calota A, 2009, TOP STROKE REHABIL, V16, P177, DOI 10.1310/tsr1603-177; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Desloovere K, 2012, EUR J PAEDIATR NEURO, V16, P229, DOI 10.1016/j.ejpn.2010.09.006; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Fleuren JFM, 2010, J NEUROL NEUROSUR PS, V81, P46, DOI 10.1136/jnnp.2009.177071; Gage JR., 2009, IDENTIFICATION TREAT; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Graham HK, 2000, GAIT POSTURE, V11, P67, DOI 10.1016/S0966-6362(99)00054-5; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hislop HJ, 1995, DANIELS WORTHINGS MU; Hornby TG, 2003, J NEUROPHYSIOL, V89, P416, DOI 10.1152/jn.00979.2001; Jobin A, 2000, DEV MED CHILD NEUROL, V42, P531, DOI 10.1017/S0012162200001018; Kamper DG, 2001, ANN BIOMED ENG, V29, P1122, DOI 10.1114/1.1424918; KATZ JN, 1992, MED CARE, V30, P917, DOI 10.1097/00005650-199210000-00004; LANCE JW, 1980, NEUROLOGY, V30, P1303, DOI 10.1212/WNL.30.12.1303; Lebiedowska MK, 2009, J NEUROSCI METH, V179, P323, DOI 10.1016/j.jneumeth.2009.02.005; Lee AS, 2007, J BIOMECH, V40, P3521, DOI 10.1016/j.jbiomech.2007.05.012; LEVIN MF, 1994, BRAIN RES, V657, P23, DOI 10.1016/0006-8993(94)90949-0; Li S, 2006, MUSCLE NERVE, V33, P183, DOI 10.1002/mus.20453; Lieber RL, 2004, MUSCLE NERVE, V29, P615, DOI 10.1002/mus.20059; Lieber RL, 2010, SKELETAL MUSCLE STRU; Malhotra S, 2008, CLIN REHABIL, V22, P1105, DOI 10.1177/0269215508095089; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; McPherson JG, 2008, J NEUROPHYSIOL, V100, P3236, DOI 10.1152/jn.90563.2008; Meinders M, 1996, ARCH PHYS MED REHAB, V77, P487, DOI 10.1016/S0003-9993(96)90038-6; Morrell DS, 2002, RADIOGRAPHICS, V22, P257, DOI 10.1148/radiographics.22.2.g02mr19257; Musampa NK, 2007, EXP BRAIN RES, V181, P579, DOI 10.1007/s00221-007-0956-6; Pandyan AD, 2006, DISABIL REHABIL, V28, P579, DOI 10.1080/09638280500242390; RAUCH HE, 1965, AIAA J, V3, P1445, DOI 10.2514/3.3166; Sheean G, 2008, UPPER MOTOR NEURONE SYNDROME AND SPASTICITY: CLINICAL MANAGEMENT AND NEUROPHYSIOLOGY, 2ND EDITION, P9, DOI 10.1017/CBO9780511544866.003; Staude G, 1999, MED ENG PHYS, V21, P449, DOI 10.1016/S1350-4533(99)00067-3; THILMANN AF, 1991, BRAIN, V114, P233; van den Noort JC, 2010, ARCH PHYS MED REHAB, V91, P615, DOI 10.1016/j.apmr.2009.12.022; van der Salm A, 2005, ARCH PHYS MED REHAB, V86, P1991, DOI 10.1016/j.apmr.2005.04.023; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wu YN, 2010, DEV MED CHILD NEUROL, V52, P563, DOI 10.1111/j.1469-8749.2009.03602.x	43	19	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91759	10.1371/journal.pone.0091759	http://dx.doi.org/10.1371/journal.pone.0091759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651860	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000333352800048
J	Bond, CE; Nancarrow, DJ; Wockner, LF; Wallace, L; Montgomery, GW; Leggett, BA; Whitehall, VLJ				Bond, Catherine E.; Nancarrow, Derek J.; Wockner, Leesa F.; Wallace, Leanne; Montgomery, Grant W.; Leggett, Barbara A.; Whitehall, Vicki L. J.			Microsatellite Stable Colorectal Cancers Stratified by the BRAF V600E Mutation Show Distinct Patterns of Chromosomal Instability	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; COPY-NUMBER ALTERATIONS; GENOMIC INSTABILITY; ANEUPLOIDY; PROGNOSIS; HETEROZYGOSITY; ASSOCIATION; ABERRATIONS; LANDSCAPE; MECHANISM	The BRAF (V600E) mutation in colorectal cancers that are microsatellite stable (MSS) confers a poor patient prognosis, whereas BRAF mutant microsatellite-unstable (MSI) colorectal cancers have an excellent prognosis. BRAF wild type cancers are typically MSS and display chromosomal instability (CIN). CIN has not been extensively studied on a genome-wide basis in relation to BRAF mutational status in colorectal cancer. BRAF mutant/MSS (BRAFmut/MSS) cancers (n = 33) and BRAF mutant/MSI (BRAFmut/MSI) cancers (n = 30) were compared for presence of copy number aberrations (CNAs) indicative of CIN, with BRAF wild type/MSS (BRAFwt/MSS) cancers (n = 18) using Illumina CytoSNP-12 arrays. BRAFmut/MSS and BRAF-wt/MSS cancers showed comparable numbers of CNAs/cancer at 32.8 and 29.8 respectively. However, there were differences in patterns of CNA length between MSS cohorts, with BRAFmut/MSS cancers having significantly greater proportions of focal CNAs compared to BRAFwt/MSS cancers (p<0.0001); whereas whole chromosomal arm CNAs were more common in BRAFwt/MSS cancers (p<0.0001). This related to a reduced average CNA length in BRAFmut/MSS compared to BRAFwt/MSS cancers (20.7 Mb vs 33.4 Mb; p<0.0001); and a smaller average percent of CIN affected genomes in BRAFmut/MSS compared to BRAFwt/MSS cancers (23.9% vs 34.9% respectively). BRAFmut/MSI cancers were confirmed to have low CNA rates (5.4/cancer) and minimal CIN-affected genomes (average of 4.5%) compared to MSS cohorts (p<0.0001). BRAFmut/MSS cancers had more frequent deletion CNAs compared to BRAFwt/MSS cancers on 6p and 17q at loci not typically correlated with colorectal cancer, and greater amplification CNAs on 8q and 18q compared to BRAFwt/MSS cancers. These results indicate that comparable rates of CIN occur between MSS subgroups, however significant differences in their patterns of instability exist, with BRAFmut/MSS cancers showing a 'focal pattern' and BRAFwt/MSS cancers having a 'whole arm pattern' of CIN. This and the genomic loci more frequently affected in BRAFmut/MSS cancers provides further evidence of the biological distinctions of this important cancer subgroup.	[Bond, Catherine E.; Leggett, Barbara A.; Whitehall, Vicki L. J.] QIMR Berghofer Med Res Inst, Conjoint Gastroenterol Lab, Brisbane, Qld, Australia; [Bond, Catherine E.; Leggett, Barbara A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Nancarrow, Derek J.] QIMR Berghofer Med Res Inst, Canc Control Grp, Brisbane, Qld, Australia; [Nancarrow, Derek J.] QIMR Berghofer Med Res Inst, Oncogen Grp, Brisbane, Qld, Australia; [Wockner, Leesa F.] QIMR Berghofer Med Res Inst, Canc & Populat Studies Grp, Brisbane, Qld, Australia; [Wallace, Leanne; Montgomery, Grant W.] QIMR Berghofer Med Res Inst, Mol Epidemiol Grp, Brisbane, Qld, Australia; [Leggett, Barbara A.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Whitehall, Vicki L. J.] Pathol Queensland, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Bond, CE (corresponding author), QIMR Berghofer Med Res Inst, Conjoint Gastroenterol Lab, Brisbane, Qld, Australia.	catherine.bond@qimrberghofer.edu.au	Montgomery, Grant W/B-7148-2008; Whitehall, Vicki L/B-6262-2013; Leggett, Barbara A/D-3579-2011; Whitehall, Vicki/E-5414-2019; WALLACE, Leanne/V-2097-2018	Montgomery, Grant W/0000-0002-4140-8139; Whitehall, Vicki L/0000-0002-8285-2391; Leggett, Barbara/0000-0003-2062-7380; WALLACE, Leanne/0000-0003-4310-7572; Wockner, Leesa/0000-0002-8921-9265; Bond, Catherine/0000-0002-9615-5300	National Health and Medical Research Council grant (NHMRC) [1050455]; Australian Postgraduate Award; Cancer Australia grant [552449]	National Health and Medical Research Council grant (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Cancer Australia grant	This research was supported by a National Health and Medical Research Council grant (NHMRC #1050455) and an Australian Postgraduate Award. DN was supported by a Cancer Australia grant #552449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2011, INT J CANCER, V129, P1848, DOI 10.1002/ijc.25841; Antelo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045357; Beggs AD, 2013, ONCOGENE, V32, P5333, DOI 10.1038/onc.2012.584; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Belaguli NS, 2010, NEOPLASIA, V12, P856, DOI 10.1593/neo.10224; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bond CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047483; Bond CE, 2012, INT J CANCER, V130, P1567, DOI 10.1002/ijc.26175; Chang SC, 2006, INT J CANCER, V118, P1721, DOI 10.1002/ijc.21563; Cheng YW, 2008, CLIN CANCER RES, V14, P6005, DOI 10.1158/1078-0432.CCR-08-0216; Deng GR, 2006, INT J CANCER, V118, P2999, DOI 10.1002/ijc.21740; Duijf PHG, 2013, ONCOGENE, V32, P4727, DOI 10.1038/onc.2012.616; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Dyrso T, 2011, CANCER GENET-NY, V204, P84, DOI 10.1016/j.cancergencyto.2010.08.019; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Gaasenbeek M, 2006, CANCER RES, V66, P3471, DOI 10.1158/0008-5472.CAN-05-3285; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hirsch D, 2013, CANCER RES, V73, P1454, DOI 10.1158/0008-5472.CAN-12-0928; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Janssen A, 2013, ONCOGENE, V32, P4459, DOI 10.1038/onc.2012.576; Jasmine F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031968; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Kakar S, 2008, ARCH PATHOL LAB MED, V132, P958, DOI 10.1043/1543-2165(2008)132[958:CCCIMP]2.0.CO;2; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TM, 2013, GENOME RES, V23, P217, DOI 10.1101/gr.140301.112; Knez K, 2012, SMALL, V8, P868, DOI 10.1002/smll.201102209; Koinuma K, 2004, INT J CANCER, V108, P237, DOI 10.1002/ijc.11523; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Kozlowska J, 2012, TUMOR BIOL, V33, P1015, DOI 10.1007/s13277-012-0334-2; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; LOTHE RA, 1993, CANCER RES, V53, P5849; Martinez C, 2010, CELL CYCLE, V9, P2275, DOI 10.4161/cc.9.12.11865; Melcher R, 2011, CARCINOGENESIS, V32, P636, DOI 10.1093/carcin/bgr011; Mosesso P, MUTAT RES, V701, P86; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; Nancarrow DJ, 2008, CANCER RES, V68, P4163, DOI 10.1158/0008-5472.CAN-07-6710; Obe G, 2010, CYTOGENET GENOME RES, V128, P8, DOI 10.1159/000303328; Ogino S, 2011, CLIN CANC RES; Ogino S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-72; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Roylance R, 2006, ONCOGENE, V25, P6544, DOI 10.1038/sj.onc.1209659; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Sawada T, 2013, GENE CHROMOSOME CANC, V52, P140, DOI 10.1002/gcc.22013; Sinicrope FA, 2006, GASTROENTEROLOGY, V131, P729, DOI 10.1053/j.gastro.2006.06.005; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Thompson SL, 2011, CHROMOSOME RES, V19, P433, DOI 10.1007/s10577-010-9179-y; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; Walther A, 2008, GUT, V57, P941, DOI 10.1136/gut.2007.135004; Watanabe T, 2012, J CLIN ONCOL; Weaver BA, 2008, CANCER CELL, V14, P431, DOI 10.1016/j.ccr.2008.11.011; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Whitehall VLJ, 2012, INT J CANCER, V131, P813, DOI 10.1002/ijc.26440; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Xie T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042001, 10.1371/journal.pone.0047577]	62	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91739	10.1371/journal.pone.0091739	http://dx.doi.org/10.1371/journal.pone.0091739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651849	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800047
J	Wang, WL; Huang, HC; Kao, SH; Hsu, YC; Wang, YT; Li, KC; Chen, YJ; Yu, SL; Wang, SP; Hsiao, TH; Yang, PC; Hong, TM				Wang, W-L; Huang, H-C; Kao, S-H; Hsu, Y-C; Wang, Y-T; Li, K-C; Chen, Y-J; Yu, S-L; Wang, S-P; Hsiao, T-H; Yang, P-C; Hong, T-M			Slug is temporally regulated by cyclin E in cell cycle and controls genome stability	ONCOGENE			English	Article							REPRESSES E-CADHERIN; DEPENDENT KINASES; NEURAL CREST; EXPRESSION; CANCER; PROLIFERATION; DEGRADATION; INSTABILITY; TRANSCRIPTION; P27(KIP1)	The transcriptional repressor Slug is best known to control epithelial-mesenchymal transition (EMT) and promote cancer invasion/metastasis. In this study, we demonstrate that Slug is temporally regulated during cell cycle progression. At G1/S transition, cyclin E-cyclin-dependent kinase 2 mediates the phosphorylation of Slug at Ser-54 and Ser-104, resulting in its ubiquitylation and degradation. Non-phosphorylatable Slug is markedly stabilized at G1/S transition compared with wild-type Slug and greatly leads to downregulation of DNA synthesis and checkpoint-related proteins, including TOP1, DNA Ligase IV and Rad17, reduces cell proliferation, delays S-phase progression and contributes to genome instability. Our results indicate that Slug has multifaceted roles in cancer progression by controlling both EMT and genome stability.	[Wang, W-L; Kao, S-H; Wang, S-P; Yang, P-C] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Wang, W-L; Hong, T-M] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan 704, Taiwan; [Huang, H-C] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Kao, S-H; Hsiao, T-H; Yang, P-C] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hsu, Y-C; Li, K-C] Acad Sinica, Inst Stat Sci, Taipei 115, Taiwan; [Wang, Y-T; Chen, Y-J] Acad Sinica, Taiwan Int Grad Program, Chem Biol & Mol Biophys Program, Taipei 115, Taiwan; [Wang, Y-T; Chen, Y-J] Acad Sinica, Inst Chem, Taipei 115, Taiwan; [Yu, S-L] Natl Taiwan Univ, Coll Med, Dept Clin, Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Yang, P-C] Natl Taiwan Univ, Coll Med, NTU Ctr Genom Med, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Cheng Kung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Hong, TM (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Coll Med, 138 Sheng Li Rd, Tainan 704, Taiwan.	tmhong@mail.ncku.edu.tw	Chen, Yu-Ju/E-9481-2015; Li, Ker-Chau/AAQ-4886-2021; Wang, Shu-Ping/S-4379-2018	Chen, Yu-Ju/0000-0002-3178-6697; Wang, Shu-Ping/0000-0002-5895-1269; YU, SUNG-LIANG/0000-0003-4535-9036; YANG, PAN-CHYR/0000-0001-6330-6048	Human Frontier Science Program long-term fellowship; National Science Council [NSC99-2628-B-006-031-MY3, NSC101-2325-B-006-018, NSC100-2321-B-002-071, NSC101-2321-B-002-068, NSC102-2811-B-002-069]; National Taiwan University [101R7601-2]	Human Frontier Science Program long-term fellowship(Human Frontier Science Program); National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	The proteomics data analysis by LTQ-Orbitrap XL hybrid mass spectrometer was performed by the Academia Sinica Common Mass Spectrometry Facilities located at the Institute of Biological Chemistry, Taipei, Taiwan. shRNA constructs were obtained from the National RNAi Core Facility at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, Taipei, Taiwan. We thank Szu-Hua Pan, Pei-Fang Hung and Shu-Wei Lin for technical assistance. S-PW is supported by a Human Frontier Science Program long-term fellowship. This work was supported by grants from the National Science Council (NSC99-2628-B-006-031-MY3, NSC101-2325-B-006-018, NSC100-2321-B-002-071, NSC101-2321-B-002-068 and NSC102-2811-B-002-069) and National Taiwan University (101R7601-2).	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Baygi ME, 2010, TUMOR BIOL, V31, P297, DOI 10.1007/s13277-010-0037-5; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Dhar SK, 2001, J BIOL CHEM, V276, P29067, DOI 10.1074/jbc.M103078200; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Hajra KM, 2002, CANCER RES, V62, P1613; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Karanjawala ZE, 1999, CURR BIOL, V9, P1501, DOI 10.1016/S0960-9822(00)80123-2; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Liu J, 2010, PROSTATE, V70, P1768, DOI 10.1002/pros.21213; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MAYOR R, 1995, DEVELOPMENT, V121, P767; Mills KD, 2004, GENE DEV, V18, P1283, DOI 10.1101/gad.1204304; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sakaue-Sawano A, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-2; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Siu KT, 2012, CELL CYCLE, V11, P57, DOI 10.4161/cc.11.1.18775; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Turner FE, 2006, J BIOL CHEM, V281, P21321, DOI 10.1074/jbc.M509731200; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Vernon AE, 2006, DEVELOPMENT, V133, P3359, DOI 10.1242/dev.02504; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wang X, 2003, GENE DEV, V17, P965, DOI 10.1101/gad.1065103; Yuan A, 2002, J CLIN ONCOL, V20, P900, DOI 10.1200/JCO.20.4.900; Zhao JY, 1998, GENE DEV, V12, P456, DOI 10.1101/gad.12.4.456	32	28	28	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 26	2015	34	9					1116	1125		10.1038/onc.2014.58	http://dx.doi.org/10.1038/onc.2014.58			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RY	24662826				2022-12-25	WOS:000350122100005
J	Herzog, C; Haun, RS; Ludwig, A; Shah, SV; Kaushal, GP				Herzog, Christian; Haun, Randy S.; Ludwig, Andreas; Shah, Sudhir V.; Kaushal, Gur P.			ADAM10 Is the Major Sheddase Responsible for the Release of Membrane-associated Meprin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM ADAMTS; Kidney; Metalloprotease; Mouse; Shedding; siRNA; ADAM10; ADAM17; Meprin	AMINOBENZOIC ACID HYDROLASE; AMYLOID PRECURSOR PROTEIN; EPITHELIAL-CELL INJURY; NECROSIS-FACTOR-ALPHA; ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; METALLOPROTEASE MEPRIN; IN-VITRO; DISINTEGRIN/METALLOPROTEINASE ADAM10; DIFFERENTIAL EXPRESSION	Background: Meprin A is a membrane-associated metalloproteinase in proximal tubules that plays an important role in acute kidney injury (AKI). Results: In ischemia-reperfusion injury, meprin A is shed from the membranes, and ADAM10 was identified as the major sheddase. Conclusion: ADAM10 is the major sheddase involved in the release of meprin A. Significance: These studies identify ADAM10 as a potential therapeutic target for AKI. Meprin A, composed of and subunits, is a membrane-bound metalloproteinase in renal proximal tubules. Meprin A plays an important role in tubular epithelial cell injury during acute kidney injury (AKI). The present study demonstrated that during ischemia-reperfusion-induced AKI, meprin A was shed from proximal tubule membranes, as evident from its redistribution toward the basolateral side, proteolytic processing in the membranes, and excretion in the urine. To identify the proteolytic enzyme responsible for shedding of meprin A, we generated stable HEK cell lines expressing meprin alone and both meprin and meprin for the expression of meprin A. Phorbol 12-myristate 13-acetate and ionomycin stimulated ectodomain shedding of meprin and meprin A. Among the inhibitors of various proteases, the broad spectrum inhibitor of the ADAM family of proteases, tumor necrosis factor- protease inhibitor (TAPI-1), was most effective in preventing constitutive, phorbol 12-myristate 13-acetate-, and ionomycin-stimulated shedding of meprin and meprin A in the medium of both transfectants. The use of differential inhibitors for ADAM10 and ADAM17 indicated that ADAM10 inhibition is sufficient to block shedding. In agreement with these results, small interfering RNA to ADAM10 but not to ADAM9 or ADAM17 inhibited meprin and meprin A shedding. Furthermore, overexpression of ADAM10 resulted in enhanced shedding of meprin from both transfectants. Our studies demonstrate that ADAM10 is the major ADAM metalloproteinase responsible for the constitutive and stimulated shedding of meprin and meprin A. These studies further suggest that inhibiting ADAM 10 activity could be of therapeutic benefit in AKI.	[Herzog, Christian; Haun, Randy S.; Shah, Sudhir V.; Kaushal, Gur P.] Univ Arkansas Med Sci, Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Herzog, Christian; Shah, Sudhir V.; Kaushal, Gur P.] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA; [Kaushal, Gur P.] Univ Arkansas Med Sci, Dept Biochem, Little Rock, AR 72205 USA; [Haun, Randy S.] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Little Rock, AR 72205 USA; [Ludwig, Andreas] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, D-52062 Aachen, Germany; [Ludwig, Andreas] Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res, D-52062 Aachen, Germany	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; RWTH Aachen University; RWTH Aachen University	Kaushal, GP (corresponding author), Cent Arkansas Vet Healthcare Syst, 4300 West 7th St,111D, Little Rock, AR 72205 USA.	kaushalgurp@uams.edu	Ludwig, Andreas/I-5685-2012	Ludwig, Andreas/0000-0001-8536-4986; Herzog, Christian/0000-0001-6024-3491	National Institutes of Health [R01 DK081690]; Veterans Affairs Merit Awards [BX000538, BX000828]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081690] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000828, I01BX000538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Awards(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK081690. This work was also supported by Veterans Affairs Merit Awards BX000538 and BX000828 (to G. P. K. and R. K. H., respectively).	Ambort D, 2010, MATRIX BIOL, V29, P31, DOI 10.1016/j.matbio.2009.08.007; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Bao JL, 2013, AM J PHYSIOL-RENAL, V305, pF714, DOI 10.1152/ajprenal.00179.2012; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Bergin E, 2000, AM J PHYSIOL-RENAL, V278, pF758, DOI 10.1152/ajprenal.2000.278.5.F758; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; Bylander J, 2008, AM J PHYSIOL-RENAL, V294, pF480, DOI 10.1152/ajprenal.00214.2007; Carmago S, 2002, KIDNEY INT, V61, P959, DOI 10.1046/j.1523-1755.2002.00209.x; Cong R, 2011, AM J PHYSIOL-CELL PH, V300, pC1366, DOI 10.1152/ajpcell.00451.2010; CRAIG SS, 1987, AM J PHYSIOL, V253, pC535, DOI 10.1152/ajpcell.1987.253.4.C535; Crawford HC, 2009, CURR PHARM DESIGN, V15, P2288, DOI 10.2174/138161209788682442; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Garcia-Caballero A, 2011, CHANNELS, V5, P14, DOI 10.4161/chan.5.1.13759; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gasbarri A, 2003, MELANOMA RES, V13, P325, DOI 10.1097/00008390-200308000-00001; Gibb DR, 2011, MOL IMMUNOL, V48, P1319, DOI 10.1016/j.molimm.2010.12.005; Hahn D, 2003, J BIOL CHEM, V278, P42829, DOI 10.1074/jbc.M211169200; Herzog C, 2007, KIDNEY INT, V71, P1009, DOI 10.1038/sj.ki.5002189; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; Huguenin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002153; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; KAUSHAL GP, 1994, J CELL BIOL, V126, P1319, DOI 10.1083/jcb.126.5.1319; Kaushal GP, 2013, AM J PHYSIOL-RENAL, V304, pF1150, DOI 10.1152/ajprenal.00014.2013; Kim J, 2010, J BIOL CHEM, V285, P22917, DOI 10.1074/jbc.M110.126649; Klein T, 2011, J PROTEOME RES, V10, P17, DOI 10.1021/pr100556z; Kohler D, 2000, FEBS LETT, V465, P2, DOI 10.1016/S0014-5793(99)01712-3; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kumar JM, 2001, BBA-GENE STRUCT EXPR, V1518, P106, DOI 10.1016/S0167-4781(01)00188-9; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Matters GL, 2005, CLIN EXP METASTAS, V22, P331, DOI 10.1007/s10585-005-0660-5; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Moss ML, 2010, COMB CHEM HIGH T SCR, V13, P358; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Oneda B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002278; Pischitzis A, 1999, EUR J BIOCHEM, V261, P421, DOI 10.1046/j.1432-1327.1999.00268.x; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Scholz F, 2007, J INVEST DERMATOL, V127, P1444, DOI 10.1038/sj.jid.5700751; Schramme A, 2008, KIDNEY INT, V74, P328, DOI 10.1038/ki.2008.181; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P105, DOI 10.1016/0003-9861(88)90376-1; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Sterchi EE, 2008, MOL ASPECTS MED, V29, P255, DOI 10.1016/j.mam.2008.08.007; Takayama J, 2008, EUR J PHARMACOL, V581, P157, DOI 10.1016/j.ejphar.2007.11.044; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; TRACHTMAN H, 1995, BIOCHEM BIOPH RES CO, V208, P498, DOI 10.1006/bbrc.1995.1366; Walker PD, 1998, KIDNEY INT, V53, P1673, DOI 10.1046/j.1523-1755.1998.00949.x; Wang Z, 2011, SHOCK, V35, P141, DOI 10.1097/SHK.0b013e3181ec39cc; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; YAMAGUCHI T, 1994, BIOL CHEM H-S, V375, P821; Yura RE, 2009, AM J PHYSIOL-RENAL, V296, pF135, DOI 10.1152/ajprenal.90524.2008	71	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13308	13322		10.1074/jbc.M114.559088	http://dx.doi.org/10.1074/jbc.M114.559088			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24662289	hybrid, Green Published			2022-12-25	WOS:000335522800030
J	Yang, XL; Smith, AA; Williams, MS; Pal, U				Yang, Xiuli; Smith, Alexis A.; Williams, Mark S.; Pal, Utpal			A Dityrosine Network Mediated by Dual Oxidase and Peroxidase Influences the Persistence of Lyme Disease Pathogens within the Vector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Host-Pathogen Interactions; Infectious Diseases; Innate Immunity; Microbiology; NADPH Oxidase; Nitric-oxide Synthase; Peroxidase; Protein Cross-linking	IXODES-SCAPULARIS TICKS; INNATE IMMUNE-RESPONSE; BORRELIA-BURGDORFERI; CAENORHABDITIS-ELEGANS; NITRIC-OXIDE; EXTRACELLULAR-MATRIX; ANNOTATED CATALOG; ANOPHELES-GAMBIAE; CROSS-LINKING; IMD PATHWAYS	Background: How tick immune components influence persistence of pathogens remains unknown. Results: Impairment of dityrosine network formed by a dual oxidase and a peroxidase activates specific immune genes and reduces pathogen survival. Conclusion: A dityrosine network influences persistence of Lyme disease pathogens. Significance: Knowledge of a Duox system in protein cross-linking may offer new strategies to disrupt pathogen life cycle. Ixodes scapularis ticks transmit a wide array of human and animal pathogens including Borrelia burgdorferi; however, how tick immune components influence the persistence of invading pathogens remains unknown. As originally demonstrated in Caenorhabditis elegans and later in Anopheles gambiae, we show here that an acellular gut barrier, resulting from the tyrosine cross-linking of the extracellular matrix, also exists in I. scapularis ticks. This dityrosine network (DTN) is dependent upon a dual oxidase (Duox), which is a member of the NADPH oxidase family. The Ixodes genome encodes for a single Duox and at least 16 potential peroxidase proteins, one of which, annotated as ISCW017368, together with Duox has been found to be indispensible for DTN formation. This barrier influences pathogen survival in the gut, as an impaired DTN in Doux knockdown or in specific peroxidase knockdown ticks, results in reduced levels of B. burgdorferi persistence within ticks. Absence of a complete DTN formation in knockdown ticks leads to the activation of specific tick innate immune pathway genes that potentially resulted in the reduction of spirochete levels. Together, these results highlighted the evolution of the DTN in a diverse set of arthropod vectors, including ticks, and its role in protecting invading pathogens like B. burgdorferi. Further understanding of the molecular basis of tick innate immune responses, vector-pathogen interaction, and their contributions in microbial persistence may help the development of new targets for disrupting the pathogen life cycle.	[Yang, Xiuli; Smith, Alexis A.; Pal, Utpal] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA; [Yang, Xiuli; Smith, Alexis A.; Pal, Utpal] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Williams, Mark S.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore	Pal, U (corresponding author), Univ Maryland, Dept Vet Med, Bldg 795,Rm 1341, College Pk, MD 20742 USA.	upal@umd.edu	Pal, Utpal/I-5265-2015		National Institutes of Health [R01AI080615]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI080615 (to U. P.).	Anderson JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-552; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; de Silva AM, 2009, FRONT BIOSCI-LANDMRK, V14, P3051, DOI 10.2741/3434; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Ghigo D, 2006, NITRIC OXIDE-BIOL CH, V15, P148, DOI 10.1016/j.niox.2006.01.002; Govind S, 2004, PLOS BIOL, V2, P1065, DOI 10.1371/journal.pbio.0020276; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hynes WL, 2005, MED VET ENTOMOL, V19, P339, DOI 10.1111/j.1365-2915.2005.00579.x; Kariu T., 2011, J VIS EXP, V48, P2544; Kariu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078376; Kopacek P, 2010, ADV EXP MED BIOL, V708, P137; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; MA Y, 1994, INFECT IMMUN, V62, P3663, DOI 10.1128/IAI.62.9.3663-3671.1994; Meitzler JL, 2010, J BIOL CHEM, V285, P40991, DOI 10.1074/jbc.M110.170902; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; MODOLELL M, 1994, IMMUNOL LETT, V40, P139, DOI 10.1016/0165-2478(94)90185-6; Moreno CX, 2006, ENVIRON MICROBIOL, V8, P761, DOI 10.1111/j.1462-2920.2005.00955.x; Moribe H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002957; MUNDERLOH UG, 1995, ANNU REV ENTOMOL, V40, P221, DOI 10.1146/annurev.en.40.010195.001253; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2003, MICROBES INFECT, V5, P659, DOI 10.1016/S1286-4579(03)00097-2; Pal U., 2010, BORRELIA MOL BIOL HO, P279; PIESMAN J, 1990, AM J TROP MED HYG, V42, P352, DOI 10.4269/ajtmh.1990.42.352; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Rudenko N, 2005, J MED ENTOMOL, V42, P36, DOI 10.1603/0022-2585(2005)042[0036:DEOIRT]2.0.CO;2; Sonenshine D.E., 1993, BIOL TICKS; Sonenshine DE, 2005, EXP APPL ACAROL, V36, P207, DOI 10.1007/s10493-005-2564-0; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Thein MC, 2009, J BIOL CHEM, V284, P17549, DOI 10.1074/jbc.M900831200; Tyson KR, 2009, ADV INSECT PHYSIOL, V37, P243, DOI 10.1016/S0065-2806(09)37005-8; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V66, P72, DOI 10.1111/j.1574-6941.2008.00468.x; Yang XL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000326; Yassine H, 2010, CELL MICROBIOL, V12, P1, DOI 10.1111/j.1462-5822.2009.01388.x; ZHU Z, 1991, PARASITOL RES, V77, P635, DOI 10.1007/BF00931028	45	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12813	12822		10.1074/jbc.M113.538272	http://dx.doi.org/10.1074/jbc.M113.538272			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24662290	Green Published, hybrid			2022-12-25	WOS:000335581400050
J	Zhang, WN; He, T; Wang, Q; Li, X; Wei, JM; Hou, XQ; Zhang, B; Huang, L; Wang, L				Zhang, Weina; He, Tao; Wang, Qiong; Li, Xin; Wei, Jianming; Hou, Xiaoqiang; Zhang, Bin; Huang, Lei; Wang, Li			Interleukin-1 Receptor-associated Kinase-2 Genetic Variant rs708035 Increases NF-kappa B Activity through Promoting TRAF6 Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Gene Regulation; Inflammation; Signal Transduction; Toll-like Receptors (TLR)	TOLL-LIKE RECEPTOR-3; INFLUENZA-A-VIRUS; IRAK-M; SIGNALING COMPLEXES; IMMUNE-RESPONSE; MICE LACKING; ACTIVATION; FAMILY; CANCER; TAB2	Background: Single nucleotide polymorphisms (SNPs) within the IRAK genes have been discovered recently. However, the functions of these IRAK SNPs remain largely unknown. Results: Non-synonymous IRAK2 variant, rs708035, increases NF-B activity through promoting TRAF6 ubiquitination. Conclusion: Genetic alteration of IRAK2 affects its regulation on NF-B activation. Significance: Our study provides an important insight of IRAK2 SNP in the regulation of NF-B activation. The IL-1 receptor-associated kinases (IRAKs) are key regulators of Toll-like receptor (TLR)/IL-1 signaling, which are critical regulators of mammalian inflammation and innate immune response. Single nucleotide polymorphisms (SNPs) within the IRAK genes have been discovered recently. However, the functions of these IRAK SNPs remain largely unknown. Here, we found that the non-synonymous IRAK2 variant rs708035 (coding D431E) increases NF-B activity and leads to more expression of NF-B-dependent proinflammatory cytokines compared with IRAK2 wild type. Moreover, when IRAK2 knockdown cells reconstituted with siRNA-resistant WT-IRAK2 or D431E-IRAK2 were infected with influenza virus, a more obvious induction of IL-6 and a stronger anti-apoptosis effect were observed in D431E-IRAK2 expressing cells. Notably, we also found that the levels of proinflammatory cytokine-IL-6 were indeed higher in people carrying D431E-IRAK2 than those carrying WT-IRAK2. Further study demonstrated that elevated NF-B activation mediated by the IRAK2 variant was due to increased TRAF6 ubiquitination and faster IB degradation. Our study provides important insight of IRAK2 SNP in the regulation of NF-B activation and indicates that IRAK2 rs708035 might be associated with human diseases caused by hyper-activation of NF-B.	[Zhang, Weina; He, Tao; Wang, Qiong; Li, Xin; Wei, Jianming; Hou, Xiaoqiang; Zhang, Bin; Wang, Li] Beijing Inst Biotechnol, Beijing 100071, Peoples R China; [Wang, Qiong] Beijing Inst Radiat Med, Beijing 100850, Peoples R China; [Wei, Jianming] PLA, Hosp 307, Beijing 100071, Peoples R China; [Huang, Lei] PLA, Hosp 302, Beijing 100071, Peoples R China	Academy of Military Medical Sciences - China; Fifth Medical Center of Chinese PLA General Hospital	Huang, L (corresponding author), PLA, Hosp 302, Beijing 100071, Peoples R China.	huangleiwa@sina.com; liwang@tsinghua.edu.cn	lei, huang/AFS-7785-2022		National Hi-tech Research and Development Program of China [2012AA022002, 2012AA02207]; Chinese Key Program for Drug Invention Grant [2012ZX09J12106-03]; National Natural Science Foundation of China [30800644, 31100940, 31271447, 61308103]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA022002] Funding Source: NIH RePORTER	National Hi-tech Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Key Program for Drug Invention Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Hi-tech Research and Development Program of China Grants 2012AA022002 and 2012AA02207, Chinese Key Program for Drug Invention Grant 2012ZX09J12106-03, and National Natural Science Foundation of China Grants 30800644, 31100940, 31271447, and 61308103.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arcaroli J, 2006, AM J RESP CRIT CARE, V173, P1335, DOI 10.1164/rccm.200603-341OC; Benosman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064256; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; CROSTON GE, 1995, J BIOL CHEM, V270, P16514, DOI 10.1074/jbc.270.28.16514; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Gao YF, 2011, NAT CELL BIOL, V13, P924, DOI 10.1038/ncb2287; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ishida R, 2003, J BONE MINER RES, V18, P419, DOI 10.1359/jbmr.2003.18.3.419; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Mills Kingston H G, 2009, Nat Med, V15, P1363, DOI 10.1038/nm1209-1363; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Pauls E, 2013, J IMMUNOL, V191, P2717, DOI 10.4049/jimmunol.1203268; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Ruland J, 2003, IMMUNOL REV, V193, P93, DOI 10.1034/j.1600-065X.2003.00049.x; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Thomas JA, 1999, J IMMUNOL, V163, P978; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Zhou H, 2013, EMBO J, V32, P583, DOI 10.1038/emboj.2013.2	43	15	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12507	12519		10.1074/jbc.M113.538009	http://dx.doi.org/10.1074/jbc.M113.538009			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24662294	hybrid, Green Published			2022-12-25	WOS:000335581400026
J	van der Steen, MC; van Vugt, FT; Keller, PE; Altenmuller, E				van der Steen, M. C.; van Vugt, Floris T.; Keller, Peter E.; Altenmueller, Eckart			Basic Timing Abilities Stay Intact in Patients with Musician's Dystonia	PLOS ONE			English	Article							FOCAL HAND DYSTONIA; SENSORIMOTOR SYNCHRONIZATION; PHASE-CORRECTION; WRITERS CRAMP; DISCRIMINATION; ABNORMALITIES; INTEGRATION; TEMPO; MOTOR; ADAPTATION	Task-specific focal dystonia is a movement disorder that is characterized by the loss of voluntary motor control in extensively trained movements. Musician's dystonia is a type of task-specific dystonia that is elicited in professional musicians during instrumental playing. The disorder has been associated with deficits in timing. In order to test the hypothesis that basic timing abilities are affected by musician's dystonia, we investigated a group of patients (N = 15) and a matched control group (N = 15) on a battery of sensory and sensorimotor synchronization tasks. Results did not show any deficits in auditory-motor processing for patients relative to controls. Both groups benefited from a pacing sequence that adapted to their timing (in a sensorimotor synchronization task at a stable tempo). In a purely perceptual task, both groups were able to detect a misaligned metronome when it was late rather than early relative to a musical beat. Overall, the results suggest that basic timing abilities stay intact in patients with musician's dystonia. This supports the idea that musician's dystonia is a highly task-specific movement disorder in which patients are mostly impaired in tasks closely related to the demands of actually playing their instrument.	[van der Steen, M. C.; Keller, Peter E.] Max Planck Inst Human Cognit & Brain Sci, Res Grp Mus Cognit & Act, Leipzig, Germany; [van der Steen, M. C.; van Vugt, Floris T.; Altenmueller, Eckart] Univ Mus Drama & Media, Inst Mus Physiol & Musicians Med, Hannover, Germany; [van Vugt, Floris T.] Univ Lyon 1, Lyon Neurosci Res Ctr CNRS UMR 5292, INSERM U1028, F-69365 Lyon, France; [Keller, Peter E.] Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Western Sydney University	van der Steen, MC (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Res Grp Mus Cognit & Act, Leipzig, Germany.	steen@cbs.mpg.de	van Vugt, Floris Tijmen/GWR-1052-2022; Altenmuller, Eckart/AAB-9948-2021	van Vugt, Floris Tijmen/0000-0003-1739-0175; Keller, Peter/0000-0001-7579-6515	European Community's Seventh Framework Programme under the EBRAMUS project [238157]	European Community's Seventh Framework Programme under the EBRAMUS project	This work was supported by funding from the European Community's Seventh Framework Programme under the EBRAMUS project - grant agreement no 238157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2001, BRAIN, V124, P537, DOI 10.1093/brain/124.3.537; Altenmuller E, 2010, MED PROBL PERFORM AR, V25, P3; Avanzino L, 2013, BRAIN, V136, P444, DOI 10.1093/brain/aws328; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Beck S, 2011, EXP BRAIN RES, V210, P165, DOI 10.1007/s00221-011-2610-6; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Chang FCF, 2013, CURR NEUROPHARMACOL, V11, P41, DOI 10.2174/157015913804999531; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Delmaire C, 2007, NEUROLOGY, V69, P376, DOI 10.1212/01.wnl.0000266591.49624.1a; Ehrle N, 2005, BRAIN COGNITION, V58, P133, DOI 10.1016/j.bandc.2004.09.014; Fairhurst MT, 2014, NEUROIMAGE, V84, P688, DOI 10.1016/j.neuroimage.2013.09.027; Fairhurst MT, 2012, CEREB CORTEX, V67, P313, DOI DOI 10.1093/CERC0R/BHS243; Fujii S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00771; Furuya S, 2013, NEUROSCIENCE, V247, P152, DOI 10.1016/j.neuroscience.2013.05.025; Grahn JA, 2009, CORTEX, V45, P54, DOI 10.1016/j.cortex.2008.01.005; Granert O, 2011, J NEUROL NEUROSUR PS, V82, P1225, DOI 10.1136/jnnp.2011.245811; GREEN DM, 1995, J ACOUST SOC AM, V97, P3749, DOI 10.1121/1.412390; GU X, 1994, J ACOUST SOC AM, V96, P93, DOI 10.1121/1.410378; HALLETT M, 1995, ANN NEUROL, V38, P139, DOI 10.1002/ana.410380203; Hu XY, 2006, CHINESE MED J-PEKING, V119, P1263, DOI 10.1097/00029330-200608010-00006; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Iversen J.R., 2008, P 10 INT C MUSIC PER, P465, DOI DOI 10.1016/J.HEARES.2007.10.007; Jabusch HC, 2005, MOVEMENT DISORD, V20, P1623, DOI 10.1002/mds.20631; Jabusch HC, 2004, MOVEMENT DISORD, V19, P171, DOI 10.1002/mds.10671; JANKOVIC J, 1989, SEMIN NEUROL, V9, P131, DOI 10.1055/s-2008-1041316; Jedynak PC, 2001, MOVEMENT DISORD, V16, P494, DOI 10.1002/mds.1094; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; Kadota H, 2010, J NEUROL, V257, P1092, DOI 10.1007/s00415-010-5468-9; Keller PE, 2008, EMERG COMMUN-STUD NE, V10, P205; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; Large EW, 2008, PSYCHOLOGY OF TIME, P189, DOI 10.1016/B978-0-08046-977-5.00006-5; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Launay J, 2014, PSYCHOL RES-PSYCH FO, V78, P721, DOI 10.1007/s00426-013-0513-9; Lebrun-Guillaud G, 2007, PERCEPT PSYCHOPHYS, V69, P1450, DOI 10.3758/BF03192959; Lim VK, 2003, J PSYCHOPHYSIOL, V17, P195, DOI 10.1027/0269-8803.17.4.195; Lim VK, 2003, MOVEMENT DISORD, V18, P1286, DOI 10.1002/mds.10528; MARSDEN CD, 1990, TRENDS NEUROSCI, V13, P148, DOI 10.1016/0166-2236(90)90007-W; McAuley JD, 1998, J EXP PSYCHOL HUMAN, V24, P1786, DOI 10.1037/0096-1523.24.6.1786; Moore RD, 2012, NEUROIMAGE, V61, P823, DOI 10.1016/j.neuroimage.2012.03.066; Pecenka N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00380; Pecenka N, 2011, EXP BRAIN RES, V211, P505, DOI 10.1007/s00221-011-2616-0; Pecenka N, 2009, ANN NY ACAD SCI, V1169, P282, DOI 10.1111/j.1749-6632.2009.04785.x; Penel A, 1998, PSYCHOL RES-PSYCH FO, V61, P12, DOI 10.1007/PL00008161; Preibisch C, 2001, J NEUROL, V248, P10, DOI 10.1007/s004150170263; Pujol J, 2000, NEUROIMAGE, V12, P257, DOI 10.1006/nimg.2000.0615; Quartarone A, 2006, TRENDS NEUROSCI, V29, P192, DOI 10.1016/j.tins.2006.02.007; Repp BH, 1999, PERCEPT PSYCHOPHYS, V61, P529, DOI 10.3758/BF03211971; Repp BH, 2008, HUM MOVEMENT SCI, V27, P423, DOI 10.1016/j.humov.2008.02.016; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Repp BH, 2012, ACTA PSYCHOL, V139, P281, DOI 10.1016/j.actpsy.2011.11.002; Repp BH, 2010, HUM MOVEMENT SCI, V29, P200, DOI 10.1016/j.humov.2009.08.002; Rosenkranz K, 2005, BRAIN, V128, P918, DOI 10.1093/brain/awh402; Rosset-Llobet J, 2007, J NEUROL NEUROSUR PS, V78, P949, DOI 10.1136/jnnp.2006.107953; Sanger TD, 2001, MOVEMENT DISORD, V16, P94, DOI 10.1002/1531-8257(200101)16:1<94::AID-MDS1020>3.0.CO;2-O; Schwartze M, 2011, BEHAV BRAIN RES, V216, P685, DOI 10.1016/j.bbr.2010.09.015; Scontrini A, 2009, J NEUROL NEUROSUR PS, V80, P1315, DOI 10.1136/jnnp.2009.178236; SHEEHY MP, 1982, BRAIN, V105, P461, DOI 10.1093/brain/105.3.461; Stamelou M, 2012, BRAIN, V135, P1668, DOI 10.1093/brain/awr224; Tinazzi M, 2003, MOVEMENT DISORD, V18, P605, DOI 10.1002/mds.10398; van der Steen MC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00253; van Vugt FT, 2014, PARKINSONISM RELAT D, V20, P8, DOI 10.1016/j.parkreldis.2013.08.009; van Vugt FT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087176; Vorberg D, 2002, J MATH PSYCHOL, V46, P56, DOI 10.1006/jmps.2001.1375; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Wu CC, 2010, J NEUROL NEUROSUR PS, V81, P659, DOI 10.1136/jnnp.2009.185637; Zelaznik HN, 2005, J MOTOR BEHAV, V37, P395, DOI 10.3200/JMBR.37.5.395-403; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	67	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92906	10.1371/journal.pone.0092906	http://dx.doi.org/10.1371/journal.pone.0092906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667273	gold, Green Published			2022-12-25	WOS:000333675600101
J	Flegr, J; Prandota, J; Sovickova, M; Israili, ZH				Flegr, Jaroslav; Prandota, Joseph; Sovickova, Michaela; Israili, Zafar H.			Toxoplasmosis - A Global Threat. Correlation of Latent Toxoplasmosis with Specific Disease Burden in a Set of 88 Countries	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; OBSESSIVE-COMPULSIVE DISORDER; CHRONIC MURINE TOXOPLASMOSIS; CENTRAL DIABETES-INSIPIDUS; PRIMARY BILIARY-CIRRHOSIS; GONDII ANTIBODY-TITERS; INFANT-DEATH-SYNDROME; PREGNANT-WOMEN; CONGENITAL TOXOPLASMOSIS	Background: Toxoplasmosis is becoming a global health hazard as it infects 30-50% of the world human population. Clinically, the life-long presence of the parasite in tissues of a majority of infected individuals is usually considered asymptomatic. However, a number of studies show that this 'asymptomatic infection' may also lead to development of other human pathologies. Aims of the Study: The purpose of the study was to collect available geoepidemiological data on seroprevalence of toxoplasmosis and search for its relationship with mortality and disability rates in different countries. Methods and Findings: Prevalence data published between 1995-2008 for women in child-bearing age were collected for 88 countries (29 European). The association between prevalence of toxoplasmosis and specific disease burden estimated with age-standardized Disability Adjusted Life Year (DALY) or with mortality, was calculated using General Linear Method with Gross Domestic Product per capita (GDP), geolatitude and humidity as covariates, and also using nonparametric partial Kendall correlation test with GDP as a covariate. The prevalence of toxoplasmosis correlated with specific disease burden in particular countries explaining 23% of variability in disease burden in Europe. The analyses revealed that for example, DALY of 23 of 128 analyzed diseases and disease categories on the WHO list showed correlations (18 positive, 5 negative) with prevalence of toxoplasmosis and another 12 diseases showed positive trends (p < 0.1). For several obtained significant correlations between the seroprevalence of toxoplasmosis and specific diseases/clinical entities, possible pathophysiological, biochemical and molecular explanations are presented. Conclusions: The seroprevalence of toxoplasmosis correlated with various disease burden. Statistical associations does not necessarily mean causality. The precautionary principle suggests however that possible role of toxoplasmosis as a triggering factor responsible for development of several clinical entities deserves much more attention and financial support both in everyday medical practice and future clinical research.	[Flegr, Jaroslav; Sovickova, Michaela] Charles Univ Prague, Fac Sci, Dept Biol, Prague, Czech Republic; [Prandota, Joseph] Wroclaw Med Univ, Fac Hlth Sci, Dept Social Pediat, Wroclaw, Poland; [Israili, Zafar H.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA	Charles University Prague; Wroclaw Medical University; Emory University	Flegr, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Biol, Prague, Czech Republic.	flegr@cesnet.cz	Flegr, Jaroslav/A-1564-2008; Flegr, Jaroslav/AAG-7568-2021	Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126	Grand Agency of the Czech Republic [P303/11/1398]; Charles University of Prague [UNCE 204004]	Grand Agency of the Czech Republic; Charles University of Prague	The authors' work was supported by the Grand Agency of the Czech Republic (Grant No. P303/11/1398) and Charles University of Prague (grant UNCE 204004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli A, 2012, ANDROLOGIA, V44, P679, DOI 10.1111/j.1439-0272.2011.01249.x; Abu-Madi MA, 2010, AM J TROP MED HYG, V82, P626, DOI 10.4269/ajtmh.2010.09-0530; Addebbous A, 2012, ACTA TROP, V123, P49, DOI 10.1016/j.actatropica.2012.02.070; Agmon-Levin N, 2009, J AUTOIMMUN, V32, P261, DOI 10.1016/j.jaut.2009.02.017; Carneiro ACAV, 2013, J CLIN MICROBIOL, V51, P901, DOI 10.1128/JCM.02502-12; Ahmed M. U., 1997, JCPSP, Journal of the College of Physicians and Surgeons - Pakistan, V7, P156; Ajzenberg D, 2002, J INFECT DIS, V186, P684, DOI 10.1086/342663; Akanmu A S, 2010, Nig Q J Hosp Med, V20, P1; Al-Gazali LI, 2001, AM J MED GENET, V103, P128, DOI 10.1002/ajmg.1509; Al-Masri AN, 2006, J PEDIATR SURG, V41, P1139, DOI 10.1016/j.jpedsurg.2006.02.022; Alibek K, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-7; AlMuhaimeed H, 1996, INT J PEDIATR OTORHI, V34, P1, DOI 10.1016/0165-5876(95)01223-0; Alvarado-Esquivel C, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-178; Alvarado-Esquivel C, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-112; Ancelle T., 1996, Bulletin Epidemiologique Hebdomadaire, P227; Andrade Glaucia Manzan Queiroz de, 2008, Braz J Otorhinolaryngol, V74, P21; [Anonymous], 2011, MED J ISLAMIC WORLD; ANSHER SS, 1994, HEPATOLOGY, V20, P984, DOI 10.1002/hep.1840200430; Antoniou M, 2004, EUR J OBSTET GYN R B, V117, P138, DOI 10.1016/j.ejogrb.2004.03.001; Appenzeller S, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/683212; Arantes TP, 2009, EXP PARASITOL, V123, P190, DOI 10.1016/j.exppara.2009.07.003; Araujo FG, 2003, INFECT IMMUN, V71, P4171, DOI 10.1128/IAI.71.7.4171-4174.2003; Arciszewski M, 2005, DIGEST DIS SCI, V50, P1661, DOI 10.1007/s10620-005-2912-2; Arias ML, 1996, REV BIOL TROP, V44, P377; Arieli G, 1979, Harefuah, V96, P338; Arling TA, 2009, J NERV MENT DIS, V197, P905, DOI 10.1097/NMD.0b013e3181c29a23; Arnson Y, 2009, ANN NY ACAD SCI, V1173, P627, DOI 10.1111/j.1749-6632.2009.04808.x; Arsenijevic D, 2001, EUR CYTOKINE NETW, V12, P518; Arsenijevic D, 1998, AM J PHYSIOL-ENDOC M, V274, pE439, DOI 10.1152/ajpendo.1998.274.3.E439; Arsenijevic D, 1997, AM J PHYSIOL-ENDOC M, V35, P908; Ashrafunnessa, 1998, J OBSTET GYNAECOL RE, V24; Asthana SP, 2006, J PARASITOL, V92, P644, DOI 10.1645/GE-762R.1; Attia Raifa A., 1995, Journal of the Egyptian Society of Parasitology, V25, P877; BALLEARI E, 1991, CLIN RHEUMATOL, V10, P326, DOI 10.1007/BF02208701; Barber N, 2004, SOC BIOL, V51, P71; BARS L, 1978, MED CHIR DIG, V7, P485; Batet CM, 2004, MED CLIN-BARCELONA, V123, P12; BEALE MG, 1979, AM J DIS CHILD, V133, P842, DOI 10.1001/archpedi.1979.02130080082017; Beaver PC, 1984, CLIN PARASITOLOGY, Vviii; BEHAN WMH, 1983, ACTA NEUROPATHOL, V61, P246, DOI 10.1007/BF00691993; Sitoe SPBL, 2010, REV INST MED TROP SP, V52, P291, DOI 10.1590/S0036-46652010000600002; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Berlin T, 2007, ANN NY ACAD SCI, V1108, P584, DOI 10.1196/annals.1422.061; BERMUDEZ LE, 1993, INFECT IMMUN, V61, P4126, DOI 10.1128/IAI.61.10.4126-4130.1993; BERTOLI F, 1995, ARCH PATHOL LAB MED, V119, P214; Bierly AL, 2008, J IMMUNOL, V181, P8485, DOI 10.4049/jimmunol.181.12.8485; Birgisdottir A, 2006, SCAND J INFECT DIS, V38, P625, DOI 10.1080/00365540600606556; Blomstrom A, 2012, SCHIZOPHR RES, V140, P25, DOI 10.1016/j.schres.2012.06.035; Bobic B, 2011, WIEN KLIN WOCHENSCHR, V123, P2, DOI 10.1007/s00508-011-0052-6; Borkakoty B J, 2007, Indian J Med Microbiol, V25, P431; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Breugelmans M, 2004, J PERINAT MED, V32, P211, DOI 10.1515/JPM.2004.039; Brynska A, 2001, EUR CHILD ADOLES PSY, V10, P200, DOI 10.1007/s007870170027; Buchy P, 2003, Bull Soc Pathol Exot, V96, P46; Caballero-Ortega H, 2012, T ROY SOC TROP MED H, V106, P653, DOI 10.1016/j.trstmh.2012.08.004; Calderon-Margalit R, 2006, CLIN CHEM, V52, P845, DOI 10.1373/clinchem.2005.059857; Camossi LG, 2011, VET PARASITOL, V177, P256, DOI 10.1016/j.vetpar.2010.12.007; CANTELLA R, 1974, TROP GEOGR MED, V26, P204; Carter CJ, 2013, J PATHOG, V2013, DOI 10.1155/2013/965046; Castellan NJ, 1988, NONPARAMETRIC STAT B; Chan WFN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045592; Chan WFN, 2012, ARTHRITIS RHEUM-US, V64, P380, DOI 10.1002/art.33358; Channon JY, 2000, INFECT IMMUN, V68, P4822, DOI 10.1128/IAI.68.8.4822-4826.2000; Charron AJ, 2002, J CELL SCI, V115, P3049; Coash M, 2012, J FORMOS MED ASSOC, V111, P3, DOI 10.1016/j.jfma.2011.11.023; CONLEY FK, 1981, INFECT IMMUN, V31, P1184, DOI 10.1128/IAI.31.3.1184-1192.1981; CONNOR TB, 1989, J CLIN INVEST, V83, P1661, DOI 10.1172/JCI114065; Contreras MC, 2009, REV INST MED TROP SP, V38, P431; Coppens I, 2006, CELL MICROBIOL, V8, P1, DOI 10.1111/j.1462-5822.2005.00647.x; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; CRITCHLEY EMR, 1982, EPILEPSIA, V23, P315, DOI 10.1111/j.1528-1157.1982.tb06197.x; Crucerescu E, 1998, Bacteriol Virusol Parazitol Epidemiol, V43, P147; Cuomo G, 2013, INFECTION, V41, P859, DOI 10.1007/s15010-013-0427-x; Cuturic M, 1997, NEUROMUSCULAR DISORD, V7, P390, DOI 10.1016/S0960-8966(97)00098-9; Da Gama LM, 2004, MICROBES INFECT, V6, P1287, DOI 10.1016/j.micinf.2004.07.008; Da Silva AS, 2013, PATHOL RES PRACT, V209, P95, DOI 10.1016/j.prp.2012.10.007; Dama MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046169; Dar FK, 1997, EUR J EPIDEMIOL, V13, P567, DOI 10.1023/A:1007392703037; Das UN, 2007, MED SCI MONITOR, V13, pRA214; Das UN, 2012, ANN HEPATOL, V11, P409, DOI 10.1016/S1665-2681(19)30940-8; de Oliveira FD, 2010, J PEDIATR SURG, V45, P1784, DOI 10.1016/j.jpedsurg.2010.04.007; De Paschale M, 2008, CLIN MICROBIOL INFEC, V14, P186, DOI 10.1111/j.1469-0691.2007.01883.x; DENIAU M, 1991, B SOC PATHOL EXOT, V84, P664; Derouin F, 2008, CLIN MICROBIOL INFEC, V14, P1089, DOI 10.1111/j.1469-0691.2008.02091.x; Diaconu G, 2009, J CLIN PSYCHIAT, V70, P1551, DOI 10.4088/JCP.08m04636; Dimier IH, 1998, IMMUNOLOGY, V94, P488, DOI 10.1046/j.1365-2567.1998.00553.x; DOEHRING E, 1995, AM J TROP MED HYG, V52, P546, DOI 10.4269/ajtmh.1995.52.546; Dubey JP, 2012, EPIDEMIOL INFECT, V140, P1935, DOI 10.1017/S0950268812001392; Dubey JP, 2012, PARASITOLOGY, V139, P1, DOI 10.1017/S0031182011001673; Dubey J.P., 1988, P1; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Edvinsson B, 2008, APMIS, V116, P345, DOI 10.1111/j.1600-0463.2008.00871.x; el Hady H M, 1991, J Egypt Soc Parasitol, V21, P811; El Mansouri B, 2007, Bull Soc Pathol Exot, V100, P289; Elhence P, 2010, TRANSFUS APHER SCI, V43, P37, DOI 10.1016/j.transci.2010.05.004; Elnahas A, 2003, SAUDI MED J, V24, P868; Elsheikha HM, 2008, PUBLIC HEALTH, V122, P335, DOI 10.1016/j.puhe.2007.08.009; Emelia O, 2012, TROP BIOMED, V29, P151; Evengard B, 2001, EPIDEMIOL INFECT, V127, P121, DOI 10.1017/S0950268801005775; Fallah M., 2008, Eastern Mediterranean Health Journal, V14, P163; FANTUZZI G, 1994, INFECT IMMUN, V62, P29, DOI 10.1128/IAI.62.1.29-32.1994; Faye O, 1998, B SOC PATHOL EXOT, V91, P249; Ferguson DJP, 2009, INT J PARASITOL, V39, P871, DOI 10.1016/j.ijpara.2009.01.003; Ferguson W, 2008, Ir Med J, V101, P220; Fiedler K, 1999, Zentralbl Gynakol, V121, P239; Fischer SA, 2006, SURG CLIN N AM, V86, P1127, DOI 10.1016/j.suc.2006.06.005; FITZGERALD JF, 1988, PEDIATR CLIN N AM, V35, P357; Flegr J, 2000, BIOL PSYCHOL, V53, P57, DOI 10.1016/S0301-0511(00)00034-X; Flegr J, 2008, PARASITOLOGY, V135, P427, DOI 10.1017/S0031182007004064; Flegr J, 2008, AM J PHYS ANTHROPOL, V137, P479, DOI 10.1002/ajpa.20888; Flegr J, 2008, NEUROENDOCRINOL LETT, V29, P475; Flegr J, 2013, TRENDS PARASITOL, V29, P156, DOI 10.1016/j.pt.2013.01.007; Flegr J, 2012, NEUROENDOCRINOL LETT, V33, P224; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Fond G, 2013, ENCEPHALE, V39, P38, DOI 10.1016/j.encep.2012.06.014; Fonseca AL, 2012, REV SOC BRAS MED TRO, V45, P357, DOI 10.1590/S0037-86822012000300015; FRANKLIN DM, 1993, ISRAEL J MED SCI, V29, P285; FRENKEL JK, 1980, NEW ENGL J MED, V302, P178, DOI 10.1056/NEJM198001173020316; FRENKEL JK, 1953, AM J TROP MED HYG, V2, P390, DOI 10.4269/ajtmh.1953.2.390; Fricker-Hidalgo H, 2009, CLIN INFECT DIS, V48, pE9, DOI 10.1086/595709; Fugazzola L, 2011, NAT REV ENDOCRINOL, V7, P89, DOI 10.1038/nrendo.2010.216; Fuks JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003051; FURTADO GD, 1992, INFECT IMMUN, V60, P4925, DOI 10.1128/IAI.60.11.4925-4931.1992; Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536; Galofre JC, 2012, J THYROID RES, V2012; GHERARDI R, 1992, ANN NEUROL, V32, P535, DOI 10.1002/ana.410320409; Gilbert RE, 2000, BRIT J OPHTHALMOL, V84, P224, DOI 10.1136/bjo.84.2.224; GLASNER PD, 1992, AM J OPHTHALMOL, V114, P136, DOI 10.1016/S0002-9394(14)73976-5; GLASSMAN MS, 1991, J PEDIATR GASTR NUTR, V13, P298, DOI 10.1097/00005176-199110000-00011; Gokce C, 2008, NATL MED J INDIA, V21, P51; Gomes AF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-110; Groer MW, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.004; GRUDZIEN M, 1968, Polski Tygodnik Lekarski, V23, P54; Gupta A, 2010, CLIN DERMATOL, V28, P287, DOI 10.1016/j.clindermatol.2010.04.003; Hafid J., 2005, American Journal of Immunology, V1, P1; Hamidou MA, 1999, J RHEUMATOL, V26, P443; Harma Muge, 2004, Journal of the Egyptian Society of Parasitology, V34, P519; HASKELL L, 1989, AM J MED SCI, V298, P185, DOI 10.1097/00000441-198909000-00008; Hassene A, 2008, JOINT BONE SPINE, V75, P603, DOI 10.1016/j.jbspin.2007.08.009; Havelaar AH, 2007, CLIN INFECT DIS, V44, P1467, DOI 10.1086/517511; Hayashida M, 2007, J PEDIATR SURG, V42, P2097, DOI 10.1016/j.jpedsurg.2007.08.039; Herold MA, 2009, INFECTION, V37, P551, DOI 10.1007/s15010-009-9007-5; Hinze-Selch D, 2010, FOLIA PARASIT, V57, P129, DOI 10.14411/fp.2010.016; Hippe D, 2006, INT J MED MICROBIOL, V296, P105; Hippe D, 2008, INFECT IMMUN, V76, P2905, DOI 10.1128/IAI.01546-07; Hippe D, 2009, J CELL SCI, V122, P3511, DOI 10.1242/jcs.050963; Hiramoto RM, 2001, REV SAUDE PUBL, V35, P113, DOI 10.1590/S0034-89102001000200002; Hollander E., 1998, CNS SPECTRUMS, V3, P48, DOI [10.1017/S1092852900007239, DOI 10.1017/S1092852900007239]; HOSTOMSKA L, 1957, Cesk Pediatr, V12, P713; Hung CC, 2007, T ROY SOC TROP MED H, V101, P134, DOI 10.1016/j.trstmh.2006.04.012; Huu SN, 2009, AM J PATHOL, V174, P630, DOI 10.2353/ajpath.2009.080566; Hwang IY, 2010, PARASITOL RES, V107, P1313, DOI 10.1007/s00436-010-1999-3; Iqbal J, 2003, CLIN MICROBIOL INFEC, V9, P336; JACOBS L, 1956, ANN NY ACAD SCI, V64, P154, DOI 10.1111/j.1749-6632.1956.tb36612.x; Jenum PA, 1998, EPIDEMIOL INFECT, V120, P87, DOI 10.1017/S0950268897008480; JOHNSON MD, 1993, HUM PATHOL, V24, P457, DOI 10.1016/0046-8177(93)90156-B; JOINER KA, 1993, INFECT IMMUN, V61, P1169, DOI 10.1128/IAI.61.4.1169-1172.1993; Jokelainen P, 2010, VET PARASITOL, V171, P331, DOI 10.1016/j.vetpar.2010.04.008; Jones JL, 2007, AM J TROP MED HYG, V77, P405, DOI 10.4269/ajtmh.2007.77.405; Jones JL, 2010, AM J TROP MED HYG, V82, P464, DOI 10.4269/ajtmh.2010.09-0664; Jones JL, 2009, CLIN INFECT DIS, V49, P878, DOI 10.1086/605433; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Jumaian N F, 2005, East Mediterr Health J, V11, P45; Kamath P, 2007, J CLIN PSYCHIAT, V68, P1741, DOI 10.4088/JCP.v68n1114; Kankova S, 2007, PARASITOLOGY, V134, P1709, DOI 10.1017/S0031182007003253; Kankova S, 2007, NATURWISSENSCHAFTEN, V94, P122, DOI 10.1007/s00114-006-0166-2; Kankova S, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-114; Kankova S, 2012, EARLY HUM DEV, V88, P879, DOI 10.1016/j.earlhumdev.2012.07.001; Kankova S, 2011, EXP PARASITOL, V128, P181, DOI 10.1016/j.exppara.2011.03.014; Kapoor S, 2012, REV INST MED TROP SP, V54, P318, DOI 10.1590/S0036-46652012000600011; KARASAWA T, 1981, ACTA PATHOL JAPON, V31, P675; Karunajeewa H, 2001, AUST NZ J OBSTET GYN, V41, P23, DOI 10.1111/j.1479-828X.2001.tb01289.x; Khan A, 2007, P NATL ACAD SCI USA, V104, P14872, DOI 10.1073/pnas.0702356104; Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025; Kim DS, 2004, INT J BIOCHEM CELL B, V36, P1482, DOI 10.1016/j.biocel.2003.10.023; Kim JY, 2006, YONSEI MED J, V47, P862, DOI 10.3349/ymj.2006.47.6.862; King MD, 2003, INT J TOXICOL, V22, P53, DOI 10.1080/10915810305075; Klaren VNA, 2002, OCUL IMMUNOL INFLAMM, V10, P1, DOI 10.1076/ocii.10.1.1.10330; KLUFIO CA, 1993, PAPUA NEW GUINEA MED, V36, P4; Kodym P, 2000, INT J PARASITOL, V30, P11; Kolbekova P, 2007, CLIN MICROBIOL INFEC, V13, P1012, DOI 10.1111/j.1469-0691.2007.01771.x; Konishi E, 2000, JPN J INFECT DIS, V53, P238; Kortbeek LM, 2004, EPIDEMIOL INFECT, V132, P839, DOI 10.1017/S0950268804002535; Koseoglu E, 2009, AM J MED SCI, V338, P120, DOI 10.1097/MAJ.0b013e31819f8cac; KOSKINIEMI M, 1992, SCAND J INFECT DIS, P70; Krause I, 2009, ANN NY ACAD SCI, V1173, P633, DOI 10.1111/j.1749-6632.2009.04619.x; Kusbeci OY, 2011, ALZ DIS ASSOC DIS, V25, P1, DOI 10.1097/WAD.0b013e3181f73bc2; Lafferty KD, 2006, P ROY SOC B-BIOL SCI, V273, P2749, DOI 10.1098/rspb.2006.3641; Laibe S, 2006, J CLIN MICROBIOL, V44, P646, DOI 10.1128/JCM.44.2.646-648.2006; Lam C, 1999, PEDIATR NEPHROL, V13, P850, DOI 10.1007/s004670050714; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lambert H, 2010, CELL MICROBIOL, V12, P292, DOI 10.1111/j.1462-5822.2009.01417.x; Lambert H, 2009, INFECT IMMUN, V77, P1679, DOI 10.1128/IAI.01289-08; Lampon N, 2012, ANN HEPATOL, V11, P356, DOI 10.1016/S1665-2681(19)30932-9; Lappin MR, 2010, TOP COMPANION ANIM M, V25, P136, DOI 10.1053/j.tcam.2010.07.002; Lebech M, 1999, LANCET, V353, P1834, DOI 10.1016/S0140-6736(98)11281-3; LELONG B, 1995, B SOC PATHOL EXOT, V88, P46; Lester D, 2012, PSYCHOL REP, V111, P196, DOI 10.2466/12.15.16.PR0.111.4.196-197; Lester D, 2010, PSYCHOL REP, V107, P713, DOI 10.2466/12.19.PR0.107.6.713-714; Lidar M, 2009, ANN NY ACAD SCI, V1173, P649, DOI 10.1111/j.1749-6632.2009.04641.x; Lidar M, 2009, ANN NY ACAD SCI, V1173, P640, DOI 10.1111/j.1749-6632.2009.04673.x; Lim A, 2013, MOL ECOL, V22, P102, DOI 10.1111/mec.12042; Lim H, 2012, KOREAN J PARASITOL, V50, P287, DOI 10.3347/kjp.2012.50.4.287; Lindsay DS, 2011, PARASITOLOGY, V138, P1829, DOI 10.1017/S0031182011001478; Ling VJ, 2011, BIOL PSYCHIAT, V69, p149S; Liu Q, 2009, T ROY SOC TROP MED H, V103, P162, DOI 10.1016/j.trstmh.2008.07.008; Logar J, 2002, SCAND J INFECT DIS, V34, P201, DOI 10.1080/00365540110080386; Lopes AP, 2012, EPIDEMIOL INFECT, V140, P872, DOI 10.1017/S0950268811001658; Lopes WDZ, 2011, PARASITOL RES, V109, P405, DOI 10.1007/s00436-011-2268-9; Lopes Welber Daniel Zanetti, 2009, J Parasitol Res, V2009, DOI 10.1155/2009/602803; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MACSWEEN RN, 1973, CLIN EXP IMMUNOL, V15, P35; Maggi P, 2009, NEW MICROBIOL, V32, P89; Mahdi NK, 2002, J BAHRAIN MED SOC, V14, P148; Makuwa M., 1992, Medecine d'Afrique Noire, V39, P493; Many A, 2006, CAN FAM PHYSICIAN, V52, P29; Marani L, 1986, Minerva Med, V77, P805; MASSA G, 1989, EUR J PEDIATR, V148, P742, DOI 10.1007/BF00443099; MASSIERE JP, 1989, PRESSE MED, V18, P1393; Massimine KM, 2005, MOL BIOCHEM PARASIT, V144, P44, DOI 10.1016/j.molbiopara.2005.07.006; McLeod R, 2012, CLIN INFECT DIS, V54, P1595, DOI 10.1093/cid/cis258; McMartin KI, 2002, J PEDIATR-US, V140, P205, DOI 10.1067/mpd.2002.121937; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mercier A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000876; MICHALOWICZ R, 1988, Acta Paediatrica Hungarica, V29, P337; Milerad J, 1998, J PEDIATR-US, V133, P232, DOI 10.1016/S0022-3476(98)70225-2; Milovanovic I, 2009, MEM I OSWALDO CRUZ, V104, P175, DOI 10.1590/S0074-02762009000200008; Miman O, 2010, NEUROSCI LETT, V475, P129, DOI 10.1016/j.neulet.2010.03.057; Miman O, 2010, PSYCHIAT RES, V177, P263, DOI 10.1016/j.psychres.2009.12.013; Moese J R, 1998, Cent Eur J Public Health, V6, P261; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morris Arthur, 2004, N Z Med J, V117, pU770; Mortensen PB, 2011, BIPOLAR DISORD, V13, P624, DOI 10.1111/j.1399-5618.2011.00962.x; MOUSA M A, 1988, Journal of the Egyptian Society of Parasitology, V18, P345; Murakami T, 2000, INTERNAL MED, V39, P1111, DOI 10.2169/internalmedicine.39.1111; Nabias R, 1998, B SOC PATHOL EXOT, V91, P318; Nagineni CN, 2002, CLIN EXP IMMUNOL, V128, P372, DOI 10.1046/j.1365-2249.2002.01815.x; Nash JQ, 2005, EPIDEMIOL INFECT, V133, P475, DOI 10.1017/S0950268804003620; Ndong-Obame T, 1997, B SOC FR PARASITOL, V15, P141; NDUMBE PM, 1992, MED MICROBIOL IMMUN, V181, P127, DOI 10.1007/BF00202052; Nejad MR, 2011, AM J GASTROENTEROL, V106, P548, DOI 10.1038/ajg.2010.425; Nelson MM, 2008, INFECT IMMUN, V76, P828, DOI 10.1128/IAI.01115-07; Nicolle C, 1908, CR HEBD ACAD SCI, V147, P763; Nigro G, 1999, PRENATAL DIAG, V19, P401, DOI 10.1002/(SICI)1097-0223(199905)19:5&lt;401::AID-PD559&gt;3.0.CO;2-X; Nissapatorn V, 2003, J Obstet Gynaecol, V23, P618, DOI 10.1080/01443610310001604376; Nitta A, 2006, J PEDIATR-US, V148, P283, DOI 10.1016/j.jpeds.2005.05.030; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Nowakowska D, 2006, CLIN MICROBIOL INFEC, V12, P913, DOI 10.1111/j.1469-0691.2006.01513.x; Okusaga O, 2011, SCHIZOPHR RES, V133, P150, DOI 10.1016/j.schres.2011.08.006; ONADEKO MO, 1992, J TROP MED HYG, V95, P143; Orefice JL, 2007, BRIT J OPHTHALMOL, V91, P773, DOI 10.1136/bjo.2006.108068; Ortiz-Munoz A B, 1984, Rev Esp Oncol, V31, P237; OSEROFF A, 1988, SOUTHERN MED J, V81, P95, DOI 10.1097/00007611-198801000-00022; Overfield J, 2007, INTRO RH BLOOD GROUP; Oygur N, 1998, AM J PERINAT, V15, P191, DOI 10.1055/s-2007-993924; Packard KA, 2003, INT IMMUNOPHARMACOL, V3, P909, DOI 10.1016/S1567-5769(02)00235-7; Palmer BS, 2007, SEIZURE-EUR J EPILEP, V16, P657, DOI 10.1016/j.seizure.2007.05.010; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Parness-Yossifon R, 2008, J CHILD NEUROL, V23, P447, DOI 10.1177/0883073807308709; Paspalaki P K, 2001, BMC Musculoskelet Disord, V2, P8, DOI 10.1186/1471-2474-2-8; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Pavlov VA, 2008, INT J CLIN EXP MED, V1, P203; Pawlowska-Kamieniak A, 1998, Pol Merkur Lekarski, V4, P217; Pawlowski Z, 1994, OUTLINE INFECT DIS C, P214; Pearce BD, 2012, BIOL PSYCHIAT, V72, P290, DOI 10.1016/j.biopsych.2012.01.003; Pedersen MG, 2012, ARCH GEN PSYCHIAT, V69, P1123, DOI 10.1001/archgenpsychiatry.2012.668; Persson CM, 2009, INFECT IMMUN, V77, P970, DOI 10.1128/IAI.00833-08; Petersen E, 2010, ZOONOSES PUBLIC HLTH, V57, P8, DOI 10.1111/j.1863-2378.2009.01278.x; Pleyer U, 2007, OPHTHALMOLOGE, V104, P603, DOI 10.1007/s00347-007-1535-8; PORTER SB, 1992, NEW ENGL J MED, V327, P1643, DOI 10.1056/NEJM199212033272306; PRABHAKAR P, 1991, W INDIAN MED J, V40, P166; Prandota J, 2012, NEUROINFLAMMATION PA, P447; Prandota J., 2012, SCI REP, V1, P256, DOI [10.4172/scientificreports.256, DOI 10.4172/SCIENTIFICREPORTS.256]; Prandota J., 2012, NEUROINFLAMMATION PA, P423; Prandota Joseph, 2004, Am J Ther, V11, P344, DOI 10.1097/01.mjt.0000117501.97441.c92004; Prandota Joseph, 2004, Am J Ther, V11, P517, DOI 10.1097/01.mjt.0000140648.30948.bd; Prandota J, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.1000241; Prandota J, 2011, RES AUTISM SPECT DIS, V5, P14, DOI 10.1016/j.rasd.2010.03.009; Prandota J, 2010, INT J NEUROSCI, V120, P81, DOI 10.3109/00207450903458647; Prandota J, 2010, RES AUTISM SPECT DIS, V4, P119, DOI 10.1016/j.rasd.2009.09.011; Prandota J, 2010, RES AUTISM SPECT DIS, V4, P103, DOI 10.1016/j.rasd.2009.09.007; Prandota J, 2009, INT J NEUROSCI, V119, P2144, DOI 10.3109/00207450903149217; Prandota J, 2009, INT J NEUROSCI, V119, P1655, DOI 10.1080/00207450802480044; Prandota Joseph, 2007, Am J Ther, V14, P63, DOI 10.1097/01.mjt.0000208272.42379.aa; Prestrud KW, 2010, ACTA VET SCAND S1, P57; Punda-Polic V, 2000, EUR J EPIDEMIOL, V16, P875, DOI 10.1023/A:1007606501923; Radford A, 2012, BRAIN BEHAV IMMUNITY, V26; Rai Shiba Kumar, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P739; Ramsewak S, 2008, REV PANAM SALUD PUBL, V23, P164, DOI 10.1590/S1020-49892008000300003; Rao AA, 2007, MED HYPOTHESES, V69, P1272, DOI 10.1016/j.mehy.2007.03.032; Renne C, 2004, J CLIN ENDOCR METAB, V89, P5810, DOI 10.1210/jc.2004-1049; Ribeiro DA, 2004, MUTAT RES-GEN TOX EN, V559, P169, DOI 10.1016/j.mrgentox.2004.01.007; Rickard E, 1999, CLIN MICROBIOL INFEC, V5, P171; Riga M, 2011, EUR ARCH OTO-RHINO-L, V268, P1087, DOI 10.1007/s00405-011-1499-9; Robert-Gangneux F, 2011, CLIN IMMUNOL, V138, P129, DOI 10.1016/j.clim.2010.12.004; ROCA B, 1992, MED CLIN-BARCELONA, V99, P595; Rockiene L, 1997, HYGIENA EPIDEMIOL, V58, P39; RODIER MH, 1995, ACTA TROP, V59, P271, DOI 10.1016/0001-706X(95)00087-U; Rosso F, 2008, AM J TROP MED HYG, V78, P504, DOI 10.4269/ajtmh.2008.78.504; RYAN P, 1993, INT J EPIDEMIOL, V22, P412, DOI 10.1093/ije/22.3.412; Sakikawa M, 2012, CLIN VACCINE IMMUNOL, V19, P365, DOI 10.1128/CVI.05486-11; Sanchez-Gutierrez A, 2003, BIOQUIMIA, V28, P3; Sanchis-Belenguer R, 1984, Rev Esp Oncol, V31, P247; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SCHRODER J, 1974, TRANSPLANTATION, V17, P346, DOI 10.1097/00007890-197404000-00003; Seabra SH, 2004, BIOCHEM BIOPH RES CO, V324, P744, DOI 10.1016/j.bbrc.2004.09.114; Sehgal A, 2005, TRAFFIC, V6, P1125, DOI 10.1111/j.1600-0854.2005.00348.x; SHAHIN B, 1974, J PEDIATR-US, V85, P366, DOI 10.1016/S0022-3476(74)80117-4; Shapira Y, 2012, EXP MOL PATHOL, V93, P386, DOI 10.1016/j.yexmp.2012.09.012; Shapira Y, 2012, J AUTOIMMUN, V39, P112, DOI 10.1016/j.jaut.2012.01.001; Sheets CW, 2009, J GLAUCOMA, V18, P129, DOI 10.1097/IJG.0b013e318179f83f; Siahanidou T, 2006, J PEDIATR ENDOCR MET, V19, P1363; Signorell LM, 2006, PEDIATR INFECT DIS J, V25, P123, DOI 10.1097/01.inf.0000195542.43369.96; Silveira C, 2003, AM J OPHTHALMOL, V136, P370, DOI 10.1016/S0002-9394(03)00191-0; Silveira C, 2011, BRIT J OPHTHALMOL, V95, P396, DOI 10.1136/bjo.2008.148205; Soares JAS, 2012, REV SOC BRAS MED TRO, V45, P55, DOI 10.1590/S0037-86822012000100011; Simpore J, 2006, J MED VIROL, V78, P730, DOI 10.1002/jmv.20615; SINGH S, 1994, INDIAN J MED RES, V99, P27; Singh S, 1993, INT C AIDS, V9, P490; Slosarkova S, 1999, VET PARASITOL, V81, P89, DOI 10.1016/S0304-4017(98)00244-1; Smith Justine R, 2002, Curr Opin Ophthalmol, V13, P387, DOI 10.1097/00055735-200212000-00008; Sroka J, 2001, ANN AGR ENV MED, V8, P25; STAHL W, 1995, PARASITOL RES, V81, P114, DOI 10.1007/BF00931615; STAHL W, 1995, PARASITOL RES, V81, P109, DOI 10.1007/BF00931614; STAHL W, 1988, ANN TROP MED PARASIT, V82, P35, DOI 10.1080/00034983.1988.11812206; Stommel EW, 2001, EPILEPSIA, V42, P436, DOI 10.1046/j.1528-1157.2001.25500.x; Studenicova C., 2008, Epidemiologie Mikrobiologie Imunologie, V57, P8; Szenasi Z, 2005, WIEN KLIN WOCHENSCHR, V117, P29, DOI 10.1007/s00508-005-0444-6; Szenasi Z, 1997, INT J EPIDEMIOL, V26, P428, DOI 10.1093/ije/26.2.428; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tabbara KS, 2005, SAUDI MED J, V26, P1383; Tedla Yared, 2011, Ethiop Med J, V49, P211; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Terpsidis KI, 2009, EXP PARASITOL, V121, P238, DOI 10.1016/j.exppara.2008.11.006; Thirugnanam S, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-8; Thomas F, 2012, BIOL LETTERS, V8, P101, DOI 10.1098/rsbl.2011.0588; Thompson B., 2006, FDN BEHAV STAT INSIG; Tomairek H A, 1982, J Egypt Soc Parasitol, V12, P17; Toporovski J, 2012, REV INST MED TROP SP, V54, P61, DOI 10.1590/S0036-46652012000200001; Torres AR, 2006, AM J PSYCHIAT, V163, P1978, DOI 10.1176/appi.ajp.163.11.1978; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2001, BRAIN BEHAV IMMUN, V15, P401, DOI 10.1006/brbi.2001.0649; Tozzoli R, 2008, AUTOIMMUN REV, V8, P112, DOI 10.1016/j.autrev.2008.07.013; Triolo-Mieses María, 2006, Kasmera, V34, P07; Ustun S, 2004, WORLD J GASTROENTERO, V10, P452; Vaillant V, 2005, FOODBORNE PATHOG DIS, V2, P221, DOI 10.1089/fpd.2005.2.221; van Velthuysen MLF, 2000, CLIN MICROBIOL REV, V13, P55, DOI 10.1128/CMR.13.1.55-66.2000; vanVelthuysen MLF, 1996, PARASITOL TODAY, V12, P102, DOI 10.1016/0169-4758(96)80669-7; Vasquez-Garibay EM, 2009, COMPREHENSIVE HANDBOOK OF IODINE: NUTRITIONAL, BIOCHEMICAL, PATHOLOGICAL AND THERAPEUTIC ASPECTS, P499, DOI 10.1016/B978-0-12-374135-6.00052-2; VETHANYAGAM A, 1976, T ROY SOC TROP MED H, V70, P524, DOI 10.1016/0035-9203(76)90142-5; Vittecoq M, 2012, INFECT GENET EVOL, V12, P496, DOI 10.1016/j.meegid.2012.01.013; VOS GH, 1987, S AFR MED J, V71, P78; Vyas A, 2013, J EXP BIOL, V216, P120, DOI 10.1242/jeb.072983; WALTON BC, 1966, AM J TROP MED HYG, V15, P492, DOI 10.4269/ajtmh.1966.15.492; Wasserman EE, 2009, AUTOIMMUNITY, V42, P439, DOI 10.1080/08916930902787716; Webster JP, 2006, P ROY SOC B-BIOL SCI, V273, P1023, DOI 10.1098/rspb.2005.3413; Weight CM, 2012, ANN NY ACAD SCI, V1258, P135, DOI 10.1111/j.1749-6632.2012.06534.x; Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004; WEITBERG AB, 1979, NEW ENGL J MED, V300, P1093, DOI 10.1056/NEJM197905103001907; WICKBOM B, 1972, ACTA PAEDIATR SCAND, V61, P470, DOI 10.1111/j.1651-2227.1972.tb15866.x; WILCOX MH, 1990, ANN RHEUM DIS, V49, P254, DOI 10.1136/ard.49.4.254; Wilson GS, 1967, HAZARDS IMMUNIZATION, P265; Wong A., 2000, SMJ, V41, P151; World Health Organization, 2008, GLOB BURD DIS 2004 U; WRENSCH M, 1993, J NEURO-ONCOL, V17, P47, DOI 10.1007/BF01054274; Yagmur F, 2010, FORENSIC SCI INT, V199, P15, DOI 10.1016/j.forsciint.2010.02.020; Yamakawa R, 1996, BRAIN DEV-JPN, V18, P75, DOI 10.1016/0387-7604(95)00099-2; Yazar S, 2006, J MED MICROBIOL, V55, P89, DOI 10.1099/jmm.0.46255-0; Yazar S, 2004, J MED MICROBIOL, V53, P1183, DOI 10.1099/jmm.0.45587-0; Yazar S, 2003, SEIZURE-EUR J EPILEP, V12, P107, DOI 10.1016/S1059-1311(02)00256-X; Yazar Suleyman, 2006, Ethiop Med J, V44, P257; Zhu S, 2009, MED HYPOTHESES, V73, P799, DOI 10.1016/j.mehy.2009.04.013	373	321	344	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90203	10.1371/journal.pone.0090203	http://dx.doi.org/10.1371/journal.pone.0090203			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662942	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900007
J	Gong, Z; Zhao, YJ; Chen, CJ; Duan, Y; Xiao, Y				Gong, Zhou; Zhao, Yunjie; Chen, Changjun; Duan, Yong; Xiao, Yi			Insights into Ligand Binding to PreQ(1) Riboswitch Aptamer from Molecular Dynamics Simulations	PLOS ONE			English	Article							CONTROLS GENE-EXPRESSION; MESSENGER-RNA STRUCTURE; AMBER FORCE-FIELD; ADD A-RIBOSWITCH; PURINE RIBOSWITCH; MODIFIED PYRIMIDINES; STRUCTURAL INSIGHTS; GLYCINE RIBOSWITCH; SENSING RIBOSWITCH; BACILLUS-SUBTILIS	Riboswitches play roles in transcriptional or translational regulation through specific ligand binding of their aptamer domains. Although a number of ligand-bound aptamer complex structures have been solved, it is important to know ligand-free conformations of the aptamers in order to understand the mechanism of specific binding by ligands. In this paper, preQ(1) riboswitch aptamer domain from Bacillus subtilis is studied by overall 1.5 mu s all-atom molecular dynamics simulations We found that the ligand-free aptamer has a stable state with a folded P1-L3 and open binding pocket. The latter forms a cytosine-rich pool in which the nucleotide C19 oscillates between close and open positions, making it a potential conformation for preQ(1) entrance. The dynamic picture further suggests that the specific recognition of preQ(1) by the aptamer domain is not only facilitated by the key nucleotide C19 but also aided and enhanced by other cytosines around the binding pocket. These results should help to understand the details of preQ(1) binding.	[Gong, Zhou; Zhao, Yunjie; Chen, Changjun; Duan, Yong; Xiao, Yi] Huazhong Univ Sci & Technol, Dept Phys, Biomol Phys & Modeling Grp, Wuhan 430074, Hubei, Peoples R China; [Duan, Yong] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Duan, Yong] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	Huazhong University of Science & Technology; University of California System; University of California Davis; University of California System; University of California Davis	Xiao, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Phys, Biomol Phys & Modeling Grp, Wuhan 430074, Hubei, Peoples R China.	yxiao@mail.hust.edu.cn	Duan, Yong/D-3475-2013	Duan, Yong/0000-0003-3793-5099	National High Technology Research and Development Program of China [2012AA020402]; National Science Foundation of China [11374113]; NIH [GM 067168]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067168] Funding Source: NIH RePORTER	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National High Technology Research and Development Program of China [2012AA020402] and the National Science Foundation of China under Grant No. 11374113, and NIH (GM 067168 to YD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqvist J, 1990, J PHYS CHEM, V94; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Butler EB, 2011, CHEM BIOL, V18, P293, DOI 10.1016/j.chembiol.2011.01.013; Case D.A., 2022, AMBER 2020; Cicmil N, 2008, PROTEINS, V72, P1084, DOI 10.1002/prot.22098; Daldrop P, 2011, CHEM BIOL, V18, P324, DOI 10.1016/j.chembiol.2010.12.020; Edwards AL, 2010, RNA, V16, P2144, DOI 10.1261/rna.2341610; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Garcia GA, 2005, BIOORG CHEM, V33, P229, DOI 10.1016/j.bioorg.2005.01.001; Gilbert SD, 2006, J AM CHEM SOC, V128, P14214, DOI 10.1021/ja063645t; Gong Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045239; Gong Z, 2011, J BIOMOL STRUCT DYN, V29, P403, DOI 10.1080/07391102.2011.10507394; Gong Z, 2010, J BIOMOL STRUCT DYN, V28, P431, DOI 10.1080/07391102.2010.10507372; Huang LL, 2011, P NATL ACAD SCI USA, V108, P14801, DOI 10.1073/pnas.1111701108; Huang LL, 2010, MOL CELL, V40, P774, DOI 10.1016/j.molcel.2010.11.026; Hubbard S. J., 1993, NACESS COMPUTER PROG; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Jenkins JL, 2011, J BIOL CHEM, V286, P24626, DOI 10.1074/jbc.M111.230375; Kang M, 2009, MOL CELL, V33, P784, DOI 10.1016/j.molcel.2009.02.019; Klein DJ, 2009, NAT STRUCT MOL BIOL, V16, P343, DOI 10.1038/nsmb.1563; Leipply D, 2011, BIOCHEMISTRY-US, V50, P2790, DOI 10.1021/bi101948k; Liberman JA, 2011, WILEY INTERDISCIP RE; Ling BP, 2009, J MOL GRAPH MODEL, V28, P37, DOI 10.1016/j.jmgm.2009.03.005; LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; Pande VS, 1999, P NATL ACAD SCI USA, V96, P9062, DOI 10.1073/pnas.96.16.9062; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Ryckaert JP, 1977, J COMPUT PHYS; Santner T, 2012, J AM CHEM SOC, V134, P11928, DOI 10.1021/ja3049964; Schneider B, 2004, NUCLEIC ACIDS RES, V32, P1666, DOI 10.1093/nar/gkh333; Serganov A, 2008, NATURE, V455, P1263, DOI 10.1038/nature07326; Sharma M, 2009, RNA, V15, P1673, DOI 10.1261/rna.1675809; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Suddala KC, 2013, NUCLEIC ACIDS RES, V41, P10462, DOI 10.1093/nar/gkt798; Suess B, 2004, NUCLEIC ACIDS RES, V32, P1610, DOI 10.1093/nar/gkh321; Villa A, 2009, NUCLEIC ACIDS RES, V37, P4774, DOI 10.1093/nar/gkp486; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; William L., 1983, J CHEM PHYS, V79; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Yildirim I, 2010, J CHEM THEORY COMPUT, V6, P1520, DOI 10.1021/ct900604a; Zhang Q, 2011, J AM CHEM SOC, V133, P5190, DOI 10.1021/ja111769g	50	20	21	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92247	10.1371/journal.pone.0092247	http://dx.doi.org/10.1371/journal.pone.0092247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663240	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900047
J	Horowitz, E; Bergman, LC; Ashkenazy, C; Moscona-Hurvitz, I; Grinvald-Fogel, H; Magnezi, R				Horowitz, Einav; Bergman, Lisa Carroll; Ashkenazy, Charna; Moscona-Hurvitz, Irit; Grinvald-Fogel, Haya; Magnezi, Racheli			Off-Label Use of Sodium Valproate for Schizophrenia	PLOS ONE			English	Article							MOOD STABILIZERS; SCHIZOAFFECTIVE DISORDER; ACUTE EXACERBATIONS; BIPOLAR DISORDER; DIVALPROEX; OLANZAPINE; ANTIPSYCHOTICS; PRESCRIPTION; RISPERIDONE; GUIDELINES	Background: Off-label use of a drug not according to its regulatory labeling has become common in medicine, especially in the field of psychiatry. Mood stabilizers are intended to be used to attenuate mood fluctuations in bipolar disorder, but their use has spread to patients with schizophrenia, as it provides greater control of impulsivity and aggressiveness. Sodium valproate is one of the most frequently used mood stabilizers in psychiatry. This study determined the prevalence of off-label use of sodium valproate for schizophrenia and schizoaffective disorder in Abarbanel Psychiatric Hospital and the demographic and clinical characteristics associated with its use. Methods: Retrospective study of patients hospitalized in 2011-2012 with a diagnosis of schizophrenia or schizoaffective disorder in one of three general psychiatric wards. Results: Valproate use was significantly lower in the geriatric group (11.6% vs. 20.1%, chi square = 4.7, p = .03), in patients with schizophrenia (14.1% vs. schizoaffective disorder (35.2%), chi square = 29, p<.001) and in patients receiving both atypical and typical antipsychotics (23.3% vs. 16.4%, p = .04). In multivariate logistic regression analysis, diagnosis and the combination of atypical and typical antipsychotics predicted the use of sodium valproate. The number of other medications prescribed did not predict sodium valproate use. Conclusions: Off-label use of sodium valproate in psychiatric patients with schizophrenia or schizoaffective disorder is extensive, especially in younger patients and those with schizoaffective disorder. More research is needed to determine whether it is being prescribed appropriately.	[Horowitz, Einav] Haim Sheba Med Ctr, Gertner Inst, Israeli Ctr Technol Assessment Hlth Care, Ramat Gan, Israel; [Bergman, Lisa Carroll; Grinvald-Fogel, Haya; Magnezi, Racheli] Bar Ilan Univ, Publ Hlth & Hlth Syst Management Program, Ramat Gan, Israel; [Ashkenazy, Charna] Abarbanel Mental Hlth Ctr, Bat Yam, Israel; [Moscona-Hurvitz, Irit] Teva Pharmaceut Ind Ltd, Petah Tiqwa, Israel	Chaim Sheba Medical Center; Bar Ilan University; Teva Pharmaceutical Industries	Horowitz, E (corresponding author), Haim Sheba Med Ctr, Gertner Inst, Israeli Ctr Technol Assessment Hlth Care, Ramat Gan, Israel.	EinavH@gertner.health.gov.il						Abou-Setta AM, 2012, AHRQ COMP EFFECTIVEN; Benabarre A, 2001, EUR PSYCHIAT, V16, P167, DOI 10.1016/S0924-9338(01)00559-4; Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Casey DE, 2009, NEUROPSYCHOPHARMACOL, V34, P1330, DOI 10.1038/npp.2008.209; Chen DT, 2009, PHARMACOEPIDEM DR S, V18, P1094, DOI 10.1002/pds.1825; Chen H, 2007, CURR MED RES OPIN, V23, P1351, DOI 10.1185/030079907X187883; Citrome L, 2004, PSYCHIAT SERV, V55, P290, DOI 10.1176/appi.ps.55.3.290; Citrome L, 2002, PSYCHIATR SERV, V53, P1212, DOI 10.1176/appi.ps.53.10.1212; Citrome L, 2000, PSYCHIATR SERV, V51, P634, DOI 10.1176/appi.ps.51.5.634; Citrome L., 2004, CURR PSYCHIAT, V3, P23; Citrome L, 2009, EXPERT REV NEUROTHER, V9, P55, DOI 10.1586/14737175.9.1.55; Conley RR, 2001, BIOL PSYCHIAT, V50, P898, DOI 10.1016/S0006-3223(01)01271-9; Davids E, 2006, PROG NEURO-PSYCHOPH, V30, P1109, DOI 10.1016/j.pnpbp.2006.04.015; European Medicines Agency, 2013, VALPR; Falkai P, 2005, WORLD J BIOL PSYCHIA, V6, P132, DOI 10.1080/15622970510030090; Gallego JA, 2012, SCHIZOPHR RES, V138, P18, DOI 10.1016/j.schres.2012.03.018; Hartling L, 2012, ANN INTERN MED, V157, P498, DOI 10.7326/0003-4819-157-7-201210020-00525; Haw C, 2005, J PSYCHOPHARMACOL, V19, P402, DOI 10.1177/0269881105053307; Healy D, 1998, PSYCHIAT B, V22, P680; Kelly DL, 2006, PSYCHIAT QUART, V77, P81, DOI 10.1007/s11126-006-7963-9; Lehman AF, 2004, AM J PSYCHIAT, V161, P1; Leslie DL, 2009, PSYCHIAT SERV, V60, P1174, DOI 10.1176/ps.2009.60.9.1175; Levinson DF, 1999, AM J PSYCHIAT, V156, P1138; Lonergan E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003945.pub3; McGorry P, 2005, AUST NZ J PSYCHIAT, V39, P1; Meltzer HY, 2011, J CLIN PSYCHIAT, V72, P1602, DOI 10.4088/JCP.10m05997; Moore TA, 2007, J CLIN PSYCHIAT, V68, P1751, DOI 10.4088/JCP.v68n1115; Murru A, 2011, EUR NEUROPSYCHOPHARM, V21, P680, DOI 10.1016/j.euroneuro.2011.03.001; National Institute for Clinical Excellence, 2003, SCHIZ FULL NAT GUID; Olfson M, 2009, PSYCHIAT SERV, V60, P210, DOI 10.1176/appi.ps.60.2.210; Pickar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003150; Qian K, 2012, ADV EXP MED BIOL, V736, P563, DOI 10.1007/978-1-4419-7210-1_33; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Schwarz C, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004028.pub3; Sim K, 2011, INT J NEUROPSYCHOPH, V14, P1157, DOI 10.1017/S1461145711000563; Suzuki T, 2009, HUM PSYCHOPHARM CLIN, V24, P628, DOI 10.1002/hup.1073; Wassef AA, 2000, J CLIN PSYCHOPHARM, V20, P357, DOI 10.1097/00004714-200006000-00011; Wessels T, 2007, PSYCHIAT QUART, V78, P91, DOI 10.1007/s11126-006-9030-y; Wittich CM, 2012, MAYO CLIN PROC, V87, P982, DOI 10.1016/j.mayocp.2012.04.017	39	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92573	10.1371/journal.pone.0092573	http://dx.doi.org/10.1371/journal.pone.0092573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664210	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900078
J	Linse, K; Jackson, JA; Malyutina, MV; Brandt, A				Linse, Katrin; Jackson, Jennifer A.; Malyutina, Marina V.; Brandt, Angelika			Shallow-Water Northern Hemisphere Jaera (Crustacea, Isopoda, Janiridae) Found on Whale Bones in the Southern Ocean Deep Sea: Ecology and Description of Jaera tyleri sp nov.	PLOS ONE			English	Article							ALBIFRONS GROUP; REPRODUCTIVE-BIOLOGY; INTERTIDAL ISOPOD; FALL; ASELLOTA; SIZE; RNA; ECOSYSTEMS; DIVERSITY; EVOLUTION	The skeleton of a natural whale fall discovered in the Southern Ocean at 1,445 m was densely covered by one small, janirid isopod. Jaera tyleri sp. nov. is the first of its genus found in the southern hemisphere and in the deep sea and is described herein. Morphological and molecular investigations revealed the systematic position of this species new to science. Phylogenetic analysis of the 18S locus confirms that this species falls in a strongly supported monophyletic clade of Jaera species. The whale bone habitat of J. tyleri sp. nov. is quite different from those of other species of the genus Jaera. The analysis of bathymetric and distribution patterns of the Janiridae in general and Jaera specifically confirm the unusualness of the habitat for this isopod species. The abundance of J. tyleri sp. nov. on the whale bones and its absence from other nearby habitats suggests it to be a whale-fall specialist. The analysis of the size-frequency distributions of J. tyleri sp. nov. suggests multimodal population structure with continuous breeding activity throughout the year. The fecundity of the species is low but in line with reduced fecundity observed in polar and small-sized isopods.	[Linse, Katrin; Jackson, Jennifer A.] British Antarctic Survey, Cambridge CB3 0ET, England; [Malyutina, Marina V.] Russian Acad Sci, Far Eastern Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia; [Brandt, Angelika] Univ Hamburg, Bioctr Grindel, Hamburg, Germany; [Brandt, Angelika] Univ Hamburg, Zool Museum, Hamburg, Germany	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; University of Hamburg; University of Hamburg	Linse, K (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	kl@bas.ac.uk	Brandt, Angelika/C-1630-2018; Malyutina, Marina/A-6839-2014	Malyutina, Marina/0000-0003-2161-3917; Linse, Katrin/0000-0003-3477-3047	German Science Foundation [DFG Br 1121/38-1, 1121/43-1]; Russian Foundation of Basis Research [11-04-98586]; Ministry of Education and Science of Russian Federation [11.G34.31.0010]; British Antarctic Survey Polar Science; Natural Environment Research Council (NERC); ChEsSO research programme; NERC Consortium Grant [NE/DO1249X/1]; NERC [NE/D01249X/1, bas0100026, NE/D013852/1, NE/D010470/2] Funding Source: UKRI; Natural Environment Research Council [NE/D013852/1, bas0100026, NE/D010470/2, NE/D01249X/1] Funding Source: researchfish	German Science Foundation(German Research Foundation (DFG)); Russian Foundation of Basis Research; Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); British Antarctic Survey Polar Science; Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ChEsSO research programme; NERC Consortium Grant; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AB and MM were supported by the German Science Foundation for financial support (DFG Br 1121/38-1, 1121/43-1), the Russian Foundation of Basis Research (project 11-04-98586) and Ministry of Education and Science of Russian Federation (grant 11.G34.31.0010). KL was supported by the British Antarctic Survey Polar Science for Planet Earth Programme funded by The Natural Environment Research Council (NERC), as well as part of the ChEsSO research programme was funded by NERC Consortium Grant (NE/DO1249X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon DJ, 2013, DEEP-SEA RES PT II, V92, P87, DOI 10.1016/j.dsr2.2013.01.028; Borza P, 2012, ZOOTAXA, P67; BOWMAN TE, 1988, P BIOL SOC WASH, V101, P171; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; Brandt A, 2004, DEEP-SEA RES PT II, V51, P1753, DOI 10.1016/j.dsr2.2004.06.033; Brandt A, 2007, DEEP-SEA RES PT II, V54, P1760, DOI 10.1016/j.dsr2.2007.07.015; Brandt A, 2009, DEEP-SEA RES PT I, V56, P2013, DOI 10.1016/j.dsr.2009.06.007; CLARKE A, 1992, POLAR BIOL, V12, P129; DELL R K, 1987, National Museum of New Zealand Records, V3, P17; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Forsman Bror, 1944, ARKIV ZOOL [STOCKHOLM], V35A, P1; Fujiwara Y, 2007, MAR ECOL-EVOL PERSP, V28, P219, DOI 10.1111/j.1439-0485.2007.00150.x; Glover AG, 2010, ADV MAR BIOL, V58, P1, DOI [10.1016/B978-0-12-381015-1.00001-0, 10.1016/S0065-2881(10)58001-5]; Glover AG, 2005, MAR ECOL-EVOL PERSP, V26, P223, DOI 10.1111/j.1439-0485.2005.00060.x; Goffredi SK, 2004, DEEP-SEA RES PT I, V51, P1295, DOI 10.1016/j.dsr.2004.05.009; Gruner H.-E., 1993, LEHRBUCH SPEZIELLEN, V1; HAAHTELA I, 1965, J MAR BIOL ASSOC UK, V45, P367, DOI 10.1017/S0025315400054898; HARRISON K, 1988, J NAT HIST, V22, P175, DOI 10.1080/00222938800770131; Harvey C. E., 1968, Crustaceana, V14, P185, DOI 10.1163/156854068X00584; HENDRIKS L, 1989, SYST APPL MICROBIOL, V12, P223, DOI 10.1016/S0723-2020(89)80066-9; International Commission on Zoological Nomenclature, 2012, ZOOKEYS, V219, P1; JAUME D, 1995, CONTRIB ZOOL, V65, P177; JONES MB, 1972, MAR BIOL, V14, P264; JONES MB, 1971, MAR BIOL, V10, P265, DOI 10.1007/BF00352817; JONES MB, 1971, J ZOOL, V165, P183; Jones MB, 1972, J MAR BIOL ASSOC UK, V54, P727; JUILFS HB, 1987, MAR BIOL, V95, P493, DOI 10.1007/BF00393092; Kaiser S, 2007, DEEP-SEA RES PT II, V54, P1776, DOI 10.1016/j.dsr2.2007.07.006; Khaitov VM, 2007, MAR BIOL, V150, P1205, DOI 10.1007/s00227-006-0450-x; Kuzmin AA, 2005, BIOLOGY, V2005, P26; Levin Lisa A., 1994, P261; Lundsten L, 2010, DEEP-SEA RES PT I, V57, P918, DOI 10.1016/j.dsr.2010.04.006; Malyutina M, 2007, DEEP-SEA RES PT II, V54, P1790, DOI 10.1016/j.dsr2.2007.07.017; MARGALEF RAM0N, 1952, HYDROBIOLOGIA, V4, P209, DOI 10.1007/BF00052900; Marshall J., 1900, J MALACOLOGY, V7, P167; Piertney SB, 1996, J MAR BIOL ASSOC UK, V76, P825, DOI 10.1017/S0025315400031490; Ramirez-Llodra E., 2010, BIOGEOSCI DISCUSS, V7, P2361, DOI DOI 10.5194/BGD-7-2361-2010; Raupach MJ, 2009, P ROY SOC B-BIOL SCI, V276, P799, DOI 10.1098/rspb.2008.1063; Rey P, 2005, SCHRIFTENREIHE UMWEL, V380, P1; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Rowe G.T., 1979, Ambio Special Report, P19, DOI 10.2307/25099603; Savill NJ, 2001, GENETICS, V157, P399; Schotte M, 2010, WORLD MARINE FRESHWA; Sjoberg B., 1969, Limnologica Berlin, V7, P69; SJOBERG B, 1970, OIKOS, V21, P241, DOI 10.2307/3543680; SJOBERG BIRGITTA, 1967, SARSIA, V29, P321; Smith CR, 1998, CAH BIOL MAR, V39, P345; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; STEELE DH, 1972, CAN J ZOOLOG, V50, P205, DOI 10.1139/z72-030; Stocsits RR, 2009, NUCLEIC ACIDS RES, V37, P6184, DOI 10.1093/nar/gkp600; SVAVARSSON J, 1982, SARSIA, V67, P223, DOI 10.1080/00364827.1982.10421337; Sye CG, 1887, BEITRAGE ANATOMIE HI; Tobias Wolfgang, 2005, P5; VEUILLE M, 1980, BIOL J LINN SOC, V13, P89, DOI 10.1111/j.1095-8312.1980.tb00072.x; WAGELE JW, 1987, POLAR BIOL, V7, P11, DOI 10.1007/BF00286819; WAGELE JW, 1990, POLAR BIOL, V10, P521, DOI 10.1007/BF00233701; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; WILSON G.D.F, 1989, B SCRIPPS I OCEAN SA, V27, P1, DOI DOI 10.1163/193724090X00500; WILSON GDF, 1987, ANNU REV ECOL SYST, V18, P185, DOI 10.1146/annurev.ecolsys.18.1.185; Wilson George D. F., 1994, Invertebrate Taxonomy, V8, P749, DOI 10.1071/IT9940749; Wilson George D. F., 1994, Invertebrate Taxonomy, V8, P683, DOI 10.1071/IT9940683; WOLFF T, 1979, SARSIA, V64, P117, DOI 10.1080/00364827.1979.10411373; Wolff T., 1962, GALATHEA REP, V6, P7	66	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93018	10.1371/journal.pone.0093018	http://dx.doi.org/10.1371/journal.pone.0093018			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663246	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000333459900144
J	Mietens, A; Tasch, S; Stammler, A; Konrad, L; Feuerstacke, C; Middendorff, R				Mietens, Andrea; Tasch, Sabine; Stammler, Angelika; Konrad, Lutz; Feuerstacke, Caroline; Middendorff, Ralf			Time-Lapse Imaging as a Tool to Investigate Contractility of the Epididymal Duct - Effects of Cgmp Signaling	PLOS ONE			English	Article							NATRIURETIC PEPTIDE RECEPTOR; NITRIC-OXIDE SYNTHASE; RAT EPIDIDYMIS; VAS-DEFERENS; IN-VITRO; FUNCTIONAL-ACTIVITY; CAPUT EPIDIDYMIDIS; DIFFERENT REGIONS; LUMINAL CONTENTS; GENE-EXPRESSION	The well orchestrated function of epididymal smooth muscle cells ensures transit of spermatozoa through the epididymal duct during which spermatozoa acquire motility and fertilizing capacity. Relaxation of smooth muscle cells is mediated by cGMP signaling and components of this pathway are found within the male reproductive tract. Whereas contractile function of caudal parts of the rat epididymal duct can be examined in organ bath studies, caput and corpus regions are fragile and make it difficult to mount them in an organ bath. We developed an ex vivo time-lapse imaging-based approach to investigate the contractile pattern in these parts of the epididymal duct. Collagen-embedding allowed immobilization without impeding contractility or diffusion of drugs towards the duct and therefore facilitated subsequent movie analyses. The contractile pattern was made visible by placing virtual sections through the acquired image stack to track wall movements over time. By this, simultaneous evaluation of contractile activity at different positions of the observed duct segment was possible. With each contraction translating into a spike, drug-induced alterations in contraction frequency could be assessed easily. Peristaltic contractions were also detectable and throughout all regions in the proximal epididymis we found regular spontaneous contractile activity that elicited movement of intraluminal contents. Stimulating cGMP production by natriuretic peptide ANP or inhibiting degradation of cGMP by the phosphodiesterase 5 inhibitor sildenafil significantly reduced contractile frequency in isolated duct segments from caput and corpus. RT-PCR analysis after laser-capture microdissection localized the corresponding molecules to the smooth muscle layer of the duct. Our time-lapse imaging approach proved to be feasible to assess contractile function in all regions of the epididymal duct under near physiological conditions and provides a tool to evaluate acute (side) effects of drugs and to investigate various signaling pathways.	[Mietens, Andrea; Tasch, Sabine; Stammler, Angelika; Feuerstacke, Caroline; Middendorff, Ralf] Univ Giessen, Inst Anat & Cell Biol, D-35390 Giessen, Germany; [Konrad, Lutz] Univ Giessen, Dept Gynecol & Obstet, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Middendorff, R (corresponding author), Univ Giessen, Inst Anat & Cell Biol, D-35390 Giessen, Germany.	Ralf.Middendorff@anatomie.med.uni-giessen.de			DFG [KFO 181]; State of Hesse, Germany (LOEWE: MIBIE); von Behring-Roentgen-Stiftung	DFG(German Research Foundation (DFG)); State of Hesse, Germany (LOEWE: MIBIE); von Behring-Roentgen-Stiftung	This investigation was funded by DFG (KFO 181), the State of Hesse, Germany (LOEWE: MIBIE) and the "von Behring-Roentgen-Stiftung". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMGARTEN HG, 1971, Z ZELLFORSCH MIK ANA, V120, P37, DOI 10.1007/BF00331243; Boselli C, 1998, J AUTON PHARMACOL, V18, P297, DOI 10.1046/j.1365-2680.1998.18598.x; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Chaturapanich G, 2002, REPRODUCTION, V124, P887, DOI 10.1530/reprod/124.6.887; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; COSENTINO MJ, 1986, UROL RES, V14, P229; COSENTINO MJ, 1984, J ANDROL, V5, P216; EHREN I, 1994, UROL RES, V22, P287, DOI 10.1007/BF00297196; Einspanier A, 1997, BIOL REPROD, V56, P416, DOI 10.1095/biolreprod56.2.416; Filippi S, 2002, MOL CELL ENDOCRINOL, V193, P89, DOI 10.1016/S0303-7207(02)00101-6; Ghofrani HA, 2006, DEUT MED WOCHENSCHR, V131, pS311, DOI 10.1055/s-2006-957199; HOFFER AP, 1973, ANAT REC, V175, P169, DOI 10.1002/ar.1091750205; Ivell R, 1998, J REPROD FERTIL, P33; JAAKKOLA UM, 1983, J REPROD FERTIL, V68, P465, DOI 10.1530/jrf.0.0680465; JAAKKOLA UM, 1983, J PHYSIOL-LONDON, V336, P453, DOI 10.1113/jphysiol.1983.sp014590; Kim SZ, 2000, GEN COMP ENDOCR, V118, P26, DOI 10.1006/gcen.1999.7445; Medina P, 2000, UROLOGY, V55, P592, DOI 10.1016/S0090-4295(99)00535-X; Mewe M, 2006, ENDOCRINOLOGY, V147, P2051, DOI 10.1210/en.2005-1324; Mewe M, 2008, AM J PHYSIOL-REG I, V294, pR895, DOI 10.1152/ajpregu.00521.2007; Mewe M, 2007, REPRODUCTION, V134, P493, DOI 10.1530/REP-07-0220; Mewe M, 2006, BIOL REPROD, V75, P651, DOI 10.1095/biolreprod.106.054577; Mietens A, 2012, MOL CELL ENDOCRINOL, V349, P145, DOI 10.1016/j.mce.2011.09.039; Morelli A, 2004, ENDOCRINOLOGY, V145, P2253, DOI 10.1210/en.2003-1699; Muller D, 2011, REPRODUCTION, V142, P333, DOI 10.1530/REP-10-0517; Muller D, 2000, MOL BRAIN RES, V75, P321, DOI 10.1016/S0169-328X(99)00324-1; Muller D, 2002, ENDOCRINOLOGY, V143, P23, DOI 10.1210/en.143.1.23; Nielsen SJ, 2008, REGUL PEPTIDES, V146, P204, DOI 10.1016/j.regpep.2007.09.022; Peri A, 1997, J CLIN ENDOCR METAB, V82, P3797, DOI 10.1210/jc.82.11.3797; PHOLPRAMOOL C, 1984, J REPROD FERTIL, V71, P173, DOI 10.1530/jrf.0.0710173; Ricker DD, 1996, INT J ANDROL, V19, P371, DOI 10.1111/j.1365-2605.1996.tb00530.x; Ricker DD, 1998, J ANDROL, V19, P1; Robaire B, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1071; Studdard PW, 2002, INT J ANDROL, V25, P65, DOI 10.1046/j.1365-2605.2002.00323.x; SUJARIT S, 1985, J REPROD FERTIL, V74, P497, DOI 10.1530/jrf.0.0740497; TALO A, 1979, J REPROD FERTIL, V57, P423, DOI 10.1530/jrf.0.0570423; Thong A, 2013, MOL CELL ENDOCRINOL, V382, P234; Turner TT, 2007, ASIAN J ANDROL, V9, P565, DOI 10.1111/j.1745-7262.2007.00302.x; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; Zini A, 1996, BIOL REPROD, V55, P935, DOI 10.1095/biolreprod55.5.935	39	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92603	10.1371/journal.pone.0092603	http://dx.doi.org/10.1371/journal.pone.0092603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662987	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900082
J	Nistelberger, H; Byrne, M; Coates, D; Roberts, JD				Nistelberger, Heidi; Byrne, Margaret; Coates, David; Roberts, J. Dale			Strong Phylogeographic Structure in a Millipede Indicates Pleistocene Vicariance between Populations on Banded Iron Formations in Semi-Arid Australia	PLOS ONE			English	Article							MICROSATELLITE LOCI; PLANT-COMMUNITIES; COMPUTER-PROGRAM; CONSERVATION; GENETICS; DNA; DIVERGENCE; EVOLUTION; DIVERSE; MODEL	The Yilgarn Banded Iron Formations of Western Australia are topographical features that behave as terrestrial islands within the otherwise flat, semi-arid landscape. The formations are characterised by a high number of endemic species, some of which are distributed across multiple formations without inhabiting the intervening landscape. These species provide an ideal context for phylogeographic analysis, to investigate patterns of genetic variation at both spatial and temporal scales. We examined genetic variation in the spirostreptid millipede, Atelomastix bamfordi, found on five of these Banded Iron Formations at two mitochondrial loci and 11 microsatellite loci. Strong phylogeographic structuring indicated the five populations became isolated during the Pleistocene, a period of intensifying aridity in this landscape, when it appears populations have been restricted to pockets of moist habitat provided by the formations. The pattern of reciprocal monophyly identified within the mtDNA and strong differentiation within the nuclear microsatellite data highlight the evolutionary significance of these divergent populations and we suggest the degree of differentiation warrants designation of each as a conservation unit.	[Nistelberger, Heidi; Roberts, J. Dale] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Byrne, Margaret; Coates, David] Dept Pk & Wildlife, Div Sci, Bentley, WA, Australia	University of Western Australia	Nistelberger, H (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia.	heidi.nistelberger@grs.uwa.edu.au	Byrne, Margaret/H-8198-2015	Byrne, Margaret/0000-0002-7197-5409; Nistelberger, Heidi/0000-0003-2957-5425	Cliffs Natural Resources	Cliffs Natural Resources	The authors would like to confirm that Cliffs Natural Resources, a commercial company contributed funding to this study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allendorf F.W., 2013, CONSERV GENET, Vsecond; Anand RR, 2002, AUST J EARTH SCI, V49, P3, DOI 10.1046/j.1440-0952.2002.00912.x; AVISE JC, 1989, EVOLUTION, V43, P1192, DOI [10.1111/j.1558-5646.1989.tb02568.x, 10.2307/2409356]; AVISE JC, 1983, MOL BIOL EVOL, V1, P38; BASKIN JM, 1988, J BIOGEOGR, V15, P829, DOI 10.2307/2845343; Beheregaray LB, 2004, P NATL ACAD SCI USA, V101, P6514, DOI 10.1073/pnas.0400393101; Bennelongia, 2008, 200850 BENN ENV CONS; Beveridge M, 2004, MOL ECOL NOTES, V4, P379, DOI 10.1111/j.1471-8286.2004.00659.x; Biota, 2009, COMMUNICATION; BOWLER JM, 1982, EVOLUTION FLORA FAUN, P35; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Buckley TR, 2001, SYST BIOL, V50, P67, DOI 10.1080/106351501750107495; Burke A, 2003, DIVERS DISTRIB, V9, P375, DOI 10.1046/j.1472-4642.2003.00035.x; Byrne M, 2007, AUST J BOT, V55, P316, DOI 10.1071/BT06072; Byrne M, 2008, BIOL J LINN SOC, V93, P177, DOI 10.1111/j.1095-8312.2007.00946.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Cooper SJB, 2011, MOL ECOL, V20, P3219, DOI 10.1111/j.1365-294X.2011.05160.x; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; DeChaine EG, 2005, AM J BOT, V92, P477, DOI 10.3732/ajb.92.3.477; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; Dodson JR, 2004, GLOBAL PLANET CHANGE, V41, P285, DOI 10.1016/j.gloplacha.2004.01.013; Driscoll DA, 1998, EVOLUTION, V52, P1147, DOI 10.1111/j.1558-5646.1998.tb01841.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edward KL, 2010, ZOOTAXA, P1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Floyd CH, 2005, ECOLOGY, V86, P2145, DOI 10.1890/04-1227; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibson Neil, 2007, Nuytsia, V17, P1; Gibson N, 2010, BIODIVERS CONSERV, V19, P3951, DOI 10.1007/s10531-010-9939-1; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; Harvey MS, 2002, INVERTEBR SYST, V16, P555, DOI 10.1071/IS02009; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Hocking R. S., 2007, GEOLOGICAL SURVEY W, V2007/8, P19; Hopper SD., 2000, INSELBERGS, P391, DOI DOI 10.1007/978-3-642-59773-2_18; Hopper Stephen D., 1996, P1; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Jacobi CM, 2007, BIODIVERS CONSERV, V16, P2185, DOI 10.1007/s10531-007-9156-8; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Jones AW, 2008, BIOL J LINN SOC, V95, P620, DOI 10.1111/j.1095-8312.2008.01073.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KIMURA M, 1964, GENETICS, V49, P561; Langella O, 2000, POPULATIONS 1 2 19 P; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; Masta SE, 2000, EVOLUTION, V54, P1699; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; Mesibov Robert, 1994, Memoirs of the Queensland Museum, V36, P133; Moir ML, 2009, J BIOGEOGR, V36, P1958, DOI 10.1111/j.1365-2699.2009.02137.x; MORAN GF, 1983, AUST J BOT, V31, P161, DOI 10.1071/BT9830161; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nistelberger H, 2013, CONSERV GENET RESOUR, V5, P533, DOI 10.1007/s12686-012-9845-9; Paetkau D, 1999, CONSERV BIOL, V13, P1507, DOI 10.1046/j.1523-1739.1999.98507.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pons J, 2010, MOL PHYLOGENET EVOL, V56, P796, DOI 10.1016/j.ympev.2010.02.007; R Core Team, 2021, R LANG ENV STAT COMP; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robin VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013321; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Salerno PE, 2012, EVOLUTION, V66, P3000, DOI 10.1111/j.1558-5646.2012.01666.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Wesener T, 2010, MOL PHYLOGENET EVOL, V57, P1184, DOI 10.1016/j.ympev.2010.08.023; Whittaker R. J., 1998, ISLAND BIOGEOGRAPHY; Wright S, 1929, AM NAT, V63, P556, DOI 10.1086/280290; Yates CJ, 2011, AUST J BOT, V59, P691, DOI 10.1071/BT11199	78	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93038	10.1371/journal.pone.0093038	http://dx.doi.org/10.1371/journal.pone.0093038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663390	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900146
J	Nobile, MS; Cazzaniga, P; Besozzi, D; Pescini, D; Mauri, G				Nobile, Marco S.; Cazzaniga, Paolo; Besozzi, Daniela; Pescini, Dario; Mauri, Giancarlo			cuTauLeaping: A GPU-Powered Tau-Leaping Stochastic Simulator for Massive Parallel Analyses of Biological Systems	PLOS ONE			English	Article							RAS/CAMP/PKA PATHWAY; SENSITIVITY-ANALYSIS; BISTABILITY; MODELS; STREAMS; COPASI; MSN2	Tau-leaping is a stochastic simulation algorithm that efficiently reconstructs the temporal evolution of biological systems, modeled according to the stochastic formulation of chemical kinetics. The analysis of dynamical properties of these systems in physiological and perturbed conditions usually requires the execution of a large number of simulations, leading to high computational costs. Since each simulation can be executed independently from the others, a massive parallelization of tau-leaping can bring to relevant reductions of the overall running time. The emerging field of General Purpose Graphic Processing Units (GPGPU) provides power-efficient high-performance computing at a relatively low cost. In this work we introduce cuTauLeaping, a stochastic simulator of biological systems that makes use of GPGPU computing to execute multiple parallel tau-leaping simulations, by fully exploiting the Nvidia's Fermi GPU architecture. We show how a considerable computational speedup is achieved on GPU by partitioning the execution of tau-leaping into multiple separated phases, and we describe how to avoid some implementation pitfalls related to the scarcity of memory resources on the GPU streaming multiprocessors. Our results show that cuTauLeaping largely outperforms the CPU-based tau-leaping implementation when the number of parallel simulations increases, with a break-even directly depending on the size of the biological system and on the complexity of its emergent dynamics. In particular, cuTauLeaping is exploited to investigate the probability distribution of bistable states in the Schlogl model, and to carry out a bidimensional parameter sweep analysis to study the oscillatory regimes in the Ras/cAMP/PKA pathway in S. cerevisiae.	[Nobile, Marco S.; Mauri, Giancarlo] Univ Milano Bicocca, Dipartimento Informat Sistemist & Comunicaz, Milan, Italy; [Cazzaniga, Paolo] Univ Bergamo, Dipartimento Sci Umane & Sociali, Bergamo, Italy; [Besozzi, Daniela] Univ Milan, Dipartimento Informat, Milan, Italy; [Pescini, Dario] Univ Milano Bicocca, Dipartimento Stat & Metodi Quantitativi, Milan, Italy; [Cazzaniga, Paolo; Besozzi, Daniela] CNR, Ist Anal Sistemi & Informat Antonio Ruberti, Rome, Italy; [Nobile, Marco S.; Cazzaniga, Paolo; Besozzi, Daniela; Pescini, Dario; Mauri, Giancarlo] SYSBIO Ctr Syst Biol, Milan, Italy	University of Milano-Bicocca; University of Bergamo; University of Milan; University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR)	Nobile, MS (corresponding author), Univ Milano Bicocca, Dipartimento Informat Sistemist & Comunicaz, Milan, Italy.	nobile@disco.unimib.it; paolo.cazzaniga@unibg.it	Mauri, Giancarlo/M-3258-2013; Nobile, Marco S./AAH-4584-2020; Pescini, Dario/H-4866-2017; Nobile, Marco S./AAP-3441-2020	Mauri, Giancarlo/0000-0003-3520-4022; Pescini, Dario/0000-0002-3090-4823; Nobile, Marco/0000-0002-7692-7203	Research Infrastructure "SYSBIO Centre of Systems Biology''	Research Infrastructure "SYSBIO Centre of Systems Biology''	This work is supported by Research Infrastructure "SYSBIO Centre of Systems Biology'' (http://www.sysbio.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Besozzi D, 2013, ELECTRON P THEOR COM, P87, DOI 10.4204/EPTCS.130.14; Besozzi D, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-10; Burrage K, 2006, PARALLEL COMPUTING B, P79; BURRAGE K., 2006, P AA MARK 150 ANN M, P21; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Cao Y, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2745299; Carrillo S, 2009, CF'09: CONFERENCE ON COMPUTING FRONTIERS & WORKSHOPS, P147; Cazzaniga P, 2008, J BIOTECHNOL, V133, P377, DOI 10.1016/j.jbiotec.2007.09.019; Chis OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027755; Cho Y.J., 2008, P 14 ACM INT C KNOWL, P142; Chou IC, 2009, MATH BIOSCI, V219, P57, DOI 10.1016/j.mbs.2009.03.002; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; Dreger A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-5; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie DT, 2008, LECT NOTES COMPUT SC, V5016, P125; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Gunawan R, 2005, BIOPHYS J, V88, P2530, DOI 10.1529/biophysj.104.053405; Hellander A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897976; Hill DRC, 2013, CONCURR COMP-PRACT E, V25, P1427, DOI 10.1002/cpe.2942; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hyduke DR, 2010, NAT REV GENET, V11, P297, DOI 10.1038/nrg2750; IBA J. KITAGAWA AND H., 2003, EVOLUTIONARY COMPUTA, P255; Kent E, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-91; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Klingbeil G, 2011, BIOINFORMATICS, V27, P1170, DOI 10.1093/bioinformatics/btr068; Komarov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037370; L'ecuyer P, 2002, OPER RES, V50, P1073, DOI 10.1287/opre.50.6.1073.358; L'Ecuyer P, 2007, ACM T MATH SOFTWARE, V33, DOI 10.1145/1268776.1268777; Leier A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919124; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Li H., 2006, TECHNICAL REPORT; Li H, 2010, INT J HIGH PERFORM C, V24, P107, DOI 10.1177/1094342009106066; Lipkow K, 2005, J BACTERIOL, V187, P45, DOI 10.1128/JB.187.1.45-53.2005; Macchiarulo L, 2008, IEEE ENG MED BIO, P1343, DOI 10.1109/IEMBS.2008.4649413; Marquez-Lago TT, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2771548; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i14, DOI 10.18637/JSS.V008.I18, 10.18637/jss.v008.i18]; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Nandapalan N, 2012, LECT NOTES COMPUT SC, V7203, P609, DOI 10.1007/978-3-642-31464-3_62; Nelson D.L., 2004, PRINCIPLES BIOCH, V4th; Nobile Marco S., 2012, Evolutionary Computation, Machine Learning and Data Mining in Bioinformatics. Proceedings of the 10th European Conference, EvoBIO 2012, P74, DOI 10.1007/978-3-642-29066-4_7; Nobile MS, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION COMPANION (GECCO'12), P1421; Nobile MS, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1594; NVIDIA, 2012, CUDA TOOLK 5 0 CURAN; NVidia, 2012, NVIDIA CUDA C PROGR; NVIDIA, 2011, TUN CUDA APPL FERM; Pahle J, 2009, BRIEF BIOINFORM, V10, P53, DOI 10.1093/bib/bbn050; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Pescini D, 2012, BIOTECHNOL ADV, V30, P99, DOI 10.1016/j.biotechadv.2011.06.014; Plyasunov S, 2007, J COMPUT PHYS, V221, P724, DOI 10.1016/j.jcp.2006.06.047; Pomerening JR, 2008, CURR OPIN BIOTECH, V19, P381, DOI 10.1016/j.copbio.2008.06.009; Raue A, 2010, CHAOS, V20, DOI 10.1063/1.3528102; Ryoo S, 2008, PPOPP'08: PROCEEDINGS OF THE 2008 ACM SIGPLAN SYMPOSIUM ON PRINCIPLES AND PRACTICE OF PARALLEL PROGRAMMING, P73, DOI 10.1145/1345206.1345220; Salis H, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1835951; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; SCHLOGL F, 1972, Z PHYS, V253, P147, DOI 10.1007/BF01379769; Sidje RB, 2007, SIAM J SCI COMPUT, V29, P2562, DOI 10.1137/060662629; Slepoy A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919546; Srinath S, 2010, J BIOTECHNOL, V149, P132, DOI 10.1016/j.jbiotec.2010.02.019; Stelling J, 2004, CURR OPIN MICROBIOL, V7, P513, DOI 10.1016/j.mib.2004.08.004; Steuer R, 2003, BIOSYSTEMS, V72, P241, DOI 10.1016/j.biosystems.2003.07.001; Stewart W, 2010, INTRO NUMERICAL SOLU; Tian TH, 2004, J CHEM PHYS, V121, P10356, DOI 10.1063/1.1810475; Tian TH, 2005, Eighth International Conference on High-Performance Computing in Asia-Pacific Region, Proceedings, P621, DOI 10.1109/HPCASIA.2005.67; van Kampen N.G., 2001, STOCHASTIC PROCESSES; Vellela M, 2009, J R SOC INTERFACE, V6, P925, DOI 10.1098/rsif.2008.0476; Vigelius M, 2011, BIOINFORMATICS, V27, P288, DOI 10.1093/bioinformatics/btq622; Wang LL, 2004, MICROBIOL-SGM, V150, P3383, DOI 10.1099/mic.0.27162-0; Wang YF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-99; Wen-mei W Hwu, 2011, GPU COMPUTING GEMS J; Widder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005399; Wilhelm T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-90; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Wolf V, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-42; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2; Zhang HX, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3563539; ZHANG J, 2007, TR0731 VIRG TECH	86	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91963	10.1371/journal.pone.0091963	http://dx.doi.org/10.1371/journal.pone.0091963			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663957	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900036
J	Plocinski, P; Laubitz, D; Cysewski, D; Stodus, K; Kowalska, K; Dziembowski, A				Plocinski, Przemyslaw; Laubitz, Daniel; Cysewski, Dominik; Stodus, Krystian; Kowalska, Katarzyna; Dziembowski, Andrzej			Identification of Protein Partners in Mycobacteria Using a Single-Step Affinity Purification Method	PLOS ONE			English	Article							INTERACTION MAP; TUBERCULOSIS; DNA; REPAIR; MODULATION; COMPLEXES; PEPTIDES; BINDING; TAGS	Tuberculosis is a leading cause of death in developing countries. Efforts are being made to both prevent its spread and improve curability rates. Understanding the biology of the bacteria causing the disease, Mycobacterium tuberculosis (M. tuberculosis), is thus vital. We have implemented improved screening methods for protein-protein interactions based on affinity purification followed by high-resolution mass spectrometry. This method can be efficiently applied to both medium-and high-throughput studies aiming to characterize protein-protein interaction networks of tubercle bacilli. Of the 4 tested epitopes FLAG, enhanced green fluorescent protein (eGFP), protein A and haemagglutinin, the eGFP tag was found to be most useful on account of its easily monitored expression and its ability to function as a simultaneous tool for subcellular localization studies. It presents a relatively low background with cost-effective purification. RNA polymerase subunit A (RpoA) was used as a model for investigation of a large protein complex. When used as bait, it co-purified with all remaining RNA polymerase core subunits as well as many accessory proteins. The amount of RpoA strongly correlated with the amount of quantification peptide used as part of the tagging system in this study (SH), making it applicable for semiquantification studies. Interactions between the components of the RpoA-eGFP protein complex were further confirmed using protein cross-linking. Dynamic changes in the composition of protein complexes under induction of UV damage were observed when UvrA-eGFP expressing cells treated with UV light were used to co-purify UvrA interaction partners.	[Plocinski, Przemyslaw; Laubitz, Daniel; Cysewski, Dominik; Stodus, Krystian; Kowalska, Katarzyna; Dziembowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Dziembowski, Andrzej] Univ Warsaw, Fac Biol, Dept Genet & Biotechnol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Dziembowski, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	andrzejd@ibb.waw.pl	Cysewski, Dominik/U-1352-2019; Płociński, Przemysław A/S-5587-2017	Cysewski, Dominik/0000-0001-6206-0672; Płociński, Przemysław A/0000-0002-6623-3494; Prokop, Katarzyna/0000-0002-8107-185X; Dziembowski, Andrzej/0000-0001-8492-7572; Laubitz, Daniel/0000-0002-7482-8500; Bijata, Krystian/0000-0002-7535-0457	European Community [241587]; Polish Ministry of Science and Higher Education	European Community(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (Health) under Grant No. 241587, SysteMTb. D.C. is a recipient of a Diamond Grant from the Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn B, 2000, MOL CELLS, V10, P592, DOI 10.1007/s100590000017; BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730; Dziedzic R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011058; Fabisiewicz A, 1998, MUTAT RES-FUND MOL M, V402, P59, DOI 10.1016/S0027-5107(97)00282-0; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; Huang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038276; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li YF, 2011, PROTEIN SCI, V20, P140, DOI 10.1002/pro.546; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Luo J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.008318; Mao YH, 2003, DNA REPAIR, V2, P1115, DOI 10.1016/S1568-7864(03)00122-8; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nesvizhskii AI, 2012, PROTEOMICS, V12, P1639, DOI 10.1002/pmic.201100537; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; ORREN DK, 1990, J BIOL CHEM, V265, P15796; Padiadpu Jyothi, 2010, Syst Synth Biol, V4, P311, DOI 10.1007/s11693-011-9076-5; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; SCHURIG H, 1995, EMBO J, V14, P442, DOI 10.1002/j.1460-2075.1995.tb07020.x; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; STOFKOHAHN RE, 1992, FEBS LETT, V302, P274, DOI 10.1016/0014-5793(92)80458-S; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Tharad M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027503; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Van Houten B, 2005, MUTAT RES-FUND MOL M, V577, P92, DOI 10.1016/j.mrfmmm.2005.03.013; Wang HY, 2003, P NATL ACAD SCI USA, V100, P478, DOI 10.1073/pnas.0236088100; Wang Y, 2010, J PROTEOME RES, V9, P6665, DOI 10.1021/pr100808n; Wepf A, 2009, NAT METHODS, V6, P203, DOI [10.1038/NMETH.1302, 10.1038/nmeth.1302]; Williams KJ, 2010, PLASMID, V64, P69, DOI 10.1016/j.plasmid.2010.04.003; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhou HF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S20	42	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91380	10.1371/journal.pone.0091380	http://dx.doi.org/10.1371/journal.pone.0091380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664103	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900020
J	Rohani, MG; Chow, YH; Razumova, MV; Ash, S; Hung, CF; Schnapp, LM				Rohani, Maryam G.; Chow, Yu-Hua; Razumova, Maria V.; Ash, Samuel; Hung, Chi F.; Schnapp, Lynn M.			uPARAP Function in Cutaneous Wound Repair	PLOS ONE			English	Article							RECEPTOR-ASSOCIATED PROTEIN; COLLAGEN GEL CONTRACTION; PROCOLLAGEN SYNTHESIS; ENDOCYTIC RECEPTOR; MANNOSE RECEPTOR; MATRIX TURNOVER; PHOTOAGED SKIN; IN-VITRO; DEGRADATION; PATHWAY	Optimal skin wound healing relies on tight balance between collagen synthesis and degradation in new tissue formation and remodeling phases. The endocytic receptor uPARAP regulates collagen uptake and intracellular degradation. In this study we examined cutaneous wound repair response of uPARAP null (uPARAP(-/-)) mice. Full thickness wounds were created on dorsal surface of uPARAP(-/-) or their wildtype littermates. Wound healing evaluation was done by macroscopic observation, histology, gene transcription and biochemical analysis at specific intervals. We found that absence of uPARAP delayed re-epithelialization during wound closure, and altered stiffness of the scar tissue. Despite the absence of the uPARAP-mediated intracellular pathway for collagen degradation, there was no difference in total collagen content of the wounds in uPARAP(-/-) compared to wildtype mice. This suggests in the absence of uPARAP, a compensatory feedback mechanism functions to keep net collagen in balance.	[Rohani, Maryam G.; Chow, Yu-Hua; Ash, Samuel; Hung, Chi F.; Schnapp, Lynn M.] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Ctr Lung Biol, Seattle, WA 98195 USA; [Razumova, Maria V.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rohani, MG (corresponding author), Univ Washington, Dept Med, Div Pulm & Crit Care Med, Ctr Lung Biol, Seattle, WA 98195 USA.	mrohani@uw.edu			NIH [F32 AR060157, HL083481, K24HL068796]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR060157] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grant F32 AR060157 (MGR), American Heart Association Grant-in-Aid (LMS), NIH HL083481 (LMS), and K24HL068796 (LMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrendt N, 2004, BIOL CHEM, V385, P103, DOI 10.1515/BC.2004.031; Behrendt N, 2000, J BIOL CHEM, V275, P1993, DOI 10.1074/jbc.275.3.1993; Bundesmann MM, 2012, AM J RESP CELL MOL, V46, P233, DOI 10.1165/rcmb.2010-0485OC; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; East L, 2003, EMBO REP, V4, P710, DOI 10.1038/sj.embor.embor882; Eddy AA, 2009, THROMB HAEMOSTASIS, V101, P656, DOI 10.1160/TH08-12-0779; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hung CF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-102; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Madsen DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071261; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Madsen DH, 2012, J PATHOL, V227, P94, DOI 10.1002/path.3981; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; McNulty M, 2006, J HUM HYPERTENS, V20, P867, DOI 10.1038/sj.jhh.1002015; Messaritou G, 2009, J CELL SCI, V122, P4042, DOI 10.1242/jcs.044305; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Ngo P, 2006, METH MOL B, V341, P103; Nielsen BS, 2002, INT J CANCER, V98, P656, DOI 10.1002/ijc.10227; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; PHAN SH, 1985, J CLIN INVEST, V76, P241, DOI 10.1172/JCI111953; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheikh H, 2000, J CELL SCI, V113, P1021; Smith L, 2008, GENE EXPR PATTERNS, V8, P486, DOI 10.1016/j.gep.2008.06.006; Sulek J, 2007, J HISTOCHEM CYTOCHEM, V55, P347, DOI 10.1369/jhc.6A7133.2006; Tang S, 2013, J DERMATOL SCI, V70, P42, DOI 10.1016/j.jdermsci.2013.01.008; TINGSTROM A, 1992, J CELL SCI, V102, P315; Varani J, 2002, J INVEST DERMATOL, V119, P122, DOI 10.1046/j.1523-1747.2002.01810.x; Varani J, 2001, AM J PATHOL, V158, P931, DOI 10.1016/S0002-9440(10)64040-0; Vernon RB, 2002, IN VITRO CELL DEV-AN, V38, P97, DOI 10.1290/1071-2690(2002)038<0097:AIMFTC>2.0.CO;2; Wagenaar-Miller RA, 2007, MOL CELL BIOL, V27, P6309, DOI 10.1128/MCB.00291-07; Wang XS, 2013, NAT PROTOC, V8, P302, DOI 10.1038/nprot.2013.002; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814	41	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92660	10.1371/journal.pone.0092660	http://dx.doi.org/10.1371/journal.pone.0092660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663959	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900092
J	Sanz-Aguilar, A; Tavecchia, G; Afan, I; Ramirez, F; Doxa, A; Bertolero, A; Gutierrez-Exposito, C; Forero, MG; Oro, D				Sanz-Aguilar, Ana; Tavecchia, Giacomo; Afan, Isabel; Ramirez, Francisco; Doxa, Aggeliki; Bertolero, Albert; Gutierrez-Exposito, Carlos; Forero, Manuela G.; Oro, Daniel			Living on the Edge: Demography of the Slender-Billed Gull in the Western Mediterranean	PLOS ONE			English	Article							POPULATION-DYNAMICS; COLONIAL CHARADRIIFORMES; PHOENICOPTERUS-ROSEUS; BREEDING DISPERSAL; MODELING SURVIVAL; GREATER FLAMINGO; SPATIAL SCALES; EBRO-DELTA; SEABIRD; RANGE	Small and peripheral populations are typically vulnerable to local extinction processes but important for the metapopulation dynamics of species. The Slender-billed gull (Chroicocephalus genei) is a long-lived species breeding in unstable ephemeral coastal habitats. Their Western Mediterranean populations are relatively small and represent the edge of their global geographical distribution. At a local scale, using long-term data (14 years) on annual breeding success and capture-resights of marked individuals, we estimated and compared the vital rates and evaluated the connectivity of two Spanish populations (Ebro Delta and Donana) varying in their local environmental conditions. At a metapopulation scale, we analyzed 22 years of data on breeding numbers to predict their future prospects by means of population demographic models. Local survival and breeding success of gulls from the Ebro Delta was lower than those from Donana, which is likely the result of higher permanent emigration and/or winter mortality in the former. Gulls from the Ebro Delta wintered mostly in Mediterranean areas whereas those from Donana did so in Atlantic coasts, where food availability is higher. Whereas adult local survival was constant, juvenile local survival showed temporal parallel variations between colonies, probably related to natal dispersal to other breeding colonies. Our results suggested that dispersal was higher at the Ebro Delta and gulls emigrating from their natal colonies settled preferentially in close patches. We found large fluctuations in breeding numbers among local populations probably related to the fact that the Slender-billed gull is a species adapted to unstable and unpredictable habitats with high abilities to disperse between suitable patches depending on environmental stochastic conditions during breeding.	[Sanz-Aguilar, Ana; Ramirez, Francisco; Gutierrez-Exposito, Carlos; Forero, Manuela G.] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Sanz-Aguilar, Ana; Tavecchia, Giacomo; Doxa, Aggeliki; Oro, Daniel] IMEDEA CSIC UIB, Populat Ecol Grp, Inst Mediterrani Estudis Avancats, Esporles, Spain; [Afan, Isabel] CSIC, Estn Biol Donana, Lab SIG & Teledetecc LAST EBD, E-41080 Seville, Spain; [Doxa, Aggeliki] Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, Montpellier, France; [Bertolero, Albert] Inst Res & Tecnol Agroalimentaries, Unitat Ecosistemes Aquat, St Carlos De La Rapita, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; IRTA	Sanz-Aguilar, A (corresponding author), CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	ana.sanzaguilar@ebd.csic.es	Gutiérrez-Expósito, Carlos/H-3478-2016; Ramírez, Francisco/I-3553-2014; Oro, Daniel/H-4208-2012; Tavecchia, Giacomo/N-3961-2014; Afán, Isabel/F-4783-2015; Bertolero, Albert/I-6448-2019; Sanz-Aguilar, Ana/D-3778-2014	Gutiérrez-Expósito, Carlos/0000-0002-2907-7998; Ramírez, Francisco/0000-0001-9670-486X; Oro, Daniel/0000-0003-4782-3007; Tavecchia, Giacomo/0000-0001-5435-2691; Afán, Isabel/0000-0003-3874-0461; Bertolero, Albert/0000-0002-6834-2600; Sanz-Aguilar, Ana/0000-0002-4177-9749; Doxa, Aggeliki/0000-0003-4279-1499	Regional Government of Balearic Islands; FEDER; Spanish Government [JCI-2011-09085, REN2002-0045, CGL2009-09801, CGL2006-02247/BOS]	Regional Government of Balearic Islands; FEDER(European Commission); Spanish Government(Spanish GovernmentEuropean Commission)	Research funds were partially provided by the Regional Government of Balearic Islands and FEDER funding, and the Spanish Government (JCI-2011-09085, REN2002-0045, CGL2009-09801 and CGL2006-02247/BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz P, 2011, ECOLOGY, V92, P1948, DOI 10.1890/11-0181.1; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Balkiz O, 2007, J ORNITHOL, V148, P347, DOI 10.1007/s10336-007-0136-2; Bechet A, 2008, IBIS, V150, P69, DOI 10.1111/j.1474-919X.2007.00740.x; Boulinier T, 2008, BIOL LETTERS, V4, P538, DOI 10.1098/rsbl.2008.0291; Breton AR, 2008, WATERBIRDS, V31, P15, DOI 10.1675/1524-4695(2008)31[15:SOAHGL]2.0.CO;2; Bustamante J, 2009, J ENVIRON MANAGE, V90, P2219, DOI 10.1016/j.jenvman.2007.08.021; Cam E, 2004, J ANIM ECOL, V73, P723, DOI 10.1111/j.0021-8790.2004.00848.x; Cama A, 2012, MAR ECOL PROG SER, V463, P285, DOI 10.3354/meps09861; Chokri M, 2008, THESIS; Chokri MA, 2012, OSTRICH, V83, P13, DOI 10.2989/00306525.2012.659226; Chokri MA, 2011, BIRD STUDY, V58, P443, DOI 10.1080/00063657.2011.602957; Chokri MA, 2008, REV ECOL-TERRE VIE, V63, P351; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cramp S, 1983, HDB BIRDS EUROPE MID, V3; Crone EE, 2001, EVOLUTION, V55, P2611; Cubaynes S, 2011, BIOL LETTERS, V7, P303, DOI 10.1098/rsbl.2010.0778; DENNIS B, 1991, ECOL MONOGR, V61, P115, DOI 10.2307/1943004; Dies Jose Ignacio, 2000, Ardeola, V47, P255; Doxa A, 2013, ANIM CONSERV, V16, P684, DOI 10.1111/acv.12048; Engen S, 2005, MATH BIOSCI, V195, P210, DOI 10.1016/j.mbs.2005.02.003; Fernandez-Chacon A, 2013, ECOGRAPHY, V36, P1117, DOI 10.1111/j.1600-0587.2013.00246.x; Frederiksen M, 2005, OIKOS, V111, P209, DOI 10.1111/j.0030-1299.2005.13746.x; Frederiksen M, 2004, J APPL ECOL, V41, P1129, DOI 10.1111/j.0021-8901.2004.00966.x; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaston KJ, 2009, P ROY SOC B-BIOL SCI, V276, P1391, DOI [10.1098/rspb.2009.0100, 10.1098/rspb.2008.1480]; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Grosbois V, 2009, ECOLOGY, V90, P2922, DOI 10.1890/08-1657.1; Hanski I, 1999, METAPOPULATION ECOLO; HARRISON S, 1989, OIKOS, V56, P293, DOI 10.2307/3565613; HOEPFFNER N, 1994, OCEANOL ACTA, V17, P431; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Isenmann P, 1993, P 2 S MEDMARAVIS SEO, P65; Jenouvrier S, 2005, OIKOS, V108, P511, DOI 10.1111/j.0030-1299.2005.13351.x; Karvonen J, 2012, J AVIAN BIOL, V43, P102, DOI 10.1111/j.1600-048X.2011.05376.x; Kloskowski J, 2009, AQUAT CONSERV, V19, P815, DOI 10.1002/aqc.1027; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lewison R., 2012, Endangered Species Research, V17, P93, DOI 10.3354/esr00419; Morris W. F., 2002, QUANTITATIVE CONSERV; Oro D, 1997, ICES J MAR SCI, V54, P695, DOI 10.1006/jmsc.1997.0246; Oro D, 2004, P ROY SOC B-BIOL SCI, V271, P387, DOI 10.1098/rspb.2003.2609; Oro D, 2003, SCI MAR, V67, P13, DOI 10.3989/scimar.2003.67s213; Oro D, 2002, WATERBIRDS, V25, P67, DOI 10.1675/1524-4695(2002)025[0067:BBAPDO]2.0.CO;2; Oro D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042753; Oro D, 2011, BIOL CONSERV, V144, P851, DOI 10.1016/j.biocon.2010.11.018; Oro D, 2009, BIOL CONSERV, V142, P1830, DOI 10.1016/j.biocon.2009.03.023; Parejo D, 2006, IBIS, V148, P146, DOI 10.1111/j.1474-919X.2006.00494.x; Peron G, 2010, OIKOS, V119, P524, DOI 10.1111/j.1600-1706.2009.17882.x; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Ramirez F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047551; Rappole JH, 2002, ARDEA, V90, P525; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; Roff Derek A., 1992; Sadoul N, 1996, COLON WATERBIRD, V19, P46, DOI 10.2307/1521945; Sadoul N, 1997, COLON WATERBIRD, V20, P330, DOI 10.2307/1521701; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; SAFRIEL UN, 1995, ISR J ZOOL, V41, P417; Sanz-Aguilar A, 2012, J ANIM ECOL, V81, P1171, DOI 10.1111/j.1365-2656.2012.01997.x; Sanz-Aguilar A, 2009, ECOGRAPHY, V32, P637, DOI 10.1111/j.1600-0587.2009.05596.x; SCHREIBER E.A., 2001, BIOL MARINE BIRDS, V1st; Sergio F, 2011, OECOLOGIA, V166, P79, DOI 10.1007/s00442-010-1795-x; Skalski J.R., 1993, P9; Sousa PM, 2011, NAT HAZARD EARTH SYS, V11, P33, DOI 10.5194/nhess-11-33-2011; Tavecchia G, 2002, IBIS, V144, pE79, DOI 10.1046/j.1474-919X.2002.00059.x; Tavecchia G, 2008, ECOLOGY, V89, P77, DOI 10.1890/06-0326.1; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; WOLFF WJ, 1993, HYDROBIOLOGIA, V258, P211, DOI 10.1007/BF00006198	72	8	8	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92674	10.1371/journal.pone.0092674	http://dx.doi.org/10.1371/journal.pone.0092674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664115	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900094
J	Sui, HS; Gui, T; Jia, L; Guo, W; Han, JW; Liu, YJ; Bao, ZY; Li, HP; Li, JY; Li, L				Sui, Hongshuai; Gui, Tao; Jia, Lei; Guo, Wei; Han, Jingwan; Liu, Yongjian; Bao, Zuoyi; Li, Hanping; Li, Jingyun; Li, Lin			Different Frequencies of Drug Resistance Mutations among HIV-1 Subtypes Circulating in China: A Comprehensive Study	PLOS ONE			English	Article							EFAVIRENZ CONCENTRATIONS; REVERSE-TRANSCRIPTASE; GENETIC DIVERSITY; VIRUS; INDIVIDUALS; DISTINCT; PLASMA; CYP2B6; TYPE-1; POLYMORPHISM	The rapid spreading of HIV drug resistance is threatening the overall success of free HAART in China. Much work has been done on drug-resistant mutations, however, most of which were based on subtype B. Due to different genetic background, subtypes difference would have an effect on the development of drug-resistant mutations, which has already been proved by more and more studies. In China, the main epidemic subtypes are CRF07_BC, CRF08_BC, Thai B and CRF01_AE. The depiction of drug resistance mutations in those subtypes will be helpful for the selection of regimens for Chinese. In this study, the distributions difference of amino acids at sites related to HIV drug resistance were compared among subtype B, CRF01_AE, CRF07_BC and CRF08_BC strains prevalent in China. The amino acid composition of sequences belonging to different subtypes, which were obtained from untreated and treated individuals separately, were also compared. The amino acids proportions of 19 sites in RT among subtype B, CRF01_AE and CRF08_BC have significant difference in drug resistance groups (chi-square test, p<0.05). Genetic barriers analysis revealed that sites 69, 138, 181, 215 and 238 were significantly different among subtypes (Kruskal Wallis test, p<0.05). All subtypes shared three highest prevalent drug resistance sites 103, 181 and 184 in common. Many drug resistant sites in protease show surprising high proportions in almost all subtypes in drug-naive patients. This is the first comprehensive study in China on different development of drug resistance among different subtypes. The detailed data will lay a foundation for HIV treatment regimens design and improve HIV therapy in China.	[Sui, Hongshuai; Gui, Tao; Jia, Lei; Guo, Wei; Han, Jingwan; Liu, Yongjian; Bao, Zuoyi; Li, Hanping; Li, Jingyun; Li, Lin] Beijing Inst Microbiol & Epidemiol, Dept AIDS Res, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Sui, Hongshuai] Beidaihe 281 Hosp, Clin Lab, Qinhuangdao, Hebei Province, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Li, JY (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept AIDS Res, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	lijy@nic.bmi.ac.cn; dearwood@sina.com			National Natural Science Foundation Key Project [30830088]	National Natural Science Foundation Key Project	National Natural Science Foundation Key Project, grant numbers is 30830088 and the URL of the funder's website is http://npd.nsfc.gov.cn/anywordSearch!search.action. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benish RL, 2010, INFECT GENET EVOL, V10, P60, DOI 10.1016/j.meegid.2009.09.018; Boffito M, 2005, CURR OPIN INFECT DIS, V18, P543, DOI 10.1097/01.qco.0000191507.48481.10; Brown KC, 2012, PHARMACOGENOMICS, V13, P113, DOI [10.2217/pgs.11.132, 10.2217/PGS.11.132]; Calcagno A, 2012, BRIT J CLIN PHARMACO, V74, P134, DOI 10.1111/j.1365-2125.2012.04163.x; Carr DF, 2010, J ANTIMICROB CHEMOTH, V65, P1889, DOI 10.1093/jac/dkq260; de la Tribonniere X, 2008, HIV CLIN TRIALS, V9, P192, DOI 10.1310/hct0903-192; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Faria N, 2012, PERFORMANCE SUBTYPIN; Foley BT, 2013, HIV SEQUENCE COMPEND, P13; FuJie Z, 2008, CHINAS NATL FREE ANT, P33; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Gandhi M, 2012, J INFECT DIS, V206, P1453, DOI 10.1093/infdis/jis508; Gatanaga H, 2007, CLIN INFECT DIS, V45, P1230, DOI 10.1086/522175; Haaland RE, 2013, PUBLIC HEALTH GENOM, V16, P31, DOI 10.1159/000345935; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Julg B, 2005, INFECTION, V33, P299, DOI 10.1007/s15010-005-6405-1; KALISH ML, 1994, AIDS RES HUM RETROV, V10, P1573, DOI 10.1089/aid.1994.10.1573; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Lehr T, 2011, PHARMACOGENET GENOM, V21, P721, DOI 10.1097/FPC.0b013e32834a522e; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P1; Lubomirov R, 2007, PHARMACOGENOMICS, V8, P623, DOI 10.2217/14622416.8.6.623; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; Pai NP, 2012, JAIDS-J ACQ IMM DEF, V59, P382, DOI 10.1097/QAI.0b013e31824a0628; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pieniazek D, 2000, AIDS, V14, P1489, DOI 10.1097/00002030-200007280-00004; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Preissner S, 2010, NUCLEIC ACIDS RES, V38, pD237, DOI 10.1093/nar/gkp970; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Santos AF, 2010, VIRUSES-BASEL, V2, P503, DOI 10.3390/v2020503; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; Stuart L, 2004, STANDARD OPERATING P; Subbarao S, 1998, AIDS RES HUM RETROV, V14, P319, DOI 10.1089/aid.1998.14.319; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; van de Vijver DA, 2006, JAIDS-J ACQ IMM DEF, V41, P352, DOI 10.1097/01.qai.0000209899.05126.e4; Vandamme AM, 1999, DRUGS, V57, P337; Wainberg MA, 2010, VIRUSES-BASEL, V2, P2493, DOI 10.3390/v2112493; YiMing S, 2010, THESTRATEGY METHODOL	42	19	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91803	10.1371/journal.pone.0091803	http://dx.doi.org/10.1371/journal.pone.0091803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663120	gold, Green Submitted, Green Published			2022-12-25	WOS:000333459900029
J	Beauregard, F; de Blois, S				Beauregard, Frieda; de Blois, Sylvie			Beyond a Climate-Centric View of Plant Distribution: Edaphic Variables Add Value to Distribution Models	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; HUMUS FORMS; SAMPLE-SIZE; PREDICTIONS; ABUNDANCE; FOREST; UNCERTAINTIES; PERFORMANCE; DIVERSITY; ACCURACY	Both climatic and edaphic conditions determine plant distribution, however many species distribution models do not include edaphic variables especially over large geographical extent. Using an exceptional database of vegetation plots (n = 4839) covering an extent of similar to 55000 km(2), we tested whether the inclusion of fine scale edaphic variables would improve model predictions of plant distribution compared to models using only climate predictors. We also tested how well these edaphic variables could predict distribution on their own, to evaluate the assumption that at large extents, distribution is governed largely by climate. We also hypothesized that the relative contribution of edaphic and climatic data would vary among species depending on their growth forms and biogeographical attributes within the study area. We modelled 128 native plant species from diverse taxa using four statistical model types and three sets of abiotic predictors: climate, edaphic, and edaphic-climate. Model predictive accuracy and variable importance were compared among these models and for species' characteristics describing growth form, range boundaries within the study area, and prevalence. For many species both the climate-only and edaphic-only models performed well, however the edaphic-climate models generally performed best. The three sets of predictors differed in the spatial information provided about habitat suitability, with climate models able to distinguish range edges, but edaphic models able to better distinguish within-range variation. Model predictive accuracy was generally lower for species without a range boundary within the study area and for common species, but these effects were buffered by including both edaphic and climatic predictors. The relative importance of edaphic and climatic variables varied with growth forms, with trees being more related to climate whereas lower growth forms were more related to edaphic conditions. Our study identifies the potential for non-climate aspects of the environment to pose a constraint to range expansion under climate change.	[Beauregard, Frieda; de Blois, Sylvie] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [de Blois, Sylvie] McGill Univ, McGill Sch Environm, Ste Anne De Bellevue, PQ, Canada	McGill University; McGill University	de Blois, S (corresponding author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.	sylvie.deblois@mcgill.ca			Fonds de Recherche du Quebec - Natures et Technologies; Natural Sciences and Engineering Research Council of Canada	Fonds de Recherche du Quebec - Natures et Technologies; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors acknowledge funding from the Fonds de Recherche du Quebec - Natures et Technologies (www.fqrnt.gouv.qc.ca) to F. Beauregard and from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) to S. de Blois. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda SC, 2011, ECOGRAPHY, V34, P31, DOI 10.1111/j.1600-0587.2010.06134.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Attorre F, 2011, APPL VEG SCI, V14, P242, DOI 10.1111/j.1654-109X.2010.01114.x; Austin MP, 2011, J BIOGEOGR, V38, P9, DOI 10.1111/j.1365-2699.2010.02415.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Berteaux Dominique, 2010, Diversity, V2, P1181, DOI 10.3390/d2111181; Bertrand R, 2012, GLOBAL CHANGE BIOL, V18, P2648, DOI 10.1111/j.1365-2486.2012.02679.x; Chambers D, 2013, FOREST ECOL MANAG, V291, P20, DOI 10.1016/j.foreco.2012.10.046; COTE B, 1994, CAN J FOREST RES, V24, P192, DOI 10.1139/x94-027; Coudun C, 2006, J BIOGEOGR, V33, P1750, DOI 10.1111/j.1365-2699.2005.01443.x; de Blois S, 2001, LANDSCAPE ECOL, V16, P421, DOI 10.1023/A:1017548003345; Dengler J, 2011, J VEG SCI, V22, P582, DOI 10.1111/j.1654-1103.2011.01265.x; Dubuis A, 2013, J VEG SCI, V24, P593, DOI 10.1111/jvs.12002; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, MAPPING SPECIES DIST; Gosselin Jocelyn, 2012, Biodiversity Ecol, V4, P432, DOI 10.7809/b-e.00219; Hanspach J, 2010, PERSPECT PLANT ECOL, V12, P219, DOI 10.1016/j.ppees.2010.04.002; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hutchinson M. F., 2002, ANUSPLIN VERSION 4 2; Jones CC, 2010, ECOL APPL, V20, P311, DOI 10.1890/08-2261.1; Lafleur B, 2010, ENVIRON REV, V18, P279, DOI 10.1139/A10-013; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Marage D, 2009, GLOBAL ECOL BIOGEOGR, V18, P88, DOI 10.1111/j.1466-8238.2008.00428.x; Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x; McKenney DW, 2011, GLOBAL CHANGE BIOL, V17, P2720, DOI 10.1111/j.1365-2486.2011.02413.x; Nelson BD., 2001, STAT DATA ANAL DATA; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Philips D. W., 1991, CANADA PRECIPITATION; Ponge JF, 2003, SOIL BIOL BIOCHEM, V35, P935, DOI 10.1016/S0038-0717(03)00149-4; Rehfeldt G.E, 2006, SPLINE MODEL CLIMATE; Rousseau C., 1974, GEOGRAPHIE FLORISTIQ; Rupprecht F, 2011, J VEG SCI, V22, P647, DOI 10.1111/j.1654-1103.2011.01269.x; Saucier J. P., 2003, VEGETATION ZONES BIO; Saucier J.P., 1994, POINT OBSERVATION EC; Sormunen H, 2011, POLAR BIOL, V34, P883, DOI 10.1007/s00300-010-0945-2; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2013, J VEG SCI, V24, P591, DOI 10.1111/jvs.12076; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Wang TL, 2012, FOREST ECOL MANAG, V279, P128, DOI 10.1016/j.foreco.2012.05.034; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Young NE, 2012, ENVIRON MONIT ASSESS, V184, P5439, DOI 10.1007/s10661-011-2351-9	48	55	57	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92642	10.1371/journal.pone.0092642	http://dx.doi.org/10.1371/journal.pone.0092642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658097	Green Submitted, gold, Green Published			2022-12-25	WOS:000333355300110
J	da Costa, OP; Hoffman, A; Rey, JW; Mansmann, U; Buch, T; Tresch, A				da Costa, Olivia Prazeres; Hoffman, Arthur; Rey, Johannes W.; Mansmann, Ulrich; Buch, Thorsten; Tresch, Achim			Selection of Higher Order Regression Models in the Analysis of Multi-Factorial Transcription Data	PLOS ONE			English	Article							YERSINIA-ENTEROCOLITICA; INFECTION; RESISTANT; NETWORK	Introduction: Many studies examine gene expression data that has been obtained under the influence of multiple factors, such as genetic background, environmental conditions, or exposure to diseases. The interplay of multiple factors may lead to effect modification and confounding. Higher order linear regression models can account for these effects. We present a new methodology for linear model selection and apply it to microarray data of bone marrow-derived macrophages. This experiment investigates the influence of three variable factors: the genetic background of the mice from which the macrophages were obtained, Yersinia enterocolitica infection (two strains, and a mock control), and treatment/non-treatment with interferon-c. Results: We set up four different linear regression models in a hierarchical order. We introduce the eruption plot as a new practical tool for model selection complementary to global testing. It visually compares the size and significance of effect estimates between two nested models. Using this methodology we were able to select the most appropriate model by keeping only relevant factors showing additional explanatory power. Application to experimental data allowed us to qualify the interaction of factors as either neutral (no interaction), alleviating (co-occurring effects are weaker than expected from the single effects), or aggravating (stronger than expected). We find a biologically meaningful gene cluster of putative C2TA target genes that appear to be co-regulated with MHC class II genes. Conclusions: We introduced the eruption plot as a tool for visual model comparison to identify relevant higher order interactions in the analysis of expression data obtained under the influence of multiple factors. We conclude that model selection in higher order linear regression models should generally be performed for the analysis of multi-factorial microarray data.	[da Costa, Olivia Prazeres; Buch, Thorsten] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Hoffman, Arthur] St Marys Hosp, Dept Med, Frankfurt, Germany; [Hoffman, Arthur; Rey, Johannes W.] Johannes Gutenberg Univ Mainz, Dept Med, D-55122 Mainz, Germany; [Mansmann, Ulrich] Univ Munich, Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany; [Tresch, Achim] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Tresch, Achim] Univ Cologne, Inst Genet, Cologne, Germany	Technical University of Munich; St. Marien Hospital; Johannes Gutenberg University of Mainz; University of Munich; Max Planck Society; University of Cologne	da Costa, OP (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany.	olivia.dacosta@mikrobio.med.tum.de	Buch, Thorsten/P-1659-2019	Buch, Thorsten/0000-0002-2236-9074	Max Planck Gesellschaft	Max Planck Gesellschaft(Max Planck Society)	This work is funded by the Max Planck Gesellschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUTENRIETH IB, 1994, INFECT IMMUN, V62, P2590, DOI 10.1128/IAI.62.6.2590-2599.1994; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breslow N E, 1980, IARC Sci Publ, P5; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Defrance M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-396; Dumcke S, 2012, NUCLEIC ACIDS RES, V40, P8883, DOI 10.1093/nar/gks695; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; HANCOCK GE, 1986, INFECT IMMUN, V53, P26, DOI 10.1128/IAI.53.1.26-31.1986; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hummel M, 2008, BIOINFORMATICS, V24, P78, DOI 10.1093/bioinformatics/btm531; Jaimovich A, 2010, BIOINFORMATICS, V26, pi228, DOI 10.1093/bioinformatics/btq197; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Li WT, 2012, J BIOINF COMPUT BIOL, V10, DOI 10.1142/S0219720012310038; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002908; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spitzer M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.31; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Trulzsch K, 2003, INT J MED MICROBIOL, V293, P167, DOI 10.1078/1438-4221-00251; van Erp K, 2006, PHYSIOL GENOMICS, V25, P75, DOI 10.1152/physiolgenomics.00188.2005; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P863, DOI 10.1097/EDE.0b013e3181ba333c; Warringer Jonas, 2008, BMC Chemical Biology, V8, P3, DOI 10.1186/1472-6769-8-3; Zhang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.80	27	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91840	10.1371/journal.pone.0091840	http://dx.doi.org/10.1371/journal.pone.0091840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658540	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300041
J	Issan, Y; Kornowski, R; Aravot, D; Shainberg, A; Laniado-Schwartzman, M; Sodhi, K; Abraham, NG; Hochhauser, E				Issan, Yossi; Kornowski, Ran; Aravot, Dan; Shainberg, Asher; Laniado-Schwartzman, Michal; Sodhi, Komal; Abraham, Nader G.; Hochhauser, Edith			Heme Oxygenase-1 Induction Improves Cardiac Function following Myocardial Ischemia by Reducing Oxidative Stress	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; REPERFUSION INJURY; ADIPOSE-TISSUE; DIABETIC MICE; ADIPONECTIN; PROTECTS; PORE; GENE; TARGET; INFLAMMATION	Background: Oxidative stress plays a key role in exacerbating diabetes and cardiovascular disease. Heme oxygenase-1 (HO-1), a stress response protein, is cytoprotective, but its role in post myocardial infarction (MI) and diabetes is not fully characterized. We aimed to investigate the protection and the mechanisms of HO-1 induction in cardiomyocytes subjected to hypoxia and in diabetic mice subjected to LAD ligation. Methods: In vitro: cultured cardiomyocytes were treated with cobalt-protoporphyrin (CoPP) and tin protoporphyrin (SnPP) prior to hypoxic stress. In vivo: CoPP treated streptozotocin-induced diabetic mice were subjected to LAD ligation for 2/24 h. Cardiac function, histology, biochemical damage markers and signaling pathways were measured. Results: HO-1 induction lowered release of lactate dehydrogenase (LDH) and creatine phospho kinase (CK), decreased propidium iodide staining, improved cell morphology and preserved mitochondrial membrane potential in cardiomyocytes. In diabetic mice, Fractional Shortening (FS) was lower than non-diabetic mice (35 +/- 1% vs. 41 +/- 2, respectively p<0.05). CoPP-treated diabetic animals improved cardiac function (43 +/- 2% p<0.01), reduced CK, Troponin T levels and infarct size compared to non-treated diabetic mice (P<0.01, P<0.001, P<0.01 respectively). CoPP-enhanced HO-1 protein levels and reduced oxidative stress in diabetic animals, as indicated by the decrease in superoxide levels in cardiac tissues and plasma TNF alpha levels (p<0.05). The increased levels of HO-1 by CoPP treatment after LAD ligation led to a shift of the Bcl-2/bax ratio towards the antiapoptotic process (p<0.05). CoPP significantly increased the expression levels of pAKT and pGSK3 beta (p<0.05) in cardiomyocytes and in diabetic mice with MI. SnPP abolished CoPP's cardioprotective effects. Conclusions: HO-1 induction plays a role in cardioprotection against hypoxic damage in cardiomyocytes and in reducing post ischemic cardiac damage in the diabetic heart as proved by the increased levels of pAKT with a concomitant inhibition of pGSK3 beta leading to preserved mitochondrial membrane potential.	[Issan, Yossi; Kornowski, Ran; Aravot, Dan; Hochhauser, Edith] Tel Aviv Univ, Felsenstein Med Res Inst, Cardiac Res Lab, Petah Tiqwa, Israel; [Kornowski, Ran] Tel Aviv Univ, Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel; [Aravot, Dan] Tel Aviv Univ, Rabin Med Ctr, Dept Cardiac Surg, Petah Tiqwa, Israel; [Shainberg, Asher] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Laniado-Schwartzman, Michal] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Sodhi, Komal; Abraham, Nader G.] Marshall Univ, Joan C Edwards Sch Med, Dept Internal Med, Huntington, WV USA	Tel Aviv University; Rabin Medical Center; Tel Aviv University; Rabin Medical Center; Tel Aviv University; Bar Ilan University; New York Medical College; Marshall University	Hochhauser, E (corresponding author), Tel Aviv Univ, Felsenstein Med Res Inst, Cardiac Res Lab, Petah Tiqwa, Israel.	hochhaus@post.tau.ac.il			National Institutes of Health [DK56601, HL-34300]; Brick Street Foundation Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brick Street Foundation Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially supported by National Institutes of Health grants DK56601, HL-34300 and Brick Street Foundation Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, CURR PHARM DESIGN, V14, P412, DOI 10.2174/138161208783597371; Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Abraham NG, 2004, AM J PHYSIOL-HEART C, V287, pH2468, DOI 10.1152/ajpheart.01187.2003; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Borger DR, 1998, AM J PHYSIOL-HEART C, V274, pH965, DOI 10.1152/ajpheart.1998.274.3.H965; Cai CX, 2012, J BIOL CHEM, V287, P33720, DOI 10.1074/jbc.M112.385542; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; CROMPTON M, 1987, BIOCHEM J, V245, P915, DOI 10.1042/bj2450915; Emanuelov AK, 2010, BIOCHEM PHARMACOL, V79, P180, DOI 10.1016/j.bcp.2009.08.010; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Halestrap AP, 1999, BIOCHEM SOC SYMP, V66, P181, DOI 10.1042/bss0660181; Hill-Kapturczak N, 2002, DNA CELL BIOL, V21, P307, DOI 10.1089/104454902753759726; Hochhauser E, 2007, CELL BIOCHEM BIOPHYS, V47, P11, DOI 10.1385/CBB:47:1:11; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Hori R, 2002, J BIOL CHEM, V277, P10712, DOI 10.1074/jbc.M107749200; Hosick PA, 2012, AM J PHYSIOL-REG I, V302, pR207, DOI 10.1152/ajpregu.00517.2011; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Issan Y, 2012, CAN J CARDIOL, V28, P728, DOI 10.1016/j.cjca.2012.01.013; Javadov S, 2009, J PHARMACOL EXP THER, V330, P670, DOI 10.1124/jpet.109.153213; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Kawamoto S, 2011, TISSUE ENG PT A, V17, P1605, DOI 10.1089/ten.tea.2010.0447; Kleschyov AL, 2002, CIRCULATION, V105, pA196; Kruger AL, 2005, CIRCULATION, V111, P3126, DOI 10.1161/CIRCULATIONAHA.104.517102; Kusmic C, 2010, J CELL BIOCHEM, V109, P1033, DOI 10.1002/jcb.22486; L'Abbate A, 2007, AM J PHYSIOL-HEART C, V293, pH3532, DOI 10.1152/ajpheart.00826.2007; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Melo LG, 2002, CIRCULATION, V105, P602, DOI 10.1161/hc0502.103363; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Quarrie R, 2012, J SURG RES, V178, P8, DOI 10.1016/j.jss.2012.05.090; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; SARDANA MK, 1987, P NATL ACAD SCI USA, V84, P2464, DOI 10.1073/pnas.84.8.2464; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Sharma HS, 1996, MOL CELL BIOCHEM, V157, P111; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shmist YA, 2005, J PHARMACOL EXP THER, V313, P1046, DOI 10.1124/jpet.104.081281; Shneyvays V, 2005, AM J PHYSIOL-HEART C, V288, pH2792, DOI 10.1152/ajpheart.01157.2004; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tompkins AJ, 2006, BBA-MOL BASIS DIS, V1762, P223, DOI 10.1016/j.bbadis.2005.10.001; Toshima S, 2000, ARTERIOSCL THROM VAS, V20, P2243, DOI 10.1161/01.ATV.20.10.2243; Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471; Xu A, 2010, AM J PHYSIOL-HEART C, V302, pH1231; Zhu WD, 2008, CLIN SCI, V114, P361, DOI 10.1042/CS20070347	47	58	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92246	10.1371/journal.pone.0092246	http://dx.doi.org/10.1371/journal.pone.0092246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658657	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300065
J	Ma, X; Wang, S; Do, T; Song, XQ; Inaba, M; Nishimoto, Y; Liu, LP; Gao, Y; Mao, Y; Li, H; McDowell, W; Park, J; Malanowski, K; Peak, A; Perera, A; Li, H; Gaudenz, K; Haug, J; Yamashita, Y; Lin, HF; Ni, JQ; Xie, T				Ma, Xing; Wang, Su; Do, Trieu; Song, Xiaoqing; Inaba, Mayu; Nishimoto, Yoshiya; Liu, Lu-ping; Gao, Yuan; Mao, Ying; Li, Hui; McDowell, William; Park, Jungeun; Malanowski, Kate; Peak, Allison; Perera, Anoja; Li, Hua; Gaudenz, Karin; Haug, Jeff; Yamashita, Yukiko; Lin, Haifan; Ni, Jian-quan; Xie, Ting			Piwi Is Required in Multiple Cell Types to Control Germline Stem Cell Lineage Development in the Drosophila Ovary	PLOS ONE			English	Article							PRIMARY PIRNA BIOGENESIS; BAG-OF-MARBLES; SELF-RENEWAL; TRANSGENIC RNAI; ASYMMETRIC DIVISION; NICHE CELLS; GENE; PATHWAY; GENOME; DIFFERENTIATION	The piRNA pathway plays an important role in maintaining genome stability in the germ line by silencing transposable elements (TEs) from fly to mammals. As a highly conserved piRNA pathway component, Piwi is widely expressed in both germ cells and somatic cells in the Drosophila ovary and is required for piRNA production in both cell types. In addition to its known role in somatic cap cells to maintain germline stem cells (GSCs), this study has demonstrated that Piwi has novel functions in somatic cells and germ cells of the Drosophila ovary to promote germ cell differentiation. Piwi knockdown in escort cells causes a reduction in escort cell (EC) number and accumulation of undifferentiated germ cells, some of which show active BMP signaling, indicating that Piwi is required to maintain ECs and promote germ cell differentiation. Simultaneous knockdown of dpp, encoding a BMP, in ECs can partially rescue the germ cell differentiation defect, indicating that Piwi is required in ECs to repress dpp. Consistent with its key role in piRNA production, TE transcripts increase significantly and DNA damage is also elevated in the piwi knockdown somatic cells. Germ cell-specific knockdown of piwi surprisingly causes depletion of germ cells before adulthood, suggesting that Piwi might control primordial germ cell maintenance or GSC establishment. Finally, Piwi inactivation in the germ line of the adult ovary leads to gradual GSC loss and germ cell differentiation defects, indicating the intrinsic role of Piwi in adult GSC maintenance and differentiation. This study has revealed new germline requirement of Piwi in controlling GSC maintenance and lineage differentiation as well as its new somatic function in promoting germ cell differentiation. Therefore, Piwi is required in multiple cell types to control GSC lineage development in the Drosophila ovary.	[Ma, Xing; Wang, Su; Do, Trieu; Song, Xiaoqing; Nishimoto, Yoshiya; McDowell, William; Park, Jungeun; Malanowski, Kate; Peak, Allison; Perera, Anoja; Li, Hua; Gaudenz, Karin; Haug, Jeff; Xie, Ting] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Ma, Xing; Wang, Su; Xie, Ting] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS USA; [Inaba, Mayu; Yamashita, Yukiko] Univ Michigan, Ctr Stem Cell Biol, Inst Life Sci, Ann Arbor, MI 48109 USA; [Liu, Lu-ping; Gao, Yuan; Mao, Ying; Li, Hui; Ni, Jian-quan] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Lin, Haifan] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Michigan System; University of Michigan; Tsinghua University; Yale University	Xie, T (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	tgx@stowers.org	Ma, Xing/S-8690-2018	Yamashita, Yukiko/0000-0001-5541-0216	National Institutes of Health [2R01 GM64428]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (2R01 GM64428) and the Stowers Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2008, COLD SH Q B, V73, P283, DOI 10.1101/sqb.2008.73.058; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Casanueva MO, 2004, DEVELOPMENT, V131, P1881, DOI 10.1242/dev.01076; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eliazer S, 2011, P NATL ACAD SCI USA, V108, P7064, DOI 10.1073/pnas.1015874108; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gong WJ, 2005, PLOS GENET, V1, P589, DOI 10.1371/journal.pgen.0010067; Guo Z, 2009, DEVELOPMENT, V136, P3627, DOI 10.1242/dev.036939; Haase AD, 2010, GENE DEV, V24, P2499, DOI 10.1101/gad.1968110; Handler D, 2011, EMBO J, V30, P3977, DOI 10.1038/emboj.2011.308; Harris AN, 2001, DEVELOPMENT, V128, P2823; Hayashi Y, 2009, J CELL BIOL, V187, P473, DOI 10.1083/jcb.200904118; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Jin ZG, 2013, CURR BIOL, V23, P1442, DOI 10.1016/j.cub.2013.06.021; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Kirilly D, 2011, DEVELOPMENT, V138, P5087, DOI 10.1242/dev.067850; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Lin H, 1994, DEVELOPMENT, V4, P947; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000740; Malone CD, 2009, COLD SH Q B, V74, P225, DOI 10.1101/sqb.2009.74.052; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Qi H, 2011, J BIOL CHEM, V286, P3789, DOI 10.1074/jbc.M110.193888; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rangan P, 2011, CURR BIOL, V21, P1373, DOI 10.1016/j.cub.2011.06.057; Rojas-Rios P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001298; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Schulz C, 2002, DEVELOPMENT, V129, P4523; Shen R, 2009, P NATL ACAD SCI USA, V106, P11623, DOI 10.1073/pnas.0903325106; Siomi MC, 2010, SEMIN CELL DEV BIOL, V21, P754, DOI 10.1016/j.semcdb.2010.01.011; Smulders-Srinivasan TK, 2010, GENETICS, V186, P573, DOI 10.1534/genetics.110.119081; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Szakmary A, 2009, J CELL BIOL, V185, P613, DOI 10.1083/jcb.200903034; Van Doren M, 1998, CURR BIOL, V8, P243; Wang XD, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-3; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Xie T, 2013, WIRES DEV BIOL, V2, P261, DOI 10.1002/wdev.60; Zamparini AL, 2011, DEVELOPMENT, V138, P4039, DOI 10.1242/dev.069187; Zhu CH, 2003, DEVELOPMENT, V130, P2579, DOI 10.1242/dev.00499	63	58	60	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90267	10.1371/journal.pone.0090267	http://dx.doi.org/10.1371/journal.pone.0090267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658126	gold, Green Published, Green Submitted			2022-12-25	WOS:000333355300013
J	Russell, ES; Mohammed, T; Smeaton, L; Jorowe, B; MacLeod, IJ; Hoffman, RM; Currier, JS; Moyo, S; Essex, M; Lockman, S				Russell, Elizabeth S.; Mohammed, Terence; Smeaton, Laura; Jorowe, Baitshepi; MacLeod, Iain J.; Hoffman, Risa M.; Currier, Judith S.; Moyo, Sikhulile; Essex, Max; Lockman, Shahin			Immune Activation Markers in Peripartum Women in Botswana: Association with Feeding Strategy and Maternal Morbidity	PLOS ONE			English	Article							C-REACTIVE PROTEIN; DISEASE PROGRESSION; HIV-INFECTION; PREGNANCY; MORTALITY; INFLAMMATION; POSTPARTUM; MODULATION; INCREASES; PROLACTIN	Hormone levels shift the immune state in HIV-uninfected pregnant and breastfeeding women away from Th1 responses and toward regulation to permit fetal tolerance. Limited data exist on inflammation during pregnancy or postpartum in HIV-infected women, though certain inflammatory markers are associated with adverse health outcomes among HIV-infected persons. We measured hsCRP, D-dimer, IFN-gamma, IL-6, IL-10 and TNF-alpha at 34 weeks gestation and six months postpartum in HIV-infected women from the Botswana Mashi PMTCT trial who were randomized to breastfeeding or formula-feeding. Differences in inflammatory markers between gestation and postpartum periods, and by randomized feeding method, were estimated using generalized estimating equations, adjusting for baseline plasma HIV-1 viral load, CD4 count, calendar time, and antiretroviral treatment status. Additionally, we studied the association between marker concentrations at six months postpartum and major adverse clinical events over the following 4.5 years, using case-cohort sampling and adjusted Cox proportional hazards models. In 86 breastfeeding and 75 formula-feeding women, hsCRP and D-dimer decreased significantly between 34 weeks gestation and six months postpartum, while IFN-gamma increased. There was no significant association between inflammatory marker change and randomized feeding method after adjusting for multiple comparisons and removing outliers. In univariate analysis, TNF-alpha, D-dimer, and IFN-gamma concentrations at six months postpartum were significant predictors of subsequent clinical events, and TNF-alpha remained significant in multivariate analysis (HR = 4.16, p = 0.001). In young HIV-infected women in Botswana inflammatory marker concentrations did not differ significantly between women who breast- vs. formula-fed. However, postpartum TNF-alpha level was predictive of subsequent adverse clinical event.	[Russell, Elizabeth S.; MacLeod, Iain J.; Essex, Max; Lockman, Shahin] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Harvard AIDS Initiat, Boston, MA 02115 USA; [Russell, Elizabeth S.; Mohammed, Terence; Jorowe, Baitshepi; MacLeod, Iain J.; Moyo, Sikhulile; Essex, Max; Lockman, Shahin] Botswana Harvard AIDS Inst, Gaborone, Botswana; [Smeaton, Laura] Harvard Univ, Sch Publ Hlth, Dept Biostat, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Hoffman, Risa M.; Currier, Judith S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lockman, Shahin] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Brigham & Women's Hospital	Russell, ES (corresponding author), Kentucky Dept Publ Hlth, Frankfort, KY 40601 USA.	elizabeth.russell@ky.gov	Moyo, Sikhulile/E-1464-2015	Moyo, Sikhulile/0000-0003-3821-4592; Russell, Elizabeth S/0000-0001-7462-9280; MacLeod, Iain/0000-0001-5608-634X	National Institutes of Health National Institute of Child Health and Human Development [R01 HD37793, R01 HD44391]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037793, R01HD044391] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009610] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by National Institutes of Health National Institute of Child Health and Human Development Grants: R01 HD37793 and R01 HD44391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns DN, 1999, J REPROD IMMUNOL, V42, P147, DOI 10.1016/S0165-0378(98)00085-0; Cai JW, 2004, BIOMETRICS, V60, P1015, DOI 10.1111/j.0006-341X.2004.00257.x; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Chaudhary M, 2008, VIRAL IMMUNOL, V21, P263, DOI 10.1089/vim.2007.0083; Coutsoudis A, 2001, AIDS, V15, P653, DOI 10.1097/00002030-200103300-00019; CUTOLO M, 1995, CLIN EXP RHEUMATOL, V13, P217; Dabis F, 2005, JAIDS-J ACQ IMM DEF, V39, P430, DOI 10.1097/01.qai.0000148531.04706.c0; Denney JM, 2011, CYTOKINE, V53, P170, DOI 10.1016/j.cyto.2010.11.005; Drain PK, 2007, AIDS, V21, P2067, DOI 10.1097/QAD.0b013e32826fb6c7; Eller MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018779; Feldman JG, 2003, JAIDS-J ACQ IMM DEF, V32, P210, DOI 10.1097/00126334-200302010-00014; Fraternale A, 2011, VACCINE, V29, P6823, DOI 10.1016/j.vaccine.2011.07.101; Grutzmeier S, 1999, SCAND J INFECT DIS, V31, P229, DOI 10.1080/00365549950163491; Kelesidis T, 2012, J INFECT DIS, V206, P1558, DOI 10.1093/infdis/jis545; Kuhn L, 2005, AIDS, V19, P1677, DOI 10.1097/01.aids.0000186817.38112.da; Kulathinal Sangita, 2007, Epidemiol Perspect Innov, V4, P15; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lau B, 2006, ARCH INTERN MED, V166, P64, DOI 10.1001/archinte.166.1.64; Lockman S, 2009, 16 C RETR OPP INF MO; MacLeod IJ, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17393; Mayanja BN, 2012, TROP MED INT HEALTH, V17, P343, DOI 10.1111/j.1365-3156.2011.02921.x; Melchior JC, 1999, NUTRITION, V15, P865, DOI 10.1016/S0899-9007(99)00210-5; Mikyas Y, 1997, J REPROD IMMUNOL, V33, P157, DOI 10.1016/S0165-0378(97)00018-1; National Institute of Allergy and Infectious Diseases, 2009, HAART STAND VERS PRO; Nduati R, 2001, LANCET, V357, P1651, DOI 10.1016/S0140-6736(00)04820-0; Otieno PA, 2007, J INFECT DIS, V195, P220, DOI 10.1086/510245; Piconi S, 2011, BLOOD, V118, P3263, DOI 10.1182/blood-2011-01-329060; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Truong HHM, 2010, CLIN VACCINE IMMUNOL, V17, P2024, DOI 10.1128/CVI.00088-10; Watts DH, 2003, JAIDS-J ACQ IMM DEF, V33, P585, DOI 10.1097/00126334-200308150-00006; Weetman AP, 2010, NAT REV ENDOCRINOL, V6, P311, DOI 10.1038/nrendo.2010.46; Yu-Lee LY, 2002, RECENT PROG HORM RES, V57, P435, DOI 10.1210/rp.57.1.435; Zimmer JP, 1996, J REPROD IMMUNOL, V30, P81, DOI 10.1016/0165-0378(96)00956-4	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89928	10.1371/journal.pone.0089928	http://dx.doi.org/10.1371/journal.pone.0089928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24657960	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300007
J	Apthorp, D; Palmisano, S				Apthorp, Deborah; Palmisano, Stephen			The Role of Perceived Speed in Vection: Does Perceived Speed Modulate the Jitter and Oscillation Advantages?	PLOS ONE			English	Article							SELF-MOTION PERCEPTION; 2ND-ORDER MOTION; OPTIC FLOW; PERIPHERAL-VISION; VIEWPOINT JITTER; GLOBAL-MOTION; IN-DEPTH; ILLUSIONS; ACCOUNTS; WALKING	Illusory self-motion ('vection') in depth is strongly enhanced when horizontal/vertical simulated viewpoint oscillation is added to optic flow inducing displays; a similar effect is found for simulated viewpoint jitter. The underlying cause of these oscillation and jitter advantages for vection is still unknown. Here we investigate the possibility that perceived speed of motion in depth (MID) plays a role. First, in a 2AFC procedure, we obtained MID speed PSEs for briefly presented (vertically oscillating and smooth) radial flow displays. Then we examined the strength, duration and onset latency of vection induced by oscillating and smooth radial flow displays matched either for simulated or perceived MID speed. The oscillation advantage was eliminated when displays were matched for perceived MID speed. However, when we tested the jitter advantage in the same manner, jittering displays were found to produce greater vection in depth than speed-matched controls. In summary, jitter and oscillation advantages were the same across experiments, but slower MID speed was required to match jittering than oscillating stimuli. Thus, to the extent that vection is driven by perceived speed of MID, this effect is greater for oscillating than for jittering stimuli, which suggests that the two effects may arise from separate mechanisms.	[Apthorp, Deborah] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia; [Apthorp, Deborah; Palmisano, Stephen] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia	Australian National University; University of Wollongong	Apthorp, D (corresponding author), Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia.	deborah.apthorp@anu.edu.au	Palmisano, Stephen/O-1553-2018; Apthorp, Deborah/N-5623-2014	Palmisano, Stephen/0000-0002-9140-5681; Apthorp, Deborah/0000-0001-5785-024X	Australian Research Council [DP0772398]	Australian Research Council(Australian Research Council)	This research was supported by an Australian Research Council Discovery grant to SP (DP0772398). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen-Stockdale C, 2012, VISION RES, V68, P28, DOI 10.1016/j.visres.2012.07.004; ANDERSEN GJ, 1985, J EXP PSYCHOL HUMAN, V11, P122, DOI 10.1037/0096-1523.11.2.122; Ash A, 2013, PERCEPTION, V42, P562, DOI 10.1068/p7449; Badcock DR, 2001, PSYCHOL RES-PSYCH FO, V65, P50, DOI 10.1007/s004260000020; BERTHOZ A, 1975, EXP BRAIN RES, V23, P471; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRANDT T, 1974, EXP BRAIN RES, V21, P337; BRANDT T, 1973, EXP BRAIN RES, V16, P476, DOI 10.1007/BF00234474; BRANDT T, 1975, PERCEPT PSYCHOPHYS, V17, P497, DOI 10.3758/BF03203301; Bruggeman H, 2007, CURR BIOL, V17, P2035, DOI 10.1016/j.cub.2007.10.059; Bubka A, 2010, PERCEPTION, V39, P627, DOI 10.1068/p6315; CASEY SM, 1992, J SAFETY RES, V23, P135, DOI 10.1016/0022-4375(92)90016-3; Cassanello CR, 2011, VISION RES, V51, P352, DOI 10.1016/j.visres.2010.11.012; Curran W, 2009, P R SOC B, V276, P263, DOI 10.1098/rspb.2008.1065; DEGRAAF B, 1990, VISION RES, V30, P637, DOI 10.1016/0042-6989(90)90074-U; DENTON GG, 1980, PERCEPTION, V9, P393, DOI 10.1068/p090393; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Dichgans Johannes, 1978, PERCEPTION, P755, DOI DOI 10.1007/978-3-642-46354-9_25; Durgin FH, 2005, J EXP PSYCHOL HUMAN, V31, P339, DOI 10.1037/0096-1523.31.2.339; Durgin FH, 2007, PERCEPTION, V36, P1465, DOI 10.1068/p5845; EDWARDS M, 1995, VISION RES, V35, P2589, DOI 10.1016/0042-6989(95)00003-I; Edwards M, 2012, VISION RES, V64, P23, DOI 10.1016/j.visres.2012.05.006; Kim J, 2012, PERCEPTION, V41, P402, DOI 10.1068/p6919; Kim J, 2010, J VISION, V10, DOI 10.1167/10.12.7; Kim J, 2010, EXP BRAIN RES, V202, P355, DOI 10.1007/s00221-009-2137-2; Kim J, 2008, BRAIN RES BULL, V77, P335, DOI 10.1016/j.brainresbull.2008.09.011; Lecuyer A, 2006, P IEEE VIRT REAL ANN, P11, DOI 10.1109/VR.2006.31; LEIBOWITZ HW, 1980, PERCEPT PSYCHOPHYS, V28, P173, DOI 10.3758/BF03204344; Li L, 2002, PSYCHOL SCI, V13, P485, DOI 10.1111/1467-9280.00486; LISHMAN JR, 1973, PERCEPTION, V2, P287, DOI 10.1068/p020287; Maloney RT, 2013, J NEUROPHYSIOL, V110, P2545, DOI 10.1152/jn.00445.2013; Nakamura S, 2013, PERCEPTION, V42, P529, DOI 10.1068/p7486; Nakamura S, 2010, PERCEPTION, V39, P320, DOI 10.1068/p6534; Palmisano S, 2004, PERCEPTION, V33, P987, DOI 10.1068/p5242; Palmisano S, 2003, PERCEPTION, V32, P97, DOI 10.1068/p3468; Palmisano S, 2002, PERCEPTION, V31, P463, DOI 10.1068/p3321; Palmisano S, 1998, PERCEPTION, V27, P1067, DOI 10.1068/p271067; Palmisano S, 1996, PERCEPT PSYCHOPHYS, V58, P1168, DOI 10.3758/BF03207550; Palmisano S, 2000, PERCEPTION, V29, P57, DOI 10.1068/p2990; Palmisano S, 2008, PERCEPTION, V37, P22, DOI 10.1068/p5806; Palmisano S, 2012, J VISION, V12, DOI 10.1167/12.12.15; Palmisano S, 2011, SEEING PERCEIVING, V24, P173, DOI 10.1163/187847511X570817; Palmisano S, 2009, ATTEN PERCEPT PSYCHO, V71, P1842, DOI 10.3758/APP.71.8.1842; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Riecke BE, 2006, ACM T APPL PERCEPT, V3, P194, DOI [10.1145/1166087.1166091., DOI 10.1145/1166087.1166091, 10.1145/1166087.1166091]; Riecke BE, 2011, VIRTUAL REALITY, P149; SCHMIDT F, 1969, J APPL PSYCHOL, V53, P536, DOI 10.1037/h0028674; Schulte-Pelkum J, 2003, 6 ANN WORKSH PRES PR, P37; Seno T, 2012, SEEING PERCEIVING, V25, P631, DOI 10.1163/18784763-00002394; Seno T, 2012, SEEING PERCEIVING, V25, P213, DOI 10.1163/187847612X626390; Seno T, 2011, VISION RES, V51, P2499, DOI 10.1016/j.visres.2011.10.007; Seno T, 2010, SEEING PERCEIVING, V23, P273, DOI 10.1163/187847510X532667; SMEETS JBJ, 1994, VISION RES, V34, P191, DOI 10.1016/0042-6989(94)90331-X; Vaina LM, 2012, ATTEN PERCEPT PSYCHO, V74, P1009, DOI 10.3758/s13414-012-0290-3; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Welchman AE, 2008, P NATL ACAD SCI USA, V105, P12087, DOI 10.1073/pnas.0804378105; Wist ER, 1975, ATTEN PERCEPT PSYCHO, V16, P549	59	34	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92260	10.1371/journal.pone.0092260	http://dx.doi.org/10.1371/journal.pone.0092260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651861	Green Submitted, gold, Green Published			2022-12-25	WOS:000333352800088
J	Clynes, D; Jelinska, C; Xella, B; Ayyub, H; Taylor, S; Mitson, M; Bachrati, CZ; Higgs, DR; Gibbons, RJ				Clynes, David; Jelinska, Clare; Xella, Barbara; Ayyub, Helena; Taylor, Stephen; Mitson, Matthew; Bachrati, Csanad Z.; Higgs, Douglas R.; Gibbons, Richard J.			ATRX Dysfunction Induces Replication Defects in Primary Mouse Cells	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; HUMAN TELOMERES; MRE11/RAD50/NBS1 COMPLEX; X SYNDROME; PROTEIN; MUTATIONS; H3.3; RECOMBINATION; RESTART; LOCALIZATION	The chromatin remodeling protein ATRX, which targets tandem repetitive DNA, has been shown to be required for expression of the alpha globin genes, for proliferation of a variety of cellular progenitors, for chromosome congression and for the maintenance of telomeres. Mutations in ATRX have recently been identified in tumours which maintain their telomeres by a telomerase independent pathway involving homologous recombination thought to be triggered by DNA damage. It is as yet unknown whether there is a central underlying mechanism associated with ATRX dysfunction which can explain the numerous cellular phenomena observed. There is, however, growing evidence for its role in the replication of various repetitive DNA templates which are thought to have a propensity to form secondary structures. Using a mouse knockout model we demonstrate that ATRX plays a direct role in facilitating DNA replication. Ablation of ATRX alone, although leading to a DNA damage response at telomeres, is not sufficient to trigger the alternative lengthening of telomere pathway in mouse embryonic stem cells.	[Clynes, David; Jelinska, Clare; Xella, Barbara; Ayyub, Helena; Mitson, Matthew; Higgs, Douglas R.; Gibbons, Richard J.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Mol Haematol Unit, Oxford OX3 9DU, England; [Taylor, Stephen] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford OX3 9DU, England; [Bachrati, Csanad Z.] Lincoln Univ, Sch Life Sci, Lincoln, England	University of Oxford; University of Oxford; University of Lincoln	Gibbons, RJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Mol Haematol Unit, Oxford OX3 9DU, England.	richard.gibbons@imm.ox.ac.uk	Bachrati, Csanad/ABF-2020-2021; Gibbons, Richard/E-6937-2011	Bachrati, Csanad/0000-0003-1703-5894; Gibbons, Richard/0000-0002-7680-9311; Higgs, Douglas/0000-0003-3579-8705; Clynes, David/0000-0003-4516-0043	Medical Research Council, United Kingdom; Medical Research Council [G0902418, G1000801, MC_U137961147, MC_UU_12009/4, MC_UU_12009/3, G1000801j, G1000801b] Funding Source: researchfish; MRC [MC_UU_12009/3, G1000801, MC_UU_12009/4, G0902418, MC_U137961147] Funding Source: UKRI	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RJG and co-workers are funded by the Medical Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Bagheri-Fam S, 2011, HUM MOL GENET, V20, P2213, DOI 10.1093/hmg/ddr109; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Clynes D, 2013, TRENDS BIOCHEM SCI, V38, P461, DOI 10.1016/j.tibs.2013.06.011; Conti C, 2007, CELL CYCLE, V6, P2760, DOI 10.4161/cc.6.22.4932; De La Fuente R, 2004, DEV BIOL, V272, P1, DOI 10.1016/j.ydbio.2003.12.012; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Ghosal G, 2005, NUCLEIC ACIDS RES, V33, P4692, DOI 10.1093/nar/gki777; GIBBONS RJ, 1995, HUM MOL GENET, V4, P1705, DOI 10.1093/hmg/4.suppl_1.1705; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Huh MS, 2012, J CLIN INVEST, V122, P4412, DOI 10.1172/JCI63765; Jiang WQ, 2005, MOL CELL BIOL, V25, P2708, DOI 10.1128/MCB.25.7.2708-2721.2005; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Leung JWC, 2013, J BIOL CHEM, V288, P6342, DOI 10.1074/jbc.M112.411603; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; Mitson M, 2011, HUM MOL GENET, V20, P2603, DOI 10.1093/hmg/ddr163; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Schwab RA, 2010, EMBO J, V29, P806, DOI 10.1038/emboj.2009.385; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Watson LA, 2013, J CLIN INVEST, V123, P2049, DOI 10.1172/JCI65634; Wojewodzka M, 2002, MUTAT RES-GEN TOX EN, V518, P9, DOI 10.1016/S1383-5718(02)00070-0; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	41	64	66	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92915	10.1371/journal.pone.0092915	http://dx.doi.org/10.1371/journal.pone.0092915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651726	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000333352800164
J	Duggan, KA; Friedman, HS; McDevitt, EA; Mednick, SC				Duggan, Katherine A.; Friedman, Howard S.; McDevitt, Elizabeth A.; Mednick, Sara C.			Personality and Healthy Sleep: The Importance of Conscientiousness and Neuroticism	PLOS ONE			English	Article							CIRCADIAN-RHYTHM; MORTALITY; QUALITY; DURATION; METAANALYSIS; COMPLAINTS; BEHAVIORS; SEROTONIN; DISEASE; TRAITS	Although previous research has shown personality and sleep are each substantial predictors of health throughout the lifespan, little is known about links between personality and healthy sleep patterns. This study examined Big Five personality traits and a range of factors related to sleep health in 436 university students (M-age = 19.88, SD = 1.50, 50% Male). Valid self-report measures of personality, chronotype, sleep hygiene, sleep quality, and sleepiness were analyzed. To remove multicollinearity between personality factors, each sleep domain was regressed on relevant demographic and principal component-derived personality factors in multiple linear regressions. Results showed that low conscientiousness and high neuroticism were the best predictors of poor sleep (poor sleep hygiene, low sleep quality, and increased sleepiness), consistent with other research on predictors of poor health and mortality risk. In this first comprehensive study of the topic, the findings suggest that personality has a significant association with sleep health, and researchers could profitably examine both personality and sleep in models of health and well-being.	[Duggan, Katherine A.; Friedman, Howard S.; McDevitt, Elizabeth A.; Mednick, Sara C.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Mednick, SC (corresponding author), Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA.	smednick@ucr.edu		mednick, sara/0000-0002-0906-3097; Duggan, Katherine A./0000-0003-1768-3365	 [K01MH080992]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH080992] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grant K01MH080992 (http://www.nimh.nih.gov/) awarded to Sara C. Mednick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Bailey SL, 2001, CHRONOBIOL INT, V18, P249, DOI 10.1081/CBI-100103189; Blagrove M, 2001, PERS INDIV DIFFER, V30, P819, DOI 10.1016/S0191-8869(00)00075-1; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; BOOTHKEWLEY S, 1994, J PERS, V62, P282; Briones B, 1996, SLEEP, V19, P583, DOI 10.1093/sleep/19.7.583; Bruni O, 1999, CEPHALALGIA, V19, P57, DOI 10.1177/0333102499019S2516; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 2003, J NEUROENDOCRINOL, V15, P432, DOI 10.1046/j.1365-2826.2003.00989.x; Calkins AW, 2013, BEHAV SLEEP MED, V11, P133, DOI 10.1080/15402002.2011.643968; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Carver CS, 2006, PSYCHIAT RES, V144, P1, DOI 10.1016/j.psychres.2006.03.013; Carver CS, 2009, CURR DIR PSYCHOL SCI, V18, P195, DOI 10.1111/j.1467-8721.2009.01635.x; CASPI A, 1989, J PERS, V57, P375, DOI 10.1111/j.1467-6494.1989.tb00487.x; Cohen J., 2003, APPL MULTIPLE REGRES; COSTA PT, 1987, J PERS, V55, P299, DOI 10.1111/j.1467-6494.1987.tb00438.x; DeYoung CG, 2007, PERS INDIV DIFFER, V43, P267, DOI 10.1016/j.paid.2006.11.030; Dorsey CM, 1997, BIOL PSYCHIAT, V41, P209, DOI 10.1016/0006-3223(95)00659-1; Friedman EM, 2007, PSYCHOSOM MED, V69, P682, DOI 10.1097/PSY.0b013e31814ceada; Friedman H.S., 2011, LONGEVITY PROJECT SU; Friedman HS, 2014, DEV PSYCHOL, V50, P1377, DOI 10.1037/a0030373; Friedman HS, 2000, J PERS, V68, P1089, DOI 10.1111/1467-6494.00127; FRIEDMAN HS, 1987, AM PSYCHOL, V42, P539, DOI 10.1037/0003-066X.42.6.539; FRIEDMAN HS, 1995, AM PSYCHOL, V50, P69, DOI 10.1037/0003-066X.50.2.69; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Gray EK, 2002, J PERS, V70, P177; Hampson SE, 2012, ANNU REV PSYCHOL, V63, P315, DOI 10.1146/annurev-psych-120710-100419; Hogben AL, 2007, CHRONOBIOL INT, V24, P1249, DOI 10.1080/07420520701791596; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Howell AJ, 2008, PERS INDIV DIFFER, V45, P773, DOI 10.1016/j.paid.2008.08.005; Hublin C, 2007, SLEEP, V30, P1245, DOI 10.1093/sleep/30.10.1245; Jackson JJ, 2009, J PERS SOC PSYCHOL, V96, P446, DOI 10.1037/a0014156; John O, 1991, BIG 5 INVENTORY VERS; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kern ML, 2008, HEALTH PSYCHOL, V27, P505, DOI 10.1037/0278-6133.27.5.505; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Mallon L, 2002, J INTERN MED, V251, P207, DOI 10.1046/j.1365-2796.2002.00941.x; Mastin DF, 2006, J BEHAV MED, V29, P223, DOI 10.1007/s10865-006-9047-6; Mastin DF, 2005, PERS INDIV DIFFER, V39, P1471, DOI 10.1016/j.paid.2005.08.007; NEUBAUER AC, 1992, PERS INDIV DIFFER, V13, P125, DOI 10.1016/0191-8869(92)90035-N; Pilcher JJ, 1997, J PSYCHOSOM RES, V42, P583, DOI 10.1016/S0022-3999(97)00004-4; PROSSER RA, 1993, J BIOL RHYTHM, V8, P1, DOI 10.1177/074873049300800101; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; REYNER A, 1995, SLEEP, V18, P127; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; SCARR S, 1983, CHILD DEV, V54, P424, DOI 10.1111/j.1467-8624.1983.tb03884.x; Schmitt DP, 2007, J CROSS CULT PSYCHOL, V38, P173, DOI 10.1177/0022022106297299; Shipley BA, 2007, PSYCHOSOM MED, V69, P923, DOI 10.1097/PSY.0b013e31815abf83; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Tonetti L, 2009, CHRONOBIOL INT, V26, P337, DOI 10.1080/07420520902750995; Urban R, 2011, CHRONOBIOL INT, V28, P238, DOI 10.3109/07420528.2010.549599; Vitiello MV, 2004, J PSYCHOSOM RES, V56, P503, DOI 10.1016/S0022-3999(04)00023-6; Voderholzer U, 2003, DEPRESS ANXIETY, V17, P162, DOI 10.1002/da.10101; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Williams PG, 2009, PERS INDIV DIFFER, V46, P598, DOI 10.1016/j.paid.2008.12.017; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979	65	118	124	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90628	10.1371/journal.pone.0090628	http://dx.doi.org/10.1371/journal.pone.0090628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651274	Green Published, gold			2022-12-25	WOS:000333352800018
J	Jahanian, H; Ni, WW; Christen, T; Moseley, ME; Tamura, MK; Zaharchuk, G				Jahanian, Hesamoddin; Ni, Wendy W.; Christen, Thomas; Moseley, Michael E.; Tamura, Manjula Kurella; Zaharchuk, Greg			Spontaneous BOLD Signal Fluctuations in Young Healthy Subjects and Elderly Patients with Chronic Kidney Disease	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; FUNCTIONAL CONNECTIVITY; PHYSIOLOGICAL NOISE; BRAIN ACTIVITY; WHITE-MATTER; MR-IMAGES; 7 TESLA; FMRI; ISCHEMIA; HUMANS	Spontaneous fluctuations in blood oxygenation level-dependent (BOLD) images are the basis of resting-state fMRI and frequently used for functional connectivity studies. However, there may be intrinsic information in the amplitudes of these fluctuations. We investigated the possibility of using the amplitude of spontaneous BOLD signal fluctuations as a biomarker for cerebral vasomotor reactivity. We compared the coefficient of variation (CV) of the time series (defined as the temporal standard deviation of the time series divided by the mean signal intensity) in two populations: 1) Ten young healthy adults and 2) Ten hypertensive elderly subjects with chronic kidney disease (CKD). We found a statistically significant increase (P<0.01) in the CV values for the CKD patients compared with the young healthy adults in both gray matter (GM) and white matter (WM). The difference was independent of the exact segmentation method, became more significant after correcting for physiological signals using RETROICOR, and mainly arose from very low frequency components of the BOLD signal fluctuation (f<0.025 Hz). Furthermore, there was a strong relationship between WM and GM signal fluctuation CV's (R-2 = 0.87) in individuals, with a ratio of about 1:3. These results suggest that amplitude of the spontaneous BOLD signal fluctuations may be used to assess the cerebrovascular reactivity mechanisms and provide valuable information about variations with age and different disease states.	[Jahanian, Hesamoddin; Ni, Wendy W.; Christen, Thomas; Moseley, Michael E.; Zaharchuk, Greg] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Ni, Wendy W.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Tamura, Manjula Kurella] Stanford Univ, Geriatr Res & Educ Clin Ctr, Palo Alto Vet Affairs Hlth Care Syst, Stanford, CA 94305 USA; [Tamura, Manjula Kurella] Stanford Univ, Div Nephrol, Stanford, CA 94305 USA	Stanford University; Stanford University; Geriatric Research Education & Clinical Center; Stanford University; Stanford University	Jahanian, H (corresponding author), Stanford Univ, Dept Radiol, Stanford, CA 94305 USA.	hesamj@stanford.edu	Tamura, Manjula Kurella/C-8284-2014; christen, thomas/O-4482-2018	Tamura, Manjula Kurella/0000-0001-5227-2479; christen, thomas/0000-0002-8791-9145	NIH [1R01NS066506, 2R01NS047607, R01DK092241]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047607, R01NS066506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by NIH grants 1R01NS066506, 2R01NS047607, R01DK092241. However, NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chang KV, 2011, J CLIN ULTRASOUND, V39, P383, DOI 10.1002/jcu.20819; Fazekas G, 1996, NUCL MED COMMUN, V17, P603, DOI 10.1097/00006231-199607000-00011; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Jain V, 2011, J CEREBR BLOOD F MET, V31, P1504, DOI 10.1038/jcbfm.2011.34; Kimoto E, 2006, J AM SOC NEPHROL, V17, P2245, DOI 10.1681/ASN.2005101038; Kozera GM, 2010, AM J HYPERTENS, V23, P1198, DOI 10.1038/ajh.2010.152; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Liu YT, 2007, J MAGN RESON IMAGING, V26, P1112, DOI 10.1002/jmri.21131; Lux S, 2010, KIDNEY INT, V78, P794, DOI 10.1038/ki.2010.253; Makedonov I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067652; Markus HS, 2000, J NEUROL NEUROSUR PS, V69, P48, DOI 10.1136/jnnp.69.1.48; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Pan WJ, 2013, NEUROIMAGE, V74, P288, DOI 10.1016/j.neuroimage.2013.02.035; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Wang HH, 2008, J MAGN RESON IMAGING, V27, P866, DOI 10.1002/jmri.21007; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Yao QL, 2012, NEUROSCI LETT, V509, P22, DOI 10.1016/j.neulet.2011.12.036; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	24	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92539	10.1371/journal.pone.0092539	http://dx.doi.org/10.1371/journal.pone.0092539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651703	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800124
J	Kedjarune-Leggat, U; Supaprutsakul, C; Chotigeat, W				Kedjarune-Leggat, Ureporn; Supaprutsakul, Chanyapat; Chotigeat, Wilaiwan			Ultrasound Treatment Increases Transfection Efficiency of Low Molecular Weight Chitosan in Fibroblasts but Not in KB Cells	PLOS ONE			English	Article							GENE DELIVERY; IN-VITRO; INTRACELLULAR TRAFFICKING; NANOPARTICLES; DNA; SYSTEM; DRUG; MICROBUBBLES; PATHWAYS	The aim of this study was to optimize transfection efficiency (TE) of the depolymerized low molecular weight (LW) chitosan with molecular weight (Mw) at 16 kDa and 54% degree of deacetylation (DDA) on three primary cells of fibroblast (F), dental pulp (P), and periodontal ligament (PDL). The effect of low frequency ultrasound treatment on the chitosan-DNA complexes prior transfection on TE was also evaluated. This LW chitosan required high N/P ratio (>34) to bind DNA completely. An N/P ratio above 56 tended to improve TE in most primary cells nearly at the level of Lipofectamine. Ultrasonication can reduce the aggregation and sizes of the chitosan-DNA microparticles. It increased TE of F cells at an N/P ratio above 34, which was higher than Lipofectamine. However, this ultrasound treatment caused loss of TE in KB cells. MTT assay of these chitosan-DNA complexes revealed no significant cytotoxicity to both KB and F cells. This LW chitosan has potential for further development into a safer alternative to gene delivery systems in various cells of interest; however the optimal conditions have to be adjusted, depending on each cell source.	[Kedjarune-Leggat, Ureporn; Supaprutsakul, Chanyapat] Prince Songkla Univ, Fac Dent, Dept Oral Biol & Occlus, Hat Yai, Songkhla, Thailand; [Supaprutsakul, Chanyapat; Chotigeat, Wilaiwan] Prince Songkla Univ, Fac Sci, Dept Mol Biotechnol & Bioinformat, Hat Yai, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University	Kedjarune-Leggat, U (corresponding author), Prince Songkla Univ, Fac Dent, Dept Oral Biol & Occlus, Hat Yai, Songkhla, Thailand.	ureporn.l@psu.ac.th			Prince of Songkla University [DEN50109900106s]; Prince of Songkla University	Prince of Songkla University; Prince of Songkla University	Prince of Songkla University grant No. DEN50109900106s and a Prince of Songkla University post graduate grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alameh M, 2012, INT J NANOMED, V7, P1399, DOI 10.2147/IJN.S26571; Bai WK, 2012, ONCOL REP, V27, P475, DOI 10.3892/or.2011.1510; Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015; Bernkop-Schnurch A, 2012, EUR J PHARM BIOPHARM; Buschmann MD, 2013, ADV DRUG DELIVER REV, V65, P1234, DOI 10.1016/j.addr.2013.07.005; Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001; Douglas KL, 2008, EUR J PHARM BIOPHARM, V68, P676, DOI 10.1016/j.ejpb.2007.09.002; Duceppe N, 2009, BIOMATERIALS; Duceppe N, 2010, EXPERT OPIN DRUG DEL, V7, P1191, DOI 10.1517/17425247.2010.514604; Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671; FRESHNEY RI, 1985, ANTICANCER RES, V5, P111; Hsu SH, 2012, BIOMATERIALS, V33, P3639, DOI 10.1016/j.biomaterials.2012.02.005; Huang M, 2004, PHARM RES-DORDR, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5; Izumisawa T, 2011, INT J PHARMACEUT, V404, P264, DOI 10.1016/j.ijpharm.2010.11.017; Jreyssaty C, 2012, ISRN PHARM, V2012, P369270; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Komamura K, 2011, DRUG DELIV, V2011; Koping-Hoggard M, 2003, J GENE MED, V5, P130, DOI 10.1002/jgm.327; Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004; Mao SR, 2004, INT J PHARMACEUT, V281, P45, DOI 10.1016/j.ijpharm.2004.05.019; Morris VB, 2008, J BIOMED MAT RES B; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nimesh S, 2010, MOL BIOTECHNOL, V46, P182, DOI 10.1007/s12033-010-9286-1; Omata D, 2011, MOL PHARMACEUT, V8, P2416, DOI 10.1021/mp200353m; Phillips LC, 2010, ULTRASOUND MED BIOL, V36, P1470, DOI 10.1016/j.ultrasmedbio.2010.06.010; Pua EC, 2009, IEEE ENG MED BIOL, V28, P64, DOI 10.1109/MEMB.2008.931017; Ramesan RM, 2012, NANOMEDICINE-UK, V7, P5, DOI [10.2217/nnm.11.170, 10.2217/NNM.11.170]; Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0; Romoren K, 2003, INT J PHARM, V261, P115, DOI 10.1016/S0378-5173(03)00301-6; Saito A, 2001, APPL ENVIRON MICROB, V67, P1268, DOI 10.1128/AEM.67.3.1268-1273.2001; Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013; Supaprutsakul S, 2010, J MATER SCI-MATER M, V21, P1553, DOI 10.1007/s10856-010-3993-9; Tang ESK, 2003, INT J PHARMACEUT, V265, P103, DOI 10.1016/S0378-5173(03)00408-3; Thibault M, 2011, BIOMATERIALS, V32, P4639, DOI 10.1016/j.biomaterials.2011.03.010; Thibault M, 2010, MOL THER, V18, P1787, DOI 10.1038/mt.2010.143; Tripathi SK, 2012, BIOMATERIALS, V33, P4204, DOI 10.1016/j.biomaterials.2012.02.035; Turan K, 2006, PHARM DEV TECHNOL, V11, P503, DOI 10.1080/10837450600940873; Wang JJ, 2011, INT J NANOMED, V6, P765, DOI 10.2147/IJN.S17296; Yuan QY, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-56; Zhang L, 2011, J HUAZHONG U SCI-MED, V31, P39, DOI 10.1007/s11596-011-0147-3; Zhao X, 2006, J CONTROL RELEASE, V112, P223, DOI 10.1016/j.jconrel.2006.01.016; Zhou SJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-170; Zhu WL, 2008, ANTICANCER RES, V28, P1575	43	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92076	10.1371/journal.pone.0092076	http://dx.doi.org/10.1371/journal.pone.0092076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651870	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800068
J	Keilwagen, J; Grosse, I; Grau, J				Keilwagen, Jens; Grosse, Ivo; Grau, Jan			Area under Precision-Recall Curves for Weighted and Unweighted Data	PLOS ONE			English	Article							CLASSIFICATION; DISCOVERY	Precision-recall curves are highly informative about the performance of binary classifiers, and the area under these curves is a popular scalar performance measure for comparing different classifiers. However, for many applications class labels are not provided with absolute certainty, but with some degree of confidence, often reflected by weights or soft labels assigned to data points. Computing the area under the precision-recall curve requires interpolating between adjacent supporting points, but previous interpolation schemes are not directly applicable to weighted data. Hence, even in cases where weights were available, they had to be neglected for assessing classifiers using precision-recall curves. Here, we propose an interpolation for precision-recall curves that can also be used for weighted data, and we derive conditions for classification scores yielding the maximum and minimum area under the precision-recall curve. We investigate accordances and differences of the proposed interpolation and previous ones, and we demonstrate that taking into account existing weights of test data is important for the comparison of classifiers.	[Keilwagen, Jens] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Inst Biosafety Plant Biotechnol, Quedlinburg, Germany; [Grosse, Ivo; Grau, Jan] Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Saale, Germany; [Grosse, Ivo] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Julius Kuhn-Institut; Martin Luther University Halle Wittenberg	Keilwagen, J (corresponding author), Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Inst Biosafety Plant Biotechnol, Quedlinburg, Germany.	jens.keilwagen@jki.bund.de	Grau, Jan/H-5465-2019	Grau, Jan/0000-0003-2081-6405; Keilwagen, Jens/0000-0002-6792-7076				Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Aslam J. A., 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P573, DOI 10.1145/1076034.1076134; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bleakley K, 2007, BIOINFORMATICS, V23, pI57, DOI 10.1093/bioinformatics/btm204; Boyd Kendrick, 2013, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2013. Proceedings: LNCS 8190, P451, DOI 10.1007/978-3-642-40994-3_29; Boyd K., 2012, ICML; Brodersen K. H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P4263, DOI 10.1109/ICPR.2010.1036; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fawcett Tom, 2004, TECHNICAL REPORT; Goldberg A.B., 2009, 10 ANN C N AM CHAPTE, P263, DOI DOI 10.3115/1620754.1620793; Grau J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt831; Grau J, 2012, J MACH LEARN RES, V13, P1967; Keilwagen J, 2007, LWA LERN WISS ABST A, P67; Kekalainen J, 2002, J AM SOC INF SCI TEC, V53, P1120, DOI 10.1002/asi.10137; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Manning C.D., 2008, INTRO INFORM RETRIEV; Martin DR, 2004, IEEE T PATTERN ANAL, V26, P530, DOI 10.1109/TPAMI.2004.1273918; Ohsaki M, 2007, ARTIF INTELL MED, V41, P177, DOI 10.1016/j.artmed.2007.07.005; Poulter GL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-108; Prechelt L, 2002, J UNIVERS COMPUT SCI, V8, P1016; Sonnenburg S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S10-S7; Stehman SV, 1997, REMOTE SENS ENVIRON, V62, P77, DOI 10.1016/S0034-4257(97)00083-7; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zheng SF, 2010, COMPUT VIS IMAGE UND, V114, P1055, DOI 10.1016/j.cviu.2010.07.004; Zucchini W, 2000, J MATH PSYCHOL, V44, P41, DOI 10.1006/jmps.1999.1276	28	71	73	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92209	10.1371/journal.pone.0092209	http://dx.doi.org/10.1371/journal.pone.0092209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651729	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800085
J	Pearson, AL; Winter, PR; McBreen, B; Stewart, G; Roets, R; Nutsford, D; Bowie, C; Donnellan, N; Wilson, N				Pearson, Amber L.; Winter, Pieta R.; McBreen, Ben; Stewart, Georgia; Roets, Rianda; Nutsford, Daniel; Bowie, Christopher; Donnellan, Niamh; Wilson, Nick			Obtaining Fruit and Vegetables for the Lowest Prices: Pricing Survey of Different Outlets and Geographical Analysis of Competition Effects	PLOS ONE			English	Article							FARMERS MARKETS; LOW-INCOME; FOOD; SUPERMARKETS; ACCESS; STORES; URBAN	Aims: Inadequate fruit and vegetable (F&V) consumption is an important dietary risk factor for disease internationally. High F&V prices can be a barrier to dietary intake and so to improve understanding of this topic we surveyed prices and potential competition between F&V outlet types. Methods: Over a three week early autumn period in 2013, prices were collected bi-weekly for 18 commonly purchased F&Vs from farmers' markets (FM) selling local produce (n = 3), other F&V markets (OFVM) (n = 5), supermarkets that neighbored markets (n = 8), and more distant supermarkets (n = 8), (in urban Wellington and Christchurch areas of New Zealand). Prices from an online supermarket were also collected. Results: A total of 3120 prices were collected. Most F&Vs (13/18) were significantly cheaper at OFVMs than supermarkets. Over half of the F&Vs (10/18) were significantly cheaper at nearby compared to distant supermarkets, providing evidence of a moderate 'halo effect' in price reductions in supermarkets that neighbored markets. Weekend (vs midweek) prices were also significantly cheaper at nearby (vs distant) supermarkets, supporting evidence for a 'halo effect'. Ideal weekly 'food basket' prices for a two adult, two child family were: OFVMs (NZ$76), online supermarket ($113), nearby supermarkets ($124), distant supermarkets ($127), and FMs ($138). This represents a savings of $49 per week (US$26) by using OFVMs relative to (non-online) supermarkets. Similarly, a shift from non-online supermarkets to the online supermarket would generate a $13 saving. Conclusions: In these locations general markets appear to be providing some substantially lower prices for fruit and vegetables than supermarkets. They also appear to be depressing prices in neighboring supermarkets. These results, when supplemented by other needed research, may help inform the case for interventions to improve access to fruit and vegetables, particularly for low-income populations.	[Pearson, Amber L.; Winter, Pieta R.; McBreen, Ben; Stewart, Georgia; Roets, Rianda; Wilson, Nick] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Pearson, Amber L.; Nutsford, Daniel; Bowie, Christopher; Donnellan, Niamh] Univ Canterbury, Dept Geog, Christchurch 1, New Zealand	University of Otago; University of Canterbury	Pearson, AL (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, New Zealand.	amber.pearson@otago.ac.nz	Donnellan, Niamh/AAR-7481-2020; Donnellan, Niamh/AAB-7147-2019	Donnellan, Niamh/0000-0002-9411-7642				Black AP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1099; Blakely T, 2011, J EPIDEMIOL COMMUN H, V65, P902, DOI 10.1136/jech.2010.118588; Caldwell EM, 2009, PUBLIC HEALTH NUTR, V12, P1743, DOI 10.1017/S1368980008004308; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Evans AE, 2012, HEALTH PLACE, V18, P1137, DOI 10.1016/j.healthplace.2012.04.007; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Freedman DA, 2013, PREV MED, V56, P288, DOI 10.1016/j.ypmed.2013.01.018; George DR, 2011, AM J PUBLIC HEALTH, V101, P2226, DOI 10.2105/AJPH.2011.300197; Herman DR, 2008, AM J PUBLIC HEALTH, V98, P98, DOI 10.2105/AJPH.2005.079418; Inland Revenue Department, 2013, G4110 SUP GROC STOR; Larsen K, 2009, HEALTH PLACE, V15, P1158, DOI 10.1016/j.healthplace.2009.06.007; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McGuirt JT, 2011, J HUNGER ENVIRON NUT, V6, P86, DOI 10.1080/19320248.2010.551031; Mhurchu CN, 2007, NEW ZEAL MED J, V120, P13; Ministry of Health, 2012, HLTH NZ AD 2011 12 K; Murphy AJ, 2011, INT J RETAIL DISTRIB, V39, P582, DOI 10.1108/09590551111148668; Pearce J, 2008, J EPIDEMIOL COMMUN H, V62, P198, DOI 10.1136/jech.2006.059196; Ruelas V, 2012, J COMMUN HEALTH, V37, P554, DOI 10.1007/s10900-011-9479-y; Sauer C, 2012, IS LOCAL FOOD MORE E; Smith DM, 2010, INT J EPIDEMIOL, V39, P277, DOI 10.1093/ije/dyp221; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Suarez-Balcazar Y., 2006, Journal of Extension, V44, p2FEA2; Swenson PJ, 2012, PAIRED PRICE COMP FA; Thornton LE, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-29; Turrell G, 2002, J HUM NUTR DIET, V15, P355, DOI 10.1046/j.1365-277X.2002.00384.x; Wall J, 2006, NUTR REV, V64, P518, DOI [10.1301/nr.2006.dec.518-531, 10.1111/j.1753-4887.2006.tb00185.x]; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059648; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058539; WRAP (The Waste and Resources Action Programme), 2009, HOUS FOOD DRINK WAST	29	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e89775	10.1371/journal.pone.0089775	http://dx.doi.org/10.1371/journal.pone.0089775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651475	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800003
J	Zhang, HT; Wei, Q; Liu, RL; Qi, SY; Liang, PH; Qi, C; Wang, AD; Sheng, B; Li, L; Xu, Y				Zhang, Hongtuan; Wei, Qiang; Liu, Ranlu; Qi, Shiyong; Liang, Peihe; Qi, Can; Wang, Andi; Sheng, Bin; Li, Liang; Xu, Yong			Overexpression of LAPTM4B-35: A Novel Marker of Poor Prognosis of Prostate Cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TETRATRANSMEMBRANE PROTEIN; EXPRESSION; PROGRESSION; NUCB2; PLAY	Background: Lysosome-associated protein transmembrane 4b-35 (LAPTM4B-35) is a member of the mammalian 4-tetratransmembrane spanning protein superfamily, which is overexpressed in several solid malignancies. However, the expression of LAPTM4B-35 and its role in the progression of prostate cancer (PCa) is unknown. The aim of the present study was to investigate the LAPTM4B-35 expression in PCa and its potential relevance to clinicopathological variables and prognosis. Methods: Immunohistochemistry was used to determine the expression of LAPTM4B-35 protein in 180 PCa tissues in comparison with 180 normal benign prostatic hyperplasia (BPH) specimens. The correlation between the expression of the LAPTM4B-35 protein and the clinicopathologic characteristics of patients with PCa was analyzed. Results: Statistical analysis showed that LAPTM4B-35 expression was significantly elevated in PCa compared with the BPH controls. High LAPTM4B-35 staining was present in 71.11% of all the cases with PCa. The overexpression of LAPTM4B-35 was significantly associated with the lymph node metastasis, seminal vesicle invasion, PCa stage, higher Gleason score, higher preoperative PSA, and biochemical recurrence (BCR). The Kaplan-Meier survival analysis showed that the high expression of LAPTM4B-35 was related to the poor overall survival and BCR-free survival of patients with PCa. Multivariate Cox analysis showed that LAPTM4B-35 was an independent prognostic factor for both overall survival and BCR-free survival of patients with PCa. Conclusions: Overexpression of LAPTM4B-35 may be associated with tumor progression and poor prognosis in PCa and thus may serve as a new molecular marker to predict the prognosis of PCa patients.	[Zhang, Hongtuan; Wei, Qiang; Liu, Ranlu; Qi, Shiyong; Qi, Can; Wang, Andi; Sheng, Bin; Xu, Yong] Tianjin Med Univ, Hosp 2, Tianjin Key Inst Urol, Dept Urol,Natl Key Clin Specialty Urol, Tianjin, Peoples R China; [Liang, Peihe] Chongqing Med Univ, Affiliated Hosp 2, Dept Urol, Chongqing, Peoples R China; [Li, Liang] Tianjin Med Univ, Hosp 2, Dept Radiol, Tianjin, Peoples R China	Tianjin Medical University; Chongqing Medical University; Tianjin Medical University	Xu, Y (corresponding author), Tianjin Med Univ, Hosp 2, Tianjin Key Inst Urol, Dept Urol,Natl Key Clin Specialty Urol, Tianjin, Peoples R China.	xymnwk@163.com		Wang, Yuzhuo/0000-0002-9749-8591	National Natural Science Foundation of China [81172451]; Tianjin Major Anti-Cancer Project [12ZCDZSY17200]; Science Foundation of Tianjin medical university [2009GSI18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Major Anti-Cancer Project; Science Foundation of Tianjin medical university	This study was supported by the National Natural Science Foundation of China (NO: 81172451), Tianjin Major Anti-Cancer Project (12ZCDZSY17200), and Science Foundation of Tianjin medical university. (NO: 2009GSI18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren O, 2006, J UROLOGY, V175, P1337, DOI 10.1016/S0022-5347(05)00734-2; Cabrita MA, 1999, CANCER RES, V59, P4890; Carroll PR, 2005, J UROLOGY, V173, P1061, DOI 10.1097/01.ju.0000156838.67623.10; Kasper G, 2005, CANCER LETT, V224, P93, DOI 10.1016/j.canlet.2004.10.004; Liu XR, 2004, WORLD J GASTROENTERO, V10, P1555, DOI 10.3748/wjg.v10.i11.1555; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Molina R, 2012, TUMOR BIOL, V33, P463, DOI 10.1007/s13277-011-0275-1; Overdevest JB, 2009, CLIN CHEM, V55, P684, DOI 10.1373/clinchem.2008.118554; Pandith AA, 2012, TUMOR BIOL, V33, P1629, DOI 10.1007/s13277-012-0418-z; Pinto A, 2012, TUMOR BIOL, V33, P421, DOI 10.1007/s13277-011-0299-6; Ribeiro R, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-32; Sardana G, 2008, CLIN CHEM, V54, P1951, DOI 10.1373/clinchem.2008.110668; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Vickers A, 2010, J CLIN ONCOL, V28, P2493, DOI 10.1200/JCO.2009.24.1968; Xiao M, 2013, J CANCER RES CLIN, V139, P661, DOI 10.1007/s00432-012-1368-y; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yang Y, 2008, ONCOL REP, V20, P1077, DOI 10.3892/or_00000112; Zhang HT, 2014, TUMOR BIOL, V35, P2025, DOI 10.1007/s13277-013-1268-z; Zhang HT, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-77; Zhang HT, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-56; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025; Zhou L, 2010, AM J SURG, V199, P515, DOI 10.1016/j.amjsurg.2009.03.031	25	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91069	10.1371/journal.pone.0091069	http://dx.doi.org/10.1371/journal.pone.0091069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651764	gold, Green Submitted, Green Published			2022-12-25	WOS:000333352800029
J	Lantier, L; Fentz, J; Mounier, R; Leclerc, J; Treebak, JT; Pehmoller, C; Sanz, N; Sakakibara, I; Saint-Amand, E; Rimbaud, S; Maire, P; Marette, A; Ventura-Clapier, R; Ferry, A; Wojtaszewski, JFP; Foretz, M; Viollet, B				Lantier, Louise; Fentz, Joachim; Mounier, Remi; Leclerc, Jocelyne; Treebak, Jonas T.; Pehmoller, Christian; Sanz, Nieves; Sakakibara, Iori; Saint-Amand, Emmanuelle; Rimbaud, Stephanie; Maire, Pascal; Marette, Andre; Ventura-Clapier, Renee; Ferry, Arnaud; Wojtaszewski, Jorgen F. P.; Foretz, Marc; Viollet, Benoit			AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity	FASEB JOURNAL			English	Article						glucose transport; force production	ACTIVATED PROTEIN-KINASE; GLUCOSE-UPTAKE; CONTRACTION; PHOSPHORYLATION; TRANSPORT; MICE; AMPK-ALPHA-2; DEFICIENCY; PGC-1-ALPHA; PERFORMANCE	AMP-activated protein kinase (AMPK) is a sensor of cellular energy status that plays a central role in skeletal muscle metabolism. We used skeletal muscle-specific AMPK alpha 1 alpha 2 double-knockout (mdKO) mice to provide direct genetic evidence of the physiological importance of AMPK in regulating muscle exercise capacity, mitochondrial function, and contraction-stimulated glucose uptake. Exercise performance was significantly reduced in the mdKO mice, with a reduction in maximal force production and fatigue resistance. An increase in the proportion of myofibers with centralized nuclei was noted, as well as an elevated expression of interleukin 6 (IL-6) mRNA, possibly consistent with mild skeletal muscle injury. Notably, we found that AMPK alpha 1 and AMPK alpha 2 isoforms are dispensable for contraction-induced skeletal muscle glucose transport, except for male soleus muscle. However, the lack of skeletal muscle AMPK diminished maximal ADP-stimulated mitochondrial respiration, showing an impairment at complex I. This effect was not accompanied by changes in mitochondrial number, indicating that AMPK regulates muscle metabolic adaptation through the regulation of muscle mitochondrial oxidative capacity and mitochondrial substrate utilization but not baseline mitochondrial muscle content. Together, these results demonstrate that skeletal muscle AMPK has an unexpected role in the regulation of mitochondrial oxidative phosphorylation that contributes to the energy demands of the exercising muscle.	[Lantier, Louise; Mounier, Remi; Leclerc, Jocelyne; Sanz, Nieves; Sakakibara, Iori; Maire, Pascal; Foretz, Marc; Viollet, Benoit] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Lantier, Louise; Mounier, Remi; Leclerc, Jocelyne; Sanz, Nieves; Sakakibara, Iori; Maire, Pascal; Foretz, Marc; Viollet, Benoit] CNRS, UMR 8104, Paris, France; [Lantier, Louise; Mounier, Remi; Leclerc, Jocelyne; Sanz, Nieves; Sakakibara, Iori; Maire, Pascal; Ferry, Arnaud; Foretz, Marc; Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Fentz, Joachim; Treebak, Jonas T.; Pehmoller, Christian; Wojtaszewski, Jorgen F. P.] Univ Copenhagen, August Krogh Ctr, Dept Nutr Exercise & Sports, Sect Mol Physiol, Copenhagen, Denmark; [Saint-Amand, Emmanuelle; Marette, Andre] Univ Laval, Ste Foy, PQ G1K 7P4, Canada; [Rimbaud, Stephanie; Ventura-Clapier, Renee] Univ Paris 11, INSERM, U769, Chatenay Malabry, France; [Ferry, Arnaud] Univ Paris 06, CNRS, Inst Myol, INSERM,U974,UMR 7215, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Viollet, B (corresponding author), Inst Cochin Genet Mol, INSERM, U1016, Dept Endocrinol Metab & Diabet, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	benoit.viollet@inserm.fr	Treebak, Jonas Thue/B-4521-2017; Fentz, Joachim/B-1973-2015; Maire, Pascal/E-6339-2016; Viollet, Benoit/O-6927-2017; Wojtaszewski, Jørgen FP/P-6583-2014; Viollet, Benoit/N-2397-2019; FORETZ, Marc/O-7334-2017; ferry, arnaud/D-2816-2019	Treebak, Jonas Thue/0000-0003-1488-7012; Fentz, Joachim/0000-0002-9334-1298; Viollet, Benoit/0000-0002-0121-0224; Wojtaszewski, Jørgen FP/0000-0001-9785-6830; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; ferry, arnaud/0000-0002-6050-4556; Marette, Andre/0000-0003-3950-5973; wojtaszewski, jorgen/0000-0001-8185-3408; Ventura-Clapier, Renee/0000-0002-7488-4123; Maire, Pascal/0000-0001-7795-0029; Pehmoller, Christian/0000-0001-7102-7727	European Commission [LSHM-CT-2004-005272/EXGENESIS]; Agence Nationale de la Recherche (ANR); Association Francaise contre les Myopathies (AFM); Fondation pour la Recherche Medicale (FRM); Canadian Institutes for Health Research; Danish Council for Independent Research Medical Sciences (FSS); Novo Nordisk Foundation; University Paris Descartes; Danish Agency for Science, Technology, and Innovation; NNF Center for Basic Metabolic Research [Treebak Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0009315] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Danish Council for Independent Research Medical Sciences (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); University Paris Descartes; Danish Agency for Science, Technology, and Innovation; NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank G. Hardie (University of Dundee, Dundee, UK) for providing the anti-AMPK alpha 1 and anti-AMPK alpha 2 antibodies, J. Melki (INSERM U788, Paris, France) for kindly providing HSA-Cre transgenic mice for breeding, and A. Schmitt (Cochin Institute electron microscopy facility) for transmission electron micrographs. This work was supported by grants from the European Commission integrated project (LSHM-CT-2004-005272/EXGENESIS) and Agence Nationale de la Recherche (ANR) to B.V., Association Francaise contre les Myopathies (AFM) to B.V. and P.M., Fondation pour la Recherche Medicale (FRM) to R.V.C., and the Canadian Institutes for Health Research to A.M. Region Ile de France contributed to the Cochin Institute animal care facility. This work was also performed as a part of the program of the University of Southern Denmark (UNIK) program Food, Fitness, and Pharma for Health and Disease (http://www.foodfitnesspharma.ku.dk). The UNIK project is supported by the Danish Ministry of Science, Technology, and Innovation. The study was funded by the Danish Council for Independent Research Medical Sciences (FSS) and the Novo Nordisk Foundation. E.S.-A. was recipient of a Bourses Doctorales de Mobilite de l'Universite (BDMU) fellowship from University Paris Descartes. J.T.T. was supported by a postdoctoral fellowship from The Danish Agency for Science, Technology, and Innovation. R.V.C. is a senior scientist at CNRS.	Abbott MJ, 2011, J APPL PHYSIOL, V111, P125, DOI 10.1152/japplphysiol.00807.2010; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Athea Y, 2007, DIABETES, V56, P786, DOI 10.2337/db06-0187; Barre L, 2007, AM J PHYSIOL-ENDOC M, V292, pE802, DOI 10.1152/ajpendo.00369.2006; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Friedrichsen M, 2013, MOL CELL ENDOCRINOL, V366, P204, DOI 10.1016/j.mce.2012.06.013; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Hadj-Said W, 2012, MUSCLE NERVE, V45, P567, DOI 10.1002/mus.22332; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jensen TE, 2009, ACTA PHYSIOL, V196, P155, DOI 10.1111/j.1748-1716.2009.01979.x; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jensen TE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002102; Jeppesen J, 2013, DIABETES, V62, P1490, DOI 10.2337/db12-1160; Joanne P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035346; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Klein DK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1242, DOI 10.1152/ajpendo.00382.2007; Kristensen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053533; Larsen S, 2012, ACTA PHYSIOL, V205, P314, DOI 10.1111/j.1748-1716.2011.02399.x; Lee-Young RS, 2011, INT J OBESITY, V35, P982, DOI 10.1038/ijo.2010.220; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Lefort N, 2008, AM J PHYSIOL-ENDOC M, V295, pE1447, DOI 10.1152/ajpendo.90362.2008; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Maarbjerg SJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE924, DOI 10.1152/ajpendo.90653.2008; Mettaure B, 2001, J AM COLL CARDIOL, V38, P947, DOI 10.1016/S0735-1097(01)01460-7; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; MORGAN JE, 1990, J CELL BIOL, V111, P2437, DOI 10.1083/jcb.111.6.2437; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; O'Neill HM, 2013, DIABETES METAB J, V37, P1, DOI 10.4093/dmj.2013.37.1.1; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Roepstorff C, 2006, J PHYSIOL-LONDON, V574, P125, DOI 10.1113/jphysiol.2006.108720; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Scheffler TL, 2014, AM J PHYSIOL-CELL PH, V306, pC354, DOI 10.1152/ajpcell.00002.2013; Shinmura K, 2011, CIRC RES, V109, P396, DOI 10.1161/CIRCRESAHA.111.243097; Tanner CB, 2013, AM J PHYSIOL-ENDOC M, V305, pE1018, DOI 10.1152/ajpendo.00227.2013; Treebak JT, 2007, AM J PHYSIOL-ENDOC M, V292, pE715, DOI 10.1152/ajpendo.00380.2006; Treebak JT, 2014, J PHYSIOL-LONDON, V592, P351, DOI 10.1113/jphysiol.2013.266338; Treebak JT, 2009, AM J PHYSIOL-CELL PH, V297, pC1041, DOI 10.1152/ajpcell.00051.2009; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Vassilopoulos A, 2014, ANTIOXID REDOX SIGN, V21, P551, DOI 10.1089/ars.2013.5420; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	55	140	146	0	35	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3211	3224		10.1096/fj.14-250449	http://dx.doi.org/10.1096/fj.14-250449			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24652947				2022-12-25	WOS:000337949400041
J	Liu, CH; Sheng, JZ; Krahn, JM; Perera, L; Xu, YM; Hsieh, PH; Dou, WF; Liu, J; Pedersen, LC				Liu, Chunhui; Sheng, Juzheng; Krahn, Juno M.; Perera, Lalith; Xu, Yongmei; Hsieh, Po-Hung; Dou, Wenfang; Liu, Jian; Pedersen, Lars C.			Molecular Mechanism of Substrate Specificity for Heparan Sulfate 2-O-Sulfotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heparan Sulfate; Heparin; Heparin-binding Protein; Oligosaccharide; Sulfotransferase	3-O-SULFOTRANSFERASE; BIOSYNTHESIS; PROTEOGLYCANS; C-5-EPIMERASE; DIVERSITY; SYSTEM; MODE	Background: Sulfotransferases with distinct specificities act in sequence in the heparan sulfate biosynthetic pathway. Results: The crystal structure of 2-O-sulfotransferase with bound substrate reveals its requirements for substrate recognition. Conclusion: The 2-O-sulfotransferase recognizes N-sulfate but excludes 6-O-sulfate on substrates. Significance: The results advance the understanding of cellular control for the biosynthesis of heparan sulfate. Heparan sulfate (HS) is an abundant polysaccharide in the animal kingdom with essential physiological functions. HS is composed of sulfated saccharides that are biosynthesized through a complex pathway involving multiple enzymes. In vivo regulation of this process remains unclear. HS 2-O-sulfotransferase (2OST) is a key enzyme in this pathway. Here, we report the crystal structure of the ternary complex of 2OST, 3-phosphoadenosine 5-phosphate, and a heptasaccharide substrate. Utilizing site-directed mutagenesis and specific oligosaccharide substrate sequences, we probed the molecular basis of specificity and 2OST position in the ordered HS biosynthesis pathway. These studies revealed that Arg-80, Lys-350, and Arg-190 of 2OST interact with the N-sulfo groups near the modification site, consistent with the dependence of 2OST on N-sulfation. In contrast, 6-O-sulfo groups on HS are likely excluded by steric and electrostatic repulsion within the active site supporting the hypothesis that 2-O-sulfation occurs prior to 6-O-sulfation. Our results provide the structural evidence for understanding the sequence of enzymatic events in this pathway.	[Liu, Chunhui; Sheng, Juzheng; Xu, Yongmei; Hsieh, Po-Hung; Dou, Wenfang; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Liu, Chunhui; Sheng, Juzheng] Shandong Univ, Sch Pharmaceut Sci, Inst Biochem & Biotechnol Drug, Jinan 250012, Peoples R China; [Krahn, Juno M.; Perera, Lalith; Pedersen, Lars C.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Dou, Wenfang] Jiangnan Univ, Sch Pharmaceut Sci, Lab Pharmaceut Engn, Wuxi 214122, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; Shandong University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Jiangnan University	Liu, J (corresponding author), Univ N Carolina, Rm 303,Beard Hall, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu	Sheng, Juzheng/G-2693-2013; perera, Lalith/B-6879-2012; Perera, Lalith/ABB-9995-2021; Pedersen, Lars/C-6173-2019	Sheng, Juzheng/0000-0003-2856-9162; perera, Lalith/0000-0003-0823-1631; Pedersen, Lars/0000-0002-4488-4077	National Institutes of Health [GM102137, HL094463]; National Institutes of Health, NIEHS [ZIAES102645, ZICES043010-28]; China Scholarship Council; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM102137 and HL094463 and by the Intramural Research Program of the National Institutes of Health, NIEHS Project ZIAES102645 and ZICES043010-28 (to L. C. P.).; Supported by the China Scholarship Council.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Axelsson J, 2012, BLOOD, V120, P1742, DOI 10.1182/blood-2012-03-417139; Bethea HN, 2008, P NATL ACAD SCI USA, V105, P18724, DOI 10.1073/pnas.0806975105; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Case DA, 2012, AMBER 12; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Li JP, 2001, J BIOL CHEM, V276, P20069, DOI 10.1074/jbc.M011783200; Li K, 2010, J BIOL CHEM, V285, P11106, DOI 10.1074/jbc.M109.081059; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Linhardt RJ, 2003, J MED CHEM, V46, P2551, DOI 10.1021/jm030176m; Linhardt RJ, 2012, CURR OPIN PHARMACOL, V12, P217, DOI 10.1016/j.coph.2011.12.002; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; Liu J, 2012, CURR OPIN STRUC BIOL, V22, P550, DOI 10.1016/j.sbi.2012.07.004; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Moon AF, 2004, J BIOL CHEM, V279, P45185, DOI 10.1074/jbc.M405013200; Moon AF, 2012, P NATL ACAD SCI USA, V109, P5265, DOI 10.1073/pnas.1117923109; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Peterson S, 2012, J BIOL CHEM, V287, P34836, DOI 10.1074/jbc.M112.390161; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Shriver Z, 2004, NAT REV DRUG DISCOV, V3, P863, DOI 10.1038/nrd1521; Witt RM, 2013, J BIOL CHEM, V288, P26275, DOI 10.1074/jbc.M112.438937; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Zhang ZQ, 2008, J AM CHEM SOC, V130, P12998, DOI 10.1021/ja8026345	38	34	35	2	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13407	13418		10.1074/jbc.M113.530535	http://dx.doi.org/10.1074/jbc.M113.530535			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652287	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000335522800039
J	Moykkynen, T; Coleman, SK; Semenov, A; Keinanen, K				Moykkynen, Tommi; Coleman, Sarah K.; Semenov, Artur; Keinanen, Kari			The N-terminal Domain Modulates alpha-Amino-3-hydroxy-5methyl-4-isoxazolepropionic acid ( AMPA) Receptor Desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Ionotropic Glutamate Receptors (AMPA; NMDA); Ion Channels; Protein Domains; Receptor Desensitization; Receptor Structure-Function	IONOTROPIC GLUTAMATE-RECEPTOR; LIGAND-BINDING DOMAIN; NMDA RECEPTOR; QUATERNARY STRUCTURE; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; KAINATE RECEPTORS; ION CHANNELS; SUBUNIT; TRAFFICKING	Background: The function of the AMPA receptor N-terminal domain (NTD) is unknown. Results: Deletion of the NTD leads to reduced desensitization and surface expression of GluA1-4 AMPA receptors. Conclusion: The NTD has a strong influence on the function and biosynthetic maturation of AMPA receptors. Significance: The NTD has the potential to mediate allosteric regulation of AMPA receptor signaling. AMPA receptors are tetrameric glutamate-gated ion channels that mediate fast synaptic neurotransmission in mammalian brain. Their subunits contain a two-lobed N-terminal domain (NTD) that comprises over 40% of the mature polypeptide. The NTD is not obligatory for the assembly of tetrameric receptors, and its functional role is still unclear. By analyzing full-length and NTD-deleted GluA1-4 AMPA receptors expressed in HEK 293 cells, we found that the removal of the NTD leads to a significant reduction in receptor transport to the plasma membrane, a higher steady state-to-peak current ratio of glutamate responses, and strongly increased sensitivity to glutamate toxicity in cell culture. Further analyses showed that NTD-deleted receptors display both a slower onset of desensitization and a faster recovery from desensitization of agonist responses. Our results indicate that the NTD promotes the biosynthetic maturation of AMPA receptors and, for membrane-expressed channels, enhances the stability of the desensitized state. Moreover, these findings suggest that interactions of the NTD with extracellular/synaptic ligands may be able to fine-tune AMPA receptor-mediated responses, in analogy with the allosteric regulatory role demonstrated for the NTD of NMDA receptors.	[Moykkynen, Tommi; Coleman, Sarah K.; Semenov, Artur; Keinanen, Kari] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, FIN-00014 Helsinki, Finland	University of Helsinki	Keinanen, K (corresponding author), Univ Helsinki, Dept Biosci, POB 56 Viikinkaari 5, FIN-00014 Helsinki, Finland.	kari.keinanen@helsinki.fi		Coleman, Sarah/0000-0002-1066-8296	Academy of Finland [137596]; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation	This study was supported by Academy of Finland grant 137596 (to K. K.), by the Sigrid Juselius Foundation (to K. K.), and by the Magnus Ehrnrooth Foundation (to T. M. and S. K. C.).	Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Baranovic J, 2013, J BIOL CHEM, V288, P8647, DOI 10.1074/jbc.M112.422105; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; Chaudhry C, 2009, P NATL ACAD SCI USA, V106, P12329, DOI 10.1073/pnas.0904175106; Christie LA, 2010, P NATL ACAD SCI USA, V107, P9412, DOI 10.1073/pnas.0908206107; Clayton A, 2009, J MOL BIOL, V392, P1125, DOI 10.1016/j.jmb.2009.07.082; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; Coleman SK, 2010, J BIOL CHEM, V285, P36032, DOI 10.1074/jbc.M110.156943; Coleman SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008715; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; Coleman SK, 2003, J NEUROSCI, V23, P798; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Dutta A, 2012, STRUCTURE, V20, P1838, DOI 10.1016/j.str.2012.08.012; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Jensen MH, 2011, J MOL BIOL, V414, P96, DOI 10.1016/j.jmb.2011.09.037; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kumar J, 2011, NEURON, V71, P319, DOI 10.1016/j.neuron.2011.05.038; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Lee CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019180; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Matsuda S, 2005, J BIOL CHEM, V280, P20021, DOI 10.1074/jbc.M410513200; Midgett CR, 2008, J MOL BIOL, V382, P578, DOI 10.1016/j.jmb.2008.07.021; Midgett CR, 2012, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmol.2011.00056, 10.3389/fnmo1.2011.00056]; Nakagawa T, 2006, BIOL CHEM, V387, P179, DOI 10.1515/BC.2006.024; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Nakagawa T, 2010, MOL NEUROBIOL, V42, P161, DOI 10.1007/s12035-010-8149-x; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Shanks NF, 2010, J NEUROSCI, V30, P2728, DOI 10.1523/JNEUROSCI.5146-09.2010; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Sirrieh RE, 2013, J BIOL CHEM, V288, P22555, DOI 10.1074/jbc.M113.482356; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sukumaran M, 2012, ADV EXP MED BIOL, V970, P241, DOI 10.1007/978-3-7091-0932-8_11; Sukumaran M, 2011, EMBO J, V30, P972, DOI 10.1038/emboj.2011.17; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Walker CS, 2009, CURR BIOL, V19, P900, DOI 10.1016/j.cub.2009.05.017; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; Yao GR, 2011, BIOCHEM J, V438, P255, DOI 10.1042/BJ20110801; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	65	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13197	13205		10.1074/jbc.M113.526301	http://dx.doi.org/10.1074/jbc.M113.526301			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652293	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000335522800021
J	Peng, F; Xiao, XQ; Jiang, YF; Luo, KZ; Tian, Y; Peng, ML; Zhang, M; Xu, Y; Gong, GZ				Peng, Feng; Xiao, Xinqiang; Jiang, Yongfang; Luo, Kaizhong; Tian, Yi; Peng, Milin; Zhang, Min; Xu, Yun; Gong, Guozhong			HBx Down-Regulated Gld2 Plays a Critical Role in HBV-Related Dysregulation of miR-122	PLOS ONE			English	Article							LIPID-METABOLISM; VIRUS; EXPRESSION; MICRORNA; PROTEIN; STABILIZATION; REPLICATION; GENE	miR-122 is a liver-rich-specific microRNA that plays an important role in hepatic gene expression via post-transcription regulation, and it is potentially associated with the development of hepatocellular carcinoma. It has been confirmed that miR-122 is down-regulated during HBV infection; however, how HBV affects miR-122 is still debated. One research provided evidence that HBx could reduce the miR-122 transcription level, but the other insisted that HBV had no significant effect on miR-122 transcription level but reduce miR-122 level via binding and sequestering endogenous miR-122. It is determinate that Gld2 could increase the specific miRNA stabilization by monoadenylation which was a post-transcription regulation. In this study, we aimed to investigate the mechanism of HBV-induced reduction of miR-122 and examine whether Gld2 is involved in it. According to the results of a microRNA microarray, we found miR-122 was the most down-regulated microRNA in HepG2.2.15 compared to HepG2. As revealed by qRT-PCR and western blotting analyses, both miR-122 and Gld2 levels were reduced in hepatic cell lines with expression of HBV or HBx but not other proteins of HBV, and overexpression of Gld2 could abolish the effect of HBV and HBx on the miR-122 level. What's more, both HBV and HBx have no significant effect on pre-miR-122 levels. And the dual-luciferase assay implicated that HBx could reduce the Gld2 promoter activity but had no significant effect on miR-122 promoter activity. In conclusion, HBx is a critical protein derived from HBV, which regulates miR-122 via down-regulating Gld2.	[Peng, Feng; Xiao, Xinqiang; Jiang, Yongfang; Luo, Kaizhong; Tian, Yi; Peng, Milin; Zhang, Min; Xu, Yun; Gong, Guozhong] Cent South Univ, Xiangya Hosp 2, Dept Infect Dis, Changsha, Hunan, Peoples R China	Central South University	Gong, GZ (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Infect Dis, Changsha, Hunan, Peoples R China.	guozhonggong@yahoo.com			Chinese National Key Clinical Specialty Project [2013]; Chinese National Science and Technology Major Project [2008ZX10202]	Chinese National Key Clinical Specialty Project; Chinese National Science and Technology Major Project	This work was supported by grants from both the Chinese National Key Clinical Specialty Project (NO. 2013) and the Chinese National Science and Technology Major Project (NO. 2008ZX10202, http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Burns DM, 2011, NATURE, V473, P105, DOI 10.1038/nature09908; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; D'Ambrogio A, 2012, CELL REP, V2, P1537, DOI 10.1016/j.celrep.2012.10.023; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Glahder JA, 2011, APMIS, V119, P769, DOI 10.1111/j.1600-0463.2011.02804.x; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kutay H, 2011, J CELL BIOCHEM, V99, P671, DOI [10.1002/jcb.20982.Downregulation, DOI 10.1002/JCB.20982.D0WNREGULATI0N]; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; Li CF, 2013, J VIROL, V87, P2193, DOI 10.1128/JVI.02831-12; Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023; Lin CJF, 2008, BIOCHEM BIOPH RES CO, V375, P315, DOI 10.1016/j.bbrc.2008.07.154; Ma LN, 2010, CANCER BIOL THER, V9, P554, DOI 10.4161/cbt.9.7.11267; Maeda Y, 2006, BIOCHEM J, V400, P303, DOI 10.1042/BJ20060614; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Murakami S, 1999, INTERVIROLOGY, V42, P81, DOI 10.1159/000024969; Ren M, 2012, ANTIVIR RES, V94, P225, DOI 10.1016/j.antiviral.2012.04.004; Song K, 2013, HEPATOLOGY, V58, P1681, DOI 10.1002/hep.26514; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wen J, 2012, J CLIN INVEST, V122, P2773, DOI 10.1172/JCI63966	30	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92998	10.1371/journal.pone.0092998	http://dx.doi.org/10.1371/journal.pone.0092998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667324	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600121
J	Alwan, H; Pruijm, M; Ponte, B; Ackermann, D; Guessous, I; Ehret, G; Staessen, JA; Asayama, K; Vuistiner, P; Younes, SE; Paccaud, F; Wuerzner, G; Pechere-Bertschi, A; Mohaupt, M; Vogt, B; Martin, PY; Burnier, M; Bochud, M				Alwan, Heba; Pruijm, Menno; Ponte, Belen; Ackermann, Daniel; Guessous, Idris; Ehret, Georg; Staessen, Jan A.; Asayama, Kei; Vuistiner, Philippe; Younes, Sandrine Estoppey; Paccaud, Fred; Wuerzner, Gregoire; Pechere-Bertschi, Antoinette; Mohaupt, Markus; Vogt, Bruno; Martin, Pierre-Yves; Burnier, Michel; Bochud, Murielle			Epidemiology of Masked and White-Coat Hypertension: The Family-Based SKIPOGH Study	PLOS ONE			English	Article							BLOOD-PRESSURE-MEASUREMENT; ISOLATED OFFICE HYPERTENSION; 10-YEAR FOLLOW-UP; SUSTAINED HYPERTENSION; GENERAL-POPULATION; TRUE NORMOTENSION; HOME HYPERTENSION; EUROPEAN-SOCIETY; RISK-FACTORS; DETERMINANTS	Objective: We investigated factors associated with masked and white-coat hypertension in a Swiss population-based sample. Methods: The Swiss Kidney Project on Genes in Hypertension is a family-based cross-sectional study. Office and 24-hour ambulatory blood pressure were measured using validated devices. Masked hypertension was defined as office blood pressure<140/90 mmHg and daytime ambulatory blood pressure >= 135/85 mmHg. White-coat hypertension was defined as office blood pressure >= 140/90 mmHg and daytime ambulatory blood pressure<135/85 mmHg. Mixed-effect logistic regression was used to examine the relationship of masked and white-coat hypertension with associated factors, while taking familial correlations into account. High-normal office blood pressure was defined as systolic/diastolic blood pressure within the 130-139/85-89 mmHg range. Results: Among the 652 participants included in this analysis, 51% were female. Mean age (+/- SD) was 48 (+/- 18) years. The proportion of participants with masked and white coat hypertension was respectively 15.8% and 2.6%. Masked hypertension was associated with age (odds ratio (OR) = 1.02, p = 0.012), high-normal office blood pressure (OR = 6.68, p<0.001), and obesity (OR = 3.63, p = 0.001). White-coat hypertension was significantly associated with age (OR = 1.07, p<0 .001) but not with education, family history of hypertension, or physical activity. Conclusions: Our findings suggest that physicians should consider ambulatory blood pressure monitoring for older individuals with high-normal office blood pressure and/or who are obese.	[Alwan, Heba; Guessous, Idris; Vuistiner, Philippe; Younes, Sandrine Estoppey; Paccaud, Fred; Bochud, Murielle] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Pruijm, Menno; Wuerzner, Gregoire; Burnier, Michel] Univ Lausanne Hosp, Serv Nephrol, Lausanne, Switzerland; [Ponte, Belen; Martin, Pierre-Yves] Univ Hosp Geneva, Dept Specialties, Serv Nephrol, Geneva, Switzerland; [Ackermann, Daniel; Mohaupt, Markus; Vogt, Bruno] Univ Hosp Bern, Clin Nephrol Hypertens & Clin Pharmacol, Inselspital, CH-3010 Bern, Switzerland; [Ackermann, Daniel; Mohaupt, Markus; Vogt, Bruno] Univ Bern, Bern, Switzerland; [Guessous, Idris] Univ Hosp Geneva, Unit Populat Epidemiol, Geneva, Switzerland; [Ehret, Georg] Univ Hosp Geneva, Dept Cardiol, Geneva, Switzerland; [Staessen, Jan A.; Asayama, Kei] Univ Leuven, Studies Coordinating Ctr, Dept Cardiovasc Dis, Div Hypertens & Cardiovasc Rehabil, Louvain, Belgium; [Staessen, Jan A.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; [Asayama, Kei] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 980, Japan; [Pechere-Bertschi, Antoinette] Univ Hosp Geneva, Dept Community Med & Primary Care & Emergency Med, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Bern; University Hospital of Bern; University of Bern; University of Geneva; University of Geneva; KU Leuven; Maastricht University; Tohoku University; University of Geneva	Bochud, M (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	murielle.bochud@chuv.ch	EHRET, Georg B/A-9532-2009; Mohaupt, Markus/AAE-3368-2020; Pruijm, Menno/AAA-4281-2020; Vogt, Bruno/AAS-2876-2020; Bochud, Murielle/A-3981-2010; paccaud, fred/M-7516-2019; Staessen, Jan A/A-1065-2011; Asayama, Kei/H-5598-2011; Vuistiner, Philippe/AAD-5010-2020	EHRET, Georg B/0000-0002-5730-0675; Pruijm, Menno/0000-0003-1027-1851; Vogt, Bruno/0000-0002-1548-6387; Bochud, Murielle/0000-0002-5727-0218; Staessen, Jan A/0000-0002-3026-1637; Asayama, Kei/0000-0003-3365-0547; Ackermann, Daniel/0000-0003-0550-354X; Alwan, Heba/0000-0001-5516-6022; Vuistiner, Philippe/0000-0002-2661-4970; Wuerzner, Gregoire/0000-0002-6424-7630	Swiss National Science Foundation [FN 33CM30-124087, FN 33CM30-140331]; Swiss School of Public Health Plus	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss School of Public Health Plus	The study is supported by the Swiss National Science Foundation FN 33CM30-124087 and FN 33CM30-140331, with specific funding for Daniel Ackermann, Heba Alwan, Georg Ehret, Idris Guessous, Belen Ponte, and Menno Pruijm. Murielle Bochud was supported by the Swiss School of Public Health Plus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli F, 2010, AM J HYPERTENS, V23, P941, DOI 10.1038/ajh.2010.112; Bidlingmeyer I, 1996, J HYPERTENS, V14, P327, DOI 10.1097/00004872-199603000-00009; Bjorklund K, 2003, CIRCULATION, V107, P1297, DOI 10.1161/01.CIR.0000054622.45012.12; Bobrie G, 2001, ARCH INTERN MED, V161, P2205, DOI 10.1001/archinte.161.18.2205; Bobrie G, 2008, J HYPERTENS, V26, P1715, DOI 10.1097/HJH.0b013e3282fbcedf; Cacciolati C, 2013, AM J HYPERTENS, V26, P367, DOI 10.1093/ajh/hps054; Cacciolati C, 2011, AM J HYPERTENS, V24, P674, DOI 10.1038/ajh.2011.23; Fagard RH, 2007, J HYPERTENS, V25, P2280, DOI 10.1097/HJH.0b013e3282efc1fe; Fagard RH, 2007, J HYPERTENS, V25, P2193, DOI 10.1097/HJH.0b013e3282ef6185; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Grassi G, 2007, HYPERTENSION, V50, P537, DOI 10.1161/HYPERTENSIONAHA.107.092528; Guessous I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039877; Gustavsen PH, 2003, J HUM HYPERTENS, V17, P811, DOI 10.1038/sj.jhh.1001643; Hanninen MRA, 2011, J HYPERTENS, V29, P1880, DOI 10.1097/HJH.0b013e32834a98ba; Hanninen MRA, 2010, J HYPERTENS, V28, P709, DOI 10.1097/HJH.0b013e3283369faa; Hansen TW, 2006, AM J HYPERTENS, V19, P243, DOI 10.1016/j.amjhyper.2005.09.018; Kuznetsova T, 2002, BLOOD PRESS MONIT, V7, P215, DOI 10.1097/00126097-200208000-00003; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mancia G, 2011, NAT REV CARDIOL, V8, P686, DOI 10.1038/nrcardio.2011.115; Mancia G, 2009, HYPERTENSION, V54, P226, DOI 10.1161/HYPERTENSIONAHA.109.129882; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; O'Brien E, 2001, BMJ-BRIT MED J, V322, P531, DOI 10.1136/bmj.322.7285.531; Obara T, 2005, J HYPERTENS, V23, P1653, DOI 10.1097/01.hjh.0000178334.33352.56; Ohkubo T, 2005, J AM COLL CARDIOL, V46, P508, DOI 10.1016/j.jacc.2005.03.070; Pickering TG, 2002, HYPERTENSION, V40, P795, DOI 10.1161/01.HYP.0000038733.08436.98; Ponte B, 2013, HYPERTENSION; Pruijm M, 2013, EUR RADIOL, V23, P2899, DOI 10.1007/s00330-013-2900-4; Pruijm MT, 2010, BLOOD PRESS MONIT, V15, P322, DOI 10.1097/MBP.0b013e32833f56a8; Sarafidis PA, 2008, AM J NEPHROL, V28, P324, DOI 10.1159/000111825; Schoenthaler AM, 2010, AM J HYPERTENS, V23, P1082, DOI 10.1038/ajh.2010.141; Sega R, 2001, CIRCULATION, V104, P1385, DOI 10.1161/hc3701.096100; Sehestedt T, 2012, J HYPERTENS, V30, P513, DOI 10.1097/HJH.0b013e32834f6f60; Shimbo D, 2012, AM J HYPERTENS, V25, P664, DOI 10.1038/ajh.2012.15; Stergiou GS, 2008, BLOOD PRESS MONIT, V13, P37, DOI 10.1097/MBP.0b013e3282c9acb0; Stergiou GS, 2007, J HYPERTENS, V25, P1590, DOI 10.1097/HJH.0b013e3281ab6c69; Trudel X, 2009, J HYPERTENS, V27, P1560, DOI 10.1097/HJH.0b013e32832cb036; Verdecchia P, 2005, HYPERTENSION, V45, P203, DOI 10.1161/01.HYP.0000151623.49780.89; Wang GL, 2007, J HYPERTENS, V25, P2398, DOI 10.1097/HJH.0b013e3282efeee7; Winnicki M, 1997, AM J HYPERTENS, V10, P419	41	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92522	10.1371/journal.pone.0092522	http://dx.doi.org/10.1371/journal.pone.0092522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663506	gold, Green Published			2022-12-25	WOS:000333459900070
J	Amann, A; Zwierzina, M; Gamerith, G; Bitsche, M; Huber, JM; Vogel, GF; Blumer, M; Koeck, S; Pechriggl, EJ; Kelm, JM; Hilbe, W; Zwierzina, H				Amann, Arno; Zwierzina, Marit; Gamerith, Gabriele; Bitsche, Mario; Huber, Julia M.; Vogel, Georg F.; Blumer, Michael; Koeck, Stefan; Pechriggl, Elisabeth J.; Kelm, Jens M.; Hilbe, Wolfgang; Zwierzina, Heinz			Development of an Innovative 3D Cell Culture System to Study Tumour - Stroma Interactions in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; FIBROBLASTS; SPHEROIDS; THERAPY; ACTIVATION; GENERATION; BIOLOGY; GROWTH	Introduction: We describe a novel 3D co-culture model using non-small cell lung cancer (NSCLC) cell lines in combination with lung fibroblasts. This model allows the investigation of tumour-stroma interactions and addresses the importance of having a more in vivo like cell culture model. Methods: Automation-compatible multi-well hanging drop microtiter plates were used for the production of 3D mono-and co-cultures. In these hanging drops the two NSCLC cell lines A549 and Colo699 were cultivated either alone or co-cultured with lung fibroblasts. The viability of tumour spheroids was confirmed after five and ten days by using Annexin V/Propidium Iodide staining for flow-cytometry. Tumour fibroblast spheroid formation was characterized by scanning electron microscope (SEM), semi-thin sections, fluorescence microscope and immunohistochemistry (IHC). In addition to conventional histology, protein expression of E-Cadherin, vimentin, Ki67, fibronectin, cytokeratin 7 and alpha-smooth muscle actin (alpha-SMA) was investigated by IHC. Results: Lower viability was observed in A549 monocultures compared to co-cultures, whereas Colo699 monocultures showed better viability compared to co-cultures. Ki67 expression varied significantly between mono-and co-cultures in both tumour cell lines. An increase of vimentin and decreased E-Cadherin expression could be detected during the course of the cultivation suggesting a transition to a more mesenchymal phenotype. Furthermore, the fibroblast cell line showed an expression of a-SMA only in co-culture with the cancer cell line A549, thereby indicating a mesenchymal to mesenchymal shift to an even more myofibroblast phenotype. Conclusion: We demonstrate that our method is a promising tool for the generation of tumour spheroid co-cultures. Furthermore, these spheroids allow the investigation of tumour-stroma interactions and a better reflection of in vivo conditions of cancer cells in their microenvironment. Our method holds potential to contribute to the development of anti-cancer agents and support the search for biomarkers.	[Amann, Arno; Gamerith, Gabriele; Huber, Julia M.; Koeck, Stefan; Hilbe, Wolfgang; Zwierzina, Heinz] Med Univ Innsbruck, Dept Internal Med 5, A-6020 Innsbruck, Tyrol, Austria; [Zwierzina, Marit; Bitsche, Mario; Vogel, Georg F.; Blumer, Michael; Pechriggl, Elisabeth J.] Med Univ Innsbruck, Dept Anat Histol & Embryol, A-6020 Innsbruck, Tyrol, Austria; [Kelm, Jens M.] InSphero AG, Schlieren, Canton Of Zuric, Switzerland	Medical University of Innsbruck; Medical University of Innsbruck; InSphero AG	Amann, A (corresponding author), Med Univ Innsbruck, Dept Internal Med 5, A-6020 Innsbruck, Tyrol, Austria.	arno.amann@i-med.ac.at		Vogel, Georg-Friedrich/0000-0002-2515-4490	Austrian Society of Haematology and Oncology (OeGHO); Verein fur Tumorfoschung	Austrian Society of Haematology and Oncology (OeGHO); Verein fur Tumorfoschung	This work was funded by means of a Ph.D grant of the Austrian Society of Haematology and Oncology (OeGHO) and further financially supported by the Verein fur Tumorfoschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Arteaga CL, 2003, BREAST CANCER RES, V5, P96, DOI 10.1186/bcr574; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Botchkina GI, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-192; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Dacic S, 2011, ARCH PATHOL LAB MED, V135, P622, DOI 10.1043/2010-0625-RAIR.1; Drewitz M, 2011, BIOTECHNOL J, V6, P1488, DOI 10.1002/biot.201100290; Dudas J, 2011, EXP CELL RES, V317, P2222, DOI 10.1016/j.yexcr.2011.05.023; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; Forde PM, 2012, EXPERT OPIN PHARMACO, V13, P1195, DOI 10.1517/14656566.2012.688029; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hazlehurst LA, 2000, ONCOGENE, V19, P4319, DOI 10.1038/sj.onc.1203782; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hess MW, 2010, METHOD CELL BIOL, V96, P649, DOI 10.1016/S0091-679X(10)96027-5; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kelm JM, 2004, TRENDS BIOTECHNOL, V22, P195, DOI 10.1016/j.tibtech.2004.02.002; Kerbel R S, 1996, Hum Cell, V9, P257; Khaitan D, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-12; Kotsakis A, 2010, EXPERT OPIN PHARMACO, V11, P2363, DOI 10.1517/14656566.2010.498581; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pearson Rachel, 2012, J Oncol Pharm Pract, V18, P271, DOI 10.1177/1078155211417477; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seemayer CA, 2003, AM J PATHOL, V162, P1549, DOI 10.1016/S0002-9440(10)64289-7; Subramanian J, 2010, J THORAC ONCOL, V5, P1116, DOI 10.1097/JTO.0b013e3181e76159; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; WOBUS AM, 1991, DIFFERENTIATION, V48, P173, DOI 10.1111/j.1432-0436.1991.tb00255.x	33	116	119	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92511	10.1371/journal.pone.0092511	http://dx.doi.org/10.1371/journal.pone.0092511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663399	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900068
J	Cambien, B; Franken, PR; Lamit, A; Mauxion, T; Richard-Fiardo, P; Guglielmi, J; Crescence, L; Mari, B; Pourcher, T; Darcourt, J; Bardies, M; Vassaux, G				Cambien, Beatrice; Franken, Philippe R.; Lamit, Audrey; Mauxion, Thibault; Richard-Fiardo, Peggy; Guglielmi, Julien; Crescence, Lydie; Mari, Bernard; Pourcher, Thierry; Darcourt, Jacques; Bardies, Manuel; Vassaux, Georges			(TcO4-)-Tc-99m-, Auger-Mediated Thyroid Stunning: Dosimetric Requirements and Associated Molecular Events	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; CELLS IN-VITRO; INTRACELLULAR UPTAKE; CLONOGENIC SURVIVAL; RADIONUCLIDE THERAPY; SIMULATION TOOLKIT; GENE-EXPRESSION; POSITIVE CELLS; BREAST-CANCER; DNA-DAMAGE	Low-energy Auger and conversion electrons deposit their energy in a very small volume (a few nm(3)) around the site of emission. From a radiotoxicological point of view the effects of low-energy electrons on normal tissues are largely unknown, understudied, and generally assumed to be negligible. In this context, the discovery that the low-energy electron emitter, Tc-99m, can induce stunning on primary thyrocytes in vitro, at low absorbed doses, is intriguing. Extrapolated in vivo, this observation suggests that a radioisotope as commonly used in nuclear medicine as Tc-99m may significantly influence thyroid physiology. The aims of this study were to determine whether Tc-99m pertechnetate ((TcO4-)-Tc-99m) is capable of inducing thyroid stunning in vivo, to evaluate the absorbed dose of (TcO4-)-Tc-99m required to induce this stunning, and to analyze the biological events associated/concomitant with this effect. Our results show that (TcO4-)-Tc-99m-mediated thyroid stunning can be observed in vivo in mouse thyroid. The threshold of the absorbed dose in the thyroid required to obtain a significant stunning effect is in the range of 20 Gy. This effect is associated with a reduced level of functional Na/I symporter (NIS) protein, with no significant cell death. It is reversible within a few days. At the cellular and molecular levels, a decrease in NIS mRNA, the generation of double-strand DNA breaks, and the activation of the p53 pathway are observed. Low-energy electrons emitted by Tc-99m can, therefore, induce thyroid stunning in vivo in mice, if it is exposed to an absorbed dose of at least 20 Gy, a level unlikely to be encountered in clinical practice. Nevertheless this report presents an unexpected effect of low-energy electrons on a normal tissue in vivo, and provides a unique experimental setup to understand the fine molecular mechanisms involved in their biological effects.	[Cambien, Beatrice; Franken, Philippe R.; Lamit, Audrey; Richard-Fiardo, Peggy; Guglielmi, Julien; Crescence, Lydie; Pourcher, Thierry; Darcourt, Jacques; Vassaux, Georges] CEA, DSV, iBEB, Lab TIRO,UMRE 4320, Nice, France; [Cambien, Beatrice; Franken, Philippe R.; Lamit, Audrey; Richard-Fiardo, Peggy; Guglielmi, Julien; Crescence, Lydie; Mari, Bernard; Pourcher, Thierry; Darcourt, Jacques; Vassaux, Georges] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Cambien, Beatrice; Franken, Philippe R.; Lamit, Audrey; Richard-Fiardo, Peggy; Guglielmi, Julien; Crescence, Lydie; Pourcher, Thierry; Darcourt, Jacques; Vassaux, Georges] Ctr Antoine Lacassagne, Dept Nucl Med, F-06054 Nice, France; [Mauxion, Thibault; Bardies, Manuel] Ctr Rech Cancerol, UMR INSERM UPS 1037, Toulouse, France; [Mari, Bernard] CNRS UMR 7275, Inst Pharmacol Mol & Cellulaire IPMC, Sophia Antipolis, France	CEA; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur	Cambien, B (corresponding author), CEA, DSV, iBEB, Lab TIRO,UMRE 4320, Nice, France.	cambien@unice.fr	Mari, Bernard P/GVS-3100-2022; Cambien, Béatrice/AAD-8973-2021; Vassaux, Georges/N-9724-2016; Mari, Bernard/Q-5832-2019; Mari, Bernard P/D-7445-2015; Mari, Bernard P/F-8960-2013; Bardies, Manuel/L-3136-2014	Mari, Bernard P/0000-0002-0422-9182; Cambien, Béatrice/0000-0002-6914-0525; Vassaux, Georges/0000-0002-1149-7716; Mari, Bernard/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Bardies, Manuel/0000-0002-1766-727X; Pourcher, Thierry/0000-0003-2839-4622	"Agence Nationale de la Recherche'' (ANR)	"Agence Nationale de la Recherche'' (ANR)(French National Research Agency (ANR))	This work is supported by grants from the "Agence Nationale de la Recherche'' (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Allman KC, 2003, J NUCL MED, V44, P1194; Association NEM, 2007, PERF MEAS GAMM CAM; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; Barton KN, 2011, MOL THER, V19, P1353, DOI 10.1038/mt.2011.89; BLOOMER WD, 1977, NATURE, V265, P620, DOI 10.1038/265620a0; Brenner W, 2002, J NUCL MED, V43, P835; Cornelissen B, 2011, J NUCL MED, V52, P776, DOI 10.2967/jnumed.110.084392; Cornelissen Bart, 2010, Curr Drug Discov Technol, V7, P263, DOI 10.2174/157016310793360657; Costantini DL, 2007, J NUCL MED, V48, P1357, DOI 10.2967/jnumed.106.037937; Cristy M., 1987, REPORT ORNLTM 8381; Eckerman KF, 2008, MIRD RADIONUCLIDE DA; Freudenberg R, 2012, INT J RADIAT BIOL, V88, P991, DOI 10.3109/09553002.2012.728303; Ginj M, 2005, CLIN CANCER RES, V11, P1136; Huc-Brandt S, 2011, BBA-BIOMEMBRANES, V1808, P65, DOI 10.1016/j.bbamem.2010.08.013; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Jan S, 2011, PHYS MED BIOL, V56, P881, DOI 10.1088/0031-9155/56/4/001; Kassis AI, 2011, RADIAT PROT DOSIM, V143, P241, DOI 10.1093/rpd/ncq385; Kotzerke J, 2012, NUKLEARMED-NUCL MED, V51, P170, DOI 10.3413/Nukmed-0506-12-05; Le Brigand K, 2007, BIOINFORMATICS, V23, P1304, DOI 10.1093/bioinformatics/btm106; Leoni SG, 2011, MOL ENDOCRINOL, V25, P1924, DOI 10.1210/me.2011-0038; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Loevinger R, 1991, MIRD PRIMER ABSORBED; Lundh C, 2007, J NUCL MED, V48, P481; Lundh C, 2009, J NUCL MED, V50, P1161, DOI 10.2967/jnumed.108.061150; Mariotti LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079541; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; McDougall IR, 2011, SEMIN NUCL MED, V41, P105, DOI 10.1053/j.semnuclmed.2010.10.004; Medvedec M, 2001, J NUCL MED, V42, P1129; Meller B, 2008, EUR J NUCL MED MOL I, V35, P1204, DOI 10.1007/s00259-007-0666-0; Merron A, 2010, EUR J NUCL MED MOL I, V37, P1377, DOI 10.1007/s00259-009-1379-3; MOORE FD, 1982, P NATL ACAD SCI-BIOL, V79, P3556, DOI 10.1073/pnas.79.11.3556; Norden MM, 2007, CANCER RES, V67, P7512, DOI 10.1158/0008-5472.CAN-07-0823; Paquet F, 2013, J RADIOL PROT, V33, pR1, DOI 10.1088/0952-4746/33/1/R1; Peerlinck I, 2009, CLIN CANCER RES, V15, P6595, DOI 10.1158/1078-0432.CCR-09-0262; Peyrottes I, 2009, EUR J ENDOCRINOL, V160, P215, DOI 10.1530/EJE-08-0505; Postgard P, 2002, J NUCL MED, V43, P828; Reilly RM, 2000, J NUCL MED, V41, P429; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Richard-Fiardo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034086; Richard-Fiardo P, 2011, EXPERT OPIN BIOL TH, V11, P1273, DOI 10.1517/14712598.2011.588596; Rudqvist N, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-32; Segars WP, 2004, MOL IMAGING BIOL, V6, P149, DOI 10.1016/j.mibio.2004.03.002; Sisson JC, 2006, J NUCL MED, V47, P1406; Tran L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062191; Wendisch M, 2010, NUKLEARMED-NUCL MED, V49, P154, DOI 10.3413/nukmed-0300; Wunderlich G, 2012, NUKLEARMED-NUCL MED, V51, P179, DOI 10.3413/Nukmed-0450-11-12; Zuckier LS, 2004, J NUCL MED, V45, P500	48	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92729	10.1371/journal.pone.0092729	http://dx.doi.org/10.1371/journal.pone.0092729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663284	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900105
J	Levin, AM; Iannuzzi, MC; Montgomery, CG; Trudeau, S; Datta, I; Adrianto, I; Chitale, DA; McKeigue, P; Rybicki, BA				Levin, Albert M.; Iannuzzi, Michael C.; Montgomery, Courtney G.; Trudeau, Sheri; Datta, Indrani; Adrianto, Indra; Chitale, Dhananjay A.; McKeigue, Paul; Rybicki, Benjamin A.			Admixture Fine-Mapping in African Americans Implicates XAF1 as a Possible Sarcoidosis Risk Gene	PLOS ONE			English	Article							X-LINKED INHIBITOR; LOCUS; EXPRESSION; APOPTOSIS; INFERENCE; FAMILY; SUSCEPTIBILITY; ASSOCIATIONS	Sarcoidosis is a complex, multi-organ granulomatous disease with a likely genetic component. West African ancestry confers a higher risk for sarcoidosis than European ancestry. Admixture mapping provides the most direct method to locate genes that underlie such ethnic variation in disease risk. We sought to identify genetic risk variants within four previously-identified ancestry-associated regions-6p24.3-p12.1, 17p13.3-13.1, 2p13.3-q12.1, and 6q23.3-q25.2-in a sample of 2,727 African Americans. We used logistic regression fit by generalized estimating equations and the MIX score statistic to determine which variants within ancestry-associated regions were associated with risk and responsible for the admixture signal. Fine mapping was performed by imputation, based on a previous genome-wide association study; significant variants were validated by direct genotyping. Within the 6p24.3-p12.1 locus, the most significant ancestry-adjusted SNP was rs74318745 (p = 9.4* 10(-11)), an intronic SNP within the HLA-DRA gene that did not solely explain the admixture signal, indicating the presence of more than a single risk variant within this well-established sarcoidosis risk region. The locus on chromosome 17p13.3-13.1 revealed a novel sarcoidosis risk SNP, rs6502976 (p = 9.5* 10(-6)), within intron 5 of the gene X-linked Inhibitor of Apoptosis Associated Factor 1 (XAF1) that accounted for the majority of the admixture linkage signal. Immunohistochemical expression studies demonstrated lack of expression of XAF1 and a corresponding high level of expression of its downstream target, X-linked Inhibitor of Apoptosis (XIAP) in sarcoidosis granulomas. In conclusion, ancestry and association fine mapping revealed a novel sarcoidosis susceptibility gene, XAF1, which has not been identified by previous genome-wide association studies. Based on the known biology of the XIAP/XAF1 apoptosis pathway and the differential expression patterns of XAF1 and XIAP in sarcoidosis granulomas, we suggest that this pathway may play a role in the maintenance of sarcoidosis granulomas.	[Levin, Albert M.; Trudeau, Sheri; Datta, Indrani; Rybicki, Benjamin A.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Iannuzzi, Michael C.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Montgomery, Courtney G.; Adrianto, Indra] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Chitale, Dhananjay A.] Henry Ford Hlth Syst, Dept Pathol, Detroit, MI USA; [McKeigue, Paul] Univ Edinburgh, Sch Med, Publ Hlth Sci Sect, Edinburgh, Midlothian, Scotland	Henry Ford Health System; Henry Ford Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Oklahoma Medical Research Foundation; Henry Ford Health System; Henry Ford Hospital; University of Edinburgh	Rybicki, BA (corresponding author), Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI 48202 USA.	brybick1@hfhs.org	Rybicki, Benjamin/L-4614-2019; Adrianto, Indra/D-4214-2013	Rybicki, Benjamin/0000-0003-3190-3467; Adrianto, Indra/0000-0002-9973-3057; Chitale, Dhananjay/0000-0002-4421-6431; Montgomery, Courtney/0000-0002-9606-3772	National Institutes of Health [R56-AI072727, R01-HL092576, R01-HL54306, U01-HL060263, 1RC2HL101499, R01HL113326, P20GM103456]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101499, U01HL060263, R01HL054306, R01HL113326, R01HL092576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant funding sources included National Institutes of Health grant numbers: R56-AI072727 and R01-HL092576 (BAR); R01-HL54306, U01-HL060263 (MCI), 1RC2HL101499, R01HL113326 (CGM); P20GM103456 (IA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrianto I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043907; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P736; Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Baughman RP, 1999, J CLIN EPIDEMIOL, V52, P1173; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; EDMONDSTONE WM, 1985, BRIT J DIS CHEST, V79, P27, DOI 10.1016/0007-0971(85)90004-X; Facco M, 2011, THORAX, V66, P144, DOI 10.1136/thx.2010.140319; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Iannuzzi MC, 2003, AM J RESP CRIT CARE, V167, P1225, DOI 10.1164/rccm.200209-1097OC; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Johns CJ, 1986, MED SECT P, P19; Judson MA, 2003, SARCOIDOSIS VASC DIF, V20, P204; Kunitake R, 1999, EUR RESPIR J, V13, P1329, DOI 10.1183/09031936.99.13613389; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lee YH, 2012, MOL BIOL REP; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Ludes-Meyers JH, 2003, CYTOGENET GENOME RES, V100, P101, DOI 10.1159/000072844; Lynch JP, 2003, SEMIN RESP CRIT CARE, V24, P393; MANA J, 1995, THORAX, V50, P1264, DOI 10.1136/thx.50.12.1264; Manichaikul A, 2012, PLOS GENET, V8, P285, DOI 10.1371/journal.pgen.1002640; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McKeigue PM, 2013, GENET EPIDEMIOL, V37, P256, DOI 10.1002/gepi.21710; McKeigue PM, 2013, GENET EPIDEMIOL; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nonas SA, 2007, AM J PHYSIOL-LUNG C, V293, pL292, DOI 10.1152/ajplung.00481.2006; Park MS, 2012, AM J RESP CRIT CARE, V186, P72, DOI 10.1164/rccm.201109-1593OC; Pasaniuc B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001371; Pasaniuc B, 2009, BIOINFORMATICS, V25, pI213, DOI 10.1093/bioinformatics/btp197; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rasmussen A, 2011, RHEUMATOLOGY, V50, P47, DOI 10.1093/rheumatology/keq302; Reich JM, 2002, CHEST, V121, P32, DOI 10.1378/chest.121.1.32; Rybicki BA, 2011, GENES IMMUN, V12, P67, DOI 10.1038/gene.2010.56; Rybicki BA, 2005, SARCOIDOSIS VASC DIF, V22, P115; Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096; Sankararaman S, 2008, GENOME RES, V18, P668, DOI 10.1101/gr.072751.107; SCADDING JG, 1961, BRIT MED J, V2, P1165, DOI 10.1136/bmj.2.5261.1165; Shikuwa C, 2002, RESPIRATION, V69, P242, DOI 10.1159/000063627; Smith DI, 1998, INT J ONCOL, V12, P187; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Straszewski-Chavez SL, 2007, J BIOL CHEM, V282, P13059, DOI 10.1074/jbc.M609038200; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang L, 2013, HUM MOL GENET; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zhang KX, 2005, BIOL REPROD, V73, P1064, DOI 10.1095/biolreprod.105.041889	62	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92646	10.1371/journal.pone.0092646	http://dx.doi.org/10.1371/journal.pone.0092646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663488	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900089
J	Ning, PG; Zhu, SC; Shi, DP; Guo, Y; Sun, MH				Ning, Peigang; Zhu, Shaocheng; Shi, Dapeng; Guo, Ying; Sun, Minghua			X-Ray Dose Reduction in Abdominal Computed Tomography Using Advanced Iterative Reconstruction Algorithms	PLOS ONE			English	Article							IMPROVED IMAGE QUALITY; CT; FEASIBILITY; PHANTOM	Objective: This work aims to explore the effects of adaptive statistical iterative reconstruction (ASiR) and model-based iterative reconstruction (MBIR) algorithms in reducing computed tomography (CT) radiation dosages in abdominal imaging. Methods: CT scans on a standard male phantom were performed at different tube currents. Images at the different tube currents were reconstructed with the filtered back-projection (FBP), 50% ASiR and MBIR algorithms and compared. The CT value, image noise and contrast-to-noise ratios (CNRs) of the reconstructed abdominal images were measured. Volumetric CT dose indexes (CTDIvol) were recorded. Results: At different tube currents, 50% ASiR and MBIR significantly reduced image noise and increased the CNR when compared with FBP. The minimal tube current values required by FBP, 50% ASiR, and MBIR to achieve acceptable image quality using this phantom were 200, 140, and 80 mA, respectively. At the identical image quality, 50% ASiR and MBIR reduced the radiation dose by 35.9% and 59.9% respectively when compared with FBP. Conclusions: Advanced iterative reconstruction techniques are able to reduce image noise and increase image CNRs. Compared with FBP, 50% ASiR and MBIR reduced radiation doses by 35.9% and 59.9%, respectively.	[Ning, Peigang; Zhu, Shaocheng; Shi, Dapeng; Guo, Ying; Sun, Minghua] Henan Prov Peoples Hosp, Dept Radiol, Zhengzhou, Henan, Peoples R China	Zhengzhou University	Zhu, SC (corresponding author), Henan Prov Peoples Hosp, Dept Radiol, Zhengzhou, Henan, Peoples R China.	zsc2686@163.com						Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Husarik DB, 2012, INVEST RADIOL, V47, P468, DOI 10.1097/RLI.0b013e318251eafd; ICRP, 1990, ANN ICRP, V55, DOI [10.1177/ANIB_20_4, DOI 10.1177/ANIB_20_4]; ICRP, 1990, ICRP PUBL, V55; IMV, 2006, IMV 2006 CT MARK SUM; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Launders Jason, 2011, Biomed Instrum Technol, V45, P453, DOI 10.2345/0899-8205-45.6.453; Leipsic J, 2010, AM J ROENTGENOL, V195, P649, DOI 10.2214/AJR.10.4285; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; McCollough CH, 2009, RADIOL CLIN N AM, V47, P27, DOI 10.1016/j.rcl.2008.10.006; Mieville FA, 2013, PHYS MEDICA, V29, P99, DOI 10.1016/j.ejmp.2011.12.004; Min James K, 2009, J Cardiovasc Comput Tomogr, V3, P246, DOI 10.1016/j.jcct.2009.06.006; Nelson RC, 2011, J CARDIOVASC COMPUT, V5, P286, DOI 10.1016/j.jcct.2011.07.001; Prakash P, 2010, INVEST RADIOL, V45, P202, DOI 10.1097/RLI.ob013e3181dzfeec; Schindera ST, 2011, RADIOLOGY, V260, P454, DOI 10.1148/radiol.11102217; Silva AC, 2010, AM J ROENTGENOL, V194, P191, DOI 10.2214/AJR.09.2953; Singh S, 2012, J COMPUT ASSIST TOMO, V36, P347, DOI 10.1097/RCT.0b013e31824e639e; Singh S, 2010, RADIOLOGY, V257, P373, DOI 10.1148/radiol.10092212; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; Vorona GA, 2011, PEDIATR RADIOL, V41, P1174, DOI 10.1007/s00247-011-2063-x; Wang G, 2008, MED PHYS, V35, P1051, DOI 10.1118/1.2836950	23	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92568	10.1371/journal.pone.0092568	http://dx.doi.org/10.1371/journal.pone.0092568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664174	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900077
J	Sasi, SP; Bae, S; Song, J; Perepletchikov, A; Schneider, D; Carrozza, J; Yan, XH; Kishore, R; Enderling, H; Goukassian, DA				Sasi, Sharath P.; Bae, Sanggyu; Song, Jin; Perepletchikov, Aleksandr; Schneider, Douglas; Carrozza, Joseph; Yan, Xinhua; Kishore, Raj; Enderling, Heiko; Goukassian, David A.			Therapeutic Non-Toxic Doses of TNF Induce Significant Regression in TNFR2-p75 Knockdown Lewis Lung Carcinoma Tumor Implants	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RECEIVING CONCOMITANT METHOTREXATE; ISOLATED LIMB PERFUSION; MONOCLONAL-ANTIBODY; RECEPTOR; EXPRESSION; P75; ETANERCEPT; P55; INHIBITION	Tumor necrosis factor-alpha (TNF) binds to two receptors: TNFR1/p55-cytotoxic and TNFR2/p75-pro-survival. We have shown that tumor growth in p75 knockout (KO) mice was decreased more than 2-fold in Lewis lung carcinoma (LLCs). We hypothesized that selective blocking of TNFR2/p75 LLCs may sensitize them to TNF-induced apoptosis and affect the tumor growth. We implanted intact and p75 knockdown (KD)-LLCs (>90%, using shRNA) into wild type (WT) mice flanks. On day 8 post-inoculation, recombinant murine (rm) TNF-alpha(12.5 ng/gr of body weight) or saline was injected twice daily for 6 days. Tumor volumes (tV) were measured daily and tumor weights (tW) on day 15, when study was terminated due to large tumors in LLC+TNF group. Tubular bones, spleens and peripheral blood (PB) were examined to determine possible TNF toxicity. There was no significant difference in tV or tW between LLC minus (-) TNF and p75KD/LLC-TNF tumors. Compared to 3 control groups, p75KD/LLC+TNF showed >2-5-fold decreases in tV (p<0.001) and tW (p<0.0001). There was no difference in tV or tW end of study vs. before injections in p75KD/LLC+TNF group. In 3 other groups tV and tW were increased 2.7-4.5-fold (p<0.01, p<0.0002 and p<0.0001). Pathological examination revealed that 1/3 of p75KD/LLC+rmTNF tumors were 100% necrotic, the remaining revealed 40-60% necrosis. No toxicity was detected in bone marrow, spleen and peripheral blood. We concluded that blocking TNFR2/p75 in LLCs combined with intra-tumoral rmTNF injections inhibit LLC tumor growth. This could represent a novel and effective therapy against lung neoplasms and a new paradigm in cancer therapeutics.	[Sasi, Sharath P.; Bae, Sanggyu; Song, Jin; Yan, Xinhua; Goukassian, David A.] GeneSys Res Inst, Cardiovasc Res Ctr, Boston, MA 02135 USA; [Bae, Sanggyu; Perepletchikov, Aleksandr; Schneider, Douglas; Carrozza, Joseph] Steward St Elizabeth Med Ctr, Dept Med, Boston, MA USA; [Bae, Sanggyu; Perepletchikov, Aleksandr; Schneider, Douglas; Carrozza, Joseph] Steward St Elizabeth Med Ctr, Dept Pathol, Boston, MA USA; [Perepletchikov, Aleksandr; Schneider, Douglas; Carrozza, Joseph; Yan, Xinhua; Goukassian, David A.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Kishore, Raj] Northwestern Univ, Feinberg Cardiovasc Inst, Chicago, IL 60611 USA; [Enderling, Heiko] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	St. Elizabeth's Medical Center; St. Elizabeth's Medical Center; Tufts University; Northwestern University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Goukassian, DA (corresponding author), GeneSys Res Inst, Cardiovasc Res Ctr, Boston, MA 02135 USA.	david.goukassian@tufts.edu	Enderling, Heiko/AAA-2423-2021	Enderling, Heiko/0000-0002-9696-6410; Goukassian, David/0000-0001-5270-5270	National Aeronautic and Space Administration [NNJ10ZSA001N]; AHA [10GRNT4710003]; NHLBI [HL106098]; NIH [HL091983]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106098, R01HL091983] Funding Source: NIH RePORTER	National Aeronautic and Space Administration(National Aeronautics & Space Administration (NASA)); AHA(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This material is based upon work supported by the National Aeronautic and Space Administration under Grant No. NNJ10ZSA001N to D.A.G., and in part by grants from AHA 10GRNT4710003 and NHLBI HL106098 to X.Y. and NIH HL091983 to R.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; Aggarwal Bharat B., 2002, Current Drug Targets - Inflammation and Allergy, V1, P327, DOI 10.2174/1568010023344571; Arnott CH, 2002, ONCOGENE, V21, P4728, DOI 10.1038/sj.onc.1205588; Arnott CH, 2004, ONCOGENE, V23, P1902, DOI 10.1038/sj.onc.1207317; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Bhardwaj A, 2003, J CLIN IMMUNOL, V23, P317, DOI 10.1023/A:1025319031417; Bossola M, 2007, EXPERT OPIN INV DRUG, V16, P1241, DOI 10.1517/13543784.16.8.1241; Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Harousseau Jean-Luc, 2006, Future Oncol, V2, P577, DOI 10.2217/14796694.2.5.577; Hasan Umbreen, 2006, N Z Med J, V119, pU2336; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hohenberger P, 2003, ANN SURG ONCOL, V10, P562, DOI 10.1245/ASO.2003.10.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KALTHOFF H, 1993, J BIOL CHEM, V268, P2762; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; KOMORI A, 1993, CANCER RES, V53, P1982; Laurenzi L, 2004, J EXP CLIN CANC RES, V23, P225; LEEUWENBERG JFM, 1995, CYTOKINE, V7, P457, DOI 10.1006/cyto.1995.0062; Lejeune Ferdy J, 2006, Cancer Immun, V6, P6; Li B, 2009, CANCER RES, V69, P338, DOI 10.1158/0008-5472.CAN-08-1565; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Madhusudan S, 2004, CLIN CANCER RES, V10, P6528, DOI 10.1158/1078-0432.CCR-04-0730; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Mirsadraee S, 2012, WORLD J RADIOL, V4, P128, DOI 10.4329/wjr.v4.i4.128; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Nair B, 2007, AM J HEMATOL, V82, P1022, DOI 10.1002/ajh.20926; Sasi SP, 2012, ONCOGENE, V31, P4117, DOI 10.1038/onc.2011.567; Scott KA, 2003, MOL CANCER THER, V2, P445; Suganuma M, 1999, CANCER RES, V59, P4516; Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012; ZABEL P, 1993, IMMUNOBIOLOGY, V187, P447, DOI 10.1016/S0171-2985(11)80356-6	37	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92373	10.1371/journal.pone.0092373	http://dx.doi.org/10.1371/journal.pone.0092373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664144	gold, Green Published			2022-12-25	WOS:000333459900057
J	Le Moyec, L; Robert, C; Triba, MN; Billat, VL; Mata, X; Schibler, L; Barrey, E				Le Moyec, Laurence; Robert, Celine; Triba, Mohamed N.; Billat, Veronique L.; Mata, Xavier; Schibler, Laurent; Barrey, Eric			Protein Catabolism and High Lipid Metabolism Associated with Long-Distance Exercise Are Revealed by Plasma NMR Metabolomics in Endurance Horses	PLOS ONE			English	Article							BLOOD-SERUM	During long distance endurance races, horses undergo high physiological and metabolic stresses. The adaptation processes involve the modulation of the energetic pathways in order to meet the energy demand. The aims were to evaluate the effects of long endurance exercise on the plasma metabolomic profiles and to investigate the relationships with the individual horse performances. The metabolomic profiles of the horses were analyzed using the non-dedicated methodology, NMR spectroscopy and statistical multivariate analysis. The advantage of this method is to investigate several metabolomic pathways at the same time in a single sample. The plasmas were obtained before exercise (BE) and post exercise (PE) from 69 horses competing in three endurance races at national level (130-160 km). Biochemical assays were also performed on the samples taken at PE. The proton NMR spectra were compared using the supervised orthogonal projection on latent structure method according to several factors. Among these factors, the race location was not significant whereas the effect of the race exercise (sample BE vs PE of same horse) was highly discriminating. This result was confirmed by the projection of unpaired samples (only BE or PE sample of different horses). The metabolomic profiles proved that protein, energetic and lipid metabolisms as well as glycoproteins content are highly affected by the long endurance exercise. The BE samples from finisher horses could be discriminated according to the racing speed based on their metabolomic lipid content. The PE samples could be discriminated according to the horse ranking position at the end of the race with lactate as unique correlated metabolite. As a conclusion, the metabolomic profiles of plasmas taken before and after the race provided a better understanding of the high energy demand and protein catabolism pathway that could expose the horses to metabolic disorders.	[Le Moyec, Laurence; Billat, Veronique L.; Barrey, Eric] Univ Evry Val Essonne, INSERM, Unite Biol Integrat & Adaptat Exercice, Evry, France; [Robert, Celine; Mata, Xavier; Schibler, Laurent; Barrey, Eric] INRA, Genet Anim & Biol Integrat, Jouy En Josas, France; [Triba, Mohamed N.] Univ Paris 13, Sorbonne Paris Cite, CNRS, Bobigny, France; [Robert, Celine] Univ Paris Est, Ecole Natl Vet Alfort, Maisons Alfort, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Paris 13; Ecole Nationale Veterinaire d'Alfort (ENVA)	Le Moyec, L (corresponding author), Univ Evry Val Essonne, INSERM, Unite Biol Integrat & Adaptat Exercice, Evry, France.	laurence.lemoyec@univ-evry.fr	Billat, Veronique/GNP-2073-2022; Robert, Céline/AAD-6158-2020; SCHIBLER, laurent/AAQ-2630-2021; Billat, Véronique/U-4398-2019	Billat, Véronique/0000-0002-6085-998X; SCHIBLER, Laurent/0000-0003-3137-0859; ROBERT, Celine/0000-0002-3899-1060	French Institute of Horse and Equitation (IFCE); Eperon funds; Arabian Horse Association (ACA); Institut National de recherche en Agronomie (INRA); Ecole Nationale Veterinaire d'Alfort (ENVA); Region Ile de France (SESAME project)	French Institute of Horse and Equitation (IFCE); Eperon funds; Arabian Horse Association (ACA); Institut National de recherche en Agronomie (INRA); Ecole Nationale Veterinaire d'Alfort (ENVA); Region Ile de France (SESAME project)(Region Ile-de-France)	This work was supported by the French Institute of Horse and Equitation (IFCE), Eperon funds, Arabian Horse Association (ACA), Institut National de recherche en Agronomie (INRA), Ecole Nationale Veterinaire d'Alfort (ENVA), and The Region Ile de France (SESAME project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assenza A, 2004, J ANIM PHYSIOL AN N, V88, P172, DOI 10.1111/j.1439-0396.2004.00493.x; Barrey E, 2006, Equine Vet J Suppl, P43; Bergero D, 2005, J ANIM PHYSIOL AN N, V89, P146, DOI 10.1111/j.1439-0396.2005.00556.x; Capomaccio S, 2010, ANIM GENET, V41, P166, DOI 10.1111/j.1365-2052.2010.02129.x; Castejon F, 2006, Equine Vet J Suppl, P70; Essen-Gustavsson B, 2002, EQUINE VET J, V34, P209; Hodavance MS, 2007, ANAL BIOANAL CHEM, V387, P533, DOI 10.1007/s00216-006-0979-z; Huang CC, 2013, J VASC SURG; Keller MD, 2011, EQUINE VET J, V43, P737, DOI 10.1111/j.2042-3306.2010.00336.x; Kohl SM, 2012, METABOLOMICS, V8, pS146, DOI 10.1007/s11306-011-0350-z; Le Moyec L, 2012, ANAL BIOANAL CHEM, V404, P593, DOI 10.1007/s00216-012-6165-6; Munoz A, 2010, EQUINE VET J, V42, P83, DOI 10.1111/j.2042-3306.2010.00211.x; Nahon P, 2012, CLIN CANCER RES, V18, P6714, DOI 10.1158/1078-0432.CCR-12-1099; Pechlivanis A, 2013, J PROTEOME RES, V12, P470, DOI 10.1021/pr300846x; Schott H C 2nd, 2006, Equine Vet J Suppl, P37; Serrano MG, 2002, EQUINE VET J, V34, P135; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Treiber K H, 2006, Equine Vet J Suppl, P631; Trigo P, 2010, EQUINE VET J, V42, P142, DOI 10.1111/j.2042-3306.2010.00238.x; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; van den Hoven R, 2011, J ANIM PHYSIOL AN N, V95, P664, DOI 10.1111/j.1439-0396.2010.01097.x; Waller AP, 2010, EQUINE VET J, V42, P274, DOI 10.2746/042516409X479603; Westermann CM, 2008, AM J VET RES, V69, P1469, DOI 10.2460/ajvr.69.11.1469	23	24	24	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90730	10.1371/journal.pone.0090730	http://dx.doi.org/10.1371/journal.pone.0090730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658361	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300019
J	Ocan, M; Bwanga, F; Bbosa, GS; Bagenda, D; Waako, P; Ogwal-Okeng, J; Obua, C				Ocan, Moses; Bwanga, Freddie; Bbosa, Godfrey S.; Bagenda, Danstan; Waako, Paul; Ogwal-Okeng, Jasper; Obua, Celestino			Patterns and Predictors of Self-Medication in Northern Uganda	PLOS ONE			English	Article							ANTIMICROBIAL DRUGS; RESISTANCE; ANTIBIOTICS; PHARMACIES; COMMUNITY; CHILDREN; INDIA; CARE	Self-medication with antimicrobial agents is a common form of self-care among patients globally with the prevalence and nature differing from country to country. Here we assessed the prevalence and predictors of antimicrobial self-medication in post-conflict northern Uganda. A cross-sectional study was carried out using structured interviews on 892 adult (>= 18 years) participants. Information on drug name, prescriber, source, cost, quantity of drug obtained, and drug use was collected. Households were randomly selected using multistage cluster sampling method. One respondent who reported having an illness within three months in each household was recruited. In each household, information was obtained from only one adult individual. Data was analyzed using STATA at 95% level of significance. The study found that a high proportion (75.7%) of the respondents practiced antimicrobial self-medication. Fever, headache, lack of appetite and body weakness were the disease symptoms most treated through self-medication (30.3%). The commonly self-medicated antimicrobials were coartem (27.3%), amoxicillin (21.7%), metronidazole (12.3%), and cotrimoxazole (11.6%). Drug use among respondents was mainly initiated by self-prescription (46.5%) and drug shop attendants (57.6%). On average, participants obtained 13.9 +/- 8.8 (95% CI: 12.6-13.8) tablets/capsules of antimicrobial drugs from drug shops and drugs were used for an average of 3.7 +/- 2.8 days (95% CI: 3.3-3.5). Over half (68.2%) of the respondents would recommend self-medication to another sick person. A high proportion (76%) of respondents reported that antimicrobial self-medication had associated risks such as wastage of money (42.1%), drug resistance (33.2%), and masking symptoms of underlying disease (15.5%). Predictors of self-medication with antimicrobial agents included gender, drug knowledge, drug leaflets, advice from friends, previous experience, long waiting time, and distance to the health facility. Despite knowledge of associated risks, use of self-medication with antimicrobial drugs in management of disease symptoms is a common practice in post-conflict northern Uganda.	[Ocan, Moses; Bbosa, Godfrey S.; Waako, Paul; Obua, Celestino] Makerere Univ, Coll Hlth Sci, Dept Pharmacol & Therapeut, Kampala, Uganda; [Bwanga, Freddie] Makerere Univ, Coll Hlth Sci, Dept Microbiol, Kampala, Uganda; [Bagenda, Danstan] Makerere Univ, Coll Hlth Sci, Dept Biostat, Kampala, Uganda; [Ogwal-Okeng, Jasper] Gulu Univ, Fac Med, Gulu, Uganda	Makerere University; Makerere University; Makerere University	Ocan, M (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Pharmacol & Therapeut, Kampala, Uganda.	mocan@chs.mak.ac.ug	Kawooya, Ismael/O-4541-2016	Kawooya, Ismael/0000-0002-7159-7153; Obua, Celestino/0000-0001-6949-3059; Ocan, Moses/0000-0002-8852-820X	OGAC; NIH; HRSA;  [5R24TW008886]; FOGARTY INTERNATIONAL CENTER [R24TW008886] Funding Source: NIH RePORTER	OGAC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by grant number 5R24TW008886 supported by OGAC, NIH and HRSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akello Grace, 2010, WARTIME CHILDRENS SU; Asiimwe D, 2000, TRANSFORMATIONS PROG; Awad A, 2005, J PHARM PHARM SCI, V8, P326; Bennet S, 1993, B INT STAT I, V55, P21; Brass EP, 2011, CLIN PHARMACOL THER, V90, P791, DOI 10.1038/clpt.2011.231; Brass EP, 2001, NEW ENGL J MED, V345, P810, DOI 10.1056/NEJMra011080; Calva J, 1996, SOC SCI MED, V42, P1121, DOI 10.1016/0277-9536(95)00385-1; Cars O., 2005, International Journal of Risk & Safety in Medicine, V17, P103; DUA V, 1994, SOC SCI MED, V38, P717, DOI 10.1016/0277-9536(94)90462-6; ETKIN NL, 1990, SOC SCI MED, V30, P919, DOI 10.1016/0277-9536(90)90220-M; Figueiras A, 2000, EUR J EPIDEMIOL, V16, P19, DOI 10.1023/A:1007608702063; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Hussain S, 2010, S MED REV, V3, P32; Kamat VR, 1998, SOC SCI MED, V47, P779, DOI 10.1016/S0277-9536(98)00134-8; KHALLAF N, 1991, LANCET, V338, P248, DOI 10.1016/0140-6736(91)90380-8; Kiwanuka SN, 2008, T ROY SOC TROP MED H, V102, P1067, DOI 10.1016/j.trstmh.2008.04.023; KUNIN CM, 1993, ANN INTERN MED, V118, P557, DOI 10.7326/0003-4819-118-7-199304010-00011; Ministry of Health, 2002, UG NAT DRUG POL; Ministry of Health, 2010, INT COMM CAS MAN IMP; Naila K, 2009, WOMENS EC EMPOWERMEN; NICHTER M, 1994, SOC SCI MED, V39, P1509, DOI 10.1016/0277-9536(94)90003-5; RICHARDS L, 1993, PEDIATR INFECT DIS J, V12, P5, DOI 10.1097/00006454-199301000-00003; Sharma R., 2005, INDIAN J PHARM, V3, P37; Skliros E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-58; STOLLER EP, 1993, MED CARE, V31, P24, DOI 10.1097/00005650-199301000-00002; Uganda Bureau of Statistics, 2002, 2002 UG POP HOUS CEN; UNICEF, 2007, UG UNICEF HUM SIT RE; Vialle-Valentin CE, 2012, TROP MED INT HEALTH, V17, P211, DOI 10.1111/j.1365-3156.2011.02895.x; WERNSDORFER WH, 1991, PHARMACOL THERAPEUT, V50, P95, DOI 10.1016/0163-7258(91)90074-V; WHO, 2001, WHOCDSCSRDRS20012; Whyte SR, 2000, P WORKSH PEOPL MED E, P127; World Health Organization, 1986, GUID ASS DRUGS US SE; World Health Organization, 2000, GUID REG ASS MED PRO	33	79	84	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92323	10.1371/journal.pone.0092323	http://dx.doi.org/10.1371/journal.pone.0092323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6GL	24658124	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300073
J	Fouqueray, TD; Blumstein, DT; Monclus, R; Martin, JGA				Fouqueray, Timothee D.; Blumstein, Daniel T.; Monclus, Raquel; Martin, Julien G. A.			Maternal Effects on Anogenital Distance in a Wild Marmot Population	PLOS ONE			English	Article							YELLOW-BELLIED MARMOTS; INTRAUTERINE POSITION; FEMALE RATS; HOUSE MICE; TRAITS; HERITABILITY; REPRODUCTION; STRATEGIES; TRANSPORT; PLAY	In mammals, prenatal exposure to sex steroid hormones may have profound effects on later behavior and fitness and have been reported under both laboratory and field conditions. Anogenital distance is a non-invasive measure of prenatal exposure to sex steroid hormones. While we know that intra-uterine position and litter sex ratio influence anogenital distance, there are other, heretofore unstudied, factors that could influence anogenital distance, including maternal effects. We capitalized on a long-term study of wild yellow-bellied marmots (Marmota flaviventris) to study the importance of maternal effects on explaining variation in anogenital distance and found significant effects. The strength of these effects varied annually. Taken together, our data highlights the strong variability due to environmental effects, and illustrates the importance of additive genetic and maternal genetic effects on neonatal anogenital distance. We suspect that, as others apply recently popularised quantitative genetic techniques to study free-living populations, such effects will be identified in other systems.	[Fouqueray, Timothee D.; Blumstein, Daniel T.; Martin, Julien G. A.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Fouqueray, Timothee D.] Ecole Normale Super Lyon, Dept Biol, F-69364 Lyon, France; [Blumstein, Daniel T.] Rocky Mt Biol Labs, Crested Butte, CO USA; [Monclus, Raquel] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Martin, Julien G. A.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	University of California System; University of California Los Angeles; Ecole Normale Superieure de Lyon (ENS de LYON); Autonomous University of Madrid; University of Aberdeen	Martin, JGA (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	marmots@ucla.edu	Monclús, Raquel/B-2540-2017; Martin, Julien GA/H-5843-2019	Martin, Julien GA/0000-0001-7726-6809; Fouqueray, Timothee/0000-0003-4773-4733; Monclus Burgoa, Raquel/0000-0001-7117-3521; Blumstein, Daniel/0000-0001-5793-9244	National Geographic Society; UCLA (Faculty Senate and the Division of Life Sciences); Rocky Mountain Biological Laboratory research fellowship; NSF [IDBR-0754247, DEB-1119660, DBI 0242960, 0731346]; Spanish Ministerio de Innovacion y Ciencia; Fulbright program; FRQNT postdoctoral fellowship; NSF	National Geographic Society(National Geographic Society); UCLA (Faculty Senate and the Division of Life Sciences); Rocky Mountain Biological Laboratory research fellowship; NSF(National Science Foundation (NSF)); Spanish Ministerio de Innovacion y Ciencia(Spanish Government); Fulbright program; FRQNT postdoctoral fellowship; NSF(National Science Foundation (NSF))	DTB was supported by the National Geographic Society, UCLA (Faculty Senate and the Division of Life Sciences), a Rocky Mountain Biological Laboratory research fellowship, and by the NSF (IDBR-0754247 and DEB-1119660 to DTB, as well as DBI 0242960 and 0731346 to the Rocky Mountain Biological Laboratory). RM was supported by postdoctoral fellowships from the Spanish Ministerio de Innovacion y Ciencia and the Fulbright program. JGAM was supported by a FRQNT postdoctoral fellowship and the NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE KB, 2003, WILD MAMMALS N AM BI, P188; Banszegi O, 2012, PHYSIOL BEHAV, V105, P1226, DOI 10.1016/j.physbeh.2012.01.002; Bayless DW, 2013, HORM BEHAV, V64, P764, DOI 10.1016/j.yhbeh.2013.10.003; Blumstein DT, 2010, J EVOLUTION BIOL, V23, P879, DOI 10.1111/j.1420-9101.2010.01967.x; Chawnshang C, 2002, ANDROGENS ANDROGEN R; DOHLER KD, 1991, EXP CLIN ENDOCRINOL, V98, P99; Drickamer LC, 1996, ANIM BEHAV, V51, P925, DOI 10.1006/anbe.1996.0096; Duckworth RA, 2009, PHILOS T R SOC B, V364, P1075, DOI 10.1098/rstb.2008.0294; Eisenberg ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018973; EVEN MD, 1992, J REPROD FERTIL, V96, P709, DOI 10.1530/jrf.0.0960709; Field EF, 2006, DEV PSYCHOBIOL, V48, P111, DOI 10.1002/dev.20121; Garnier R, 2012, EVOLUTION, V66, P3067, DOI 10.1111/j.1558-5646.2012.01665.x; Gilmour AR, 2009, ASREML USER GUIDE RE; Gobrogge KL, 2008, ARCH SEX BEHAV, V37, P112, DOI 10.1007/s10508-007-9272-2; Kerin TK, 2003, PHYSIOL BEHAV, V78, P697, DOI 10.1016/S0031-9384(03)00054-4; Kruuk LEB, 2007, J EVOLUTION BIOL, V20, P1890, DOI 10.1111/j.1420-9101.2007.01377.x; MEANEY MJ, 1986, BRAIN RES, V398, P324, DOI 10.1016/0006-8993(86)91492-7; Mendiola J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-90; Monclus R, 2012, BIOL LETTERS, V8, P208, DOI 10.1098/rsbl.2011.0754; Monclus R, 2012, J ANIM ECOL, V81, P80, DOI 10.1111/j.1365-2656.2011.01888.x; Monclus R, 2011, HORM BEHAV, V60, P660, DOI 10.1016/j.yhbeh.2011.08.019; Nelson E, 2010, PRIMATES, V51, P1, DOI 10.1007/s10329-009-0173-y; PALANZA P, 1995, PHYSIOL BEHAV, V58, P827, DOI 10.1016/0031-9384(95)00107-T; Paul SN, 2006, TWIN RES HUM GENET, V9, P215, DOI 10.1375/twin.9.2.215; Pinheiro J, 2001, MIXED EFFECTS MODELS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodel HG, 2008, J COMP PSYCHOL, V122, P73, DOI 10.1037/0735-7036.122.1.73; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; SAAL FSV, 1980, SCIENCE, V208, P597, DOI 10.1126/science.7367881; SAAL FSV, 1989, J ANIM SCI, V67, P1824; Sathishkumar K, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-110; SRIDARAN R, 1981, ENDOCRINOLOGY, V108, P855, DOI 10.1210/endo-108-3-855; VANDENBERGH JG, 1995, LAB ANIM SCI, V45, P567; Vandenbergh John G., 2009, P203; Voracek M, 2009, AM J PHYS ANTHROPOL, V140, P376, DOI 10.1002/ajpa.21105; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Zehr JL, 2001, DEV PSYCHOBIOL, V38, P229, DOI 10.1002/dev.1017	38	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92718	10.1371/journal.pone.0092718	http://dx.doi.org/10.1371/journal.pone.0092718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651864	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800148
J	Grosse-Dresselhaus, F; Galinovic, I; Villringer, K; Audebert, HJ; Fiebach, JB				Grosse-Dresselhaus, Florian; Galinovic, Ivana; Villringer, Kersten; Audebert, Heinrich J.; Fiebach, Jochen B.			Difficulty of MRI Based Identification of Lesion Age by Acute Infra-Tentorial Ischemic Stroke	PLOS ONE			English	Article							SYMPTOM ONSET; MISMATCH; TIME	Background: Systemic thrombolysis in acute ischemic stroke is restricted to the 4.5 h time window. Many patients are excluded from this treatment because symptom onset is unknown. Magnetic resonance imaging (MRI) studies have shown that stroke patients presenting with acute supra-tentorial diffusion-weighted imaging (DWI) lesions that do not have matching lesions on fluid attenuated inversion recovery (FLAIR) are likely to be within a 4.5 hour time window. This study examines the DWI-FLAIR mismatch in infra-tentorial stroke. Methods: This was a retrospectively conducted substudy of the "1000+" study; a prospective, single-center observational study (http://clinicaltrials.gov; NCT00715533). Fifty-six patients with infra-tentorial stroke confirmed by MRI and known symptom onset who underwent the scan within 24 h after symptom onset were analysed. Two neurologists blinded to clinical information separately rated the DWI lesion visibility on FLAIR. Lesion volume, relative signal intensities of DWI and relative apparent diffusion coefficient values were determined. Results: Regarding baseline characteristics our study population had a median age of 66 years, a median time from symptom onset to MRI of 616.5 minutes, a median NIHSS of 3 and a median DWI lesion volume of 0.26 ml. A negative FLAIR allocated patients to a time window under 4.5 h correctly with a sensitivity of 55% and a specificity of 61%, a positive predictive value of 44% and a negative predictive value of 71%. FLAIR positivity decreased with age (p = 0.018), and showed no significant correlation to lesion volume (p = 0.145). Conclusions: In our study the DWI-FLAIR-Mismatch does not help to reliably identify patients within 4.5 h of symptom onset in acute ischemic infra-tentorial stroke. Thus therapeutical decisions based on the DWI-FLAIR mismatch estimation of time from onset cannot be recommended in patients with infra-tentorial stroke.	[Grosse-Dresselhaus, Florian; Galinovic, Ivana; Villringer, Kersten; Audebert, Heinrich J.; Fiebach, Jochen B.] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Grosse-Dresselhaus, F (corresponding author), Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany.	grosse-dresselhaus@gmx.de		Fiebach, Jochen B./0000-0002-7936-6958; Galinovic, Ivana/0000-0003-4904-8251; Audebert, Heinrich J./0000-0002-4785-0366	Charite University, Berlin, Germany; German Federal Ministry of Education and Research	Charite University, Berlin, Germany; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The work was supported by Charite University, Berlin, Germany and German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2011, CEREBROVASC DIS, V31, P435, DOI 10.1159/000323850; Aoki J, 2010, J NEUROL SCI, V293, P39, DOI 10.1016/j.jns.2010.03.011; Ebinger M, 2010, STROKE, V41, P250, DOI 10.1161/STROKEAHA.109.568410; Fiebach JB, 2002, NEURORADIOLOGY, V44, P294, DOI 10.1007/s00234-001-0720-8; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Oppenheim C, 2000, AM J NEURORADIOL, V21, P1434; Petkova M, 2010, RADIOLOGY, V257, P782, DOI 10.1148/radiol.10100461; Schaefer PW, 2008, STROKE, V39, P3107, DOI 10.1161/STROKEAHA.108.517680; Thomalla G, 2011, LANCET NEUROL, V10, P978, DOI 10.1016/S1474-4422(11)70192-2; Thomalla G, 2009, ANN NEUROL, V65, P724, DOI 10.1002/ana.21651	10	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92868	10.1371/journal.pone.0092868	http://dx.doi.org/10.1371/journal.pone.0092868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651570	gold, Green Published, Green Submitted			2022-12-25	WOS:000333352800160
J	He, Q; Wu, C; Luo, H; Wang, ZY; Ma, XQ; Zhao, YF; Lu, J; Xiang, C; Qin, YY; Wu, SQ; Yu, FF; He, J				He, Qian; Wu, Cheng; Luo, Hong; Wang, Zhi-Yong; Ma, Xiu-Qiang; Zhao, Yan-Fang; Lu, Jian; Xiang, Chun; Qin, Ying-Yi; Wu, Shun-Quan; Yu, Fei-Fei; He, Jia			Trends in In-Hospital Mortality among Patients with Stroke in China	PLOS ONE			English	Article							BIRACIAL POPULATION; 30-DAY MORTALITY; ISCHEMIC-STROKE; CARE; SUBTYPES; AGE	Background: The incidence and burden of stroke in China is increasing rapidly. However, little is known about trends in mortality during stroke hospitalization. The objectives of this study were to assess trends of in-hospital mortality among patients with stroke and explore influence factors of in-hospital death after stroke in China. Methods: 109 grade III class A hospitals were sampled by multistage stratified cluster sampling. All patients admitted to hospitals between 2007 and 2010 with a discharge diagnosis of stroke were included. Trends in in-hospital mortality among patients with stroke were assessed. Influence factors of in-hospital death after stroke were explored using multivariable logistic regression. Results: Overall stroke hospitalizations increased from 79,894 in 2007 to 85,475 in 2010, and in-hospital mortality of stroke decreased from 3.16% to 2.30% (P<0.0001). The percentage of severe patients increased while odds of mortality (2010 versus 2007) decreased regardless of stroke type: subarachnoid hemorrhage (OR 0.792, 95% CI = 0.636 to 0.987), intracerebral hemorrhage (OR 0.647, 95% CI = 0.591 to 0.708), and ischemic stroke (OR 0.588, 95% CI = 0.532 to 0.649). In multivariable analyses, older age, male, basic health insurance, multiple comorbidities and severity of disease were linked to higher odds of in-hospital mortality. Conclusions: The mortality of stroke hospitalizations decreased likely reflecting advancements in stroke care and prevention. Decreasing of mortality with increasing of severe stroke patients indicated that we should pay more attention to rehabilitation and life quality of stroke patients. Specific individual and hospital-level characteristics may be targets for facilitating further declines.	[He, Qian; Wu, Cheng; Ma, Xiu-Qiang; Zhao, Yan-Fang; Lu, Jian; Xiang, Chun; Qin, Ying-Yi; Wu, Shun-Quan; Yu, Fei-Fei; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Luo, Hong] Second Mil Med Univ, Ctr Educ Technol, Shanghai, Peoples R China; [Wang, Zhi-Yong] Second Mil Med Univ, Changhai Hosp, Dept Informat, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	He, J (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yeah.net	zhao, yan/GWC-9174-2022	He, Jia/0000-0002-2338-9501	key discipline construction of Evidence-based Public Health in Shanghai [12GWZX0602]; 2 national "Eleven Five" "Significant new drugs creation" special science and technology major [2008ZX09312-007, 2009ZX09312-025]; foundation of Faculty of Health Service, Second Military Medical University [2013wk02]; foundation of Second Military Medical University [2012JS11]	key discipline construction of Evidence-based Public Health in Shanghai; 2 national "Eleven Five" "Significant new drugs creation" special science and technology major; foundation of Faculty of Health Service, Second Military Medical University; foundation of Second Military Medical University	This study was funded by the key discipline construction of Evidence-based Public Health in Shanghai No 12GWZX0602, 2 national "Eleven Five" "Significant new drugs creation" special science and technology major (2008ZX09312-007, 2009ZX09312-025), the foundation of Faculty of Health Service, Second Military Medical University (2013wk02), the foundation of Second Military Medical University (2012JS11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	China Ministry of Health, 2010, CHIN HLTH STAT YB 20; Cole JW, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-37; Deng YX, 2012, CNS NEUROSCI THER, V18, P819, DOI 10.1111/j.1755-5949.2012.00378.x; Heeley E, 2009, STROKE, V40, P2149, DOI 10.1161/STROKEAHA.108.540054; Jiang B, 2006, STROKE, V37, P63, DOI 10.1161/01.STR.0000194955.34820.78; Kissela B, 2004, STROKE, V35, P426, DOI 10.1161/01.STR.0000110982.74967.39; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Lichtman JH, 2013, STROKE, V44, P531, DOI 10.1161/STROKEAHA.112.670547; Lichtman JH, 2011, STROKE, V42, P3387, DOI 10.1161/STROKEAHA.111.622613; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Liu ZR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-394; Nimptsch U, 2012, DTSCH ARZTEBL INT, V109, P885, DOI 10.3238/arztebl.2012.0885; Ovbiagele B, 2010, STROKE, V41, P1748, DOI 10.1161/STROKEAHA.110.585455; Rao Y, 2007, XIANDAI YUFANG YIXUE, V34, P1615; Rao Y, 2007, XIANDAI YUFANG, V34, P1610; Wang De-zheng, 2012, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V30, P902; Wang PL, 2012, CHINESE MED J-PEKING, V125, P2449, DOI 10.3760/cma.j.issn.0366-6999.2012.14.010; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056459; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807; [赵玉华 Zhao Yuhua], 2011, [中华神经医学杂志, Chinese Journal of Neuromedicine], V10, P1255	22	33	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92763	10.1371/journal.pone.0092763	http://dx.doi.org/10.1371/journal.pone.0092763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651454	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800155
J	Perez, AG; Leon, L; Pascual, M; Romero-Segura, C; Sanchez-Ortiz, A; de la Rosa, R; Sanz, C				Perez, Ana G.; Leon, Lorenzo; Pascual, Mar; Romero-Segura, Carmen; Sanchez-Ortiz, Araceli; de la Rosa, Raul; Sanz, Carlos			Variability of Virgin Olive Oil Phenolic Compounds in a Segregating Progeny from a Single Cross in Olea europaea L. and Sensory and Nutritional Quality Implications	PLOS ONE			English	Article							HYDROXYTYROSYL ACETATE; MEDITERRANEAN DIET; POLYPHENOLS; PROFILE; SECOIRIDOIDS; METABOLISM; TYROSOL; CHEMISTRY; LIGNANS; HEALTH	Virgin olive oil phenolic compounds are responsible for its nutritional and sensory quality. The synthesis of phenolic compounds occurs when enzymes and substrates meet as olive fruit is crushed during the industrial process to obtain the oil. The genetic variability of the major phenolic compounds of virgin olive oil was studied in a progeny of the cross of Picual x Arbequina olive cultivars (Olea europaea L.). They belong to four different groups: compounds that included tyrosol or hydroxytyrosol in their molecules, lignans, flavonoids, and phenolic acids. Data of phenolics in the oils showed that the progeny displayed a large degree of variability, widely transgressing the genitor levels. This high variability can be of interest on breeding programs. Thus, multivariate analysis allowed to identify genotypes within the progeny particularly interesting in terms of phenolic composition and deduced organoleptic and nutritional quality. The present study has demonstrated that it is possible to obtain enough degree of variability with a single cross of olive cultivars for compounds related to the nutritional and organoleptic properties of virgin olive oil.	[Perez, Ana G.; Pascual, Mar; Romero-Segura, Carmen; Sanchez-Ortiz, Araceli; Sanz, Carlos] CSIC, Inst Grasa, Dept Biochem & Mol Biol Plant Prod, E-41080 Seville, Spain; [Leon, Lorenzo; de la Rosa, Raul] Ctr Alameda Obispo, IFAPA, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG)	Sanz, C (corresponding author), CSIC, Inst Grasa, Dept Biochem & Mol Biol Plant Prod, E-41080 Seville, Spain.	carlos.sanz@ig.csic.es	Pérez, Ana/GQA-6861-2022; Pérez, Ana G. G/K-1221-2014; SANCHEZ, ARACELI/M-1413-2014; De la Rosa, Raul/AIB-1463-2022; Pérez, Ana G./AAB-4513-2021; Sanz, Carlos/K-1743-2014; De la Rosa, Raul/B-5755-2008; Leon, Lorenzo/N-7355-2013	Pérez, Ana G. G/0000-0002-8096-9190; SANCHEZ, ARACELI/0000-0003-1648-2924; De la Rosa, Raul/0000-0002-0752-9607; Pérez, Ana G./0000-0002-8096-9190; Sanz, Carlos/0000-0002-7387-3393; De la Rosa, Raul/0000-0002-0752-9607; Leon, Lorenzo/0000-0002-5664-3393	OLEAGEN project by Genoma Espana; Programa Nacional de Recursos y Tecnologias Agroalimentarias [AGL2011-24442]; Spanish Government	OLEAGEN project by Genoma Espana; Programa Nacional de Recursos y Tecnologias Agroalimentarias; Spanish Government(Spanish GovernmentEuropean Commission)	The financial support of the OLEAGEN project by Genoma Espana and AGL2011-24442 from the Programa Nacional de Recursos y Tecnologias Agroalimentarias funded by the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrewes P, 2003, J AGR FOOD CHEM, V51, P1415, DOI 10.1021/jf026042j; Artajo LS, 2006, EUR J LIPID SCI TECH, V108, P19, DOI 10.1002/ejlt.200500227; Bouallagui Z, 2011, APPL BIOCHEM BIOTECH, V163, P592, DOI 10.1007/s12010-010-9065-2; Caruso D, 1999, NUTR METAB CARDIOVAS, V9, P102; Cicerale S, 2009, CRIT REV FOOD SCI, V49, P218, DOI 10.1080/10408390701856223; Cook NC, 1996, J NUTR BIOCHEM, V7, P66, DOI 10.1016/0955-2863(95)00168-9; de la Puerta R, 1999, BIOCHEM PHARMACOL, V57, P445, DOI 10.1016/S0006-2952(98)00320-7; DZIEDZIC SZ, 1983, FOOD CHEM, V12, P205, DOI 10.1016/0308-8146(83)90007-9; El Riachy M, 2012, SPAN J AGRIC RES, V10, P443, DOI 10.5424/sjar/2012102-264-11; El Riachy M, 2012, J SCI FOOD AGR, V92, P2524, DOI 10.1002/jsfa.5662; El Riachy M, 2012, EUR J LIPID SCI TECH, V114, P542, DOI 10.1002/ejlt.201100129; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Garcia-Gonzalez DL, 2010, J AGR FOOD CHEM, V58, P8357, DOI 10.1021/jf101316d; Garcia-Rodriguez R, 2011, FOOD RES INT, V44, P629, DOI 10.1016/j.foodres.2010.12.023; Giovannini C, 1999, J NUTR, V129, P1269, DOI 10.1093/jn/129.7.1269; Grasso S, 2007, BIOORG CHEM, V35, P137, DOI 10.1016/j.bioorg.2006.09.003; Konstantinidou V, 2010, FASEB J, V24, P2546, DOI 10.1096/fj.09-148452; Leon L, 2011, EUR J LIPID SCI TECH, V113, P870, DOI 10.1002/ejlt.201000535; Luaces P, 2007, J SCI FOOD AGR, V87, P2721, DOI 10.1002/jsfa.3049; Lucas L, 2011, CURR PHARM DESIGN, V17, P754, DOI 10.2174/138161211795428911; Inarejos-Garcia AM, 2009, FOOD RES INT, V42, P279, DOI 10.1016/j.foodres.2008.11.009; Martines Suarez J. M., 1975, Grasas y Aceites, V26, P379; Mateos R, 2005, J AGR FOOD CHEM, V53, P9897, DOI 10.1021/jf051721q; Mateos R, 2004, J AM OIL CHEM SOC, V81, P71, DOI 10.1007/s11746-004-0859-x; Mateos R, 2011, FOOD CHEM, V125, P865, DOI 10.1016/j.foodchem.2010.09.054; Mateos R, 2001, J AGR FOOD CHEM, V49, P2185, DOI 10.1021/jf0013205; Menendez JA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-377; Menendez JA, 2009, INT J ONCOL, V34, P43, DOI 10.3892/ijo_00000127; Miro-Casas E, 2003, EUR J CLIN NUTR, V57, P186, DOI 10.1038/sj.ejcn.1601532; Montedoro G, 2002, ACTA HORTIC, P551, DOI 10.17660/ActaHortic.2002.586.115; Neveu V, 2010, PHEN EXPL ONL COMPR; Obied HK, 2008, NAT PROD REP, V25, P1167, DOI 10.1039/b719736e; Pereira-Caro G, 2012, INT J FOOD SCI NUTR, V63, P703, DOI 10.3109/09637486.2011.652943; Pinto J, 2011, BRIT J NUTR, V105, P1607, DOI 10.1017/S000711451000526X; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; Rjiba I, 2011, J FOOD BIOCHEM, V35, P1413, DOI 10.1111/j.1745-4514.2010.00462.x; Romero-Segura C, 2012, FOOD RES INT, V45, P191, DOI 10.1016/j.foodres.2011.10.024; Santos-Antunes F, 2005, HORTSCIENCE, V40, P1213, DOI 10.21273/HORTSCI.40.5.1213; Savarese M, 2007, FOOD CHEM, V105, P761, DOI 10.1016/j.foodchem.2007.01.037; Scotece M, 2013, CURR MED CHEM, V20, P2467, DOI 10.2174/0929867311320190006; Servili M, 2004, J CHROMATOGR A, V1054, P113, DOI 10.1016/S0021-9673(04)01423-2; Visioli F, 2011, CURR PHARM DESIGN, V17, P786, DOI 10.2174/138161211795428885	42	24	25	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92898	10.1371/journal.pone.0092898	http://dx.doi.org/10.1371/journal.pone.0092898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651694	gold, Green Published			2022-12-25	WOS:000333352800163
J	Yilancioglu, K; Cokol, M; Pastirmaci, I; Erman, B; Cetiner, S				Yilancioglu, Kaan; Cokol, Murat; Pastirmaci, Inanc; Erman, Batu; Cetiner, Selim			Oxidative Stress Is a Mediator for Increased Lipid Accumulation in a Newly Isolated Dunaliella salina Strain	PLOS ONE			English	Article							REACTIVE OXYGEN; NILE RED; GROWTH; MICROALGAE; REINHARDTII; EXPRESSION; RESPONSES; PROTEIN; ALGAE; OIL	Green algae offer sustainable, clean and eco-friendly energy resource. However, production efficiency needs to be improved. Increasing cellular lipid levels by nitrogen depletion is one of the most studied strategies. Despite this, the underlying physiological and biochemical mechanisms of this response have not been well defined. Algae species adapted to hypersaline conditions can be cultivated in salty waters which are not useful for agriculture or consumption. Due to their inherent extreme cultivation conditions, use of hypersaline algae species is better suited for avoiding culture contamination issues. In this study, we identified a new halophilic Dunaliella salina strain by using 18S ribosomal RNA gene sequencing. We found that growth and biomass productivities of this strain were directly related to nitrogen levels, as the highest biomass concentration under 0.05 mM or 5 mM nitrogen regimes were 495 mg/l and 1409 mg/l, respectively. We also confirmed that nitrogen limitation increased cellular lipid content up to 35% under 0.05 mM nitrogen concentration. In order to gain insight into the mechanisms of this phenomenon, we applied fluorometric, flow cytometric and spectrophotometric methods to measure oxidative stress and enzymatic defence mechanisms. Under nitrogen depleted cultivation conditions, we observed increased lipid peroxidation by measuring an important oxidative stress marker, malondialdehyde and enhanced activation of catalase, ascorbate peroxidase and superoxide dismutase antioxidant enzymes. These observations indicated that oxidative stress is accompanied by increased lipid content in the green alga. In addition, we also showed that at optimum cultivation conditions, inducing oxidative stress by application of exogenous H2O2 leads to increased cellular lipid content up to 44% when compared with non-treated control groups. Our results support that oxidative stress and lipid overproduction are linked. Importantly, these results also suggest that oxidative stress mediates lipid accumulation. Understanding such relationships may provide guidance for efficient production of algal biodiesels.	[Yilancioglu, Kaan; Cokol, Murat; Pastirmaci, Inanc; Erman, Batu; Cetiner, Selim] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey; [Cokol, Murat] Sabanci Univ, Nanotechnol Res & Applicat Ctr, Istanbul, Turkey	Sabanci University; Sabanci University	Cetiner, S (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey.	cetiner@sabanciuniv.edu	Cetiner, Selim/AAX-1782-2020; erman, batu/AAE-1963-2020	Pastirmaci, Inanc/0000-0002-0316-0718	Sabanci University	Sabanci University(Sabanci University)	This work was financially supported by research fund of Sabanci University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H., 1984, METHODS ENZYMOL, V105, P121, DOI [10.1016/S0076-6879(84)05016-3, DOI 10.1016/S0076-6879(84)05016-3]; Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Barbarino E, 2005, J APPL PHYCOL, V17, P447, DOI 10.1007/s10811-005-1641-4; Bhaduri AM, 2012, REV ENVIRON SCI BIO, V11, P55, DOI 10.1007/s11157-011-9251-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cakmak T, 2012, BIOENGINEERED, V3, P343, DOI 10.4161/bioe.21427; Cash TP, 2007, FREE RADICAL BIO MED, V43, P1219, DOI 10.1016/j.freeradbiomed.2007.07.001; Chen M, 2011, BIORESOURCE TECHNOL, V102, P1649, DOI 10.1016/j.biortech.2010.09.062; Chen W, 2011, BIORESOURCE TECHNOL, V102, P135, DOI 10.1016/j.biortech.2010.06.076; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; COLE TA, 1990, EUR J PROTISTOL, V25, P361, DOI 10.1016/S0932-4739(11)80129-X; Converti A, 2009, CHEM ENG PROCESS, V48, P1146, DOI 10.1016/j.cep.2009.03.006; Courchesne NMD, 2009, J BIOTECHNOL, V141, P31, DOI 10.1016/j.jbiotec.2009.02.018; Csavina JL, 2011, J APPL MICROBIOL, V111, P312, DOI 10.1111/j.1365-2672.2011.05064.x; del Rio LA, 2006, PLANT PHYSIOL, V141, P330, DOI 10.1104/pp.106.078204; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Fredslund J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-315; Camacho FG, 2007, BIOTECHNOL ADV, V25, P176, DOI 10.1016/j.biotechadv.2006.11.008; GARCIAFERRIS C, 1993, PHOTOSYNTH RES, V35, P55, DOI 10.1007/BF02185411; Gordillo FJL, 1998, J APPL PHYCOL, V10, P135, DOI 10.1023/A:1008067022973; Govender T, 2012, BIORESOURCE TECHNOL, V114, P507, DOI 10.1016/j.biortech.2012.03.024; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Griffiths MJ, 2012, J APPL PHYCOL, V24, P989, DOI 10.1007/s10811-011-9723-y; Ho SH, 2010, BIORESOURCE TECHNOL, V101, P8725, DOI 10.1016/j.biortech.2010.06.112; Hong Y, 2008, ECOTOX ENVIRON SAFE, V71, P527, DOI 10.1016/j.ecoenv.2007.10.010; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kimura K, 2004, J MICROBIOL METH, V56, P331, DOI 10.1016/j.mimet.2003.10.018; Kobayashi M, 2003, BIOTECHNOL BIOPROC E, V8, P322, DOI 10.1007/BF02949275; Lee SJ, 1998, BIOTECHNOL TECH, V12, P553, DOI 10.1023/A:1008811716448; LEVASSEUR M, 1993, J PHYCOL, V29, P587, DOI 10.1111/j.0022-3646.1993.00587.x; Li X, 2011, BIORESOURCE TECHNOL, V102, P3098, DOI 10.1016/j.biortech.2010.10.055; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; Liang ZJ, 2013, AQUAT TOXICOL, V138, P81, DOI 10.1016/j.aquatox.2013.04.010; Lin QA, 2011, BIORESOURCE TECHNOL, V102, P1615, DOI 10.1016/j.biortech.2010.09.008; Liu WH, 2012, J EXP MAR BIOL ECOL, V418, P24, DOI 10.1016/j.jembe.2012.03.005; Mallick N, 2000, J PLANT PHYSIOL, V157, P183, DOI 10.1016/S0176-1617(00)80189-3; Miller SR, 2002, ARCH MICROBIOL, V177, P392, DOI 10.1007/s00203-002-0404-8; Msanne J, 2012, PHYTOCHEMISTRY, V75, P50, DOI 10.1016/j.phytochem.2011.12.007; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Olmos J, 2000, LETT APPL MICROBIOL, V30, P80, DOI 10.1046/j.1472-765x.2000.00672.x; Pinto E, 2003, J PHYCOL, V39, P1008, DOI 10.1111/j.0022-3646.2003.02-193.x; Sabatini SE, 2009, ECOTOX ENVIRON SAFE, V72, P1200, DOI 10.1016/j.ecoenv.2009.01.003; Schonswetter P, 2002, MOL ECOL, V11, P2637, DOI 10.1046/j.1365-294X.2002.01651.x; Sharma KK, 2012, ENERGIES, V5, P1532, DOI 10.3390/en5051532; Singh SP, 2010, AGEING RES REV, V9, P79, DOI 10.1016/j.arr.2009.05.004; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Tang HY, 2011, APPL ENERG, V88, P3324, DOI 10.1016/j.apenergy.2010.09.013; Tsukagoshi H, 2012, PLANT SCI, V197, P30, DOI 10.1016/j.plantsci.2012.08.011; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Zhang YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069225; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004	54	187	191	2	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91957	10.1371/journal.pone.0091957	http://dx.doi.org/10.1371/journal.pone.0091957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651514	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800059
J	Hu, CM; Zhu, J; Guo, XE; Chen, W; Qiu, XL; Ngo, B; Chien, R; Wang, YV; Tsai, CY; Wu, G; Kim, Y; Lopez, R; Chamberlin, AR; Lee, EH; Lee, WH				Hu, C-M; Zhu, J.; Guo, X. E.; Chen, W.; Qiu, X-L; Ngo, B.; Chien, R.; Wang, Y. V.; Tsai, C. Y.; Wu, G.; Kim, Y.; Lopez, R.; Chamberlin, A. R.; Lee, Ey-Hp; Lee, W-H			Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism	ONCOGENE			English	Article							FAITHFUL CHROMOSOME SEGREGATION; CENTROSOMAL KINASE NEK2; HUMAN BREAST-CANCER; IN-VIVO; MICROTUBULE DYNAMICS; TUMORIGENIC GROWTH; PROTEIN-KINASE; P53 FUNCTION; HEC1; CHECKPOINT	Hec1 (highly expressed in cancer 1) or Nek2 (NIMA-related kinase 2) is often overexpressed in cancers with poor prognosis. Both are critical mitotic regulators, and phosphorylation of Hec1 S165 by Nek2 is required for proper chromosome segregation. Therefore, inactivation of Hec1 and Nek2 by targeting their interaction with small molecules represents an ideal strategy for tackling these types of cancers. Here we showed that new derivatives of INH (inhibitor for Nek2 and Hec1 binding) bind to Hec1 at amino acids 394-408 on W395, L399 and K400 residues, effectively blocking Hec1 phosphorylation on S165 by Nek2, and killing cancer cells at the nanomolar range. Mechanistically, the D-box (destruction-box) region of Nek2 specifically binds to Hec1 at amino acids 408-422, immediately adjacent to the INH binding motif. Subsequent binding of Nek2 to INH-bound Hec1 triggered proteasome-mediated Nek2 degradation, whereas the Hec1 binding defective Nek2 mutant, Nek2 R361L, resisted INH-induced Nek2 degradation. This finding unveils a novel drug-action mechanism where the binding of INHs to Hec1 forms a virtual death-trap to trigger Nek2 degradation and eventually cell death. Furthermore, analysis of the gene expression profiles of breast cancer patient samples revealed that co-elevated expressions of Hec1 and Nek2 correlated with the shortest survival. Treatment of mice with this kind of tumor with INHs significantly suppressed tumor growth without obvious toxicity. Taken together, the new INH derivatives are suitable for translation into clinical application.	[Hu, C-M; Zhu, J.; Guo, X. E.; Chen, W.; Qiu, X-L; Ngo, B.; Chien, R.; Wang, Y. V.; Tsai, C. Y.; Wu, G.; Kim, Y.; Lee, Ey-Hp; Lee, W-H] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA; [Hu, C-M; Lee, W-H] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lopez, R.; Chamberlin, A. R.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Lee, W-H] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	University of California System; University of California Irvine; Academia Sinica - Taiwan; University of California System; University of California Irvine; China Medical University Taiwan	Lee, WH (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, 240 Med Sci D, Irvine, CA 92697 USA.	whlee@uci.edu	Zhu, Jiewen/P-8220-2018	Zhu, Jiewen/0000-0002-6742-8138; Ngo, Bryan/0000-0002-7733-2658	NIH [CA107568]; NATIONAL CANCER INSTITUTE [R01CA107568] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the initial efforts by Guideng Li, Randy Wei and Yumay Chen on this project. This work was supported by an NIH grant (CA107568) to WHL.	Andreasson U, 2009, AM J HEMATOL, V84, P803, DOI 10.1002/ajh.21549; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Barbagallo F, 2009, J PATHOL, V217, P431, DOI 10.1002/path.2471; Bieche I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-23; Cavasotto CN, 2003, PROTEINS, V51, P423, DOI 10.1002/prot.10362; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Chen YM, 2002, J BIOL CHEM, V277, P49408, DOI 10.1074/jbc.M207069200; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Diaz-Rodriguez E, 2008, P NATL ACAD SCI USA, V105, P16719, DOI 10.1073/pnas.0803504105; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gurzov EN, 2006, GENE THER, V13, P1, DOI 10.1038/sj.gt.3302595; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Hayward DG, 2006, CANCER LETT, V237, P155, DOI 10.1016/j.canlet.2005.06.017; Hayward DG, 2004, CANCER RES, V64, P7370, DOI 10.1158/0008-5472.CAN-04-0960; Hu J, 2012, J AM CHEM SOC, V124, P10940; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kokuryo T, 2007, CANCER RES, V67, P9637, DOI 10.1158/0008-5472.CAN-07-1489; Li L, 2007, GENE THER, V14, P814, DOI 10.1038/sj.gt.3302933; Lin YT, 2006, ONCOGENE, V25, P6901, DOI 10.1038/sj.onc.1209687; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Ngo B, 2013, J BIOL CHEM, V288, P34403, DOI 10.1074/jbc.M113.490524; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Qiu XL, 2009, J MED CHEM, V52, P1757, DOI 10.1021/jm8015969; Rath O, 2012, NAT REV CANCER, V12, P527, DOI 10.1038/nrc3310; Rowinsky EK, 1997, ANNU REV MED, V48, P353; Sakowicz R, 2004, CANCER RES, V64, P3276, DOI 10.1158/0008-5472.CAN-03-3839; SCHMID I, 1994, CYTOMETRY, V15, P12, DOI 10.1002/cyto.990150104; Schmit TL, 2007, MOL CANCER THER, V6, P1920, DOI 10.1158/1535-7163.MCT-06-0781; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Sundin LJR, 2011, MOL BIOL CELL, V22, P759, DOI 10.1091/mbc.E10-08-0671; Umbreit NT, 2012, P NATL ACAD SCI USA, V109, P16113, DOI 10.1073/pnas.1209615109; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wang SL, 2012, J CELL BIOCHEM, V113, P1904, DOI 10.1002/jcb.24059; Wei R, 2011, MOL BIOL CELL, V22, P3584, DOI 10.1091/mbc.E11-01-0012; Wu GK, 2008, CANCER RES, V68, P8393, DOI 10.1158/0008-5472.CAN-08-1915; Zhou W, 2013, CANCER CELL, V23, P48, DOI 10.1016/j.ccr.2012.12.001; Zhu JW, 2013, EMBO MOL MED, V5, P353, DOI 10.1002/emmm.201201760	48	35	40	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2015	34	10					1220	1230		10.1038/onc.2014.67	http://dx.doi.org/10.1038/onc.2014.67			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC9JX	24662830	Green Accepted, Green Submitted			2022-12-25	WOS:000350687100002
J	Hulikova, A; Swietach, P				Hulikova, Alzbeta; Swietach, Pawel			Rapid CO2 permeation across biological membranes: implications for CO2 venting from tissue	FASEB JOURNAL			English	Article						carbon dioxide; metabolism; excretion; gas channels	RELATIVE CO2/NH3 SELECTIVITIES; CARBON-DIOXIDE TRANSPORT; LIPID BILAYER-MEMBRANES; INTRACELLULAR PH; TUMOR PH; PERMEABILITY; AQUAPORIN-1; ANHYDRASE; DIFFUSION; BLOOD	The degree to which cell membranes are barriers to CO2 transport remains controversial. Proteins, such as aquaporins and Rh complex, have been proposed to facilitate CO2 transport, implying that the nonchannel component of membranes must have greatly reduced CO2 permeability. To determine whether membrane CO2 permeation is rate limiting for gas transport, the spread of CO2 across multicellular tissue growths (spheroids) was measured using intracellular pH as a spatial readout. Colorectal HCT116 cells have basal water and NH3 permeability, indicating the functional absence of aquaporins and gas channels. However, CO2 diffusivity in HCT116 spheroids was only 24 +/- 4% lower than in pure water, which can be accounted for fully by volume exclusion due to proteins. Diffusivity was unaffected by blockers of aquaporins and Rh complex (Hg2+, p-chloromercuribenzoic acid, and 4,4'-diisothiocyano-2,2'-stilbene-disulfonic acid) but decreased under hypertonic conditions (by addition of 300 mOsm mannitol), which increases intracellular protein crowding. Similar CO2 diffusivity was measured in spheroids of T47D breast cells (basal water permeability) and NHDF-Ad fibroblasts (aquaporin-facilitated water permeability). In contrast, diffusivity of NH3, a smaller but less lipophilic gas, was considerably slower than in pure water, as expected from rate-limiting membrane permeation. In conclusion, membranes, even in the functional absence of proposed gas channels, do not restrict CO2 venting from tissue growths.	[Hulikova, Alzbeta; Swietach, Pawel] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Swietach, P (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	pawel.swietach@dpag.ox.ac.uk	Swietach, Pawel/AAK-4169-2020	Swietach, Pawel/0000-0002-9945-9473	Association for International Cancer Research; Royal Society; Worldwide Cancer Research [12-0027] Funding Source: researchfish	Association for International Cancer Research; Royal Society(Royal Society of London); Worldwide Cancer Research	This study was supported by the Association for International Cancer Research and the Royal Society. The authors thank Professor Richard D. Vaughan-Jones for comments on the manuscript, and mentoring, Professor Kenneth W. Spitzer (University of Utah, Salt Lake City, UT, USA) for training in the dual microperfusion technique, Dr. Daniele Dini (Imperial College London, London, UK) for discussions on fluid mechanics, and Dr. Steven Niederer (King's College London, London, UK) for advice on diffusion modeling.	Antonenko YN, 1997, BIOPHYS J, V72, P2187, DOI 10.1016/S0006-3495(97)78862-3; Boron WF, 2011, CHEMPHYSCHEM, V12, P1017, DOI 10.1002/cphc.201100034; Boron WF, 2010, EXP PHYSIOL, V95, P1107, DOI 10.1113/expphysiol.2010.055244; CLAUSS MA, 1990, CANCER RES, V50, P3487; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Endeward V, 2005, J PHYSIOL-LONDON, V567, P253, DOI 10.1113/jphysiol.2005.085761; Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com; Forster RE, 1998, P NATL ACAD SCI USA, V95, P15815, DOI 10.1073/pnas.95.26.15815; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; Geyer RR, 2013, J MEMBRANE BIOL, V246, P915, DOI 10.1007/s00232-013-9593-0; Geyer RR, 2013, AM J PHYSIOL-CELL PH, V304, pC985, DOI 10.1152/ajpcell.00033.2013; GROS G, 1971, PFLUG ARCH EUR J PHY, V324, P249, DOI 10.1007/BF00586422; GUTKNECHT J, 1977, J GEN PHYSIOL, V69, P779; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Hulikova A, 2011, J BIOL CHEM, V286, P13815, DOI 10.1074/jbc.M111.219899; Itel F, 2012, FASEB J, V26, P5182, DOI 10.1096/fj.12-209916; Leem CH, 1999, J PHYSIOL-LONDON, V517, P159, DOI 10.1111/j.1469-7793.1999.0159z.x; LOEWENSTEIN WR, 1966, NATURE, V209, P1248, DOI 10.1038/2091248a0; Mathai JC, 1996, J BIOL CHEM, V271, P1309, DOI 10.1074/jbc.271.3.1309; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Missner A, 2009, CHEMPHYSCHEM, V10, P1405, DOI 10.1002/cphc.200900270; Missner A, 2008, P NATL ACAD SCI USA, V105, pE123, DOI 10.1073/pnas.0809606106; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Nitsche JM, 1999, ANNU REV BIOMED ENG, V1, P463, DOI 10.1146/annurev.bioeng.1.1.463; PEDLEY TJ, 1983, Q REV BIOPHYS, V16, P115, DOI 10.1017/S0033583500005060; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; SIMON SA, 1980, BIOCHIM BIOPHYS ACTA, V596, P352, DOI 10.1016/0005-2736(80)90122-4; Somersalo E, 2012, J THEOR BIOL, V309, P185, DOI 10.1016/j.jtbi.2012.06.016; Spitzer KW, 2000, AM J PHYSIOL-HEART C, V278, pH1371, DOI 10.1152/ajpheart.2000.278.4.H1371; Swietach P, 2010, ONCOGENE, V29, P6509, DOI 10.1038/onc.2010.455; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Swietach P, 2007, BIOPHYS J, V92, P641, DOI 10.1529/biophysj.106.096560; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; Tucker W. A., 1982, HDB CHEM PROPERTY ES, P17; Vanysek P., 1999, CRC HDB CHEM PHYS, P93; VAUPEL P, 1989, CANCER RES, V49, P6449; Verkman AS, 2002, J PHYSIOL-LONDON, V542, P31, DOI 10.1113/jphysiol.2002.024398; WAISBREN SJ, 1994, NATURE, V368, P332, DOI 10.1038/368332a0; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127	43	25	27	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2762	2774		10.1096/fj.13-241752	http://dx.doi.org/10.1096/fj.13-241752			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24652949				2022-12-25	WOS:000337949400004
J	Hong, SK; Zhao, B; Lombard, DB; Fingar, DC; Inoki, K				Hong, Sungki; Zhao, Bin; Lombard, David B.; Fingar, Diane C.; Inoki, Ken			Cross-talk between Sirtuin and Mammalian Target of Rapamycin Complex 1 ( mTORC1) Signaling in the Regulation of S6 Kinase 1 ( S6K1) Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR; mTOR Complex (mTORC); Phosphorylation; S6 Kinase; Sirt1; Sirtuins; Acetylation; Rapamycin	EXTENDS LIFE-SPAN; PROTEIN-KINASE; CELL-GROWTH; DEPENDENT REGULATION; DEACETYLASE SIRT1; HYDROPHOBIC MOTIF; ACETYLATION SITE; AGC KINASES; TOS MOTIF; IN-VIVO	Background: The mTOR complex 1 (mTORC1) phosphorylates ribosomal S6 kinase (S6K1) on Thr-389, leading to S6K1 activation. Results: Inhibition of SIRT1/2, members of the sirtuin family of proteins, induces S6K1 acetylation and inhibits mTORC1-dependent S6K1 phosphorylation. Conclusion: The SIRT1/2 support mTORC1-induced S6K1 activation by inhibiting S6K1 acetylation. Significance: The study provides a novel mechanistic insight into the cross-talk between sirtuins and mTORC1 signaling. p70 ribosomal S6 kinase (S6K1), a major substrate of the mammalian target of rapamycin (mTOR) kinase, regulates diverse cellular processes including protein synthesis, cell growth, and survival. Although it is well known that the activity of S6K1 is tightly coupled to its phosphorylation status, the regulation of S6K1 activity by other post-translational modifications such as acetylation has not been well understood. Here we show that the acetylation of the C-terminal region (CTR) of S6K1 blocks mTORC1-dependent Thr-389 phosphorylation, an essential phosphorylation site for S6K1 activity. The acetylation of the CTR of S6K1 is inhibited by the class III histone deacetylases, SIRT1 and SIRT2. An S6K1 mutant lacking acetylation sites in its CTR shows enhanced Thr-389 phosphorylation and kinase activity, whereas the acetylation-mimetic S6K1 mutant exhibits decreased Thr-389 phosphorylation and kinase activity. Interestingly, relative to the acetylation-mimetic S6K1 mutant, the acetylation-defective mutant displays higher affinity toward Raptor, an essential scaffolding component of mTORC1 that recruits mTORC1 substrates. These observations indicate that sirtuin-mediated regulation of S6K1 acetylation is an additional important regulatory modification that impinges on the mechanisms underlying mTORC1-dependent S6K1 activation.	[Hong, Sungki; Inoki, Ken] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Lombard, David B.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lombard, David B.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Fingar, Diane C.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Inoki, Ken] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Inoki, Ken] Univ Michigan, Ann Arbor, MI 48109 USA; [Zhao, Bin] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhao, Bin] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Zhejiang University; Zhejiang University	Inoki, K (corresponding author), 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	inokik@umich.edu		Lombard, David/0000-0002-4292-0185	National Institutes of Health [DK083491, GM101171, CA177925]; NATIONAL CANCER INSTITUTE [R21CA177925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083491, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK083491 (to K. I.) and GM101171 and CA177925 (to D. B. L.).	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; BANERJEE P, 1990, P NATL ACAD SCI USA, V87, P8550, DOI 10.1073/pnas.87.21.8550; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Black JC, 2008, MOL CELL, V32, P449, DOI 10.1016/j.molcel.2008.09.018; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CHEATHAM L, 1995, P NATL ACAD SCI USA, V92, P11696, DOI 10.1073/pnas.92.25.11696; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Fenton TR, 2010, INT J BIOCHEM CELL B, V42, P359, DOI 10.1016/j.biocel.2009.11.022; Fenton TR, 2010, BIOCHEM BIOPH RES CO, V398, P400, DOI 10.1016/j.bbrc.2010.06.081; Gagarina V, 2010, ARTHRITIS RHEUM-US, V62, P1383, DOI 10.1002/art.27369; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Guo WJ, 2011, J NEUROSCI RES, V89, P1723, DOI 10.1002/jnr.22725; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Ikenoue T, 2008, CANCER RES, V68, P6908, DOI 10.1158/0008-5472.CAN-08-1107; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Li YZ, 2011, GENES CELLS, V16, P34, DOI 10.1111/j.1365-2443.2010.01460.x; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; PRICE DJ, 1991, J BIOL CHEM, V266, P16281; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Roth M, 2014, ONCOGENE, V33, P1609, DOI 10.1038/onc.2013.120; Saitoh M, 1998, BIOCHEM BIOPH RES CO, V253, P470, DOI 10.1006/bbrc.1998.9784; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Satoh Akiko, 2011, Handb Exp Pharmacol, V206, P125, DOI 10.1007/978-3-642-21631-2_7; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Su B, 2011, CRIT REV BIOCHEM MOL, V46, P527, DOI 10.3109/10409238.2011.618113; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Tanny JC, 2004, MOL CELL BIOL, V24, P6931, DOI 10.1128/MCB.24.16.6931-6946.2004; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wang JC, 2013, BIOCHEM J, V454, P39, DOI 10.1042/BJ20121863; Wang YH, 2003, J BIOL CHEM, V278, P25568, DOI 10.1074/jbc.M212574200; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Zhang J, 2007, J BIOL CHEM, V282, P34356, DOI 10.1074/jbc.M706644200; Zhou X, 2013, J CLIN INVEST, V123, P3084, DOI 10.1172/JCI64401	63	65	66	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13132	13141		10.1074/jbc.M113.520734	http://dx.doi.org/10.1074/jbc.M113.520734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652283	Green Published, hybrid			2022-12-25	WOS:000335522800015
J	Bhattacharyya, N; Hu, X; Chen, CZ; Griner, LAM; Zheng, W; Inglese, J; Austin, CP; Marugan, JJ; Southall, N; Neumann, S; Northup, JK; Ferrer, M; Collins, MT				Bhattacharyya, Nisan; Hu, Xin; Chen, Catherine Z.; Griner, Lesley A. Mathews; Zheng, Wei; Inglese, James; Austin, Christopher P.; Marugan, Juan J.; Southall, Noel; Neumann, Susanne; Northup, John K.; Ferrer, Marc; Collins, Michael T.			A High Throughput Screening Assay System for the Identification of Small Molecule Inhibitors of gsp	PLOS ONE			English	Article							MCCUNE-ALBRIGHT SYNDROME; STIMULATORY G-PROTEIN; ADENYLYL-CYCLASE; ALPHA; MUTATIONS	Mis-sense mutations in the alpha-subunit of the G-protein, G(s)alpha, cause fibrous dysplasia of bone/McCune-Albright syndrome. The biochemical outcome of these mutations is constitutively active Gsa and increased levels of cAMP. The aim of this study was to develop an assay system that would allow the identification of small molecule inhibitors specific for the mutant G(s)alpha protein, the so-called gsp oncogene. Commercially available Chinese hamster ovary cells were stably transfected with either wild-type (WT) or mutant G(s)alpha proteins (R201C and R201H). Stable cell lines with equivalent transfected G(s)alpha protein expression that had relatively lower (WT) or higher (R201C and R201H) cAMP levels were generated. These cell lines were used to develop a fluorescence resonance energy transfer (FRET)-based cAMP assay in 1536-well microplate format for high throughput screening of small molecule libraries. A small molecule library of 343,768 compounds was screened to identify modulators of gsp activity. A total of 1,356 compounds with inhibitory activity were initially identified and reconfirmed when tested in concentration dose responses. Six hundred eighty-six molecules were selected for further analysis after removing cytotoxic compounds and those that were active in forskolin-induced WT cells. These molecules were grouped by potency, efficacy, and structural similarities to yield 22 clusters with more than 5 of structurally similar members and 144 singleton molecules. Seven chemotypes of the major clusters were identified for further testing and analyses.	[Bhattacharyya, Nisan; Collins, Michael T.] Natl Inst Dent & Craniofacial Res, Skeletal Clin Studies Unit, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA; [Hu, Xin; Chen, Catherine Z.; Griner, Lesley A. Mathews; Zheng, Wei; Inglese, James; Austin, Christopher P.; Marugan, Juan J.; Southall, Noel; Ferrer, Marc] NIH, Dept Preclin Innovat, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Neumann, Susanne] NIDDK, Clin Endocrinol Branch, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Northup, John K.] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Collins, MT (corresponding author), Natl Inst Dent & Craniofacial Res, Skeletal Clin Studies Unit, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA.	mc247k@nih.gov	Zheng, Wei/GOE-5990-2022; Southall, Noel T/H-8991-2012; Zheng, Wei/J-8889-2014	Southall, Noel T/0000-0003-4500-880X; Zheng, Wei/0000-0003-1034-0757	Division of Intramural Research, National Institute of Dental Research, National Center for Advancing Translational Sciences; National Institute of Diabetes, Digestive and Kidney Diseases; National Institute of Alcoholism and Alcohol Abuse, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000052, ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000649] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Dental Research, National Center for Advancing Translational Sciences; National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Alcoholism and Alcohol Abuse, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Division of Intramural Research, National Institute of Dental Research, National Center for Advancing Translational Sciences, National Institute of Diabetes, Digestive and Kidney Diseases, and National Institute of Alcoholism and Alcohol Abuse, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361; Celi FS, 2008, J CLIN ENDOCR METAB, V93, P2383, DOI 10.1210/jc.2007-2237; CHANSON P, 1994, EUR J ENDOCRINOL, V131, P229, DOI 10.1530/eje.0.1310229; Collins MT, 2011, ORPHANET J IN PRESS; Dumitrescu CE, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-12; Ham J, 1997, MOL CELL ENDOCRINOL, V127, P41, DOI 10.1016/S0303-7207(96)03987-1; HAPPLE R, 1986, CLIN GENET, V29, P321; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Kim Eunhee, 2005, Pituitary, V8, P155, DOI 10.1007/s11102-005-5245-4; Kim IS, 1999, HORM RES, V52, P235, DOI 10.1159/000023467; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LAWRENCE TS, 1979, J CELL BIOL, V80, P21, DOI 10.1083/jcb.80.1.21; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Robey Pamela Gehron, 2007, Pediatr Endocrinol Rev, V4 Suppl 4, P386; SCHWINDINGER WF, 1992, P NATL ACAD SCI USA, V89, P5152, DOI 10.1073/pnas.89.11.5152; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Wang Yuhong, 2010, Curr Chem Genomics, V4, P57, DOI 10.2174/1875397301004010057; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543	23	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e90766	10.1371/journal.pone.0090766	http://dx.doi.org/10.1371/journal.pone.0090766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667240	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600003
J	Tang, NKY; Sanborn, AN				Tang, Nicole K. Y.; Sanborn, Adam N.			Better Quality Sleep Promotes Daytime Physical Activity in Patients with Chronic Pain? A Multilevel Analysis of the Within-Person Relationship	PLOS ONE			English	Article							ELECTRONIC DIARY ASSESSMENT; LOW-BACK-PAIN; FEAR-AVOIDANCE; INDIVIDUAL-DIFFERENCES; MUSCULOSKELETAL PAIN; MOOD DISTURBANCE; INSOMNIA; CONSEQUENCES; VALIDATION; ACTIGRAPHY	Background: Promoting physical activity is key to the management of chronic pain, but little is understood about the factors facilitating an individual's engagement in physical activity on a day-to-day basis. This study examined the within-person effect of sleep on next day physical activity in patients with chronic pain and insomnia. Methods: 119 chronic pain patients monitored their sleep and physical activity for a week in their usual sleeping and living environment. Physical activity was measured using actigraphy to provide a mean activity score each hour. Sleep was estimated with actigraphy and an electronic diary, providing an objective and subjective index of sleep efficiency (A-SE, SE) and a sleep quality rating (SQ). The individual and relative roles of these sleep parameters, as well as morning ratings of pain and mood, in predicting subsequent physical activity were examined in multilevel models that took into account variations in relationships at the 'Day' and 'Participant' levels. Results: Of the 5 plausible predictors SQ was the only significant within-person predictor of subsequent physical activity, such that nights of higher sleep quality were followed by days of more physical activity, from noon to 11 pm. The temporal association was not explained by potential confounders such as morning pain, mood or effects of the circadian rhythm. Conclusions: In the absence of interventions, chronic pain patients spontaneously engaged in more physical activity following a better night of sleep. Improving nighttime sleep may well be a novel avenue for promoting daytime physical activity in patients with chronic pain.	[Tang, Nicole K. Y.; Sanborn, Adam N.] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England	University of Warwick	Sanborn, AN (corresponding author), Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England.	n.tang@warwick.ac.uk	Tang, Nicole KY/B-9998-2009; Sanborn, Adam/G-3715-2010	Tang, Nicole KY/0000-0001-7836-9965; Sanborn, Adam/0000-0003-0442-4372	National Institute for Health Research, UK [PDA/02/06/085]	National Institute for Health Research, UK(National Institute for Health Research (NIHR))	The study was funded by a personal award to NT from the National Institute for Health Research, UK (PDA/02/06/085). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron LA, 2005, J PAIN, V6, P107, DOI 10.1016/j.jpain.2004.11.003; AFFLECK G, 1991, HEALTH PSYCHOL, V10, P419, DOI 10.1037/0278-6133.10.6.419; AFFLECK G, 1994, J PERS SOC PSYCHOL, V66, P329, DOI 10.1037/0022-3514.66.2.329; Affleck G, 1999, J CONSULT CLIN PSYCH, V67, P746, DOI 10.1037/0022-006X.67.5.746; AKERSTEDT T, 1994, PERCEPT MOTOR SKILL, V79, P287, DOI 10.2466/pms.1994.79.1.287; Asmundson GJG, 1999, CLIN PSYCHOL REV, V19, P97, DOI 10.1016/S0272-7358(98)00034-8; Asmundson GJG, 1998, J ANXIETY DISORD, V12, P57, DOI 10.1016/S0887-6185(97)00049-2; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bolger N, 2003, ANNU REV PSYCHOL, V54, P579, DOI 10.1146/annurev.psych.54.101601.145030; Booth JN, 2012, OBESITY, V20, P278, DOI 10.1038/oby.2011.306; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Dam TTL, 2008, J AM GERIATR SOC, V56, P1665, DOI 10.1111/j.1532-5415.2008.01846.x; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Edinger J.D., 2006, DUKE STRUCTURED INTE; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Goldman SE, 2007, SLEEP, V30, P1317, DOI 10.1093/sleep/30.10.1317; Haack M, 2005, PAIN, V119, P56, DOI 10.1016/j.pain.2005.09.011; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Harris S, 2003, PAIN, V105, P363, DOI 10.1016/S0304-3959(03)00251-3; Harvey AG, 2008, SLEEP, V31, P383, DOI 10.1093/sleep/31.3.383; HASENBRING M, 1994, SPINE, V19, P2759, DOI 10.1097/00007632-199412150-00004; Hasenbring MI, 2010, CLIN J PAIN, V26, P747, DOI 10.1097/AJP.0b013e3181e104f2; HAYTHORNTHWAITE JA, 1991, J PAIN SYMPTOM MANAG, V6, P65, DOI 10.1016/0885-3924(91)90520-E; Helmus M, 2012, EUR J PAIN, V16, P1158, DOI 10.1002/j.1532-2149.2011.00109.x; Huijnen IPJ, 2011, EUR J PAIN, V15, P748, DOI 10.1016/j.ejpain.2010.11.015; Huijnen IPJ, 2010, PAIN, V150, P161, DOI 10.1016/j.pain.2010.04.021; Keklund G, 1997, J SLEEP RES, V6, P217, DOI 10.1111/j.1365-2869.1997.00217.x; Lentz MJ, 1999, J RHEUMATOL, V26, P1586; Leonhardt C, 2009, GMS PSYCHOSOCIAL MED, V6; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; Lichstein KL, 2006, SLEEP, V29, P232; MOLDOFSKY H, 1976, PSYCHOSOM MED, V38, P35, DOI 10.1097/00006842-197601000-00006; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Morin CM, 1998, CLIN J PAIN, V14, P311, DOI 10.1097/00002508-199812000-00007; National Institute for Clinical Excellence, 2013, PH44 PHYS ACT BRIEF; National Institute for Clinical Excellence, 2012, PH41 WALK CYCL GUID; National Institute for Clinical Excellence, 2006, PH2 4 COMM US METH I; Peters ML, 2000, PAIN, V84, P181, DOI 10.1016/S0304-3959(99)00206-7; PHILIPS HC, 1987, BEHAV RES THER, V25, P273, DOI 10.1016/0005-7967(87)90005-2; Pilsworth SN, 2001, SLEEP, V24, pA106; Pincus T, 2001, PSYCHOL BULL, V127, P599, DOI 10.1037//0033-2909.127.5.599; Roehrs T, 2006, SLEEP, V29, P145, DOI 10.1093/sleep/29.2.145; Smith MT, 2007, SLEEP, V30, P494, DOI 10.1093/sleep/30.4.494; Smith MT, 2009, CURR PAIN HEADACHE R, V13, P447, DOI 10.1007/s11916-009-0073-2; Stone AA, 2003, CONTROL CLIN TRIALS, V24, P182, DOI 10.1016/S0197-2456(02)00320-3; Tang NKY, 2007, J SLEEP RES, V16, P85, DOI 10.1111/j.1365-2869.2007.00571.x; Tang NKY, 2012, SLEEP, V35, P675, DOI 10.5665/sleep.1830; The IASP Taxonomy Working Group, 2013, CLASS CHRON PAIN DES; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Vendrig AA, 1997, PAIN, V73, P71, DOI 10.1016/S0304-3959(97)00075-4; Verbunt J, 2004, UNDERSTANDING TREATI, P139; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	55	50	51	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92158	10.1371/journal.pone.0092158	http://dx.doi.org/10.1371/journal.pone.0092158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667276	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600023
J	Ajendra, J; Specht, S; Neumann, AL; Gondorf, F; Schmidt, D; Gentil, K; Hoffmann, WH; Taylor, MJ; Hoerauf, A; Hubner, MP				Ajendra, Jesuthas; Specht, Sabine; Neumann, Anna-Lena; Gondorf, Fabian; Schmidt, David; Gentil, Katrin; Hoffmann, Wolfgang H.; Taylor, Mark J.; Hoerauf, Achim; Huebner, Marc P.			ST2 Deficiency Does Not Impair Type 2 Immune Responses during Chronic Filarial Infection but Leads to an Increased Microfilaremia Due to an Impaired Splenic Microfilarial Clearance	PLOS ONE			English	Article							LITOMOSOIDES-SIGMODONTIS; MURINE FILARIASIS; MAST-CELLS; MICE; IL-33; INTERLEUKIN-5; RECEPTOR; SUSCEPTIBILITY; CYTOKINE; ABSENCE	Background: Interactions of the Th2 cytokine IL-33 with its receptor ST2 lead to amplified Type 2 immune responses. As Type 2 immune responses are known to mediate protection against helminth infections we hypothesized that the lack of ST2 would lead to an increased susceptibility to filarial infections. Methodology/Principal Finding: ST2 deficient and immunocompetent BALB/c mice were infected with the filarial nematode Litomosoides sigmodontis. At different time points after infection mice were analyzed for worm burden and their immune responses were examined within the thoracic cavity, the site of infection, and systemically using spleen cells and plasma. Absence of ST2 led to significantly increased levels of peripheral blood microfilariae, the filarial progeny, whereas L. sigmodontis adult worm burden was not affected. Development of local and systemic Type 2 immune responses were not impaired in ST2 deficient mice after the onset of microfilaremia, but L. sigmodontis infected ST2-ko mice had significantly reduced total numbers of cells within the thoracic cavity and spleen compared to infected immunocompetent controls. Pronounced microfilaremia in ST2-ko mice did not result from an increased microfilariae release by adult female worms, but an impaired splenic clearance of microfilariae. Conclusions/Significance: Our findings suggest that the absence of ST2 does not impair the establishment of adult L. sigmodontis worms, but is important for the splenic clearance of microfilariae from peripheral blood. Thus, ST2 interactions may be important for therapies that intend to block the transmission of filarial disease.	[Ajendra, Jesuthas; Specht, Sabine; Neumann, Anna-Lena; Gondorf, Fabian; Schmidt, David; Gentil, Katrin; Hoerauf, Achim; Huebner, Marc P.] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Hoffmann, Wolfgang H.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Taylor, Mark J.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Filariasis Res Lab, Liverpool L3 5QA, Merseyside, England	University of Bonn; Eberhard Karls University of Tubingen; Liverpool School of Tropical Medicine; University of Liverpool	Hubner, MP (corresponding author), Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany.	huebner@microbiology-bonn.de	Hübner, Marc P/O-1684-2019; Hübner, Marc P/W-9529-2018; Hoffmann, Wolfgang H/C-9696-2010	Hübner, Marc P/0000-0001-8885-418X; Hübner, Marc P/0000-0001-8885-418X; Taylor, Mark/0000-0003-3396-9275; Ajendra, Jesuthas/0000-0002-9256-5396	European Commission: Enhanced Protective Immunity Against Filariasis (EPIAF) [242131]; German Research Foundation [HU 2144/1-1]; University Hospital Bonn (BONFOR) [2010-1-16, 2011-1-10]; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme under Research Executive Agency Grant [GA 276704]	European Commission: Enhanced Protective Immunity Against Filariasis (EPIAF); German Research Foundation(German Research Foundation (DFG)); University Hospital Bonn (BONFOR); People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme under Research Executive Agency Grant	This work was funded by the European Commission: Enhanced Protective Immunity Against Filariasis (EPIAF), agreement number 242131, by the German Research Foundation (HU 2144/1-1), intramural funding by the University Hospital Bonn (BONFOR, 2010-1-16 and 2011-1-10), and the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under Research Executive Agency Grant GA 276704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qaoud KM, 1998, INT IMMUNOL, V10, P17, DOI 10.1093/intimm/10.1.17; Al-Qaoud KM, 2000, INT IMMUNOL, V12, P899, DOI 10.1093/intimm/12.6.899; Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; Bouchery T, 2012, PARASITE, V19, P351, DOI 10.1051/parasite/2012194351; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Carter T, 2007, J IMMUNOL, V178, P5116, DOI 10.4049/jimmunol.178.8.5116; CHANDRASHEKAR R, 1984, J HELMINTHOL, V58, P69, DOI 10.1017/S0022149X00028078; Gray CA, 2002, EUR J IMMUNOL, V32, P1114, DOI 10.1002/1521-4141(200204)32:4<1114::AID-IMMU1114>3.0.CO;2-B; HAAS B, 1981, T ROY SOC TROP MED H, V75, P143, DOI 10.1016/0035-9203(81)90046-8; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; HAWKING F, 1962, ANN TROP MED PARASIT, V56, P168, DOI 10.1080/00034983.1962.11686104; Hoffmann WH, 2001, PARASITOLOGY, V122, P641, DOI 10.1017/S0031182001007892; Hoffmann WH, 2000, PARASITOL TODAY, V16, P387, DOI 10.1016/S0169-4758(00)01738-5; HOOK WA, 1974, INFECT IMMUN, V9, P903, DOI 10.1128/IAI.9.5.903-908.1974; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Hubner MP, 2009, IMMUNOLOGY, V127, P512, DOI 10.1111/j.1365-2567.2008.02958.x; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Hung LY, 2012, P NATL ACAD SCI USA; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Martin C, 2000, INFECT IMMUN, V68, P3651, DOI 10.1128/IAI.68.6.3651-3656.2000; Martin C, 2000, MED MICROBIOL IMMUN, V189, P67, DOI 10.1007/PL00008258; Moritz DR, 1998, J IMMUNOL, V161, P4866; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Saeftel M, 2003, INFECT IMMUN, V71, P6978, DOI 10.1128/IAI.71.12.6978-6985.2003; Saeftel M, 2001, MICROBES INFECT, V3, P203, DOI 10.1016/S1286-4579(01)01372-7; Scalfone LK, 2013, INFECT IMMUN, V81, P1354, DOI 10.1128/IAI.01307-12; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Simons JE, 2010, PARASITE IMMUNOL, V32, P473, DOI 10.1111/j.1365-3024.2010.01210.x; Simons JE, 2005, EUR J IMMUNOL, V35, P189, DOI 10.1002/eji.200425541; Specht S, 2006, INFECT IMMUN, V74, P5236, DOI 10.1128/IAI.00329-06; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Volkmann L, 2003, MED MICROBIOL IMMUN, V192, P23, DOI 10.1007/S00430-002-0155-9; WENK P, 1993, TROP MED PARASITOL, V44, P299; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109; Ziewer S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001558	41	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93072	10.1371/journal.pone.0093072	http://dx.doi.org/10.1371/journal.pone.0093072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663956	gold, Green Published, Green Accepted			2022-12-25	WOS:000333459900150
J	Bottero, J; Boyd, A; Lemoine, M; Carrat, F; Gozlan, J; Collignon, A; Boo, N; Dhotte, P; Varsat, B; Muller, G; Cha, O; Valin, N; Nau, J; Campa, P; Silbermann, B; Bary, M; Girard, PM; Lacombe, K				Bottero, Julie; Boyd, Anders; Lemoine, Maud; Carrat, Fabrice; Gozlan, Joel; Collignon, Anne; Boo, Nicolas; Dhotte, Philippe; Varsat, Brigitte; Muller, Gerard; Cha, Olivier; Valin, Nadia; Nau, Jean; Campa, Pauline; Silbermann, Benjamin; Bary, Marc; Girard, Pierre-Marie; Lacombe, Karine			Current State of and Needs for Hepatitis B Screening: Results of a Large Screening Study in a Low-Prevalent, Metropolitan Region	PLOS ONE			English	Article							VIRUS INFECTION; MANAGEMENT; IMPACT	Background: In low hepatitis B virus (HBV)-prevalent countries, most HBV-infected persons are unaware of their status. We aimed to evaluate whether (i) previous HBV-testing, (ii) physicians decision to screen, and (iii) CDC's recommendations identified infected individuals and which risk-factor groups needing testing. Methods: During a mass, multi-center HBV-screening study from September 2010-August 2011, 3929 participants were screened for hepatitis B surface antigen (HBsAg), anti-HBs and anti-Hepatitis B core antibodies (anti-HBcAb). Questions on HBV risk-factors and testing practices were asked to participants, while participants' eligibility for HBV-testing was asked to study medical professionals. Results: 85 (2.2%) participants were HBsAg-positive, while 659 (16.8%) had either resolved HBV infection or isolated anti-HBcAb. When comparing practices, HBV-testing was more likely to occur in HBV-infected participants if Centers for Disease Control and Prevention (CDC) recommendations were used (Sensitivity = 100%, 95%CI: 95.8-100) than physicians' discretion (Sensitivity = 87.1%, 95%CI: 78.0-93.4) or previous HBV-test (Sensitivity = 36.5%, 95%CI: 26.3-47.6) (p<0.0001). Nevertheless, many non-infected individuals would still have been screened using CDC-recommendations (Specificity = 31.1%, 95%CI: 29.6-32.6). Using multivariable logistic regression, HBsAg-positive status was significantly associated with the following: males, originating from high HBV-endemic region, contact with HBV-infected individual, without national healthcare, and intravenous-drug user (IDU). Of these risk-factors, physician's discretion for testing HBV was not significantly associated with participants' geographical origin or IDU. Conclusions: Missed opportunities of HBV-screening are largely due to underestimating country of origin as a risk-factor. Applying CDC-recommendations could improve HBV-screening, but with the disadvantage of many tests. Further development of HBV-testing strategies is necessary, especially before severe disease occurs.	[Bottero, Julie; Boyd, Anders; Carrat, Fabrice; Girard, Pierre-Marie; Lacombe, Karine] Inserm UMR S707, Paris, France; [Bottero, Julie; Carrat, Fabrice; Girard, Pierre-Marie; Lacombe, Karine] Univ Paris 06, Paris, France; [Bottero, Julie; Valin, Nadia; Campa, Pauline; Girard, Pierre-Marie; Lacombe, Karine] Hop St Antoine, AP HP, Serv Malad Infect, F-75571 Paris, France; [Lemoine, Maud] Hop St Antoine, AP HP, Serv Hepatol, F-75571 Paris, France; [Carrat, Fabrice] Hop St Antoine, AP HP, Unite Sante Publ, F-75571 Paris, France; [Gozlan, Joel] Hop St Antoine, AP HP, Virol Lab, F-75571 Paris, France; [Collignon, Anne] Mairie Paris, Lab St Marcel, Paris, France; [Boo, Nicolas] Mairie Paris, Direct Act Sociale Enfance & Sante, Paris, France; [Dhotte, Philippe] Mairie Paris, Ctr Depistage Anonyme & Gratuit CDAG Figuier, Paris, France; [Varsat, Brigitte] CPAM Paris, Dept Examens Period Sante, Paris, France; [Muller, Gerard] CDAG Belleville, Paris, France; [Cha, Olivier] Hop St Antoine, AP HP, Policlin Baudelaire, F-75571 Paris, France; [Nau, Jean] Med Monde, Ctr Accueil Soins & Orientat, Paris, France; [Silbermann, Benjamin] Maison Arret Sante, Unite Consultat & Soins Ambulatoires, Paris, France; [Bary, Marc] Ctr Croix Rouge Moulin Joly, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Bottero, J (corresponding author), Inserm UMR S707, Paris, France.	julie.bottero@sat.aphp.fr	GOZLAN, Joël/P-6014-2017; Boyd, Anders/GLQ-8906-2022; Carrat, Fabrice/AAU-8480-2020	Boyd, Anders/0000-0001-9512-8928; Carrat, Fabrice/0000-0002-8672-7918	Agence Nationale de Recherche sur le Sida et les Hepatites virales [2010-334]; Gilead Sciences; Roche; ANRS	Agence Nationale de Recherche sur le Sida et les Hepatites virales(ANRSFrench National Research Agency (ANR)); Gilead Sciences(Gilead Sciences); Roche(Roche Holding); ANRS(ANRSFrench National Research Agency (ANR))	This study was funded largely in part by the Agence Nationale de Recherche sur le Sida et les Hepatites virales (grant number: 2010-334), Gilead Sciences and Roche. Material support was also provided from the Mairie de Paris. AB was awarded a post-doctoral fellowship from the ANRS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HEP LIV CANC NAT STR; Bottero J, 2013, J HEPATOL, V58, P473, DOI 10.1016/j.jhep.2012.11.016; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Crutzen Rik, 2012, J Infect Public Health, V5, P195, DOI 10.1016/j.jiph.2011.12.001; d'Almeida KW, 2012, ARCH INTERN MED, V172, P12, DOI 10.1001/archinternmed.2011.535; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Direction generale de la sante (DGS), 2009, PLAN NAT LUTT HEP B; ECDC, 2010, SURV PREV HEP B C EU; ELPA, 2010, REP HEP PAT SELF HEL; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Hatzakis A, 2011, J VIRAL HEPATITIS, V18, P1, DOI 10.1111/j.1365-2893.2011.01499.x; Hu DJ, 2013, HEPATOLOGY; IGF, 2010, AN EV DEP TITR AID M; Insee, 2009, REC 2009 EXPL PRINC; Insee, 2010, EV AG MOYEN AG MED P; Meffre C, 2006, PREVALENCE HEPATITES; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Perumalswami PV, 2013, J HEPATOL, V58, P890, DOI 10.1016/j.jhep.2013.01.004; Scott C, 2010, J INFECTION, V60, P351, DOI 10.1016/j.jinf.2010.01.013; Spenatto N, 2013, J HEPATOL, V58, P690, DOI 10.1016/j.jhep.2012.11.044; Tosini S, 2009, B EPIDEMIOL HEBD, V20-21, P217; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; WHO, 2002, HEP B; WHO, 2012, HEP B WHO FACT SHEET; Wong WWL, 2011, LIVER INT, V31, P1179, DOI 10.1111/j.1478-3231.2011.02559.x; Xiong M, 2013, J IMMIGR MINOR HLTH	26	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92266	10.1371/journal.pone.0092266	http://dx.doi.org/10.1371/journal.pone.0092266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663387	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900049
J	Mamik, MK; Ghorpade, A				Mamik, Manmeet K.; Ghorpade, Anuja			Chemokine CXCL8 Promotes HIV-1 Replication in Human Monocyte-Derived Macrophages and Primary Microglia via Nuclear Factor-kappa B Pathway	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; POLYMERASE-CHAIN-REACTION; BLOOD-BRAIN-BARRIER; IN-VITRO; MONONUCLEAR PHAGOCYTES; TYPE-1 REPLICATION; MULTIPLE-SCLEROSIS; NEURONAL INJURY; RECEPTORS CCR3	Background: Chemokine CXCL8 is an important neutrophil chemoattractant implicated in various neurodegenerative disorders. Cytokine/chemokine imbalance, with an increase in proinflammatory cytokines like interleukin-1 beta and tumor necrosis factor-a within the central nervous system, is a hallmark of human immunodeficiency virus (HIV)-1 infection. We previously reported that HIV-1 infection is linked to upregulation of CXCL8 in brain tissues and human astrocytes. Chemokines play crucial roles in trafficking of leukocytes and trafficking of HIV-1-infected across the blood-brain barrier play an important role in HIV-1 central nervous system disease. In the post-antiretroviral therapy era, low level of productive replication of HIV-1 in brain is a critical component of neuropathogenesis regulation. The present study investigated the effect of CXCL8 on productive infection of HIV-1 in human monocytes-derived macrophages (MDM) and primary human microglia. Results: Human MDM and microglia were infected with the blood or brain derived HIV-1 isolates, HIV-1(ADA) or HIV-1(JRFL). Treatment with CXCL8 significantly upregulated HIV-1p24 levels in supernatants of both HIV-1-infected MDM as well as microglia. In addition, the formation of 2-long terminal repeat (LTR) circles, a measure of viral genome integration, was significantly higher in CXCL8-treated, HIV-1-infected MDM and microglia. Transient transfection of U937 cells with HIV-1 LTR luciferase reporter construct resulted in increased promoter activity when treated with CXCL8. Moreover, increased nuclear translocation of nuclear factor-kappa B was seen in HIV-1-infected MDM following CXCL8 treatment. Blocking CXCL8 receptors CXCR1 and CXCR2 abrogated the CXCL8-mediated enhanced HIV-1 replication. Conclusion: Our results show that CXCL8 mediates productive infection of HIV-1 in MDM and microglia via receptors CXCR1 and CXCR2. These results demonstrate that CXCL8 exerts its downstream effects by increasing translocation of nuclear factor-kappa B into the nucleus, thereby promotin g HIV-1 LTR activity.	[Mamik, Manmeet K.; Ghorpade, Anuja] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Ghorpade, A (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA.	anuja.ghorpade@unthsc.edu	Mamik, Manmeet/E-2534-2016	Mamik, Manmeet/0000-0002-7212-5430	NIMH [R01MH087345]; NIH from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [5R24HD0008836]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087345] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH from the Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by R01MH087345 from NIMH to A. Ghorpade. The project entitled 'Laboratory of Developmental Biology' was supported by NIH Award Number 5R24HD0008836 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The content does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bachu M, 2012, AIDS RES HUM RETROV, V28, P1362, DOI 10.1089/aid.2011.0388; Bagasra O, 1996, AIDS, V10, P573, DOI 10.1097/00002030-199606000-00002; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bergamini A, 1999, J INFECT DIS, V179, P832, DOI 10.1086/314662; Borgmann Kathleen, 2005, Methods Mol Biol, V304, P49; Brosnan CF, 2013, GLIA, V61, P453, DOI 10.1002/glia.22443; Burkala EJ, 2005, AIDS, V19, P675, DOI 10.1097/01.aids.0000166090.31693.aa; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Carrol ED, 2007, JAIDS-J ACQ IMM DEF, V44, P443, DOI 10.1097/QAI.0b013e31802f8390; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Coffey MJ, 1997, AM J PHYSIOL-LUNG C, V272, pL1025, DOI 10.1152/ajplung.1997.272.5.L1025; Coltart I, 2013, ARCH BIOCHEM BIOPHYS, V536, P189, DOI 10.1016/j.abb.2013.03.016; Copeland KFT, 1998, CLIN EXP IMMUNOL, V114, P87; Cosenza-Nashat M, 2007, J NEUROVIROL, V13, P536, DOI 10.1080/13550280701549417; Cota M, 2000, J NEUROVIROL, V6, P75, DOI 10.3109/13550280009006384; D'Aversa TG, 2008, J NEUROSCI RES, V86, P630, DOI 10.1002/jnr.21525; D'Aversa TG, 2004, J NEUROVIROL, V10, P86, DOI 10.1080/13550280490279807; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Dolei A, 1998, AIDS, V12, P183, DOI 10.1097/00002030-199802000-00008; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Garau A, 2005, CYTOKINE, V30, P125, DOI 10.1016/j.cyto.2004.12.014; Gartner S, 2002, J NEUROVIROL, V8, P69, DOI 10.1080/13550280290049525; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Ghorpade A, 2005, J NEUROIMMUNOL, V163, P135, DOI 10.1016/j.jneuroim.2005.01.021; Ghorpade A, 2005, J NEUROIMMUNOL, V163, P145, DOI 10.1016/j.jneuroim.2005.01.022; Ghorpade A, 1998, J VIROL, V72, P3351, DOI 10.1128/JVI.72.4.3351-3361.1998; Ghorpade A, 1998, J VIROL, V72, P3340, DOI 10.1128/JVI.72.4.3340-3350.1998; Ghorpade A, 2001, J VIROL, V75, P6572, DOI 10.1128/JVI.75.14.6572-6583.2001; Giovannelli A, 1998, J NEUROIMMUNOL, V92, P122, DOI 10.1016/S0165-5728(98)00192-1; Goczalik I, 2008, INVEST OPHTH VIS SCI, V49, P4578, DOI 10.1167/iovs.08-1887; Gordon CJ, 1999, J VIROL, V73, P684, DOI 10.1128/JVI.73.1.684-694.1999; Gouwy M, 2008, MOL PHARMACOL, V74, P485, DOI 10.1124/mol.108.045146; Huang YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005397; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Jones MV, 2000, AIDS, V14, P2709, DOI 10.1097/00002030-200012010-00010; Julias JG, 2001, J VIROL, V75, P6537, DOI 10.1128/JVI.75.14.6537-6546.2001; Kandel E.R., 2000, PRINCIPLES NEURAL SC, Vxli, P1414; KARAGEORGOS L, 1993, AIDS RES HUM RETROV, V9, P817, DOI 10.1089/aid.1993.9.817; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Kim YK, 2006, EMBO J, V25, P3596, DOI 10.1038/sj.emboj.7601248; KLAVER B, 1994, J VIROL, V68, P3830, DOI 10.1128/JVI.68.6.3830-3840.1994; Kostic M, 2013, REV NEUROSCIENCE, V24, P71, DOI 10.1515/revneuro-2012-0062; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Lamers SL, 2012, INT REV IMMUNOL, V31, P432, DOI 10.3109/08830185.2012.737073; Lane BR, 2001, J VIROL, V75, P8195, DOI 10.1128/JVI.75.17.8195-8202.2001; Langford D, 2001, BRAIN PATHOL, V11, P306; Li MH, 2012, INT IMMUNOPHARMACOL, V12, P643, DOI 10.1016/j.intimp.2011.12.022; Mamik MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045596; Mandal Dibyakanti, 2009, V485, P73, DOI 10.1007/978-1-59745-170-3_6; MANTHORPE M, 1986, DEV BRAIN RES, V25, P191, DOI 10.1016/0165-3806(86)90208-7; MATSUMOTO T, 1993, CLIN EXP IMMUNOL, V93, P149; Miller-Jensen K, 2012, INTEGR BIOL-UK, V4, P661, DOI 10.1039/c2ib20009k; Mirani M, 2002, J IMMUNOL, V169, P6361, DOI 10.4049/jimmunol.169.11.6361; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munkanta M, 2005, AIDS RES HUM RETROV, V21, P901, DOI 10.1089/aid.2005.21.901; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197; Nagira M, 1999, VIROLOGY, V264, P422, DOI 10.1006/viro.1999.0011; OBRIEN WA, 1990, NATURE, V348, P69, DOI 10.1038/348069a0; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Pierson TC, 2002, J VIROL, V76, P4138, DOI 10.1128/JVI.76.8.4138-4144.2002; Puma C, 2001, J NEUROCHEM, V78, P960, DOI 10.1046/j.1471-4159.2001.00469.x; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; RICH EA, 1992, J CLIN INVEST, V89, P176, DOI 10.1172/JCI115559; Roth AD, 2005, BIOL RES, V38, P381, DOI 10.4067/S0716-97602005000400011; Sanders VJ, 1998, AIDS, V12, P1021, DOI 10.1097/00002030-199809000-00008; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, pL1094, DOI 10.1152/ajplung.2001.280.6.L1094; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Sopper S, 1996, VIROLOGY, V220, P320, DOI 10.1006/viro.1996.0320; Stroud JC, 2009, J MOL BIOL, V393, P98, DOI 10.1016/j.jmb.2009.08.023; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Thea DM, 1996, ANN INTERN MED, V124, P757, DOI 10.7326/0003-4819-124-8-199604150-00009; Trkola A, 1999, J VIROL, V73, P6370, DOI 10.1128/JVI.73.8.6370-6379.1999; Tufekci KU, 2012, ADV PROTEIN CHEM STR, V88, P69, DOI 10.1016/B978-0-12-398314-5.00004-0; Vogel CFA, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-17; Weinstein James D, 2013, Consult Pharm, V28, P443, DOI 10.4140/TCP.n.2013.443; Wires ES, 2012, J NEUROVIROL, V18, P400, DOI 10.1007/s13365-012-0103-4; Xing HQ, 2009, NEUROPATHOLOGY, V29, P433, DOI 10.1111/j.1440-1789.2008.00996.x; Yim HCH, 2009, AIDS, V23, P1473, DOI 10.1097/QAD.0b013e32832d7abe; Zhang Xia, 2009, V531, P123, DOI 10.1007/978-1-59745-396-7_9; Zheng JC, 2008, J NEUROIMMUNOL, V200, P100, DOI 10.1016/j.jneuroim.2008.06.015; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002	90	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92145	10.1371/journal.pone.0092145	http://dx.doi.org/10.1371/journal.pone.0092145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662979	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900043
J	Nordey, T; Lechaudel, M; Saudreau, M; Joas, J; Genard, M				Nordey, Thibault; Lechaudel, Mathieu; Saudreau, Marc; Joas, Jacques; Genard, Michel			Model-Assisted Analysis of Spatial and Temporal Variations in Fruit Temperature and Transpiration Highlighting the Role of Fruit Development	PLOS ONE			English	Article							VAPOR-PRESSURE DEFICIT; MANGIFERA-INDICA L.; MANGO FRUIT; RESPIRATION RATE; TOMATO FRUITS; PEACH FRUIT; APPLE FRUIT; SURFACE CONDUCTANCE; AEROBIC CONDITIONS; SIMULATION-MODEL	Fruit physiology is strongly affected by both fruit temperature and water losses through transpiration. Fruit temperature and its transpiration vary with environmental factors and fruit characteristics. In line with previous studies, measurements of physical and thermal fruit properties were found to significantly vary between fruit tissues and maturity stages. To study the impact of these variations on fruit temperature and transpiration, a modelling approach was used. A physical model was developed to predict the spatial and temporal variations of fruit temperature and transpiration according to the spatial and temporal variations of environmental factors and thermal and physical fruit properties. Model predictions compared well to temperature measurements on mango fruits, making it possible to accurately simulate the daily temperature variations of the sunny and shaded sides of fruits. Model simulations indicated that fruit development induced an increase in both the temperature gradient within the fruit and fruit water losses, mainly due to fruit expansion. However, the evolution of fruit characteristics has only a very slight impact on the average temperature and the transpiration per surface unit. The importance of temperature and transpiration gradients highlighted in this study made it necessary to take spatial and temporal variations of environmental factors and fruit characteristics into account to model fruit physiology.	[Nordey, Thibault; Lechaudel, Mathieu] CIRAD, UPR HORTSYS, St Pierre, Reunion, France; [Saudreau, Marc] INRA, UMR PIAF 547, F-10448 Clermont Ferrand, France; [Joas, Jacques] CIRAD, UMR QUALISUD, Montpellier, France; [Genard, Michel] INRA, UR 1115, Avignon, France	CIRAD; INRAE; CIRAD; Universite de Montpellier; INRAE	Nordey, T (corresponding author), CIRAD, UPR HORTSYS, St Pierre, Reunion, France.	thibault.nordey@cirad.fr			CIRAD	CIRAD	The CIRAD (http://www.cirad.fr/) has supported this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SR, 2001, ANN BOT-LONDON, V88, P869, DOI 10.1006/anbo.2001.1524; Ahrens J., 2005, VISUALIZATION HDB, P717, DOI [10.1016/B978-012387582-2/50038-1, DOI 10.1016/B978-012387582-2/50038-1]; Ayala-Silva T, 2005, PROC FL STATE HORTIC, V118, P253; Bally ISE, 1999, SCI HORTIC-AMSTERDAM, V79, P13, DOI 10.1016/S0304-4238(98)00159-9; Bengtsson H, 2011, R MATLAB READ WRITE; BUCK AL, 1981, J APPL METEOROL, V20, P1527, DOI 10.1175/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2; CELLIER P, 1993, AGR FOREST METEOROL, V63, P35, DOI 10.1016/0168-1923(93)90021-9; Courant R, 1928, MATH ANN, V100, P32, DOI 10.1007/BF01448839; da Luz BR, 2006, NEW PHYTOL, V172, P305, DOI 10.1111/j.1469-8137.2006.01823.x; Fishman S, 1998, PLANT CELL ENVIRON, V21, P739, DOI 10.1046/j.1365-3040.1998.00322.x; Fonseca SC, 2002, J FOOD ENG, V52, P99, DOI 10.1016/S0260-8774(01)00106-6; Gautier H, 2008, J AGR FOOD CHEM, V56, P1241, DOI 10.1021/jf072196t; GENARD M, 1992, SCI HORTIC-AMSTERDAM, V52, P37, DOI 10.1016/0304-4238(92)90006-X; Genard M, 1996, J AM SOC HORTIC SCI, V121, P1122, DOI 10.21273/JASHS.121.6.1122; Gibert C, 2010, FUNCT PLANT BIOL, V37, P264, DOI 10.1071/FP09118; GROSSMAN YL, 1994, TREE PHYSIOL, V14, P329, DOI 10.1093/treephys/14.4.329; Guichard S, 2005, J PLANT GROWTH REGUL, V24, P201, DOI 10.1007/s00344-005-0040-z; Guilioni L, 2006, AGR FOREST METEOROL, V138, P258, DOI 10.1016/j.agrformet.2006.05.010; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Hetherington SE, 1997, J HORTIC SCI, V72, P755, DOI 10.1080/14620316.1997.11515568; Hewett E. W., 2006, International Journal of Postharvest Technology and Innovation, V1, P4, DOI 10.1504/IJPTI.2006.009178; Ho QT, 2010, J EXP BOT, V61, P2745, DOI 10.1093/jxb/erq108; Ho QT, 2010, J EXP BOT, V61, P2071, DOI 10.1093/jxb/erq026; Honda C, 2002, PLANT PHYSIOL BIOCH, V40, P955, DOI 10.1016/S0981-9428(02)01454-7; Ihaka Ross, 2012, COLORSPACE COLOR SPA; Jordan RB, 2000, POSTHARVEST BIOL TEC, V20, P163, DOI 10.1016/S0925-5214(00)00125-3; Kang SP, 2008, POSTHARVEST BIOL TEC, V49, P77, DOI 10.1016/j.postharvbio.2007.12.011; Khabba S, 2001, EUR J AGRON, V14, P197, DOI 10.1016/S1161-0301(00)00095-2; Lancaster JE, 1997, J AM SOC HORTIC SCI, V122, P594, DOI 10.21273/JASHS.122.4.594; Lechaudel M, 2005, TREE PHYSIOL, V25, P583, DOI 10.1093/treephys/25.5.583; Lechaudel M, 2002, J HORTIC SCI BIOTECH, V77, P773, DOI 10.1080/14620316.2002.11511571; Lechaudel M, 2012, J PLANT PHYSL; Léchaudel Mathieu, 2007, Braz. J. Plant Physiol., V19, P287, DOI 10.1590/S1677-04202007000400004; Lechaudel M, 2007, TREE PHYSIOL, V27, P219, DOI 10.1093/treephys/27.2.219; Leonardi C, 2000, SCI HORTIC-AMSTERDAM, V84, P285, DOI 10.1016/S0304-4238(99)00127-2; Leonardi C, 2000, SCI HORTIC-AMSTERDAM, V84, P297, DOI 10.1016/S0304-4238(99)00130-2; Lescourret F, 2001, TREE PHYSIOL, V21, P735, DOI 10.1093/treephys/21.11.735; Lewicki PP, 2004, J FOOD ENG, V61, P483, DOI 10.1016/S0260-8774(03)00219-X; Maguire KM, 1999, POSTHARVEST BIOL TEC, V17, P11, DOI 10.1016/S0925-5214(99)00034-4; Mangaraj S, 2011, FOOD BIOPROCESS TECH, V4, P272, DOI 10.1007/s11947-008-0145-z; Maxwell E. L., 1987, SERITR2153087, P35; MCDONALD RE, 1993, HORTSCIENCE, V28, P311, DOI 10.21273/HORTSCI.28.4.311; MEDLICOTT AP, 1986, ANN APPL BIOL, V109, P651, DOI 10.1111/j.1744-7348.1986.tb03222.x; Merzlyak MN, 2003, POSTHARVEST BIOL TEC, V27, P197, DOI 10.1016/S0925-5214(02)00066-2; Montanaro G, 2006, PLANT SCI, V170, P520, DOI 10.1016/j.plantsci.2005.10.004; Montanaro G, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls036; Montanaro G, 2010, J PLANT NUTR SOIL SC, V173, P618, DOI 10.1002/jpln.200900376; Monteith J.L., 1990, PRINCIPLES ENV PHYS, V2nd; Morandi B, 2007, J EXP BOT, V58, P3941, DOI 10.1093/jxb/erm248; NORDBY HE, 1995, J AGR FOOD CHEM, V43, P1828, DOI 10.1021/jf00055a015; Normand F, 2001, J HORTIC SCI BIOTECH, V76, P541; Paull RE, 2000, POSTHARVEST BIOL TEC, V21, P21, DOI 10.1016/S0925-5214(00)00162-9; Picard A, 2008, METROLOGIA, V45, P149, DOI 10.1088/0026-1394/45/2/004; PROCTOR JTA, 1969, PHYTOCHEMISTRY, V8, P2108, DOI 10.1016/S0031-9422(00)88106-6; Ravindra MR, 2008, BIOSYST ENG, V99, P239, DOI 10.1016/j.biosystemseng.2007.10.005; Reda I, 2004, SOL ENERGY, V76, P577, DOI 10.1016/j.solener.2003.12.003; Richter A, 2012, INT J HEAT MASS TRAN, V55, P1343, DOI 10.1016/j.ijheatmasstransfer.2011.09.005; Saudreau M, 2009, AGR FOREST METEOROL, V149, P362, DOI 10.1016/j.agrformet.2008.09.001; Saudreau M, 2007, AGR FOREST METEOROL, V147, P1, DOI 10.1016/j.agrformet.2007.06.006; Siebel JE., 1982, ICE REFRIGERATION, V2, P256; Steyn WJ, 2009, PHYSIOL PLANTARUM, V136, P461, DOI 10.1111/j.1399-3054.2009.01246.x; Team RC, 2012, R LANG ENV STAT COMP; Valente M, 1990, ENG FOOD PHYS PROPER, V1, P432; Verboven P, 2008, PLANT PHYSIOL, V147, P518, DOI 10.1104/pp.108.118935; Vogg G, 2004, J EXP BOT, V55, P1401, DOI 10.1093/jxb/erh149; WALTER WM, 1990, J AM SOC HORTIC SCI, V115, P444, DOI 10.21273/JASHS.115.3.444; WHITAKER S, 1972, AICHE J, V18, P361, DOI 10.1002/aic.690180219; Woolf AB, 1999, POSTHARVEST BIOL TEC, V15, P143, DOI 10.1016/S0925-5214(98)00077-5	68	13	13	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92532	10.1371/journal.pone.0092532	http://dx.doi.org/10.1371/journal.pone.0092532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663687	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900071
J	Stimpson, KM; Sullivan, LL; Kuo, ME; Sullivan, BA				Stimpson, Kaitlin M.; Sullivan, Lori L.; Kuo, Molly E.; Sullivan, Beth A.			Nucleolar Organization, Ribosomal DNA Array Stability, and Acrocentric Chromosome Integrity Are Linked to Telomere Function	PLOS ONE			English	Article							RNA-POLYMERASE-I; BETA-SATELLITE DNA; MAMMALIAN TELOMERES; FACTOR UBF; TRANSCRIPTION; TRF2; LOCALIZATION; PROTEINS; BINDING; GENOME	The short arms of the ten acrocentric human chromosomes share several repetitive DNAs, including ribosomal RNA genes (rDNA). The rDNA arrays correspond to nucleolar organizing regions that coalesce each cell cycle to form the nucleolus. Telomere disruption by expressing a mutant version of telomere binding protein TRF2 (dnTRF2) causes non-random acrocentric fusions, as well as large-scale nucleolar defects. The mechanisms responsible for acrocentric chromosome sensitivity to dysfunctional telomeres are unclear. In this study, we show that TRF2 normally associates with the nucleolus and rDNA. However, when telomeres are crippled by dnTRF2 or RNAi knockdown of TRF2, gross nucleolar and chromosomal changes occur. We used the controllable dnTRF2 system to precisely dissect the timing and progression of nucleolar and chromosomal instability induced by telomere dysfunction, demonstrating that nucleolar changes precede the DNA damage and morphological changes that occur at acrocentric short arms. The rDNA repeat arrays on the short arms decondense, and are coated by RNA polymerase I transcription binding factor UBF, physically linking acrocentrics to one another as they become fusogenic. These results highlight the importance of telomere function in nucleolar stability and structural integrity of acrocentric chromosomes, particularly the rDNA arrays. Telomeric stress is widely accepted to cause DNA damage at chromosome ends, but our findings suggest that it also disrupts chromosome structure beyond the telomere region, specifically within the rDNA arrays located on acrocentric chromosomes. These results have relevance for Robertsonian translocation formation in humans and mechanisms by which acrocentric-acrocentric fusions are promoted by DNA damage and repair.	[Stimpson, Kaitlin M.; Sullivan, Lori L.; Sullivan, Beth A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Stimpson, Kaitlin M.; Kuo, Molly E.; Sullivan, Beth A.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Sullivan, Beth A.] Duke Univ, Div Human Genet, Durham, NC USA	Duke University; Duke University; Duke University	Sullivan, BA (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	beth.sullivan@duke.edu	Sullivan, Beth A/Q-3456-2017	Sullivan, Beth A/0000-0001-5216-4603	NIH grants [F31 AG034749, R01 GM098500]; March of Dimes Research Grant [6-FY10-294]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG034749] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Research Grant(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants F31 AG034749 (to KMS) and R01 GM098500 (to BAS) and March of Dimes Research Grant 6-FY10-294 (to BAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Amato A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-119; ANASTASSOVAKRISTEVA M, 1977, J CELL SCI, V25, P103; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bell P, 1997, J CELL SCI, V110, P2053; BENAVENTE R, 1987, J CELL BIOL, V105, P1483, DOI 10.1083/jcb.105.4.1483; Bradshaw PS, 2005, NAT GENET, V37, P193, DOI 10.1038/ng1506; Bridger JM, 1998, CHROMOSOME RES, V6, P13, DOI 10.1023/A:1009210206855; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; BROSS K, 1973, HUMANGENETIK, V18, P71; BUSCH H, 1963, EXP CELL RES, P150; CHOO KHA, 1992, AM J HUM GENET, V50, P706; Csonka E, 2000, J CELL SCI, V113, P3207; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; de Planell-Saguer M, 2010, NAT PROTOC, V5, P1061, DOI 10.1038/nprot.2010.62; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Fouche N, 2006, J BIOL CHEM, V281, P37486, DOI 10.1074/jbc.M608778200; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; GREIG GM, 1992, GENOMICS, V12, P573, DOI 10.1016/0888-7543(92)90450-7; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Haaf T, 1996, EXP CELL RES, V224, P163, DOI 10.1006/excr.1996.0124; HAMERTON JL, 1975, CLIN GENET, V8, P223; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Heliot L, 1997, MOL BIOL CELL, V8, P2199, DOI 10.1091/mbc.8.11.2199; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; JIMENEZGARCIA LF, 1994, MOL BIOL CELL, V5, P955, DOI 10.1091/mbc.5.9.955; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Krystosek A, 1998, EXP CELL RES, V241, P202, DOI 10.1006/excr.1998.4046; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; Moore HM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009241; Mravinac B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006602; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Pondarre C, 1997, NUCLEIC ACIDS RES, V25, P4111, DOI 10.1093/nar/25.20.4111; Samoshkin A, 2012, CHROMOSOMA, V121, P191, DOI 10.1007/s00412-011-0353-6; Sanij E, 2009, EPIGENETICS-US, V4, P274, DOI 10.4161/epi.4.6.9449; Shiels C, 1997, CYTOGENET CELL GENET, V76, P20, DOI 10.1159/000134504; Simonet T, 2011, CELL RES, V21, P1028, DOI 10.1038/cr.2011.40; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; SPADARI S, 1973, MOL GEN GENET, V127, P57, DOI 10.1007/BF00267783; Stansel RM, 2001, EMBO J, V20, P5532; Stimpson KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001061; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; TROWELL HE, 1993, HUM MOL GENET, V2, P1639, DOI 10.1093/hmg/2.10.1639; Tsai RYL, 2009, CELL CYCLE, V8, P2912; Tsang CK, 2007, EMBO J, V26, P448, DOI 10.1038/sj.emboj.7601488; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6; WAYE JS, 1989, P NATL ACAD SCI USA, V86, P6250, DOI 10.1073/pnas.86.16.6250; WEIER HUG, 1991, CHROMOSOMA, V100, P371, DOI 10.1007/BF00337515; Yang D, 2011, CELL RES, V21, P1013, DOI 10.1038/cr.2011.39; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897; ZATSEPINA OV, 1993, CHROMOSOMA, V102, P599, DOI 10.1007/BF00352307; Zhang SS, 2004, J CELL SCI, V117, P3935, DOI 10.1242/jcs.01249	58	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92432	10.1371/journal.pone.0092432	http://dx.doi.org/10.1371/journal.pone.0092432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662969	gold, Green Submitted, Green Published			2022-12-25	WOS:000333459900062
J	Zhang, H; Chen, J; Liu, FH; Gao, CT; Wang, XC; Zhao, TS; Liu, JC; Gao, S; Zhao, X; Ren, H; Hao, JH				Zhang, Huan; Chen, Jing; Liu, Fenghua; Gao, Chuntao; Wang, Xiuchao; Zhao, Tiansuo; Liu, Jingcheng; Gao, Song; Zhao, Xiao; Ren, He; Hao, Jihui			CypA, a Gene Downstream of HIF-1 alpha, Promotes the Development of PDAC	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; EPIDERMAL-GROWTH-FACTOR; PANCREATIC-CANCER; CYCLOPHILIN-A; CROSS-TALK; KAPPA-B; CYCLOSPORINE; EXPRESSION; AGENTS; CELLS	Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a highly important transcription factor involved in cell metabolism. HIF-1 alpha promotes glycolysis and inhibits of mitochondrial respiration in pancreatic ductal adenocarcinoma (PDAC). In response to tumor hypoxia, cyclophilin A (CypA) is over-expressed in various cancer types, and is associated with cell apoptosis, tumor invasion, metastasis, and chemoresistance in PDAC. In this study, we showed that both HIF-1 alpha and CypA expression were significantly associated with lymph node metastasis and tumor stage. The expression of CypA was correlated with HIF-1 alpha. Moreover, the mRNA and protein expression of CypA markedly decreased or increased following the suppression or overexpression of HIF-1 alpha in vitro. Chromatin immunoprecipitation analysis showed that HIF-1 alpha could directly bind to the hypoxia response element (HRE) in the CypA promoter regions and regulated CypA expression. Consistent with other studies, HIF-1 alpha and CypA promoted PDAC cell proliferation and invasion, and suppressed apoptosis in vitro. Furthermore, we proved the combination effect of 2-methoxyestradiol and cyclosporin A both in vitro and in vivo. These results suggested that, CypA, a gene downstream of HIF-1 alpha, could promote the development of PDAC. Thus, CypA might serve as a potential therapeutic target for PDAC.	[Zhang, Huan; Chen, Jing; Liu, Fenghua; Gao, Chuntao; Wang, Xiuchao; Zhao, Tiansuo; Liu, Jingcheng; Gao, Song; Zhao, Xiao; Ren, He; Hao, Jihui] Tianjin Med Univ Canc Inst & Hosp, Dept Pancreat Canc, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China	Tianjin Medical University	Ren, H (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Pancreat Canc, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	renhe@tjmuch.com; haojihui@tjmuch.com			National Natural Science Foundation of China [81302082, 81272685, 31301151, 81172355]; Doctoral Fund of Ministry of Education of China [20101202110002]; Key program of Natural Science Foundation of Tianjin [09JCZDJC17100, 11JCZDJC18400]; major anticancer Technologies R & D Program of Tianjin [12ZCDZSY16700]; Tianjin Educational Commission [20100123]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Key program of Natural Science Foundation of Tianjin; major anticancer Technologies R & D Program of Tianjin; Tianjin Educational Commission	Funding: National Natural Science Foundation of China (Grant No. 81302082, 81272685, 31301151, 81172355); Doctoral Fund of Ministry of Education of China (Grant No. 20101202110002; Key program of Natural Science Foundation of Tianjin (Grant No. 09JCZDJC17100, 11JCZDJC18400); major anticancer Technologies R & D Program of Tianjin (Grant No. 12ZCDZSY16700); project of Tianjin Educational Commission (Grant No. 20100123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Y, 2009, BRIT J CANCER, V101, P1307, DOI 10.1038/sj.bjc.6605312; Andre N, 2004, MED HYPOTHESES, V63, P647, DOI 10.1016/j.mehy.2004.03.030; Bane FT, 2009, J PHARMACOL EXP THER, V329, P38, DOI 10.1124/jpet.108.148130; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Chen S, 2008, CANCER CHEMOTH PHARM, V61, P459, DOI 10.1007/s00280-007-0491-y; Choi KJ, 2007, CANCER RES, V67, P3654, DOI 10.1158/0008-5472.CAN-06-1759; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Fong GH, 2008, ANGIOGENESIS, V11, P121, DOI 10.1007/s10456-008-9107-3; Grigoryeva ES, 2013, PATHOL ONCOL RES; Hamel E, 2003, CELL BIOCHEM BIOPHYS, V38, P1, DOI 10.1385/CBB:38:1:1; Han XZ, 2010, ONCOL REP, V23, P1053, DOI 10.3892/or_00000732; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; Hao JH, 2004, CANCER RES, V64, P3607, DOI 10.1158/0008-5472.CAN-03-3648; Hu YZ, 2013, J CELL BIOCHEM, V114, P498, DOI 10.1002/jcb.24390; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lee J, 2010, ARCH PHARM RES, V33, P1401, DOI 10.1007/s12272-010-0914-x; Lee J, 2010, ARCH PHARM RES, V33, P181, DOI 10.1007/s12272-010-0200-y; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Levy G, 2002, TRANSPLANTATION, V73, P953, DOI 10.1097/00007890-200203270-00022; Li L, 2013, CLIN CANCER RES, V19, P6703, DOI 10.1158/1078-0432.CCR-13-0621; Meijer TWH, 2012, CLIN CANCER RES, V18, P5585, DOI 10.1158/1078-0432.CCR-12-0858; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Miyake K, 2012, EXP CELL RES, V318, P1554, DOI 10.1016/j.yexcr.2012.03.013; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Mueck AO, 2010, STEROIDS, V75, P625, DOI 10.1016/j.steroids.2010.02.016; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Obchoei S, 2009, MED SCI MONITOR, V15, pRA221; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Philip PA, 2009, J CLIN ONCOL, V27, P5660, DOI 10.1200/JCO.2009.21.9022; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Qi YJ, 2008, J CELL BIOCHEM, V104, P1625, DOI 10.1002/jcb.21727; Schneiderhan W, 2009, GUT, V58, P1391, DOI 10.1136/gut.2009.181412; Singh AK, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/480642; Song FJ, 2008, CANCER CAUSE CONTROL, V19, P443, DOI 10.1007/s10552-007-9105-6; Sun HC, 2007, INT J ONCOL, V30, P1359; Tamesa MS, 2009, ELECTROPHORESIS, V30, P2168, DOI 10.1002/elps.200800675; Vakeva L, 2008, ACTA DERM-VENEREOL, V88, P117, DOI 10.2340/00015555-0360; Verenich S, 2010, MOL PHARMACEUT, V7, P2030, DOI 10.1021/mp100190f; Weischer M, 2007, EXP DERMATOL, V16, P385, DOI 10.1111/j.1600-0625.2007.00555.x; Yang L, 2008, YONSEI MED J, V49, P295, DOI 10.3349/ymj.2008.49.2.295; Yu G, 2014, BIOCHEM BIOPH RES CO, V444, P75, DOI 10.1016/j.bbrc.2014.01.015; Zhu ZN, 2012, ONCOL REP, V27, P1567, DOI 10.3892/or.2012.1697	43	19	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92824	10.1371/journal.pone.0092824	http://dx.doi.org/10.1371/journal.pone.0092824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662981	Green Submitted, gold, Green Published			2022-12-25	WOS:000333459900121
J	Dose, F; Zanon, P; Coslovich, T; Taccola, G				Dose, Francesco; Zanon, Patrizia; Coslovich, Tamara; Taccola, Giuliano			Nanomolar Oxytocin Synergizes with Weak Electrical Afferent Stimulation to Activate the Locomotor CPG of the Rat Spinal Cord In Vitro	PLOS ONE			English	Article							CENTRAL PATTERN GENERATORS; VENTRAL HORN NEURONS; NEONATAL-RAT; DORSAL-HORN; PARAVENTRICULAR NUCLEUS; SYNAPTIC-TRANSMISSION; EPIDURAL STIMULATION; LUMBAR MOTONEURONS; VASOPRESSIN; RECEPTOR	Synergizing the effect of afferent fibre stimulation with pharmacological interventions is a desirable goal to trigger spinal locomotor activity, especially after injury. Thus, to better understand the mechanisms to optimize this process, we studied the role of the neuropeptide oxytocin (previously shown to stimulate locomotor networks) on network and motoneuron properties using the isolated neonatal rat spinal cord. On motoneurons oxytocin (1 nM-1 mu M) generated sporadic bursts with superimposed firing and dose-dependent depolarization. No desensitization was observed despite repeated applications. Tetrodotoxin completely blocked the effects of oxytocin, demonstrating the network origin of the responses. Recording motoneuron pool activity from lumbar ventral roots showed oxytocin mediated depolarization with synchronous bursts, and depression of reflex responses in a stimulus and peptide-concentration dependent fashion. Disinhibited bursting caused by strychnine and bicuculline was accelerated by oxytocin whose action was blocked by the oxytocin antagonist atosiban. Fictive locomotion appeared when subthreshold concentrations of NMDA plus 5HT were coapplied with oxytocin, an effect prevented after 24 h incubation with the inhibitor of 5HT synthesis, PCPA. When fictive locomotion was fully manifested, oxytocin did not change periodicity, although cycle amplitude became smaller. A novel protocol of electrical stimulation based on noisy waveforms and applied to one dorsal root evoked stereotypic fictive locomotion. Whenever the stimulus intensity was subthreshold, low doses of oxytocin triggered fictive locomotion although oxytocin per se did not affect primary afferent depolarization evoked by dorsal root pulses. Among the several functional targets for the action of oxytocin at lumbar spinal cord level, the present results highlight how small concentrations of this peptide could bring spinal networks to threshold for fictive locomotion in combination with other protocols, and delineate the use of oxytocin to strengthen the efficiency of electrical stimulation to activate locomotor circuits.	[Dose, Francesco; Zanon, Patrizia; Coslovich, Tamara; Taccola, Giuliano] Int Sch Adv Studies SISSA, Dept Neurosci, Trieste, Italy; [Dose, Francesco; Zanon, Patrizia; Coslovich, Tamara; Taccola, Giuliano] IMFR, SPINL, Udine, Italy	International School for Advanced Studies (SISSA)	Taccola, G (corresponding author), Int Sch Adv Studies SISSA, Dept Neurosci, Trieste, Italy.	taccola@sissa.it		Taccola, Giuliano/0000-0003-2675-1438	Vertical Foundation, Rome, Italy	Vertical Foundation, Rome, Italy	This work was supported by Vertical Foundation, Rome, Italy (http://www.fondazione-vertical.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; ARTMAN HG, 1984, DEV PHARMACOL THERAP, V7, P39, DOI 10.1159/000457142; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Barriere G, 2005, PEPTIDES, V26, P277, DOI 10.1016/j.peptides.2004.09.002; Beato M, 1998, P ROY SOC B-BIOL SCI, V265, P2073, DOI 10.1098/rspb.1998.0542; Bertrand SS, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00015; Boulenguez P, 2009, CURR OPIN NEUROBIOL, V19, P587, DOI 10.1016/j.conb.2009.10.005; Bracci E, 1996, J NEUROPHYSIOL, V75, P640, DOI 10.1152/jn.1996.75.2.640; Bracci E, 1998, J NEUROPHYSIOL, V79, P2643, DOI 10.1152/jn.1998.79.5.2643; Branchereau P, 2002, J NEUROSCI, V22, P2598, DOI 10.1523/JNEUROSCI.22-07-02598.2002; Butt SJB, 2002, J NEUROSCI, V22, P9961; Chini B, 2007, BIOCHEM SOC T, V35, P737, DOI 10.1042/BST0350737; Cina C, 2000, J COMP NEUROL, V423, P590, DOI 10.1002/1096-9861(20000807)423:4<590::AID-CNE5>3.0.CO;2-L; Condes-Lara M, 2003, BRAIN RES, V976, P75, DOI 10.1016/S0006-8993(03)02690-8; Domingo A, 2012, J NEUROTRAUM, V29, P865, DOI 10.1089/neu.2011.2052; Dose F, 2012, J NEUROPHYSIOL, V108, P2977, DOI 10.1152/jn.00554.2012; Dunbar MJ, 2010, J PHYSIOL-LONDON, V588, P139, DOI 10.1113/jphysiol.2009.177378; Eaton JL, 2012, DEV PSYCHOBIOL, V54, P92, DOI 10.1002/dev.20566; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Etlin A, 2013, J NEUROSCI, V33, P734, DOI 10.1523/JNEUROSCI.4390-12.2013; Fong AJ, 2009, PROG BRAIN RES, V175, P393, DOI 10.1016/S0079-6123(09)17526-X; Frigon A, 2012, NEUROSCIENTIST, V18, P56, DOI 10.1177/1073858410396101; FULTON BP, 1986, J PHYSIOL-LONDON, V370, P651, DOI 10.1113/jphysiol.1986.sp015956; Gad P, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-108; Garraway SM, 2001, BRIT J PHARMACOL, V132, P1789, DOI 10.1038/sj.bjp.0703983; Gerasimenko YP, 2007, J NEUROPHYSIOL, V98, P2525, DOI 10.1152/jn.00836.2007; GIBSON SJ, 1981, J COMP NEUROL, V201, P65, DOI 10.1002/cne.902010106; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hagglund M, 2013, P NATL ACAD SCI USA, V110, P11589, DOI 10.1073/pnas.1304365110; Han P, 2007, J NEUROSCI, V27, P13192, DOI 10.1523/JNEUROSCI.1279-07.2007; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Harris-Warrick RM, 2011, CURR OPIN NEUROBIOL, V21, P685, DOI 10.1016/j.conb.2011.05.011; HAWTHORN J, 1985, BRAIN RES, V346, P51, DOI 10.1016/0006-8993(85)91093-5; Hochman S, 2013, ANN NY ACAD SCI, V1279, P103, DOI 10.1111/nyas.12055; Hochman S, 2012, FRONT BIOSCI-LANDMRK, V17, P2158, DOI 10.2741/4043; Hochman S, 2010, ANN NY ACAD SCI, V1198, P140, DOI 10.1111/j.1749-6632.2010.05436.x; Ichiyama RM, 2008, NEUROSCI LETT, V438, P281, DOI 10.1016/j.neulet.2008.04.080; JACOBS BL, 1993, TRENDS NEUROSCI, V16, P346, DOI 10.1016/0166-2236(93)90090-9; Jo YH, 1998, J NEUROSCI, V18, P2377; Jojart J, 2009, ACTA BIOL HUNG, V60, P333, DOI 10.1556/ABiol.60.2009.4.1; Juif PE, 2013, J NEUROSCI, V33, P16617, DOI 10.1523/JNEUROSCI.3084-12.2013; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kombian SB, 2002, PROG BRAIN RES, V139, P235; LANG RE, 1983, BRAIN RES, V260, P326, DOI 10.1016/0006-8993(83)90690-X; Liu X, 2003, EUR J NEUROSCI, V17, P1833, DOI 10.1046/j.1460-9568.2003.02625.x; Mandadi S, 2013, J COMP NEUROL, V521, P2870, DOI 10.1002/cne.23321; Marazziti D, 2012, EUR NEUROPSYCHOPHARM, V22, P578, DOI 10.1016/j.euroneuro.2011.12.010; Marchetti C, 2001, J PHYSIOL-LONDON, V530, P105, DOI 10.1111/j.1469-7793.2001.0105m.x; Martinez-Lorenzan G, 2008, PAIN, V140, P265, DOI 10.1016/j.pain.2008.08.015; Miles GB, 2011, PHYSIOLOGY, V26, P393, DOI 10.1152/physiol.00013.2011; Moreno-Lopez Y, 2013, NEUROPEPTIDES, V47, P117, DOI 10.1016/j.npep.2012.09.008; Musienko P, 2011, J NEUROSCI, V31, P9264, DOI 10.1523/JNEUROSCI.5796-10.2011; Oz M, 2001, J NEUROPHYSIOL, V86, P1202, DOI 10.1152/jn.2001.86.3.1202; Pearson SA, 2003, J NEUROSCI, V23, P10154; REITER MK, 1994, EUR J NEUROSCI, V6, P98, DOI 10.1111/j.1460-9568.1994.tb00251.x; RYCKEBUSCH S, 1994, J NEUROPHYSIOL, V72, P2771, DOI 10.1152/jn.1994.72.6.2771; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; SCHOENEN J, 1985, NEUROLOGY, V35, P881, DOI 10.1212/WNL.35.6.881; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; Strauss I, 2003, J NEUROPHYSIOL, V89, P773, DOI 10.1152/jn.00716.2002; SUZUE T, 1981, NEUROSCI LETT, V26, P137, DOI 10.1016/0304-3940(81)90339-6; Taccola G, 2006, NEUROSCIENCE, V137, P659, DOI 10.1016/j.neuroscience.2005.09.025; Taccola G, 2005, NEUROSCIENCE, V132, P1187, DOI 10.1016/j.neuroscience.2005.02.012; Taccola G, 2004, EXP BRAIN RES, V156, P495, DOI 10.1007/s00221-003-1798-5; Taccola G, 2012, NEUROSCIENCE, V222, P191, DOI 10.1016/j.neuroscience.2012.07.030; Taccola G, 2011, J NEUROPHYSIOL, V106, P872, DOI 10.1152/jn.00170.2011; Taccola G, 2010, EUR J NEUROSCI, V31, P60, DOI 10.1111/j.1460-9568.2009.07040.x; TRIBOLLET E, 1989, J NEUROSCI, V9, P1764; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Veronneau-Longueville F, 1999, NEUROSCIENCE, V93, P1437, DOI 10.1016/S0306-4522(99)00262-6; Viero C, 2010, CNS NEUROSCI THER, V16, pe138, DOI 10.1111/j.1755-5949.2010.00185.x; Wilson LA, 2009, J SEX MED, V6, P947, DOI 10.1111/j.1743-6109.2008.01150.x; Wrobel L, 2011, NEUROSCI LETT, V495, P49, DOI 10.1016/j.neulet.2011.03.033	76	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92967	10.1371/journal.pone.0092967	http://dx.doi.org/10.1371/journal.pone.0092967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658101	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300149
J	Jardeleza, C; Rao, S; Thierry, B; Gajjar, P; Vreugde, S; Prestidge, CA; Wormald, PJ				Jardeleza, Camille; Rao, Shasha; Thierry, Benjamin; Gajjar, Pratik; Vreugde, Sarah; Prestidge, Clive A.; Wormald, Peter-John			Liposome-Encapsulated ISMN: A Novel Nitric Oxide-Based Therapeutic Agent against Staphylococcus aureus Biofilms	PLOS ONE			English	Article							ENDOSCOPIC SINUS SURGERY; DRUG-DELIVERY SYSTEMS; CHRONIC RHINOSINUSITIS; CATIONIC LIPOSOMES; BACTERIAL BIOFILMS; HELICOBACTER-PYLORI; MAXILLARY SINUSITIS; PARANASAL SINUSES; NANOPARTICLES; INFECTIONS	Background: Staphylococcus aureus in its biofilm form has been associated with recalcitrant chronic rhinosinusitis with resistance to conventional therapies. This study aims to determine if liposomal-encapsulation of a precursor of naturally occurring antimicrobial nitric oxide (NO) enhances its desired anti-biofilm effects against S. aureus, in the hope improving its efficacy can provide an effective topical agent for future clinical use. Methodology: S. aureus ATCC 25923 biofilms were grown in-vitro using the Minimum Biofilm Eradication Concentration (MBEC) device and exposed to 3 and 60 mg/mL of the NO donor isosorbide mononitrate (ISMN) encapsulated into different anionic liposomal formulations based on particle size (unilamellar ULV, multilamellar MLV) and lipid content (5 and 25 mM) at 24 h and 5 min exposure times. Biofilms were viewed using Live-Dead Baclight stain and confocal scanning laser microscopy and quantified using the software COMSTAT2. Results: At 3 and 60 mg/mL, ISMN-ULV liposomes had comparable and significant anti-biofilm effects compared to untreated control at 24 h exposure (p = 0.012 and 0.02 respectively). ULV blanks also had significant anti-biofilm effects at both 24 h and 5 min exposure (p = 0.02 and 0.047 respectively). At 5 min exposure, 60 mg/mL ISMN-MLV liposomes appeared to have greater anti-biofilm effects compared to pure ISMN or ULV particles. Increasing liposomal lipid content improved the anti-biofilm efficacy of both MLV and ULVs at 5 min exposure. Conclusion: Liposome-encapsulated "nitric oxide" is highly effective in eradicating S. aureus biofilms in-vitro, giving great promise for use in the clinical setting to treat this burdensome infection. Further studies however are needed to assess its safety and efficacy in-vivo before clinical translation is attempted.	[Jardeleza, Camille; Vreugde, Sarah; Wormald, Peter-John] Univ Adelaide, Queen Elizabeth Hosp, Dept Surg Otorhinolaryngol Head & Neck Surg, Adelaide, SA, Australia; [Rao, Shasha; Thierry, Benjamin; Gajjar, Pratik; Prestidge, Clive A.] Univ S Australia, Ian Wark Inst, Mawson Lakes, SA, Australia	University of Adelaide; University of South Australia	Wormald, PJ (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Dept Surg Otorhinolaryngol Head & Neck Surg, Adelaide, SA, Australia.	peterj.wormald@adelaide.edu.au	Thierry, benjamin/B-2785-2009	Thierry, benjamin/0000-0002-6757-2842; Vreugde, Sarah/0000-0003-4719-9785; Prestidge, Clive/0000-0001-5401-7535	Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council (NHMRC) [GNT1047576]	Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from The Garnett Passe and Rodney Williams Memorial Foundation to CJ and from The National Health and Medical Research Council (NHMRC: GNT1047576). The contents of the published material are solely the responsibility of the Administering Institution, a Participating Institution or individual authors and do not reflect the views of NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, LANCET, V345, P669; Baek YW, 2011, SCI TOTAL ENVIRON, V409, P1603, DOI 10.1016/j.scitotenv.2011.01.014; Barraud N, 2009, MICROB BIOTECHNOL, V2, P370, DOI 10.1111/j.1751-7915.2009.00098.x; Bradley JS, 2007, LANCET INFECT DIS, V7, P68, DOI 10.1016/S1473-3099(06)70689-2; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Campanha MTN, 1999, J LIPID RES, V40, P1495; Chaturvedi R, 2007, INFECT IMMUN, V75, P4305, DOI 10.1128/IAI.00578-07; CHRYSANT SG, 1993, AM J CARDIOL, V72, P1249, DOI 10.1016/0002-9149(93)90292-K; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cunha BA, 1996, INFECT DIS CLIN N AM, V10, P811, DOI 10.1016/S0891-5520(05)70328-7; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Degano B, 2005, CHEST, V128, P1699, DOI 10.1378/chest.128.3.1699; Deja M, 2003, AM J RESP CRIT CARE, V168, P281, DOI 10.1164/rccm.200207-640OC; Foreman A, 2010, LARYNGOSCOPE, V120, P1701, DOI 10.1002/lary.21024; Foreman A, 2009, AM J RHINOL ALLERGY, V23, P556, DOI 10.2500/ajra.2009.23.3413; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Ha KR, 2008, LARYNGOSCOPE, V118, P535, DOI 10.1097/MLG.0b013e31815bf2e3; Habimana O, 2011, APPL ENVIRON MICROB, V77, P367, DOI 10.1128/AEM.02163-10; Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004; Hetrick EM, 2009, BIOMATERIALS, V30, P2782, DOI 10.1016/j.biomaterials.2009.01.052; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Huang CM, 2011, BIOMATERIALS, V32, P214, DOI 10.1016/j.biomaterials.2010.08.076; Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Jardeleza C, 2011, INT FORUM ALLERGY RH, V1, P438, DOI 10.1002/alr.20083; Jervis-Bardy J, 2009, AM J RHINOL ALLERGY, V23, P549, DOI 10.2500/ajra.2009.23.3366; Jones MN, 2005, METHOD ENZYMOL, V391, P211, DOI 10.1016/S0076-6879(05)91013-6; Kilty SJ, 2008, CURR ALLERGY ASTHM R, V8, P227, DOI 10.1007/s11882-008-0038-2; Kim HJ, 1999, COLLOID SURFACE A, V149, P561, DOI 10.1016/S0927-7757(98)00765-1; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; Lian T, 2001, J PHARM SCI-US, V90, P667, DOI 10.1002/jps.1023; Lindberg S, 1997, ACTA OTO-LARYNGOL, V117, P113, DOI 10.3109/00016489709118001; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; LUNDBERG JON, 1995, NAT MED, V1, P370, DOI 10.1038/nm0495-370; Lundberg JO, 2008, ANAT REC, V291, P1479, DOI 10.1002/ar.20782; Maherani B, 2011, CURR NANOSCI, V7, P436, DOI 10.2174/157341311795542453; Meng JR, 2009, ANTIMICROB AGENTS CH, V53, P2871, DOI 10.1128/AAC.01542-08; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Obonyo M, 2012, MOL PHARMACEUT, V9, P2677, DOI 10.1021/mp300243w; Peulen TO, 2011, ENVIRON SCI TECHNOL, V45, P3367, DOI 10.1021/es103450g; Runer T, 1998, OTOLARYNG HEAD NECK, V119, P278, DOI 10.1016/S0194-5998(98)70063-4; Samadikhah HR, 2011, INT J NANOMED, V6, P2275, DOI 10.2147/IJN.S23074; Singhal D, 2011, LARYNGOSCOPE, V121, P1578, DOI 10.1002/lary.21805; Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632	46	31	34	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92117	10.1371/journal.pone.0092117	http://dx.doi.org/10.1371/journal.pone.0092117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658315	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000333355300056
J	Takamatsu, A; Ohkawara, B; Ito, M; Masuda, A; Sakai, T; Ishiguro, N; Ohno, K				Takamatsu, Akira; Ohkawara, Bisei; Ito, Mikako; Masuda, Akio; Sakai, Tadahiro; Ishiguro, Naoki; Ohno, Kinji			Verapamil Protects against Cartilage Degradation in Osteoarthritis by Inhibiting Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							BETA-CATENIN; ARTICULAR-CARTILAGE; CHONDROCYTE DIFFERENTIATION; HIP OSTEOARTHRITIS; JOINT DEGENERATION; HYALURONAN EXPORT; GROWTH; PATHWAY; SOX9; EXPRESSION	In past years, the canonical Wnt/beta-catenin signaling pathway has emerged as a critical regulator of cartilage development and homeostasis. FRZB, a soluble antagonist of Wnt signaling, has been studied in osteoarthritis (OA) animal models and OA patients as a modulator of Wnt signaling. We screened for FDA-approved drugs that induce FRZB expression and suppress Wnt/beta-catenin signaling. We found that verapamil, a widely prescribed L-type calcium channel blocker, elevated FRZB expression and suppressed Wnt/beta-catenin signaling in human OA chondrocytes. Expression and nuclear translocation of beta-catenin was attenuated by verapamil in OA chondrocytes. Lack of the verapamil effects in LiCl-treated and FRZB-downregulated OA chondrocytes also suggested that verpamil suppressed Wnt signaling by inducing FRZB. Verapamil enhanced gene expressions of chondrogenic markers of ACAN encoding aggrecan, COL2A1 encoding collagen type II alpha 1, and SOX9, and suppressed Wnt-responsive AXIN2 and MMP3 in human OA chondrocytes. Verapamil ameliorated Wnt3A-induced proteoglycan loss in chondrogenically differentiated ATDC5 cells. Verapamil inhibited hypertrophic differentiation of chondrocytes in the explant culture of mouse tibiae. Intraarticular injection of verapamil inhibited OA progression as well as nuclear localizations of b-catenin in a rat OA model. We propose that verapamil holds promise as a potent therapeutic agent for OA by upregulating FRZB and subsequently downregulating Wnt/beta-catenin signaling.	[Takamatsu, Akira; Ohkawara, Bisei; Ito, Mikako; Masuda, Akio; Ohno, Kinji] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan; [Takamatsu, Akira; Sakai, Tadahiro; Ishiguro, Naoki] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Ohno, K (corresponding author), Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan.	ohnok@med.nagoya-u.ac.jp	Masuda, Akio/H-6323-2012; Ito, Mikako/I-1941-2012; Ohno, Kinji/H-4020-2012; Ishiguro, Naoki/I-1563-2012; Ohno, Kinji/ABD-5787-2020	Ohno, Kinji/0000-0002-1529-2750; Ohno, Kinji/0000-0002-1529-2750; Ohkawara, Bisei/0000-0002-1987-458X	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Health, Labor and Welfare (MHLW) of Japan; Hori Sciences & Arts foundation; Grants-in-Aid for Scientific Research [23710253] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare (MHLW) of Japan(Ministry of Health, Labour and Welfare, Japan); Hori Sciences & Arts foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Ministry of Health, Labor and Welfare (MHLW) of Japan, and the Hori Sciences & Arts foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2002, NATURE, V417, P109, DOI 10.1038/417109a; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Beck E, 2005, AM FAM PHYSICIAN, V71, P717; Bian Y, 2009, HUM MOL GENET, V18, P1229, DOI 10.1093/hmg/ddp023; Chan BY, 2011, OSTEOARTHR CARTILAGE, V19, P874, DOI 10.1016/j.joca.2011.04.014; Correa S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-303; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; Furman BD, 2007, J ORTHOP RES, V25, P578, DOI 10.1002/jor.20331; HAMERMAN D, 1986, J CELL PHYSIOL, V127, P317, DOI 10.1002/jcp.1041270220; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Hoang B, 1996, J BIOL CHEM, V271, P26131, DOI 10.1074/jbc.271.42.26131; Hunter DJ, 2006, BMJ-BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639; Hwang SG, 2005, J BIOL CHEM, V280, P12758, DOI 10.1074/jbc.M413367200; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Lane NE, 2007, ARTHRITIS RHEUM-US, V56, P3319, DOI 10.1002/art.22867; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Leijten JCH, 2012, ARTHRITIS RHEUM-US, V64, P3302, DOI 10.1002/art.34535; Little CB, 2010, CURR DRUG TARGETS, V11, P561; Lories RJU, 2007, ARTHRITIS RHEUM-US, V56, P4095, DOI 10.1002/art.23137; Loughlin J, 2004, P NATL ACAD SCI USA, V101, P9757, DOI 10.1073/pnas.0403456101; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Nalesso G, 2011, J CELL BIOL, V193, P551, DOI 10.1083/jcb.201011051; Ouskova G, 2004, GLYCOBIOLOGY, V14, P931, DOI 10.1093/glycob/cwh115; Prehm P, 2004, BIOCHEM PHARMACOL, V68, P1401, DOI 10.1016/j.bcp.2004.06.017; Prehm P, 2005, J RHEUMATOL, V32, P690; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Stewart AJ, 2006, J CELL PHYSIOL, V206, P435, DOI 10.1002/jcp.20481; Strazielle N, 2013, MOL PHARMACEUT, V10, P1473, DOI 10.1021/mp300518e; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Thomas RS, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3536; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Weng LH, 2012, ARTHRITIS RHEUM-US, V64, P3267, DOI 10.1002/art.34602; Yan W, 2004, BONE, V35, P1273, DOI 10.1016/j.bone.2004.09.009; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Zhu M, 2008, ARTHRITIS RHEUM-US, V58, P2053, DOI 10.1002/art.23614; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	42	54	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92699	10.1371/journal.pone.0092699	http://dx.doi.org/10.1371/journal.pone.0092699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658359	gold, Green Published, Green Submitted			2022-12-25	WOS:000333355300118
J	Robert, A; Herrmann, H; Davidson, MW; Gelfand, VI				Robert, Amelie; Herrmann, Harald; Davidson, Michael W.; Gelfand, Vladimir I.			Microtubule-dependent transport of vimentin filament precursors is regulated by actin and by the concerted action of Rho- and p21-activated kinases	FASEB JOURNAL			English	Article						cytoskeleton; particle tracking; motor proteins	INTERMEDIATE-FILAMENTS; CYTOPLASMIC DYNEIN; CELL-MIGRATION; PHOSPHORYLATION; CYTOSKELETON; DYNAMICS; KINESIN; NETWORK; REORGANIZATION; FIBROBLASTS	Intermediate filaments (IFs) form a dense and dynamic network that is functionally associated with microtubules and actin filaments. We used the GFP-tagged vimentin mutant Y117L to study vimentin-cytoskeletal interactions and transport of vimentin filament precursors. This mutant preserves vimentin interaction with other components of the cytoskeleton, but its assembly is blocked at the unit-length filament (ULF) stage. ULFs are easy to track, and they allow a reliable and quantifiable analysis of movement. Our results show that in cultured human vimentin-negative SW13 cells, 2% of vimentin-ULFs move along microtubules bidirectionally, while the majority are stationary and tightly associated with actin filaments. Rapid motor-dependent transport of ULFs along microtubules is enhanced >5-fold by depolymerization of actin cytoskeleton with latrunculin B. The microtubule-dependent transport of vimentin ULFs is further regulated by Rho-kinase (ROCK) and p21-activated kinase (PAK): ROCK inhibits ULF transport, while PAK stimulates it. Both kinases act on microtubule transport independently of their effects on actin cytoskeleton. Our study demonstrates the importance of the actin cytoskeleton to restrict IF transport and reveals a new role for PAK and ROCK in the regulation of IF precursor transport.	[Robert, Amelie; Gelfand, Vladimir I.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	Northwestern University; Feinberg School of Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); State University System of Florida; Florida State University; State University System of Florida; Florida State University	Gelfand, VI (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave,Ward 11-100, Chicago, IL 60611 USA.	vgelfand@northwestern.edu	Gelfand, Vladimir/M-1974-2019; Gelfand, Vladimir I/D-2545-2013	Gelfand, Vladimir/0000-0002-6361-2798; Gelfand, Vladimir I/0000-0002-6361-2798	National Institute of General Medical Science of the U. S. National Institutes of Health [P01GM09697, R01 GM52111]; American Heart Association [13POST16210010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052111, P01GM096971] Funding Source: NIH RePORTER	National Institute of General Medical Science of the U. S. National Institutes of Health; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Science of the U. S. National Institutes of Health under awards P01GM09697 and R01 GM52111. A. R. was supported by a fellowship from the American Heart Association (13POST16210010). The authors thank the Goldman Laboratory (Fineberg School of Medicine, Northwestern University) for sharing materials that contributed to this work and Caroline Hookway and Robert Goldman for critical reading of the manuscript.	Ally S, 2009, J CELL BIOL, V187, P1071, DOI 10.1083/jcb.200908075; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Bayless KJ, 2011, J VASC RES, V48, P369, DOI 10.1159/000324751; Burgstaller G, 2010, MOL BIOL CELL, V21, P3362, DOI 10.1091/mbc.E10-02-0094; Chan W, 2002, EUR J CELL BIOL, V81, P692, DOI 10.1078/0171-9335-00281; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; Dave JM, 2013, J BIOL CHEM, V288, P30720, DOI 10.1074/jbc.M113.512467; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; DHAMODHARAN R, 1995, MOL BIOL CELL, V6, P1215, DOI 10.1091/mbc.6.9.1215; Eckes B, 1998, J CELL SCI, V111, P1897; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Esue O, 2006, J BIOL CHEM, V281, P30393, DOI 10.1074/jbc.M605452200; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; FRANKE WW, 1982, CELL, V30, P103, DOI 10.1016/0092-8674(82)90016-2; Georgakopoulou S, 2009, J MOL BIOL, V386, P544, DOI 10.1016/j.jmb.2008.12.053; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Goldman RD, 2012, J STRUCT BIOL, V177, P14, DOI 10.1016/j.jsb.2011.11.017; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Goto H, 2002, GENES CELLS, V7, P91, DOI 10.1046/j.1356-9597.2001.00504.x; GYOEVA FK, 1991, NATURE, V353, P445, DOI 10.1038/353445a0; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; HOLLENBECK PJ, 1989, J CELL SCI, V92, P621; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Liu TG, 2010, AM J PHYSIOL-CELL PH, V299, pC363, DOI 10.1152/ajpcell.00057.2010; Lu W, 2013, CURR BIOL, V23, P1018, DOI 10.1016/j.cub.2013.04.050; Meier M, 2009, J MOL BIOL, V390, P245, DOI 10.1016/j.jmb.2009.04.067; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Minin AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1453, DOI 10.1134/S0006297908130063; Nekrasova OE, 2011, MOL BIOL CELL, V22, P2282, DOI 10.1091/mbc.E10-09-0766; Pan YR, 2013, J CELL SCI, V126, P657, DOI 10.1242/jcs.116624; Potokar M, 2010, GLIA, V58, P1208, DOI 10.1002/glia.21000; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Sakamoto Y, 2013, J CELL BIOL, V200, P249, DOI 10.1083/jcb.201206010; SARRIA AJ, 1990, J CELL BIOL, V111, P553, DOI 10.1083/jcb.111.2.553; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Sin WC, 1998, MOL CELL BIOL, V18, P6325, DOI 10.1128/MCB.18.11.6325; STARGER JM, 1978, J CELL BIOL, V78, P93, DOI 10.1083/jcb.78.1.93; Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246; SUN TT, 1978, CELL, V14, P469, DOI 10.1016/0092-8674(78)90233-7; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Takahashi K, 2009, CELL SIGNAL, V21, P695, DOI 10.1016/j.cellsig.2009.01.007; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095; Wirth A, 2003, J PHYSIOL-LONDON, V549, P489, DOI 10.1113/jphysiol.2002.033167; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147	56	44	45	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2879	2890		10.1096/fj.14-250019	http://dx.doi.org/10.1096/fj.14-250019			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24652946	Green Published			2022-12-25	WOS:000337949400013
J	Wang, YL; Shen, G; Gong, JJ; Shen, DY; Whittington, A; Qing, J; Treloar, JS; Boisvert, S; Zhang, ZG; Yang, C; Wang, P				Wang, Yanli; Shen, Gui; Gong, Jinjun; Shen, Danyu; Whittington, Amy; Qing, Jiang; Treloar, Joshua; Boisvert, Scott; Zhang, Zhengguang; Yang, Cai; Wang, Ping			Noncanonical G beta Gib2 Is a Scaffolding Protein Promoting cAMP Signaling through Functions of Ras1 and Cac1 Proteins in Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenylate Cyclase (Adenylyl Cyclase); Cyclic AMP (cAMP); G Proteins; Ras; Signal Transduction; G-like; RACK1; Fungal Growth and Virulence; Protein Interactive Network	HETEROTRIMERIC G-PROTEINS; SACCHAROMYCES-CEREVISIAE; MAMMALIAN RACK1; SCHIZOSACCHAROMYCES-POMBE; ADENYLATE-CYCLASE; KINASE-C; VIRULENCE; SUBUNIT; HOMOLOG; YEAST	Background: Gib2 interacts with Gpa1, Gpg1, Gpg2, Cin1, and Pkc1. Gib2 overexpression promotes cAMP levels in cells lacking Gpa1. Results: Gib2 regulates cAMP through a novel mechanism involving functions of Ras1 and Cac1. Conclusion: Gib2 functions as a scaffolding adaptor protein. Significance: This study reveals a novel mechanism of cAMP signaling and identifies Gib2 as a key element in fungal regulatory networks. G-like/RACK1 functions as a key mediator of various pathways and contributes to numerous cellular functions in eukaryotic organisms. In the pathogenic fungus Cryptococcus neoformans, noncanonical G Gib2 promotes cAMP signaling in cells lacking normal Gpa1 function while displaying versatility in interactions with G Gpa1, protein kinase Pkc1, and endocytic intersectin Cin1. To elucidate the Gib2 functional mechanism(s), we demonstrate that Gib2 is required for normal growth and virulence. We show that Gib2 directly binds to Gpa1 and G Gpg1/Gpg2 and that it interacts with phosphodiesterase Pde2 and monomeric GTPase Ras1. Pde2 remains functionally dispensable, but Ras1 is found to associate with adenylyl cyclase Cac1 through the conserved Ras association domain. In addition, the ras1 mutant exhibits normal capsule formation, whereas the ras1 gpa1 mutant displays enhanced capsule formation, and the ras1 gpa1 cac1 mutant is acapsular. Collectively, these findings suggest that Gib2 promotes cAMP levels by relieving an inhibitory function of Ras1 on Cac1 in the absence of Gpa1. In addition, using GST affinity purification combined with mass spectrometry, we identified 47 additional proteins that interact with Gib2. These proteins have putative functions ranging from signal transduction, energy generation, metabolism, and stress response to ribosomal function. After establishing and validating a protein-protein interactive network, we believe Gib2 to be a key adaptor/scaffolding protein that drives the formation of various protein complexes required for growth and virulence. Our study reveals Gib2 as an essential component in deciphering the complexity of regulatory networks that control growth and virulence in C. neoformans.	[Wang, Yanli; Shen, Gui; Gong, Jinjun; Qing, Jiang; Yang, Cai; Wang, Ping] Childrens Hosp New Orleans, Res Inst Children, New Orleans, LA 70118 USA; [Shen, Danyu; Zhang, Zhengguang] Nanjing Agr Univ, Dept Plant Pathol, Nanjing 210095, Jiangsu, Peoples R China; [Whittington, Amy; Wang, Ping] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; [Wang, Ping] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA; [Treloar, Joshua] Tulane Univ, Sch Sci & Engn, New Orleans, LA 70118 USA; [Boisvert, Scott] Duke Univ, Trinity Coll Arts & Sci, Durham, NC 27708 USA	Children's Hospital of New Orleans; Nanjing Agricultural University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University; Duke University	Wang, P (corresponding author), Childrens Hosp New Orleans, Res Inst Children, New Orleans, LA 70118 USA.	pwang@lsuhsc.edu	Shen, Danyu/AAF-1644-2019		National Institutes of Health [R01AI054958, R01AI074001]; Research Institute for Children, Children's Hospital of New Orleans, Louisiana; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054958, R01AI074001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Institute for Children, Children's Hospital of New Orleans, Louisiana; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI054958 and R01AI074001 (to P. W.). This work was also supported by a fund from The Research Institute for Children, Children's Hospital of New Orleans, Louisiana (to P. W.). Research in the Zhang laboratory was supported in part by an especially appointed professorship (Jiangsu, China).	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Bolger GB, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-24; Buchanan KL, 1998, EMERG INFECT DIS, V4, P71, DOI 10.3201/eid0401.980109; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chen SH, 2005, J BIOL CHEM, V280, P33445, DOI 10.1074/jbc.M505422200; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Cramer KL, 2006, EUKARYOT CELL, V5, P1147, DOI 10.1128/EC.00145-06; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Dell EJ, 2002, J BIOL CHEM, V277, P49888, DOI 10.1074/jbc.M202755200; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; EDMAN JC, 1992, MOL CELL BIOL, V12, P2777, DOI 10.1128/MCB.12.6.2777; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GUILLEMOT F, 1989, P NATL ACAD SCI USA, V86, P4594, DOI 10.1073/pnas.86.12.4594; Hicks JK, 2005, EUKARYOT CELL, V4, P1971, DOI 10.1128/EC.4.12.1971-1981.2005; Hoffman CS, 2005, EUKARYOT CELL, V4, P495, DOI 10.1128/EC.4.3.495-503.2005; Hsueh YP, 2007, MOL BIOL CELL, V18, P3237, DOI 10.1091/mbc.E07-02-0133; James P, 1996, GENETICS, V144, P1425; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; KATAOKA T, 1985, CELL, V43, P493, DOI 10.1016/0092-8674(85)90179-5; Kays AM, 2004, MYCOTA, V3, P175; Kido M, 2002, J BIOL CHEM, V277, P3117, DOI 10.1074/jbc.M109526200; KOZEL TR, 1995, TRENDS MICROBIOL, V3, P295, DOI 10.1016/S0966-842X(00)88957-X; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Li L, 2007, MOL BIOL CELL, V18, P4201, DOI 10.1091/mbc.E07-02-0136; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; LINDER P, 1989, P NATL ACAD SCI USA, V86, P2286, DOI 10.1073/pnas.86.7.2286; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; McLeod M, 2000, MOL CELL BIOL, V20, P4016, DOI 10.1128/MCB.20.11.4016-4027.2000; MINTZER KA, 1994, CELL SIGNAL, V6, P681, DOI 10.1016/0898-6568(94)90050-7; MOHSENIZADEH S, 2004, GENOME INFORM 2004; Mudge DK, 2014, EUKARYOT CELL, V13, P202, DOI 10.1128/EC.00277-13; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Palmer DA, 2006, J BIOL CHEM, V281, P32596, DOI 10.1074/jbc.M602768200; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PERFECT JR, 1993, INFECT IMMUN, V61, P4446, DOI 10.1128/IAI.61.10.4446-4451.1993; Qian JA, 2011, J MASS SPECTROM, V46, P1, DOI 10.1002/jms.1854; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sambrook J, 2001, MOL CLONING LAB MANU; Shen G, 2008, EUKARYOT CELL, V7, P1540, DOI 10.1128/EC.00154-08; Shen G, 2012, EUKARYOT CELL, V11, P471, DOI 10.1128/EC.00011-12; Shen G, 2010, MOL MICROBIOL, V76, P662, DOI 10.1111/j.1365-2958.2010.07121.x; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; TOLKACHEVA T, 1994, INFECT IMMUN, V62, P2849, DOI 10.1128/IAI.62.7.2849-2856.1994; Valerius O, 2007, MOL CELL PROTEOMICS, V6, P1968, DOI 10.1074/mcp.M700184-MCP200; Wang L, 2011, MOL MICROBIOL, V81, P1484, DOI 10.1111/j.1365-2958.2011.07783.x; Wang P, 2000, MOL CELL BIOL, V20, P352, DOI 10.1128/MCB.20.1.352-362.2000; Wang P, 2004, CURR GENET, V46, P247, DOI 10.1007/s00294-004-0529-1; Wang P, 2004, EUKARYOT CELL, V3, P1028, DOI 10.1128/EC.3.4.1028-1035.2004; Waugh MS, 2002, MICROBIOL-SGM, V148, P191, DOI 10.1099/00221287-148-1-191; Xue CY, 2008, MOL MICROBIOL, V70, P379, DOI 10.1111/j.1365-2958.2008.06417.x; Xue CY, 2006, MOL BIOL CELL, V17, P667, DOI 10.1091/mbc.E05-07-0699; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200	63	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12202	12216		10.1074/jbc.M113.537183	http://dx.doi.org/10.1074/jbc.M113.537183			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24659785	hybrid, Green Published			2022-12-25	WOS:000335581400003
J	Bona, S; Silvanto, J				Bona, Silvia; Silvanto, Juha			Accuracy and Confidence of Visual Short-Term Memory Do Not Go Hand-In-Hand: Behavioral and Neural Dissociations	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; POSTERIOR PARIETAL CORTEX; NONINVASIVE BRAIN-STIMULATION; TRANSCRANIAL DC-STIMULATION; IMPROVING WORKING-MEMORY; HUMAN MOTOR CORTEX; PREFRONTAL CORTEX; RECOGNITION MEMORY; JUDGMENTS; METAMEMORY	Currently influential models of working memory posit that memory content is highly accessible to conscious inspection. These models predict that metacognition of memory performance should go hand-in-hand with the accuracy of the underlying memory representation. To test this view, we investigated how visual information presented during the maintenance period affects VSTM accuracy and confidence. We used a delayed cue-target orientation discrimination task in which participants were asked to hold in memory a grating, and during the maintenance period a second memory cue could be presented. VSTM accuracy of the first memory cue was impaired when the orientation of the second memory cue was sufficiently different. However, participants' response confidence was reduced whenever the second memory cue was presented; thus VSTM accuracy and confidence were dissociated. In a second experiment, we applied transcranial direct current stimulation (tDCS) over the right dorsolateral prefrontal cortex (DLPFC) to investigate the causal role of this region in VSTM metacognition. Relative to the sham condition, anodal tDCS induced a general reduction in confidence ratings but did not affect VSTM accuracy. Overall, these results indicate that our metacognition of memory performance is influenced by factors other than the accuracy of the underlying memory representation.	[Bona, Silvia; Silvanto, Juha] Aalto Univ, Sch Sci, Brain Res Unit, OV Lounasmaa Lab, Espoo, Finland; [Bona, Silvia] Univ Helsinki, Cent Hosp, HUS Med Imaging Ctr, BioMag Lab, Helsinki, Finland; [Bona, Silvia] Univ Helsinki, Dept Behav Sci, Helsinki, Finland; [Silvanto, Juha] Univ Westminster, Fac Sci & Technol, Dept Psychol, London W1R 8AL, England	Aalto University; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Westminster	Bona, S (corresponding author), Aalto Univ, Sch Sci, Brain Res Unit, OV Lounasmaa Lab, Espoo, Finland.	silvia.bona@aalto.fi		Silvanto, Juha/0000-0001-6044-5296	Academy of Finland [137485]; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); Emil Aaltonen Foundation	JS is supported by Academy of Finland (137485) and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus GG, 2011, NEUROPSYCHOLOGIA, V49, P1974, DOI 10.1016/j.neuropsychologia.2011.03.026; Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Antal A, 2003, EXP BRAIN RES, V150, P375, DOI 10.1007/s00221-003-1459-8; Antal A, 2008, PERCEPTION, V37, P367, DOI 10.1068/p5872; Baars BJ, 2003, TRENDS COGN SCI, V7, P166, DOI 10.1016/S1364-6613(03)00056-1; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Beck DM, 2006, CEREB CORTEX, V16, P712, DOI 10.1093/cercor/bhj017; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1767, DOI 10.1016/j.neuropsychologia.2008.01.009; Berryhill ME, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00031; Berryhill ME, 2010, NEUROSCI LETT, V479, P312, DOI 10.1016/j.neulet.2010.05.087; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Boggio PS, 2007, J AFFECT DISORDERS, V101, P91, DOI 10.1016/j.jad.2006.10.026; Bona S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00062; Bradfield AL, 2002, J APPL PSYCHOL, V87, P112, DOI 10.1037//0021-9010.87.1.112; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Busey TA, 2000, PSYCHON B REV, V7, P26, DOI 10.3758/BF03210724; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; CAMPBELL FW, 1971, VISION RES, V11, P833, DOI 10.1016/0042-6989(71)90005-8; Cattaneo Z, 2011, NEUROSCIENCE, V183, P64, DOI 10.1016/j.neuroscience.2011.03.058; CHANDLER CC, 1994, MEM COGNITION, V22, P273, DOI 10.3758/BF03200854; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Chua EF, 2009, J COGNITIVE NEUROSCI, V21, P1751, DOI 10.1162/jocn.2009.21123; Courtney Susan M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P501, DOI 10.3758/CABN.4.4.501; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; DaSilva AF, 2011, JOVE-J VIS EXP, DOI 10.3791/2744; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Ferrucci R, 2013, CEREBELLUM, V12, P485, DOI 10.1007/s12311-012-0436-9; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleck MS, 2006, CEREB CORTEX, V16, P1623, DOI 10.1093/cercor/bhj097; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Floel A, 2008, J COGNITIVE NEUROSCI, V20, P1415, DOI 10.1162/jocn.2008.20098; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; GREENLEE MW, 1988, VISION RES, V28, P1303, DOI 10.1016/0042-6989(88)90061-2; HART JT, 1967, J VERB LEARN VERB BE, V6, P685, DOI 10.1016/S0022-5371(67)80072-0; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jeon SY, 2012, ANN REHABIL MED-ARM, V36, P585, DOI 10.5535/arm.2012.36.5.585; Jonsson AC, 2003, PERS INDIV DIFFER, V34, P559, DOI 10.1016/S0191-8869(02)00028-4; Kao YC, 2005, NAT NEUROSCI, V8, P1776, DOI 10.1038/nn1595; KELLEY CM, 1993, J MEM LANG, V32, P1, DOI 10.1006/jmla.1993.1001; Kikyo H, 2004, NEUROIMAGE, V23, P1348, DOI 10.1016/j.neuroimage.2004.08.013; KING JF, 1980, AM J PSYCHOL, V93, P329, DOI 10.2307/1422236; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; Ladeira A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025399; Lang N, 2003, SUPPL CLIN NEUROPHYS, V56, P277; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; LEONESIO RJ, 1990, J EXP PSYCHOL LEARN, V16, P464, DOI 10.1037/0278-7393.16.3.464; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Magnussen S, 1999, PSYCHOL RES-PSYCH FO, V62, P81, DOI 10.1007/s004260050043; MAGNUSSEN S, 1991, VISION RES, V31, P1213, DOI 10.1016/0042-6989(91)90046-8; Magnussen S, 1988, J EXP PSYCHOL HUMAN, V24, P707; Magnussen S, 2009, SCAND J PSYCHOL, V50, P535, DOI 10.1111/j.1467-9450.2009.00783.x; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; Marshall L, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-23; Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277; Moos K, 2012, J NEUROSCI, V32, P16360, DOI 10.1523/JNEUROSCI.6233-11.2012; Moritz S, 2006, NEUROIMAGE, V33, P1188, DOI 10.1016/j.neuroimage.2006.08.003; Mulquiney PG, 2011, CLIN NEUROPHYSIOL, V122, P2384, DOI 10.1016/j.clinph.2011.05.009; Nelson T.O., 1990, PSYCHOL LEARNING MOT, V26, P125, DOI [10.1016/S0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5, 10.1016/s0079-7421(08)60053-5]; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P2220, DOI 10.1016/S1388-2457(03)00235-9; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Olson IR, 2009, NEUROBIOL LEARN MEM, V91, P155, DOI 10.1016/j.nlm.2008.09.006; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Peters MAK, 2013, NEUROPSYCHOLOGIA, V51, P1234, DOI 10.1016/j.neuropsychologia.2013.03.013; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Rademaker RL, 2012, J VISION, V12, DOI 10.1167/12.13.21; Rounis E, 2010, COGN NEUROSCI-UK, V1, P165, DOI 10.1080/17588921003632529; Sahraie A, 1997, P NATL ACAD SCI USA, V94, P9406, DOI 10.1073/pnas.94.17.9406; Schnyer DM, 2005, J COGNITIVE NEUROSCI, V17, P832, DOI 10.1162/0898929053747694; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; Shaw JS, 2003, LAW HUMAN BEHAV, V27, P315, DOI 10.1023/A:1023487908640; Shields WE, 2005, J GEN PSYCHOL, V132, P165; Silvanto J, 2012, NEUROIMAGE, V59, P840, DOI 10.1016/j.neuroimage.2011.07.062; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Teo Florence, 2011, Front Psychiatry, V2, P45, DOI 10.3389/fpsyt.2011.00045; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; Tseng P, 2010, NEUROPSYCHOLOGIA, V48, P1063, DOI 10.1016/j.neuropsychologia.2009.12.005; TULVING E, 1981, J VERB LEARN VERB BE, V20, P479, DOI 10.1016/S0022-5371(81)90129-8; VESONDER GT, 1985, J MEM LANG, V24, P363, DOI 10.1016/0749-596X(85)90034-8; Walter H, 2003, CORTEX, V39, P897, DOI 10.1016/S0010-9452(08)70869-4; WELLS GL, 1981, J APPL PSYCHOL, V66, P688, DOI 10.1037/0021-9010.66.6.688; Yokoyama O, 2010, NEUROSCI RES, V68, P199, DOI 10.1016/j.neures.2010.07.2041; YONELINAS AP, 1994, J EXP PSYCHOL LEARN, V20, P1341, DOI 10.1037/0278-7393.20.6.1341; Zaehle T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-2	90	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90808	10.1371/journal.pone.0090808	http://dx.doi.org/10.1371/journal.pone.0090808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7QO	24663094	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900010
J	Bratanic, B; Pernus, F; Likar, B; Tomazevic, D				Bratanic, Blaz; Pernus, Franjo; Likar, Bostjan; Tomazevic, Dejan			Real-Time Rotation Estimation Using Histograms of Oriented Gradients	PLOS ONE			English	Article							AUTOMATED VISUAL INSPECTION	This paper focuses on real-time rotation estimation for model-based automated visual inspection. In the case of model-based inspection, spatial alignment is essential to distinguish visual defects from normal appearance variations. Defects are detected by comparing the inspected object with its spatially aligned ideal reference model. Rotation estimation is crucial for the inspection of rotationally symmetric objects where mechanical manipulation is unable to ensure the correct object rotation. We propose a novel method for in-plane rotation estimation. Rotation is estimated with an ensemble of nearest-neighbor estimators. Each estimator contains a spatially local representation of an object in a feature space for all rotation angles and is constructed with a semi-supervised self-training approach from a set of unlabeled training images. An individual representation in a feature space is obtained by calculating the Histograms of Oriented Gradients (HOG) over a spatially local region. Each estimator votes separately for the estimated angle; all votes are weighted and accumulated. The final estimation is the angle with the most votes. The method was evaluated on several datasets of pharmaceutical tablets varying in size, shape, and color. The results show that the proposed method is superior in robustness with comparable speed and accuracy to previously proposed methods for rotation estimation of pharmaceutical tablets. Furthermore, all evaluations were performed with the same set of parameters, which implies that the method requires minimal human intervention. Despite the evaluation focused on pharmaceutical tablets, we consider the method useful for any application that requires robust real-time in-plane rotation estimation.	[Bratanic, Blaz; Pernus, Franjo; Likar, Bostjan; Tomazevic, Dejan] Sensum, Comp Vis Syst, Ljubljana, Slovenia; [Pernus, Franjo; Likar, Bostjan; Tomazevic, Dejan] Univ Ljubljana, Fac Elect Engn, Lab Imaging Technol, Ljubljana, Slovenia	University of Ljubljana	Bratanic, B (corresponding author), Sensum, Comp Vis Syst, Ljubljana, Slovenia.	blaz.bratanic@sensum.eu			Ministry of Higher Education, Science, and Technology, Republic of Slovenia [L2-4072, L2-5472]; Sensum, Computer Vision Systems; European Union, European Social Fund	Ministry of Higher Education, Science, and Technology, Republic of Slovenia; Sensum, Computer Vision Systems; European Union, European Social Fund(European Social Fund (ESF))	This work was supported by the Ministry of Higher Education, Science, and Technology, Republic of Slovenia under grants L2-4072 and L2-5472, by Sensum, Computer Vision Systems, and by the European Union, European Social Fund. Bostjan Likar and Franjo Pernus. (two co-authors of this manuscript) are co-owners of the commercial funder of this research, Sensum, Computer Vision Systems. Bostjan Likar and Franjo Pernus. had a role in study design and preparation of the manuscript.	ALPERT NM, 1990, J NUCL MED, V31, P1717; BENTLEY JL, 1975, COMMUN ACM, V18, P509, DOI 10.1145/361002.361007; Bukovec M, 2007, MEAS SCI TECHNOL, V18, P2921, DOI 10.1088/0957-0233/18/9/023; Bunn G, 2006, GOOD MANUFACTURING P, V169; Chen FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054328; CHIN RT, 1982, IEEE T PATTERN ANAL, V4, P557, DOI 10.1109/TPAMI.1982.4767309; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Ferreira AJ, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P35, DOI 10.1007/978-1-4419-9326-7_2; Garcia-Pedrajas N, 2005, IEEE T EVOLUT COMPUT, V9, P271, DOI 10.1109/TEVC.2005.844158; Goshtasby AA, 2011, IMAGE REGISTRATION FOR REMOTE SENSING, P153; Hill DLG, 2001, PHYS MED BIOL, V46, pR1, DOI 10.1088/0031-9155/46/3/201; Holden M, 2008, IEEE T MED IMAGING, V27, P111, DOI 10.1109/TMI.2007.904691; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Mendes-Moreira J, 2012, ACM COMPUT SURV, V45, DOI 10.1145/2379776.2379786; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Mozina M, 2011, MACH VISION APPL, P1; Mozina M, 2011, MACH VISION APPL, V22, P145, DOI 10.1007/s00138-009-0218-7; Muja M, 2009, VISAPP 2009: PROCEEDINGS OF THE FOURTH INTERNATIONAL CONFERENCE ON COMPUTER VISION THEORY AND APPLICATIONS, VOL 1, P331; NEWMAN TS, 1995, COMPUT VIS IMAGE UND, V61, P231, DOI 10.1006/cviu.1995.1017; Spiclin Z, 2011, MACH VISION APPL, V22, P197, DOI 10.1007/s00138-007-0104-0; Zhou L, 2013, PATTERN RECOGN, V46, P424, DOI 10.1016/j.patcog.2012.07.017; Zhu Qiang, 2006, CVPR, DOI DOI 10.1109/CVPR.2006.119; Zhu X., 2005, 1530 U WISC	24	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92137	10.1371/journal.pone.0092137	http://dx.doi.org/10.1371/journal.pone.0092137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662954	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900042
J	Madinier, A; Quattromani, MJ; Sjolund, C; Ruscher, K; Wieloch, T				Madinier, Alexandre; Quattromani, Miriana Jlenia; Sjolund, Carin; Ruscher, Karsten; Wieloch, Tadeusz			Enriched Housing Enhances Recovery of Limb Placement Ability and Reduces Aggrecan-Containing Perineuronal Nets in the Rat Somatosensory Cortex after Experimental Stroke	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; INDUCED MOVEMENT THERAPY; TRAUMATIC BRAIN-INJURY; FORCED ARM USE; ENVIRONMENTAL ENRICHMENT; PHOTOTHROMBOTIC STROKE; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; NEUROTROPHIC FACTOR; MOTOR RECOVERY	Stroke causes life long disabilities where few therapeutic options are available. Using electrical and magnetic stimulation of the brain and physical rehabilitation, recovery of brain function can be enhanced even late after stroke. Animal models support this notion, and housing rodents in an enriched environment (EE) several days after experimental stroke stimulates lost brain function by multisensory mechanisms. We studied the dynamics of functional recovery of rats with a lesion to the fore and hind limb motor areas induced by photothrombosis (PT), and with subsequent housing in either standard (STD) or EE. In this model, skilled motor function is not significantly enhanced by enriched housing, while the speed of recovery of sensori-motor function substantially improves over the 9-week study period. In particular, this stroke lesion completely obliterates the fore and hind limb placing ability when visual and whisker guidance is prevented, a deficit that persists for up to 9 weeks of recovery, but that is markedly restored within 2 weeks by enriched housing. Enriched housing after stroke also leads to a significant loss of perineuronal net (PNN) immunoreactivity; detection of aggrecan protein backbone with AB1031 antibody was decreased by 13-22%, and labelling of a glycan moiety of aggrecan with Cat-315 antibody was reduced by 25-30% in the peri-infarct area and in the somatosensory cortex, respectively. The majority of these cells are parvalbumin/GABA inhibitory interneurons that are important in sensori-information processing. We conclude that damage to the fore and hind limb motor areas provides a model of loss of limb placing response without visual guidance, a deficit also seen in more than 50% of stroke patients. This loss is amenable to recovery induced by multiple sensory stimulation and correlates with a decrease in aggrecan-containing PNNs around inhibitory interneurons. Modulating the PNN structure after ischemic damage may provide new therapies enhancing tactile/proprioceptive function after stroke.	[Madinier, Alexandre; Quattromani, Miriana Jlenia; Sjolund, Carin; Ruscher, Karsten; Wieloch, Tadeusz] Lund Univ, Dept Clin Sci, Expt Brain Res Lab, Div Neurosurg, Lund, Sweden	Lund University	Wieloch, T (corresponding author), Lund Univ, Dept Clin Sci, Expt Brain Res Lab, Div Neurosurg, Lund, Sweden.	tadeusz.wieloch@med.lu.se		Wieloch, Tadeusz/0000-0002-7669-2520	Swedish Research Council [2011-2652, 2011-2684]; EU through the European Stroke Network [201024]; Hans-Christian and Alice Wachtmeister Foundation; Swedish Brain Fund; Greta och Johan Kocks Stiftelser; Thorsten och Elsa Segerfalk Stiftelse; Crafoord Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU through the European Stroke Network; Hans-Christian and Alice Wachtmeister Foundation; Swedish Brain Fund; Greta och Johan Kocks Stiftelser; Thorsten och Elsa Segerfalk Stiftelse; Crafoord Foundation	This study was supported by the Swedish Research Council grants no. 2011-2652 (TW) and no. 2011-2684 (KR), the EU 7th work program through the European Stroke Network grant no. 201024, the Hans-Christian and Alice Wachtmeister Foundation (TW, KR), the Swedish Brain Fund (TW), the Greta och Johan Kocks Stiftelser (KR), the Thorsten och Elsa Segerfalk Stiftelse (KR) and the Crafoord Foundation (KR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; Ballermann M, 2001, J NEUROSCI METH, V106, P39, DOI 10.1016/S0165-0270(01)00326-0; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bezard E, 2003, J NEUROSCI, V23, P10999; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Carey LM, 2011, NEUROREHAB NEURAL RE, V25, P443, DOI 10.1177/1545968310395777; Carey LM, 1996, ARCH PHYS MED REHAB, V77, P1271, DOI 10.1016/S0003-9993(96)90192-6; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; Dahlqvist P, 2003, NEUROSCIENCE, V119, P643, DOI 10.1016/S0306-4522(03)00195-7; Dancause N, 2006, REV NEUROSCIENCE, V17, P561; DERYCK M, 1992, BRAIN RES, V573, P44; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Diederich K, 2012, STROKE, V43, P185, DOI 10.1161/STROKEAHA.111.622159; Dino MR, 2006, NEUROSCIENCE, V142, P1055, DOI 10.1016/j.neuroscience.2006.07.054; DONOGHUE JP, 1994, J CLIN NEUROPHYSIOL, V11, P382; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; Edwardson MA, 2013, EXP BRAIN RES, V224, P335, DOI 10.1007/s00221-012-3315-1; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Foscarin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016666; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Frischknecht R, 2012, ADV EXP MED BIOL, V970, P153, DOI 10.1007/978-3-7091-0932-8_7; Gherardini L., 2013, CEREB CORTEX; Giamanco KA, 2010, NEUROSCIENCE, V170, P1314, DOI 10.1016/j.neuroscience.2010.08.032; GUIMARAES A, 1990, J NEUROSCI, V10, P3014; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; HARTIG W, 1994, BRAIN RES, V635, P307, DOI 10.1016/0006-8993(94)91452-4; Hebb DO., 1947, AM PSYCHOL, V2, P306; Hill JJ, 2012, P NATL ACAD SCI USA, V109, P9155, DOI 10.1073/pnas.1205697109; Hobohm C, 2005, J NEUROSCI RES, V80, P539, DOI 10.1002/jnr.20459; HOCKFIELD S, 1990, COLD SPRING HARB SYM, V55, P505; HOCKFIELD S, 1983, P NATL ACAD SCI-BIOL, V80, P5758, DOI 10.1073/pnas.80.18.5758; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Inacio AR, 2011, NEUROBIOL DIS, V41, P270, DOI 10.1016/j.nbd.2010.09.015; Jablonka JA, 2010, NEUROSCIENCE, V165, P90, DOI 10.1016/j.neuroscience.2009.09.074; Janssen H, 2010, NEUROREHAB NEURAL RE, V24, P802, DOI 10.1177/1545968310372092; Jin Z, 2010, BRAIN RES, V1363, P191, DOI 10.1016/j.brainres.2010.09.081; Johansson BB, 2002, J CEREBR BLOOD F MET, V22, P89, DOI 10.1097/00004647-200201000-00011; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P399, DOI 10.1016/S0003-9993(95)80567-2; Karetko-Sysa M, 2011, EXP NEUROL, V231, P113, DOI 10.1016/j.expneurol.2011.05.022; Katsman D, 2003, J CEREBR BLOOD F MET, V23, P997, DOI 10.1097/01.WCB.0000084252.20114.BE; Keyvani K, 2004, J NEUROPATH EXP NEUR, V63, P598, DOI 10.1093/jnen/63.6.598; Kitago T, 2013, NEUROREHAB NEURAL RE, V27, P99, DOI 10.1177/1545968312452631; Knieling M, 2009, NEUROSCIENCE, V163, P759, DOI 10.1016/j.neuroscience.2009.07.004; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Lander C, 1997, J NEUROSCI, V17, P1928; Lendvai D, 2013, ACTA NEUROPATHOL, V125, P215, DOI 10.1007/s00401-012-1042-0; Lenzlinger PM, 2004, RESTOR NEUROL NEUROS, V22, P73; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Martinez-Cue C, 2005, BEHAV BRAIN RES, V163, P174, DOI 10.1016/j.bbr.2005.04.016; Matthews RT, 2002, J NEUROSCI, V22, P7536; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Moon SK, 2009, EXP NEUROL, V218, P145, DOI 10.1016/j.expneurol.2009.04.021; Morawski M, 2012, INT J BIOCHEM CELL B, V44, P690, DOI 10.1016/j.biocel.2012.01.010; Muller HD, 2008, STROKE, V39, P1012, DOI 10.1161/STROKEAHA.107.495069; Muntner P, 2002, STROKE, V33, P1209, DOI 10.1161/01.STR.0000015031.57955.D1; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Overman JJ, 2014, NEUROSCIENTIST, V20, P15, DOI 10.1177/1073858413491146; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rogers DC, 1997, PHARMACOL BIOCHEM BE, V56, P747, DOI 10.1016/S0091-3057(96)00430-3; Rosell A, 2008, CURR OPIN PHARMACOL, V8, P82, DOI 10.1016/j.coph.2007.12.001; Ruscher K, 2011, BRAIN, V134, P732, DOI 10.1093/brain/awq367; Ruscher K, 2009, J CEREBR BLOOD F MET, V29, P1796, DOI 10.1038/jcbfm.2009.96; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schulz R, 2013, NEUROPHARMACOLOGY, V64, P579, DOI 10.1016/j.neuropharm.2012.05.016; Shanina EV, 2006, NEUROSCIENCE, V139, P1495, DOI 10.1016/j.neuroscience.2006.01.016; Sigler A, 2008, J NEUROSCI METH, V170, P35, DOI 10.1016/j.jneumeth.2007.12.015; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; Starkey ML, 2012, BRAIN, V135, P3265, DOI 10.1093/brain/aws270; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; Wang YG, 2008, J CEREBR BLOOD F MET, V28, P1936, DOI 10.1038/jcbfm.2008.82; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Wood NI, 1996, BEHAV BRAIN RES, V78, P113, DOI 10.1016/0166-4328(95)00237-5; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690	89	51	52	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93121	10.1371/journal.pone.0093121	http://dx.doi.org/10.1371/journal.pone.0093121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664200	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900155
J	Ramachandran, VK; Shearer, N; Thompson, A				Ramachandran, Vinoy K.; Shearer, Neil; Thompson, Arthur			The Primary Transcriptome of Salmonella enterica Serovar Typhimurium and Its Dependence on ppGpp during Late Stationary Phase	PLOS ONE			English	Article							PATHOGENICITY ISLAND 2; III SECRETION SYSTEM; VIRULENCE GENE-EXPRESSION; BACTERIAL SIGNAL MOLECULE; ESCHERICHIA-COLI; SMALL RNAS; MYCOBACTERIUM-TUBERCULOSIS; ENVIRONMENTAL-REGULATION; LEGIONELLA-PNEUMOPHILA; STRINGENT RESPONSE	We have used differential RNA-seq (dRNA-seq) to characterise the transcriptomic architecture of S. Typhimurium SL1344, and its dependence on the bacterial alarmone, guanosine tetraphosphate (ppGpp) during late stationary phase, (LSP). Under LSP conditions we were able to identify the transcriptional start sites (TSSs) for 53% of the S. Typhimurium open reading frames (ORFs) and discovered 282 candidate non-coding RNAs (ncRNAs). The mapping of LSP TSSs enabled a detailed comparison with a previous dRNA-seq study of the early stationary phase (ESP) transcriptional architecture of S. Typhimurium SL1344 and its dependence on ppGpp. For the purposes of this study, LSP was defined as an aerobic LB culture grown to a later optical density reading (OD600 = 3.6) compared to ESP (OD600 = 2.3). The precise nucleotide positions of the majority of S. Typhimurium TSSs at LSP agreed closely with those identified at ESP. However, the identification of TSSs at different positions, or where additional or fewer TSSs were found at LSP compared to ESP enabled the genome-wide categorisation of growth phase dependent changes in promoter structure, the first time such an analysis has been done on this scale. Comparison of the ppGpp-dependency LSP and ESP TSSs for mRNAs and ncRNAs revealed a similar breadth of ppGpp-activation and repression. However, we note several ncRNAs previously shown to be involved in virulence were highly ppGpp-dependent at LSP. Finally, although SPI1 was expressed at ESP, we found SPI1 was not as highly expressed at LSP, instead we observed elevated expression of SPI2 encoded genes. We therefore also report an analysis of SPI2 transcriptional architecture at LSP resulting in localisation of SsrB binding sites and identification of a previously unreported SPI2 TSS. We also show that ppGpp is required for nearly all of SPI2 expression at LSP as well as for expression of SPI1 at ESP.	[Ramachandran, Vinoy K.] Univ Oxford, Dept Plant Sci, Oxford, England; [Shearer, Neil; Thompson, Arthur] Inst Food Res, Norwich NR4 7UA, Norfolk, England	University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Thompson, A (corresponding author), Inst Food Res, Norwich NR4 7UA, Norfolk, England.	arthur.thompson@ifr.ac.uk			Biotechnology Biological Science Research Council (BBSRC), UK; BBSRC [BB/F00978X/1]; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR5885, BB/F00978X/1, BBS/E/F/00044404, BBS/E/T/000PR6193] Funding Source: researchfish; BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193, BBS/E/F/00044404] Funding Source: UKRI	Biotechnology Biological Science Research Council (BBSRC), UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	NS and AT were supported by a core funded programme from the Biotechnology Biological Science Research Council (BBSRC), UK. VKR was supported by BBSRC grant number BB/F00978X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026896; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Bittner M, 2002, MICROBIOL-SGM, V148, P3789, DOI 10.1099/00221287-148-12-3789; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; Cabeza ML, 2007, J BACTERIOL, V189, P7335, DOI 10.1128/JB.00801-07; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Erickson DL, 2004, INFECT IMMUN, V72, P5638, DOI 10.1128/IAI.72.10.5638-5645.2004; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Frohlich KS, 2012, NUCLEIC ACIDS RES, V40, P3623, DOI 10.1093/nar/gkr1156; Golubeva YA, 2012, GENETICS, V190, P79, DOI 10.1534/genetics.111.132779; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Guillier M, 2008, NUCLEIC ACIDS RES, V36, P6781, DOI 10.1093/nar/gkn742; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Haralalka S, 2003, J BACTERIOL, V185, P4672, DOI 10.1128/JB.185.16.4672-4682.2003; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Hensel M, 1999, MOL MICROBIOL, V31, P489, DOI 10.1046/j.1365-2958.1999.01190.x; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Humphreys S, 1999, INFECT IMMUN, V67, P1560; Ismail TM, 2003, J BIOL CHEM, V278, P32602, DOI 10.1074/jbc.M305994200; Jiang Huiyuan, 2010, Weishengwu Xuebao, V50, P1537; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jonas K, 2009, FEMS MICROBIOL LETT, V297, P80, DOI 10.1111/j.1574-6968.2009.01661.x; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012; Lucchetti-Miganeh C, 2008, MICROBIOL-SGM, V154, P16, DOI 10.1099/mic.0.2007/012286-0; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Minagawa S, 2003, J BACTERIOL, V185, P3696, DOI 10.1128/JB.185.13.3696-3702.2003; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Moest TP, 2013, CURR OPIN MICROBIOL, V16, P38, DOI 10.1016/j.mib.2012.11.006; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Nagy G, 2006, INFECT IMMUN, V74, P5914, DOI 10.1128/IAI.00619-06; Nairz M, 2009, BLOOD, V114, P3642, DOI 10.1182/blood-2009-05-223354; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Papenfort K, 2008, MOL MICROBIOL, V68, P890, DOI 10.1111/j.1365-2958.2008.06189.x; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Pizarro-Cerda J, 2004, MOL MICROBIOL, V52, P1827, DOI 10.1111/j.1365-2958.2004.04122.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Ramachandran VK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-25; Ross W, 2013, MOL CELL, V50, P420, DOI 10.1016/j.molcel.2013.03.021; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shi Liang, 2009, J Proteomics Bioinform, V2, P388; Song M, 2010, J MICROBIOL, V48, P89, DOI 10.1007/s12275-009-0179-6; Song MY, 2004, J BIOL CHEM, V279, P34183, DOI 10.1074/jbc.M313491200; Tani TH, 2002, P NATL ACAD SCI USA, V99, P13471, DOI 10.1073/pnas.212510999; Taylor CA, 2002, J BACTERIOL, V184, P621, DOI 10.1128/JB.184.3.621-628.2002; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; Timmermans J, 2010, CELL MOL LIFE SCI, V67, P2897, DOI 10.1007/s00018-010-0381-z; Tomljenovic-Berube AM, PLOS GENET, V6; TORRIANI AM, 1990, BIOESSAYS, V12, P371, DOI 10.1002/bies.950120804; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908; Zusman T, 2002, J BACTERIOL, V184, P67, DOI 10.1128/JB.184.1.67-75.2002	77	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92690	10.1371/journal.pone.0092690	http://dx.doi.org/10.1371/journal.pone.0092690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664308	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900098
J	Tseng, MN; Chung, CL; Tzean, SS				Tseng, Min-Nan; Chung, Chia-Ling; Tzean, Shean-Shong			Mechanisms Relevant to the Enhanced Virulence of a Dihydroxynaphthalene-Melanin Metabolically Engineered Entomopathogen	PLOS ONE			English	Article							FUNGUS METARHIZIUM-ANISOPLIAE; BEAUVERIA-BASSIANA; PAECILOMYCES-FUMOSOROSEUS; COLLETOTRICHUM-LAGENARIUM; MAGNAPORTHE-GRISEA; BIOSYNTHESIS GENES; PATHOGENIC FUNGUS; FONSECAEA-PEDROSOI; STRESS TOLERANCE; TURGOR PRESSURE	The entomopathogenic fungus Metarhizium anisopliae MA05-169 is a transformant strain that has been metabolically engineered to express dihydroxynaphthalene-melanin biosynthesis genes. In contrast to the wild type strain, the transformant displays a greater resistance to environmental stress and a higher virulence toward target insect host. However, the underlying mechanisms for these characteristics remain unclear; hence experiments were initiated to explore the possible mechanism(s) through physiological and molecular approaches. Although both transformant and wild type strains could infect and share the same insect host range, the former germinated faster and produced more appressoria than the latter, both in vivo and in vitro. The transformant showed a significantly shorter median lethal time (LT50) when infecting the diamondback moth (Plutella xylostella) and the striped flea beetle (Phyllotreta striolata), than the wild type. Additionally, the transformant was more tolerant to reactive oxygen species (ROS), produced 40-fold more orthosporin and notably overexpressed the transcripts of the pathogenicity-relevant hydrolytic enzymes (chitinase, protease, and phospholipase) genes in vivo. In contrast, appressorium turgor pressure and destruxin A content were slightly decreased compared to the wild type. The transformant's high anti-stress tolerance, its high virulence against five important insect pests (cowpea aphid Aphis craccivora, diamondback moth Pl. xylostella, striped flea beetle Ph. striolata, and silverleaf whitefly Bemisia argentifolii) and its capacity to colonize the root system are key properties for its potential bio-control field application.	[Tseng, Min-Nan; Chung, Chia-Ling; Tzean, Shean-Shong] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Tseng, Min-Nan] Council Agr, Execut Yuan, Kaohsiung Dist Agr Res & Extens Stn, Div Plant Protect, Pingtung, Taiwan	National Taiwan University	Tzean, SS (corresponding author), Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan.	sst@ntu.edu.tw		CHUNG, CHIA-LIN/0000-0002-1612-0109	National Science Council, Taiwan [NSC 102-2313-B002-006]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thanks the financial support from National Science Council, Taiwan by a grant (NSC 102-2313-B002-006).	Altre JA, 1999, J INVERTEBR PATHOL, V73, P332, DOI 10.1006/jipa.1999.4844; Altre JA, 2001, J INVERTEBR PATHOL, V78, P81, DOI 10.1006/jipa.2001.5046; Amparyup P, 2010, DEV COMP IMMUNOL, V34, P168, DOI 10.1016/j.dci.2009.09.004; Andre CM, 2010, CURR NUTR FOOD SCI, V6, P2, DOI 10.2174/157340110790909563; Arruda W, 2005, EXP APPL ACAROL, V37, P231, DOI 10.1007/s10493-005-3818-6; Bagga S, 2004, GENE, V324, P159, DOI 10.1016/j.gene.2003.09.031; Barnes SE, 1997, MYCOL RES, V101, P662, DOI 10.1017/S0953756296003152; Bechinger C, 1999, SCIENCE, V285, P1896, DOI 10.1126/science.285.5435.1896; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Bogo MR, 1998, CURR MICROBIOL, V37, P221, DOI 10.1007/s002849900368; Boucias D.G., 1991, P101; BOUCIAS DG, 1988, APPL ENVIRON MICROB, V54, P1795, DOI 10.1128/AEM.54.7.1795-1805.1988; Boucias DG, 2012, BIOCOMMUNICATION FUN, P305, DOI DOI 10.1007/978-94-007-4264-2_20; Braga GUL, 2001, PHOTOCHEM PHOTOBIOL, V74, P734, DOI 10.1562/0031-8655(2001)074&lt;0734:BSUAUR&gt;2.0.CO;2; Broetto L, 2010, FEMS MICROBIOL LETT, V312, P101, DOI 10.1111/j.1574-6968.2010.02103.x; BUTT TM, 1995, MYCOL RES, V99, P945, DOI 10.1016/S0953-7562(09)80754-5; Campos RA, 2005, CURR MICROBIOL, V50, P257, DOI 10.1007/s00284-004-4460-y; Chen ZJ, 2004, MYCOLOGIA, V96, P1199, DOI 10.2307/3762135; Cosentino-Gomes D, 2013, CURR MICROBIOL, V66, P467, DOI 10.1007/s00284-012-0296-z; Cunha MML, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-80; Cunha MML, 2005, MICROSC RES TECHNIQ, V68, P377, DOI 10.1002/jemt.20260; Czarna M, 2005, FEBS LETT, V579, P3136, DOI 10.1016/j.febslet.2005.04.081; Devi KU, 2012, BIOTECHNOLOGY OF FUNGAL GENES, P343; Doering TL, 1999, MED MYCOL, V37, P175, DOI 10.1046/j.1365-280X.1999.00218.x; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; Engh I, 2007, FEMS MICROBIOL LETT, V275, P62, DOI 10.1111/j.1574-6968.2007.00867.x; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Entz SC, 2008, BIOCONTROL, V53, P327, DOI 10.1007/s10526-006-9061-1; Fang WG, 2010, FUNGAL GENET BIOL, V47, P602, DOI 10.1016/j.fgb.2010.03.011; Fang WG, 2005, APPL ENVIRON MICROB, V71, P363, DOI 10.1128/AEM.71.1.363-370.2005; FROYD JD, 1976, PHYTOPATHOLOGY, V66, P1135, DOI 10.1094/Phyto-66-1135; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Gorb S., 2001, ATTACHMENT DEVICES I; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; HALLOCK YF, 1988, PHYTOCHEMISTRY, V27, P3123, DOI 10.1016/0031-9422(88)80012-8; Harris JP, 2001, PHYTOCHEMISTRY, V57, P165, DOI 10.1016/S0031-9422(01)00004-8; Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014; HOCH HC, 1987, SCIENCE, V235, P1659, DOI 10.1126/science.235.4796.1659; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Hunt VL, 2011, J INSECT PHYSIOL, V57, P1341, DOI 10.1016/j.jinsphys.2011.06.008; Inyang EN, 1999, MYCOL RES, V103, P419, DOI 10.1017/S0953756298007333; Jacobson ES, 2005, MED MYCOL, V43, P327, DOI 10.1080/13693780412331271081; James RR, 2003, J INVERTEBR PATHOL, V84, P67, DOI 10.1016/j.jip.2003.08.006; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; KERRIGAN JE, 1995, J MED CHEM, V38, P544, DOI 10.1021/jm00003a017; Kershaw MJ, 1999, J INVERTEBR PATHOL, V74, P213, DOI 10.1006/jipa.1999.4884; Kihara J, 2008, FEMS MICROBIOL LETT, V281, P221, DOI 10.1111/j.1574-6968.2008.01101.x; Kubo Y, 1998, DEV PLANT PATHOL, V13, P253; KUBO Y, 1982, PHYTOPATHOLOGY, V72, P1198, DOI 10.1094/Phyto-77-1198; Kumar Susheel, 2008, V3, P365, DOI 10.1007/978-1-4020-8571-0_17; Lee In-Kyoung, 2006, Mycobiology, V34, P38, DOI 10.4489/MYCO.2006.34.1.038; Leger R, 1987, J GEN MICROBIOL, V133, P1371; LIU ZY, 1993, J INVERTEBR PATHOL, V62, P248, DOI 10.1006/jipa.1993.1107; Ment D, 2010, APPL ENVIRON MICROB, V76, P3521, DOI 10.1128/AEM.02596-09; Meyer EE, 2006, P NATL ACAD SCI USA, V103, P15739, DOI 10.1073/pnas.0606422103; Moon YS, 2008, APPL ENVIRON MICROB, V74, P4366, DOI 10.1128/AEM.00285-08; Nakazawa T, 2012, CHEMBIOCHEM, V13, P855, DOI 10.1002/cbic.201200107; Nappi AJ, 1995, EUR J CELL BIOL, V68, P450; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Pochet L, 2004, CURR PHARM DESIGN, V10, P3781, DOI 10.2174/1381612043382684; Rangel DEN, 2006, J INVERTEBR PATHOL, V93, P170, DOI 10.1016/j.jip.2006.06.008; Rozanowska M, 1999, FREE RADICAL BIO MED, V26, P518, DOI 10.1016/S0891-5849(98)00234-2; Shah FA, 2005, FEMS MICROBIOL LETT, V251, P259, DOI 10.1016/j.femsle.2005.08.010; SMITH RJ, 1982, J INVERTEBR PATHOL, V39, P15, DOI 10.1016/0022-2011(82)90153-7; St Leger RJ, 2001, FUNGI BIOCONTROL AGE, P219; St Leger RJ, 2000, MYCOL RES; StLeger RJ, 1996, P NATL ACAD SCI USA, V93, P6349, DOI 10.1073/pnas.93.13.6349; Taborda CP, 2008, MYCOPATHOLOGIA, V165, P331, DOI 10.1007/s11046-007-9061-4; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Tseng MN, 2011, APPL ENVIRON MICROB, V77, P4508, DOI 10.1128/AEM.02033-10; Tsuji G, 2000, MOL MICROBIOL, V38, P940, DOI 10.1046/j.1365-2958.2000.02181.x; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; Wang CS, 2007, J BIOL CHEM, V282, P21110, DOI 10.1074/jbc.M609592200; Wang CS, 2007, EUKARYOT CELL, V6, P808, DOI 10.1128/EC.00409-06; Wang QX, 2012, FITOTERAPIA, V83, P209, DOI 10.1016/j.fitote.2011.10.013; WANG YL, 1994, INFECT IMMUN, V62, P3004, DOI 10.1128/IAI.62.7.3004-3007.1994; Wheeler M, 2000, INFECT IMMUN, V68, P3696, DOI 10.1128/IAI.68.6.3696-3703.2000; WHITE LP, 1958, NATURE, V182, P1427, DOI 10.1038/1821427a0	81	15	16	8	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90473	10.1371/journal.pone.0090473	http://dx.doi.org/10.1371/journal.pone.0090473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662974	gold, Green Submitted, Green Published			2022-12-25	WOS:000333459900008
J	Wang, JM; Su, HX; Zhang, T; Du, J; Cui, S; Yang, F; Jin, Q				Wang, Jianmin; Su, Haoxiang; Zhang, Ting; Du, Jiang; Cui, Sheng; Yang, Fan; Jin, Qi			Inhibition of Enterovirus 71 Replication by 7-Hydroxyflavone and Diisopropyl-Flavon7-yl Phosphate	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; 3C PROTEASE; ANTIVIRAL ACTIVITY; MOUTH-DISEASE; IN-VITRO; CRYSTAL-STRUCTURE; VIRUS; PROTEINASE; INFECTION; RESPONSES	Enterovirus 71 (EV71) is the major causative agent of hand, foot, and mouth disease, which has been continuously prevalent in Asia in recent years. In children, severe cases can lead to death, and no prophylactic or therapeutic measures against EV71 infection are available. The 3C proteases of EV71 play an important role in viral replication and are an ideal drug target. In previous work, we resolved the crystal structure for EV71 3C(pro). In this report, we took advantage of the automated docking program AutoDock 4.0 to simulate EV71 3C(pro)-ligand conformation. 7-hydroxyflavone (HF) and its phosphate ester(FIP) were predicted to bind with EV71 3C(pro). In an in vitro protease inhibition assay, FIP inhibited EV71 3C(pro) protease activity. Both flavones were highly active against EV71, protecting cells from EV71 infection. Replication of viral RNA and formation of EV71 plaque were all strongly inhibited in cells. These results indicated that HF and FIP may serve as potential protective agents in the treatment of patients with chronic EV71 infection.	[Yang, Fan] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, F (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	ymf129@163.com; zdsys@vip.sina.com	Zhang, Ting/S-8215-2019; wang, jian/GVS-0711-2022; Sheng, CUI/M-6405-2013	Sheng, CUI/0000-0001-6329-3582	National Science and Technology Major Project of China [2013ZX10004-601, 2011ZX10004-001, 2013ZX10004-101]	National Science and Technology Major Project of China	The work was supported by the National Science and Technology Major Project of China (Project No. 2013ZX10004-601, No. 2011ZX10004-001 and No. 2013ZX10004-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; Birtley JR, 2005, J BIOL CHEM, V280, P11520, DOI 10.1074/jbc.M413254200; Chen Xiao-lan, 2007, Yaoxue Xuebao, V42, P396; Chen XL, 2004, ANAL CHEM, V76, P211, DOI 10.1021/ac035027q; Cui S, 2011, J MOL BIOL, V408, P449, DOI 10.1016/j.jmb.2011.03.007; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; HARRIS KS, 1992, J VIROL, V66, P7481, DOI 10.1128/JVI.66.12.7481-7489.1992; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hu YC, 2003, BIOTECHNOL LETT, V25, P919, DOI 10.1023/A:1024071514438; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Hwang YC, 2006, APPL ENVIRON MICROB, V72, P3710, DOI 10.1128/AEM.72.5.3710-3715.2006; Johari J, 2012, INT J MOL SCI, V13, P16785, DOI 10.3390/ijms131216785; Jung HA, 2012, CHEM-BIOL INTERACT, V197, P110, DOI 10.1016/j.cbi.2012.04.004; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Kuo CJ, 2008, BIOORGAN MED CHEM, V16, P7388, DOI 10.1016/j.bmc.2008.06.015; Lee CC, 2009, J BIOL CHEM, V284, P7646, DOI 10.1074/jbc.M807947200; Lei XB, 2013, J VIROL, V87, P1690, DOI 10.1128/JVI.01855-12; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Liu AL, 2008, BIOORGAN MED CHEM, V16, P7141, DOI 10.1016/j.bmc.2008.06.049; Lu GW, 2011, J VIROL, V85, P10319, DOI 10.1128/JVI.00787-11; Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215; MALCOLM BA, 1995, PROTEIN SCI, V4, P1439, DOI 10.1002/pro.5560040801; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; Matthews DA, 1999, P NATL ACAD SCI USA, V96, P11000, DOI 10.1073/pnas.96.20.11000; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mosimann SC, 1997, J MOL BIOL, V273, P1032, DOI 10.1006/jmbi.1997.1306; Nolan MA, 2003, NEUROLOGY, V60, P1651, DOI 10.1212/01.WNL.0000066810.62490.FF; Parsley TB, 1997, RNA, V3, P1124; Plevka P, 2012, SCIENCE, V336, P1274, DOI 10.1126/science.1218713; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tyler KL, 2009, ARCH NEUROL-CHICAGO, V66, P939, DOI 10.1001/archneurol.2009.153; Wang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038035; Wang J, 2011, J VIROL, V85, P10021, DOI 10.1128/JVI.05107-11; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; Weng KF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000593; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560; Zhang Shou-Bin, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P38; Zhang T, 2004, BIOORGAN MED CHEM, V12, P6097, DOI 10.1016/j.bmc.2004.09.013; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030259	46	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92565	10.1371/journal.pone.0092565	http://dx.doi.org/10.1371/journal.pone.0092565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664133	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900076
J	Li, LM; Yan, H; Feng, LP; Li, YL; Lu, P; Hu, YB; Chen, SY				Li, Lamei; Yan, Huan; Feng, Lipeng; Li, Yunlong; Lu, Pei; Hu, Yangbo; Chen, Shiyun			LcrQ Blocks the Role of LcrF in Regulating the Ysc-Yop Type III Secretion Genes in Yersinia pseudotuberculosis	PLOS ONE			English	Article							LOW-CALCIUM RESPONSE; TRANSCRIPTIONAL ACTIVATOR; VIRULENCE PLASMID; ESCHERICHIA-COLI; ARABINOSE OPERON; PYV PLASMID; ENTEROCOLITICA; EXPRESSION; PESTIS; SYSTEM	Pathogenic Yersinia species employ the Ysc-Yop type III secretion system (T3SS) encoded by a highly conserved pYV virulence plasmid to export the virulence effectors into host cells. The Ysc-Yop T3SS is tightly regulated by multiple contributing proteins that function at different levels. However, systematic transcriptional regulation analysis of Ysc-Yop T3SS is lacking and the detailed mechanism under this regulation process is still elusive. Aimed at systematically characterizing transcriptional regulations of all T3SS genes in Y. pseudotuberculosis, we amplified 97 non-coding fragments from the pYV plasmid and analyzed transcriptional responses of the T3SS genes under different growth conditions. Transcriptions of T3SS genes were induced at 37 degrees C and genes encoding T3SS effectors were highly induced by further depletion of Ca2+. The temperature induced gene transcription process is mediated by modules encoded on the chromosome, while the Ca2+ depletion-induced process is controlled by the positive regulatory protein LcrF as well as the negative regulatory protein LcrQ. In this process, LcrQ shares the same targets with LcrF and the effect of LcrQ is dependent on the presence of LcrF. Furthermore, over-expression of LcrF showed the same phenotype as that of the lcrQ mutant strain and intracellular amount balance of LcrQ and LcrF is important in T3SS regulation. When the expression level of LcrF exceeds LcrQ, expression of the Ysc-Yop T3SS genes is activated and vice versa. Together, these data support a model in which LcrQ blocks the activation role of LcrF in regulating the transcription of T3SS genes in Yersinia.	[Li, Lamei; Yan, Huan; Feng, Lipeng; Li, Yunlong; Lu, Pei; Hu, Yangbo; Chen, Shiyun] Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Hu, YB (corresponding author), Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, Wuhan, Peoples R China.	ybhu@wh.iov.cn; sychen@wh.iov.cn		hu, yang bo/0000-0001-6153-1348; chen, shi yun/0000-0002-6224-2975; Feng, Lipeng/0000-0003-1696-6435	National Science Foundation of China [31170133]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by the National Science Foundation of China (#31170133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer AAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077767; Axler-DiPerte GL, 2006, J BACTERIOL, V188, P8033, DOI 10.1128/JB.01159-06; Axler-DiPerte GL, 2009, J BACTERIOL, V191, P514, DOI 10.1128/JB.01305-08; Balada-Llasat JM, 2006, PLOS PATHOG, V2, P816, DOI 10.1371/journal.ppat.0020086; Bohme K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002518; Cambronne ED, 2000, MOL MICROBIOL, V37, P263, DOI 10.1046/j.1365-2958.2000.01974.x; Cambronne ED, 2004, J BACTERIOL, V186, P829, DOI 10.1128/JB.186.3.829-841.2004; Cambronne ED, 2002, J BACTERIOL, V184, P5880, DOI 10.1128/JB.184.21.5880-5893.2002; Chen YQ, 2011, MOL MICROBIOL, V80, P966, DOI 10.1111/j.1365-2958.2011.07623.x; Cheng LW, 2000, J BACTERIOL, V182, P3183, DOI 10.1128/JB.182.11.3183-3190.2000; CHINA B, 1990, MOL MICROBIOL, V4, P1585, DOI 10.1111/j.1365-2958.1990.tb02070.x; CORNELIS G, 1989, J BACTERIOL, V171, P254, DOI 10.1128/jb.171.1.254-262.1989; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Costa TRD, 2010, J BIOL CHEM, V285, P25269, DOI 10.1074/jbc.M110.144311; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; DEROUVROIT CL, 1992, MOL MICROBIOL, V6, P395, DOI 10.1111/j.1365-2958.1992.tb01483.x; Dewoody RS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00004; HOE NP, 1992, J BACTERIOL, V174, P4275, DOI 10.1128/JB.174.13.4275-4286.1992; Hu YB, 2009, MICROBIOL-SGM, V155, P2522, DOI 10.1099/mic.0.028381-0; Jackson MW, 2004, MOL MICROBIOL, V54, P1364, DOI 10.1111/j.1365-2958.2004.04353.x; Joseph SS, 2007, ADV EXP MED BIOL, V603, P235; Juris SJ, 2002, CELL MICROBIOL, V4, P201, DOI 10.1046/j.1462-5822.2002.00182.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kopaskie KS, 2013, J BIOL CHEM, V288, P35478, DOI 10.1074/jbc.M113.504811; Lee VT, 1998, MOL MICROBIOL, V28, P593, DOI 10.1046/j.1365-2958.1998.00822.x; Li YL, 2014, MOL MICROBIOL, V91, P494, DOI 10.1111/mmi.12474; Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014; Nilles ML, 1997, J BACTERIOL, V179, P1307, DOI 10.1128/jb.179.4.1307-1316.1997; OToole R, 1996, MOL MICROBIOL, V19, P625, DOI 10.1046/j.1365-2958.1996.412927.x; RIMPILAINEN M, 1992, J BACTERIOL, V174, P3355, DOI 10.1128/jb.174.10.3355-3363.1992; Rohde JR, 1999, J BACTERIOL, V181, P4198, DOI 10.1128/JB.181.14.4198-4204.1999; ROHDE JR, 1994, MOL MICROBIOL, V12, P187, DOI 10.1111/j.1365-2958.1994.tb01008.x; Schiano CA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00129; Schleif R, 2010, FEMS MICROBIOL REV, V34, P779, DOI 10.1111/j.1574-6976.2010.00226.x; SKURNIK M, 1992, J BACTERIOL, V174, P2047, DOI 10.1128/jb.174.6.2047-2051.1992; Stainier I, 1997, MOL MICROBIOL, V26, P833, DOI 10.1046/j.1365-2958.1997.6281995.x; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; WATTIAU P, 1994, J BACTERIOL, V176, P3878, DOI 10.1128/JB.176.13.3878-3884.1994; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; YOTHER J, 1986, J BACTERIOL, V165, P443, DOI 10.1128/jb.165.2.443-447.1986	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92243	10.1371/journal.pone.0092243	http://dx.doi.org/10.1371/journal.pone.0092243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658611	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300064
J	Montasser, ME; Shimmin, LC; Gu, DF; Chen, J; Gu, C; Kelly, TN; Jaquish, CE; Rice, TK; Rao, DC; Cao, J; Chen, JC; De-Peliu; Whelton, PK; Hamm, LL; He, J; Hixson, JE				Montasser, May E.; Shimmin, Lawrence C.; Gu, Dongfeng; Chen, Jing; Gu, Charles; Kelly, Tanika N.; Jaquish, Cashell E.; Rice, Treva K.; Rao, Dabeeru C.; Cao, Jie; Chen, Jichun; De-Peliu; Whelton, Paul K.; Hamm, Lotuce Lee; He, Jiang; Hixson, James E.			Variation in Genes that Regulate Blood Pressure Are Associated with Glomerular Filtration Rate in Chinese	PLOS ONE			English	Article							ALPHA-ADDUCIN GENE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; RENIN-ANGIOTENSIN SYSTEM; CHRONIC KIDNEY-DISEASE; CHANNEL GAMMA-SUBUNIT; BETA(2)-ADRENERGIC RECEPTOR; ESSENTIAL-HYPERTENSION; METABOLIC SYNDROME; SERUM CREATININE; LINKAGE ANALYSIS	Chronic kidney disease (CKD) can be a consequence of diabetes, hypertension, immunologic disorders, and other exposures, as well as genetic factors that are still largely unknown. Glomerular filtration rate (GFR), which is widely used to measure kidney function, has a heritability ranging from 25% to 75%, but only 1.5% of this heritability is explained by genetic loci that have been identified to date. In this study we tested for associations between GFR and 234 SNPs in 26 genes from pathways of blood pressure regulation in 3,025 rural Chinese participants of the "Genetic Epidemiology Network of Salt Sensitivity" (GenSalt) study. We estimated GFR (eGFR) using baseline serum creatinine measurements obtained prior to dietary intervention. We identified significant associations between eGFR and 12 SNPs in 6 genes (ACE, ADD1, AGT, GRK4, HSD11B1, and SCNN1G). The cumulative effect of the protective alleles was an increase in mean eGFR of 4 mL/min per 1.73 m(2), while the cumulative effect of the risk alleles was a decrease in mean eGFR of 3 mL/min per 1.73 m(2). In addition, we identified a significant interaction between SNPs in CYP11B1 and ADRB2. We have identified common variants in genes from pathways that regulate blood pressure and influence kidney function as measured by eGFR, providing new insights into the genetic determinants of kidney function. Complex genetic effects on kidney function likely involve interactions among genes as we observed for CYP11B1 and ADRB2.	[Montasser, May E.; Shimmin, Lawrence C.; Hixson, James E.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Sch Publ Hlth, Houston, TX 77030 USA; [Gu, Dongfeng; Cao, Jie; Chen, Jichun] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Gu, Dongfeng; Cao, Jie; Chen, Jichun] Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100730, Peoples R China; [Chen, Jing; Hamm, Lotuce Lee] Tulane Univ, Sch Med, New Orleans, LA 70112 USA; [Gu, Charles; Rice, Treva K.; Rao, Dabeeru C.] Washington Univ, Sch Med, St Louis, MO USA; [Kelly, Tanika N.; Whelton, Paul K.; He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Jaquish, Cashell E.] NHLBI, NIH, Bethesda, MD 20892 USA; [De-Peliu] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Tulane University; Washington University (WUSTL); Tulane University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Montasser, ME (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA.	mmontass@medicine.umaryland.edu	He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652; Hixson, James/0000-0002-0849-9315; Rice, Treva/0000-0001-7452-2600	National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland [U01HL072507, R01HL087263, R01HL090682]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072507, R01HL087263, R01HL090682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Genetic Epidemiology Network of Salt Sensitivity (GenSalt) is supported by several grants (U01HL072507, R01HL087263, and R01HL090682) from the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Adler S, 2006, ETHN DIS, V16; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahluwalia TS, 2009, DNA CELL BIOL, V28, P141, DOI 10.1089/dna.2008.0810; Arar NH, 2008, NEPHROL DIAL TRANSPL, V23, P3184, DOI 10.1093/ndt/gfn215; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basson J, 2012, CURR HYPERTENS REP, V14, P46, DOI 10.1007/s11906-011-0241-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit G, 2010, ANN NY ACAD SCI, V1214, P83, DOI 10.1111/j.1749-6632.2010.05817.x; Bianchi G, 2005, HYPERTENSION, V45, P331, DOI 10.1161/01.HYP.0000156497.39375.37; Boger CA, 2011, KIDNEY BLOOD PRESS R, V34, P225, DOI 10.1159/000326901; Bray MS, 2000, AM J HYPERTENS, V13, P699, DOI 10.1016/S0895-7061(00)00242-9; Brodde OE, 2008, PHARMACOL THERAPEUT, V117, P1, DOI 10.1016/j.pharmthera.2007.07.002; Busst CJ, 2011, HYPERTENSION, V58, P1073, DOI 10.1161/HYPERTENSIONAHA.111.176370; Busst CJ, 2007, HYPERTENSION, V50, P672, DOI 10.1161/HYPERTENSIONAHA.107.089128; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Chang Hung-Rong, 2003, J Chin Med Assoc, V66, P51; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; de Borst MH, 2008, NAT CLIN PRACT NEPHR, V4, P265, DOI 10.1038/ncpneph0785; Dluhy RG, 1999, J CLIN ENDOCR METAB, V84, P4341, DOI 10.1210/jc.84.12.4341; Fox CS, 2004, J AM SOC NEPHROL, V15, P2457, DOI 10.1097/01.ASN.0000135972.13396.6F; Freedman BI, 2007, CLIN J AM SOC NEPHRO, V2, P1306, DOI 10.2215/CJN.02560607; Freel EM, 2004, J AM SOC NEPHROL, V15, P1993, DOI 10.1097/01.ASN.0000132473.50966.14; Ge D, 2005, ANN HUM GENET, V69, P36, DOI 10.1046/j.1529-8817.2003.00093.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gjesing AP, 2007, DIABETOLOGIA, V50, P563, DOI 10.1007/s00125-006-0578-8; Gong R, 2008, LIFE SCI, V82, P631, DOI 10.1016/j.lfs.2007.12.019; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Harris DM, 2008, CLIN SCI, V115, P79, DOI 10.1042/CS20070442; He J, 2007, J HUM HYPERTENS, V21, P639, DOI 10.1038/sj.jhh.1002207; He X, 2001, CLIN EXP HYPERTENS, V23, P579, DOI 10.1081/CEH-100106828; Hinds DR, 1999, ASPEX PACKAGE AFFECT; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; [黄晓红 HUANG Xiaohong], 2007, [中华医学杂志, National Medical Journal of China], V87, P1682; Ichihara A, 2004, CONTRIB NEPHROL, V143, P117; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; Ju ZY, 2003, J HYPERTENS, V21, P1861, DOI 10.1097/00004872-200310000-00013; Kelly JJ, 1998, CLIN EXP PHARMACOL P, V25, pS51, DOI 10.1111/j.1440-1681.1998.tb02301.x; Kim S, 2000, PHARMACOL REV, V52, P11; Kiryluk K, 2008, KIDNEY INT, V74, P1109, DOI 10.1038/ki.2008.479; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Lu XF, 2013, NEPHROL DIAL TRANSPL, V28, P2977, DOI 10.1093/ndt/gft333; Maeda Shiro, 2008, Ther Adv Cardiovasc Dis, V2, P363, DOI 10.1177/1753944708094768; Morris BJ, 2009, AM J HYPERTENS, V22, P235, DOI 10.1038/ajh.2008.337; Morton NM, 2008, FRONT HORM RES, V36, P146, DOI 10.1159/000115363; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Park HS, 2008, METABOLISM, V57, P1064, DOI 10.1016/j.metabol.2008.03.009; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Pereira TV, 2008, HYPERTENSION, V51, P778, DOI 10.1161/HYPERTENSIONAHA.107.100370; Phillips JK, 2005, CLIN EXP PHARMACOL P, V32, P415, DOI 10.1111/j.1440-1681.2005.04204.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritz E, 2003, HERZ, V28, P663, DOI 10.1007/s00059-003-2509-5; Rodriguez-Soriano J, 2000, PEDIATR NEPHROL, V14, P1121, DOI 10.1007/s004670000407; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Saran Anita M, 2008, Ther Adv Cardiovasc Dis, V2, P425, DOI 10.1177/1753944708096379; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Schelling JR, 2008, DIABETES, V57, P235, DOI 10.2337/db07-0313; Shioji K, 2004, HYPERTENS RES, V27, P31, DOI 10.1291/hypres.27.31; Staessen JA, 2005, PHARMACOGENOMICS, V6, P665, DOI 10.2217/14622416.6.7.665; Stimson R H, 2007, Minerva Endocrinol, V32, P141; Strautnieks SS, 1996, NAT GENET, V13, P248, DOI 10.1038/ng0696-248; Tesson F, 2007, HYPERTENSION, V50, P607, DOI 10.1161/HYPERTENSIONAHA.107.096800; Tobler Andreas R, 2005, J Biomol Tech, V16, P398; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; Wang JG, 2002, KIDNEY INT, V62, P2152, DOI 10.1046/j.1523-1755.2002.00691.x; Warnock DG, 2001, AM J MED SCI, V322, P302, DOI 10.1097/00000441-200112000-00002; WHITWORTH JA, 1995, STEROIDS, V60, P76, DOI 10.1016/0039-128X(94)00033-9; Yamagishi K, 2004, AM J HYPERTENS, V17, P385, DOI 10.1016/j.amjhyper.2003.12.018; Yu SF, 2008, BIOMED ENVIRON SCI, V21, P239, DOI 10.1016/S0895-3988(08)60036-7; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zeng CY, 2008, HYPERTENSION, V51, P1449, DOI 10.1161/HYPERTENSIONAHA.107.096487; Zhuo Jia L, 2013, Front Endocrinol (Lausanne), V4, P166, DOI 10.3389/fendo.2013.00166	75	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92468	10.1371/journal.pone.0092468	http://dx.doi.org/10.1371/journal.pone.0092468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658007	Green Submitted, gold, Green Published			2022-12-25	WOS:000333355300086
J	Park, MK; Cho, MK; Kang, SA; Park, HK; Kim, DH; Yu, HS				Park, Mi Kyung; Cho, Min Kyoung; Kang, Shin Ae; Park, Hye-Kyung; Kim, Dong-Hee; Yu, Hak Sun			Acanthamoeba Protease Activity Promotes Allergic Airway Inflammation via Protease-Activated Receptor 2	PLOS ONE			English	Article							DENDRITIC CELLS; EXPERIMENTAL SENSITIZATION; INDUCE; DIFFERENTIATION; EXPRESSION; SUBTILISIN; PHYSIOLOGY; CHEMOKINE; ADHESION; INNATE	Acanthamoeba is a free-living amoeba commonly present in the environment and often found in human airway cavities. Acanthamoeba possesses strong proteases that can elicit allergic airway inflammation. To our knowledge, the aeroallergenicity of Acanthamoeba has not been reported. We repeatedly inoculated mice with Acanthamoeba trophozoites or excretory-secretory (ES) proteins intra-nasally and evaluated symptoms and airway immune responses. Acanthamoeba trophozoites or ES proteins elicited immune responses in mice that resembled allergic airway inflammation. ES proteins had strong protease activity and activated the expression of several chemokine genes (CCL11, CCL17, CCL22, TSLP, and IL-25) in mouse lung epithelial cells. The serine protease inhibitor phenyl-methane-sulfonyl fluoride (PMSF) inhibited ES protein activity. ES proteins also stimulated dendritic cells and enhanced the differentiation of naive T cells into IL-4-secreting T cells. After repeated inoculation of the protease-activated receptor 2 knockout mouse with ES proteins, airway inflammation and Th2 immune responses were markedly reduced, but not to basal levels. Furthermore, asthma patients had higher Acanthamoeba-specific IgE titers than healthy controls and we found Acanthamoeba specific antigen from house dust in typical living room. Our findings suggest that Acanthamoeba elicits allergic airway symptoms in mice via a protease	[Park, Mi Kyung; Cho, Min Kyoung; Kang, Shin Ae; Yu, Hak Sun] Pusan Natl Univ, Sch Med, Dept Parasitol, Yangsan, South Korea; [Park, Mi Kyung; Kang, Shin Ae; Yu, Hak Sun] Immunoregulatory Therapeut Grp, Brain Busan Project 21, Pusan, South Korea; [Park, Hye-Kyung] Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan, South Korea; [Kim, Dong-Hee] Pusan Natl Univ, Coll Nursing, Dept Nursing, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University	Yu, HS (corresponding author), Pusan Natl Univ, Sch Med, Dept Parasitol, Yangsan, South Korea.	hsyu@pusan.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A2042979]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2042979). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Bouyer S, 2009, EXP PARASITOL, V123, P90, DOI 10.1016/j.exppara.2009.06.006; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Cho HJ, 2012, J ALLERGY CLIN IMMUN, V129, P529, DOI 10.1016/j.jaci.2011.11.024; CURSONS RTM, 1980, INFECT IMMUN, V29, P401; Dudley R, 2008, FEMS MICROBIOL LETT, V286, P9, DOI 10.1111/j.1574-6968.2008.01249.x; Feng T, 2010, J IMMUNOL, V185, P5915, DOI 10.4049/jimmunol.1001233; Ferreira GA, 2009, ACTA TROP, V112, P156, DOI 10.1016/j.actatropica.2009.07.015; HILLEBRAND JA, 1987, TOXICOL APPL PHARM, V89, P449, DOI 10.1016/0041-008X(87)90164-5; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Jeong HJ, 2007, EXP PARASITOL, V117, P357, DOI 10.1016/j.exppara.2007.05.003; Jeong Hae Jin, 2005, Korean Journal of Parasitology, V43, P47, DOI 10.3347/kjp.2005.43.2.47; Kauffman HF, 2000, J ALLERGY CLIN IMMUN, V105, P1185, DOI 10.1067/mai.2000.106210; Kawabata A, 2005, J PHARMACOL SCI, V97, P20, DOI 10.1254/jphs.FMJ04005X4; Khan NA, 2000, J CLIN MICROBIOL, V38, P2858, DOI 10.1128/JCM.38.8.2858-2861.2000; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim Won-Tae, 2006, Korean Journal of Parasitology, V44, P321, DOI 10.3347/kjp.2006.44.4.321; Kim YS, 2013, CLIN EXP ALLERGY, V43, P443, DOI 10.1111/cea.12085; Leino MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071278; Lewkowich IP, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-122; Liang GQ, 2012, J ALLERGY CLIN IMMUN, V129, P1377, DOI 10.1016/j.jaci.2012.02.035; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Martinez AJ, 1996, MED MICROBIOLOGY; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; MITRO K, 1994, EXP PARASITOL, V78, P377, DOI 10.1006/expr.1994.1041; Muccioli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2785; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Park HK, 2011, EXP PARASITOL, V127, P539, DOI 10.1016/j.exppara.2010.10.004; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Puxeddu I, 2006, J ALLERGY CLIN IMMUN, V117, P103, DOI 10.1016/j.jaci.2005.08.057; Ritter M, 2005, BIOCHEM BIOPH RES CO, V334, P254, DOI 10.1016/j.bbrc.2005.06.084; Roelandt T, 2008, J INVEST DERMATOL, V128, P1878, DOI 10.1038/jid.2008.168; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Salazar F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00356; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Serrano-Luna JD, 2006, CAN J MICROBIOL, V52, P16, DOI 10.1139/W05-114; Singh B, 2012, FEMS MICROBIOL REV, V36, P1122, DOI 10.1111/j.1574-6976.2012.00340.x; Sissons J, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-42; Takai T, 2005, INT ARCH ALLERGY IMM, V137, P194, DOI 10.1159/000086331; THORNE PS, 1986, TOXICOL APPL PHARM, V86, P112, DOI 10.1016/0041-008X(86)90404-7; Traynelis SF, 2007, CURR OPIN HEMATOL, V14, P230, DOI 10.1097/MOH.0b013e3280dce568; Tripathi P, 2011, IMMUNOBIOLOGY, V216, P402, DOI 10.1016/j.imbio.2010.06.009; Trujillo-Vargas CM, 2005, CLIN EXP ALLERGY, V35, P1003, DOI 10.1111/j.1365-2222.2005.02287.x; Vergnolle N, 1999, J IMMUNOL, V163, P5064; Yu HS, 2010, J KOREAN MED SCI, V25, P829, DOI 10.3346/jkms.2010.25.6.829; Zhou XX, 2012, J IMMUNOL, V188, P6046, DOI 10.4049/jimmunol.1102760	48	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92726	10.1371/journal.pone.0092726	http://dx.doi.org/10.1371/journal.pone.0092726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658532	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300122
J	Amato, MC; Pizzolanti, G; Torregrossa, V; Misiano, G; Milano, S; Giordano, C				Amato, Marco C.; Pizzolanti, Giuseppe; Torregrossa, Vittoria; Misiano, Gabriella; Milano, Salvatore; Giordano, Carla			Visceral Adiposity Index (VAI) Is Predictive of an Altered Adipokine Profile in Patients with Type 2 Diabetes	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; INSULIN-RESISTANCE; CARDIOMETABOLIC RISK; LIVER HISTOLOGY; NORMAL-WEIGHT; OBESITY; ADIPONECTIN; SENSITIVITY; DISEASE; PROTEIN	Aims: Although there is still no clear definition of "adipose tissue dysfunction'' or ATD, the identification of a clinical marker of altered fat distribution and function may provide the needed tools for early identification of a condition of cardiometabolic risk. Our aim was to evaluate the correlations among various anthropometric indices [BMI, Waist Circumference (WC), Hip Circumference (HC), Waist/Hip ratio (WHR), Body Adiposity Index (BAI) and Visceral adiposity Index (VAI)] and several adipocytokines [Visfatin, Resistin, Leptin, Soluble leptin receptors (sOB-R), Adiponectin, Ghrelin, Adipsin, PAI-1, vascular endothelial growth factor (VEGF), Hepatocyte growth factor (HGF) TNF-alpha, hs-CRP, IL-6, IL-18] in patients with type 2 diabetes (DM2). Materials and Methods: Ninety-one DM2 patients (age: 65.25 +/- 6.38 years; 42 men and 49 women) in stable treatment for the last six months with metformin in monotherapy (1.5-2 g/day) were cross-sectionally studied. Clinical, anthropometric, and metabolic parameters were evaluated. Serum adipocytokine levels were assayed with Luminex based kits. Results: At the Pearson's correlation, among all the indices investigated, VAI showed a significant correlation with almost all adipocytokines analyzed [Visfatin, Resistin and hsCRP (all p<0.001); Adiponectin, sOb-R, IL-6, IL-18, HGF (all p<0.010); Ghrelin and VEGF (both p<0.05)]. Through a two-step cluster analysis, 55 patients were identified with the most altered adipocytokine profile (patients with ATD). At a ROC analysis, VAI showed the highest C-statistic [0.767 (95% CI 0.66-0.84)] of all the indices. Conclusions: Our study suggests that the VAI, among the most common indexes of adiposity assessment, shows the best correlation with the best known adipocytokines and cardiometabolic risk serum markers. Although to date we are still far from clearly identifying an ATD, the VAI would be an easy tool for clearly mirroring a condition of cardiometabolic risk, in the absence of an overt metabolic syndrome.	[Amato, Marco C.; Pizzolanti, Giuseppe; Torregrossa, Vittoria; Giordano, Carla] Univ Palermo, Dipartimento Biomed Med Interna & Specialist DiBi, Sect Endocrinol Diabetol & Metab, Palermo, Italy; [Misiano, Gabriella; Milano, Salvatore] Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi D, Sect Clin Pathol, Palermo, Italy	University of Palermo; University of Palermo	Giordano, C (corresponding author), Univ Palermo, Dipartimento Biomed Med Interna & Specialist DiBi, Sect Endocrinol Diabetol & Metab, Palermo, Italy.	carla.giordano@unipa.it	Pizzolanti, Giuseppe/I-4547-2019; GIORDANO, Carla/R-4296-2017; Pizzolanti, Giuseppe/K-7097-2016	GIORDANO, Carla/0000-0003-1731-9395; Pizzolanti, Giuseppe/0000-0001-6052-8438				Abbasi F, 2002, J AM COLL CARDIOL, V40, P937, DOI 10.1016/S0735-1097(02)02051-X; Al-Daghri NM, 2013, EUR J CLIN INVEST, V43, P183, DOI 10.1111/eci.12030; Amato MC, 2013, NUTR METAB CARDIOVAS, V23, pE31, DOI 10.1016/j.numecd.2013.04.006; Amato MC, 2013, HUM REPROD, V28, P1919, DOI 10.1093/humrep/det105; Amato MC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-183; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Amato MC, 2011, HUM REPROD, V26, P1486, DOI 10.1093/humrep/der088; Bays H, 2005, FUTUR CARDIOL, V1, P39, DOI 10.1517/14796678.1.1.39; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Boyle JG, 2011, DIABETOLOGIA, V54, P1799, DOI 10.1007/s00125-011-2126-4; Bremer AA, 2013, J OBES, V2013, DOI 10.1155/2013/393192; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Chandalia M, 1999, J CLIN ENDOCR METAB, V84, P2329, DOI 10.1210/jc.84.7.2329; Ciresi A, 2012, J CLIN ENDOCR METAB, V97, P2907, DOI 10.1210/jc.2012-1518; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Devaraj Sridevi, 2010, Expert Rev Endocrinol Metab, V5, P19; Elisha B, 2013, APPL PHYSIOL NUTR ME, V38, P892, DOI 10.1139/apnm-2012-0307; Fernandez-Real JM, 2007, DIABETES CARE, V30, P616, DOI 10.2337/dc06-1581; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Garg Abhimanyu, 2006, Clin Cornerstone, V8 Suppl 4, pS7, DOI 10.1016/S1098-3597(06)80039-6; Kennedy A, 1997, J CLIN ENDOCR METAB, V82, P1293, DOI 10.1210/jc.82.4.1293; Kizer JR, 2012, DIABETES CARE, V35, P415, DOI 10.2337/dc11-1519; Knowles KM, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/931402; Musso G, 2012, HEPATOLOGY, V56, DOI 10.1002/hep.25677; Oh JY, 2013, OBESITY, V21, P1690, DOI 10.1002/oby.20096; Petta S, 2012, ALIMENT PHARM THER, V35, P238, DOI 10.1111/j.1365-2036.2011.04929.x; Petta S, 2010, HEPATOLOGY, V52, P1543, DOI 10.1002/hep.23859; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Soino M, 2006, DIABETES CARE, V29, P329, DOI 10.2337/diacare.29.02.06.dc05-1700; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Vongsuvanh R, 2012, J HEPATOL, V57, P392, DOI 10.1016/j.jhep.2012.03.013; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Zhang XL, 2013, INT J CARDIOL, V168, P2141, DOI 10.1016/j.ijcard.2013.01.275	41	79	85	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91969	10.1371/journal.pone.0091969	http://dx.doi.org/10.1371/journal.pone.0091969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651545	Green Published, gold			2022-12-25	WOS:000333352800060
J	Han, ZP; Ku, LX; Zhang, ZZ; Zhang, J; Guo, SL; Liu, HY; Zhao, RF; Ren, ZZ; Zhang, LK; Su, HH; Dong, L; Chen, YH				Han, Zanping; Ku, Lixia; Zhang, Zhenzhen; Zhang, Jun; Guo, ShuLei; Liu, Haiying; Zhao, Ruifang; Ren, Zhenzhen; Zhang, Liangkun; Su, Huihui; Dong, Lei; Chen, Yanhui			QTLs for Seed Vigor-Related Traits Identified in Maize Seeds Germinated under Artificial Aging Conditions	PLOS ONE			English	Article							CONTROLLED DETERIORATION; LONGEVITY; LOCI; ARABIDOPSIS; PROTEINS; STORABILITY; GERMINABILITY; ANTIOXIDANTS; PERFORMANCE; POPULATION	High seed vigor is important for agricultural production due to the associated potential for increased growth and productivity. However, a better understanding of the underlying molecular mechanisms is required because the genetic basis for seed vigor remains unknown. We used single-nucleotide polymorphism (SNP) markers to map quantitative trait loci (QTLs) for four seed vigor traits in two connected recombinant inbred line (RIL) maize populations under four treatment conditions during seed germination. Sixty-five QTLs distributed between the two populations were identified and a meta-analysis was used to integrate genetic maps. Sixty-one initially identified QTLs were integrated into 18 meta-QTLs (mQTLs). Initial QTLs with contribution to phenotypic variation values of R-2>10% were integrated into mQTLs. Twenty-three candidate genes for association with seed vigor traits coincided with 13 mQTLs. The candidate genes had functions in the glycolytic pathway and in protein metabolism. QTLs with major effects (R-2>10%) were identified under at least one treatment condition for mQTL2, mQTL3-2, and mQTL3-4. Candidate genes included a calcium-dependent protein kinase gene (302810918) involved in signal transduction that mapped in the mQTL3-2 interval associated with germination energy (GE) and germination percentage (GP), and an hsp20/alpha crystallin family protein gene (At5g51440) that mapped in the mQTL3-4 interval associated with GE and GP. Two initial QTLs with a major effect under at least two treatment conditions were identified for mQTL5-2. A cucumisin-like Ser protease gene (At5g67360) mapped in the mQTL5-2 interval associated with GP. The chromosome regions for mQTL2, mQTL3-2, mQTL3-4, and mQTL5-2 may be hot spots for QTLs related to seed vigor traits. The mQTLs and candidate genes identified in this study provide valuable information for the identification of additional quantitative trait genes.	[Han, Zanping; Ku, Lixia; Zhang, Zhenzhen; Zhang, Jun; Guo, ShuLei; Liu, Haiying; Zhao, Ruifang; Ren, Zhenzhen; Zhang, Liangkun; Su, Huihui; Dong, Lei; Chen, Yanhui] Henan Agr Univ, Synerget Innovat Ctr Henan Grain Crops, Coll Agron, Zhengzhou, Peoples R China; [Han, Zanping; Ku, Lixia; Zhang, Zhenzhen; Zhang, Jun; Guo, ShuLei; Liu, Haiying; Zhao, Ruifang; Ren, Zhenzhen; Zhang, Liangkun; Su, Huihui; Dong, Lei; Chen, Yanhui] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China; [Han, Zanping] Henan Univ Sci & Technol, Coll Agron, Luoyang, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan University of Science & Technology	Chen, YH (corresponding author), Henan Agr Univ, Synerget Innovat Ctr Henan Grain Crops, Coll Agron, Zhengzhou, Peoples R China.	chy9890@163.com			National Basic Research Program of China [2009CB118400]; Key Base Research Project of Henan Province; Corn Industry Technology System in Henan Province [S2010-02]	National Basic Research Program of China(National Basic Research Program of China); Key Base Research Project of Henan Province; Corn Industry Technology System in Henan Province	This work was supported by grants from the National Basic Research Program of China (No. 2009CB118400), and the Key Base Research Project of Henan Province and Corn Industry Technology System in Henan Province (S2010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almoguera C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-75; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Arif MAR, 2012, EUPHYTICA, V186, P1, DOI 10.1007/s10681-011-0471-5; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; BASAVARAJAPPA BS, 1991, SEED SCI TECHNOL, V19, P279; Bentsink L, 2000, PLANT PHYSIOL, V124, P1595, DOI 10.1104/pp.124.4.1595; BEWLEY J. D, 2013, SEEDS, V3, DOI [DOI 10.1007/978-1-4614-4693-4_1, 10.1017/S0960258513000287]; Bingham IJ, 1999, SEED SCI TECHNOL, V27, P151; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; CHING TM, 1968, CROP SCI, V8, P407, DOI 10.2135/cropsci1968.0011183X000800040003x; Clerkx EJM, 2004, PHYSIOL PLANTARUM, V121, P448, DOI 10.1111/j.0031-9317.2004.00339.x; Contreras S, 2008, HORTSCIENCE, V43, P845, DOI 10.21273/HORTSCI.43.3.845; Contreras S, 2009, HORTSCIENCE, V44, P130, DOI 10.21273/HORTSCI.44.1.130; Devaiah SP, 2007, PLANT J, V50, P950, DOI 10.1111/j.1365-313X.2007.03103.x; DeVries M, 2007, CROP SCI, V47, P2089, DOI 10.2135/cropsci2007.01.0005; DICKSON MH, 1980, HORTSCIENCE, V15, P771; Galleschi L, 2002, J AGR FOOD CHEM, V50, P5450, DOI 10.1021/jf0201430; Goffinet B, 2000, GENETICS, V155, P463; Gupta ML, 2005, SEED SCI TECHNOL, V33, P167, DOI 10.15258/sst.2005.33.1.17; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hilhorst HWM, 2010, TOP CURR GENET, V21, P43, DOI 10.1007/978-3-642-12422-8_4; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Kazmi RH, 2012, PLANT CELL ENVIRON, V35, P929, DOI 10.1111/j.1365-3040.2011.02463.x; Kibinza S, 2006, PHYSIOL PLANTARUM, V128, P496, DOI 10.1111/j.1399-3054.2006.00771.x; Kocsy G, 2001, PLANT PHYSIOL, V127, P1147, DOI 10.1104/pp.010107; Kumar GNM, 1999, PLANT PHYSIOL, V119, P89, DOI 10.1104/pp.119.1.89; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; McDonald MB, 1999, SEED SCI TECHNOL, V27, P177; Miura K, 2002, THEOR APPL GENET, V104, P981, DOI 10.1007/s00122-002-0872-x; Nagel M, 2009, EUPHYTICA, V170, P5, DOI 10.1007/s10681-009-9975-7; Nagel M, 2011, PLANT GENET RESOUR-C, V9, P260, DOI 10.1017/S1479262111000372; Oge L, 2008, PLANT CELL, V20, P3022, DOI 10.1105/tpc.108.058479; Prieto-Dapena P, 2006, PLANT PHYSIOL, V142, P1102, DOI 10.1104/pp.106.087817; Rajjou L, 2004, PLANT PHYSIOL, V134, P1598, DOI 10.1104/pp.103.036293; Rajjou L, 2008, CR BIOL, V331, P796, DOI 10.1016/j.crvi.2008.07.021; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; Rodo Angélica B., 2003, Hortic. Bras., V21, P220, DOI 10.1590/S0102-05362003000200020; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Schwember AR, 2010, J EXP BOT, V61, P4423, DOI 10.1093/jxb/erq248; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; Shin JH, 2009, PLANT PHYSIOL, V149, P905, DOI 10.1104/pp.108.130716; Soti C, 2007, J BIOSCIENCES, V32, P511, DOI 10.1007/s12038-007-0050-z; STONE JM, 1995, PLANT PHYSIOL, V108, P451, DOI 10.1104/pp.108.2.451; Suzuki Y, 1996, J AGR FOOD CHEM, V44, P3479, DOI 10.1021/jf9600465; TEKRONY DM, 1989, CROP SCI, V29, P1523, DOI 10.2135/cropsci1989.0011183X002900060042x; Trachsel S, 2009, THEOR APPL GENET, V119, P1413, DOI 10.1007/s00122-009-1144-9; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Vazquez-Ramos JM, 2000, SEED BIOLOGY: ADVANCES AND APPLICATIONS, P261, DOI 10.1079/9780851994048.0261; Wang SJ, 2003, AM J PHYSIOL-HEART C, V284, pH1917, DOI 10.1152/ajpheart.00861.2002; Wu XL, 2011, ACTA PHYSIOL PLANT, V33, P181, DOI 10.1007/s11738-010-0536-4; Xin X, 2011, PHYSIOL PLANTARUM, V143, P126, DOI 10.1111/j.1399-3054.2011.01497.x; Xue Y, 2008, EUPHYTICA, V164, P739, DOI 10.1007/s10681-008-9696-3; [曾大力 Zeng Dali], 2002, [作物学报, Acta Agronomica Sinica], V28, P551; Zeng DL, 2006, PLANT BREEDING, V125, P57, DOI 10.1111/j.1439-0523.2006.01169.x; ZENG ZB, 1994, GENETICS, V136, P1457	60	54	60	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92535	10.1371/journal.pone.0092535	http://dx.doi.org/10.1371/journal.pone.0092535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651614	Green Submitted, gold, Green Published			2022-12-25	WOS:000333352800122
J	Lenoir, B; Wagner, DR; Blacher, S; Sala-Newby, GB; Newby, AC; Noel, A; Devaux, Y				Lenoir, Benedicte; Wagner, Daniel R.; Blacher, Silvia; Sala-Newby, Graciela B.; Newby, Andrew C.; Noel, Agnes; Devaux, Yvan			Effects of Adenosine on Lymphangiogenesis	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE-9 SECRETION; ANGIOGENIC SWITCH; MACROPHAGES; INFLAMMATION; CELLS; RECEPTORS; GROWTH; CANCER; VEGF	Background: The lymphatic system controls tissue homeostasis by draining protein-rich lymph to the vascular system. Lymphangiogenesis, the formation of lymphatic vessels, is a normal event in childhood but promotes tumor spread and metastasis during adulthood. Blocking lymphangiogenesis may therefore be of therapeutic interest. Production of adenosine is enhanced in the tumor environment and contributes to tumor progression through stimulation of angiogenesis. In this study, we determined whether adenosine affects lymphangiogenesis. Methods: Lymphatic endothelial cells (HMVEC-dLy) were cultured in presence of adenosine and their proliferation, migration and tube formation was assessed. Gelatin sponges embedded with the stable analogue of adenosine 2-chloro adenosine were implanted in mice ear and lymphangiogenesis was quantified. Mice were intravenously injected with adenoviruses containing expression vector for 5'-endonucleotidase, which plays a major role in the formation of adenosine. Results: In vitro, we observed that adenosine decreased the proliferation of lymphatic endothelial cells, their migration and tube formation. However, in vivo, gelatin sponges containing 2-chloro adenosine and implanted in mice ear displayed an elevated level of lymphangiogenesis (2.5-fold, p<0.001). Adenovirus-mediated over-expression of cytosolic 5'-nucleotidase IA stimulated lymphangiogenesis and the recruitment of macrophages in mouse liver. Proliferation of lymphatic endothelial cells was enhanced (2-fold, p<0.001) when incubated in the presence of conditioned medium from murine macrophages. Conclusion: We have shown that adenosine stimulates lymphangiogenesis in vivo, presumably through a macrophage-mediated mechanism. This observation suggests that blockade of adenosine receptors may help in anti-cancer therapies.	[Lenoir, Benedicte; Wagner, Daniel R.; Devaux, Yvan] CRP Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg; [Wagner, Daniel R.] Ctr Hosp Luxembourg, Div Cardiol, Luxembourg, Luxembourg; [Blacher, Silvia; Noel, Agnes] Univ Liege, Lab Tumor & Dev Biol, Grp Interdisciplinaire Genoprote Appl Canc, Liege, Belgium; [Sala-Newby, Graciela B.; Newby, Andrew C.] Univ Bristol, Bristol Royal Infirm, Bristol Heart Inst, Bristol, Avon, England	Luxembourg Institute of Health; Luxembourg Hospital Center; University of Liege; Bristol Royal Infirmary; University of Bristol	Devaux, Y (corresponding author), CRP Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg.	yvan.devaux@crp-sante.lu	DEVAUX, Yvan/AAK-3463-2020	Devaux, Yvan/0000-0002-5321-8543; Noel, Agnes/0000-0002-7670-6179	Ministry of Higher Education; Health of Luxembourg; Research of Luxembourg [PhD-AFR-09-110]; Fondation contre le Cancer (foundation of public interest, Belgium); Fonds speciaux de la Recherche (University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege); Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium)	Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); Health of Luxembourg; Research of Luxembourg; Fondation contre le Cancer (foundation of public interest, Belgium); Fonds speciaux de la Recherche (University of Liege)(University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege)(University of Liege); Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office)	This study was funded by the Ministry of Higher Education and Health of Luxembourg. BL was supported by a fellowship from the National Fund of Research of Luxembourg (grant PhD-AFR-09-110). This work was also supported by grants from the Fondation contre le Cancer (foundation of public interest, Belgium), the Fonds speciaux de la Recherche (University of Liege), the Centre Anticancereux pres l'Universite de Liege, the Fonds Leon Fredericq (University of Liege), the Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Auchampach JA, 2007, CIRC RES, V101, P1075, DOI 10.1161/CIRCRESAHA.107.165761; Avraham-Davidi I, 2013, J EXP MED, V210, P2611, DOI 10.1084/jem.20120690; Azuaje F, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-7; Blay J, 1997, CANCER RES, V57, P2602; Bruyere F, 2010, FASEB J, V24, P8, DOI 10.1096/fj.09-132852; Cekic C, 2012, J IMMUNOL, V188, P198, DOI 10.4049/jimmunol.1101845; Chiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069114; Chung CH, 2013, CLIN MOL HEPATOL, V19, P99, DOI 10.3350/cmh.2013.19.2.99; Detry B, 2013, INVEST OPHTH VIS SCI, V54, P3082, DOI 10.1167/iovs.12-10856; Eklund L, 2013, MOL ONCOL, V7, P259, DOI 10.1016/j.molonc.2013.02.007; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Ernens I, 2010, BIOCHEM BIOPH RES CO, V392, P351, DOI 10.1016/j.bbrc.2010.01.023; Feoktistov Igor, 2009, Handb Exp Pharmacol, P383, DOI 10.1007/978-3-540-89615-9_13; Ferrante CJ, 2013, INFLAMMATION, V36, P921, DOI 10.1007/s10753-013-9621-3; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Goblyos A, 2009, PURINERG SIGNAL, V5, P51, DOI 10.1007/s11302-008-9105-3; Harvey NL, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-15; Hasko G, 2012, ARTERIOSCL THROM VAS, V32, P865, DOI 10.1161/ATVBAHA.111.226852; Hocher B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017891; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Ji RC, 2012, CELL MOL LIFE SCI, V69, P897, DOI 10.1007/s00018-011-0848-6; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kelley PM, 2013, AM J PATHOL, V182, P2418, DOI 10.1016/j.ajpath.2013.02.025; Kumar V, 2013, PURINERG SIGNAL, V9, P145, DOI 10.1007/s11302-012-9349-9; Leonard F, 2011, J LEUKOCYTE BIOL, V90, P199, DOI 10.1189/jlb.0910505; Martin C, 2000, CRIT CARE MED, V28, P3198, DOI 10.1097/00003246-200009000-00014; Norrmen C, 2011, CIRCULATION, V123, P1335, DOI 10.1161/CIRCULATIONAHA.107.704098; Olah Mark E, 2003, Mol Interv, V3, P370, DOI 10.1124/mi.3.7.370; Paupert J, 2011, MOL ASPECTS MED, V32, P146, DOI 10.1016/j.mam.2011.04.002; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; Ramanathan M, 2009, J LEUKOCYTE BIOL, V86, P681, DOI 10.1189/jlb.0109021; Ran Sophia, 2012, Cancers (Basel), V4, P618, DOI 10.3390/cancers4030618; Rolland-Turner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054135; Sala-Newby GB, 1999, J BIOL CHEM, V274, P17789, DOI 10.1074/jbc.274.25.17789; Sala-Newby GB, 2003, AM J PHYSIOL-HEART C, V285, pH991, DOI 10.1152/ajpheart.00053.2003; Sperlagh B, 2000, J NEUROIMMUNOL, V111, P45, DOI 10.1016/S0165-5728(00)00365-9; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Utrera-Barillas D, 2010, EXP MOL PATHOL, V89, P190, DOI 10.1016/j.yexmp.2010.06.002; Velot E, 2008, CARDIOVASC RES, V80, P246, DOI 10.1093/cvr/cvn201	44	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92715	10.1371/journal.pone.0092715	http://dx.doi.org/10.1371/journal.pone.0092715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651845	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800146
J	Muziasari, WI; Managaki, S; Parnanen, K; Karkman, A; Lyra, C; Tamminen, M; Suzuki, S; Virta, M				Muziasari, Windi Indra; Managaki, Satoshi; Parnanen, Katariina; Karkman, Antti; Lyra, Christina; Tamminen, Manu; Suzuki, Satoru; Virta, Marko			Sulphonamide and Trimethoprim Resistance Genes Persist in Sediments at Baltic Sea Aquaculture Farms but Are Not Detected in the Surrounding Environment	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; WASTE-WATER; BACTERIA; INTEGRONS; QUANTIFICATION; CASSETTES; ABUNDANCE; SPREAD; SITE	Persistence and dispersal of antibiotic resistance genes (ARGs) are important factors for assessing ARG risk in aquaculture environments. Here, we quantitatively detected ARGs for sulphonamides (sul1 and sul2) and trimethoprim (dfrA1) and an integrase gene for a class 1 integron (intI1) at aquaculture facilities in the northern Baltic Sea, Finland. The ARGs persisted in sediments below fish farms at very low antibiotic concentrations during the 6-year observation period from 2006 to 2012. Although the ARGs persisted in the farm sediments, they were less prevalent in the surrounding sediments. The copy numbers between the sul1 and intI1 genes were significantly correlated suggesting that class 1 integrons may play a role in the prevalence of sul1 in the farm sediments through horizontal gene transfer. In conclusion, the presence of ARGs may limit the effectiveness of antibiotics in treating fish illnesses, thereby causing a potential risk to the aquaculture industry. However, the restricted presence of ARGs at the farms is unlikely to cause serious effects in the northern Baltic Sea sediment environments around the farms.	[Muziasari, Windi Indra; Parnanen, Katariina; Karkman, Antti; Lyra, Christina; Tamminen, Manu; Virta, Marko] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Managaki, Satoshi] Musashino Univ, Dept Environm Sci, Tokyo, Japan; [Suzuki, Satoru] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime, Japan	University of Helsinki; Ehime University	Virta, M (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	windi.muziasari@helsinki.fi	Muziasari, Windi/C-7746-2017; Karkman, Antti/AAW-9096-2021; Virta, Marko/B-4292-2010; Karkman, Antti/HFZ-8618-2022; Pärnänen, Katariina M M/P-5176-2016	Muziasari, Windi/0000-0002-5542-4375; Karkman, Antti/0000-0003-0983-3319; Virta, Marko/0000-0001-5981-7566; Pärnänen, Katariina M M/0000-0003-2220-1738; /0000-0001-5891-7653	Maj and Tor Nessling Foundation; Academy of Finland; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [22241014] Funding Source: KAKEN	Maj and Tor Nessling Foundation; Academy of Finland(Academy of Finland); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The research was funded by the Maj and Tor Nessling Foundation, Academy of Finland and Japan Society for the Promotion of Science (JSPS) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbowale OL, 2006, J APPL MICROBIOL, V100, P1103, DOI 10.1111/j.1365-2672.2006.02812.x; Blahna MT, 2006, J ANTIMICROB CHEMOTH, V57, P666, DOI 10.1093/jac/dkl020; Buschmann AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042724; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Cabello FC, 2013, ENVIRON MICROBIOL, V15, P1917, DOI 10.1111/1462-2920.12134; Capone DG, 1996, AQUACULTURE, V145, P55, DOI 10.1016/S0044-8486(96)01330-0; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Gao PP, 2012, WATER RES, V46, P2355, DOI 10.1016/j.watres.2012.02.004; Giraud E, 2006, FEMS MICROBIOL ECOL, V55, P439, DOI 10.1111/j.1574-6941.2005.00036.x; Goebel NL, 2010, ENVIRON MICROBIOL, V12, P3272, DOI 10.1111/j.1462-2920.2010.02303.x; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Hardwick SA, 2008, FEMS MICROBIOL LETT, V278, P207, DOI 10.1111/j.1574-6968.2007.00992.x; Hastings PJ, 2004, TRENDS MICROBIOL, V12, P401, DOI 10.1016/j.tim.2004.07.003; Hoa PTP, 2008, SCI TOTAL ENVIRON, V405, P377, DOI 10.1016/j.scitotenv.2008.06.023; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; L'Abee-Lund TM, 2001, MICROB DRUG RESIST, V7, P263, DOI 10.1089/10766290152652819; Lai HT, 2011, BIORESOURCE TECHNOL, V102, P5017, DOI 10.1016/j.biortech.2011.01.070; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Luo Y, 2011, ENVIRON SCI TECHNOL, V45, P1827, DOI 10.1021/es104009s; Nonaka L, 2007, MICROBES ENVIRON, V22, P355, DOI 10.1264/jsme2.22.355; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; Serrano PH, 2005, 469 FAO FISH; Shah SQA, 2012, ENVIRON SCI TECHNOL, V46, P8672, DOI 10.1021/es3018607; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Stalder T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00119; Stokes HW, 2006, J BACTERIOL, V188, P5722, DOI 10.1128/JB.01950-05; Suzuki S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00067; Szczepanowski R, 2009, MICROBIOL-SGM, V155, P2306, DOI 10.1099/mic.0.028233-0; Tamminen M, 2011, ENVIRON SCI TECHNOL, V45, P386, DOI 10.1021/es102725n	35	79	84	4	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92702	10.1371/journal.pone.0092702	http://dx.doi.org/10.1371/journal.pone.0092702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651770	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800145
J	Nguyen, HG; Yang, JC; Kung, HJ; Shi, XB; Tilki, D; Lara, PN; White, RWD; Gao, AC; Evans, CP				Nguyen, H. G.; Yang, J. C.; Kung, H-J; Shi, X-B; Tilki, D.; Lara, P. N., Jr.; White, R. W. DeVere; Gao, A. C.; Evans, C. P.			Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model	ONCOGENE			English	Article							ANDROGEN RECEPTOR; APOPTOSIS; DEPRIVATION; METFORMIN; SURVIVAL; RAPTOR; PHOSPHORYLATION; COMBINATION; INHIBITION; INDUCTION	Macro-autophagy is associated with drug resistance in various cancers and can function as an adaptive response to maintain cell survival under metabolic stresses, including androgen deprivation. Androgen deprivation or treatment with androgen receptor (AR) signaling inhibitor (ARSI), Enzalutamide (MDV-3100, ENZA) or bicalutamide induced autophagy in androgen-dependent and in castration-resistant CaP (castration-resistant prostate cancer (CRPC)) cell lines. The autophagic cascade triggered by AR blockage, correlated with the increased light chain 3-II/I ratio and ATG-5 expression. Autophagy was observed in a subpopulation of C4-2B cells that developed insensitivity to ENZA after sustained exposure in culture. Using flow cytometry and clonogenic assays, we showed that inhibiting autophagy with clomipramine (CMI), chloroquine or metformin increased apoptosis and significantly impaired cell viability. This autophagic process was mediated by AMP-dependent protein kinase (AMPK) activation and the suppression of mammalian target of rapamycin (mTOR) through Raptor phosphorylation (Serine 792). Furthermore, small interfering RNA targeting AMPK significantly inhibited autophagy and promoted cell death in CaP cells acutely or chronically exposed to ENZA or androgen deprivation, suggesting that autophagy is an important survival mechanism in CRPC. Lastly, in vivo studies with mice orthotopically implanted with ENZA-resistant cells demonstrated that the combination of ENZA and autophagy modulators, CMI or metformin significantly reduced tumor growth when compared with control groups (P < 0.005). In conclusion, autophagy is as an important mechanism of resistance to ARSI in CRPC. Antiandrogen-induced autophagy is mediated through the activation of AMPK pathway and the suppression of mTOR pathway. Blocking autophagy pharmacologically or genetically significantly impairs prostate cancer cell survival in vitro and in vivo, implying the therapeutics potential of autophagy inhibitors in the antiandrogen-resistance setting.	[Nguyen, H. G.; Yang, J. C.; Shi, X-B; Tilki, D.; White, R. W. DeVere; Gao, A. C.; Evans, C. P.] Univ Calif Davis, Sch Med, Dept Urol, Sacramento, CA 95817 USA; [Kung, H-J] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Kung, H-J; Lara, P. N., Jr.; White, R. W. DeVere; Gao, A. C.; Evans, C. P.] Univ Calif Davis, Sch Med, UC Davis Comprehens Canc Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Evans, CP (corresponding author), Univ Calif Davis, Sch Med, Dept Urol, 4860 Y St,Suite 3500, Sacramento, CA 95817 USA.	christopher.evans@ucdmc.ucdavis.edu		Nguyen, Hao/0000-0001-8275-5375	DOD [PC111467]; Medivation/Astellas; NIH [RO1 CA 165263 - 13]; Stand Up To Cancer-Prostate Cancer Foundation-Prostate Dream Team Translational Cancer Research Grant [SU2C-AACR-PCF DT0812]; Movember Foundation; NATIONAL CANCER INSTITUTE [R01CA165263, P30CA093373] Funding Source: NIH RePORTER	DOD(United States Department of Defense); Medivation/Astellas; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up To Cancer-Prostate Cancer Foundation-Prostate Dream Team Translational Cancer Research Grant; Movember Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by Grants DOD PC111467 and Medivation/Astellas to CPE, NIH RO1 CA 165263 - 13 to H-JK and by a Stand Up To Cancer-Prostate Cancer Foundation-Prostate Dream Team Translational Cancer Research Grant SU2C-AACR-PCF DT0812 to Eric Small, Owen Witte and CPE. This research grant is made possible by the generous support of the Movember Foundation. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research: The costs of publication of this article were defrayed. Mention of trade name, proprietary product or specific equipment does not constitute a guaranty of warranty by the Department of Defense, nor does it imply approval to the exclusion of other products. The views expressed herein represent those of the authors and do not necessarily represent the position of the Department of Defense.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Ben Sahra I, 2010, AUTOPHAGY, V6, P670, DOI 10.4161/auto.6.5.12434; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Bennett HL, 2013, BJU INT, V111, P672, DOI 10.1111/j.1464-410X.2012.11409.x; Boutin B, 2013, PROSTATE, V73, P1090, DOI 10.1002/pros.22658; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chhipa RR, 2011, CELL SIGNAL, V23, P1466, DOI 10.1016/j.cellsig.2011.04.008; Gillman PK, 2007, BRIT J PHARMACOL, V151, P737, DOI 10.1038/sj.bjp.0707253; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jiang Q, 2012, J UROLOGY, V188, P1361, DOI 10.1016/j.juro.2012.06.004; Kim RH, 2009, AUTOPHAGY, V5, P567, DOI 10.4161/auto.5.4.8252; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Kung H- J, 2013, PROSTATE CANC, V16, P497; Kung Hsing-Jien, 2011, Hormones & Cancer, V2, P38, DOI 10.1007/s12672-010-0053-3; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Li MQ, 2008, AUTOPHAGY, V4, P54, DOI 10.4161/auto.5209; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Liu HY, 2012, ANTICANCER RES, V32, P1627; Luo J, 2013, EUR UROL, V64, P339, DOI 10.1016/j.eururo.2013.05.012; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Nadiminty N, 2013, MOL CANCER THER, V12, P1629, DOI 10.1158/1535-7163.MCT-13-0027; Nguyen HG, 2009, FASEB J, V23, P2741, DOI 10.1096/fj.09-130963; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Rossi M, 2009, J CELL SCI, V122, P3330, DOI 10.1242/jcs.048181; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Wu Zhaoju, 2010, Genes Cancer, V1, P40, DOI 10.1177/1947601909358324	37	128	134	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 4	2014	33	36					4521	4530		10.1038/onc.2014.25	http://dx.doi.org/10.1038/onc.2014.25			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MY	24662833	Green Published, hybrid			2022-12-25	WOS:000341158800007
J	Kim, SB; Yoon, M; Ku, NS; Kim, MH; Song, JE; Ahn, JY; Jeong, SJ; Kim, C; Kwon, HD; Lee, J; Smith, DM; Choi, JY				Kim, Sun Bean; Yoon, Myoungho; Ku, Nam Su; Kim, Min Hyung; Song, Je Eun; Ahn, Jin Young; Jeong, Su Jin; Kim, Changsoo; Kwon, Hee-Dae; Lee, Jeehyun; Smith, Davey M.; Choi, Jun Yong			Mathematical Modeling of HIV Prevention Measures Including Pre-Exposure Prophylaxis on HIV Incidence in South Korea	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MORTALITY; MEN; INFECTION; EFFICACY; SAFETY; NEED; SEX	Background: Multiple prevention measures have the possibility of impacting HIV incidence in South Korea, including early diagnosis, early treatment, and pre-exposure prophylaxis (PrEP). We investigated how each of these interventions could impact the local HIV epidemic, especially among men who have sex with men (MSM), who have become the major risk group in South Korea. A mathematical model was used to estimate the effects of each these interventions on the HIV epidemic in South Korea over the next 40 years, as compared to the current situation. Methods: We constructed a mathematical model of HIV infection among MSM in South Korea, dividing the MSM population into seven groups, and simulated the effects of early antiretroviral therapy (ART), early diagnosis, PrEP, and combination interventions on the incidence and prevalence of HIV infection, as compared to the current situation that would be expected without any new prevention measures. Results: Overall, the model suggested that the most effective prevention measure would be PrEP. Even though PrEP effectiveness could be lessened by increased unsafe sex behavior, PrEP use was still more beneficial than the current situation. In the model, early diagnosis of HIV infection was also effectively decreased HIV incidence. However, early ART did not show considerable effectiveness. As expected, it would be most effective if all interventions (PrEP, early diagnosis and early treatment) were implemented together. Conclusions: This model suggests that PrEP and early diagnosis could be a very effective way to reduce HIV incidence in South Korea among MSM.	[Kim, Sun Bean; Ku, Nam Su; Kim, Min Hyung; Song, Je Eun; Ahn, Jin Young; Jeong, Su Jin; Choi, Jun Yong] Yonsei Univ, Coll Med, Dept Internal Med, Div Infect Dis,Severance Hosp, Seoul, South Korea; [Kim, Sun Bean; Ku, Nam Su; Kim, Min Hyung; Song, Je Eun; Ahn, Jin Young; Jeong, Su Jin; Choi, Jun Yong] Yonsei Univ, Coll Med, Severance Hosp, AIDS Res Inst, Seoul, South Korea; [Yoon, Myoungho] Yonsei Univ, Dept Math, Seoul 120749, South Korea; [Kim, Changsoo] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kwon, Hee-Dae] Inha Univ, Dept Math, Inchon, South Korea; [Lee, Jeehyun] Yonsei Univ, Dept Computat Sci & Engn, Seoul 120749, South Korea; [Smith, Davey M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Inha University; Yonsei University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Choi, JY (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Infect Dis,Severance Hosp, Seoul, South Korea.	SERAN@yuhs.ac		Choi, Jun Yong/0000-0002-2775-3315; Jeong, Su Jin/0000-0003-4025-4542; Kim, Sun Bean/0000-0002-8830-1144; Smith, Davey/0000-0003-3603-1733; a, gokul/0000-0003-2226-4691; Kim, Changsoo/0000-0002-5940-5649; Ku, Nam Su/0000-0002-9717-4327	National Research Foundation of Korea; Korean Government [NRF-2011-220-E00015, NRF-2012R1A1A2005605]; Chronic Infectious Disease Cohort from Korea Centers for Disease Control and Prevention [4800-4859-304-260]; NIH [DA034978, AI100665]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI100665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA034978] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); Chronic Infectious Disease Cohort from Korea Centers for Disease Control and Prevention; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2011-220-E00015). The work of HDK was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2012R1A1A2005605) and a grant from Chronic Infectious Disease Cohort (4800-4859-304-260) from Korea Centers for Disease Control and Prevention. DMS's involvement was supported by NIH grants DA034978 and AI100665. The funders had a major role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arasteh K, 2009, ANTIVIR THER, V14, P859, DOI 10.3851/IMP1301; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Choe KW, 2007, J KOREAN MED ASSOC, V50, P296, DOI 10.5124/jkma.2007.50.4.296; Choe PG, 2011, J INFECTION, V63, P60, DOI 10.1016/j.jinf.2011.05.002; Clements MS, 2004, JAIDS-J ACQ IMM DEF, V35, P401, DOI 10.1097/00126334-200404010-00010; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Costagliola D, 2012, LANCET INFECT DIS, V12, P119, DOI 10.1016/S1473-3099(11)70248-1; de Ven PV, 1999, AIDS, V13, P2289, DOI 10.1097/00002030-199911120-00011; Gilmour S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043473; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Ichikawa S, 2011, SEX HEALTH, V8, P123, DOI 10.1071/SH10073; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Katlama C, 2010, ANTIVIR THER, V15, P1045, DOI 10.3851/IMP1662; Kee MK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-128; Keller SB, 2011, AIDS, V25, P2308, DOI 10.1097/QAD.0b013e32834d3cab; Korea Centers for Disease Control and Prevention (KCDC), 2012, AN HIV AIDS NOT KOR, P5; Korea Centers of Diseasce Control and Prevention, 2020, ANN REPORT NOTIFIED; 김명수, 2007, Infection and Chemotherapy, V39, P142; Law MG, 2001, AIDS, V15, P1287, DOI 10.1097/00002030-200107060-00011; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Li HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023431; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Maxmen A, 2012, NATURE, V487, P283, DOI 10.1038/487283a; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Myers GM, 2011, AIDS PATIENT CARE ST, V25, P63, DOI 10.1089/apc.2010.0222; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Siegfried N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008272.pub2; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Van de Ven P, 2000, AIDS, V14, P2951, DOI 10.1097/00002030-200012220-00023; Yang BM, 2004, 7 INT AIDS S; Zhou JL, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/375217	34	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90080	10.1371/journal.pone.0090080	http://dx.doi.org/10.1371/journal.pone.0090080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662776	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900005
J	Li, YH; Yu, B; Duan, ZZ; Akinyi, OM; Yu, JH; Zhou, K; Zhang, Y; Gao, XM				Li, Yu Hong; Yu, Bin; Duan, Zhen Zhen; Akinyi, Olunga Mary; Yu, Jia Hui; Zhou, Kun; Zhang, Yue; Gao, Xiu Mei			The Coronary Dilation Effect of Shen Fu Injection Was Mediated through NO	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ISCHEMIA/REPERFUSION INJURY; CARDIOVASCULAR-SYSTEM; ISCHEMIA-REPERFUSION; PERFUSION PRESSURE; ENDOTHELIAL-CELLS; CARDIAC-FUNCTION; GINSENOSIDE RB1; RAT-HEART; IN-VIVO	Objectives: Shen Fu Injection (SF), which consisted of Red ginseng extraction injection (RG) and prepared aconite extraction injection (RA), is a traditional Chinese medicine mainly used for various cardiac diseases. This study is to analyse SF's effects on cardiac performance and coronary circulation. And the coronary dilating effect and mechanism of the above three injections were also explored. Methods: Mature male guinea pigs were used as our animal model. We employed two types of perfusion methods (constant pressure and constant flow) in vitro, using Langendorff heart preparations to observe the cardiac function and coronary response to SF (1/200). The coronary dilation effects of the above three injections (1/800, 1/400 and 1/200) were recorded at basal coronary resting tone and when coronary vessels were pre-contracted with a thromboxane A2 analogue (U46619), in the presence or the absence of the inhibitor of nitric oxide synthesis (L-NAME, 10(-4) M), the blocker of Ca2+-activated potassium channel(TEA, 10(-3) M), or the blocker of adenosine triphosphate (ATP)-sensitive potassium channel (glybenclamide) (10(-5) M). Results: When perfused with constant pressure, SF significantly increased coronary flow, left ventricular developed pressure (LVDP) and the rate-pressure product (RPP). When perfused with constant flow, SF produced a significant reduction in the coronary perfusion pressure (CPP), LVDP and RPP. The coronary vasodilatation response of the above three injections can be reduced by L-NAME but was unaffected by TEA or glybenclamide when coronary vessels were pre-contracted with U46619 but not at resting tone. SF, RG and RA can all up-regulate eNOS expression in the human umbilical vein cells (EA.hy926). Conclusion: We demonstrated that SF does not contribute to the inotropic change of myocardium whose improvement is due to alternation of coronary flow. The coronary dilation effect of SF was mediated through RG and RA, via promoting NO release.	[Li, Yu Hong; Yu, Bin; Duan, Zhen Zhen; Akinyi, Olunga Mary; Yu, Jia Hui; Zhou, Kun; Zhang, Yue; Gao, Xiu Mei] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Li, Yu Hong; Yu, Bin; Duan, Zhen Zhen; Akinyi, Olunga Mary; Yu, Jia Hui; Zhou, Kun; Zhang, Yue; Gao, Xiu Mei] Tianjin Univ Tradit Chinese Med, Minist Educ, Key Lab Pharmacol Tradit Chinese Med Formulae, Tianjin, Peoples R China; [Li, Yu Hong; Yu, Bin; Duan, Zhen Zhen; Akinyi, Olunga Mary; Yu, Jia Hui; Zhou, Kun; Zhang, Yue; Gao, Xiu Mei] Tianjin Univ Tradit Chinese Med, Inst Tradit Chinese Med Res, Tianjin, Peoples R China; [Gao, Xiu Mei] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Minist Educ, Key Lab Pharmacol Tradit Chinese Med Formulae, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Gao, XM (corresponding author), Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China.	gaoxiumei@tjutcm.edu.cn			National Basic Research Program of China [2012CB518400, 2012CB518404]; National Natural Science Foundation of China [81202779]; Tianjin Science and Technology Developmeng Fund for Colleges and Universities [2011ZD01]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Developmeng Fund for Colleges and Universities	This work was supported by the financial support from the National Basic Research Program of China(2012CB518400) to (2012CB518404) http://www.973.gov.cn/AreaAppl.aspx; The National Natural Science Foundation of China (81202779); http://www.nsfc.gov.cn/Portal0/default166.htm. Tianjin Science and Technology Developmeng Fund for Colleges and Universities (2011ZD01). http://www.tstc.gov.cn/english. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD G, 1968, PFLUG ARCH EUR J PHY, V299, P339, DOI 10.1007/BF00602910; Bak MJ, 2012, MOLECULES, V17, P13769, DOI 10.3390/molecules171213769; Cao J, 2005, CHINESE MED J-PEKING, V118, P505; Chen IJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/595271; Chen X, 1996, CLIN EXP PHARMACOL P, V23, P728, DOI 10.1111/j.1440-1681.1996.tb01767.x; Choi KT, 2008, ACTA PHARMACOL SIN, V29, P1109, DOI 10.1111/j.1745-7254.2008.00869.x; Chong Won-Seog, 1998, Korean Journal of Physiology and Pharmacology, V2, P323; Deng J, 2010, BIOL PHARM BULL, V33, P631, DOI 10.1248/bpb.33.631; DUBE GP, 1995, J PHARMACOL EXP THER, V272, P799; Favaloro JL, 2007, CARDIOVASC RES, V73, P587, DOI 10.1016/j.cardiores.2006.11.018; GREGG DE, 1963, CIRC RES, V13, P497, DOI 10.1161/01.RES.13.6.497; Guo Liang, 2009, Journal of Pharmacological and Toxicological Methods, V60, P130, DOI 10.1016/j.vascn.2009.07.002; Hambrecht R, 2003, CIRCULATION, V107, P3152, DOI 10.1161/01.CIR.0000074229.93804.5C; Han JY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/479016; Ji XF, 2011, SHOCK, V35, P530, DOI 10.1097/SHK.0b013e31820e2058; Montoya JJ, 2011, J CARDIOVASC PHARM, V58, P392, DOI 10.1097/FJC.0b013e318226bcf7; Li HX, 2012, PHYTOMEDICINE, V19, P477, DOI 10.1016/j.phymed.2012.01.002; Liao RL, 2012, AM J PHYSIOL-HEART C, V303, pH156, DOI 10.1152/ajpheart.00333.2012; Liu CH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/408187; Garcia-Villalon AL, 2011, EUR J PHARMACOL, V660, P394, DOI 10.1016/j.ejphar.2011.04.006; Luo X.Y., 2009, CHINESE J INTEGRATED, V8, P685; MANTELLI L, 1992, EUR J PHARMACOL, V213, P79, DOI 10.1016/0014-2999(92)90235-V; McLean PG, 2002, CIRC RES, V90, P465, DOI 10.1161/hh0402.105372; Meng XZ, 1997, SHOCK, V7, P111, DOI 10.1097/00024382-199702000-00007; Mishra RC, 2013, CARDIOVASC RES, V97, P339, DOI 10.1093/cvr/cvs326; Morrison RR, 2006, AM J PHYSIOL-HEART C, V291, pH1875, DOI 10.1152/ajpheart.00158.2005; NISHIDA M, 1993, AM J PHYSIOL, V264, pH639, DOI 10.1152/ajpheart.1993.264.2.H639; Niu C., 2004, ZHONG YAO YAO LI YU, V20, P23; Peng L, 2012, CARDIOVASC THER, V30, pe183, DOI 10.1111/j.1755-5922.2011.00271.x; Ponto LLB, 2004, J CLIN PHARMACOL, V44, P751, DOI 10.1177/0091270004265699; Popovich DG, 2011, INT J BIOMEDICAL PHA, V6, P56; SAKUMA I, 1989, CAN J PHYSIOL PHARM, V67, P943, DOI 10.1139/y89-148; SHIBATA S, 1963, CHEM PHARM BULL, V11, P762; Shouyuan T, 2009, CHINESE J INTEGRATIV, V7, P1317; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Stowe DF, 1996, AM J PHYSIOL-HEART C, V271, pH1884, DOI 10.1152/ajpheart.1996.271.5.H1884; Wen-Ting S, 2012, EVID-BASED COMPL ALT, V2012; Yang Fang-ju, 2003, Zhongguo Zhongyao Zazhi, V28, P259; Yi XQ, 2010, PHYTOMEDICINE, V17, P1006, DOI 10.1016/j.phymed.2010.06.012; Yoshimura M, 1998, HUM GENET, V103, P65, DOI 10.1007/s004390050785; Yoshizaki K, 2012, CHEM PHARM BULL, V60, P354, DOI 10.1248/cpb.60.354; Yu J, 2007, BIOCHEM BIOPH RES CO, V353, P764, DOI 10.1016/j.bbrc.2006.12.119; ZeLong H, 2001, CHINESE J INTEGRATIV, V21, P386; Zhao DD, 2012, J TRADIT CHIN MED, V32, P308, DOI 10.1016/S0254-6272(13)60030-8; Zheng CD, 2008, CHIN J INTEGR MED, V14, P10, DOI 10.1007/s11655-008-0010-y; Zhou Su-juan, 2003, Zhongguo Zhongyao Zazhi, V28, P910; Zhou W, 2005, J VASC SURG, V41, P861, DOI 10.1016/j.jvs.2005.01.054; Zhu J, 2013, PLOS ONE, V30, P8	48	14	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92415	10.1371/journal.pone.0092415	http://dx.doi.org/10.1371/journal.pone.0092415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662941	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900061
J	Al-Thani, R; Al-Najjar, MAA; Al-Raei, AM; Ferdelman, T; Thang, NM; Al Shaikh, I; Al-Ansi, M; de Beer, D				Al-Thani, Roda; Al-Najjar, Mohammad A. A.; Al-Raei, Abdul Munem; Ferdelman, Tim; Thang, Nguyen M.; Al Shaikh, Ismail; Al-Ansi, Mehsin; de Beer, Dirk			Community Structure and Activity of a Highly Dynamic and Nutrient-Limited Hypersaline Microbial Mat in Um Alhool Sabkha, Qatar	PLOS ONE			English	Article							SOLAR LAKE SINAI; SULFATE REDUCTION; EUKARYOTIC DIVERSITY; CYANOBACTERIAL MATS; OXYGEN-CONSUMPTION; MARINE-SEDIMENTS; MICROSENSOR; BACTERIAL; PHOTOSYNTHESIS; ARCHAEAL	The Um Alhool area in Qatar is a dynamic evaporative ecosystem that receives seawater from below as it is surrounded by sand dunes. We investigated the chemical composition, the microbial activity and biodiversity of the four main layers (L1-L4) in the photosynthetic mats. Chlorophyll a (Chl a) concentration and distribution (measured by HPLC and hyperspectral imaging, respectively), the phycocyanin distribution (scanned with hyperspectral imaging), oxygenic photosynthesis (determined by microsensor), and the abundance of photosynthetic microorganisms (from 16S and 18S rRNA sequencing) decreased with depth in the euphotic layer (L1). Incident irradiance exponentially attenuated in the same zone reaching 1% at 1.7-mm depth. Proteobacteria dominated all layers of the mat (24%-42% of the identified bacteria). Anoxygenic photosynthetic bacteria (dominated by Chloroflexus) were most abundant in the third red layer of the mat (L3), evidenced by the spectral signature of Bacteriochlorophyll as well as by sequencing. The deep, black layer (L4) was dominated by sulfate reducing bacteria belonging to the Deltaproteobacteria, which were responsible for high sulfate reduction rates (measured using S-35 tracer). Members of Halobacteria were the dominant Archaea in all layers of the mat (92%-97%), whereas Nematodes were the main Eukaryotes (up to 87%). Primary productivity rates of Um Alhool mat were similar to those of other hypersaline microbial mats. However, sulfate reduction rates were relatively low, indicating that oxygenic respiration contributes more to organic material degradation than sulfate reduction, because of bioturbation. Although Um Alhool hypersaline mat is a nutrient-limited ecosystem, it is interestingly dynamic and phylogenetically highly diverse. All its components work in a highly efficient and synchronized way to compensate for the lack of nutrient supply provided during regular inundation periods.	[Al-Thani, Roda] Qatar Univ, Dept Biol & Environm Sci, Doha, Qatar; [Al-Najjar, Mohammad A. A.; Al-Raei, Abdul Munem; Ferdelman, Tim; Thang, Nguyen M.; de Beer, Dirk] Max Planck Inst Marine Microbiol, Bremen, Germany; [Al Shaikh, Ismail; Al-Ansi, Mehsin] Qatar Univ, Ctr Environm Studies, Doha, Qatar	Qatar University; Max Planck Society; Qatar University	Al-Najjar, MAA (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	mohammad.alnajjar@kaust.edu.sa	de Beer, Dirk/L-4840-2013; Ferdelman, Timothy G/A-3758-2013; AlNajjar, Mohammad/AAB-1377-2019	de Beer, Dirk/0000-0001-5274-1781; Ferdelman, Timothy G/0000-0002-9701-3793; Al-Najjar, Mohammad A. A./0000-0003-0001-6902	Qatar University [QUUG-CAS-BES-11/12-]; Max-Planck Institute for Marine Microbiology	Qatar University(Qatar National Research Fund (QNRF)); Max-Planck Institute for Marine Microbiology	Funding provided by Qatar University (www.qu.edu.qa), fund number QUUG-CAS-BES-11/12-, and Max-Planck Institute for Marine Microbiology (www.mpi-bremen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Najjar MAA, 2012, ENVIRON MICROBIOL, V14, P982, DOI 10.1111/j.1462-2920.2011.02676.x; Al-Najjar MAA, 2010, ISME J, V4, P440, DOI 10.1038/ismej.2009.121; Al-Raei AM, 2009, OCEAN DYNAM, V59, P351, DOI 10.1007/s10236-009-0186-5; Allen MA, 2009, GEOBIOLOGY, V7, P82, DOI 10.1111/j.1472-4669.2008.00187.x; Bolhuis H, 2011, ISME J, V5, P1701, DOI [10.1038/Ismej.2011.52, 10.1038/ismej.2011.52]; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; CAUMETTE P, 1994, FEMS MICROBIOL ECOL, V13, P273, DOI 10.1016/0168-6496(94)90065-5; Chennu A, 2013, LIMNOL OCEANOGR-METH, V11, P511, DOI 10.4319/lom.2013.11.511; Cline JD, 1969, SPECTROPHOTOMETRIC D, P454; Couradeau E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028767; DasSarma P, 2012, J BACTERIOL, V194, P5530, DOI 10.1128/JB.01153-12; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Earle SA, 2009, NATL GEOGRAPHIC; Feazel LM, 2008, APPL ENVIRON MICROB, V74, P329, DOI 10.1128/AEM.01448-07; Franks J, 2009, EARTH-SCI REV, V96, P163, DOI 10.1016/j.earscirev.2008.10.004; Garrity GM, 2003, TAXONOMIC OUTLINE PR; Guerrero R., 2002, International Microbiology, V5, P177; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; Ionescu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038319; Jonkers HM, 2003, FEMS MICROBIOL ECOL, V44, P175, DOI 10.1016/S0168-6496(02)00464-6; JORGENSEN BB, 1977, LIMNOL OCEANOGR, V22, P657, DOI 10.4319/lo.1977.22.4.0657; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P11; JORGENSEN BB, 1988, LIMNOL OCEANOGR, V33, P99, DOI 10.4319/lo.1988.33.1.0099; JORGENSEN BB, 1988, APPL ENVIRON MICROB, V54, P176; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; KUHL M, 1992, APPL ENVIRON MICROB, V58, P1164; Kuhl M, 2008, AQUAT MICROB ECOL, V53, P99, DOI 10.3354/ame01224; LASSEN C, 1992, FEMS MICROBIOL ECOL, V86, P247, DOI 10.1111/j.1574-6968.1992.tb04816.x; Lovelock CE, 2010, WETL ECOL MANAG, V18, P37, DOI 10.1007/s11273-009-9146-6; Ludwig R, 2006, FEMS MICROBIOL ECOL, V57, P9, DOI 10.1111/j.1574-6941.2006.00109.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; McGregor GB, 2008, FEMS MICROBIOL ECOL, V63, P23, DOI 10.1111/j.1574-6941.2007.00405.x; Thang NM, 2013, ESTUAR COAST, V36, P98, DOI 10.1007/s12237-012-9557-0; Oremland RS, 2005, NAT REV MICROBIOL, V3, P572, DOI 10.1038/nrmicro1182; Pfeffer C, 2012, NATURE, V491, P218, DOI 10.1038/nature11586; Polerecky L, 2009, APPL ENVIRON MICROB, V75, P758, DOI 10.1128/AEM.00819-08; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P749, DOI 10.4319/lo.1983.28.4.0749; Schneider D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066662; SHERWOOD JE, 1991, LIMNOL OCEANOGR, V36, P235, DOI 10.4319/lo.1991.36.2.0235; Stal L.J., 2000, ECOLOGY CYANOBACTERI, P61; Stolz JF, 2003, FOSSIL AND RECENT BIOFILMS, P65; Stolz JF, 2000, MICROBIAL SEDIMENTS, P1; Teske A, 1998, APPL ENVIRON MICROB, V64, P2943; van der Loeff MMR, 1999, METHODS SEAWATER ANA; Volkenborn N, 2010, LIMNOL OCEANOGR, V55, P1231, DOI 10.4319/lo.2010.55.3.1231; Wieland A, 2003, MICROB ECOL, V46, P371, DOI 10.1007/s00248-002-0108-2; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183	50	18	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92405	10.1371/journal.pone.0092405	http://dx.doi.org/10.1371/journal.pone.0092405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658360	gold, Green Published, Green Submitted			2022-12-25	WOS:000333355300079
J	Nabae, K; Satoh, H; Nishiura, H; Tanaka-Taya, K; Okabe, N; Oishi, K; Matsumoto, K; Hasegawa, T				Nabae, Koji; Satoh, Hiroshi; Nishiura, Hiroshi; Tanaka-Taya, Keiko; Okabe, Nobuhiko; Oishi, Kazunori; Matsumoto, Kunichika; Hasegawa, Tomonori			Estimating the Risk of Parvovirus B19 Infection in Blood Donors and Pregnant Women in Japan	PLOS ONE			English	Article							SEROLOGICAL SURVEY DATA; 5TH DISEASE; AGE; RUBELLA; EPIDEMIOLOGY; PREVALENCE; VACCINE; VIREMIA; MEASLES	Background: Seroepidemiological study of parvovirus B19 has not taken place for some 20 years in Japan. To estimate the risk of parvovirus B19 infection in Japan among blood donors and pregnant women in this century, a seroepidemiological survey and statistical modeling of the force of infection were conducted. Methodology/Principal Findings: The time- and age-specific seroprevalence data were suggestive of strong age-dependency in the risk of infection. Employing a piecewise constant model, the highest forces of infection of 0.05 and 0.12 per year were observed among those aged 0-4 and 5-9 years, respectively, while estimates among older individuals were less than 0.01 per year. Analyzing the antigen detection data among blood donors, the age-specific proportion positive was highest among those aged 30-39 years, agreeing with the presence of dip in seroprevalence in this age-group. Among pregnant women, up to 107 fetal deaths and 21 hydrops fetalis were estimated to have occurred annually across Japan. Conclusions: Seroepidemiological profiles of PVB19 infection in Japan was characterized with particular emphasis on the risk of infection in blood donors and the burden of infection among pregnant women. When a vaccine becomes available in the future, a similar seroepidemiological study is expected to play a key role in planning the appropriate immunization policy.	[Nabae, Koji] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Field Epidemiol Training Program, Tokyo, Japan; [Nabae, Koji; Matsumoto, Kunichika; Hasegawa, Tomonori] Toho Univ, Sch Med, Dept Social Med, Tokyo, Japan; [Satoh, Hiroshi; Tanaka-Taya, Keiko; Okabe, Nobuhiko; Oishi, Kazunori] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Nishiura, Hiroshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Okabe, Nobuhiko] Kawasaki City Inst Publ Hlth, Kanagawa, Japan	National Institute of Infectious Diseases (NIID); Toho University; National Institute of Infectious Diseases (NIID); University of Tokyo	Nabae, K (corresponding author), Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Field Epidemiol Training Program, Tokyo, Japan.	k-nabae@umin.ac.jp		Nishiura, Hiroshi/0000-0003-0941-8537	Ministry of Health, Labour, and Welfare, Japan [H.21-Shinko-Ippan-002]; Japan Science and Technology Agency PRESTO program	Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency PRESTO program(Japan Science & Technology Agency (JST))	This study is partly supported by a Health Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare, Japan (grant number: H.21-Shinko-Ippan-002). HN received financial support from the Japan Science and Technology Agency PRESTO program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MJ, 1983, LANCET, V1, P1378; ANDERSON RM, 1986, J HYG-CAMBRIDGE, V96, P305, DOI 10.1017/S0022172400066079; Bernstein DI, 2011, VACCINE, V29, P7357, DOI 10.1016/j.vaccine.2011.07.080; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cohen BJ, 1986, PUBLIC HLTH VIROLOGY, P130; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P617, DOI 10.1017/S0950268800004660; Efron B., 1994, INTRO BOOTSTRAP; Ejima K, 2012, INT J BIOL SCI, V8, P620, DOI 10.7150/ijbs.4329; FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811; Farrington CP, 2001, J R STAT SOC C-APPL, V50, P251, DOI 10.1111/1467-9876.00233; Gay N J, 1994, Commun Dis Rep CDR Rev, V4, pR104; Japanese Red Cross Society, 2011, ANN REP BLOOD PROD; Kelly HA, 2000, EPIDEMIOL INFECT, V124, P449, DOI 10.1017/S0950268899003817; Kooistra K, 2011, VOX SANG, V100, P261, DOI 10.1111/j.1423-0410.2010.01423.x; Matsunaga Y, 1995, Kansenshogaku Zasshi, V69, P1371; Miller E, 1998, BRIT J OBSTET GYNAEC, V105, P174, DOI 10.1111/j.1471-0528.1998.tb10048.x; Ministry of Health Labour and Welfare (MHLW) Committee of NESVPD in National Institute of Infectious Diseases, 2011, PROC NAT EP SURV VAC; Mossong J, 2008, EPIDEMIOL INFECT, V136, P1059, DOI 10.1017/S0950268807009661; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nishiura H, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-5; OKABE N, 1984, ARCH DIS CHILD, V59, P1016, DOI 10.1136/adc.59.11.1016; Rohrer C, 2008, EPIDEMIOL INFECT, V136, P1564, DOI 10.1017/S0950268807009958; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Satou Kunio, 2007, BMC Vet Res, V3, P9, DOI 10.1186/1746-6148-3-9; Taniguchi K, 2007, J EPIDEMIOL, V17, pS3, DOI 10.2188/jea.17.S3; Vyse AJ, 2007, EPIDEMIOL INFECT, V135, P1354, DOI 10.1017/S0950268807007856; Whitaker HJ, 2004, STAT MED, V23, P2429, DOI 10.1002/sim.1819; Yaegashi N, 1999, J INFECTION, V38, P30, DOI 10.1016/S0163-4453(99)90026-9; Yaegashi N, 1998, J INFECTION, V37, P28, DOI 10.1016/S0163-4453(98)90346-2; YAMASHITA K, 1992, JPN J MED SCI BIOL, V45, P49, DOI 10.7883/yoken1952.45.49; Zaaijer HL, 2004, EPIDEMIOL INFECT, V132, P1161, DOI 10.1017/S0950268804002730	31	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92519	10.1371/journal.pone.0092519	http://dx.doi.org/10.1371/journal.pone.0092519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658180	Green Submitted, gold, Green Published			2022-12-25	WOS:000333355300093
J	Park, W; Kim, J; Kim, HJ; Choi, JY; Park, JW; Cho, HW; Kim, BW; Park, MH; Shin, TS; Cho, SK; Park, JK; Kim, H; Hwang, JY; Lee, CK; Lee, HK; Cho, S; Cho, BW				Park, Woncheoul; Kim, Jaemin; Kim, Hyeon Jeong; Choi, Jae Young; Park, Jeong-Woong; Cho, Hyun-Woo; Kim, Byeong-Woo; Park, Myung Hum; Shin, Teak-Soon; Cho, Seong-Keun; Park, Jun-Kyu; Kim, Heebal; Hwang, Jae Yeon; Lee, Chang-Kyu; Lee, Hak-Kyo; Cho, Seoae; Cho, Byung-Wook			Investigation of De Novo Unique Differentially Expressed Genes Related to Evolution in Exercise Response during Domestication in Thoroughbred Race Horses	PLOS ONE			English	Article							RNA-SEQ DATA; SKELETAL-MUSCLE; GENOME; SELECTION; DISCOVERY; FRAMEWORK; APOPTOSIS; FORMAT; SCANS; P53	Previous studies of horse RNA-seq were performed by mapping sequence reads to the reference genome during transcriptome analysis. However in this study, we focused on two main ideas. First, differentially expressed genes (DEGs) were identified by de novo-based analysis (DBA) in RNA-seq data from six Thoroughbreds before and after exercise, hereafter referred to as "de novo unique differentially expressed genes'' (DUDEG). Second, by integrating both conventional DEGs and genes identified as being selected for during domestication of Thoroughbred and Jeju pony from whole genome re-sequencing (WGS) data, we give a new concept to the definition of DEG. We identified 1,034 and 567 DUDEGs in skeletal muscle and blood, respectively. DUDEGs in skeletal muscle were significantly related to exercise-induced stress biological process gene ontology (BP-GO) terms: 'immune system process'; 'response to stimulus'; and, 'death' and a KEGG pathways: 'JAK-STAT signaling pathway'; 'MAPK signaling pathway'; 'regulation of actin cytoskeleton'; and, 'p53 signaling pathway'. In addition, we found TIMELESS, EIF4A3 and ZNF592 in blood and CHMP4C and FOXO3 in skeletal muscle, to be in common between DUDEGs and selected genes identified by evolutionary statistics such as FST and Cross Population Extended Haplotype Homozygosity (XP-EHH). Moreover, in Thoroughbreds, three out of five genes (CHMP4C, EIF4A3 and FOXO3) related to exercise response showed relatively low nucleotide diversity compared to the Jeju pony. DUDEGs are not only conceptually new DEGs that cannot be attained from reference-based analysis (RBA) but also supports previous RBA results related to exercise in Thoroughbred. In summary, three exercise related genes which were selected for during domestication in the evolutionary history of Thoroughbred were identified as conceptually new DEGs in this study.	[Park, Woncheoul; Hwang, Jae Yeon; Lee, Chang-Kyu] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Park, Woncheoul; Hwang, Jae Yeon; Lee, Chang-Kyu] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Kim, Jaemin] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Kim, Hyeon Jeong; Kim, Heebal; Cho, Seoae] Seoul Natl Univ, C&K Genom, Seoul, South Korea; [Choi, Jae Young; Park, Jeong-Woong; Cho, Hyun-Woo; Kim, Byeong-Woo; Shin, Teak-Soon; Cho, Seong-Keun; Cho, Byung-Wook] Pusan Natl Univ, Coll Life Sci, Dept Anim Sci, Miryang, South Korea; [Park, Myung Hum] TNT Res, Anyang, South Korea; [Park, Jun-Kyu] Pusan Natl Univ, Leaders Ind Univ Cooperat, Miryang, South Korea; [Lee, Hak-Kyo] Hankyong Natl Univ, Genom Informat Ctr, Anseong, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Pusan National University; Pusan National University; Hankyong National University	Cho, S (corresponding author), Seoul Natl Univ, C&K Genom, Seoul, South Korea.	seoae@cnkgenomics.com; bwcho@pusan.ac.kr	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Park, WonCheoul/0000-0003-3140-5628; Hwang, Jae Yeon/0000-0002-6493-4182	Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008106]; 'Leaders Industry-University Cooperation' project, Ministry of Education (MOE), Republic of Korea	Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; 'Leaders Industry-University Cooperation' project, Ministry of Education (MOE), Republic of Korea	This work was supported by a grant from the Next Generation BioGreen 21 Program (No. PJ008106), Rural Development Administration, Republic of Korea and 'Leaders Industry-University Cooperation' project, Ministry of Education (MOE), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterovitz G., 2011, KNOWL BAS BIOINF AN; Andersson L, 2012, J INTERN MED, V271, P1, DOI 10.1111/j.1365-2796.2011.02450.x; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Cecchetti L, 2011, BLOOD, V118, P1903, DOI 10.1182/blood-2010-12-324517; Chen G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-590; Chen G, 2011, SCI CHINA LIFE SCI, V54, P1129, DOI 10.1007/s11427-011-4256-9; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dousset E, 2007, MED SCI SPORT EXER, V39, P453, DOI 10.1249/mss.0b013e31802dd74e; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Gunn H, 1987, MUSCLE BONE FAT PROP; Henschel R, 2012, TRINITY RNA SEQ ASSE, P45; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jamart C, 2012, EUR J APPL PHYSIOL, V112, P3173, DOI 10.1007/s00421-011-2287-3; KAYAR SR, 1989, PFLUG ARCH EUR J PHY, V413, P343, DOI 10.1007/BF00584481; KESTIN AS, 1993, CIRCULATION, V88, P1502, DOI 10.1161/01.CIR.88.4.1502; Kim H, 2013, DNA RES; Kingston SG, 1996, PHYSIOL BEHAV, V60, P145, DOI 10.1016/0031-9384(95)02241-4; Kinsella M, 2011, BIOINFORMATICS, V27, P1068, DOI 10.1093/bioinformatics/btr085; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long YC, 2004, P NUTR SOC, V63, P227, DOI 10.1079/PNS2004346; Martin JA, 2011, NATURE REV GENETICS; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; McGivney BA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-398; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Niess AC, 1999, EXERC IMMUNOL REV, V5, P22; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; Park KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-473; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Poole D. C., 2004, Equine and Comparative Exercise Physiology, V1, P5, DOI 10.1079/ECP20036; REYNOLDS J, 1983, GENETICS, V105, P767; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Stefansson S, 2004, J BIOL CHEM, V279, P29981, DOI 10.1074/jbc.M401913200; STEVEN L, 2005, BIOINFORMATICS, V21, P320; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tao T, 2006, PROGRAM PARAMETERS B; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Weatherby J., 1791, INTRO GEN STUD BOOK; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Young BL, 2002, EQUINE VET J, V34, P469, DOI 10.2746/042516402776117755; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	69	14	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91418	10.1371/journal.pone.0091418	http://dx.doi.org/10.1371/journal.pone.0091418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658125	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300032
J	Mao, L; Kawao, N; Tamura, Y; Okumoto, K; Okada, K; Yano, M; Matsuo, O; Kaji, H				Mao, Li; Kawao, Naoyuki; Tamura, Yukinori; Okumoto, Katsumi; Okada, Kiyotaka; Yano, Masato; Matsuo, Osamu; Kaji, Hiroshi			Plasminogen Activator Inhibitor-1 Is Involved in Impaired Bone Repair Associated with Diabetes in Female Mice	PLOS ONE			English	Article							FRACTURE; TYPE-1; MELLITUS; RISK; DEFICIENCY; MECHANISMS; RESORPTION; CARTILAGE; OBESITY; LACKING	Previous studies suggest that fracture healing is impaired in diabetes; however, the underlying mechanism remains unclear. Here, we investigated the roles of plasminogen activator inhibitor-1 (PAI-1) in the impaired bone repair process by using streptozotocin (STZ)-induced diabetic female wild-type (PAI-1(+/+)) and PAI-1-deficient (PAI-1(-/-)) mice. Bone repair and the number of alkaline phosphatase (ALP)-positive cells at the site of a femoral bone damage were comparable in PAI-1(+/+) and PAI-1(-/-) mice without STZ treatment. Although the bone repair process was delayed by STZ treatment in PAI-1(+/+) mice, this delayed bone repair was blunted in PAI-1(-/-) mice. The reduction in the number of ALP-positive cells at the site of bone damage induced by STZ treatment was attenuated in PAI-1(-/-) mice compared to PAI-1(+/+) mice. On the other hand, PAI-1 deficiency increased the levels of ALP and type I collagen mRNA in female mice with or without STZ treatment, and the levels of Osterix and osteocalcin mRNA, suppressed by diabetic state in PAI-1(+/+) mice, were partially protected in PAI-1(-/-) mice. PAI-1 deficiency did not affect formation of the cartilage matrix and the levels of types II and X collagen and aggrecan mRNA suppressed by STZ treatment, although PAI-1 deficiency increased the expression of chondrogenic markers in mice without STZ treatment. The present study indicates that PAI-1 is involved in the impaired bone repair process induced by the diabetic state in part through a decrease in the number of ALP-positive cells.	[Mao, Li; Kawao, Naoyuki; Tamura, Yukinori; Okada, Kiyotaka; Yano, Masato; Matsuo, Osamu; Kaji, Hiroshi] Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, Osaka, Japan; [Okumoto, Katsumi] Kinki Univ, Life Sci Res Inst, Osaka, Japan	Kindai University (Kinki University); Kindai University (Kinki University)	Kaji, H (corresponding author), Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, Osaka, Japan.	hkaji@med.kindai.ac.jp	MATSUO, OSAMU/AAM-9703-2020; Kaji, Hiroshi/AAI-5628-2020	Kawao, Naoyuki/0000-0002-4148-5476; Matsuo, Osamu/0000-0002-9806-2204	Ministry of Science, Education [24590289]; Japan China Sasakawa Medical Fellowship; Grants-in-Aid for Scientific Research [24590289] Funding Source: KAKEN	Ministry of Science, Education; Japan China Sasakawa Medical Fellowship; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a grant-in-aid (24590289) from the Ministry of Science, Education to H. Kaji and Japan China Sasakawa Medical Fellowship to L. Mao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN EH, 1995, CLIN ORTHOP RELAT R, P54; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Daci E, 1999, J BONE MINER RES, V14, P946, DOI 10.1359/jbmr.1999.14.6.946; Daci E, 2000, J BONE MINER RES, V15, P1510, DOI 10.1359/jbmr.2000.15.8.1510; Declerck PJ, 2013, SEMIN THROMB HEMOST, V39, P356, DOI 10.1055/s-0033-1334487; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Fadini GP, 2013, DIABETES CARE, V36, P943, DOI 10.2337/dc12-1084; Gandhi A, 2005, BONE, V37, P482, DOI 10.1016/j.bone.2005.04.039; Hofbauer LC, 2007, J BONE MINER RES, V22, P1317, DOI 10.1359/JBMR.070510; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kawao N, 2013, J BONE MINER RES, V28, P1561, DOI 10.1002/jbmr.1921; Kayal RA, 2007, J BONE MINER RES, V22, P560, DOI 10.1359/JBMR.070115; Kayal RA, 2010, J BONE MINER RES, V25, P1604, DOI 10.1002/jbmr.59; Kayal R, 2009, BONE, V44, P357, DOI 10.1016/j.bone.2008.10.042; Krause MP, 2011, DIABETES, V60, P1964, DOI 10.2337/db11-0007; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; Liao YF, 2010, VASC MED, V15, P279, DOI 10.1177/1358863X10367537; Lu HF, 2003, ENDOCRINOLOGY, V144, P346, DOI 10.1210/en.2002-220072; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; McCabe LR, 2007, J CELL BIOCHEM, V102, P1343, DOI 10.1002/jcb.21573; Merlotti D, 2010, NUTR METAB CARDIOVAS, V20, P683, DOI 10.1016/j.numecd.2010.07.008; Oh CK, 2002, BIOCHEM BIOPH RES CO, V294, P1155, DOI 10.1016/S0006-291X(02)00577-6; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P673, DOI 10.1111/j.1600-0501.2010.01923.x; Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20; Rundle CH, 2008, CALCIFIED TISSUE INT, V83, P276, DOI 10.1007/s00223-008-9169-7; Shin L, 2012, STEM CELL TRANSL MED, V1, P125, DOI [10.5966/sctm.2011-0031, 10.5966/sctm.2012-0031]; Shoji T, 2006, DIABETES, V55, P2245, DOI 10.2337/db05-1375; Simpson CM, 2012, EXPERT OPIN DRUG SAF, V11, P215, DOI 10.1517/14740338.2012.639359; SPRENGERS ED, 1987, BLOOD, V69, P381; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Tamura Y, 2013, DIABETES, V62, P3170, DOI 10.2337/db12-1552; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Wang H, 2007, FEBS LETT, V581, P3098, DOI 10.1016/j.febslet.2007.05.049; Wongdee K, 2011, WORLD J DIABETES, V2, P41, DOI 10.4239/wjd.v2.i3.41	36	44	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92686	10.1371/journal.pone.0092686	http://dx.doi.org/10.1371/journal.pone.0092686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651693	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800143
J	Morimoto, T; Kanda, H; Miyoshi, T; Hirohara, Y; Mihashi, T; Kitaguchi, Y; Nishida, K; Fujikado, T				Morimoto, Takeshi; Kanda, Hiroyuki; Miyoshi, Tomomitsu; Hirohara, Yoko; Mihashi, Toshifumi; Kitaguchi, Yoshiyuki; Nishida, Kohji; Fujikado, Takashi			Characteristics of Retinal Reflectance Changes Induced by Transcorneal Electrical Stimulation in Cat Eyes	PLOS ONE			English	Article							INTRINSIC OPTICAL SIGNALS; EVOKED RESPONSE; BLOOD-FLOW; FUNCTIONAL ARCHITECTURE; MACAQUE RETINA; VISUAL-SYSTEM; NERVE; VOLUME	Transcorneal electrical stimulation (TES) activates retinal neurons leading to visual sensations. How the retinal cells are activated by TES has not been definitively determined. Investigating the reflectance changes of the retina is an established technique and has been used to determine the mechanism of retinal activation. The purpose of this study was to evaluate the reflectance changes elicited by TES in cat eyes. Eight eyes of Eight cats were studied under general anesthesia. Biphasic electrical pulses were delivered transcornealy. The fundus images observed with near-infrared light (800-880 nm) were recorded every 25 ms for 26 s. To improve the signal-to-noise ratio, the images of 10 consecutive recordings were averaged. Two-dimensional topographic maps of the reflective changes were constructed by subtracting images before from those after the TES. The effects of different stimulus parameters, e. g., current intensity, pulse duration, frequency, and stimulus duration, on the reflective changes were studied. Our results showed that after TES, the reflective changes appeared on the retinal vessels and optic disc. The intensity of reflectance changes increased as the current intensity, pulse duration, and stimulation duration increased (P<0.05 for all). The maximum intensity of the reflective change was obtained when the stimulus frequency was 20 Hz. The time course of the reflectance changes was also altered by the stimulation parameters. The response started earlier and returned to the baseline later with higher current intensities, longer pulse durations, but the time of the peak of the response was not changed. These results showed that the reflective changes were due to the activation of retinal neurons by TES and might involve the vascular changes induced by an activation of the retinal neurons.	[Morimoto, Takeshi; Kanda, Hiroyuki; Kitaguchi, Yoshiyuki; Fujikado, Takashi] Osaka Univ, Grad Sch Med, Dept Appl Visual Sci, Suita, Osaka, Japan; [Miyoshi, Tomomitsu] Osaka Univ, Grad Sch Med, Dept Integrat Physiol, Suita, Osaka, Japan; [Hirohara, Yoko] Topcon Corp, Res Inst, Itabashi Ku, Tokyo, Japan; [Mihashi, Toshifumi] Tokyo Inst Technol, Innovat Res Initiat, Yokohama, Kanagawa 227, Japan; [Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan	Osaka University; Osaka University; Topcon Corporation; Tokyo Institute of Technology; Osaka University	Morimoto, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Appl Visual Sci, Suita, Osaka, Japan.	takeshi.morimoto@ophthal.med.osaka-u.ac.jp		Nishida, Kohji/0000-0001-9069-3610	Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder; Grants-in-Aid for Scientific Research [25670730, 22249058] Funding Source: KAKEN	Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2006, INVEST OPHTH VIS SCI, V47, P715, DOI 10.1167/iovs.05-0008; COHEN LB, 1973, PHYSIOL REV, V53, P373; Delbeke J, 2001, INVEST OPHTH VIS SCI, V42, P291; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Fujikado T, 2007, GRAEF ARCH CLIN EXP, V245, P1411, DOI 10.1007/s00417-007-0563-z; Fujikado T, 2006, JPN J OPHTHALMOL, V50, P266, DOI 10.1007/s10384-005-0304-y; Fukuda M, 2005, CEREB CORTEX, V15, P823, DOI 10.1093/cercor/bhh183; Gall C, 2010, NEUROREHABILITATION, V27, P335, DOI 10.3233/NRE-2010-0617; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hanazono G, 2008, INVEST OPHTH VIS SCI, V49, P4655, DOI 10.1167/iovs.08-1936; Hanazono G, 2007, INVEST OPHTH VIS SCI, V48, P2903, DOI 10.1167/iovs.06-1294; Inomata K, 2008, INVEST OPHTH VIS SCI, V49, P2193, DOI 10.1167/iovs.07-0727; Inomata K, 2007, GRAEF ARCH CLIN EXP, V245, P1773, DOI 10.1007/s00417-007-0610-9; KNIGHTON RW, 1975, J NEUROPHYSIOL, V38, P185, DOI 10.1152/jn.1975.38.1.185; Kurimoto T, 2010, CLIN OPHTHALMOL, V4, P1441, DOI 10.2147/OPTH.S14573; Mihashi T, 2011, JPN J OPHTHALMOL, V55, P49, DOI 10.1007/s10384-010-0906-x; Miyake Y, 1980, Nippon Ganka Gakkai Zasshi, V84, P354; Morimoto T, 2006, GRAEF ARCH CLIN EXP, V244, P1283, DOI 10.1007/s00417-006-0260-3; Naycheva L, 2012, INVEST OPHTH VIS SCI, V53, P7440, DOI 10.1167/iovs.12-9612; Okawa Y, 2007, INVEST OPHTH VIS SCI, V48, P4777, DOI 10.1167/iovs.07-0209; POTTS AM, 1968, INVEST OPHTH VISUAL, V7, P269; POTTS AM, 1969, INVEST OPHTH VISUAL, V8, P605; RIVA CE, 1991, NEUROSCI LETT, V128, P291, DOI 10.1016/0304-3940(91)90282-X; Riva CE, 1996, MICROVASC RES, V52, P258, DOI 10.1006/mvre.1996.0063; Riva CE, 2005, PROG RETIN EYE RES, V24, P183, DOI 10.1016/j.preteyeres.2004.07.002; Roy C S, 1890, J Physiol, V11, P85; Schallek J, 2011, INVEST OPHTH VIS SCI, V52, P1325, DOI 10.1167/iovs.10-5215; Schallek J, 2009, INVEST OPHTH VIS SCI, V50, P4873, DOI 10.1167/iovs.08-3291; Schallek J, 2009, INVEST OPHTH VIS SCI, V50, P4865, DOI 10.1167/iovs.08-3290; Schatz A, 2011, INVEST OPHTH VIS SCI, V52, P4485, DOI 10.1167/iovs.10-6932; Shah HA, 2006, EXP EYE RES, V83, P247, DOI 10.1016/j.exer.2005.11.023; Shimazu K, 1999, VISION RES, V39, P2251, DOI 10.1016/S0042-6989(98)00331-9; Ts'o D, 2009, JPN J OPHTHALMOL, V53, P334, DOI 10.1007/s10384-009-0687-2; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Tsunoda K, 2004, INVEST OPHTH VIS SCI, V45, P3820, DOI 10.1167/iovs.04-0394; Tsunoda K, 2009, JPN J OPHTHALMOL, V53, P297, DOI 10.1007/s10384-009-0686-3	36	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92186	10.1371/journal.pone.0092186	http://dx.doi.org/10.1371/journal.pone.0092186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651530	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800080
J	Thompson, RL; Williams, RW; Kotb, M; Sawtell, NM				Thompson, Richard L.; Williams, Robert W.; Kotb, Malak; Sawtell, Nancy M.			A Forward Phenotypically Driven Unbiased Genetic Analysis of Host Genes That Moderate Herpes Simplex Virus Virulence and Stromal Keratitis in Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GAMMA-INTERFERON; THYMIDINE KINASE; TYPE-1 INFECTION; MURINE MODEL; MOUSE LINES; WILD-TYPE; SUSCEPTIBILITY; REACTIVATION; ENCEPHALITIS	Both viral and host genetics affect the outcome of herpes simplex virus type 1 (HSV-1) infection in humans and experimental models. Little is known about specific host gene variants and molecular networks that influence herpetic disease progression, severity, and episodic reactivation. To identify such host gene variants we have initiated a forward genetic analysis using the expanded family of BXD strains, all derived from crosses between C57BL/6J and DBA/2J strains of mice. One parent is highly resistant and one highly susceptible to HSV-1. Both strains have also been fully sequenced, greatly facilitating the search for genetic modifiers that contribute to differences in HSV-1 infection. We monitored diverse disease phenotypes following infection with HSV-1 strain 17syn+ including percent mortality (herpes simplex encephalitis, HSE), body weight loss, severity of herpetic stromal keratitis (HSK), spleen weight, serum neutralizing antibody titers, and viral titers in tear films in BXD strains. A significant quantitative trait locus (QTL) on chromosome (Chr) 16 was found to associate with both percent mortality and HSK severity. Importantly, this QTL maps close to a human QTL and the gene proposed to be associated with the frequency of recurrent herpetic labialis (cold sores). This suggests that a single host locus may influence these seemingly diverse HSV-1 pathogenic phenotypes by as yet unknown mechanisms. Additional suggestive QTLs for percent mortality were identified-one on Chr X that is epistatically associated with that on Chr 16. As would be anticipated the Chr 16 QTL also modulated weight loss, reaching significance in females. A second significant QTL for maximum weight loss in male and female mice was mapped to Chr 12. To our knowledge this is the first report of a host genetic locus that modulates the severity of both herpetic disease in the nervous system and herpetic stromal keratitis.	[Thompson, Richard L.; Kotb, Malak] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Ctr Genom & Bioinformat, Memphis, TN 38163 USA; [Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Sawtell, Nancy M.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Thompson, RL (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	richard.thompson@uc.edu; nancy.sawtell@cchmc.org	Williams, Robert W./H-8789-2016	Williams, Robert W./0000-0001-8924-4447; Thompson, Richard/0000-0002-0246-2810	NIH [RC1 AI087336]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093614, RC1AI087336] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH RC1 AI087336, www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RC, 1996, NEUROPSYCHOPHARMACOL, V15, P484, DOI 10.1016/S0893-133X(96)00058-9; Aziz RK, 2007, GENES IMMUN, V8, P404, DOI 10.1038/sj.gene.6364402; Bourane S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-97; BRANDT CR, 1992, J VIROL METHODS, V36, P209, DOI 10.1016/0166-0934(92)90052-F; Brandt CR, 2005, EXP EYE RES, V80, P607, DOI 10.1016/j.exer.2004.09.007; Brandt CR, 2004, CURR EYE RES, V29, P103, DOI 10.1080/02713680490504533; Brandt CR, 2007, INVEST OPHTH VIS SCI, V48, P5118, DOI 10.1167/iovs.07-0302; Broman KW, 2001, LAB ANIMAL, V30, P44; Cantin E, 1999, J VIROL, V73, P5196, DOI 10.1128/JVI.73.6.5196-5200.1999; Cantin E, 1999, J VIROL, V73, P3418, DOI 10.1128/JVI.73.4.3418-3423.1999; Carneiro AMD, 2009, P NATL ACAD SCI USA, V106, P2047, DOI 10.1073/pnas.0809449106; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Conejero-Goldberg C, 2003, SCHIZOPHR RES, V60, P65, DOI 10.1016/S0920-9964(02)00160-3; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Corey L, 2007, NEW ENGL J MED, V356, P854, DOI 10.1056/NEJMe068302; Du T, 2010, P NATL ACAD SCI USA, V107, P15904, DOI 10.1073/pnas.1010741107; Everett RD, 2010, J VIROL, V84, P3476, DOI 10.1128/JVI.02544-09; FOSTER CS, 1986, CLIN IMMUNOL IMMUNOP, V40, P313, DOI 10.1016/0090-1229(86)90036-X; Geisert EE, 2009, MOL VIS, V15, P1730; Gimenez F, 2013, PROG RETIN EYE RES, V33, P1, DOI 10.1016/j.preteyeres.2012.07.002; Glynn JR, 2009, AIDS, V23, P1595, DOI 10.1097/QAD.0b013e32832e15e8; Griffiths A, 2003, J VIROL, V77, P4703, DOI 10.1128/JVI.77.8.4703-4709.2003; Griffiths A, 2003, J VIROL, V77, P2282, DOI 10.1128/JVI.77.3.2282-2286.2003; Gu Wei, 1995, Journal of Biomedical Science, V2, P203, DOI 10.1007/BF02253381; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Han X, 2001, J VIROL, V75, P3048, DOI 10.1128/JVI.75.6.3048-3052.2001; Hazlett LD, 2010, OCUL IMMUNOL INFLAMM, V18, P237, DOI 10.3109/09273948.2010.501946; HILL TJ, 1986, J GEN VIROL, V67, P309, DOI 10.1099/0022-1317-67-2-309; Hobbs MR, 2008, J INFECT DIS, V197, P340, DOI 10.1086/525540; Horsburgh BC, 1998, J INFECT DIS, V178, P618, DOI 10.1086/515375; Huster KM, 2002, EUR J IMMUNOL, V32, P1414, DOI 10.1002/1521-4141(200205)32:5<1414::AID-IMMU1414>3.0.CO;2-Q; Inoue Yoshitsugu, 2008, Semin Ophthalmol, V23, P221, DOI 10.1080/08820530802111390; Kanno H, 2009, J NEUROTRAUM, V26, P31, DOI 10.1089/neu.2008.0667; Kriesel JD, 1997, J INFECT DIS, V175, P821, DOI 10.1086/513977; Kriesel JD, 2011, J INFECT DIS, V204, P1654, DOI 10.1093/infdis/jir633; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Levitz RE, 1998, HEART LUNG, V27, P209, DOI 10.1016/S0147-9563(98)90009-7; Lieu PT, 2000, VIROLOGY, V272, P191, DOI 10.1006/viro.2000.0365; LOPEZ C, 1975, NATURE, V258, P152, DOI 10.1038/258152a0; Lu H, 2011, MOL VIS, V17, P2455; Lundberg P, 2003, J VIROL, V77, P11661, DOI 10.1128/JVI.77.21.11661-11673.2003; METCALF JF, 1984, INVEST OPHTH VIS SCI, V25, P1222; Nedelko T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-411; Norose K, 2002, J VIROL, V76, P3502, DOI 10.1128/JVI.76.7.3502-3510.2002; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Piers TM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00199; PLUMMER G, 1974, VIROLOGY, V60, P206, DOI 10.1016/0042-6822(74)90378-X; Pruett ND, 2004, J BIOL CHEM, V279, P51524, DOI 10.1074/jbc.M404331200; Rantakallio P, 1997, INT J EPIDEMIOL, V26, P837, DOI 10.1093/ije/26.4.837; Roizman B, 2005, CELL CYCLE, V4, P1019, DOI 10.4161/cc.4.8.1902; Rulten SL, 2006, GENES BRAIN BEHAV, V5, P257, DOI 10.1111/j.1601-183X.2005.00157.x; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Sawtell NA, 2004, J VIROL, V78, P7784, DOI 10.1128/JVI.78.14.7784-7794.2004; SHIMELD C, 1985, ARCH VIROL, V85, P175, DOI 10.1007/BF01314229; Smith G, 2012, ANNU REV MICROBIOL, V66, P153, DOI 10.1146/annurev-micro-092611-150051; Steiner I, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0414-8; Suryawanshi A, 2011, J IMMUNOL, V187, P1919, DOI 10.4049/jimmunol.1100736; TAYLOR BA, 1973, P SOC EXP BIOL MED, V143, P629, DOI 10.3181/00379727-143-37380; Thompson RL, 2011, J NEUROVIROL, V17, P552, DOI 10.1007/s13365-011-0071-0; Thompson RL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000352; THOMPSON RL, 1989, VIROLOGY, V172, P435, DOI 10.1016/0042-6822(89)90186-4; THOMPSON RL, 1986, J VIROL, V58, P203, DOI 10.1128/JVI.58.1.203-211.1986; THOMPSON RL, 1983, VIROLOGY, V131, P171, DOI 10.1016/0042-6822(83)90543-3; Veiga-Parga T, 2013, MICROBES INFECT, V15, P677, DOI 10.1016/j.micinf.2013.07.001; Veiga-Parga T, 2012, J IMMUNOL, V189, P5924, DOI 10.4049/jimmunol.1202322; Whitley Richard J, 2002, Semin Pediatr Infect Dis, V13, P6, DOI 10.1053/spid.2002.29752; WHITLEY RJ, 1990, NEW ENGL J MED, V323, P242, DOI 10.1056/NEJM199007263230406; Whitley RJ, FIELDS VIROLOGY FIEL, V2, P297; Yadav JS, 2011, INFECT IMMUN, V79, P3204, DOI 10.1128/IAI.01389-10; Zhang SY, 2013, HAND CLINIC, V112, P1091, DOI 10.1016/B978-0-444-52910-7.00027-1; Zhao ZS, 1998, SCIENCE, V279, P1344, DOI 10.1126/science.279.5355.1344; Zumbrun EE, 2012, VIRUSES-BASEL, V4, P3468, DOI 10.3390/v4123468	74	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92342	10.1371/journal.pone.0092342	http://dx.doi.org/10.1371/journal.pone.0092342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651695	Green Submitted, gold, Green Published			2022-12-25	WOS:000333352800103
J	Wu, YL; Hwang, DY; Hsiao, HP; Ting, WH; Huang, CY; Tsai, WY; Chen, HC; Chao, MC; Lo, FS; Tsai, JD; Yang, S; Shih, SL; Lin, SP; Lin, CL; Lee, YJ				Wu, Yi-Lei; Hwang, Daw-Yang; Hsiao, Hui-Pin; Ting, Wei-Hsin; Huang, Chi-Yu; Tsai, Wen-Yu; Chen, Hung-Chun; Chao, Mei-Chyn; Lo, Fu-Sung; Tsai, Jeng-Daw; Yang, Stone; Shih, Shin-Lin; Lin, Shuan-Pei; Lin, Chiung-Ling; Lee, Yann-Jinn			Mutations in Pseudohypoparathyroidism 1a and Pseudopseudohypoparathyroidism in Ethnic Chinese	PLOS ONE			English	Article							ALBRIGHT HEREDITARY OSTEODYSTROPHY; GS-ALPHA GENE; IDENTIFIES PDE4D MUTATIONS; NONSENSE-MEDIATED DECAY; STIMULATORY G-PROTEIN; HORMONE RESISTANCE; PARATHYROID-HORMONE; MULTIPLE HORMONES; GNAS; DELETION	An inactivating mutation in the GNAS gene causes either pseudohypoparathyroidism 1a (PHP1A) when it is maternally inherited or pseudopseudohypoparathyroidism (PPHP) when it is paternally inherited. We investigated clinical manifestations and mutations of the GNAS gene in ethnic Chinese patients with PHP1A or PPHP. Seven patients from 5 families including 4 girls and 2 boys with PHP1A and 1 girl with PPHP were studied. All PHP1A patients had mental retardation. They were treated with calcitriol and CaCO3 with regular monitoring of serum Ca levels, urinary Ca/Cr ratios, and renal sonography. Among them, 5 patients also had primary hypothyroidism suggesting TSH resistance. One female patient had a renal stone which was treated with extracorporeal shockwave lithotripsy. She had an increased urinary Ca/Cr ratio of 0.481 mg/mg when the stone was detected. We detected mutations using PCR and sequencing as well as analysed a splice acceptor site mutation using RT-PCR, sequencing, and minigene construct. We detected 5 mutations: c.85C>T (Q29*), c.103C>T (Q35*), c.840-2A>G (R280Sfs*21), c.1027_1028delGA (D343*), and c.1174G>A (E392K). Mutations c.840-2A>G and c.1027_1028delGA were novel. The c.840-2A>G mutation at the splice acceptor site of intron 10 caused retention of intron 10 in the minigene construct but skipping of exon 11 in the peripheral blood cells. The latter was the most probable mechanism which caused a frameshift, changing Arg to Ser at residue 280 and invoking a premature termination of translation at codon 300 (R280Sfs*21). Five GNAS mutations in ethnic Chinese with PHP1A and PPHP were reported. Two of them were novel. Mutation c.840-2A>G destroyed a spice acceptor site and caused exon skipping. Regular monitoring and adjustment in therapy are mandatory to achieve optimal therapeutic effects and avoid nephrolithiasis in patients with PHP1A.	[Wu, Yi-Lei; Ting, Wei-Hsin; Huang, Chi-Yu; Tsai, Jeng-Daw; Lin, Shuan-Pei; Lee, Yann-Jinn] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Wu, Yi-Lei] Changhua Christian Hosp, Dept Pediat, Changhua, Taiwan; [Hwang, Daw-Yang; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Dept Med, Div Nephrol, Kaohsiung, Taiwan; [Hsiao, Hui-Pin] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Pediat, Kaohsiung, Taiwan; [Tsai, Wen-Yu] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Dept Med, Fac Renal Care, Kaohsiung, Taiwan; [Chao, Mei-Chyn] Kaohsiung Med Univ Hosp, Dept Pediat, Div Genet Endocrinol & Metab, Kaohsiung, Taiwan; [Chao, Mei-Chyn] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Lo, Fu-Sung] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Lo, Fu-Sung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Ting, Wei-Hsin; Huang, Chi-Yu; Lin, Shuan-Pei] Mackay Jr Coll Med Nursing & Management, New Taipei City, Taiwan; [Yang, Stone] Mackay Mem Hosp, Dept Urol, Taipei, Taiwan; [Shih, Shin-Lin] Mackay Mem Hosp, Dept Radiol, Taipei, Taiwan; [Lin, Shuan-Pei; Lin, Chiung-Ling; Lee, Yann-Jinn] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Lin, Shuan-Pei] Natl Taipei Univ Nursing & Hlth, Dept Infant & Child Care, Taipei, Taiwan; [Tsai, Jeng-Daw; Shih, Shin-Lin; Lee, Yann-Jinn] Taipei Med Univ, Coll Med, Taipei, Taiwan; [Lin, Shuan-Pei; Lee, Yann-Jinn] Mackay Med Coll, Inst Biomed Sci, New Taipei City, Taiwan; [Lin, Shuan-Pei; Lee, Yann-Jinn] Mackay Med Coll, Dept Med, New Taipei City, Taiwan	Mackay Memorial Hospital; Changhua Christian Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; National Taipei University of Nursing & Health Science (NTUNHS); Taipei Medical University; Mackay Medical College; Mackay Medical College	Lee, YJ (corresponding author), Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan.	yannlee@mmh.org.tw		TSAI, WEN-YU/0000-0003-1332-2650	Mackay Memorial Hospital [MMH-E-10007, MMH10170]; Kaohsiung Medical University Hospital [KMUH 99-9M35]; KMUH Nephrology Research Fund from Kaohsiung Medical University Hospital	Mackay Memorial Hospital; Kaohsiung Medical University Hospital; KMUH Nephrology Research Fund from Kaohsiung Medical University Hospital	This work was supported by grants MMH-E-10007 and MMH10170 from Mackay Memorial Hospital and KMUH 99-9M35 and KMUH Nephrology Research Fund from Kaohsiung Medical University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbite NS, 2008, AM J MED GENET A, V146A, P1788, DOI 10.1002/ajmg.a.32346; Albright F, 1942, ENDOCRINOLOGY, V30, P922; Allgrove J, 2009, CLIN PEDIAT ENDOCRIN, P374; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2003, J CLIN ENDOCR METAB, V88, P4055, DOI 10.1210/jc.2003-031271; Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; Bastepe M, 2001, AM J HUM GENET, V68, P1283, DOI 10.1086/320117; Bastepe M, 2013, ENDOCR DEV, V24, P11, DOI 10.1159/000342494; Bertaux K, 2006, BONE, V38, P943, DOI 10.1016/j.bone.2005.11.025; Bringhurst FR., 2011, WILLIAMS TXB ENDOCRI, P1237, DOI [10.1016/B978-1-4377-0324-5.00028-6, DOI 10.1016/B978-1-4377-0324-5.00028-6]; Chen W, 2010, PEDIATR NEONATOL, V51, P69, DOI 10.1016/S1875-9572(10)60014-9; Chillambhi S, 2010, J CLIN ENDOCR METAB, V95, P3993, DOI 10.1210/jc.2009-2205; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; Craigen WJ, 1997, AM J MED GENET, V72, P63; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; D'Souza-Li L, 2001, HUM MUTAT, V18, P411, DOI 10.1002/humu.1212; de Sanctis L, 2004, J CLIN ENDOCR METAB, V89, P1650, DOI 10.1210/jc.2003-030850; de Sanctis L, 2003, PEDIATR RES, V53, P749, DOI 10.1203/01.PDR.0000059752.07086.A2; Elli FM, 2013, HUM MUTAT, V34, P411, DOI 10.1002/humu.22265; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; Fernandez-Rebollo E, 2013, J CLIN ENDOCR METAB, V98, pE996, DOI 10.1210/jc.2012-4164; Fernandez-Rebollo E, 2011, J BONE MINER RES, V26, P1854, DOI 10.1002/jbmr.408; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gelfand IM, 2006, J PEDIATR-US, V149, P877, DOI 10.1016/j.jpeds.2006.08.050; Germain-Lee EL, 2003, J CLIN ENDOCR METAB, V88, P4059, DOI 10.1210/jc.2003-030028; Germain-Lee EL, 2002, BIOCHEM BIOPH RES CO, V296, P67, DOI 10.1016/S0006-291X(02)00833-1; Greer FR, 2006, PEDIATRICS, V117, P578, DOI 10.1542/peds.2005-2822; Harries LW, 2004, DIABETES, V53, P500, DOI 10.2337/diabetes.53.2.500; Hwang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025492; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Ishikawa Y, 2001, J HUM GENET, V46, P426, DOI 10.1007/s100380170062; Jin HY, 2011, CLIN ENDOCRINOL, V75, P207, DOI 10.1111/j.1365-2265.2011.04026.x; KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081; Lam ACF, 2006, HK J PAEDIAT, V11, P284; Lee H, 2012, AM J HUM GENET, V90, P746, DOI 10.1016/j.ajhg.2012.03.004; LEVINE MA, 1983, AM J MED, V74, P545, DOI 10.1016/0002-9343(83)91008-2; LEVINE MA, 1988, P NATL ACAD SCI USA, V85, P617, DOI 10.1073/pnas.85.2.617; Lim SHM, 2002, J PEDIATR ENDOCR MET, V15, P259; Linglart A, 2005, AM J HUM GENET, V76, P804, DOI 10.1086/429932; Linglart A, 2002, J CLIN ENDOCR METAB, V87, P189, DOI 10.1210/jc.87.1.189; Linglart A, 2013, HORM RES PAEDIAT, V79, P119, DOI 10.1159/000348516; Linglart A, 2011, NEW ENGL J MED, V364, P2218, DOI 10.1056/NEJMoa1012717; Mantovani G, 2002, J CLIN ENDOCR METAB, V87, P4736, DOI 10.1210/jc.2002-020183; Mantovani G, 2000, J CLIN ENDOCR METAB, V85, P4243, DOI 10.1210/jc.85.11.4243; Mantovani G, 2011, J CLIN ENDOCR METAB, V96, P3020, DOI 10.1210/jc.2011-1048; Miao ZM, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/509549; Michot C, 2012, AM J HUM GENET, V90, P740, DOI 10.1016/j.ajhg.2012.03.003; Nakamura Y, 2000, J Epidemiol, V10, P29; Park CH, 2010, ANN CLIN LAB SCI, V40, P261; PHELAN MC, 1995, AM J MED GENET, V58, P1, DOI 10.1002/ajmg.1320580102; Richard N, 2012, J CLIN ENDOCR METAB, V97, pE863, DOI 10.1210/jc.2011-2804; Romano M, 2001, NUCLEIC ACIDS RES, V29, P886, DOI 10.1093/nar/29.4.886; STONE MD, 1993, BONE, V14, P727, DOI 10.1016/8756-3282(93)90204-N; Strachan T, 2011, HUMAN MOLECULAR GENETICS 4TH EDITION, P405; Sun LH, 2009, ENDOCRINE, V36, P25, DOI 10.1007/s12020-009-9193-z; Thiele S, 2011, HUM MUTAT, V32, P653, DOI 10.1002/humu.21489; Wu SJ, 2007, ASIA PAC J CLIN NUTR, V16, P518	57	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90640	10.1371/journal.pone.0090640	http://dx.doi.org/10.1371/journal.pone.0090640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651309	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800019
J	Yoshida, K; Nakashima, E; Kubo, Y; Yamaoka, M; Kajimura, J; Kyoizumi, S; Hayashi, T; Ohishi, W; Kusunoki, Y				Yoshida, Kengo; Nakashima, Eiji; Kubo, Yoshiko; Yamaoka, Mika; Kajimura, Junko; Kyoizumi, Seishi; Hayashi, Tomonori; Ohishi, Waka; Kusunoki, Yoichiro			Inverse Associations between Obesity Indicators and Thymic T-Cell Production Levels in Aging Atomic-Bomb Survivors	PLOS ONE			English	Article							AGE-RELATED-CHANGES; CALORIC RESTRICTION; LYMPHOCYTE POPULATIONS; GROWTH-HORMONE; HOMEOSTASIS; LEPTIN; DEFICIENCY; INCREASES; IMMUNITY; SUBSETS	Reduction of the naive T-cell population represents a deteriorating state in the immune system that occurs with advancing age. In animal model studies, obesity compromises the T-cell immune system as a result of enhanced adipogenesis in primary lymphoid organs and systemic inflammation. In this study, to test the hypothesis that obesity may contribute to the aging of human T-cell immunity, a thousand atomic-bomb survivors were examined for obesity status and ability to produce naive T cells, i.e., T-cell receptor excision circle (TREC) numbers in CD4 and CD8 T cells. The number of TRECs showed a strong positive correlation with naive T cell numbers, and lower TREC numbers were associated with higher age. We found that the TREC number was inversely associated with levels of obesity indicators (BMI, hemoglobin A1c) and serum CRP levels. Development of type-2 diabetes and fatty liver was also associated with lower TREC numbers. This population study suggests that obesity with enhanced inflammation is involved in aging of the human T-cell immune system. Given the fact that obesity increases the risk of numerous age-related diseases, attenuated immune competence is a possible mechanistic link between obesity and disease development among the elderly.	[Yoshida, Kengo; Kubo, Yoshiko; Yamaoka, Mika; Kajimura, Junko; Kyoizumi, Seishi; Hayashi, Tomonori; Kusunoki, Yoichiro] Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Hiroshima, Japan; [Nakashima, Eiji] Radiat Effects Res Fdn, Dept Stat, Hiroshima, Japan; [Ohishi, Waka] Radiat Effects Res Fdn, Dept Clin Studies, Hiroshima, Japan	Radiation Effects Research Foundation - Japan; Radiation Effects Research Foundation - Japan; Radiation Effects Research Foundation - Japan	Yoshida, K (corresponding author), Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Hiroshima, Japan.	kyoshi@rerf.or.jp			Japanese Ministry of Health, Labour and Welfare (MHLW); U.S. Department of Energy (DOE) [DE-HS0000031]; MHLW; U.S. National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200900059C]	Japanese Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); MHLW(Ministry of Health, Labour and Welfare, Japan); U.S. National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Radiation Effects Research Foundation (RERF, http://www.rerf.or.jp), Hiroshima and Nagasaki, Japan is a private, non-profit foundation funded by the Japanese Ministry of Health, Labour and Welfare (MHLW) and the U.S. Department of Energy (DOE), the latter in part through DOE Award DE-HS0000031 to the National Academy of Sciences. This study is based on RERF Research Protocols #4-02 and 3-09, and is supported by the MHLW (http://www.mhlw.go.jp) Grant-in-Aid and the U.S. National Institute of Allergy and Infectious Diseases (NIAID Contract HHSN272200900059C, http://www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views of the authors do not necessarily reflect those of the two governments.	Beebe GW, 1960, 1060 AT BOMB CAS COM; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Chen J, 2010, MECH AGEING DEV, V131, P29, DOI 10.1016/j.mad.2009.11.003; Chinn IK, 2012, SEMIN IMMUNOL, V24, P309, DOI 10.1016/j.smim.2012.04.005; Cullings HM, 2006, RADIAT RES, V166, P219, DOI 10.1667/RR3546.1; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Ferrando-Martinez S, 2013, AGE, V35, P251, DOI 10.1007/s11357-011-9341-2; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Haynes L, 2012, SEMIN IMMUNOL, V24, P350, DOI 10.1016/j.smim.2012.04.001; Herasimtschuk AA, 2013, CLIN EXP IMMUNOL, V173, P444, DOI 10.1111/cei.12141; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Hsu HC, 2010, CURR OPIN IMMUNOL, V22, P541, DOI 10.1016/j.coi.2010.05.002; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; Koetz K, 2000, P NATL ACAD SCI USA, V97, P9203, DOI 10.1073/pnas.97.16.9203; Kusunoki Y, 2008, INT J RADIAT BIOL, V84, P1, DOI 10.1080/09553000701616106; Kyoizumi S, 2010, INT J RADIAT BIOL, V86, P56, DOI 10.3109/09553000903272641; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103; Morrhaye G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005668; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Nikolich-Zugich J, 2012, SEMIN IMMUNOL, V24, P356, DOI 10.1016/j.smim.2012.04.009; Oysyannikova IG, 2014, VACCINE, V32, P881, DOI 10.1016/j.vaccine.2013.12.009; Palmer G, 2006, J IMMUNOL, V177, P2899, DOI 10.4049/jimmunol.177.5.2899; Prasad S, 2012, PREV MED, V54, pS29, DOI 10.1016/j.ypmed.2011.11.011; Priceman SJ, 2013, P NATL ACAD SCI USA, V110, P13079, DOI 10.1073/pnas.1311557110; Qiu Q, 2010, J IMMUNOL, V184, P1681, DOI 10.4049/jimmunol.0900062; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; Serana F, 2011, J CLIN IMMUNOL, V31, P540, DOI 10.1007/s10875-011-9526-6; Thewissen M, 2007, CLIN IMMUNOL, V123, P209, DOI 10.1016/j.clim.2007.01.005; Verschuren MCM, 1997, J IMMUNOL, V158, P1208; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yamaoka M, 2004, RADIAT RES, V161, P290, DOI 10.1667/RR3143; Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595; Yang HW, 2009, J IMMUNOL, V183, P3040, DOI 10.4049/jimmunol.0900562; Yasunaga J, 2001, BLOOD, V97, P3177, DOI 10.1182/blood.V97.10.3177; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	40	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91985	10.1371/journal.pone.0091985	http://dx.doi.org/10.1371/journal.pone.0091985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651652	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800062
J	Costa, ET; Barnabee, GF; Li, M; Dias, AAM; Machado, TR; Asprino, PF; Cavalher, FP; Ferreira, EN; Inda, MD; Nagai, MH; Malnic, B; Duarte, ML; Leite, KRM; de Barros, ACSD; Carraro, DM; Chammas, R; Armelin, HA; Cavenee, W; Furnari, F; Camargo, A				Costa, E. T.; Barnabe, G. F.; Li, M.; Dias, A. A. M.; Machado, T. R.; Asprino, P. F.; Cavalher, F. P.; Ferreira, E. N.; Inda, M. del Mar; Nagai, M. H.; Malnic, B.; Duarte, M. L.; Leite, K. R. M.; de Barros, A. C. S. D.; Carraro, D. M.; Chammas, R.; Armelin, H. A.; Cavenee, W.; Furnari, F.; Camargo, A. A.			Intratumoral heterogeneity of ADAM23 promotes tumor growth and metastasis through LGI4 and nitric oxide signals	ONCOGENE			English	Article							CELL-LINES; EVOLUTION; CANCER; METHYLATION; CARCINOMA; GENE; PROGRESSION; EXPRESSION; INTEGRIN; ADHESION	Intratumoral heterogeneity (ITH) represents an obstacle for cancer diagnosis and treatment, but little is known about its functional role in cancer progression. The A Desintegrin And Metalloproteinase 23 (ADAM23) gene is epigenetically silenced in different types of tumors, and silencing is often associated with advanced disease and metastasis. Here, we show that invasive breast tumors exhibit significant ADAM23-ITH and that this heterogeneity is critical for tumor growth and metastasis. We demonstrate that while loss of ADAM23 expression enhances invasion, it causes a severe proliferative deficiency and is not itself sufficient to trigger metastasis. Rather, we observed that, in ADAM23-heterotypic environments, ADAM23-negative cells promote tumor growth and metastasis by enhancing the proliferation and invasion of adjacent A23-positive cells through the production of LGI4 (Leucine-rich Glioma Inactivated 4) and nitric oxide (NO). Ablation of LGI4 and NO in A23-negative cells significantly attenuates A23-positive cell proliferation and invasion. Our work denotes a driving role of ADAM23-ITH during disease progression, shifting the malignant phenotype from the cellular to the tissue level. Our findings also provide insights for therapeutic intervention, enforcing the need to ascertain ITH to improve cancer diagnosis and therapy.	[Costa, E. T.; Barnabe, G. F.; Asprino, P. F.; Duarte, M. L.; Camargo, A. A.] Hosp Sirio Libanes, Ctr Mol Oncol, BR-01308060 Sao Paulo, Brazil; [Costa, E. T.; Barnabe, G. F.; Machado, T. R.; Asprino, P. F.; Cavalher, F. P.; Duarte, M. L.; Camargo, A. A.] LICR, Sao Paulo, Brazil; [Li, M.; Inda, M. del Mar; Cavenee, W.; Furnari, F.] Univ Calif San Diego, LICR, San Diego, CA 92103 USA; [Dias, A. A. M.] Univ Fed Minas Gerais, Dept Biol Geral ICB, Belo Horizonte, MG, Brazil; [Ferreira, E. N.; Carraro, D. M.] Hosp AC Camargo Fund Antonio Prudente, Ctr Internacl Pesquisa, Sao Paulo, Brazil; [Nagai, M. H.; Malnic, B.; Armelin, H. A.] Univ Sao Paulo, Dept Bioquim IQ, Sao Paulo, Brazil; [Leite, K. R. M.; Chammas, R.] Univ Sao Paulo, Fac Med, Dept Urol, Sao Paulo, Brazil; [de Barros, A. C. S. D.] Hosp Sirio Libanes, Dept Mastol, BR-01308060 Sao Paulo, Brazil; [Armelin, H. A.] Inst Butantan, Sao Paulo, Brazil	University of California System; University of California San Diego; Universidade Federal de Minas Gerais; A.C.Camargo Cancer Center; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan	Camargo, A (corresponding author), Hosp Sirio Libanes, Ctr Mol Oncol, LICR, Rua Cel Nicolau Dos Santos 69, BR-01308060 Sao Paulo, Brazil.	aacamargo@mochsl.org.br	Armelin, Hugo/P-4390-2015; LEITE, KATIA RM/C-2055-2008; Chammas, Roger/A-8004-2011; Barros, Alfredo/M-2525-2017; Malnic, Bettina/A-4905-2008; Ferreira, Elisa N/A-6485-2011; Asprino, Paula/AAB-5600-2021; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Lemos Duarte, Mariana/K-6233-2012; carraro, dirce/C-9179-2009; Dias, Adriana Abalen Martins/B-4974-2014; Camargo, Anamaria A/E-9388-2012	Armelin, Hugo/0000-0001-9557-0804; LEITE, KATIA RM/0000-0002-2615-7730; Chammas, Roger/0000-0003-0342-8726; Barros, Alfredo/0000-0003-2535-3040; Malnic, Bettina/0000-0002-5877-4784; Ferreira, Elisa N/0000-0001-7809-7349; Lemos Duarte, Mariana/0000-0002-1611-7102; carraro, dirce/0000-0001-5667-1418; Camargo, Anamaria A/0000-0002-6076-9597; Abalen Martins Dias, Adriana/0000-0001-9415-3240; Furnari, Frank/0000-0003-1909-4361; Li, Ming/0000-0002-2540-1738	FAPESP [06/60219-2, 07/51194-9, 07/52920-5, 11/50541-2]; LICR; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080939] Funding Source: NIH RePORTER	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); LICR; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Dr Andrew Simpson and Dr Raphael Parmigiani for critical reading of this manuscript and to Dr Rodrigo Perez, Dr Alicia Kowaltowski, Dr Beatriz Geronymo, Dr Camila Machado, Dr Vilma Martins, Dr Tiago dos Santos and Dr Anibal Vercesi for scientific discussions and technical assistance. This work was supported by grants from FAPESP (06/60219-2, 07/51194-9, 07/52920-5, 11/50541-2) and LICR.	Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Bermingham JR, 2006, NAT NEUROSCI, V9, P76, DOI 10.1038/nn1598; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cal S, 2000, MOL BIOL CELL, V11, P1457, DOI 10.1091/mbc.11.4.1457; Calmon MF, 2007, CANCER GENET CYTOGEN, V173, P31, DOI 10.1016/j.cancergencyto.2006.09.008; Choi JS, 2009, INT J CANCER, V124, P1258, DOI 10.1002/ijc.24023; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; Costa FF, 2005, NEUROSCI LETT, V380, P260, DOI 10.1016/j.neulet.2005.01.050; Costa FF, 2004, ONCOGENE, V23, P1481, DOI 10.1038/sj.onc.1207263; Cottu PH, 2008, ANN ONCOL, V19, P596, DOI 10.1093/annonc/mdn021; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Gauthier N, 2004, CARCINOGENESIS, V25, P1559, DOI 10.1093/carcin/bgh158; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hagihara A, 2004, ONCOGENE, V23, P8705, DOI 10.1038/sj.onc.1207783; Hu CY, 2011, INT J EXP PATHOL, V92, P333, DOI 10.1111/j.1365-2613.2011.00766.x; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jadeski LC, 2000, INT J CANCER, V86, P30, DOI 10.1002/(SICI)1097-0215(20000401)86:1<30::AID-IJC5>3.0.CO;2-I; Kim HA, 2012, BBA-MOL CELL BIOL L, V1821, P914, DOI 10.1016/j.bbalip.2012.02.010; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lampson BL, 2012, CANCER RES, V72, P4472, DOI 10.1158/0008-5472.CAN-12-0057; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Michor F, 2010, CANCER PREV RES, V3, P1361, DOI 10.1158/1940-6207.CAPR-10-0234; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nishino J, 2010, J NEUROSCI, V30, P15228, DOI 10.1523/JNEUROSCI.2286-10.2010; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Orucevic A, 1999, INT J CANCER, V81, P889, DOI 10.1002/(SICI)1097-0215(19990611)81:6<889::AID-IJC9>3.0.CO;2-2; Ozkaynak E, 2010, J NEUROSCI, V30, P3857, DOI 10.1523/JNEUROSCI.6287-09.2010; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRICE JE, 1990, CANCER RES, V50, P717; Sagane K, 2008, INT J BIOL SCI, V4, P387; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Sens-Abuazar C, 2012, TRANSL ONCOL, V5, P113, DOI 10.1593/tlo.11280; SUZUKI N, 1978, CANCER RES, V38, P3349; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Takada H, 2005, ONCOGENE, V24, P8051, DOI 10.1038/sj.onc.1208952; Takahashi T, 1998, CANCER RES, V58, P5835; Teixeira MR, 1996, CANCER RES, V56, P855; Verbisck NV, 2009, CANCER RES, V69, P5546, DOI 10.1158/0008-5472.CAN-08-2976; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854	49	12	12	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2015	34	10					1270	1279		10.1038/onc.2014.70	http://dx.doi.org/10.1038/onc.2014.70			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC9JX	24662834				2022-12-25	WOS:000350687100007
J	Wu, HZ; Zhang, K; Gong, PH; Qiao, FC; Wang, L; Cui, H; Sui, XY; Gao, JF; Fan, H				Wu, Huazhang; Zhang, Kun; Gong, Pihai; Qiao, Fengchang; Wang, Ling; Cui, He; Sui, Xinyuan; Gao, Jifan; Fan, Hong			A Novel Functional TagSNP Rs7560488 in the DNMT3A1 Promoter Is Associated with Susceptibility to Gastric Cancer by Modulating Promoter Activity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISM; ABERRANT DNA METHYLATION; GENE; MUTATIONS; RISK; LOCI; METHYLTRANSFERASES; EPIGENETICS; STRATEGIES	DNA-methyltransferase (DNMT)-3A which contains DNMT3A1 and DNMT3A2 isoforms have been suggested to play a crucial role in carcinogenesis and showed aberrant expression in most cancers. Accumulated evidences also indicated that single nucleotide polymorphisms (SNP) in DNMT genes were associated with susceptibility to different tumors. We hypothesized that genetic variants in DNMT3A1 promoter region are associated with gastric cancer risk. We selected the tagSNPs from the HapMap database for the Chinese and genotyped in a case-control study to evaluate the association with gastric cancer (GC) in a Chinese population. We identified that the functional tagSNP rs7560488 T>C associated with a significantly increased risk of GC. In vitro functional analysis by luciferase reporter assay and EMSA indicated that the tagSNP rs7560488 T>C substantially altered transcriptional activity of DNMT3A1 gene via influencing the binding of some transcriptional factors, although a definite transcriptional factor remains to be established. Compared with TT homozygotes, subjects who were TC heterozygotes and CC homozygotes exhibited a reduced expression of DNMT3A1. Furthermore, stratified analysis showed that individuals who harbor TC or CC genotypes less than 60 years old were more susceptible to GC. Our results suggest that the genetic variations in the DNMT3A1 promoter contribute to the susceptibility to GC and also provide an insight that tagSNP rs7560488 T>C may be a promising biomarker for predicting GC genetic susceptibility and a valuable information in GC pathogenesis.	[Wu, Huazhang; Gong, Pihai; Qiao, Fengchang; Wang, Ling; Cui, He; Sui, Xinyuan; Gao, Jifan; Fan, Hong] Southeast Univ, Sch Med, Dept Med Genet, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Wu, Huazhang; Gong, Pihai; Qiao, Fengchang; Wang, Ling; Cui, He; Sui, Xinyuan; Gao, Jifan; Fan, Hong] Southeast Univ, Sch Med, Dept Dev Biol, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Zhang, Kun] Harbin Med Univ, Harbin Med Univ Canc Hosp, Affiliated Hosp 3, Harbin, Peoples R China	Southeast University - China; Southeast University - China; Harbin Medical University	Fan, H (corresponding author), Southeast Univ, Sch Med, Dept Med Genet, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing, Jiangsu, Peoples R China.	fanh@seu.edu.cn		Wu, Huazhang/0000-0002-5482-3761	National Natural Science Foundation of China [81171915, 91229107]; Scientific Research and Innovation Plan for College Graduates of Jiangsu Province, China [CXZZ13_0082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research and Innovation Plan for College Graduates of Jiangsu Province, China	This work was supported by the National Natural Science Foundation of China (Grant No. 81171915 and No. 91229107) and the Scientific Research and Innovation Plan for College Graduates of Jiangsu Province, China (Grant No. CXZZ13_0082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aung PP, 2005, ONCOL REP, V14, P1151; Balassiano K, 2011, CANCER LETT, V311, P85, DOI 10.1016/j.canlet.2011.06.038; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chang BL, 2009, HUM MOL GENET, V18, P1368, DOI 10.1093/hmg/ddp035; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Chung CC, 2010, CARCINOGENESIS, V31, P111, DOI 10.1093/carcin/bgp273; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fan H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-12; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu JB, 2010, DIGEST DIS SCI, V55, P1011, DOI 10.1007/s10620-009-0831-3; Kanai Y, 1998, CANCER LETT, V122, P135, DOI 10.1016/S0304-3835(97)00380-7; Khatami F, 2009, ASIAN PAC J CANCER P, V10, P1177; Kim J, 2012, INT J CANCER, V130, P817, DOI 10.1002/ijc.26038; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kotini AG, 2011, MOL CELL BIOL, V31, P1577, DOI 10.1128/MCB.01093-10; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Menges M, 2009, J CANCER RES CLIN, V135, P29, DOI 10.1007/s00432-008-0425-z; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Saeki N, 2013, CANCER SCI, V104, P1, DOI 10.1111/cas.12042; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Stram Daniel O., 2005, Human Genomics, V2, P144; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wang XL, 2011, CURR HYPERTENS REP, V13, P442, DOI 10.1007/s11906-011-0230-y; Weisenberger DJ, 2002, GENE, V298, P91, DOI 10.1016/S0378-1119(02)00976-9; Wu QY, 2012, MOL BIOL REP, V39, P10949, DOI 10.1007/s11033-012-1996-y; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yang XX, 2012, INT J MOL SCI, V13, P8364, DOI 10.3390/ijms13078364; Zhao Z, 2012, ONCOL LETT, V3, P450, DOI 10.3892/ol.2011.488	41	18	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92911	10.1371/journal.pone.0092911	http://dx.doi.org/10.1371/journal.pone.0092911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667323	gold, Green Submitted, Green Published			2022-12-25	WOS:000333675600102
J	Busse, K; Strotmann, R; Strecker, K; Wegner, F; Devanathan, V; Gohla, A; Schoneberg, T; Schwarz, J				Busse, Kathy; Strotmann, Rainer; Strecker, Karl; Wegner, Florian; Devanathan, Vasudharani; Gohla, Antje; Schoeneberg, Torsten; Schwarz, Johannes			Adaptive Gene Regulation in the Striatum of RGS9-Deficient Mice	PLOS ONE			English	Article							LONG-TERM DEPRESSION; D-2 DOPAMINE-RECEPTORS; MEDIUM SPINY NEURONS; ADENYLYL-CYCLASE; AMPA RECEPTORS; ENDOCANNABINOID RELEASE; PARKINSONS-DISEASE; INDUCED DYSKINESIA; CA2+ CURRENTS; RAT	Background: RGS9-deficient mice show drug-induced dyskinesia but normal locomotor activity under unchallenged conditions. Results: Genes related to Ca2+ signaling and their functions were regulated in RGS9-deficient mice. Conclusion: Changes in Ca2+ signaling that compensate for RGS9 loss-of-function can explain the normal locomotor activity in RGS9-deficient mice under unchallenged conditions. Significance: Identified signaling components may represent novel targets in antidyskinetic therapy. The long splice variant of the regulator of G-protein signaling 9 (RGS9-2) is enriched in striatal medium spiny neurons and dampens dopamine D2 receptor signaling. Lack of RGS9-2 can promote while its overexpression prevents drug-induced dyskinesia. Other animal models of drug-induced dyskinesia rather pointed towards overactivity of dopamine receptor-mediated signaling. To evaluate changes in signaling pathways mRNA expression levels were determined and compared in wild-type and RGS9-deficient mice. Unexpectedly, expression levels of dopamine receptors were unchanged in RGS9-deficient mice, while several genes related to Ca2+ signaling and long-term depression were differentially expressed when compared to wild type animals. Detailed investigations at the protein level revealed hyperphosphorylation of DARPP32 at Thr34 and of ERK1/2 in striata of RGS9-deficient mice. Whole cell patch clamp recordings showed that spontaneous synaptic events are increased (frequency and size) in RGS9-deficient mice while long-term depression is reduced in acute brain slices. These changes are compatible with a Ca2+-induced potentiation of dopamine receptor signaling which may contribute to the drug-induced dyskinesia in RGS9-deficient mice.	[Busse, Kathy; Strecker, Karl; Wegner, Florian; Schwarz, Johannes] Univ Leipzig, Fac Med, Dept Neurol, D-04109 Leipzig, Germany; [Busse, Kathy; Strotmann, Rainer; Schoeneberg, Torsten] Univ Leipzig, Fac Med, Inst Biochem, D-04109 Leipzig, Germany; [Wegner, Florian; Schwarz, Johannes] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany; [Devanathan, Vasudharani] Univ Tubingen, Inst Pharmacol & Toxicol, Tubingen, Germany; [Gohla, Antje] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Schwarz, Johannes] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany	Leipzig University; Leipzig University; Leipzig University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Wurzburg; Technical University of Munich	Busse, K (corresponding author), Univ Leipzig, Fac Med, Dept Neurol, D-04109 Leipzig, Germany.	kathy.busse@medizin.uni-leipzig.de; schoberg@medizin.uni-leipzig.de		Gohla, Antje/0000-0002-7442-1487	Deutsche Forschungsgemeinschaft [Schw 704/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Schw 704/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000664; Alcacer C, 2012, J NEUROSCI, V32, P5900, DOI 10.1523/JNEUROSCI.0837-12.2012; ANTONINI A, 1994, NEUROLOGY, V44, P1325, DOI 10.1212/WNL.44.7.1325; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Blundell J, 2008, BRAIN RES, V1190, P78, DOI 10.1016/j.brainres.2007.11.017; Brunk I, 2008, FASEB J, V22, P3736, DOI 10.1096/fj.08-111245; Burchett SA, 2000, J NEUROCHEM, V75, P1335, DOI 10.1046/j.1471-4159.2000.0751335.x; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Camarillo C, 2011, METHODS MOL BIOL, V698, P419, DOI 10.1007/978-1-60761-999-4_30; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Darmopil S, 2009, BIOL PSYCHIAT, V66, P603, DOI 10.1016/j.biopsych.2009.04.025; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Fernandes AMAP, 2008, NEUROCHEM RES, V33, P1749, DOI 10.1007/s11064-008-9619-7; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; GREIF GJ, 1995, J NEUROSCI, V15, P4533; HALLETT M, 1993, CAN J NEUROL SCI, V20, P177, DOI 10.1017/S0317167100047909; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Holloway R, 2000, CLIN NEUROPHARMACOL, V23, P34; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kunert R, 2005, P NATL ACAD SCI USA, V102, P5826, DOI 10.1073/pnas.0501316102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundblad M, 2004, NEUROBIOL DIS, V16, P110, DOI 10.1016/j.nbd.2004.01.007; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Ogata H, 1998, BIOSYSTEMS, V47, P119, DOI 10.1016/S0303-2647(98)00017-3; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; OUIMET CC, 1984, J NEUROSCI, V4, P111; Perreault ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033348; Perreault ML, 2010, J BIOL CHEM, V285, P36625, DOI 10.1074/jbc.M110.159954; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rascol O, 2001, CLIN NEUROPHARMACOL, V24, P313, DOI 10.1097/00002826-200111000-00002; Rogojina A, 2003, MOL VIS, V9, P482; Rozen S, 2000, Methods Mol Biol, V132, P365; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Santini E, 2007, J NEUROSCI, V27, P6995, DOI 10.1523/JNEUROSCI.0852-07.2007; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; Schliebe N, 2008, AM J PHYSIOL-RENAL, V295, pF1177, DOI 10.1152/ajprenal.00465.2007; Seeman P, 2007, SYNAPSE, V61, P303, DOI 10.1002/syn.20368; Seeman P, 2006, SYNAPSE, V60, P319, DOI 10.1002/syn.20303; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Stefani A, 1998, DEV NEUROSCI-BASEL, V20, P242, DOI 10.1159/000017318; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung KW, 2001, J NEUROPHYSIOL, V86, P2405, DOI 10.1152/jn.2001.86.5.2405; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; Thomas EA, 1998, J NEUROSCI RES, V52, P118, DOI 10.1002/(SICI)1097-4547(19980401)52:1<118::AID-JNR11>3.0.CO;2-6; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Toyoda H, 2007, J CELL PHYSIOL, V211, P336, DOI 10.1002/jcp.20940; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vonk A, 2008, J PHARMACOL SCI, V108, P63, DOI 10.1254/jphs.08019FP; Waszczak BL, 1998, P NATL ACAD SCI USA, V95, P11440, DOI 10.1073/pnas.95.19.11440; Westin JE, 2007, BIOL PSYCHIAT, V62, P800, DOI 10.1016/j.biopsych.2006.11.032; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Xie KQ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002922; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003	67	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92605	10.1371/journal.pone.0092605	http://dx.doi.org/10.1371/journal.pone.0092605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663062	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900083
J	Chu, LL; Xu, Y; Yang, JR; Hu, YA; Chang, HH; Lai, HY; Tseng, CC; Wang, HY; Johnson, MD; Wang, JK; Lin, CY				Chu, Li-Ling; Xu, Yuan; Yang, Jie-Ru; Hu, Yi-An; Chang, Hsiang-Hua; Lai, Hong-Yu; Tseng, Chun-Che; Wang, Hue-Yu; Johnson, Michael D.; Wang, Jehng-Kang; Lin, Chen-Yong			Human Cancer Cells Retain Modest Levels of Enzymatically Active Matriptase Only in Extracellular Milieu following Induction of Zymogen Activation	PLOS ONE			English	Article							TRANSMEMBRANE SERINE-PROTEASE; IN-VITRO; OVARIAN-CANCER; INHIBITION; PROSTATE; GROWTH; EXPRESSION; BIOMARKER; SURFACE; HAI-1	The type 2 transmembrane serine protease matriptase is broadly expressed in human carcinomas and hematological cancers. The proteolytic activity of matriptase is a potential target of drugs and imaging probes. We assessed the fate of active matriptase following the induction of matriptase zymogen activation. Exposing eight human carcinoma cells to pH 6.0 buffer induced robust matriptase zymogen activation followed by rapid inhibition of the nascent active matriptase by hepatocyte growth factor activator inhibitor (HAI)-1. Consequently, no enzymatically active matriptase was detected in these cells. Some active matriptase is, however, rapidly shed to the extracellular milieu by these carcinoma cells. The lack of cell-associated active matriptase and the shedding of active matriptase were also observed in two hematological cancer lines. Matriptase shedding is correlated closely with the induction of matriptase activation, suggesting that matriptase activation and shedding are kinetically coupled. The coupling allows a proportion of active matriptase to survive HAI-1 inhibition by rapid shedding from cell surface. Our study suggests that cellular free, active matriptase is scarce and might not be an effective target for in vivo imaging and drug development.	[Chu, Li-Ling; Wang, Hue-Yu] Chi Mei Med Ctr, Dept Pharm, Tainan, Taiwan; [Xu, Yuan; Chang, Hsiang-Hua; Lai, Hong-Yu; Tseng, Chun-Che; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Yang, Jie-Ru; Hu, Yi-An; Chang, Hsiang-Hua] Natl Def Med Ctr, Dept Med, Taipei 10764, Taiwan; [Tseng, Chun-Che] Carleton Coll, Dept Biol, Northfield, MN 55057 USA; [Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan	Chi Mei Hospital; Georgetown University; National Defense Medical Center; Carleton College; National Defense Medical Center	Wang, JK (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan.	jkwang@ndmctsgh.edu.tw; lincy@georgetown.edu		johnson, Michael/0000-0001-6260-7586; Tseng, Chun-che/0000-0001-9637-4127	National Cancer Institute (NCI) [RO1 CA 123223]; Taiwan Department of Defense [MAB-102-08]; Chi-Mei Medical Center [CMNDMC-10211]; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA123223] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Taiwan Department of Defense; Chi-Mei Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by National Cancer Institute (NCI) Grants RO1 CA 123223 (to M. Johnson and C.-Y. Lin); Taiwan Department of Defense Grant MAB-102-08 (to J.-K. Wang); and Chi-Mei Medical Center grant CMNDMC-10211 (to J.-K. Wang and L.-L. Chu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Bugge TH, 2007, FRONT BIOSCI-LANDMRK, V12, P5060, DOI 10.2741/2448; Cary KC, 2013, THER ADV UROL, V5, P318, DOI 10.1177/1756287213495915; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062826; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Cheng MF, 2007, EUR J DERMATOL, V17, P375; Cheng TS, 2013, CANCER PREV RES, V6, P495, DOI 10.1158/1940-6207.CAPR-12-0293-T; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Chou FP, 2013, AM J PATHOL, V183, P1306, DOI 10.1016/j.ajpath.2013.06.024; Darragh MR, 2010, CANCER RES, V70, P1505, DOI 10.1158/0008-5472.CAN-09-1640; Deng DW, 2013, BIOSENS BIOELECTRON, V49, P216, DOI 10.1016/j.bios.2013.05.018; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Enyedy IJ, 2001, J MED CHEM, V44, P1349, DOI 10.1021/jm000395x; Fang JD, 2011, J BIOL CHEM, V286, P5667, DOI 10.1074/jbc.M110.153866; Farady CJ, 2007, J MOL BIOL, V369, P1041, DOI 10.1016/j.jmb.2007.03.078; Fonovic M, 2007, CURR PHARM DESIGN, V13, P253, DOI 10.2174/138161207779313623; Forbs D, 2005, INT J ONCOL, V27, P1061; Galkin AV, 2004, PROSTATE, V61, P228, DOI 10.1002/pros.20094; Gao L, 2013, LEUKEMIA, V27, P1191, DOI 10.1038/leu.2012.289; Godiksen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077146; Hung RJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1159, DOI 10.1152/ajpcell.00400.2003; Ihara S, 2002, J BIOL CHEM, V277, P16960, DOI 10.1074/jbc.M200673200; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; LeBeau AM, 2013, P NATL ACAD SCI USA, V110, P93, DOI 10.1073/pnas.1218694110; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; Marverti G, 2008, J INORG BIOCHEM, V102, P699, DOI 10.1016/j.jinorgbio.2007.10.015; Milner JM, 2010, ARTHRITIS RHEUM-US, V62, P1955, DOI 10.1002/art.27476; Nimishakavi S, 2012, AM J PHYSIOL-LUNG C, V303, pL97, DOI 10.1152/ajplung.00303.2011; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Oberst MD, 2002, CLIN CANCER RES, V8, P1101; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Steinmetzer T, 2006, J MED CHEM, V49, P4116, DOI 10.1021/jm051272l; Tseng IC, 2008, AM J PHYSIOL-CELL PH, V295, pC423, DOI 10.1152/ajpcell.00164.2008; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Welman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034182; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; Xu ZH, 2011, J MED CHEM, V54, P7567, DOI 10.1021/jm200920s	49	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92244	10.1371/journal.pone.0092244	http://dx.doi.org/10.1371/journal.pone.0092244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663123	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900046
J	Yu, Y; Lee, JS; Xie, N; Li, E; Hurtado-Coll, A; Fazli, L; Cox, M; Plymate, S; Gleave, M; Dong, XS				Yu, Yue; Lee, Jennifer Suehyun; Xie, Ning; Li, Estelle; Hurtado-Coll, Antonio; Fazli, Ladan; Cox, Michael; Plymate, Stephen; Gleave, Martin; Dong, Xuesen			Prostate Stromal Cells Express the Progesterone Receptor to Control Cancer Cell Mobility	PLOS ONE			English	Article							LIGAND-INDEPENDENT ACTIVATION; ANDROGEN RECEPTOR; MALIGNANT-TRANSFORMATION; SIGNALING PATHWAY; IN-VIVO; INTERLEUKIN-6; GROWTH; CXCR4; CXCL12; MICROENVIRONMENT	Background: Reciprocal interactions between epithelium and stroma play vital roles for prostate cancer development and progression. Enhanced secretions of cytokines and growth factors by cancer associated fibroblasts in prostate tumors create a favorable microenvironment for cancer cells to grow and metastasize. Our previous work showed that the progesterone receptor (PR) was expressed specifically in prostate stromal fibroblasts and smooth muscle cells. However, the expression levels of PR and its impact to tumor microenvironment in prostate tumors are poorly understood. Methods: Immunohistochemistry assays are applied to human prostate tissue biopsies. Cell migration, invasion and proliferation assays are performed using human prostate cells. Real-time PCR and ELISA are applied to measure gene expression at molecular levels. Results: Immunohistochemistry assays showed that PR protein levels were decreased in cancer associated stroma when compared with paired normal prostate stroma. Using in vitro prostate stromal cell models, we showed that conditioned media collected from PR positive stromal cells inhibited prostate cancer cell migration and invasion, but had minor suppressive impacts on cancer cell proliferation. PR suppressed the secretion of stromal derived factor-1 (SDF-1) and interlukin-6 (IL-6) by stromal cells independent to PR ligands. Blocking PR expression by siRNA or supplementation of exogenous SDF-1 or IL-6 to conditioned media from PR positive stromal cells counteracted the inhibitory effects of PR to cancer cell migration and invasion. Conclusions: Decreased expression of the PR in cancer associated stroma may contribute to the elevated SDF-1 and IL-6 levels in prostate tumors and enhance prostate tumor progression.	[Yu, Yue; Lee, Jennifer Suehyun; Xie, Ning; Li, Estelle; Hurtado-Coll, Antonio; Fazli, Ladan; Cox, Michael; Gleave, Martin; Dong, Xuesen] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Plymate, Stephen] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Plymate, Stephen] VAPSHCS GRECC, Seattle, WA USA; [Dong, Xuesen] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of British Columbia; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; University of Toronto	Dong, XS (corresponding author), Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada.	xdong@prostatecentre.com	Dong, Xuesen/AGF-9228-2022	Gleave, Martin/0000-0003-4235-0167	Canadian Institutes of Health Research [MOP- 97934]; Prostate Cancer Canada; PNW Prostate Cancer SPORE pilot grant; NATIONAL CANCER INSTITUTE [P50CA097186] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Prostate Cancer Canada; PNW Prostate Cancer SPORE pilot grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Canadian Institutes of Health Research Operating Grant (MOP- 97934), Rising Star Award and Discovery Grant from Prostate Cancer Canada to XSD and PNW Prostate Cancer SPORE pilot grant to XSD and MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Arnett-Mansfield RL, 2004, J CLIN ENDOCR METAB, V89, P1429, DOI 10.1210/jc.2003-031111; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Daniel AR, 2009, P NATL ACAD SCI USA, V106, P14287, DOI 10.1073/pnas.0905118106; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Domanska UM, 2012, NEOPLASIA, V14, P709, DOI 10.1593/neo.12324; Domingo-Domenech J, 2006, CLIN CANCER RES, V12, P5578, DOI 10.1158/1078-0432.CCR-05-2767; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Dong XS, 2009, MOL ENDOCRINOL, V23, P1147, DOI 10.1210/me.2008-0357; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Gabal Samia M, 2007, J Egypt Natl Canc Inst, V19, P239; Gao LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063563; George DJ, 2005, CLIN CANCER RES, V11, P1815, DOI 10.1158/1078-0432.CCR-04-1560; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hardy DB, 2008, MOL ENDOCRINOL, V22, P1812, DOI 10.1210/me.2007-0443; Hartmann TN, 2005, ONCOGENE, V24, P4462, DOI 10.1038/sj.onc.1208621; Hayward SW, 2001, CANCER RES, V61, P8135; Henshall SM, 2001, CANCER RES, V61, P423; Hobisch A, 1998, CANCER RES, V58, P4640; Jacobsen BM, 2002, J BIOL CHEM, V277, P27793, DOI 10.1074/jbc.M202584200; Karlou M, 2010, NAT REV UROL, V7, P494, DOI 10.1038/nrurol.2010.134; Kasina S, 2012, MOL CELL ENDOCRINOL, V351, P249, DOI 10.1016/j.mce.2011.12.015; Kryczek I, 2005, CANCER RES, V65, P465; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/en.139.11.4708; Lai KP, 2012, EMBO MOL MED, V4, P791, DOI 10.1002/emmm.201101140; Lee SO, 2003, CLIN CANCER RES, V9, P370; Lee SO, 2004, PROSTATE, V60, P178, DOI 10.1002/pros.20045; Li YR, 2008, J CELL MOL MED, V12, P2790, DOI 10.1111/j.1582-4934.2008.00279.x; Lim CS, 1999, MOL ENDOCRINOL, V13, P366, DOI 10.1210/me.13.3.366; Liu LL, 2013, ONCOGENE; McPherson SJ, 2010, P NATL ACAD SCI USA, V107, P3123, DOI 10.1073/pnas.0905524107; Olapade-Alaopa EO, 1999, CLIN CANCER RES, V5, P569; Ricke WA, 2006, INT J CANCER, V118, P2123, DOI 10.1002/ijc.21614; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Sun YX, 2003, J CELL BIOCHEM, V89, P462, DOI 10.1002/jcb.10522; Sung ML, 2009, CIRC RES, V105, P755, DOI 10.1161/CIRCRESAHA.109.206524; Taichman RS, 2002, CANCER RES, V62, P1832; Tanner MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016027; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Wang JH, 2005, CELL SIGNAL, V17, P1578, DOI 10.1016/j.cellsig.2005.03.022; Wang YZ, 2001, CANCER RES, V61, P6064; Wedel SA, 2008, MOL MED REP, V1, P257; Xie N, 2012, MOL ENDOCRINOL, V26, P1370, DOI 10.1210/me.2012-1088; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; Yu Y, 2013, J CLIN ENDOCRINOL ME	49	31	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92714	10.1371/journal.pone.0092714	http://dx.doi.org/10.1371/journal.pone.0092714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664419	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900100
J	Liew, YJ; Aranda, M; Carr, A; Baumgarten, S; Zoccola, D; Tambutte, S; Allemand, D; Micklem, G; Voolstra, CR				Liew, Yi Jin; Aranda, Manuel; Carr, Adrian; Baumgarten, Sebastian; Zoccola, Didier; Tambutte, Sylvie; Allemand, Denis; Micklem, Gos; Voolstra, Christian R.			Identification of MicroRNAs in the Coral Stylophora pistillata	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENE-EXPRESSION; CLIMATE-CHANGE; SMALL RNAS; PROTEIN; EVOLUTION; RESPONSES; STRESS; INTERPROSCAN; INSIGHTS	Coral reefs are major contributors to marine biodiversity. However, they are in rapid decline due to global environmental changes such as rising sea surface temperatures, ocean acidification, and pollution. Genomic and transcriptomic analyses have broadened our understanding of coral biology, but a study of the microRNA (miRNA) repertoire of corals is missing. miRNAs constitute a class of small non-coding RNAs of similar to 22 nt in size that play crucial roles in development, metabolism, and stress response in plants and animals alike. In this study, we examined the coral Stylophora pistillata for the presence of miRNAs and the corresponding core protein machinery required for their processing and function. Based on small RNA sequencing, we present evidence for 31 bona fide microRNAs, 5 of which (miR-100, miR-2022, miR-2023, miR-2030, and miR-2036) are conserved in other metazoans. Homologues of Argonaute, Piwi, Dicer, Drosha, Pasha, and HEN1 were identified in the transcriptome of S. pistillata based on strong sequence conservation with known RNAi proteins, with additional support derived from phylogenetic trees. Examination of putative miRNA gene targets indicates potential roles in development, metabolism, immunity, and biomineralisation for several of the microRNAs. Here, we present first evidence of a functional RNAi machinery and five conserved miRNAs in S. pistillata, implying that miRNAs play a role in organismal biology of scleractinian corals. Analysis of predicted miRNA target genes in S. pistillata suggests potential roles of miRNAs in symbiosis and coral calcification. Given the importance of miRNAs in regulating gene expression in other metazoans, further expression analyses of small non-coding RNAs in transcriptional studies of corals should be informative about miRNA-affected processes and pathways.	[Liew, Yi Jin; Aranda, Manuel; Baumgarten, Sebastian; Voolstra, Christian R.] KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Liew, Yi Jin; Carr, Adrian; Micklem, Gos] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Liew, Yi Jin; Carr, Adrian; Micklem, Gos] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Zoccola, Didier; Tambutte, Sylvie; Allemand, Denis] Ctr Sci Monaco, Monaco, Monaco	King Abdullah University of Science & Technology; University of Cambridge; University of Cambridge	Micklem, G (corresponding author), Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England.	g.micklem@gen.cam.ac.uk; christian.voolstra@kaust.edu.sa	Aranda Lastra, Manuel/D-9530-2011; Voolstra, Christian R/H-7158-2014; Liew, Yi Jin/AAI-6307-2021; Zoccola, Didier/A-5997-2009	Aranda Lastra, Manuel/0000-0001-6673-016X; Voolstra, Christian R/0000-0003-4555-3795; Liew, Yi Jin/0000-0003-2553-8870; Zoccola, Didier/0000-0002-1524-8098; Micklem, Gos/0000-0002-6883-6168; Baumgarten, Sebastian/0000-0003-2646-7699	Cambridge Commonwealth Trust; Trinity Hall; Academic Excellence Alliance (AEA) Award [1000000533]	Cambridge Commonwealth Trust; Trinity Hall; Academic Excellence Alliance (AEA) Award	This project was partially funded by bursaries from Cambridge Commonwealth Trust and Trinity Hall to YJL, and an Academic Excellence Alliance (AEA) Award (Award Number 1000000533) to CRV and GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Aranda M, 2011, MOL ECOL, V20, P2955, DOI 10.1111/j.1365-294X.2011.05153.x; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Babenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029441; BAK RPM, 1987, MAR POLLUT BULL, V18, P534, DOI 10.1016/0025-326X(87)90537-6; Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691; Baumgarten S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-704; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Brown CT, 2012, ARXIV12034802; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Campo-Paysaa F, 2011, EVOL DEV, V13, P15, DOI 10.1111/j.1525-142X.2010.00452.x; Cao H, 2010, J DENT RES, V89, P779, DOI 10.1177/0022034510369304; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen CZ, 2013, IMMUNOL REV, V253, P112, DOI 10.1111/imr.12060; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chen Y, 2013, BIOCHEM BIOPH RES CO, V438, P133, DOI 10.1016/j.bbrc.2013.07.040; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2012, CORAL REEFS, V31, P215, DOI 10.1007/s00338-011-0833-4; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fromm B, 2013, MOL BIOL EVOL, V30, P2619, DOI 10.1093/molbev/mst155; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Horie T, 2009, BIOCHEM BIOPH RES CO, V389, P315, DOI 10.1016/j.bbrc.2009.08.136; Huang Y, 2009, NATURE, V461, P823, DOI 10.1038/nature08433; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jiao Y, 2014, MAR BIOTECHNOL, V16, P54, DOI 10.1007/s10126-013-9528-x; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li BH, 2011, EUR J CANCER, V47, P2166, DOI 10.1016/j.ejca.2011.04.037; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Maniar JM, 2011, CURR BIOL, V21, P449, DOI 10.1016/j.cub.2011.02.019; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Michalak P, 2008, GENOMICS, V91, P158, DOI 10.1016/j.ygeno.2007.10.013; Moran Y, 2013, MOL BIOL EVOL; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Moya A, 2008, MAR BIOTECHNOL, V10, P653, DOI 10.1007/s10126-008-9101-1; Mukherjee K, 2013, MOL BIOL EVOL, V30, P627, DOI 10.1093/molbev/mss263; Mulder Nicola, 2007, V396, P59; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; PASTOROK RA, 1985, MAR ECOL PROG SER, V21, P175, DOI 10.3354/meps021175; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Philippe L, 2012, J IMMUNOL, V188, P454, DOI 10.4049/jimmunol.1102348; Polato NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011221; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song XW, 2012, PLANT J, V71, P378, DOI 10.1111/j.1365-313X.2012.05001.x; Sun H, 2010, MOL BIOL REP, V37, P2951, DOI 10.1007/s11033-009-9861-3; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarver JE, 2012, BIOESSAYS, V34, P857, DOI 10.1002/bies.201200055; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; Vidal-Dupiol J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058652; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; Wang K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.233; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng Y, 2012, FEBS LETT, V586, P2375, DOI 10.1016/j.febslet.2012.05.049; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng YS, 2012, ONCOGENE, V31, P80, DOI 10.1038/onc.2011.208; Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004	102	36	39	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91101	10.1371/journal.pone.0091101	http://dx.doi.org/10.1371/journal.pone.0091101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658574	gold, Green Published			2022-12-25	WOS:000333355300024
J	Moloney, TM; Witney, AG				Moloney, Tonya M.; Witney, Alice G.			Pressure Pain Thresholds Increase after Preconditioning 1 Hz Repetitive Transcranial Magnetic Stimulation with Transcranial Direct Current Stimulation	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; NEUROPATHIC PAIN; HOMEOSTATIC METAPLASTICITY; INTRACORTICAL INHIBITION; ELECTRICAL-STIMULATION; WRITERS CRAMP; FIBROMYALGIA; TDCS; EXCITABILITY; MODULATION	Background: The primary motor cortex (M1) is an effective target of non-invasive cortical stimulation (NICS) for pain threshold modulation. It has been suggested that the initial level of cortical excitability of M1 plays a key role in the plastic effects of NICS. Objective: Here we investigate whether transcranial direct current stimulation (tDCS) primed 1 Hz repetitive transcranial magnetic stimulation (rTMS) modulates experimental pressure pain thresholds and if this is related to observed alterations in cortical excitability. Method: 15 healthy, male participants received 10 min 1 mA anodal, cathodal and sham tDCS to the left M1 before 15 min 1 Hz rTMS in separate sessions over a period of 3 weeks. Motor cortical excitability was recorded at baseline, post-tDCS priming and post-rTMS through recording motor evoked potentials (MEPs) from right FDI muscle. Pressure pain thresholds were determined by quantitative sensory testing (QST) through a computerized algometer, on the palmar thenar of the right hand pre- and post-stimulation. Results: Cathodal tDCS-primed 1 Hz-rTMS was found to reverse the expected suppressive effect of 1 Hz rTMS on cortical excitability; leading to an overall increase in activity (p < 0.001) with a parallel increase in pressure pain thresholds (p < 0.01). In contrast, anodal tDCS-primed 1 Hz-rTMS resulted in a corresponding decrease in cortical excitability (p < 0.05), with no significant effect on pressure pain. Conclusion: This study demonstrates that priming the M1 before stimulation of 1 Hz-rTMS modulates experimental pressure pain thresholds in a safe and controlled manner, producing a form of analgesia.	[Moloney, Tonya M.] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dept Physiol, Dublin, Ireland; Trinity Coll Dublin, Trinity Ctr BioEngn, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Moloney, TM (corresponding author), Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dept Physiol, Dublin, Ireland.	molonet@tcd.ie	Witney, Alice G./AAH-3107-2021	Witney, Alice G./0000-0002-3726-8479	Department of Physiology, Trinity College, Dublin	Department of Physiology, Trinity College, Dublin	This study was supported by the Department of Physiology, Trinity College, Dublin [http://www.tcd.ie/Graduate_Studies/prospectivestudents/awards/studentships/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2008, CEREB CORTEX, V18, P2701, DOI 10.1093/cercor/bhn032; Antal A, 2010, J PAIN SYMPTOM MANAG, V39, P890, DOI 10.1016/j.jpainsymman.2009.09.023; Bachmann CG, 2010, CLIN NEUROPHYSIOL, V121, P2083, DOI 10.1016/j.clinph.2010.05.005; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Borckardt JJ, 2011, CLIN J PAIN, V27, P486, DOI 10.1097/AJP.0b013e31820d2733; Borckardt JJ, 2006, J ECT, V22, P259, DOI 10.1097/01.yct.0000244248.40662.9a; Carli G, 2002, PAIN, V100, P259, DOI 10.1016/S0304-3959(02)00297-X; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Cosentino G, 2012, EUR J NEUROSCI, V35, P119, DOI 10.1111/j.1460-9568.2011.07939.x; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P525, DOI 10.1007/s002210050649; FISCHER AA, 1987, PAIN, V30, P115, DOI 10.1016/0304-3959(87)90089-3; Fregni F, 2007, LANCET NEUROL, V6, P188, DOI 10.1016/S1474-4422(07)70032-7; Garcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1; Garcia-Larrea L, 2007, NEUROIMAGE, V37, pS71, DOI 10.1016/j.neuroimage.2007.05.062; Harstall C, 2003, PAIN CLIN UPDATES, V11, P1, DOI DOI 10.1016/S1070-7212(03)00004-6; Harte SE, 2013, MED BIOL ENG COMPUT, P1, DOI DOI 10.1002/MMA.2899; Lang N, 2004, BIOL PSYCHIAT, V56, P634, DOI 10.1016/j.biopsych.2004.07.017; Lefaucheur JP, 2006, NEUROLOGY, V67, P1568, DOI 10.1212/01.wnl.0000242731.10074.3c; Lucas JM, 2011, PAIN, V152, P1398, DOI 10.1016/j.pain.2011.02.025; Marlow NM, 2013, PAIN PRACT, V13, P131, DOI 10.1111/j.1533-2500.2012.00562.x; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Moloney TM, 2013, NEUROSCI LETT, V534, P289, DOI 10.1016/j.neulet.2012.11.049; Mylius V, 2012, PAIN, V153, P1350, DOI 10.1016/j.pain.2012.04.009; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; O'Connell NE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008208.pub2; Peyron R, 2007, NEUROIMAGE, V34, P310, DOI 10.1016/j.neuroimage.2006.08.037; Pleger B, 2004, NEUROSCI LETT, V356, P87, DOI 10.1016/j.neulet.2003.11.037; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Ruohonen J, 2012, CLIN NEUROPHYSIOL, V123, P2006, DOI 10.1016/j.clinph.2012.02.082; Schepers RJ, 2010, NEUROSCI BIOBEHAV R, V34, P177, DOI 10.1016/j.neubiorev.2009.10.003; Siebner HR, 1999, NEUROSCI LETT, V262, P133, DOI 10.1016/S0304-3940(99)00056-7; Siebner HR, 1999, NEUROLOGY, V52, P529, DOI 10.1212/WNL.52.3.529; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Summers J, 2004, NEUROSCI LETT, V368, P197, DOI 10.1016/j.neulet.2004.07.008; Tamura Y, 2004, PAIN, V107, P107, DOI 10.1016/j.pain.2003.10.011; Treede RD, 2002, PAIN, V98, P235, DOI 10.1016/S0304-3959(02)00203-8; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Valle Angela, 2009, J Pain Manag, V2, P353; Villamar MF, 2013, J PAIN, V14, P371, DOI 10.1016/j.jpain.2012.12.007; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zaghi Soroush, 2009, J Pain Manag, V2, P339; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	45	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92540	10.1371/journal.pone.0092540	http://dx.doi.org/10.1371/journal.pone.0092540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658333	gold, Green Submitted, Green Published			2022-12-25	WOS:000333355300096
J	Sergeant, MJ; Constantinidou, C; Cogan, TA; Bedford, MR; Penn, CW; Pallen, MJ				Sergeant, Martin J.; Constantinidou, Chrystala; Cogan, Tristan A.; Bedford, Michael R.; Penn, Charles W.; Pallen, Mark J.			Extensive Microbial and Functional Diversity within the Chicken Cecal Microbiome	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; GASTROINTESTINAL-TRACT; GUT MICROFLORA; DIETARY FIBER; AVIAN CECUM; BACTERIAL; METABOLISM; ACID; SUPPLEMENTATION; PURIFICATION	Chickens are major source of food and protein worldwide. Feed conversion and the health of chickens relies on the largely unexplored complex microbial community that inhabits the chicken gut, including the ceca. We have carried out deep microbial community profiling of the microbiota in twenty cecal samples via 16S rRNA gene sequences and an in-depth metagenomics analysis of a single cecal microbiota. We recovered 699 phylotypes, over half of which appear to represent previously unknown species. We obtained 648,251 environmental gene tags (EGTs), the majority of which represent new species. These were binned into over two-dozen draft genomes, which included Campylobacter jejuni and Helicobacter pullorum. We found numerous polysaccharide- and oligosaccharide-degrading enzymes encoding within the metagenome, some of which appeared to be part of polysaccharide utilization systems with genetic evidence for the co-ordination of polysaccharide degradation with sugar transport and utilization. The cecal metagenome encodes several fermentation pathways leading to the production of short-chain fatty acids, including some with novel features. We found a dozen uptake hydrogenases encoded in the metagenome and speculate that these provide major hydrogen sinks within this microbial community and might explain the high abundance of several genera within this microbiome, including Campylobacter, Helicobacter and Megamonas.	[Sergeant, Martin J.; Constantinidou, Chrystala; Pallen, Mark J.] Univ Warwick, Warwick Med Sch, Div Microbiol & Infect, Coventry CV4 7AL, W Midlands, England; [Cogan, Tristan A.] Sch Clin Vet Sci, Bristol, Avon, England; [Bedford, Michael R.] AB Vista Feed Ingredients, Marlborough, MA USA; [Penn, Charles W.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England	University of Warwick; University of Bristol; University of Birmingham	Pallen, MJ (corresponding author), Univ Warwick, Warwick Med Sch, Div Microbiol & Infect, Coventry CV4 7AL, W Midlands, England.	m.pallen@warwick.ac.uk	Bedford, Michael/AAV-8204-2020	Bedford, Michael/0000-0002-5308-4290; Sergeant, Martin/0000-0001-7264-2668; Pallen, Mark/0000-0003-1807-3657	BBSRC; Biotechnology and Biological Sciences Research Council [BB/H019340/2, BB/H019340/1] Funding Source: researchfish; BBSRC [BB/H019340/2, BB/H019340/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Amit-Romach E, 2004, POULTRY SCI, V83, P1093, DOI 10.1093/ps/83.7.1093; Apajalahti J, 2005, J APPL POULTRY RES, V14, P444, DOI 10.1093/japr/14.2.444; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bott M, 1997, EUR J BIOCHEM, V250, P590, DOI 10.1111/j.1432-1033.1997.0590a.x; Burt DW, 2007, POULTRY SCI, V86, P1460, DOI 10.1093/ps/86.7.1460; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CLENCH MH, 1995, WILSON BULL, V107, P93; Clokie Martha Rj, 2011, Bacteriophage, V1, P31, DOI 10.4161/bact.1.1.14942; COLBY GD, 1992, APPL ENVIRON MICROB, V58, P3297, DOI 10.1128/AEM.58.10.3297-3302.1992; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Darwin Ch., 1868, P411; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Eastwood M, 1995, DIETARY FIBRE MECH A; Eddy SR, 1998, FASEB J, V12, pA1327; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Eeckhaut V, 2011, MICROB BIOTECHNOL, V4, P503, DOI 10.1111/j.1751-7915.2010.00244.x; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10; Gross R, 2003, FEMS MICROBIOL LETT, V227, P197, DOI 10.1016/S0378-1097(03)00681-5; Harre R, 1981, ARISTOTLE EMBRYOLOGY, P31; HEGDE SN, 1982, BRIT J NUTR, V48, P73, DOI 10.1079/BJN19820089; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Howlett RM, 2012, MICROBIOL-SGM, V158, P1645, DOI 10.1099/mic.0.054130-0; Hubener K, 2002, ARCH ANIM NUTR, V56, P167, DOI 10.1080/00039420214191; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Jorgensen H, 1996, BRIT J NUTR, V75, P379, DOI 10.1079/BJN19960141; Jozefiak D, 2004, ANIM FEED SCI TECH, V113, P1, DOI 10.1016/j.anifeedsci.2003.09.007; Karasawa Y, 1999, J EXP ZOOL, V283, P418, DOI 10.1002/(SICI)1097-010X(19990301/01)283:4/5&lt;418::AID-JEZ11&gt;3.0.CO;2-G; Kien CL, 2007, J NUTR, V137, P916, DOI 10.1093/jn/137.4.916; Kim T, 2011, METHODS MOL BIOL, V733, P185, DOI 10.1007/978-1-61779-089-8_13; Lan PTN, 2002, MICROBIOL IMMUNOL, V46, P371, DOI 10.1111/j.1348-0421.2002.tb02709.x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Louis P, 2007, FEMS MICROBIOL LETT, V269, P240, DOI 10.1111/j.1574-6968.2006.00629.x; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; MCNAB JM, 1973, WORLD POULTRY SCI J, V29, P251, DOI 10.1079/WPS19730014; McWhorter TJ, 2009, BIOL REV, V84, P533, DOI 10.1111/j.1469-185X.2009.00086.x; MEAD GC, 1989, J EXP ZOOL, P48, DOI 10.1002/jez.1402520508; Medie FM, 2012, NAT REV MICROBIOL, V10, P227, DOI 10.1038/nrmicro2729; Meimandipour A, 2011, ARCH GEFLUGELKD, V75, P164; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; OBST BS, 1989, J EXP ZOOL, P117, DOI 10.1002/jez.1402520519; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Saengkerdsub S, 2007, APPL ENVIRON MICROB, V73, P353, DOI 10.1128/AEM.01931-06; SALANITR.JP, 1974, APPL MICROBIOL, V28, P439, DOI 10.1128/AEM.28.3.439-447.1974; SALANITRO JP, 1978, APPL ENVIRON MICROB, V35, P782, DOI 10.1128/AEM.35.4.782-790.1978; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sergeant MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038094; STAMS AJM, 1994, ANTON LEEUW INT J G, V66, P271, DOI 10.1007/BF00871644; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Torok VA, 2011, APPL ENVIRON MICROB, V77, P3380, DOI 10.1128/AEM.02300-10; Van Immerseel F, 2005, POULTRY SCI, V84, P1851, DOI 10.1093/ps/84.12.1851; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Zhou W, 2012, APPL ENVIRON MICROB, V78, P3028, DOI 10.1128/AEM.06920-11; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002	70	262	279	1	182	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91941	10.1371/journal.pone.0091941	http://dx.doi.org/10.1371/journal.pone.0091941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24657972	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300046
J	Wijgerde, T; van Melis, A; Silva, CIF; Leal, MC; Vogels, L; Mutter, C; Osinga, R				Wijgerde, Tim; van Melis, Anne; Silva, Catarina I. F.; Leal, Miguel C.; Vogels, Luc; Mutter, Claudia; Osinga, Ronald			Red Light Represses the Photophysiology of the Scleractinian Coral Stylophora pistillata	PLOS ONE			English	Review							GREEN FLUORESCENT PROTEIN; REEF-BUILDING CORALS; CHLOROPHYLL BIOSYNTHESIS; ZINC TOXICITY; CELL-CYCLE; ZOOXANTHELLAE; PHOTOSYNTHESIS; AQUACULTURE; PERFORMANCE; PIGMENTS	Light spectrum plays a key role in the biology of symbiotic corals, with blue light resulting in higher coral growth, zooxanthellae density, chlorophyll a content and photosynthesis rates as compared to red light. However, it is still unclear whether these physiological processes are blue-enhanced or red-repressed. This study investigated the individual and combined effects of blue and red light on the health, zooxanthellae density, photophysiology and colouration of the scleractinian coral Stylophora pistillata over 6 weeks. Coral fragments were exposed to blue, red, and combined 50/50% blue red light, at two irradiance levels (128 and 256 mu mol m(-2) s(-1)). Light spectrum affected the health/survival, zooxanthellae density, and NDVI (a proxy for chlorophyll a content) of S. pistillata. Blue light resulted in highest survival rates, whereas red light resulted in low survival at 256 mu mol m(-2) s(-1). Blue light also resulted in higher zooxanthellae densities compared to red light at 256 mu mol m(-2) s(-1), and a higher NDVI compared to red and combined blue red light. Overall, our results suggest that red light negatively affects the health, survival, symbiont density and NDVI of S. pistillata, with a dominance of red over blue light for NDVI.	[Wijgerde, Tim; van Melis, Anne; Osinga, Ronald] Wageningen Univ, Dept Anim Sci, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands; [Wijgerde, Tim; van Melis, Anne; Osinga, Ronald] Res Ctr, Wageningen, Netherlands; [Silva, Catarina I. F.] Royal Netherlands Inst Sea Res, Texel, Netherlands; [Leal, Miguel C.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Leal, Miguel C.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Leal, Miguel C.] Univ Georgia, Skidaway Inst Oceanog, Savannah, GA USA; [Vogels, Luc; Mutter, Claudia] Philips Lighting BG Light Sources & Elect LED Pla, Eindhoven, Netherlands	Wageningen University & Research; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Universidade de Aveiro; Universidade de Aveiro; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography; Philips	Wijgerde, T (corresponding author), Wageningen Univ, Dept Anim Sci, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands.	wijgerde@coralpublications.com	Leal, Miguel Costa/C-8611-2009	Leal, Miguel Costa/0000-0003-0672-6251	EU [244161]	EU(European Commission)	This study was funded by the EU Seventh Framework Programme (FP7 / 2007-2013) under grant agreement no. 244161 (FORCE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIA, 1995, PHYTOCHEMISTRY, V39, P45, DOI 10.1016/0031-9422(94)00919-K; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Brunelle SA, 2007, J PHYCOL, V43, P509, DOI 10.1111/j.1529-8817.2007.00339.x; D'Angelo C, 2008, MAR ECOL PROG SER, V364, P97, DOI 10.3354/meps07588; Daniels WMU, 2004, METAB BRAIN DIS, V19, P79, DOI 10.1023/B:MEBR.0000027419.79032.bd; DAVIES PS, 1984, CORAL REEFS, V2, P181; DemmigAdams B, 1996, PLANTA, V198, P460, DOI 10.1007/BF00620064; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Ferrier-Pages C, 2005, CORAL REEFS, V24, P636, DOI 10.1007/s00338-005-0045-x; Gilmore AM, 2003, PHOTOCHEM PHOTOBIOL, V77, P515, DOI 10.1562/0031-8655(2003)077<0515:STROTE>2.0.CO;2; HALLDAL P, 1968, BIOL BULL, V134, P411, DOI 10.2307/1539860; Hoadley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019755; HUANG XD, 1995, ECOTOX ENVIRON SAFE, V32, P194, DOI 10.1006/eesa.1995.1102; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; JEFFREY SW, 1968, BIOL BULL, V135, P149, DOI 10.2307/1539622; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; KINZIE RA, 1987, MAR BIOL, V94, P95, DOI 10.1007/BF00392902; KINZIE RA, 1984, MAR BIOL, V78, P239, DOI 10.1007/BF00393009; Leal MC, 2013, TRENDS BIOTECHNOL, V31, P555, DOI 10.1016/j.tibtech.2013.06.004; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Liu XC, 2013, PLANT CELL, V25, P1258, DOI 10.1105/tpc.113.109710; Mass T, 2010, J EXP BIOL, V213, P4084, DOI 10.1242/jeb.039891; Matz MV, 2006, PHOTOCHEM PHOTOBIOL, V82, P345, DOI 10.1562/2005-08-18-RA-653; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Osinga R, 2011, MAR BIOTECHNOL, V13, P658, DOI 10.1007/s10126-011-9382-7; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; Prasad KVSK, 1999, ENVIRON EXP BOT, V42, P1, DOI 10.1016/S0098-8472(99)00013-1; Reef R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007995; Reichelt-Brushett AJ, 2005, CORAL REEFS, V24, P524, DOI 10.1007/s00338-005-0013-5; Rocha RJM, 2013, AQUACULTURE, V414, P235, DOI 10.1016/j.aquaculture.2013.08.018; Rocha RJM, 2013, AQUACULTURE, V402, P38, DOI 10.1016/j.aquaculture.2013.03.028; Rocha RJM, 2013, AQUACULTURE, V388, P24, DOI 10.1016/j.aquaculture.2013.01.013; Rouse W., 1973, P 3 ETRS S, VI, P309; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Sheridan C, 2013, AQUACULTURE, V396, P124, DOI 10.1016/j.aquaculture.2013.02.037; Shoguchi E, 2013, GENE, V515, P426, DOI 10.1016/j.gene.2012.12.038; Sorek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043264; Titlyanov EA, 2002, RUSS J MAR BIOL, V28, pS19; Wang LH, 2008, CORAL REEFS, V27, P823, DOI 10.1007/s00338-008-0434-z; Wilmann PG, 2005, J MOL BIOL, V349, P223, DOI 10.1016/j.jmb.2005.03.020	43	33	34	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92781	10.1371/journal.pone.0092781	http://dx.doi.org/10.1371/journal.pone.0092781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658108	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300128
J	Barhoumi, R; Mouneimne, Y; Chapkin, RS; Burghardt, RC				Barhoumi, Rola; Mouneimne, Youssef; Chapkin, Robert S.; Burghardt, Robert C.			Effects of Fatty Acids on Benzo[a]pyrene Uptake and Metabolism in Human Lung Adenocarcinoma A549 Cells	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; MULTIPHOTON SPECTRAL-ANALYSIS; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; ANTAGONIST ACTIVITY; BREAST-CANCER; RAT; LIVER; LINES; SUPPLEMENTATION	Dietary supplementation with natural chemoprotective agents is receiving considerable attention because of health benefits and lack of toxicity. In recent in vivo and in vitro experimental studies, diets rich in n-3 polyunsaturated fatty acids have been shown to provide significant anti-tumor action. In this investigation, the effects of control fatty acids (oleic acid (OA), linoleic acid (LA)) and n-3 PUFA, e. g., docosahexaenoic acid (DHA) on the uptake and metabolism of the carcinogenic polycyclic aromatic hydrocarbon, benzo[a] pyrene (BaP) was investigated in A549 cells, a human adenocarcinoma alveolar basal epithelial cell line. A549 cells activate BaP through the cytochrome P450 enzyme system to form reactive metabolites, a few of which covalently bind to DNA and proteins. Therefore, multiphoton microscopy spectral analysis combined with linear unmixing was used to identify the parent compound and BaP metabolites formed in cells, in the presence and absence of fatty acids. The relative abundance of select metabolites was associated with altered P450 activity as determined using ethoxyresorufin-O-deethylase activity in cells cultured in the presence of BSA-conjugated fatty acids. In addition, the parent compound within cellular membranes increases significantly in the presence of each of the fatty acids, with the greatest accumulation observed following DHA treatment. DHA treated cells exhibit significantly lower pyrene-like metabolites indicative of lower adducts including DNA adducts compared to control BSA, OA or LA treated cells. Further, DHA reduced the abundance of the proximate carcinogen BaP 7,8-dihydrodiol and the 3-hydroxybenzo[a]pyene metabolites compared to other treatments. The significant changes in BaP metabolites in DHA treated cells may be mediated by the effects on the physicochemical properties of the membrane known to affect enzyme activity related to phase I and phase II metabolism. In summary, DHA is a highly bioactive chemo-protective agent capable of modulating BaP-induced DNA adducts.	[Barhoumi, Rola; Chapkin, Robert S.; Burghardt, Robert C.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Mouneimne, Youssef] Amer Univ Beirut, KAS CRSL, Beirut, Lebanon; [Chapkin, Robert S.] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; American University of Beirut; Texas A&M University System; Texas A&M University College Station	Barhoumi, R (corresponding author), Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.	rmouneimne@cvm.tamu.edu	PANTAZI, DESPINA/F-4170-2016; Burghardt, Robert C./AAF-4847-2021	PANTAZI, DESPINA/0000-0002-3534-8889; Burghardt, Robert C./0000-0003-1021-8444; Chapkin, Robert/0000-0002-6515-3898	National Institutes of Health-National Center for Research Resources (NIH-NCRR) [1S10RR22532-01]; NIH [P30-ES09106, P42-ES04917, R01 CA129444]; NATIONAL CANCER INSTITUTE [R01CA129444] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023512, P30ES009106, P42ES004917] Funding Source: NIH RePORTER	National Institutes of Health-National Center for Research Resources (NIH-NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Institutes of Health-National Center for Research Resources (NIH-NCRR) (1S10RR22532-01), and NIH grants P30-ES09106, P42-ES04917 and R01 CA129444. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin Z, 2012, CHEM RES TOXICOL, V25, P113, DOI 10.1021/tx200272v; Banni M, 2009, FISH PHYSIOL BIOCHEM, V35, P293, DOI 10.1007/s10695-008-9210-9; BARHOUMI R, 1995, CYTOMETRY, V19, P226, DOI 10.1002/cyto.990190306; Barhoumi R, 2011, TOXICOL APPL PHARM, V253, P45, DOI 10.1016/j.taap.2011.03.009; Barhoumi R, 2009, J TOXICOL SCI, V34, P13, DOI 10.2131/jts.34.13; BEGIN ME, 1985, PROSTA LEUKOTR MED, V19, P177, DOI 10.1016/0262-1746(85)90084-8; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; BROWN ER, 1994, LIPIDS, V29, P825, DOI 10.1007/BF02536249; Calviello G, 1998, INT J CANCER, V75, P699, DOI 10.1002/(SICI)1097-0215(19980302)75:5&lt;699::AID-IJC7&gt;3.0.CO;2-U; CARROLL KK, 1991, NUTR CANCER, V16, P79, DOI 10.1080/01635589109514146; Casper RF, 1999, MOL PHARMACOL, V56, P784; Castell JV, 2005, EXP TOXICOL PATHOL, V57, P189, DOI 10.1016/j.etp.2005.05.008; CAVE WT, 1982, J NATL CANCER I, V68, P319; Chang KW, 1999, LIFE SCI, V65, P1339, DOI 10.1016/S0024-3205(99)00373-2; Chapkin RS, 2008, BBA-BIOMEMBRANES, V1778, P466, DOI 10.1016/j.bbamem.2007.11.003; Dai JF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-71; DANNENBERG AJ, 1992, J NUTR, V122, P1607, DOI 10.1093/jn/122.8.1607; DONATO MT, 1993, ANAL BIOCHEM, V213, P29, DOI 10.1006/abio.1993.1381; Gammon MD, 2004, ARCH ENVIRON HEALTH, V59, P640, DOI 10.1080/00039890409602948; Gasiewicz TA, 1996, BIOCHEM PHARMACOL, V52, P1787, DOI 10.1016/S0006-2952(96)00600-4; Genies C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078356; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; HATALA MA, 1994, LIPIDS, V29, P831, DOI 10.1007/BF02536250; Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847; KINOSHITA N, 1978, SCIENCE, V199, P307, DOI 10.1126/science.619459; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Little JM, 2002, DRUG METAB DISPOS, V30, P531, DOI 10.1124/dmd.30.5.531; Lutz M, 1998, ANN NUTR METAB, V42, P350, DOI 10.1159/000012755; MAHONEY EM, 1977, P NATL ACAD SCI USA, V74, P4895, DOI 10.1073/pnas.74.11.4895; Ramesh A, 2004, INT J TOXICOL, V23, P301, DOI 10.1080/10915810490517063; Registration OotF, 1982, FED REG, V47; SANTOSTEFANO M, 1993, MOL PHARMACOL, V43, P200; Sawada N, 2012, GASTROENTEROLOGY, V142, P1468, DOI 10.1053/j.gastro.2012.02.018; Seo J, 2006, FASEB J, V20, P770, DOI 10.1096/fj.05-4683fje; Shimada T, 2002, CARCINOGENESIS, V23, P1199, DOI 10.1093/carcin/23.7.1199; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; THAKKER DR, 1984, J BIOL CHEM, V259, P1249; Turk HF, 2012, FASEB J, V26; Turk HF, 2012, PLOS ONE, V7; Uno S, 2004, MOL PHARMACOL, V65, P1225, DOI 10.1124/mol.65.5.1225; Uno S, 2006, MOL PHARMACOL, V69, P1103, DOI 10.1124/mol.105.021501; Urani C, 1998, CHEMOSPHERE, V37, P2785, DOI 10.1016/S0045-6535(98)00321-X; Wang LQ, 2004, DRUG METAB DISPOS, V32, P1162, DOI 10.1124/dmd.104.000273; WEEKS SJ, 1991, APPL SPECTROSC, V45, P1093, DOI 10.1366/0003702914336066; WILLIAMS CM, 1994, BRIT J NUTR, V71, P543, DOI 10.1079/BJN19940161; Zhou GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026589; Zhu SQ, 2008, J CHROMATOGR B, V863, P141, DOI 10.1016/j.jchromb.2008.01.018	47	15	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90908	10.1371/journal.pone.0090908	http://dx.doi.org/10.1371/journal.pone.0090908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651647	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800026
J	Bjerke, GA; Pietrzak, K; Melhuish, TA; Frierson, HF; Paschal, BM; Wotton, D				Bjerke, Glen A.; Pietrzak, Karolina; Melhuish, Tiffany A.; Frierson, Henry F., Jr.; Paschal, Bryce M.; Wotton, David			Prostate Cancer Induced by Loss of Apc Is Restrained by TGF beta Signaling	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; TRANSCRIPTION FACTORS; MOLECULAR-GENETICS; ANIMAL-MODELS; CELL-SURVIVAL; MOUSE MODELS; II RECEPTORS; PTEN; GROWTH; PTEN/MMAC1	Recent work with mouse models of prostate cancer (CaP) has shown that inactivation of TGF beta signaling in prostate epithelium can cooperate with deletion of the Pten tumor suppressor to drive locally aggressive cancer and metastatic disease. Here, we show that inactivating the TGF beta pathway by deleting the gene encoding the TGF beta type II receptor (Tgfbr2) in combination with a deletion of the Apc tumor suppressor gene specifically in mouse prostate epithelium, results in the rapid onset of invasive CaP. Micro-metastases were observed in the lymph nodes and lungs of a proportion of the double mutant mice, whereas no metastases were observed in Apc single mutant mice. Prostate-specific Apc; Tgfbr2 mutants had a lower frequency of metastasis and survived significantly longer than Pten; Tgfbr2 double mutants. However, all Apc; Tgfbr2 mutants developed invasive cancer by 30 weeks of age, whereas invasive cancer was rarely observed in Apc single mutant animals, even by one year of age. Further comparison of the Pten and Apc models of CaP revealed additional differences, including adenosquamous carcinoma in the Apc; Tgfbr2 mutants that was not seen in the Pten model, and a lack of robust induction of the TGF beta pathway in Apc null prostate. In addition to causing high-grade prostate intra-epithelial neoplasia (HGPIN), deletion of either Pten or Apc induced senescence in affected prostate ducts, and this restraint was overcome by loss of Tgfbr2. In summary, this work demonstrates that TGF beta signaling restrains the progression of CaP induced by different tumor suppressor mutations, suggesting that TGF beta signaling exerts a general tumor suppressive effect in prostate.	[Bjerke, Glen A.; Pietrzak, Karolina; Melhuish, Tiffany A.; Paschal, Bryce M.; Wotton, David] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Bjerke, Glen A.; Pietrzak, Karolina; Melhuish, Tiffany A.; Paschal, Bryce M.; Wotton, David] Univ Virginia, Ctr Cell Signaling, Charlottesville, VA USA; [Pietrzak, Karolina] Univ Lodz, Dept Cytobiochem, PL-90131 Lodz, Poland; [Frierson, Henry F., Jr.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; University of Lodz; University of Virginia	Wotton, D (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	dw2p@virginia.edu		Wotton, David/0000-0002-4652-5350	National Cancer Institute [2P01CA104106]; UVA Cancer Center; CCSG [P30 CA44579]; James and Rebecca CraigFoundation; UVA Women's Oncology fund; NATIONAL CANCER INSTITUTE [P01CA104106, P30CA044579] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UVA Cancer Center; CCSG; James and Rebecca CraigFoundation; UVA Women's Oncology fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Program Project Grant from the National Cancer Institute (2P01CA104106 to B. Paschal and D. Wotton), and by a pilot grant from the UVA Cancer Center (funded from the CCSG P30 CA44579, the James and Rebecca CraigFoundation, and UVA Women's Oncology fund) to D. Wotton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison AA, 2008, PROSTATE, V68, P661, DOI 10.1002/pros.20730; Bartholin L, 2008, DEV BIOL, V319, P285, DOI 10.1016/j.ydbio.2008.04.027; Bjerke GA, 2013, ONCOGENE; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Cairns P, 1997, CANCER RES, V57, P4997; Chen Y, 2013, EUR J HUM GENET, V21, P929, DOI 10.1038/ejhg.2012.281; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fine SW, 2012, ADV ANAT PATHOL, V19, P204, DOI 10.1097/PAP.0b013e31825c6b92; Francis JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003180; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Galgano MT, 2009, HUM PATHOL, V40, P1434, DOI 10.1016/j.humpath.2009.02.008; Guo YP, 1997, INT J CANCER, V71, P573, DOI 10.1002/(SICI)1097-0215(19970516)71:4<573::AID-IJC11>3.3.CO;2-1; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Jakel H, 2012, CELL CYCLE, V11, P1910, DOI 10.4161/cc.19957; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kim J, 2012, ONCOGENE, V31, P322, DOI 10.1038/onc.2011.236; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Kypta RM, 2012, NAT REV UROL; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Pearson HB, 2009, CANCER RES, V69, P94, DOI 10.1158/0008-5472.CAN-08-2895; Pienta KJ, 2008, PROSTATE, V68, P629, DOI 10.1002/pros.20726; Powers SE, 2010, DEVELOPMENT, V137, P249, DOI 10.1242/dev.040782; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Roy-Burman P, 2004, ENDOCR-RELAT CANCER, V11, P225, DOI 10.1677/erc.0.0110225; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki H, 1998, CANCER RES, V58, P204; Taniguchi K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002524; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tu WH, 2003, NEOPLASIA, V5, P267, DOI 10.1016/S1476-5586(03)80058-1; Voeller HJ, 1998, CANCER RES, V58, P2520; Wang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041330; Wang SI, 1998, CLIN CANCER RES, V4, P811; Williams RH, 1996, CLIN CANCER RES, V2, P635; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Yamada KM, 2001, J CELL SCI, V114, P2375; Yu XP, 2009, PROSTATE, V69, P249, DOI 10.1002/pros.20877; Zhang Y, 1999, TRENDS CELL BIOL, V9, P274, DOI 10.1016/S0962-8924(99)01579-2; Zhao H, 2005, CANCER-AM CANCER SOC, V104, P44, DOI 10.1002/cncr.21135	60	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92800	10.1371/journal.pone.0092800	http://dx.doi.org/10.1371/journal.pone.0092800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651496	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800158
J	Zucchi, FCR; Yao, YL; Ilnytskyy, Y; Robbins, JC; Soltanpour, N; Kovalchuk, I; Kovalchuk, O; Metz, GAS				Zucchi, Fabiola C. R.; Yao, Youli; Ilnytskyy, Yaroslav; Robbins, Jerrah C.; Soltanpour, Nasrin; Kovalchuk, Igor; Kovalchuk, Olga; Metz, Gerlinde A. S.			Lifetime Stress Cumulatively Programs Brain Transcriptome and Impedes Stroke Recovery: Benefit of Sensory Stimulation	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; ANXIETY-LIKE BEHAVIOR; TACTILE STIMULATION; SKILLED MOVEMENT; MASSAGE THERAPY; CORTICAL INJURY; PRENATAL STRESS; MOTOR FUNCTION; BLOOD-FLOW; EXPRESSION	Prenatal stress (PS) represents a critical variable affecting lifetime health trajectories, metabolic and vascular functions. Beneficial experiences may attenuate the effects of PS and its programming of health outcomes in later life. Here we investigated in a rat model (1) if PS modulates recovery following cortical ischemia in adulthood; (2) if a second hit by adult stress (AS) exaggerates stress responses and ischemic damage; and (3) if tactile stimulation (TS) attenuates the cumulative effects of PS and AS. Prenatally stressed and non-stressed adult male rats underwent focal ischemic motor cortex lesion and were tested in skilled reaching and skilled walking tasks. Two groups of rats experienced recurrent restraint stress in adulthood and one of these groups also underwent daily TS therapy. Animals that experienced both PS and AS displayed the most severe motor disabilities after lesion. By contrast, TS promoted recovery from ischemic lesion and reduced hypothalamic-pituitary-adrenal axis activity. The data also showed that cumulative effects of adverse and beneficial lifespan experiences interact with disease outcomes and brain plasticity through the modulation of gene expression. Microarray analysis of the lesion motor cortex revealed that cumulative PS and AS interact with genes related to growth factors and transcription factors, which were not affected by PS or lesion alone. TS in PS+AS animals reverted these changes, suggesting a critical role for these factors in activity-dependent motor cortical reorganization after ischemic lesion. These findings suggest that beneficial experience later in life can moderate adverse consequences of early programming to improve cerebrovascular health.	[Zucchi, Fabiola C. R.; Yao, Youli; Robbins, Jerrah C.; Soltanpour, Nasrin; Metz, Gerlinde A. S.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Zucchi, Fabiola C. R.] Univ Mato Grosso State, Dept Med, Caceres, MT, Brazil; [Zucchi, Fabiola C. R.] Univ Mato Grosso State, Dept Biol Sci, Caceres, MT, Brazil; [Yao, Youli; Ilnytskyy, Yaroslav; Kovalchuk, Igor; Kovalchuk, Olga] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge; Universidade Estadual de Mato Grosso do Sul; Universidade Estadual de Mato Grosso do Sul; University of Lethbridge	Metz, GAS (corresponding author), Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada.	gerlinde.metz@uleth.ca	Zucchi, Fabiola/K-1296-2017	Zucchi, Fabiola/0000-0002-2252-613X; Metz, Gerlinde/0000-0002-5801-7716	Alberta Innovates - Health Solutions (AI-HS); Preterm Birth and Healthy Outcomes; AI-HS Interdisciplinary Team Grant [200700595]; Hotchkiss Brain Institute; Norlien Foundation; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Alberta Innovates - Health Solutions (AI-HS); Preterm Birth and Healthy Outcomes; AI-HS Interdisciplinary Team Grant; Hotchkiss Brain Institute; Norlien Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by Alberta Innovates - Health Solutions (AI-HS; FZ and GM), Preterm Birth and Healthy Outcomes funded by the AI-HS Interdisciplinary Team Grant #200700595 (GM), Hotchkiss Brain Institute (FZ), Norlien Foundation (FZ), the Canadian Institutes of Health Research (GM), and the Natural Sciences and Engineering Research Council of Canada (GM). GM is a Senior Scholar of Alberta Innovates-Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhatzira L, 2011, J BIOL CHEM, V286, P42051, DOI 10.1074/jbc.M111.300541; Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; Arai Y, 2005, J NEUROSCI, V25, P9752, DOI 10.1523/JNEUROSCI.2512-05.2005; Armitage GA, 2010, J CEREBR BLOOD F MET, V30, P1432, DOI 10.1038/jcbfm.2010.73; Babenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029441; Babenko O, 2012, BRAIN RES, V1444, P96, DOI 10.1016/j.brainres.2012.01.038; Bernal GM, 2011, AGING CELL, V10, P466, DOI 10.1111/j.1474-9726.2011.00694.x; Bernal-Pacheco O, 2007, J NEUROL SCI, V262, P60, DOI 10.1016/j.jns.2007.06.026; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; Bruno E, 2010, NEUROSCI LETT, V482, P112, DOI 10.1016/j.neulet.2010.07.012; Canu MH, 2007, BEHAV NEUROSCI, V121, P177, DOI 10.1037/0735-7044.121.1.177; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cohen DRS, 2003, MOL CELL NEUROSCI, V22, P417, DOI 10.1016/S1044-7431(03)00026-5; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Crane JD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002882; Devaux J, 2008, J CELL BIOL, V183, P909, DOI 10.1083/jcb.200808034; DeVries AC, 2001, P NATL ACAD SCI USA, V98, P11824, DOI 10.1073/pnas.201215298; Donoyama N, 2011, J ALTERN COMPLEM MED, V17, P553, DOI 10.1089/acm.2010.0209; Faraji J, 2013, BEHAV BRAIN RES, V253, P78, DOI 10.1016/j.bbr.2013.07.022; Field T, 2002, MED CLIN N AM, V86, P163, DOI 10.1016/S0025-7125(03)00078-6; Field T, 1996, INT J NEUROSCI, V86, P197, DOI 10.3109/00207459608986710; FIELD TM, 1986, PEDIATRICS, V77, P654; Furusawa T, 2006, MOL CELL BIOL, V26, P592, DOI 10.1128/MCB.26.2.592-604.2006; Garcia-Caceres C, 2011, ENDOCRINOLOGY, V152, P1809, DOI 10.1210/en.2010-1252; Gibb RL, 2010, BEHAV BRAIN RES, V214, P102, DOI 10.1016/j.bbr.2010.04.008; Gray JD, 2012, NEUROSCIENCE; Guzzetta A, 2009, J NEUROSCI, V29, P6042, DOI 10.1523/JNEUROSCI.5548-08.2009; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hauser J, 2008, ENDOCRINOLOGY, V149, P6343, DOI 10.1210/en.2008-0615; Hellstrom IC, 2012, PHILOS T R SOC B, V367, P2495, DOI 10.1098/rstb.2012.0223; Holmes MC, 2006, J NEUROSCI, V26, P3840, DOI 10.1523/JNEUROSCI.4464-05.2006; Hsu FC, 2003, P NATL ACAD SCI USA, V100, P12213, DOI 10.1073/pnas.2131679100; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jadavji NM, 2006, NEUROSCIENCE, V140, P1127, DOI 10.1016/j.neuroscience.2006.03.027; Jadavji NM, 2008, BEHAV BRAIN RES, V195, P251, DOI 10.1016/j.bbr.2008.09.011; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Kirkland SW, 2008, BRAIN RES, V1201, P151, DOI 10.1016/j.brainres.2008.01.032; Kirkland SW, 2012, J INTEGR NEUROSCI, V11, P33, DOI 10.1142/S0219635212500033; Knieling M, 2009, NEUROSCIENCE, V163, P759, DOI 10.1016/j.neuroscience.2009.07.004; Kolb B, 2010, BEHAV BRAIN RES, V214, P115, DOI 10.1016/j.bbr.2010.04.024; Koning-Tijssen M. A. J., 1993, GENEREVIEWS; Kovalchuk I, 2007, MUTAT RES-FUND MOL M, V624, P101, DOI 10.1016/j.mrfmmm.2007.04.009; KUHN CM, 1991, J PEDIATR-US, V119, P434, DOI 10.1016/S0022-3476(05)82059-1; Laloux C, 2012, PSYCHONEUROENDOCRINO, V37, P1646, DOI 10.1016/j.psyneuen.2012.02.010; Li Y, 2007, J CEREBR BLOOD F MET, V27, P1043, DOI 10.1038/sj.jcbfm.9600417; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Marrocco J, 2012, J NEUROSCI, V32, P17143, DOI 10.1523/JNEUROSCI.1040-12.2012; McArthur S, 2007, NEUROPSYCHOPHARMACOL, V32, P1462, DOI 10.1038/sj.npp.1301277; Merrett DL, 2010, BEHAV BRAIN RES, V214, P55, DOI 10.1016/j.bbr.2010.04.035; Metz G.A., 2009, J VIS EXP, V28; Metz GA, 2005, EUR J NEUROSCI, V22, P1190, DOI 10.1111/j.1460-9568.2005.04285.x; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Metz GAS, 2000, BEHAV BRAIN RES, V116, P111, DOI 10.1016/S0166-4328(00)00245-X; Metz GAS, 2001, PHYSIOL BEHAV, V72, P29, DOI 10.1016/S0031-9384(00)00371-1; Metz GA, 2007, REV NEUROSCIENCE, V18, P209; Mok Esther, 2004, Complement Ther Nurs Midwifery, V10, P209, DOI 10.1016/j.ctnm.2004.05.006; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Muhammad A, 2012, NEUROSCIENCE, V216, P103, DOI 10.1016/j.neuroscience.2012.04.041; Muller-Oerlinghausen B, 2004, DEUT MED WOCHENSCHR, V129, P1363, DOI 10.1055/s-2004-826874; PASH J, 1990, P NATL ACAD SCI USA, V87, P3836, DOI 10.1073/pnas.87.10.3836; PAUK J, 1986, LIFE SCI, V39, P2081, DOI 10.1016/0024-3205(86)90359-0; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010; Rasmussen MH, 2007, OBESITY, V15, P879, DOI 10.1038/oby.2007.607; Rodrigues AL, 2004, BRAIN RES, V1002, P94, DOI 10.1016/j.brainres.2003.12.020; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; SCHEFF SW, 1980, EXP NEUROL, V68, P195, DOI 10.1016/0014-4886(80)90077-1; Schwab Matthias, 2009, Gynaekologisch-Geburtshilfliche Rundschau, V49, P13, DOI 10.1159/000184442; Seckl JR, 2006, ANN NY ACAD SCI, V1071, P351, DOI 10.1196/annals.1364.027; Shan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028105; Sharp H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045446; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Sokolova OO, 2009, B EXP BIOL MED+, V148, P227, DOI 10.1007/s10517-009-0660-6; Suenaga T, 2012, NEUROREPORT, V23, P430, DOI 10.1097/WNR.0b013e3283529805; Takenaga K, 2006, GLIA, V53, P313, DOI 10.1002/glia.20284; Vansthertem D, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/193259; Vyas A, 2002, J NEUROSCI, V22, P6810; Ward AMV, 2004, J HYPERTENS, V22, P2295, DOI 10.1097/00004872-200412000-00011; Ward ID, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S9; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Whishaw IQ, 2000, NEUROPHARMACOLOGY, V39, P788, DOI 10.1016/S0028-3908(99)00259-2; WHISHAW IQ, 1993, BEHAV BRAIN RES, V56, P59, DOI 10.1016/0166-4328(93)90022-I; Xie GL, 2011, MOL VIS, V17, P32; Yao YL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00061; Zucchi FCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056967; Zucchi Fabiola C. R., 2012, Frontiers in Genetics, V3, P96, DOI 10.3389/fgene.2012.00096; Zucchi FCR, 2009, BEHAV BRAIN RES, V205, P67, DOI 10.1016/j.bbr.2009.06.030	90	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92130	10.1371/journal.pone.0092130	http://dx.doi.org/10.1371/journal.pone.0092130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651125	Green Published, gold			2022-12-25	WOS:000333352800071
J	Paskaleva, EE; Arra, M; Liu, YZ; Guo, HJ; Swartz, G; Kennedy, JS; Breneman, C; Shekhtman, A; Canki, M				Paskaleva, Elena E.; Arra, Manoj; Liu, Yanze; Guo, Huijun; Swartz, Glenn; Kennedy, Jeffrey S.; Breneman, Curt; Shekhtman, Alexander; Canki, Mario			Evaluation of Potential Genotoxicity of HIV Entry Inhibitors Derived from Natural Sources	PLOS ONE			English	Article							ERYTHROCYTE MICRONUCLEUS ASSAY; GENE MUTATION ASSAY; PALMITIC ACID; INTERNATIONAL WORKSHOP; PERIPHERAL-BLOOD; STEARIC-ACID; APOPTOSIS; ACCEPTANCE; PROTOCOL; DESIGN	AIDS is a global pandemic that has seen the development of novel and effective treatments to improve the quality of life of those infected and reduction of spread of the disease. Palmitic Acid (PA), which we identified and isolated from Sargassum fusiforme, is a naturally occurring fatty acid that specifically inhibits HIV entry by binding to a novel pocket on the CD4 receptor. We also identified a structural analogue, 2-bromopalmitate (2-BP), as a more effective HIV entry inhibitor with a 20-fold increase in efficacy. We have used the structure-activity relationship (SAR) of 2-BP as a platform to identify new small chemical molecules that fit into the various identified active sites in an effort to identify more potent CD4 entry inhibitors. To validate further drug development, we tested the PA and 2-BP scaffold molecules for genotoxic potential. The FDA and International Conference on Harmonisation (ICH) recommends using a standardized 3-test battery for testing compound genotoxicity consisting of the bacterial reverse mutation assay, mouse lymphoma assay, and rat micronucleus assay. PA and 2-BP and their metabolites tested negative in all three genotoxicty tests. 2-BP is the first derivative of PA to undergo preclinical screening, which will enable us to now test multiple simultaneous small chemical structures based on activity in scaffold modeling across the dimension of pre-clinical testing to enable transition to human testing.	[Paskaleva, Elena E.; Arra, Manoj; Shekhtman, Alexander; Canki, Mario] Palm Biol LLC, Albany, NY USA; [Paskaleva, Elena E.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA; [Arra, Manoj; Canki, Mario] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Liu, Yanze] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Liu, Yanze] Peking Union Med Coll, Beijing 100021, Peoples R China; [Guo, Huijun] Henan Univ Tradit Chinese Med, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Swartz, Glenn] Adv Biosci Labs Inc, Rockville, MD USA; [Kennedy, Jeffrey S.] Albany Med Coll, Albany, NY 12208 USA; [Breneman, Curt] Rensselaer Polytech Inst, Dept Chem, Troy, NY USA; [Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA	Rensselaer Polytechnic Institute; Albany Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Henan University of Traditional Chinese Medicine; Albany Medical College; Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Canki, M (corresponding author), Palm Biol LLC, Albany, NY USA.	cankim@mail.amc.edu		Paskaleva, Elena/0000-0002-4291-9969; Shekhtman, Alexander/0000-0003-2649-2675	NIH/NIAID/DAIDS [HHSN272201000001C]	NIH/NIAID/DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a NIH/NIAID/DAIDS contract: "Comprehensive Resources for HIV Microbicides and Biomedical Prevention" (#HHSN272201000001C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1973, P NATL ACAD SCI USA, V70, P782, DOI 10.1073/pnas.70.3.782; Aparna V, 2012, CHEM BIOL DRUG DES, V80, P434, DOI 10.1111/j.1747-0285.2012.01418.x; Belosludtsev K, 2006, J BIOENERG BIOMEMBR, V38, P113, DOI 10.1007/s10863-006-9010-9; Clements J, 2000, MUTAT RES-FUND MOL M, V455, P97, DOI 10.1016/S0027-5107(00)00066-X; CLIVE D, 1972, MUTAT RES, V16, P77, DOI 10.1016/0027-5107(72)90066-8; Conner WE, 1999, AM J CLIN NUTR, V70, P951; Dyntar D, 2001, DIABETES, V50, P2105, DOI 10.2337/diabetes.50.9.2105; Fattore E, 2013, INT J FOOD SCI NUTR, V64, P648, DOI 10.3109/09637486.2013.768213; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hayashi M, 2000, ENVIRON MOL MUTAGEN, V35, P234, DOI 10.1002/(SICI)1098-2280(2000)35:3<234::AID-EM10>3.0.CO;2-L; Hayashi M, 2007, MUTAT RES-GEN TOX EN, V627, P10, DOI 10.1016/j.mrgentox.2006.08.010; HEDDLE JA, 1983, MUTAT RES, V123, P61, DOI 10.1016/0165-1110(83)90047-7; Huang CB, 2011, ARCH ORAL BIOL, V56, P650, DOI 10.1016/j.archoralbio.2011.01.011; KASTENBAUM MA, 1970, MUTAT RES, V9, P527, DOI 10.1016/0027-5107(70)90038-2; Krishna G, 2000, MUTAT RES-FUND MOL M, V455, P155, DOI 10.1016/S0027-5107(00)00117-2; Leach AR, 2010, J MED CHEM, V53, P539, DOI 10.1021/jm900817u; Lee DYW, 2009, AIDS RES HUM RETROV, V25, P1231, DOI 10.1089/aid.2009.0019; Lin XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024803; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; MAVOURNIN KH, 1990, MUTAT RES, V239, P29, DOI 10.1016/0165-1110(90)90030-F; Moore MM, 2006, ENVIRON MOL MUTAGEN, V47, P1, DOI 10.1002/em.20159; Moore MM, 2003, MUTAT RES-GEN TOX EN, V540, P127, DOI 10.1016/j.mrgentox.2003.07.003; Mu YM, 2001, ENDOCRINOLOGY, V142, P3590, DOI 10.1210/en.142.8.3590; Paskaleva EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012168; Paskaleva Elena E, 2006, AIDS Res Ther, V3, P15, DOI 10.1186/1742-6405-3-15; Paskaleva EE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-8; SCHEIG R, 1968, J AM OIL CHEM SOC, V45, P31, DOI 10.1007/BF02679042; Schisler MR, 2013, METHODS MOL BIOL, V1044, P27, DOI 10.1007/978-1-62703-529-3_2; Suzuki J, 2011, NEUROSCIENCE, V176, P188, DOI 10.1016/j.neuroscience.2010.11.035; Szkudelski T, 2011, LIFE SCI, V89, P450, DOI 10.1016/j.lfs.2011.07.010; Wakata A, 1998, ENVIRON MOL MUTAGEN, V32, P84, DOI 10.1002/(SICI)1098-2280(1998)32:1<84::AID-EM10>3.0.CO;2-K; Zhou BR, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/530429	33	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93108	10.1371/journal.pone.0093108	http://dx.doi.org/10.1371/journal.pone.0093108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667334	gold, Green Submitted, Green Published			2022-12-25	WOS:000333675600141
J	Watanabe, M; Nakatsuka, A; Murakami, K; Inoue, K; Terami, T; Higuchi, C; Katayama, A; Teshigawara, S; Eguchi, J; Ogawa, D; Watanabe, E; Wada, J; Makino, H				Watanabe, Mayu; Nakatsuka, Atsuko; Murakami, Kazutoshi; Inoue, Kentaro; Terami, Takahiro; Higuchi, Chigusa; Katayama, Akihiro; Teshigawara, Sanae; Eguchi, Jun; Ogawa, Daisuke; Watanabe, Eijiro; Wada, Jun; Makino, Hirofumi			Pemt Deficiency Ameliorates Endoplasmic Reticulum Stress in Diabetic Nephropathy	PLOS ONE			English	Article							PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; KIDNEY-DISEASE; THERAPEUTIC APPROACH; HOMOCYSTEINE; APOPTOSIS; PATHWAY; CELLS; MICE; PHOSPHATIDYLCHOLINE; MECHANISMS	Phosphatidylethanolamine N-methyltransferase (Pemt) catalyzes the methylation of phosphatidylethanolamine (PE) to phosphatidylcholine (PC) mainly in the liver. Under an obese state, the upregulation of Pemt induces endoplasmic reticulum (ER) stress by increasing the PC/PE ratio in the liver. We targeted the Pemt gene in mice to explore the therapeutic impact of Pemt on the progression of diabetic nephropathy and diabetes, which was induced by the injection of streptozotocin (STZ). Although the blood glucose levels were similar in STZ-induced diabetic Pemt+/+ and Pemt-/-mice, the glomerular hypertrophy and albuminuria in Pemt-/- mice were significantly reduced. Pemt deficiency reduced the intraglomerular F4/80-positive macrophages, hydroethidine fluorescence, tubulointerstitial fibrosis and tubular atrophy. The expression of glucose-regulated protein-78 (GRP78) was enriched in the renal tubular cells in STZ-induced diabetic mice, and this was ameliorated by Pemt deficiency. In mProx24 renal proximal tubular cells, the treatment with ER-stress inducers, tunicamycin and thapsigargin, increased the expression of GRP78, which was reduced by transfection of a shRNA lentivirus for Pemt (shRNA-Pemt). The number of apoptotic cells in the renal tubules was significantly reduced in Pemt-/- diabetic mice, and shRNA-Pemt upregulated the phosphorylation of Akt and decreased the cleavage of caspase 3 and 7 in mProx24 cells. Taken together, these findings indicate that the inhibition of Pemt activity ameliorates the ER stress associated with diabetic nephropathy in a model of type 1 diabetes and corrects the functions of the three major pathways downstream of ER stress, i.e. oxidative stress, inflammation and apoptosis.	[Watanabe, Mayu; Nakatsuka, Atsuko; Murakami, Kazutoshi; Inoue, Kentaro; Terami, Takahiro; Higuchi, Chigusa; Katayama, Akihiro; Teshigawara, Sanae; Eguchi, Jun; Wada, Jun; Makino, Hirofumi] Okayama Univ, Dept Med & Clin Sci, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Japan; [Nakatsuka, Atsuko; Ogawa, Daisuke] Okayama Univ, Dept Diabet Nephropathy, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Japan; [Murakami, Kazutoshi] Okayama Univ, Dept Gen Med, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Japan; [Watanabe, Eijiro] Dainippon Sumitomo Pharma, Chuo Ku, Osaka, Japan	Okayama University; Okayama University; Okayama University	Nakatsuka, A (corresponding author), Okayama Univ, Dept Med & Clin Sci, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Japan.	atsuko-n@md.okayama-u.ac.jp; junwada@md.okayama-u.ac.jp	WADA, Jun/B-2023-2011; Murakami, Kazutoshi/AAV-1940-2020; Nakatsuka, Atsuko/L-2765-2017	WADA, Jun/0000-0003-1468-5170; Murakami, Kazutoshi/0000-0002-6042-8960; 	JSPS [24790926, 23390241, 25126716]; Health Labor Sciences Research Grant, Japan; Grants-in-Aid for Scientific Research [24790926] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labor Sciences Research Grant, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS Grant-in-Aid for Scientific Research, (Grant number 24790926, 23390241, 25126716) and Health Labor Sciences Research Grant, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Brezniceanu ML, 2010, J AM SOC NEPHROL, V21, P943, DOI 10.1681/ASN.2009030242; Cunard R, 2011, AM J PHYSIOL-RENAL, V300, pF1054, DOI 10.1152/ajprenal.00021.2011; Cybulsky AV, 2010, KIDNEY INT, V77, P187, DOI 10.1038/ki.2009.389; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dickhout JG, 2007, ANTIOXID REDOX SIGN, V9, P1863, DOI 10.1089/ars.2007.1780; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Friedman AN, 2005, J AM SOC NEPHROL, V16, P3397, DOI 10.1681/ASN.2004100846; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Hartz CS, 2006, J NUTR, V136, P3005, DOI 10.1093/jn/136.12.3005; Inagi R, 2010, CURR OPIN PHARMACOL, V10, P156, DOI 10.1016/j.coph.2009.11.006; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Kimura K, 2008, BIOCHEM BIOPH RES CO, V366, P1048, DOI 10.1016/j.bbrc.2007.12.098; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Liu GG, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI 10.1016/j.bbrc.2008.04.031; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Menon V, 2006, CIRCULATION, V113, P1572, DOI 10.1161/CIRCULATIONAHA.105.570127; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Ohse T, 2006, KIDNEY INT, V70, P1447, DOI 10.1038/sj.ki.5001704; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tachibana H, 2012, J AM SOC NEPHROL, V23, P1835, DOI 10.1681/ASN.2012010022; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Vance DE, 2013, BBA-MOL CELL BIOL L, V1831, P626, DOI 10.1016/j.bbalip.2012.07.017; Velagapudi C, 2011, J AM SOC NEPHROL, V22, P262, DOI 10.1681/ASN.2010040352; Wada J, 2013, CLIN SCI, V124, P139, DOI 10.1042/CS20120198; Yi F, 2008, AM J NEPHROL, V28, P254, DOI 10.1159/000110876; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang YL, 2006, J AM SOC NEPHROL, V17, P1090, DOI 10.1681/ASN.2005111148; Zhao Y, 2009, ARTERIOSCL THROM VAS, V29, P1349, DOI 10.1161/ATVBAHA.109.188672; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zou W, 2002, BBA-MOL CELL BIOL L, V1581, P49, DOI 10.1016/S1388-1981(02)00120-8	34	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92647	10.1371/journal.pone.0092647	http://dx.doi.org/10.1371/journal.pone.0092647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667182	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600060
J	Cannon, EN; Yoo, KH; Vanderwert, RE; Ferrari, PF; Woodward, AL; Fox, NA				Cannon, Erin N.; Yoo, Kathryn H.; Vanderwert, Ross E.; Ferrari, Pier F.; Woodward, Amanda L.; Fox, Nathan A.			Action Experience, More than Observation, Influences Mu Rhythm Desynchronization	PLOS ONE			English	Article							HIGH-RESOLUTION EEG; PRIMARY MOTOR CORTEX; MIRROR NEURON SYSTEM; PREMOTOR CORTEX; ALPHA-RHYTHMS; TOOL-USE; PERCEPTION; INFANTS; OSCILLATIONS; ACTIVATION	Since the discovery of mirror neurons in premotor and parietal areas of the macaque monkey, the idea that action and perception may share the same neural code has been of central interest in social, developmental, and cognitive neurosciences. A fundamental question concerns how a putative human mirror neuron system may be tuned to the motor experiences of the individual. The current study tested the hypothesis that prior motor experience modulated the sensorimotor mu and beta rhythms. Specifically, we hypothesized that these sensorimotor rhythms would be more desynchronized after active motor experience compared to passive observation experience. To test our hypothesis, we collected EEG from adult participants during the observation of a relatively novel action: an experimenter used a claw-like tool to pick up a toy. Prior to EEG collection, we trained one group of adults to perform this action with the tool (performers). A second group comprised trained video coders, who only had experience observing the action (observers). Both the performers and the observers had no prior motor and visual experience with the action. A third group of novices was also tested. Performers exhibited the greatest mu rhythm desynchronization in the 8-13 Hz band, particularly in the right hemisphere compared to observers and novices. This study is the first to contrast active tool-use experience and observation experience in the mu rhythm and to show modulation with relatively shorter amounts of experience than prior mirror neuron expertise studies. These findings are discussed with respect to its broader implication as a neural signature for a mechanism of early social learning.	[Cannon, Erin N.; Yoo, Kathryn H.; Fox, Nathan A.] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Vanderwert, Ross E.] Childrens Hosp Boston, Div Dev Med, Cognit Neurosci Lab, Boston, MA USA; [Ferrari, Pier F.] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Woodward, Amanda L.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University System of Maryland; University of Maryland College Park; Harvard University; Boston Children's Hospital; University of Parma; University of Chicago	Cannon, EN (corresponding author), Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA.	ecannon@umd.edu	Ferrari, Pier Francesco/G-5547-2017	Woodward, Amanda/0000-0002-9383-9969; Vanderwert, Ross/0000-0002-2280-8401	National Institutes of Health [P01HD064653]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD064653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by a grant from the National Institutes of Health P01HD064653. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnstein D, 2011, J NEUROSCI, V31, P14243, DOI 10.1523/JNEUROSCI.0963-11.2011; Avanzini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037534; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Babiloni C, 1999, NEUROIMAGE, V10, P658, DOI 10.1006/nimg.1999.0504; Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; Babiloni C, 2008, J PHYSIOL-LONDON, V586, P131, DOI 10.1113/jphysiol.2007.141630; Baldwin J.M., 1897, SOCIAL ETHICAL INTER; Barresi J, 1996, BEHAV BRAIN SCI, V19, P107, DOI 10.1017/S0140525X00041790; Brune CW, 2007, J COGN DEV, V8, P133, DOI 10.1080/15248370701202331; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Cannon EN, 2012, DEVELOPMENTAL SCI, V15, P35, DOI 10.1111/j.1467-7687.2011.01095.x; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross ES, 2012, NEUROPSYCHOLOGIA, V50, P3207, DOI 10.1016/j.neuropsychologia.2012.09.028; Del Percio C, 2007, CLIN NEUROPHYSIOL, V118, P1711, DOI 10.1016/j.clinph.2007.04.029; Del Percio C, 2010, CLIN NEUROPHYSIOL, V121, P482, DOI 10.1016/j.clinph.2009.12.004; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Ferrari PF, 2005, J COGNITIVE NEUROSCI, V17, P212, DOI 10.1162/0898929053124910; Ferrari PF, TRENDS COGN IN PRESS, V1222; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gredeback G, 2010, EXP BRAIN RES, V202, P493, DOI 10.1007/s00221-009-2138-1; Hadjidimitriou SK, 2011, IEEE T BIO-MED ENG, V58, P1120, DOI 10.1109/TBME.2010.2047016; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Holmes P, 2006, J SPORT SCI, V24, P605, DOI 10.1080/02640410500244507; Jarvelainen J, 2004, NEUROIMAGE, V23, P187, DOI 10.1016/j.neuroimage.2004.06.010; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lepage JF, 2010, NEUROREPORT, V21, P250, DOI 10.1097/WNR.0b013e328334ddcc; Marshall PJ, 2011, DEV COGN NEUROS-NETH, V1, P110, DOI 10.1016/j.dcn.2010.09.001; Marshall PJ, 2009, NEUROPSYCHOLOGIA, V47, P2100, DOI 10.1016/j.neuropsychologia.2009.03.022; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; McGarry LM, 2012, EXP BRAIN RES, V218, P527, DOI 10.1007/s00221-012-3046-3; Meltzoff A.N., 2005, PERSPECTIVES IMITATI, V2, P55; Moore A, 2012, BEHAV BRAIN RES, V226, P309, DOI 10.1016/j.bbr.2011.07.048; Muthukumaraswamy SD, 2004, CLIN NEUROPHYSIOL, V115, P1760, DOI 10.1016/j.clinph.2004.03.004; Muthukumaraswamy SD, 2004, COGNITIVE BRAIN RES, V19, P195, DOI 10.1016/j.cogbrainres.2003.12.001; Muthukumaraswamy SD, 2004, PSYCHOPHYSIOLOGY, V41, P152, DOI 10.1046/j.1469-8986.2003.00129.x; Orgs G, 2008, EUR J NEUROSCI, V27, P3380, DOI 10.1111/j.1460-9568.2008.06271.x; Paulus M, 2012, DEV COGN NEUROS-NETH, V2, P90, DOI 10.1016/j.dcn.2011.05.006; Pfurtscheller G, 2003, EPILEPSIA, V44, P2, DOI 10.1111/j.0013-9580.2003.12001.x; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Piaget Jean, 1952, ORIGINS INTELLIGENCE; Pineda JOA, 2006, BRAIN RES, V1121, P128, DOI 10.1016/j.brainres.2006.08.128; Quandt LC, 2013, BRAIN RES, V1534, P55, DOI 10.1016/j.brainres.2013.08.043; Quandt LC, 2012, NEUROPSYCHOLOGIA, V50, P2745, DOI 10.1016/j.neuropsychologia.2012.08.005; Quandt LC, 2011, NEUROSCI LETT, V499, P37, DOI 10.1016/j.neulet.2011.05.028; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rochat MJ, 2010, EXP BRAIN RES, V204, P605, DOI 10.1007/s00221-010-2329-9; Ruther NN, 2014, BEHAV BRAIN RES, V261, P328, DOI 10.1016/j.bbr.2013.12.033; Sommerville JA, 2005, INFANCY, V8, P119, DOI 10.1207/s15327078in0802_2; Sommerville JA, 2008, DEV PSYCHOL, V44, P1249, DOI 10.1037/a0012296; Tomasello M, 1999, DEVELOPING THEORIES OF INTENTION, P63; Umilta MA, 2008, P NATL ACAD SCI USA, V105, P2209, DOI 10.1073/pnas.0705985105; van Elk M, 2008, NEUROIMAGE, V43, P808, DOI 10.1016/j.neuroimage.2008.07.057; Vanderwert RE, 2012, NEUROSCI LETT; Vernon PA, 1992, BIOL APPROACHES STUD; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005; Woodward A., CHILD DEV IN PRESS; Woodward AL, 2005, ADV CHILD DEV BEHAV, V33, P229, DOI 10.1016/S0065-2407(05)80009-6	62	61	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92002	10.1371/journal.pone.0092002	http://dx.doi.org/10.1371/journal.pone.0092002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663967	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000333459900037
J	Dimant, H; Zhu, LY; Kibuuka, LN; Fan, Z; Hyman, BT; McLean, PJ				Dimant, Hemi; Zhu, Liya; Kibuuka, Laura N.; Fan, Zhanyun; Hyman, Bradley T.; McLean, Pamela J.			Direct Visualization of CHIP-Mediated Degradation of Alpha-Synuclein In Vivo: Implications for PD Therapeutics	PLOS ONE			English	Article							PARKINSONS-DISEASE; LEWY BODIES; C-TERMINUS; AGGREGATION; OLIGOMERS; TOXICITY; APOPTOSIS; PROTEINS; TARGETS	Parkinson's disease is a neurodegenerative disorder characterized by Lewy bodies, a pathological hallmark comprised mostly of aggregated alpha synuclein. Accumulating evidence demonstrates the association of smaller oligomeric aggregates to disease etiology and many therapeutic approaches are aimed at inhibiting and reducing the aggregation process. Molecular chaperones and co-chaperones play a key role in protein homeostasis and have potential as therapeutics to inhibit alpha synuclein associated toxicity. Here we use a gene therapy approach to evaluate the applicability of the Hsp70 co-chaperone CHIP (C-terminal Hsp70 interacting protein) as a therapeutic candidate and examine its direct effect on alpha synuclein aggregates in vivo. Utilizing a novel viral vector mediated rat model to directly detect alpha synuclein aggregates, we show that CHIP can mediate the degradation of alpha synuclein aggregates in vivo. However, our studies also reveal that CHIP may potentially degrade tyrosine hydroxylase which would compromise the applicability of CHIP as a therapeutic approach for Parkinson's disease.	[Dimant, Hemi; Zhu, Liya; Kibuuka, Laura N.; Fan, Zhanyun; Hyman, Bradley T.; McLean, Pamela J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis,Dept Neurol, Charlestown, MA 02129 USA; [McLean, Pamela J.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Harvard University; Massachusetts General Hospital; Mayo Clinic	McLean, PJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis,Dept Neurol, Charlestown, MA 02129 USA.	mclean.pamela@mayo.edu		McLean, Pamela/0000-0003-4870-5715	NIH [NS063963]; Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073740, R01NS063963] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	PM is supported by NIH NS063963. HD is supported by Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Dimant Hemi, 2013, Acta Neuropathol Commun, V1, P6, DOI 10.1186/2051-5960-1-6; Hwang JR, 2005, CELL STRESS CHAPERON, V10, P147, DOI 10.1379/CSC-90R.1; Irizarry MC, 1998, J NEUROPATH EXP NEUR, V57, P334, DOI 10.1097/00005072-199804000-00005; Kalia LV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014695; Kalia SK, 2010, CNS NEUROL DISORD-DR, V9, P741; McFarland NR, 2007, COMP ADENO ASS VIRAL; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Woo CH, 2010, FASEB J, V24, P4917, DOI 10.1096/fj.10-162636	19	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92098	10.1371/journal.pone.0092098	http://dx.doi.org/10.1371/journal.pone.0092098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664141	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900040
J	Nakayoshi, T; Sasaki, K; Kajimoto, H; Koiwaya, H; Ohtsuka, M; Ueno, T; Chibana, H; Itaya, N; Sasaki, M; Yokoyama, S; Fukumoto, Y; Imaizumi, T				Nakayoshi, Takaharu; Sasaki, Ken-ichiro; Kajimoto, Hidemi; Koiwaya, Hiroshi; Ohtsuka, Masanori; Ueno, Takafumi; Chibana, Hidetoshi; Itaya, Naoki; Sasaki, Masahiro; Yokoyama, Shinji; Fukumoto, Yoshihiro; Imaizumi, Tsutomu			FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; BONE-MARROW-CELLS; THERAPEUTIC ANGIOGENESIS; MONONUCLEAR-CELLS; METABOLIC INTERVENTION; TRANSPLANTATION; PATHWAYS; DISEASE; HINDLIMB; REDOX	The effects of therapeutic angiogenesis by intramuscular injection of early pro-angiogenic cells (EPCs) to ischemic limbs are unsatisfactory. Oxidative stress in the ischemic limbs may accelerate apoptosis of injected EPCs, leading to less neovascularization. Forkhead transcription factor 4 (FOXO4) was reported to play a pivotal role in apoptosis signaling of EPCs in response to oxidative stress. Accordingly, we assessed whether FOXO4-knockdown EPCs (FOXO4(KD)-EPCs) could suppress the oxidative stress-induced apoptosis and augment the neovascularization capacity in ischemic limbs. We transfected small interfering RNA targeted against FOXO4 of human EPCs to generate FOXO4(KD)-EPCs and confirmed a successful knockdown. FOXO4(KD)-EPCs gained resistance to apoptosis in response to hydrogen peroxide in vitro. Oxidative stress stained by dihydroethidium was stronger for the immunodeficient rat ischemic limb tissue than for the rat non-ischemic one. Although the number of apoptotic EPCs injected into the rat ischemic limb was greater than that of apoptotic EPCs injected into the rat non-ischemic limb, FOXO4(KD)-EPCs injected into the rat ischemic limb brought less apoptosis and more neovascularization than EPCs. Taken together, the use of FOXO4(KD)-EPCs with resistance to oxidative stress-induced apoptosis may be a new strategy to augment the effects of therapeutic angiogenesis by intramuscular injection of EPCs.	[Nakayoshi, Takaharu; Sasaki, Ken-ichiro; Koiwaya, Hiroshi; Ohtsuka, Masanori; Ueno, Takafumi; Chibana, Hidetoshi; Itaya, Naoki; Sasaki, Masahiro; Yokoyama, Shinji; Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Fukuoka, Japan; [Sasaki, Ken-ichiro; Kajimoto, Hidemi] Kurume Univ, Cardiovasc Res Inst, Fukuoka, Japan; [Imaizumi, Tsutomu] Int Univ Hlth & Welf, Fukuoka, Japan	Kurume University; Kurume University; International University of Health & Welfare	Sasaki, K (corresponding author), Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Fukuoka, Japan.	sasaken@med.kurume-u.ac.jp		Kajimoto, Hidemi/0000-0003-2624-7928	Strategic Research Foundation for Private Universities from MEXT, Japan; Kimura Memorial Heart Foundation;  [23791509]	Strategic Research Foundation for Private Universities from MEXT, Japan; Kimura Memorial Heart Foundation; 	This work was supported by the Grant-in-Aid from the Strategic Research Foundation for Private Universities from MEXT, Japan (http://www.mext.go.jp), to Kurume University; the Grant-in-Aid for Young Scientists (B) [23791509] to T.N; and the Grant from Kimura Memorial Heart Foundation (http://kimura-kinen.com/contents/zaidan/index.html) to T.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Alves WF, 2010, ANN VASC SURG, V24, P461, DOI 10.1016/j.avsg.2010.01.005; Balestrieri ML, 2010, ATHEROSCLEROSIS, V209, P403, DOI 10.1016/j.atherosclerosis.2009.10.022; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; de Nigris F, 2007, J CARDIOVASC PHARM, V50, P424, DOI 10.1097/FJC.0b013e31812564e4; Gonzalez F. B., 1991, FREE RADIC BIOL MED, V10, P93, DOI DOI 10.1016/0891-5849(91)90002-K; Haddad JJ, 2004, INT IMMUNOPHARMACOL, V4, P475, DOI 10.1016/j.intimp.2004.02.002; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Koiwaya H, 2011, J MOL CELL CARDIOL, V51, P33, DOI 10.1016/j.yjmcc.2011.03.012; Krotz F, 2003, J VASC RES, V40, P425, DOI 10.1159/000073901; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Matoba S, 2008, AM HEART J, V156, P1010, DOI 10.1016/j.ahj.2008.06.025; Moriya J, 2009, CIRC-CARDIOVASC INTE, V2, P245, DOI 10.1161/CIRCINTERVENTIONS.108.799361; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Pattillo CB, 2011, FREE RADICAL BIO MED, V50, P262, DOI 10.1016/j.freeradbiomed.2010.10.714; Saito Y, 2007, CIRC J, V71, P1187, DOI 10.1253/circj.71.1187; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Toyama Y, 2012, CARDIOVASC RES, V95, P448, DOI 10.1093/cvr/cvs173; Urao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057618; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Urbich C, 2011, J MOL CELL CARDIOL, V50, P333, DOI 10.1016/j.yjmcc.2010.11.022; Xu SJ, 2011, J PHARMACOL SCI, V117, P265, DOI 10.1254/jphs.11149FP	26	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92626	10.1371/journal.pone.0092626	http://dx.doi.org/10.1371/journal.pone.0092626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663349	gold, Green Submitted, Green Published			2022-12-25	WOS:000333459900087
J	Zhao, PM; Torcaso, A; Mariano, A; Xu, L; Mohsin, S; Zhao, LX; Han, RZ				Zhao, Piming; Torcaso, Audrey; Mariano, Andrew; Xu, Li; Mohsin, Sadia; Zhao, Lixia; Han, Renzhi			Anoctamin 6 Regulates C2C12 Myoblast Proliferation	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; CONTRIBUTES; FAMILY; DIFFERENTIATION; INHIBITION; EXPRESSION; KINASE; CELLS; ANO1	Anoctamin 6 (Ano6) belongs to a conserved gene family (TMEM16) predicted to code for eight transmembrane proteins with putative Ca2+-activated chloride channel (CaCC) activity. Recent work revealed that disruption of ANO6 leads to a blood coagulation defect and impaired skeletal development. However, its function in skeletal muscle cells remains to be determined. By using a RNA interference mediated (RNAi) loss-of-function approach, we show that Ano6 regulates C2C12 myoblast proliferation. Ano6 is highly expressed in C2C12 myoblasts and its expression decreases upon differentiation. Knocking down Ano6 significantly reduces C2C12 myoblast proliferation but has minimal effect on differentiation. Ano6 deficiency significantly reduces ERK/AKT phosphorylation, which has been shown to be involved in regulation of cancer cell proliferation by another Anoctamin member. Taken together, our data demonstrate for the first time that Ano6 plays an essential role in C2C12 myoblast proliferation, likely via regulating the ERK/AKT signaling pathway.	[Zhao, Piming; Torcaso, Audrey; Mariano, Andrew; Xu, Li; Mohsin, Sadia; Zhao, Lixia; Han, Renzhi] Loyola Univ, Dept Cell & Mol Physiol, Chicago Hlth Sci Div, Maywood, IL 60153 USA	Loyola University Chicago	Han, RZ (corresponding author), Loyola Univ, Dept Cell & Mol Physiol, Chicago Hlth Sci Div, Maywood, IL 60153 USA.	renhan@lumc.edu	xu, li/M-1661-2015	Han, Renzhi/0000-0002-8202-9186	American Heart Association [10SDG4140138]; Muscular Dystrophy Association [MDA171667]; NIH [R01 AR064241, R01 HL116546]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064241] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was partially supported by the American Heart Association grant 10SDG4140138 to RH, the Muscular Dystrophy Association grant MDA171667 to RH, the NIH grants R01 AR064241 and R01 HL116546 to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Kmit A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.135; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Mazzone A, 2012, BIOCHEM BIOPH RES CO, V427, P248, DOI 10.1016/j.bbrc.2012.09.022; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Otsuka M, 2005, BIOL PHARM BULL, V28, P1707, DOI 10.1248/bpb.28.1707; Park SH, 2011, ACTA CRYSTALLOGR F, V67, P1250, DOI 10.1107/S1744309111027989; Saidu SP, 2013, J GEN PHYSIOL, V141, P691, DOI 10.1085/jgp.201210937; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Stanich JE, 2011, AM J PHYSIOL-GASTR L, V301, pG1044, DOI 10.1152/ajpgi.00196.2011; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Wang M, 2012, CIRCULATION, V125, P697, DOI 10.1161/CIRCULATIONAHA.111.041806; Xu CX, 2013, MAT SCI ENG C-MATER, V33, P1783, DOI 10.1016/j.msec.2013.01.005; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027884; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang JM, 1999, EMBO J, V18, P926, DOI 10.1093/emboj/18.4.926	30	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92749	10.1371/journal.pone.0092749	http://dx.doi.org/10.1371/journal.pone.0092749			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663380	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900107
J	Aguilar, C; Schmid, N; Lardi, M; Pessi, G; Eberl, L				Aguilar, Claudio; Schmid, Nadine; Lardi, Martina; Pessi, Gabriella; Eberl, Leo			The IclR-Family Regulator BapR Controls Biofilm Formation in B-cenocepacia H111	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA; SP-NOV.; IDENTIFICATION; DIVERSITY; MEMBERS	In Burkholderia cenocepacia H111, the large surface protein BapA plays a crucial role in the formation of highly structured communities, known as biofilms. We have recently demonstrated that quorum sensing (QS) is necessary for the maximal expression of bapA. In this study we identify BapR, a protein from the IclR family of transcriptional regulators that, in conjunction with QS, controls biofilm formation by affecting the expression of bapA. We present evidence that, in addition to bapA, BapR influences the expression of extracellular proteases, swimming motility and has a profound impact in the incidence of persister cells, making this regulator an interesting target for persister cells and biofilm eradication.	[Aguilar, Claudio; Schmid, Nadine; Lardi, Martina; Pessi, Gabriella; Eberl, Leo] Univ Zurich, Inst Plant Biol, Dept Microbiol, CH-8008 Zurich, Switzerland	University of Zurich	Aguilar, C (corresponding author), Univ Zurich, Inst Plant Biol, Dept Microbiol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	claudio_aguilar@access.uzh.ch	Eberl, Leo/A-8380-2012; Pessi, Gabriella/AGW-2342-2022; Eberl, Leo/AAE-8165-2019	Eberl, Leo/0000-0002-7241-0864; Pessi, Gabriella/0000-0002-8138-5541; Aguilar, Claudio/0000-0001-8551-3347	Swiss National Science Foundation [31003A_143773]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (Project 31003A_143773). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETTER M, 1983, CELL, V35, P479, DOI 10.1016/0092-8674(83)90181-2; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Huber B, 2002, MOL MICROBIOL, V46, P411, DOI 10.1046/j.1365-2958.2002.03182.x; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Inhulsen S, 2012, MICROBIOLOGYOPEN, V1, P225, DOI 10.1002/mbo3.24; Lewenza S, 1999, J BACTERIOL, V181, P748, DOI 10.1128/JB.181.3.748-756.1999; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; Ortega XP, 2007, J BACTERIOL, V189, P3639, DOI 10.1128/JB.00153-07; Parke JL, 2001, ANNU REV PHYTOPATHOL, V39, P225, DOI 10.1146/annurev.phyto.39.1.225; Sambrook J, 2001, MOL CLONING LAB MANU; Schmid N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049966; Suppiger A, 2013, VIRULENCE, V4, P400, DOI 10.4161/viru.25338; Van Acker H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058943; Vandamme P, 2007, INT J SYST EVOL MICR, V57, P2228, DOI 10.1099/ijs.0.65142-0; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524	20	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92920	10.1371/journal.pone.0092920	http://dx.doi.org/10.1371/journal.pone.0092920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658785	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000333355300145
J	Hood, RR; Kendall, EL; Junqueira, M; Vreeland, WN; Quezado, Z; Finkel, JC; Devoe, DL				Hood, Renee R.; Kendall, Eric L.; Junqueira, Mariana; Vreeland, Wyatt N.; Quezado, Zenaide; Finkel, Julia C.; Devoe, Don L.			Microfluidic-Enabled Liposomes Elucidate Size-Dependent Transdermal Transport	PLOS ONE			English	Article							PORCINE EAR SKIN; PARTICLE-SIZE; IN-VITRO; LIPID VESICLES; DRUG CARRIERS; DELIVERY; PENETRATION; NANOPARTICLES; PERMEABILITY	Microfluidic synthesis of small and nearly-monodisperse liposomes is used to investigate the size-dependent passive transdermal transport of nanoscale lipid vesicles. While large liposomes with diameters above 105 nm are found to be excluded from deeper skin layers past the stratum corneum, the primary barrier to nanoparticle transport, liposomes with mean diameters between 31-41 nm exhibit significantly enhanced penetration. Furthermore, multicolor fluorescence imaging reveals that the smaller liposomes pass rapidly through the stratum corneum without vesicle rupture. These findings reveal that nanoscale liposomes with well-controlled size and minimal size variance are excellent vehicles for transdermal delivery of functional nanoparticle drugs.	[Hood, Renee R.; Devoe, Don L.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA; [Kendall, Eric L.; Devoe, Don L.] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA; [Junqueira, Mariana; Quezado, Zenaide; Finkel, Julia C.] Childrens Natl Med Ctr, Dept Anesthesiol Sedat & Perioperat Med, Washington, DC 20010 USA; [Vreeland, Wyatt N.] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Children's National Health System; National Institute of Standards & Technology (NIST) - USA	Devoe, DL (corresponding author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.	ddev@umd.edu	DeVoe, Don L/A-2891-2011; Quezado, Zenaide/O-4860-2016	DeVoe, Don L/0000-0002-7740-9993; Quezado, Zenaide/0000-0001-9793-4368	Sheikh Zayed Institute - Clark School of Engineering; National Science Foundation [CBET0966407]; Div Of Chem, Bioeng, Env, & Transp Sys [0966407] Funding Source: National Science Foundation	Sheikh Zayed Institute - Clark School of Engineering; National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was funded by a Sheikh Zayed Institute - Clark School of Engineering seed grant and the National Science Foundation through grant CBET0966407. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akomeah FK, 2007, J PHARM SCI-US, V96, P824, DOI 10.1002/jps.20773; BARENHOLZT Y, 1979, FEBS LETT, V99, P210, DOI 10.1016/0014-5793(79)80281-1; BATZRI S, 1973, BIOCHIM BIOPHYS ACTA, V298, P1015, DOI 10.1016/0005-2736(73)90408-2; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bouwstra JA, 2003, PROG LIPID RES, V42, P1, DOI 10.1016/S0163-7827(02)00028-0; Brewer J, 2013, J INVEST DERMATOL, V133, P1260, DOI 10.1038/jid.2012.461; Cevc G, 1998, BBA-BIOMEMBRANES, V1368, P201, DOI 10.1016/S0005-2736(97)00177-6; Cevc G, 2004, ADV DRUG DELIVER REV, V56, P675, DOI 10.1016/j.addr.2003.10.028; Chu MQ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455103; DUPLESSIS J, 1994, INT J PHARMACEUT, V103, P277, DOI 10.1016/0378-5173(94)90178-3; Elsayed MMA, 2007, INT J PHARMACEUT, V332, P1, DOI 10.1016/j.ijpharm.2006.12.005; [Gao Shumei 高淑梅], 2004, Chinese Optics Letters, V2, P160; HAMILTON RL, 1980, J LIPID RES, V21, P981; Hood RR, 2013, PHARM RES-DORDR, V30, P1597, DOI 10.1007/s11095-013-0998-3; Immordino ML, 2006, INT J NANOMED, V1, P297; Jacobi U, 2007, SKIN RES TECHNOL, V13, P19, DOI 10.1111/j.1600-0846.2006.00179.x; Jahn A, 2004, J AM CHEM SOC, V126, P2674, DOI 10.1021/ja0318030; Jahn A, 2007, LANGMUIR, V23, P6289, DOI 10.1021/la070051a; Jahn A, 2010, ACS NANO, V4, P2077, DOI 10.1021/nn901676x; Karande P, 2005, P NATL ACAD SCI USA, V102, P4688, DOI 10.1073/pnas.0501176102; Kong R, 2011, ANALYST, V136, P2359, DOI 10.1039/c1an15111h; Kuchler S, 2009, EUR J PHARM BIOPHARM, V71, P243, DOI 10.1016/j.ejpb.2008.08.019; Maulucci G, 2005, BIOPHYS J, V88, P3545, DOI 10.1529/biophysj.104.048876; Mitragotri S, 2003, J CONTROL RELEASE, V86, P69, DOI 10.1016/S0168-3659(02)00321-8; Mordon S, 2003, LASER SURG MED, V33, P119, DOI 10.1002/lsm.10204; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Prow TW, 2011, ADV DRUG DELIVER REV, V63, P470, DOI 10.1016/j.addr.2011.01.012; ROLLAND A, 1993, PHARMACEUT RES, V10, P1738, DOI 10.1023/A:1018922114398; Ryman-Rasmussen JP, 2006, TOXICOL SCI, V91, P159, DOI 10.1093/toxsci/kfj122; Schleich N, 2012, RSC DRUG DISCOV, V22, P316, DOI 10.1039/9781849735292-00316; SCHREIER H, 1994, J CONTROL RELEASE, V30, P1, DOI 10.1016/0168-3659(94)90039-6; Sekkat N, 2002, J PHARM SCI-US, V91, P2376, DOI 10.1002/jps.10220; Sentjurc M, 1999, J CONTROL RELEASE, V59, P87, DOI 10.1016/S0168-3659(98)00181-3; Sudhakar C.K., 2012, NANOMEDICINE DRUG DE, P1, DOI [10.1201/b13119-5, DOI 10.1201/B13119-5]; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Touitou E, 2000, J CONTROL RELEASE, V65, P403, DOI 10.1016/S0168-3659(99)00222-9; Verma DD, 2003, INT J PHARM, V258, P141, DOI 10.1016/S0378-5173(03)00183-2; Vogt A, 2006, J INVEST DERMATOL, V126, P1316, DOI 10.1038/sj.jid.5700226; Zook JM, 2010, SOFT MATTER, V6, P1352, DOI 10.1039/b923299k	39	29	31	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92978	10.1371/journal.pone.0092978	http://dx.doi.org/10.1371/journal.pone.0092978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658111	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300150
J	Bergada, L; Yeramian, A; Sorolla, A; Matias-Guiu, X; Dolcet, X				Bergada, Laura; Yeramian, Andree; Sorolla, Annabel; Matias-Guiu, Xavier; Dolcet, Xavier			Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; CANCER-CELLS; HDAC INHIBITORS; PROTEASOME INHIBITOR; DEPENDENT APOPTOSIS; ANTICANCER AGENTS; OXIDATIVE STRESS; CARCINOMA-CELLS; LEUKEMIA-CELLS	We have recently demonstrated that histone deacetylase inhibitor, Vorinostat, applied as a single therapy or in combination with caspase-8 downregulation exhibits high anti-tumoral activity on endometrial carcinoma cell lines. In the present study, we have assessed the signalling processes underlying anti-tumoral effects of Vorinostat. Increasing evidence suggests that reactive oxygen species are responsible for histone deacetylase inhibitor-induced cell killing. We have found that Vorinostat induces formation of reactive oxygen species and DNA damage. To investigate the role of oxidative stress as anti-neoplastic mechanism, we have evaluated the effects of different antioxidants (Bha, Nac and Tiron) on endometrial carcinoma cell line Ishikawa treated with Vorinostat. We show that Bha, Nac and Tiron markedly inhibited the cytotoxic effects of Vorinostat, increasing cell viability in vitro. We found that all three antioxidants did not inhibited accumulation of acetyl Histone H4, so that antioxidants did not inhibit Vorinostat activity. Finally, we have evaluated the effects of antioxidants on anti-tumoral activity of Vorinostat as monotherapy or in combination with caspase-8 downregulation in vivo. Interestingly, antioxidants blocked the reduction of tumour growth caused by Vorinostat, but they were unable to inhibit anti-tumoral activity of Vorinostat plus caspase-8 inhibition.	[Bergada, Laura; Yeramian, Andree; Sorolla, Annabel; Matias-Guiu, Xavier; Dolcet, Xavier] Univ Lleida, Hosp Univ Arnau de Vilanova, Inst Recerca Biomed Lleida, Oncol Pathol Grp,Dept Ciencies Med Basiques,IRBLl, Lleida, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University Hospital Arnau de Vilanova	Dolcet, X (corresponding author), Univ Lleida, Hosp Univ Arnau de Vilanova, Inst Recerca Biomed Lleida, Oncol Pathol Grp,Dept Ciencies Med Basiques,IRBLl, Lleida, Spain.	dolcet@cmb.udl.cat	yeramian, andree/B-5936-2009; Dolcet, Xavi/B-5665-2009; Sorolla, Anabel/E-2546-2012; matias-guiu, xavier/C-3039-2009; Yeramian, Andree/P-6724-2019	yeramian, andree/0000-0002-9569-6316; Dolcet, Xavi/0000-0003-1921-0449; Sorolla, Anabel/0000-0001-8238-8763; matias-guiu, xavier/0000-0002-7201-6605; 	Grupos estables AECC; Catalunya contra el cancer; programa de intensificacion de la investigacion, Instituto Carlos III; Alicia Cuello de Merigo Fellowship;  [FIS PI10/00604];  [PI10/00922];  [RD06/0020/1034];  [2009SGR794];  [2004XT00090]	Grupos estables AECC; Catalunya contra el cancer; programa de intensificacion de la investigacion, Instituto Carlos III; Alicia Cuello de Merigo Fellowship; ; ; ; ; 	Supported by grants FIS PI10/00604, PI10/00922, RD06/0020/1034, 2009SGR794, and 2004XT00090, Grupos estables AECC, Catalunya contra el cancer and programa de intensificacion de la investigacion, Instituto Carlos III. LB holds an Alicia Cuello de Merigo Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barneda-Zahonero B, 2012, MOL ONCOL, V6, P579, DOI 10.1016/j.molonc.2012.07.003; Basu HS, 2011, CANCER CHEMOTH PHARM, V67, P705, DOI 10.1007/s00280-010-1364-3; Bergada L, 2013, MOL ONCOL, V7, P763, DOI 10.1016/j.molonc.2013.03.003; Bi GF, 2006, CELL MOL IMMUNOL, V3, P285; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Catalano MG, 2012, J CLIN ENDOCR METAB, V97, pE1150, DOI 10.1210/jc.2011-2970; Catalano MG, 2012, INT J CANCER, V130, P694, DOI 10.1002/ijc.26057; Fuchs-Tarlovsky V, 2013, NUTRITION, V29, P15, DOI 10.1016/j.nut.2012.02.014; Gilbert J, 2004, CLIN CANCER RES, V10, P4589, DOI 10.1158/1078-0432.CCR-03-0297; Guasconi V, 2004, CANCER BIOL THER, V3, P825, DOI 10.4161/cbt.3.9.1102; He Hongpeng, 2003, Briefings in Functional Genomics & Proteomics, V2, P234, DOI 10.1093/bfgp/2.3.234; Hu YM, 2010, BLOOD, V116, P2732, DOI 10.1182/blood-2009-11-256354; Jin JS, 2012, PATHOL ONCOL RES, V18, P713, DOI 10.1007/s12253-012-9499-7; Kim DH, 2003, J BIOCHEM MOL BIOL, V36, P110; Kubo M, 2013, BREAST CANCER RES TR, V137, P93, DOI 10.1007/s10549-012-2332-x; La Thangue NB, 2004, J CHEMOTHERAPY, V16, P64, DOI 10.1179/joc.2004.16.Supplement-1.64; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Llobet D, 2008, ANTI-CANCER DRUG, V19, P115, DOI 10.1097/CAD.0b013e3282f24031; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Martinez-Iglesias O, 2008, CLIN TRANSL ONCOL, V10, P395, DOI 10.1007/s12094-008-0221-x; Mataga MA, 2012, ANTICANCER RES, V32, P2523; Mei SP, 2004, INT J ONCOL, V25, P1509; Miller CP, 2007, BLOOD, V110, P267, DOI 10.1182/blood-2006-03-013128; New M, 2012, MOL ONCOL, V6, P637, DOI 10.1016/j.molonc.2012.09.003; Nihal M, 2010, PHARM RES-DORDR, V27, P1103, DOI 10.1007/s11095-010-0054-5; Papi A, 2012, ANTICANCER RES, V32, P2855; Petruccelli LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020987; Portanova P, 2008, INT J ONCOL, V33, P325, DOI 10.3892/ijo_00000012; Robert C, 2012, ADV CANCER RES, V116, P87, DOI 10.1016/B978-0-12-394387-3.00003-3; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Singh BN, 2011, FUTURE ONCOL, V7, P1415, DOI [10.2217/fon.11.124, 10.2217/FON.11.124]; Singh BN, 2010, EXPERT REV ANTICANC, V10, P935, DOI [10.1586/era.10.62, 10.1586/ERA.10.62]; Villar-Garea A, 2004, INT J CANCER, V112, P171, DOI 10.1002/ijc.20372; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044265; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang DF, 2012, J IMMUNOL, V188, P4441, DOI 10.4049/jimmunol.1103035; Yaseen A, 2012, MOL PHARMACOL, V82, P1030, DOI 10.1124/mol.112.079624; You BR, 2013, INT J ONCOL, V42, P359, DOI 10.3892/ijo.2012.1705; You BR, 2010, MOL CELL BIOCHEM, V344, P203, DOI 10.1007/s11010-010-0543-1; Yu CR, 2007, CLIN CANCER RES, V13, P1140, DOI 10.1158/1078-0432.CCR-06-1751	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92764	10.1371/journal.pone.0092764	http://dx.doi.org/10.1371/journal.pone.0092764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651472	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800156
J	Hocevar, BA; Kamendulis, LM; Pu, XZ; Perkins, SM; Wang, ZY; Johnston, EL; DeWitt, JM; Li, L; Loehrer, PJ; Klaunig, JE; Chiorean, EG				Hocevar, Barbara A.; Kamendulis, Lisa M.; Pu, Xinzhu; Perkins, Susan M.; Wang, Zheng-Yu; Johnston, Erica L.; DeWitt, John M.; Li, Lang; Loehrer, Patrick J.; Klaunig, James E.; Chiorean, E. Gabriela			Contribution of Environment and Genetics to Pancreatic Cancer Susceptibility	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; ANTIOXIDANT STATUS; REPAIR GENES; POLYMORPHISMS; RISK; STRESS; SMOKING; DISEASE; EPIDEMIOLOGY; INFLAMMATION	Several risk factors have been identified as potential contributors to pancreatic cancer development, including environmental and lifestyle factors, such as smoking, drinking and diet, and medical conditions such as diabetes and pancreatitis, all of which generate oxidative stress and DNA damage. Oxidative stress status can be modified by environmental factors and also by an individual's unique genetic makeup. Here we examined the contribution of environment and genetics to an individual's level of oxidative stress, DNA damage and susceptibility to pancreatic cancer in a pilot study using three groups of subjects: a newly diagnosed pancreatic cancer group, a healthy genetically-unrelated control group living with the case subject, and a healthy genetically-related control group which does not reside with the subject. Oxidative stress and DNA damage was evaluated by measuring total antioxidant capacity, direct and oxidative DNA damage by Comet assay, and malondialdehyde levels. Direct DNA damage was significantly elevated in pancreatic cancer patients (age and sex adjusted mean 6 standard error: 1.00 +/- 0.05) versus both healthy unrelated and related controls (0.70 +/- 0.06, p<0.001 and 0.82 +/- 0.07, p = 0.046, respectively). Analysis of 22 selected SNPs in oxidative stress and DNA damage genes revealed that CYP2A6 L160H was associated with pancreatic cancer. In addition, DNA damage was found to be associated with TNFA -308G>A and ERCC4 R415Q polymorphisms. These results suggest that measurement of DNA damage, as well as select SNPs, may provide an important screening tool to identify individuals at risk for development of pancreatic cancer.	[Hocevar, Barbara A.; Kamendulis, Lisa M.; Pu, Xinzhu; Klaunig, James E.] Indiana Univ, Dept Environm Hlth, Bloomington, IN 47405 USA; [Perkins, Susan M.; Wang, Zheng-Yu; DeWitt, John M.; Li, Lang; Loehrer, Patrick J.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hocevar, Barbara A.; Kamendulis, Lisa M.; Perkins, Susan M.; Johnston, Erica L.; Li, Lang; Loehrer, Patrick J.; Klaunig, James E.; Chiorean, E. Gabriela] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Chiorean, E. Gabriela] Univ Washington, Seattle, WA 98195 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; University of Washington; University of Washington Seattle	Klaunig, JE (corresponding author), Indiana Univ, Dept Environm Hlth, Bloomington, IN 47405 USA.	jklauni@indiana.edu; gchiorea@uw.edu	DeWitt, John/AAP-3977-2020	Klaunig, James/0000-0002-4736-2223	Indiana University Simon Cancer Center Translational Research Acceleration Collaboration; Robert B. Forney professorship [R01 CA100908, P30 CA82709]; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408] Funding Source: NIH RePORTER	Indiana University Simon Cancer Center Translational Research Acceleration Collaboration; Robert B. Forney professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded in part by the Indiana University Simon Cancer Center Translational Research Acceleration Collaboration (EGC), the Robert B. Forney professorship (JEK), R01 CA100908 (JEK), and P30 CA82709 (SMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Blasiak J, 2004, MUTAT RES-FUND MOL M, V554, P297, DOI 10.1016/j.mrfmmm.2004.05.011; Collins AR, 1998, FREE RADICAL BIO MED, V25, P373, DOI 10.1016/S0891-5849(98)00053-7; Duell EJ, 2006, CANCER EPIDEM BIOMAR, V15, P726, DOI 10.1158/1055-9965.EPI-05-0797; Duell EJ, 2002, CANCER RES, V62, P4630; Duell EJ, 2002, JNCI-J NATL CANCER I, V94, P297, DOI 10.1093/jnci/94.4.297; Elahi MM, 2009, BBA-MOL BASIS DIS, V1792, P163, DOI 10.1016/j.bbadis.2009.01.007; Fuss JO, 2006, PLOS BIOL, V4, P899, DOI 10.1371/journal.pbio.0040203; Hadidi H, 1997, FOOD CHEM TOXICOL, V35, P903, DOI 10.1016/S0278-6915(97)00066-5; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Jiao L, 2007, CANCER-AM CANCER SOC, V109, P840, DOI 10.1002/cncr.22468; Jiao L, 2006, CANCER DETECT PREV, V30, P284, DOI 10.1016/j.cdp.2006.05.002; Jorgensen TJ, 2009, CANCER EPIDEM BIOMAR, V18, P346, DOI 10.1158/1055-9965.EPI-08-0659; Kadlubar S, 2009, J PANCREAS, V10, P263; Klaunig JE, 2011, TOXICOL APPL PHARM, V254, P86, DOI 10.1016/j.taap.2009.11.028; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Koorstra JBM, 2009, MODERN PATHOL, V22, P1439, DOI 10.1038/modpathol.2009.114; Kubaszek A, 2003, DIABETES, V52, P1872, DOI 10.2337/diabetes.52.7.1872; Kushwaha S, 2011, MUTAT RES-GEN TOX EN, V726, P242, DOI 10.1016/j.mrgentox.2011.10.004; Li DH, 2009, CLIN CANCER RES, V15, P740, DOI 10.1158/1078-0432.CCR-08-1607; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Maisonneuve P, 2010, DIGEST DIS, V28, P645, DOI 10.1159/000320068; McWilliams RR, 2008, CANCER RES, V68, P4928, DOI 10.1158/0008-5472.CAN-07-5539; McWilliams RR, 2009, CANCER EPIDEM BIOMAR, V18, P1295, DOI 10.1158/1055-9965.EPI-08-1109; Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017; Miri R, 2012, FOOD CHEM TOXICOL, V50, P920, DOI 10.1016/j.fct.2011.12.031; Pannuru P, 2011, HUM EXP TOXICOL, V30, P1475, DOI 10.1177/0960327110396527; Paz-Elizur T, 2008, CANCER LETT, V266, P60, DOI 10.1016/j.canlet.2008.02.032; Pu XZ, 2009, TOXICOL SCI, V111, P64, DOI 10.1093/toxsci/kfp133; Qidwai T, 2011, SCAND J IMMUNOL, V74, P522, DOI 10.1111/j.1365-3083.2011.02602.x; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rojas E, 1999, J CHROMATOGR B, V722, P225, DOI 10.1016/S0378-4347(98)00313-2; Rotunno M, 2009, PLOS ONE, V4, P1; Sachse C, 2002, CARCINOGENESIS, V23, P1839, DOI 10.1093/carcin/23.11.1839; Sengerova B, 2011, CELL CYCLE, V10, P3999, DOI 10.4161/cc.10.23.18385; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Smith TR, 2003, CANCER EPIDEM BIOMAR, V12, P1200; Song FF, 2007, CLIN SCI, V112, P599, DOI 10.1042/CS20060323; Verlaan M, 2006, WORLD J GASTROENTERO, V12, P5705, DOI 10.3748/wjg.v12.i35.5705; Vuppalanchi R, 2011, AM J MED SCI, V342, P314, DOI 10.1097/MAJ.0b013e31821d9905; Weng HC, 2009, MUTAT RES-GEN TOX EN, V679, P59, DOI 10.1016/j.mrgentox.2009.07.005; Xu C, 2002, ADV DRUG DELIVER REV, V54, P1245, DOI 10.1016/S0169-409X(02)00065-0	45	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90052	10.1371/journal.pone.0090052	http://dx.doi.org/10.1371/journal.pone.0090052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651674	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800008
J	Kondo, R; Atsuta, I; Ayukawa, Y; Yamaza, T; Matsuura, Y; Furuhashi, A; Tsukiyama, Y; Koyano, K				Kondo, Ryosuke; Atsuta, Ikiru; Ayukawa, Yasunori; Yamaza, Takayoshi; Matsuura, Yuri; Furuhashi, Akihiro; Tsukiyama, Yoshihiro; Koyano, Kiyoshi			Therapeutic Interaction of Systemically-Administered Mesenchymal Stem Cells with Peri-Implant Mucosa	PLOS ONE			English	Article							JUNCTIONAL EPITHELIUM; IN-VIVO; TITANIUM; ATTACHMENT; LAMININ-5; TISSUE; TRANSPLANTATION; FIBROBLASTS; MECHANISMS; INTERFACE	Objectives: The objective of this study was to investigate the effect of systemically transplanted mesenchymal stem cells (MSCs) on the peri-implant epithelial sealing around dental implants. Materials and Methods: MSCs were isolated from bone marrow of donor rats and expanded in culture. After recipient rats received experimental titanium dental implants in the bone sockets after extraction of maxillary right first molars, donor rat MSCs were intravenously transplanted into the recipient rats. Results: The injected MSCs were found in the oral mucosa surrounding the dental implants at 24 hours post-transplantation. MSC transplantation accelerated the formation of the peri-implant epithelium (PIE)-mediated mucosa sealing around the implants at an early stage after implantation. Subsequently, enhanced deposition of laminin-332 was found along the PIE-implant interface at 4 weeks after the replacement. We also observed enhanced attachment and proliferation of oral mucous epithelial cells. Conclusion: Systemically transplanted MSCs might play a critical role in reinforcing the epithelial sealing around dental implants.	[Kondo, Ryosuke; Atsuta, Ikiru; Ayukawa, Yasunori; Matsuura, Yuri; Furuhashi, Akihiro; Tsukiyama, Yoshihiro; Koyano, Kiyoshi] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Implant & Rehabilitat Dent, Fukuoka 812, Japan; [Yamaza, Takayoshi] Kyushu Univ, Grad Sch Dent Sci, Dept Mol Cell Biol & Oral Anat, Fukuoka 812, Japan	Kyushu University; Kyushu University	Atsuta, I (corresponding author), Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Implant & Rehabilitat Dent, Fukuoka 812, Japan.	atyuta@dent.kyushu-u.ac.jp	Ayukawa, Yasunori/AAS-8602-2020; Ayukawa, Yasunori/I-2342-2014	Ayukawa, Yasunori/0000-0003-0039-716X; Yamaza, Takayoshi/0000-0001-7055-3370	Ministry of Education, Culture, Sports, Science and Technology of Japan [23592888]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Scientific Research (C) No. 23592888 (to I. Atsuta) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Kentaro, 2012, Methods Mol Biol, V887, P111, DOI 10.1007/978-1-61779-860-3_11; Atsuta I, 2005, BIOMATERIALS, V26, P6280, DOI 10.1016/j.biomaterials.2005.03.046; Atsuta I, 2005, BIOMATERIALS, V26, P1751, DOI 10.1016/j.biomaterials.2004.05.033; Atsuta I, 2013, J BIOMED A IN PRESS; Atsuta I, 2013, CLIN ORAL I IN PRESS; Atsuta I, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt322; Atsuta I, 2012, CLIN ORAL IMPLAN RES, V23, P459, DOI 10.1111/j.1600-0501.2011.02163.x; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; BRANEMARK PI, 1983, BIOMATERIALS, V4, P25, DOI 10.1016/0142-9612(83)90065-0; BUSER D, 1992, J PERIODONTOL, V63, P225, DOI 10.1902/jop.1992.63.3.225; Chen WL, 2008, INVEST OPHTH VIS SCI, V49, P2416, DOI 10.1167/iovs.07-1085; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Egusa H, 2012, J PROSTHODONT RES, V56, P151, DOI 10.1016/j.jpor.2012.06.001; Esposito M, 1997, CLIN ORAL IMPLAN RES, V8, P352, DOI 10.1034/j.1600-0501.1997.080502.x; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Furuhashi A, 2012, ODONTOLOGY, V100, P199, DOI 10.1007/s10266-011-0029-y; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; GOULD TRL, 1984, J PROSTHET DENT, V52, P418, DOI 10.1016/0022-3913(84)90459-1; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Ikeda H, 2002, CLIN ORAL IMPLAN RES, V13, P243, DOI 10.1034/j.1600-0501.2002.130303.x; Ikeda H, 2000, J PERIODONTOL, V71, P961, DOI 10.1902/jop.2000.71.6.961; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lindhe J, 1998, PERIODONTOL 2000, V17, P47, DOI 10.1111/j.1600-0757.1998.tb00122.x; Metrailler-Ruchonnet I, 2007, FREE RADICAL BIO MED, V42, P1062, DOI 10.1016/j.freeradbiomed.2007.01.008; Okawachi H, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0027-9; SCHROEDER A, 1981, J MAXILLOFAC SURG, V9, P15, DOI 10.1016/S0301-0503(81)80007-0; SCHROEDER HE, 1986, DEUT ZAHNAERZTL Z, V41, P536; Shimono M, 2003, J ELECTRON MICROSC, V52, P627, DOI 10.1093/jmicro/52.6.627; Shiraiwa M, 2002, J PERIODONTOL, V73, P852, DOI 10.1902/jop.2002.73.8.852; Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021; Takano T, 2014, LAB INVEST IN PRESS; Tamura RN, 1997, J PERIODONTAL RES, V32, P287, DOI 10.1111/j.1600-0765.1997.tb00536.x; Tarnawski AS, 2005, DIGEST DIS SCI, V50, pS24, DOI 10.1007/s10620-005-2803-6; Wang L, 2013, STEM CELLS IN PRESS; Yamaza T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002615; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	39	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90681	10.1371/journal.pone.0090681	http://dx.doi.org/10.1371/journal.pone.0090681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651408	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800020
J	Yu, BB; Wang, Y; Zhou, QX				Yu, Binbin; Wang, Yu; Zhou, Qixing			Human Health Risk Assessment Based on Toxicity Characteristic Leaching Procedure and Simple Bioaccessibility Extraction Test of Toxic Metals in Urban Street Dust of Tianjin, China	PLOS ONE			English	Article							HEAVY-METALS; CONTAMINATED SOILS; BIOAVAILABILITY; GEOCHEMISTRY; AREA	The potential ecological and human health risk related with urban street dust from urban areas of Tianjin, China was quantitatively analyzed using the method of toxicity characteristic leaching procedure (TCLP) and simple bioaccessibility extraction test (SBET). In the study, Hakason index, Nemerow index (P), the hazard index (HI) and the cancer risk index (RI) were calculated to assess the potential risk. The sequence of potential ecological risk based on Hakason index was arsenic (As) > cadmium (Cd) > lead (Pb) > copper (Cu) > chromium (Cr), in particular, As and Cd were regarded as high polluted metals. While the results of extraction of TCLP were assessed using P, the sequence was As > Pb > Cd > Cr > Cu, which mean that As and Pb should be low polluted, and Cd, Cr and Cu would barely not polluted. For human health, total carcinogenic risk for children and adults was 2.01x10(-3) and 1.05x10(-3), respectively. This could be considered to be intolerable in urban street dust exposure. The sequence in the hazard quotient (HQ) of each element was As > Cr > Pb > Cu > Cd. The HI value of these toxic metals in urban street dust for children and adults was 5.88x10(-1) and 2.80x10(-1), respectively. According to the characters of chemistry, mobility, and bioavailability of metals in urban street dust, we estimated the hazards on the environment and human health, which will help us to get more reasonable information for risk management of metals in urban environment.	[Yu, Binbin; Zhou, Qixing] Nankai Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin 300071, Peoples R China; [Wang, Yu] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA	Nankai University; State University System of Florida; University of Florida	Zhou, QX (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin 300071, Peoples R China.	zhouqx@nankai.edu.cn	Wang, Yu/M-4220-2013	Wang, Yu/0000-0002-9614-5057	National Natural Science Foundation of China [21037002]; Ministry of Science and Technology, People's Republic of China [2012AA101403-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China)	This work was financially supported by the National Natural Science Foundation of China as a key project (grant No. 21037002) and the Ministry of Science and Technology, People's Republic of China as a 863 project (grant No. 2012AA101403-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khashman OA, 2004, ATMOS ENVIRON, V38, P6803, DOI 10.1016/j.atmosenv.2004.09.011; [Anonymous], 1561811995 GB; Arslan H, 2001, J TRACE MICROPROBE T, V19, P439, DOI 10.1081/TMA-100105058; BMEPRI, 2007, GUID SIT ENV ASS; Calabrese E., 1987, Comments on Toxicology. Comments on Modern Biology, Part B, V1, P229; Chang EE, 2001, CHEMOSPHERE, V45, P91, DOI 10.1016/S0045-6535(01)00002-9; Chen BL, 2001, J ENVIRON MONITOR, V3, P7, DOI 10.1039/b006633h; China National Environmental Monitoring Centre, EL BACKGR VAL SOIL C; Ferreira-Baptista L, 2005, ATMOS ENVIRON, V39, P4501, DOI 10.1016/j.atmosenv.2005.03.026; Ge Y, 2000, ENVIRON POLLUT, V107, P137, DOI 10.1016/S0269-7491(99)00119-0; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Han YM, 2006, SCI TOTAL ENVIRON, V355, P176, DOI 10.1016/j.scitotenv.2005.02.026; HARRISON RM, 1981, ENVIRON SCI TECHNOL, V15, P1378, DOI 10.1021/es00093a013; Hu X, 2011, ENVIRON POLLUT, V159, P1215, DOI 10.1016/j.envpol.2011.01.037; Kim JY, 2005, ENVIRON GEOCHEM HLTH, V27, P193, DOI 10.1007/s10653-005-0127-2; Li XD, 2001, APPL GEOCHEM, V16, P1361, DOI 10.1016/S0883-2927(01)00045-2; Liu Rui, 2007, Frontiers of Environmental Science and Engineering in China, V1, P114, DOI 10.1007/s11783-007-0021-5; Lu SG, 2010, ENVIRON EARTH SCI, V60, P1481, DOI 10.1007/s12665-009-0283-2; Lu Y, 2003, GEODERMA, V115, P101, DOI 10.1016/S0016-7061(03)00079-X; Luo XS, 2011, ENVIRON POLLUT, V159, P1317, DOI 10.1016/j.envpol.2011.01.013; Mahanta MJ, 2011, ENVIRON MONIT ASSESS, V173, P221, DOI 10.1007/s10661-010-1383-x; NEMEROW N.L., 1970, 16110 DAJ US EPA SYR; NRIAGU JO, 1988, ENVIRON POLLUT, V50, P139, DOI 10.1016/0269-7491(88)90189-3; Oomen AG, 2002, ENVIRON SCI TECHNOL, V36, P3326, DOI 10.1021/es010204v; OSTAPCZUK P, 1987, SCI TOTAL ENVIRON, V60, P1, DOI 10.1016/0048-9697(87)90403-7; Peng C, 2011, ENVIRON POLLUT, V159, P802, DOI 10.1016/j.envpol.2010.11.003; Poggio L, 2009, ENVIRON POLLUT, V157, P680, DOI 10.1016/j.envpol.2008.08.009; Shi G, 2010, ENVIRON POLLUT, V158, P694, DOI 10.1016/j.envpol.2009.10.020; Shi GT, 2011, ATMOS ENVIRON, V45, P764, DOI 10.1016/j.atmosenv.2010.08.039; Sun Y, 2006, ENVIRON GEOCHEM HLTH, V28, P73, DOI 10.1007/s10653-005-9014-0; Sun YB, 2010, J HAZARD MATER, V174, P455, DOI 10.1016/j.jhazmat.2009.09.074; Tang L, 2005, ENVIRON INT, V31, P822, DOI 10.1016/j.envint.2005.05.031; Tanner PA, 2008, ENVIRON SCI TECHNOL, V42, P7111, DOI 10.1021/es8007613; Thornton I, 2008, ENVIRON GEOCHEM HLTH, V30, P565, DOI 10.1007/s10653-008-9182-9; Tong STY, 2000, SCI TOTAL ENVIRON, V256, P115, DOI 10.1016/S0048-9697(00)00471-X; U.S. E.P.A., 1992, 1311 USEPA; U.S. Environmental Protection Agency, 2007, GUID EV OR BIOAV MET; United States Environmental Protection Agency (USEPA), 2008, STANDARD OPERATING P; US EPA, 2001, RISK ASS GUID SUP A; US EPA, 1997, EPA600P95002F OFF RE; US EPA (United States Environment Protection Agency), 2010, REG 9 REG SCREEN LEV; Wang G, 2012, ATMOS ENVIRON, V46, P289, DOI 10.1016/j.atmosenv.2011.09.059; Wang XS, 2007, ENVIRON MONIT ASSESS, V129, P221, DOI 10.1007/s10661-006-9355-x; Wong CSC, 2006, ENVIRON POLLUT, V142, P1, DOI 10.1016/j.envpol.2005.09.004; Yaman M, 2006, CURR MED CHEM, V13, P2513, DOI 10.2174/092986706778201620; Yeung ZLL, 2003, APPL RADIAT ISOTOPES, V58, P339, DOI 10.1016/S0969-8043(02)00351-2; Zhang L, 2012, FRONT ENV SCI ENG, V6, P360, DOI 10.1007/s11783-011-0353-z; Zheng N, 2010, SCI TOTAL ENVIRON, V408, P726, DOI 10.1016/j.scitotenv.2009.10.075; Zhou Q., 2011, POLLUTION ECOCHEMIST; Zhou QX, 2010, J SOIL SEDIMENT, V10, P1324, DOI 10.1007/s11368-010-0247-x	50	68	70	5	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92459	10.1371/journal.pone.0092459	http://dx.doi.org/10.1371/journal.pone.0092459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651129	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800110
J	Subramanian, M; Francis, P; Bilke, S; Li, XL; Hara, T; Lu, X; Jones, MF; Walker, RL; Zhu, Y; Pineda, M; Lee, C; Varanasi, L; Yang, Y; Martinez, LA; Luo, J; Ambs, S; Sharma, S; Wakefield, LM; Meltzer, PS; Lal, A				Subramanian, M.; Francis, P.; Bilke, S.; Li, X. L.; Hara, T.; Lu, X.; Jones, M. F.; Walker, R. L.; Zhu, Y.; Pineda, M.; Lee, C.; Varanasi, L.; Yang, Y.; Martinez, L. A.; Luo, J.; Ambs, S.; Sharma, S.; Wakefield, L. M.; Meltzer, P. S.; Lal, A.			A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis	ONCOGENE			English	Article							P53 MUTANTS; ACTIVATION; P63; P73; MYC; EXPRESSION; REPRESSION; MICRORNAS; GAIN; TRANSACTIVATION	Most p53 mutations in human cancers are missense mutations resulting in a full-length mutant p53 protein. Besides losing tumor suppressor activity, some hotspot p53 mutants gain oncogenic functions. This effect is mediated in part, through gene expression changes due to inhibition of p63 and p73 by mutant p53 at their target gene promoters. Here, we report that the tumor suppressor microRNA let-7i is downregulated by mutant p53 in multiple cell lines expressing endogenous mutant p53. In breast cancer patients, significantly decreased let-7i levels were associated with missense mutations in p53. Chromatin immunoprecipitation and promoter luciferase assays established let-7i as a transcriptional target of mutant p53 through p63. Introduction of let-7i to mutant p53 cells significantly inhibited migration, invasion and metastasis by repressing a network of oncogenes including E2F5, LIN28B, MYC and NRAS. Our findings demonstrate that repression of let-7i expression by mutant p53 has a key role in enhancing migration, invasion and metastasis.	[Subramanian, M.; Francis, P.; Bilke, S.; Li, X. L.; Hara, T.; Jones, M. F.; Walker, R. L.; Zhu, Y.; Pineda, M.; Meltzer, P. S.; Lal, A.] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Lu, X.; Sharma, S.] Howard Univ, Dept Biochem & Mol Biol, Coll Med, Washington, DC 20059 USA; [Lee, C.; Luo, J.] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Varanasi, L.; Martinez, L. A.] Univ Mississippi, Med Ctr, Inst Canc, Dept Biochem, Jackson, MS 39216 USA; [Yang, Y.; Wakefield, L. M.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Ambs, S.] NCI, Lab Human Carcinogenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Mississippi; University of Mississippi Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lal, A (corresponding author), NCI, Regulatory RNAs & Canc Sect, Genet Branch, NIH, Bldg 37,Room 6134,37 Convent Dr, Bethesda, MD 20892 USA.	ashish.lal@nih.gov	Sharma, Sudha/AAV-6152-2021; Wakefield, Lalage M/M-1963-2017	Sharma, Sudha/0000-0003-2765-2482; Wakefield, Lalage M/0000-0003-4124-5250; Ambs, Stefan/0000-0001-7651-9309; Walker, Robert/0000-0001-8235-4686	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Institute of General Medical Sciences of the National Institutes of Health [SC1GM093999]; NATIONAL CANCER INSTITUTE [ZIABC011091, ZIABC011399, ZIABC011400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM093999] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. Sudha Sharma was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number SC1GM093999. We thank K Prasanth, W Bodmer, B Hassel, M Thomas, J Lieberman and M Gorospe for their comments on this manuscript. We thank B Vogelstein for the DLD1 isogenic cell lines, K Vousden for the H1299-EV and H1299-p53R273H cells, S O'Hara for the pGL4-let-7i and Z Mourelators for the Ago2 (2A8) antibody.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hamano R, 2012, BRIT J CANCER, V106, P1415, DOI 10.1038/bjc.2012.90; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; Muller PAJ, 2013, ONCOGENE, V32, P1252, DOI 10.1038/onc.2012.148; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Neilsen PM, 2013, ONCOGENE, V32, P2992, DOI 10.1038/onc.2012.305; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Thomson DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055214; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.97; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Yang WH, 2012, NAT CELL BIOL, V14, P366, DOI 10.1038/ncb2455; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	53	55	55	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 26	2015	34	9					1094	1104		10.1038/onc.2014.46	http://dx.doi.org/10.1038/onc.2014.46			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RY	24662829	Green Accepted			2022-12-25	WOS:000350122100003
J	Tomiyama, L; Sezaki, T; Matsuo, M; Ueda, K; Kioka, N				Tomiyama, L.; Sezaki, T.; Matsuo, M.; Ueda, K.; Kioka, N.			Loss of Dlg5 expression promotes the migration and invasion of prostate cancer cells via Girdin phosphorylation	ONCOGENE			English	Article							BINDING PROTEIN GIRDIN; G-ALPHA-I; DOWN-REGULATION; KINASE; METASTASIS; MOTILITY; RECEPTOR; GROWTH; GIV; DIFFERENTIATION	Dlg5 has been reported to participate in cancer progression; however, its role in prostate cancer still remains poorly understood. In this study, we demonstrate that Dlg5 is frequently downregulated in prostate cancer. We show here that Dlg5 is involved in the regulation of cell migration and cancer cell invasion. Knockdown of endogenous Dlg5 markedly increased prostate cancer cell migration and invasion. Our studies, for the first time, demonstrate the interaction between Dlg5 and Girdin, an actin-binding Akt substrate. Importantly, we found that levels of Akt-mediated Girdin phosphorylation (p-Girdin-Ser1416) are increased in Dlg5-depleted cells. Small interfering RNA directed against Girdin and wortmannin treatment, which was found to reduce Girdin phosphorylation, impaired the effect of Dlg5 depletion on cell migration. Taken together, our findings demonstrate that Dlg5 interacts with and inhibits the activity of Girdin, thereby suppressing the migration of prostate cancer cells.	[Tomiyama, L.; Sezaki, T.; Matsuo, M.; Ueda, K.; Kioka, N.] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan; [Ueda, K.] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto 6068502, Japan	Kyoto University; Kyoto University	Kioka, N (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	nkioka@kais.kyoto-u.ac.jp		Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X	Asahi Glass Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Bio-oriented Technology Research Advancement Institution; Grants-in-Aid for Scientific Research [26660291] Funding Source: KAKEN	Asahi Glass Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-oriented Technology Research Advancement Institution; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Asahi Glass Foundation, a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the Bio-oriented Technology Research Advancement Institution.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Aranjuez G, 2012, G3-GENES GENOM GENET, V2, P1379, DOI 10.1534/g3.112.004093; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chang YJ, 2010, CELL CYCLE, V9, P1990, DOI 10.4161/cc.9.10.11730; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Goel HL, 2008, ENDOCR-RELAT CANCER, V15, P657, DOI 10.1677/ERC-08-0019; Hong SK, 2011, EXP CELL RES, V317, P2671, DOI 10.1016/j.yexcr.2011.08.008; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Lee YC, 2013, MOL CANCER RES, V11, P405, DOI 10.1158/1541-7786.MCR-12-0551; Lopez-Sanchez I, 2013, P NATL ACAD SCI USA, V110, P5510, DOI 10.1073/pnas.1303392110; Miyake H, 2011, CIRC RES, V108, P1170, DOI 10.1161/CIRCRESAHA.110.236174; Nakamura H, 1998, FEBS LETT, V433, P63, DOI 10.1016/S0014-5793(98)00882-5; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Natsume A, 2012, ONCOGENE, V31, P2715, DOI 10.1038/onc.2011.466; Nechiporuk T, 2007, DEV CELL, V13, P338, DOI 10.1016/j.devcel.2007.07.017; Nechiporuk T, 2013, DEV BIOL, V377, P375, DOI 10.1016/j.ydbio.2013.02.019; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sezaki T, 2013, FEBS LETT, V587, P1624, DOI 10.1016/j.febslet.2013.04.015; Sezaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035519; Shah C, 2002, BMC GENOMICS, V3; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smolen GA, 2010, GENE DEV, V24, P2654, DOI 10.1101/gad.1989110; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Taniuchi K, 2005, CANCER RES, V65, P105; Umemoto T, 2009, BIOCHEM BIOPH RES CO, V387, P191, DOI 10.1016/j.bbrc.2009.07.009; Wakabayashi M, 2003, J BIOL CHEM, V278, P21709, DOI 10.1074/jbc.M211004200; Woollard DJ, 2013, PROSTATE, V73, P563, DOI 10.1002/pros.22596; Yamashita H, 2011, J BIOL CHEM, V286, P3907, DOI 10.1074/jbc.M110.145409	37	22	24	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 26	2015	34	9					1141	1149		10.1038/onc.2014.31	http://dx.doi.org/10.1038/onc.2014.31			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RY	24662825				2022-12-25	WOS:000350122100007
J	Ikari, A; Tonegawa, C; Sanada, A; Kimura, T; Sakai, H; Hayashi, H; Hasegawa, H; Yamaguchi, M; Yamazaki, Y; Endo, S; Matsunaga, T; Sugatani, J				Ikari, Akira; Tonegawa, Chie; Sanada, Ayumi; Kimura, Toru; Sakai, Hideki; Hayashi, Hisayoshi; Hasegawa, Hajime; Yamaguchi, Masahiko; Yamazaki, Yasuhiro; Endo, Satoshi; Matsunaga, Toshiyuki; Sugatani, Junko			Tight Junctional Localization of Claudin-16 Is Regulated by Syntaxin 8 in Renal Tubular Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Confocal Microscopy; Kidney; Magnesium Homeostasis; Tight Junctions; Trafficking; Claudin; Syntaxin	THICK ASCENDING LIMB; PROTEIN-KINASE-A; MAGNESIUM TRANSPORT; HYPERTENSIVE-RATS; MEDIATED PATHWAY; MEMBRANE-FUSION; SODIUM-CHANNEL; MG2+ TRANSPORT; HENLES LOOP; TRAFFICKING	Background: Disease-associated claudin-16 mutants cause mislocalization and decrease reabsorption of Mg2+ in the kidney. Results: Knockdown of syntaxin 8 in kidney cells decreased the tight junctional localization of claudin-16 in parallel with a decrease in Mg2+ permeability. Conclusion: Syntaxin 8 controls the localization of claudin-16. Significance: Our findings provide a new insight into the trafficking mechanism of tight junctional proteins. Claudin-16 (CLDN16) regulates the paracellular reabsorption of Mg2+ in the thick ascending limb of Henle's loop. However, the mechanism regulating the tight junctional localization of CLDN16 remains unknown. In yeast two-hybrid systems, we found that CLDN16 bound to syntaxin 8 (STX8), a target soluble N-ethylmaleimide-sensitive factor attachment protein receptor. We have examined the effect of STX8 on the localization and function of CLDN16 using Madin-Darby canine kidney cells expressing FLAG-tagged CLDN16. A pulldown assay showed that the carboxyl cytoplasmic region of human CLDN16 bound to STX8. CLDN16 was localized in the thick ascending limb, whereas STX8 was widely distributed throughout the rat kidney. An association between CLDN16 and STX8 was observed in rat renal homogenates and Madin-Darby canine kidney cells. STX8 siRNA decreased the cell surface localization of CLDN16 and transepithelial electrical resistance and permeability to Mg2+ but increased the co-localization of CLDN16 with early endosome and lysosome markers. Dephosphorylation of CLDN16 by protein kinase A inhibitors and S217A mutant, a dephosphorylated form, decreased the association with STX8 and the cell surface localization of CLDN16. Recycling assays indicated that STX8 siRNA decreased the trafficking of CLDN16 to the plasma membrane without affecting endocytosis. Dominant negative Rab11 and recycling inhibitor primaquine decreased the cell surface localization of CLDN16, which was similar to that in STX8 siRNA-transfected cells. These results suggest that STX8 mediates the recycling of CLDN16 and constitutes an important component of the CLDN16 trafficking machinery in the kidney.	[Ikari, Akira; Endo, Satoshi; Matsunaga, Toshiyuki] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, Gifu 5011196, Japan; [Ikari, Akira; Tonegawa, Chie; Sanada, Ayumi; Yamaguchi, Masahiko; Yamazaki, Yasuhiro; Sugatani, Junko] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan; [Kimura, Toru] Kyorin Univ, Sch Med, Tokyo 1818611, Japan; [Sakai, Hideki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Hayashi, Hisayoshi] Univ Shizuoka, Sch Food & Nutr Sci, Shizuoka 4228526, Japan; [Hasegawa, Hajime] Saitama Med Univ, Saitama Med Ctr, Saitama 3508550, Japan	Gifu Pharmaceutical University; University of Shizuoka; Kyorin University; University of Toyama; University of Shizuoka; Saitama Medical University	Ikari, A (corresponding author), Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	ikari@gifu-pu.ac.jp	Hayashi, Hisayoshi/K-5883-2013; Endo, Satoshi/F-8059-2011	Endo, Satoshi/0000-0003-0578-9672	Japan Society for the Promotion of Science KAKENHI [23590263]; Salt Science Research Foundation [1124]; Takeda Science Foundation; Research Foundation for Pharmaceutical Sciences; Grants-in-Aid for Scientific Research [23590263] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Salt Science Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Research Foundation for Pharmaceutical Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science KAKENHI 23590263 and by grants from the Salt Science Research Foundation (1124), Takeda Science Foundation, and Research Foundation for Pharmaceutical Sciences (to A. I.).	Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Angelow S, 2007, AM J PHYSIOL-RENAL, V293, pF166, DOI 10.1152/ajprenal.00087.2007; Angelow S, 2009, J BIOL CHEM, V284, P29205, DOI 10.1074/jbc.M109.043752; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Borner GHH, 2007, TRAFFIC, V8, P893, DOI 10.1111/j.1600-0854.2007.00576.x; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Cayouette S, 2010, BBA-MOL CELL RES, V1803, P805, DOI 10.1016/j.bbamcr.2010.03.010; Darsow T, 1998, J CELL BIOL, V142, P913, DOI 10.1083/jcb.142.4.913; Dukes JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028659; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gee HY, 2010, J BIOL CHEM, V285, P35519, DOI 10.1074/jbc.M110.162438; Gunzel D, 2009, ANN NY ACAD SCI, V1165, P152, DOI 10.1111/j.1749-6632.2009.04051.x; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; Hou JH, 2005, J CELL SCI, V118, P5109, DOI 10.1242/jcs.02631; Hou JH, 2007, J BIOL CHEM, V282, P17114, DOI 10.1074/jbc.M700632200; Ikari A, 2006, J CELL SCI, V119, P1781, DOI 10.1242/jcs.02901; Ikari A, 2004, J BIOL CHEM, V279, P54826, DOI 10.1074/jbc.M406331200; Ikari A, 2001, BIOCHEM BIOPH RES CO, V287, P671, DOI 10.1006/bbrc.2001.5644; Ikari A, 2008, BBA-BIOMEMBRANES, V1778, P283, DOI 10.1016/j.bbamem.2007.10.002; Ikari A, 2008, J CELL PHYSIOL, V214, P221, DOI 10.1002/jcp.21178; Ikari A, 2006, J PHYSIOL SCI, V56, P379, DOI 10.2170/physiolsci.SC008906; Ikari A, 2013, BBA-MOL CELL RES, V1833, P2617, DOI 10.1016/j.bbamcr.2013.06.016; Ikari A, 2011, J CELL PHYSIOL, V226, P2448, DOI 10.1002/jcp.22590; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Kausalya PJ, 2006, J CLIN INVEST, V116, P878, DOI 10.1172/JCI26323; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Lanaspa MA, 2008, P NATL ACAD SCI USA, V105, P15797, DOI 10.1073/pnas.0805761105; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Muller D, 2003, AM J HUM GENET, V73, P1293, DOI 10.1086/380418; Murata M, 2005, CELL TISSUE RES, V319, P341, DOI 10.1007/s00441-004-1017-0; Nguyen N, 2013, AM J PHYSIOL-GASTR L, V304, pG157, DOI 10.1152/ajpgi.00346.2012; Ohta H, 2006, J VET MED SCI, V68, P453, DOI 10.1292/jvms.68.453; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Prekeris R, 1999, MOL BIOL CELL, V10, P3891, DOI 10.1091/mbc.10.11.3891; Quamme GA, 2000, FRONT BIOSCI-LANDMRK, V5, pD694, DOI 10.2741/Quamme; Saxena S, 1999, J BIOL CHEM, V274, P20812, DOI 10.1074/jbc.274.30.20812; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Subramaniam VN, 2000, J CELL SCI, V113, P997; Touyz RM, 1999, AM J HYPERTENS, V12, P757, DOI 10.1016/S0895-7061(99)00064-3; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; WHELTON PK, 1989, AM J CARDIOL, V63, pG26, DOI 10.1016/0002-9149(89)90215-4; Yang Y, 2007, J GEN PHYSIOL, V129, P233, DOI 10.1085/jgp.200609685	47	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13112	13123		10.1074/jbc.M113.541193	http://dx.doi.org/10.1074/jbc.M113.541193			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24659781	Green Published, hybrid			2022-12-25	WOS:000335522800013
J	Unno, H; Goda, S; Hatakeyama, T				Unno, Hideaki; Goda, Shuichiro; Hatakeyama, Tomomitsu			Hemolytic Lectin CEL-III Heptamerizes via a Large Structural Transition from alpha- Helices to a beta- Barrel during the Transmembrane Pore Formation Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate; Lectin; Membrane; Toxins; X-ray Crystallography; -Barrel; Hemolysin; Oligomer; Pore-forming Toxin	INVERTEBRATE CUCUMARIA-ECHINATA; CRYSTAL-STRUCTURE; OLIGOMERIZATION; FEATURES; REVEALS; BINDING	Background: The hemolytic lectin CEL-III self-oligomerizes upon binding to cell surface carbohydrates to form transmembrane pores. Results: The CEL-III oligomer crystal structure revealed a membrane-inserted pore structure. Conclusion: CEL-III forms a heptamer containing a long -barrel as the pore structure, resulting from large conformational changes. Significance: The heptameric structure of CEL-III provides insights into the action mechanisms of pore-forming proteins. CEL-III is a hemolytic lectin isolated from the sea cucumber Cucumaria echinata. This lectin is composed of two carbohydrate-binding domains (domains 1 and 2) and one oligomerization domain (domain 3). After binding to the cell surface carbohydrate chains through domains 1 and 2, domain 3 self-associates to form transmembrane pores, leading to cell lysis or death, which resembles other pore-forming toxins of diverse organisms. To elucidate the pore formation mechanism of CEL-III, the crystal structure of the CEL-III oligomer was determined. The CEL-III oligomer has a heptameric structure with a long -barrel as a transmembrane pore. This -barrel is composed of 14 -strands resulting from a large structural transition of -helices accommodated in the interface between domains 1 and 2 and domain 3 in the monomeric structure, suggesting that the dissociation of these -helices triggered their structural transition into a -barrel. After heptamerization, domains 1 and 2 form a flat ring, in which all carbohydrate-binding sites remain bound to cell surface carbohydrate chains, stabilizing the transmembrane -barrel in a position perpendicular to the plane of the lipid bilayer.	[Unno, Hideaki; Goda, Shuichiro; Hatakeyama, Tomomitsu] Nagasaki Univ, Grad Sch Engn, Lab Biomol Chem, Nagasaki 8528521, Japan	Nagasaki University	Hatakeyama, T (corresponding author), Nagasaki Univ, Grad Sch Engn, Lab Biomol Chem, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	thata@nagasaki-u.ac.jp	Hideaki, UNNO/ABG-9471-2020	Hideaki, UNNO/0000-0001-5917-269X; Hatakeyama, Tomomitsu/0000-0002-9505-1980	Japan Society for the Promotion of Science [23580137, 24570135, 25450133]; Grants-in-Aid for Scientific Research [25450133] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research (C) 23580137 (to T. H.) and Grants-in-aid for Young Scientists (B) 24570135 (to H. U.) and 25450133 (to S. G.) from the Japan Society for the Promotion of Science.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujisawa T, 1997, FEBS LETT, V414, P79, DOI 10.1016/S0014-5793(97)00976-9; Goda S, 2013, BIOSCI BIOTECH BIOCH, V77, P679, DOI 10.1271/bbb.120981; HATAKEYAMA T, 1995, J BIOL CHEM, V270, P3560, DOI 10.1074/jbc.270.8.3560; HATAKEYAMA T, 1994, J BIOCHEM, V116, P209, DOI 10.1093/oxfordjournals.jbchem.a124495; Hatakeyama T, 1996, J BIOL CHEM, V271, P16915, DOI 10.1074/jbc.271.28.16915; Hatakeyama T, 2007, J BIOL CHEM, V282, P37826, DOI 10.1074/jbc.M705604200; Hisamatsu K, 2013, BBA-GEN SUBJECTS, V1830, P4211, DOI 10.1016/j.bbagen.2013.04.010; Hisamatsu K, 2009, PROTEIN PEPTIDE LETT, V16, P411, DOI 10.2174/092986609787848054; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kouzuma Y, 2003, J BIOCHEM, V134, P395, DOI 10.1093/jb/mvg157; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mancheno JM, 2005, J BIOL CHEM, V280, P17251, DOI 10.1074/jbc.M413933200; Montoya M, 2003, BBA-BIOMEMBRANES, V1609, P19, DOI 10.1016/S0005-2736(02)00663-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Uchida T, 2004, J BIOL CHEM, V279, P37133, DOI 10.1074/jbc.M404065200; Unno H, 2013, ACTA CRYSTALLOGR F, V69, P416, DOI 10.1107/S1744309113004065; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108	32	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12805	12812		10.1074/jbc.M113.541896	http://dx.doi.org/10.1074/jbc.M113.541896			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24652284	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000335581400049
J	Abduljaleel, Z; Al-Allaf, FA; Khan, W; Athar, M; Shahzad, N; Taher, MM; Elrobh, M; Alanazi, MS; El-Huneidi, W				Abduljaleel, Zainularifeen; Al-Allaf, Faisal A.; Khan, Wajahatullah; Athar, Mohammad; Shahzad, Naiyer; Taher, Mohiuddin M.; Elrobh, Mohamed; Alanazi, Mohammed S.; El-Huneidi, Waseem			Evidence of Trem2 Variant Associated with Triple Risk of Alzheimer's Disease	PLOS ONE			English	Article							IN-SILICO MUTAGENESIS; PROTEIN-STRUCTURE; MUTATIONS	Alzheimer's disease is one of the main causes of dementia among elderly individuals and leads to the neurodegeneration of different areas of the brain, resulting in memory impairments and loss of cognitive functions. Recently, a rare variant that is associated with 3-fold higher risk of Alzheimer's disease onset has been found. The rare variant discovered is a missense mutation in the loop region of exon 2 of Trem2 (rs75932628-T, Arg47His). The aim of this study was to investigate the evidence for potential structural and functional significance of Trem2 gene variant (Arg47His) through molecular dynamics simulations. Our results showed the alteration caused due to the variant in TREM2 protein has significant effect on the ligand binding affinity as well as structural configuration. Based on molecular dynamics (MD) simulation under salvation, the results confirmed that native form of the variant (Arg47His) might be responsible for improved compactness, hence thereby improved protein folding. Protein simulation was carried out at different temperatures. At 300K, the deviation of the theoretical model of TREM2 protein increased from 2.0 angstrom at 10 ns. In contrast, the deviation of the Arg47His mutation was maintained at 1.2 angstrom until the end of the simulation (t = 10 ns), which indicated that Arg47His had reached its folded state. The mutant residue was a highly conserved region and was similar to "immunoglobulin V-set" and "immunoglobulin-like folds". Taken together, the result from this study provides a biophysical insight on how the studied variant could contribute to the genetic susceptibility to Alzheimer's disease.	[Abduljaleel, Zainularifeen; Al-Allaf, Faisal A.; Athar, Mohammad; Taher, Mohiuddin M.] Umm Al Qura Univ, Fac Med, Dept Med Genet, Mecca, Saudi Arabia; [Khan, Wajahatullah; El-Huneidi, Waseem] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Sci & Hlth Profess, Dept Basic Sci, Riyadh, Saudi Arabia; [Shahzad, Naiyer] Umm Al Qura Univ, Fac Med, Dept Pharmacol & Toxicol, Mecca, Saudi Arabia; [Abduljaleel, Zainularifeen; Elrobh, Mohamed; Alanazi, Mohammed S.] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair Unit, Riyadh 11451, Saudi Arabia	Umm Al Qura University; King Saud Bin Abdulaziz University for Health Sciences; Umm Al Qura University; King Saud University	Abduljaleel, Z (corresponding author), Umm Al Qura Univ, Fac Med, Dept Med Genet, Mecca, Saudi Arabia.	zainulbio@gmail.com	Athar, Mohammad/U-9467-2019; abduljaleel, zainularifeen/AAE-8036-2021; Elrobh, Mohamed S/H-5696-2012; EL-HUNEIDI, WASEEM/AAD-9698-2022	Athar, Mohammad/0000-0001-7874-7890; abduljaleel, zainularifeen/0000-0001-9791-1924; Shahzad, Naiyer/0000-0001-9125-8979; , Mohamed/0000-0003-1967-8850; AL-ALLAF, FAISAL/0000-0001-8430-3532; El-Huneidi, Waseem/0000-0002-1580-2589	Deanship of Scientific Research at King Saud University [RGP-VPP-200]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through the research group project No: RGP-VPP-200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bowers KJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2191489; Bromberg Y, 2008, BIOINFORMATICS, V24, pI207, DOI 10.1093/bioinformatics/btn268; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Bromberg Y, 2009, FASEB J, V23, P3059, DOI 10.1096/fj.08-127530; Choi WC, 2005, FEBS LETT, V579, P3461, DOI 10.1016/j.febslet.2005.05.016; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Delarue M, 2004, P NATL ACAD SCI USA, V101, P6957, DOI 10.1073/pnas.0400301101; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kamal MZ, 2010, BBA-PROTEINS PROTEOM, V1804, P1850, DOI 10.1016/j.bbapap.2010.06.014; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Prlic A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-333; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Schaefer C, 2012, BIOINFORMATICS, V28, P601, DOI 10.1093/bioinformatics/btr705; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Torkamani A, 2009, CANCER LETT, V281, P117, DOI 10.1016/j.canlet.2008.11.008; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Xu XJ, 2010, J HAZARD MATER, V175, P423, DOI 10.1016/j.jhazmat.2009.10.023	26	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92648	10.1371/journal.pone.0092648	http://dx.doi.org/10.1371/journal.pone.0092648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663666	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900090
J	Al-Sadi, R; Ye, DM; Boivin, M; Guo, SH; Hashimi, M; Ereifej, L; Ma, TY				Al-Sadi, Rana; Ye, Dongmei; Boivin, Michel; Guo, Shuhong; Hashimi, Mariam; Ereifej, Lisa; Ma, Thomas Y.			Interleukin-6 Modulation of Intestinal Epithelial Tight Junction Permeability Is Mediated by JNK Pathway Activation of Claudin-2 Gene	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LIGHT-CHAIN KINASE; CULTURED CACO-2 CELLS; KAPPA-B ACTIVATION; BARRIER DYSFUNCTION; PROTEIN-KINASE; IN-VIVO; IL-6; MECHANISM; EXPRESSION	Defective intestinal epithelial tight junction (TJ) barrier has been shown to be a pathogenic factor in the development of intestinal inflammation. Interleukin-6 (IL-6) is a pleiotropic, pro-inflammatory cytokine which plays an important role in promoting inflammatory response in the gut and in the systemic circulation. Despite its key role in mediating variety inflammatory response, the effect of IL-6 on intestinal epithelial barrier remains unclear. The purpose of this study was to investigate the effect of IL-6 on intestinal epithelial TJ barrier and to delineate the intracellular mechanisms involved using in-vitro (filter-grown Caco-2 monolayers) and in-vivo model (mouse intestinal perfusion) systems. Our results indicated that IL-6 causes a site-selective increase in Caco-2 intestinal epithelia TJ permeability, causing an increase in flux of small-sized molecules having molecular radius < 4 angstrom. The size-selective increase in Caco-2 TJ permeability was regulated by protein-specific increase in claudin-2 expression. The IL-6 increase in TJ permeability required activation of JNK signaling cascade. The JNK pathway activation of AP-1 resulted in AP-1 binding to its binding sequence on the claudin-2 promoter region, leading to promoter activation and subsequent increase in claudin-2 gene transcription and protein synthesis and TJ permeability. Our in-vivo mouse perfusion showed that IL-6 modulation of mouse intestinal permeability was also mediated by AP-1 dependent increase in claudin-2 expression. In conclusion, our studies show for the first time that the IL-6 modulation of intestinal TJ permeability was regulated by JNK activation of AP-1 and AP-1 activation of claudin-2 gene.	[Al-Sadi, Rana; Ye, Dongmei; Boivin, Michel; Guo, Shuhong; Hashimi, Mariam; Ereifej, Lisa; Ma, Thomas Y.] Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA; [Al-Sadi, Rana; Guo, Shuhong; Ma, Thomas Y.] Albuquerque Vet Affairs Med Ctr, Albuquerque, NM USA	University of New Mexico	Ma, TY (corresponding author), Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA.	tma@salud.unm.edu		Al-Sadi, Rana/0000-0002-9826-5132	Veterans Affairs (VA) Merit Review grant from the VA Research Service and National Institute of Diabetes and Digestive and Kidney Diseases [RO 1-DK-81429-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081429] Funding Source: NIH RePORTER	Veterans Affairs (VA) Merit Review grant from the VA Research Service and National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research project was supported by a Veterans Affairs (VA) Merit Review grant from the VA Research Service and National Institute of Diabetes and Digestive and Kidney Diseases Grant RO 1-DK-81429-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, AM J PHYSL GASTROINT, V300, pG1054; Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Al-Sadi R, 2009, FRONT BIOSCI-LANDMRK, V14, P2765, DOI 10.2741/3413; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Boivin MA, 2007, AM J PHYSIOL-GASTR L, V292, pG590, DOI 10.1152/ajpgi.00252.2006; Choy EHS, 2002, ARTHRITIS RHEUM-US, V46, P3143, DOI 10.1002/art.10623; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Fischer A, AM J PHYSL GASTROINT, V304, pG970; Garat C, 2003, CYTOKINE, V23, P31, DOI 10.1016/S1043-4666(03)00182-0; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Hershko DD, 2002, AM J PHYSIOL-REG I, V283, pR1140, DOI 10.1152/ajpregu.00161.2002; Hollander D, 1999, Curr Gastroenterol Rep, V1, P410, DOI 10.1007/s11894-999-0023-5; Hungness ES, 2000, SHOCK, V14, P386, DOI 10.1097/00024382-200014030-00025; Ito H, 2005, J GASTROENTEROL, V40, P32, DOI 10.1007/BF02990576; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Ma TY, 2000, AM J PHYSIOL-GASTR L, V279, pG875, DOI 10.1152/ajpgi.2000.279.5.G875; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Ma TY., 2012, PHYSL GASTROINTESTIN, V5; Mazzon E, 2002, MOL MED, V8, P353, DOI 10.1007/BF03402016; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Pallua N, 2003, CRIT CARE MED, V31, P1495, DOI 10.1097/01.CCM.0000065725.80882.BD; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; RadfordSmith G, 1996, BAILLIERE CLIN GASTR, V10, P151, DOI 10.1016/S0950-3528(96)90045-7; Rittirsch D, AM J PHYSL LUNG CELL, V304, pL863; Rollwagen FM, 1998, CLIN IMMUNOL IMMUNOP, V89, P205, DOI 10.1006/clin.1998.4600; Romagnoli C, 2001, EUR J PEDIATR, V160, P345, DOI 10.1007/PL00008445; SCHLUTER B, 1991, J TRAUMA, V31, P1663, DOI 10.1097/00005373-199112000-00017; Seegert D, 2001, GUT, V48, P326, DOI 10.1136/gut.48.3.326; Severson EA, 2009, ANN NY ACAD SCI, V1165, P10, DOI 10.1111/j.1749-6632.2009.04034.x; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tazuke Y, 2003, PEDIATR SURG INT, V19, P321, DOI 10.1007/s00383-003-1003-8; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; vanHogezand RA, 1996, NETH J MED, V48, P64, DOI 10.1016/0300-2977(95)00091-7; Wang LX, 2007, J BIOL CHEM, V282, P8219, DOI 10.1074/jbc.M604068200; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; Wang Q, 2008, SHOCK, V29, P531, DOI 10.1097/SHK.0b013e318150737f; Yang RK, 2003, AM J PHYSIOL-GASTR L, V285, pG621, DOI 10.1152/ajpgi.00177.2003; Ye D, GASTROENTEROLOGY, V141, P1323; Ye DM, 2006, AM J PHYSIOL-GASTR L, V290, pG496, DOI 10.1152/ajpgi.00318.2005; Ye D, 2008, J CELL MOL MED, V12, P1331, DOI 10.1111/j.1582-4934.2008.00302.x	43	146	155	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e85345	10.1371/journal.pone.0085345	http://dx.doi.org/10.1371/journal.pone.0085345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662742	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900001
J	Ferraye, MU; Debu, B; Heil, L; Carpenter, M; Bloem, BR; Toni, I				Ferraye, Murielle Ursulla; Debu, Bettina; Heil, Lieke; Carpenter, Mark; Bloem, Bastiaan Roelof; Toni, Ivan			Using Motor Imagery to Study the Neural Substrates of Dynamic Balance	PLOS ONE			English	Article							PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PROGRESSIVE SUPRANUCLEAR PALSY; POSTERIOR PARIETAL CORTEX; PARKINSONS-DISEASE; BRAIN ACTIVATION; CORTICOPONTINE PROJECTION; POSTURAL INSTABILITY; GAIT DISTURBANCES; FUNCTIONAL MRI; OLDER-ADULTS	This study examines the cerebral structures involved in dynamic balance using a motor imagery (MI) protocol. We recorded cerebral activity with functional magnetic resonance imaging while subjects imagined swaying on a balance board along the sagittal plane to point a laser at target pairs of different sizes (small, large). We used a matched visual imagery (VI) control task and recorded imagery durations during scanning. MI and VI durations were differentially influenced by the sway accuracy requirement, indicating that MI of balance is sensitive to the increased motor control necessary to point at a smaller target. Compared to VI, MI of dynamic balance recruited additional cortical and subcortical portions of the motor system, including frontal cortex, basal ganglia, cerebellum and mesencephalic locomotor region, the latter showing increased effective connectivity with the supplementary motor area. The regions involved in MI of dynamic balance were spatially distinct but contiguous to those involved in MI of gait (Bakker et al., 2008; Snijders et al., 2011; Cremers et al., 2012), in a pattern consistent with existing somatotopic maps of the trunk (for balance) and legs (for gait). These findings validate a novel, quantitative approach for studying the neural control of balance in humans. This approach extends previous reports on MI of static stance (Jahn et al., 2004, 2008), and opens the way for studying gait and balance impairments in patients with neurodegenerative disorders.	[Ferraye, Murielle Ursulla; Heil, Lieke; Toni, Ivan] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Debu, Bettina] Univ Grenoble, INSERM U838, Grenoble Inst Neurosci, Grenoble, France; [Carpenter, Mark] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Bloem, Bastiaan Roelof] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of British Columbia; Radboud University Nijmegen	Bloem, BR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands.	b.bloem@neuro.umcn.nl	Debû, Bettina/AAB-9935-2019; Bloem, Bastiaan/H-8013-2014; Toni, Ivan/D-1980-2009	Debû, Bettina/0000-0002-2195-8846; Bloem, Bastiaan/0000-0002-6371-3337; Toni, Ivan/0000-0003-0936-3601	Prinses Beatrix Fonds [W.OR10-35]; France Parkinson [R10078CC]; Netherlands Organisation for Scientific Research [825.10.031]	Prinses Beatrix Fonds; France Parkinson; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Prinses Beatrix Fonds (W.OR10-35); France Parkinson (R10078CC for M.U.F.); and the Netherlands Organisation for Scientific Research (825.10.031 for M.U.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Aravamuthan BR, 2007, NEUROIMAGE, V37, P694, DOI 10.1016/j.neuroimage.2007.05.050; Aravamuthan B R, 2008, Br J Neurosurg, V22 Suppl 1, pS25, DOI 10.1080/02688690802448251; Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Bakker M, 2008, NEUROIMAGE, V41, P998, DOI 10.1016/j.neuroimage.2008.03.020; Bakker M, 2007, EXP BRAIN RES, V179, P497, DOI 10.1007/s00221-006-0807-x; Ballanger B, 2009, HUM BRAIN MAPP, V30, P3901, DOI 10.1002/hbm.20815; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; BRENIERE Y, 1988, CR ACAD SCI III-VIE, V307, P617; BRODAL P, 1978, BRAIN, V101, P251, DOI 10.1093/brain/101.2.251; Crawford JD, 2011, ANNU REV NEUROSCI, V34, P309, DOI 10.1146/annurev-neuro-061010-113749; Cremers J, 2012, MOVEMENT DISORD, V27, P1498, DOI 10.1002/mds.25139; Decety Jean, 1995, Behavioural Brain Research, V72, P127, DOI 10.1016/0166-4328(96)00141-6; DHANARAJAN P, 1977, NEUROSCIENCE, V2, P913, DOI 10.1016/0306-4522(77)90114-2; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ferraye MU, 2010, BRAIN, V133, P205, DOI 10.1093/brain/awp229; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; Gemba H, 2004, NEUROSCI LETT, V357, P68, DOI 10.1016/j.neulet.2003.12.033; Heed T, 2011, J NEUROSCI, V31, P3066, DOI 10.1523/JNEUROSCI.4370-10.2011; HIRSCH EC, 1987, P NATL ACAD SCI USA, V84, P5976, DOI 10.1073/pnas.84.16.5976; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Horak FB, 2005, EXP NEUROL, V193, P504, DOI 10.1016/j.expneurol.2004.12.008; HUMMELSHEIM H, 1986, EXP BRAIN RES, V65, P75; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; JELLINGER K, 1988, J NEUROL NEUROSUR PS, V51, P540, DOI 10.1136/jnnp.51.4.540; KARNI A, 1995, NATURE, V377, P155; KEIZER K, 1989, EXP BRAIN RES, V74, P311; Koo BB, 2012, ARCH NEUROL-CHICAGO, V69, P733, DOI 10.1001/archneurol.2011.2272; la Fougere C, 2010, NEUROIMAGE, V50, P1589, DOI 10.1016/j.neuroimage.2009.12.060; Lund TE, 2005, NEUROIMAGE, V26, P960, DOI 10.1016/j.neuroimage.2005.02.021; Maillet A, 2012, J NEUROL NEUROSUR PS, V83, P986, DOI 10.1136/jnnp-2012-302461; Martinez-Gonzalez C, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00022; MASDEU JC, 1994, ANN NEUROL, V35, P619, DOI 10.1002/ana.410350517; MASDEU JC, 1988, ANN NEUROL, V23, P596, DOI 10.1002/ana.410230612; Matsumura M, 2000, NEUROSCIENCE, V98, P97, DOI 10.1016/S0306-4522(00)00099-3; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Mori F., 2003, NEUROSCI RES, V46, pS157; MORI S, 1987, PROG NEUROBIOL, V28, P161, DOI 10.1016/0301-0082(87)90010-4; Moro E, 2010, BRAIN, V133, P215, DOI 10.1093/brain/awp261; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Musienko PE, 2012, J NEUROSCI, V32, P17442, DOI 10.1523/JNEUROSCI.3757-12.2012; Muthusamy KA, 2007, J NEUROSURG, V107, P814, DOI 10.3171/JNS-07/10/0814; Ouchi Y, 1999, BRAIN, V122, P329, DOI 10.1093/brain/122.2.329; Pahapill PA, 2000, BRAIN, V123, P1767, DOI 10.1093/brain/123.9.1767; Penfield W, 1950, CEREBRAL CORTEX MAN; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Poser BA, 2006, MAGN RESON MED, V55, P1227, DOI 10.1002/mrm.20900; Preuss TM, 1996, J COMP NEUROL, V371, P649, DOI 10.1002/(SICI)1096-9861(19960805)371:4<649::AID-CNE12>3.0.CO;2-E; Roberts R, 2008, J SPORT EXERCISE PSY, V30, P200, DOI 10.1123/jsep.30.2.200; Rosano C, 2007, J GERONTOL A-BIOL, V62, P1048, DOI 10.1093/gerona/62.9.1048; Sahyoun C, 2004, NEUROIMAGE, V21, P568, DOI 10.1016/j.neuroimage.2003.09.065; Schweder PM, 2010, NEUROREPORT, V21, P914, DOI 10.1097/WNR.0b013e32833ce5f1; Sehm B, 2014, NEUROBIOL AGING, V35, P232, DOI 10.1016/j.neurobiolaging.2013.06.021; Slobounov S, 2006, MOTOR CONTROL, V10, P69, DOI 10.1123/mcj.10.1.69; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Takakusaki K, 2004, PROG BRAIN RES, V143, P231, DOI 10.1016/S0079-6123(03)43023-9; Takakusaki K, 2004, NEUROSCIENCE, V124, P467, DOI 10.1016/j.neuroscience.2003.12.016; Takakusaki K, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-4004-7; Thevathasan W, 2011, NEUROSURGERY, V69, P1248, DOI 10.1227/NEU.0b013e31822b6f71; Toni I, 2001, EXP BRAIN RES, V141, P359, DOI 10.1007/s002210100877; van Duinen H, 2005, NEUROIMAGE, V27, P240, DOI 10.1016/j.neuroimage.2005.04.003; Woollacott MH, 2000, J GERONTOL A-BIOL, V55, pM424, DOI 10.1093/gerona/55.8.M424; Zwergal A, 2011, NEUROLOGY, V77, P101, DOI 10.1212/WNL.0b013e318223c79d; Zwergal A, 2012, NEUROBIOL AGING, V33, P1073, DOI 10.1016/j.neurobiolaging.2010.09.022	70	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91183	10.1371/journal.pone.0091183	http://dx.doi.org/10.1371/journal.pone.0091183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663383	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900014
J	Lindfield, SJ; McIlwain, JL; Harvey, ES				Lindfield, Steven J.; McIlwain, Jennifer L.; Harvey, Euan S.			Depth Refuge and the Impacts of SCUBA Spearfishing on Coral Reef Fishes	PLOS ONE			English	Article							MARINE PROTECTED AREAS; STEREO-VIDEO; MANAGEMENT; PACIFIC; BIOMASS; PARROTFISHES; CONNECTIVITY; COMMUNITIES; MICRONESIA; POPULATION	In recent decades, spearfishing with SCUBA has emerged as an efficient method for targeting reef fish in deeper waters. However, deeper waters are increasingly recognised as a potential source of refuge that may help sustain fishery resources. We used a combination of historical catch data over a 20-year time period and fishery-independent surveys to investigate the effects of SCUBA spearfishing on coral reef fish populations in the southern Mariana Islands. Two jurisdictions were studied; Guam, where SCUBA spearfishing is practiced, and the nearby Commonwealth of Northern Mariana Islands (CNMI), where SCUBA spearfishing has been banned since 2003. Fishery-independent data were collected using baited remote underwater stereo-video systems (stereo-BRUVs) stratified by depth, marine protected area status and jurisdiction. Herbivores (primary consumers) dominated spearfishing catches, with parrotfish (scarines) and surgeonfish/unicornfish (acanthurids) the main groups harvested. However, the large, endangered humphead wrasse (Cheilinus undulatus) was the main species by weight landed by SCUBA spearfishers. SCUBA spearfishing was associated with declining size of scarines over time and catches shifting from a dominance of large parrotfishes to a mixed assemblage with increasing proportions of acanthurids. Comparisons between Guam and the nearby CNMI revealed differences in the assemblage of fished species and also greater size of scarines and acanthurids in deep water where SCUBA fishing is banned. These results suggest that SCUBA spearfishing impacts reef fish populations and that the restriction of this fishing method will ensure refuge for fish populations in deeper waters. We recommend a ban on SCUBA spearfishing to preserve or aid the recovery of large, functionally important coral reef species and to improve the sustainability of coral reef fisheries.	[Lindfield, Steven J.] Univ Western Australia, Fac Nat & Agr Sci, UWA Oceans Inst, Crawley, WA, Australia; [Lindfield, Steven J.] Univ Western Australia, Fac Nat & Agr Sci, Sch Plant Biol, Crawley, WA, Australia; [McIlwain, Jennifer L.; Harvey, Euan S.] Curtin Univ, Dept Environm & Agr, Bentley, WA, Australia	University of Western Australia; University of Western Australia; Curtin University	Lindfield, SJ (corresponding author), Univ Western Australia, Fac Nat & Agr Sci, UWA Oceans Inst, Crawley, WA, Australia.	steve.lindfield@yahoo.com	McIlwain, Jennifer L/J-9179-2012; Lindfield, Steven/HGE-5640-2022; Harvey, Euan/B-2896-2011	McIlwain, Jennifer L/0000-0002-7790-5081; Lindfield, Steven/0000-0002-7933-6206; Harvey, Euan/0000-0002-9069-4581	National Oceanic and Atmospheric Administration (NOAA) Coral Reef Initiative [CRI-GU-09/W090900011]	National Oceanic and Atmospheric Administration (NOAA) Coral Reef Initiative	Financial support was provided by the National Oceanic and Atmospheric Administration (NOAA) Coral Reef Initiative to the Guam Bureau of Statistics and Planning, grant number (CRI-GU-09/W090900011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The statements, findings, conclusions, and recommendations are those of the authors and do not necessarily reflect the views of the NOAA or the Guam Bureau of Statistics and Planning.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; [Anonymous], 2007, 116 U GUAM MAR LAB; Bejarano S, 2013, MAR ECOL PROG SER, V482, P197, DOI 10.3354/meps10270; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bridge TCL, 2013, NAT CLIM CHANGE, V3, P528, DOI 10.1038/nclimate1879; Burdick David, 2008, NOAA Technical Memorandum NOS NCCOS, V73, P465; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Cappo M, 2003, AQUATIC PROTECTED AR, P455; Chavarro SB, 2014, ANIM CONSERV, V17, P133, DOI 10.1111/acv.12066; Cheung WWL, 2007, MAR ECOL PROG SER, V333, P1, DOI 10.3354/meps333001; Christie P, 2007, MAR POLICY, V31, P239, DOI 10.1016/j.marpol.2006.08.001; Cinner JE, 2009, J APPL ECOL, V46, P724, DOI 10.1111/j.1365-2664.2009.01648.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clua E, 2008, AQUAT LIVING RESOUR, V21, P339, DOI 10.1051/alr:2008036; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; Davis GW, 1998, 2 PAC COMM FISH MAN, V29; Dulvy NK, 2004, ANIM CONSERV, V7, P365, DOI 10.1017/S1367943004001519; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; Fitzpatrick BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039634; Flores T, 2006, OFFSHORE FISHERIES P; Frisch AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051938; Gillett R., 2006, SPEARFISHING PACIFIC; Gillett R., 2010, MONITORING MANAGEMEN; Godoy N, 2010, ECOL APPL, V20, P1504, DOI 10.1890/09-1806.1; Goetze JS, 2011, CORAL REEFS, V30, P507, DOI 10.1007/s00338-011-0732-8; Green A., 2003, MONITORING CORAL REE, P38; Hamilton RJ, 2012, BIOL CONSERV, V145, P246, DOI 10.1016/j.biocon.2011.11.020; Hamilton RJ, 2012, FISH FISHERIES SERIE, P490; Harvey E, 2002, FISH RES, V57, P255, DOI 10.1016/S0165-7836(01)00356-3; Harvey ES, 1998, MAR TECHNOL SOC J, V32, P3; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Harvey ES, 2010, MAR TECHNOL SOC J, V44, P75, DOI 10.4031/MTSJ.44.1.3; Hensley R.A., 1993, MAR FISH REV, V55, P129; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Horne JB, 2013, J HERED, V104, P532, DOI 10.1093/jhered/est021; Houk P, 2012, CORAL REEFS, V31, P13, DOI 10.1007/s00338-011-0826-3; IUCN, 2013, IUCN RED LIST CAT CR; Karpov KA, 1998, J SHELLFISH RES, V17, P863; Langlois TJ, 2010, AQUAT BIOL, V9, P155, DOI 10.3354/ab00235; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lloret J, 2008, FISH RES, V94, P84, DOI 10.1016/j.fishres.2008.07.002; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2005, FISHERIES MANAG ECOL, V12, P105, DOI 10.1111/j.1365-2400.2004.00431.x; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; Mumby P. J., 2013, CONSERV LETT, P1; Mumby PJ, 2012, MAR ECOL PROG SER, V445, P13, DOI 10.3354/meps09450; Myers RF., 1993, MAR FISH REV, V55, P117; Nevill J, 2006, IMPACTS SPEARFISHING; Ong L, 2010, MAR BIOL, V157, P1313, DOI 10.1007/s00227-010-1411-y; Pacific Islands Benthic Habitat Mapping Center, 2022, COMMONWEALTH NO MARI; Page M, 1998, BIOL COMMUNITY STRUC; Priest MA, 2012, ECOL EVOL, V2, P3195, DOI 10.1002/ece3.260; Rhodes KL, 2008, CORAL REEFS, V27, P443, DOI 10.1007/s00338-007-0331-x; Rhodes KL, 2007, CORAL REEFS, V26, P335, DOI 10.1007/s00338-007-0202-5; Richards BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031374; Richmond Robert H., 2008, V1, P719, DOI 10.1007/978-1-4020-6847-8_19; Russ GR, 2010, OECOLOGIA, V163, P1103, DOI 10.1007/s00442-010-1692-3; Sabater MG, 2009, REV FISH SCI, V17, P318, DOI 10.1080/10641260802702872; Sadovy Y, 2003, REV FISH BIOL FISHER, V13, P327, DOI 10.1023/B:RFBF.0000033122.90679.97; Sandin SA, 2010, TROPHIC CLASSIFICATI; SAVIDGE JA, 1984, BIOL CONSERV, V30, P305, DOI 10.1016/0006-3207(84)90049-1; Seager J, 2013, MEASUREMENT SCI SPEC; Shin YJ, 2005, ICES J MAR SCI, V62, P384, DOI 10.1016/j.icesjms.2005.01.004; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Taylor BM, 2014, J FISH BIOL, V84, P383, DOI 10.1111/jfb.12294; Taylor BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039599; Taylor BM, 2010, MAR ECOL PROG SER, V411, P243, DOI 10.3354/meps08672; Tyler EHM, 2009, BIOL CONSERV, V142, P652, DOI 10.1016/j.biocon.2008.11.017; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; Williams I.D., 2012, STATUS CORAL REEF FI; Zeller D, 2007, FISH B-NOAA, V105, P266; Zgliczynski BJ, 2013, CORAL REEFS, V32, P637, DOI 10.1007/s00338-013-1018-0	80	78	79	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92628	10.1371/journal.pone.0092628	http://dx.doi.org/10.1371/journal.pone.0092628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663400	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900088
J	Awan, TH; Chauhan, BS; Cruz, PCS				Awan, Tahir Hussain; Chauhan, Bhagirath Singh; Cruz, Pompe C. Sta.			Influence of Environmental Factors on the Germination of Urena lobata L. and Its Response to Herbicides	PLOS ONE			English	Article							SEED-GERMINATION; SUBTERRANEAN CLOVER; SIERRA-LEONE; HARD SEEDS; EMERGENCE; ECOLOGY; DORMANCY; SOIL; WEEDS; RICE	Urena lobata is becoming a noxious and invasive weed in rangelands, pastures, and undisturbed areas in the Philippines. This study determined the effects of seed scarification, light, salt and water stress, amount of rice residue, and seed burial depth on seed germination and emergence of U. lobata; and evaluated the weed's response to post-emergence herbicides. Germination was stimulated by both mechanical and chemical seed scarifications. The combination of the two scarification methods provided maximum (99%) seed germination. Germination was slightly stimulated when seeds were placed in light (65%) compared with when seeds were kept in the dark (46%). Sodium chloride concentrations ranging from 0 to 200 mM and osmotic potential ranging from 0 to -1.6 MPa affected the germination of U. lobata seeds significantly. The osmotic potential required for 50% inhibition of the maximum germination was -0.1 MPa; however, some seeds germinated at -0.8 MPa, but none germinated at -1.6 MPa. Seedling emergence and biomass increased with increase in rice residue amount up to 4 t ha(-1), but declined beyond this amount. Soil surface placement of weed seeds resulted in the highest seedling emergence (84%), which declined with increase in burial depth. The burial depth required for 50% inhibition of maximum emergence was 2 cm; emergence was greatly reduced (93%) at burial depth of 4 cm or more. Weed seedling biomass also decreased with increase in burial depth. Bispyribac-sodium, a commonly used herbicide in rice, sprayed at the 4-leaf stage of the weed, provided 100% control, which did not differ much with 2,4-D (98%), glyphosate (97%), and thiobencarb + 2,4-D (98%). These herbicides reduced shoot and root biomass by 99-100%.	[Awan, Tahir Hussain; Chauhan, Bhagirath Singh] Int Rice Res Inst, Weed Sci Crop & Environm Sci Div, Los Banos, Laguna, Philippines; [Cruz, Pompe C. Sta.] Univ Philippines Los Banos, Coll Agr, Crop Sci Cluster, Los Banos, Laguna, Philippines	CGIAR; International Rice Research Institute (IRRI); University of the Philippines System; University of the Philippines Los Banos	Awan, TH (corresponding author), Int Rice Res Inst, Weed Sci Crop & Environm Sci Div, Los Banos, Laguna, Philippines.	t.awan@irri.org	Chauhan, Bhagirath/G-8892-2014	Chauhan, Bhagirath/0000-0003-1540-4668				AULD TD, 1991, AUST J ECOL, V16, P53, DOI 10.1111/j.1442-9993.1991.tb01481.x; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Benvenuti S, 2003, AGRON J, V95, P191, DOI 10.2134/agronj2003.0191; Benvenuti S, 1998, WEED RES, V38, P199, DOI 10.1046/j.1365-3180.1998.00086.x; BENVENUTI S, 1995, WEED RES, V35, P343, DOI 10.1111/j.1365-3180.1995.tb01629.x; Bolfrey-Arku GEK, 2011, WEED SCI, V59, P182, DOI 10.1614/WS-D-10-00095.1; BRADFORD KJ, 1990, PLANT PHYSIOL, V94, P840, DOI 10.1104/pp.94.2.840; Carter Ed, 1989, P 5 AUSTR AGR C 24 2, P437; Chauhan BS, 2008, WEED SCI, V56, P722, DOI 10.1614/WS-08-049.1; Chauhan BS, 2008, WEED SCI, V56, P567, DOI 10.1614/WS-07.200.1; Chauhan BS, 2008, WEED SCI, V56, P383, DOI 10.1614/WS-07-154.1; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2009, WEED SCI, V57, P379, DOI 10.1614/WS-08-179.1; Chauhan BS, 2012, WEED SCI, V60, P199, DOI 10.1614/WS-D-11-00137.1; Crocker W, 1907, BOT GAZ, V44, P0375, DOI 10.1086/329379; Culpepper AS, 2001, WEED TECHNOL, V15, P56, DOI 10.1614/0890-037X(2001)015[0056:MISALC]2.0.CO;2; Dasgupta DK, 1973, SOLS AFR, V18, P33; Dempsey JM, 1975, FIBER CROPS, P382; EVANS CE, 1990, NEW PHYTOL, V115, P539, DOI 10.1111/j.1469-8137.1990.tb00482.x; FAIRBROTHER TE, 1991, SEED SCI TECHNOL, V19, P93; FLERPC, 2008, WILDLAND WEEDS, V10, P13; Foley ME, 2001, WEED SCI, V49, P305, DOI 10.1614/0043-1745(2001)049[0305:SDAUOT]2.0.CO;2; Forest Research Institute of Malaysia, 2003, PLANT INF UR LOB GRI; Francis JK, 2003, URENA LOBATA; Ghorbani R, 1999, WEED SCI, V47, P505, DOI 10.1017/S0043174500092183; HAGON M W, 1971, Australian Journal of Experimental Agriculture and Animal Husbandry, V11, P440, DOI 10.1071/EA9710440; HARRIS PJC, 1986, TROP AGR, V63, P30; HARRIS PJC, 1985, TROP AGR, V62, P229; HARRIS PJC, 1981, TROP AGR, V58, P205; Horn Claud L., 1942, JOUR AMER SOC AGRON, V34, P1137; Kirby RH, 1963, VEGETABLE FIBRES, P135; Lafitte H.R., 2006, ORYZA, V43, P171; Liu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069364; MACDONALD GE, 1992, WEED SCI, V40, P424, DOI 10.1017/S0043174500051857; MANN RK, 1981, WEED SCI, V29, P83, DOI 10.1017/S0043174500025881; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Moody K, 1989, WEEDS REPORTE RICE S; Pearson TRH, 2002, ECOLOGY, V83, P2798, DOI 10.1890/0012-9658(2002)083[2798:GEONPI]2.0.CO;2; PEART MH, 1984, J ECOL, V72, P437, DOI 10.2307/2260057; Sanchez PA, 1976, PROPERTIES MANAGEMEN, P413; SCOTT KA, 2006, P 15 AUSTR WEEDS C A, P268; SMITH CA, 1992, WEED RES, V32, P103, DOI 10.1111/j.1365-3180.1992.tb01867.x; Squella F, 1993, P 17 INT GRASSL C PA, V1, p[419, 437]; Tanji K. K., 2002, 61 FAO; TAYLOR GB, 1985, AUST J EXP AGR, V25, P568, DOI 10.1071/EA9850568; TAYLOR GB, 1988, AUST J EXP AGR, V28, P77, DOI 10.1071/EA9880077; Taylor GB, 1982, ANN REPORT; Thomas WE, 2006, WEED SCI, V54, P316; THOMPSON K, 1994, FUNCT ECOL, V8, P29, DOI 10.2307/2390108; Tieu A, 2001, ANN BOT-LONDON, V88, P259, DOI 10.1006/anbo.2001.1451; Wing JJ, 2009, WEED SCI, V57, P31, DOI 10.1614/WS-08-092.1; WOOLLEY JT, 1978, PLANT PHYSIOL, V61, P597, DOI 10.1104/pp.61.4.597	52	20	21	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90305	10.1371/journal.pone.0090305	http://dx.doi.org/10.1371/journal.pone.0090305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658143	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300014
J	Gonzalez-Orozco, CE; Ebach, MC; Laffan, S; Thornhill, AH; Knerr, NJ; Schmidt-Lebuhn, AN; Cargill, CC; Clements, M; Nagalingum, NS; Mishler, BD; Miller, JT				Gonzalez-Orozco, Carlos E.; Ebach, Malte C.; Laffan, Shawn; Thornhill, Andrew H.; Knerr, Nunzio J.; Schmidt-Lebuhn, Alexander N.; Cargill, Christine C.; Clements, Mark; Nagalingum, Nathalie S.; Mishler, Brent D.; Miller, Joseph T.			Quantifying Phytogeographical Regions of Australia Using Geospatial Turnover in Species Composition	PLOS ONE			English	Article							BIOGEOGRAPHICAL REGIONS; SPATIAL TURNOVER; BETA DIVERSITY; RICHNESS; CLIMATE; DISTRIBUTIONS; COMMUNITIES; EVOLUTION; FRAMEWORK; ENDEMISM	The largest digitized dataset of land plant distributions in Australia assembled to date (750,741 georeferenced herbarium records; 6,043 species) was used to partition the Australian continent into phytogeographical regions. We used a set of six widely distributed vascular plant groups and three non-vascular plant groups which together occur in a variety of landscapes/habitats across Australia. Phytogeographical regions were identified using quantitative analyses of species turnover, the rate of change in species composition between sites, calculated as Simpson's beta. We propose six major phytogeographical regions for Australia: Northern, Northern Desert, Eremaean, Eastern Queensland, Euronotian and South-Western. Our new phytogeographical regions show a spatial agreement of 65% with respect to previously defined phytogeographical regions of Australia. We also confirm that these new regions are in general agreement with the biomes of Australia and other contemporary biogeographical classifications. To assess the meaningfulness of the proposed phytogeographical regions, we evaluated how they relate to broad scale environmental gradients. Physiographic factors such as geology do not have a strong correspondence with our proposed regions. Instead, we identified climate as the main environmental driver. The use of an unprecedentedly large dataset of multiple plant groups, coupled with an explicit quantitative analysis, makes this study novel and allows an improved historical bioregionalization scheme for Australian plants. Our analyses show that: (1) there is considerable overlap between our results and older biogeographic classifications; (2) phytogeographical regions based on species turnover can be a powerful tool to further partition the landscape into meaningful units; (3) further studies using phylogenetic turnover metrics are needed to test the taxonomic areas.	[Gonzalez-Orozco, Carlos E.; Thornhill, Andrew H.; Knerr, Nunzio J.; Schmidt-Lebuhn, Alexander N.; Cargill, Christine C.; Clements, Mark; Miller, Joseph T.] Commonwealth Sci & Ind Res Org, Ctr Australian Natl Biodivers Res, Canberra, ACT, Australia; [Ebach, Malte C.; Laffan, Shawn] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Nagalingum, Nathalie S.] Natl Herbarium New South Wales, Bot Gardens Trust, Sydney, NSW, Australia; [Mishler, Brent D.] Univ Calif Berkeley, Dept Integrat Biol, Univ & Jepson Herbaria, Berkeley, CA 94720 USA; [Thornhill, Andrew H.] James Cook Univ, Australian Trop Herbarium, Cairns, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of New South Wales Sydney; University of California System; University of California Berkeley; James Cook University	Gonzalez-Orozco, CE (corresponding author), Commonwealth Sci & Ind Res Org, Ctr Australian Natl Biodivers Res, Canberra, ACT, Australia.	carlos.gonzalez-orozco@canberra.edu.au	Yeates, David K/A-9917-2008; Laffan, Shawn W/A-3761-2008; Schmidt-Lebuhn, Alexander N/C-2482-2009; Knerr, Nunzio/AAW-1449-2021; Thornhill, Andrew/I-3363-2012; Cargill, Christine/Z-2856-2019; Miller, Joseph T./M-2693-2016; Ebach, Malte/D-8274-2016	Yeates, David K/0000-0001-7729-6143; Laffan, Shawn W/0000-0002-5996-0570; Schmidt-Lebuhn, Alexander N/0000-0002-7402-8941; Knerr, Nunzio/0000-0002-0562-9479; Thornhill, Andrew/0000-0002-0325-5725; Cargill, Christine/0000-0001-8390-3245; Miller, Joseph T./0000-0002-5788-9010; Ebach, Malte/0000-0002-9594-9010	Australian Research Council [FT0992002]; University of New South Wales, Australia [RG114989, RG124461]; CSIRO (Australia); Cancer Research UK; EPSRC Cancer Imaging Centre; MRC; Department of Health (England) [C1060/A10334]; NHS; Chang Gung Medical Foundation (Taiwan) [CMRPG370443, CMRPG3B1922]	Australian Research Council(Australian Research Council); University of New South Wales, Australia; CSIRO (Australia)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Cancer Research UK(Cancer Research UK); EPSRC Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); NHS; Chang Gung Medical Foundation (Taiwan)	MCE's contribution was supported under Australian Research Council's 'Future Fellow' funding scheme (project number FT0992002). MCE and SWL also wish to thank the University of New South Wales, Australia for two Goldstar Grants (RG114989 & RG124461). The authors would like to thank Bernd Gruber for supporting the spatial overlap analyses. BDM thanks CSIRO (Australia) for a Distinguished Visiting Scientist Award. The authors acknowledge the support received from the Cancer Research UK and EPSRC Cancer Imaging Centre in association with the MRC and Department of Health (England) grant C1060/A10334, also NHS funding to the NIHR Biomedical Research Centre, MRC-funded studentship, also Chang Gung Medical Foundation (Taiwan) grants CMRPG370443 and CMRPG3B1922. MOL is an NIHR Senior Investigator. The authors thank Alice Warley at the Kings College London Centre for Ultrastructural Imaging (CUI) for assistance with electron microscopy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	BARLOW B A, 1984, Brunonia, V7, P195, DOI 10.1071/BRU9840195; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; BEADLE NCW, 1962, ECOLOGY, V43, P281, DOI 10.2307/1931983; Beard J.S., 1981, ECOLOGICAL BIOGEOGRA, P335; Brooker MIH, 2006, EUCLID EUC SO AUSTR; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; BURBRIDGE NANCY T., 1960, AUSTRALIAN JOUR BOT, V8, P75, DOI 10.1071/BT9600075; CHAH, 2010, AUSTR PLANT CENS; CHAH [Council of Heads of Australasian Herbaria], 2020, AUSTR PLANT CENSUS; Clarke GL, 1980, GEOLOGY, V4, P1; Conran JG, 1995, J BIOGEOGR, V22, P1023, DOI 10.2307/2845832; CRACRAFT J, 1991, Australian Systematic Botany, V4, P211, DOI 10.1071/SB9910211; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crisp MD, 1995, SYST BIOL, V44, P457, DOI 10.2307/2413654; Dapporto L, 2013, ECOGRAPHY, V36, P1070, DOI 10.1111/j.1600-0587.2013.00444.x; DOING H., 1970, Miscellaneous Papers. Landbouwhogeschool Wageningen, No. 6, P81; DWER, 2007, AUSTR NAT VEG SUMM A; Ebach MC, 2012, ZOOTAXA, P1; Ebach MC, 2013, ZOOTAXA, V3619, P315, DOI 10.11646/zootaxa.3619.3.4; *ESRI, 2005, ARCGIS 9 2; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Garcillan PP, 2003, J VEG SCI, V14, P475, DOI 10.1111/j.1654-1103.2003.tb02174.x; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Gonzalez-Orozco CE, 2014, DIVERS DISTRIB, V20, P46, DOI 10.1111/ddi.12129; Gonzalez-Orozco CE, 2013, J BIOGEOGR, V40, P2156, DOI 10.1111/jbi.12153; Gonzalez-Orozco CE, 2011, AUST J BOT, V59, P600, DOI 10.1071/BT11112; Hedley C., 1894, REPORTS AUSTR ASS AD, V5, P444, DOI DOI 10.1080/00222939408677821; HNATIUK RJ, 1988, AUST J BOT, V36, P361, DOI 10.1071/BT9880361c; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Houlder D. J., 2000, ANUCLIM USERS GUIDE; Hutchinson MF, 2000, BIOCLIM USERS GUIDE; Integrated Marine and Coastal Regionalisation of Australia, 2006, IMCRA VERS 4 0; Interim Biogeographic Regionalisation for Australia, 1995, IBRA VERS 6 1; Johnston RM, 2003, AUST J SOIL RES, V41, P1021, DOI 10.1071/SR02033; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Kulheim C, 2011, NEW PHYTOL, V191, P1041, DOI 10.1111/j.1469-8137.2011.03769.x; Ladiges PY, 2005, J BIOGEOGR, V32, P1909, DOI 10.1111/j.1365-2699.2005.01347.x; Ladiges PY, 1991, AUSTRAL BIOGEOGRAPHY; Laffan SW, 2010, ECOGRAPHY, V33, P643, DOI 10.1111/j.1600-0587.2010.06237.x; Laffan SW, 2002, INT J GEOGR INF SCI, V16, P245, DOI 10.1080/13658810110099107; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; Mackey BG, 2008, J BIOGEOGR, V35, P213, DOI 10.1111/j.1365-2699.2007.01822.x; MOORE CWE, 1959, ECOLOGY, V40, P734, DOI 10.2307/1929834; Nicholls G. E., 1933, Report Australian and New Zealand Association for the Advancement of Science, V21, P93; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Parenti L. R., 2009, COMP BIOGEOGRAPHY DI; Pepper M, 2013, J BIOGEOGR, V40, P1225, DOI 10.1111/jbi.12080; R Development Core Team, 2005, R LANG ENV STAT COMP; Rosauer DF, 2014, ECOGRAPHY, V37, P21, DOI 10.1111/j.1600-0587.2013.00466.x; Stern H, 1985, OBJECTIVE CLASSIFICA; Stevenson LA, 2012, J BRYOL, V34, P101, DOI 10.1179/1743282012Y.0000000004; Tate R, 1889, 1 M AUSTR ASS ADV SC, P312; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Udvardy M.D.F, 1975, 18 IUCN; von Mueller F, 1858, ESQ PRECEDING ROYAL, V2, P137; Wulff EV, 1950, INTRO HIST PLANT GEO, P223; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	57	71	78	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92558	10.1371/journal.pone.0092558	http://dx.doi.org/10.1371/journal.pone.0092558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658356	Green Accepted, Green Published, gold			2022-12-25	WOS:000333355300097
J	Wang, Y; Kou, Y; Wang, XD; Cederbaum, A; Wang, R				Wang, Yuan; Kou, Yan; Wang, Xiaodong; Cederbaum, Arthur; Wang, Rong			Multifactorial Comparative Proteomic Study of Cytochrome P450 2E1 Function in Chronic Alcohol Administration	PLOS ONE			English	Article							INDUCED LIVER-INJURY; GLUTATHIONE-S-TRANSFERASES; OXIDATIVE STRESS; FATTY LIVER; MITOCHONDRIAL PROTEOME; T-LYMPHOCYTES; RAT-LIVER; ETHANOL; EXPRESSION; DISEASE	With the use of iTRAQ technique, a multifactorial comparative proteomic study can be performed. In this study, to obtain an overview of ethanol, CYP2E1 and gender effects on liver injury and gain more insight into the underlying molecular mechanism, mouse liver proteomes were quantitatively analyzed using iTRAQ under eight conditions including mice of different genders, wild type versus CYP2E1 knockout, and normal versus alcohol diet. A series of statistical and bioinformatic analyses were explored to simplify and clarify multifactorial comparative proteomic data. First, with the Principle Component analysis, six proteins, CYP2E1, FAM25, CA3, BHMT, HIBADH and ECHS1, involved in oxidation reduction, energy and lipid metabolism and amino acid metabolism, were identified as the most differentially expressed gene products across all of the experimental conditions of our chronic alcoholism model. Second, hierarchical clustering analysis showed CYP2E1 knockout played a primary role in the overall differential protein expression compared with ethanol and gender factors. Furthermore, pair-wise multiple comparisons have revealed that the only significant expression difference lied in wild-type and CYP2E1 knockout mice both treated with ethanol. Third, K-mean clustering analysis indicated that the CYP2E1 knockout had the reverse effect on ethanol induced oxidative stress and lipid oxidation. More importantly, IPA analysis of proteomic data inferred that the gene expressions of two upstream regulators, NRF2 and PPAR alpha, regulated by chronic alcohol feeding and CYP2E1 knockout, are involved in ethanol induced oxidative stress and lipid oxidation. The present study provides an effectively comprehensive data analysis strategy to compare multiple biological factors, contributing to biochemical effects of alcohol on the liver. The mass spectrometry proteomics data have been deposited to the ProteomeXchange with data set identifier of PXD000635.	[Wang, Yuan; Wang, Rong] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kou, Yan; Wang, Xiaodong; Cederbaum, Arthur] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Wang, R (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	rong.wang@mssm.edu	Wang, Rong/A-8721-2009		USPHS NIH [R01 AA018790, R21 AA021362, P30 NS061777, S10 RR022415]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA021362, R01AA018790] Funding Source: NIH RePORTER	USPHS NIH(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported, in part, by USPHS NIH grants R01 AA018790 and R21 AA021362 to AC, and P30 NS061777 and S10 RR022415 to RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2009, J MED FOOD, V12, P1190, DOI 10.1089/jmf.2009.0017; Apte UM, 2004, TOXICOL PATHOL, V32, P567, DOI 10.1080/01926230490508812; Aroor AR, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-29; Arteel GE, 2003, GASTROENTEROLOGY, V124, P778, DOI 10.1053/gast.2003.50087; Banerjee A, 2006, J PATHOL, V208, P473, DOI 10.1002/path.1917; Banerjee A, 2008, PROTEOMICS, V8, P4327, DOI 10.1002/pmic.200700368; BONDY SC, 1992, TOXICOL LETT, V63, P231, DOI 10.1016/0378-4274(92)90086-Y; Braeuning A, 2009, DRUG METAB DISPOS, V37, P1138, DOI 10.1124/dmd.108.026179; BRUDZYNSKI K, 1992, DIABETOLOGIA, V35, P316, DOI 10.1007/BF00401198; Cederbaum AI, 2001, FREE RADICAL BIO MED, V31, P1524, DOI 10.1016/S0891-5849(01)00741-9; Cohen JI, 2011, ANTIOXID REDOX SIGN, V15, P523, DOI 10.1089/ars.2010.3746; Colantoni A, 2000, ALCOHOL CLIN EXP RES, V24, P1467, DOI 10.1097/00000374-200009000-00020; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Diehl AM, 2002, ALCOHOL, V27, P7, DOI 10.1016/S0741-8329(02)00204-5; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fogle RL, 2011, PHYSIOL GENOMICS, V43, P346, DOI 10.1152/physiolgenomics.00203.2010; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gallucci RM, 2004, ALCOHOL CLIN EXP RES, V28, P365, DOI 10.1097/01.ALC.0000118316.20560.0D; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; HOLOSHITZ J, 1986, LANCET, V2, P305; Jia XF, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-39; Jia ZQ, 2008, MOL CELL BIOCHEM, V307, P185, DOI 10.1007/s11010-007-9598-z; Khana AJ, 2009, DRUG ALCOHOL DEPEN, V101, P183, DOI 10.1016/j.drugalcdep.2008.12.001; Kharbanda KK, 2009, BIOCHEM BIOPH RES CO, V381, P523, DOI 10.1016/j.bbrc.2009.02.082; Klouckova I, 2006, PROTEOMICS, V6, P3060, DOI 10.1002/pmic.200500725; Kohls D, 1999, ACTA CRYSTALLOGR D, V55, P1206, DOI 10.1107/S0907444999003601; Kono H, 2000, AM J PHYSIOL-GASTR L, V278, pG652, DOI 10.1152/ajpgi.2000.278.4.G652; Ladero JM, 2005, SCAND J GASTROENTERO, V40, P348, DOI 10.1080/00365520510012109; Lai XY, 2009, ELECTROPHORESIS, V30, P2207, DOI 10.1002/elps.200800775; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Lapierre P, 1999, GASTROENTEROLOGY, V116, P643, DOI 10.1016/S0016-5085(99)70186-1; Leung TM, 2012, HEPATOLOGY, V55, P1596, DOI 10.1002/hep.25543; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Lieber CS, 1997, CLIN CHIM ACTA, V257, P59, DOI 10.1016/S0009-8981(96)06434-0; LIEBER CS, 1984, MED CLIN N AM, V68, P3, DOI 10.1016/S0025-7125(16)31238-X; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Lu YK, 2011, DRUG METAB DISPOS, V39, P330, DOI 10.1124/dmd.110.035691; Lu YK, 2010, FREE RADICAL BIO MED, V49, P1406, DOI 10.1016/j.freeradbiomed.2010.07.026; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; Mandrekar P, 2009, J HEPATOL, V50, P1258, DOI 10.1016/j.jhep.2009.03.007; Medici V, 2012, MOL NUTR FOOD RES; Medici V, 2010, J HEPATOL, V53, P551, DOI 10.1016/j.jhep.2010.03.029; Min H, 2005, ALCOHOL CLIN EXP RES, V29, P2188, DOI 10.1097/01.alc.0000191756.02856.a8; Moon KH, 2006, HEPATOLOGY, V44, P1218, DOI 10.1002/hep.21372; Muller C, 2006, WIEN MED WOCHENSCHR, V156, P523, DOI [10.1007/s10354-006-0348-8, 10.1007/s10354-006-0314-5]; Nanji AA, 2001, AM J PHYSIOL-GASTR L, V281, pG1348, DOI 10.1152/ajpgi.2001.281.6.G1348; Nanji AA, 2004, J PHARMACOL EXP THER, V310, P417, DOI 10.1124/jpet.103.064717; Nanji AA, 2002, ALCOHOL CLIN EXP RES, V26, P731, DOI 10.1097/00000374-200205000-00020; Newton BW, 2009, J PROTEOME RES, V8, P1663, DOI 10.1021/pr800905w; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; Park B, 2004, PROTEOMICS, V4, P3413, DOI 10.1002/pmic.200400975; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Ramaiah SK, 2004, INT J TOXICOL, V23, P217, DOI 10.1080/10915810490502069; Rao Prahlad K, 2009, J Proteomics Bioinform, V2, P19; REINKE LA, 1985, DRUG METAB DISPOS, V13, P548; Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131; Shi L, 2008, J PROTEOME RES, V7, P3137, DOI 10.1021/pr700853j; Sun W, 2007, MOL CELL PROTEOMICS, V6, P1798, DOI 10.1074/mcp.M600449-MCP200; Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321; Venkatraman A, 2004, J BIOL CHEM, V279, P22092, DOI 10.1074/jbc.M402245200; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; WISEMAN MS, 1991, ARCH BIOCHEM BIOPHYS, V290, P191, DOI 10.1016/0003-9861(91)90607-K; XU QB, 1993, J CLIN INVEST, V91, P2693, DOI 10.1172/JCI116508; Zhang LJ, 2011, ACTA BIOCH BIOPH SIN, V43, P19, DOI 10.1093/abbs/gmq108; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P71, DOI 10.1007/s12012-008-9016-0; Zhu H, 2012, J DIGEST DIS, V13, P133, DOI 10.1111/j.1751-2980.2011.00569.x	67	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92504	10.1371/journal.pone.0092504	http://dx.doi.org/10.1371/journal.pone.0092504			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658151	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300092
J	Zhai, WH; Huang, ZG; Chen, L; Feng, C; Li, B; Li, TS				Zhai, Wenhui; Huang, Zhigang; Chen, Li; Feng, Cong; Li, Bei; Li, Tanshi			Thyroid Endocrine Disruption in Zebrafish Larvae after Exposure to Mono-(2-Ethylhexyl) Phthalate (MEHP)	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; DI-(2-ETHYLHEXYL) PHTHALATE; DI(2-ETHYLHEXYL) PHTHALATE; URINARY PHTHALATE; OXIDATIVE STRESS; ACID MONOESTERS; HORMONE LEVELS; BISPHENOL-A; GC-MS; MODEL	Phthalates are extensively used as plasticizers in a variety of daily-life products, resulting in widespread distribution in aquatic environments. However, limited information is available on the endocrine disrupting effects of phthalates in aquatic organisms. The aim of the present study was to examine whether exposure to mono-(2-ethylhexyl) phthalate (MEHP), the hydrolytic metabolite of di-(2-ethylhexyl) phthalate (DEHP) disrupts thyroid endocrine system in fish. In this study, zebrafish (Danio rerio) embryos were exposed to different concentrations of MEHP (1.6, 8, 40, and 200 mu g/L) from 2 h post-fertilization (hpf) to 168 hpf. The whole-body content of thyroid hormone and transcription of genes involved in the hypothalamic-pituitary-thyroid (HPT) axis were examined. Treatment with MEHP significantly decreased whole-body T4 contents and increased whole-body T3 contents, indicating thyroid endocrine disruption. The upregulation of genes related to thyroid hormone metabolism (Dio2 and UGT1ab) might be responsible for decreased T4 contents. Elevated gene transcription of Dio1 was also observed in this study, which might assist to degrade increased T3 contents. Exposure to MEHP also significantly induced transcription of genes involved in thyroid development (Nkx2.1 and Pax8) and thyroid hormone synthesis (TSH beta, NIS and TG). However, the genes encoding proteins involved in TH transport (transthyretin, TTR) was transcriptionally significantly down-regulated after exposure to MEHP. Overall, these results demonstrate that acute exposure to MEHP alters whole-body contents of thyroid hormones in zebrafish embryos/larvae and changes the transcription of genes involved in the HPT axis, thus exerting thyroid endocrine toxicity.	[Zhai, Wenhui; Chen, Li; Feng, Cong; Li, Bei; Li, Tanshi] Chinese Peoples Liberat Army Gen Hosp, Dept Emergency, Beijing, Peoples R China; [Zhai, Wenhui; Huang, Zhigang] PLA, Hosp 350, Dept Emergency, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Li, TS (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Emergency, Beijing, Peoples R China.	stujs58@163.com						ARBIN A, 1980, J CHROMATOGR, V193, P405, DOI 10.1016/S0021-9673(00)87740-7; Babu B, 2010, SCI TOTAL ENVIRON, V408, P4969, DOI 10.1016/j.scitotenv.2010.07.032; Boas M, 2012, MOL CELL ENDOCRINOL, V355, P240, DOI 10.1016/j.mce.2011.09.005; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Briggs JP, 2002, AM J PHYSIOL-REG I, V282, pR3, DOI 10.1152/ajpregu.00589.2001; Carr JA, 2011, GEN COMP ENDOCR, V170, P299, DOI 10.1016/j.ygcen.2010.06.001; Chan WK, 2012, AQUAT TOXICOL, V108, P106, DOI 10.1016/j.aquatox.2011.10.013; Chen Q, 2012, AQUAT TOXICOL, V110, P141, DOI 10.1016/j.aquatox.2012.01.008; Cheng Z, 2013, ENVIRON INT, V57-58, P75, DOI 10.1016/j.envint.2013.04.005; Erkekoglu P, 2012, J ENVIRON PATHOL TOX, V31, P143, DOI 10.1615/JEnvironPatholToxicolOncol.v31.i2.60; Fernie KJ, 2005, TOXICOL SCI, V88, P375, DOI 10.1093/toxsci/kfi295; Fromme H, 2002, WATER RES, V36, P1429, DOI 10.1016/S0043-1354(01)00367-0; Fromme H, 2011, ENVIRON INT, V37, P715, DOI 10.1016/j.envint.2011.02.008; Gayathri NS, 2004, INDIAN J MED RES, V119, P139; Hallgren S, 2002, TOXICOLOGY, V177, P227, DOI 10.1016/S0300-483X(02)00222-6; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610; HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356; Hood A, 2000, TOXICOL SCI, V55, P78, DOI 10.1093/toxsci/55.1.78; Howarth JA, 2001, TOXICOL LETT, V121, P35, DOI 10.1016/S0378-4274(01)00313-7; Ji C, 2012, TOXICOL APPL PHARM, V262, P149, DOI 10.1016/j.taap.2012.04.029; Kambe F, 1996, MOL ENDOCRINOL, V10, P801, DOI 10.1210/me.10.7.801; Kim S, 2014, SCI TOTAL ENVIRON, V472, P49, DOI 10.1016/j.scitotenv.2013.10.118; Kloas W, 2006, J CHROMATOGR A, V1130, P16, DOI 10.1016/j.chroma.2006.04.001; Latini G, 2006, TOXICOLOGY, V226, P90, DOI 10.1016/j.tox.2006.07.011; Lema SC, 2009, J ENDOCRINOL, V202, P43, DOI 10.1677/JOE-08-0472; Liu LP, 2012, ENVIRON INT, V42, P78, DOI 10.1016/j.envint.2011.04.005; Lowell Center for Sustainable Production, 2011, U L PHTHLAT THEIR AL; Magdouli S, 2013, J ENVIRON MANAGE, V127, P36, DOI 10.1016/j.jenvman.2013.04.013; Martinez-Arguelles DB, 2013, J STEROID BIOCHEM, V137, P5, DOI 10.1016/j.jsbmb.2013.01.007; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Orozco A, 2005, THYROID, V15, P799, DOI 10.1089/thy.2005.15.799; Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293; Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638; Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6; Power DM, 2000, GEN COMP ENDOCR, V119, P241, DOI 10.1006/gcen.2000.7520; PRICE SC, 1988, TOXICOL LETT, V40, P37, DOI 10.1016/0378-4274(88)90181-6; Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025; Scholz S, 2013, ARCH TOXICOL, V87, P767, DOI 10.1007/s00204-013-1044-2; Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467; SHINTANI H, 1985, J CHROMATOGR, V337, P279, DOI 10.1016/0378-4347(85)80041-4; Suzuki T, 2001, ENVIRON SCI TECHNOL, V35, P3757, DOI 10.1021/es001860i; Szabo DT, 2009, TOXICOL SCI, V107, P27, DOI 10.1093/toxsci/kfn230; Tellez-Rojo MM, 2013, SCI TOTAL ENVIRON, V461, P386, DOI 10.1016/j.scitotenv.2013.05.021; Thienpont B, 2011, ENVIRON SCI TECHNOL, V45, P7525, DOI 10.1021/es202248h; Van der Geyten S, 2005, J ENDOCRINOL, V184, P467, DOI 10.1677/joe.1.05986; Wang AL, 2012, SOIL SEDIMENT CONTAM, V21, P996, DOI 10.1080/15320383.2012.712072; Wang QW, 2013, AQUAT TOXICOL, V126, P207, DOI 10.1016/j.aquatox.2012.11.009; Wenzel A, 2005, MOL CELL ENDOCRINOL, V244, P63, DOI 10.1016/j.mce.2005.02.008; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Yu L, 2013, AQUAT TOXICOL, V138, P35, DOI [10.1016/j.aquatox.2013.04.001, 10.1016/j.aquatox.2013.04.010]; Yu LQ, 2010, AQUAT TOXICOL, V97, P226, DOI 10.1016/j.aquatox.2009.10.022; Zhou T, 2001, TOXICOL SCI, V61, P76, DOI 10.1093/toxsci/61.1.76; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446	55	79	88	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92465	10.1371/journal.pone.0092465	http://dx.doi.org/10.1371/journal.pone.0092465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658602	gold, Green Submitted, Green Published			2022-12-25	WOS:000333355300085
J	Sheppard, NC; Jones, RB; Burwitz, BJ; Nimityongskul, FA; Newman, LP; Buechler, MB; Reed, JS; Piaskowski, SM; Weisgrau, KL; Castrovinci, PA; Wilson, NA; Ostrowski, MA; Park, B; Nixon, DF; Rakasz, EG; Sacha, JB				Sheppard, Neil C.; Jones, R. Brad; Burwitz, Benjamin J.; Nimityongskul, Francesca A.; Newman, Laura P.; Buechler, Matthew B.; Reed, Jason S.; Piaskowski, Shari M.; Weisgrau, Kim L.; Castrovinci, Philip A.; Wilson, Nancy A.; Ostrowski, Mario A.; Park, Byung; Nixon, Douglas F.; Rakasz, Eva G.; Sacha, Jonah B.			Vaccination against Endogenous Retrotransposable Element Consensus Sequences Does Not Protect Rhesus Macaques from SIVsmE660 Infection and Replication	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL RESPONSES; RETROVIRUS-K; L1 RETROTRANSPOSITION; POOR-PROGNOSIS; EXPRESSION; HIV-1; SIV; GAG; ACQUISITION	The enormous sequence diversity of HIV remains a major roadblock to the development of a prophylactic vaccine and new approaches to induce protective immunity are needed. Endogenous retrotransposable elements (ERE) such as endogenous retrovirus K (ERV)-K and long interspersed nuclear element-1 (LINE-1) are activated during HIV-1-infection and could represent stable, surrogate targets to eliminate HIV-1-infected cells. Here, we explored the hypothesis that vaccination against ERE would protect macaques from acquisition and replication of simian immunodeficiency virus (SIV). Following vaccination with antigens derived from LINE-1 and ERV-K consensus sequences, animals mounted immune responses that failed to delay acquisition of SIVsmE660. We observed no differences in acute or set point viral loads between ERE-vaccinated and control animals suggesting that ERE-specific responses were not protective. Indeed, ERE-specific T cells failed to expand anamnestically in vivo following infection with SIVsmE660 and did not recognize SIV-infected targets in vitro, in agreement with no significant induction of targeted ERE mRNA by SIV in macaque CD4+ T cells. Instead, lower infection rates and viral loads correlated significantly to protective TRIM5 alpha alleles. Cumulatively, these data demonstrate that vaccination against the selected ERE consensus sequences in macaques did not lead to immune-mediated recognition and killing of SIV-infected cells, as has been shown for HIV-infected human cells using patient-derived HERV-K-specific T cells. Thus, further research is required to identify the specific nonhuman primate EREs and retroviruses that recapitulate the activity of HIV-1 in human cells. These results also highlight the complexity in translating observations of the interplay between HIV-1 and human EREs to animal models.	[Sheppard, Neil C.] Pfizer Inc, Vaccine Res, Worldwide R&D, San Diego, CA USA; [Jones, R. Brad; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Burwitz, Benjamin J.; Reed, Jason S.; Sacha, Jonah B.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97239 USA; [Burwitz, Benjamin J.; Reed, Jason S.; Sacha, Jonah B.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Nimityongskul, Francesca A.; Newman, Laura P.; Buechler, Matthew B.; Piaskowski, Shari M.; Weisgrau, Kim L.; Castrovinci, Philip A.; Wilson, Nancy A.; Rakasz, Eva G.] Univ Wisconsin, Wisconsin Natl Primate Ctr, Madison, WI USA; [Nixon, Douglas F.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Expt Med, San Francisco, CA USA; [Sacha, Jonah B.] Oregon Hlth & Sci Univ, Dept Med Microbiol & Immunol, Portland, OR 97201 USA; [Park, Byung] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Div Biostat, Portland, OR 97201 USA	Pfizer; University of Toronto; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; University of Wisconsin System; University of Wisconsin Madison; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Oregon Health & Science University; Oregon Health & Science University	Sacha, JB (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97239 USA.	sacha@ohsu.edu	Rakasz, Eva G/H-9197-2019; Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786; Sheppard, Neil/0000-0002-9551-9491; Buechler, Matthew/0000-0003-1902-622X	Pfizer Inc. [140-N-2076312]; National Institutes of Health [R21 AI087474]; National Center for Research Resources [P51 OD011092]; Bill and Melinda Gates Foundation [01526000084]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, C06RR015459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087474] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092, P51OD011106] Funding Source: NIH RePORTER	Pfizer Inc.(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Pfizer Inc.-sponsored research agreement 140-N-2076312 with JBS, National Institutes of Health (R21 AI087474 to JBS), the National Center for Research Resources (P51 OD011092), and the Bill and Melinda Gates Foundation (grant 01526000084 to JBS). Additionally, this research was conducted at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. RBJ is a Canadian Institute for Health Research Banting fellow and an Ontario HIV Treatment Network Junior Investigator Development awardee. Neil C. Sheppard, an employee of Pfizer, had a role in the design of the study, the data collection and analysis, and preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Asch HL, 1996, ONCOL RES, V8, P239; Baroncelli S, 2008, EXPERT REV VACCINES, V7, P1419, DOI 10.1586/14760584.7.9.1419; Buscher K, 2006, MELANOMA RES, V16, P223; Buscher K, 2005, CANCER RES, V65, P4172, DOI 10.1158/0008-5472.CAN-04-2983; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Contreras-Galindo R, 2013, GENOME RES, V23, P1505, DOI 10.1101/gr.144303.112; Contreras-Galindo R, 2012, J VIROL, V86, P262, DOI 10.1128/JVI.00602-11; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Esqueda D, 2013, ANN CLIN LAB SCI, V43, P122; Evans LH, 2009, J VIROL, V83, P2429, DOI 10.1128/JVI.01926-08; Feng WJN, 2007, INT J CANCER, V120, P81, DOI 10.1002/ijc.22256; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Gasior SL, 2008, DNA REPAIR, V7, P983, DOI 10.1016/j.dnarep.2008.02.006; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Goering W, 2011, CARCINOGENESIS, V32, P1484, DOI 10.1093/carcin/bgr181; Gonzalez-Hernandez MJ, 2012, J VIROL, V86, P7790, DOI 10.1128/JVI.07215-11; Hakim ST, 2008, BIOCHEM BIOPH RES CO, V369, P357, DOI 10.1016/j.bbrc.2008.02.025; Han K, 2007, SCIENCE, V316, P238, DOI 10.1126/science.1139462; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Herbst H, 1996, AM J PATHOL, V149, P1727; Iramaneerat K, 2011, INT J GYNECOL CANCER, V21, P51, DOI 10.1097/IGC.0b013e3182021c1a; Jones RB, 2013, J VIROL, V87, P13307, DOI 10.1128/JVI.02257-13; Jones RB, 2012, J CLIN INVEST, V122, P4473, DOI 10.1172/JCI64560; Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7; Kamada K, 2006, MICROBES INFECT, V8, P1075, DOI 10.1016/j.micinf.2005.11.006; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Laderoute MP, 2007, AIDS, V21, P2417, DOI 10.1097/QAD.0b013e3282f14d64; Lee YN, 2008, J VIROL, V82, P8762, DOI 10.1128/JVI.00751-08; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Marsh AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040158; Medstrand P, 1998, J VIROL, V72, P9782, DOI 10.1128/JVI.72.12.9782-9787.1998; Monde K, 2012, J VIROL, V86, P11194, DOI 10.1128/JVI.00301-12; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Nomaguchi M, 2013, J VIROL, V87, P11447, DOI 10.1128/JVI.01549-13; Ormsby CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041021; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Reynolds MR, 2011, J VIROL, V85, P9637, DOI 10.1128/JVI.05074-11; Reynolds MR, 2010, J VIROL, V84, P9190, DOI 10.1128/JVI.00041-10; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Sacha JB, 2012, J IMMUNOL, V189, P1467, DOI 10.4049/jimmunol.1200079; Sacha JB, 2010, NAT PROTOC, V5, P239, DOI 10.1038/nprot.2009.227; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Saito A, 2011, MICROBES INFECT, V13, P58, DOI 10.1016/j.micinf.2010.10.001; Saito K, 2010, CLIN CANCER RES, V16, P2418, DOI 10.1158/1078-0432.CCR-09-2819; SAUTER M, 1995, J VIROL, V69, P414, DOI 10.1128/JVI.69.1.414-421.1995; Schiavetti F, 2002, CANCER RES, V62, P5510; SenGupta D, 2011, J VIROL, V85, P6977, DOI 10.1128/JVI.00179-11; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stoddart CA, 2011, VIROLOGY, V417, P154, DOI 10.1016/j.virol.2011.05.013; Takahashi Y, 2008, J CLIN INVEST, V118, P1099, DOI 10.1172/JCI34409; Tandon R, 2011, J VIROL, V85, P11526, DOI 10.1128/JVI.05418-11; Tenbusch M, 2012, J VIROL, V86, P10533, DOI 10.1128/JVI.00796-12; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Vincent BJ, 2003, MOL BIOL EVOL, V20, P1338, DOI 10.1093/molbev/msg146; Wang-Johanning F, 2008, CANCER RES, V68, P5869, DOI 10.1158/0008-5472.CAN-07-6838; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Yeh WW, 2011, J VIROL, V85, P10389, DOI 10.1128/JVI.00854-11; Zhao Jing, 2011, Genes Cancer, V2, P914, DOI 10.1177/1947601911431841; Zwolinska K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077820	67	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92012	10.1371/journal.pone.0092012	http://dx.doi.org/10.1371/journal.pone.0092012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651676	gold, Green Submitted, Green Published			2022-12-25	WOS:000333352800063
J	Silva, MA; Jonsen, I; Russell, DJF; Prieto, R; Thompson, D; Baumgartner, MF				Silva, Monica A.; Jonsen, Ian; Russell, Deborah J. F.; Prieto, Rui; Thompson, Dave; Baumgartner, Mark F.			Assessing Performance of Bayesian State-Space Models Fit to Argos Satellite Telemetry Locations Processed with Kalman Filtering	PLOS ONE			English	Article							MEASUREMENT ERROR; MOVEMENT; ACCURACY; TRACKING; GPS	Argos recently implemented a new algorithm to calculate locations of satellite-tracked animals that uses a Kalman filter (KF). The KF algorithm is reported to increase the number and accuracy of estimated positions over the traditional Least Squares (LS) algorithm, with potential advantages to the application of state-space methods to model animal movement data. We tested the performance of two Bayesian state-space models (SSMs) fitted to satellite tracking data processed with KF algorithm. Tracks from 7 harbour seals (Phoca vitulina) tagged with ARGOS satellite transmitters equipped with Fastloc GPS loggers were used to calculate the error of locations estimated from SSMs fitted to KF and LS data, by comparing those to "true" GPS locations. Data on 6 fin whales (Balaenoptera physalus) were used to investigate consistency in movement parameters, location and behavioural states estimated by switching state-space models (SSSM) fitted to data derived from KF and LS methods. The model fit to KF locations improved the accuracy of seal trips by 27% over the LS model. 82% of locations predicted from the KF model and 73% of locations from the LS model were <5 km from the corresponding interpolated GPS position. Uncertainty in KF model estimates (5.6 +/- 5.6 km) was nearly half that of LS estimates (11.6 +/- 8.4 km). Accuracy of KF and LS modelled locations was sensitive to precision but not to observation frequency or temporal resolution of raw Argos data. On average, 88% of whale locations estimated by KF models fell within the 95% probability ellipse of paired locations from LS models. Precision of KF locations for whales was generally higher. Whales' behavioural mode inferred by KF models matched the classification from LS models in 94% of the cases. State-space models fit to KF data can improve spatial accuracy of location estimates over LS models and produce equally reliable behavioural estimates.	[Silva, Monica A.; Prieto, Rui] Univ Azores, Ctr Inst Marine Res IMAR, Horta, Portugal; [Silva, Monica A.; Prieto, Rui] Univ Azores, Dept Oceanog & Fisheries, Horta, Portugal; [Silva, Monica A.; Prieto, Rui] Lab Robot & Syst Engn & Sci LARSyS, Lisbon, Portugal; [Silva, Monica A.; Baumgartner, Mark F.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Jonsen, Ian] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Russell, Deborah J. F.; Thompson, Dave] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Russell, Deborah J. F.] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland	Universidade dos Acores; Universidade dos Acores; Woods Hole Oceanographic Institution; Dalhousie University; University of St Andrews; University of St Andrews	Silva, MA (corresponding author), Univ Azores, Ctr Inst Marine Res IMAR, Horta, Portugal.	monica@uac.pt	Silva, Mónica/D-1893-2012; Prieto, Rui/G-8286-2011; Russell, Debbie J.F./AAA-6487-2021	Silva, Mónica/0000-0002-2683-309X; Prieto, Rui/0000-0002-0354-2572; Russell, Debbie J.F./0000-0002-1969-102X; Thompson, David/0000-0003-1546-2876; Jonsen, Ian/0000-0001-5423-6076	Fundacao para a Ciencia e a Tecnologia (FCT); Fundo Regional da Ciencia, Tecnologia (FRCT) [TRACE-PTDC/MAR/74071/2006, MAPCET-M2.1.2/F/012/2011]; Competitiveness Factors Operational (COMPETE); QREN European Social Fund; Proconvergencia Acores/EU Program; FCT; IMAR-University of the Azores/the Thematic Area D & E of the Strategic Project [PEst-OE/EEI/LA0009/2011-1012]; FRCT - Government of the Azores; FCT [SFRH/BPD/29841/2006, SFRH/BD/41192/2007]; POPH; Portuguese Ministry for Science and Education through an FCT Investigator grant; Azores Regional Fund for Science and Technology [M3.1.5/F/115/2012]; Natural Sciences and Engineering Research Council (NSERC); Canada Foundation for Innovation (CFI) through Ocean Tracking Network; United Kingdom Department of Energy and Climate Change as part of their Offshore Energy Strategic Environmental Assessment program; Natural Environment Research Council; Marine Scotland; LARSyS Associated Laboratory through FCT/MCE project [PEst-OE/EEI/LA0009/2013-2014]; Natural Environment Research Council [smru10001] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Regional da Ciencia, Tecnologia (FRCT); Competitiveness Factors Operational (COMPETE); QREN European Social Fund; Proconvergencia Acores/EU Program; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); IMAR-University of the Azores/the Thematic Area D & E of the Strategic Project; FRCT - Government of the Azores; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); POPH; Portuguese Ministry for Science and Education through an FCT Investigator grant; Azores Regional Fund for Science and Technology; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI) through Ocean Tracking Network; United Kingdom Department of Energy and Climate Change as part of their Offshore Energy Strategic Environmental Assessment program; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Marine Scotland; LARSyS Associated Laboratory through FCT/MCE project; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was primarily funded by Fundacao para a Ciencia e a Tecnologia (FCT), Fundo Regional da Ciencia, Tecnologia (FRCT), through research projects TRACE-PTDC/MAR/74071/2006 and MAPCET-M2.1.2/F/012/2011 [FEDER], the Competitiveness Factors Operational (COMPETE), QREN European Social Fund, and Proconvergencia Acores/EU Program]. We acknowledge funds provided by FCT to LARSyS Associated Laboratory and IMAR-University of the Azores/the Thematic Area D & E of the Strategic Project PEst-OE/EEI/LA0009/2011-1012 and 2013-2014 (OE & Compete) and by the FRCT - Government of the Azores pluriannual funding. MAS was supported by an FCT postdoctoral grant (SFRH/BPD/29841/2006) and is currently supported by POPH, QREN European Social Fund and the Portuguese Ministry for Science and Education through an FCT Investigator grant. RP was supported by an FCT doctoral grant (SFRH/BD/41192/2007) and by the research grant from the Azores Regional Fund for Science and Technology (M3.1.5/F/115/2012). IJ was supported by the Natural Sciences and Engineering Research Council (NSERC) and the Canada Foundation for Innovation (CFI) through their support of the Ocean Tracking Network. DJFR is funded by the United Kingdom Department of Energy and Climate Change as part of their Offshore Energy Strategic Environmental Assessment program. DT is funded by Natural Environment Research Council and Marine Scotland. Publication fees for this open access publication were supported by LARSyS Associated Laboratory through FCT/MCE project Project PEst-OE/EEI/LA0009/2013-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bailey H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036401; Bestley S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2262; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Boyd JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063051; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Breed GA, 2012, ECOL MODEL, V235, P49, DOI 10.1016/j.ecolmodel.2012.03.021; Breed GA, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00021.1; Bryant E, 2007, FASTLOCTR01 WILDTR T; CLS (Collecte Localisation Satellites), 2011, COLLECTE LOCALISATIO; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Dragon AC, 2012, MAR ECOL PROG SER, V452, P253, DOI 10.3354/meps09618; Fancy S. G., 1988, US FISH WILDLIFE SER, V172; Flemming JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014245; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Kuhn CE, 2009, MAR ECOL PROG SER, V393, P97, DOI 10.3354/meps08229; Lopez R., 2011, CLSDTMEMO1165; McClintock BT, 2013, ECOLOGY, V94, P838, DOI 10.1890/12-0954.1; Morehouse AT, 2013, WILDLIFE SOC B, V37, P596, DOI 10.1002/wsb.292; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Sharples RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037216; Silva MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076507; TINBERGEN N, 1967, BEHAVIOUR, V28, P307, DOI 10.1163/156853967X00064; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Winship AJ, 2012, METHODS ECOL EVOL, V3, P291, DOI 10.1111/j.2041-210X.2011.00161.x; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022	36	26	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92277	10.1371/journal.pone.0092277	http://dx.doi.org/10.1371/journal.pone.0092277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651252	Green Published, gold			2022-12-25	WOS:000333352800092
J	Spolding, B; Connor, T; Wittmer, C; Abreu, LLF; Kaspi, A; Ziemann, M; Kaur, G; Cooper, A; Morrison, S; Lee, S; Sinclair, A; Gibert, Y; Trevaskis, JL; Roth, JD; El-Osta, A; Standish, R; Walder, K				Spolding, Briana; Connor, Timothy; Wittmer, Carrie; Abreu, Lelia L. F.; Kaspi, Antony; Ziemann, Mark; Kaur, Gunveen; Cooper, Adrian; Morrison, Shona; Lee, Scott; Sinclair, Andrew; Gibert, Yann; Trevaskis, James L.; Roth, Jonathon D.; El-Osta, Assam; Standish, Richard; Walder, Ken			Rapid Development of Non-Alcoholic Steatohepatitis in Psammomys obesus (Israeli Sand Rat)	PLOS ONE			English	Article							FATTY LIVER; HEPATIC STEATOSIS; GENE-EXPRESSION; CHOLESTEROL; METABOLISM; THERAPY; MICE	Background and Aims: A major impediment to establishing new treatments for non-alcoholic steatohepatitis is the lack of suitable animal models that accurately mimic the biochemical and metabolic characteristics of the disease. The aim of this study was to explore a unique polygenic animal model of metabolic disease as a model of non-alcoholic steatohepatitis by determining the effects of 2% dietary cholesterol supplementation on metabolic and liver endpoints in Psammomys obesus (Israeli sand rat). Methods: P. obesus were provided ad libitum access to either a standard rodent diet (20% kcal/fat) or a standard rodent diet supplemented with 2% cholesterol (w/w) for 4 weeks. Histological sections of liver from animals on both diets were examined for key features of non-alcoholic steatohepatitis. The expression levels of key genes involved in hepatic lipid metabolism were measured by real-time PCR. Results: P. obesus fed a cholesterol-supplemented diet exhibited profound hepatomegaly and steatosis, and higher plasma transaminase levels. Histological analysis identified extensive steatosis, inflammation, hepatocyte injury and fibrosis. Hepatic gene expression profiling revealed decreased expression of genes involved in delivery and uptake of lipids, and fatty acid and triglyceride synthesis, and increased expression of genes involved in very low density lipoprotein cholesterol synthesis, triglyceride and cholesterol export. Conclusions: P. obesus rapidly develop non-alcoholic steatohepatitis when fed a cholesterol-supplemented diet that appears to be histologically and mechanistically similar to patients.	[Spolding, Briana; Connor, Timothy; Abreu, Lelia L. F.; Cooper, Adrian; Morrison, Shona; Lee, Scott; Sinclair, Andrew; Gibert, Yann; Standish, Richard; Walder, Ken] Deakin Univ, Sch Med, Metab Res Unit, Geelong, Vic 3217, Australia; [Wittmer, Carrie; Trevaskis, James L.; Roth, Jonathon D.] Amylin Pharmaceut LLC, San Diego, CA USA; [Kaspi, Antony; Ziemann, Mark; El-Osta, Assam] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Kaur, Gunveen] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia	Deakin University; Baker Heart and Diabetes Institute; Victoria University	Spolding, B (corresponding author), Deakin Univ, Sch Med, Metab Res Unit, Geelong, Vic 3217, Australia.	briana.spolding@deakin.edu.au	Ziemann, Mark Daniel/AAE-8466-2019	Randall, Briana/0000-0001-7453-4580; El-Osta, Assam/0000-0003-2969-9137; Ziemann, Mark/0000-0002-7688-6974; Trevaskis, James/0000-0002-5356-6118; El-Osta, Assam/0000-0001-7968-7375; Kaspi, Antony/0000-0001-6576-5862	Amylin Pharmaceuticals, Inc., San Diego, USA; Deakin University Molecular and Medical Research Strategic Research Centre	Amylin Pharmaceuticals, Inc., San Diego, USA; Deakin University Molecular and Medical Research Strategic Research Centre	This research was supported in part by Amylin Pharmaceuticals, Inc., San Diego, USA, and in part by the Deakin University Molecular and Medical Research Strategic Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNETT M, 1994, DIABETOLOGIA, V37, P671, DOI 10.1007/s001250050162; Boone LR, 2011, J LIPIDS, V2011, DOI 10.1155/2011/101242; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016; Chang XX, 2010, J LIPID RES, V51, P2504, DOI 10.1194/jlr.M001958; Charlton M, 2009, HEPATOLOGY, V49, P1375, DOI 10.1002/hep.22927; Collier GR, 2000, DIABETES, V49, P1766, DOI 10.2337/diabetes.49.11.1766; Du R, 2011, EUR J PHARMACOL, V666, P183, DOI 10.1016/j.ejphar.2011.05.014; FOLCH J, 1957, J BIOL CHEM, V226, P497; Harano Y, 2006, LIVER INT, V26, P613, DOI 10.1111/j.1478-3231.2006.01265.x; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohjima M, 2007, INT J MOL MED, V20, P351; Maislos M, 2006, DIABETES RES CLIN PR, V72, P1, DOI 10.1016/j.diabres.2005.09.007; Masterton GS, 2010, ALIMENT PHARM THER, V31, P679, DOI 10.1111/j.1365-2036.2010.04230.x; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Mitsuyoshi H, 2009, HEPATOL RES, V39, P366, DOI 10.1111/j.1872-034X.2008.00464.x; Moseley RH, 2008, J CLIN GASTROENTEROL, V42, P332, DOI 10.1097/MCG.0b013e31815e4079; Nakamuta M, 2005, INT J MOL MED, V16, P631; Obika M, 2012, EXP DIABETES RES, DOI 10.1155/2012/145754; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; RUDEL L, 1994, J CLIN INVEST, V93, P2463, DOI 10.1172/JCI117255; Savard C, 2013, HEPATOLOGY, V57, P81, DOI 10.1002/hep.25789; SINCLAIR AJ, 1987, LIPIDS, V22, P523, DOI 10.1007/BF02540369; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Trevaskis JL, 2012, AM J PHYSIOL-GASTR L, V302, pG762, DOI 10.1152/ajpgi.00476.2011; Walder K, 2002, DIABETES, V51, P1859, DOI 10.2337/diabetes.51.6.1859; Walder K R, 2000, Int J Exp Diabetes Res, V1, P177, DOI 10.1155/EDR.2000.177; Walder Ken, 2002, Endocr Regul, V36, P1; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Zhang B, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-48	32	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92656	10.1371/journal.pone.0092656	http://dx.doi.org/10.1371/journal.pone.0092656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651520	Green Published, Green Accepted, gold			2022-12-25	WOS:000333352800138
J	Tang, GQ; Nandakumar, D; Bandwar, RP; Lee, KS; Roy, R; Ha, T; Patel, SS				Tang, Guo-Qing; Nandakumar, Divya; Bandwar, Rajiv P.; Lee, Kyung Suk; Roy, Rahul; Ha, Taekjip; Patel, Smita S.			Relaxed Rotational and Scrunching Changes in P266L Mutant of T7 RNA Polymerase Reduce Short Abortive RNAs while Delaying Transition into Elongation	PLOS ONE			English	Article							OPEN COMPLEX-FORMATION; TRANSCRIPTION INITIATION; PROMOTER CLEARANCE; SINGLE-MOLECULE; MECHANISM; DNA; BINDING; DYNAMICS; PROCEEDS; RELEASE	Abortive cycling is a universal feature of transcription initiation catalyzed by DNA-dependent RNA polymerases (RNAP). In bacteriophage T7 RNAP, mutation of proline 266 to leucine (P266L) in the C-linker region connecting the N-terminal promoter binding domain with the C-terminal catalytic domain drastically reduces short abortive products (4-7 nt) while marginally increasing long abortives (9-11 nt). Here we have investigated the transcription initiation pathway of P266L with the goal of understanding the mechanistic basis for short and long abortive synthesis. We show that the P266L mutation does not alter the affinity for the promoter, mildly affects promoter opening, and increases the +1/+2 GTP K-d by 2-fold. However, unlike wild-type T7 RNAP that undergoes stepwise rotation of the promoter binding domain and DNA scrunching during initial transcription, the P266L mutant does not undergo coupled rotational/scrunching movements until 7 nt RNA synthesis. The lack of rotation/scrunching correlates with greater stabilities of the initiation complexes of the P266L and decreased short abortive products. The results indicate that the increased flexibility in the C-linker due to P266L mutation enables T7 RNAP to absorb the stress from the growing RNA: DNA hybrid thereby decreasing short abortive products. Increased C-linker flexibility, however, has an adverse effect of delaying the transition into elongation by 1-2 nt, which gives rise to long abortive products. However, a mutation in the upstream promoter region greatly decreases long abortive products in P266L reactions, rendering the combination of P266L and A-15C promoter a desirable pair for efficient in vitro transcription for RNA production. We conclude that the conformational rigidity in the C-linker region conferred by the proline at position 266 is responsible for the undesirable short abortive products, but the rigidity is critical for efficient promoter clearance and transition into elongation.	[Tang, Guo-Qing; Nandakumar, Divya; Bandwar, Rajiv P.; Patel, Smita S.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Lee, Kyung Suk; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL USA; [Lee, Kyung Suk; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL USA; [Roy, Rahul; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Patel, SS (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	patelss@rwjms.rutgers.edu	Roy, Rahul/D-5329-2009; Nandakumar, Divya/K-6250-2014; Ha, Taekjip/B-9506-2009; Roy, Rahul/Y-5878-2019	Roy, Rahul/0000-0003-3329-8803; Nandakumar, Divya/0000-0001-7672-0213; Ha, Taekjip/0000-0003-2195-6258; Roy, Rahul/0000-0003-3329-8803; Bandwar, Rajiv/0000-0002-8081-8958	National Institutes for Health (NIH) [R37 GM051966, GM065367]; National Science Foundation [0822613]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051966, R01GM065367] Funding Source: NIH RePORTER	National Institutes for Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the National Institutes for Health (NIH) grant R37 GM051966 to SSP and NIH grant GM065367 and National Science Foundation grant 0822613 to TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandwar RP, 2007, J BIOL CHEM, V282, P22879, DOI 10.1074/jbc.M702589200; Bandwar RP, 2006, J MOL BIOL, V360, P466, DOI 10.1016/j.jmb.2006.05.029; Bandwar RP, 2001, J BIOL CHEM, V276, P14075, DOI 10.1074/jbc.M011289200; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; DIAZ GA, 1993, J MOL BIOL, V229, P805, DOI 10.1006/jmbi.1993.1086; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; Guillerez J, 2005, P NATL ACAD SCI USA, V102, P5958, DOI 10.1073/pnas.0407141102; Guo Q, 2005, J BIOL CHEM, V280, P14956, DOI 10.1074/jbc.M500518200; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Jia YP, 1997, J BIOL CHEM, V272, P30147, DOI 10.1074/jbc.272.48.30147; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; KING GC, 1986, BIOCHEMISTRY-US, V25, P36, DOI 10.1021/bi00349a006; MULLER DK, 1988, BIOCHEMISTRY-US, V27, P5763, DOI 10.1021/bi00415a055; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Patel Smita S., 2003, P87; Ramirez-Tapia LE, 2012, J BIOL CHEM, V287, P37352, DOI 10.1074/jbc.M112.370643; Rasnik I, 2004, J MOL BIOL, V336, P395, DOI 10.1016/j.jmb.2003.12.031; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; SOUSA R, 1992, J MOL BIOL, V224, P319, DOI 10.1016/0022-2836(92)90997-X; Stano NM, 2002, J BIOL CHEM, V277, P37292, DOI 10.1074/jbc.M201600200; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Tang GQ, 2005, J BIOL CHEM, V280, P40707, DOI 10.1074/jbc.M508013200; Tang GQ, 2008, MOL CELL, V30, P567, DOI 10.1016/j.molcel.2008.04.003; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	32	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91859	10.1371/journal.pone.0091859	http://dx.doi.org/10.1371/journal.pone.0091859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651161	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800052
J	Xu, B; Liu, P				Xu, Bei; Liu, Peng			No Survival Improvement for Patients with Angioimmunoblastic T-Cell Lymphoma over the Past Two Decades: A Population-Based Study of 1207 Cases	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMAS; PROGNOSTIC-FACTORS; MARROW TRANSPLANTATION; CLINICAL-FEATURES; EUROPEAN GROUP; WORKING PARTY; LYMPHADENOPATHY; CHEMOTHERAPY; REMISSIONS; SUBTYPE	Angioimmunoblastic T-cell lymphoma (AITL) is a rare lymphoid malignancy with dismal prognosis. We conducted a large population-based study using the Surveillance, Epidemiology, and End Results (SEER) database (1973-2010) to determine the temporal survival trends and prognostic factors of AITL patients. A total of 1207 patients with AITL were included in this study, with a median age at diagnosis of 69 years. At presentation, most patients (79.5%) had an advanced-stage disease. Overall survival (OS) probabilities at 2, 5 and 10 years were 46.8%, 32.9%, and 21.9% respectively. Two-year, 5-year, and 10-year disease-specific survival (DSS) rates were 56.1%, 44.0%, and 35.9% respectively. On multivariate analysis, age older than 70 years, advanced-stage disease and male sex were identified adverse predictors for OS and DSS. We failed to find any survival differences among subgroups diagnosed in the 5 periods studied (1992 to 1998, 1999 to 2001, 2002 to 2004, 2005 to 2007, and 2008 to 2010). The current study represents the largest specific series of patients with AITL and the first investigation on temporal changes in survival of AITL patients. There has been no survival improvement for AITL patients over the past two decades. Further investigations are warranted to develop more effective treatment for AITL.	[Xu, Bei] Nanjing Med Univ, Affiliated Hosp 1, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Liu, Peng] Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Liu, P (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Nanjing, Jiangsu, Peoples R China.	liupeng9098@163.com			National Natural Science Foundation of China [81170486, 81101498]; Natural Science Fund for Distinguished Young Scholars of Jiangsu Province [BK20130049]; Scientific Research Foundation from the Ministry of Education of China [43-NJYKDX-3]; Jiangsu Province's Medical Elite Program [RC2011168]; Jiangsu Province Health Agency [K201107]; "Liu Da Ren Cai Gao Feng" Project [2012-WS-017]; Priority Academic Program Development of Jiangsu Higher Education Institut [JX10231801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund for Distinguished Young Scholars of Jiangsu Province; Scientific Research Foundation from the Ministry of Education of China; Jiangsu Province's Medical Elite Program; Jiangsu Province Health Agency; "Liu Da Ren Cai Gao Feng" Project; Priority Academic Program Development of Jiangsu Higher Education Institut	This work was supported by National Natural Science Foundation of China (81170486, 81101498), Natural Science Fund for Distinguished Young Scholars of Jiangsu Province (BK20130049), Scientific Research Foundation from the Ministry of Education of China (43-NJYKDX-3), Jiangsu Province's Medical Elite Program (RC2011168), Key Project of Jiangsu Province Health Agency (K201107), "Liu Da Ren Cai Gao Feng" Project (2012-WS-017), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institute (JX10231801). Web site: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOZASA K, 1989, CANCER, V63, P1625, DOI 10.1002/1097-0142(19890415)63:8<1625::AID-CNCR2820630832>3.0.CO;2-J; ARCHIMBAUD E, 1987, CANCER-AM CANCER SOC, V59, P208, DOI 10.1002/1097-0142(19870115)59:2<208::AID-CNCR2820590205>3.0.CO;2-7; Chang HJ, 1997, ONCOLOGY, V54, P193; Clarke CA, 2004, CANCER EPIDEM BIOMAR, V13, P138, DOI 10.1158/1055-9965.EPI-03-0250; Corradini P, 2004, J CLIN ONCOL, V22, P2172, DOI 10.1200/JCO.2004.12.050; de Leval L, 2010, BRIT J HAEMATOL, V148, P673, DOI 10.1111/j.1365-2141.2009.08003.x; Delfau-Larue MH, 2012, HAEMATOL-HEMATOL J, V97, P1594, DOI 10.3324/haematol.2011.061507; Delmer A, 2009, ASCO M ABSTR S, V27, P8554; Federico M, 2013, J CLIN ONCOL, V31, P240, DOI 10.1200/JCO.2011.37.3647; Gallamini A, 2007, BLOOD, V110, P2316, DOI 10.1182/blood-2007-02-074641; Hershman DL, 2012, J CLIN ONCOL, V30, P4215, DOI 10.1200/JCO.2012.41.6701; Iannitto E, 2008, CRIT REV ONCOL HEMAT, V68, P264, DOI 10.1016/j.critrevonc.2008.06.012; Kyriakou C, 2008, J CLIN ONCOL, V26, P218, DOI 10.1200/JCO.2007.12.6219; Kyriakou C, 2009, J CLIN ONCOL, V27, P3951, DOI 10.1200/JCO.2008.20.4628; Le Gouill S, 2008, J CLIN ONCOL, V26, P2264, DOI 10.1200/JCO.2007.14.1366; Lee SS, 2003, INT J CANCER, V103, P12, DOI 10.1002/ijc.10758; Lin HN, 2010, LEUKEMIA LYMPHOMA, V51, P2208, DOI 10.3109/10428194.2010.525270; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Mourad N, 2008, BLOOD, V111, P4463, DOI 10.1182/blood-2007-08-105759; O'Connor OA, 2007, BRIT J HAEMATOL, V139, P425, DOI 10.1111/j.1365-2141.2007.06658.x; Odejide O, 2013, BLOOD; PANGALIS GA, 1983, CANCER-AM CANCER SOC, V52, P318, DOI 10.1002/1097-0142(19830715)52:2<318::AID-CNCR2820520221>3.0.CO;2-G; Park BB, 2007, LEUKEMIA LYMPHOMA, V48, P716, DOI 10.1080/10428190601123989; Percy C., 1990, INT CLASSIFICATION D; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Rudiger T, 2002, ANN ONCOL, V13, P140, DOI 10.1093/annonc/mdf033; Schetelig J, 2003, HAEMATOLOGICA, V88, P1272; SIEGERT W, 1995, ANN ONCOL, V6, P659, DOI 10.1093/oxfordjournals.annonc.a059281; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; Tokunaga T, 2012, BLOOD, V119, P2837, DOI 10.1182/blood-2011-08-374371; Yu JB, 2009, ONCOLOGY-NY, V23, P288	32	38	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92585	10.1371/journal.pone.0092585	http://dx.doi.org/10.1371/journal.pone.0092585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651162	gold, Green Published, Green Submitted			2022-12-25	WOS:000333352800130
J	Coward, WR; Feghali-Bostwick, CA; Jenkins, G; Knox, AJ; Pang, LH				Coward, William R.; Feghali-Bostwick, Carol A.; Jenkins, Gisli; Knox, Alan J.; Pang, Linhua			A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis	FASEB JOURNAL			English	Article						histone hypermethylation; DNA methylation; histone deacetylation; antifibrotic gene; lung fibroblasts	SMALL-MOLECULE INHIBITOR; BINDING PROTEIN MECP2; HISTONE METHYLTRANSFERASE; DNA METHYLATION; TRANSCRIPTIONAL REPRESSION; LUNG FIBROBLASTS; EXPRESSION; CONTRIBUTE; CHROMATIN; ENHANCER	Selective silencing of the cyclooxygenase-2 (COX-2) gene with the loss of the antifibrotic mediator prostaglandin E-2 contributes to the fibrotic process in idiopathic pulmonary fibrosis (IPF). This study explored the role of G9a- and enhancer of zeste homolog 2 (EZH2)-mediated methylation of histone H3 lysine 9 (H3K9me3) and histone H3 lysine 27 (H3K27me3) in COX-2 silencing in IPF. Chromatin immunoprecipitation (ChIP) and re-ChIP assays demonstrated marked increases in H3K9me3, H3K27me3, and DNA methylation, together with their respective modifying enzymes G9a, EZH2, and DNA methyltransferases (Dnmts) and respective binding proteins heterochromatin protein 1 (HP1), polycomb protein complex 1 (PRC1) and methyl CpG binding protein 2 (MeCP2), at the COX-2 promoter in lung fibroblasts from patients with IPF (F-IPFs) compared with fibroblasts from nonfibrotic lungs. HP1, EZH2, and MeCP2 in turn were associated with additional repressive chromatin modifiers in F-IPFs. G9a and EZH2 inhibitors and small interfering RNAs and the Dnmt1 inhibitor markedly reduced H3K9me3 (49-79%), H3K27me3 (44-81%), and DNA methylation (61-97%) at the COX-2 promoter. These reductions were correlated with increased histone H3 and H4 acetylation, resulting in COX-2 mRNA and protein reexpression in F-IPFs. Our results support a central role for G9a- and EZH2-mediated histone hypermethylation and a model of bidirectional, mutually reinforcing, and interdependent crosstalk between histone hypermethylation and DNA methylation in COX-2 epigenetic silencing in IPF.	[Coward, William R.; Jenkins, Gisli; Knox, Alan J.; Pang, Linhua] Univ Nottingham, City Hosp, Div Resp Med, Nottingham NG5 1PB, England; [Coward, William R.; Jenkins, Gisli; Knox, Alan J.; Pang, Linhua] Univ Nottingham, City Hosp, Nottingham Resp Biomed Res Unit, Nottingham NG5 1PB, England; [Feghali-Bostwick, Carol A.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pang, LH (corresponding author), Univ Nottingham, City Hosp, Div Resp Med, Clin Sci Bldg, Nottingham NG5 1PB, England.	linhua.pang@nottingham.ac.uk	Jenkins, Gisli/R-8143-2017	Jenkins, Gisli/0000-0002-7929-2119; Knox, Alan/0000-0002-5906-4143	UK Medical Research Council [G0600890, MR/K003259/1]; Wellcome Trust [088751]; MRC [G0600890, MR/K003259/1] Funding Source: UKRI; Medical Research Council [G0600890, MR/K003259/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (grants G0600890 and MR/K003259/1) and the Wellcome Trust (grant 088751).	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; BOROK Z, 1991, AM REV RESPIR DIS, V144, P1080, DOI 10.1164/ajrccm/144.5.1080; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Choi JY, 2013, APOPTOSIS, V18, P99, DOI 10.1007/s10495-012-0768-4; Coward WR, 2010, MOL CELL BIOL, V30, P2874, DOI 10.1128/MCB.01527-09; Coward WR, 2009, MOL CELL BIOL, V29, P4325, DOI 10.1128/MCB.01776-08; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Failla M, 2009, AM J RESP CELL MOL, V41, P50, DOI 10.1165/rcmb.2007-0438OC; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Hodges RJ, 2004, AM J PATHOL, V165, P1663, DOI 10.1016/S0002-9440(10)63423-2; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Kondo Y, 2007, HEPATOL RES, V37, P974, DOI 10.1111/j.1872-034X.2007.00141.x; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee JK, 2013, BIOCHEM BIOPH RES CO, V438, P647, DOI 10.1016/j.bbrc.2013.07.128; Liu XQ, 2004, AM J PHYSIOL-CELL PH, V286, pC1089, DOI 10.1152/ajpcell.00461.2003; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Pang LH, 2002, FASEB J, V16, P1435, DOI 10.1096/fj.02-0169fje; Pero R, 2011, INT J MED MICROBIOL, V301, P140, DOI 10.1016/j.ijmm.2010.06.009; Petkova DK, 2003, HISTOPATHOLOGY, V43, P381, DOI 10.1046/j.1365-2559.2003.01718.x; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Sanders YY, 2011, AM J RESP CELL MOL, V45, P16, DOI 10.1165/rcmb.2010-0154OC; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Song SH, 2001, CANCER RES, V61, P4628; Toyota M, 2000, CANCER RES, V60, P4044; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866	36	66	72	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3183	3196		10.1096/fj.13-241760	http://dx.doi.org/10.1096/fj.13-241760			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24652950	hybrid, Green Published			2022-12-25	WOS:000337949400038
J	Goetzenich, A; Kraemer, S; Rossaint, R; Bleilevens, C; Dollo, F; Siry, L; Rajabi-Alampour, S; Beckers, C; Soppert, J; Lue, HQ; Rex, S; Bernhagen, J; Stoppe, C				Goetzenich, Andreas; Kraemer, Sandra; Rossaint, Rolf; Bleilevens, Christian; Dollo, Florian; Siry, Laura; Rajabi-Alampour, Setareh; Beckers, Christian; Soppert, Josefin; Lue, Hongqi; Rex, Steffen; Bernhagen, Juergen; Stoppe, Christian			The Role of Macrophage Migration Inhibitory Factor in Anesthetic-Induced Myocardial Preconditioning	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MITOCHONDRIAL-PERMEABILITY; CARDIOPROTECTION; MECHANISMS; ISCHEMIA; MIF; PROTECTION; SECRETION; EPSILON; PATHWAY	Introduction: Anesthetic-induced preconditioning (AIP) is known to elicit cardioprotective effects that are mediated at least in part by activation of the kinases AMPK and PKC epsilon as well as by inhibition of JNK. Recent data demonstrated that the pleiotropic cytokine macrophage migration inhibitory factor (MIF) provides cardioprotection through activation and/or inhibition of kinases that are also known to mediate effects of AIP. Therefore, we hypothesized that MIF could play a key role in the AIP response. Methods: Cardiomyocytes were isolated from rats and subjected to isoflurane preconditioning (4 h; 1.5 vol. %). Subsequently, MIF secretion and alterations in the activation levels of protective kinases were compared to a control group that was exposed to ambient air conditions. MIF secretion was quantified by ELISA and AIP-induced activation of protein kinases was assessed by Western blotting of cardiomyocyte lysates after isoflurane treatment. Results: In cardiomyocytes, preconditioning with isoflurane resulted in a significantly elevated secretion of MIF that followed a biphasic behavior (30 min vs. baseline: p = 0.020; 24 h vs. baseline p = 0.000). Moreover, quantitative polymerase chain reaction demonstrated a significant increase in MIF mRNA expression 8 h after AIP. Of note, activation of AMPK and PKCe coincided with the observed peaks in MIF secretion and differed significantly from baseline. Conclusions: These results suggest that the pleiotropic mediator MIF is involved in anesthetic-induced preconditioning of cardiomyocytes through stimulation of the protective kinases AMPK and PKC epsilon.	[Goetzenich, Andreas; Kraemer, Sandra; Beckers, Christian; Stoppe, Christian] Rhein Westfal TH Aachen, Dept Thorac Cardiac & Vasc Surg, Univ Hosp, D-52062 Aachen, Germany; [Kraemer, Sandra; Dollo, Florian; Siry, Laura; Rajabi-Alampour, Setareh; Soppert, Josefin; Lue, Hongqi; Bernhagen, Juergen; Stoppe, Christian] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany; [Rossaint, Rolf; Bleilevens, Christian; Beckers, Christian] Rhein Westfal TH Aachen, Dept Anesthesiol, D-52062 Aachen, Germany; [Rex, Steffen] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Anesthesiol & Cardiovasc Sci, Leuven, Belgium	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University; KU Leuven; University Hospital Leuven	Bernhagen, J (corresponding author), Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany.	jbernhagen@ukaachen.de; christian.stoppe@gmail.com	Bleilevens, Christian/AAG-8034-2020	Bleilevens, Christian/0000-0002-2104-1843; , Ngobrolgame.com/0000-0001-6815-9112; Rex, Steffen/0000-0002-3536-9321	Deutsche Forschungsgemeinschaft (DFG) [Be1977/4-2 (TP1 of DFG-FOR809), DFG-IRTG1508/1-P13, Ra969/6-1]; Medical School of RWTH Aachen University	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Medical School of RWTH Aachen University	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) grants Be1977/4-2 (TP1 of DFG-FOR809), DFG-IRTG1508/1-P13 and Ra969/6-1 to JB, and by a Rotation Program-and START Program grant of the Medical School of RWTH Aachen University to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; Bouwman RA, 2004, ANESTHESIOLOGY, V100, P506, DOI 10.1097/00000542-200403000-00008; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Crystal GJ, 2012, ACTA ANAESTH SCAND, V56, P39, DOI 10.1111/j.1399-6576.2011.02583.x; De Hert SG, 2005, ANESTH ANALG, V100, P1584, DOI 10.1213/01.ANE.0000153483.61170.0C; Feng JH, 2005, ANESTHESIOLOGY, V103, P987, DOI 10.1097/00000542-200511000-00013; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Frassdorf J, 2009, BRIT J ANAESTH, V103, P89, DOI 10.1093/bja/aep141; Gao XM, 2011, J MOL CELL CARDIOL, V50, P991, DOI 10.1016/j.yjmcc.2010.12.022; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kato R, 2002, CAN J ANAESTH, V49, P777, DOI 10.1007/BF03017409; Koga K, 2011, ANTIOXID REDOX SIGN, V14, P1191, DOI 10.1089/ars.2010.3163; Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Luedike P, 2012, CIRCULATION, V125, P1880, DOI 10.1161/CIRCULATIONAHA.111.069104; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Pagel PS, 2007, ANESTH ANALG, V105, P562, DOI 10.1213/01.ane.0000278083.31991.36; Pagel PS, 2010, J CARDIOTHOR VASC AN, V24, P143, DOI 10.1053/j.jvca.2009.03.016; Pravdic D, 2009, ANESTHESIOLOGY, V111, P267, DOI 10.1097/ALN.0b013e3181a91957; Qi D, 2009, J CLIN INVEST, V119, P3807, DOI 10.1172/JCI39738; REIMER KA, 1990, CIRCULATION, V82, P2266, DOI 10.1161/01.CIR.82.6.2266; Simons D, 2011, J CELL MOL MED, V15, P668, DOI 10.1111/j.1582-4934.2010.01041.x; Stoppe C, 2013, ANTIOXID REDOX SIGN, V19, P231, DOI 10.1089/ars.2012.5015; Stoppe C, 2012, MOL MED, V18, P843, DOI 10.2119/molmed.2012.00071; Takahashi M, 2001, CARDIOVASC RES, V52, P438, DOI 10.1016/S0008-6363(01)00408-4; Tanaka K, 2004, ANESTHESIOLOGY, V100, P707, DOI 10.1097/00000542-200403000-00035; Thiele M, 2005, ANTIOXID REDOX SIGN, V7, P1234, DOI 10.1089/ars.2005.7.1234; Weber N. C., 2008, V182, P187, DOI 10.1007/978-3-540-74806-9_9; Weber NC, 2005, EUR J ANAESTH, V22, P647, DOI 10.1017/S0265021505001080; Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92827	10.1371/journal.pone.0092827	http://dx.doi.org/10.1371/journal.pone.0092827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667295	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600081
J	Baldassi, C; Zamparo, M; Feinauer, C; Procaccini, A; Zecchina, R; Weigt, M; Pagnani, A				Baldassi, Carlo; Zamparo, Marco; Feinauer, Christoph; Procaccini, Andrea; Zecchina, Riccardo; Weigt, Martin; Pagnani, Andrea			Fast and Accurate Multivariate Gaussian Modeling of Protein Families: Predicting Residue Contacts and Protein-Interaction Partners	PLOS ONE			English	Article							CORRELATED MUTATIONS; SEQUENCE; INFORMATION; SPECIFICITY; COVARIANCE; PATHWAYS	In the course of evolution, proteins show a remarkable conservation of their three-dimensional structure and their biological function, leading to strong evolutionary constraints on the sequence variability between homologous proteins. Our method aims at extracting such constraints from rapidly accumulating sequence data, and thereby at inferring protein structure and function from sequence information alone. Recently, global statistical inference methods (e. g. direct-coupling analysis, sparse inverse covariance estimation) have achieved a breakthrough towards this aim, and their predictions have been successfully implemented into tertiary and quaternary protein structure prediction methods. However, due to the discrete nature of the underlying variable (amino-acids), exact inference requires exponential time in the protein length, and efficient approximations are needed for practical applicability. Here we propose a very efficient multivariate Gaussian modeling approach as a variant of direct-coupling analysis: the discrete amino-acid variables are replaced by continuous Gaussian random variables. The resulting statistical inference problem is efficiently and exactly solvable. We show that the quality of inference is comparable or superior to the one achieved by mean-field approximations to inference with discrete variables, as done by direct-coupling analysis. This is true for (i) the prediction of residue-residue contacts in proteins, and (ii) the identification of protein-protein interaction partner in bacterial signal transduction. An implementation of our multivariate Gaussian approach is available at the website http://areeweb.polito.it/ricerca/cmp/code.	[Baldassi, Carlo; Zamparo, Marco; Feinauer, Christoph; Zecchina, Riccardo; Pagnani, Andrea] Politecn Torino, Dept Appl Sci & Technol, Turin, Italy; [Baldassi, Carlo; Zamparo, Marco; Feinauer, Christoph; Zecchina, Riccardo; Pagnani, Andrea] Politecn Torino, Ctr Computat Sci, Turin, Italy; [Baldassi, Carlo; Zamparo, Marco; Procaccini, Andrea; Zecchina, Riccardo; Pagnani, Andrea] Human Genet Fdn Torino, Turin, Italy; [Weigt, Martin] Univ Paris 06, Univ Sorbonne, UMR 7238, Paris, France; [Weigt, Martin] CNRS, UMR 7238, Paris, France	Polytechnic University of Turin; Polytechnic University of Turin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Pagnani, A (corresponding author), Politecn Torino, Dept Appl Sci & Technol, Turin, Italy.	andrea.pagnani@polito.it	Weigt, Martin/L-8851-2016; Pagnani, Andrea/J-2363-2015; Baldassi, Carlo/I-2212-2017; Feinauer, Christoph/AAU-3423-2021	Weigt, Martin/0000-0002-0492-3684; Pagnani, Andrea/0000-0002-6509-0807; Baldassi, Carlo/0000-0002-5451-8388; ZECCHINA, Riccardo/0000-0002-1221-5207	European Union under REA [290038]; European Research Council [267915]	European Union under REA; European Research Council(European Research Council (ERC)European Commission)	Christoph Feinauer acknowledges funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement No. 290038. Riccardo Zecchina and Carlo Baldassi acknowledge the European Research Council for grant No. 267915. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Balakrishnan S, 2011, PROTEINS, V79, P1061, DOI 10.1002/prot.22934; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Cocco S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003176; Dago AE, 2012, P NATL ACAD SCI; de Juan D, 2013, NATURE REV GENETICS; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ekeberg M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012707; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Garbuzynskiy SO, 2004, PROTEIN SCI, V13, P2871, DOI 10.1110/ps.04881304; Gelman A., 2003, BAYESIAN DATA ANAL; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Hoch JA, 2001, J BACTERIOL, V183, P4941, DOI 10.1128/JB.183.17.4941-4949.2001; Hopf T, 2012, CELL; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jaynes ET, 1957, PHYS REV 2, V108; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Lapedes A, 2012, ARXIV12072484; Lapedes A.S., 1999, LECT NOTES MONOGR SE, V33, P236, DOI [10.1214/lnms/1215455556, DOI 10.1214/LNMS/1215455556]; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003; Procaccini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019729; Sadowski MI, 2011, COMPUT BIOL CHEM, V35, P323, DOI 10.1016/j.compbiolchem.2011.08.002; Schug A, 2009, P NATL ACAD SCI USA, V106, P22124, DOI 10.1073/pnas.0912100106; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Sreekumar J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-444; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Taylor WR, 2012, PROTEIN SCI, V21, P299, DOI 10.1002/pro.2002; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106	45	99	100	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92721	10.1371/journal.pone.0092721	http://dx.doi.org/10.1371/journal.pone.0092721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663061	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900102
J	Boiko, N; Kucher, V; Wang, B; Stockand, JD				Boiko, Nina; Kucher, Volodymyr; Wang, Bin; Stockand, James D.			Restrictive Expression of Acid-Sensing Ion Channel 5 (Asic5) in Unipolar Brush Cells of the Vestibulocerebellum	PLOS ONE			English	Article							CEREBELLAR PURKINJE NEURONS; RESURGENT SODIUM CURRENT; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL EXPRESSION; NA+ CHANNEL; RECEPTOR; CLONING; HYDRA; GENE; FORM	Acid-sensing ion channels (Asic) are ligand-gated ion channels in the Degenerin/Epithelial Na+ channel (Deg/ENaC) family. Asic proteins are richly expressed in mammalian neurons. Mammals express five Asic genes: Asic1-5. The gene product of Asic5 is an orphan member of the family about which little is known. To investigate Asic5 expression, we created an Asic5 reporter mouse. We find that Asic5 is chiefly expressed in the brain in the cerebellum, specifically in the ventral uvula and nodulus of the vestibulocerebellum. Here, Asic5 is restrictively expressed in a subset of interneurons in the granular layer. The locale, distinctive shape and immunohistochemical properties of these Asic5-expressing interneurons identify them as unipolar brush cells (UBC). Asic5 is richly expressed in a subset of UBCs that also express the metabotropic glutamate receptor 1 alpha (mGluR1 alpha) but not those that express calretinin. Results from single cell RT-PCR and electrophysiological examination of these cells are consistent with this identity. Such observations are consistent with Asic5 playing a key role in the physiology of UBCs and in the function of the vestibulocerebellum.	[Boiko, Nina; Kucher, Volodymyr; Wang, Bin; Stockand, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Stockand, JD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.	stockand@uthscsa.edu		Stockand, James/0000-0002-3817-4319	American Heart Association [EIA 0640054N]; UTHSCSA; NIH [NCI P30 CA54174]; NIA [P30 AG013319, P01AG19316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013319, P01AG019316] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); UTHSCSA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the American Heart Association grant EIA 0640054N to JDS. The Core Optical Imaging Facility at UTHSCSA is supported by UTHSCSA and the NIH (NCI P30 CA54174 to the San Antonio Cancer Institute; NIA P30 AG013319 to the Nathan Shock Center; and NIA P01AG19316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; Chu XP, 2013, ADV EXP MED BIOL, V961, P419, DOI 10.1007/978-1-4614-4756-6_36; Diana MA, 2007, J NEUROSCI, V27, P3823, DOI 10.1523/JNEUROSCI.4719-06.2007; Dino MR, 2000, NEUROSCIENCE, V98, P625, DOI 10.1016/S0306-4522(00)00123-8; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Durrnagel S, 2010, J BIOL CHEM, V285, P11958, DOI 10.1074/jbc.M109.059998; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grieco TM, 2002, J NEUROSCI, V22, P3100, DOI 10.1523/JNEUROSCI.22-08-03100.2002; Hogan B, 1994, MANIPULATING MOUSE E; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kim JA, 2012, CEREBELLUM, V11, P1012, DOI 10.1007/s12311-012-0380-8; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leng TD, 2013, ACTA PHARMACOL SIN, V34, P33, DOI 10.1038/aps.2012.81; Mugnaini E, 2011, BRAIN RES REV, V66, P220, DOI 10.1016/j.brainresrev.2010.10.001; Nunzi MG, 2002, J COMP NEUROL, V451, P189, DOI 10.1002/cne.10344; Nunzi MG, 2000, J COMP NEUROL, V422, P55, DOI 10.1002/(SICI)1096-9861(20000619)422:1<55::AID-CNE4>3.0.CO;2-9; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; REGAN LJ, 1991, J NEUROSCI, V11, P2259; ROSSI DJ, 1995, J NEUROPHYSIOL, V74, P24, DOI 10.1152/jn.1995.74.1.24; Ruigrok TJH, 2011, J NEUROSCI, V31, P712, DOI 10.1523/JNEUROSCI.1959-10.2011; Russo MJ, 2007, J PHYSIOL-LONDON, V581, P709, DOI 10.1113/jphysiol.2007.129106; Russo MJ, 2008, J NEUROPHYSIOL, V100, P3351, DOI 10.1152/jn.90533.2008; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; Sekerkova G, 2014, BRAIN STRUCT FUNCT, V219, P719, DOI 10.1007/s00429-013-0531-9; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Vergo S, 2011, BRAIN, V134, P571, DOI 10.1093/brain/awq337; Wiemuth D, 2013, CHANNELS, V7, P38, DOI 10.4161/chan.22406; Wiemuth D, 2012, FASEB J, V26, P4122, DOI 10.1096/fj.12-207043; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	36	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91326	10.1371/journal.pone.0091326	http://dx.doi.org/10.1371/journal.pone.0091326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663811	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900018
J	Conter, LJ; Song, E; Shlomchik, MJ; Tomayko, MM				Conter, Laura J.; Song, Eunice; Shlomchik, Mark J.; Tomayko, Mary M.			CD73 Expression Is Dynamically Regulated in the Germinal Center and Bone Marrow Plasma Cells Are Diminished in Its Absence	PLOS ONE			English	Article							MEMORY B-CELLS; CD4 T-CELLS; MURINE MEMORY; ADENOSINE GENERATION; IMMUNE SUPPRESSION; PURINE METABOLISM; VASCULAR LEAKAGE; CUTTING EDGE; SELECTION; HYPOXIA	CD73 catalyzes the conversion of extracellular nucleosides to adenosine, modulating inflammatory and T cell responses. Elevated expression of CD73 marks subpopulations of murine memory B cells (MBC), but its role in memory development or function is unknown. Here, we demonstrate that CD73 is progressively upregulated on germinal center (GC) B cells following immunization, is expressed at even higher levels among T follicular helper cells, but is absent among plasma cells (PC) and plasmablasts (PB). We analyzed the T-dependent B cell response in CD73 knockout mice (CD73KO). During the early response, CD73KO and wild type (WT) mice formed GCs, MBCs and splenic PBs and PCs similarly, and MBCs functioned similarly in the early secondary response. Late in the primary response, however, bone marrow (BM) PCs were markedly decreased in CD73KO animals. Tracking this phenotype, we found that CD73 expression was required on BM-derived cells for optimal BM PC responses. However, deletion of CD73 from either B or T lymphocytes alone did not recapitulate the phenotype. This suggests that CD73 expression is sufficient on either cell type, consistent with its function as an ectoenzyme. Together, these findings suggest that CD73-dependent adenosine signaling is prominent in the mature GC and required for establishment of the long-lived PC compartment, thus identifying a novel role for CD73 in humoral immunity.	[Conter, Laura J.; Tomayko, Mary M.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Song, Eunice; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Tomayko, MM (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.	mary.tomayko@yale.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959	National Institutes of Health [AI43603, K08AI78533]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI078533, R01AI043603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI43603 (MJS) and K08AI78533 (MMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2011, BLOOD, V117, P4387, DOI 10.1182/blood-2010-11-321646; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Anderson SM, 2006, IMMUNOL REV, V211, P280, DOI 10.1111/j.0105-2896.2006.00398.x; Anderson SM, 2009, J IMMUNOL, V183, P7314, DOI 10.4049/jimmunol.0902452; BASTIAN JF, 1984, J IMMUNOL, V132, P1767; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Clayton A, 2011, J IMMUNOL, V187, P676, DOI 10.4049/jimmunol.1003884; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gomez MR, 2010, J IMMUNOL, V185, P7180, DOI 10.4049/jimmunol.1002319; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Hershberg U, 2008, INT IMMUNOL, V20, P683, DOI 10.1093/intimm/dxn026; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Jin DC, 2010, CANCER RES, V70, P2245, DOI 10.1158/0008-5472.CAN-09-3109; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kiss J, 2007, EUR J IMMUNOL, V37, P3334, DOI 10.1002/eji.200737793; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Kumar V, 2009, EUR J PHARMACOL, V616, P7, DOI 10.1016/j.ejphar.2009.05.005; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Pabst O, 2005, J IMMUNOL, V174, P7492, DOI 10.4049/jimmunol.174.12.7492; Regateiro FS, 2013, CLIN EXP IMMUNOL, V171, P1, DOI 10.1111/j.1365-2249.2012.04623.x; Regateiro FS, 2011, EUR J IMMUNOL, V41, P2955, DOI 10.1002/eji.201141512; Resta R, 1998, IMMUNOL REV, V161, P95, DOI 10.1111/j.1600-065X.1998.tb01574.x; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Romio M, 2011, AM J PHYSIOL-CELL PH, V301, pC530, DOI 10.1152/ajpcell.00385.2010; Scholz JL, 2008, P NATL ACAD SCI USA, V105, P15517, DOI 10.1073/pnas.0807841105; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; SHLOMCHIK MJ, 1993, INT IMMUNOL, V5, P1329, DOI 10.1093/intimm/5.10.1329; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Stewart M, 2002, HISTOPATHOLOGY, V40, P253, DOI 10.1046/j.1365-2559.2002.01357.x; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Takedachi M, 2012, J CELL PHYSIOL, V227, P2622, DOI 10.1002/jcp.23001; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Yamashita Y, 1998, EUR J IMMUNOL, V28, P2981, DOI 10.1002/(SICI)1521-4141(199810)28:10<2981::AID-IMMU2981>3.0.CO;2-D; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yegutkin GG, 2010, J IMMUNOL, V184, P5112, DOI 10.4049/jimmunol.0902760; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	55	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92009	10.1371/journal.pone.0092009	http://dx.doi.org/10.1371/journal.pone.0092009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664100	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900038
J	Hu, R; Ling, W; Xu, W; Han, DM				Hu, Rong; Ling, Wei; Xu, Wen; Han, Demin			Fibroblast-Like Cells Differentiated from Adipose-Derived Mesenchymal Stem Cells for Vocal Fold Wound Healing	PLOS ONE			English	Article							TISSUE REGENERATION; HYALURONIC-ACID; LAMINA PROPRIA; STROMAL CELLS; MATRIX; EXPRESSION; INJECTION; DECORIN; VIVO	Tissue engineering has revealed the potential to regenerate injured vocal folds, and identification of the most suitable seed cells has remained a hot topic of research. The aim of this study was to implant fibroblast-like cells differentiated from adipose-derived mesenchymal stem cells (ADSCs) in a canine acute vocal fold wound model. We then sought to characterize changes in the extracellular matrix (ECM) proteins of vocal fold lamina propria. For this purpose, ADSCs were induced to differentiate into fibroblasts under the regulation of connective tissue growth factor in vitro. Cell surface proteins were identified by immunofluorescence staining. Thirty vocal folds of 17 canines were injured by localized resection and injected with fibroblast-like cells (differentiated ADSCs, dADSCs), ADSCs or vocal fold fibroblasts (VFFs). The morphology of vocal folds was observed, and the characteristics of ECM protein components (collagen, elastin, hyaluronic acid, decorin and fibronectin) were evaluated by immunofluorescence staining from 15 days to 6 months following implantation. The results showed that in vitro, the dADSCs showed morphology and cell surface protein expression similar to those of VFFs. After implantation in vivo, the surfaces of the recipient vocal folds became almost smooth in the dADSCs and ADSCs groups at 6 months but remained slightly concave and stiff in the VFFs group. The elastin fluorescence intensity increased significantly and was maintained at a high level in the dADSCs group. The collagen fluorescence intensity increased slightly in the dADSCs and ADSCs groups, whereas it demonstrated a more irregular arrangement in the VFFs group. The fluorescence intensity of hyaluronic acid, decorin and fibronectin was similar between the three implanted groups. These results indicated that dADSCs may confer an advantage for vocal fold wound healing. Furthermore, dADSCs have the ability to secrete ECM components in vivo, particularly elastin, which may be beneficial for vocal fold vibration recovery.	[Hu, Rong; Xu, Wen; Han, Demin] Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol Head Neck Surg, Beijing, Peoples R China; [Ling, Wei] Capital Med Univ, Dept Anat, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Xu, W (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol Head Neck Surg, Beijing, Peoples R China.	xuwendoc@gmail.com; handm@trhos.com			National Natural Science Foundation of China [30973294]; Beijing Natural Science Foundation [7102031]; program for Beijing Health Foundation of High-level Technical Personnel [2009-3-33]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); program for Beijing Health Foundation of High-level Technical Personnel	This study was supported by the National Natural Science Foundation of China (30973294), Beijing Natural Science Foundation (7102031) and program for Beijing Health Foundation of High-level Technical Personnel (2009-3-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2009, CELL TISSUE RES, V335, P565, DOI 10.1007/s00441-008-0729-y; Bourget JM, 2012, BIOMATERIALS, V33, P9205, DOI 10.1016/j.biomaterials.2012.09.015; Cedervall J, 2007, LARYNGOSCOPE, V117, P2075, DOI 10.1097/MLG.0b013e3181379c7c; Chhetri DK, 2011, LARYNGOSCOPE, V121, P785, DOI 10.1002/lary.21417; Chhetri DK, 2004, OTOLARYNG HEAD NECK, V131, P864, DOI 10.1016/j.otohns.2004.07.010; Gaston J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030965; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Hall-Glenn F, 2011, CELL MOL LIFE SCI, V68, P3209, DOI 10.1007/s00018-011-0782-7; Hertegard S, 2006, LARYNGOSCOPE, V116, P1248, DOI 10.1097/01.mlg.0000224548.68499.35; Hirano M, 1981, CLIN EXAMINATION VOI, P5; Hirano S, 2003, ANN OTO RHINOL LARYN, V112, P617, DOI 10.1177/000348940311200708; Johnson BQ, 2010, LARYNGOSCOPE, V120, P537, DOI 10.1002/lary.20782; Kanemaru S, 2005, ANN OTO RHINOL LARYN, V114, P907, DOI 10.1177/000348940511401203; Kanemaru SI, 2003, ANN OTO RHINOL LARYN, V112, P915, DOI 10.1177/000348940311201101; Kim YM, 2014, LARYNGOSCOPE, V124, pE64, DOI 10.1002/lary.24405; Krishna P, 2006, OTOLARYNG HEAD NECK, V135, P937, DOI 10.1016/j.otohns.2006.07.011; Krishna P, 2010, LARYNGOSCOPE, V120, P2247, DOI 10.1002/lary.21087; Kumai Y, 2010, LARYNGOSCOPE, V120, P330, DOI 10.1002/lary.20753; Lee BJ, 2006, CELLS TISSUES ORGANS, V184, P198, DOI 10.1159/000099627; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Liang Q, 2012, LARYNGOSCOPE, V122, P1815, DOI 10.1002/lary.23330; Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054256; Ohno T, 2008, EUR ARCH OTO-RHINO-L, V265, P669, DOI 10.1007/s00405-007-0522-7; Rodriguez-Menocal L, 2012, STEM CELL TRANSL MED, V1, P221, DOI 10.5966/sctm.2011-0029; Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007; Sahiner N, 2008, J BIOMAT SCI-POLYM E, V19, P223, DOI 10.1163/156856208783432462; Svensson B, 2010, LARYNGOSCOPE, V120, P1370, DOI 10.1002/lary.20926; Tateya I, 2006, ANN OTO RHINOL LARYN, V115, P135, DOI 10.1177/000348940611500210; Tateya T, 2006, ANN OTO RHINOL LARYN, V115, P285, DOI 10.1177/000348940611500406; Thibeault SL, 2002, ANN OTO RHINOL LARYN, V111, P8, DOI 10.1177/000348940211100102; Thibeault SL, 2009, TISSUE ENG PT A, V15, P1481, DOI 10.1089/ten.tea.2008.0299; Tong ZX, 2011, TISSUE ENG PT A, V17, P2773, DOI [10.1089/ten.TEA.2011.0219, 10.1089/ten.tea.2011.0219]; Xu W, 2011, ANN OTO RHINOL LARYN, V120, P123, DOI 10.1177/000348941112000209; Zinchuk V, 2011, NAT PROTOC, V6, P1554, DOI 10.1038/nprot.2011.384; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	35	38	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92676	10.1371/journal.pone.0092676	http://dx.doi.org/10.1371/journal.pone.0092676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664167	Green Submitted, gold, Green Published			2022-12-25	WOS:000333459900095
J	Mirshahi, S; Soria, C; Kouchakji, B; Kierzek, G; Borg, JY; Varin, R; Chidiac, J; Drouet, L; Mirshahi, M; Soria, J				Mirshahi, Shahsoltan; Soria, Claudine; Kouchakji, Basile; Kierzek, Gerald; Borg, Jeanne Yvonne; Varin, Remi; Chidiac, Jean; Drouet, Ludovic; Mirshahi, Massoud; Soria, Jeannette			New Combinational Assay Using Soluble Fibrin and D-Dimer Determinations: A Promising Strategy for Identifying Patients with Suspected Venous Thromboembolism	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; MONOCLONAL-ANTIBODY; ENZYME-IMMUNOASSAY; DIAGNOSTIC-AID; PLASMA; DISEASE; ANTITHROMBIN; EXCLUSION	Aim: To establish a new and reliable assay for quantification of the soluble fibrin (SF) in combination with that of D-dimer for early diagnosis of venous thromboembolism. Methods and Samples: The SF assay is based on D-dimer generated after incubation of plasma with tissue-type plasminogen activator (t-PA). SF and standard D-dimer assays, run in blind, were used to test 119 untreated outpatients with clinically suspected deep-vein thrombosis (DVT, 49 patients) or pulmonary embolism (PE, 70 patients) consulting at the emergency unit of the hospital. Thromboses were confirmed by current imaging methods such as ultrasonography, scintigraphy, computed tomographic pulmonary angiography (CTPA) and ventilation/perfusion scan. Results: SF assay was validated in 270 healthy volunteers [51.8% males; mean age years +/- SD: 41 +/- 13; age range 19 to 65]. Among these normal plasmas, SF levels were <= 200 ng/mL in 97.8% of them, and 200-250 ng/mL in the remainder [26-46 years old; 50% males]. ROC curves were used to determine the SF cut-off value for plasma SF positivity, which was found to be 300 ng/mL. In patients with suspected venous thromboembolism, SF sensitivities for DVT and PE (92% and 94%, respectively) were comparable to those of D-dimer (96% and 94%), whereas SF specificities (86% and 95%) were higher than those of D-dimer (50% and 54%). Positive-predictive values for SF (89% and 94%) were again higher than those of D-dimer (70% and 65%) in DVT and PE. The amount of circulating SF normalized rapidly after anticoagulant therapy. Conclusion: Results from this small group of patients suggest that the evaluation of plasma SF, in combination with that of D-dimer, represents a potentially useful tool for the early diagnosis of venous thromboembolism, provided that the patients have not been treated previously by anticoagulants.	[Mirshahi, Shahsoltan; Chidiac, Jean; Mirshahi, Massoud; Soria, Jeannette] Hop Hotel Dieu, Serv Oncohematol, Paris, France; [Mirshahi, Shahsoltan; Mirshahi, Massoud; Soria, Jeannette] Univ Paris 07, INSERM, UMR U965, Paris, France; [Soria, Claudine; Drouet, Ludovic] Hop Lariboisiere, Hematol Lab, F-75475 Paris, France; Fac Med & Pharm, Lab MERCI, Rouen, France; [Kouchakji, Basile] Hop Neuilly, Serv Pneumol, Neuilly, France; [Kierzek, Gerald] Hop Hotel Dieu, Serv Urgences, Paris, France; [Borg, Jeanne Yvonne; Varin, Remi] Hop Charles Nicolle, Rouen, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen	Soria, J (corresponding author), Hop Hotel Dieu, Serv Oncohematol, Paris, France.	jeannette.soria@htd.aphp.fr	DROUET, ludovic/GYR-3249-2022					Arkel YS, 2002, BLOOD COAGUL FIBRIN, V13, P199, DOI 10.1097/00001721-200204000-00005; Arkel YS, 2001, THROMB HAEMOSTASIS, V86, P1127; BIANCONE L, 1994, ITAL J GASTROENTEROL, V26, P116; BOUNAMEAUX H, 1991, LANCET, V337, P196, DOI 10.1016/0140-6736(91)92158-X; BOUNAMEAUX H, 1992, THROMB HAEMOSTASIS, V67, P603; BOUNAMEAUX H, 1991, J MAL VASCUL, V16, P133; Bounameaux H, 1990, BLOOD COAGUL FIBRIN, V1, P1577; Brimble KS, 1997, THROMB RES, V88, P291, DOI 10.1016/S0049-3848(97)00256-9; Brummel KE, 1999, J BIOL CHEM, V274, P22862, DOI 10.1074/jbc.274.32.22862; CHANDLER WL, 1990, BLOOD, V76, P930; Crowther MA, 2001, THROMB HAEMOSTASIS, V85, P390; DEMPFLE CE, 1993, BLOOD COAGUL FIBRIN, V4, P79, DOI 10.1097/00001721-199304010-00013; Dempfle CE, 2004, THROMB HAEMOSTASIS, V91, P812, DOI 10.1160/TH03-09-0577; Dempfle CE, 2001, THROMB HAEMOSTASIS, V86, P1204; DEMPFLE CE, 1995, THROMB HAEMOSTASIS, V74, P673; Derhaschnig U, 2002, CLIN CHEM, V48, P1924; Dirix LY, 2002, BRIT J CANCER, V86, P389, DOI 10.1038/sj.bjc.6600069; Duet M, 1998, THROMB RES, V91, P1, DOI 10.1016/S0049-3848(98)00048-6; EISENBERG PR, 1990, CIRCULATION, V82, P841, DOI 10.1161/01.CIR.82.3.841; Flores J, 2003, ARCH PATHOL LAB MED, V127, P310; Ginsberg JS, 1996, THROMB HAEMOSTASIS, V75, P551; GINSBERG JS, 1995, THROMB HAEMOSTASIS, V74, P833; Goldhaber SZ, 1992, J AM COLL CARDIOL, V9, P246; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hetland O, 2002, BLOOD COAGUL FIBRIN, V13, P301, DOI 10.1097/00001721-200206000-00005; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; Iversen LH, 1996, THROMB RES, V81, P569, DOI 10.1016/0049-3848(96)00031-X; Koga Shin, 2004, Rinsho Byori, V52, P355; LaCapra S, 2000, BLOOD COAGUL FIBRIN, V11, P371, DOI 10.1097/00001721-200006000-00009; Lehman CM, 2004, AM J CLIN PATHOL, V122, P178, DOI 10.1309/X4YN001GU51NGG9Y; Lippi G, 2007, HAEMATOLOGICA, V92, P53, DOI 10.3324/haematol.12237; Mac Gillavry MR, 2000, THROMB HAEMOSTASIS, V84, P474; MIRSHAHI SS, 1992, CANCER, V69, P2289, DOI 10.1002/1097-0142(19920501)69:9<2289::AID-CNCR2820690914>3.0.CO;2-A; MOSESSON MW, 1963, J LAB CLIN MED, V62, P663; Nakahara K, 2003, THROMB HAEMOSTASIS, V89, P832; NIEUWENHUIZEN W, 1992, THROMB HAEMOSTASIS, V68, P273; NIEUWENHUIZEN W, 1993, BLOOD COAGUL FIBRIN, V4, P93, DOI 10.1097/00001721-199304010-00015; Okajima K, 1996, AM J HEMATOL, V51, P186, DOI 10.1002/(SICI)1096-8652(199603)51:3<186::AID-AJH2>3.0.CO;2-T; Reber G, 1999, THROMB HAEMOSTASIS, V81, P221; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; ROTKER J, 1986, EUR J BIOCHEM, V155, P583, DOI 10.1111/j.1432-1033.1986.tb09528.x; Scarano L, 1999, BLOOD COAGUL FIBRIN, V10, P245, DOI 10.1097/00001721-199907000-00005; SORIA J, 1983, BRIT J HAEMATOL, V53, P575, DOI 10.1111/j.1365-2141.1983.tb07309.x; Wada H, 2003, CLIN APPL THROMB-HEM, V9, P233, DOI 10.1177/107602960300900308; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010	46	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92379	10.1371/journal.pone.0092379	http://dx.doi.org/10.1371/journal.pone.0092379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664182	Green Submitted, gold, Green Published			2022-12-25	WOS:000333459900058
J	Su, S; Panmanee, W; Wilson, JJ; Mahtani, HK; Li, Q; VanderWielen, BD; Makris, TM; Rogers, M; McDaniel, C; Lipscomb, JD; Irvin, RT; Schurr, MJ; Lancaster, JR; Kovall, RA; Hassett, DJ				Su, Shengchang; Panmanee, Warunya; Wilson, Jeffrey J.; Mahtani, Harry K.; Li, Qian; VanderWielen, Bradley D.; Makris, Thomas M.; Rogers, Melanie; McDaniel, Cameron; Lipscomb, John D.; Irvin, Randall T.; Schurr, Michael J.; Lancaster, Jack R., Jr.; Kovall, Rhett A.; Hassett, Daniel J.			Catalase (KatA) Plays a Role in Protection against Anaerobic Nitric Oxide in Pseudomonas aeruginosa	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DINITROSYL-IRON COMPLEXES; CYSTIC-FIBROSIS PATIENTS; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; SUPEROXIDE-DISMUTASE; BURKHOLDERIA-CEPACIA; TREATMENT STRATEGIES; NITRATE RESPIRATION	Pseudomonas aeruginosa (PA) is a common bacterial pathogen, responsible for a high incidence of nosocomial and respiratory infections. KatA is the major catalase of PA that detoxifies hydrogen peroxide (H2O2), a reactive oxygen intermediate generated during aerobic respiration. Paradoxically, PA displays elevated KatA activity under anaerobic growth conditions where the substrate of KatA, H2O2, is not produced. The aim of the present study is to elucidate the mechanism underlying this phenomenon and define the role of KatA in PA during anaerobiosis using genetic, biochemical and biophysical approaches. We demonstrated that anaerobic wild-type PAO1 cells yielded higher levels of katA transcription and expression than aerobic cells, whereas a nitrite reductase mutant Delta nirS produced similar to 50% the KatA activity of PAO1, suggesting that a basal NO level was required for the increased KatA activity. We also found that transcription of the katA gene was controlled, in part, by the master anaerobic regulator, ANR. A Delta katA mutant and a mucoid mucA22 Delta katA bacteria demonstrated increased sensitivity to acidified nitrite (an NO generator) in anaerobic planktonic and biofilm cultures. EPR spectra of anaerobic bacteria showed that levels of dinitrosyl iron complexes (DNIC), indicators of NO stress, were increased significantly in the DkatA mutant, and dramatically in a Delta norCB mutant compared to basal levels of DNIC in PAO1 and DnirS mutant. Expression of KatA dramatically reduced the DNIC levels in Delta norCB mutant. We further revealed direct NO-KatA interactions in vitro using EPR, optical spectroscopy and X-ray crystallography. KatA has a 5-coordinate high spin ferric heme that binds NO without prior reduction of the heme iron (K-d similar to 6 mu M). Collectively, we conclude that KatA is expressed to protect PA against NO generated during anaerobic respiration. We proposed that such protective effects of KatA may involve buffering of free NO when potentially toxic concentrations of NO are approached.	[Su, Shengchang; Panmanee, Warunya; Wilson, Jeffrey J.; VanderWielen, Bradley D.; McDaniel, Cameron; Kovall, Rhett A.; Hassett, Daniel J.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45221 USA; [Mahtani, Harry K.; Li, Qian; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL USA; [Mahtani, Harry K.; Li, Qian; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Cell, Birmingham, AL USA; [Mahtani, Harry K.; Li, Qian; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Dev & Integrat Biol, Birmingham, AL USA; [Mahtani, Harry K.; Li, Qian; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Environm Hlth Sci, Birmingham, AL USA; [Makris, Thomas M.; Rogers, Melanie; Lipscomb, John D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Irvin, Randall T.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Schurr, Michael J.] Univ Colorado, Dept Microbiol, Aurora, CO USA; [Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL USA	University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; University of Alberta; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Alabama System; University of Alabama Birmingham	Hassett, DJ (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45221 USA.	Daniel.Hassett@UC.Edu	Makris, Thomas/W-9965-2019; Schurr, Michael/AAX-6596-2020; Schurr, Michael/I-2481-2013	Makris, Thomas/0000-0001-7927-620X; Schurr, Michael/0000-0003-2585-0477; Lipscomb, John/0000-0002-8158-5594	Department of Veterans Affairs; Cincinnati VA Hospital (Cincinnati, OH); National Institutes of Health [GM100943]; Daniel Tyler Health and Education Foundation (Fort Collins, CO); Cystic Fibrosis Research, Inc. (Mountain View, CA); Cure Finders, Inc. (Sevierville, TN); Aires Pharma (San Diego, CA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024689, R01GM100943] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Cincinnati VA Hospital (Cincinnati, OH); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daniel Tyler Health and Education Foundation (Fort Collins, CO); Cystic Fibrosis Research, Inc. (Mountain View, CA); Cure Finders, Inc. (Sevierville, TN); Aires Pharma (San Diego, CA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Merit Review from the Department of Veterans Affairs, Cincinnati VA Hospital (Cincinnati, OH) (D.J.H.) and a National Institutes of Health Grant (GM100943, J.D.L.). Additional support was received from and the Daniel Tyler Health and Education Foundation (Fort Collins, CO) and from Cystic Fibrosis Research, Inc. (Mountain View, CA), Cure Finders, Inc. (Sevierville, TN), and Aires Pharma (San Diego, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antus B, 2010, AM J RESP CRIT CARE, V182, P1492, DOI 10.1164/rccm.201003-0451OC; ARAI H, 1995, FEBS LETT, V371, P73, DOI 10.1016/0014-5793(95)00885-D; ARAI H, 1995, BBA-GENE STRUCT EXPR, V1261, P279, DOI 10.1016/0167-4781(95)00018-C; Arai H, 2005, J BACTERIOL, V187, P3960, DOI 10.1128/JB.187.12.3960-3968.2005; Arai H, 1999, FEMS MICROBIOL LETT, V170, P19, DOI 10.1111/j.1574-6968.1999.tb13350.x; Arai H, 1997, MOL MICROBIOL, V25, P1141, DOI 10.1046/j.1365-2958.1997.5431906.x; Bandara DMI, 2011, J INORG BIOCHEM, V105, P1786, DOI 10.1016/j.jinorgbio.2011.09.026; BROWN GC, 1995, EUR J BIOCHEM, V232, P188, DOI 10.1111/j.1432-1033.1995.tb20798.x; BROWN SM, 1995, J BACTERIOL, V177, P6536, DOI 10.1128/jb.177.22.6536-6544.1995; BUZY A, 1995, J PROTEIN CHEM, V14, P59, DOI 10.1007/BF01888363; Castiglione N, 2009, MICROBIOL-SGM, V155, P2838, DOI 10.1099/mic.0.028027-0; Crack JC, 2013, J BIOL CHEM, V288, P11492, DOI 10.1074/jbc.M112.439901; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Downey DG, 2009, THORAX, V64, P81, DOI 10.1136/thx.2007.082388; Elkins JG, 1999, APPL ENVIRON MICROB, V65, P4594; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Favero MS, 1996, AM J INFECT CONTROL, V24, P380; Frederick JR, 2001, APPL ENVIRON MICROB, V67, P1375, DOI 10.1128/AEM.67.3.1375-1379.2001; GALIMAND M, 1991, J BACTERIOL, V173, P1598, DOI 10.1128/jb.173.5.1598-1606.1991; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Garrett ES, 1999, J BACTERIOL, V181, P7401, DOI 10.1128/JB.181.23.7401-7404.1999; Giardina G, 2008, J MOL BIOL, V378, P1002, DOI 10.1016/j.jmb.2008.03.013; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; HANCOCK REW, 1983, INFECT IMMUN, V42, P170, DOI 10.1128/IAI.42.1.170-177.1983; Hasset DJ, 2000, J BACTERIOL, V182, P4557, DOI 10.1128/JB.182.16.4557-4563.2000; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; HASSETT DJ, 1992, INFECT IMMUN, V60, P328, DOI 10.1128/IAI.60.2.328-336.1992; Hassett DJ, 1999, METHOD ENZYMOL, V310, P599; Hassett DJ, 2006, OXIDATIVE STRESS SYS, P544; Heo YJ, 2010, J BACTERIOL, V192, P381, DOI 10.1128/JB.00980-09; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kim SH, 2009, J MICROBIOL BIOTECHN, V19, P1520, DOI 10.4014/jmb.0906.06028; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Korshunov S, 2010, MOL MICROBIOL, V75, P1389, DOI 10.1111/j.1365-2958.2010.07059.x; Landry AP, 2011, FREE RADICAL BIO MED, V50, P1582, DOI 10.1016/j.freeradbiomed.2011.03.005; Lee JS, 2005, INFECT IMMUN, V73, P4399, DOI 10.1128/IAI.73.7.4399-4403.2005; Lu TT, 2010, CHEM-EUR J, V16, P8088, DOI 10.1002/chem.201000524; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; Major TA, 2010, ANTIMICROB AGENTS CH, V54, P4671, DOI 10.1128/AAC.00379-10; Maniatis T., 1982, MOL CLONING LAB MANU; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Mayburd AL, 2002, BIOCHEMISTRY-US, V41, P11582, DOI 10.1021/bi020058l; Miller JH., 1992, SHORT COURSE BACTERI, P72; O'Toole GA, 2003, J BACTERIOL, V185, P2687, DOI 10.1128/JB.185.9.2687-2689.2003; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; OHMAN DE, 1981, INFECT IMMUN, V33, P142, DOI 10.1128/IAI.33.1.142-148.1981; Panmanee W, 2008, J BACTERIOL, V190, P3658, DOI 10.1128/JB.00022-08; Panmanee W, 2009, FEMS MICROBIOL LETT, V295, P238, DOI 10.1111/j.1574-6968.2009.01605.x; Pela R, 1998, Monaldi Arch Chest Dis, V53, P262; Petrova OE, 2012, P NATL ACAD SCI USA, V109, P16690, DOI 10.1073/pnas.1207832109; Platt MD, 2008, J BACTERIOL, V190, P2739, DOI 10.1128/JB.01683-07; Purwar N, 2011, BIOCHEMISTRY-US, V50, P4491, DOI 10.1021/bi200130r; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Ren BB, 2008, MOL MICROBIOL, V70, P953, DOI 10.1111/j.1365-2958.2008.06464.x; Schobert M, 2010, INT J MED MICROBIOL, V300, P549, DOI 10.1016/j.ijmm.2010.08.007; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; SHIMIZU N, 1988, J BIOCHEM-TOKYO, V104, P136, DOI 10.1093/oxfordjournals.jbchem.a122409; Shin DH, 2008, J BACTERIOL, V190, P2663, DOI 10.1128/JB.01580-07; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith AW, 1999, J MED MICROBIOL, V48, P419, DOI 10.1099/00222615-48-5-419; Soum E, 2003, J BIOL INORG CHEM, V8, P226, DOI 10.1007/s00775-002-0412-9; Su SC, 2012, EXPERT OPIN THER TAR, V16, P859, DOI 10.1517/14728222.2012.708025; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Valderrey AD, 2010, DIAGN MICR INFEC DIS, V68, P20, DOI 10.1016/j.diagmicrobio.2010.04.008; Vanin AF, 2007, NITRIC OXIDE-BIOL CH, V16, P82, DOI 10.1016/j.niox.2006.07.005; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Ye SF, 2010, J AM CHEM SOC, V132, P3646, DOI 10.1021/ja9091616; Yoon SS, 2007, EMBO J, V26, P3662, DOI 10.1038/sj.emboj.7601787; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	88	32	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91813	10.1371/journal.pone.0091813	http://dx.doi.org/10.1371/journal.pone.0091813			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663218	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900030
J	Akbarzadeh, S; Arof, AK; Ramesh, S; Khanmirzaei, MH; Nor, RM				Akbarzadeh, S.; Arof, A. K.; Ramesh, S.; Khanmirzaei, M. H.; Nor, R. M.			Prediction of Conductivity by Adaptive Neuro-Fuzzy Model	PLOS ONE			English	Article							INFERENCE SYSTEM; SPECTROSCOPY; TRANSPORT; ANFIS	Electrochemical impedance spectroscopy (EIS) is a key method for the characterizing the ionic and electronic conductivity of materials. One of the requirements of this technique is a model to forecast conductivity in preliminary experiments. The aim of this paper is to examine the prediction of conductivity by neuro-fuzzy inference with basic experimental factors such as temperature, frequency, thickness of the film and weight percentage of salt. In order to provide the optimal sets of fuzzy logic rule bases, the grid partition fuzzy inference method was applied. The validation of the model was tested by four random data sets. To evaluate the validity of the model, eleven statistical features were examined. Statistical analysis of the results clearly shows that modeling with an adaptive neuro-fuzzy is powerful enough for the prediction of conductivity.	[Akbarzadeh, S.; Arof, A. K.; Khanmirzaei, M. H.] Univ Malaya, Ctr Ion, Dept Phys, Kuala Lumpur, Malaysia; [Ramesh, S.; Nor, R. M.] Univ Malaya, Fac Sci, Dept Phys, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Nor, RM (corresponding author), Univ Malaya, Fac Sci, Dept Phys, Kuala Lumpur, Malaysia.	rmdnor@um.edu.my	Ramesh, T.Subramaniam/C-2353-2009; Arof, Abdul Kariem BinHj M/A-3389-2009; NOR, ROSLAN MD/B-5221-2010; Khanmirzaei, Mohammad Hassan/F-7826-2011; Akbarzadeh, Saman/I-6287-2013	Ramesh, T.Subramaniam/0000-0002-5505-6429; NOR, ROSLAN MD/0000-0003-0649-2272; Khanmirzaei, Mohammad Hassan/0000-0003-3372-0867; Akbarzadeh, Saman/0000-0003-4293-1797	University of Malaya under IPPP [PV094-2012A]	University of Malaya under IPPP	This work was funded by the University of Malaya under IPPP Grant no. PV094-2012A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII; Beitollah H, 2012, J MOL LIQ, V173, P137, DOI 10.1016/j.molliq.2012.06.026; Bonanos N, 2012, IMPEDANCE SPECTROSCO; Caydas U, 2009, EXPERT SYST APPL, V36, P6135, DOI 10.1016/j.eswa.2008.07.019; Chang BY, 2010, ANNU REV ANAL CHEM, V3, P207, DOI 10.1146/annurev.anchem.012809.102211; Cohen A, 2009, ORGAN RES METHODS, V12, P148, DOI 10.1177/1094428107300365; Costa SIR, 2013, RSC ADV, V3, P7030, DOI 10.1039/c3ra40216a; Dudek M, 2008, J EUR CERAM SOC, V28, P965, DOI 10.1016/j.jeurceramsoc.2007.09.004; Erdinc O, 2010, RENEW SUST ENERG REV, V14, P2874, DOI 10.1016/j.rser.2010.07.060; Erdinc O, 2009, J POWER SOURCES, V194, P369, DOI 10.1016/j.jpowsour.2009.04.072; Jancikova Z, 2013, METALURGIJA, V52, P379; Jang J-SR., 1997, IEEE T AUTOMAT CONTR, V42, P1482, DOI [10.1109/TAC.1997.633847, DOI 10.1109/TAC.1997.633847]; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Khanmirzaei MH, 2013, INT J ELECTROCHEM SC, V8, P9977; Liu J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.174122; Macdonald DD, 2006, ELECTROCHIM ACTA, V51, P1376, DOI 10.1016/j.electacta.2005.02.107; Mendel J. M., 2017, UNCERTAIN RULE BASED, V2nd, DOI 10.1007/978-3-319-51370-6; Mizuno Y, 2012, ELECTROCHIM ACTA, V63, P139, DOI 10.1016/j.electacta.2011.12.068; Montero J, 2007, FUZZY SET SYST, V158, P2429, DOI 10.1016/j.fss.2007.04.021; Nauck D., 1997, FDN NEUROFUZZY SYSTE, DOI DOI 10.1029/2009GL041009; Onat N, 2010, INT J PHOTOENERGY, V2010, DOI 10.1155/2010/245316; Pedrycz W, 2009, NEUROCOMPUTING, V73, P10, DOI 10.1016/j.neucom.2008.10.027; Peng HJ, 2012, J POWER SOURCES, V197, P310, DOI 10.1016/j.jpowsour.2011.09.046; Prashantha K, 2009, COMPOS SCI TECHNOL, V69, P1756, DOI 10.1016/j.compscitech.2008.10.005; Rabinovich S, 2013, INT VOCABULARY METRO, P269; Rao BS, 2012, CHALCOGENIDE LETT, V9, P517; Ravanbod H, 2005, NDT&E INT, V38, P643, DOI 10.1016/j.ndteint.2005.03.001; Ross T.J., 2009, FUZZY LOGIC ENG APPL; Schneider H, 2008, J EUR CERAM SOC, V28, P329, DOI 10.1016/j.jeurceramsoc.2007.03.017; Thirugnanasambandam M, 2010, RENEW SUST ENERG REV, V14, P312, DOI 10.1016/j.rser.2009.07.014; Tkacik G, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/03/P03011; Tonurist K, 2012, ELECTROCHEM COMMUN, V22, P77, DOI 10.1016/j.elecom.2012.05.029; Wieland D, 2002, COMPUT-AIDED CIV INF, V17, P104, DOI 10.1111/1467-8667.00259; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Yetilmezsoy K, 2011, COLLOID SURFACE A, V389, P50, DOI 10.1016/j.colsurfa.2011.08.051; Ying LC, 2008, ENERG CONVERS MANAGE, V49, P205, DOI 10.1016/j.enconman.2007.06.015; Yoon S, 2010, J POWER SOURCES, V195, P4391, DOI 10.1016/j.jpowsour.2010.01.086; Zandi M, 2011, IEEE T VEH TECHNOL, V60, P433, DOI 10.1109/TVT.2010.2091433	38	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92241	10.1371/journal.pone.0092241	http://dx.doi.org/10.1371/journal.pone.0092241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658582	gold, Green Submitted, Green Published			2022-12-25	WOS:000333355300063
J	Chen, X; Yousef, KP; Duwe, S; Karsch, K; Grover, S; Wahlisch, S; Obermeier, P; Tief, F; Muhlhans, S; Seeber, L; von Kleist, M; Schweiger, B; Rath, B				Chen, Xi; Yousef, Kaveh Pouran; Duwe, Susanne; Karsch, Katharina; Grover, Sandeep; Waehlisch, Stephanie; Obermeier, Patrick; Tief, Franziska; Muehlhans, Susann; Seeber, Lea; von Kleist, Max; Schweiger, Brunhilde; Rath, Barbara			Quantitative Influenza Follow-Up Testing (QIFT)-A Novel Biomarker for the Monitoring of Disease Activity at the Point-of-Care	PLOS ONE			English	Article							RAPID INFLUENZA; FLUORESCENT IMMUNOASSAY; OSELTAMIVIR TREATMENT; B VIRUSES; CHILDREN; MANAGEMENT; RESISTANCE; ACCURACY; INFANTS; IMPACT	Background: Influenza infections induce considerable disease burden in young children. Biomarkers for the monitoring of disease activity at the point-of-care (POC) are currently lacking. Recent methodologies for fluorescence-based rapid testing have been developed to provide improved sensitivities with the initial diagnosis. The present study aims to explore the utility of second-generation rapid testing during longitudinal follow-up of influenza patients (Rapid Influenza Follow-up Testing = RIFT). Signal/control fluorescent readouts (Quantitative Influenza Follow-up Testing = QIFT) are evaluated as a potential biomarker for the monitoring of disease activity at the POC. Methods and Findings: RIFT (SOFIA) and QIFT were performed at the POC and compared to blinded RT-PCR at the National Reference Centre for Influenza. From 10/2011-4/2013, a total of 2048 paediatric cases were studied prospectively; 273 cases were PCR-confirmed for influenza. During follow-up, RIFT results turned negative either prior to PCR (68%), or simultaneously (30%). The first negative RIFT occurred after a median of 8 days with a median virus load (VL) of 5.6x10 boolean AND 3 copies/ml and cycle threshold of 37, with no evidence of viral rebound. Binning analysis revealed that QIFT differentiated accurately between patients with low, medium and high viral titres. QIFT increase/decrease showed 88% agreement (sensitivity = 52%, specificity = 95%) with VL increase/decrease, respectively. QIFT-based viral clearance estimates showed similar values compared to PCR-based estimates. Variations in viral clearance rates were lower in treated compared to untreated patients. The study was limited by use of non-invasive, semi-quantitative nasopharyngeal samples. VL measurements below the limit of detection could not be quantified reliably. Conclusions: During follow-up, RIFT provides a first surrogate measure for influenza disease activity. A "switch" from positive to negative values may indicate a drop in viral load below a critical threshold, where rebound is no longer expected. QIFT may provide a useful tool for the monitoring of disease burden and viral clearance at the POC.	[Chen, Xi; Karsch, Katharina; Grover, Sandeep; Obermeier, Patrick; Tief, Franziska; Muehlhans, Susann; Seeber, Lea; Rath, Barbara] Charite Univ Med Ctr, Dept Paediat, Div Pneumonol Immunol, Berlin, Germany; [Yousef, Kaveh Pouran] Free Univ Berlin, AG Syst Pharmacol & Dis Control, Dept Math & Comp Sci, Berlin, Germany; [Waehlisch, Stephanie; Schweiger, Brunhilde] Robert Koch Inst, Natl Reference Ctr Influenza, Div Influenza & Other Resp Viruses 17, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Robert Koch Institute	Rath, B (corresponding author), Charite Univ Med Ctr, Dept Paediat, Div Pneumonol Immunol, Berlin, Germany.	Barbara.Rath@gmail.com	von Kleist, Max/K-3023-2016	von Kleist, Max/0000-0001-6587-6394; Obermeier, Patrick E./0000-0002-5631-9112; Duwe, Susanne/0000-0003-3171-819X	Hoffmann La Roche Inc.; DFG research centre "MATHEON" [A21]	Hoffmann La Roche Inc.(Hoffmann-La Roche); DFG research centre "MATHEON"(German Research Foundation (DFG))	Charite received an unrestricted grant by Hoffmann La Roche Inc. for the analysis of virologic outcomes in hospitalized children with influenza infection. KPY and MvK received funding through the DFG research centre "MATHEON" (project A21: "Modelling, Simulation and Therapy Optimization for Infectious Diseases"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benito-Fernandez J, 2006, PEDIATR INFECT DIS J, V25, P1153, DOI 10.1097/01.inf.0000246826.93142.b0; Biswas B, 2006, FDA IND STAT WORKSH; Bonner AB, 2003, PEDIATRICS, V112, P363, DOI 10.1542/peds.112.2.363; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Brady MT, 2013, PEDIATRICS, V132, pE1089, DOI 10.1542/peds.2013-2377; Chin BS, 2012, JPN J INFECT DIS, V65, P105; Cho CH, 2013, J VIROL METHODS, V187, P51, DOI 10.1016/j.jviromet.2012.09.003; Dunn G, 1995, STAT MED, V15, P2121; Esposito S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-349; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fleiss J. L., 1981, STAT METHODS RATES P, V2; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; Gavin P.J., 2004, CLIN APPL IMMUNOL RE, V4, P151, DOI DOI 10.1016/S1529-1049(03)00064-3; Grijalva CG, 2007, PEDIATRICS, V119, pE6, DOI 10.1542/peds.2006-1694; Jennings LC, 2009, INFLUENZA OTHER RESP, V3, P91, DOI 10.1111/j.1750-2659.2009.00079.x; Lee CK, 2012, J CLIN VIROL, V55, P239, DOI 10.1016/j.jcv.2012.07.008; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Leonardi GP, 2013, J VIROL METHODS, V189, P379, DOI 10.1016/j.jviromet.2013.02.008; Lewandrowski K, 2013, AM J CLIN PATHOL, V139, P684, DOI 10.1309/AJCP7ZTLJCP3LLMA; Moore C, 2013, J HOSP INFECT, V85, P1, DOI 10.1016/j.jhin.2013.06.005; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Pepe M. S., 2003, STAT EVALUATION MED; Poehling KA, 2006, ARCH PEDIAT ADOL MED, V160, P713, DOI 10.1001/archpedi.160.7.713; Pongthanapisith V, 2011, INFECTION, V39, P105, DOI 10.1007/s15010-011-0092-x; Rath B, 2013, 15 INT S RESP VIR IN; Rath B, 2012, J CLIN VIROL, V55, P329, DOI 10.1016/j.jcv.2012.08.002; Rath B, 2012, PEDIATR INFECT DIS J, V31, P899, DOI 10.1097/INF.0b013e31825c7304; Schulze M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009966; Siqueira M, 2013, INFLUENZA OTHER RESP, V7, P1, DOI 10.1111/irv.12041; Stephenson I, 2009, CLIN INFECT DIS, V48, P389, DOI 10.1086/596311; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; van der Vries E, 2013, ADV PHARMACOL, V67, P217, DOI 10.1016/B978-0-12-405880-4.00006-8; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; Weitzel T, 2007, CLIN MICROBIOL INFEC, V13, P665, DOI 10.1111/j.1469-0691.2007.01739.x; WHO-EURO, 2011, SEAS INFL KEY ISS CA	36	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92500	10.1371/journal.pone.0092500	http://dx.doi.org/10.1371/journal.pone.0092500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658130	Green Submitted, gold, Green Published			2022-12-25	WOS:000333355300091
J	Ge, C; Cui, YN; Jing, PY; Hong, XY				Ge, Cheng; Cui, Yu-Nan; Jing, Peng-Yu; Hong, Xiao-Yue			An Alternative Suite of Universal Primers for Genotyping in Multiplex PCR	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE MARKERS; COMPUTER-PROGRAM; SOFTWARE; LINKAGE; REPEAT	The universal primer three-primer approach can dramatically reduce the cost when genotyping the microsatellites. One former research reported four universal primers that can be used in singleplex and multiplex genotyping. In this study, we proposed an alternative suite of universal primers with four dyes for genotyping 8-12 loci in one single run. This multiplex method was tested on Tetranychus truncatus. Published microsatellite loci of T. kanzawai, Frankliniella occidentalis and Nilaparvata lugens were modified as needed and also tested. The robustness of the method was confirmed by comparing with singleplex using multiple fluorophores and genotyping two populations of T. truncatus. This method showed lower signal strength than the singleplex three-primer system, but it was still sufficient to determine the fragment length. The cost of such a project can be reduced dramatically when many loci of different species are involved. In this way, laboratories performing population genetic analyses or studying several different species may benefit from the use of this cost-effective protocol.	[Ge, Cheng; Cui, Yu-Nan; Jing, Peng-Yu; Hong, Xiao-Yue] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Hong, XY (corresponding author), Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China.	xyhong@njau.edu.cn	Hong, Xiao-Yue/AAF-4759-2020	Ge, Cheng/0000-0002-0740-5428	National Public Welfare Professional Fund from the Ministry of Agriculture of China [201103020]; National Natural Science Foundation of China [31172131]	National Public Welfare Professional Fund from the Ministry of Agriculture of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by a Grant-in-Aid from the Science and Technology Program of the National Public Welfare Professional Fund (No. 201103020) from the Ministry of Agriculture of China (www.moa.gov.cn) and a Grant-in-Aid for Scientific Research (No. 31172131) from the National Natural Science Foundation of China (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blacket MJ, 2012, MOL ECOL RESOUR, V12, P456, DOI 10.1111/j.1755-0998.2011.03104.x; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; de Arruda MP, 2010, MOL BIOL REP, V37, P2031, DOI 10.1007/s11033-009-9655-7; Ge C, 2013, EXP APPL ACAROL, V61, P195, DOI 10.1007/s10493-013-9684-8; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; LITT M, 1989, AM J HUM GENET, V44, P397; Miller AD, 2013, MOL BIOL REP, V40, P4415, DOI 10.1007/s11033-013-2531-5; Miller AD, 2013, MOL BIOL REP, V40, P35, DOI 10.1007/s11033-012-1950-z; Miller AD, 2012, CONSERV GENET RESOUR, V4, P257, DOI 10.1007/s12686-011-9519-z; Missiaggia A, 2006, GENET MOL RES, V5, P72; Neilan BA, 1997, NUCLEIC ACIDS RES, V25, P2938, DOI 10.1093/nar/25.14.2938; Nishimura S, 2003, EXP APPL ACAROL, V31, P93, DOI 10.1023/B:APPA.0000005128.70282.a4; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Smith TM, 2013, CONSERV GENET RESOUR, V5, P607, DOI 10.1007/s12686-013-9862-3; Spathis R, 2008, J FORENSIC SCI, V53, P1353, DOI 10.1111/j.1556-4029.2008.00881.x; STEFFENS DL, 1993, BIOTECHNIQUES, V15, P580; Sun JT, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.13401; Tsagkarakou A, 2007, PHYTOPARASITICA, V35, P519, DOI 10.1007/BF03020610; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Yang XM, 2012, INT J MOL SCI, V13, P2863, DOI 10.3390/ijms13032863	26	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92826	10.1371/journal.pone.0092826	http://dx.doi.org/10.1371/journal.pone.0092826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658225	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300132
J	Liu, HJ; Xu, YF; Sun, YH; Dumenci, L				Liu, Hongjie; Xu, Yongfang; Sun, Yehuan; Dumenci, Levent			Measuring HIV Stigma at the Family Level: Psychometric Assessment of the Chinese Courtesy Stigma Scales (CCSSs)	PLOS ONE			English	Article							SERVICE PROVIDERS; AIDS; INFECTION; CAREGIVERS; DEPRESSION; DISEASE; ILLNESS; PEOPLE; AREA; CARE	Courtesy stigma is the stigmatization a person perceives or experiences due to their association with a stigmatized individual or group. Most HIV-related stigma scales have been developed for people living with HIV/AIDS (PLWHAs), but not for their HIV-uninfected family members. To date, few measurement scales have been designed to measure the degree of stigma among both PLWHAs and their HIV-uninfected family members at the family level. We developed a set of courtesy stigma scales and estimated their reliability and validity from 256 PLWHAs and 256 of their HIV-uninfected family members. Exploratory and confirmatory factor analyses were performed in two independent samples: a development sample (N = 216) and a validation sample (N = 296), respectively. Two factors ("public stigma'' and "self-perceived stigma'') had high internal consistency reliability (Cronbach's alpha coefficient between 0.83-0.90) and good construct validity (standardized factor loading range: 0.37-0.95) in both samples. These findings document that the newly developed brief instrument is a psychometrically sound measure of HIV-related stigma among both PLWHAs and their HIV-uninfected family members.	[Liu, Hongjie] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Xu, Yongfang] Nanning Ctr Dis Control & Prevent, Dept HIV AIDS Control, Nanning, Guangxi, Peoples R China; [Sun, Yehuan] Anhui Med Univ, Dept Epidemiol, Hefei, Anhui, Peoples R China; [Dumenci, Levent] Virginia Commonwealth Univ, Dept Social & Behav Hlth, Richmond, VA USA	University System of Maryland; University of Maryland College Park; Anhui Medical University; Virginia Commonwealth University	Liu, HJ (corresponding author), Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA.	hliu1210@umd.edu			Virginia Commonwealth University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041041] Funding Source: NIH RePORTER	Virginia Commonwealth University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a research grant from the Virginia Commonwealth University School of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2012, MPLUS USERS GUIDE; Badahdah A, 2009, AIDS CARE, V21, P754, DOI 10.1080/09540120802511927; Bogart LM, 2008, AIDS BEHAV, V12, P244, DOI 10.1007/s10461-007-9231-x; Boyes ME, 2013, CLIN PSYCHOL SCI, V1, P323, DOI 10.1177/2167702613478595; Boyes ME, 2013, AIDS CARE, V25, P215, DOI 10.1080/09540121.2012.699668; Cohen MS, 2012, CURR OPIN HIV AIDS, V7, P99, DOI 10.1097/COH.0b013e32834f5cf2; Corrigan PW, 2005, ON THE STIGMA OF MENTAL ILLNESS: PRACTICAL STRATEGIES FOR RESEARCH AND SOCIAL CHANGE, P11, DOI 10.1037/10887-001; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Goffman E., 1968, STIGMA NOTES MANAGEM; Ha TH, 2012, AIDS CARE, V24, P39, DOI 10.1080/09540121.2011.592820; Herek GM, 1997, J APPL SOC PSYCHOL, V27, P1, DOI 10.1111/j.1559-1816.1997.tb00621.x; Herek GM, 1999, AM BEHAV SCI, V42, P1106, DOI 10.1177/00027649921954787; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Kingori C, 2013, AIDS PATIENT CARE ST, V27, P481, DOI 10.1089/apc.2012.0403; KLEINMAN A, 1995, SOC SCI MED, V40, P1319, DOI 10.1016/0277-9536(94)00254-Q; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Li Li, 2008, Fam Syst Health, V26, P431; Lin K-M, 1981, NORMAL ABNORMAL BEHA, P95; Lin XY, 2010, AIDS CARE, V22, P545, DOI 10.1080/09540120903253999; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Liu H, 2009, SEX TRANSM INFECT, V85, P65, DOI 10.1136/sti.2008.032714; Liu HJ, 2006, AIDS PATIENT CARE ST, V20, P133, DOI 10.1089/apc.2006.20.133; Liu HJ, 2002, SEX TRANSM DIS, V29, P335, DOI 10.1097/00007435-200206000-00005; Liu HJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056815, 10.1371/journal.pone.0055680]; Logie C, 2013, AIDS PATIENT CARE ST, V27, P114, DOI 10.1089/apc.2012.0296; Louw J, 2012, SCI WORLD J, DOI 10.1100/2012/817315; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Ministry of Health of the People's Republic of China, 2012, 2012 CHIN AIDS RESP; Molina Y, 2013, AIDS CARE, V25, P1559, DOI 10.1080/09540121.2013.793268; Mwinituo PP, 2006, WESTERN J NURS RES, V28, P369, DOI 10.1177/0193945906286602; Rutledge SE, 2011, AIDS PATIENT CARE ST, V25, P673, DOI 10.1089/apc.2011.0008; Sayles JN, 2008, AIDS BEHAV, V12, P748, DOI 10.1007/s10461-008-9375-3; Scambler G, 1998, LANCET, V352, P1054, DOI 10.1016/S0140-6736(98)08068-4; Schumacker RE, 2010, BEGINNERS GUIDE STRU; Sherr L, 2011, PSYCHOL HEALTH MED, V16, P612, DOI 10.1080/13548506.2011.579991; Singh D, 2011, AIDS CARE, V23, P839, DOI 10.1080/09540121.2010.542122; Stein JA, 2008, AIDS BEHAV, V12, P789, DOI 10.1007/s10461-007-9339-z; Wight RG, 2006, SOC SCI MED, V62, P444, DOI 10.1016/j.socscimed.2005.06.004; Wilson DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001231; ZHANG JX, 1995, PSYCHOLOGIA, V38, P174; Zhu TF, 2005, CELL RES, V15, P852, DOI 10.1038/sj.cr.7290358	41	14	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92855	10.1371/journal.pone.0092855	http://dx.doi.org/10.1371/journal.pone.0092855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6GL	24658364	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300135
J	Das, T; Sehar, S; Koop, L; Wong, YK; Ahmed, S; Siddiqui, KS; Manefield, M				Das, Theerthankar; Sehar, Shama; Koop, Leena; Wong, Yie Kuan; Ahmed, Safia; Siddiqui, Khawar Sohail; Manefield, Mike			Influence of Calcium in Extracellular DNA Mediated Bacterial Aggregation and Biofilm Formation	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-EPIDERMIDIS; STREPTOCOCCUS-MUTANS; VIRULENCE FACTORS; ADHESION; ATTACHMENT; PROTEINS; EXPOSURE; RELEASE; CATIONS	Calcium (Ca2+) has an important structural role in guaranteeing the integrity of the outer lipopolysaccharide layer and cell walls of bacterial cells. Extracellular DNA (eDNA) being part of the slimy matrix produced by bacteria promotes biofilm formation through enhanced structural integrity of the matrix. Here, the concurrent role of Ca2+ and eDNA in mediating bacterial aggregation and biofilm formation was studied for the first time using a variety of bacterial strains and the thermodynamics of DNA to Ca2+ binding. It was found that the eDNA concentrations under both planktonic and biofilm growth conditions were different among bacterial strains. Whilst Ca2+ had no influence on eDNA release, presence of eDNA by itself favours bacterial aggregation via attractive acid-base interactions in addition, its binding with Ca2+ at biologically relevant concentrations was shown further increase in bacterial aggregation via cationic bridging. Negative Gibbs free energy (Delta G) values in iTC data confirmed that the interaction between DNA and Ca2+ is thermodynamically favourable and that the binding process is spontaneous and exothermic owing to its highly negative enthalpy. Removal of eDNA through DNase I treatment revealed that Ca2+ alone did not enhance cell aggregation and biofilm formation. This discovery signifies the importance of eDNA and concludes that existence of eDNA on bacterial cell surfaces is a key facilitator in binding of Ca2+ to eDNA thereby mediating bacterial aggregation and biofilm formation.	[Das, Theerthankar; Sehar, Shama; Koop, Leena; Wong, Yie Kuan; Manefield, Mike] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Marine BioInnovat, Sydney, NSW, Australia; [Sehar, Shama; Ahmed, Safia] Quaid I Azam Univ, Dept Microbiol, Islamabad, Pakistan; [Siddiqui, Khawar Sohail] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of New South Wales Sydney; Quaid I Azam University; University of New South Wales Sydney	Das, T (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Marine BioInnovat, Sydney, NSW, Australia.	theerthankar_das11@rediffmail.com	Ahmed, Safia/GNH-4127-2022	Ahmed, Safia/0000-0001-9773-6433; Das, Theerthankar/0000-0003-0581-6060; Siddiqui, Khawar/0000-0001-8574-3177	Australian Research Council (ARC) [FT100100078]	Australian Research Council (ARC)(Australian Research Council)	This work was funded by Australian Research Council (ARC) Future Fellowship Project ID FT100100078, http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammendolia MG, 1999, J CLIN MICROBIOL, V37, P3235, DOI 10.1128/JCM.37.10.3235-3238.1999; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Barnes AMT, 2012, MBIO, V3, DOI 10.1128/mBio.00193-12; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0; Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2; Chen CZS, 2002, BIOMATERIALS, V23, P3359, DOI 10.1016/S0142-9612(02)00036-4; Chiang WC, 2013, ANTIMICROB AGENTS CH, V57, P2352, DOI 10.1128/AAC.00001-13; Chong G, 2010, THESIS U NEW S WALES; Crismaru M, 2011, ANTIMICROB AGENTS CH, V55, P5010, DOI 10.1128/AAC.05062-11; Cruz LF, 2012, APPL ENVIRON MICROB, V78, P1321, DOI 10.1128/AEM.06501-11; Das Theerthankar, 2013, Commun Integr Biol, V6, pe23570, DOI 10.4161/cib.23570; Das T, 2013, ENV MICROBIOL REP, V5, P778, DOI 10.1111/1758-2229.12085; Das T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058299; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Das T, 2011, LANGMUIR, V27, P10113, DOI 10.1021/la202013m; Das T, 2011, SOFT MATTER, V7, P2927, DOI 10.1039/c0sm01142h; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Davey CA, 2002, P NATL ACAD SCI USA, V99, P11169, DOI 10.1073/pnas.172271399; De Kerchove AJ, 2008, LANGMUIR, V24, P3392, DOI 10.1021/la7036229; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FLETCHER M, 1988, J BACTERIOL, V170, P2027, DOI 10.1128/jb.170.5.2027-2030.1988; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HAYNES CA, 1995, J COLLOID INTERF SCI, V169, P313, DOI 10.1006/jcis.1995.1039; HEPTINSTALL S, 1970, NATURE, V225, P519, DOI 10.1038/225519a0; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Kaplan JB, 2011, RES MICROBIOL, V162, P535, DOI 10.1016/j.resmic.2011.03.008; Kirkpatrick CL, 2010, MOL MICROBIOL, V77, P801, DOI 10.1111/j.1365-2958.2010.07268.x; Lattner D, 2003, INT J BIOL MACROMOL, V33, P81, DOI 10.1016/S0141-8130(03)00070-9; Lee M, 2012, ENVIRON MICROBIOL, V14, P883, DOI 10.1111/j.1462-2920.2011.02656.x; Liu HH, 2008, CURR MICROBIOL, V57, P139, DOI 10.1007/s00284-008-9166-0; McKenney D, 1998, INFECT IMMUN, V66, P4711, DOI 10.1128/IAI.66.10.4711-4720.1998; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c; Patrauchan MA, 2005, MICROBIOL-SGM, V151, P2885, DOI 10.1099/mic.0.28041-0; Peterson BW, 2013, MBIO, V4, DOI 10.1128/mBio.00497-13; Postollec F, 2003, J MICROBIOL METH, V55, P241, DOI 10.1016/S0167-7012(03)00145-3; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Sarkisova S, 2005, J BACTERIOL, V187, P4327, DOI 10.1128/JB.187.13.4327-4337.2005; Sharma PK, 2003, COLLOID SURFACE B, V29, P21, DOI 10.1016/S0927-7765(02)00180-7; Shoji T, 2008, WATER SCI TECHNOL, V58, P1023, DOI 10.2166/wst.2008.457; SMITHIES WR, 1955, CAN J MICROBIOL, V1, P614, DOI 10.1139/m55-074; Spiliopoulou AI, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-76; Steichen CT, 2011, INFECT IMMUN, V79, P1504, DOI 10.1128/IAI.01162-10; Subirana JA, 2003, ANNU REV BIOPH BIOM, V32, P27, DOI 10.1146/annurev.biophys.32.110601.141726; Tsuneda S, 2003, FEMS MICROBIOL LETT, V223, P287, DOI 10.1016/S0378-1097(03)00399-9; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7; Venkataraman A, 2010, ELECTROCHEM COMMUN, V12, P459, DOI 10.1016/j.elecom.2010.01.019; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Xu CP, 2007, COLLOID SURFACE B, V54, P193, DOI 10.1016/j.colsurfb.2006.10.016; Xu CP, 2008, APPL ENVIRON MICROB, V74, P7522, DOI 10.1128/AEM.00948-08	57	103	110	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91935	10.1371/journal.pone.0091935	http://dx.doi.org/10.1371/journal.pone.0091935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651318	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800055
J	Kasama, Y; Mizukami, T; Kusunoki, H; Peveling-Oberhag, J; Nishito, Y; Ozawa, M; Kohara, M; Mizuochi, T; Tsukiyama-Kohara, K				Kasama, Yuri; Mizukami, Takuo; Kusunoki, Hideki; Peveling-Oberhag, Jan; Nishito, Yasumasa; Ozawa, Makoto; Kohara, Michinori; Mizuochi, Toshiaki; Tsukiyama-Kohara, Kyoko			B-Cell-Intrinsic Hepatitis C Virus Expression Leads to B-Cell-Lymphomagenesis and Induction of NF-kappa B Signalling	PLOS ONE			English	Article							LYMPHOTOXIN-BETA RECEPTOR; NON-HODGKINS-LYMPHOMA; MICRORNA EXPRESSION; CORE PROTEIN; FULL GENOME; STEM-CELLS; A20; INFECTION; PATHWAY; EPIDEMIOLOGY	Hepatitis C virus (HCV) infection leads to the development of hepatic diseases, as well as extrahepatic disorders such as B-cell non-Hodgkin's lymphoma (B-NHL). To reveal the molecular signalling pathways responsible for HCV-associated B-NHL development, we utilised transgenic (Tg) mice that express the full-length HCV genome specifically in B cells and develop non-Hodgkin type B-cell lymphomas (BCLs). The gene expression profiles in B cells from BCL-developing HCV-Tg mice, from BCL-non-developing HCV-Tg mice, and from BCL-non-developing HCV-negative mice were analysed by genome-wide microarray. In BCLs from HCV-Tg mice, the expression of various genes was modified, and for some genes, expression was influenced by the gender of the animals. Markedly modified genes such as Fos, C3, LT beta R, A20, NF-kappa B and miR-26b in BCLs were further characterised using specific assays. We propose that activation of both canonical and alternative NF-kappa B signalling pathways and down-regulation of miR-26b contribute to the development of HCV-associated B-NHL.	[Kasama, Yuri] Kumamoto Univ, Fac Life Sci, Dept Expt Phylaxiol, Kumamoto, Japan; [Mizukami, Takuo; Kusunoki, Hideki; Mizuochi, Toshiaki] Natl Inst Infect Dis, Dept Res Blood & Biol Prod, Musashimurayama, Tokyo, Japan; [Peveling-Oberhag, Jan] Goethe Univ Hosp, Dept Internal Med, Frankfurt, Germany; [Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Ctr Microarray Anal, Tokyo 113, Japan; [Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan; [Ozawa, Makoto; Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima 890, Japan; [Ozawa, Makoto; Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Lab Anim Hyg, Kagoshima 890, Japan	Kumamoto University; National Institute of Infectious Diseases (NIID); Goethe University Frankfurt; Goethe University Frankfurt Hospital; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Kagoshima University; Kagoshima University	Tsukiyama-Kohara, K (corresponding author), Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima 890, Japan.	kkohara@vet.kagoshima-u.ac.jp	Mizukami, Takuo/F-9248-2016; Ozawa, Makoto/AFM-4137-2022	Mizukami, Takuo/0000-0001-6105-6049; Ozawa, Makoto/0000-0002-7731-5321	Ministry of Education, Culture, Sports, Science and Technology of Japan [23590547]; Ministry of Health, Labour and Welfare of Japan [H21-011]; Grants-in-Aid for Scientific Research [23791093] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23590547) and the Ministry of Health, Labour and Welfare of Japan (H21-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh A, 1999, CLIN EXP IMMUNOL, V118, P23; Arsura M, 2005, CANCER LETT, V229, P157, DOI 10.1016/j.canlet.2005.07.008; Ascoli V, 1998, AM J CLIN PATHOL, V109, P600, DOI 10.1093/ajcp/109.5.600; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Bassig BA, 2012, ENVIRON MOL MUTAGEN, V53, P145, DOI 10.1002/em.21675; Cai X, 2013, GENE, V517, P205, DOI 10.1016/j.gene.2012.12.026; Chen CM, 1997, J VIROL, V71, P9417, DOI 10.1128/JVI.71.12.9417-9426.1997; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Dammacco F, 2000, SEMIN LIVER DIS, V20, P143, DOI 10.1055/s-2000-9613; De Re V, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/623465; De Sanjose S, 2008, CLIN GASTROENTEROL H, V6, P451, DOI 10.1016/j.cgh.2008.02.011; Dondelinger Y, 2013, CELL DEATH DIFFER, V20, P1381, DOI 10.1038/cdd.2013.94; Fischer WH, 1999, J IMMUNOL, V162, P453; Fognani E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062965; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gisbert JP, 2003, GASTROENTEROLOGY, V125, P1723, DOI 10.1053/j.gastro.2003.09.025; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; HE L, 2004, NAT REV GENET, V5, P522; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Honma K, 2008, GENE CHROMOSOME CANC, V47, P1, DOI 10.1002/gcc.20499; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Hother C, 2013, INVEST OPHTH VIS SCI, V54, P5169, DOI 10.1167/iovs.13-12272; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Ito M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00177; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Ji YH, 2010, FEBS LETT, V584, P961, DOI 10.1016/j.febslet.2010.01.036; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kasama Y, 2010, BLOOD, V116, P4926, DOI 10.1182/blood-2010-05-283358; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Koh CM, 2011, ONCOTARGET, V2, P669, DOI 10.18632/oncotarget.327; Lawrie CH, 2007, EXPERT OPIN BIOL TH, V7, P1363, DOI 10.1517/14712598.7.9.1363; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Libra M, 2005, FRONT BIOSCI, V10, P2460, DOI 10.2741/1710; Ma YL, 2011, J CELL MOL MED, V15, P1941, DOI 10.1111/j.1582-4934.2010.01170.x; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; Matsumoto M, 1997, J VIROL, V71, P1301, DOI 10.1128/JVI.71.2.1301-1309.1997; Matsuo K, 2004, CANCER SCI, V95, P745, DOI 10.1111/j.1349-7006.2004.tb03256.x; Mele A, 2003, BLOOD, V102, P996, DOI 10.1182/blood-2002-10-3230; Nishimura T, 2009, J BIOL CHEM, V284, P36442, DOI 10.1074/jbc.M109.043232; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Palumbo T, 2013, ONCOGENE, V32, P1651, DOI 10.1038/onc.2012.190; Parvatiyar K, 2011, MICROBES INFECT, V13, P209, DOI 10.1016/j.micinf.2010.11.003; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Pekarsky Y, 2008, P NATL ACAD SCI USA, V105, P19643, DOI 10.1073/pnas.0810965105; Peveling-Oberhag J, 2012, LEUKEMIA, V26, P1654, DOI 10.1038/leu.2012.29; Peveling-Oberhag J, 2013, J HEPATOL, V59, P169, DOI 10.1016/j.jhep.2013.03.018; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Silvestri F, 1996, BLOOD, V87, P4296, DOI 10.1182/blood.V87.10.4296.bloodjournal87104296; Simonin Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003234; Song GX, 2014, GENE, V533, P481, DOI 10.1016/j.gene.2013.10.011; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Sun B, 2008, ONCOGENE, V27, P6228, DOI 10.1038/onc.2008.300; Szremska AP, 2003, BLOOD, V102, P4159, DOI 10.1182/blood-2003-03-0915; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Tsukiyama-Kohara K, 2004, J BIOL CHEM, V279, P14531, DOI 10.1074/jbc.M312822200; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Vladareanu Ana-Maria, 2010, J Med Life, V3, P320; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yamazaki J, 2009, BLOOD, V114, P2709, DOI 10.1182/blood-2008-08-174425; You LR, 1999, J VIROL, V73, P1672, DOI 10.1128/JVI.73.2.1672-1681.1999; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	73	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91373	10.1371/journal.pone.0091373	http://dx.doi.org/10.1371/journal.pone.0091373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651473	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800039
J	Krings, M; Nyakatura, JA; Fischer, MS; Wagner, H				Krings, Markus; Nyakatura, John A.; Fischer, Martin S.; Wagner, Hermann			The Cervical Spine of the American Barn Owl (Tyto furcata pratincola): I. Anatomy of the Vertebrae and Regionalization in Their S-Shaped Arrangement	PLOS ONE			English	Article							NECK; MORPHOLOGY; RECONSTRUCTION; MOVEMENTS; DINOSAURS; COLUMN	Background: Owls possess an extraordinary neck and head mobility. To understand this mobility it is necessary to have an anatomical description of cervical vertebrae with an emphasis on those criteria that are relevant for head positioning. No functional description specific to owls is available. Methodology/Principal findings: X-ray films and micro-CT scans were recorded from American barn owls (Tyto furcata pratincola) and used to obtain three-dimensional head movements and three-dimensional models of the 14 cervical vertebrae (C1-C14). The diameter of the vertebral canal, the zygapophyseal protrusion, the distance between joint centers, and the pitching angle were quantified. Whereas the first two variables are purely osteological characteristics of single vertebrae, the latter two take into account interactions between vertebrae. These variables change in characteristic ways from cranial to caudal. The vertebral canal is wide in the cranial and caudal neck regions, but narrow in the middle, where both the zygapophyseal protrusion and the distance between joint centers are large. Pitching angles are more negative in the cranial and caudal neck regions than in the middle region. Cluster analysis suggested a complex regionalization. Whereas the borders (C1 and C13/C14) formed stable clusters, the other cervical vertebrae were sorted into 4 or 5 additional clusters. The borders of the clusters were influenced by the variables analyzed. Conclusions/Significance: A statistical analysis was used to evaluate the regionalization of the cervical spine in the barn owl. While earlier measurements have shown that there appear to be three regions of flexibility of the neck, our indicators suggest 3-7 regions. These many regions allow a high degree of flexibility, potentially facilitating the large head turns that barn owls are able to make. The cervical vertebral series of other species should also be investigated using statistical criteria to further characterize morphology and the potential movements associated with it.	[Krings, Markus; Wagner, Hermann] Rhein Westfal TH Aachen, Inst Zool, Aachen, Germany; [Nyakatura, John A.; Fischer, Martin S.] Univ Jena, Inst Spezielle Zool & Evolut Biol, Phylet Museum, Jena, Germany	RWTH Aachen University; Friedrich Schiller University of Jena	Wagner, H (corresponding author), Rhein Westfal TH Aachen, Inst Zool, Aachen, Germany.	wagner@bio2.rwth-aachen.de	Nyakatura, John A./AAC-9807-2019; Wagner, Hermann/G-5454-2012	Nyakatura, John A./0000-0001-8088-8684; 				Bachmann T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-23; Baumel JJ, 1993, HDB AVIAN ANATOMY NO, V23, P45; Boas J.E.V., 1929, K DANSK VIDENSK SELS, V9, P101; Bout RG, 1997, J MORPHOL, V231, P287, DOI 10.1002/(SICI)1097-4687(199703)231:3<287::AID-JMOR7>3.0.CO;2-8; Brainerd EL, 2010, J EXP ZOOL PART A, V313A, P262, DOI 10.1002/jez.589; Buchholtz EA, 2009, EVOL DEV, V11, P69, DOI 10.1111/j.1525-142X.2008.00303.x; Christian Andreas, 2007, Fossil Record, V10, P38; Cobley MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072187; de Kok-Mercado F, 2013, SCIENCE, V339, P514; DESSELBERGER HERMANN, 1930, JOUR ORNITH [BERLIN], V78, P86, DOI 10.1007/BF01950903; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Fischer MS, 2010, ZOOLOGY, V113, P67, DOI 10.1016/j.zool.2009.07.001; Gatesy SM, 2010, J EXP ZOOL PART A, V313A, P244, DOI 10.1002/jez.588; Gray H., 2000, ANATOMY HUMAN BODY; Guinard G, 2010, POLAR BIOL, V33, P807, DOI 10.1007/s00300-009-0759-2; Hivernaud EA, 2010, THESIS U TOULOUSE; Kaiser G., 2007, INNER BIRD ANATOMY E; King AS, 1978, ANATOMIE VOGEL; Krings M, 2013, THESIS RWTH U; Martin John, 1998, Oryctos, V1, P113; MASINO T, 1990, NATURE, V345, P434, DOI 10.1038/345434a0; Nyakatura JA, 2010, ZOOLOGY, V113, P221, DOI 10.1016/j.zool.2009.11.003; Ohayon S, 2006, J COMP PHYSIOL A, V192, P927, DOI 10.1007/s00359-006-0130-9; Owen R., 1866, ANATOMY VERTEBRATES; Proctor NS, 1993, MANUAL ORNITHOLOGY; Spaeth H., 1985, CLUSTER DISSECTION A; STEINBACH MJ, 1973, VISION RES, V13, P889, DOI 10.1016/0042-6989(73)90055-2; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Tambussi CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037701; Van der Leeuw AHJ, 2001, NETH J ZOOL, V51, P243, DOI 10.1163/156854201750385172; VANDERLEEUW AHJ, 1992, NETH J ZOOL, V42, P23, DOI 10.1163/156854292X00026; VIDAL PP, 1986, EXP BRAIN RES, V61, P549; Wolff RG, 1991, FUNCTIONAL CHRODATE	33	25	26	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91653	10.1371/journal.pone.0091653	http://dx.doi.org/10.1371/journal.pone.0091653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651767	Green Submitted, gold, Green Published			2022-12-25	WOS:000333352800046
J	Andersen, JT; Dalhus, B; Viuff, D; Ravn, BT; Gunnarsen, KS; Plumridge, A; Bunting, K; Antunes, F; Williamson, R; Athwal, S; Allan, E; Evans, L; Bjoras, M; Kjaerulff, S; Sleep, D; Sandlie, I; Cameron, J				Andersen, Jan Terje; Dalhus, Bjorn; Viuff, Dorthe; Ravn, Birgitte Thue; Gunnarsen, Kristin Stoen; Plumridge, Andrew; Bunting, Karen; Antunes, Filipa; Williamson, Rebecca; Athwal, Steven; Allan, Elizabeth; Evans, Leslie; Bjoras, Magnar; Kjaerulff, Soren; Sleep, Darrell; Sandlie, Inger; Cameron, Jason			Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor ( FcRn) Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Albumin; Animal Models; Antibody Engineering; Biodegradation; Bioengineering; FC Receptors; pH Regulation; Pharmacokinetics	I-RELATED RECEPTOR; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-G; THERAPEUTIC ANTIBODIES; HUMAN-IGG; COMPLEX; REVEALS; PHARMACOKINETICS; MUTAGENESIS; EXPRESSION	Background: FcRn controls the long serum half-life of albumin. Results: A single amino acid substitution of albumin considerably improved binding to FcRn and extended serum half-life in mice and rhesus monkeys. Conclusion: Serum half-life of albumin may be tailored by engineering the FcRn-albumin interaction. Significance: This study reports on engineered albumin that may be attractive for improving the serum half-life of biopharmaceuticals. A major challenge for the therapeutic use of many peptides and proteins is their short circulatory half-life. Albumin has an extended serum half-life of 3 weeks because of its size and FcRn-mediated recycling that prevents intracellular degradation, properties shared with IgG antibodies. Engineering the strictly pH-dependent IgG-FcRn interaction is known to extend IgG half-life. However, this principle has not been extensively explored for albumin. We have engineered human albumin by introducing single point mutations in the C-terminal end that generated a panel of variants with greatly improved affinities for FcRn. One variant (K573P) with 12-fold improved affinity showed extended serum half-life in normal mice, mice transgenic for human FcRn, and cynomolgus monkeys. Importantly, favorable binding to FcRn was maintained when a single-chain fragment variable antibody was genetically fused to either the N- or the C-terminal end. The engineered albumin variants may be attractive for improving the serum half-life of biopharmaceuticals.	[Andersen, Jan Terje; Gunnarsen, Kristin Stoen; Sandlie, Inger] Univ Oslo, Ctr Immune Regulat, N-0316 Oslo, Norway; [Andersen, Jan Terje; Gunnarsen, Kristin Stoen; Sandlie, Inger] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Andersen, Jan Terje; Gunnarsen, Kristin Stoen; Sandlie, Inger] Natl Hosp Norway, Ctr Immune Regulat, Oslo Univ Hosp, N-0424 Oslo, Norway; [Andersen, Jan Terje; Gunnarsen, Kristin Stoen; Sandlie, Inger] Natl Hosp Norway, Dept Immunol, Oslo Univ Hosp, N-0424 Oslo, Norway; [Dalhus, Bjorn; Bjoras, Magnar] Natl Hosp Norway, Dept Microbiol, Oslo Univ Hosp, N-0424 Oslo, Norway; [Dalhus, Bjorn] Natl Hosp Norway, Dept Med Biochem, Oslo Univ Hosp, N-0424 Oslo, Norway; [Dalhus, Bjorn] Univ Oslo, N-0424 Oslo, Norway; [Viuff, Dorthe; Plumridge, Andrew; Bunting, Karen; Williamson, Rebecca; Athwal, Steven; Allan, Elizabeth; Evans, Leslie; Kjaerulff, Soren; Sleep, Darrell; Cameron, Jason] Novozymes Biopharma UK, Nottingham NG7 1FD, England; [Ravn, Birgitte Thue; Antunes, Filipa] Novozymes AS, DK-2880 Bagsvaerd, Denmark	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; Novozymes; Novozymes	Andersen, JT (corresponding author), Natl Hosp Norway, Dept Immunol, Oslo Univ Hosp, POB 4950, N-0424 Oslo, Norway.	j.t.andersen@ibv.uio.no; jsoc@novozymes.com	Andersen, Jan Terje/AAB-6209-2020; Dalhus, Bjørn/AAK-2895-2020; Bjørås, Magnar/N-9286-2017	Sleep, Darrell/0000-0001-8287-9538; Andersen, Jan Terje/0000-0003-1710-1628	Research Council of Norway through Centres of Excellence Funding Scheme Project [179573]; Norwegian Research Council [179573, 179573/V40]; South-Eastern Norway Regional Health Authority [39375]; South-Eastern Norway Regional Health Authority through Regional Technology Platform for Structural Biology and Bioinformatics Grants [2009100, 2011040, 2012085]	Research Council of Norway through Centres of Excellence Funding Scheme Project; Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norway Regional Health Authority; South-Eastern Norway Regional Health Authority through Regional Technology Platform for Structural Biology and Bioinformatics Grants	This work was supported in part by the Research Council of Norway through Centres of Excellence Funding Scheme Project Number 179573. This work was also supported by Norwegian Research Council Grant 179573/V40 and South-Eastern Norway Regional Health Authority Grant 39375 (to J. T. A.), Norwegian Research Council Grant 179573 (to K. S. G.), and South-Eastern Norway Regional Health Authority through Regional Technology Platform for Structural Biology and Bioinformatics Grants 2009100, 2011040, and 2012085 (to M. B. and B. D.). I. S., J. T. A., B. D., J. C., A. P., L. E., and D. S. are co-inventors of pending patent applications related to the data described in this paper.	Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Andersen JT, 2008, FEBS J, V275, P4097, DOI 10.1111/j.1742-4658.2008.06551.x; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2013, J BIOL CHEM, V288, P24277, DOI 10.1074/jbc.M113.463000; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Andersen JT, 2010, CLIN BIOCHEM, V43, P367, DOI 10.1016/j.clinbiochem.2009.12.001; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Elsadek B, 2012, J CONTROL RELEASE, V157, P4, DOI 10.1016/j.jconrel.2011.09.069; Evans L, 2010, PROTEIN EXPRES PURIF, V73, P113, DOI 10.1016/j.pep.2010.05.009; Ghetie V, 1997, NAT BIOTECHNOL, V15, P637, DOI 10.1038/nbt0797-637; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; Kobayashi K, 2009, GASTROENTEROLOGY, V137, P1746, DOI 10.1053/j.gastro.2009.07.059; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Santagostino E, 2012, BLOOD, V120, P2405, DOI 10.1182/blood-2012-05-429688; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; SIMISTER NE, 1989, COLD SPRING HARB SYM, V54, P571, DOI 10.1101/SQB.1989.054.01.068; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; VANZETTI G, 1979, HUM GENET, V46, P5, DOI 10.1007/BF00278896; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zunszain PA, 2008, J MOL BIOL, V381, P394, DOI 10.1016/j.jmb.2008.06.016; Zunszain Patricia A, 2003, BMC Struct Biol, V3, P6, DOI 10.1186/1472-6807-3-6	36	103	123	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13492	13502		10.1074/jbc.M114.549832	http://dx.doi.org/10.1074/jbc.M114.549832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652290	Green Published, hybrid			2022-12-25	WOS:000335522800045
J	Porcelli, V; Fiermonte, G; Longo, A; Palmieri, F				Porcelli, Vito; Fiermonte, Giuseppe; Longo, Antonella; Palmieri, Ferdinando			The Human Gene SLC25A29, of Solute Carrier Family 25, Encodes a Mitochondrial Transporter of Basic Amino Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; Liposomes; Mitochondrial Transport; Recombinant Protein Expression; Reconstitution of Membrane Transporters; SLC25 Family; SLC25A29; Basic Amino Acids; Membrane Transport Protein; Mitochondrial Carrier	BACTERIAL EXPRESSION; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; TISSUE DISTRIBUTION; CARNITINE/ACYLCARNITINE CARRIER; CARNITINE CARRIER; OXOGLUTARATE CARRIER; ARGINASE-II; IDENTIFICATION; RECONSTITUTION	Background: SLC25A29 encoded by the human SLC25A29 gene was suggested to be a mitochondrial carnitine/acylcarnitine- or ornithine-like transporter. Results: The recombinant, purified SLC25A29 transports arginine, lysine, and to a lesser extent ornithine and histidine but not carnitine and acylcarnitines. Conclusion: SLC25A29 is a mitochondrial transporter for basic amino acids. Significance: Another member of the mitochondrial carrier superfamily responsible for 12 monogenic diseases has been thoroughly characterized. The human genome encodes 53 members of the solute carrier family 25 (SLC25), also called the mitochondrial carrier family, many of which have been shown to transport carboxylates, amino acids, nucleotides, and cofactors across the inner mitochondrial membrane, thereby connecting cytosolic and matrix functions. In this work, a member of this family, SLC25A29, previously reported to be a mitochondrial carnitine/acylcarnitine- or ornithine-like carrier, has been thoroughly characterized biochemically. The SLC25A29 gene was overexpressed in Escherichia coli, and the gene product was purified and reconstituted in phospholipid vesicles. Its transport properties and kinetic parameters demonstrate that SLC25A29 transports arginine, lysine, homoarginine, methylarginine and, to a much lesser extent, ornithine and histidine. Carnitine and acylcarnitines were not transported by SLC25A29. This carrier catalyzed substantial uniport besides a counter-exchange transport, exhibited a high transport affinity for arginine and lysine, and was saturable and inhibited by mercurial compounds and other inhibitors of mitochondrial carriers to various degrees. The main physiological role of SLC25A29 is to import basic amino acids into mitochondria for mitochondrial protein synthesis and amino acid degradation.	[Porcelli, Vito; Fiermonte, Giuseppe; Longo, Antonella; Palmieri, Ferdinando] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Lab Biochem & Mol Biol, I-70125 Bari, Italy; [Fiermonte, Giuseppe; Palmieri, Ferdinando] Univ Bari, Ctr Excellence Comparat Genom, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Palmieri, F (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy.	ferdpalmieri@gmail.com	Fiermonte, Giuseppe/D-3680-2018	Fiermonte, Giuseppe/0000-0002-6764-9395; PORCELLI, Vito/0000-0002-3634-9613	Ministero dell'Universita e della Ricerca (MIUR); National Research Council (CNR); Centro di Eccellenza in Genomica Comparata (CEGBA); Apulia Region; Italian Human ProteomeNet Grant (MIUR) [RBRN07BMCT_009]	Ministero dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); National Research Council (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Centro di Eccellenza in Genomica Comparata (CEGBA); Apulia Region; Italian Human ProteomeNet Grant (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Ministero dell'Universita e della Ricerca (MIUR), the National Research Council (CNR), Centro di Eccellenza in Genomica Comparata (CEGBA), Apulia Region, and the Italian Human ProteomeNet Grant RBRN07BMCT_009 (MIUR).	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; BISACCIA F, 1985, BIOCHIM BIOPHYS ACTA, V810, P362, DOI 10.1016/0005-2728(85)90222-1; BLEMINGS KP, 1994, J NUTR, V124, P1215, DOI 10.1093/jn/124.8.1215; Camacho JA, 1999, NAT GENET, V22, P151, DOI 10.1038/9658; Camacho JA, 2009, PEDIATR RES, V66, P35, DOI 10.1203/PDR.0b013e3181a283c1; Capobianco L, 1996, BIOCHEMISTRY-US, V35, P8974, DOI 10.1021/bi960258v; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Fiermonte G, 2003, J BIOL CHEM, V278, P32778, DOI 10.1074/jbc.M302317200; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Fiermonte G, 2001, J BIOL CHEM, V276, P8225, DOI 10.1074/jbc.M009607200; Fiermonte G, 1998, J BIOL CHEM, V273, P24754, DOI 10.1074/jbc.273.38.24754; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Ghafourifar P, 2005, METHOD ENZYMOL, V396, P424, DOI 10.1016/S0076-6879(05)96036-9; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Giangregorio N, 2010, BBA-BIOENERGETICS, V1797, P839, DOI 10.1016/j.bbabio.2010.03.017; Hoyos ME, 2003, PLANT J, V33, P1027, DOI 10.1046/j.1365-313X.2003.01685.x; Huizing M, 1997, AM J HUM GENET, V61, P1239, DOI 10.1086/301628; Indiveri C, 1998, BIOCHEM BIOPH RES CO, V249, P589, DOI 10.1006/bbrc.1998.9197; INDIVERI C, 1990, BIOCHIM BIOPHYS ACTA, V1020, P81, DOI 10.1016/0005-2728(90)90096-M; Indiveri C, 1997, BIOCHEM J, V321, P713, DOI 10.1042/bj3210713; Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Lim HK, 2007, AM J PHYSIOL-HEART C, V293, pH3317, DOI 10.1152/ajpheart.00700.2007; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574; Marobbio CMT, 2002, EMBO J, V21, P5653, DOI 10.1093/emboj/cdf583; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 1979, Methods Enzymol, V56, P279; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI [10.1042/BSE0470037, 10.1042/bse0470037]; Palmieri F, 2010, FEBS LETT, V584, P1931, DOI 10.1016/j.febslet.2009.10.063; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Palmieri L, 1999, FEBS LETT, V462, P472, DOI 10.1016/S0014-5793(99)01555-0; Palmieri L, 2000, J BIOENERG BIOMEMBR, V32, P67, DOI 10.1023/A:1005564429242; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Palmieri L, 1997, FEBS LETT, V410, P447, DOI 10.1016/S0014-5793(97)00630-3; Palmieri L, 2001, J BIOL CHEM, V276, P1916, DOI 10.1074/jbc.M004332200; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Persichini T, 2005, NEUROSCI LETT, V384, P254, DOI 10.1016/j.neulet.2005.04.085; Picault N, 2002, J BIOL CHEM, V277, P24204, DOI 10.1074/jbc.M202702200; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Ryoo S, 2008, CIRC RES, V102, P923, DOI 10.1161/CIRCRESAHA.107.169573; Sekoguchi E, 2003, J BIOL CHEM, V278, P38796, DOI 10.1074/jbc.M306372200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Todisco S, 2014, BBA-BIOENERGETICS, V1837, P326, DOI 10.1016/j.bbabio.2013.11.013; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Wibom R, 2009, NEW ENGL J MED, V361, P489, DOI 10.1056/NEJMoa0900591; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Zinnanti WJ, 2007, J CLIN INVEST, V117, P3258, DOI 10.1172/JCI31617	56	60	64	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13374	13384		10.1074/jbc.M114.547448	http://dx.doi.org/10.1074/jbc.M114.547448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652292	hybrid, Green Published			2022-12-25	WOS:000335522800036
J	Fu, R; Li, J; Zhong, H; Yu, DH; Zeng, XP; Deng, MX; Sun, YQ; Wen, WP; Li, HB				Fu, Ran; Li, Jian; Zhong, Hua; Yu, Dehong; Zeng, Xianping; Deng, Mengxia; Sun, Yueqi; Wen, Weiping; Li, Huabin			Broncho-Vaxom Attenuates Allergic Airway Inflammation by Restoring GSK3 beta-Related T Regulatory Cell Insufficiency	PLOS ONE			English	Article							DENDRITIC CELLS; ASTHMA; RHINITIS; INHIBITION; MATURATION; DISEASES; MUCOSAL; UPDATE; IMPACT; LYSATE	Background: Oral administration of bacterial extracts (eg, Broncho-Vaxom (BV)) has been proposed to attenuate asthma through modulating Treg cells. However, the underlying mechanism has not been fully characterized. This study sought to assess the effects of oral administration of BV on GSK-3 beta expression and Treg cells in ovalbumin (OVA)-induced asthmatic mice models. Method: Asthmatic mice models were established with OVA challenge and treated with oral administration of BV. Next, infiltration of inflammatory cells including eosinophil and neutrophils, mucous metaplasia, levels of Th1/Th2/Treg-typed cytokines and expression of GSK3 beta and Foxp3 were examined in asthmatic mice models by histological analysis, Bio-Plex and western blot, respectively. Moreover, the frequencies of Treg cells were evaluated in cultured splenocytes by flow cytometry in the presence of BV or GSK3 beta siRNA interference. Results: We found significant decrease of infiltrated inflammatory cells in bronchoalveolar lavage fluid (BALF) in asthmatic mice models after oral administration of BV. Oral administration of BV was shown to significantly suppress mucus metaplasia, Th2-typed cytokine levels and GSK3 beta expression while increasing Foxp3 production in asthmatic mice models. Moreover, BV significantly enhanced GSK3 beta-related expansion of Treg cells in cultured spleen cells in vitro. Conclusion: Our findings provide evidence that oral administration of BV is capable of attenuating airway inflammation in asthmatic mice models, which may be associated with GSK3 beta-related expansion of Treg cells.	[Fu, Ran; Li, Jian; Zhong, Hua; Zeng, Xianping; Deng, Mengxia; Sun, Yueqi; Wen, Weiping; Li, Huabin] Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolarygol Hosp, Allergy & Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Dehong; Li, Huabin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China	Sun Yat Sen University; Shanghai Jiao Tong University	Wen, WP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolarygol Hosp, Allergy & Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.	wenwp@mail.sysu.edu.cn; allergyli@163.com	温, 家琦/GYV-3177-2022; Sun, Yueqi/N-4528-2018	Sun, Yueqi/0000-0002-2382-0429; Zhong, Hua/0000-0002-9120-2323	National Nature and Science Grant of China [81271055, 81371071]; Program from Administration of Hygiene [201202005, 2014BAI07B04]; Program for New Century Excellent Talents in University [NCET-10-0851]	National Nature and Science Grant of China; Program from Administration of Hygiene; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was supported by the National Nature and Science Grant of China (No. 81271055, 81371071) and Program from Administration of Hygiene (No. 201202005, 2014BAI07B04) and Program for New Century Excellent Talents in University (No. NCET-10-0851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens B, 2011, INT ARCH ALLERGY IMM, V156, P196, DOI 10.1159/000322352; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Banche G, 2007, INT J IMMUNOPATH PH, V20, P129, DOI 10.1177/039463200702000115; Bao Z, 2007, AM J RESP CRIT CARE, V176, P431, DOI 10.1164/rccm.200609-1292OC; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brooks C, 2013, CURR OPIN ALLERGY CL, V13, P70, DOI 10.1097/ACI.0b013e32835ad0d2; Chu KH, 2012, AM J RESP CELL MOL, V46, P651, DOI 10.1165/rcmb.2011-0246OC; Gagliardo R, 2003, AM J RESP CRIT CARE, V168, P1190, DOI 10.1164/rccm.200205-479OC; Graham JA, 2010, J BIOL CHEM, V285, P32852, DOI 10.1074/jbc.M110.150904; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Morandi B, 2011, IMMUNOL LETT, V138, P86, DOI 10.1016/j.imlet.2011.03.006; Navarro S, 2011, MUCOSAL IMMUNOL, V4, P53, DOI 10.1038/mi.2010.51; Parola C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082867; Pritchard DI, 2012, CLIN EXP ALLERGY, V42, P505, DOI 10.1111/j.1365-2222.2011.03911.x; Robinson DS, 2009, CLIN EXP ALLERGY, V39, P1314, DOI 10.1111/j.1365-2222.2009.03301.x; Rosenwasser LJ, 2011, IMMUNOL ALLERGY CLIN, V31, P433, DOI 10.1016/j.iac.2011.05.009; Russell SL, 2012, CURR OPIN GASTROEN, V28, P563, DOI 10.1097/MOG.0b013e3283573017; Schaad UB, 2010, WORLD J PEDIATR, V6, P5, DOI 10.1007/s12519-010-0001-x; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Strickland DH, 2011, MUCOSAL IMMUNOL, V4, P43, DOI 10.1038/mi.2010.43; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Vighi G, 2008, CLIN EXP IMMUNOL, V153, P3, DOI 10.1111/j.1365-2249.2008.03713.x; Zelle-Rieser C, 2001, IMMUNOL LETT, V76, P63, DOI 10.1016/S0165-2478(00)00326-6	24	24	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92912	10.1371/journal.pone.0092912	http://dx.doi.org/10.1371/journal.pone.0092912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667347	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600103
J	Llaneza, L; Garcia, EJ; Lopez-Bao, JV				Llaneza, Luis; Garcia, Emilio J.; Vicente Lopez-Bao, Jose			Intensity of Territorial Marking Predicts Wolf Reproduction: Implications for Wolf Monitoring	PLOS ONE			English	Article							SCENT-MARKING; IBERIAN WOLF; WOLVES; POPULATION; CONSERVATION; ABUNDANCE; PATTERNS; FOREST; FECES; BEAR	Background: The implementation of intensive and complex approaches to monitor large carnivores is resource demanding, restricted to endangered species, small populations, or small distribution ranges. Wolf monitoring over large spatial scales is difficult, but the management of such contentious species requires regular estimations of abundance to guide decision-makers. The integration of wolf marking behaviour with simple sign counts may offer a cost-effective alternative to monitor the status of wolf populations over large spatial scales. Methodology/Principal Findings: We used a multi-sampling approach, based on the collection of visual and scent wolf marks (faeces and ground scratching) and the assessment of wolf reproduction using howling and observation points, to test whether the intensity of marking behaviour around the pup-rearing period (summer-autumn) could reflect wolf reproduction. Between 1994 and 2007 we collected 1,964 wolf marks in a total of 1,877 km surveyed and we searched for the pups' presence (1,497 howling and 307 observations points) in 42 sampling sites with a regular presence of wolves (120 sampling sites/year). The number of wolf marks was ca. 3 times higher in sites with a confirmed presence of pups (20.3 vs. 7.2 marks). We found a significant relationship between the number of wolf marks (mean and maximum relative abundance index) and the probability of wolf reproduction. Conclusions/Significance: This research establishes a real-time relationship between the intensity of wolf marking behaviour and wolf reproduction. We suggest a conservative cutting point of 0.60 for the probability of wolf reproduction to monitor wolves on a regional scale combined with the use of the mean relative abundance index of wolf marks in a given area. We show how the integration of wolf behaviour with simple sampling procedures permit rapid, real-time, and cost-effective assessments of the breeding status of wolf packs with substantial implications to monitor wolves at large spatial scales.	[Llaneza, Luis; Garcia, Emilio J.] Asesores Recursos Nat SL, A RE NA, Lugo, Spain; [Vicente Lopez-Bao, Jose] Univ Oviedo, Res Unit Biodivers UO CSIC PA, Mieres, Spain; [Vicente Lopez-Bao, Jose] Swedish Univ Agr Sci SLU, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Swedish University of Agricultural Sciences	Lopez-Bao, JV (corresponding author), Univ Oviedo, Res Unit Biodivers UO CSIC PA, Mieres, Spain.	jv.lopezbao@gmail.com	VICENTE, LIERN/B-6112-2008; Llaneza, Luis/R-3597-2018	VICENTE, LIERN/0000-0001-5883-9640; Lopez-Bao, Jose Vicente/0000-0001-9213-998X; Llaneza, Luis/0000-0001-9529-5128	Regional Government of Asturias; Spanish Environmental Ministry; Regional Government of Galicia	Regional Government of Asturias(Principality of Asturias); Spanish Environmental Ministry(Spanish Government); Regional Government of Galicia	Regional wolf surveys were funded by the Regional Government of Asturias, the Spanish Environmental Ministry and the Regional Government of Galicia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares F, 2005, FRONTIERS WOLF RECOV; [Anonymous], 2006, SAS MIXED MODELS; Ausband DE, 2010, J WILDLIFE MANAGE, V74, P1043, DOI 10.2193/2009-303; Barja I, 2008, REPROD DOMEST ANIM, V43, P701, DOI 10.1111/j.1439-0531.2007.00974.x; Barja I, 2005, FOLIA ZOOL, V54, P21; Blanco J.C., 2002, ECOLOGIA CENSOS PERC; Boitani L, 2012, TECH ECOL CONSERVAT, P1, DOI 10.1093/acprof:oso/9780199558520.001.0001; Caniglia R, 2012, CONSERV GENET, V13, P53, DOI 10.1007/s10592-011-0266-1; Blanco JC, 2012, HYSTRIX, V23, P35; CRETE M, 1987, CAN FIELD NAT, V101, P147; FULLER TK, 1988, J WILDLIFE MANAGE, V52, P60, DOI 10.2307/3801059; Galaverni M, 2012, EUR J WILDLIFE RES, V58, P47, DOI 10.1007/s10344-011-0539-5; Garcia D, 2005, FOREST ECOL MANAG, V208, P29, DOI 10.1016/j.foreco.2004.10.071; Garcia E, 2012, 3 IB WOLF C, P44; Godinho R, 2011, 10 JORN ESP CONS EST, P64; GORMAN ML, 1990, REV SUISSE ZOOL, V97, P3, DOI 10.5962/bhl.part.79722; Gude JA, 2012, J WILDLIFE MANAGE, V76, P108, DOI 10.1002/jwmg.201; HARRINGTON FH, 1982, J WILDLIFE MANAGE, V46, P686, DOI 10.2307/3808560; Holling CrawfordS., 1978, ADAPTIVE ENV ASSESSM; Jhala Y, 2011, J APPL ECOL, V48, P14, DOI 10.1111/j.1365-2664.2010.01901.x; Johansson Maria, 2012, Human Dimensions of Wildlife, V17, P58, DOI 10.1080/10871209.2012.619001; Kaczensky P, 2013, STATUS MANAGEMENT DI; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; KLEIMAN DEVRA, 1966, SYMP ZOOL SOC LONDON, V18, P167; Kunkel K, 2005, ASSESSMENT CURRENT M; LEADERWILLIAMS N, 1988, NATURE, V336, P533, DOI 10.1038/336533a0; Liberg O, 2012, HYSTRIX, V23, P29, DOI 10.4404/hystrix-23.1-4670; Linnell, 1998, NINA OPPDRAGSMELDING, V549, P1; Linnell JDC, 2012, HYSTRIX, V23, P80, DOI 10.4404/hystrix-23.1-4676; Llaneza L., 2005, Wildlife Biology in Practice, V1, P108; Llaneza L, 2012, DIVERS DISTRIB, V18, P459, DOI 10.1111/j.1472-4642.2011.00869.x; Long RA, 2008, NONINVASIVE SURVEY M; Lopez-Bao JV, 2013, CONSERV LETT, V6, P448, DOI 10.1111/conl.12014; Marucco F, 2012, HYSTRIX, V23, P1, DOI 10.4404/hystrix-23.1-6364; Marucco F, 2009, J APPL ECOL, V46, P1003, DOI 10.1111/j.1365-2664.2009.01696.x; Mech D., 2003, WOLVES BEHAV ECOLOGY; Mech LD, 2012, BIOL CONSERV, V150, P143, DOI 10.1016/j.biocon.2012.03.003; MECH LD, 1995, CONSERV BIOL, V9, P270, DOI 10.1046/j.1523-1739.1995.9020270.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; Palomares F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052923; Palomares F, 2011, CONSERV BIOL, V25, P4, DOI 10.1111/j.1523-1739.2010.01607.x; PETERS RP, 1975, AM SCI, V63, P628; Ralls K, 2010, J WILDLIFE MANAGE, V74, P1457, DOI 10.2193/2009-401; ROTHMAN RJ, 1979, ANIM BEHAV, V27, P750, DOI 10.1016/0003-3472(79)90010-1; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Sands J, 2004, ANIM BEHAV, V67, P387, DOI 10.1016/j.anbehav.2003.03.019; Scandura M, 2011, EUR J WILDLIFE RES, V57, P949, DOI 10.1007/s10344-011-0509-y; Soulliere C., 2012, WILDLIFE SOC TECHNIC; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; VILA C, 1994, CAN J ZOOL, V72, P374, DOI 10.1139/z94-053; Zub K, 2003, BEHAVIOUR, V140, P635, DOI 10.1163/156853903322149478	54	27	28	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93015	10.1371/journal.pone.0093015	http://dx.doi.org/10.1371/journal.pone.0093015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663068	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900142
J	Anyamba, A; Small, JL; Britch, SC; Tucker, CJ; Pak, EW; Reynolds, CA; Crutchfield, J; Linthicum, KJ				Anyamba, Assaf; Small, Jennifer L.; Britch, Seth C.; Tucker, Compton J.; Pak, Edwin W.; Reynolds, Curt A.; Crutchfield, James; Linthicum, Kenneth J.			Recent Weather Extremes and Impacts on Agricultural Production and Vector-Borne Disease Outbreak Patterns	PLOS ONE			English	Article							RIFT-VALLEY FEVER; WEST NILE VIRUS; EL-NINO; CROP YIELDS; NOAA-AVHRR; CLIMATE; ENCEPHALITIS; DYNAMICS; TEMPERATURE; RESPONSES	We document significant worldwide weather anomalies that affected agriculture and vector-borne disease outbreaks during the 2010-2012 period. We utilized 2000-2012 vegetation index and land surface temperature data from NASA's satellite-based Moderate Resolution Imaging Spectroradiometer (MODIS) to map the magnitude and extent of these anomalies for diverse regions including the continental United States, Russia, East Africa, Southern Africa, and Australia. We demonstrate that shifts in temperature and/or precipitation have significant impacts on vegetation patterns with attendant consequences for agriculture and public health. Weather extremes resulted in excessive rainfall and flooding as well as severe drought, which caused similar to 10 to 80% variation in major agricultural commodity production (including wheat, corn, cotton, sorghum) and created exceptional conditions for extensive mosquito-borne disease outbreaks of dengue, Rift Valley fever, Murray Valley encephalitis, and West Nile virus disease. Analysis of MODIS data provided a standardized method for quantifying the extreme weather anomalies observed during this period. Assessments of land surface conditions from satellite-based systems such as MODIS can be a valuable tool in national, regional, and global weather impact determinations.	[Anyamba, Assaf; Small, Jennifer L.; Tucker, Compton J.; Pak, Edwin W.; Reynolds, Curt A.] NASA, Goddard Space Flight Ctr, Biospher Sci Lab, Greenbelt, MD 20771 USA; [Britch, Seth C.; Linthicum, Kenneth J.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Crutchfield, James] USDA, Int Prod & Assessment Div, Foreign Agr Serv, Washington, DC 20250 USA; [Anyamba, Assaf] Univ Space Res Assoc, Columbia, MD USA; [Small, Jennifer L.; Pak, Edwin W.] Sci Syst & Applicat Inc, Lanham, MD USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Universities Space Research Association (USRA); Science Systems and Applications Inc	Anyamba, A (corresponding author), NASA, Goddard Space Flight Ctr, Biospher Sci Lab, Greenbelt, MD 20771 USA.	assaf.anyamba@nasa.gov		Anyamba, Assaf/0000-0003-0932-9585	USDA Foreign Agricultural Service; DoD Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response System (AFHSC/GEIS) under the Human Febrile and Vector -Borne Illnesses (FVBI) Program; USDA Agricultural Research Service	USDA Foreign Agricultural Service; DoD Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response System (AFHSC/GEIS) under the Human Febrile and Vector -Borne Illnesses (FVBI) Program; USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was made possible by funding from USDA Foreign Agricultural Service towards the Global Agricultural Monitoring project, DoD Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response System (AFHSC/GEIS) under the Human Febrile and Vector -Borne Illnesses (FVBI) Program and USDA Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Anderson DP, 2012, CHOICES MAGAZINE FOO, V27, P1; Anyamba A, 2005, J ARID ENVIRON, V63, P596, DOI 10.1016/j.jaridenv.2005.03.007; Anyamba A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001465; Australian Government Bureau of Meteorology Queensland Climate Services Centre, 2010, MONTHL WEATH REV QUE; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Becker-Reshef I, 2010, REMOTE SENS-BASEL, V2, P1589, DOI 10.3390/rs2061589; Blunden J, 2013, B AM METEOROL SOC, V94, pS1, DOI 10.1175/2013BAMSStateoftheClimate.1; Bouma MJ, 1997, JAMA-J AM MED ASSOC, V278, P1772, DOI 10.1001/jama.278.21.1772; Caviedes C.N., 1992, P355, DOI 10.1017/CBO9780511565625.015; Chanson H, 2011, CH8211 U QUEENSL SCH; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; Congressional Research Service, 2012, R42046 C RES SERV; Epstein P.R., 2001, GLOBAL CHANGE HUMAN, V2, P105, DOI DOI 10.1023/A:1015089901425; Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; Glantz M. H, 1991, TELECONNECTIONS LINK, P1; Grobbelaar AA, 2011, EMERG INFECT DIS, V17, P2270, DOI 10.3201/eid1712.111035; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hoerling M, 2013, J CLIMATE, V26, P2811, DOI 10.1175/JCLI-D-12-00270.1; Hoerling MP, 2000, EL NINO SO OSCILLATI, P57, DOI DOI 10.1017/CBO9780511573125.003; IRIN, 2011, KEN MED OV DENG FEV; Johnson BJ, 2013, J MED ENTOMOL, V50, P195, DOI 10.1603/ME12035; Justice CO, 2002, REMOTE SENS ENVIRON, V83, P3, DOI 10.1016/S0034-4257(02)00084-6; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Knox J, 2012, MED J AUSTRALIA, V196, P322, DOI 10.5694/mja11.11026; Legler DM, 1999, CLIMATIC CHANGE, V42, P351, DOI 10.1023/A:1005401101129; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Lyon B, 2005, J CLIMATE, V18, P5095, DOI 10.1175/JCLI3598.1; Matsueda M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046557; Metras R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001808; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; MUELLERDOMBOIS D, 1990, ECOL STU AN, V84, P1; Munich RE, 2010, GEORISKS RES HEAT WA; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; NICHOLLS N, 1986, AUST J EXP BIOL MED, V64, P587, DOI 10.1038/icb.1986.62; Nicholls N, 1996, GEOPHYS RES LETT, V23, P3357, DOI 10.1029/96GL03166; Nielsen-Gammon JW., 2012, TEX WATER J, V3, P59, DOI DOI 10.21423/TWJ.V3I1.6463; NOAA National Climatic Data Center, 2011, STAT CLIM WILDF ANN; NOAA/NWS, 2011, NOAA NWS CLIM DIAGN; Padmanabha H, 2010, ECOHEALTH, V7, P78, DOI 10.1007/s10393-010-0301-6; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; PRINCE SD, 1986, INT J REMOTE SENS, V7, P1555, DOI 10.1080/01431168608948953; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; SEMENOV MA, 1995, AGR FOREST METEOROL, V73, P265, DOI 10.1016/0168-1923(94)05078-K; SUBRA R, 1983, ANN TROP MED PARASIT, V77, P195, DOI 10.1080/00034983.1983.11811697; Trenberth KE, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018020; Tubiello FN, 2007, P NATL ACAD SCI USA, V104, P19686, DOI 10.1073/pnas.0701728104; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; TURELL MJ, 1993, AM J TROP MED HYG, V49, P672, DOI 10.4269/ajtmh.1993.49.672; TURNER NC, 1986, FIELD CROP RES, V14, P153, DOI 10.1016/0378-4290(86)90054-7; USDA Foreign Agricultural Service, 2011, AS1101 USDA FOR AGR; USDA Foreign Agricultural Service, 2010, CA0043 USDA FOR AGR; Van Den Hurk AF, 2010, ANN TROP MED PARASIT, V104, P623, DOI 10.1179/136485910X12851868779984; Wan ZM, 2008, REMOTE SENS ENVIRON, V112, P59, DOI 10.1016/j.rse.2006.06.026; Winters KE, 2013, 20135113 US DEP INT; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]	58	88	90	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92538	10.1371/journal.pone.0092538	http://dx.doi.org/10.1371/journal.pone.0092538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658301	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300095
J	Chang, HH; Wang, YL; Chiang, YC; Chen, YL; Chuang, YH; Tsai, SJ; Heish, KH; Lin, FH; Lin, CP				Chang, Hao-Hueng; Wang, Yin-Lin; Chiang, Yu-Chih; Chen, Yen-Liang; Chuang, Yu-Horng; Tsai, Shang-Jye; Heish, Kuo-Huang; Lin, Feng-Huei; Lin, Chun-Pin			A Novel Chitosan-gamma PGA Polyelectrolyte Complex Hydrogel Promotes Early New Bone Formation in the Alveolar Socket Following Tooth Extraction	PLOS ONE			English	Article							RIDGE PRESERVATION; FORMATION ADJACENT; TISSUE; SCAFFOLD; BIOCHEMISTRY; BIOMATERIAL; IMPLANTS; COLLAGEN; MODEL	A novel chitosan-gamma PGA polyelectrolyte complex hydrogel (C-PGA) has been developed and proven to be an effective dressing for wound healing. The purpose of this study was to evaluate if C-PGA could promote new bone formation in the alveolar socket following tooth extraction. An animal model was proposed using radiography and histomorphology simultaneously to analyze the symmetrical sections of Wistar rats. The upper incisors of Wistar rats were extracted and the extraction sockets were randomly treated with gelatin sponge, neat chitosan, C-PGA, or received no treatment. The extraction sockets of selected rats from each group were evaluated at 1, 2, 4, or 6 wk post-extraction. The results of radiography and histopathology indicated that the extraction sockets treated with C-PGA exhibited lamellar bone formation (6.5%) as early as 2 wk after the extraction was performed. Moreover, the degree of new bone formation was significantly higher (P < 0.05) in the extraction sockets treated with C-PGA at 6 wk post-extraction than that in the other study groups. In this study, we demonstrated that the proposed animal model involving symmetrical sections and simultaneous radiography and histomorphology evaluation is feasible. We also conclude that the novel C-PGA has great potential for new bone formation in the alveolar socket following tooth extraction.	[Chang, Hao-Hueng; Wang, Yin-Lin; Chiang, Yu-Chih; Chen, Yen-Liang; Chuang, Yu-Horng; Tsai, Shang-Jye; Lin, Chun-Pin] Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan; [Chang, Hao-Hueng; Wang, Yin-Lin; Chiang, Yu-Chih; Chen, Yen-Liang; Lin, Chun-Pin] Natl Taiwan Univ, Dept Dent, Taipei 10764, Taiwan; [Tsai, Shang-Jye] Cardinal Tien Hosp, Dept Dent, Yonghe Branch, New Taipei, Taiwan; [Heish, Kuo-Huang] Natl Taiwan Univ, Dept Chem Engn, Taipei 10764, Taiwan; [Lin, Feng-Huei] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Lin, CP (corresponding author), Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan.	pinlin@ntu.edu.tw		CHIANG, YU-CHIH/0000-0001-8110-3033; WANG, YIN-LIN/0000-0001-6790-1311; Lin, Chun-Pin/0000-0002-3498-1113	National Science Council, Taiwan [98-2314-B-002-070-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The authors also declare this study was supported in part by a grant from the National Science Council, Taiwan (98-2314-B-002-070-MY2) and no additional or current funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x; Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x; Arruda T, 2013, J BIOMED MATER RES A, V101, P1971, DOI 10.1002/jbm.a.34501; Badawy Mohamed E. I., 2011, International Journal of Carbohydrate Chemistry, DOI 10.1155/2011/460381; Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x; Boyan BD, 2006, J PERIODONTOL, V77, P1555, DOI 10.1902/jop.2006.060019; Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P423, DOI 10.1163/156856203766652048; Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P1401, DOI 10.1163/156856203322599734; DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x; Ezoddini-Ardakani Fatemeh, 2012, Dent Res J (Isfahan), V9, P694; Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375; Hsieh CY, 2006, DENT MATER, V22, P622, DOI 10.1016/j.dental.2005.05.012; Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012; Khanna R, 2011, ACTA BIOMATER, V7, P1173, DOI 10.1016/j.actbio.2010.10.028; Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009; Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170; Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9; Liu HH, 2013, BIOMATERIALS, V34, P4404, DOI 10.1016/j.biomaterials.2013.02.048; Miranda SCCC, 2011, ARCH ORAL BIOL, V56, P1, DOI 10.1016/j.archoralbio.2010.08.018; MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0; Muzzarelli RAA, 1999, EXS, V87, P235; Muzzarelli RAA, 1999, EXS, V87, P293; Muzzarelli RAA, 1999, EXS, V87, P251; Oka S, 2013, TISSUE ENG PT A, V19, P1233, DOI [10.1089/ten.tea.2012.0325, 10.1089/ten.TEA.2012.0325]; Roriz VM, 2010, CLIN ORAL IMPLAN RES, V21, P148, DOI 10.1111/j.1600-0501.2009.01812.x; Santos FA, 2010, CLIN IMPLANT DENT R, V12, P18, DOI 10.1111/j.1708-8208.2008.00126.x; SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x; Shokrgozar Mohammad Ali, 2012, Iranian Biomedical Journal, V16, P68, DOI 10.6091/ibj.1053.2012; Tsao CT, 2011, CARBOHYD POLYM, V84, P812, DOI 10.1016/j.carbpol.2010.04.034; Tsao CT, 2011, CARBOHYD RES, V346, P94, DOI 10.1016/j.carres.2010.10.010; Tsao CT, 2010, CARBOHYD RES, V345, P1774, DOI 10.1016/j.carres.2010.06.002; TSUCHIDA E, 1994, J MACROMOL SCI PURE, VA31, P1; Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x	33	17	17	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92362	10.1371/journal.pone.0092362	http://dx.doi.org/10.1371/journal.pone.0092362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658174	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300075
J	Feenstra, F; van Gennip, RGP; van de Water, SGP; van Rijn, PA				Feenstra, Femke; van Gennip, Rene G. P.; van de Water, Sandra G. P.; van Rijn, Piet A.			RNA Elements in Open Reading Frames of the Bluetongue Virus Genome Are Essential for Virus Replication	PLOS ONE			English	Article							INTRAGENIC RECOMBINATION; INSECT CELLS; VP6 PROTEIN; SEGMENT; BINDING; NS2; IDENTIFICATION; LOCALIZATION; TRAFFICKING; BACULOVIRUS	Members of the Reoviridae family are non-enveloped multi-layered viruses with a double stranded RNA genome consisting of 9 to 12 genome segments. Bluetongue virus is the prototype orbivirus (family Reoviridae, genus Orbivirus), causing disease in ruminants, and is spread by Culicoides biting midges. Obviously, several steps in the Reoviridae family replication cycle require virus specific as well as segment specific recognition by viral proteins, but detailed processes in these interactions are still barely understood. Recently, we have shown that expression of NS3 and NS3a proteins encoded by genome segment 10 of bluetongue virus is not essential for virus replication. This gave us the unique opportunity to investigate the role of RNA sequences in the segment 10 open reading frame in virus replication, independent of its protein products. Reverse genetics was used to generate virus mutants with deletions in the open reading frame of segment 10. Although virus with a deletion between both start codons was not viable, deletions throughout the rest of the open reading frame led to the rescue of replicating virus. However, all bluetongue virus deletion mutants without functional protein expression of segment 10 contained inserts of RNA sequences originating from several viral genome segments. Subsequent studies showed that these RNA inserts act as RNA elements, needed for rescue and replication of virus. Functionality of the inserts is orientation-dependent but is independent from the position in segment 10. This study clearly shows that RNA in the open reading frame of Reoviridae members does not only encode proteins, but is also essential for virus replication.	[Feenstra, Femke; van Gennip, Rene G. P.; van de Water, Sandra G. P.; van Rijn, Piet A.] Cent Vet Inst Wageningen UR CVI, Dept Virol, Lelystad, Netherlands; [Feenstra, Femke] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [van Rijn, Piet A.] North West Univ, Ctr Human Metabon, Dept Biochem, Potchefstroom, South Africa	Wageningen University & Research; Utrecht University; North West University - South Africa	Feenstra, F (corresponding author), Cent Vet Inst Wageningen UR CVI, Dept Virol, Lelystad, Netherlands.	femke2.feenstra@wur.nl	van Rijn, Piet A/C-1163-2017; van Rijn, Piet A./AAG-7398-2019	van Rijn, Piet A/0000-0002-2594-1232; van Rijn, Piet A./0000-0002-2594-1232; van Gennip, Rene/0000-0002-5450-3493	Dutch Ministry of Economic Affairs [1600020-01]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This study was funded by the Dutch Ministry of Economic Affairs (CVI-project 1600020-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITA GY, 1992, J VET DIAGN INVEST, V4, P400, DOI 10.1177/104063879200400405; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Boyce M, 2004, J VIROL, V78, P3994, DOI 10.1128/JVI.78.8.3994-4002.2004; Boyce M, 2012, 11 INT S DOUBL STRAN, P45; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Boyce M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-178; Brierley I, 2007, NAT REV MICROBIOL, V5, P598, DOI 10.1038/nrmicro1704; Celma CCP, 2011, J VIROL, V85, P4783, DOI 10.1128/JVI.02352-10; Celma CCP, 2009, J VIROL, V83, P6806, DOI 10.1128/JVI.00263-09; Chauveau E, 2013, J VIROL, V87, P8241, DOI 10.1128/JVI.00678-13; Fillmore GC, 2002, J VIROL, V76, P499, DOI 10.1128/JVI.76.2.499-506.2002; Fujii Y, 2003, P NATL ACAD SCI USA, V100, P2002, DOI 10.1073/pnas.0437772100; GOTTLIEB P, 1994, VIROLOGY, V200, P42, DOI 10.1006/viro.1994.1160; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; He CQ, 2010, J VIROL, V84, P11487, DOI 10.1128/JVI.00889-10; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; Kalthoff D, 2013, J VIROL, V87, P13556, DOI 10.1128/JVI.02244-13; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; King A.M.Q., 2012, VIRUS TAXONOMY, P541; KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8; Kortekaas J, 2011, J VIROL, V85, P12622, DOI 10.1128/JVI.00841-11; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; LOUDON PT, 1992, VIROLOGY, V191, P231, DOI 10.1016/0042-6822(92)90184-Q; Lymperopoulos K, 2003, J BIOL CHEM, V278, P31722, DOI 10.1074/jbc.M301072200; Lymperopoulos K, 2006, VIROLOGY, V353, P17, DOI 10.1016/j.virol.2006.04.022; Maan NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032601; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Markotter W, 2004, VIRUS RES, V105, P1, DOI 10.1016/j.virusres.2004.04.005; Matsuo E, 2013, J VIROL, V87, P882, DOI 10.1128/JVI.02363-12; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; Nagy PD, 1997, VIROLOGY, V235, P1, DOI 10.1006/viro.1997.8681; Noad R, 2009, BIOL ANIM INFECT, P53, DOI 10.1016/B978-012369368-6.50008-3; ONODERA S, 1993, J VIROL, V67, P4914, DOI 10.1128/JVI.67.8.4914-4922.1993; Orru G, 2006, J VIROL METHODS, V137, P34, DOI 10.1016/j.jviromet.2006.05.028; Paillart JC, 1996, BIOCHIMIE, V78, P639, DOI 10.1016/S0300-9084(96)80010-1; Phan TG, 2007, J VIROL, V81, P10188, DOI 10.1128/JVI.00337-07; Ramadevi N, 1998, J GEN VIROL, V79, P2475, DOI 10.1099/0022-1317-79-10-2475; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; Roner MR, 2007, VIROLOGY, V358, P89, DOI 10.1016/j.virol.2006.08.017; Roy P, 2005, ADV VIRUS RES, V64, P69, DOI 10.1016/S0065-3527(05)64004-3; ROY P, 1990, J VIROL, V64, P1; SATO M, 1977, ARCH VIROL, V54, P333, DOI 10.1007/BF01314778; Schneemann A, 2006, ANNU REV MICROBIOL, V60, P51, DOI 10.1146/annurev.micro.60.080805.142304; Stauber N, 1997, J VIROL, V71, P7220; Sutton G, 2007, NAT STRUCT MOL BIOL, V14, P449, DOI 10.1038/nsmb1225; THOMAS CP, 1990, J GEN VIROL, V71, P2073, DOI 10.1099/0022-1317-71-9-2073; URAKAWA T, 1989, NUCLEIC ACIDS RES, V17, P7395, DOI 10.1093/nar/17.18.7395; van Gennip HGP, 2013, VACCINE; van Gennip RGP, 2012, PLOS ONE, V7; van Rijn PA, 2014, PLOS ONE IN PRESS; van Rijn PA, 2012, J VET DIAGN INVEST, V24, P469, DOI 10.1177/1040638712440986; WENSVOORT G, 1986, VET MICROBIOL, V12, P101, DOI 10.1016/0378-1135(86)90072-6; WU XY, 1992, J VIROL, V66, P7104, DOI 10.1128/JVI.66.12.7104-7112.1992; ZHAO Y, 1994, J VIROL, V68, P2179, DOI 10.1128/JVI.68.4.2179-2185.1994	57	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92377	10.1371/journal.pone.0092377	http://dx.doi.org/10.1371/journal.pone.0092377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658296	gold, Green Published, Green Submitted			2022-12-25	WOS:000333355300077
J	Jennelle, CS; Henaux, V; Wasserberg, G; Thiagarajan, B; Rolley, RE; Samuel, MD				Jennelle, Christopher S.; Henaux, Viviane; Wasserberg, Gideon; Thiagarajan, Bala; Rolley, Robert E.; Samuel, Michael D.			Transmission of Chronic Wasting Disease in Wisconsin White-Tailed Deer: Implications for Disease Spread and Management	PLOS ONE			English	Article							MULE DEER; PRION DISEASE; SPATIAL EPIDEMIOLOGY; POPULATION-DYNAMICS; WILDLIFE EPIDEMIC; MODELS; PATTERNS; PREVALENCE; INFECTION; DEERYARDS	Few studies have evaluated the rate of infection or mode of transmission for wildlife diseases, and the implications of alternative management strategies. We used hunter harvest data from 2002 to 2013 to investigate chronic wasting disease (CWD) infection rate and transmission modes, and address how alternative management approaches affect disease dynamics in a Wisconsin white-tailed deer population. Uncertainty regarding demographic impacts of CWD on cervid populations, human and domestic animal health concerns, and potential economic consequences underscore the need for strategies to control CWD distribution and prevalence. Using maximum-likelihood methods to evaluate alternative multistate deterministic models of CWD transmission, harvest data strongly supports a frequency-dependent transmission structure with sex-specific infection rates that are two times higher in males than females. As transmissible spongiform encephalopathies are an important and difficult-to-study class of diseases with major economic and ecological implications, our work supports the hypothesis of frequency-dependent transmission in wild deer at a broad spatial scale and indicates that effective harvest management can be implemented to control CWD prevalence. Specifically, we show that harvest focused on the greater-affected sex (males) can result in stable population dynamics and control of CWD within the next 50 years, given the constraints of the model. We also provide a quantitative estimate of geographic disease spread in southern Wisconsin, validating qualitative assessments that CWD spreads relatively slowly. Given increased discovery and distribution of CWD throughout North America, insights from our study are valuable to management agencies and to the general public concerned about the impacts of CWD on white-tailed deer populations.	[Jennelle, Christopher S.; Henaux, Viviane; Thiagarajan, Bala] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53715 USA; [Wasserberg, Gideon] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Rolley, Robert E.] Wisconsin Dept Nat Resources, Madison, WI USA; [Samuel, Michael D.] Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Greensboro; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Jennelle, CS (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53715 USA.	chris.jennelle@dnr.iowa.gov		Jennelle, Christopher/0000-0003-4133-814X	Wisconsin Department of Natural Resources; U.S. Geological Survey; University of Wisconsin Department of Forest and Wildlife Ecology	Wisconsin Department of Natural Resources; U.S. Geological Survey(United States Geological Survey); University of Wisconsin Department of Forest and Wildlife Ecology	Funding was provided by the Wisconsin Department of Natural Resources and U.S. Geological Survey. The University of Wisconsin Department of Forest and Wildlife Ecology provided assistance with publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almberg ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019896; ANDERSON R M, 1991; Barlow ND, 1996, J APPL ECOL, V33, P303, DOI 10.2307/2404752; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Blanchong JA, 2008, BIOL LETTERS, V4, P130, DOI 10.1098/rsbl.2007.0523; Bolker B, 2008, ECOLOGICAL MODELS DA; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Burnham K. P., 1998, MODEL SELECTION INFE; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Conner MM, 2004, ECOL APPL, V14, P1870, DOI 10.1890/03-5309; Cross ML, 2007, VET J, V174, P472, DOI 10.1016/j.tvjl.2006.10.005; Cross Paul C., 2009, P9, DOI 10.1007/978-4-431-77134-0_2; Dunkley L., 2003, COMPREHENSIVE REV EC; Ewald PW, 2011, ECOL RES, V26, P1017, DOI 10.1007/s11284-011-0874-8; Farnsworth ML, 2005, ECOL APPL, V15, P119, DOI 10.1890/04-0194; Fenichel EP, 2007, AM J AGR ECON, V89, P904, DOI 10.1111/j.1467-8276.2007.01025.x; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; GETZ WM, 1983, AM NAT, V121, P892, DOI 10.1086/284112; Grear DA, 2006, J WILDLIFE MANAGE, V70, P546, DOI 10.2193/0022-541X(2006)70[546:DPAHVO]2.0.CO;2; Grear DA, 2010, J APPL ECOL, V47, P532, DOI 10.1111/j.1365-2664.2010.01813.x; Gross JE, 2001, J WILDLIFE MANAGE, V65, P205, DOI 10.2307/3802899; Habib TJ, 2011, ECOL MODEL, V222, P2722, DOI 10.1016/j.ecolmodel.2011.05.007; HALLS L, 1984, WHITE TAILED DEER EC; Heisey DM, 2010, ECOL MONOGR, V80, P221, DOI 10.1890/09-0052.1; Hilborn Ray, 1997, V28; Holsman R. H., 2006, Human Dimensions of Wildlife, V11, P177, DOI 10.1080/10871200600669916; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Joly DO, 2006, J WILDLIFE DIS, V42, P578, DOI 10.7589/0090-3558-42.3.578; Joly DO, 2003, EMERG INFECT DIS, V9, P599, DOI 10.3201/eid0905.020721; Keane DP, 2008, J VET DIAGN INVEST, V20, P698, DOI 10.1177/104063870802000534; Keane DP, 2008, J VET DIAGN INVEST, V20, P58, DOI 10.1177/104063870802000110; Kjaer LJ, 2008, J WILDLIFE MANAGE, V72, P1819, DOI 10.2193/2007-489; Klepac P, 2011, THEOR ECOL-NETH, V4, P301, DOI 10.1007/s12080-010-0079-8; Lang KR, 2012, J WILDLIFE MANAGE, V76, P832, DOI 10.1002/jwmg.292; Long ES, 2005, J MAMMAL, V86, P623, DOI 10.1644/1545-1542(2005)86[623:FCIDDO]2.0.CO;2; Magle SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056568; Manache G, 2004, J WATER RES PL-ASCE, V130, P232, DOI 10.1061/(ASCE)0733-9496(2004)130:3(232); McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Oli MK, 2006, ECOL MODEL, V198, P183, DOI 10.1016/j.ecolmodel.2006.04.007; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Oyer AM, 2007, J WILDLIFE MANAGE, V71, P1635, DOI 10.2193/2006-381; Palmer MV, 2004, J WILDLIFE DIS, V40, P87, DOI 10.7589/0090-3558-40.1.87; Potapov A, 2013, ECOL MODEL, V250, P244, DOI 10.1016/j.ecolmodel.2012.11.012; Potapov A, 2012, P ROY SOC B-BIOL SCI, V279, P3139, DOI 10.1098/rspb.2012.0520; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Roberts MG, 1996, J ANIM ECOL, V65, P451, DOI 10.2307/5780; Robinson SJ, 2013, LANDSCAPE ECOL, V28, P1923, DOI 10.1007/s10980-013-9919-4; Robinson SJ, 2012, MOL ECOL, V21, P4190, DOI 10.1111/j.1365-294X.2012.05681.x; Robinson SJ, 2012, ECOL APPL, V22, P1050, DOI 10.1890/11-0907.1; Roseberry JL, 1991, WILDLIFE MONOGR, V117, P3; Rudolf VHW, 2005, AM NAT, V166, P112, DOI 10.1086/430674; Schauber EM, 2003, WILDLIFE SOC B, V31, P610; Silbernagel ER, 2011, J WILDLIFE MANAGE, V75, P1453, DOI 10.1002/jwmg.172; Storm DJ, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00141.1; Van Deelen TR, 1998, J WILDLIFE MANAGE, V62, P205, DOI 10.2307/3802280; Van Deelen TR, 1999, NAT AREA J, V19, P263; Walter WD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1203; Wasserberg G, 2009, J APPL ECOL, V46, P457, DOI 10.1111/j.1365-2664.2008.01576.x; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Williams ES, 2002, J WILDLIFE MANAGE, V66, P551, DOI 10.2307/3803123; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wisconsin Department of Natural Resources, 2010, WISC CHRON WAST DIS; Wobeser G.A, 2007, DIS WILD ANIMALS, V2nd; Wolfe LL, 2004, WILDLIFE SOC B, V32, P500, DOI 10.2193/0091-7648(2004)32[500:FOTFMC]2.0.CO;2	69	41	41	4	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91043	10.1371/journal.pone.0091043	http://dx.doi.org/10.1371/journal.pone.0091043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658535	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300023
J	Kefi, S; Guttal, V; Brock, WA; Carpenter, SR; Ellison, AM; Livina, VN; Seekell, DA; Scheffer, M; van Nes, EH; Dakos, V				Kefi, Sonia; Guttal, Vishwesha; Brock, William A.; Carpenter, Stephen R.; Ellison, Aaron M.; Livina, Valerie N.; Seekell, David A.; Scheffer, Marten; van Nes, Egbert H.; Dakos, Vasilis			Early Warning Signals of Ecological Transitions: Methods for Spatial Patterns	PLOS ONE			English	Article							PATCH-SIZE DISTRIBUTION; REGIME SHIFTS; VEGETATION PATTERNS; CATASTROPHIC SHIFTS; SUITABLE INDICATOR; LEADING INDICATOR; SLOWING-DOWN; CLIMATE; DESERTIFICATION; LAW	A number of ecosystems can exhibit abrupt shifts between alternative stable states. Because of their important ecological and economic consequences, recent research has focused on devising early warning signals for anticipating such abrupt ecological transitions. In particular, theoretical studies show that changes in spatial characteristics of the system could provide early warnings of approaching transitions. However, the empirical validation of these indicators lag behind their theoretical developments. Here, we summarize a range of currently available spatial early warning signals, suggest potential null models to interpret their trends, and apply them to three simulated spatial data sets of systems undergoing an abrupt transition. In addition to providing a step-by-step methodology for applying these signals to spatial data sets, we propose a statistical toolbox that may be used to help detect approaching transitions in a wide range of spatial data. We hope that our methodology together with the computer codes will stimulate the application and testing of spatial early warning signals on real spatial data.	[Kefi, Sonia] Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France; [Guttal, Vishwesha] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Brock, William A.] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [Brock, William A.; Carpenter, Stephen R.] Univ Missouri, Dept Econ, Columbia, MO USA; [Carpenter, Stephen R.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Ellison, Aaron M.] Harvard Univ, Petersham, MA USA; [Livina, Valerie N.] Natl Phys Lab, Teddington TW11 0LW, Middx, England; [Seekell, David A.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Scheffer, Marten; van Nes, Egbert H.] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AP Wageningen, Netherlands; [Dakos, Vasilis] Integrat Ecol Grp, Estn Biol Donana, Seville, Spain	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Indian Institute of Science (IISC) - Bangalore; University of Wisconsin System; University of Wisconsin Madison; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison; Harvard University; National Physical Laboratory - UK; University of Virginia; Wageningen University & Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Kefi, S (corresponding author), Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France.	sonia.kefi@univ-montp2.fr	van Nes, Egbert H/F-2681-2011; Carpenter, Stephen/AAQ-6404-2020; Livina, Valerie N/C-7636-2011; Guttal, Vishwesha/A-3007-2008	Livina, Valerie N/0000-0003-3759-9013; Guttal, Vishwesha/0000-0002-2677-857X; Ellison, Aaron/0000-0003-4151-6081; Kefi, Sonia/0000-0002-9678-7770; van Nes, Egbert/0000-0002-6345-104X; Dakos, Vasilis/0000-0001-8862-718X	Santa Fe Institute; Arizona State University; European Union [283068]; Ramalingaswami Fellowship; Department of Biotechnology, Government of India; Ministry of Environment and Forests, Government of India; NSF; NSF [11-44056]; NERC of the AXA Research Fund [NE/F005474/1]; National Measurement Office; RUBICON; EU Marie Curie fellowship; Direct For Biological Sciences [1144683] Funding Source: National Science Foundation; Natural Environment Research Council [NE/F005474/1] Funding Source: researchfish; NERC [NE/F005474/1] Funding Source: UKRI	Santa Fe Institute; Arizona State University; European Union(European Commission); Ramalingaswami Fellowship; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Ministry of Environment and Forests, Government of India(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of India); NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NERC of the AXA Research Fund(AXA Research Fund); National Measurement Office; RUBICON(European Commission); EU Marie Curie fellowship(European Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors are grateful to the Santa Fe Institute and the Arizona State University for the financial support. SK acknowledges support from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 283068 (CASCADE). VG acknowledges support from a Ramalingaswami Fellowship, Department of Biotechnology, Government of India, and the Ministry of Environment and Forests, Government of India. SRC's work is supported by NSF. AME is supported by NSF award 11-44056. VNL is supported by NERC (NE/F005474/1) postdoctoral fellowship of the AXA Research Fund and grant of the National Measurement Office (2013-2016). VD acknowledges a RUBICON (NWO funded) grant and an EU Marie Curie fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier N, 2006, J ECOL, V94, P537, DOI 10.1111/j.1365-2745.2006.01126.x; Blois JL, 2013, P NATL ACAD SCI USA, V110, P9374, DOI 10.1073/pnas.1220228110; Boettiger C, 2013, NATURE, V493, P157, DOI 10.1038/493157a; Boettiger C, 2012, J R SOC INTERFACE, V9, P2527, DOI 10.1098/rsif.2012.0125; Carpenter SR, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00016.1; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Corrado R, 2013, 2013 22ND INTERNATIONAL CONFERENCE ON NOISE AND FLUCTUATIONS (ICNF), DOI 10.1109/ICNF.2013.6578895; Couteron P, 2002, INT J REMOTE SENS, V23, P3407, DOI 10.1080/01431160110107699; Dai L, 2013, NATURE, V496, P355, DOI 10.1038/nature12071; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2013, THEOR ECOL-NETH, V6, P309, DOI 10.1007/s12080-013-0186-4; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Deblauwe V, 2011, ECOGRAPHY, V34, P990, DOI 10.1111/j.1600-0587.2010.06694.x; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Foti R, 2013, P NATL ACAD SCI USA, V110, P6296, DOI 10.1073/pnas.1302558110; Gilmore R., 1981, CATASTROPHE THEORY S; Guttal V, 2008, THESIS OHIO STATE U, V3, P39; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Guttal V, 2007, ECOL MODEL, V201, P420, DOI 10.1016/j.ecolmodel.2006.10.005; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Kefi S, 2010, ECOLOGY, V91, P3739, DOI 10.1890/09-1915.1; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kefi S, 2013, OIKOS, V122, P641, DOI 10.1111/j.1600-0706.2012.20838.x; Kefi S, 2011, ECOL LETT, V14, P29, DOI 10.1111/j.1461-0248.2010.01553.x; Kefi S, 2010, THEOR ECOL-NETH, V3, P257, DOI 10.1007/s12080-009-0067-z; Keitt TH, 2001, AM NAT, V157, P203, DOI 10.1086/318633; Lade SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002360; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lin Y, 2010, LANDSCAPE ECOL, V25, P1519, DOI 10.1007/s10980-010-9520-z; Litzow MA, 2008, ECOL APPL, V18, P1331, DOI 10.1890/07-0998.1; Livina VN, 2011, CLIM DYNAM, V37, P2437, DOI 10.1007/s00382-010-0980-2; Livina VN, 2010, CLIM PAST, V6, P77, DOI 10.5194/cp-6-77-2010; Maestre FT, 2010, ECOLOGY, V91, P3742, DOI 10.1890/10-0391.1; Manor A, 2008, J THEOR BIOL, V253, P838, DOI 10.1016/j.jtbi.2008.04.012; Marcos-Nikolaus P, 2002, INT J BIFURCAT CHAOS, V12, P369, DOI 10.1142/S0218127402004371; Mocenni C, 2010, P NATL ACAD SCI USA, V107, P8097, DOI 10.1073/pnas.0910414107; Mugglestone MA, 1998, COMPUT GEOSCI, V24, P771, DOI 10.1016/S0098-3004(98)00065-X; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Oborny B, 2005, OIKOS, V109, P291; Pueyo S, 2011, LANDSCAPE ECOL, V26, P305, DOI 10.1007/s10980-010-9569-8; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Scanlon TM, 2007, NATURE, V449, P209, DOI 10.1038/nature06060; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Seekell DA, 2012, ECOSYSTEMS, V15, P741, DOI 10.1007/s10021-012-9542-2; Sethna JP, 2007, STAT MECH ENTROPY OR; Shnerb NM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.038101; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; van Nes EH, 2005, ECOLOGY, V86, P1797, DOI 10.1890/04-0550; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; von Hardenberg J, 2010, P ROY SOC B-BIOL SCI, V277, P1771, DOI 10.1098/rspb.2009.2208; Walters C, 1999, ECOSYSTEMS, V2, P539, DOI 10.1007/s100219900101; Wang R, 2012, NATURE, V492, P419, DOI 10.1038/nature11655; Weerman EJ, 2012, ECOLOGY, V93, P608, DOI 10.1890/11-0625.1; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	69	200	205	6	201	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92097	10.1371/journal.pone.0092097	http://dx.doi.org/10.1371/journal.pone.0092097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658137	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000333355300053
J	Monsel, A; Lecart, S; Roquilly, A; Broquet, A; Jacqueline, C; Mirault, T; Troude, T; Fontaine-Aupart, MP; Asehnoune, K				Monsel, Antoine; Lecart, Sandrine; Roquilly, Antoine; Broquet, Alexis; Jacqueline, Cedric; Mirault, Tristan; Troude, Thibaut; Fontaine-Aupart, Marie-Pierre; Asehnoune, Karim			Analysis of Autofluorescence in Polymorphonuclear Neutrophils: A New Tool for Early Infection Diagnosis	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; BRONCHOALVEOLAR LAVAGE FLUID; ANTIBIOTIC-TREATMENT; CELLS; FLUORESCENCE; ACTIVATION; IDENTIFICATION; RECOGNITION; BACTEREMIA; EXPRESSION	Diagnosing bacterial infection (BI) remains a challenge for the attending physician. An ex vivo infection model based on human fixed polymorphonuclear neutrophils (PMNs) gives an autofluorescence signal that differs significantly between stimulated and unstimulated cells. We took advantage of this property for use in an in vivo pneumonia mouse model and in patients hospitalized with bacterial pneumonia. A 2-fold decrease was observed in autofluorescence intensity for cytospined PMNs from broncho-alveolar lavage (BAL) in the pneumonia mouse model and a 2.7-fold decrease was observed in patients with pneumonia when compared with control mice or patients without pneumonia, respectively. This optical method provided an autofluorescence mean intensity cut-off, allowing for easy diagnosis of BI. Originally set up on a confocal microscope, the assay was also effective using a standard epifluorescence microscope. Assessing the autofluorescence of PMNs provides a fast, simple, cheap and reliable method optimizing the efficiency and the time needed for early diagnosis of severe infections. Rationalized therapeutic decisions supported by the results from this method can improve the outcome of patients suspected of having an infection.	[Monsel, Antoine] La Pitie Salpetriere Hosp, AP HP, Dept Anesthesiol & Crit Care, Multidisciplinary Intens Care Unit, Paris, France; [Monsel, Antoine] Univ Paris 06, Paris, France; [Lecart, Sandrine; Fontaine-Aupart, Marie-Pierre] Univ Paris 11, CPBM CLUPS, Orsay, France; [Roquilly, Antoine; Broquet, Alexis; Jacqueline, Cedric; Asehnoune, Karim] Fac Nantes, Fac Med, Lab UPRES EA 3826, Nantes, France; [Roquilly, Antoine; Asehnoune, Karim] CHU Nantes, Serv Anesthesie Reanimat Chirurg, F-44035 Nantes 01, France; [Mirault, Tristan] Paris Descartes Univ, European Hosp Georges Pompidou, AP HP, PRES Paris Sorbonne Cite,Vasc Med Unit, Paris, France; [Troude, Thibaut; Fontaine-Aupart, Marie-Pierre] Univ Paris 11, CNRS, ISMO, F-91405 Orsay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Monsel, A (corresponding author), La Pitie Salpetriere Hosp, AP HP, Dept Anesthesiol & Crit Care, Multidisciplinary Intens Care Unit, Paris, France.	monsela@anesthesia.ucsf.edu	Jacqueline, Cédric/G-5650-2010; Roquilly, Antoine/P-9826-2017; Mirault, Tristan/AAB-3997-2020	Jacqueline, Cédric/0000-0001-9606-5930; Mirault, Tristan/0000-0001-8690-1093; Broquet, Alexis/0000-0002-6635-9601; Monsel, Antoine/0000-0002-9647-7043	Fondation pour la Recherche Medicale (France); University of Orsay	Fondation pour la Recherche Medicale (France)(Fondation pour la Recherche Medicale); University of Orsay	This work was supported by the following institutions and grants: the Master Research grant from the Fondation pour la Recherche Medicale (France), and the University of Orsay funded the Argon UV laser. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaouchiche B, 1999, BRIT J ANAESTH, V83, P845, DOI 10.1093/bja/83.6.845; Andrade SS, 2008, SHOCK, V30, P41, DOI 10.1097/SHK.0b013e3181819f6c; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; BABIOR BM, 1984, J CLIN INVEST, V73, P599, DOI 10.1172/JCI111249; BABIOR BM, 1984, BLOOD, V64, P959; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; CRADDOCK PR, 1979, SEMIN HEMATOL, V16, P140; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; Erden V, 2003, INTENS CARE MED, V29, P1856, DOI 10.1007/s00134-003-1964-z; Evans ND, 2005, J PHOTOCH PHOTOBIO B, V80, P122, DOI 10.1016/j.jphotobiol.2005.04.001; Fabregas N, 1999, THORAX, V54, P867, DOI 10.1136/thx.54.10.867; FUERST DE, 1965, NATURE, V205, P1333, DOI 10.1038/2051333a0; HAFEMAN DG, 1982, SCIENCE, V215, P673, DOI 10.1126/science.6800035; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Heintzelman DL, 2000, PHOTOCHEM PHOTOBIOL, V71, P327, DOI 10.1562/0031-8655(2000)071<0327:COTAOP>2.0.CO;2; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; Kim YS, 2009, ANN CLIN LAB SCI, V39, P114; Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583; LIANG B, 1992, J CELL PHYSIOL, V152, P145, DOI 10.1002/jcp.1041520119; Liang J, 2007, SPECTROCHIM ACTA A, V67, P355, DOI 10.1016/j.saa.2006.07.035; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; Ng PC, 2007, PEDIATR RES, V61, P93, DOI 10.1203/01.pdr.0000250207.95723.96; Nupponen I, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e12; Nuutila J, 2007, J IMMUNOL METHODS, V328, P189, DOI 10.1016/j.jim.2007.09.002; PAPAZIAN L, 1995, AM J RESP CRIT CARE, V152, P1982, DOI 10.1164/ajrccm.152.6.8520766; PINSKY MR, 1993, CHEST, V103, P565, DOI 10.1378/chest.103.2.565; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; Rintala EM, 2001, SCAND J CLIN LAB INV, V61, P523; Roquilly A, 2013, EUR RESPIR J; Roquilly A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013228; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Sherwin C, 2008, AM J PERINAT, V25, P629, DOI 10.1055/s-0028-1090585; Singh N, 2000, AM J RESP CRIT CARE, V162, P505, DOI 10.1164/ajrccm.162.2.9909095; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; van Rijt LS, 2004, J IMMUNOL METHODS, V288, P111, DOI 10.1016/j.jim.2004.03.004; VERGHESE A, 1988, EXP LUNG RES, V14, P797, DOI 10.3109/01902148809087845; WATT SM, 1980, J HISTOCHEM CYTOCHEM, V28, P934, DOI 10.1177/28.9.7410816; Wu LP, 2007, AM J PHYSIOL-RENAL, V292, pF261, DOI 10.1152/ajprenal.00263.2006	44	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92564	10.1371/journal.pone.0092564	http://dx.doi.org/10.1371/journal.pone.0092564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658436	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300099
J	Wei, L; Zhou, QY; Hou, SP; Bai, L; Liu, YJ; Qi, J; Xiang, Q; Zhou, Y; Kijlstra, A; Yang, PZ				Wei, Lin; Zhou, Qingyun; Hou, Shengping; Bai, Lin; Liu, Yunjia; Qi, Jian; Xiang, Qin; Zhou, Yan; Kijlstra, Aize; Yang, Peizeng			MicroRNA-146a and Ets-1 Gene Polymorphisms Are Associated with Pediatric Uveitis	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; EXPRESSION; MIR-146A; LUPUS; SUSCEPTIBILITY; EPIDEMIOLOGY; PRE-MIR-146A; CONTRIBUTES; ACTIVATION; MEMBRANE	Background: MicroRNA-146a (miR-146a) was a key negative regulator of autoimmunity. V-Ets oncogene homolog 1 (Ets-1) was demonstrated to bind to the miR-146a promoter region and markedly affects miR-146a promoter activity. This study aimed to investigate the association of miR-146a and Ets-1 gene polymorphisms with pediatric uveitis in a Han Chinese population. Methodology/Principal Findings: A total of 520 patients and 1204 healthy controls were included in the present study. Five single-nucleotide polymorphisms (SNPs), miR-146a/rs2910164, miR-146a/rs57095329, miR-146a/rs6864584, ets-1/rs1128334 and ets-1/rs10893872 were genotyped using a polymerase chain reaction-restriction fragment length polymorphism assay. The expression of Ets-1 in peripheral blood mononuclear cells from genotyped healthy controls was tested by real-time PCR. Two SNPs (rs2910164 and rs10893872) were associated with pediatric uveitis in this study. The frequencies of the rs2910164 GG genotype and G allele were significantly increased (P-c = -3.11x10(-4); P-c = -2.75x10(-6)) while the CC genotype and C allele were significantly decreased (P-c = 0.001; P-c = 2.75x10(-6)) in patients compared with normal controls. The frequencies of the rs10893872 CC genotype and C allele were significantly increased (P-c = 3.89x10(-4); P-c = 0.01) while the CT genotype and T allele were significantly decreased (P-c = 0.004; P-c = 0.01) in patients compared with normal controls. The SNP rs2910164 GG genotype and G/C allele were also associated with the presence of microvascular leakage as detected by fundus fluorescein angiography in pediatric uveitis (P-c = 0.01; P-c = 0.005, respectively). Ets-1 expression in rs10893872 CC carriers was significantly higher than in CT and TT individuals (P-c = 0.013). There was no association of the other three SNPs with pediatric uveitis. Conclusions: This study shows that miR-146a and Ets-1 are both associated with pediatric uveitis in Han Chinese. SNP rs10893872 may affect the genetic predisposition to pediatric uveitis by modulating expression of Ets-1.	[Wei, Lin; Zhou, Qingyun; Hou, Shengping; Bai, Lin; Liu, Yunjia; Qi, Jian; Xiang, Qin; Zhou, Yan; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Wei, Lin; Zhou, Qingyun; Hou, Shengping; Bai, Lin; Liu, Yunjia; Qi, Jian; Xiang, Qin; Zhou, Yan; Yang, Peizeng] Chongqing Eye Inst, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Eye Clin Maastricht, Maastricht, Netherlands	Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com			National Basic Research Program of China (973 Program) [2011CB510200]; Key Project of Natural Science Foundation [81130019]; Research Fund for the Doctoral Program of Higher Education of China [20115503110002]; Ministry of Health, Basic Research program of Chongqing, Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Key Project of Health Bureau of Chongqing [2012-1-003]; Fund for PAR-EU Scholars Program	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Project of Natural Science Foundation; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Ministry of Health, Basic Research program of Chongqing, Chongqing Key Laboratory of Ophthalmology (CSTC); Key Project of Health Bureau of Chongqing; Fund for PAR-EU Scholars Program	This work was supported by National Basic Research Program of China (973 Program)(2011CB510200), Key Project of Natural Science Foundation(81130019), Research Fund for the Doctoral Program of Higher Education of China (20115503110002), Clinic Key Project of Ministry of Health, Basic Research program of Chongqing, Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), Key Project of Health Bureau of Chongqing(2012-1-003) and Fund for PAR-EU Scholars Program. The authors have declared that no competing interests exist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu K, 2013, INDIAN J OPHTHALMOL, V61, P277, DOI 10.4103/0301-4738.114099; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Clarke LAL, 2013, CLIN EXP RHEUMATOL, V31, P633; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cunningham ET, 2000, OCUL IMMUNOL INFLAMM, V8, P251; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Guo H, 2010, FAM CANCER, V9, P599, DOI 10.1007/s10689-010-9370-5; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jimenez-Morales S, 2012, TISSUE ANTIGENS, P9999; Leng RX, 2011, AUTOIMMUN REV, V10, P439, DOI 10.1016/j.autrev.2011.01.007; Lerman MA, 2013, J RHEUMATOL, V40, P1394, DOI 10.3899/jrheum.121180; Li Y, 2010, CHINESE MED J-PEKING, V123, P2287, DOI 10.3760/cma.j.issn.0366-6999.2010.16.025; Luo XB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002128; MELINALDANA H, 1992, J PEDIATR-US, V121, P56, DOI 10.1016/S0022-3476(05)82541-7; Nunn MF, 1983, TRIPARTITE STRUCTURE; Paivonsalo-Hietanen T, 2000, ACTA OPHTHALMOL SCAN, V78, P84, DOI 10.1034/j.1600-0420.2000.078001084.x; Petty RE, 2004, J RHEUMATOL, V31, P390; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; Qi J, 2013, HUM GENET, P1; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; Russell L, 2010, CYTOKINE, V51, P217, DOI 10.1016/j.cyto.2010.03.006; Smith JA, 2009, OPHTHALMOLOGY, V116, P1544, DOI 10.1016/j.ophtha.2009.05.002; Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Tugal-Tutkun Ilknur, 2011, J Ophthalmic Vis Res, V6, P259; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zeggini E, 2006, RHEUMATOLOGY, V45, P972, DOI 10.1093/rheumatology/kel049; Zhang J, 2013, ANN HUMAN GENETICS; Zhou FY, 2012, DNA CELL BIOL, V31, P1290, DOI 10.1089/dna.2011.1596; Zhou Q, 2012, ANN RHEUMATIC DIS; Zhou QY, 2012, MOL VIS, V18, P426; Zulian F, 2002, J RHEUMATOL, V29, P2446	38	21	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91199	10.1371/journal.pone.0091199	http://dx.doi.org/10.1371/journal.pone.0091199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658012	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300027
J	Aguilar, A; Gimenez, J; Gomez-Campos, E; Cardona, L; Borrell, A				Aguilar, Alex; Gimenez, Joan; Gomez-Campos, Encarna; Cardona, Luis; Borrell, Asuncion			delta N-15 Value Does Not Reflect Fasting in Mysticetes	PLOS ONE			English	Article							ELEPHANT SEAL PUPS; STABLE-ISOTOPES; NUTRITIONAL CONDITION; NITROGEN-METABOLISM; PROTEIN CATABOLISM; BALAENA-MYSTICETUS; FEEDING ECOLOGY; FIN WHALES; BALEEN; CARBON	The finding that tissue delta N-15 values increase with protein catabolism has led researchers to apply this value to gauge nutritive condition in vertebrates. However, its application to marine mammals has in most occasions failed. We investigated the relationship between delta N-15 values and the fattening/fasting cycle in a model species, the fin whale, a migratory capital breeder that experiences severe seasonal variation in body condition. We analyzed two tissues providing complementary insights: one with isotopic turnover (muscle) and one that keeps a permanent record of variations in isotopic values (baleen plates). In both tissues delta N-15 values increased with intensive feeding but decreased with fasting, thus contradicting the pattern previously anticipated. The apparent inconsistency during fasting is explained by the fact that a) individuals migrate between different isotopic isoscapes, b) starvation may not trigger significant negative nitrogen balance, and c) excretion drops and elimination of N-15-depleted urine is minimized. Conversely, when intensive feeding is resumed in the northern grounds, protein anabolism and excretion start again, triggering N-15 enrichment. It can be concluded that in whales and other mammals that accrue massive depots of lipids as energetic reserves and which have limited access to drinking water, the delta N-15 value is not affected by fasting and therefore cannot be used as an indicatior of nutritive condition.	[Aguilar, Alex] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; Univ Barcelona, Fac Biol, Biodivers Res Inst IrBio, Barcelona, Spain	University of Barcelona; University of Barcelona	Aguilar, A (corresponding author), Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain.	aaguilar@ub.edu	Borrell, Asunción/B-8257-2009; Aguilar, Alex/L-1283-2014; Cardona, Luis/AAL-1354-2021; Cardona, Luis/L-1680-2014; Gimenez, Joan/C-6107-2015	Borrell, Asunción/0000-0002-6714-0724; Aguilar, Alex/0000-0002-5751-2512; Cardona, Luis/0000-0002-7892-1323; Cardona, Luis/0000-0002-7892-1323; Gimenez, Joan/0000-0001-9207-4792	Fundacio Barcelona Zoo	Fundacio Barcelona Zoo	This work was conducted as part of a project on fin whale population structure supported by the Fundacio Barcelona Zoo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SH, 1993, J COMP PHYSIOL B, V163, P367; Aguilar A., 1999, Journal of Cetacean Research and Management Special Issue, V1, P83; AGUILAR A, 1990, J MAMMAL, V71, P544, DOI 10.2307/1381793; Aguilar A, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P433; AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; AMBROSE SH, 1987, NATURE, V325, P201, DOI 10.1038/325201a0; AMBROSE SH, 1986, J HUM EVOL, V15, P707, DOI 10.1016/S0047-2484(86)80006-9; Anonymous, 1977, Report int Whal Commn, V27, P369; Bahar B, 2009, J ANIM SCI, V87, P905, DOI 10.2527/jas.2008-1360; Barboza PS, 1997, CAN J ZOOL, V75, P2129, DOI 10.1139/z97-848; Ben-David M, 1999, CAN J ZOOL, V77, P1373, DOI 10.1139/cjz-77-9-1373; Bentaleb I, 2011, MAR ECOL PROG SER, V438, P285, DOI 10.3354/meps09269; BENTLEY PJ, 1963, COMP BIOCHEM PHYSIOL, V10, P257, DOI 10.1016/0010-406X(63)90040-9; Best PB, 1996, MAR BIOL, V124, P483, DOI 10.1007/BF00351030; Borrell A, 2012, RAPID COMMUN MASS SP, V26, P1596, DOI 10.1002/rcm.6267; Caraveo-Patino J, 2007, HYDROBIOLOGIA, V586, P17, DOI 10.1007/s10750-006-0477-5; Castellote M, 2012, MAR MAMMAL SCI, V28, P325, DOI 10.1111/j.1748-7692.2011.00491.x; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Ciancio JE, 2008, J FISH BIOL, V72, P1708, DOI 10.1111/j.1095-8649.2008.01846.x; Cormie AB, 1996, GEOCHIM COSMOCHIM AC, V60, P4161, DOI 10.1016/S0016-7037(96)00251-7; Costa DP, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P801; Das K, 2004, MAR ECOL PROG SER, V281, P283, DOI 10.3354/meps281283; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; DELGIUDICE GD, 1994, J WILDLIFE MANAGE, V58, P430, DOI 10.2307/3809313; Doucett RR, 1999, CAN J FISH AQUAT SCI, V56, P2172, DOI 10.1139/cjfas-56-11-2172; FISHER LR, 1959, J MAR BIOL ASSOC UK, V38, P291, DOI 10.1017/S0025315400006093; Florin ST, 2011, FUNCT ECOL, V25, P519, DOI 10.1111/j.1365-2435.2010.01799.x; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Gaye-Siessegger J, 2007, J FISH BIOL, V71, P90, DOI 10.1111/j.1095-8649.2007.01469.x; Gimenez J, 2013, RAPID COMMUN MASS SP, V27, P1801, DOI 10.1002/rcm.6633; Gomez-Campos E, 2011, J EXP MAR BIOL ECOL, V405, P18, DOI 10.1016/j.jembe.2011.05.013; Gomez-Campos E, 2011, RAPID COMMUN MASS SP, V25, P1343, DOI 10.1002/rcm.4999; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Habran S, 2010, MAR MAMMAL SCI, V26, P880, DOI 10.1111/j.1748-7692.2010.00372.x; Hartman G, 2011, FUNCT ECOL, V25, P122, DOI 10.1111/j.1365-2435.2010.01782.x; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Hobson KA, 1999, OECOLOGIA, V120, P312, DOI 10.1007/s004420050864; Hobson KA, 1998, CAN J FISH AQUAT SCI, V55, P2601, DOI 10.1139/cjfas-55-12-2601; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Houser DS, 2001, J COMP PHYSIOL B, V171, P635, DOI 10.1007/s003600100214; HUI CA, 1981, PHYSIOL ZOOL, V54, P430, DOI 10.1086/physzool.54.4.30155836; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Knoche M, 2007, SC59BRG13 INT WHAL C; Kurle CM, 2001, OECOLOGIA, V126, P254, DOI 10.1007/s004420000518; Lee SH, 2005, MAR ECOL PROG SER, V285, P271, DOI 10.3354/meps285271; Lee TN, 2012, J EXP BIOL, V215, P3354, DOI 10.1242/jeb.068528; Lockyer C., 1987, S ZOOLOGICAL SOC LON, V57, P343; Lockyer C., 1981, FAO FISHERIES SERIES, V5, P379; Lohuis TD, 2007, COMP BIOCHEM PHYS B, V147, P20, DOI 10.1016/j.cbpb.2006.12.020; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; Mitani Y, 2006, FISHERIES SCI, V72, P69, DOI 10.1111/j.1444-2906.2006.01118.x; Nelson R.A., 1989, P299; Nelson RA, 1983, BEARS THEIR BIOL MAN, V5, P284, DOI [DOI 10.2307/3872551, 10.2307/3872551]; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; NORDOY ES, 1990, ACTA PHYSIOL SCAND, V139, P361, DOI 10.1111/j.1748-1716.1990.tb08935.x; Oelbermann K, 2002, OECOLOGIA, V130, P337, DOI 10.1007/s004420100813; Ortiz RM, 2001, J EXP BIOL, V204, P1831; Polischuk SC, 2001, CAN J ZOOL, V79, P499, DOI 10.1139/cjz-79-3-499; ROBBINS CT, 1974, J ANIM SCI, V38, P186, DOI 10.2527/jas1974.381186x; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Saltz D, 1995, WILDLIFE SOC B, V23, P694; Schell D.M., 1989, Ecological Studies, V68, P260; Schell DM, 2000, LIMNOL OCEANOGR, V45, P459, DOI 10.4319/lo.2000.45.2.0459; SCHELL DM, 1989, MAR BIOL, V103, P433, DOI 10.1007/BF00399575; Schmidt K, 2010, ADV MAR BIOL, V57, P127, DOI 10.1016/S0065-2881(10)57005-6; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; Sick H, 1997, Z ERNAHRUNGSWISS, V36, P340, DOI 10.1007/BF01617819; Sonanez-Organis JG, 2012, J EXP BIOL, V215, P1448, DOI 10.1242/jeb.067173; Summers Erin L., 2006, Journal of Cetacean Research and Management, V8, P241; TELFER N, 1970, J AM VET MED ASSOC, V157, P555; YOUNG VR, 1971, SCI AM, V225, P14, DOI 10.1038/scientificamerican1071-14	73	45	47	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92288	10.1371/journal.pone.0092288	http://dx.doi.org/10.1371/journal.pone.0092288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651388	Green Published, gold			2022-12-25	WOS:000333352800095
J	Cui, J; Wang, HD; Liu, SK; Zhu, LF; Qiu, XM; Jiang, ZQ; Wang, XL; Liu, ZJ				Cui, Jun; Wang, Hongdi; Liu, Shikai; Zhu, Lifu; Qiu, Xuemei; Jiang, Zhiqiang; Wang, Xiuli; Liu, Zhanjiang			SNP Discovery from Transcriptome of the Swimbladder of Takifugu rubripes	PLOS ONE			English	Article							EMBRYONIC LUNG GROWTH; RNA-SEQ ANALYSIS; SONIC HEDGEHOG; GENE POLYMORPHISMS; READ ALIGNMENT; BETA-CATENIN; LINKAGE MAP; EXPRESSION; CATFISH; GENOME	Single nucleotide polymorphisms (SNPs) have become the marker of choice for genome-wide association studies in many species. High-throughput sequencing of RNA was developed primarily to analyze global gene expression, while it is an efficient way to discover SNPs from the expressed genes. In this study, we conducted transcriptome sequencing of the swimbladder of Takifugu rubripes using Illumina HiSeq2000 platform to identify gene-associated SNPs in the swimbladder. A total of 30,312,181 unique-mapped-reads were obtained from 44,736,850 raw reads. A total of 62,270 putative SNPs were discovered, which were located in 11,306 expressed genes and 2,246 scaffolds. The average minor allele frequency (MAF) of the SNPs was 0.26. GO and KEGG pathway analysis were conducted to analyze the genes containing SNPs. Validation of selected SNPs revealed that 54% of SNPs (26/48) were true SNPs. The results suggest that RNA-Seq is an efficient and cost-effective approach to discover gene-associated SNPs. In this study, a large number of SNPs were identified and these data will be useful resources for population genetic study, evolution analysis, resource assessment, genetic linkage analysis and genome-wide association studies.	[Cui, Jun; Wang, Hongdi; Qiu, Xuemei; Jiang, Zhiqiang; Wang, Xiuli] Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Fish Mol Genet & Biotechnol Lab, Aquat Genom Unit, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Program Cell & Mol Biosci, Auburn, AL 36849 USA; [Zhu, Lifu] Dalian Jiaotong Univ, Sch Environm & Chem Engn, Dalian, Peoples R China	Dalian Ocean University; Ministry of Agriculture & Rural Affairs; Auburn University System; Auburn University; Auburn University System; Auburn University; Dalian Jiaotong University	Jiang, ZQ (corresponding author), Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China.	zhqjiang@dlou.edu.cn; xiuliwang417@sina.com; LIUZHAN@auburn.edu	Liu, Zhanjiang/R-9633-2019; Liu, Shikai/AAO-2247-2021; Cui, Jun/P-9378-2015	Liu, Shikai/0000-0001-5777-489X; 	Program for Liaoning Excellent Talents in University [LR201010]; Dalian Ocean University [2012HYDX07]	Program for Liaoning Excellent Talents in University; Dalian Ocean University	This project was supported by the Program for Liaoning Excellent Talents in University (LR201010) and the grant of Dalian Ocean University (2012HYDX07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; Bekker V, 2010, J VIRAL HEPATITIS, V17, P192, DOI 10.1111/j.1365-2893.2009.01166.x; Bellusci S, 1997, DEVELOPMENT, V124, P53; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Cui P, 2010, GENOMICS, V96, P259, DOI 10.1016/j.ygeno.2010.07.010; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Gu Jing-jing, 2010, Fisheries Science (Liaoning), V29, P527; Hao Jun, 2007, Dalian Shuichan Xueyuan Xuebao, V22, P97; Hao Jun, 2006, Shanghai Shuichan Daxue Xuebao, V15, P21; Hirata H, 2009, CANCER-AM CANCER SOC, V115, P4488, DOI 10.1002/cncr.24491; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kai W, 2011, GENOME BIOL EVOL, V3, P424, DOI 10.1093/gbe/evr041; Kim IC, 2011, J NUTR BIOCHEM, V22, P252, DOI 10.1016/j.jnutbio.2010.02.002; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lako M, 1998, GENE, V219, P101, DOI 10.1016/S0378-1119(98)00393-X; Lewis KE, 1999, DEV BIOL, V208, P14, DOI 10.1006/dbio.1998.9169; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu SK, 2013, PHYSIOL GENOMICS, V45, P462, DOI 10.1152/physiolgenomics.00026.2013; Liu SK, 2013, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-595; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Loh YH, 2004, GENOME RES, V14, P1248, DOI 10.1101/gr.2400004; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Moen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-223; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Perry SF, 2004, RESP PHYSIOL NEUROBI, V144, P125, DOI 10.1016/j.resp.2004.06.018; Perry SF, 2011, COMP BIOCH PHYSL A, V129, P37; Quilang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-157; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Ross-Hansen K, 2013, BRIT J DERMATOL, V168, P762, DOI 10.1111/bjd.12126; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Shin H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-30; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Shu WG, 2002, DEVELOPMENT, V129, P4831; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Wang BB, 2012, J ANDROL, V33, P951, DOI 10.2164/jandrol.110.012849; Wang FS, 2003, AM J RESP CELL MOL, V29, P62, DOI 10.1165/rcmb.2002-0180OC; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Winata CL, 2009, DEV BIOL, V331, P222, DOI 10.1016/j.ydbio.2009.04.035; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059703; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Yang AF, 2012, J GENET, V91, pE49; Yin A, 2012, BBA-MOL CELL RES, V1823, P236, DOI 10.1016/j.bbamcr.2011.09.018; Yin A, 2010, GENE EXPR PATTERNS, V10, P338, DOI 10.1016/j.gep.2010.07.005; Zabek T, 2013, HEREDITAS, V150, P38, DOI 10.1111/j.1601-5223.2013.02282.x; [张丽 Zhang Li], 2012, [生物技术通报, Biotechnology Bulletin], P97; Zhao XX, 2012, MAR BIOTECHNOL, V14, P730, DOI 10.1007/s10126-012-9438-3; Zheng WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024019; Zheng Xian-Hu, 2011, Yichuan, V33, P1366, DOI 10.3724/SP.J.1005.2011.01366	66	20	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92502	10.1371/journal.pone.0092502	http://dx.doi.org/10.1371/journal.pone.0092502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651578	gold, Green Published, Green Submitted			2022-12-25	WOS:000333352800121
J	Lacotte, S; Oldani, G; Slits, F; Orci, LA; Rubbia-Brandt, L; Morel, P; Mentha, G; Toso, C				Lacotte, Stephanie; Oldani, Graziano; Slits, Florence; Orci, Lorenzo A.; Rubbia-Brandt, Laura; Morel, Philippe; Mentha, Gilles; Toso, Christian			Alloimmune Activation Promotes Anti-Cancer Cytotoxicity after Rat Liver Transplantation	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HEPATOCELLULAR-CARCINOMA; NK-CELLS; DENDRITIC CELLS; RISK-FACTORS; RECURRENCE; EXPRESSION; ALLOGRAFTS; MONOCYTES; INNATE	Liver transplantation for hepatocellular carcinoma (HCC) results in a specific condition where the immune response is potentially directed against both allogeneic and cancer antigens. We have investigated the level of anti-cancer immunity during allogeneic immune response. Dark Agouti-to-Lewis and Lewis-to-Lewis rat liver transplantations were performed and the recipients anti-cancer immunity was analysed at the time of alloimmune activation. The occurrence of rejection in the allogeneic recipients was confirmed by a shorter survival (p<0.01), increased liver function tests (p<0.01), the presence of signs of rejection on histology, and a donor-specific ex vivo mixed lymphocyte reaction. At the time of alloimmune activation, blood mononuclear cells of the allogeneic group demonstrated increased anti-cancer cytotoxicity (p<0.005), which was related to an increased natural killer (NK) cell frequency (p<0.05) and a higher monocyte/macrophage activation level (p<0.01). Similarly, liver NK cell anti-cancer cytotoxicity (p<0.005), and liver monocyte/macrophage activation levels (p<0.01) were also increased. The alloimmune-associated cytotoxicity was mediated through the NKG2D receptor, whose expression was increased in the rejected graft (p<0.05) and on NK cells and monocyte/macrophages. NKG2D ligands were expressed on rat HCC cells, and its inhibition prevented the alloimmune-associated cytotoxicity. Although waiting for in vivo validation, alloimmune-associated cytotoxicity after rat liver transplantation appears to be linked to increased frequencies and levels of activation of NK cells and monocyte/macrophages, and is at least in part mediated through the NKG2D receptor.	[Lacotte, Stephanie; Oldani, Graziano; Slits, Florence; Orci, Lorenzo A.; Morel, Philippe; Mentha, Gilles; Toso, Christian] Univ Geneva, Univ Hosp Geneva, Dept Surg, Geneva, Switzerland; [Rubbia-Brandt, Laura] Univ Geneva, Univ Hosp Geneva, Hepatopancreatobiliary Ctr, Geneva, Switzerland; [Rubbia-Brandt, Laura; Mentha, Gilles; Toso, Christian] Univ Geneva, Univ Hosp Geneva, Dept Pathol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Lacotte, S (corresponding author), Univ Geneva, Univ Hosp Geneva, Dept Surg, Geneva, Switzerland.	stephanie.lacotte@unige.ch; christian.toso@hcuge.ch	Stéphanie, LACOTTE/I-1693-2019	Stéphanie, LACOTTE/0000-0002-5921-6389	Swiss National Science Foundation [PP00P3_139021]; Arteres Foundation; Astellas European Foundation; Boninchi Foundation; Elsie and Carlos de Reuter; Marie-France and Francis Minkoff Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Arteres Foundation; Astellas European Foundation(Astellas Pharmaceuticals); Boninchi Foundation; Elsie and Carlos de Reuter; Marie-France and Francis Minkoff Foundation	This study was supported by grants from the Swiss National Science Foundation (PP00P3_139021), the Arteres Foundation, the Astellas European Foundation, and the Boninchi Foundation, the Elsie and Carlos de Reuter, and the Marie-France and Francis Minkoff Foundation. Christian Toso was supported by a Professorship from the Swiss National Science Foundation (PP00P3_139021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chanvillard C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00063; Chen GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033626; Cheng JW, 2011, J CANCER RES CLIN, V137, P1445, DOI 10.1007/s00432-011-1014-0; Decaens T, 2006, WORLD J GASTROENTERO, V12, P7319, DOI 10.3748/wjg.v12.i45.7319; Demetris AJ, 1997, HEPATOLOGY, V25, P658; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; Eissens DN, 2010, AM J TRANSPLANT, V10, P1981, DOI 10.1111/j.1600-6143.2010.03242.x; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Hama N, 2009, LIVER TRANSPLANT, V15, P509, DOI 10.1002/lt.21708; Ishiyama K, 2006, HEPATOLOGY, V43, P362, DOI 10.1002/hep.21035; Ishiyama K, 2011, TRANSPLANTATION, V91, P952, DOI 10.1097/TP.0b013e3182139dc1; Jose MD, 2003, TRANSPLANTATION, V76, P1015, DOI 10.1097/01.TP.0000083507.67995.13; Kamimura H, 2012, J HEPATOL, V56, P381, DOI 10.1016/j.jhep.2011.06.017; Kohga K, 2008, CANCER SCI, V99, P1643, DOI 10.1111/j.1349-7006.2008.00859.x; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Kveberg L, 2010, J LEUKOCYTE BIOL, V88, P87, DOI 10.1189/jlb.0110039; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; McGilvray RW, 2009, CLIN CANCER RES, V15, P6993, DOI 10.1158/1078-0432.CCR-09-0991; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; NOVICKI DL, 1983, IN VITRO CELL DEV B, V19, P191; Obara H, 2005, AM J TRANSPLANT, V5, P2094, DOI 10.1111/j.1600-6143.2005.00995.x; Oertel M, 2001, TRANSPLANTATION, V72, P116, DOI 10.1097/00007890-200107150-00023; Oldani G, 2012, JOVE-J VIS EXP, DOI 10.3791/4143; Poggi A, 1997, EUR J IMMUNOL, V27, P2965, DOI 10.1002/eji.1830271132; Pozo D, 2006, J IMMUNOL, V176, P2397, DOI 10.4049/jimmunol.176.4.2397; Rolstad B, 1997, IMMUNOL REV, V155, P91, DOI 10.1111/j.1600-065X.1997.tb00942.x; Sageshima J, 2011, TRANSPL IMMUNOL, V25, P104, DOI 10.1016/j.trim.2011.07.002; Sharma R, 2014, IMMUNOL RES, V58, P125, DOI 10.1007/s12026-013-8477-9; Sorrentino C, 2006, J PATHOL, V209, P400, DOI 10.1002/path.1980; Sposito C, 2013, J HEPATOL, V59, P59, DOI 10.1016/j.jhep.2013.02.026; Srivastava RM, 2008, J IMMUNOL, V180, P1117, DOI 10.4049/jimmunol.180.2.1117; Toso C, 2011, AM J TRANSPLANT, V11, P2031, DOI 10.1111/j.1600-6143.2011.03689.x; Toso C, 2009, TRANSPL INT, V22, P182, DOI 10.1111/j.1432-2277.2008.00746.x; Vivarelli M, 2005, LIVER TRANSPLANT, V11, P497, DOI 10.1002/lt.20391; Vivarelli M, 2008, ANN SURG, V248, P857, DOI 10.1097/SLA.0b013e3181896278; Werner JM, 2011, TRANSPL IMMUNOL, V25, P27, DOI 10.1016/j.trim.2011.05.006; Zerbini A, 2010, GASTROENTEROLOGY, V138, P1931, DOI 10.1053/j.gastro.2009.12.051; Zhou ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036928; Zhuo M, 2010, EUR J IMMUNOL, V40, P1748, DOI 10.1002/eji.200939779; ZIMMERMANN FA, 1984, TRANSPLANTATION, V37, P406, DOI 10.1097/00007890-198404000-00019	41	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91515	10.1371/journal.pone.0091515	http://dx.doi.org/10.1371/journal.pone.0091515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651497	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800041
J	Lee, MF; Yang, KJ; Wang, NM; Chiu, YT; Chen, PC; Chen, YH				Lee, Mey-Fann; Yang, Kai-Jei; Wang, Nancy M.; Chiu, Yung-Tsung; Chen, Pei-Chih; Chen, Yi-Hsing			The Development of a Murine Model for Forcipomyia taiwana (Biting Midge) Allergy	PLOS ONE			English	Article							ITCH-ASSOCIATED RESPONSE; MOUSE MODEL; MOSQUITO ALLERGY; IMMUNE-RESPONSES; ANIMAL-MODELS; SAND FLIES; MICE; ALLERGENICITY; BITES; IGE	Background: Forcipomyia taiwana (biting midge) allergy is the most prevalent biting insect allergy in Taiwan. An animal model corresponding to the human immuno-pathologic features of midge allergy is needed for investigating the mechanisms and therapies. This study successfully developed a murine model of Forcipomyia taiwana allergy. Methods: BALB/c mice were sensitized intra-peritoneally with midge extract on days 0, 7, 14, 21 then intra-dermally on days 28, 31 and 35. Serum midge-specific IgE, IgG1, and IgG2a were measured every 14 days by indirect ELISA. The mice were challenged intradermally with midge extract at day 40 and then sacrificed. Proliferation and cytokine production of splenocytes after stimulation with midge extract were determined by MTT assay and ELISA, respectively. The cytokine mRNA expression in response to midge stimulation was analyzed by RT-PCR. Results: Serum IgE, total IgG, and IgG1 antibody levels against midge extract were significantly higher in the midge-sensitized mice than in the control mice. After the two-step sensitization, all mice in the midge-sensitized group displayed immediate itch and plasma extravasation reactions in response to challenge with midge extract. Skin histology from midge-sensitized mice showed marked eosinophil and lymphocyte infiltrations similar to that observed in humans. Stimulation of murine splenocytes with midge extract elicited significant proliferation, IL-4, IL-10, IL-13 and IFN-gamma protein production, and up-regulation of mRNA in a dose-dependent manner in the midge-sensitized group, but not in the control group. Conclusions: A murine model of midge bite allergy has been successfully developed using a two-step sensitization protocol. The sensitized mice have very similar clinical and immunologic reactions to challenge with midge proteins as the reactions of human to midge bites. This murine model may be a useful platform for future research and the development of treatment strategies for insect bite allergy.	[Lee, Mey-Fann; Chiu, Yung-Tsung] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Lee, Mey-Fann; Chen, Yi-Hsing] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Yang, Kai-Jei; Wang, Nancy M.] Natl Changhua Univ Educ, Inst Biotechnol, Changhua, Taiwan; [Chen, Pei-Chih; Chen, Yi-Hsing] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Yi-Hsing] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan	Taichung Veterans General Hospital; Tunghai University; National Changhua University of Education; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, YH (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	ysanne@vghtc.gov.tw			Taiwan National Science Council [NSC-98-2314-B-075A-008-MY3]; Taichung Veterans General Hospital [TCVGH-1023804C]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital	This study was supported by grants NSC-98-2314-B-075A-008-MY3 from the Taiwan National Science Council (www.nsc.gov.tw) and TCVGH-1023804C from Taichung Veterans General Hospital (www.vghtc.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldemir H, 2009, REGUL TOXICOL PHARM, V54, pS52, DOI 10.1016/j.yrtph.2008.11.004; Andoh T, 2010, J PHARMACOL SCI, V114, P292, DOI 10.1254/jphs.10180FP; Aslan H, 2013, J INFECT DIS, V207, P1328, DOI 10.1093/infdis/jis932; CHEN C-S, 1981, Chinese Journal of Microbiology and Immunology (Taipei), V14, P54; Chen YH, 2005, ALLERGY, V60, P1518, DOI 10.1111/j.1398-9995.2005.00918.x; Chen YH, 2009, INT ARCH ALLERGY IMM, V150, P66, DOI 10.1159/000210382; Chen YL, 1998, INT ARCH ALLERGY IMM, V116, P269, DOI 10.1159/000023955; Chuang YY, 2000, J MED ENTOMOL, V37, P205, DOI 10.1603/0022-2585-37.2.205; Dearman RJ, 2009, CLIN EXP ALLERGY, V39, P458, DOI 10.1111/j.1365-2222.2008.03194.x; Dearman RJ, 2007, METHODS, V41, P91, DOI 10.1016/j.ymeth.2006.07.008; Depinay N, 2006, J IMMUNOL, V176, P4141, DOI 10.4049/jimmunol.176.7.4141; Diesner SC, 2008, IMMUNOL LETT, V121, P45, DOI 10.1016/j.imlet.2008.08.006; Elberink JNGO, 2003, CURR OPIN ALLERGY CL, V3, P287, DOI [10.1097/00130832-200308000-00009, 10.1097/01.all.0000083957.99396.b7]; Fischer R, 2005, AM J PATHOL, V167, P1621, DOI 10.1016/S0002-9440(10)61246-1; Gotoh Y, 2011, J PHARMACOL SCI, V115, P417, DOI 10.1254/jphs.10305SC; Hardy CL, 2003, AM J RESP CRIT CARE, V167, P1393, DOI 10.1164/rccm.200209-1002OC; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Kuraishi Y, 2007, J PHARMACOL SCI, V105, P41, DOI 10.1254/jphs.FP0070404; Lehrer SB, 2009, REGUL TOXICOL PHARM, V54, pS46, DOI 10.1016/j.yrtph.2009.01.001; Nakano T, 2008, ACTA DERM-VENEREOL, V88, P449, DOI 10.2340/00015555-0479; Nakano T, 2008, NEUROREPORT, V19, P723, DOI 10.1097/WNR.0b013e3282fdf6c5; Ohtsuka E, 2003, J PHARMACOL SCI, V91, P263, DOI 10.1254/jphs.91.263; Parvataneni S, 2009, INT ARCH ALLERGY IMM, V149, P299, DOI 10.1159/000205575; Pauluhn M, 2005, EXP TOXICOL PATHOL, V56, P203, DOI 10.1016/j.etp.2004.10.002; Rupa P, 2008, INT ARCH ALLERGY IMM, V146, P11, DOI 10.1159/000112498; Van Gramberg JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051386; Wang HS, 1999, INT ARCH ALLERGY IMM, V120, P135, DOI 10.1159/000024231; Winkler B, 2003, IMMUNOLOGY, V110, P376, DOI 10.1046/j.1365-2567.2003.01751.x; Yeh CC, 1996, J MED ENTOMOL, V33, P445, DOI 10.1093/jmedent/33.3.445	30	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91871	10.1371/journal.pone.0091871	http://dx.doi.org/10.1371/journal.pone.0091871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651257	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800053
J	Sanders, SS; Mui, KKN; Sutton, LM; Hayden, MR				Sanders, Shaun S.; Mui, Katherine K. N.; Sutton, Liza M.; Hayden, Michael R.			Identification of Binding Sites in Huntingtin for the Huntingtin Interacting Proteins HIP14 and HIP14L	PLOS ONE			English	Article							PALMITOYLATION; TRAFFICKING; DOMAIN; LOCALIZATION; FEATURES; DISEASE	Huntington disease is an adult onset neurodegenerative disease characterized by motor, cognitive, and psychiatric dysfunction, caused by a CAG expansion in the HTT gene. Huntingtin Interacting Protein 14 (HIP14) and Huntingtin Interacting Protein 14-like (HIP14L) are palmitoyl acyltransferases (PATs), enzymes that mediate the post-translational addition of long chain fatty acids to proteins in a process called palmitoylation. HIP14 and HIP14L interact with and palmitoylate HTT and are unique among PATs as they are the only two that have an ankyrin repeat domain, which mediates the interaction between HIP14 and HTT. These enzymes show reduced interaction with and palmitoylation of mutant HTT, leading to increased mutant HTT inclusion formation and toxicity. The interaction between HIP14 and HTT goes beyond that of only an enzyme-substrate interaction as HTT is essential for the full enzymatic activity of HIP14. It is important to further understand and characterize the interactions of HTT with HIP14 and HIP14L to guide future efforts to target and enhance this interaction and increase enzyme activity to remediate palmitoylation of HTT and their substrates, as well as to understand the relationship between the three proteins. HIP14 and HIP14L have been previously shown to interact with HTT amino acids 1-548. Here the interaction of HIP14 and HIP14L with N- and C-terminal HTT 1-548 deletion mutations was assessed. We show that HTT amino acids 1-548 were sufficient for full interaction of HTT with HIP14 and HIP14L, but partial interaction was also possible with HTT 1-427 and HTT 224-548. To further characterize the binding domain we assessed the interaction of HIP14-GFP and HIP14L-GFP with 15Q HTT 1-548D257-315. Both enzymes showed reduced but not abolished interaction with 15Q HTT 1-548D257-315. This suggests that two potential binding domains exist, one around residues 224 and the other around 427, for the PAT enzymes HIP14 and HIP14L.	[Hayden, Michael R.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Child & Family Research Institute; University of British Columbia	Hayden, MR (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419	CHDI Foundation, Inc.; Canadian Institutes for Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); Ripples of Hope Pfizer Trainee Award in Rare Diseases	CHDI Foundation, Inc.; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Ripples of Hope Pfizer Trainee Award in Rare Diseases	This work was supported by the CHDI Foundation, Inc. (chdifoundation.org operating grant to MRH). SSS is funded by the Canadian Institutes for Health Research (CIHR; www.cihr-irsc.gc.ca; Doctoral Research Award) and the Michael Smith Foundation for Health Research (MSFHR; www.msfhr.org; Junior Graduate Scholarship). LMS was funded by the Ripples of Hope Pfizer 2011 Trainee Award in Rare Diseases (http://www.cmmt.ubc.ca/getinvolved/trainees/funding/Ripples-of-Hope). MRH is a University Killam Professor and the Canada Research Chair in Human Genetics and Molecular Medicine. The funders had no role in study design and analysis, decision to publish or preparation of the manuscript.	Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Gao TY, 2009, PROTEINS, V76, P772, DOI 10.1002/prot.22452; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; HALLAK H, 1994, J BIOL CHEM, V269, P4713; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Li W, 2006, J BIOL CHEM, V281, P15916, DOI 10.1074/jbc.M511007200; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Palidwor GA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000304; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Singaraja RR, 2011, HUM MOL GENET, V20, P3899, DOI 10.1093/hmg/ddr308; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sturrock A, 2010, J GERIATR PSYCH NEUR, V23, P243, DOI 10.1177/0891988710383573; Sutton LM, 2013, HUM MOL GENET, V22, P452, DOI 10.1093/hmg/dds441; Takano H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-15; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002	22	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90669	10.1371/journal.pone.0090669	http://dx.doi.org/10.1371/journal.pone.0090669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24651384	Green Published, gold, Green Submitted			2022-12-25	WOS:000332396200242
J	Dodd, K; Nance, S; Quezada, M; Janke, L; Morrison, JB; Williams, RT; Beere, HM				Dodd, K.; Nance, S.; Quezada, M.; Janke, L.; Morrison, J. B.; Williams, R. T.; Beere, H. M.			Tumor-derived inducible heat-shock protein 70 (HSP70) is an essential component of anti-tumor immunity	ONCOGENE			English	Article							HEAT-SHOCK PROTEINS; ANTIGEN; CELLS; PEPTIDES; TOLERANCE; FACTOR-1; INNATE; ROLES	The anti-apoptotic function and tumor-associated expression of heat-shock protein 70 (HSP70) is consistent with HSP70 functioning as a survival factor to promote tumorigenesis. However, its immunomodulatory activities to induce anti-tumor immunity predict the suppression of tumor growth. Using the Hsp70.1/3(-/-) (Hsp70(-/-)) mouse model, we observed that tumor-derived HSP70 was neither required for cellular transformation nor for in vivo tumor growth. Hsp70(-/-) murine embryonic fibroblasts (MEFs) were transformed by E1A/Ras and generated tumors in immunodeficient hosts as efficiently as wild-type (WT) transformants. Comparison of Bcr-Abl-mediated transformation of WT and Hsp70(-/-) bone marrow and progression of B-cell leukemogenesis in vivo revealed no differences in disease onset or survival rates, and E mu-Myc-driven lymphoma in Hsp70(-/-) mice was phenotypically indistinguishable from that in WT E mu-Myc mice. However, Hsp70(-/-)E1A/Ras MEFs generated significantly larger tumors than their WT counterparts in C57BL/6 J immune-competent hosts. Concurrent with this was a reduction in intra-tumoral infiltration of innate and adaptive immune cells, including macrophages and CD8(+) T cells. Evaluation of several potential mechanisms revealed an HSP70-chemokine-like activity to promote cellular migration. These observations support a role for tumor-derived HSP70 in facilitating anti-tumor immunity to limit tumor growth and highlight the potential consequences of anti-HSP70 therapy as an efficacious anti-cancer strategy.	[Dodd, K.; Nance, S.; Quezada, M.; Beere, H. M.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Janke, L.] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA; [Morrison, J. B.; Williams, R. T.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Williams, R. T.] PUMA Biotechnol, Los Angeles, CA USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Beere, HM (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	helen.beere@stjude.org	Janke, Laura/N-8121-2018	Janke, Laura/0000-0002-9871-6239	core funding; Cancer Center Supporting Grant (CCSG) developmental funds [5P30CA021765-29]; American Lebanese-Syrian Associated Charities of St Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	core funding; Cancer Center Supporting Grant (CCSG) developmental funds; American Lebanese-Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Douglas Green for discussion during the preparation of this manuscript and Eleanora Puetz and Alex Yu for genotyping. Special thanks to the husbandry staff of the Animal Resource Center and to the Animal Imaging Center, including Christopher Calabrese, Melissa Johnson and Monique Payton. We are grateful to the flow cytometry facility for their assistance in FACS and flow analysis. This work was funded in part by core funding and Cancer Center Supporting Grant (CCSG) developmental funds (5P30CA021765-29) (to HMB) and the American Lebanese-Syrian Associated Charities of St Jude Children's Research Hospital.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Binder RJ, 2005, NAT IMMUNOL, V6, P593, DOI 10.1038/ni1201; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Borges TJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00095; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Chen TY, 2009, J IMMUNOL, V182, P1449, DOI 10.4049/jimmunol.182.3.1449; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Effendi K, 2010, ONCOLOGY-BASEL, V78, P157, DOI 10.1159/000312658; Elsner L, 2007, J IMMUNOL, V179, P5523, DOI 10.4049/jimmunol.179.8.5523; Gross C, 2003, BIOL CHEM, V384, P267, DOI 10.1515/BC.2003.030; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Kottke T, 2009, CANCER RES, V69, P7767, DOI 10.1158/0008-5472.CAN-09-1597; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li ZH, 2002, CURR OPIN IMMUNOL, V14, P45, DOI 10.1016/S0952-7915(01)00297-7; Malusecka E, 2008, ANTICANCER RES, V28, P501; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Mignot G, 2011, AM J PATHOL, V178, P1403, DOI 10.1016/j.ajpath.2010.11.078; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Multhoff G, INT J HYPERTHERMIA, V18, P576; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Stocki P, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/617213; Stocki P, 2012, J BIOL CHEM, V287, P12387, DOI 10.1074/jbc.M111.307579; Torronteguy C, 2006, CELL STRESS CHAPERON, V11, P34, DOI 10.1379/CSC-159R.1; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; van Eden W, 2012, CELL STRESS CHAPERON, V17, P281, DOI 10.1007/s12192-011-0311-5; van Herwijnen MJC, 2012, P NATL ACAD SCI USA, V109, P14134, DOI 10.1073/pnas.1206803109; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Wachstein J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051747; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Zietara N, 2009, J IMMUNOL, V183, P1099, DOI 10.4049/jimmunol.0803214	39	15	15	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2015	34	10					1312	1322		10.1038/onc.2014.63	http://dx.doi.org/10.1038/onc.2014.63			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC9JX	24662819	Green Accepted			2022-12-25	WOS:000350687100011
J	Fioretti, JM; Bello, G; Rocha, MS; Victoria, M; Leite, JPG; Miagostovich, MP				Fioretti, Julia Monassa; Bello, Gonzalo; Rocha, Monica Simoes; Victoria, Matias; Gagliardi Leite, Jose Paulo; Miagostovich, Marize Pereira			Temporal Dynamics of Norovirus GII.4 Variants in Brazil between 2004 and 2012	PLOS ONE			English	Article							NORWALK-LIKE VIRUSES; RIO-DE-JANEIRO; ACUTE GASTROENTERITIS; MOLECULAR EPIDEMIOLOGY; MAXIMUM-LIKELIHOOD; EPOCHAL EVOLUTION; UNITED-STATES; GENOGROUP-I; OUTBREAKS; IDENTIFICATION	Noroviruses (NoVs) are the major cause of acute gastroenteritis outbreaks, and, despite a wide genetic diversity, genotype II.4 is the most prevalent strain worldwide. Mutations and homologous recombination have been proposed as mechanisms driving the epochal evolution of the GII.4, with the emergence of new variants in 1-3-year intervals causing global epidemics. There are no data reporting the dynamics of GII.4 variants along a specific period in Brazil. Therefore, to improve the understanding of the comportment of these variants in the country, the aim of this study was to evaluate the circulation of NoV GII.4 variants during a 9-year period in 3 out of 5 Brazilian regions. A total of 147 samples were sequenced, and a phylogenetic analysis of subdomain P2 demonstrated the circulation of six GII.4 variants, Asia_2003, Hunter_2004, Den Haag_2006b, Yerseke_2006a, New Orleans_2009, and Sydney_2012, during this period. The most prevalent variant was Den Haag_2006b, circulating in different Brazilian regions from 2006 to 2011. A Bayesian coalescent analysis was used to calculate the mean evolutionary rate of subdomain P2 as 7.3x10(-3) (5.85x10(-3) -8.82x10(-3)) subst./site/year. These analyses also demonstrated that clade Den Haag_2006b experienced a rapid expansion in 2005 and another in 2008 after a period of decay. The evaluation of the temporal dynamics of NoV GII.4 in Brazil revealed a similar pattern, with few exceptions, to the worldwide observation. These data highlight the importance of surveillance for monitoring the emergence of new strains of NoV GII.4 and its impact on cases of acute gastroenteritis.	[Fioretti, Julia Monassa; Rocha, Monica Simoes; Gagliardi Leite, Jose Paulo; Miagostovich, Marize Pereira] Inst Oswaldo Cruz Fiocruz, Lab Virol Comparada & Ambiental, Rio De Janeiro, Brazil; [Bello, Gonzalo] Inst Oswaldo Cruz Fiocruz, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil; [Victoria, Matias] Univ La Republ, Lab Virol Mol Reg Norte, Ciudad De Salto, Uruguay	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidad de la Republica, Uruguay	Fioretti, JM (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Virol Comparada & Ambiental, Rio De Janeiro, Brazil.	juliafior@ioc.fiocruz.br	Bello, Gonzalo/E-6842-2013; Bentancor, Gonzalo Jose Bello/N-7377-2019; Victoria, Matias/ABE-1729-2020; LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; 	Excellence Program of Research (PROEP-CNPq/IOC); General Coordination of Laboratories/Secretary of Health Surveillance, Ministry of Health	Excellence Program of Research (PROEP-CNPq/IOC); General Coordination of Laboratories/Secretary of Health Surveillance, Ministry of Health	This work was funded by Excellence Program of Research (PROEP-CNPq/IOC) and General Coordination of Laboratories/Secretary of Health Surveillance, Ministry of Health. MP Miagostovich, JPG Leite and G Bello are CNPq fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aragao GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056608; Belliot G, 2010, J CLIN MICROBIOL, V48, P994, DOI 10.1128/JCM.01888-09; Bennett S, 2013, EUROSURVEILLANCE, V18, P20349, DOI DOI 10.1017/S0950268813000435; Beuret C, 2002, APPL ENVIRON MICROB, V68, P1925, DOI 10.1128/AEM.68.4.1925-1931.2002; Fernandez MDB, 2012, SCI TOTAL ENVIRON, V437, P262, DOI 10.1016/j.scitotenv.2012.08.033; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Borges AMT, 2006, MEM I OSWALDO CRUZ, V101, P721, DOI 10.1590/S0074-02762006000700003; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Campos GS, 2008, ARCH VIROL, V153, P1125, DOI 10.1007/s00705-008-0078-x; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P41; Chen R, 2006, P NATL ACAD SCI USA, V103, P8048, DOI 10.1073/pnas.0600421103; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; Debbink K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002921; DINGLE KE, 1995, J GEN VIROL, V76, P2349, DOI 10.1099/0022-1317-76-9-2349; Donaldson EF, 2008, IMMUNOL REV, V225, P190, DOI 10.1111/j.1600-065X.2008.00680.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; Ferreira MSR, 2010, J MED VIROL, V82, P1442, DOI 10.1002/jmv.21831; Fioretti JM, 2011, MEM I OSWALDO CRUZ, V106, P942, DOI 10.1590/S0074-02762011000800008; Galeano ME, 2013, J CLIN VIROL, V58, P378, DOI 10.1016/j.jcv.2013.07.008; Gallimore CI, 2007, ARCH VIROL, V152, P1295, DOI 10.1007/s00705-007-0954-9; Gallimore CI, 2004, BRAZ J MED BIOL RES, V37, P321, DOI 10.1590/S0100-879X2004000300005; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Barreira DMPG, 2010, J CLIN VIROL, V47, P60, DOI 10.1016/j.jcv.2009.11.012; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall AJ, 2013, EMERG INFECT DIS, V19, P1305, DOI 10.3201/eid1908.130482; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Larsson MM, 2006, J INFECT DIS, V194, P1422, DOI 10.1086/508430; Leshem E, 2013, EMERG INFECT DIS, V19, P1231, DOI 10.3201/eid1908.130458; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Meijer A, 2012, EUROSURVEILLANCE, V17, P2; Morillo SG, 2011, REV INST MED TROP SP, V53, P119, DOI 10.1590/S0036-46652011000200011; Motomura K, 2008, J VIROL, V82, P11247, DOI 10.1128/JVI.00897-08; Motomura K, 2010, J VIROL, V84, P8085, DOI 10.1128/JVI.02125-09; Noel JS, 1999, J INFECT DIS, V179, P1334, DOI 10.1086/314783; Okada M, 2006, ARCH VIROL, V151, P1635, DOI 10.1007/s00705-006-0739-6; Parker TD, 2005, J VIROL, V79, P7402, DOI 10.1128/JVI.79.12.7402-7409.2005; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Rambaut A, 2009, FIGTREE V1 3 1 TREE; Ribeiro LR, 2008, MEM I OSWALDO CRUZ, V103, P201, DOI 10.1590/S0074-02762008000200013; Ferreira MSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033754; Seto Y, 2005, MICROBIOL IMMUNOL, V49, P275, DOI 10.1111/j.1348-0421.2005.tb03718.x; Siebenga J, 2008, EUROSURVEILLANCE, P13; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Silva LD, 2013, MEM I O CRUZ, V11; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran TNH, 2013, J CLIN VIROL, V56, P185, DOI 10.1016/j.jcv.2012.11.011; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Vicentini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069348; Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Wright PJ, 1998, J MED VIROL, V55, P312, DOI 10.1002/(SICI)1096-9071(199808)55:4&lt;312::AID-JMV10&gt;3.0.CO;2-G; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	71	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92988	10.1371/journal.pone.0092988	http://dx.doi.org/10.1371/journal.pone.0092988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667283	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600120
J	Marrale, M; Albanese, NN; Cali, F; Romano, V				Marrale, Maurizio; Albanese, Nadia Ninfa; Cali, Francesco; Romano, Valentino			Assessing the Impact of Copy Number Variants on miRNA Genes in Autism by Monte Carlo Simulation	PLOS ONE			English	Article							LYMPHOBLASTOID CELL-LINES; DE-NOVO MUTATIONS; SPECTRUM DISORDERS; EXPRESSION; MICRORNAS; REVEALS; GENETICS; ETIOLOGY	Autism Spectrum Disorders (ASDs) are childhood neurodevelopmental disorders with complex genetic origins. Previous studies have investigated the role of de novo Copy Number Variants (CNVs) and microRNAs as important but distinct etiological factors in ASD. We developed a novel computational procedure to assess the potential pathogenic role of microRNA genes overlapping de novo CNVs in ASD patients. Here we show that for chromosomes # 1, 2 and 22 the actual number of miRNA loci affected by de novo CNVs in patients was found significantly higher than that estimated by Monte Carlo simulation of random CNV events. Out of 24 miRNA genes over-represented in CNVs from these three chromosomes only hsa-mir-4436b-1 and hsa-mir-4436b-2 have not been detected in CNVs from non-autistic subjects as reported in the Database of Genomic Variants. Altogether the results reported in this study represent a first step towards a full understanding of how a dysregulated expression of the 24 miRNAs genes affect neurodevelopment in autism. We also propose that the procedure used in this study can be effectively applied to CNVs/miRNA genes association data in other genomic disorders beyond autism.	[Marrale, Maurizio; Albanese, Nadia Ninfa; Romano, Valentino] Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy; [Cali, Francesco; Romano, Valentino] Assoc Oasi Maria SS IRCCS, UOC Genet Med Lab Genet Mol, Troina, Italy	University of Palermo; IRCCS Oasi Maria SS	Romano, V (corresponding author), Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy.	valentino.romano@unipa.it	Calì, Francesco/D-9178-2017; Albanese, Nadia/AAN-3634-2020; MARRALE, MAURIZIO/I-9926-2014; Scavuzzo, Cataldo/D-5048-2017	Calì, Francesco/0000-0001-8667-8223; MARRALE, MAURIZIO/0000-0002-0091-3243; Romano, Valentino/0000-0003-3238-5702; Scavuzzo, Cataldo/0000-0002-3905-4191	University of Palermo; Italian Ministry of Health	University of Palermo; Italian Ministry of Health(Ministry of Health, Italy)	The authors acknowledge funding from University of Palermo and from the Italian Ministry of Health: "Ricerca corrente 2013" entitled: "Ritardo mentale, epilessia e autismo: studio genetico, clinico e neurofisiologico". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; [Anonymous], 2012, MIRPATH VERSION 20; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baron CA, 2006, J AUTISM DEV DISORD, V36, P973, DOI 10.1007/s10803-006-0134-x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.2307/1165312; Bressler JP, 2012, PEDIATR NEUROL, V47, P337, DOI 10.1016/j.pediatrneurol.2012.06.017; Burstyn I, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-2; Buxbaum JD, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-68; Chan A.W.S., 2012, FRONT GENET, V82, P1; Correia CT, 2010, PHARMACOGENOMICS J, V10, P418, DOI 10.1038/tpj.2009.63; Coutinho AM, 2007, HUM GENET, V121, P243, DOI 10.1007/s00439-006-0301-3; Cusco I, 2009, HUM MOL GENET, V18, P1795, DOI 10.1093/hmg/ddp092; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Griswold AJ, 2012, HUM MOL GENET, V21, P3513, DOI 10.1093/hmg/dds164; Hu VW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005775; James SJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.8; Kalos M. H., 2008, MONTE CARLO METHODS; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; LaSalle JM, 2011, EPIGENETICS-US, V6, P862, DOI 10.4161/epi.6.7.16353; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Liftover, 2002, TOOL UCSC GENOME BRO; Marcinkowska M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-183; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Miller M, 2013, AUTISM RES; Miyake K, 2012, ADV EXP MED BIOL, V724, P91, DOI 10.1007/978-1-4614-0653-2_7; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Pike N, SPREADSHEET CALCULAT; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Purcell AE, 2001, J AUTISM DEV DISORD, V31, P545, DOI 10.1023/A:1013290826504; Qiao Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-544; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sarachana T, 2010, GENOME MED, V2, DOI 10.1186/gm144; Schaaf CP, 2011, NEURON, V70, P806, DOI 10.1016/j.neuron.2011.05.025; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Talebizadeh Z, 2008, AUTISM RES, V1, P240, DOI 10.1002/aur.33; Vaishnavi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056781; van den Berg A, 2008, BBA-GENE REGUL MECH, V1779, P668, DOI 10.1016/j.bbagrm.2008.07.005; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Xu B, 2010, BRAIN RES, V1338, P78, DOI 10.1016/j.brainres.2010.03.109; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	55	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e90947	10.1371/journal.pone.0090947	http://dx.doi.org/10.1371/journal.pone.0090947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667286	Green Published, gold			2022-12-25	WOS:000333675600004
J	Mishra, R; Karande, AA				Mishra, Ritu; Karande, Anjali A.			Endoplasmic Reticulum Stress-Mediated Activation of p38 MAPK, Caspase-2 and Caspase-8 Leads to Abrin-Induced Apoptosis	PLOS ONE			English	Article							RIBOSOME-INACTIVATING PROTEINS; RICIN-A-CHAIN; ER; KINASE; INDUCTION; PATHWAY; DEATH; CELLS; PURIFICATION; INVOLVEMENT	Abrin from Abrus precatorius plant is a potent protein synthesis inhibitor and induces apoptosis in cells. However, the relationship between inhibition of protein synthesis and apoptosis is not well understood. Inhibition of protein synthesis by abrin can lead to accumulation of unfolded protein in the endoplasmic reticulum causing ER stress. The observation of phosphorylation of eukaryotic initiation factor 2 alpha and upregulation of CHOP (CAAT/enhancer binding protein (C/EBP) homologous protein), important players involved in ER stress signaling by abrin, suggested activation of ER stress in the cells. ER stress is also known to induce apoptosis via stress kinases such as p38 MAPK and JNK. Activation of both the pathways was observed upon abrin treatment and found to be upstream of the activation of caspases. Moreover, abrin-induced apoptosis was found to be dependent on p38 MAPK but not JNK. We also observed that abrin induced the activation of caspase-2 and caspase-8 and triggered Bid cleavage leading to mitochondrial membrane potential loss and thus connecting the signaling events from ER stress to mitochondrial death machinery.	[Mishra, Ritu; Karande, Anjali A.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Karande, AA (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	anjali@biochem.iisc.ernet.in			Council of Scientific and Industrial Research (CSIR); Department of Biotechnology (DBT), Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	Support was provided by the Council of Scientific and Industrial Research (CSIR) and the Department of Biotechnology (DBT), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2004, J NEUROCHEM, V89, P232, DOI 10.1111/j.1471-4159.2004.02317.x; Bolognesi A, 1996, INT J CANCER, V68, P349, DOI 10.1002/(SICI)1097-0215(19961104)68:3<349::AID-IJC13>3.0.CO;2-3; Brigotti M, 2002, FASEB J, V16, DOI 10.1096/fj.01-0521com; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cheung HH, 2006, EXP CELL RES, V312, P2347, DOI 10.1016/j.yexcr.2006.03.027; ENDO Y, 1987, J BIOL CHEM, V262, P8128; FRAKER PJ, 1995, METHOD CELL BIOL, V46, P57; Gadadhar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058304; GODAL A, 1987, CANCER RES, V47, P6243; Gupta S, 2010, INT J CELL BIOL, V2010; Hartley MR, 2004, BBA-PROTEINS PROTEOM, V1701, P1, DOI 10.1016/j.bbapap.2004.06.004; He Q, 2002, ONCOGENE, V21, P2623, DOI 10.1038/sj.onc.1205345; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HEGDE R, 1991, ANAL BIOCHEM, V194, P101, DOI 10.1016/0003-2697(91)90156-N; Homma K, 2009, EXPERT OPIN THER TAR, V13, P653, DOI 10.1517/14728220902980249; Horrix C, 2011, CELL MOL LIFE SCI, V68, P1269, DOI 10.1007/s00018-010-0524-2; Jetzt AE, 2009, INT J BIOCHEM CELL B, V41, P2503, DOI 10.1016/j.biocel.2009.08.007; Jimbo A, 2003, EXP CELL RES, V283, P156, DOI 10.1016/S0014-4827(02)00033-2; Kim DS, 2010, BIOL PHARM BULL, V33, P545, DOI 10.1248/bpb.33.545; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021533; Lee SY, 2008, CELL MICROBIOL, V10, P770, DOI 10.1111/j.1462-5822.2007.01083.x; Liu N, 2006, VIROLOGY, V348, P398, DOI 10.1016/j.virol.2006.01.002; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; Narayanan S, 2005, FEBS LETT, V579, P1324, DOI 10.1016/j.febslet.2005.01.038; Nielsen K, 2001, ANNU REV PLANT PHYS, V52, P785, DOI 10.1146/annurev.arplant.52.1.785; Park HS, 2011, BIOCHEM PHARMACOL, V82, P1110, DOI 10.1016/j.bcp.2011.07.085; Penna F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045327; Peumans WJ, 2001, FASEB J, V15, P1493, DOI 10.1096/fj.00-0751rev; Roncuzzi L, 1996, FEBS LETT, V392, P16, DOI 10.1016/0014-5793(96)00776-4; Roxas-Duncan VI, 2012, BEANS BEADS RICIN AB; Saxena N, 2013, TOXICOLOGICAL SCI; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Sharma S, 1999, MOL CELL BIOCHEM, V200, P133, DOI 10.1023/A:1007043218769; Smith WE, 2003, INFECT IMMUN, V71, P1497, DOI 10.1128/IAI.71.3.1497-1504.2003; Surendranath K, 2008, CLIN VACCINE IMMUNOL, V15, P737, DOI 10.1128/CVI.00254-07; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Talukder KA, 2012, MICROB PATHOGENESIS, V52, P311, DOI 10.1016/j.micpath.2012.02.007; Tyagi A, 2006, CARCINOGENESIS, V27, P2269, DOI 10.1093/carcin/bgl098; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; WAWRZYNCZAK EJ, 1990, CANCER RES, V50, P7519; WEI CH, 1974, J BIOL CHEM, V249, P3061; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhu GY, 2011, EUR J PHARMACOL, V668, P88, DOI 10.1016/j.ejphar.2011.06.008	46	42	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92586	10.1371/journal.pone.0092586	http://dx.doi.org/10.1371/journal.pone.0092586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664279	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000333459900080
J	Park, YM; Lee, BH; Um, TH; Kim, S				Park, Young-Min; Lee, Bun-Hee; Um, Tae Hyun; Kim, Sollip			Serum BDNF Levels in Relation to Illness Severity, Suicide Attempts, and Central Serotonin Activity in Patients with Major Depressive Disorder: A Pilot Study	PLOS ONE			English	Article							AUDITORY-EVOKED-POTENTIALS; LOUDNESS DEPENDENCE; INTENSITY DEPENDENCE; NEUROTROPHIC FACTOR; ERP COMPONENTS; NORADRENERGIC ANTIDEPRESSANTS; TREATMENT RESPONSE; CLINICAL-RESPONSE; BIPOLAR DISORDER; N1/P2 COMPONENT	The aim of this study was to test the hypothesis that serum levels of brain-derived neurotrophic factor (BDNF) are correlated with the loudness dependence of auditory evoked potentials (LDAEP). The question of whether there is a difference in BDNF levels between depressive patients according to their illness severity, history of suicide attempts, and central serotonin activity was also addressed. A sample of 51 patients who met the criteria for major depressive disorder following diagnosis using axis I of the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders - text revision comprised the study subjects. The patients were stratified into two subgroups based on their illness severity, history of suicide attempts, and their LDAEP values. The LDAEP was evaluated by measuring the auditory event-related potentials, and serum BDNF was measured using blood sampling before beginning medication with serotonergic agents. There was no difference in serum BDNF levels between the two patient subgroups. The subgroup with moderate-to-severe depression (n = 16) was reanalyzed after stratifying it into two subgroups according to LDAEP and BDNF values (dichotomized at the medians into low and high). The high-LDAEP subgroup had higher serum BDNF levels and total Barratt Impulsiveness Scale score than the low-LDAEP subgroup (p = 0.03 and 0.036, respectively). Serum BDNF levels were positively correlated with LDAEP and total Beck Hopelessness Scale (BHS) score (r = 0.56, p = 0.025, and r = 0.59, p = 0.016, respectively). The high-BDNF subgroup had a higher LDAEP and total BHS score than the low-BDNF subgroup (p = 0.046 and p = 0.011, respectively). This is the first study to demonstrate a relationship between the BDNF level and LDAEP in Asian depressive patients. Intriguingly, the high-BDNF subgroup (divided according to illness severity) exhibited a more severe psychopathology on some psychometric rating scales, a finding that conflicts with previous results.	[Park, Young-Min] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Psychiat, Goyang, South Korea; [Lee, Bun-Hee] Eulji Univ, Gangnam Eulji Hosp, Dept Psychiat, Seoul, South Korea; [Um, Tae Hyun; Kim, Sollip] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Lab Med, Goyang, South Korea	Inje University; Eulji University; Inje University	Park, YM (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Psychiat, Goyang, South Korea.	medipark@hanmail.net	Kim, Sollip/AAB-5748-2022; Kim, Sollip/E-8546-2011	Kim, Sollip/0000-0003-0474-5897; Kim, Sollip/0000-0003-0474-5897	National Research Foundation of Korea (NRF); Ministry of Education and Science Technology (MEST) [2011-0010562]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education and Science Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant from the National Research Foundation of Korea (NRF), funded by the Ministry of Education and Science Technology (MEST) (no. 2011-0010562). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Blais M, 2010, CURR CLIN PSYCHIAT, P1, DOI 10.1007/978-1-59745-387-5_1; Brocke B, 2000, NEUROPSYCHOBIOLOGY, V41, P24, DOI 10.1159/000026629; Chung Y, 1997, KOREAN J CLIN PSYCHO, V16, P117; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Fitzgerald PB, 2009, J AFFECT DISORDERS, V117, P212, DOI 10.1016/j.jad.2009.01.009; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Gallinat J, 2000, PSYCHOPHARMACOLOGY, V148, P404, DOI 10.1007/s002130050070; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Gudlowski Y, 2009, SCHIZOPHR RES, V109, P141, DOI 10.1016/j.schres.2009.02.008; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HEGERL U, 1993, BIOL PSYCHIAT, V33, P173, DOI 10.1016/0006-3223(93)90137-3; Hegerl U, 2001, J AFFECT DISORDERS, V62, P93, DOI 10.1016/S0165-0327(00)00353-0; Hensch T, 2007, J AFFECT DISORDERS, V101, P13, DOI 10.1016/j.jad.2006.11.018; Jaworska N, 2013, PROG NEURO-PSYCHOPH, V44, P100, DOI 10.1016/j.pnpbp.2013.01.012; Juckel G, 2003, SCHIZOPHR RES, V64, P115, DOI 10.1016/S0920-9964(03)00016-1; Juckel G, 2008, PSYCHIAT RES, V158, P79, DOI 10.1016/j.psychres.2007.08.013; Juckel G, 2007, J CLIN PSYCHIAT, V68, P1206, DOI 10.4088/JCP.v68n0806; Juckel G, 2010, J PSYCHIATR RES, V44, P541, DOI 10.1016/j.jpsychires.2009.11.006; Kim DH, 2013, J AFFECT DISORDERS, V148, P72, DOI 10.1016/j.jad.2012.11.051; Kim YK, 2007, PROG NEURO-PSYCHOPH, V31, P78, DOI 10.1016/j.pnpbp.2006.06.024; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lang UE, 2005, NEUROPSYCHOPHARMACOL, V30, P1148, DOI 10.1038/sj.npp.1300666; Lee BH, 2007, J AFFECT DISORDERS, V101, P239, DOI 10.1016/j.jad.2006.11.005; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; Lee BH, 2009, PROG NEURO-PSYCHOPH, V33, P849, DOI 10.1016/j.pnpbp.2009.04.002; Lee KS, 2012, PSYCHIAT INVEST, V9, P298, DOI 10.4306/pi.2012.9.3.298; Linka T, 2005, PHARMACOPSYCHIATRY, V38, P139, DOI 10.1055/s-2005-864126; Linka T, 2004, NEUROSCI LETT, V367, P375, DOI 10.1016/j.neulet.2004.06.038; Linka T, 2007, J AFFECT DISORDERS, V103, P139, DOI 10.1016/j.jad.2007.01.018; Linka T, 2009, NEUROSCI LETT, V463, P26, DOI 10.1016/j.neulet.2009.07.038; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Miro X, 2002, NEUROPHARMACOLOGY, V43, P1148, DOI 10.1016/S0028-3908(02)00220-4; Mulert C, 2002, CLIN NEUROPHYSIOL, V113, P1566, DOI 10.1016/S1388-2457(02)00252-3; Mulert C, 2007, J AFFECT DISORDERS, V98, P215, DOI 10.1016/j.jad.2006.07.021; O'Neill BV, 2008, HUM PSYCHOPHARM CLIN, V23, P355, DOI 10.1002/hup.940; Papakostas GI, 2013, MOL PSYCHIATR, V18, P332, DOI 10.1038/mp.2011.166; Park G.B., 1991, KOREAN J CLIN PSYCHO, V10, P298; Park YM, 2013, PSYCHIAT INVEST, V10, P233, DOI 10.4306/pi.2013.10.3.233; Park YM, 2013, PSYCHIAT INVEST, V10, P143, DOI 10.4306/pi.2013.10.2.143; Park YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060340; Park YM, 2012, PSYCHIAT INVEST, V9, P80, DOI 10.4306/pi.2012.9.1.80; Park YM, 2011, PSYCHOPHARMACOLOGY, V213, P625, DOI 10.1007/s00213-010-2061-y; Park YM, 2010, PROG NEURO-PSYCHOPH, V34, P313, DOI 10.1016/j.pnpbp.2009.12.004; 이중서, 2005, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V44, P456; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PliegoRivero FB, 1997, BIOCHEM PHARMACOL, V54, P207, DOI 10.1016/S0006-2952(97)00073-7; Radka SF, 1996, BRAIN RES, V709, P122, DOI 10.1016/0006-8993(95)01321-0; Rothman SM, 2013, NEUROSCIENCE, V239, P228, DOI 10.1016/j.neuroscience.2012.10.014; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shin MS, 1990, KOREAN J CLIN PSYCHO, V9, P1; Strobel A, 2003, AM J MED GENET B, V118B, P41, DOI 10.1002/ajmg.b.10019; Zarate C, 2013, ANN NY ACAD SCI, V1292, P21, DOI 10.1111/nyas.12223; Zarate CA, 2013, BIOL PSYCHIAT, V73, P1142, DOI 10.1016/j.biopsych.2012.11.031	64	24	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91061	10.1371/journal.pone.0091061	http://dx.doi.org/10.1371/journal.pone.0091061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663244	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900012
J	Rudrabhatla, P; Utreras, E; Jaffe, H; Kulkarni, AB				Rudrabhatla, Parvathi; Utreras, Elias; Jaffe, Howard; Kulkarni, Ashok B.			Regulation of Sox6 by Cyclin Dependent Kinase 5 in Brain	PLOS ONE			English	Article							APOPTOTIC CELL-DEATH; PROTEIN-KINASE; OLIGODENDROCYTE DIFFERENTIATION; NERVOUS-SYSTEM; CDK5; MOUSE; GENE; EXPRESSION; SURVIVAL; P35	Cyclin dependent kinase 5 (Cdk5) is a proline-directed Ser/Thr kinase involved in various biological functions during normal brain development and neurodegeneration. In brain, Cdk5 activity is specific to post-mitotic neurons, due to neuronal specific expression of its activator p35. The biological functions of Cdk5 have been ascribed to its cytoplasmic substrates, however not much is known in nucleus. Here, we show that nuclear transcription factor Sox6 is a direct nuclear target of Cdk5. Sox6 is expressed in Tuj1 positive neurons, suggesting that Sox6 is expressed in differentiating neurons. The expression of Sox6 is high in mitotic nuclei during embryonic day 12 (E12) and gradually decreases during development into adult. On the other hand, Cdk5 expression gradually increases during its development. We show that Sox6 is expressed in mitotic nuclei in embryonic day 12 (E12) and in migrating neurons of E16. Sox6 is phosphorylated in vivo. Sox6 was detected by phospho-Ser/Thr and phospho-Ser/Thr-Pro and MPM-2 (Mitotic protein # 2) antibodies in brain. Furthermore, calf intestinal alkaline phosphatase (CIAP) digestion resulted in faster migration of Sox6 band. The GST-Sox6 was phosphorylated by Cdk5/p35. The mass spectrometry analysis revealed that Sox6 is phosphorylated at T 119 PER motif. We show that Sox6 steady state levels are regulated by Cdk5. Cdk5 knockout mice die in utero and Sox6 protein expression is remarkably high in Cdk52/2 brain, however, there is no change in mRNA expression, suggesting a post-translational regulation of Sox6 by Cdk5. Transfection of primary cortical neurons with WT Cdk5 reduced Sox6 levels, while dominant negative (DN) Cdk5 and p35 increased Sox6 levels. Thus, our results indicate that Cdk5 regulates Sox6 steady state protein level that has an important role in brain development and function.	[Rudrabhatla, Parvathi] NINDS, Neurochem Lab, NIH, Bethesda, MD 20892 USA; [Rudrabhatla, Parvathi] NINDS, Neurobiol Lab, NIH, Bethesda, MD 20892 USA; [Jaffe, Howard] NINDS, Prot Peptide Sequencing Facil, NIH, Bethesda, MD 20892 USA; [Utreras, Elias; Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Utreras, Elias] Univ Chile, Biol Dept, Fac Sci, Santiago, Chile	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Universidad de Chile	Rudrabhatla, P (corresponding author), NINDS, Neurochem Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	parvathir@ninds.nih.gov	Utreras, Elias/I-1038-2013	Utreras, Elias/0000-0002-1004-0466; Rudrabhatla, Parvathi/0000-0002-7537-3130	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000664] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ahuja HS, 1997, DEV GENET, V21, P258, DOI 10.1002/(SICI)1520-6408(1997)21:4<258::AID-DVG3>3.0.CO;2-6; Alvarez A, 1999, FEBS LETT, V459, P421, DOI 10.1016/S0014-5793(99)01279-X; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; CONNOR F, 1995, NUCLEIC ACIDS RES, V23, P3365, DOI 10.1093/nar/23.17.3365; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Dumitriu B, 2006, BLOOD, V108, P1198, DOI 10.1182/blood-2006-02-004184; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Grant P, 2001, EUR J BIOCHEM, V268, P1534, DOI 10.1046/j.1432-1033.2001.02025.x; Hagiwara N, 2000, P NATL ACAD SCI USA, V97, P4180, DOI 10.1073/pnas.97.8.4180; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Hirasawa M, 2004, P NATL ACAD SCI USA, V101, P6249, DOI 10.1073/pnas.0307322101; Ino H, 1996, BRAIN RES, V732, P179, DOI 10.1016/0006-8993(96)00523-9; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Ko J, 2001, J NEUROSCI, V21, P6758; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Ohshima T, 2001, P NATL ACAD SCI USA, V98, P2764, DOI 10.1073/pnas.051628498; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Rudrabhatla P, 2010, FASEB J, V24, P4396, DOI 10.1096/fj.10-157859; Rudrabhatla P, 2009, J NEUROSCI, V29, P14869, DOI 10.1523/JNEUROSCI.4469-09.2009; Rudrabhatla P, 2008, J BIOL CHEM, V283, P26737, DOI 10.1074/jbc.M801633200; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stone K. L., 1993, PRACTICAL GUIDE PROT, P43; TAKAMATSU N, 1995, MOL CELL BIOL, V15, P3759; Tanaka T, 2001, J NEUROSCI, V21, P550, DOI 10.1523/JNEUROSCI.21-02-00550.2001; TSAI LH, 1993, DEVELOPMENT, V119, P1029; Ueda R, 2004, ONCOGENE, V23, P1420, DOI 10.1038/sj.onc.1207252; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wu J, 2007, J PROTEOME RES, V6, P4684, DOI 10.1021/pr070481m; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105; Zhang Q, 1997, DEV BIOL, V183, P222, DOI 10.1006/dbio.1996.8494; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	41	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e89310	10.1371/journal.pone.0089310	http://dx.doi.org/10.1371/journal.pone.0089310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662752	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900003
J	Kim, KM; Choi, YJ; Hwang, JH; Kim, AR; Cho, HJ; Hwang, ES; Park, JY; Lee, SH; Hong, JH				Kim, Kyung Min; Choi, Yoon Jung; Hwang, Jun-Ha; Kim, A. Rum; Cho, Hang Jun; Hwang, Eun Sook; Park, Joong Yull; Lee, Sang-Hoon; Hong, Jeong-Ho			Shear Stress Induced by an Interstitial Level of Slow Flow Increases the Osteogenic Differentiation of Mesenchymal Stem Cells through TAZ Activation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTIONAL COACTIVATOR; BONE; YAP; MECHANOTRANSDUCTION; ADIPOGENESIS; TRANSITION; INTERACTS; ENHANCER; CULTURE	Shear stress activates cellular signaling involved in cellular proliferation, differentiation, and migration. However, the mechanisms of mesenchymal stem cell (MSC) differentiation under interstitial flow are not fully understood. Here, we show the increased osteogenic differentiation of MSCs under exposure to constant, extremely low shear stress created by osmotic pressure-induced flow in a microfluidic chip. The interstitial level of shear stress in the proposed microfluidic system stimulated nuclear localization of TAZ (transcriptional coactivator with PDZ-binding motif), a transcriptional modulator of MSCs, activated TAZ target genes such as CTGF and Cyr61, and induced osteogenic differentiation. TAZ-depleted cells showed defects in shear stress-induced osteogenic differentiation. In shear stress induced cellular signaling, Rho signaling pathway was important forthe nuclear localization of TAZ. Taken together, these results suggest that TAZ is an important mediator of interstitial flow-driven shear stress signaling in osteoblast differentiation of MSCs.	[Kim, Kyung Min; Hwang, Jun-Ha; Kim, A. Rum; Cho, Hang Jun; Hong, Jeong-Ho] Korea Univ, Div Life Sci, Seoul, South Korea; [Choi, Yoon Jung; Lee, Sang-Hoon] Korea Univ, Dept Biomed Engn, Seoul, South Korea; [Hwang, Eun Sook] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Hwang, Eun Sook] Ewha Womans Univ, Global Top5 Res Program, Seoul, South Korea; [Park, Joong Yull] Chung Ang Univ, Coll Engn, Sch Mech Engn, Seoul 156756, South Korea	Korea University; Korea University; Ewha Womans University; Ewha Womans University; Chung Ang University	Lee, SH (corresponding author), Korea Univ, Dept Biomed Engn, Seoul, South Korea.	dbiomed@korea.ac.kr; jh_hong@korea.ac.kr	Park, Joong Yull/L-4969-2018		Industrial Core Technology Development Program; Ministry of Knowledge Economy [10041913]; Korea Healthcare Technology R&D project, Ministry for Health & Welfare, Republic of Korea [A120349, A120476]; NRF; Ministry of Education, Science and Technology, Republic of Korea [2012R1A1A1015181]	Industrial Core Technology Development Program; Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Healthcare Technology R&D project, Ministry for Health & Welfare, Republic of Korea; NRF; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Industrial Core Technology Development Program funded by the Ministry of Knowledge Economy (No. 10041913) and a grant from the Korea Healthcare Technology R&D project, Ministry for Health & Welfare (A120349 & A120476), Republic of Korea. J. Y. P. is supported by the Basic Science Research Program through the NRF funded by the Ministry of Education, Science and Technology, Republic of Korea (2012R1A1A1015181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Case N, 2010, J ORTHOP RES, V28, P1531, DOI 10.1002/jor.21156; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Estes BT, 2004, CURR TOP DEV BIOL, V60, P91; Halder A, 2000, CLIN BIOMECH, V15, P456, DOI 10.1016/S0268-0033(99)00095-9; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huang Y, 2010, ARCH MED RES, V41, P497, DOI 10.1016/j.arcmed.2010.10.002; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Jeong H, 2010, FASEB J, V24, P3310, DOI 10.1096/fj.09-151324; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Park JY, 2007, LAB CHIP, V7, P1673, DOI 10.1039/b710777c; Park JY, 2009, STEM CELLS, V27, P2646, DOI 10.1002/stem.202; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Sen B, 2011, J BIOMECH, V44, P593, DOI 10.1016/j.jbiomech.2010.11.022; Shieh AC, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015012; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Tada S, 2000, AM J PHYSIOL-HEART C, V278, pH1589, DOI 10.1152/ajpheart.2000.278.5.H1589; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; van der Pol L, 1998, TRENDS BIOTECHNOL, V16, P323, DOI 10.1016/S0167-7799(98)01209-8; Vanapalli SA, 2009, BIOMICROFLUIDICS, V3, DOI 10.1063/1.3067820; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; WANG DM, 1995, J BIOMECH ENG-T ASME, V117, P358, DOI 10.1115/1.2794192; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; YEDGAR S, 1986, LIPIDS, V21, P629, DOI 10.1007/BF02537211; Yourek G, 2010, REGEN MED, V5, P713, DOI 10.2217/RME.10.60; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200	41	119	122	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92427	10.1371/journal.pone.0092427	http://dx.doi.org/10.1371/journal.pone.0092427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658423	gold, Green Published, Green Submitted			2022-12-25	WOS:000333355300081
J	Li, J; Han, YP; Xing, YP; Li, S; Kong, LH; Zhang, YX; Zhang, LL; Liu, N; Wang, Q; Wang, SX; Lu, S; Huang, ZH				Li, Jun; Han, Yaping; Xing, Yiping; Li, Shuang; Kong, Lianhua; Zhang, Yongxiang; Zhang, Lili; Liu, Ning; Wang, Qian; Wang, Shixia; Lu, Shan; Huang, Zuhu			Concurrent Measurement of Dynamic Changes in Viral Load, Serum Enzymes, T Cell Subsets, and Cytokines in Patients with Severe Fever with Thrombocytopenia Syndrome	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; BUNYAVIRUS; CHINA; STORM	Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infection caused by a novel Bunyavirus. Analysis on the dynamic changes of clinical, laboratory, and immunological abnormalities associated with SFTS in a concurrent study is lacking. Thirty-three SFTS patients were admitted to Jiangsu People's Hospital, Nanjing, China, and diagnosis was made based on the clinical symptoms and positive viral RNA detected by RT-PCR. Four patients deceased and twenty-nine survived. Blood samples were collected every other day between Day 5 and Day 15 from the onset of fever. Samples from healthy volunteers were used as normal controls. Peak viral RNA load, serum enzymes, IL-6, and IL-10 were significantly higher in deceased patients compared to survivors. Viral load, serum enzymes, and cytokines declined in survivors within 2 weeks from onset of fever. CD69+ T cells were elevated early after infection while HLA-DR+ and CTLA4+ T cells were elevated during the recovery phase of those who survived. High level SFTSV viral load was concurrently observed with reduced PLT, elevated serum enzymes, elevated pro-inflammatory and anti-inflammatory cytokines, and activation of CD69+ T cells. The degree and pattern of changes in these parameters may indicate the clinical outcome in SFTSV-infected patients.	[Li, Jun; Han, Yaping; Xing, Yiping; Li, Shuang; Kong, Lianhua; Zhang, Yongxiang; Zhang, Lili; Liu, Ning; Wang, Qian; Huang, Zuhu] Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Li, Jun; Wang, Shixia; Lu, Shan] Nanjing Med Univ, Affiliated Hosp 1, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China; [Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Lab Nucle Acid Vaccines, Worcester, MA USA	Nanjing Medical University; Nanjing Medical University; University of Massachusetts System; University of Massachusetts Worcester	Li, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China.	dr-lijun@vip.sina.com; shan.lu@umassmed.edu			Ministry of Science and Technology; Ministry of Health (China Mega-Project for Infectious Diseases Grants) [2013ZX10004905, 2013ZX10002005-002-005]; Jiangsu Province Science and Technology Support Project [BE2012770]; Jiangsu Innovation of Medical Team and Leading Talents [LJ201121]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]; National Institutes of Health National Institute of Allergy and Infectious Disease Grant [U01-AI078073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078073] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health (China Mega-Project for Infectious Diseases Grants); Jiangsu Province Science and Technology Support Project; Jiangsu Innovation of Medical Team and Leading Talents; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Institutes of Health National Institute of Allergy and Infectious Disease Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by from the Ministry of Science and Technology and the Ministry of Health (China Mega-Project for Infectious Diseases Grants: 2013ZX10004905 and 2013ZX10002005-002-005), Jiangsu Province Science and Technology Support Project (BE2012770), Jiangsu Innovation of Medical Team and Leading Talents (LJ201121), the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801), and National Institutes of Health National Institute of Allergy and Infectious Disease Grant (U01-AI078073 to S.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; CDC, 2009, INT GUID CLIN ID CAR; Deng BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080802; Deng BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041365; Haque A, 2007, EMERG INFECT DIS, V13, P1512, DOI 10.3201/eid1310.061262; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Li DX, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.1; Li SB, 2011, BIOSCI TRENDS, V5, P273, DOI 10.5582/bst.2011.v5.6.273; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Ministry of Health People's Republic of China, 2010, NAT GUID PREV CONTR; Sun L, 2013, CLIN EXP MED; Sun YL, 2012, J INFECT DIS, V206, P1085, DOI 10.1093/infdis/jis452; Sun YL, 2012, J CLIN VIROL, V53, P48, DOI 10.1016/j.jcv.2011.09.031; Weng Y, 2013, BRAZ J INFECT DIS; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang XS, 2013, SCI CHINA LIFE SCI, V56, P697, DOI 10.1007/s11427-013-4518-9; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209	19	28	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91679	10.1371/journal.pone.0091679	http://dx.doi.org/10.1371/journal.pone.0091679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658451	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300039
J	Smith, ZA; Vastardis, GA; Carandang, G; Havey, RM; Hannon, S; Dahdaleh, N; Voronov, LI; Fessler, RG; Patwardhan, AG				Smith, Zachary A.; Vastardis, Georgios A.; Carandang, Gerard; Havey, Robert M.; Hannon, Sean; Dahdaleh, Nader; Voronov, Leonard I.; Fessler, Richard G.; Patwardhan, Avinash G.			Biomechanical Effects of a Unilateral Approach to Minimally Invasive Lumbar Decompression	PLOS ONE			English	Article							SPINAL STENOSIS; INTERBODY FUSION; LAMINECTOMY; OUTCOMES; LAMINOTOMY	Minimally invasive (MI) lumbar decompression became a common approach to treat lumbar stenosis. This approach may potentially mitigate postoperative increases in segmental motion. The goal of this study was to evaluate modifications to segmental motion in the lumbar spine following a MI unilateral approach as compared to traditional facet-sparing and non-facet sparing decompressions. Six human lumbar cadaveric specimens were used. Each specimen was tested in flexion-extension 0 N and 400 N of follower preload), axial rotation, and lateral bending. Each testing condition was evaluated following three separate interventions at L4-L5: 1) Minimally invasive decompression, 2) Facet-sparing, bilateral decompression, and 3) Bilateral decompression with a wide facetectomy. Range of motion following each testing condition was compared to intact specimens. Both MI and traditional decompression procedures create significant increases in ROM in all modes of loading. However, when compared to the MI approach, traditional decompression produces significantly larger increase in ROM in flexion-extension (p<0.005) and axial rotation (p<0.05). It additionally creates increased ROM with lateral bending on the approach side (p<0.05). Lateral bending on the non-approach side is not significantly changed. Lastly, wide medial facet removal (40% to 50%) causes significant hypermobility, especially in axial rotation. While both MI and traditional lumbar decompressions may increase post-operative ROM in all conditions, a MI approach causes significantly smaller increase in ROM. With an MI approach, increased movement with lateral bending is only toward the approach side. Further, non-facet sparing decompression is further destabilizing in all loading modes.	[Smith, Zachary A.; Dahdaleh, Nader; Fessler, Richard G.] Northwestern Univ, Northwest Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA; [Vastardis, Georgios A.; Carandang, Gerard; Havey, Robert M.; Hannon, Sean; Voronov, Leonard I.; Patwardhan, Avinash G.] Loyola Univ, Stritch Sch Med, Dept Orthopaed Surg, Maywood, IL 60153 USA; [Vastardis, Georgios A.; Carandang, Gerard; Havey, Robert M.; Hannon, Sean; Voronov, Leonard I.; Patwardhan, Avinash G.] Edward Hines Jr VA Hosp, Hines, IL USA	Northwestern University; Feinberg School of Medicine; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Patwardhan, AG (corresponding author), Loyola Univ, Stritch Sch Med, Dept Orthopaed Surg, Maywood, IL 60153 USA.	apatwar@lumc.edu	Voronov, Leonard/AFU-5796-2022	Vastardis, Georgios/0000-0002-2663-9561	AANS/CNS Apfelbaum Award; CNS Spine Fellowship Award; US Department of Veterans Affairs, Washington, DC	AANS/CNS Apfelbaum Award; CNS Spine Fellowship Award; US Department of Veterans Affairs, Washington, DC(US Department of Veterans Affairs)	The first author (Dr. Smith) was supported by the AANS/CNS Apfelbaum Award and the CNS Spine Fellowship Award. The last author (Dr. Patwardhan) received funding from the US Department of Veterans Affairs, Washington, DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMI K, 1990, SPINE, V15, P1142, DOI 10.1097/00007632-199011010-00011; Billinghurst J, 2009, CURR ORTHOP PRACT, V20, P238, DOI 10.1097/BCO.0b013e3181a32ead; Bisschop A, 2012, EUR SPINE J; Bisschop A, 2012, EUR SPINE J, V21, P530, DOI 10.1007/s00586-011-1968-2; Bresnahan L, 2009, SPINE, V34, P17, DOI 10.1097/BRS.0b013e318191438b; Fessler RG., 2002, NEUROSURGERY S, V51, pIII; Fox MW, 1996, J NEUROSURG, V85, P793, DOI 10.3171/jns.1996.85.5.0793; Fu YS, 2008, SPINE, V33, P514, DOI 10.1097/BRS.0b013e3181657dde; Hamasaki T, 2009, J SPINAL DISORD TECH, V22, P486, DOI 10.1097/BSD.0b013e31818d7dc9; Iguchi T, 2000, SPINE, V25, P1754, DOI 10.1097/00007632-200007150-00003; Ikuta K, 2005, J NEUROSURG-SPINE, V2, P624, DOI 10.3171/spi.2005.2.5.0624; Isaacs RE, 2005, J NEUROSURG-SPINE, V3, P98, DOI 10.3171/spi.2005.3.2.0098; Jonsson B, 1997, SPINE, V11, P107; KATZ JN, 1991, J BONE JOINT SURG AM, V73A, P809, DOI 10.2106/00004623-199173060-00003; Khoo LT, 2011, J NEUROSURG-SPINE, V14, P250, DOI 10.3171/2010.10.SPINE09456; Khoo LT, 2002, NEUROSURGERY, V51, pS146, DOI 10.1227/01.NEU.0000031220.75770.29; Lawton CD, 2011, J NEUROSURG SCI, V55, P259; Lee MJ, 2010, SPINE, V35, P1789, DOI 10.1097/BRS.0b013e3181c9b8d6; McCulloch J, 1998, ESSENTIALS MICROSURG, P453; Ogden AT, 2009, CLIN BIOMECH, V24, P143, DOI 10.1016/j.clinbiomech.2008.11.005; Palmer S, 2002, J NEUROSURG, V97, P213, DOI 10.3171/spi.2002.97.2.0213; Palmer S, 2012, SURG NEUROL INT, V3; Patwardhan AG, 1999, SPINE, V24, P1003, DOI 10.1097/00007632-199905150-00014; Perez-Cruet MJ, 2002, NEUROSURGERY, V51, pS129, DOI 10.1227/01.NEU.0000031004.69814.2D; Rosen DS, 2008, NEUROSURGERY, V63, P956, DOI 10.1227/01.NEU.0000313626.23194.3F; Rosen DS, 2007, NEUROSURGERY, V60, P503, DOI 10.1227/01.NEU.0000255332.87909.58; Scholz M, 1998, SPINAL CORD, V36, P200, DOI 10.1038/sj.sc.3100567; Weiner BK, 1999, SPINE, V24, P2268, DOI 10.1097/00007632-199911010-00016	28	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92611	10.1371/journal.pone.0092611	http://dx.doi.org/10.1371/journal.pone.0092611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658010	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300106
J	Antal, M; Braunitzer, G; Mattheos, N; Gyulai, R; Nagy, K				Antal, Mark; Braunitzer, Gabor; Mattheos, Nikos; Gyulai, Rolland; Nagy, Katalin			Smoking as a Permissive Factor of Periodontal Disease in Psoriasis	PLOS ONE			English	Article							GINGIVAL BLOOD-FLOW; CIGARETTE-SMOKE; RISK-FACTORS; ALPHA; CELLS; IL-12	Background: Population-based studies have identified smoking as a pathogenetic factor in chronic periodontitis. At the same time, chronic periodontal disease has also been found to occur more often in persons suffering from psoriasis than in controls with no psoriasis. It is known that smoking aggravates both periodontal disease and psoriasis, but so far it has not been investigated how smoking influences the occurrence and severity of periodontal disease in psoriasis. Methods: A hospital-based study was conducted to investigate this question. The study population consisted of 82 psoriasis patients and 89 controls. All patients received a full-mouth periodontal examination, and a published classification based on bleeding on probing, clinical attachment level and probing depth was utilized for staging. Both patients and controls were divided into smoker and non-smoker groups, and the resulting groups were compared in terms of periodontal status. Beyond the descriptive statistics, odds ratios were computed. Results: Psoriasis in itself increased the likelihood of severe periodontal disease to 4.373 (OR, as compared to non-smoker controls, p<0.05), while smoking increased it to 24.278 (OR, as compared to non-smoker controls, p<0.001) in the studied population. In other words, the risk of severe periodontal disease in psoriasis turned out to be six times higher in smokers than in non-smokers. Conclusions: The results of this study corroborate those of other studies regarding the link between psoriasis and periodontal disease, but they also seem to reveal a powerful detrimental effect of smoking on the periodontal health of psoriasis patients, whereby the authors propose that smoking may have a permissive effect on the development of severe periodontal disease in psoriasis.	[Antal, Mark] Univ Szeged, Fac Dent, Dept Operat & Esthet Dent, Szeged, Hungary; [Braunitzer, Gabor; Nagy, Katalin] Univ Szeged, Fac Dent, Dept Oral Surg, Szeged, Hungary; [Mattheos, Nikos] Univ Hong Kong, Fac Dent, Dept Oral Rehabil, Hong Kong, Hong Kong, Peoples R China; [Gyulai, Rolland] Univ Szeged, Fac Dent, Dept Dermatol & Allergol, Szeged, Hungary; [Gyulai, Rolland] Univ Pecs, Sch Med, Dept Dermatol Venerol & Oncodermatol, Pecs, Hungary	Szeged University; Szeged University; University of Hong Kong; Szeged University; University of Pecs	Antal, M (corresponding author), Univ Szeged, Fac Dent, Dept Operat & Esthet Dent, Szeged, Hungary.	antalmarkdr@gmail.com	Lauschner, Flavia H/P-2457-2018; Mattheos, Nikos/C-8614-2011; Antal, Mark Adam/AAB-3996-2022; Nagy, Katalin/ABG-5846-2021; Antal, Mark/AAJ-5947-2021; Gyulai, Rolland/AAE-2765-2020	Mattheos, Nikos/0000-0001-7358-7496; Antal, Mark/0000-0002-4109-9356; Gyulai, Rolland/0000-0002-3286-8846; Nagy, Katalin/0000-0001-9383-5952				Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Barmes D, 1994, Int Dent J, V44, P523; BECK JD, 1990, J PERIODONTOL, V61, P521, DOI 10.1902/jop.1990.61.8.521; Cortina-Borja M SD, 2009, BMC RES NOTES, V2; Curry JL, 2003, ARCH PATHOL LAB MED, V127, P178; Del Prete G, 1998, Int Rev Immunol, V16, P427, DOI 10.3109/08830189809043004; Durali D, 2003, BLOOD, V102, P4084, DOI 10.1182/blood-2003-02-0518; Edwards R, 2004, BRIT MED J, V328, P217, DOI 10.1136/bmj.328.7433.217; Emre S, 2012, J EUR ACAD DERMATOL; FALKOFF RJM, 1983, J IMMUNOL, V131, P801; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernandes JK, 2009, J PERIODONTOL, V80, P1062, DOI 10.1902/jop.2009.080486; Genco RJ, 1996, J PERIODONTOL, V67, P1041, DOI 10.1902/jop.1996.67.10s.1041; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Keller JJ, 2012, BRIT J DERMATOL, V167, P1338, DOI 10.1111/j.1365-2133.2012.11126.x; Korn S, 2005, AM J RESP CELL MOL, V32, P142, DOI 10.1165/rcmb.2004-0239OC; Kubota M, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-1; Lazaridou E, 2013, J EUR ACAD DERMATOL, V27, P967, DOI 10.1111/j.1468-3083.2012.04615.x; Masdottir B, 2000, RHEUMATOLOGY, V39, P1202, DOI 10.1093/rheumatology/39.11.1202; MATHEWS JD, 1973, LANCET, V2, P754; Mavropoulos A, 2007, J PERIODONTOL, V78, P1774, DOI 10.1902/jop.2007.060472; Morozumi T, 2004, J CLIN PERIODONTOL, V31, P267, DOI 10.1111/j.1600-051X.2004.00476.x; Netea MG, 2005, ANTIMICROB AGENTS CH, V49, P3991, DOI 10.1128/AAC.49.10.3991-3996.2005; Ohlrich EJ, 2009, AUST DENT J, V54, pS2, DOI 10.1111/j.1834-7819.2009.01139.x; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Preus HR, 2010, ACTA ODONTOL SCAND, V68, P165, DOI 10.3109/00016350903583678; RIECKMANN P, 1991, J IMMUNOL, V146, P3462; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Sullivan AK, 2005, AM J RESP CRIT CARE, V172, P590, DOI 10.1164/rccm.200410-1332OC; Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Tonetti M S, 1998, Ann Periodontol, V3, P88; YAMADA J, 1992, J PERIODONTOL, V63, P854, DOI 10.1902/jop.1992.63.10.854	34	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92333	10.1371/journal.pone.0092333	http://dx.doi.org/10.1371/journal.pone.0092333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651659	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000333352800102
J	Morgan, HM; Davis, NJ; Bracewell, RM				Morgan, Helen M.; Davis, Nick J.; Bracewell, R. Martyn			Does Transcranial Direct Current Stimulation to Prefrontal Cortex Affect Mood and Emotional Memory Retrieval in Healthy Individuals?	PLOS ONE			English	Article							MAGNETIC STIMULATION; DOUBLE-BLIND; MAJOR DEPRESSION; COGNITIVE CONTROL; BRAIN-STIMULATION; NEGATIVE AFFECT; CLINICAL-TRIAL; RISK-TAKING; TDCS; EFFICACY	Studies using transcranial direct current stimulation (tDCS) of prefrontal cortex to improve symptoms of depression have had mixed results. We examined whether using tDCS to change the balance of activity between left and right dorsolateral prefrontal cortex (DLPFC) can alter mood and memory retrieval of emotional material in healthy volunteers. Participants memorised emotional images, then tDCS was applied bilaterally to DLPFC while they performed a stimulus-response compatibility task. Participants were then presented with a set of images for memory retrieval. Questionnaires to examine mood and motivational state were administered at the beginning and end of each session. Exploratory data analyses showed that the polarity of tDCS to DLPFC influenced performance on a stimulus-response compatibility task and this effect was dependent on participants' prior motivational state. However, tDCS polarity had no effect on the speed or accuracy of memory retrieval of emotional images and did not influence positive or negative affect. These findings suggest that the balance of activity between left and right DLPFC does not play a critical role in the mood state of healthy individuals. We suggest that the efficacy of prefrontal tDCS depends on the initial activation state of neurons and future work should take this into account.	[Morgan, Helen M.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England; [Davis, Nick J.] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Bracewell, R. Martyn] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Bracewell, R. Martyn] Bangor Univ, Sch Med Sci, Bangor, Gwynedd, Wales	Liverpool John Moores University; Swansea University; Bangor University; Bangor University	Morgan, HM (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England.	H.M.Morgan@ljmu.ac.uk		Davis, Nick/0000-0001-7630-2097	Future and Emerging Technologies (FET) program within the Seventh Framework Programme for Research of the European Commission (FET-Open grant) [222079]	Future and Emerging Technologies (FET) program within the Seventh Framework Programme for Research of the European Commission (FET-Open grant)	This work was supported by the Future and Emerging Technologies (FET) program within the Seventh Framework Programme for Research of the European Commission (FET-Open grant no. 222079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P516, DOI 10.1037//0894-4105.15.4.516; AHERN GL, 1985, NEUROPSYCHOLOGIA, V23, P745, DOI 10.1016/0028-3932(85)90081-8; American Electroencephalographic Society, J CLIN NEUROPHYSIOL, V8, P200; Baeken C, 2006, J AFFECT DISORDERS, V90, P63, DOI 10.1016/j.jad.2005.09.013; Berlim MT, 2013, NEUROPSYCHOPHARMACOL, V38, P543, DOI 10.1038/npp.2012.237; Berlim MT, 2013, J PSYCHIATR RES, V47, P1, DOI 10.1016/j.jpsychires.2012.09.025; Berman RM, 2000, BIOL PSYCHIAT, V47, P332, DOI 10.1016/S0006-3223(99)00243-7; BLANEY PH, 1986, PSYCHOL BULL, V99, P229, DOI 10.1037/0033-2909.99.2.229; Blumberger Daniel M, 2012, Front Psychiatry, V3, P74, DOI 10.3389/fpsyt.2012.00074; Boggio PS, 2008, INT J NEUROPSYCHOPH, V11, P249, DOI 10.1017/S1461145707007833; Boggio PS, 2010, DRUG ALCOHOL DEPEN, V112, P220, DOI 10.1016/j.drugalcdep.2010.06.019; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; British Psychological Society (BPS), 2009, COD ETH COND; Brunoni AR, 2013, PSYCHONEUROENDOCRINO, V38, P58, DOI 10.1016/j.psyneuen.2012.04.020; Campbell S., 2001, P HUMAN FACTORS ERGO, V45, P906, DOI [10.1177/154193120104501302, DOI 10.1177/154193120104501302]; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; DONALDSON W, 1993, B PSYCHONOMIC SOC, V31, P271; Egner T, 2009, NAT NEUROSCI, V12, P821, DOI 10.1038/nn0709-821; Fecteau S, 2007, J NEUROSCI, V27, P12500, DOI 10.1523/JNEUROSCI.3283-07.2007; Figiel GS, 1998, J NEUROPSYCH CLIN N, V10, P20, DOI 10.1176/jnp.10.1.20; FITTS PM, 1954, J EXP PSYCHOL, V48, P483, DOI 10.1037/h0054967; Fregni F, 2006, BIPOLAR DISORD, V8, P203, DOI 10.1111/j.1399-5618.2006.00291.x; Fregni F, 2006, DEPRESS ANXIETY, V23, P482, DOI 10.1002/da.20201; Gainotti G, 1972, Cortex, V8, P41; George MS, 1997, AM J PSYCHIAT, V154, P1752, DOI 10.1176/ajp.154.12.1752; GRIER JB, 1971, PSYCHOL BULL, V75, P424, DOI 10.1037/h0031246; Grisaru N, 2001, J ECT, V17, P184, DOI 10.1097/00124509-200109000-00007; Hagler DJ, 2006, NEUROIMAGE, V29, P567, DOI 10.1016/j.neuroimage.2005.08.058; Heller W, 1997, COGNITION EMOTION, V11, P637, DOI 10.1080/026999397379845a; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jenkins J, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-1; Kalu UG, 2012, PSYCHOL MED, V42, P1791, DOI 10.1017/S0033291711003059; Kessler SK, 2012, BRAIN STIMUL, V5, P155, DOI 10.1016/j.brs.2011.02.007; Kirov R, 2009, P NATL ACAD SCI USA, V106, P15460, DOI 10.1073/pnas.0904438106; Klein E, 1999, ARCH GEN PSYCHIAT, V56, P315, DOI 10.1001/archpsyc.56.4.315; Koenigs M, 2009, CLIN NEUROPHYSIOL, V120, P80, DOI 10.1016/j.clinph.2008.10.010; Koessler L, 2009, NEUROIMAGE, V46, P64, DOI 10.1016/j.neuroimage.2009.02.006; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Lenth RV., 2006, JAVA APPLETS POWER S; Loo CK, 2012, BRIT J PSYCHIAT, V200, P52, DOI 10.1192/bjp.bp.111.097634; Loo CK, 2010, INT J NEUROPSYCHOPH, V13, P61, DOI 10.1017/S1461145709990411; Maeoka H, 2012, NEUROSCI LETT, V512, P12, DOI 10.1016/j.neulet.2012.01.037; Marshall L, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-23; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Metuki N, 2012, BRAIN STIMUL, V5, P110, DOI 10.1016/j.brs.2012.03.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miranda PC, 2009, CLIN NEUROPHYSIOL, V120, P1183, DOI 10.1016/j.clinph.2009.03.023; Morey RD, 2011, PSYCHOL METHODS, V16, P406, DOI 10.1037/a0024377; Mosimann UP, 2000, PSYCHIAT RES, V94, P251, DOI 10.1016/S0165-1781(00)00146-3; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche M A, 2012, Front Psychiatry, V3, P58, DOI 10.3389/fpsyt.2012.00058; Nitsche MA, 2009, EXP NEUROL, V219, P14, DOI 10.1016/j.expneurol.2009.03.038; O'Connell NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047514; Palm U, 2012, BRAIN STIMUL, V5, P242, DOI 10.1016/j.brs.2011.08.005; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; Pena-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022812; Penolazzi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010623; Plazier M, 2012, BRAIN STIMUL, V5, P454, DOI 10.1016/j.brs.2011.07.005; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Russo R, 2013, BRAIN STIMUL, V6, P946, DOI 10.1016/j.brs.2013.05.009; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Schaller G, 2011, J PSYCHIATR RES, V45, P1178, DOI 10.1016/j.jpsychires.2011.02.006; Sela T, 2012, NEUROPSYCHOLOGIA, V50, P2271, DOI 10.1016/j.neuropsychologia.2012.05.031; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Slotema CW, 2010, J CLIN PSYCHIAT, V71, P873, DOI 10.4088/JCP.08m04872gre; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wise EA, 2012, J PSYCHIATR RES, V46, P412, DOI 10.1016/j.jpsychires.2011.11.005	77	21	22	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92162	10.1371/journal.pone.0092162	http://dx.doi.org/10.1371/journal.pone.0092162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651375	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800075
J	Brash, AR; Niraula, NP; Boeglin, WE; Mashhadi, Z				Brash, Alan R.; Niraula, Narayan P.; Boeglin, William E.; Mashhadi, Zahra			An Ancient Relative of Cyclooxygenase in Cyanobacteria Is a Linoleate 10S-Dioxygenase That Works in Tandem with a Catalase-related Protein with Specific 10S-Hydroperoxide Lyase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; Dioxygenase; Fatty Acid Metabolism; Peroxidase; Polyunsaturated Fatty Acids; HPODE; Catalase; Cyclooxygenase; Linoleic Acid	ALLENE OXIDE SYNTHASE; LIPOXYGENASE FUSION PROTEIN; FATTY-ACID HYDROPEROXIDES; 10-HYDROPEROXIDE ISOMER; GENE-TRANSFER; 1-OCTEN-3-OL; IDENTIFICATION; BIOSYNTHESIS; PRODUCTS; ANABAENA	Background: Fatty acid heme dioxygenases occur in eukaryotes, often associated with a cytochrome P450 that transforms the peroxide product. Results: Neighboring cyanobacterial genes, dioxygenase and catalase, are identified as linoleate 10S-dioxygenase and 10S-hydroperoxide lyase, respectively. Conclusion: These Nostoc hemoproteins show novel activities. Significance: Our results identify a heme dioxygenase ancestor and a catalase that substitutes in function for a cytochrome P450. In the course of exploring the scope of catalase-related hemoprotein reactivity toward fatty acid hydroperoxides, we detected a novel candidate in the cyanobacterium Nostoc punctiforme PCC 73102. The immediate neighboring upstream gene, annotated as cyclooxygenase-2, appeared to be a potential fatty acid heme dioxygenase. We cloned both genes and expressed the cDNAs in Escherichia coli, confirming their hemoprotein character. Oxygen electrode recordings demonstrated a rapid (>100 turnovers/s) reaction of the heme dioxygenase with oleic and linoleic acids. HPLC, including chiral column analysis, UV, and GC-MS of the oxygenated products, identified a novel 10S-dioxygenase activity. The catalase-related hemoprotein reacted rapidly and specifically with linoleate 10S-hydroperoxide (>2,500 turnovers/s) with a hydroperoxide lyase activity specific for the 10S-hydroperoxy enantiomer. The products were identified by NMR as (8E)10-oxo-decenoic acid and the C8 fragments, 1-octen-3-ol and 2Z-octen-1-ol, in approximate to 3:1 ratio. Chiral HPLC analysis established strict enzymatic control in formation of the 3R alcohol configuration (99% enantiomeric excess) and contrasted with racemic 1-octen-3-ol formed in reaction of linoleate 10S-hydroperoxide with hematin or ferrous ions. The Nostoc linoleate 10S-dioxygenase, the sequence of which contains the signature catalytic sequence of cyclooxygenases and fungal linoleate dioxygenases (YRWH), appears to be a heme dioxygenase ancestor. The novel activity of the lyase expands the known reactions of catalase-related proteins and functions in Nostoc in specific transformation of the 10S-hydroperoxylinoleate.	[Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Brash, AR (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu			National Institutes of Health [GM-074888]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-074888 (to A. R. B.).	Akakabe Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1539, DOI 10.1271/bbb.69.1539; ASSAF S, 1995, J AGR FOOD CHEM, V43, P2173, DOI 10.1021/jf00056a040; Barofsky A, 2007, ORG LETT, V9, P1017, DOI 10.1021/ol063051v; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; Brash AR, 1996, METHOD ENZYMOL, V272, P250, DOI 10.1016/S0076-6879(96)72030-X; BRASH AR, 1991, J BIOL CHEM, V266, P22926; CAUDALES R, 1992, INT J SYST BACTERIOL, V42, P246, DOI 10.1099/00207713-42-2-246; CHACON JN, 1987, CHEM PHYS LIPIDS, V43, P81; De Luna P, 2013, J PHYS CHEM B, V117, P14635, DOI 10.1021/jp408486n; Gao B, 2008, ARCH BIOCHEM BIOPHYS, V477, P285, DOI 10.1016/j.abb.2008.07.011; Gao BL, 2009, J BIOL CHEM, V284, P22087, DOI 10.1074/jbc.M109.013151; GARDNER HW, 1989, FREE RADICAL BIO MED, V7, P65, DOI 10.1016/0891-5849(89)90102-0; GARSSEN GJ, 1971, BIOCHEM J, V122, P327, DOI 10.1042/bj1220327; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Grechkin AN, 2006, BBA-MOL CELL BIOL L, V1761, P1419, DOI 10.1016/j.bbalip.2006.09.002; Hamberg M, 1999, J BIOL CHEM, V274, P24503, DOI 10.1074/jbc.274.35.24503; Herrero-Garcia E, 2011, FUNGAL BIOL-UK, V115, P393, DOI 10.1016/j.funbio.2011.02.005; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; IMAI T, 1993, J BIOL CHEM, V268, P19681; Klotz MG, 2003, MOL BIOL EVOL, V20, P1098, DOI 10.1093/molbev/msg129; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; LABEQUE R, 1988, BIOCHEMISTRY-US, V27, P7060, DOI 10.1021/bi00418a059; Lang I, 2008, BIOCHEM J, V410, P347, DOI 10.1042/BJ20071277; Liu XJ, 2003, CURR MICROBIOL, V47, P467, DOI 10.1007/s00284-003-4059-8; Lohelaid H, 2008, BBA-GEN SUBJECTS, V1780, P315, DOI 10.1016/j.bbagen.2007.10.010; Martinez E, 2010, J BIOL CHEM, V285, P9339, DOI 10.1074/jbc.M109.078147; Maruyama S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-197; Meeks JC, 1998, BIOSCIENCE, V48, P266, DOI 10.2307/1313353; Nemcovic M, 2008, FEMS MICROBIOL LETT, V284, P231, DOI 10.1111/j.1574-6968.2008.01202.x; Ni T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-83; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Oliw EH, 2011, J LIPID RES, V52, P1995, DOI 10.1194/jlr.M018259; PEERS KE, 1981, J SCI FOOD AGR, V32, P898, DOI 10.1002/jsfa.2740320908; Schneider C, 2007, P NATL ACAD SCI USA, V104, P18941, DOI 10.1073/pnas.0707148104; Senger T, 2005, J BIOL CHEM, V280, P7588, DOI 10.1074/jbc.M411738200; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Spiteller P, 2008, CHEM-EUR J, V14, P9100, DOI 10.1002/chem.200800292; Thomas CP, 2013, CHEM PHYS LIPIDS, V167, P21, DOI 10.1016/j.chemphyslip.2013.01.002; Tijet N, 2002, PROSTAG OTH LIPID M, V68-9, P423, DOI 10.1016/S0090-6980(02)00046-1; Tosha T, 2006, J BIOL CHEM, V281, P12610, DOI 10.1074/jbc.M600061200; Watson SB, 2003, PHYCOLOGIA, V42, P332, DOI 10.2216/i0031-8884-42-4-332.1; WURZENBERGER M, 1984, BIOCHIM BIOPHYS ACTA, V794, P25, DOI 10.1016/0005-2760(84)90293-5; WURZENBERGER M, 1984, BIOCHIM BIOPHYS ACTA, V795, P163, DOI 10.1016/0005-2760(84)90117-6; WURZENBERGER M, 1984, BIOCHIM BIOPHYS ACTA, V794, P18, DOI 10.1016/0005-2760(84)90292-3; WURZENBERGER M, 1982, Z LEBENSM UNTERS FOR, V175, P186, DOI 10.1007/BF01139769; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200	48	27	27	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13101	13111		10.1074/jbc.M114.555904	http://dx.doi.org/10.1074/jbc.M114.555904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24659780	Green Published, hybrid			2022-12-25	WOS:000335522800012
J	Fu, D; Tan, P; Kuznetsov, A; Molkov, YI				Fu, Daniel; Tan, Patrick; Kuznetsov, Alexey; Molkov, Yaroslav I.			Chaos and Robustness in a Single Family of Genetic Oscillatory Networks	PLOS ONE			English	Article							TEMPERATURE INDEPENDENCE; TOGGLE SWITCH; TIME; MECHANISM; DYNAMICS; CLOCK; DELAY; MODEL	Genetic oscillatory networks can be mathematically modeled with delay differential equations (DDEs). Interpreting genetic networks with DDEs gives a more intuitive understanding from a biological standpoint. However, it presents a problem mathematically, for DDEs are by construction infinitely-dimensional and thus cannot be analyzed using methods common for systems of ordinary differential equations (ODEs). In our study, we address this problem by developing a method for reducing infinitely-dimensional DDEs to two-and three-dimensional systems of ODEs. We find that the three-dimensional reductions provide qualitative improvements over the two-dimensional reductions. We find that the reducibility of a DDE corresponds to its robustness. For non-robust DDEs that exhibit high-dimensional dynamics, we calculate analytic dimension lines to predict the dependence of the DDEs' correlation dimension on parameters. From these lines, we deduce that the correlation dimension of non-robust DDEs grows linearly with the delay. On the other hand, for robust DDEs, we find that the period of oscillation grows linearly with delay. We find that DDEs with exclusively negative feedback are robust, whereas DDEs with feedback that changes its sign are not robust. We find that non-saturable degradation damps oscillations and narrows the range of parameter values for which oscillations exist. Finally, we deduce that natural genetic oscillators with highly-regular periods likely have solely negative feedback.	[Fu, Daniel] Pk Tudor Sch, Dept Math, Indianapolis, IN 46240 USA; [Tan, Patrick] Carmel High Sch, Dept Math, Carmel, IN USA; [Kuznetsov, Alexey; Molkov, Yaroslav I.] Indiana Univ Purdue Univ, Dept Math Sci, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Fu, D (corresponding author), Pk Tudor Sch, Dept Math, Indianapolis, IN 46240 USA.	danielyfu@hotmail.com	Kuznetsov, Alexey/L-1128-2017; Molkov, Yaroslav/C-6336-2012	Molkov, Yaroslav/0000-0002-0862-1974; Fu, Daniel/0000-0002-2500-2577	Indiana University Research Support Funds	Indiana University Research Support Funds	AK acknowledges financial support from the Indiana University Research Support Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz A., 1972, HDB MATH FUNCTIONS F; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; HASTINGS JW, 1957, P NATL ACAD SCI USA, V43, P804, DOI 10.1073/pnas.43.9.804; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hasty J, 2001, CHAOS, V11, P207, DOI 10.1063/1.1345702; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Kaern M, 2001, FARADAY DISCUSS, V120, P295, DOI 10.1039/b103244p; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Martin A, 2001, J MATH BIOL, V43, P247, DOI 10.1007/s002850100095; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Purcell O, 2010, J R SOC INTERFACE, V7, P1503, DOI 10.1098/rsif.2010.0183; Raghothama A, 2002, NONLINEAR DYNAM, V27, P341, DOI 10.1023/A:1015207726565; Smolen P, 2002, BIOPHYS J, V83, P2349, DOI 10.1016/S0006-3495(02)75249-1; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; THEILER J, 1990, J OPT SOC AM A, V7, P1055, DOI 10.1364/JOSAA.7.001055; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tsaneva-Atanasova K, 2006, BIOPHYS J, V90, P3434, DOI 10.1529/biophysj.105.078360; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6	30	4	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e90666	10.1371/journal.pone.0090666	http://dx.doi.org/10.1371/journal.pone.0090666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667178	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600002
J	Bayala, B; Bassole, IHN; Gnoula, C; Nebie, R; Yonli, A; Morel, L; Figueredo, G; Nikiema, JB; Lobaccaro, JMA; Simpore, J				Bayala, Bagora; Bassole, Imael Henri Nestor; Gnoula, Charlemagne; Nebie, Roger; Yonli, Albert; Morel, Laurent; Figueredo, Gilles; Nikiema, Jean-Baptiste; Lobaccaro, Jean-Marc A.; Simpore, Jacques			Chemical Composition, Antioxidant, Anti-Inflammatory and Anti-Proliferative Activities of Essential Oils of Plants from Burkina Faso	PLOS ONE			English	Article							OCIMUM-BASILICUM L.; HUMAN PROSTATIC-CARCINOMA; AGERATUM-CONYZOIDES L.; IN-VITRO; ANTIMICROBIAL ACTIVITY; LARVICIDAL ACTIVITY; BIOLOGICAL-ACTIVITY; LIPPIA-MULTIFLORA; MEDICINAL-PLANTS; OXIDATIVE STRESS	This research highlights the chemical composition, antioxidant, anti-inflammatory and anti-proliferative activities of essential oils from leaves of Ocimum basilicum, Ocimum americanum, Hyptis spicigera, Lippia multiflora, Ageratum conyzoides, Eucalyptus camaldulensis and Zingiber officinale. Essential oils were analyzed by gas chromatography-mass spectrometry and gas chromatography-flame ionization detector. Major constituents were alpha-terpineol (59.78%) and beta-caryophyllene (10.54%) for Ocimum basilicum; 1, 8-cineol (31.22%), camphor (12.730%), alpha-pinene (6.87%) and trans alpha-bergamotene (5.32%) for Ocimum americanum; beta-caryophyllene (21%), alpha-pinene (20.11%), sabinene (10.26%), beta-pinene (9.22%) and alpha-phellandrene (7.03%) for Hyptis spicigera; p-cymene (25.27%), beta-caryophyllene (12.70%), thymol (11.88), gamma-terpinene (9.17%) and thymyle acetate (7.64%) for Lippia multiflora; precocene (82.10%) for Ageratum conyzoides; eucalyptol (59.55%), a-pinene (9.17%) and limonene (8.76%) for Eucalyptus camaldulensis; arcurcumene (16.67%), camphene (12.70%), zingiberene (8.40%), beta-bisabolene (7.83%) and beta-sesquiphellandrene (5.34%) for Zingiber officinale. Antioxidant activities were examined using 1,1-diphenyl-2-picryl-hydrazyl (DPPH) and 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) methods. O. basilicum and L. multiflora exhibited the highest antioxidant activity in DPPH and ABTS tests, respectively. Anti-inflammatory properties were evaluated by measuring the inhibition of lipoxygenase activity and essential oil of Z. officinale was the most active. Anti-proliferative effect was assayed by the measurement of MTT on LNCaP and PC-3 prostate cancer cell lines, and SF-763 and SF-767 glioblastoma cell lines. Essential oils from A. conyzoides and L. multiflora were the most active on LNCaP and PC-3 cell lines, respectively. The SF-767 glioblastoma cell line was the most sensitive to O. basilicum and L. multiflora EOs while essential oil of A. conyzoides showed the highest activity on SF-763 cells. Altogether these results justify the use of these plants in traditional medicine in Burkina Faso and open a new field of investigation in the characterization of the molecules involved in anti-proliferative processes.	[Bayala, Bagora; Gnoula, Charlemagne; Yonli, Albert; Nikiema, Jean-Baptiste; Simpore, Jacques] Univ Ouagadougou, Ctr Med St Camille, Lab Biol & Genet LABIOGENE, Ctr Rech Biomol Pietro Annigoni CERBA, Ouagadougou, Burkina Faso; [Bayala, Bagora; Morel, Laurent; Lobaccaro, Jean-Marc A.] Univ Clermont Ferrand 2, Univ Blaise Pascal, Clermont Ferrand, France; [Bayala, Bagora; Morel, Laurent; Lobaccaro, Jean-Marc A.] CNRS, Unite Mixte Rech UMR 6293, GReD, Aubiere, France; [Bayala, Bagora; Morel, Laurent; Lobaccaro, Jean-Marc A.] INSERM, UMR 1103, GReD, Aubiere, France; [Bayala, Bagora; Morel, Laurent; Lobaccaro, Jean-Marc A.] Ctr Rech Nutr Humaine Auvergne, Clermont Ferrand, France; [Bassole, Imael Henri Nestor] Univ Ouagadougou, Lab Biochim Alimentaire Enzymol Biotechnol Ind &, Unite Format & Rech Sci Vie & Terre UFR SVT, Ouagadougou, Burkina Faso; [Gnoula, Charlemagne] Univ Ouagadougou, Lab Pharmacol Toxicol & Chim Therapeut, Unite Format & Rech Sci Sante UFR SDS, Ouagadougou, Burkina Faso; [Nebie, Roger] Inst Rech Sci Appl & Tech, Dept Subst Nat, Ouagadougou, Burkina Faso; [Figueredo, Gilles] Biopole Clermont Limagne, LEXVA Analyt, St Beauzire, France; [Nikiema, Jean-Baptiste; Simpore, Jacques] Ctr Med St Camille Ouagadougou, Ouagadougou, Burkina Faso	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Lobaccaro, JMA (corresponding author), Univ Clermont Ferrand 2, Univ Blaise Pascal, Clermont Ferrand, France.	j-marc.lobaccaro@univ-bpclermont.fr; jacques.simpore@yahoo.fr	SIMPORE, Jacques/ABA-4873-2020; NEBIE, Roger/AAR-6586-2020; Lobaccaro, Jean-Marc/Q-3926-2019; Bassolé, Imaël Henri Nestor/Z-1151-2019; LOBACCARO, Jean-Marc/L-6151-2015	SIMPORE, Jacques/0000-0002-0415-9161; Lobaccaro, Jean-Marc/0000-0001-9890-2392; Bassolé, Imaël Henri Nestor/0000-0003-3538-0018; 	Conference Episcopale Italienne (CEI); Union Economique Monetaire Ouest Africaine (UEMOA); Fondation BNP-Paris; Region Auvergne; Fond Europeen de Developpement Regional (FEDER); Association de Recherche sur les Tumeurs Prostatiques (ARTP); Fondation ARC; Ligue contre le Cancer	Conference Episcopale Italienne (CEI); Union Economique Monetaire Ouest Africaine (UEMOA); Fondation BNP-Paris; Region Auvergne(Region Auvergne-Rhone-Alpes); Fond Europeen de Developpement Regional (FEDER)(European Commission); Association de Recherche sur les Tumeurs Prostatiques (ARTP); Fondation ARC; Ligue contre le Cancer(Ligue nationale contre le cancer)	This study was supported by Conference Episcopale Italienne (CEI), Union Economique Monetaire Ouest Africaine (UEMOA) and Campus France for BB, CG, IHNB, AY, J-BN, JS; Fondation BNP-Paris, Region Auvergne, Fond Europeen de Developpement Regional (FEDER), Association de Recherche sur les Tumeurs Prostatiques (ARTP), Fondation ARC, Ligue contre le Cancer for JMAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkader MSA, 2011, NAT PROD RES, V25, P909, DOI 10.1080/14786419.2010.531724; Abena AA, 2003, FITOTERAPIA, V74, P231, DOI 10.1016/S0367-326X(03)00029-7; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Alinkina E S, 2012, Prikl Biokhim Mikrobiol, V48, P564; Alzogaray RA, 2011, J ECON ENTOMOL, V104, P595, DOI 10.1603/EC10045; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Bassole IHN, 2011, PHYTOMEDICINE, V18, P1070, DOI 10.1016/j.phymed.2011.05.009; Bassole IHN, 2010, MOLECULES, V15, P7825, DOI 10.3390/molecules15117825; Bicas JL, 2011, FOOD CHEM TOXICOL, V49, P1610, DOI 10.1016/j.fct.2011.04.012; Bouda H, 2001, EFFECT ESSENTIAL OIL; Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015; Cengiz S, 2011, MAR BIOTECHNOL, V13, P321, DOI 10.1007/s10126-010-9303-1; Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038; Cimanga K, 2002, J ETHNOPHARMACOL, V79, P213, DOI 10.1016/S0378-8741(01)00384-1; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dar MY, 2011, FOOD CHEM, V129, P1606, DOI 10.1016/j.foodchem.2011.06.016; de Melo NI, 2011, MOLECULES, V16, P762, DOI 10.3390/molecules16010762; del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q; Djibo AK, 2004, CR CHIM, V7, P1033, DOI 10.1016/j.crci.2003.12.029; Edris AE, 2007, PHYTOTHER RES, V21, P308, DOI 10.1002/ptr.2072; Fragoso-Serrano M, 1999, J NAT PROD, V62, P45, DOI 10.1021/np980222z; Francisco JD, 2001, J AGR FOOD CHEM, V49, P2339, DOI 10.1021/jf0013611; Garcia DG, 2010, MOL CELL BIOCHEM, V345, P29, DOI 10.1007/s11010-010-0556-9; Yamamoto-Ribeiro MMG, 2013, FOOD CHEM, V141, P3147, DOI 10.1016/j.foodchem.2013.05.144; Ghasemi V, 2011, EXP APPL ACAROL, V55, P147, DOI 10.1007/s10493-011-9457-1; Gould MN, 1997, ENVIRON HEALTH PERSP, V105, P977, DOI 10.2307/3433313; Govindarajan M, 2013, EXP PARASITOL, V134, P7, DOI 10.1016/j.exppara.2013.01.018; Graham JG, 2000, J ETHNOPHARMACOL, V73, P347, DOI 10.1016/S0378-8741(00)00341-X; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; Herzi N, 2013, J FOOD SCI, V78, pC667, DOI 10.1111/1750-3841.12113; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Ilboudo Z, 2010, J STORED PROD RES, V46, P124, DOI 10.1016/j.jspr.2009.12.002; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kalaivani K, 2012, PARASITOL RES, V110, P1261, DOI 10.1007/s00436-011-2623-x; Kathirvel P, 2012, NAT PROD RES, V26, P1112, DOI 10.1080/14786419.2010.545357; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Lompo O M, 2009, J AFRICAIN CANC, V1, P207, DOI DOI 10.1007/S12558-009-0052-X; Lopez-Reyes JG, 2013, J FOOD PROTECT, V76, P631, DOI 10.4315/0362-028X.JFP-12-342; LYCKANDER IM, 1992, ACTA PHARM NORDICA, V4, P159; Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a; Martinez-Velazquez M, 2011, PARASITOL RES, V108, P481, DOI 10.1007/s00436-010-2069-6; McNeil M, 2011, NAT PROD COMMUN, V6, P1775; Miguel MG, 2010, FLAVOUR FRAG J, V25, P291, DOI 10.1002/ffj.1961; Misharina T A, 2009, Prikl Biokhim Mikrobiol, V45, P710; Moura ACA, 2005, PHYTOMEDICINE, V12, P138, DOI 10.1016/j.phymed.2003.12.003; Murata S, 2013, ONCOL REP, V30, P2647, DOI 10.3892/or.2013.2763; Nacoulma O. G., 1996, THESIS, P328; Newell DR, 2005, EUR J CANCER, V41, P676, DOI 10.1016/j.ejca.2004.12.024; de Melo GAN, 2011, J NAT MED-TOKYO, V65, P241, DOI 10.1007/s11418-010-0479-5; Nogueira JHC, 2010, INT J FOOD MICROBIOL, V137, P55, DOI 10.1016/j.ijfoodmicro.2009.10.017; Pidgeon GP, 2002, CANCER RES, V62, P2721; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; RICEEVANS C, 1993, PROG LIPID RES, V32, P71, DOI 10.1016/0163-7827(93)90006-I; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sanchez-Suarez JF, 2013, IRAN J PARASITOL, V8, P129; Sawadogo WR, 2012, NAT PROD RES, V26, P575, DOI 10.1080/14786419.2010.534737; Senatore F, 1998, FLAVOUR FRAG J, V13, P1, DOI 10.1002/(SICI)1099-1026(199801/02)13:1&lt;1::AID-FFJ672&gt;3.0.CO;2-4; Sims JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055509; Soares DG, 2003, J AGR FOOD CHEM, V51, P1077, DOI 10.1021/jf020864z; Stein S., 2002, NIST MASS SPECTRAL S; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Takayama C, 2011, J ETHNOPHARMACOL, V135, P147, DOI 10.1016/j.jep.2011.03.002; Thaweboon S, 2009, SE ASIAN J TROP MED, V40, P1025; TRUSH MA, 1991, FREE RADICAL BIO MED, V10, P201, DOI 10.1016/0891-5849(91)90077-G; Wang SY, 2000, J AGR FOOD CHEM, V48, P5677, DOI 10.1021/jf000766i; Yu LL, 2002, J AGR FOOD CHEM, V50, P1619, DOI 10.1021/jf010964p; Zheljazkov VD, 2008, J AGR FOOD CHEM, V56, P241, DOI 10.1021/jf072447y; Zu YG, 2010, MOLECULES, V15, P3200, DOI 10.3390/molecules15053200	71	104	113	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92122	10.1371/journal.pone.0092122	http://dx.doi.org/10.1371/journal.pone.0092122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662935	gold, Green Submitted, Green Published			2022-12-25	WOS:000333459900041
J	Thai, A; Papapanou, PN; Jacobs, DR; Desvarieux, M; Demmer, RT				Thai, Ashley; Papapanou, Panos N.; Jacobs, David R., Jr.; Desvarieux, Moise; Demmer, Ryan T.			Periodontal Infection and Cardiorespiratory Fitness in Younger Adults: Results from Continuous National Health and Nutrition Examination Survey 1999-2004	PLOS ONE			English	Article							EXAMINATION SURVEY NHANES; VASCULAR-DISEASE EPIDEMIOLOGY; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; PHYSICAL-FITNESS; EXERCISE CAPACITY; QUALITY-ASSURANCE; ORAL INFECTIONS; TOOTH LOSS; RISK	Objective: Previous studies report associations between periodontal infection and cardiorespiratory fitness but no study has examined the association among younger adults. Our objective was to study the association between clinical measures of periodontal infection and cardiorespiratory fitness levels among a population-based sample of younger adults. Methods: The Continuous National Health and Nutrition Examination Survey 1999-2004 enrolled 2,863 participants (46% women) who received a partial-mouth periodontal examination and completed a submaximal treadmill test for the assessment of estimated VO2 max(eVO(2) max). Participants were mean +/- SD age 33 +/- 9 years (range = 20-49 years), 30% Hispanic, 48% White, 19% Black, and 3% other. Mean eVO(2) max (mL/kg/minute) as well as eVO(2) max <= 32 mL/kg/minute (20th percentile) were regressed across quartiles of mean probing depth and mean attachment loss in multivariable linear and logistic regression models. Results: After multivariable adjustment, mean eVO(2) max levels +/- SE across quartiles of attachment loss were 39.72 +/- 0.37, 39.64 +/- 0.34, 39.59 +/- 0.36, and 39.85 +/- 0.39 (P = 0.99). Mean eVO(2) max +/- SE across quartiles of probing depth were 39.57 +/- 0.32, 39.78 +/- 0.38, 39.19 +/- 0.25, and 40.37 +/- 0.53 (P = 0.28). Similarly, multivariable adjusted mean eVO(2) max values were similar between healthy participants vs. those with moderate/severe periodontitis: 39.70 +/- 0.21 vs. 39.70 +/- 0.90 (P = 1.00). The odds ratio (OR) for low eVO(2) max comparing highest vs. lowest quartile of attachment loss = 0.89[95% CI 0.64-1.24]. The OR for comparing highest vs. lowest probing depth quartile = 0.77[95% CI 0.51-1.15]. Conclusion: Clinical measures of periodontal infection were not related to cardiorespiratory fitness in a sample of generally healthy younger adults.	[Thai, Ashley; Desvarieux, Moise; Demmer, Ryan T.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Papapanou, Panos N.] Columbia Univ, Div Periodont, Coll Dent Med, Sect Oral & Diagnost Sci, New York, NY USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway; [Desvarieux, Moise] Ctr Rech Epidemiol & Biostat, INSERM, U1153, Equipe Methodes Evaluat Therapeut Malad Chron, Paris, France	Columbia University; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Demmer, RT (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.	rtd2106@columbia.edu	Desvarieux, Moise/C-4991-2019	Jacobs, David/0000-0002-7232-0543; Papapanou, Panos N./0000-0002-6538-3618; Demmer, Ryan/0000-0003-3429-0379	NIH grants [R00 DE-018739, R21 DE-022422]; Diabetes and Endocrinology Research Center, College of Physicians and Surgeons, Columbia University [DK-63608]; Chair in Chronic Disease, Ecole des Hautes Etudes en Sante Publique, France;  [R01 DE-13094]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013094, R21DE022422, R00DE018739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063608] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Endocrinology Research Center, College of Physicians and Surgeons, Columbia University; Chair in Chronic Disease, Ecole des Hautes Etudes en Sante Publique, France; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by NIH grants R00 DE-018739 and R21 DE-022422 to Dr. Demmer. Additional funding support was provided by a Pilot & Feasibility Award to Dr. Demmer from the Diabetes and Endocrinology Research Center, College of Physicians and Surgeons, Columbia University (DK-63608); a Chair in Chronic Disease, Ecole des Hautes Etudes en Sante Publique, France (Dr. Desvarieux); Dr. Desvarieux is also supported by R01 DE-13094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2009, ACSMS GUID EX TEST P, P8; Beck JD, 2001, ARTERIOSCL THROM VAS, V21, P1816, DOI 10.1161/hq1101.097803; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Centers for Disease Control, 2004, NHANES CARD FITN PRO; Centers for Disease Control and Prevention, 2010, DEF OV OB; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Demmer RT, 2008, COMMUNITY DENT ORAL, V36, P493, DOI 10.1111/j.1600-0528.2008.00435.x; Demmer RT, 2008, DIABETES CARE, V31, P1373, DOI 10.2337/dc08-0026; Demmer RT, 2006, J AM DENT ASSOC, V137, p14S, DOI 10.14219/jada.archive.2006.0402; Demmer RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077441; Demmer RT, 2012, DIABETES CARE, V35, P2235, DOI 10.2337/dc12-0072; Demmer RT, 2010, DIABETES CARE, V33, P1037, DOI 10.2337/dc09-1778; Demmer RT, 2010, PERIODONTOL 2000, V53, P28, DOI 10.1111/j.1600-0757.2009.00326.x; Demmer RT, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-2; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Desvarieux M, 2004, STROKE, V35, P2029, DOI 10.1161/01.STR.0000136767.71518.36; Dowsett SA, 2002, J PERIODONTOL, V73, P975, DOI 10.1902/jop.2002.73.9.975; Duncan Glen E, 2006, Curr Diab Rep, V6, P29, DOI 10.1007/s11892-006-0048-1; Dye BA, 2007, COMMUNITY DENT ORAL, V35, P140, DOI 10.1111/j.1600-0528.2007.00310.x; Dye BA, 2008, J PUBLIC HEALTH DENT, V68, P218, DOI 10.1111/j.1752-7325.2007.00076.x; Eberhard J, 2013, J CLIN PERIODONTOL; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Hoyert DL, 2012, NATL VITAL STAT REPO, V21, P29; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; Joshipura KJ, 2003, STROKE, V34, P47, DOI 10.1161/01.STR.0000052974.79428.0C; Kaur G, 2009, J CLIN PERIODONTOL, V36, P765, DOI 10.1111/j.1600-051X.2009.01445.x; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Koromantzos PA, 2011, J CLIN PERIODONTOL, V38, P142, DOI 10.1111/j.1600-051X.2010.01652.x; Lu B, 2008, ATHEROSCLEROSIS, V200, P199, DOI 10.1016/j.atherosclerosis.2007.12.037; Mullooly Cathy, 2002, Curr Diab Rep, V2, P441, DOI 10.1007/s11892-002-0109-z; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Owens JD, 2003, J PERIODONTOL, V74, P1206, DOI 10.1902/jop.2003.74.8.1206; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Sfyroeras GS, 2012, J VASC SURG, V55, P1178, DOI 10.1016/j.jvs.2011.10.008; Shimazaki Y, 2010, J PERIODONTOL, V81, P1124, DOI 10.1902/jop.2010.100017; Slade GD, 2000, J DENT RES, V79, P49, DOI 10.1177/00220345000790010701; Smith AC, 2012, INT J STROKE, V7, P499, DOI 10.1111/j.1747-4949.2012.00791.x; Sullivan PW, 2007, OBESITY, V15, P3150, DOI 10.1038/oby.2007.375; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; U. S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Wakai K, 1999, J CLIN PERIODONTOL, V26, P664, DOI 10.1034/j.1600-051X.1999.261006.x; Wang CY, 2010, AM J EPIDEMIOL, V171, P426, DOI 10.1093/aje/kwp412; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Wu TJ, 2000, ARCH INTERN MED, V160, P2749, DOI 10.1001/archinte.160.18.2749	49	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92441	10.1371/journal.pone.0092441	http://dx.doi.org/10.1371/journal.pone.0092441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663097	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900064
J	Tighiouart, M; Liu, Y; Rogatko, A				Tighiouart, Mourad; Liu, Yuan; Rogatko, Andre			Escalation with Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials	PLOS ONE			English	Article							CONTINUAL REASSESSMENT METHOD; DOSE-ESCALATION; DESIGNS	Escalation with overdose control (EWOC) is a Bayesian adaptive phase I clinical trial design that produces consistent sequences of doses while controlling the probability that patients are overdosed. However, this design does not take explicitly into account the time it takes for a patient to exhibit dose limiting toxicity (DLT) since the occurrence of DLT is ascertained within a predetermined window of time. Models to estimate the Maximum Tolerated Dose (MTD) that use the exact time when the DLT occurs are expected to be more precise than those where the variable of interest is categorized as presence or absence of DLT, given that information is lost in the process of categorization of the variable. We develop a class of parametric models for time to toxicity data in order to estimate the MTD efficiently, and present extensive simulations showing that the method has good design operating characteristics relative to the original EWOC and a version of time to event EWOC (TITE-EWOC) which allocates weights to account for the time it takes for a patient to exhibit DLT. The methodology is exemplified by a cancer phase I clinical trial we designed in order to estimate the MTD of Veliparib (ABT-888) in combination with fixed doses of gemcitabine and intensity modulated radiation therapy in patients with locally advanced, un-resectable pancreatic cancer.	[Tighiouart, Mourad; Rogatko, Andre] Samuel Oschin Comprehens Canc Inst, Biostat & Bioinformat Res Ctr, Los Angeles, CA 90048 USA; [Liu, Yuan] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Cedars Sinai Medical Center; Emory University	Tighiouart, M (corresponding author), Samuel Oschin Comprehens Canc Inst, Biostat & Bioinformat Res Ctr, Los Angeles, CA 90048 USA.	mourad.tighiouart@cshs.org			National Center for Research Resources [UL1RR033176]; National Center for Advancing Translational Sciences [UL1TR000124, 5P01CA098912-05, P01DK046763, 2R01CA108646-07A1]; NATIONAL CANCER INSTITUTE [P01CA098912, R01CA108646] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Center for Research Resources, Grant UL1RR033176, and is now at the National Center for Advancing Translational Sciences, Grant UL1TR000124 (M. T and A. R), Grant 5P01CA098912-05 (A. R.), P01DK046763 (A. R.), and 2R01CA108646-07A1 (A. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babb J, 1998, STAT MED, V17, P1103, DOI 10.1002/(SICI)1097-0258(19980530)17:10<1103::AID-SIM793>3.0.CO;2-9; Braun TM, 2007, CLIN TRIALS, V4, P113, DOI 10.1177/1740774507076934; Cheung YK, 2005, BIOMETRIKA, V92, P863, DOI 10.1093/biomet/92.4.863; Cheung YK, 2000, BIOMETRICS, V56, P1177, DOI 10.1111/j.0006-341X.2000.01177.x; COX DR, 1972, J R STAT SOC B, V34, P187; Faries D, 1994, J Biopharm Stat, V4, P147, DOI 10.1080/10543409408835079; Fedorov V. V., 2011, BEST INTENTION DESIG; GOODMAN SN, 1995, STAT MED, V14, P1149, DOI 10.1002/sim.4780141102; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Klein JP, 2003, SURVIVAL ANAL; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mauguen A, 2011, STAT MED, V30, P1584, DOI 10.1002/sim.4128; Maur M, 2007, HEMATOL ONCOL, V25, P53, DOI 10.1002/hon.808; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MOLLER S, 1995, STAT MED, V14, P911, DOI 10.1002/sim.4780140909; OQUIGLEY J, 1990, BIOMETRICS, V46, P33, DOI 10.2307/2531628; Oron AP, 2013, CLIN TRIALS, V10, P63, DOI 10.1177/1740774512469311; Piantadosi S, 1998, CANCER CHEMOTH PHARM, V41, P429, DOI 10.1007/s002800050763; Polley MYC, 2011, STAT MED, V30, P2130, DOI 10.1002/sim.4255; Rogatko A., 2012, USER GUIDE WEB BASED; Rosenberger WF, 2002, STAT MED, V21, P2757, DOI 10.1002/sim.1229; Storer BE, 2001, STAT MED, V20, P2399, DOI 10.1002/sim.903.abs; Tighiouart M, 2005, STAT MED, V24, P2183, DOI 10.1002/sim.2106; Tighiouart M, 2012, J PROBABILITY STAT, V2012, P18; TIGHIOUART M, 2012, J PROBABILITY STAT, V2012, P16, DOI DOI 10.1155/2012/692725; Tighiouart M, 2012, J PROBAB STAT, V2012, DOI 10.1155/2012/567819; Tighiouart M, 2010, STAT SCI, V25, P217, DOI 10.1214/10-STS333; Ting N., 2006, DOSE FINDING DRUG DE; Zacks S, 1998, STAT PROBABIL LETT, V38, P215, DOI 10.1016/S0167-7152(98)00016-9	30	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93070	10.1371/journal.pone.0093070	http://dx.doi.org/10.1371/journal.pone.0093070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663812	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900149
J	Yu, Z; Yang, J; Liu, LM				Yu, Zheng; Yang, Jun; Liu, Lemian			Denitrifier Community in the Oxygen Minimum Zone of a Subtropical Deep Reservoir	PLOS ONE			English	Article							NITRATE-REDUCING COMMUNITY; NITROUS-OXIDE REDUCTASE; NOSZ GENES; NITRIC-OXIDE; PCR PRIMERS; BACTERIA; NIRK; NARG; ABUNDANCE; QUANTIFICATION	Denitrification is an important pathway for nitrogen removal from aquatic systems and this could benefit water quality. However, little is known about the denitrifier community composition and key steps of denitrification in the freshwater environments, and whether different bacteria have a role in multiple processes of denitrification reduction. In this study, quantitative PCR, quantitative RT-PCR, clone library and 454 pyrosequencing were used together to investigate the bacterial and denitrifier community in a subtropical deep reservoir during the strongly stratified period. Our results indicated that the narG gene recorded the highest abundance among the denitrifying genes (2.76x10(9) copies L-1 for DNA and 4.19x10(8) copies L-1 for RNA), and the lowest value was nosZ gene (7.56x10(5) copies L-1 for DNA and undetected for RNA). The RNA: DNA ratios indicated that narG gene was the most active denitrifying gene in the oxygen minimum zone of Dongzhen Reservoir. Further, alpha-, beta- and gamma- Proteobacteria were the overwhelmingly dominant classes of denitrifier communities. Each functional gene had its own dominant groups which were different at the genus level: the narG gene was dominated by Albidiferax, while nirS gene was dominated by Dechloromonas. The main OTU of nirK gene was Rhodopseudomonas palustris, but for norB and nosZ genes, they were Bacillus and Bradyrhizobium, respectively. These results contribute to the understanding of linkages between denitrifier community, function and how they work together to complete the denitrification process. Studies on denitrifier community and activity may be useful in managing stratified reservoirs for the ecosystem services and aiding in constructing nitrogen budgets.	[Yu, Zheng; Yang, Jun; Liu, Lemian] Chinese Acad Sci, Inst Urban Environm, Aquat EcoHlth Grp, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China; [Yu, Zheng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, J (corresponding author), Chinese Acad Sci, Inst Urban Environm, Aquat EcoHlth Grp, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China.	jyang@iue.ac.cn	Yang, Jun/E-6680-2011; CAS, KLUEH/T-5743-2019; YANG, Jun/J-2819-2014	Yang, Jun/0000-0002-7920-2777; YANG, Jun/0000-0002-5069-507X; Liu, Lemian/0000-0002-8977-6969	National High-Tech Research and Development Program of China [2012AA062607]; International Science and Technology Cooperation Program of China [2011DFB91710]; Natural Science Foundation for Distinguished Young Scholars of Fujian Province [2012J06009]; National Natural Science Foundation of China [31172114, 31370471]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); International Science and Technology Cooperation Program of China; Natural Science Foundation for Distinguished Young Scholars of Fujian Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National High-Tech Research and Development Program of China (2012AA062607), the International Science and Technology Cooperation Program of China (2011DFB91710), the Natural Science Foundation for Distinguished Young Scholars of Fujian Province (2012J06009), the National Natural Science Foundation of China (31172114, 31370471). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Angeloni NL, 2006, FEMS MICROBIOL LETT, V263, P86, DOI 10.1111/j.1574-6968.2006.00409.x; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Beaulieu JJ, 2011, P NATL ACAD SCI USA, V108, P214, DOI 10.1073/pnas.1011464108; Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; Braker G, 2003, APPL ENVIRON MICROB, V69, P3476, DOI 10.1128/AEM.69.6.3476-3483.2003; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Burgin AJ, 2012, AQUAT MICROB ECOL, V66, P283, DOI 10.3354/ame01574; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Casciotti KL, 2005, FEMS MICROBIOL ECOL, V52, P197, DOI 10.1016/j.femsec.2004.11.002; Cheneby D, 2003, MICROBIAL ECOL, V46, P113, DOI 10.1007/s00248-002-2042-8; Chon K, 2011, ECOL ENG, V37, P64, DOI 10.1016/j.ecoleng.2009.04.005; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Deiglmayr K, 2006, ENVIRON MICROBIOL, V8, P1600, DOI 10.1111/j.1462-2920.2006.01051.x; Finneran KT, 2003, INT J SYST EVOL MICR, V53, P669, DOI 10.1099/ijs.0.02298-0; Gruber N., 2004, OCEAN CARBON CYCLE C, P97, DOI DOI 10.1007/978-1-4020-2087-2_4; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Henry S, 2004, J MICROBIOL METH, V59, P327, DOI 10.1016/j.mimet.2004.07.002; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Kandeler E, 2006, APPL ENVIRON MICROB, V72, P5957, DOI 10.1128/AEM.00439-06; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Mounier E, 2004, ENVIRON MICROBIOL, V6, P301, DOI 10.1111/j.1462-2920.2004.00571.x; Naqvi SWA, 2008, BIOGEOSCIENCES, V5, P1033, DOI 10.5194/bg-5-1033-2008; Philippot L, 2002, APPL ENVIRON MICROB, V68, P6121, DOI 10.1128/AEM.68.12.6121-6128.2002; Philippot L, 2002, BBA-GENE STRUCT EXPR, V1577, P355, DOI 10.1016/S0167-4781(02)00420-7; Philippot L, 2007, ADV AGRON, V96, P249, DOI 10.1016/S0065-2113(07)96003-4; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Saunders DL, 2001, HYDROBIOLOGIA, V443, P205, DOI 10.1023/A:1017506914063; Scala DJ, 1998, FEMS MICROBIOL LETT, V162, P61, DOI 10.1111/j.1574-6968.1998.tb12979.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Smith CJ, 2007, APPL ENVIRON MICROB, V73, P3612, DOI 10.1128/AEM.02894-06; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Vidali M, 2001, PURE APPL CHEM, V73, P1163, DOI 10.1351/pac200173071163; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wallenstein MD, 2006, ECOL APPL, V16, P2143, DOI 10.1890/1051-0761(2006)016[2143:ECODCA]2.0.CO;2; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Yang J, 2012, ENVIRON SCI POLLUT R, V19, P1432, DOI 10.1007/s11356-011-0683-1; Yoshida M, 2010, MICROBES ENVIRON, V25, P45, DOI 10.1264/jsme2.ME09160; Yoshida M, 2009, SOIL BIOL BIOCHEM, V41, P2044, DOI 10.1016/j.soilbio.2009.07.012; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819; ZUMFT WG, 1993, ARCH MICROBIOL, V160, P253, DOI 10.1007/BF00292074; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	47	23	24	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92055	10.1371/journal.pone.0092055	http://dx.doi.org/10.1371/journal.pone.0092055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664112	gold, Green Submitted, Green Published			2022-12-25	WOS:000333459900039
J	Bilano, VL; Ota, E; Ganchimeg, T; Mori, R; Souza, JP				Bilano, Ver Luanni; Ota, Erika; Ganchimeg, Togoobaatar; Mori, Rintaro; Souza, Joao Paulo			Risk Factors of Pre-Eclampsia/Eclampsia and Its Adverse Outcomes in Low- and Middle-Income Countries: A WHO Secondary Analysis	PLOS ONE			English	Article							PREECLAMPSIA; MORTALITY; HEALTH; WOMEN; CARE	Background: Pre-eclampsia has an immense adverse impact on maternal and perinatal health especially in low-and middle-income settings. We aimed to estimate the associations between pre-eclampsia/eclampsia and its risk factors, and adverse maternal and perinatal outcomes. Methods: We performed a secondary analysis of the WHO Global Survey on Maternal and Perinatal Health. The survey was a multi-country, facility-based cross-sectional study. A global sample consisting of 24 countries from three regions and 373 health facilities was obtained via a stratified multi-stage cluster sampling design. Maternal and offspring data were extracted from records using standardized questionnaires. Multi-level logistic regression modelling was conducted with random effects at the individual, facility and country levels. Results: Data for 276,388 mothers and their infants was analysed. The prevalence of pre-eclampsia/eclampsia in the study population was 10,754 (4%). At the individual level, sociodemographic characteristics of maternal age >= 30 years and low educational attainment were significantly associated with higher risk of pre-eclampsia/eclampsia. As for clinical and obstetric variables, high body mass index (BMI), nulliparity (AOR: 2.04; 95% CI 1.92-2.16), absence of antenatal care (AOR: 1.41; 95% CI 1.26-1.57), chronic hypertension (AOR: 7.75; 95% CI 6.77-8.87), gestational diabetes (AOR: 2.00; 95% CI 1.63-2.45), cardiac or renal disease (AOR: 2.38; 95% CI 1.86-3.05), pyelonephritis or urinary tract infection (AOR: 1.13; 95% CI 1.03-1.24) and severe anemia (AOR: 2.98; 95% CI 2.47-3.61) were found to be significant risk factors, while having >8 visits of antenatal care was protective (AOR: 0.90; 95% CI 0.83-0.98). Pre-eclampsia/eclampsia was found to be a significant risk factor for maternal death, perinatal death, preterm birth and low birthweight. Conclusion: Chronic hypertension, obesity and severe anemia were the highest risk factors of preeclampsia/eclampsia. Implementation of effective interventions prioritizing risk factors, provision of quality health services during pre-pregnancy and during pregnancy for joint efforts in the areas of maternal health are recommended.	[Bilano, Ver Luanni] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Ota, Erika; Ganchimeg, Togoobaatar; Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Souza, Joao Paulo] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of Tokyo; National Center for Child Health & Development - Japan; World Health Organization	Ota, E (corresponding author), Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan.	e-i@umin.ac.jp	Souza, João Paulo/G-1982-2010	Souza, João Paulo/0000-0002-2288-4244; Bilano, Ver/0000-0002-1220-6220; Ota, Erika/0000-0002-3945-7441; Mori, Rintaro/0000-0001-7656-6156	UNDP/UNFPA/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP); Department of Reproductive Health and Research (RHR); Ministry of Health, Labor and Welfare of Japan; United States Agency for International Development (USAID); Ministry of Public Health, Beijing, China; Indian Council of Medical Research, Delhi, India; Grants-in-Aid for Scientific Research [24790612] Funding Source: KAKEN	UNDP/UNFPA/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP); Department of Reproductive Health and Research (RHR); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Ministry of Public Health, Beijing, China; Indian Council of Medical Research, Delhi, India(Indian Council of Medical Research (ICMR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by the UNDP/UNFPA/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP); Department of Reproductive Health and Research (RHR); Ministry of Health, Labor and Welfare of Japan; the United States Agency for International Development (USAID); Ministry of Public Health, Beijing, China; and Indian Council of Medical Research, Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman E, 2007, NEONATAL PERINATAL M; Ali Abdelaziem A, 2011, BMC Res Notes, V4, P311, DOI 10.1186/1756-0500-4-311; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466; Conde-Agudelo A, 2000, BRIT J OBSTET GYNAEC, V107, P75, DOI 10.1111/j.1471-0528.2000.tb11582.x; Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040; Countdown Coverage Writing G, 2008, LANCET, V371, P1247; Dowswell T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000934.pub2; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Haelterman E, 2003, EUR J OBSTET GYN R B, V111, P25, DOI 10.1016/S0301-2115(03)00161-1; Jammeh A., 2011, OPEN J OBSTETR GYNEC, V01, P94, DOI [10.4236/ojog.2011.13017, DOI 10.4236/OJOG.2011.13017]; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lee CJ, 2000, INT J GYNECOL OBSTET, V70, P327, DOI 10.1016/S0020-7292(00)00240-X; Lopez-Jaramillo P, 2005, J HYPERTENS, V23, P1121, DOI 10.1097/01.hjh.0000170371.49010.4a; Lopez-Jaramillo P, 2009, COLOMB MEDICA, V40, P226; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Reyes LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041622; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x; WHO, 2004, LOW BIRTHW COUNTR RE; *WORLD BANK GROUP, 2012, WE CLASS COUNTR	23	175	185	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91198	10.1371/journal.pone.0091198	http://dx.doi.org/10.1371/journal.pone.0091198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24657964	Green Published, gold			2022-12-25	WOS:000333355300026
J	Vieira, VMNDD; Mateus, MD				de Carvalho da Silva Vieira, Vasco Manuel Nobre; Mateus, Marcos Duarte			Regulation of the Demographic Structure in Isomorphic Biphasic Life Cycles at the Spatial Fine Scale	PLOS ONE			English	Article							GELIDIUM-SESQUIPEDALE RHODOPHYTA; CHONDRUS-CRISPUS RHODOPHYTA; POPULATION-DYNAMICS; WAVE EXPOSURE; TEMPORAL VARIATION; HISTORY STAGES; DIPLOID RATIO; NOVA-SCOTIA; RED ALGA; GIGARTINALES	Isomorphic biphasic algal life cycles often occur in the environment at ploidy abundance ratios (Haploid:Diploid) different from 1. Its spatial variability occurs within populations related to intertidal height and hydrodynamic stress, possibly reflecting the niche partitioning driven by their diverging adaptation to the environment argued necessary for their prevalence (evolutionary stability). Demographic models based in matrix algebra were developed to investigate which vital rates may efficiently generate an H:D variability at a fine spatial resolution. It was also taken into account time variation and type of life strategy. Ploidy dissimilarities in fecundity rates set an H:D spatial structure miss-fitting the ploidy fitness ratio. The same happened with ploidy dissimilarities in ramet growth whenever reproductive output dominated the population demography. Only through ploidy dissimilarities in looping rates (stasis, breakage and clonal growth) did the life cycle respond to a spatially heterogeneous environment efficiently creating a niche partition. Marginal locations were more sensitive than central locations. Related results have been obtained experimentally and numerically for widely different life cycles from the plant and animal kingdoms. Spore dispersal smoothed the effects of ploidy dissimilarities in fertility and enhanced the effects of ploidy dissimilarities looping rates. Ploidy dissimilarities in spore dispersal could also create the necessary niche partition, both over the space and time dimensions, even in spatial homogeneous environments and without the need for conditional differentiation of the ramets. Fine scale spatial variability may be the key for the prevalence of isomorphic biphasic life cycles, which has been neglected so far.	[de Carvalho da Silva Vieira, Vasco Manuel Nobre; Mateus, Marcos Duarte] Univ Tecn Lisboa, Inst Super Tecn, MARETEC, P-1096 Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico	Vieira, VMNDD (corresponding author), Univ Tecn Lisboa, Inst Super Tecn, MARETEC, P-1096 Lisbon, Portugal.	vasco.vieira@ist.utl.pt	Mateus, Marcos Duarte/C-3083-2012	Mateus, Marcos Duarte/0000-0003-4916-6821; Vieira, Vasco/0000-0001-9858-6254	Portuguese Science Foundation (FCT) [SFRH/BD/19339/2004/MS47]; Portuguese Science Foundation (FCT) program Ciencia	Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology); Portuguese Science Foundation (FCT) program Ciencia	V.V. was supported by a Ph D grant from the Portuguese Science Foundation (FCT), SFRH/BD/19339/2004/MS47. M.M. was supported by the Portuguese Science Foundation (FCT) program Ciencia2008. www.fct.pt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbuti R, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-49; Carmona R, 2006, J PHYCOL, V42, P259, DOI 10.1111/j.1529-8817.2006.00190.x; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Vieira VMNCS, 2012, J PHYCOL, V48, P1012, DOI 10.1111/j.1529-8817.2012.01192.x; Vieira VMNDD, 2010, J PHYCOL, V46, P1128, DOI 10.1111/j.1529-8817.2010.00924.x; DESTOMBE C, 1989, J EVOLUTION BIOL, V2, P317, DOI 10.1046/j.1420-9101.1989.2050317.x; DeWreede R.E., 1999, PHYCOL RES, V47, P153; Dyck LJ, 2006, PHYCOL RES, V54, P21, DOI 10.1111/j.1440-1835.2006.00405.x; Ehrlen J, 1999, MODELLING MEASURING; Engel C, 2001, J ECOL, V89, P436, DOI 10.1046/j.1365-2745.2001.00567.x; Fierst J, 2005, J PHYCOL, V41, P238, DOI 10.1111/j.1529-8817.2005.04024.x; Franco M, 1996, PHILOS T R SOC B, V351, P1341, DOI 10.1098/rstb.1996.0117; Garza-Sanchez F, 2000, BOT MAR, V43, P205, DOI 10.1515/BOT.2000.022; Gonzalez J, 1996, AQUACULTURE, V143, P91, DOI 10.1016/0044-8486(95)01203-6; Hughes JS, 1999, AM NAT, V154, P306, DOI 10.1086/303241; Lindgren A, 1998, J APPL PHYCOL, V10, P273, DOI 10.1023/A:1008065810904; Mudge B, 2003, J MAR BIOL ASSOC UK, V83, P701, DOI 10.1017/S0025315403007665h; Oostermeijer JGB, 1996, J ECOL, V84, P153, DOI 10.2307/2261351; Otaiza RD, 2001, J APPL PHYCOL, V13, P161, DOI 10.1023/A:1011135308283; Pacheco-Ruiz I, 2011, BOT MAR, V54, P127, DOI 10.1515/BOT.2011.019; Pandey M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-48; Prathep A, 2009, AQUAT BOT, V90, P179, DOI 10.1016/j.aquabot.2008.09.003; Rojas-Sandoval J, 2013, POPUL ECOL, V55, P479, DOI 10.1007/s10144-013-0378-1; Roleda MY, 2008, PHYCOLOGIA, V47, P361, DOI 10.2216/PH07-84.1; Santos R, 1996, HYDROBIOLOGIA, V327, P223, DOI 10.1007/BF00047811; Santos R, 1998, J APPL PHYCOL, V10, P261, DOI 10.1023/A:1008083926349; SCROSATI R, 1994, BOT MAR, V37, P293, DOI 10.1515/botm.1994.37.4.293; Scrosati R, 2004, HYDROBIOLOGIA, V520, P199, DOI 10.1023/B:HYDR.0000027839.48584.6c; Scrosati R, 2004, HYDROBIOLOGIA, V519, P215, DOI 10.1023/B:HYDR.0000026600.88646.31; Serviere-Zaragoza Elisa, 2002, Pacific Science, V56, P285, DOI 10.1353/psc.2002.0029; Thornber C, 2006, ECOLOGY, V87, P2255, DOI 10.1890/0012-9658(2006)87[2255:TTMSHO]2.0.CO;2; Thornber CS, 2004, ECOLOGY, V85, P1661, DOI 10.1890/02-4101; Thornber CS, 2003, MAR ECOL PROG SER, V258, P65, DOI 10.3354/meps258065; Verges A, 2008, ECOLOGY, V89, P1334, DOI 10.1890/07-0248.1; Vieira VMNCS, 2012, J BIOL DYNAM, V6, P1067, DOI 10.1080/17513758.2012.721901	35	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92602	10.1371/journal.pone.0092602	http://dx.doi.org/10.1371/journal.pone.0092602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658603	Green Submitted, gold, Green Published			2022-12-25	WOS:000333355300103
J	Bertness, MD; Brisson, CP; Bevil, MC; Crotty, SM				Bertness, Mark D.; Brisson, Caitlin P.; Bevil, Matthew C.; Crotty, Sinead M.			Herbivory Drives the Spread of Salt Marsh Die-Off	PLOS ONE			English	Article							CONSUMER CONTROL; CRAB HERBIVORY; DIEBACK; EUTROPHICATION; DEGRADATION; COLLAPSE	Salt marsh die-off is a Western Atlantic conservation problem that has recently spread into Narragansett Bay, Rhode Island, USA. It has been hypothesized to be driven by: 1) eutrophication decreasing plant investment into belowground biomass causing plant collapse, 2) boat wakes eroding creek banks, 3) pollution or disease affecting plant health, 4) substrate hardness controlling herbivorous crab distributions and 5) trophic dysfunction releasing herbivorous crabs from predator control. To distinguish between these hypotheses we quantified these variables at 14 Narragansett Bay salt marshes where die-off intensity ranged from <5% to nearly 98%. Nitrogen availability, wave intensity and plant growth did not explain any variation in die-off. Herbivory explained 73% of inter-site variation in die-off and predator control of herbivores and substrate hardness also varied significantly with die-off. This suggests that salt marsh die-off is being largely driven by intense herbivory via the release of herbivorous crabs from predator control. Our results and those from other marsh systems suggest that consumer control may not simply be a factor to consider in marsh conservation, but with widespread predator depletion impacting near shore habitats globally, trophic dysfunction and runaway consumption may be the largest and most urgent management challenge for salt marsh conservation.	[Bertness, Mark D.; Brisson, Caitlin P.; Bevil, Matthew C.; Crotty, Sinead M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Brown University	Bertness, MD (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	Mark_Bertness@brown.edu		Brisson, Caitlin/0000-0001-8567-1863	National Science Foundation Biological Oceanography Program [BIO OCE-0927090]; Brown University Undergraduate Teaching and Research Award Program; Voss Environmental Fellowship Program	National Science Foundation Biological Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Brown University Undergraduate Teaching and Research Award Program; Voss Environmental Fellowship Program	This research was made possible by a grant from the National Science Foundation Biological Oceanography Program BIO OCE-0927090, the Brown University Undergraduate Teaching and Research Award Program, and the Voss Environmental Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber M, 2008, ESTUAR COAST SHELF S, V80, P1, DOI 10.1016/j.ecss.2008.08.009; Alberti J, 2008, ECOLOGY, V89, P155, DOI 10.1890/07-0045.1; Altieri AH, 2012, ECOLOGY, V93, P1402, DOI 10.1890/11-1314.1; Anisfeld SC, 2012, ESTUAR COAST, V35, P201, DOI 10.1007/s12237-011-9440-4; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bertness MD, 2008, CONSERV BIOL, V22, P618, DOI 10.1111/j.1523-1739.2008.00962.x; Bertness MD, 2008, CONSERV BIOL, V22, P131, DOI 10.1111/j.1523-1739.2007.00801.x; Bertness MD, 2009, ECOLOGY, V90, P2108, DOI 10.1890/08-1396.1; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; BERTNESS MD, 1988, ECOLOGY, V69, P703, DOI 10.2307/1941018; Coverdale TC, 2013, FRONT ECOL ENVIRON, V11, P69, DOI 10.1890/120130; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; Elmer WH, 2013, PLANT DIS, V97, P436, DOI 10.1094/PDIS-09-12-0871-FE; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; HINES AH, 1982, MAR BIOL, V69, P309, DOI 10.1007/BF00397496; Holdredge C, 2009, CONSERV BIOL, V23, P672, DOI 10.1111/j.1523-1739.2008.01137.x; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jefferies RL, 2006, J ECOL, V94, P234, DOI 10.1111/j.1365-2745.2005.01086.x; Kiehn WM, 2009, WETLANDS, V29, P818, DOI 10.1672/08-178.1; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Mendelssohn IA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P59; ODUM E P, 1971, P574; Ogburn MB, 2006, ESTUAR COAST, V29, P54, DOI 10.1007/BF02784698; OLMI EJ, 1983, J CRUSTACEAN BIOL, V3, P575; Randelli G., 2011, LNAI, V6556, P278; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; SMITH JP, 2007, SURVEY POTENTIAL MAR; VALIELA I, 1995, MARINE ECOLOGICAL PR, V2; Wigley S. E., 2003, NMFSNE171 NOAA; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; YUND PO, 1991, LIMNOL OCEANOGR, V36, P1167, DOI 10.4319/lo.1991.36.6.1167	32	42	43	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92916	10.1371/journal.pone.0092916	http://dx.doi.org/10.1371/journal.pone.0092916			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651837	Green Submitted, gold, Green Published			2022-12-25	WOS:000333352800165
J	Chan, KP; Wong, CM; Chiu, SSS; Chan, KH; Wang, XL; Chan, ELY; Peiris, JSM; Yang, L				Chan, King Pan; Wong, Chit Ming; Chiu, Susan S. S.; Chan, Kwok Hung; Wang, Xi Ling; Chan, Eunice L. Y.; Peiris, J. S. Malik; Yang, Lin			A Robust Parameter Estimation Method for Estimating Disease Burden of Respiratory Viruses	PLOS ONE			English	Article							INFLUENZA-ASSOCIATED MORTALITY; SYNCYTIAL VIRUS; HONG-KONG; INFECTIOUS-DISEASES; SEASONAL INFLUENZA; ELDERLY PERSONS; UNITED-STATES; TIME-SERIES; HOSPITALIZATION; CHILDREN	Background: Poisson model has been widely applied to estimate the disease burden of influenza, but there has been little success in providing reliable estimates for other respiratory viruses. Methods: We compared the estimates of excess hospitalization rates derived from the Poisson models with different combinations of inference methods and virus proxies respectively, with the aim to determine the optimal modeling approach. These models were validated by comparing the estimates of excess hospitalization attributable to respiratory viruses with the observed rates of laboratory confirmed paediatric hospitalization for acute respiratory infections obtained from a population based study. Results: The Bayesian inference method generally outperformed the classical likelihood estimation, particularly for RSV and parainfluenza, in terms of providing estimates closer to the observed hospitalization rates. Compared to the other proxy variables, age-specific positive counts provided better estimates for influenza, RSV and parainfluenza, regardless of inference methods. The Bayesian inference combined with age-specific positive counts also provided valid and reliable estimates for excess hospitalization associated with multiple respiratory viruses in both the 2009 H1N1 pandemic and interpandemic period. Conclusions: Poisson models using the Bayesian inference method and virus proxies of age-specific positive counts should be considered in disease burden studies on multiple respiratory viruses.	[Chan, King Pan; Wong, Chit Ming; Wang, Xi Ling; Peiris, J. S. Malik; Yang, Lin] Univ Hong Kong, Sch Publish Hlth, Hong Kong, Hong Kong, Peoples R China; [Chiu, Susan S. S.; Chan, Eunice L. Y.] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Kwok Hung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Squina Int Ctr Infect Control, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Hong Kong Polytechnic University	Wong, CM (corresponding author), Univ Hong Kong, Sch Publish Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrwcm@hku.hk; ssschiu@hkucc.hku.hk	Chan, Kwok Hung/ABD-5399-2021; YANG, Lin/F-9601-2014; Peiris, Joseph Sriyal Malik/C-4380-2009	YANG, Lin/0000-0002-5964-3233; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995	Research Fund for the Control of Infectious Diseases [RFCID 11100582]; Area of Excellence Scheme of the University Grants Committee of the Hong Kong Special Administrative Region Government [AoE/M-12/06]	Research Fund for the Control of Infectious Diseases; Area of Excellence Scheme of the University Grants Committee of the Hong Kong Special Administrative Region Government	This work was supported by the Research Fund for the Control of Infectious Diseases [RFCID 11100582] and the Area of Excellence Scheme of the University Grants Committee [AoE/M-12/06] of the Hong Kong Special Administrative Region Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl J, 2011, P NATL ACAD SCI USA, V108, P19359, DOI 10.1073/pnas.1109314108; Belongia EA, 2010, JAMA-J AM MED ASSOC, V304, P1091, DOI 10.1001/jama.2010.1277; Birrell PJ, 2011, P NATL ACAD SCI USA, V108, P18238, DOI 10.1073/pnas.1103002108; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Charu V, 2013, INFLUENZA OTHER RESP; Chiu SS, 2009, CLIN INFECT DIS, V49, P1016, DOI 10.1086/605570; Christensen R, 2011, BAYESIAN IDEAS DATA; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Engelhard D, 2011, EMERG INFECT DIS, V17, P1740, DOI 10.3201/eid1709.102022; Fleming DM, 2007, EPIDEMIOL INFECT, V135, P1099, DOI 10.1017/S0950268807007881; Foppa IM, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-26; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hernandez JE, 2012, INFLUENZA OTHER RESP, V6, P305, DOI 10.1111/j.1750-2659.2011.00303.x; Hui SL, 2006, VACCINE, V24, P5371, DOI 10.1016/j.vaccine.2006.04.032; Karageorgopoulos D. E., 2011, PLoS ONE, pe21690, DOI 10.1371/journal.pone.0021690; Lemaitre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045051; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Munoz Flor M, 2003, Paediatr Respir Rev, V4, P99, DOI 10.1016/S1526-0542(03)00027-7; Newall AT, 2010, EPIDEMIOL INFECT, V138, P836, DOI 10.1017/S095026880999118X; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Redlberger-Fritz M, 2012, EUR J EPIDEMIOL, V27, P567, DOI 10.1007/s10654-012-9701-y; Song XY, 2012, INFLUENZA OTHER RESP, V6, P25, DOI 10.1111/j.1750-2659.2011.00258.x; Thompson WW, 2012, EPIDEMIOLOGY, V23, P839, DOI 10.1097/EDE.0b013e31826cc1df; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; van Asten L, 2012, J INFECT DIS, V206, P628, DOI 10.1093/infdis/jis415; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; Wong JY, 2013, AM J EPIDEMIOL, V177, P834, DOI 10.1093/aje/kws314; Wu JT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001103; Wu P, 2012, J INFECT DIS, V206, P1862, DOI 10.1093/infdis/jis628; Yang L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-342; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017882; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211; [No title captured]	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90126	10.1371/journal.pone.0090126	http://dx.doi.org/10.1371/journal.pone.0090126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651832	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800011
J	Gorski, L; Walker, S; Liang, AS; Nguyen, KM; Govoni, J; Carychao, D; Cooley, MB; Mandrell, RE				Gorski, Lisa; Walker, Samarpita; Liang, Anita S.; Nguyen, Kimberly M.; Govoni, Jessica; Carychao, Diana; Cooley, Michael B.; Mandrell, Robert E.			Comparison of Subtypes of Listeria monocytogenes Isolates from Naturally Contaminated Watershed Samples with and without a Selective Secondary Enrichment	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; LOCUS VARIABLE-NUMBER; IMMUNOMAGNETIC SEPARATION; CHROMOGENIC AGAR; FOOD; STRAINS; DIFFERENTIATION; IDENTIFICATION; DIVERSITY; RECOVERY	Two enrichment methods for Listeria monocytogenes using Immuno Magnetic Separation (IMS) were tested to determine if they selected the same subtypes of isolates. Both methods used a non-selective primary enrichment and one included subculture in Fraser Broth, while the other involved direct plating of IMS beads. Sixty-two naturally contaminated watershed samples from the Central California Coast were used as a source of L. monocytogenes, and subtype diversity was measured by serotype and Multiple Number Variable Tandem Repeat Analysis (MLVA). Three different serotypes were detected from both methods with serotype 4b strains making up 87% of the isolates, serotype 1/2a making up 8%, and serotype 1/2b making up 5%. The data suggest that serotype 1/2a strains were more likely to be isolated from the Fraser Broth culture method. Sixty-two different MLVA types were detected and the more common MLVA types were detected by both culture methods. Forty-three MLVA types were detected only from one culture method or the other, while 19 types were detected from both culture methods. The most common MLVA type-12 was detected in 33 of the 62 water samples, and represented 31% of the isolates from both culture methods. This limited study provides evidence that using both enrichment culture methods allowed for detection of a greater diversity of isolates among the samples than the use of one method alone, and that a wide diversity of L. monocytogenes strains exist in this watershed.	[Gorski, Lisa; Walker, Samarpita; Liang, Anita S.; Nguyen, Kimberly M.; Govoni, Jessica; Carychao, Diana; Cooley, Michael B.; Mandrell, Robert E.] USDA ARS, Prod Safety & Microbiol Res Unit, Albany, CA 94710 USA	United States Department of Agriculture (USDA)	Gorski, L (corresponding author), USDA ARS, Prod Safety & Microbiol Res Unit, Albany, CA 94710 USA.	lisa.gorski@ars.usda.gov	Mandrell, Robert E/O-9814-2018	Gorski, Lisa/0000-0003-2387-1012	Agricultural Research Service CRIS project [5325-42000-046-00D]; FDA grant [224-11-2044]; USDA-NIFA [5325-42000-047-05R]	Agricultural Research Service CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); FDA grant; USDA-NIFA(United States Department of Agriculture (USDA))	This work was funded through funds from Agricultural Research Service CRIS project 5325-42000-046-00D, FDA grant #224-11-2044, and USDA-NIFA grant project agreement 5325-42000-047-05R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT TJ, 1980, J CLIN MICROBIOL, V11, P385, DOI 10.1128/JCM.11.4.385-388.1980; Bauwens L, 2003, VET MICROBIOL, V91, P115, DOI 10.1016/S0378-1135(02)00265-1; Benoit PW, 2003, J FOOD PROTECT, V66, P1935, DOI 10.4315/0362-028X-66.10.1935; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P961, DOI 10.1128/AEM.71.2.961-967.2005; CURIALE MS, 1994, J FOOD PROTECT, V57, P1048, DOI 10.4315/0362-028X-57.12.1048; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Duarte G, 1999, INT J FOOD MICROBIOL, V52, P163, DOI 10.1016/S0168-1605(99)00121-X; FDA, 2012, FIN UPD MULT OUTBR L; FRANCES N, 1991, EPIDEMIOL INFECT, V107, P235, DOI 10.1017/S0950268800048858; Gelbicova T, 2012, CZECH J FOOD SCI, V30, P83, DOI 10.17221/7/2011-CJFS; Gorski L, 2006, APPL ENVIRON MICROB, V72, P776, DOI 10.1128/AEM.72.1.776-783.2006; Graves LM, 2001, INT J FOOD MICROBIOL, V65, P55, DOI 10.1016/S0168-1605(00)00501-8; Hitchins AD, 2003, BACTERIAL ANAL MANUA; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Loncarevic S, 1996, LETT APPL MICROBIOL, V22, P381, DOI 10.1111/j.1472-765X.1996.tb01184.x; Lyautey E, 2007, APPL ENVIRON MICROB, V73, P5401, DOI 10.1128/AEM.00354-07; Lyautey E, 2012, CAN J MICROBIOL, V58, P1405, DOI 10.1139/cjm-2012-0418; Murphy M, 2007, INT J FOOD MICROBIOL, V115, P187, DOI 10.1016/j.ijfoodmicro.2006.10.022; Ngutter C, 2003, J FOOD PROTECT, V66, P2252, DOI 10.4315/0362-028X-66.12.2252; Norton DM, 2001, APPL ENVIRON MICROB, V67, P198, DOI 10.1128/AEM.67.1.198-205.2001; Osborne CM, 2002, J FOOD PROTECT, V65, P1122, DOI 10.4315/0362-028X-65.7.1122; Palumbo JD, 2003, J CLIN MICROBIOL, V41, P564, DOI 10.1128/JCM.41.2.564-571.2003; PERRY CM, 1990, J FOOD PROTECT, V53, P642, DOI 10.4315/0362-028X-53.8.642; PETRAN RL, 1993, J FOOD PROTECT, V56, P616, DOI 10.4315/0362-028X-56.7.616; Pritchard TJ, 1999, J FOOD PROTECT, V62, P532, DOI 10.4315/0362-028X-62.5.532; Ryser ET, 1996, APPL ENVIRON MICROB, V62, P1781, DOI 10.1128/AEM.62.5.1781-1787.1996; Saleh-Lakha S, 2013, APPL ENVIRON MICROB, DOI [10.1128/AEM.00759-00713, DOI 10.1128/AEM.00759-00713]; Sauders BD, 2012, APPL ENVIRON MICROB, V78, P4420, DOI 10.1128/AEM.00282-12; Silk BJ, 2013, MMWR-MORBID MORTAL W, V62, P448, DOI 10.1016/j.annemergmed.2013.08.006; Silk TM, 2002, J FOOD PROTECT, V65, P1333, DOI 10.4315/0362-028X-65.8.1333; Sperry KEV, 2008, J CLIN MICROBIOL, V46, P1435, DOI 10.1128/JCM.02207-07; Sperry KEV, 2009, J CLIN MICROBIOL, V47, P1984, DOI 10.1128/JCM.00730-09; Szymczak B, 2013, FOLIA MICROBIOL, V58, DOI [10.1007/s12223-12013-10260-12228, DOI 10.1007/S12223-12013-10260-12228]; Uyttendaele M, 2000, INT J FOOD MICROBIOL, V54, P205, DOI 10.1016/S0168-1605(99)00196-8; Wadud S, 2010, J MICROBIOL METH, V81, P153, DOI 10.1016/j.mimet.2010.02.014; Willis C, 2006, J APPL MICROBIOL, V101, P711, DOI 10.1111/j.1365-2672.2006.02917.x	37	13	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92467	10.1371/journal.pone.0092467	http://dx.doi.org/10.1371/journal.pone.0092467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651315	Green Published, gold			2022-12-25	WOS:000333352800114
J	Kato, K; Takamura, T; Takeshita, Y; Ryu, Y; Misu, H; Ota, T; Tokuyama, K; Nagasaka, S; Matsuhisa, M; Matsui, O; Kaneko, S				Kato, Ken-ichiro; Takamura, Toshinari; Takeshita, Yumie; Ryu, Yasuji; Misu, Hirofumi; Ota, Tsuguhito; Tokuyama, Kumpei; Nagasaka, Shoichiro; Matsuhisa, Munehide; Matsui, Osamu; Kaneko, Shuichi			Ectopic Fat Accumulation and Distant Organ-Specific Insulin Resistance in Japanese People with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							ENDOGENOUS GLUCOSE-PRODUCTION; OXIDATIVE-PHOSPHORYLATION; STEATOSIS; MUSCLE; ACIDS; STEATOHEPATITIS; SPECTROSCOPY; VALIDATION; SECRETION; PROTEIN	Objective: The aim of this study was to examine the association between ectopic fat and organ-specific insulin resistance (IR) in insulin-target organs in patients with nonalcoholic fatty liver disease (NAFLD). Methods: Organ-specific IR in the liver (hepatic glucose production (HGP)xfasting plasma insulin (FPI) and suppression of HGP by insulin [%HGP]), skeletal muscle (insulin-stimulated glucose disposal [Rd]), and adipose tissue (suppression of FFA by insulin [%FFA]) was measured in 69 patients with NAFLD using a euglycemic hyperinsulinemic clamp with tracer infusion ([6,6-H-2(2)]glucose). Liver fat, intramyocellular lipid (IMCL), and body composition were measured by liver biopsy, proton magnetic resonance spectroscopy, and bioelectrical impedance analysis, respectively. Results: HGPxFPI was significantly correlated with Rd (r = -0.57, P<0.001), %HGP with %FFA (r = 0.38, P<0.01), and Rd with %FFA (r = 0.27, P<0.05). Liver steatosis score was negatively associated with Rd (r = -0.47, P<0.001) as well as with HGPxFPI (r = 0.43, P<0.001). Similarly, intrahepatic lipid was negatively associated with Rd (r = -0.32, P<0.05). IMCL was not associated with Rd (r = -0.16, P = 0.26). Fat mass and its percentage were associated with HGPxFPI (r = 0.50, P<0.001; r = 0.48, P<0.001, respectively) and Rd (r = -0.59, P<0.001; r = -0.52, P<0.001, respectively), but not with % FFA (r = -0.21, P = 0.10; r = -0.001, P = 0.99, respectively). Conclusion: Unexpectedly, fat accumulation in the skeletal muscle and adipose tissue was not associated with organ-specific IR. Instead, liver fat was associated not only with hepatic IR but also with skeletal muscle IR, suggesting a central role of fatty liver in systemic IR and that a network exists between liver and skeletal muscle.	[Kato, Ken-ichiro; Takamura, Toshinari; Takeshita, Yumie; Misu, Hirofumi; Ota, Tsuguhito; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Ryu, Yasuji; Matsui, Osamu] Kanazawa Univ, Grad Sch Med Sci, Dept Radiol, Kanazawa, Ishikawa, Japan; [Tokuyama, Kumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Nagasaka, Shoichiro] Jichi Med Univ, Dept Med, Div Endocrinol & Metab, Shimono, Tochigi, Japan; [Matsuhisa, Munehide] Univ Tokushima, Clin Res Ctr Diabet, Tokushima 770, Japan	Kanazawa University; Kanazawa University; University of Tsukuba; Jichi Medical University; Tokushima University	Takamura, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan.	ttakamura@m-kanazawa.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [C-20591054]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for Scientific Research (C-20591054 to TT) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; COBELLI C, 1987, AM J PHYSIOL, V252, pE679, DOI 10.1152/ajpendo.1987.252.5.E679; COBELLI C, 1987, AM J PHYSIOL, V253, pE551, DOI 10.1152/ajpendo.1987.253.5.E551; D'Adamo E, 2010, DIABETES CARE, V33, P1817, DOI 10.2337/dc10-0284; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; FINEGOOD DT, 1987, DIABETES, V36, P914, DOI 10.2337/diabetes.36.8.914; Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206; Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068; Iozzo P, 2009, DIABETES CARE, V32, pS168, DOI 10.2337/dc09-S304; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kotronen A, 2008, DIABETOLOGIA, V51, P130, DOI 10.1007/s00125-007-0867-x; Kurioka S, 2002, ENDOCR J, V49, P459, DOI 10.1507/endocrj.49.459; Lomonaco R, 2011, HEPATOLOGY, V54, P837, DOI 10.1002/hep.24483; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; Misu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034952; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nagasaka S, 1999, DIABETES, V48, P1054, DOI 10.2337/diabetes.48.5.1054; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Ryysy L, 2000, DIABETES, V49, P749, DOI 10.2337/diabetes.49.5.749; Sakurai M, 2007, J GASTROENTEROL, V42, P312, DOI 10.1007/s00535-006-1948; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Takamura T, 2008, OBESITY, V16, P2601, DOI 10.1038/oby.2008.419; Takamura T, 2012, ENDOCR J, V59, P745, DOI 10.1507/endocrj.EJ12-0228; Thamer C, 2003, J CLIN ENDOCR METAB, V88, P1785, DOI 10.1210/jc.2002-021674; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Wolfe RR, 1992, RADIOACTIVE STABLE I; YKIJARVINEN H, 1987, J CLIN INVEST, V79, P1713, DOI 10.1172/JCI113011	40	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92170	10.1371/journal.pone.0092170	http://dx.doi.org/10.1371/journal.pone.0092170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651470	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800077
J	Narimatsu, Y; Kuno, A; Ito, H; Kaji, H; Kaneko, S; Usui, J; Yamagata, K; Narimatsu, H				Narimatsu, Yoshiki; Kuno, Atsushi; Ito, Hiromi; Kaji, Hiroyuki; Kaneko, Syuzo; Usui, Joichi; Yamagata, Kunihiro; Narimatsu, Hisashi			IgA Nephropathy Caused by Unusual Polymerization of IgA1 with Aberrant N-Glycosylation in a Patient with Monoclonal Immunoglobulin Deposition Disease	PLOS ONE			English	Article							LINKED GLYCOSYLATION; LIGHT-CHAINS; SERUM IGA; CARBOHYDRATE; CONFORMATION; ANTIBODIES; BINDING; GLYCAN; LECTIN; REGION	Immunoglobulin A nephropathy (IgAN) is a form of chronic glomerulonephritis characterized by the deposition of IgA immune complexes in the glomerular region. The cause of IgAN is unknown, but multiple mechanisms have been suggested. We previously reported a rare case of mesangioproliferative glomerulonephritis in a patient with monoclonal immunoglobulin deposition disease associated with monoclonal IgA1. In this study, we performed the detailed analyses of serum IgA1 from this patient in comparison with those from patients with mIgA plasma cell disorder without renal involvement and healthy volunteers. We found unusual polymerization of IgA1 with additional N-glycosylation distinctive in this patient, which was different from known etiologies. Glycan profiling of IgA1 by the lectin microarray revealed an intense signal for Wisteria floribunda agglutinin (WFA). This signal was reduced by disrupting the native conformation of IgA1, suggesting that the distinct glycan profile was reflecting the conformational alteration of IgA1, including the glycan conformation detected as additional N-glycans on both the heavy and light chains. This unusually polymerized state of IgA1 would cause an increase of the binding avidity for lectins. WFA specifically recognized highly polymerized and glycosylated IgA1. Our results of analysis in the rare case of a patient with monoclonal immunoglobulin deposition disease suggest that the formation of unusually polymerized IgA1 is caused by divergent mechanisms including multiple structural alterations of glycans, which contributes to IgA1 deposition and mesangium proliferation.	[Narimatsu, Yoshiki; Kuno, Atsushi; Ito, Hiromi; Kaji, Hiroyuki; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki, Japan; [Ito, Hiromi] Fukushima Med Univ, Sch Med, Dept Biochem Life Sci & Social Med, Fukushima, Japan; [Kaneko, Syuzo; Usui, Joichi; Yamagata, Kunihiro] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Nephrol, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Fukushima Medical University; University of Tsukuba	Narimatsu, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki, Japan.	h.narimatsu@aist.go.jp	Narimatsu, Hisashi/M-4757-2018; Kaji, Hiroyuki/L-7122-2018; Kuno, Atsushi/M-2151-2018; Narimatsu, Yoshiki/G-8388-2019	Narimatsu, Hisashi/0000-0002-8402-133X; Kaji, Hiroyuki/0000-0002-0910-9999; Kuno, Atsushi/0000-0002-6147-6171; Narimatsu, Yoshiki/0000-0003-1428-5695	New Energy and Industrial Technology Development Organization of Japan	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by a grant from New Energy and Industrial Technology Development Organization of Japan. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; Allen AC, 1999, J AM SOC NEPHROL, V10, P1763; Amore A, 2001, J AM SOC NEPHROL, V12, P1862, DOI 10.1681/ASN.V1291862; ANDRE PM, 1990, J CLIN LAB ANAL, V4, P115, DOI 10.1002/jcla.1860040208; ANDREOTTI AH, 1993, J AM CHEM SOC, V115, P3352, DOI 10.1021/ja00061a053; Boumediene A, 2011, NEPHROL DIAL TRANSPL, V26, P3930, DOI 10.1093/ndt/gfr131; Chen MM, 2010, P NATL ACAD SCI USA, V107, P22528, DOI 10.1073/pnas.1015356107; Chuang PD, 1997, J IMMUNOL, V158, P724; DAVIS JT, 1994, J BIOL CHEM, V269, P3331; Elliott S, 2004, J BIOL CHEM, V279, P16854, DOI 10.1074/jbc.M311095200; GERKEN TA, 1989, BIOCHEMISTRY-US, V28, P5536, DOI 10.1021/bi00439a030; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Hashimoto R, 2007, INT J HEMATOL, V85, P203, DOI 10.1532/IJH97.06074; Ikehara Y, 2006, GLYCOBIOLOGY, V16, P777, DOI 10.1093/glycob/cwl005; Imperiali B, 1995, BIOORGAN MED CHEM, V3, P1565, DOI 10.1016/0968-0896(95)00142-5; Kaneko S, 2010, CLIN EXP NEPHROL, V14, P389, DOI 10.1007/s10157-010-0285-0; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Kuno A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01065; Kuno A, 2009, MOL CELL PROTEOMICS, V8, P99, DOI 10.1074/mcp.M800308-MCP200; Lee RT, 2000, GLYCOCONJUGATE J, V17, P543, DOI 10.1023/A:1011070425430; Leibiger H, 1999, BIOCHEM J, V338, P529, DOI 10.1042/0264-6021:3380529; Matsuda A, 2010, HEPATOLOGY, V52, P174, DOI 10.1002/hep.23654; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; MESTECKY J, 1993, CONTRIB NEPHROL, V104, P172; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; MONTEIRO RC, 1985, KIDNEY INT, V28, P666, DOI 10.1038/ki.1985.181; Narimatsu Y, 2010, J AM CHEM SOC, V132, P5548, DOI 10.1021/ja9106429; Nishie T, 2007, CONTRIB NEPHROL, V157, P125; Omtvedt LA, 1997, SCAND J IMMUNOL, V45, P551, DOI 10.1046/j.1365-3083.1997.d01-431.x; Omtvedt LA, 2000, AMYLOID, V7, P227, DOI 10.3109/13506120009146437; Oyelaran O, 2009, J PROTEOME RES, V8, P3529, DOI 10.1021/pr9002245; Price JL, 2010, J AM CHEM SOC, V132, P15359, DOI 10.1021/ja106896t; Royle L, 2003, J BIOL CHEM, V278, P20140, DOI 10.1074/jbc.M301436200; SOX HC, 1970, P NATL ACAD SCI USA, V66, P975, DOI 10.1073/pnas.66.3.975; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; TOMINO Y, 1982, CLIN EXP IMMUNOL, V49, P419; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; WORMALD MR, 1991, EUR J BIOCHEM, V198, P131, DOI 10.1111/j.1432-1033.1991.tb15995.x; Wu AM, 2004, FEBS LETT, V562, P51, DOI 10.1016/S0014-5793(04)00180-2; Wu AM, 2003, BIOCHEM J, V371, P311, DOI 10.1042/BJ20021361; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Yoo EM, 2005, CLIN IMMUNOL, V116, P3, DOI 10.1016/j.clim.2005.03.010	44	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91079	10.1371/journal.pone.0091079	http://dx.doi.org/10.1371/journal.pone.0091079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651839	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800030
J	Peron, J; Grandjean, D; Drapier, S; Verin, M				Peron, Julie; Grandjean, Didier; Drapier, Sophie; Verin, Marc			Effect of Dopamine Therapy on Nonverbal Affect Burst Recognition in Parkinson's Disease	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS; EMOTION RECOGNITION; STIMULATION; LEVODOPA; PROSODY; PERFORMANCE; PERCEPTION; COGNITION; VOICES; MIND	Background: Parkinson's disease (PD) provides a model for investigating the involvement of the basal ganglia and mesolimbic dopaminergic system in the recognition of emotions from voices (i.e., emotional prosody). Although previous studies of emotional prosody recognition in PD have reported evidence of impairment, none of them compared PD patients at different stages of the disease, or ON and OFF dopamine replacement therapy, making it difficult to determine whether their impairment was due to general cognitive deterioration or to a more specific dopaminergic deficit. Methods: We explored the involvement of the dopaminergic pathways in the recognition of nonverbal affect bursts (onomatopoeias) in 15 newly diagnosed PD patients in the early stages of the disease, 15 PD patients in the advanced stages of the disease and 15 healthy controls. The early PD group was studied in two conditions: ON and OFF dopaminergic therapy. Results: Results showed that the early PD patients performed more poorly in the ON condition than in the OFF one, for overall emotion recognition, as well as for the recognition of anger, disgust and fear. Additionally, for anger, the early PD ON patients performed more poorly than controls. For overall emotion recognition, both advanced PD patients and early PD ON patients performed more poorly than controls. Analysis of continuous ratings on target and nontarget visual analog scales confirmed these patterns of results, showing a systematic emotional bias in both the advanced PD and early PD ON (but not OFF) patients compared with controls. Conclusions: These results i) confirm the involvement of the dopaminergic pathways and basal ganglia in emotional prosody recognition, and ii) suggest a possibly deleterious effect of dopatherapy on affective abilities in the early stages of PD.	[Peron, Julie; Grandjean, Didier] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Peron, Julie; Grandjean, Didier] Univ Geneva, Dept Psychol, Neurosci Emot & Affect Dynam Lab, Geneva, Switzerland; [Drapier, Sophie; Verin, Marc] Univ Rennes 1, Host Team 4712, Behav & Basal Ganglia Res Unit, Rennes, France; [Drapier, Sophie; Verin, Marc] Rennes Univ Hosp, Pontchaillou Hosp, Rennes, France; [Drapier, Sophie; Verin, Marc] Rennes Univ Hosp, Pontchaillou Hosp, Neurol Unit, Rennes, France	University of Geneva; University of Geneva; Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes	Peron, J (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.	julie.peron@unige.ch	Péron, Julie/C-5658-2013; Verin, Marc/ABC-6924-2020	Péron, Julie/0000-0002-6579-4011; Grandjean, Didier/0000-0001-6125-4520	University Hospital of Rennes (France); National Center of Competence in Research (NCCR); Swiss National Science Foundation [51NF40-104897]	University Hospital of Rennes (France); National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was carried out at the Neurology Unit of Pontchaillou Hospital (Rennes University Hospital, rue Henri Le Guilloux, 35033 Rennes, France). The first author (JP) was funded by the University Hospital of Rennes (France) during the data acquisition and by National Center of Competence in Research (NCCR), financed by the Swiss National Science Foundation (no. 51NF40-104897) and hosted by the University of Geneva during the data analysis and writing of the manuscript. The funders had no role in data collection, discussion of content, preparation of the manuscript, or decision to publish.	Baik JH, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00152; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Breitenstein C, 2001, BRAIN COGNITION, V45, P277, DOI 10.1006/brcg.2000.1246; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2007, NEUROPSYCHOPHARMACOL, V32, P180, DOI 10.1038/sj.npp.1301153; Delaveau P, 2005, CLIN NEUROPHARMACOL, V28, P255, DOI 10.1097/01.wnf.0000186651.96351.2e; Derouesne C, 2001, REV NEUROL-FRANCE, V157, P567; Ferreri F, 2006, CAN MED ASSOC J, V175, P1545, DOI 10.1503/cmaj.060542; Fruhholz S, 2012, CEREB CORTEX, V22, P1107, DOI 10.1093/cercor/bhr184; GANCHER ST, 1987, NEUROLOGY, V37, P940, DOI 10.1212/WNL.37.6.940; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Grandjean D, 2006, PROG BRAIN RES, V156, P235, DOI 10.1016/S0079-6123(06)56012-1; Gray HA, 2010, NEUROPSYCHOLOGY, V24, P176, DOI 10.1037/a0018104; Hariri AR, 2002, NEUROPSYCHOPHARMACOL, V27, P1036, DOI 10.1016/S0893-133X(02)00373-1; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Kvernmo T, 2006, CLIN THER, V28, P1065, DOI 10.1016/j.clinthera.2006.08.004; Lawrence AD, 2002, NEUROREPORT, V13, P881, DOI 10.1097/00001756-200205070-00029; Le Jeune F, 2008, BRAIN, V131, P1599, DOI 10.1093/brain/awn084; MacDonald AA, 2013, MOVEMENT DISORD, V28, P153, DOI 10.1002/mds.25152; MacDonald P.A., 2011, PARKINSONS DIS-US, V2011, DOI DOI 10.4061/2011/572743; MacDonald PA, 2011, BRAIN, V134, P1447, DOI 10.1093/brain/awr075; Mattis S, 1988, PSYCHOL ASSESSMENT; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Paulmann S, 2009, BRAIN RES, V1295, P159, DOI 10.1016/j.brainres.2009.07.102; Peron J, 2013, NEUROSCI BIOBEHAV R, V37, P358, DOI 10.1016/j.neubiorev.2013.01.001; Peron J, 2012, MOVEMENT DISORD, V27, P186, DOI 10.1002/mds.24025; Peron J, 2011, PROG NEURO-PSYCHOPH, V35, P987, DOI 10.1016/j.pnpbp.2011.01.019; Peron J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009919; Peron J, 2010, NEUROPSYCHOLOGIA, V48, P1053, DOI 10.1016/j.neuropsychologia.2009.12.003; Peron J, 2010, NEUROPSYCHOLOGY, V24, P1, DOI 10.1037/a0017433; Peron J, 2009, NEUROPSYCHOLOGIA, V47, P406, DOI 10.1016/j.neuropsychologia.2008.09.008; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Salgado-Pineda P, 2005, CLIN NEUROPHARMACOL, V28, P228, DOI 10.1097/01.wnf.0000185824.57690.f0; Sander D, 2005, NEUROIMAGE, V28, P848, DOI 10.1016/j.neuroimage.2005.06.023; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Schwab R.S., 1969, 3 S PARK DIS, P152; Spielberger C. D., 1993, MANUEL INVENTAIRE AN; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Swainson R, 2000, NEUROPSYCHOLOGIA, V38, P596, DOI 10.1016/S0028-3932(99)00103-7; Takahashi H, 2005, NEUROIMAGE, V27, P991, DOI 10.1016/j.neuroimage.2005.05.039; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; UHL GR, 1985, NEUROLOGY, V35, P1215, DOI 10.1212/WNL.35.8.1215; Welter ML, 2002, BRAIN, V125, P575, DOI 10.1093/brain/awf050; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460	48	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90092	10.1371/journal.pone.0090092	http://dx.doi.org/10.1371/journal.pone.0090092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651759	gold, Green Published, Green Submitted			2022-12-25	WOS:000333352800010
J	Johnston, JM; Filizola, M				Johnston, Jennifer M.; Filizola, Marta			Differential Stability of the Crystallographic Interfaces of Mu- and Kappa-Opioid Receptors	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; FORCE-FIELD; PROTEIN; PALMITOYLATION; COMPLEX; DIMER	The recent mu-opioid receptor (MOPr) and kappa-opioid receptor (KOPr) crystal structures have inspired hypotheses of physiologically relevant dimerization contacts, specifically: a closely packed interface involving transmembrane (TM) helices TM5 and TM6, and a less compact interface, involving TM1, TM2, and helix 8 (H8). While the former was only found in MOPr crystals, similar arrangements of the latter were identified for both KOPr and MOPr. The relevance of these interfaces outside of a crystal lattice is called into question by the possibility that they might be influenced by the specific crystallization conditions. In this study, we have employed umbrella sampling molecular dynamics simulations of coarse-grained representations of the interacting MOPr or KOPr crystallographic structures, in the absence of the T4 lysozyme, and in an explicit lipid-water environment, to determine the strength of receptor dimerization at the different crystallographic interfaces. We note that the shape of the interface plays a dominant role in the strength of the interaction, and the pattern of contacting residues defines the shape of the potential of mean force. This information can be used to guide experiments aimed at exploring the role of dimerization in opioid receptor function.	[Johnston, Jennifer M.; Filizola, Marta] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Filizola, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA.	marta.filizola@mssm.edu		Filizola, Marta/0000-0002-4382-8276	National Institutes of Health [DA026434, DA034049]; NIDA [T32 DA007135]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034049, T32DA007135, K02DA026434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this work was provided, in whole or in part, by National Institutes of Health grants DA026434 and DA034049. JMJ was supported in part by NIDA grant T32 DA007135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TW, 2004, P NATL ACAD SCI USA, V101, P117, DOI 10.1073/pnas.2635314100; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bertheleme N, 2013, BBA-BIOMEMBRANES, V1828, P2583, DOI 10.1016/j.bbamem.2013.07.013; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Chen CG, 1998, FEBS LETT, V441, P148, DOI 10.1016/S0014-5793(98)01547-6; Cherezov V, 2010, METHODS MOL BIOL, V654, P141, DOI 10.1007/978-1-60761-762-4_8; Duarte JM, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-21; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Hu JX, 2013, J BIOL CHEM, V288, P34777, DOI 10.1074/jbc.M113.503714; Hu JX, 2012, FASEB J, V26, P604, DOI 10.1096/fj.11-191510; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Johnston JM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002649; Johnston JM, 2011, BIOCHEMISTRY-US, V50, P1682, DOI 10.1021/bi101474v; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; O'Dowd BF, 2012, BIOCHEM BIOPH RES CO, V422, P556, DOI 10.1016/j.bbrc.2012.05.023; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Provasi D, 2010, BIOCHEMISTRY-US, V49, P6771, DOI 10.1021/bi100686t; Roux B, 1999, BIOPHYS J, V77, P139, DOI 10.1016/S0006-3495(99)76878-5; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Salom D, 2013, METHOD CELL BIOL, V117, P451, DOI 10.1016/B978-0-12-408143-7.00024-4; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Zheng H, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-6; Zhu FQ, 2012, J COMPUT CHEM, V33, P453, DOI 10.1002/jcc.21989	33	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90694	10.1371/journal.pone.0090694	http://dx.doi.org/10.1371/journal.pone.0090694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24651466	Green Submitted, Green Published, gold			2022-12-25	WOS:000332396200245
J	Staege, MS; Muller, K; Kewitz, S; Volkmer, I; Mauz-Korholz, C; Bernig, T; Korholz, D				Staege, Martin S.; Mueller, Katja; Kewitz, Stefanie; Volkmer, Ines; Mauz-Koerholz, Christine; Bernig, Toralf; Koerholz, Dieter			Expression of Dual-Specificity Phosphatase 5 Pseudogene 1 (DUSP5P1) in Tumor Cells	PLOS ONE			English	Article							REED-STERNBERG CELLS; HODGKINS-DISEASE; GENE-EXPRESSION; ENDOGENOUS RETROVIRUSES; DNA-MICROARRAYS; BIM EXPRESSION; LYMPHOMA; VIRUS; EBV; SUPERANTIGEN	Sequencing of individual clones from a newly established cDNA library from the chemoresistant Hodgkin's lymphoma cell line L-1236 led to the isolation of a cDNA clone corresponding to a short sequence from chromosome 1. Reverse transcriptase-polymerase chain reaction indicated high expression of this sequence in Hodgkin's lymphoma derived cell lines but not in normal blood cells. Further characterization of this sequence and the surrounding genomic DNA revealed that this sequence is part of a human endogenous retrovirus locus. The sequence of this endogenous retrovirus is interrupted by a pseudogene of the dual specificity phosphatase 5 (DUSP5). Reverse transcriptase-polymerase chain reaction revealed high expression of this pseudogene (DUSP5P1) in HL cell lines but not in normal blood cells or Epstein-Barr virus-immortalized B cells. Cells from other tumor types (Burkitt's lymphoma, leukemia, neuroblastoma, Ewing sarcoma) also showed a higher DUSP5P1/DUSP5 ratio than normal cells. Furthermore, we observed that higher expression of DUSP5 in relation to DUSP5P1 correlated with the expression of the pro-apoptotic factor B cell leukemia/lymphoma 2-like 11 (BCL2L11) in peripheral blood cells and HL cells. Knock-down of DUSP5 in HL cells resulted in down-regulation of BCL2L11. Thus, the DUSP5/DUSP5P1 system could be responsible for regulation of BCL2L11 leading to inhibition of apoptosis in these tumor cells.	[Staege, Martin S.; Mueller, Katja; Kewitz, Stefanie; Volkmer, Ines; Mauz-Koerholz, Christine; Bernig, Toralf; Koerholz, Dieter] Univ Halle Wittenberg, Dept Pediat, D-06108 Halle, Germany	Martin Luther University Halle Wittenberg	Staege, MS (corresponding author), Univ Halle Wittenberg, Dept Pediat, D-06108 Halle, Germany.	martin.staege@medizin.uni-halle.de	Körholz, Dieter/AAX-4347-2020; Mauz-Koerholz, Christine/AAX-4349-2020; Staege, Martin/AAX-8994-2021	Staege, Martin/0000-0003-3765-7068	Peter-Escher-Foundation; Konrad-Adenauer-Stiftung	Peter-Escher-Foundation; Konrad-Adenauer-Stiftung	This work was supported by grants from the Peter-Escher-Foundation for children with cancer and a fellowship from the Konrad-Adenauer-Stiftung (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrarova ND, 2010, MOL BIOL+, V44, P552, DOI 10.1134/S0026893310040084; Aleman BMP, 2007, BLOOD, V109, P1878, DOI 10.1182/blood-2006-07-034405; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambinder Richard F, 2007, Hematology Am Soc Hematol Educ Program, P204, DOI 10.1182/asheducation-2007.1.204; Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Balada E, 2010, INT REV IMMUNOL, V29, P351, DOI 10.3109/08830185.2010.485333; Benharroch D, 2004, BRIT J CANCER, V91, P572, DOI 10.1038/sj.bjc.6601900; Buzdin A, 2007, THESCIENTIFICWORLDJO, V7, P1848, DOI 10.1100/tsw.2007.270; Carbone A, 2008, ONCOLOGIST, V13, P577, DOI 10.1634/theoncologist.2008-0036; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; CHEZZI C, 1976, P NATL ACAD SCI USA, V73, P4649, DOI 10.1073/pnas.73.12.4649; Christensen T, 2010, J NEUROIMMUNE PHARM, V5, P326, DOI 10.1007/s11481-010-9214-y; Clybouw C, 2005, J IMMUNOL, V175, P2968, DOI 10.4049/jimmunol.175.5.2968; DIEHL V, 1981, J CANCER RES CLIN, V101, P111, DOI 10.1007/BF00405072; DREXLER HG, 1986, LEUKEMIA RES, V10, P487, DOI 10.1016/0145-2126(86)90084-6; Emmer A, 2008, SCAND J IMMUNOL, V67, P464, DOI 10.1111/j.1365-3083.2008.02094.x; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Figueiredo CP, 2007, LEUKEMIA LYMPHOMA, V48, P731, DOI 10.1080/10428190701203954; Foell JL, 2008, J IMMUNOL METHODS, V339, P99, DOI 10.1016/j.jim.2008.08.006; Gergely P, 2005, CLIN IMMUNOL, V116, P124, DOI 10.1016/j.clim.2005.04.002; Haase R, 2012, KLIN PADIATR, V224, P377, DOI 10.1055/s-0032-1323824; Habek M, 2008, MULT SCLER, V14, P284, DOI 10.1177/1352458507082600; Hoennscheidt C, 2009, SCAND J IMMUNOL, V70, P216, DOI 10.1111/j.1365-3083.2009.02286.x; Hsiao FC, 2009, VIROLOGY, V385, P261, DOI 10.1016/j.virol.2008.11.025; Huang GS, 2002, INT J ONCOL, V21, P31; Hughes R, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-69; Hwang J, 2013, BMB REP, V46, P9, DOI 10.5483/BMBRep.2013.46.1.002; Jeong DG, 2007, PROTEINS, V66, P253, DOI 10.1002/prot.21224; KAMESAKI H, 1986, BLOOD, V68, P285; Kovanen PE, 2008, J BIOL CHEM, V283, P17362, DOI 10.1074/jbc.M709887200; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Kuppers Ralf, 2009, Hematology Am Soc Hematol Educ Program, P491, DOI 10.1182/asheducation-2009.1.491; Lacroix A, 2010, CLIN CANCER RES, V16, P4711, DOI 10.1158/1078-0432.CCR-10-0470; LAMANTIA G, 1991, NUCLEIC ACIDS RES, V19, P1513; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lin HMJ, 2005, J PEDIAT HEMATOL ONC, V27, P28, DOI 10.1097/01.mph.0000150740.80690.d4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mauz-Korholz C, 2010, J CLIN ONCOL, V28, P3680, DOI 10.1200/JCO.2009.26.9381; McCullough L, 2010, CANCER-AM CANCER SOC, V116, P4866, DOI 10.1002/cncr.25442; Neumann I, 2010, PEDIATR BLOOD CANCER, V55, P464, DOI 10.1002/pbc.22603; NEWELL GR, 1984, CANCER, V54, P1117, DOI 10.1002/1097-0142(19840915)54:6<1117::AID-CNCR2820540633>3.0.CO;2-Y; Ortega-Paino E, 2008, BLOOD, V111, P1617, DOI 10.1182/blood-2007-02-068791; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Paschos K, 2012, NUCLEIC ACIDS RES, V40, P7233, DOI 10.1093/nar/gks391; Paschos K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000492; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Sieniawski M, 2008, ANN ONCOL, V19, P1795, DOI 10.1093/annonc/mdn376; Sospedra Mireia, 2005, PLoS Pathog, V1, pe41; Staege MS, 2008, EXP HEMATOL, V36, P886, DOI 10.1016/j.exphem.2008.02.014; Staege MS, 2003, KLIN PADIATR, V215, P135; Tai AK, 2009, J CLIN VIROL, V46, P47, DOI 10.1016/j.jcv.2009.05.019; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vermeer MH, 2008, CANCER RES, V68, P2689, DOI 10.1158/0008-5472.CAN-07-6398; Villesen Palle, 2004, Retrovirology, V1, P32, DOI 10.1186/1742-4690-1-32; Watanabe M, 2005, CANCER RES, V65, P7628, DOI 10.1158/0008-5472.CAN-05-0925; Watanabe M, 2011, ONCOL RES, V19, P463, DOI 10.3727/096504012X13285365944292; Wolf J, 1996, BLOOD, V87, P3418, DOI 10.1182/blood.V87.8.3418.bloodjournal8783418; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Yip KW, 2004, MOL THER, V10, P533, DOI 10.1016/j.ymthe.2004.05.026; Zheng B, 2003, BLOOD, V102, P1019, DOI 10.1182/blood-2002-11-3507	63	16	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89577	10.1371/journal.pone.0089577	http://dx.doi.org/10.1371/journal.pone.0089577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24651368	Green Submitted, Green Published, gold			2022-12-25	WOS:000331880700061
J	Beristain, AG; Molyneux, SD; Joshi, PA; Pomroy, NC; Di Grappa, MA; Chang, MC; Kirschner, LS; Prive, GG; Pujana, MA; Khokha, R				Beristain, A. G.; Molyneux, S. D.; Joshi, P. A.; Pomroy, N. C.; Di Grappa, M. A.; Chang, M. C.; Kirschner, L. S.; Prive, G. G.; Pujana, M. A.; Khokha, R.			PKA signaling drives mammary tumorigenesis through Src	ONCOGENE			English	Article							PROTEIN-KINASE-A; ELEVATED AROMATASE EXPRESSION; ESTROGEN-RECEPTOR-ALPHA; SUBUNIT TYPE 1A; BREAST-CANCER; CARNEY COMPLEX; REGULATORY SUBUNITS; CELL-CYCLE; C-SRC; PRKAR1A	Protein kinase A (PKA) hyperactivation causes hereditary endocrine neoplasias; however, its role in sporadic epithelial cancers is unknown. Here, we show that heightened PKA activity in the mammary epithelium generates tumors. Mammary-restricted biallelic ablation of Prkar1a, which encodes for the critical type-I PKA regulatory subunit, induced spontaneous breast tumors characterized by enhanced type-II PKA activity. Downstream of this, Src phosphorylation occurs at residues serine-17 and tyrosine-416 and mammary cell transformation is driven through a mechanism involving Src signaling. The phenotypic consequences of these alterations consisted of increased cell proliferation and, accordingly, expansion of both luminal and basal epithelial cell populations. In human breast cancer, low PRKAR1A/high SRC expression defines basal-like and HER2 breast tumors associated with poor clinical outcome. Together, the results of this study define a novel molecular mechanism altered in breast carcinogenesis and highlight the potential strategy of inhibiting SRC signaling in treating this cancer subtype in humans.	[Beristain, A. G.; Molyneux, S. D.; Joshi, P. A.; Pomroy, N. C.; Di Grappa, M. A.; Khokha, R.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Molyneux, S. D.; Joshi, P. A.; Prive, G. G.; Khokha, R.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Chang, M. C.; Khokha, R.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada; [Kirschner, L. S.] Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Pujana, M. A.] Hosp Llobregat, IDIBELL, Catalan Inst Oncol, Breast Canc & Syst Biol Unit,Translat Res Lab, Barcelona, Spain	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University System of Ohio; Ohio State University; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Khokha, R (corresponding author), Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada.	rkhokha@uhnres.utoronto.ca	Chang, Martin/J-2329-2016; Pujana, Miquel Angel/N-3127-2014	Pujana, Miquel Angel/0000-0003-3222-4044; Khokha, Rama/0000-0002-6028-1524; Joshi, Purna/0000-0002-1628-9940; Beristain, Alexander/0000-0002-1117-6242; Prive, Gilbert/0000-0002-0712-4319	Canadian Breast Cancer Foundation (CBCF); Spanish Ministry of Health grant [FIS-PI12/01528, RD12/0036/0008]; CBCF fellowship; NATIONAL CANCER INSTITUTE [P01CA124570] Funding Source: NIH RePORTER	Canadian Breast Cancer Foundation (CBCF); Spanish Ministry of Health grant; CBCF fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Megan K Barker and Paul Waterhouse for critical reading of the manuscript. We would also like to acknowledge Shareen Ezzat for sharing the small molecule Dasatinib, Vuk Stambolic for offering insight into biochemistry experiments and the IDIBELL's Biostatistics Unit for help in analyzing breast cancer data sets. This work was supported by a Canadian Breast Cancer Foundation (CBCF) grant to RK and the Spanish Ministry of Health grant FIS-PI12/01528 and RD12/0036/0008 to MAP. AGB holds a CBCF fellowship.	Almeida MQ, 2011, MOL CELL ENDOCRINOL, V336, P162, DOI 10.1016/j.mce.2010.11.018; Almeida MQ, 2010, HUM MOL GENET, V19, P1387, DOI 10.1093/hmg/ddq014; Amieux PS, 2002, ANN NY ACAD SCI, V968, P75, DOI 10.1111/j.1749-6632.2002.tb04328.x; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bossis I, 2004, ENDOCRINOLOGY, V145, P5452, DOI 10.1210/en.2004-0900; Burton KA, 1997, P NATL ACAD SCI USA, V94, P11067, DOI 10.1073/pnas.94.20.11067; CARNEY JA, 1991, AM J SURG PATHOL, V15, P722, DOI 10.1097/00000478-199108000-00002; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Elsberger B, 2009, AM J PATHOL, V175, P1389, DOI 10.2353/ajpath.2009.090273; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Gold MG, 2013, J BIOL CHEM, V288, P17111, DOI 10.1074/jbc.M112.447326; Griffin KJ, 2004, CANCER RES, V64, P8811, DOI 10.1158/0008-5472.CAN-04-3620; Griffin KJ, 2004, J MED GENET, V41, P923, DOI 10.1136/jmg.2004.028043; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Kirschner LS, 2005, CANCER RES, V65, P4506, DOI 10.1158/0008-5472.CAN-05-0580; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kok M, 2011, BREAST CANCER RES TR, V125, P1, DOI 10.1007/s10549-010-0798-y; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Marcotte R, 2012, P NATL ACAD SCI USA, V109, P2808, DOI 10.1073/pnas.1018861108; Michalides R, 2004, CANCER CELL, V5, P597, DOI 10.1016/j.ccr.2004.05.016; Miller WR, 2002, ANN NY ACAD SCI, V968, P37, DOI 10.1111/j.1749-6632.2002.tb04325.x; Molyneux SD, 2010, J CLIN INVEST, V120, P3310, DOI 10.1172/JCI42391; Moujalled D, 2011, EMBO REP, V12, P77, DOI 10.1038/embor.2010.190; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nadella KS, 2008, CANCER RES, V68, P2671, DOI 10.1158/0008-5472.CAN-07-6002; Neary CL, 2004, ONCOGENE, V23, P8847, DOI 10.1038/sj.onc.1208165; Obara Y, 2004, J CELL SCI, V117, P6085, DOI 10.1242/jcs.01527; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pavel E, 2008, MOL ENDOCRINOL, V22, P430, DOI 10.1210/me.2007-0369; Prat A, 2012, BREAST CANCER RES TR, V135, P301, DOI 10.1007/s10549-012-2143-0; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Smalley MJ, 2012, J MAMMARY GLAND BIOL, V17, P91, DOI 10.1007/s10911-012-9257-1; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Subbaramaiah K, 2008, J BIOL CHEM, V283, P3433, DOI 10.1074/jbc.M705409200; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tharakan R, 2008, MOL CELL ENDOCRINOL, V295, P70, DOI 10.1016/j.mce.2008.07.018; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wilson GR, 2006, BRIT J CANCER, V95, P1410, DOI 10.1038/sj.bjc.6603444; Yin ZR, 2008, CIRCULATION, V117, P1414, DOI 10.1161/CIRCULATIONAHA.107.759233	48	61	61	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 26	2015	34	9					1160	1173		10.1038/onc.2014.41	http://dx.doi.org/10.1038/onc.2014.41			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RY	24662820				2022-12-25	WOS:000350122100009
J	Choi, YJ; Yoon, Y; Lee, KY; Hien, TT; Kang, KW; Kim, KC; Lee, J; Lee, MY; Lee, SM; Kang, DH; Lee, BH				Choi, You-Jin; Yoon, Yujin; Lee, Kang-Yo; Hien, Tran Thi; Kang, Keon Wook; Kim, Kyong-Cheol; Lee, Jeewoo; Lee, Moo-Yeol; Lee, Seung Mi; Kang, Duk-Hee; Lee, Byung-Hoon			Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis	FASEB JOURNAL			English	Article						eNOS; hypertension	ENDOPLASMIC-RETICULUM STRESS; CARDIOVASCULAR-DISEASE; CELL FUNCTION; HYPERTENSION; RAT; HYPERURICEMIA; ACTIVATION; SYNTHASE; AORTA; RISK	Endothelial dysfunction is defined as impairment of the balance between endothelium-dependent vasodilation and constriction. Despite evidence of uric acid-induced endothelial dysfunction, a relationship with insulin resistance has not been clearly established. In this study, we investigated the role of vascular insulin resistance in uric acid-induced endothelial dysfunction. Uric acid inhibited insulin-induced endothelial nitric oxide synthase (eNOS) phosphorylation and NO production more substantially than endothelin-1 expression in HUVECs, with IC50 of 51.0, 73.6, and 184.2, respectively. Suppression of eNOS phosphorylation and NO production by uric acid was PI3K/Akt-dependent, as verified by the transfection with p110. Treatment of rats with the uricase inhibitor allantoxanamide induced mild hyperuricemia and increased mean arterial pressure by 25%. While hyperuricemic rats did not show systemic insulin resistance, they showed impaired vasorelaxation induced by insulin by 56%. A compromised insulin response in terms of the Akt/eNOS pathway was observed in the aortic ring of hyperuricemic rats. Coadministration with allopurinol reduced serum uric acid levels and blood pressure and restored the effect of insulin on Akt-eNOS pathway and vasorelaxation. Taken together, uric acid induced endothelial dysfunction by contributing to vascular insulin resistance in terms of insulin-induced NO production, potentially leading to the development of hypertension.	[Choi, You-Jin; Yoon, Yujin; Lee, Kang-Yo; Hien, Tran Thi; Kang, Keon Wook; Kim, Kyong-Cheol; Lee, Jeewoo; Lee, Byung-Hoon] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea; [Choi, You-Jin; Yoon, Yujin; Lee, Kang-Yo; Hien, Tran Thi; Kang, Keon Wook; Kim, Kyong-Cheol; Lee, Jeewoo; Lee, Byung-Hoon] Seoul Natl Univ, Coll Med, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Lee, Seung Mi] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul 151742, South Korea; [Lee, Moo-Yeol] Dongguk Univ, Coll Pharm, Goyang, South Korea; [Lee, Seung Mi] Seoul Metropolitan Boramae Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Kang, Duk-Hee] Ewha Womans Univ, Sch Med, Dept Internal Med, Div Nephrol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Dongguk University; Ewha Womans University	Lee, BH (corresponding author), Seoul Natl Univ, Coll Pharm, Gwanak Ro 1, Seoul 151742, South Korea.	lee@snu.ac.kr	Lee, Byung-Hoon/L-7490-2018	Lee, Jeewoo/0000-0002-7832-6719	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A100096]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2007-0056817]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea; National Research Foundation of Korea (NRF) - Korea government (MSIP)	This study was supported by grants of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea (A100096) and by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP; 2007-0056817).	Clerk LH, 2006, DIABETES, V55, P1436, DOI 10.2337/db05-1373; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Dincer HE, 2002, CLEV CLIN J MED, V69, P594, DOI 10.3949/ccjm.69.8.594; Eringa EC, 2004, AM J PHYSIOL-HEART C, V287, pH2043, DOI 10.1152/ajpheart.00067.2004; Gersch C, 2008, NUCLEOS NUCLEOT NUCL, V27, P967, DOI 10.1080/15257770802257952; Go YM, 2001, AM J PHYSIOL-HEART C, V281, pH2705, DOI 10.1152/ajpheart.2001.281.6.H2705; HOLMES EW, 1979, ARTHRITIS RHEUM, V22, P737, DOI 10.1002/art.1780220707; Hong Q, 2012, CELL CALCIUM, V51, P402, DOI 10.1016/j.ceca.2012.01.003; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JOHNSON WJ, 1978, LIFE SCI, V23, P2239, DOI 10.1016/0024-3205(78)90210-2; Johnson-Delaney C, 1996, EXOTIC ANIMAL COMPAN; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Li SS, 2013, NEPHROLOGY, V18, P682, DOI 10.1111/nep.12127; Liu ZQ, 2009, J CLIN ENDOCR METAB, V94, P3543, DOI 10.1210/jc.2009-0027; Lovren F, 2009, AM J PHYSIOL-ENDOC M, V296, pE1440, DOI 10.1152/ajpendo.90780.2008; Mangge Harald, 2008, Diabetes Care, V31, pe21, DOI 10.2337/dc07-2411; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; MILLER RC, 1985, BRIT J PHARMACOL, V85, P481, DOI 10.1111/j.1476-5381.1985.tb08885.x; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Noone DG, 2013, J PEDIATR-US, V162, P128, DOI 10.1016/j.jpeds.2012.06.008; Noronha BT, 2005, DIABETES, V54, P1082, DOI 10.2337/diabetes.54.4.1082; Papezikova I, 2013, FREE RADICAL RES, V47, P82, DOI 10.3109/10715762.2012.747677; Park JH, 2013, NITRIC OXIDE-BIOL CH, V32, P36, DOI 10.1016/j.niox.2013.04.003; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; Potenza MA, 2005, AM J PHYSIOL-HEART C, V289, pH813, DOI 10.1152/ajpheart.00092.2005; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Santos CXC, 1999, ARCH BIOCHEM BIOPHYS, V372, P285, DOI 10.1006/abbi.1999.1491; Schulman IH, 2007, AM J PHYSIOL-HEART C, V293, pH853, DOI 10.1152/ajpheart.00138.2007; Short RA, 2005, SEMIN NEPHROL, V25, P25, DOI 10.1016/j.semnephrol.2004.09.005; So A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2509; Szasz T, 2010, J PHARMACOL EXP THER, V333, P758, DOI 10.1124/jpet.109.160184; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; Wu GY, 2009, BIOFACTORS, V35, P21, DOI 10.1002/biof.3; Zecchin HG, 2007, DIABETES, V56, P1014, DOI 10.2337/db05-1147; Zhang WL, 2009, CLIN CHEM, V55, P2026, DOI 10.1373/clinchem.2009.124891; Zharikov S, 2008, AM J PHYSIOL-CELL PH, V295, pC1183, DOI 10.1152/ajpcell.00075.2008; Zhou QG, 2012, AM J PHYSIOL-HEART C, V303, pH1154, DOI 10.1152/ajpheart.00407.2012	44	126	146	2	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3197	3204		10.1096/fj.13-247148	http://dx.doi.org/10.1096/fj.13-247148			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24652948				2022-12-25	WOS:000337949400039
J	Masuyama, H; Hiramatsu, Y				Masuyama, Hisashi; Hiramatsu, Yuji			Additive Effects of Maternal High Fat Diet during Lactation on Mouse Offspring	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; SATURATED FAT; OBESITY; LEPTIN; ADIPONECTIN; PREGNANCY; NUTRITION; EXPOSURE; GLUCOSE	Recent reports indicated that nutrition in early infancy might influence later child health outcomes such as obesity and metabolic syndrome. Therefore, we examined the effects of maternal high fat diet (HFD) during lactation on the onset of a metabolic syndrome in their offspring. All offspring were cross-fostered by dams on the same or opposite diet to yield 4 groups: offspring from HFD-fed dams suckled by HFD-fed dams (OHH) and by control diet (CD)-fed dams (OHC) and CD-fed dams suckled by HFD-fed dams (OCH) and by CD-fed dams (OCC) mice. We examined several metabolic syndrome-related factors including body weight, blood pressure, glucose tolerance and adipocytokines. Mean body weights of OHH and OCH mice were significantly higher than those of OHC and OCC mice, respectively, with elevated systolic blood pressure. Moreover, OHH and OCH mice revealed significantly worse glucose tolerance compared with the OHC and OCC mice, respectively. Triglyceride and leptin levels were significantly increased and adiponectin levels were significantly reduced by the maternal HFD during lactation, with similar changes in leptin and adiponectin mRNA expression but without histone modifications in adipose tissues. In addition, maternal obesity induced by HFD during lactation increased and prolonged the leptin surge in the offspring and the gender differences of leptin surge were observed. Our data suggested that maternal HFD during lactation might have an additive effect on the onset of the metabolic syndrome in the offspring, irrespective of the nutritional status in utero through the modified leptin surge.	[Masuyama, Hisashi; Hiramatsu, Yuji] Okayama Univ, Dept Obstet & Gynecol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Okayama University	Masuyama, H (corresponding author), Okayama Univ, Dept Obstet & Gynecol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	masuyama@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22591856, 25462558]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants (numbers 22591856 and 25462558) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Buckley AJ, 2005, METABOLISM, V54, P500, DOI 10.1016/j.metabol.2004.11.003; Cai F, 2007, J ENDOCRINOL, V192, P605, DOI 10.1677/JOE-06-0080; Carlyle M, 2002, HYPERTENSION, V39, P496, DOI 10.1161/hy0202.104398; Carter LG, 2012, AM J PHYSIOL-ENDOC M, V303, pE1061, DOI 10.1152/ajpendo.00213.2012; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Cerf ME, 2006, BRIT J NUTR, V95, P391, DOI 10.1079/BJN20051632; Cerf ME, 2005, AM J PHYSIOL-REG I, V288, pR1122, DOI 10.1152/ajpregu.00335.2004; Choi SW, 2010, ADV NUTR, V1, P8, DOI 10.3945/an.110.1004; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; DelPrado M, 1997, J NUTR, V127, P458, DOI 10.1093/jn/127.3.458; Fasshauer M, 2003, DIABETOLOGIA, V46, P1594, DOI 10.1007/s00125-003-1228-z; Gao J, 2009, J BIOL CHEM, V284, P25984, DOI 10.1074/jbc.M109.016808; Gil-Campos M, 2004, CLIN NUTR, V23, P963, DOI 10.1016/j.clnu.2004.04.010; Gniuli D, 2008, J LIPID RES, V49, P1936, DOI 10.1194/jlr.M800033-JLR200; Granado M, 2012, OBESITY FACTS, V5, P138, DOI 10.1159/000336967; Gregersen S, 2005, METABOLISM, V54, P1316, DOI 10.1016/j.metabol.2005.04.020; Grummer-Strawn LM, 2004, PEDIATRICS, V113, P81; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; HOSKER JP, 1985, DIABETOLOGIA, V28, P401, DOI 10.1007/BF00280882; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Jansson N, 2008, AM J CLIN NUTR, V87, P1743, DOI 10.1093/ajcn/87.6.1743; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Koukkou E, 1998, CIRCULATION, V98, P2899, DOI 10.1161/01.CIR.98.25.2899; Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Masuyama H, 2012, ENDOCRINOLOGY, V153, P2823, DOI 10.1210/en.2011-2161; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Neary NM, 2004, CLIN ENDOCRINOL, V60, P153, DOI 10.1046/j.1365-2265.2003.01839.x; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Palou M, 2011, BRIT J NUTR, V106, P769, DOI 10.1017/S0007114511000973; Qiu J, 2006, NATURE, V441, P143, DOI 10.1038/441143a; Rosenbloom A, 2000, DIABETES CARE, V23, P381; Sakurai N, 2009, J NUTR SCI VITAMINOL, V55, P131, DOI 10.3177/jnsv.55.131; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Stefan N, 2002, HORM METAB RES, V34, P469, DOI 10.1055/s-2002-34785; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Tan KCB, 2004, J CLIN ENDOCR METAB, V89, P765, DOI 10.1210/jc.2003-031012; Trout KK, 2011, CURR DIABETES REP, V11, P7, DOI 10.1007/s11892-010-0159-6; van Schothorst EM, 2009, FASEB J, V23, P1092, DOI 10.1096/fj.08-117119; Wiedmeier JE, 2011, NUTR REV, V69, P76, DOI 10.1111/j.1753-4887.2010.00370.x; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; Yokomori N, 2002, DIABETOLOGIA, V45, P140, DOI 10.1007/s125-002-8255-4	49	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92805	10.1371/journal.pone.0092805	http://dx.doi.org/10.1371/journal.pone.0092805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664181	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900116
J	Miller-Gallacher, JL; Nehme, R; Warne, T; Edwards, PC; Schertler, GFX; Leslie, AGW; Tate, CG				Miller-Gallacher, Jennifer L.; Nehme, Rony; Warne, Tony; Edwards, Patricia C.; Schertler, Gebhard F. X.; Leslie, Andrew G. W.; Tate, Christopher G.			The 2.1 angstrom Resolution Structure of Cyanopindolol-Bound beta(1)-Adrenoceptor Identifies an Intramembrane Na+ Ion that Stabilises the Ligand-Free Receptor	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; CRYSTALLIZING MEMBRANE-PROTEINS; CONSERVED ASPARTATE RESIDUE; BETA-ADRENERGIC-RECEPTORS; ADENOSINE A(2A) RECEPTOR; NEUROTENSIN RECEPTOR; TRANSMEMBRANE DOMAIN; AGONIST BINDING; MUTATION; SODIUM	The beta(1)-adrenoceptor (beta(1)AR) is a G protein-coupled receptor (GPCR) that is activated by the endogenous agonists adrenaline and noradrenaline. We have determined the structure of an ultra-thermostable beta(1)AR mutant bound to the weak partial agonist cyanopindolol to 2.1 angstrom resolution. High-quality crystals (100 mm plates) were grown in lipidic cubic phase without the assistance of a T4 lysozyme or BRIL fusion in cytoplasmic loop 3, which is commonly employed for GPCR crystallisation. An intramembrane Na+ ion was identified co-ordinated to Asp87(2.50), Ser128(3.39) and 3 water molecules, which is part of a more extensive network of water molecules in a cavity formed between transmembrane helices 1, 2, 3, 6 and 7. Remarkably, this water network and Na+ ion is highly conserved between beta(1)AR and the adenosine A(2A) receptor (rmsd of 0.3 angstrom), despite an overall rmsd of 2.4 angstrom for all C alpha atoms and only 23% amino acid identity in the transmembrane regions. The affinity of agonist binding and nanobody Nb80 binding to beta(1)AR is unaffected by Na+ ions, but the stability of the receptor is decreased by 7.5 degrees C in the absence of Na+. Mutation of amino acid side chains that are involved in the co-ordination of either Na+ or water molecules in the network decreases the stability of beta(1)AR by 5-10 degrees C. The data suggest that the intramembrane Na+ and associated water network stabilise the ligand-free state of beta(1)AR, but still permits the receptor to form the activated state which involves the collapse of the Na+ binding pocket on agonist binding.	[Miller-Gallacher, Jennifer L.; Nehme, Rony; Warne, Tony; Edwards, Patricia C.; Schertler, Gebhard F. X.; Leslie, Andrew G. W.; Tate, Christopher G.] MRC, Mol Biol Lab, Struct Studies Div, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Tate, CG (corresponding author), MRC, Mol Biol Lab, Struct Studies Div, Hills Rd, Cambridge CB2 2QH, England.	cgt@mrc-lmb.cam.ac.uk	Schertler, Gebhard/M-9512-2014	Miller-Gallacher, Jennifer/0000-0003-0539-0223; Tate, Christopher/0000-0002-2008-9183; Schertler, Gebhard F.X./0000-0002-5846-6810; Warne, Tony/0000-0001-9646-6080	Commonwealth Scholarship; Medical Research Council [MRC U105197215]; Wellcome Trust; BBSRC [BB/G003653/1]; Heptares Therapeutics; Biotechnology and Biological Sciences Research Council [BB/G003653/1] Funding Source: researchfish; Medical Research Council [MC_U105197215, MC_U105184325] Funding Source: researchfish; MRC [MC_U105197215, MC_U105184325] Funding Source: UKRI	Commonwealth Scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Heptares Therapeutics; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JLMG was the recipient of a Commonwealth Scholarship. Research in CGT's laboratory on G protein-coupled receptors is funded by the Medical Research Council (MRC U105197215), the Wellcome Trust, the BBSRC (BB/G003653/1) and by grants from Heptares Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2006, J PHARMACOL SCI, V102, P167, DOI 10.1254/jphs.FP0060640; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barbhaiya H, 1996, MOL PHARMACOL, V50, P1635; BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caffrey M, 2012, BIOCHEMISTRY-US, V51, P6266, DOI 10.1021/bi300010w; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHUNG FZ, 1988, J BIOL CHEM, V263, P4052; Congreve M, 2012, J MED CHEM, V55, P1898, DOI 10.1021/jm201376w; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRASER CM, 1989, MOL PHARMACOL, V36, P840; Gaisford W, 2011, NATURE METHODS, V8, pi; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; KONG HY, 1993, J BIOL CHEM, V268, P23055; KONG HY, 1993, MOL PHARMACOL, V44, P380; Lebon G, 2012, CURR OPIN STRUC BIOL, V22, P482, DOI 10.1016/j.sbi.2012.03.007; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Mason JS, 2012, TRENDS PHARMACOL SCI, V33, P249, DOI 10.1016/j.tips.2012.02.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller JL, 2011, J MOL BIOL, V413, P628, DOI 10.1016/j.jmb.2011.08.057; MINUTH M, 1986, N-S ARCH PHARMACOL, V333, P124, DOI 10.1007/BF00506514; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEVE KA, 1991, MOL PHARMACOL, V39, P733; Parent JL, 1996, BIOCHEM BIOPH RES CO, V219, P968, DOI 10.1006/bbrc.1996.0341; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Proulx CD, 2008, MOL PHARMACOL, V74, P552, DOI 10.1124/mol.108.045054; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2013, BBA-BIOMEMBRANES, V1828, P1293, DOI 10.1016/j.bbamem.2013.01.008; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; STRADER CD, 1988, J BIOL CHEM, V263, P10267; SURPRENANT A, 1992, SCIENCE, V257, P977, DOI 10.1126/science.1354394; Tao Q, 1998, J PHARMACOL EXP THER, V285, P651; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2013, BIOCHEM SOC T, V41, P159, DOI 10.1042/BST20120228; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Warne T, 2009, PROTEIN EXPRES PURIF, V65, P204, DOI 10.1016/j.pep.2009.01.014; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wilson MH, 2001, MOL PHARMACOL, V59, P929, DOI 10.1124/mol.59.4.929; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zeidel ML, 2010, ENDOCR PRACT, V16, P882, DOI 10.4158/EP10154.RA; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	66	130	132	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92727	10.1371/journal.pone.0092727	http://dx.doi.org/10.1371/journal.pone.0092727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663151	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900104
J	Zahoor, Z; Lockyer, AE; Davies, AJ; Kirk, RS; Emery, AM; Rollinson, D; Jones, CS; Noble, LR; Walker, AJ				Zahoor, Zahida; Lockyer, Anne E.; Davies, Angela J.; Kirk, Ruth S.; Emery, Aidan M.; Rollinson, David; Jones, Catherine S.; Noble, Leslie R.; Walker, Anthony J.			Differences in the Gene Expression Profiles of Haemocytes from Schistosome-Susceptible and -Resistant Biomphalaria glabrata Exposed to Schistosoma mansoni Excretory-Secretory Products	PLOS ONE			English	Article							LYMNAEA-STAGNALIS HEMOCYTES; DEFENSE CELLS; HEAT-SHOCK-PROTEIN-70 FAMILY; IN-VITRO; PROTEINS; IDENTIFICATION; KINASE; PHAGOCYTOSIS; ACTIVATION; PARASITE	During its life cycle, the helminth parasite Schistosoma mansoni uses the freshwater snail Biomphalaria glabrata as an intermediate host to reproduce asexually generating cercariae for infection of the human definitive host. Following invasion of the snail, the parasite develops from a miracidium to a mother sporocyst and releases excretory-secretory products (ESPs) that likely influence the outcome of host infection. To better understand molecular interactions between these ESPs and the host snail defence system, we determined gene expression profiles of haemocytes from S. mansoni-resistant or -susceptible strains of B. glabrata exposed in vitro to S. mansoni ESPs (20 mg/ ml) for 1 h, using a 5K B. glabrata cDNA microarray. Ninety-eight genes were found differentially expressed between haemocytes from the two snail strains, 57 resistant specific and 41 susceptible specific, 60 of which had no known homologue in GenBank. Known differentially expressed resistant-snail genes included the nuclear factor kappa B subunit Relish, elongation factor 1 alpha, 40S ribosomal protein S9, and matrilin; known susceptible-snail specific genes included cathepsins D and L, and theromacin. Comparative analysis with other gene expression studies revealed 38 of the 98 identified genes to be uniquely differentially expressed in haemocytes in the presence of ESPs, thus identifying for the first time schistosome ESPs as important molecules that influence global snail host-defence cell gene expression profiles. Such immunomodulation may benefit the schistosome, enabling its survival and successful development in the snail host.	[Zahoor, Zahida; Davies, Angela J.; Kirk, Ruth S.; Walker, Anthony J.] Univ Kingston, Sch Life Sci, Mol Parasitol Lab, Kingston Upon Thames KT1 2EE, Surrey, England; [Zahoor, Zahida; Lockyer, Anne E.; Emery, Aidan M.; Rollinson, David] Nat Hist Museum, Wolfson Wellcome Biomed Lab, London SW7 5BD, England; [Lockyer, Anne E.; Jones, Catherine S.; Noble, Leslie R.] Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen, Scotland	Kingston University; Natural History Museum London; University of Aberdeen	Walker, AJ (corresponding author), Univ Kingston, Sch Life Sci, Mol Parasitol Lab, Kingston Upon Thames KT1 2EE, Surrey, England.	t.walker@kingston.ac.uk	Kirk, Ruth/B-6246-2009; Rollinson, David/C-7406-2009; Lockyer, Anne/AAO-4327-2021	Lockyer, Anne/0000-0002-3498-2423; Noble, leslie/0000-0003-3076-0759; Emery, Aidan/0000-0001-9028-8586; ZAHOOR, ZAHIDA/0000-0002-7487-7097	Kingston University; Wellcome Trust [9068589/Z/02/Z]	Kingston University; Wellcome Trust(Wellcome TrustEuropean Commission)	A Kingston University studentship award funded ZZ. AEL, CSJ, LRN and DR acknowledge support with funding from the Wellcome Trust 9068589/Z/02/Z; www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne CJ, 2009, MOL BIOCHEM PARASIT, V165, P8, DOI 10.1016/j.molbiopara.2009.01.005; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; CHERNIN E, 1963, J PARASITOL, V49, P353, DOI 10.2307/3275797; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; CONNORS VA, 1991, J INVERTEBR PATHOL, V58, P387, DOI 10.1016/0022-2011(91)90185-S; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Genard B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064534; Guillou F, 2007, MOL BIOCHEM PARASIT, V155, P45, DOI 10.1016/j.molbiopara.2007.05.009; Hahn UK, 2000, DEV COMP IMMUNOL, V24, P531, DOI 10.1016/S0145-305X(00)00017-3; Hahn UK, 2001, J PARASITOL, V87, P778, DOI 10.1645/0022-3395(2001)087[0778:IONOIK]2.0.CO;2; Hanington PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001591; Hanington PC, 2010, INT J PARASITOL, V40, P819, DOI 10.1016/j.ijpara.2009.12.005; Huang XD, 2012, FISH SHELLFISH IMMUN, V33, P659, DOI 10.1016/j.fsi.2012.06.029; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Ittiprasert W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002677; Ittiprasert W, 2010, MOL BIOCHEM PARASIT, V169, P27, DOI 10.1016/j.molbiopara.2009.09.009; Jiang YG, 2006, DEV COMP IMMUNOL, V30, P855, DOI 10.1016/j.dci.2005.12.004; Jiang YS, 2007, DEV COMP IMMUNOL, V31, P121, DOI 10.1016/j.dci.2006.05.014; Jung S, 2012, J BIOL CHEM, V287, P14246, DOI 10.1074/jbc.M111.336495; Karlin S, 1998, J MOL EVOL, V47, P565, DOI 10.1007/PL00006413; Lacchini AH, 2006, J EXP BIOL, V209, P4829, DOI 10.1242/jeb.02561; LIE KJ, 1977, J INVERTEBR PATHOL, V29, P118, DOI 10.1016/0022-2011(77)90183-5; Lockyer AE, 2004, EXP PARASITOL, V107, P97, DOI 10.1016/j.exppara.2004.04.004; Lockyer AE, 2007, DEV COMP IMMUNOL, V31, P763, DOI 10.1016/j.dci.2006.11.004; Lockyer AE, 2007, MOL BIOCHEM PARASIT, V151, P18, DOI 10.1016/j.molbiopara.2006.09.009; Lockyer AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051102; Lockyer AE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-634; LODES MJ, 1989, J PARASITOL, V75, P853, DOI 10.2307/3282863; LODES MJ, 1990, J INVERTEBR PATHOL, V56, P75, DOI 10.1016/0022-2011(90)90147-X; Ludtmann MHR, 2009, INT J PARASITOL, V39, P1223, DOI 10.1016/j.ijpara.2009.04.002; Mitta G, 2005, DEV COMP IMMUNOL, V29, P393, DOI 10.1016/j.dci.2004.10.002; Mitta G, 2012, DEV COMP IMMUNOL, V37, P1, DOI 10.1016/j.dci.2011.09.002; Mone Y, 2011, INT J PARASITOL, V41, P721, DOI 10.1016/j.ijpara.2011.01.007; PARAENSE W. L., 1963, REV INST MED TROP SAO PAULO, V5, P15; Petalidis L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng142; Plows LD, 2006, J INVERTEBR PATHOL, V91, P74, DOI 10.1016/j.jip.2005.10.011; Plows LD, 2004, BBA-MOL CELL RES, V1692, P25, DOI 10.1016/j.bbamer.2004.03.002; Plows LD, 2006, BBA-MOL CELL RES, V1763, P779, DOI 10.1016/j.bbamcr.2006.04.008; Roger E, 2008, MOL BIOCHEM PARASIT, V157, P217, DOI 10.1016/j.molbiopara.2007.11.015; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Walker AJ, 2006, TRENDS PARASITOL, V22, P154, DOI 10.1016/j.pt.2006.02.003; Walker AJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-203; Wu XJ, 2009, MOL BIOCHEM PARASIT, V164, P32, DOI 10.1016/j.molbiopara.2008.11.005; Zahoor Z, 2008, DEV COMP IMMUNOL, V32, P1561, DOI 10.1016/j.dci.2008.05.014; Zahoor Z, 2010, CELL STRESS CHAPERON, V15, P639, DOI 10.1007/s12192-010-0176-z; Zahoor Z, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-18; Zhang SM, 2011, MOL IMMUNOL, V48, P1868, DOI 10.1016/j.molimm.2011.05.017; Zhou Z, 2013, FISH SHELLFISH IMMUN, V34, P1209, DOI 10.1016/j.fsi.2013.01.009	50	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93215	10.1371/journal.pone.0093215	http://dx.doi.org/10.1371/journal.pone.0093215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663063	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000333459900162
J	Zhang, L; Borror, CM; Sandrin, TR				Zhang, Lin; Borror, Connie M.; Sandrin, Todd R.			A Designed Experiments Approach to Optimization of Automated Data Acquisition during Characterization of Bacteria with MALDI-TOF Mass Spectrometry	PLOS ONE			English	Article							DESORPTION-IONIZATION-TIME; RESISTANT STAPHYLOCOCCUS-AUREUS; SAMPLE PREPARATION METHODS; RAPID IDENTIFICATION; SPECTRUM QUALITY; STRAIN LEVEL; MS; REPRODUCIBILITY; DIFFERENTIATION; DISCRIMINATION	MALDI-TOF MS has been shown capable of rapidly and accurately characterizing bacteria. Highly reproducible spectra are required to ensure reliable characterization. Prior work has shown that spectra acquired manually can have higher reproducibility than those acquired automatically. For this reason, the objective of this study was to optimize automated data acquisition to yield spectra with reproducibility comparable to those acquired manually. Fractional factorial design was used to design experiments for robust optimization of settings, in which values of five parameters (peak selection mass range, signal to noise ratio (S:N), base peak intensity, minimum resolution and number of shots summed) commonly used to facilitate automated data acquisition were varied. Pseudomonas aeruginosa was used as a model bacterium in the designed experiments, and spectra were acquired using an intact cell sample preparation method. Optimum automated data acquisition settings (i.e., those settings yielding the highest reproducibility of replicate mass spectra) were obtained based on statistical analysis of spectra of P. aeruginosa. Finally, spectrum quality and reproducibility obtained from non-optimized and optimized automated data acquisition settings were compared for P. aeruginosa, as well as for two other bacteria, Klebsiella pneumoniae and Serratia marcescens. Results indicated that reproducibility increased from 90% to 97% (p-value congruent to 0.002) for P. aeruginosa when more shots were summed and, interestingly, decreased from 95% to 92% (p-value congruent to 0.013) with increased threshold minimum resolution. With regard to spectrum quality, highly reproducible spectra were more likely to have high spectrum quality as measured by several quality metrics, except for base peak resolution. Interaction plots suggest that, in cases of low threshold minimum resolution, high reproducibility can be achieved with fewer shots. Optimization yielded more reproducible spectra than non-optimized settings for all three bacteria.	[Zhang, Lin; Borror, Connie M.; Sandrin, Todd R.] Arizona State Univ, Sch Math & Nat Sci, Phoenix, AZ 85004 USA	Arizona State University; Arizona State University-Downtown Phoenix	Sandrin, TR (corresponding author), Arizona State Univ, Sch Math & Nat Sci, Phoenix, AZ 85004 USA.	Todd.Sandrin@asu.edu		Sandrin, Todd/0000-0001-5079-2999	New College of Interdisciplinary Arts & Sciences at Arizona State University	New College of Interdisciplinary Arts & Sciences at Arizona State University	This work was supported by the New College of Interdisciplinary Arts & Sciences at Arizona State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo PW, 1996, TRAC-TREND ANAL CHEM, V15, P26, DOI 10.1016/0165-9936(96)88034-4; Avila A, 2005, CHEMOMETR INTELL LAB, V77, P247, DOI 10.1016/j.chemolab.2004.10.010; Barbuddhe SB, 2008, APPL ENVIRON MICROB, V74, P5402, DOI 10.1128/AEM.02689-07; Benagli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048441; Dieckmann R, 2005, APPL MICROBIOL BIOT, V67, P539, DOI 10.1007/s00253-004-1812-2; Eddabra R, 2012, MICROBIOL RES, V167, P226, DOI 10.1016/j.micres.2011.09.002; Edwards-Jones V, 2000, J MED MICROBIOL, V49, P295, DOI 10.1099/0022-1317-49-3-295; Evason DJ, 2001, J AM SOC MASS SPECTR, V12, P49, DOI 10.1016/S1044-0305(00)00192-6; Feldsine PT, 2003, J AOAC INT, V86, P275; Ford BA, 2013, J CLIN MICROBIOL, V51, P1412, DOI 10.1128/JCM.01803-12; Giebel R, 2010, ADV APPL MICROBIOL, V71, P149, DOI 10.1016/S0065-2164(10)71006-6; Giebel RA, 2008, WATER RES, V42, P931, DOI 10.1016/j.watres.2007.09.005; Goldstein JE, 2013, LETT APPL MICROBIOL, V57, P144, DOI 10.1111/lam.12092; Goyer M, 2012, J CLIN MICROBIOL, V50, P3066, DOI 10.1128/JCM.06381-11; Haag AM, 1998, J MASS SPECTROM, V33, P750, DOI 10.1002/(SICI)1096-9888(199808)33:8<750::AID-JMS680>3.0.CO;2-1; Hsieh SY, 2008, MOL CELL PROTEOMICS, V7, P448, DOI 10.1074/mcp.M700339-MCP200; Ichiki Y, 2008, J PESTIC SCI, V33, P122, DOI 10.1584/jpestics.G07-22; Jackson KA, 2005, J MICROBIOL METH, V62, P273, DOI 10.1016/j.mimet.2005.04.015; Johnson RA, 2007, APPL MULTIVARIATE ST; Kern CC, 2013, J MICROBIOL METH, V93, P185, DOI 10.1016/j.mimet.2013.03.012; Khot PD, 2012, J CLIN MICROBIOL, V50, P3845, DOI 10.1128/JCM.00626-12; Kincl M, 2005, INT J PHARMACEUT, V291, P39, DOI 10.1016/j.ijpharm.2004.07.041; Koubek J, 2012, INT BIODETER BIODEGR, V69, P82, DOI 10.1016/j.ibiod.2011.12.007; Liu HH, 2007, APPL ENVIRON MICROB, V73, P1899, DOI 10.1128/AEM.02391-06; Mellmann A, 2009, J CLIN MICROBIOL, V47, P3732, DOI 10.1128/JCM.00921-09; Montgomery D.C., 2013, DESIGN ANAL EXPT; Ruelle V, 2004, RAPID COMMUN MASS SP, V18, P2013, DOI 10.1002/rcm.1584; Rupf S, 2005, ORAL MICROBIOL IMMUN, V20, P267, DOI 10.1111/j.1399-302X.2005.00223.x; Salaun S, 2010, TALANTA, V80, P1758, DOI 10.1016/j.talanta.2009.10.020; Sandrin TR, 2013, MASS SPECTROM REV, V32, P188, DOI 10.1002/mas.21359; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Schumaker S, 2012, RAPID COMMUN MASS SP, V26, P243, DOI 10.1002/rcm.5309; Sedo O, 2011, SYST APPL MICROBIOL, V34, P30, DOI 10.1016/j.syapm.2010.11.008; Stafsnes MH, 2013, ANTON LEEUW INT J G, V103, P603, DOI 10.1007/s10482-012-9844-6; STATHAM PJ, 1977, ANAL CHEM, V49, P2149, DOI 10.1021/ac50022a014; Stephan R, 2011, J MICROBIOL METH, V87, P150, DOI 10.1016/j.mimet.2011.08.016; Stets MI, 2013, J BIOTECHNOL, V165, P167, DOI 10.1016/j.jbiotec.2013.04.001; Stojanovic BJ, 2013, CHROMATOGRAPHIA, V76, P227, DOI 10.1007/s10337-012-2350-1; Tani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040784; Thevenon F, 2012, ECOTOX ENVIRON SAFE, V78, P50, DOI 10.1016/j.ecoenv.2011.11.005; Toh-Boyo GM, 2012, ANAL CHEM, V84, P9971, DOI 10.1021/ac302375e; Uhlik O, 2011, APPL ENVIRON MICROB, V77, P6858, DOI 10.1128/AEM.05465-11; Vargha M, 2006, J MICROBIOL METH, V66, P399, DOI 10.1016/j.mimet.2006.01.006; Walker J, 2002, J MICROBIOL METH, V48, P117, DOI 10.1016/S0167-7012(01)00316-5; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047152; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002; Zhang X, 2007, CHEMOMETR INTELL LAB, V89, P45, DOI 10.1016/j.chemolab.2007.05.006; Ziegler D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037189	48	15	15	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92720	10.1371/journal.pone.0092720	http://dx.doi.org/10.1371/journal.pone.0092720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662978	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900101
J	Brischoux, F; Kornilev, YV				Brischoux, Francois; Kornilev, Yurii V.			Hypernatremia in Dice Snakes (Natrix tessellata) from a Coastal Population: Implications for Osmoregulation in Marine Snake Prototypes	PLOS ONE			English	Article							PELAGIC SEA-SNAKE; SALT-GLANDS; FRESH-WATER; LATICAUDA SPP.; CONVERGENT EVOLUTION; NOTECHIS-SCUTATUS; TIGER SNAKE; ESTUARINE; SALINITY; SODIUM	The widespread relationship between salt excreting structures (e.g., salt glands) and marine life strongly suggests that the ability to regulate salt balance has been crucial during the transition to marine life in tetrapods. Elevated natremia (plasma sodium) recorded in several marine snakes species suggests that the development of a tolerance toward hypernatremia, in addition to salt gland development, has been a critical feature in the evolution of marine snakes. However, data from intermediate stage (species lacking salt glands but occasionally using salty environments) are lacking to draw a comprehensive picture of the evolution of an euryhaline physiology in these organisms. In this study, we assessed natremia of free-ranging Dice snakes (Natrix tessellata, a predominantly fresh water natricine lacking salt glands) from a coastal population in Bulgaria. Our results show that coastal N. tessellata can display hypernatremia (up to 195.5 mmol.l(-1)) without any apparent effect on several physiological and behavioural traits (e.g., hematocrit, body condition, foraging). More generally, a review of natremia in species situated along a continuum of habitat use between fresh- and seawater shows that snake species display a concomitant tolerance toward hypernatremia, even in species lacking salt glands. Collectively, these data suggest that a physiological tolerance toward hypernatremia has been critical during the evolution of an euryhaline physiology, and may well have preceded the evolution of salt glands.	[Brischoux, Francois] CEBC, UMR 7372 CNRS ULR, Villiers En Bois, France; [Kornilev, Yurii V.] NCC Poda, Bulgarian Soc Protect Birds, Burgas, Bulgaria	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Brischoux, F (corresponding author), CEBC, UMR 7372 CNRS ULR, Villiers En Bois, France.	francois.brischoux@gmail.com	Kornilev, Yurii V/N-7035-2013	Kornilev, Yurii V/0000-0002-8596-8728	CNRS (France)	CNRS (France)(Centre National de la Recherche Scientifique (CNRS))	Funding was provided by the CNRS (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babonis LS, 2012, INTEGR COMP BIOL, V52, P245, DOI 10.1093/icb/ics073; Babonis LS, 2011, J EXP BIOL, V214, P2140, DOI 10.1242/jeb.052852; Baha El Din S., 2006, GUIDE REPTILES AMPHI; Bonnet X., 1995, P237; Bonnet X, 2008, AUSTRAL ECOL, V33, P911, DOI 10.1111/j.1442-9993.2008.01917.x; Brischoux F, 2013, COMP BIOCHEM PHYS A, V166, P333, DOI 10.1016/j.cbpa.2013.07.007; Brischoux F, 2012, ECOGRAPHY, V35, P994, DOI 10.1111/j.1600-0587.2012.07717.x; Brischoux F, 2012, INTEGR COMP BIOL, V52, P235, DOI 10.1093/icb/ics081; Campbell T.W, 2004, 55 ANN M AM COLL VET; Carlsson Martin, 2011, Mertensiella, V18, P237; DUGGAN RT, 1978, GEN COMP ENDOCR, V36, P510, DOI 10.1016/0016-6480(78)90090-4; Dunson W.A., 1975, J COMP PHYSL, V101, P89; DUNSON WA, 1983, PHYSIOL ZOOL, V56, P106, DOI 10.1086/physzool.56.1.30159971; DUNSON WA, 1976, J COMP PHYSIOL, V108, P303, DOI 10.1007/BF00691678; DUNSON WA, 1968, AM J PHYSIOL, V215, P1512, DOI 10.1152/ajplegacy.1968.215.6.1512; DUNSON WA, 1973, J COMP PHYSIOL, V86, P193, DOI 10.1007/BF00696339; DUNSON WA, 1974, AM J PHYSIOL, V227, P430, DOI 10.1152/ajplegacy.1974.227.2.430; DUNSON WA, 1971, SCIENCE, V173, P437, DOI 10.1126/science.173.3995.437; DUNSON WA, 1980, COPEIA, P268; DUNSON WA, 1986, COPEIA, P741, DOI 10.2307/1444958; DUNSON WA, 1989, B MAR SCI, V44, P229; Gruschwitz M., 1999, HDB REPTILIEN AMPHIB, V3, P581; Houser DS, 2005, ECOLOGY WATER RELATI, DOI [10.1038/npg.els.0003216, DOI 10.1038/NPG.ELS.0003216)]; Ioannidis Yannis, 2011, Mertensiella, V18, P302; Jelic Dusan, 2011, Mertensiella, V18, P217; Kidera N, 2013, J COMP PHYSIOL A, V199, P191, DOI 10.1007/s00359-012-0782-6; Ladyman M, 2003, J COMP PHYSIOL B, V173, P239, DOI 10.1007/s00360-003-0328-x; Ladyman M, 2006, J COMP PHYSIOL B, V176, P547, DOI 10.1007/s00360-006-0077-8; Lillywhite HB, 2009, J EXP BIOL, V212, P1921, DOI 10.1242/jeb.028704; Lillywhite HB, 2008, PHYSIOL BIOCHEM ZOOL, V81, P785, DOI 10.1086/588306; Lillywhite HB, 2008, BIOSCIENCE, V58, P947, DOI 10.1641/B581008; Lillywhite HB, 2012, INTEGR COMP BIOL, V52, P227, DOI 10.1093/icb/ics039; Mazin J.M., 2001, SECONDARY ADAPTATION; Mebert K., 2011, MERTENSIELLA, V18; Mebert Konrad, 2011, Mertensiella, V18, P234; Mrsic N, 1997, REPTILES REPTILIA SL; Murphy JC, 2012, INTEGR COMP BIOL, V52, P217, DOI 10.1093/icb/ics060; Naumov Borislav, 2011, Mertensiella, V18, P288; Nollert A., 1986, Herpetofauna (Weinstadt), V8, P30; Ortiz RM, 2001, J EXP BIOL, V204, P1831; Peaker M., 1975, SALT GLANDS BIRDS RE; Peterson CC, 2002, CAN J ZOOL, V80, P461, DOI 10.1139/Z02-021; Poda Protected Area Management Plan, 2002, POD PROT AR MAN PLAN; Randall DJ, 2002, ECKERT ANIMAL PHYSL, V5; Roe LJ, 1998, ADV VERT PALEOBIOL, P399; Schmidt-Nielsen K., 1983, ANIMAL PHYSL ADAPTAT; Stoyanov A, 2011, DIE AMPHIBIEN REPTIL; Thieme U., 1986, Sauria, V8, P3; Tome S, 2002, SNAKES WHY DO WE FEA; Tuniyev Boris, 2011, Mertensiella, V18, P343; Zagar Anamarija, 2011, Mertensiella, V18, P207	51	9	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92617	10.1371/journal.pone.0092617	http://dx.doi.org/10.1371/journal.pone.0092617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658047	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300107
J	Shan, L; Schipper, P; Nonkes, LJP; Homberg, JR				Shan, Ling; Schipper, Pieter; Nonkes, Lourens J. P.; Homberg, Judith R.			Impaired Fear Extinction as Displayed by Serotonin Transporter Knockout Rats Housed in Open Cages Is Disrupted by IVC Cage Housing	PLOS ONE			English	Article							STRESS; ENVIRONMENT; BEHAVIOR; GENE; MICE; GENOTYPE; TESTS	Anxiety disorders are influenced by both environmental and genetic factors. A well-known example for gene x environment interactions in psychiatry is the low activity (s) allelic variant of the serotonin transporter (5-HTT) promoter polymorphism (5-HTTLPR) that in the context of stress increases risk for depression and post-traumatic stress disorder (PTSD). Previously, we observed robust anxiety-related phenotypes, such as an impairment in fear extinction, in 5-HTT knockout (5-HTT-/-) versus wild-type (5-HTT+/+) rats housed in open cages. Recently, housing conditions were changed from open cages to individually ventilated cages (IVC), which are associated with a high ventilation fold and noise. This switch in housing conditions prompted an unplanned 5-HTT gene x environment interaction study in our rats. The current study shows that lifetime stress by means of IVC cage housing abolished genotype differences in fear extinction between 5-HTT-/- and 5-HTT+/+ rats. Although this effect was not attributed specifically to either the 5-HTT+/+ or the 5-HTT-/- genotype, the findings are in agreement with the modulatory role of serotonin in the processing of environmental stimuli. Our findings also underline the possibility that housing conditions confound the interpretation of anxiety-related behaviours in rodents.	[Shan, Ling; Schipper, Pieter; Nonkes, Lourens J. P.; Homberg, Judith R.] Radboud Univ Nijmegen, Med Ctr, Ctr Neurosci, Donders Inst Brain Cognit & Behaviour,Dept Cognit, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Homberg, JR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Ctr Neurosci, Donders Inst Brain Cognit & Behaviour,Dept Cognit, NL-6525 ED Nijmegen, Netherlands.	Judith.Homberg@radboudumc.nl	Shan, Ling/N-7075-2019; Homberg, Judith R/D-2473-2010; Shan, Ling/E-4281-2012; Homberg, J.R./N-4172-2019	Shan, Ling/0000-0002-4765-2474; Shan, Ling/0000-0002-4765-2474; 	Netherlands Organization for Scientific Research (NWO) [864.10.003]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO), grant #864.10.003 awarded to J. R. Homberg. NWO had no further role in the design of the study, in the collection, analysis and interpretation of data.	Bilkei-Gorzo A, 2008, BEHAV BRAIN RES, V186, P289, DOI 10.1016/j.bbr.2007.08.027; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Clement Y, 2002, BRAIN RES BULL, V57, P57, DOI 10.1016/S0361-9230(01)00637-2; Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009; Homberg JR, 2007, NEUROSCIENCE, V146, P1662, DOI 10.1016/j.neuroscience.2007.03.030; Homberg JR, 2012, PROG NEUROBIOL, V99, P117, DOI 10.1016/j.pneurobio.2012.08.003; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Jansen F, 2010, BEHAV BRAIN RES, V207, P21, DOI 10.1016/j.bbr.2009.09.033; Joeyen-Waldorf J, 2009, BRAIN RES, V1286, P84, DOI 10.1016/j.brainres.2009.06.079; Kalueff AV, 2010, NEUROSCI BIOBEHAV R, V34, P373, DOI 10.1016/j.neubiorev.2009.08.003; Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064; Lewejohann L, 2006, GENES BRAIN BEHAV, V5, P64, DOI 10.1111/j.1601-183X.2005.00140.x; Muller JM, 2011, GENES BRAIN BEHAV, V10, P166, DOI 10.1111/j.1601-183X.2010.00652.x; Narayanan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022600; Nonkes LJP, 2012, J PSYCHIATR NEUROSCI, V37, P224, DOI 10.1503/jpn.110116; Schipper P, 2011, BEHAV BRAIN RES, V223, P169, DOI 10.1016/j.bbr.2011.04.037; Swaab DF, 2000, PROG BRAIN RES, V126, P369; van der Doelen RHA, 2013, MOL PSYCHIATR, V18, P1244, DOI 10.1038/mp.2012.186; Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103	21	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91472	10.1371/journal.pone.0091472	http://dx.doi.org/10.1371/journal.pone.0091472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658187	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300034
J	Tachibana, RO; Oosugi, N; Okanoya, K				Tachibana, Ryosuke O.; Oosugi, Naoya; Okanoya, Kazuo			Semi-Automatic Classification of Birdsong Elements Using a Linear Support Vector Machine	PLOS ONE			English	Article							CONTINUOUS RECORDINGS; RECOGNITION; SEQUENCE	Birdsong provides a unique model for understanding the behavioral and neural bases underlying complex sequential behaviors. However, birdsong analyses require laborious effort to make the data quantitatively analyzable. The previous attempts had succeeded to provide some reduction of human efforts involved in birdsong segment classification. The present study was aimed to further reduce human efforts while increasing classification performance. In the current proposal, a linear-kernel support vector machine was employed to minimize the amount of human-generated label samples for reliable element classification in birdsong, and to enable the classifier to handle highly-dimensional acoustic features while avoiding the over-fitting problem. Bengalese finch's songs in which distinct elements (i.e., syllables) were aligned in a complex sequential pattern were used as a representative test case in the neuroscientific research field. Three evaluations were performed to test (1) algorithm validity and accuracy with exploring appropriate classifier settings, (2) capability to provide accuracy with reducing amount of instruction dataset, and (3) capability in classifying large dataset with minimized manual labeling. The results from the evaluation (1) showed that the algorithm is 99.5% reliable in song syllables classification. This accuracy was indeed maintained in evaluation (2), even when the instruction data classified by human were reduced to one-minute excerpt (corresponding to 300-400 syllables) for classifying two-minute excerpt. The reliability remained comparable, 98.7% accuracy, when a large target dataset of whole day recordings (similar to 30,000 syllables) was used. Use of a linear-kernel support vector machine showed sufficient accuracies with minimized manually generated instruction data in bird song element classification. The methodology proposed would help reducing laborious processes in birdsong analysis without sacrificing reliability, and therefore can help accelerating behavior and studies using songbirds.	[Tachibana, Ryosuke O.; Oosugi, Naoya; Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Okanoya, Kazuo] RIKEN, Okanoya Emot Informat Project, ERATO, Japan Sci & Technol Agcy, Wako, Saitama, Japan	University of Tokyo; Japan Science & Technology Agency (JST); RIKEN	Okanoya, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan.	cokanoya@mail.ecc.u-tokyo.ac.jp	Tachibana, Ryosuke/Q-2510-2019	Tachibana, Ryosuke/0000-0002-4766-4504	MEXT, JAPAN [23118003]	MEXT, JAPAN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Adolescent Mind & Self-Regulation, Grant-in-Aid for Scientific Research on Innovative Areas, MEXT, JAPAN (Grant Number: 23118003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 1996, J ACOUST SOC AM, V100, P1209, DOI 10.1121/1.415968; Chen ZX, 2006, J ACOUST SOC AM, V120, P2974, DOI 10.1121/1.2345831; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dufour O, 2013, P 1 WORKSH MACH LEAR, P89; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Hamaguchi K, 2012, J NEUROSCI, V32, P11671, DOI 10.1523/JNEUROSCI.1666-12.2012; Kogan JA, 1998, J ACOUST SOC AM, V103, P2185, DOI 10.1121/1.421364; Mencia EL, 2013, P NEUR INF PROC SCAL, P184; Okanoya K, 2004, ANN NY ACAD SCI, V1016, P724, DOI 10.1196/annals.1298.026; Peeters G., 2004, LARGE SET AUDIO FEAT; Peeters G, 2011, J ACOUST SOC AM, V130, P2902, DOI 10.1121/1.3642604; Rajan R, 2013, CURR BIOL, V23, P87, DOI 10.1016/j.cub.2012.11.040; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031	15	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92584	10.1371/journal.pone.0092584	http://dx.doi.org/10.1371/journal.pone.0092584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658578	gold, Green Published, Green Submitted			2022-12-25	WOS:000333355300102
J	Cody, JJ; Markert, JM; Hurst, DR				Cody, James J.; Markert, James M.; Hurst, Douglas R.			Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; TRICHOSTATIN; EFFICACY; MUTANT; GLIOMA; RISK; G207	New therapies are needed for metastatic breast cancer patients. Oncolytic herpes simplex virus (oHSV) is an exciting therapy being developed for use against aggressive tumors and established metastases. Although oHSV have been demonstrated safe in clinical trials, a lack of sufficient potency has slowed the clinical application of this approach. We utilized histone deacetylase (HDAC) inhibitors, which have been noted to impair the innate antiviral response and improve gene transcription from viral vectors, to enhance the replication of oHSV in breast cancer cells. A panel of chemically diverse HDAC inhibitors were tested at three different doses (<, =, and >LD50) for their ability to modulate the replication of oHSV in breast cancer cells. Several of the tested HDAC inhibitors enhanced oHSV replication at low multiplicity of infection (MOI) following pre-treatment of the metastatic breast cancer cell line MDA-MB-231 and the oHSV-resistant cell line 4T1, but not in the normal breast epithelial cell line MCF10A. Inhibitors of class I HDACs, including pan-selective compounds, were more effective for increasing oHSV replication compared to inhibitors that selectively target class II HDACs. These studies demonstrate that select HDAC inhibitors increase oHSV replication in breast cancer cells and provides support for preclinical evaluation of this combination strategy.	[Cody, James J.; Hurst, Douglas R.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Markert, James M.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Hurst, DR (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	dhurst@uab.edu		Hurst, Douglas/0000-0002-1296-2210	American Cancer Society [RSG-11-259-01-CSM]; METAvivor Research and Support, Inc.; National Institutes of Health [P50 CA097247, P01 CA71933]; NATIONAL CANCER INSTITUTE [P50CA097247, P01CA071933] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); METAvivor Research and Support, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by funding from the American Cancer Society RSG-11-259-01-CSM (DRH), METAvivor Research and Support, Inc. (DRH), and the National Institutes of Health P50 CA097247 and P01 CA71933 (JMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Breckenridge CA, 2012, J VIROL, V86, P4566, DOI 10.1128/JVI.05545-11; Andreansky S, 1998, GENE THER, V5, P121, DOI 10.1038/sj.gt.3300550; Bowles EJA, 2012, JNCI-J NATL CANCER I, V104, P1293, DOI 10.1093/jnci/djs317; Campadelli-Fiume G, 2011, REV MED VIROL, V21, P213, DOI 10.1002/rmv.691; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; Cody JJ, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/628697; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Hellums EK, 2005, NEURO-ONCOLOGY, V7, P213, DOI 10.1215/S1152851705000074; Hurst DR, 2008, J BIOL CHEM, V283, P7438, DOI 10.1074/jbc.M709446200; Hurst DR, 2009, CLIN EXP METASTAS, V26, P89, DOI 10.1007/s10585-008-9216-9; Kanai R, 2010, FUTURE ONCOL, V6, P619, DOI [10.2217/fon.10.18, 10.2217/FON.10.18]; Katsura T, 2009, CANCER GENE THER, V16, P237, DOI 10.1038/cgt.2008.81; Liu TC, 2008, MOL THER, V16, P1041, DOI 10.1038/mt.2008.58; MacTavish H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014462; Markert JM, 2012, J VIROL, V86, P5304, DOI 10.1128/JVI.06998-11; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Markert JM, 2000, GENE THER, V7, P867, DOI 10.1038/sj.gt.3301205; Nguyen TLA, 2010, CYTOKINE GROWTH F R, V21, P153, DOI 10.1016/j.cytogfr.2010.03.002; Nguyen TLA, 2008, P NATL ACAD SCI USA, V105, P14981, DOI 10.1073/pnas.0803988105; Otsuki A, 2008, MOL THER, V16, P1546, DOI 10.1038/mt.2008.155; Ottolino-Perry K, 2010, MOL THER, V18, P251, DOI 10.1038/mt.2009.283; Parker JN, 2000, P NATL ACAD SCI USA, V97, P2208, DOI 10.1073/pnas.040557897; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smith KT, 2009, INT J BIOCHEM CELL B, V41, P21, DOI 10.1016/j.biocel.2008.09.008; THOMAS D, 2003, MANAGE TODAY     JAN, P8	27	38	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92919	10.1371/journal.pone.0092919	http://dx.doi.org/10.1371/journal.pone.0092919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651853	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800166
J	Mendoza, JD; Caso, WS; Valdez, CT; Pons, MJ; del Valle, LJ; Ore, VC; Michelena, DC; Mayra, JB; Gavidea, VZ; Vargas, M; Ruiz, J				del Valle Mendoza, Juana; Silva Caso, Wilmer; Tinco Valdez, Carmen; Pons, Maria J.; del Valle, Luis J.; Casabona Ore, Veronica; Champin Michelena, Denisse; Bazan Mayra, Jorge; Zavaleta Gavidea, Victor; Vargas, Martha; Ruiz, Joaquim			Diagnosis of Carrion's Disease by Direct Blood PCR in Thin Blood Smear Negative Samples	PLOS ONE			English	Article							BARTONELLA-BACILLIFORMIS; INFECTION; IDENTIFICATION; OUTBREAK; ENTRY; FEVER	Bartonella bacilliformis is the etiologic agent of Carrion's disease. This disease has two well established phases, the most relevant being the so called Oroya Fever, in which B. bacilliformis infect the erythrocytes resulting in severe anemia and transient immunosuppression, with a high lethality in the absence of adequate antibiotic treatment. The presence of B. bacilliformis was studied in 113 blood samples suspected of Carrion's disease based on clinical criteria, despite the absence of a positive thin blood smear, by two different PCR techniques (using Bartonella-specific and universal 16S rRNA gene primers), and by bacterial culture. The specific 16S rRNA gene primers revealed the presence of 21 B. bacilliformis and 1 Bartonella elizabethae, while universal primers showed both the presence of 3 coinfections in which a concomitant pathogen was detected plus Bartonella, in addition to the presence of infections by other microorganisms such as Agrobacterium or Bacillus firmus. These data support the need to implement molecular tools to diagnose Carrion's disease.	[del Valle Mendoza, Juana; Silva Caso, Wilmer; Casabona Ore, Veronica; Champin Michelena, Denisse] Univ Peruana Ciencias Aplicadas UPC, Fac Ciencias Salud, Lima, Peru; [del Valle Mendoza, Juana; Tinco Valdez, Carmen; Casabona Ore, Veronica] Inst Invest Nutr, Lima, Peru; [Pons, Maria J.; Ruiz, Joaquim] Univ Barcelona, Hosp Clin Barcelona, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [del Valle, Luis J.] Univ Politecn Cataluna, Barcelona, Spain; [Bazan Mayra, Jorge; Zavaleta Gavidea, Victor] DIRESA Cajamarca, Direcc Reg Salud Cajamarca, Cajamarca, Peru; [Vargas, Martha] Hosp Clin Barcelona, IDIBAPS, Fdn Clin, Barcelona, Spain	Universidad Peruana de Ciencias Aplicadas (UPC); ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Universitat Politecnica de Catalunya; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Mendoza, JD (corresponding author), Univ Peruana Ciencias Aplicadas UPC, Fac Ciencias Salud, Lima, Peru.	jdelvall@upc.edu.pe	CASABONA ORE, VERONICA DANIXA/F-1248-2018; del Valle Mendoza, Juana/C-9805-2018; Ruiz, Joaquim/D-2704-2013; Silva, Wilmer Gianfranco/D-2699-2018; Del Valle, Luis J./I-1342-2015; Pons, Maria J/Q-6516-2016	CASABONA ORE, VERONICA DANIXA/0000-0002-9922-3786; del Valle Mendoza, Juana/0000-0002-6011-5040; Ruiz, Joaquim/0000-0002-4431-2036; Silva, Wilmer Gianfranco/0000-0003-1086-8084; Del Valle, Luis J./0000-0001-9916-1741; CHAMPIN MICHELENA, DENISSE/0000-0002-7563-8661; Pons, Maria Jesus/0000-0001-8384-2315; Bazan Mayra, jorge enrique/0000-0002-9984-8196; Zavaleta Gavidia, Victor/0000-0003-1760-4241; Vargas, Martha/0000-0002-6260-4403	Optimus Foundation; JdVM; program I3, of the ISCIII [CES11/012]; ISCIII [PI11/00983]	Optimus Foundation; JdVM; program I3, of the ISCIII; ISCIII(Instituto de Salud Carlos III)	This work has been partially supported by Optimus Foundation and by personal funds of JdVM. JR is supported by the program I3, of the ISCIII (grant number: CES11/012) and by ISCIII grant PI11/00983. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSON LA, 1986, INFECT IMMUN, V54, P347, DOI 10.1128/IAI.54.2.347-353.1986; BREÑA CHÁVEZ Judith Patricia, 2006, Rev Med Hered, V17, P122; Chamberlin J, 2002, J INFECT DIS, V186, P983, DOI 10.1086/344054; Chinga-Alayo E, 2004, T ROY SOC TROP MED H, V98, P116, DOI 10.1016/S0035-9203(03)00017-8; Clemente NS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001819; de Vegas EZS, 2006, INFECT CONT HOSP EP, V27, P397, DOI 10.1086/503177; del Valle LJ, 2014, J MICROBIOL RES, V2, P15; del Valle LJ, 2010, INT J INFECT DIS, V14, pE506, DOI 10.1016/j.ijid.2009.07.025; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Eicher SC, 2012, CELL MICROBIOL, V14, P1166, DOI 10.1111/j.1462-5822.2012.01806.x; Ellis BA, 1999, AM J TROP MED HYG, V61, P344; Eremeeva ME, 2007, NEW ENGL J MED, V356, P2381, DOI 10.1056/NEJMoa065987; Garcia-Esteban C, 2008, J CLIN MICROBIOL, V46, P776, DOI 10.1128/JCM.01720-07; Gray KJ, 2000, J INFECTION, V41, P227, DOI 10.1053/jinf.2000.0730; Henríquez César, 2002, Rev Med Hered, V13, P58; Ihler GM, 1996, FEMS MICROBIOL LETT, V144, P1, DOI [10.1016/0378-1097(96)00307-2, 10.1111/j.1574-6968.1996.tb08501.x]; Liberto MC, 2013, J MED MICROBIOL, V62, P1081, DOI 10.1099/jmm.0.050617-0; Liberto MC, 2011, MOL CELL PROBE, V25, P238, DOI 10.1016/j.mcp.2011.07.001; Lu JJ, 2000, J CLIN MICROBIOL, V38, P2076; Maguina C, 2000, INFECT DIS CLIN N AM, V14, P1, DOI 10.1016/S0891-5520(05)70215-4; Pachas P, 2000, SERIE MODULOS TECNIC; Paphitou NI, 2003, INFECTION, V31, P421, DOI 10.1007/s15010-003-3175-5; Rolain JM, 2003, J CLIN MICROBIOL, V41, P4001, DOI 10.1128/JCM.41.8.4001-4002.2003; Ruiz J, 2012, BLOOD TRANSFUS-ITALY, V10, P563, DOI 10.2450/2012.0152-11; Smit PW, 2013, AM J TROP MED HYG, V89, P988, DOI 10.4269/ajtmh.13-0246; Song SH, 2009, J MED MICROBIOL, V58, P270, DOI 10.1099/jmm.0.004697-0; Ticona E, 2010, MED HYPOTHESES, V74, P45, DOI 10.1016/j.mehy.2009.06.054; Tokuyasu H, 2012, INTERNAL MED, V51, P1133, DOI 10.2169/internalmedicine.51.6930	28	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92283	10.1371/journal.pone.0092283	http://dx.doi.org/10.1371/journal.pone.0092283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651298	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800093
J	Kinney, NA; Sharakhov, IV; Onufriev, AV				Kinney, Nicholas Allen; Sharakhov, Igor V.; Onufriev, Alexey V.			Investigation of the Chromosome Regions with Significant Affinity for the Nuclear Envelope in Fruit Fly - A Model Based Approach	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; SPATIAL-ORGANIZATION; 3-DIMENSIONAL ORGANIZATION; POLYTENE CHROMOSOMES; CHROMATIN; DNA; DYNAMICS; GENE; ARCHITECTURE; DOMAINS	Three dimensional nuclear architecture is important for genome function, but is still poorly understood. In particular, little is known about the role of the "boundary conditions'' - points of attachment between chromosomes and the nuclear envelope. We describe a method for modeling the 3D organization of the interphase nucleus, and its application to analysis of chromosome-nuclear envelope (Chr-NE) attachments of polytene (giant) chromosomes in Drosophila melanogaster salivary glands. The model represents chromosomes as self-avoiding polymer chains confined within the nucleus; parameters of the model are taken directly from experiment, no fitting parameters are introduced. Methods are developed to objectively quantify chromosome territories and intertwining, which are discussed in the context of corresponding experimental observations. In particular, a mathematically rigorous definition of a territory based on convex hull is proposed. The self-avoiding polymer model is used to re-analyze previous experimental data; the analysis suggests 33 additional Chr-NE attachments in addition to the 15 already explored Chr-NE attachments. Most of these new Chr-NE attachments correspond to intercalary heterochromatin - gene poor, dark staining, late replicating regions of the genome; however, three correspond to euchromatin - gene rich, light staining, early replicating regions of the genome. The analysis also suggests 5 regions of anti-contact, characterized by aversion for the NE, only two of these correspond to euchromatin. This composition of chromatin suggests that heterochromatin may not be necessary or sufficient for the formation of a Chr-NE attachment. To the extent that the proposed model represents reality, the confinement of the polytene chromosomes in a spherical nucleus alone does not favor the positioning of specific chromosome regions at the NE as seen in experiment; consequently, the 15 experimentally known Chr-NE attachment positions do not appear to arise due to non-specific (entropic) forces. Robustness of the key conclusions to model assumptions is thoroughly checked.	[Kinney, Nicholas Allen] Virginia Tech, Blacksburg, VA USA; [Sharakhov, Igor V.] Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA; [Onufriev, Alexey V.] Virginia Tech, Dept Phys, Blacksburg, VA USA; [Onufriev, Alexey V.] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Sharakhov, IV (corresponding author), Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA.	igor@vt.edu; alexey@cs.vt.edu	Sharakhov, Igor/B-1972-2008; Kinney, Nicholas/I-7168-2016	Sharakhov, Igor/0000-0003-0752-3747; Kinney, Nicholas/0000-0002-4563-1813; Onufriev, Alexey/0000-0002-4930-6612	graduate program in Genomics Bioinformatics and Computational Biology (GBCB) of Virginia Tech; National Institutes of Health [1R21AI094289, R01 GM099450]; NSF [CNS-0960081]; HokieSpeed supercomputer at Virginia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099450] Funding Source: NIH RePORTER	graduate program in Genomics Bioinformatics and Computational Biology (GBCB) of Virginia Tech; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); HokieSpeed supercomputer at Virginia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the graduate program in Genomics Bioinformatics and Computational Biology (GBCB) of Virginia Tech to Nicholas Kinney and by the grants from the National Institutes of Health 1R21AI094289 to Igor V. Sharakhov and R01 GM099450 to Alexey V. Onufriev. This work was also supported in part by the NSF grant CNS-0960081 and the HokieSpeed supercomputer at Virginia Tech. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2013, NAT CELL BIOL, V15, P694, DOI 10.1038/ncb2745; Albert B, 2013, J CELL BIOL, V202, P201, DOI 10.1083/jcb.201208186; Baricheva EA, 1996, GENE, V171, P171, DOI 10.1016/0378-1119(96)00002-9; Bau D, 2011, CHROMOSOME RES, V19, P25, DOI 10.1007/s10577-010-9167-2; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Bohn M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014428; Cacciuto A, 2006, NANO LETT, V6, P901, DOI 10.1021/nl052351n; Caracciolo S, 1998, PHYS REV E, V57, pR1215, DOI 10.1103/PhysRevE.57.R1215; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cook PR, 2009, J CELL BIOL, V186, P825, DOI 10.1083/jcb.200903083; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Daban JR, 2003, BIOCHEM CELL BIOL, V81, P91, DOI 10.1139/o03-037; DAYANTIS J, 1994, PHYS REV B, V49, P3217, DOI 10.1103/PhysRevB.49.3217; De Gennes PG., 1979, SCALING CONCEPTS POL; de Nooijer S, 2009, NUCLEIC ACIDS RES, V37, P3558, DOI 10.1093/nar/gkp219; Demakov SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-566; Dietzel S, 1998, CHROMOSOME RES, V6, P25, DOI 10.1023/A:1009262223693; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Finan K, 2011, CHROMOSOME RES, V19, P53, DOI 10.1007/s10577-010-9150-y; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Gilbert LI, 2008, MOL CELL ENDOCRINOL, V293, P25, DOI 10.1016/j.mce.2008.02.009; Gonzalez-Melendi P, 2000, J MICROSC-OXFORD, V198, P199, DOI 10.1046/j.1365-2818.2000.00701.x; Grosberg A. I. U., 2011, GIANT MOL HERE THERE; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; GRUENBAUM Y, 1984, J CELL SCI, P223; GUTTMANN AJ, 1989, J PHYS A-MATH GEN, V22, P2807, DOI 10.1088/0305-4470/22/14/027; HAHNFELDT P, 1993, P NATL ACAD SCI USA, V90, P7854, DOI 10.1073/pnas.90.16.7854; Heermann DW, 2012, METHODS, V58, P307, DOI 10.1016/j.ymeth.2012.04.010; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1455, DOI 10.1083/jcb.104.6.1455; HOCHSTRASSER M, 1987, CHROMOSOMA, V95, P197, DOI 10.1007/BF00330351; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Jerabek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037525; Jinfeng Zhang RC, 2003, J CHEM PHYS, V118, P7; Jun S, 2008, ARXIV08082646; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; KREMER K, 1990, J CHEM PHYS, V92, P5057, DOI 10.1063/1.458541; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; Lowenstein MG, 2004, MOL BIOL CELL, V15, P5678, DOI 10.1091/mbc.E04-04-0289; MADRAS N, 1988, J STAT PHYS, V50, P109, DOI 10.1007/BF01022990; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Marshall WF, 2001, CURR BIOL, V11, P569, DOI 10.1016/S0960-9822(01)00180-4; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Marti-Renom MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002125; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; MATHOG D, 1984, NATURE, V308, P414, DOI 10.1038/308414a0; MATHOG D, 1989, GENETICS, V121, P293; MATLAB, 2010, MATLAB 2010 VERS 7 1; Michael Plischke BB, 2006, EQUILIBRIUM STAT PHY; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; Munkel C, 1998, PHYS REV E, V57, P5888, DOI 10.1103/PhysRevE.57.5888; Munkel C, 1999, J MOL BIOL, V285, P1053, DOI 10.1006/jmbi.1998.2361; Neal Madras GS, 1993, SELF AVOIDING WALK; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Riddle NC, 2009, BIOCHEM CELL BIOL, V87, P229, DOI 10.1139/O08-119; Rosa A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000153; ROSENBLUTH MN, 1955, J CHEM PHYS, V23, P356, DOI 10.1063/1.1741967; Rubinstein M, 2003, POLYM PHYS; Rzepecki R, 1998, J CELL SCI, V111, P121; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Tokuda N, 2012, BIOPHYS J, V102, P296, DOI 10.1016/j.bpj.2011.12.005; van Bemmel JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015013; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wako T, 2010, CYTOGENET GENOME RES, V129, P55, DOI 10.1159/000314639; Wong H, 2013, NUCLEUS, V4; Wong H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000877; Wong H, 2012, CURR BIOL, V22, P1881, DOI 10.1016/j.cub.2012.07.069; Wong H, 2009, BIOESSAYS, V31, P1357, DOI 10.1002/bies.200900062; Zhao K, 1996, FEBS LETT, V380, P161, DOI 10.1016/0014-5793(96)00034-8; Zhimolev IF, 1996, ADV GENET, V34, P1; Zhimulev IF, 2003, CHROMOSOMA, V111, P377, DOI 10.1007/s00412-002-0218-0; Zhimulev IF, 2012, BIOESSAYS, V34, P498, DOI 10.1002/bies.201100142; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686	80	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91943	10.1371/journal.pone.0091943	http://dx.doi.org/10.1371/journal.pone.0091943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651400	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800056
J	Galvan-Diaz, AL; Magnet, A; Fenoy, S; Henriques-Gil, N; Haro, M; Gordo, FP; Miro, G; del Aguila, C; Izquierdo, F; Millan, J				Luz Galvan-Diaz, Ana; Magnet, Angela; Fenoy, Soledad; Henriques-Gil, Nuno; Haro, Maria; Ponce Gordo, Francisco; Miro, Guadalupe; del Aguila, Carmen; Izquierdo, Fernando; Millan, Javier			Microsporidia Detection and Genotyping Study of Human Pathogenic E. bieneusi in Animals from Spain	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ENTEROCYTOZOON-BIENEUSI; MOLECULAR CHARACTERIZATION; ENCEPHALITOZOON-CUNICULI; AIDS PATIENT; IDENTIFICATION; SAMPLES; EPIDEMIOLOGY; INFECTIONS; CULTURE	Microsporidia are ubiquitous parasites infecting all animal phyla and we present evidence that supports their zoonotic potential. Fecal samples taken from domestic (cats and dogs), farm (pigs, rabbits and ostriches) and wild animals (foxes) from different provinces of Spain were evaluated for microsporidia infection by light microscopy and PCR. After Microsporidia species identification, E. bieneusi genotypes were additionally studied by sequence analysis of the ITS region. Eighty-five samples out of 159 exhibited structures that were compatible with microsporidia spores by Webers stain with 37 of them being confirmed by PCR. Microsporidia species identified included E. bieneusi, E. intestinalis and A. algerae. We report the first diagnosis of E. intestinalis and E. bieneusi in ostriches and A. algerae in pigs. We also provide new information on the molecular characterization of E. bieneusi isolates both in rabbits and ostriches. All of the E. bieneusi genotypes identified belonged to the zoonotic group of genotypes (Group I) including genotypes A (dogs), I (pigs), D (rabbits and foxes) and type IV (ostriches). Our results demonstrate that microsporidia are present in domestic, farm and wild animals in Spain, corroborating their potential role as a source of human infection and environmental contamination.	[Luz Galvan-Diaz, Ana; Magnet, Angela; Fenoy, Soledad; Haro, Maria; del Aguila, Carmen; Izquierdo, Fernando] Univ San Pablo CEU, Fac Farm, Madrid, Spain; [Luz Galvan-Diaz, Ana] Univ Antioquia, Escuela Microbiol, Grp Parasitol, Medellin, Colombia; [Henriques-Gil, Nuno] Univ San Pablo CEU, Fac Med, Madrid, Spain; [Ponce Gordo, Francisco] Univ Complutense Madrid, Fac Farm, Madrid, Spain; [Miro, Guadalupe] Univ Complutense Madrid, Fac Vet, Madrid, Spain; [Millan, Javier] Univ Andres Bello, Fac Ecol & Nat Resources, Santiago, Chile	San Pablo CEU University; Universidad de Antioquia; San Pablo CEU University; Complutense University of Madrid; Complutense University of Madrid; Universidad Andres Bello	Izquierdo, F (corresponding author), Univ San Pablo CEU, Fac Farm, Madrid, Spain.	ferizqui@ceu.es	MIRO, GUADALUPE/A-9666-2019; Ponce-Gordo, Francisco/Q-2469-2017; Magnet, Angela/G-5325-2013; Arias, Fernando Izquierdo/AAE-3073-2019; Fenoy, Soledad/A-9633-2016; del Aguila, Carmen/A-6063-2016; Millan, Javier/B-5399-2008; Ponce-Gordo, Francisco/AAL-7138-2020	MIRO, GUADALUPE/0000-0003-0981-2470; Magnet, Angela/0000-0002-8642-4343; Arias, Fernando Izquierdo/0000-0003-0367-007X; Fenoy, Soledad/0000-0002-5218-6308; del Aguila, Carmen/0000-0003-0063-7899; Millan, Javier/0000-0001-5608-781X; Ponce-Gordo, Francisco/0000-0001-9034-8606	Instituto de Salud Carlos III; FEDER [FIS-PI061593]; USP-CEU [PC04/07]; Colciencias (Antioquia University, Colombia) in Spain; Ministerio de Educacion y Ciencia de Espana (FPU grant) [AP2009-0415]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER(European Commission); USP-CEU; Colciencias (Antioquia University, Colombia) in Spain; Ministerio de Educacion y Ciencia de Espana (FPU grant)(German Research Foundation (DFG))	This work was funded by grants from Instituto de Salud Carlos III and FEDER (FIS-PI061593); and USP-CEU (PC04/07). Ana Luz Galvan-Diaz was supported in Spain by an overseas fellowship from Colciencias (Antioquia University, Colombia). Angela Magnet was supported by Ministerio de Educacion y Ciencia de Espana (FPU grant AP2009-0415). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Acosta N, 2005, T ROY SOC TROP MED H, V99, P848, DOI 10.1016/j.trstmh.2005.05.010; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; Andreu-Ballester JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062107; Cali A, 2005, FOLIA PARASIT, V52, P51, DOI 10.14411/fp.2005.007; Cali A, 2004, J EUKARYOT MICROBIOL, V51, P678, DOI 10.1111/j.1550-7408.2004.tb00608.x; Cali A, 2010, J EUKARYOT MICROBIOL, V57, P562, DOI 10.1111/j.1550-7408.2010.00510.x; da Silva AJ, 1999, MOL DIAGN, V4, P57, DOI 10.1016/S1084-8592(99)80050-2; Dado D, 2012, ZOONOSES PUBLIC HLTH, V59, P23, DOI 10.1111/j.1863-2378.2011.01411.x; DaSilva AJ, 1996, J CLIN MICROBIOL, V34, P986, DOI 10.1128/JCM.34.4.986-987.1996; DaSilva AJ, 1997, MOL DIAGN, V2, P47, DOI 10.1016/S1084-8592(97)80010-0; DEGROOTE MA, 1995, J INFECT DIS, V171, P1375, DOI 10.1093/infdis/171.5.1375; Del Aguila C, 1999, J EUKARYOT MICROBIOL, V46, p8S; del Aguila C, 2001, J CLIN MICROBIOL, V39, P1105, DOI 10.1128/JCM.39.3.1105-1108.2001; Del Aguila C, 1997, J EUKARYOT MICROBIOL, V44, p84S, DOI 10.1111/j.1550-7408.1997.tb05798.x; delAguila C, 1997, J CLIN MICROBIOL, V35, P1862, DOI 10.1128/JCM.35.7.1862-1866.1997; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; Dowd Scot E., 2003, Journal of Water and Health, V1, P117; Galvan AL, 2011, J CLIN MICROBIOL, V49, P1301, DOI 10.1128/JCM.01833-10; Ghosh Kaya, 2009, Interdiscip Perspect Infect Dis, V2009, P926521, DOI 10.1155/2009/926521; Gray ML, 1998, AVIAN DIS, V42, P832, DOI 10.2307/1592726; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Haro M, 2005, APPL ENVIRON MICROB, V71, P3153, DOI 10.1128/AEM.71.6.3153-3157.2005; Haro M, 2006, J EUKARYOT MICROBIOL, V53, pS58, DOI 10.1111/j.1550-7408.2006.00173.x; Henriques-Gil N, 2010, APPL ENVIRON MICROB, V76, P3333, DOI 10.1128/AEM.03026-09; Izquierdo F, 2011, WATER RES, V45, P4837, DOI 10.1016/j.watres.2011.06.033; Kasickova D, 2009, VET PARASITOL, V165, P125, DOI 10.1016/j.vetpar.2009.06.033; Li W, 2012, INT J PARASITOL, V42, P287, DOI 10.1016/j.ijpara.2012.01.003; Lopez-Velez R, 1999, J TRAVEL MED, V6, P223, DOI 10.1111/j.1708-8305.1999.tb00522.x; Lores B, 2002, MEM I OSWALDO CRUZ, V97, P941, DOI 10.1590/S0074-02762002000700003; Lores B, 2002, CLIN INFECT DIS, V34, P918, DOI 10.1086/339205; Galvan AL, 2013, APPL ENVIRON MICROB, V79, P449, DOI 10.1128/AEM.02737-12; Magnet A, 2012, PARASITOL RES, V111, P383, DOI 10.1007/s00436-012-2849-2; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; Matos Olga, 2012, J Parasitol Res, V2012, P981424, DOI 10.1155/2012/981424; Santin M, 2008, AM J TROP MED HYG, V79, P215, DOI 10.4269/ajtmh.2008.79.215; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Santin M, 2009, J EUKARYOT MICROBIOL, V56, P34, DOI 10.1111/j.1550-7408.2008.00380.x; Snowden K, 1999, AVIAN DIS, V43, P779, DOI 10.2307/1592748; Sulaiman IM, 2004, PARASITOL RES, V92, P328, DOI 10.1007/s00436-003-1049-5; Sulaiman IM, 2003, APPL ENVIRON MICROB, V69, P4495, DOI 10.1128/AEM.69.8.4495-4501.2003; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; Visvesvara GS, 1999, J EUKARYOT MICROBIOL, V46, p10S; VISVESVARA GS, 1994, J CLIN MICROBIOL, V32, P2760, DOI 10.1128/JCM.32.11.2760-2768.1994; WEBER R, 1992, NEW ENGL J MED, V326, P161, DOI 10.1056/NEJM199201163260304; Zhang X, 2011, J CLIN MICROBIOL, V49, P2006, DOI 10.1128/JCM.00372-11	46	55	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92289	10.1371/journal.pone.0092289	http://dx.doi.org/10.1371/journal.pone.0092289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651457	gold, Green Published, Green Submitted			2022-12-25	WOS:000333352800096
J	Nyambega, B; Helbig, C; Masiga, DK; Clayton, C; Levin, MJ				Nyambega, Benson; Helbig, Claudia; Masiga, Daniel K.; Clayton, Christine; Levin, Mariano J.			Proteins Associated with SF3a60 in T. brucei	PLOS ONE			English	Article							SPLICING FACTOR SF3A; BOX RNA HELICASE; TRYPANOSOMA-BRUCEI; MESSENGER-RNA; BLOOD-STREAM; YEAST GENES; HEAT-SHOCK; U2 SNRNP; COMPLEX; PRP9	Trypanosoma brucei relies on Spliced leader trans splicing to generate functional messenger RNAs. Trans splicing joins the specialized SL exon from the SL RNA to pre-mRNAs and is mediated by the trans-spliceosome, which is made up of small nuclear ribonucleoprotein particles and non-snRNP factors. Although the trans spliceosome is essential for trypanosomatid gene expression, not all spliceosomal protein factors are known and of these, only a few are completely characterized. In this study, we have characterized the trypanosome Splicing Factor, SF3a60, the only currently annotated SF3a component. As expected, epitope-tagged SF3a60 localizes in the trypanosome nucleus. SF3a60 is essential for cell viability but its depletion seem to have no detectable effect on trans-splicing. In addition, we used SF3a60 as bait in a Yeast-2-hybrid system screen and identified its interacting protein factors. The interactions with SF3a120, SF3a66 and SAP130 were confirmed by tandem affinity purification and mass spectrometry.	[Nyambega, Benson; Levin, Mariano J.] Inst Invest Ingn Genet & Biol Mol INGEBI, Lab Biol Mol Enfermedad Chagas, Buenos Aires, DF, Argentina; [Nyambega, Benson; Masiga, Daniel K.] Int Ctr Insect Physiol & Ecol, Dept Mol Biol & Biotechnol, Nairobi, Kenya; [Nyambega, Benson; Helbig, Claudia; Clayton, Christine] Heidelberg Univ, Zentrum Mol Biol, Heidelberg, Germany	International Centre of Insect Physiology & Ecology (ICIPE); Ruprecht Karls University Heidelberg	Nyambega, B (corresponding author), Maseno Univ, Dept Med Biochem, Kisumu, Kenya.	nyambegadnaubaar@gmail.com	Nyambega, Benson/GOH-3417-2022	Nyambega, Benson/0000-0002-0947-0354; Masiga, Daniel/0000-0001-7513-0887	World Health Organization/Special Program for Research and Training in Tropical Diseases (TDR) [A50737]; European Molecular Biology Organization;  [Sonderforschungsbereich 544]	World Health Organization/Special Program for Research and Training in Tropical Diseases (TDR); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); 	This research has been supported by grants from the World Health Organization/Special Program for Research and Training in Tropical Diseases (TDR ID. A50737) to BN. Fellowships from Sonderforschungsbereich 544 and the European Molecular Biology Organization is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; Ambrosio DL, 2009, EUKARYOT CELL, V8, P990, DOI 10.1128/EC.00075-09; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; BENNETT M, 1993, SCIENCE, V262, P105, DOI 10.1126/science.8211113; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Chang KJ, 2009, RNA, V15, P1729, DOI 10.1261/rna.1625309; CHANG TH, 1988, MOL CELL BIOL, V8, P2379, DOI 10.1128/MCB.8.6.2379; CHAPON C, 1992, EMBO J, V11, P3279, DOI 10.1002/j.1460-2075.1992.tb05406.x; Chen JJ, 2001, J MOL BIOL, V314, P683, DOI 10.1006/jmbi.2001.5162; Colasante C, 2006, EUKARYOT CELL, V5, P1194, DOI 10.1128/EC.00096-06; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Das A, 2006, MOL BIOCHEM PARASIT, V150, P201, DOI 10.1016/j.molbiopara.2006.08.002; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; EVERS R, 1989, CELL, V56, P585, DOI 10.1016/0092-8674(89)90581-3; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Greiner EF, 2000, P NATL ACAD SCI USA, V97, P7160, DOI 10.1073/pnas.97.13.7160; Gunzl A, 2010, EUKARYOT CELL, V9, P1159, DOI 10.1128/EC.00113-10; Haile S, 2007, MOL BIOCHEM PARASIT, V151, P52, DOI 10.1016/j.molbiopara.2006.10.005; Hartmann C, 2007, EUKARYOT CELL, V6, P1964, DOI 10.1128/EC.00279-07; Hendriks EF, 2003, J BIOL CHEM, V278, P26870, DOI 10.1074/jbc.M302405200; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hong WJ, 1997, NUCLEIC ACIDS RES, V25, P354, DOI 10.1093/nar/25.2.354; Jae N, 2011, RNA BIOL, V8, P90, DOI 10.4161/rna.8.1.13985; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Kao HY, 1996, MOL CELL BIOL, V16, P960; Kondo-Okamoto N, 2008, EMBO REP, V9, P63, DOI 10.1038/sj.embor.7401113; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; KRAMER A, 1994, NUCLEIC ACIDS RES, V22, P5223, DOI 10.1093/nar/22.24.5223; KRAMER A, 1995, RNA, V1, P260; KRAMER A, 1992, MOL CELL BIOL, V12, P4545; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuwasako K, 2006, STRUCTURE, V14, P1677, DOI 10.1016/j.str.2006.09.009; LEGRAIN P, 1991, MOL GEN GENET, V225, P199, DOI 10.1007/BF00269848; LEGRAIN P, 1990, EMBO J, V9, P2775, DOI 10.1002/j.1460-2075.1990.tb07465.x; LEGRAIN P, 1993, SCIENCE, V262, P108, DOI 10.1126/science.8211114; LEGRAIN P, 1993, GENE DEV, V7, P1390, DOI 10.1101/gad.7.7b.1390; Liang XH, 2006, MOL BIOCHEM PARASIT, V145, P29, DOI 10.1016/j.molbiopara.2005.09.004; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Mair G, 2000, RNA, V6, P163, DOI 10.1017/S135583820099229X; Manful T, 2009, MOL BIOCHEM PARASIT, V166, P186, DOI 10.1016/j.molbiopara.2009.03.003; MCNALLY KP, 1992, MOL CELL BIOL, V12, P4844, DOI 10.1128/MCB.12.11.4844; McPheeters DS, 2000, NUCLEIC ACIDS RES, V28, P1313, DOI 10.1093/nar/28.6.1313; Morris DP, 2000, J BIOL CHEM, V275, P39935, DOI 10.1074/jbc.M004118200; MUHICH ML, 1989, GENE, V82, P169, DOI 10.1016/0378-1119(89)90042-5; MUHICH ML, 1988, MOL CELL BIOL, V8, P3837, DOI 10.1128/MCB.8.9.3837; Nesic D, 2001, MOL CELL BIOL, V21, P6406, DOI 10.1128/MCB.21.19.6406-6417.2001; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Ouna BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034256; OVERATH P, 1986, EUR J BIOCHEM, V160, P175, DOI 10.1111/j.1432-1033.1986.tb09955.x; Palfi Z, 2005, NUCLEIC ACIDS RES, V33, P2493, DOI 10.1093/nar/gki548; Palfi Z, 2009, GENE DEV, V23, P1650, DOI 10.1101/gad.526109; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Schwer B, 1998, EMBO J, V17, P2086, DOI 10.1093/emboj/17.7.2086; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Stewart M, 2010, MOL BIOCHEM PARASIT, V172, P99, DOI 10.1016/j.molbiopara.2010.03.016; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Tkacz ID, 2007, RNA, V13, P30, DOI 10.1261/rna.174307; Vazquez M, 2003, MOL BIOCHEM PARASIT, V128, P77, DOI 10.1016/S0166-6851(03)00007-0; Vazquez MP, 2009, MOL BIOCHEM PARASIT, V164, P137, DOI 10.1016/j.molbiopara.2008.12.009; Wiest DK, 1996, J BIOL CHEM, V271, P33268, DOI 10.1074/jbc.271.52.33268; Wolkow TD, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-6	73	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91956	10.1371/journal.pone.0091956	http://dx.doi.org/10.1371/journal.pone.0091956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651488	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800058
J	Tuominen, I; Heliovaara, E; Raitila, A; Rautiainen, MR; Mehine, M; Katainen, R; Donner, I; Aittomaki, V; Lehtonen, HJ; Ahlsten, M; Kivipelto, L; Schalin-Jantti, C; Arola, J; Hautaniemi, S; Karhu, A				Tuominen, I.; Heliovaara, E.; Raitila, A.; Rautiainen, M-R; Mehine, M.; Katainen, R.; Donner, I.; Aittomaki, V.; Lehtonen, H. J.; Ahlsten, M.; Kivipelto, L.; Schalin-Jantti, C.; Arola, J.; Hautaniemi, S.; Karhu, A.			AIP inactivation leads to pituitary tumorigenesis through defective G alpha(i)-cAMP signaling	ONCOGENE			English	Article							INTERACTING PROTEIN GENE; STIMULATORY G-PROTEIN; ADENOMA PREDISPOSITION; ADENYLYL-CYCLASE; CELL-PROLIFERATION; MUTATIONS; CAMP; EXPRESSION; SUBUNIT; XAP2	The aryl hydrocarbon receptor interacting protein (AIP) is a tumor-suppressor gene underlying the pituitary adenoma predisposition. Thus far, the exact molecular mechanisms by which inactivated AIP exerts its tumor-promoting action have been unclear. To better understand the role of AIP in pituitary tumorigenesis, we performed gene expression microarray analysis to examine changes between Aip wild-type and knockout mouse embryonic fibroblast (MEF) cell lines. Transcriptional analyses implied that Aip deficiency causes a dysfunction in cyclic adenosine monophosphate (cAMP) signaling, as well as impairments in signaling cascades associated with developmental and immune-inflammatory responses. In vitro experiments showed that AIP deficiency increases intracellular cAMP concentrations in both MEF and murine pituitary adenoma cell lines. Based on knockdown of various G protein a subunits, we concluded that AIP deficiency leads to elevated cAMP concentrations through defective G alpha(i)-2 and G alpha(i)-3 proteins that normally inhibit cAMP synthesis. Furthermore, immunostaining of G alpha(i)-2 revealed that AIP deficiency is associated with a clear reduction in G alpha(i)-2 protein expression levels in human and mouse growth hormone (GH)-secreting pituitary adenomas, thus indicating defective Gai signaling in these tumors. By contrast, all prolactin-secreting tumors showed prominent G alpha(i)-2 protein levels, irrespective of Aip mutation status. We additionally observed reduced expression of phosphorylated extracellular signal-regulated kinases 1/2 and cAMP response element-binding protein levels in mouse and human AIP-deficient somatotropinomas. This study implies for the first time that a failure to inhibit cAMP synthesis through dysfunctional G alpha(i) signaling underlies the development of GH-secreting pituitary adenomas in AIP mutation carriers.	[Tuominen, I.; Heliovaara, E.; Raitila, A.; Rautiainen, M-R; Mehine, M.; Katainen, R.; Donner, I.; Lehtonen, H. J.; Ahlsten, M.; Karhu, A.] Univ Helsinki, Inst Biomed Biomed Helsinki, Genome Scale Biol Res Program, Dept Med Genet, Helsinki 00014, Finland; [Aittomaki, V.; Hautaniemi, S.] Univ Helsinki, Inst Biomed Biomed Helsinki, Genome Scale Biol Res Program, Syst Biol Lab, Helsinki 00014, Finland; [Kivipelto, L.] Univ Helsinki, Dept Neurosurg, Helsinki 00014, Finland; [Kivipelto, L.; Schalin-Jantti, C.] Helsinki Univ Hosp, Helsinki, Finland; [Schalin-Jantti, C.] Univ Helsinki, Dept Med, Div Endocrinol, Helsinki 00014, Finland; [Tuominen, I.; Heliovaara, E.; Arola, J.] Univ Helsinki, Cent Hosp, HUSLAB, Dept Pathol, Helsinki 00014, Finland; [Arola, J.] Univ Helsinki, Haartman Inst, Helsinki 00014, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Karhu, A (corresponding author), Univ Helsinki, Inst Biomed Biomed Helsinki, Genome Scale Biol Res Program, Dept Med Genet, Helsinki 00014, Finland.	auli.karhu@helsinki.fi	Hautaniemi, Sampsa/A-3122-2009; Katainen, Riku/GYR-0921-2022; Hautaniemi, Sampsa/CAG-0362-2022	Hautaniemi, Sampsa/0000-0002-7749-2694; Hautaniemi, Sampsa/0000-0002-7749-2694; Karhu, Auli/0000-0002-7927-0796; Katainen, Riku/0000-0003-4575-4239	Academy of Finland [250345]; Cancer Society of Finland [4700325]; Novo Nordisk Foundation [A14582]; Association for International Cancer Research [13-1075]	Academy of Finland(Academy of Finland); Cancer Society of Finland; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Association for International Cancer Research	We thank Inga-Lill Svedberg, Mairi Kuris, Alison Ollikainen and Iina Vuoristo for technical assistance. The Biomedicum Imaging Unit is acknowledged for the microscopy service and the Biomedicum Functional Genomics Unit (FuGU) for expression array and virus core services. This study was supported by the Academy of Finland (250345), the Cancer Society of Finland (4700325), the Novo Nordisk Foundation (A14582) and the Association for International Cancer Research (13-1075). This work was supported in part by the Novo Nordisk Foundation (AK).	Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; Ben-Shlomo A, 2007, MOL ENDOCRINOL, V21, P2565, DOI 10.1210/me.2007-0081; Ben-Shlomo A, 2010, TRENDS ENDOCRIN MET, V21, P123, DOI 10.1016/j.tem.2009.12.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTHERAT J, 1995, MOL ENDOCRINOL, V9, P777, DOI 10.1210/me.9.7.777; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; Boikos SA, 2007, HUM MOL GENET, V16, pR80, DOI 10.1093/hmg/ddm019; Bolger GB, 2003, J BIOL CHEM, V278, P33351, DOI 10.1074/jbc.M303269200; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008; Chahal HS, 2012, J CLIN ENDOCR METAB, V97, pE1411, DOI 10.1210/jc.2012-1111; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; Daly AF, 2010, J CLIN ENDOCR METAB, V95, pE373, DOI 10.1210/jc.2009-2556; de Oliveira SK, 2007, J BIOL CHEM, V282, P13656, DOI 10.1074/jbc.M610942200; Formosa R, 2013, ENDOCR-RELAT CANCER, V20, P495, DOI 10.1530/ERC-13-0043; Georgitsi M, 2007, P NATL ACAD SCI USA, V104, P4101, DOI 10.1073/pnas.0700004104; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; Grant M, 2008, MOL ENDOCRINOL, V22, P2278, DOI 10.1210/me.2007-0334; Gueorguiev M, 2011, NAT REV ENDOCRINOL, V7, P71, DOI 10.1038/nrendo.2010.233; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Heliovaara E, 2009, AM J PATHOL, V175, P2501, DOI 10.2353/ajpath.2009.081131; Jiang LI, 2008, J BIOL CHEM, V283, P23429, DOI 10.1074/jbc.M803281200; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Kazlauskas A, 2000, J BIOL CHEM, V275, P41317, DOI 10.1074/jbc.M007765200; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Lahlou H, 2003, J BIOL CHEM, V278, P39356, DOI 10.1074/jbc.M304524200; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lania A, 2003, J CLIN ENDOCR METAB, V88, P1692, DOI 10.1210/jc.2002-021207; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Liu YF, 1999, J BIOL CHEM, V274, P16444, DOI 10.1074/jbc.274.23.16444; LIU YF, 1994, J BIOL CHEM, V269, P13880; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Moran TB, 2012, TOXICOL APPL PHARM, V265, P139, DOI 10.1016/j.taap.2012.08.026; Nakata A, 2009, EMBO REP, V10, P622, DOI 10.1038/embor.2009.35; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Nurnberg B, 2004, NAT REV DRUG DISCOV, V575, P577; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peri A, 2001, J CLIN ENDOCR METAB, V86, P2111, DOI 10.1210/jc.86.5.2111; Raitila A, 2010, AM J PATHOL, V177, P1969, DOI 10.2353/ajpath.2010.100138; Sandrini Fabiano, 2004, Arq Bras Endocrinol Metab, V48, P637, DOI 10.1590/S0004-27302004000500007; SCHWINDINGER WF, 1992, P NATL ACAD SCI USA, V89, P5152, DOI 10.1073/pnas.89.11.5152; Stefan E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1605; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Trivellin G, 2011, J ENDOCRINOL, V210, P137, DOI 10.1530/JOE-11-0054; VALLAR L, 1987, NATURE, V330, P566, DOI 10.1038/330566a0; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Vlotides G, 2008, CANCER RES, V68, P6377, DOI 10.1158/0008-5472.CAN-08-0508; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Wettschureck N, 2004, PHARMACOL THERAPEUT, V101, P75, DOI 10.1016/j.pharmthera.2003.10.005; Zatelli MC, 2003, J CLIN ENDOCR METAB, V88, P2797, DOI 10.1210/jc.2002-021825	61	65	68	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 26	2015	34	9					1174	1184		10.1038/onc.2014.50	http://dx.doi.org/10.1038/onc.2014.50			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RY	24662816				2022-12-25	WOS:000350122100010
J	Barkallah, M; Gharbi, Y; Ben Hassena, A; Ben Slima, A; Mallek, Z; Gautier, M; Greub, G; Gdoura, R; Fendri, I				Barkallah, Mohamed; Gharbi, Yaakoub; Ben Hassena, Amal; Ben Slima, Ahlem; Mallek, Zouhir; Gautier, Michel; Greub, Gilbert; Gdoura, Radhouane; Fendri, Imen			Survey of Infectious Etiologies of Bovine Abortion during Mid- to Late Gestation in Dairy Herds	PLOS ONE			English	Article							REAL-TIME PCR; LINKED-IMMUNOSORBENT-ASSAY; COXIELLA-BURNETII; WADDLIA-CHONDROPHILA; CATTLE; PARACHLAMYDIA; PREVALENCE; IDENTIFICATION; BRUCELLOSIS; SAMPLES	Bovine abortion of unknown infectious etiology still remains a major economic problem. Thus, we investigated whether Brucella spp., Listeria monocytogenes, Salmonella spp., Campylobacter spp. and Coxiella burnetii are associated with abortion and/or stillbirth in Tunisian dairy cattle. Using a pan-Chlamydiales PCR, we also investigated the role of Chlamydiaceae, Waddlia chondrophila, Parachlamydia acanthamoebae and other members of the Chlamydiales order in this setting. Veterinary samples taken from mid to late-term abortions from twenty dairy herds were tested. From a total of 150 abortion cases collected, infectious agents were detected by PCR in 73 (48.66%) cases, 13 (8.66%) of which represented co-infections with two infectious agents. Detected pathogens include Brucella spp (31.3%), Chlamydiaceae (4.66%), Waddlia chondrophila (8%), Parachlamydia acanthamoebae (5.33%), Listeria monocytogenes (4.66%) and Salmonella spp. (3.33%). In contrast, Campylobacter spp. and Coxiella burnetii DNA were not detected among the investigated veterinary samples. This demonstrates that different bacterial agents may cause bovine abortion in Tunisia. This is the first report suggesting the role of Parachlamydia acanthamoebae in bovine abortion in Africa. Further studies with a larger number of samples are necessary to confirm whether this emerging pathogen is directly linked to abortion in cattle.	[Barkallah, Mohamed; Gharbi, Yaakoub; Ben Hassena, Amal; Ben Slima, Ahlem; Gdoura, Radhouane; Fendri, Imen] Univ Sfax Tunisia, Fac Sci Sfax, Unite Rech Toxicol Microbiol Environm & Sante UR1, Sfax, Tunisia; [Mallek, Zouhir] Ctr Vet Rech, Sfax, Tunisia; [Gautier, Michel; Fendri, Imen] Agrocampus Ouest, Microbiol Lab, Dept Agroalimentaire, Rennes, France; [Greub, Gilbert] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Greub, Gilbert] Univ Lausanne, Lausanne, Switzerland	Universite de Sfax; Faculty of Sciences Sfax; Institut Agro; Agrocampus Ouest; University of Lausanne	Fendri, I (corresponding author), Univ Sfax Tunisia, Fac Sci Sfax, Unite Rech Toxicol Microbiol Environm & Sante UR1, Sfax, Tunisia.	imen.fendri@yahoo.fr	Greub, Gilbert GG/K-5804-2017; ben hassena, amal/GNP-4643-2022; Gdoura, Radhouane/I-6865-2018; Gdoura, Radhouane/AAD-6486-2022	Greub, Gilbert GG/0000-0001-9529-3317; ben hassena, amal/0000-0001-7046-487X; Gdoura, Radhouane/0000-0003-1140-3780; FENDRI, Imen/0000-0002-4071-5444	Ministere de l'enseignement superieur et de la recherche scientifique; ISESCO Organization	Ministere de l'enseignement superieur et de la recherche scientifique; ISESCO Organization	This work received financial support from "Ministere de l'enseignement superieur et de la recherche scientifique'' and the ISESCO Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla A, 2012, TROP ANIM HEALTH PRO, V44, P1151, DOI 10.1007/s11250-011-0051-7; Aggad H., 2006, Eastern Mediterranean Health Journal, V12, P119; Al-Majali AM, 2009, J VET SCI, V10, P61, DOI 10.4142/jvs.2009.10.1.61; Alter T, 2011, BUNDESGESUNDHEITSBLA, V54, P728, DOI 10.1007/s00103-011-1289-y; Alton GG, 1975, WHO MONOGR SER, V5, P1; Anderson ML, 2007, THERIOGENOLOGY, V68, P474, DOI 10.1016/j.theriogenology.2007.04.001; Barkallah M, 2013, VET MICROBIOL, V164, P101, DOI 10.1016/j.vetmic.2013.01.036; Baud D, 2008, CURR OPIN INFECT DIS, V21, P70, DOI 10.1097/QCO.0b013e3282f3e6a5; Baud D, 2011, CLIN INFECT DIS, V52, P1469, DOI 10.1093/cid/cir205; Berri M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-130; Blumer S, 2011, VET MICROBIOL, V152, P385, DOI 10.1016/j.vetmic.2011.05.024; Borel N, 2006, VET PATHOL, V43, P702, DOI 10.1354/vp.43-5-702; Borel N, 2007, EMERG INFECT DIS, V13, P1904, DOI 10.3201/eid1312.070655; Boukary AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083175; Carrique-Mas JJ, 2010, VET REC, V167, P560, DOI 10.1136/vr.c4943; Casson N, 2008, J CLIN MICROBIOL, V46, P1491, DOI 10.1128/JCM.02302-07; *CDCP, 2007, MMWR-MORBID MORTAL W, V57, P1097; Centers for Disease Control and Prevention (CDC), 2006, MMWR-MORBID MORTAL W, P432; Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071501; Fishbein DB, 1999, AM J TROP MED, V247, P35; Givens MD, 2006, THERIOGENOLOGY, V66, P648, DOI 10.1016/j.theriogenology.2006.04.021; Guatteo R, 2012, VET MICROBIOL, V155, P430, DOI 10.1016/j.vetmic.2011.09.026; Gutierrez J, 2011, VET MICROBIOL, V147, P119, DOI 10.1016/j.vetmic.2010.06.015; Hinic V, 2008, J MICROBIOL METH, V75, P375, DOI 10.1016/j.mimet.2008.07.002; HOLLIMAN A, 1994, VET REC, V134, P500, DOI 10.1136/vr.134.19.500; Iraola G, 2012, J VET SCI, V13, P371, DOI 10.4142/jvs.2012.13.4.371; Kirkbride C. A., 1990, Laboratory diagnosis of livestock abortion., P17; Lienard J, 2011, J CLIN MICROBIOL, V49, P2637, DOI 10.1128/JCM.00114-11; Livingstone M, 2006, VET J, V172, P3, DOI 10.1016/j.tvjl.2005.05.001; Makita K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-60; Mayfield J. E., 1990, Animal brucellosis., P97; Mshelia GD, 2010, VET ITAL, V46, P337; Mshelia GD, 2012, TROP ANIM HEALTH PRO, V44, P1487, DOI 10.1007/s11250-012-0092-6; Natale A, 2012, COMP IMMUNOL MICROB, V35, P375, DOI 10.1016/j.cimid.2012.03.002; Ning P, 2012, J DAIRY SCI, V95, P4863, DOI 10.3168/jds.2012-5600; Njiro SM, 2011, J S AFR VET ASSOC, V82, P213; Okwumabua O, 2005, FEMS MICROBIOL LETT, V249, P275, DOI 10.1016/j.femsle.2005.06.018; ON SLW, 1991, J CLIN MICROBIOL, V29, P1785, DOI 10.1128/JCM.29.9.1785-1788.1991; Ortega-Mora L.M., 2007, RUMINANTS GUIDELINES; Pantchev A, 2010, COMP IMMUNOL MICROB, V33, P473, DOI 10.1016/j.cimid.2009.08.002; PETER O, 1987, J CLIN MICROBIOL, V25, P1063; Petit T, 2008, VET MICROBIOL, V127, P325, DOI 10.1016/j.vetmic.2007.08.022; Poudel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044961; Radostits O.M., 2007, VET MED TXB DIS CATT, VTenth Edition, P3; RANKIN JD, 1966, VET REC, V78, P706, DOI 10.1136/vr.78.21.706; Rekiki A, 2005, REV MED VET-TOULOUSE, V156, P395; Rekiki A, 2004, CHLAMYDIOSE ABORTIVE, P233; RICHARDSON A, 1975, VET REC, V96, P329, DOI 10.1136/vr.96.15.329; RINGS DM, 1985, VET CLIN N AM-FOOD A, V1, P529; Rodolakis A, 2007, J DAIRY SCI, V90, P5352, DOI 10.3168/jds.2006-815; ROMERO C, 1995, J CLIN MICROBIOL, V33, P3198, DOI 10.1128/JCM.33.12.3198-3200.1995; Storz J., 1988, Microbiology of Chlamydia., P167; Storz J, 1993, RICKETTSIAL CHLAMYDI, P27; THOMAS R, 1990, BRIT VET J, V146, P364, DOI 10.1016/S0007-1935(11)80031-X; Tramuta C, 2011, J VET DIAGN INVEST, V23, P657, DOI 10.1177/1040638711407880; Wheelhouse N, 2012, VET J, V193, P586, DOI 10.1016/j.tvjl.2012.01.008; Yang N, 2012, ACTA VET HUNG, V60, P83, DOI 10.1556/AVet.2012.007	57	51	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91549	10.1371/journal.pone.0091549	http://dx.doi.org/10.1371/journal.pone.0091549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662769	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900023
J	Kinnebrew, MA; Lee, YJ; Jenq, RR; Lipuma, L; Littmann, ER; Gobourne, A; No, D; van den Brink, M; Pamer, EG; Taur, Y				Kinnebrew, Melissa A.; Lee, Yeon Joo; Jenq, Robert R.; Lipuma, Lauren; Littmann, Eric R.; Gobourne, Asia; No, Daniel; van den Brink, Marcel; Pamer, Eric G.; Taur, Ying			Early Clostridium difficile Infection during Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							VANCOMYCIN-RESISTANT ENTEROCOCCI; VERSUS-HOST-DISEASE; REAL-TIME PCR; DIARRHEA; RISK; COLONIZATION; EPIDEMIOLOGY; MICROBIOTA; FIDAXOMICIN; DOMINATION	Clostridium difficile infection (CDI) is frequently diagnosed in recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT). We characterized early-transplant CDI and its associations, and analyzed serially-collected feces to determine intestinal carriage of toxigenic C. difficile. Fecal specimens were collected longitudinally from 94 patients during allo-HSCT hospitalization, from the start of pre-transplant conditioning until up to 35 days after stem cell infusion. Presence of C. difficile 16S rRNA and tcdB genes was determined. Clinical variables and specimen data were analyzed for association with development of CDI. Historical data from an additional 1144 allo-HSCT patients was also used. Fecal specimens from 37 patients (39%) were found to harbor C. difficile. Early-transplant CDI was diagnosed in 16 of 94 (17%) patients undergoing allo-HSCT; cases were generally mild and resembled non-CDI diarrhea associated with transplant conditioning. CDI was associated with preceding colonization with tcdB-positive C. difficile and conditioning regimen intensity. We found no associations between early-transplant CDI and graft-versus-host disease or CDI later in transplant. CDI occurs with high frequency during the early phase of allo-HSCT, where recipients are pre-colonized with toxigenic C. difficile. During this time, CDI incidence peaks during pre-transplant conditioning, and is correlated to intensity of the treatment. In this unique setting, high rates of CDI may be explained by prior colonization and chemotherapy; however, cases were generally mild and resembled non-infectious diarrhea due to conditioning, raising concerns of misdiagnosis. Further study of this unique population with more discriminating CDI diagnostic tests are warranted.	[Lee, Yeon Joo; Littmann, Eric R.; Pamer, Eric G.; Taur, Ying] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10021 USA; [Jenq, Robert R.; van den Brink, Marcel] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplant Serv, New York, NY 10021 USA; [Lipuma, Lauren; Gobourne, Asia; No, Daniel; van den Brink, Marcel; Pamer, Eric G.; Taur, Ying] Mem Sloan Kettering Canc Ctr, Lucille Castori Ctr Microbes Inflammat & Canc, New York, NY 10021 USA; [Kinnebrew, Melissa A.; van den Brink, Marcel; Pamer, Eric G.] Sloan Kettering Inst, Program Immunol, New York, NY USA; [Kinnebrew, Melissa A.; Jenq, Robert R.; van den Brink, Marcel; Pamer, Eric G.; Taur, Ying] Weill Cornell Med Coll, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Taur, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10021 USA.	taury@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022	Lee, Yeon Joo/0000-0002-2997-0217; Taur, Ying/0000-0002-6601-8284	National Institutes of Health [1K23 AI095398-01, 1RO1 AI42135, T32GM07739]; Lucille Castori Center for Microbes, Inflamation, and Cancer; Tow Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA023766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI095398, R01AI042135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucille Castori Center for Microbes, Inflamation, and Cancer; Tow Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [grant numbers 1K23 AI095398-01 to Y.T., 1RO1 AI42135 to E.G.P., and T32GM07739 to M.A.K.], the Lucille Castori Center for Microbes, Inflamation, and Cancer, and the Tow Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso CD, 2012, CLIN INFECT DIS, V54, P1053, DOI 10.1093/cid/cir1035; Avery R, 2000, BONE MARROW TRANSPL, V25, P67, DOI 10.1038/sj.bmt.1702086; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Chakrabarti S, 2000, BONE MARROW TRANSPL, V26, P871, DOI 10.1038/sj.bmt.1702627; Chopra T, 2011, CLIN TRANSPLANT, V25, pE82, DOI 10.1111/j.1399-0012.2010.01331.x; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Donskey CJ, 1999, J INFECT DIS, V180, P384, DOI 10.1086/314874; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Dubberke ER, 2010, CLIN TRANSPLANT, V24, P192, DOI 10.1111/j.1399-0012.2009.01035.x; Heinze G, 2001, BIOMETRICS, V57, P114, DOI 10.1111/j.0006-341X.2001.00114.x; Jakubowski AA, 2011, BIOL BLOOD MARROW TR, V17, P1335, DOI 10.1016/j.bbmt.2011.01.005; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kaltsas A, 2012, J CLIN MICROBIOL, V50, P1303, DOI 10.1128/JCM.05711-11; Knetsch CW, 2011, J CLIN MICROBIOL, V49, P227, DOI 10.1128/JCM.01743-10; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Leung S, 2010, INFECT CONT HOSP EP, V31, P313, DOI 10.1086/651066; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Mullane KM, 2011, CLIN INFECT DIS, V53, P440, DOI 10.1093/cid/cir404; Naaber P, 2011, J CLIN MICROBIOL, V49, P3656, DOI 10.1128/JCM.05115-11; Nerandzic MM, 2012, CLIN INFECT DIS, V55, pS121, DOI 10.1093/cid/cis440; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Pultz NJ, 2005, J INFECT DIS, V191, P949, DOI 10.1086/428090; Rowlings PA, 1997, BRIT J HAEMATOL, V97, P855, DOI 10.1046/j.1365-2141.1997.1112925.x; Ryder AB, 2010, J CLIN MICROBIOL, V48, P4129, DOI 10.1128/JCM.01104-10; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; van den Berg RJ, 2007, J MED MICROBIOL, V56, P36, DOI 10.1099/jmm.0.46680-0; van den Berg RJ, 2006, CLIN MICROBIOL INFEC, V12, P184, DOI 10.1111/j.1469-0691.2005.01301.x; Walker AS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001172; Wilcox MH, 2012, CLIN MICROBIOL INFEC, V18, P13, DOI 10.1111/1469-0691.12057; Willems L, 2012, BIOL BLOOD MARROW TR, V18, P1295, DOI 10.1016/j.bbmt.2012.02.010	35	49	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90158	10.1371/journal.pone.0090158	http://dx.doi.org/10.1371/journal.pone.0090158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662889	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900006
J	Li, YQ; Zhou, CM; Shao, XF; Liu, XY; Guo, J; Zhang, Y; Wang, HL; Wang, XH; Li, B; Deng, KP; Liu, Q; Holthofer, H; Zou, HQ				Li, Yongqiang; Zhou, Chaomin; Shao, Xiaofei; Liu, Xinyu; Guo, Jia; Zhang, Ying; Wang, Honglei; Wang, Xiaohong; Li, Bin; Deng, Kangping; Liu, Qin; Holthoefer, Harry; Zou, Hequn			Hypertriglyceridemic Waist Phenotype and Chronic Kidney Disease in a Chinese Population Aged 40 Years and Older	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; BODY-MASS INDEX; METABOLIC SYNDROME; ABDOMINAL OBESITY; INSULIN-RESISTANCE; RISK; ASSOCIATION; SENSITIVITY; PREVALENCE; MEN	Objective: To examine the relationship between the HW phenotype and risk for CKD in a community population aged 40 years and older. Methods: A cross-sectional study was conducted in Zhuhai from June to October 2012. The participants were divided into three groups: Group 1, Waist circumference >90 cm in men or >85 cm in women and triglycerides >= 2 mmol/l; Group 3, Waist circumference <= 90 cm in men or <= 85 cm in women and triglycerides <2 mmol/l; Group 2, The remaining participants. The prevalence of the three subgroups and CKD were determined. The association between HW phenotype and CKD was then analyzed using SPSS (version 13.0). Results: After adjusting for age and sex, Group 1 was associated with CKD (OR 3.08, 95% CI 2.01, 4.73, P<0.001), when compared with Group 3. Further adjustment for factors which were potential confounders and unlikely to be in the causal pathway between the HW phenotype and CKD, Group 1 was still significantly associated with CKD. The OR for CKD was 2.65 (95% CI 1.65, 4.26, P<0.001). When adjusted for diabetes and hypertension, the association of Group 1 and CKD was still significant (OR 2.09, 95% CI 1.26, 3.45, P = 0.004). Group 2 was associated with CKD (OR 1.81, 95% CI 1.29, 2.53, P = 0.001), when compared with Group 3. Further adjustment for factors which were potential confounders, Group 2 was still significantly associated with CKD. The OR for CKD was 1.75 (95% CI 1.22, 2.51, P = 0.002). When adjusted for diabetes and hypertension, the association between Group 2 and CKD still existed. The OR for CKD was 1.48 (95% CI 1.01, 2.16, P = 0.046). Conclusion: Our results showed that HW phenotype was associated with CKD in the population aged 40 years and older.	[Li, Yongqiang; Zhou, Chaomin; Shao, Xiaofei; Liu, Xinyu; Guo, Jia; Zhang, Ying; Wang, Honglei; Wang, Xiaohong; Li, Bin; Deng, Kangping; Liu, Qin; Zou, Hequn] Southern Med Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Holthoefer, Harry] Dublin City Univ, Natl Ctr Sensor Res BioAnalyt Sci, Dublin 9, Ireland	Southern Medical University - China; Dublin City University	Zou, HQ (corresponding author), Southern Med Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China.	hequnzou@hotmail.com	Zou, He/GXH-0280-2022; wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341	EU FP7 Program, UroSense; Guangdong Provincial Science and Technique Program [2011B031800386]	EU FP7 Program, UroSense; Guangdong Provincial Science and Technique Program	This study was supported by the following Science Foundation: 1. EU FP7 Program, UroSense, 2011; 2. Guangdong Provincial Science and Technique Program (No. 2011B031800386), 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault BJ, 2010, CAN MED ASSOC J, V182, P1427, DOI 10.1503/cmaj.091276; Ayodele OE, 2010, ADV CHRONIC KIDNEY D, V17, P215, DOI 10.1053/j.ackd.2010.02.001; Blackburn P, 2012, METABOLISM, V61, P56, DOI 10.1016/j.metabol.2011.05.017; Buchholz AC, 2005, SPINAL CORD, V43, P513, DOI 10.1038/sj.sc.3101744; Carlsson AC, 2014, OBESITY, V22, P526, DOI 10.1002/oby.20434; Curhan GC, 2010, CLIN J AM SOC NEPHRO, V5, P557, DOI 10.2215/CJN.01650210; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Esmaillzadeh A, 2006, AM J CLIN NUTR, V83, P36; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gomez-Huelgas R, 2011, INT J OBESITY, V35, P292, DOI 10.1038/ijo.2010.127; Hallan S, 2006, AM J KIDNEY DIS, V47, P396, DOI 10.1053/j.ajkd.2005.11.027; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Irwin M, 2000, AM POETRY REV, V29, P23; Kahn HS, 2003, AM J CLIN NUTR, V78, P928, DOI 10.1093/ajcn/78.5.928; Kwakernaak AJ, 2013, J AM SOC NEPHROL, V24, P987, DOI 10.1681/ASN.2012050460; LaMonte MJ, 2003, ATHEROSCLEROSIS, V171, P123, DOI 10.1016/j.atherosclerosis.2003.07.008; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lemieux I, 2002, CAN J CARDIOL, V18, P725; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Li YQ, 2013, INT J ENV RES PUB HE, V10, P3987, DOI 10.3390/ijerph10093987; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MATSUBARA K, 1989, METABOLISM, V38, P698, DOI 10.1016/0026-0495(89)90110-8; Rosolova H, 2008, MED SCI MONITOR, V14, pCR411; Ross R, 2002, J CLIN ENDOCR METAB, V87, P5044, DOI 10.1210/jc.2002-020570; Ross R, 2002, AM J PHYSIOL-ENDOC M, V282, pE657, DOI 10.1152/ajpendo.00469.2001; Sam S, 2009, DIABETES CARE, V32, P1916, DOI 10.2337/dc09-0412; St-Pierre J, 2002, AM J CARDIOL, V90, P15, DOI 10.1016/S0002-9149(02)02378-0; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Wang HY, 2005, KIDNEY INT, V67, pS63, DOI 10.1111/j.1523-1755.2005.09416.x; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Yao Q, 2008, PERITON DIALYSIS INT, V28, pS42; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhe XW, 2012, NEPHRON CLIN PRACT, V122, P146, DOI 10.1159/000351042	33	13	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92322	10.1371/journal.pone.0092322	http://dx.doi.org/10.1371/journal.pone.0092322			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663403	Green Submitted, gold, Green Published			2022-12-25	WOS:000333459900050
J	Nzonza, A; Lecollinet, S; Chat, S; Lowenski, S; Merour, E; Biacchesi, S; Bremont, M				Nzonza, Angella; Lecollinet, Sylvie; Chat, Sophie; Lowenski, Steeve; Merour, Emilie; Biacchesi, Stephane; Bremont, Michel			A Recombinant Novirhabdovirus Presenting at the Surface the E Glycoprotein from West Nile Virus (WNV) Is Immunogenic and Provides Partial Protection against Lethal WNV Challenge in BALB/c Mice	PLOS ONE			English	Article							ENVELOPE PROTEIN VACCINE; DOMAIN-III; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; ENCEPHALITIS; IMMUNIZATION; ANTIBODY; INFECTION; VECTOR; DENGUE	West Nile Virus (WNV) is a zoonotic mosquito-transmitted flavivirus that can infect and cause disease in mammals including humans. Our study aimed at developing a WNV vectored vaccine based on a fish Novirhabdovirus, the Viral Hemorrhagic Septicemia virus (VHSV). VHSV replicates at temperatures lower than 20 degrees C and is naturally inactivated at higher temperatures. A reverse genetics system has recently been developed in our laboratory for VHSV allowing the addition of genes in the viral genome and the recovery of the respective recombinant viruses (rVHSV). In this study, we have generated rVHSV vectors bearing the complete WNV envelope gene (E-WNV) (rVHSV-E-WNV) or fragments encoding E subdomains (either domain III alone or domain III fused to domain II) (rVHSV-DIIIWNV and rVHSV-DII-DIIIWNV, respectively) in the VHSV genome between the N and P cistrons. With the objective to enhance the targeting of the E-WNV protein or E-WNV-derived domains to the surface of VHSV virions, Novirhadovirus G-derived signal peptide and transmembrane domain (SPG and TMG) were fused to E-WNV at its amino and carboxy termini, respectively. By Western-blot analysis, electron microscopy observations or inoculation experiments in mice, we demonstrated that both the E-WNV and the DIIIWNV could be expressed at the viral surface of rVHSV upon addition of SPG. Every constructs expressing E-WNV fused to SPG protected 40 to 50% of BALB/cJ mice against WNV lethal challenge and specifically rVHSV-SPGEWNV induced a neutralizing antibody response that correlated with protection. Surprisingly, rVHSV expressing E-WNV-derived domain III or II and III were unable to protect mice against WNV challenge, although these domains were highly incorporated in the virion and expressed at the viral surface. In this study we demonstrated that a heterologous glycoprotein and non membrane-anchored protein, can be efficiently expressed at the surface of rVHSV making this approach attractive to develop new vaccines against various pathogens.	[Nzonza, Angella; Merour, Emilie; Biacchesi, Stephane; Bremont, Michel] CRJ, INRA, Unite Virol & Immunol Mol UR0892, Jouy En Josas, France; [Lecollinet, Sylvie; Lowenski, Steeve] UPEC ENVA, ANSES, INRA, UMR Virol 1161, Maisons Alfort, France; [Chat, Sophie] CRJ, INRA, Unite Genom & Physiol Lactat UR1196, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); INRAE; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Bremont, M (corresponding author), CRJ, INRA, Unite Virol & Immunol Mol UR0892, Jouy En Josas, France.	michel.bremont@jouy.inra.fr	Lecollinet, Sylvie/M-1728-2019; Biacchesi, Stephane/A-6924-2010; Lecollinet, Sylvie/AAV-5276-2021	Biacchesi, Stephane/0000-0002-7020-2391; Chat, Sophie/0000-0003-0671-5229; Lecollinet, Sylvie/0000-0001-8535-2133	Region Ile de France through a DIM Malinf project; Animal Health Division of INRA	Region Ile de France through a DIM Malinf project(Region Ile-de-France); Animal Health Division of INRA	The PhD fellowship to AN has been supported by the Region Ile de France through a DIM Malinf project. This work has been in part supported by the Animal Health Division of INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Padilla J, 2011, VACCINE, V29, P1830, DOI 10.1016/j.vaccine.2010.12.081; An HY, 2013, VIRUS RES, V171, P168, DOI 10.1016/j.virusres.2012.11.007; Bellier B, 2009, VACCINE, V27, P5772, DOI 10.1016/j.vaccine.2009.07.059; Biacchesi S, 2002, J VIROL, V76, P2881, DOI 10.1128/JVI.76.6.2881-2889.2002; Biacchesi S, 2000, J VIROL, V74, P11247, DOI 10.1128/JVI.74.23.11247-11253.2000; Biacchesi S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-12; Biacchesi S, 2010, J VIROL, V84, P10038, DOI 10.1128/JVI.00343-10; Bonafe N, 2009, VACCINE, V27, P213, DOI 10.1016/j.vaccine.2008.10.046; Chu JHJ, 2007, J IMMUNOL, V178, P2699, DOI 10.4049/jimmunol.178.5.2699; Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0; Chua AJS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-129; Coutant F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003973; De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16; Despres P, 2005, J INFECT DIS, V191, P207, DOI 10.1086/426824; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Diamond MS, 2009, FRONT BIOSCI-LANDMRK, V14, P3024, DOI 10.2741/3432; Escribano-Romero E, 2013, VACCINE, V31, P4523, DOI 10.1016/j.vaccine.2013.07.071; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Harmache A, 2006, J VIROL, V80, P3655, DOI 10.1128/JVI.80.7.3655-3659.2006; Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837; Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06; Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3; Ledizet M, 2005, VACCINE, V23, P3915, DOI 10.1016/j.vaccine.2005.03.006; Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09; Lucas M, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-9; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Martina BE, 2008, VACCINE, V26, P153, DOI 10.1016/j.vaccine.2007.10.055; Martina BEE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018995; MATHEWS JH, 1984, J IMMUNOL, V132, P1533; McLean Robert G., 2007, P17, DOI 10.1002/9780470344668.ch2; Minke JM, 2011, VACCINE, V29, P4608, DOI 10.1016/j.vaccine.2011.04.058; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Purdy DE, 2005, VIROLOGY, V333, P239, DOI 10.1016/j.virol.2004.12.036; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Roehrig JT, 2001, ANN NY ACAD SCI, V951, P286; Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116; Spohn G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-146; Tan LCM, 2010, PROTEIN EXPRES PURIF, V74, P129, DOI 10.1016/j.pep.2010.06.015; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11; Wang T, 2001, J IMMUNOL, V167, P5273, DOI 10.4049/jimmunol.167.9.5273; Watts DM, 2007, VACCINE, V25, P2913, DOI 10.1016/j.vaccine.2006.08.008; Wertz GW, 2002, J VIROL, V76, P7642, DOI 10.1128/JVI.76.15.7642-7650.2002; Zlatkovic J, 2011, J VIROL, V85, P1994, DOI 10.1128/JVI.01886-10	49	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91766	10.1371/journal.pone.0091766	http://dx.doi.org/10.1371/journal.pone.0091766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663075	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900028
J	Song, LH; Lu, YF; He, J; Yu, YH; Zuo, TT; Li, YW; Zhu, H; Duan, Q				Song, Lihua; Lu, Yongfeng; He, Jun; Yu, Yonghui; Zuo, Tingting; Li, Yanwei; Zhu, Hong; Duan, Qing			Multi-Organ Lesions in Suckling Mice Infected with SARS-Associated Mammalian Reovirus Linked with Apoptosis Induced by Viral Proteins mu 1 and sigma 1	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; CENTRAL-NERVOUS-SYSTEM; OBLITERANS ORGANIZING PNEUMONIA; ATTACHMENT PROTEIN; DIFFERENTIAL ROLE; TISSUE-INJURY; T-CELLS; CORONAVIRUS; MENINGITIS; DISEASE	We reported the isolation and characterization of a novel mammalian reassortant reovirus BYD1 that may have played an accomplice role with SARS-coronavirus during the 2003 SARS pandemic. The pathogenic mechanism of this novel reovirus is unknown. Reovirus pathogenicity has been associated with virus-induced apoptosis in cultured cells and in vivo. The reovirus outer capsid protein mu 1 is recognized as the primary determinant of reovirus-induced apoptosis. Here, we investigated the apoptosis induced by BYD1, its outer capsid protein mu 1, and its cell-attachment protein sigma 1 to understand the pathogenesis of BYD1. We also investigated BYD1 caused systemic complications in suckling mice. Under electron microscopy, BYD1-infected cells showed characteristics typical of apoptosis. Notably, ectopically expressed mu 1 and sigma 1 induced similar pathological apoptosis, independent of BYD1 infection, in host cells in which they were expressed, which suggests that mu 1 and sigma 1 are both apoptotic virulence factors. Consistent with previous reports of reovirus pathogenicity, suckling mice intracranially inoculated with BYD1 developed central nerve damage, myocarditis, and pneumonia. Collectively, our data suggest that BYD1 mu 1- and sigma 1-induced apoptosis is involved in the multi-organ lesions in a suckling mouse BYD1 infection model.	[Song, Lihua; Lu, Yongfeng; He, Jun; Yu, Yonghui; Zuo, Tingting; Li, Yanwei; Zhu, Hong; Duan, Qing] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Song, LH (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	songlihua@gmail.com; hongz62@gmail.com; duanq@nic.bmi.ac.cn	li, yan/GTI-4638-2022		National Natural Science Foundation of China [81071360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81071360) to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avasarala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057285; Beckham JD, 2007, J VIROL, V81, P6984, DOI 10.1128/JVI.00467-07; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Clarke P, 2005, VIRAL IMMUNOL, V18, P89, DOI 10.1089/vim.2005.18.89; Coffey CM, 2006, J VIROL, V80, P8422, DOI 10.1128/JVI.02601-05; Connolly JL, 2001, J VIROL, V75, P4029, DOI 10.1128/JVI.75.9.4029-4039.2001; Danthi P, 2006, J VIROL, V80, P1261, DOI 10.1128/JVI.80.3.1261-1270.2006; Danthi P, 2008, J VIROL, V82, P161, DOI 10.1128/JVI.01739-07; Danthi P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000248; DeBiasi RL, 2004, J VIROL, V78, P11040, DOI 10.1128/JVI.78.20.11040-11050.2004; ESTES MK, 2001, FIELDS VIROLOGY, V2, P1747; He C, 2005, DNA CELL BIOL, V24, P491, DOI 10.1089/dna.2005.24.491; Hermann L, 2004, PEDIATR INFECT DIS J, V23, P373, DOI 10.1097/00006454-200404000-00026; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Johansson PJH, 1996, SCAND J INFECT DIS, V28, P117, DOI 10.3109/00365549609049060; Law PTW, 2005, J GEN VIROL, V86, P1921, DOI 10.1099/vir.0.80813-0; LEE PWK, 1981, VIROLOGY, V108, P156, DOI 10.1016/0042-6822(81)90535-3; Liang LC, 2005, DNA CELL BIOL, V24, P485, DOI 10.1089/dna.2005.24.485; London L, 2002, EXP MOL PATHOL, V72, P24, DOI 10.1006/exmp.2001.2414; Lopez AD, 2009, J IMMUNOL, V183, P8244, DOI 10.4049/jimmunol.0901958; Majeski EI, 2003, AM J RESP CELL MOL, V28, P208, DOI 10.1165/rcmb.4891; Mandell GL, 2010, MANDELL DOUGLAS BENN; Markotic A, 2003, J GEN VIROL, V84, P2197, DOI 10.1099/vir.0.19090-0; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; Nibert ML., 2001, FIELDS VIROLOGY, P1679; O'Donnell SM, 2005, J CLIN INVEST, V115, P2341, DOI 10.1172/JCI22428; Oberhaus SM, 1997, J VIROL, V71, P2100, DOI 10.1128/JVI.71.3.2100-2106.1997; RAZVI ES, 1995, ADV VIRUS RES, V45, P1, DOI 10.1016/S0065-3527(08)60057-3; Richardson-Burns SM, 2004, J VIROL, V78, P5466, DOI 10.1128/JVI.78.10.5466-5475.2004; Rodgers SE, 1997, J VIROL, V71, P2540, DOI 10.1128/JVI.71.3.2540-2546.1997; SABIN AB, 1959, SCIENCE, V130, P1387, DOI 10.1126/science.130.3386.1387; Song LH, 2008, VIRUS GENES, V37, P392, DOI 10.1007/s11262-008-0283-4; [苏裕心 Su Yuxin], 2005, [军事医学科学院院刊, Bulletin of the Academy of Military Medical Sciences], V29, P418; TYLER KL, 1995, J VIROL, V69, P6972, DOI 10.1128/JVI.69.11.6972-6979.1995; Tyler KL, 2004, J INFECT DIS, V189, P1664, DOI 10.1086/383129; TYLER KL, 2001, FIELDS VIROLOGY, P1725; WEINER HL, 1980, J IMMUNOL, V124, P2143; Wisniewski ML, 2011, J VIROL, V85, P296, DOI 10.1128/JVI.01982-10; Xu J, 2005, CLIN INFECT DIS, V41, P1089, DOI 10.1086/444461; Yan HM, 2004, J MED VIROL, V73, P323, DOI 10.1002/jmv.20094; [左庭婷 Zuo Tingting], 2003, [军事医学科学院院刊, Bulletin of the Academy of Military Medical Sciences], V27, P241; 端青, 2003, [科学通报, Chinese science bulletin], V48, P1369; [No title captured]	43	1	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92678	10.1371/journal.pone.0092678	http://dx.doi.org/10.1371/journal.pone.0092678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664247	gold, Green Submitted, Green Published			2022-12-25	WOS:000333459900097
J	White, WM; Garrett, AT; Craici, IM; Wagner, SJ; Fitz-Gibbon, PD; Butters, KA; Brost, BC; Rose, CH; Grande, JP; Garovic, VD				White, Wendy M.; Garrett, Angelica T.; Craici, Iasmina M.; Wagner, Steven J.; Fitz-Gibbon, Patrick D.; Butters, Kim A.; Brost, Brian C.; Rose, Carl H.; Grande, Joseph P.; Garovic, Vesna D.			Persistent Urinary Podocyte Loss following Preeclampsia May Reflect Subclinical Renal Injury	PLOS ONE			English	Article							ANGIOGENIC FACTORS; DISEASE-ACTIVITY; RISK-FACTOR; PREGNANCY; EXCRETION; NEPHRIN; MICROALBUMINURIA; HYPERTENSION; PROTEINURIA; MARKER	Objective: Studies have shown that podocyturia, i.e., urinary loss of viable podocytes (glomerular epithelial cells), is associated with proteinuria in preeclampsia. We postulated that urinary podocyte loss may persist after preeclamptic pregnancies, thus resulting in renal injury. This may lead to future chronic renal injury. In addition, we compared the postpartum levels of the angiogenic factors, which previously have been associated with preeclampsia, between normotensive versus preeclamptic pregnancies. Study Design: The diagnosis of preeclampsia was confirmed using standard clinical criteria. Random blood and urine samples were obtained within 24 hours prior to delivery and 5 to 8 weeks postpartum. Urine sediments were cultured for 24 hours to select for viable cells and staining for podocin was used to identify podocytes. Serum samples were analyzed for the levels of angiogenic markers using ELISA (enzyme-linked immunosorbent assay) methodology. Results: At delivery, preeclamptic patients (n = 10) had significantly higher proteinuria (p = 0.006) and podocyturia (p<0.001) than normotensive pregnant patients (n = 18). Postpartum proteinuria was similar between these two groups (p = 0.37), while podocyturia was present in 3 of 10 women with preeclampsia and in none of the normotensive controls (p = 0.037). Angiogenic marker levels, including placental growth factor, soluble vascular endothelial growth factor receptor fms-like tyrosine kinase receptor-1 and endoglin, were not significantly different between women with preeclampsia and women with a normotensive pregnancy, either at delivery or postpartum. Conclusion: Persistent urinary podocyte loss after preeclamptic pregnancies may constitute a marker of ongoing, subclinical renal injury.	[White, Wendy M.; Garrett, Angelica T.; Brost, Brian C.; Rose, Carl H.] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN USA; [Craici, Iasmina M.; Wagner, Steven J.; Butters, Kim A.; Garovic, Vesna D.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Fitz-Gibbon, Patrick D.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Grande, Joseph P.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Garovic, VD (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA.	garovic.vesna@mayo.edu	Grande, Joseph P./AAG-2128-2020	Grande, Joseph P./0000-0001-5674-1682; Garovic, Vesna/0000-0001-6891-0578; Brost, Brian/0000-0002-4903-4186	Fulk Career Development Fund for Research in Nephrology, Glomerular Diseases and Clinical Trials; Eunice Kennedy Shriver National Institute of Child Health & Human Development [K08 HD051714]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD051714] Funding Source: NIH RePORTER	Fulk Career Development Fund for Research in Nephrology, Glomerular Diseases and Clinical Trials; Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project described was supported by: (1) Fulk Career Development Fund for Research in Nephrology, Glomerular Diseases and Clinical Trials (Wendy M. White) and (2) Award Number K08 HD051714 (Vesna D. Garovic) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health. The writing of the manuscript and the decision to submit it for publication were solely the authors' responsibilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach J, 2008, NEPHROL DIAL TRANSPL, V23, P3138, DOI 10.1093/ndt/gfn235; Aita K, 2009, NEPHRON CLIN PRACT, V112, pC65, DOI 10.1159/000213083; Bar J, 1999, NEPHROL DIAL TRANSPL, V14, P1129, DOI 10.1093/ndt/14.5.1129; Chen GX, 2013, REPROD SCI, V20, P579, DOI 10.1177/1933719112459227; Craici IM, 2013, HYPERTENSION; Garovic VD, 2007, NAT CLIN PRACT NEPHR, V3, P613, DOI 10.1038/ncpneph0623; Garovic VD, 2013, NEPHROL DIAL TRANSPL, V28, P1555, DOI 10.1093/ndt/gfs074; Garovic VD, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.02.007; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Hara M, 2001, NEPHRON, V89, P342, DOI 10.1159/000046097; HEATON JM, 1985, J PATHOL, V147, P121, DOI 10.1002/path.1711470207; Jim B, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/984630; Jones SL, 1998, HEMATOPATHOL MOL HEM, V11, P147; Kattah AG, 2013, J CLIN HYPERTENS, V15, P617, DOI 10.1111/jch.12116; Kelder TP, 2012, HYPERTENSION, V60, P1538, DOI 10.1161/HYPERTENSIONAHA.112.201681; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Nakamura T, 2000, NEPHROL DIAL TRANSPL, V15, P1379, DOI 10.1093/ndt/15.9.1379; Nakamura T, 2000, AM J MED SCI, V320, P112, DOI 10.1097/00000441-200008000-00009; Petermann AT, 2003, KIDNEY INT, V64, P1222, DOI 10.1046/j.1523-1755.2003.00217.x; Roest M, 2001, CIRCULATION, V103, P3057, DOI 10.1161/hc2501.091353; Sato Y, 2009, J AM SOC NEPHROL, V20, P1041, DOI 10.1681/ASN.2007121328; Son GH, 2013, EUR J OBSTET GYN R B, V166, P139, DOI 10.1016/j.ejogrb.2012.10.011; Verhave JC, 2004, KIDNEY INT, V66, pS18, DOI 10.1111/j.1523-1755.2004.09205.x; Vikse BE, 2008, NEW ENGL J MED, V359, P800, DOI 10.1056/NEJMoa0706790; Vogelmann SU, 2003, AM J PHYSIOL-RENAL, V285, pF40, DOI 10.1152/ajprenal.00404.2002; Wang IK, 2013, CAN MED ASSOC J, V185, P207, DOI 10.1503/cmaj.120230; Wang YP, 2012, AM J PHYSIOL-RENAL, V302, pF1084, DOI 10.1152/ajprenal.00597.2011; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159; Zhao S, 2011, REPROD SCI, V18, P772, DOI 10.1177/1933719111398145	31	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92693	10.1371/journal.pone.0092693	http://dx.doi.org/10.1371/journal.pone.0092693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664365	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900099
J	Yang, SY; Kim, NH; Cho, YS; Lee, H; Kwon, HJ				Yang, Seung Ya; Kim, Nam Hee; Cho, Yoon Sun; Lee, Hukeun; Kwon, Ho Jeong			Convallatoxin, a Dual Inducer of Autophagy and Apoptosis, Inhibits Angiogenesis In Vitro and In Vivo	PLOS ONE			English	Article							CANCER; CYTOTOXICITY; GLYCOSIDES; DEATH; CELLS	Autophagy and apoptosis are important processes that control cellular homeostasis and have been highlighted as promising targets for novel cancer therapies. Here, we identified convallatoxin (CNT), isolated from Antiaris toxicaria, as a dual inducer of autophagy and apoptosis. CNT exerts cytotoxic effects on a number of cancer and normal cell lines and induces apoptosis by increasing caspase-3 and poly ADP ribose polymerase (PARP) cleavage. Moreover, dose-and time-dependent autophagic activity was detected in CNT-treated cells, and mammalian target of rapamycin (mTOR)/p70S6K signal pathway inhibition was observed. Notably, CNT inhibits human umbilical vein endothelial cell (HUVEC) growth and exerts anti-angiogenic activity in vitro and in vivo. Collectively, these results demonstrate that the naturally occurring compound, CNT, is a novel anti-angiogenic compound via dual inducing of autophagy and apoptosis.	[Yang, Seung Ya; Kim, Nam Hee; Cho, Yoon Sun; Lee, Hukeun; Kwon, Ho Jeong] Yonsei Univ, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Dept Biotechnol, Seoul 120749, South Korea	Yonsei University	Kwon, HJ (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Dept Biotechnol, Seoul 120749, South Korea.	kwonhj@yonsei.ac.kr	권, 호정/AAS-3642-2021		National Research Foundation of Korea (NRF); Korean government (MSIP) [2009-0092964, 2009-0083522, 2011-0006165, 2012M3A9D1054520]; Center for Food and Drug Materials of Agriculture Science & Technology Development [PJ0079772012]; Rural Development Administration; National RD Program; Ministry of Health Welfare [0620360-1]; Brain Korea 21 Plus Project	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MSIP); Center for Food and Drug Materials of Agriculture Science & Technology Development; Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); National RD Program; Ministry of Health Welfare; Brain Korea 21 Plus Project	This study was partly supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP; 2009-0092964, 2009-0083522, 2011-0006165, 2012M3A9D1054520), the Center for Food and Drug Materials of Agriculture Science & Technology Development (PJ0079772012), the Rural Development Administration, the National R&D Program, the Ministry of Health & Welfare (0620360-1), and the Brain Korea 21 Plus Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; BATTEGAY EJ, 1995, J MOL MED, V73, P333; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Dong WH, 2011, PLANTA MED, V77, P1730, DOI 10.1055/s-0030-1271045; Felth J, 2009, J NAT PROD, V72, P1969, DOI 10.1021/np900210m; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kim KH, 2011, BIOCHEM BIOPH RES CO, V404, P541, DOI 10.1016/j.bbrc.2010.12.022; Kim NH, 2010, BIOCHEM BIOPH RES CO, V399, P20, DOI 10.1016/j.bbrc.2010.07.025; Klausmeyer P, 2009, J NAT PROD, V72, P805, DOI 10.1021/np8006342; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lian J, 2011, CELL DEATH DIFFER, V18, P60, DOI 10.1038/cdd.2010.74; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Prassas I, 2011, MOL CANCER THER, V10, P2083, DOI 10.1158/1535-7163.MCT-11-0421; Shim JS, 2003, CHEM BIOL, V10, P695, DOI 10.1016/S1074-5521(03)00169-8; Wang TM, 2007, J NAT PROD, V70, P1429, DOI 10.1021/np070150o; WEHRLI W, 1962, HELV CHIM ACTA, V45, P1183, DOI 10.1002/hlca.19620450416; Yokoyama T, 2008, AUTOPHAGY, V4, P629, DOI 10.4161/auto.5941	24	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91094	10.1371/journal.pone.0091094	http://dx.doi.org/10.1371/journal.pone.0091094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663328	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900013
J	Glenthoj, A; Dahl, S; Larsen, MT; Cowland, JB; Borregaard, N				Glenthoj, Andreas; Dahl, Sara; Larsen, Maria T.; Cowland, Jack B.; Borregaard, Niels			Human alpha-Defensin Expression Is Not Dependent on CCAAT/Enhancer Binding Protein-epsilon in a Murine Model	PLOS ONE			English	Article							COPY NUMBER POLYMORPHISMS; C/EBP-EPSILON; GRANULE DEFICIENCY; TRANSCRIPTION FACTORS; MESSENGER-RNA; NEUTROPHIL; CELLS; MUTATION; GENES; BETA	Specific granule deficiency (SGD) is a rare congenital disorder characterized by recurrent infections. The disease is caused by inactivating mutations of the CCAAT/enhancer binding protein-epsilon (C/EBP-epsilon) gene. As a consequence, specific and gelatinase granules lack most matrix proteins. Furthermore, azurophil granules contain diminished amounts of their most abundant proteins, alpha-defensins, also known as human neutrophil peptides (HNPs). In accordance with this, in vitro models have demonstrated induction of HNPs by C/EBP-epsilon. Since mice do not express myeloid defensins, they cannot per se be used to characterize the role of C/EBP-epsilon in controlling HNP expression in vivo. We therefore crossed a transgenic HNP-1-expressing mouse with the Cebpe(-/-) mouse to study the in vivo significance of C/EBP-epsilon for HNP-1 transcription and expression. Surprisingly, neither expression nor processing of HNP-1 was affected by lack of C/EBP-epsilon in these mice. Transduction of C/EBP-epsilon into primary bone marrow cells from HNP-1 mice induced some HNP-1 expression, but not to levels comparable to expression human cells. Taken together, our data infer that the HNP-1 of the transgenic mouse does not show an expression pattern equivalent to endogenous secondary granule proteins. This limits the use of these transgenic mice as a model for human conditions.	[Glenthoj, Andreas; Dahl, Sara; Larsen, Maria T.; Cowland, Jack B.; Borregaard, Niels] Univ Copenhagen, Natl Univ Hosp, Dept Hematol, Granulocyte Res Lab, Copenhagen, Denmark	University of Copenhagen	Glenthoj, A (corresponding author), Univ Copenhagen, Natl Univ Hosp, Dept Hematol, Granulocyte Res Lab, Copenhagen, Denmark.	angl@rh.dk	Glenthøj, Andreas/ABD-5948-2021	Glenthøj, Andreas/0000-0003-2082-0738; Cowland, Jack Bernard/0000-0002-7429-5388	Danish Medical Research Council; National University Hospital; Danish Cancer Society	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National University Hospital; Danish Cancer Society(Danish Cancer Society)	This work was supported by grants from The Danish Medical Research Council (NB), The National University Hospital (AG), and The Danish Cancer Society (MBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; Arnljots K, 1998, LEUKEMIA, V12, P1789, DOI 10.1038/sj.leu.2401202; Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; Bedi R, 2009, BLOOD, V113, P317, DOI 10.1182/blood-2008-02-139741; Bjerregaard MD, 2003, BLOOD, V101, P4322, DOI 10.1182/blood-2002-03-0835; BORREGAARD N, 1985, AM J HEMATOL, V18, P255, DOI 10.1002/ajh.2830180306; Chen QX, 2010, ANESTHESIOLOGY, V112, P1428, DOI 10.1097/ALN.0b013e3181d968eb; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Du ZP, 2011, BIOCHEM CELL BIOL, V89, P314, DOI 10.1139/O11-002; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3446, DOI 10.1128/IAI.60.8.3446-3447.1992; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Faurschou M, 2005, J LEUKOCYTE BIOL, V78, P785, DOI 10.1189/jlb.1104688; Faurschou M, 2002, BBA-MOL CELL RES, V1591, P29, DOI 10.1016/S0167-4889(02)00243-4; GANZ T, 1990, EUR J HAEMATOL, V44, P1; GANZ T, 1988, J CLIN INVEST, V82, P552, DOI 10.1172/JCI113631; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Glenthoj A, 2013, EUR J CLIN INVEST, V43, P836, DOI 10.1111/eci.12114; Glenthoj A, 2011, BLOOD, V118, P4440, DOI 10.1182/blood-2011-06-362947; Gombart AF, 2001, BLOOD, V97, P2561, DOI 10.1182/blood.V97.9.2561; Gombart AF, 2003, BLOOD, V101, P3265, DOI 10.1182/blood-2002-04-1039; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; JOHNSTON JJ, 1992, BLOOD, V80, P2088; Khanna-Gupta A, 2003, BLOOD, V101, P3460, DOI 10.1182/blood-2002-09-2767; Larsen MT, 2014, BLOOD, V123, P1079, DOI 10.1182/blood-2013-08-523233; Lekstrom-Himes J, 1999, BLOOD, V93, P3096; Lekstrom-Himes JA, 1999, J EXP MED, V189, P1847, DOI 10.1084/jem.189.11.1847; Lennartsson A, 2006, J LEUKOCYTE BIOL, V80, P196, DOI 10.1189/jlb.1205759; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Linzmeier RM, 2006, GENOMICS, V88, P122, DOI 10.1016/j.ygeno.2006.03.005; McBurney MW, 2002, EXP CELL RES, V274, P1, DOI 10.1006/excr.2001.5443; Rorvig S, 2009, J LEUKOCYTE BIOL, V86, P1439, DOI 10.1189/jlb.1008606; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; TAMURA A, 1994, INT J HEMATOL, V59, P137; Tanaka M, 2007, INT J HEMATOL, V85, P304, DOI 10.1532/IJH97.05162; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Truong BTH, 2003, BLOOD, V101, P1141, DOI 10.1182/blood-2002-05-1374; Tsutsumi-Ishii Y, 2000, J IMMUNOL, V164, P3264, DOI 10.4049/jimmunol.164.6.3264; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; Verbeek W, 1999, BLOOD, V93, P3327, DOI 10.1182/blood.V93.10.3327; Verbeek W, 2001, LEUKEMIA, V15, P103, DOI 10.1038/sj.leu.2401995; Verbeek W, 2013, GENE EXPRESSION NEUT, P3141; Williams SC, 1998, J BIOL CHEM, V273, P13493, DOI 10.1074/jbc.273.22.13493; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92471	10.1371/journal.pone.0092471	http://dx.doi.org/10.1371/journal.pone.0092471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658030	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300087
J	Hsieh, LC; Chen, JW; Wang, LY; Tsang, YM; Shueng, PW; Liao, LJ; Lo, WC; Lin, YC; Tseng, CF; Kuo, YS; Jhuang, JY; Tien, HJ; Juan, HF; Hsieh, CH				Hsieh, Li-Chun; Chen, John W.; Wang, Li-Ying; Tsang, Yuk-Ming; Shueng, Pei-Wei; Liao, Li-Jen; Lo, Wu-Chia; Lin, Yu-Chin; Tseng, Chien-Fu; Kuo, Ying-Shiung; Jhuang, Jie-Yang; Tien, Hui-Ju; Juan, Hsueh-Fen; Hsieh, Chen-Hsi			Predicting the Severity and Prognosis of Trismus after Intensity-Modulated Radiation Therapy for Oral Cancer Patients by Magnetic Resonance Imaging	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA; POSTOPERATIVE TREATMENT; NECK RADIOTHERAPY; CAVITY CANCER; HEAD; EXPERIENCE; SEQUELAE; TERMS	To develop magnetic resonance imaging (MRI) indicators to predict trismus outcome for post-operative oral cavity cancer patients who received adjuvant intensity-modulated radiation therapy (IMRT), 22 patients with oral cancer treated with IMRT were studied over a two-year period. Signal abnormality scores (SA scores) were computed from Likert-type ratings of the abnormalities of nine masticator structures and compared with the Mann-Whitney U-test and Kruskal-Wallis one-way ANOVA test between groups. Seventeen patients (77.3%) experienced different degrees of trismus during the two-year follow-up period. The SA score correlated with the trismus grade (r = 0.52, p < 0.005). Patients having progressive trismus had higher mean doses of radiation to multiple structures, including the masticator and lateral pterygoid muscles, and the parotid gland (p < 0.05). In addition, this group also had higher SA-masticator muscle dose product at 6 months and SA scores at 12 months (p < 0.05). At the optimum cut-off points of 0.38 for the propensity score, the sensitivity was 100% and the specificity was 93% for predicting the prognosis of the trismus patients. The SA score, as determined using MRI, can reflect the radiation injury and correlate to trismus severity. Together with the radiation dose, it could serve as a useful biomarker to predict the outcome and guide the management of trismus following radiation therapy.	[Hsieh, Li-Chun; Tsang, Yuk-Ming] Far Eastern Mem Hosp, Dept Radiol, Div Med Imaging, Taipei, Taiwan; [Shueng, Pei-Wei; Tien, Hui-Ju; Hsieh, Chen-Hsi] Far Eastern Mem Hosp, Dept Radiol, Div Radiat Oncol, Taipei, Taiwan; [Liao, Li-Jen; Lo, Wu-Chia] Far Eastern Mem Hosp, Dept Otolaryngol, Taipei, Taiwan; [Lin, Yu-Chin] Far Eastern Mem Hosp, Dept Internal Med, Div Med Oncol & Hematol, Taipei, Taiwan; [Tseng, Chien-Fu; Kuo, Ying-Shiung] Far Eastern Mem Hosp, Dept Dent & Oral Surg, Taipei, Taiwan; [Jhuang, Jie-Yang] Far Eastern Mem Hosp, Dept Anat Pathol, Taipei, Taiwan; [Hsieh, Chen-Hsi] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; [Hsieh, Chen-Hsi] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Wang, Li-Ying] Natl Taiwan Univ, Coll Med, Sch & Grad Inst Phys Therapy, Taipei 10764, Taiwan; [Shueng, Pei-Wei] Natl Def Med Ctr, Dept Radiat Oncol, Taipei, Taiwan; [Chen, John W.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Syst Biol, Cambridge, MA 02138 USA; [Chen, John W.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Cambridge, MA 02138 USA; [Hsieh, Li-Chun] Natl Taiwan Univ, Ctr Syst Biol, Inst Mol & Cellular Biol, Dept Life Sci, Taipei 10764, Taiwan; [Juan, Hsueh-Fen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Hsieh, Li-Chun; Juan, Hsueh-Fen] Taipei Med Univ Hosp, Med Imaging Ctr, Taipei, Taiwan	Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; National Defense Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; National Taiwan University; National Taiwan University; Taipei Medical University; Taipei Medical University Hospital	Hsieh, CH (corresponding author), Far Eastern Mem Hosp, Dept Radiol, Div Radiat Oncol, Taipei, Taiwan.	chenciab@gmail.com		WANG, LI-YING/0000-0003-3075-6872; JUAN, HSUEH-FEN/0000-0003-4876-3309	Far Eastern Memorial Hospital [FEMH-2012-C-055, FEMH 101-2314-B-418-010-MY3]	Far Eastern Memorial Hospital	This work was supported by the Far Eastern Memorial Hospital grants (FEMH-2012-C-055; FEMH 101-2314-B-418-010-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXEL L, 1987, RADIOLOGY, V162, P874, DOI 10.1148/radiology.162.3.3809508; Bensadoun RJ, 2010, SUPPORT CARE CANCER, V18, P1033, DOI 10.1007/s00520-010-0847-4; Bhatia KSS, 2009, EUR RADIOL, V19, P2586, DOI 10.1007/s00330-009-1445-z; Chen WC, 2009, ORAL ONCOL, V45, P505, DOI 10.1016/j.oraloncology.2008.07.002; Chen YY, 2011, CANCER-AM CANCER SOC, V117, P2910, DOI 10.1002/cncr.25773; Chua DTT, 2001, AM J CLIN ONCOL-CANC, V24, P366, DOI 10.1097/00000421-200108000-00010; Dijkstra PU, 2004, ORAL ONCOL, V40, P879, DOI 10.1016/j.oraloncology.2004.04.003; Goldstein M, 1999, ORAL SURG ORAL MED O, V88, P365, DOI 10.1016/S1079-2104(99)70044-2; Gomez DR, 2009, INT J RADIAT ONCOL, V73, P1096, DOI 10.1016/j.ijrobp.2008.05.024; HENDEE WR, 1989, JAMA-J AM MED ASSOC, V262, P2420; Hsieh CH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-37; Hsiung CY, 2008, BRIT J RADIOL, V81, P809, DOI 10.1259/bjr/17942449; Israel HA, 2003, J ORAL MAXIL SURG, V61, P662, DOI 10.1053/joms.2003.50133; JANSMA J, 1992, INT J RADIAT ONCOL, V24, P359, DOI 10.1016/0360-3016(92)90692-B; Johnson J, 2010, MED SCI MONITOR, V16, pCR278; Keeling AN, 2011, J CARDIOVASC MED, V12, P460, DOI 10.2459/JCM.0b013e3283483916; Kent ML, 2008, SUPPORT CARE CANCER, V16, P305, DOI 10.1007/s00520-007-0345-5; Liu Yuan, 2007, Ai Zheng, V26, P64; QIN DX, 1988, CANCER, V61, P1117, DOI 10.1002/1097-0142(19880315)61:6<1117::AID-CNCR2820610611>3.0.CO;2-J; Steelman R, 1986, Mo Dent J, V66, P21; Teguh DN, 2008, HEAD NECK-J SCI SPEC, V30, P622, DOI 10.1002/hed.20760; van der Molen L, 2011, DYSPHAGIA, V26, P155, DOI 10.1007/s00455-010-9288-y; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305; Wang CJ, 2005, LARYNGOSCOPE, V115, P1458, DOI 10.1097/01.mlg.0000171019.80351.46; Yao M, 2007, INT J RADIAT ONCOL, V67, P1332, DOI 10.1016/j.ijrobp.2006.11.030	25	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92561	10.1371/journal.pone.0092561	http://dx.doi.org/10.1371/journal.pone.0092561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658376	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300098
J	Morris, EJ; Nader, GPF; Ramalingam, N; Bartolini, F; Gundersen, GG				Morris, Edward J.; Nader, Guilherme P. F.; Ramalingam, Nagendran; Bartolini, Francesca; Gundersen, Gregg G.			Kif4 Interacts with EB1 and Stabilizes Microtubules Downstream of Rho-mDia in Migrating Fibroblasts	PLOS ONE			English	Article							DETYROSINATED GLU MICROTUBULES; PLUS-END; INTERMEDIATE-FILAMENTS; CELL-MIGRATION; ALPHA-TUBULIN; SELECTIVE STABILIZATION; STABLE MICROTUBULES; KINESIN SUPERFAMILY; MTOC REORIENTATION; MIDZONE FORMATION	Selectively stabilized microtubules (MTs) form in the lamella of fibroblasts and contribute to cell migration. A Rho-mDia-EB1 pathway regulates the formation of stable MTs, yet how selective stabilization of MTs is achieved is unknown. Kinesin activity has been implicated in selective MT stabilization and a number of kinesins regulate MT dynamics both in vitro and in cells. Here, we show that the mammalian homolog of Xenopus XKLP1, Kif4, is both necessary and sufficient for the induction of selective MT stabilization in fibroblasts. Kif4 localized to the ends of stable MTs and participated in the Rho-mDia-EB1 MT stabilization pathway since Kif4 depletion blocked mDia- and EB1-induced selective MT stabilization and EB1 was necessary for Kif4 induction of stable MTs. Kif4 and EB1 interacted in cell extracts, and binding studies revealed that the tail domain of Kif4 interacted directly with the N-terminal domain of EB1. Consistent with its role in regulating formation of stable MTs in interphase cells, Kif4 knockdown inhibited migration of cells into wounded monolayers. These data identify Kif4 as a novel factor in the Rho-mDia-EB1 MT stabilization pathway and cell migration.	[Morris, Edward J.; Nader, Guilherme P. F.; Ramalingam, Nagendran; Bartolini, Francesca; Gundersen, Gregg G.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA	Columbia University	Gundersen, GG (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.	ggg1@columbia.edu		Morris, Edward/0000-0002-7960-2842	National Institutes of Health [GM062939]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM062939 to GGG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Andres-Delgado L, 2012, J CELL BIOL, V198, P1025, DOI 10.1083/jcb.201202137; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Bartolini F, 2009, BIOCH BIOPHYS ACTA; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Bartolini F, 2012, MOL BIOL CELL, V23, P4032, DOI 10.1091/mbc.E12-05-0338; Bastos RN, 2013, J CELL BIOL, V202, P605, DOI 10.1083/jcb.201301094; Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; Bisbal M, 2009, J BIOL CHEM, V284, P9489, DOI 10.1074/jbc.M808586200; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Browning H, 2005, J BIOL CHEM, V280, P12299, DOI 10.1074/jbc.M413620200; Butler B, 2009, CURR BIOL, V19, P1886, DOI 10.1016/j.cub.2009.10.029; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Du YQ, 2010, CURR BIOL, V20, P374, DOI 10.1016/j.cub.2009.12.049; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Gardner MK, 2008, TRENDS CELL BIOL, V18, P307, DOI 10.1016/j.tcb.2008.05.003; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; GUNDERSEN GG, 1987, J CELL BIOL, V105, P251, DOI 10.1083/jcb.105.1.251; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; GURLAND G, 1995, J CELL BIOL, V131, P1275, DOI 10.1083/jcb.131.5.1275; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hu CK, 2011, CURR BIOL, V21, P815, DOI 10.1016/j.cub.2011.04.019; Infante AS, 2000, J CELL SCI, V113, P3907; Jaulin F, 2010, J CELL BIOL, V190, P443, DOI 10.1083/jcb.201006044; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; KHAWAJA S, 1988, J CELL BIOL, V106, P141, DOI 10.1083/jcb.106.1.141; Kim WK, 1998, J VIROL, V72, P6898, DOI 10.1128/JVI.72.8.6898-6901.1998; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; KOONCE MP, 1984, J CELL BIOL, V98, P1999, DOI 10.1083/jcb.98.6.1999; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lewkowicz E, 2008, J CELL BIOL, V183, P1287, DOI 10.1083/jcb.200807023; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; Luxton GWG, 2011, CURR OPIN CELL BIOL, V23, P579, DOI 10.1016/j.ceb.2011.08.001; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Oliver Constance, 2010, Methods Mol Biol, V588, piv; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Palazzo RE, 2001, CENTROSOMES SPINDLE; Peretti D, 2000, J CELL BIOL, V149, P141, DOI 10.1083/jcb.149.1.141; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Schmoranzer J, 2003, J CELL SCI, V116, P4513, DOI 10.1242/jcs.00748; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; Stumpff J, 2011, MOL CELL, V43, P764, DOI 10.1016/j.molcel.2011.07.022; Su XL, 2012, TRENDS CELL BIOL, V22, P567, DOI 10.1016/j.tcb.2012.08.003; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Thurston SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048041; Wakida NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015462; Weaver LN, 2011, CURR BIOL, V21, P1500, DOI 10.1016/j.cub.2011.08.005; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; WEBSTER DR, 1990, J CELL BIOL, V111, P113, DOI 10.1083/jcb.111.1.113; Wen YD, 2004, KENYON REV, V26, P1; Wordeman L, 2005, CURR OPIN CELL BIOL, V17, P82, DOI 10.1016/j.ceb.2004.12.003; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	83	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91568	10.1371/journal.pone.0091568	http://dx.doi.org/10.1371/journal.pone.0091568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658398	gold, Green Published, Green Submitted			2022-12-25	WOS:000333355300038
J	Norgaard, LN; Gjerris, ACR; Kirkegaard, I; Berlac, JF; Tabor, A				Norgaard, Lone Nikoline; Gjerris, Anne Cathrine Roslev; Kirkegaard, Ida; Berlac, Janne Foss; Tabor, Ann		Danish Fetal Med Res Grp	Fetal Growth in Pregnancies Conceived after Gastric Bypass Surgery in Relation to Surgery-to-Conception Interval: A Danish National Cohort Study	PLOS ONE			English	Article							BARIATRIC SURGERY; OUTCOMES; OBESITY; WOMEN	Objective: To describe early and late fetal growth in pregnancies conceived after gastric bypass surgery in relation to time from surgery to conception of pregnancy. Methods: National cohort study on 387 Danish women, who had laparoscopic or open gastric bypass surgery prior to a singleton pregnancy in which first trimester screening was performed between January 2008 and June 2011. Data were derived from national registers (Danish National Registry of Patients and Danish National Birth Registry, Pregnancy Complications and Abortion - clinical quality database (PreCAb) and the Danish Fetal Medicine Database). Main outcome measures were early and late fetal growth in relation to time from bariatric surgery to conception of the pregnancy. Early fetal growth was expressed as "Fetal Growth Index": the ratio between the estimated number of days from first trimester ultrasound to second trimester ultrasound biometries and the actual calender time elapsed in days. Late fetal growth was expressed as the observed versus expected birthweight according to gestational age (GA). Results: The surgery-to-conception interval ranged from 3 to 1851 days with a mean value of 502 (SD, 351) days. The mean "fetal growth index" was 0.99 (SD, 0.02) days/day and thus significantly lower than in the background population (mean, 1.04 (SD, 0.09) days/day, p<0.0001). The proportion of infants being small for gestational age was 18.8% and the proportion of large for gestational age infants was 6.7%. The correlation coefficients between surgery-to-conception time and "fetal growth index" and birthweight according to GA were 0.01 (p = 0.8) and 0.04 (p = 0.4), respectively. Conclusion: Fetal growth index was lower than reported in the background population. No correlation was found between the surgery-to-conception interval and early or late fetal growth in pregnancies conceived after gastric bypass surgery.	[Norgaard, Lone Nikoline; Gjerris, Anne Cathrine Roslev] Copenhagen Univ Hosp, Hillerod Hosp, Dept Obstet & Gynecol, Hillerod, Denmark; [Kirkegaard, Ida] Aarhus Univ Hosp, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark; [Berlac, Janne Foss] Copenhagen Univ Hosp, Rigshosp, Dept Obstet, Copenhagen, Denmark; [Tabor, Ann] Copenhagen Univ Hosp, Rigshosp, Dept Obstet, Ctr Fetal Med, Copenhagen, Denmark; [Tabor, Ann] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Norgaard, LN (corresponding author), Copenhagen Univ Hosp, Hillerod Hosp, Dept Obstet & Gynecol, Hillerod, Denmark.	lonenoergaard@dadlnet.dk		Norgaard, Lone Nikoline/0000-0002-6511-9796; Jorgensen, Finn Stener/0000-0002-1592-5407; Farlie, Richard/0000-0001-5286-3244; Tabor, Ann/0000-0001-7450-1543				Altman DG, 1997, ULTRASOUND OBST GYN, V10, P174, DOI 10.1046/j.1469-0705.1997.10030174.x; [Anonymous], 2009, Obstet Gynecol, V113, P1405, DOI 10.1097/AOG.0b013e3181ac0544; Dao T, 2006, AM J SURG, V192, P762, DOI 10.1016/j.amjsurg.2006.08.041; Ducarme G, 2007, INT J GYNECOL OBSTET, V98, P244, DOI 10.1016/j.ijgo.2007.02.020; Ducarme G, 2013, J MATERN-FETAL NEO M, V26, P275, DOI 10.3109/14767058.2012.735723; Guelinckx I, 2009, HUM REPROD UPDATE, V15, P189, DOI 10.1093/humupd/dmn057; Hezelgrave NL, 2011, J OBES, V2011, DOI 10.1155/2011/501939; Josefsson A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.025; Karmon A, 2008, AM J PERINAT, V25, P331, DOI 10.1055/s-2008-1078760; Kirkegaard I, 2011, ULTRASOUND OBST GYN, V37, P341, DOI 10.1002/uog.8808; Lesko J, 2012, OBSTET GYNECOL, V119, P547, DOI 10.1097/AOG.0b013e318239060e; Magdaleno R, 2012, ARCH GYNECOL OBSTET, V285, P559, DOI 10.1007/s00404-011-2187-0; Marceau P, 2004, OBES SURG, V14, P318, DOI 10.1381/096089204322917819; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Patel JA, 2008, SURG OBES RELAT DIS, V4, P39, DOI 10.1016/j.soard.2007.10.008; Renault Kristina, 2012, Ugeskr Laeger, V174, P1076; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Sergienko R, 2011, AM J OBSTET GYNECOL, V204, pS58; Wax JR, 2008, OBES SURG, V18, P540, DOI 10.1007/s11695-008-9459-1	20	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90317	10.1371/journal.pone.0090317	http://dx.doi.org/10.1371/journal.pone.0090317			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658186	gold, Green Published, Green Submitted			2022-12-25	WOS:000333355300015
J	Ouyang, M; Li, SY; Tian, X				Ouyang, Mei; Li, Shuangyan; Tian, Xin			Functional Connectivity among Spikes in Low Dimensional Space during Working Memory Task in Rat	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX	Working memory (WM) is critically important in cognitive tasks. The functional connectivity has been a powerful tool for understanding the mechanism underlying the information processing during WM tasks. The aim of this study is to investigate how to effectively characterize the dynamic variations of the functional connectivity in low dimensional space among the principal components (PCs) which were extracted from the instantaneous firing rate series. Spikes were obtained from medial prefrontal cortex (mPFC) of rats with implanted microelectrode array and then transformed into continuous series via instantaneous firing rate method. Granger causality method is proposed to study the functional connectivity. Then three scalar metrics were applied to identify the changes of the reduced dimensionality functional network during working memory tasks: functional connectivity (GC), global efficiency (E) and casual density (CD). As a comparison, GC, E and CD were also calculated to describe the functional connectivity in the original space. The results showed that these network characteristics dynamically changed during the correct WM tasks. The measure values increased to maximum, and then decreased both in the original and in the reduced dimensionality. Besides, the feature values of the reduced dimensionality were significantly higher during the WM tasks than they were in the original space. These findings suggested that functional connectivity among the spikes varied dynamically during the WM tasks and could be described effectively in the low dimensional space.	[Ouyang, Mei; Li, Shuangyan; Tian, Xin] Tianjin Med Univ, Sch Biomed Engn, Lab Neurobiol Med, Tianjin, Peoples R China	Tianjin Medical University	Tian, X (corresponding author), Tianjin Med Univ, Sch Biomed Engn, Lab Neurobiol Med, Tianjin, Peoples R China.	tianx@tmu.edu.cn			National Natural Science Foundation of China [61375113, 91132722]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants 61375113 and 91132722 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bai WW, 2012, NEUROSCI BULL, V28, P693, DOI 10.1007/s12264-012-1291-x; D'Ardenne K, 2012, P NATL ACAD SCI USA, V109, P19900, DOI 10.1073/pnas.1116727109; Eldawlatly S, 2009, NEURAL COMPUT, V21, P450, DOI 10.1162/neco.2008.09-07-606; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Gao L, 2013, BRAIN TOPOGR, V26, P201, DOI 10.1007/s10548-012-0250-1; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Gordon EM, 2012, HUM BRAIN MAPP; Gow DW, 2008, NEUROIMAGE, V43, P614, DOI 10.1016/j.neuroimage.2008.07.027; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Heitger MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062133; Hu J, 2005, IEEE T NEUR SYS REH, V13, P256, DOI 10.1109/TNSRE.2005.847389; Kispersky Tilman, 2011, Neural Syst Circuits, V1, P9, DOI 10.1186/2042-1001-1-9; Leonardi N, 2013, NEUROIMAGE, V83, P937, DOI 10.1016/j.neuroimage.2013.07.019; Li SY, 2012, BRAIN RES BULL, V89, P115, DOI 10.1016/j.brainresbull.2012.07.012; Mikula S, 2006, INT J NEUROSCI, V116, P419, DOI 10.1080/00207450500505761; Nicolaou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033869; Prasad A, 2009, IEEE ENG MED BIO, P582, DOI 10.1109/IEMBS.2009.5332818; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Ries ML, 2012, NEUROPSYCHOLOGIA, V50, P603, DOI 10.1016/j.neuropsychologia.2011.12.014; Roux F, 2012, J NEUROSCI, V32, P12411, DOI 10.1523/JNEUROSCI.0421-12.2012; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seth AK, 2007, NEURAL COMPUT, V19, P910, DOI 10.1162/neco.2007.19.4.910; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Uddin Lucina Q, 2013, Front Hum Neurosci, V7, P458, DOI 10.3389/fnhum.2013.00458; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Zhou ZY, 2009, BRAIN RES, V1289, P22, DOI 10.1016/j.brainres.2009.06.096; Zhou ZY, 2009, HUM BRAIN MAPP, V30, P2197, DOI 10.1002/hbm.20661; Zhu LQ, 2005, MATH BIOSCI ENG, V2, P1	34	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91481	10.1371/journal.pone.0091481	http://dx.doi.org/10.1371/journal.pone.0091481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658291	Green Submitted, gold, Green Published			2022-12-25	WOS:000333355300035
J	Qi, Z; Tretter, F; Voit, EO				Qi, Zhen; Tretter, Felix; Voit, Eberhard O.			A Heuristic Model of Alcohol Dependence	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS MICRODIALYSATE; EXTRACELLULAR DOPAMINE; IN-VIVO; ETHANOL; WITHDRAWAL; SEROTONIN; GLUTAMATE; RELEASE; NEUROTRANSMISSION; INCREASES	Background: Substance dependence poses a critical health problem. Sadly, its neurobiological mechanisms are still unclear, and this lack of real understanding is reflected in insufficient treatment options. It has been hypothesized that alcohol effects are due to an imbalance between neuroexcitatory and neuroinhibitory amino acids. However, glutamate and GABA interact with other neurotransmitters, which form a complicated network whose functioning evades intuition and should be investigated systemically with methods of biomedical systems analysis. Methods and Results: We present a heuristic model of neurotransmitters that combines a neurochemical interaction matrix at the biochemical level with a mobile describing the balances between pairs of neurotransmitters at the physiological and behavioral level. We investigate the effects of alcohol on the integrated neurotransmitter systems at both levels. The model simulation results are consistent with clinical and experimental observations. The model demonstrates that the drug diazepam for symptoms of alcohol withdrawal effectively reduces the imbalances between neurotransmitters. Moreover, the acetylcholine signal is suggested as a novel target for treatment of symptoms associated with alcohol withdrawal. Conclusions: Efficient means of integrating clinical symptoms across multiple levels are still scarce and difficult to establish. We present a heuristic model of systemic neurotransmitter functionality that permits the assessment of genetic, biochemical, and pharmacological perturbations. The model can serve as a tool to represent clinical and biological observations and explore various scenarios associated with alcohol dependence and its treatments. It also is very well suited for educational purposes.	[Qi, Zhen; Voit, Eberhard O.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Qi, Zhen; Voit, Eberhard O.] Emory Univ, Sch Med, Atlanta, GA USA; [Qi, Zhen; Voit, Eberhard O.] Georgia Inst Technol, Integrat BioSyst Inst, Atlanta, GA 30332 USA; [Qi, Zhen] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA USA; [Tretter, Felix] Isar Amper Klinikum Gemeinnutzige GmbH, Klinikum Munchen Ost, Munich, Germany	University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University	Voit, EO (corresponding author), Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.	eberhard.voit@bme.gatech.edu		Tretter, Felix/0000-0002-1076-1220	National Institutes of Health [P01-ES016731]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from the National Institutes of Health (P01-ES016731, Gary W. Miller, PI) and an endowment from the Georgia Research Alliance (to EOV, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barik Jacques, 2009, Handb Exp Pharmacol, P173, DOI 10.1007/978-3-540-69248-5_7; Bender W, 2006, PHARMACOPSYCHIATRY, V39, pS4, DOI 10.1055/s-2006-931482; Bunin MA, 1998, J NEUROSCI, V18, P4854; CARBONI S, 1993, NEUROSCI LETT, V152, P133, DOI 10.1016/0304-3940(93)90501-B; Carlson RW, 2012, CRIT CARE CLIN, V28, P549, DOI 10.1016/j.ccc.2012.07.004; CHURCH WH, 1987, EUR J PHARMACOL, V139, P345, DOI 10.1016/0014-2999(87)90592-9; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Dahchour A, 1996, BRAIN RES, V735, P9; Dahchour A, 1998, PSYCHIAT RES-NEUROIM, V82, P107, DOI 10.1016/S0925-4927(98)00016-X; De Witte P, 2004, ADDICT BEHAV, V29, P1325, DOI 10.1016/j.addbeh.2004.06.020; Devaud LL, 1997, J NEUROCHEM, V69, P126; ELGUEBALY N, 1981, INT J ADDICT, V16, P1207, DOI 10.3109/10826088109039174; Ferguson JA, 1996, J GEN INTERN MED, V11, P410, DOI 10.1007/BF02600188; Fritze J, 1989, BIOL PSYCHIAT; GLUE P, 1990, BRIT J PSYCHIAT, V157, P491, DOI 10.1192/bjp.157.4.491; GOLDSTEIN DB, 1973, J PHARMACOL EXP THER, V186, P1; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Greene SL, 2008, EMERG MED AUSTRALAS, V20, P391, DOI 10.1111/j.1742-6723.2008.01114.x; GUINDON GE, 2003, 6 HNP WORLD BANK; Hutchinson PJ, 2002, J NEUROL NEUROSUR PS, V72, P99, DOI 10.1136/jnnp.72.1.99; KANTHAN R, 1995, STROKE, V26, P870, DOI 10.1161/01.STR.26.5.870; Kuczenski R, 1997, J NEUROCHEM, V68, P2032; LEIBOWITZ JO, 1967, BRIT J ADDICT, V62, P83; LIEBER CS, 1991, ALCOHOL CLIN EXP RES, V15, P573, DOI 10.1111/j.1530-0277.1991.tb00563.x; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Nirogi R, 2010, BIOMED CHROMATOGR, V24, P39, DOI 10.1002/bmc.1347; Noble D, 2011, PHARMACOPSYCHIATRY, V44, pS9, DOI 10.1055/s-0031-1271703; NUTT D, 1988, ALCOHOL CLIN EXP RES, V12, P14, DOI 10.1111/j.1530-0277.1988.tb00125.x; POMERLEAU OF, 1989, PSYCHONEUROENDOCRINO, V14, P407, DOI 10.1016/0306-4530(89)90040-1; Popa D, 2010, EUR J PHARMACOL, V628, P83, DOI 10.1016/j.ejphar.2009.11.037; Qi Z, 2013, PHARMACOPSYCHIATRY, V46, pS53, DOI 10.1055/s-0033-1337920; Qi Z, 2012, SYSTEMS BIOL PARKINS; Qi Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-26; Qi Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002444; ROSSETTI ZL, 1995, EUR J PHARMACOL, V283, P177, DOI 10.1016/0014-2999(95)00344-K; SANO H, 1992, ALCOHOL CLIN EXP RES, V16, P1047, DOI 10.1111/j.1530-0277.1992.tb00697.x; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Smith TD, 2000, SYNAPSE, V38, P460, DOI 10.1002/1098-2396(20001215)38:4<460::AID-SYN11>3.0.CO;2-D; Steinberg LL, 1998, SPINAL CORD, V36, P18, DOI 10.1038/sj.sc.3100516; Torres N., 2005, PATHWAY ANAL OPTIMIZ; Tretter F, 2004, EINFURHUNG PSYCHIOPH; Tsai GC, 1998, ANNU REV MED, V49, P173; Uutela P, 2005, RAPID COMMUN MASS SP, V19, P2950, DOI 10.1002/rcm.2160; Valenzuela CF, 1997, ALCOHOL HEALTH RES W, V21, P144; Victor M, 1953, RES PUBL ASSOC RES N, V32, P526; Voit EO, 2012, PHARMACOPSYCHIATRY, V45, pS22, DOI 10.1055/s-0032-1304653; Voit E. O., 2013, ISRN BIOMATH, V2013, P53, DOI [10.1155/2013/897658, DOI 10.1155/2013/897658]; Voit E. O., 2000, COMPUTATIONAL ANAL B; Voit EO, 2014, BBA-PROTEINS PROTEOM, V1844, P258, DOI 10.1016/j.bbapap.2013.03.023; Weiss F, 1996, J NEUROSCI, V16, P3474; Zhang XZ, 2007, RAPID COMMUN MASS SP, V21, P3621, DOI 10.1002/rcm.3251	53	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92221	10.1371/journal.pone.0092221	http://dx.doi.org/10.1371/journal.pone.0092221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658530	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300061
J	Yukawa, M; Akiyama, T; Franke, V; Mise, N; Isagawa, T; Suzuki, Y; Suzuki, MG; Vlahovicek, K; Abe, K; Aburatani, H; Aoki, F				Yukawa, Masashi; Akiyama, Tomohiko; Franke, Vedran; Mise, Nathan; Isagawa, Takayuki; Suzuki, Yutaka; Suzuki, Masataka G.; Vlahovicek, Kristian; Abe, Kuniya; Aburatani, Hiroyuki; Aoki, Fugaku			Genome-Wide Analysis of the Chromatin Composition of Histone H2A and H3 Variants in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							DNA METHYLATION; CPG ISLANDS; NUCLEOSOME DEPLETION; POLYCOMB COMPLEX; CORE PROMOTER; SELF-RENEWAL; TRANSCRIPTION; CTCF; HETEROCHROMATIN; PLURIPOTENT	Genome-wide distribution of the majority of H2A and H3 variants (H2A, H2AX, H2AZ, macroH2A, H3.1, H3.2 and H3.3) was simultaneously investigated in mouse embryonic stem cells by chromatin immunoprecipitation sequencing. Around the transcription start site, histone variant distribution differed between genes possessing promoters of high and low CpG density, regardless of their expression levels. In the intergenic regions, regulatory elements were enriched in H2A.Z and H3.3, whereas repeat elements were abundant in H2A and macroH2A, and H3.1, respectively. Analysis of H2A and H3 variant combinations composing nucleosomes revealed that the H2A.Z and H3.3 combinations were present at a higher frequency throughout the genome than the other combinations, suggesting that H2A. Z and H3.3 associate preferentially with each other to comprise the nucleosomes independently of genome region. Finally, we found that chromatin was unstable only in regions where it was enriched in both H2A.Z and H3.3, but strongly quantified stable in regions in which only H3.3 was abundant. Therefore, histone variant composition is an important determinant of chromatin structure, which is associated with specific genomic functions.	[Yukawa, Masashi; Akiyama, Tomohiko; Suzuki, Masataka G.; Aoki, Fugaku] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Franke, Vedran; Vlahovicek, Kristian] Univ Zagreb, Fac Sci, Div Biol, Bioinformat Grp, Zagreb 41000, Croatia; [Mise, Nathan; Abe, Kuniya] RIKEN, Bioresource Ctr, Tsukuba Inst, Mammalian Cellular Dynam Team, Tsukuba, Ibaraki, Japan; [Isagawa, Takayuki; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba, Japan	University of Tokyo; University of Zagreb; RIKEN; University of Tokyo; University of Tokyo	Aoki, F (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	aokif@k.u-tokyo.ac.jp	Vlahoviček, Kristian/D-9661-2011; 名丹, 三瀬/AAD-1036-2021; AOKI, FUGAKU/AAO-7617-2021	Vlahoviček, Kristian/0000-0002-5705-2464; Yukawa, Masashi/0000-0003-1798-2410; Franke, Vedran/0000-0003-3606-6792	Ministry of Education, Culture, Sports, Science and Technology of Japan [20062002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#20062002; URL: http://www.jsps.go.jp/english/index.html). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almouzni G, 2011, NUCLEUS-PHILA, V2, P332, DOI 10.4161/nucl.2.5.17707; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Chakravarthy S, 2005, MOL CELL BIOL, V25, P7616, DOI 10.1128/MCB.25.17.7616-7624.2005; Changolkar LN, 2010, MOL CELL BIOL, V30, P5473, DOI 10.1128/MCB.00518-10; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Collas P, 2009, BBA-GEN SUBJECTS, V1790, P900, DOI 10.1016/j.bbagen.2008.10.006; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dimitri P, 1997, GENETICA, V100, P85, DOI 10.1023/A:1018304922862; Dimitri P, 2009, CHROMOSOMA, V118, P419, DOI 10.1007/s00412-009-0211-y; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Huang C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003558; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jamai A, 2007, MOL CELL, V25, P345, DOI 10.1016/j.molcel.2007.01.019; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Lee BK, 2012, J BIOL CHEM, V287, P30906, DOI 10.1074/jbc.R111.324962; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Nashun B, 2010, DEVELOPMENT, V137, P3785, DOI 10.1242/dev.051805; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Seo J, 2012, NUCLEIC ACIDS RES, V40, P5965, DOI 10.1093/nar/gks287; Shechter D, 2009, P NATL ACAD SCI USA, V106, P749, DOI 10.1073/pnas.0812207106; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tolstorukov MY, 2012, MOL CELL, V47, P596, DOI 10.1016/j.molcel.2012.06.011; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Wang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042414; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; WEST MHP, 1980, BIOCHEMISTRY-US, V19, P3238, DOI 10.1021/bi00555a022; Wollmann H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002658; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	73	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92689	10.1371/journal.pone.0092689	http://dx.doi.org/10.1371/journal.pone.0092689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658136	Green Submitted, gold, Green Published			2022-12-25	WOS:000333355300114
J	Zhao, C; Wu, NN; Deng, F; Zhang, HM; Wang, N; Zhang, WW; Chen, X; Wen, S; Zhang, JH; Yin, LJ; Liao, Z; Zhang, ZL; Zhang, Q; Yan, ZJ; Liu, W; Wu, D; Ye, JX; Deng, YL; Zhou, GL; Luu, HH; Haydon, RC; Si, W; He, TC				Zhao, Chen; Wu, Ningning; Deng, Fang; Zhang, Hongmei; Wang, Ning; Zhang, Wenwen; Chen, Xian; Wen, Sheng; Zhang, Junhui; Yin, Liangjun; Liao, Zhan; Zhang, Zhonglin; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Wu, Di; Ye, Jixing; Deng, Youlin; Zhou, Guolin; Luu, Hue H.; Haydon, Rex C.; Si, Weike; He, Tong-Chuan			Adenovirus-Mediated Gene Transfer in Mesenchymal Stem Cells Can Be Significantly Enhanced by the Cationic Polymer Polybrene	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; BMP-9-INDUCED OSTEOGENIC DIFFERENTIATION; HEPATIC PROGENITOR CELLS; OSTEOBLAST DIFFERENTIATION; RECOMBINANT ADENOVIRUSES; TUMOR-GROWTH; IN-VITRO; DNA; TRANSDUCTION; EFFICIENCY	Mesenchymal stem cells (MSCs) are multipotent progenitors, which can undergo self-renewal and give rise to multi-lineages. A great deal of attentions have been paid to their potential use in regenerative medicine as potential therapeutic genes can be introduced into MSCs. Genetic manipulations in MSCs requires effective gene deliveries. Recombinant adenoviruses are widely used gene transfer vectors. We have found that although MSCs can be infected in vitro by adenoviruses, high virus titers are needed to achieve high efficiency. Here, we investigate if the commonly-used cationic polymer Polybrene can potentiate adenovirus-mediated transgene delivery into MSCs, such as C2C12 cells and iMEFs. Using the AdRFP adenovirus, we find that AdRFP transduction efficiency is significantly increased by Polybrene in a dose-dependent fashion peaking at 8 mu g/ml in C2C12 and iMEFs cells. Quantitative luciferase assay reveals that Polybrene significantly enhances AdFLuc-mediated luciferase activity in C2C12 and iMEFs at as low as 4 mu g/ml and 2 mu g/ml, respectively. FACS analysis indicates that Polybrene (at 4 mu g/ml) increases the percentage of RFP-positive cells by approximately 430 folds in AdRFP-transduced iMEFs, suggesting Polybrene may increase adenovirus infection efficiency. Furthermore, Polybrene can enhance AdBMP9-induced osteogenic differentiation of MSCs as early osteogenic marker alkaline phosphatase activity can be increased more than 73 folds by Polybrene (4 mg/ml) in AdBMP9-transduced iMEFs. No cytotoxicity was observed in C2C12 and iMEFs at Polybrene up to 40 mu g/ml, which is about 10-fold higher than the effective concentration required to enhance adenovirus transduction in MSCs. Taken together, our results demonstrate that Polybrene should be routinely used as a safe, effective and inexpensive augmenting agent for adenovirus-mediated gene transfer in MSCs, as well as other types of mammalian cells.	[Zhao, Chen; Deng, Fang; Wang, Ning; Si, Weike] Third Mil Med Univ, Affiliated Southwest Hosp, Dept Clin Hematol Cell Biol & Oncol, Chongqing, Peoples R China; [Zhao, Chen; Wu, Ningning; Deng, Fang; Zhang, Hongmei; Wang, Ning; Zhang, Wenwen; Chen, Xian; Wen, Sheng; Zhang, Junhui; Yin, Liangjun; Liao, Zhan; Zhang, Zhonglin; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Wu, Di; Ye, Jixing; Deng, Youlin; Zhou, Guolin; Luu, Hue H.; Haydon, Rex C.; Si, Weike; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Orthopaed Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Wu, Ningning; Wen, Sheng; Zhang, Qian; Liu, Wei; He, Tong-Chuan] Chongqing Med Univ, Childrens Hosp, Stem Cell Biol & Therapy Lab, Key Lab Pediat,Minist Educ, Chongqing, Peoples R China; [Zhang, Hongmei; Chen, Xian; Zhang, Junhui; Yin, Liangjun; Yan, Zhengjian; Deng, Youlin] Chongqing Med Univ, Key Lab Diagnost Med, Minist Educ, Chongqing, Peoples R China; [Zhang, Hongmei; Chen, Xian; Zhang, Junhui; Yin, Liangjun; Yan, Zhengjian; Deng, Youlin] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China; [Zhang, Wenwen] Bingzhou Med Univ, Affiliated Hosp, Dept Lab Med, Yantai, Peoples R China; [Liao, Zhan] Cent S Univ, Affiliated Xiang Ya Hosp, Dept Orthopaed Surg, Changsha, Peoples R China; [Zhang, Zhonglin] Wuhan Univ, Affiliated Zhongnan Hosp, Dept Surg, Wuhan 430072, Peoples R China; [Ye, Jixing] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China	Army Medical University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Central South University; Wuhan University; Chongqing University	Si, W (corresponding author), Third Mil Med Univ, Affiliated Southwest Hosp, Dept Clin Hematol Cell Biol & Oncol, Chongqing, Peoples R China.	weikesi2004@hotmail.com; tche@uchicago.edu		Yin, Liang-jun/0000-0002-9244-4965; Deng, Fang/0000-0002-7927-5394	National Institutes of Health; 973 Program of the Ministry of Science and Technology (MOST) of China [2011CB707906]; Natural Science Foundation of China [81370624]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 Program of the Ministry of Science and Technology (MOST) of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The reported work was supported in part by research grants from the National Institutes of Health (RCH, TCH and HHL), the 973 Program of the Ministry of Science and Technology (MOST) of China (#2011CB707906 to TCH), and the Natural Science Foundation of China (Grant# 81370624 to WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy SM, 1997, GENE THER, V4, P32, DOI 10.1038/sj.gt.3300349; Aubin Remy A., 1994, Molecular Biotechnology, V1, P29, DOI 10.1007/BF02821509; AUBIN RJ, 1988, SOMAT CELL MOLEC GEN, V14, P155, DOI 10.1007/BF01534401; Benihoud K, 1999, CURR OPIN BIOTECH, V10, P440, DOI 10.1016/S0958-1669(99)00007-5; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Breyer Benjamin, 2001, Current Gene Therapy, V1, P149, DOI 10.2174/1566523013348689; CHANEY WG, 1986, SOMAT CELL MOLEC GEN, V12, P237, DOI 10.1007/BF01570782; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; COELEN RJ, 1983, ARCH VIROL, V75, P307, DOI 10.1007/BF01314897; Crystal RG, 1999, CANCER CHEMOTH PHARM, V43, pS90, DOI 10.1007/s002800051105; Davis HE, 2002, BIOPHYS CHEM, V97, P159, DOI 10.1016/S0301-4622(02)00057-1; Davis HE, 2004, BIOPHYS J, V86, P1234, DOI 10.1016/S0006-3495(04)74197-1; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Doebis C, 2002, TRANSPL IMMUNOL, V9, P323, DOI 10.1016/S0966-3274(02)00034-5; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Gerard RD, 1997, CARDIOVASC RES, V35, P451, DOI 10.1016/S0008-6363(97)00134-X; He BC, 2011, MOL PHARMACOL, V79, P211, DOI 10.1124/mol.110.068668; He BC, 2011, INT J ONCOL, V38, P437, DOI 10.3892/ijo.2010.858; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; He T.-C., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P363; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 2004, ADENOVIRAL VECTORS C; Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231; Huang EY, 2012, J BONE MINER RES, V27, P1566, DOI 10.1002/jbmr.1622; Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; Jacobsen F, 2006, J GENE MED, V8, P138, DOI 10.1002/jgm.843; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Lamplot JD, 2013, AM J STEM CELLS, V2, P1; Landazuri N, 2007, BIOTECHNOL PROGR, V23, P480, DOI 10.1021/bp060336y; Liu H, 2003, CURR TOP MICROBIOL, V272, P131; Luo J, 2005, CURR GENE THER, V5, P167, DOI 10.2174/1566523053544218; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luther G, 2011, CURR GENE THER, V11, P229; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; MORGAN TL, 1986, IN VITRO CELL DEV B, V22, P317, DOI 10.1007/BF02623404; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Sambrook J., 2006, CSH PROTOC; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shenaq DS, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/519028; Shui W, 2013, J BIOMED MAT RES A; Shui W, 2014, J BIOMED MAT RES A; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; TOYOSHIMA K, 1969, VIROLOGY, V38, P414, DOI 10.1016/0042-6822(69)90154-8; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Wagner Eric R, 2011, Curr Mol Pharmacol, V4, P14; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073086; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhang WW, 2013, INT J MED SCI, V10, P1888, DOI 10.7150/ijms.6019	57	77	82	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92908	10.1371/journal.pone.0092908	http://dx.doi.org/10.1371/journal.pone.0092908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658746	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300144
J	Becker, A; Durante, M; Taucher-Scholz, G; Jakob, B				Becker, Annabelle; Durante, Marco; Taucher-Scholz, Gisela; Jakob, Burkhard			ATM Alters the Otherwise Robust Chromatin Mobility at Sites of DNA Double-Strand Breaks (DSBs) in Human Cells	PLOS ONE			English	Article							END-JOINING PATHWAY; MAMMALIAN-CELLS; HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; LIVING CELLS; H2AX PHOSPHORYLATION; POSITIONAL STABILITY; IONIZING-RADIATION; GENOME INTEGRITY; REPAIR	Ionizing radiation induces DNA double strand breaks (DSBs) which can lead to the formation of chromosome rearrangements through error prone repair. In mammalian cells the positional stability of chromatin contributes to the maintenance of genome integrity. DSBs exhibit only a small, submicron scale diffusive mobility, but a slight increase in the mobility of chromatin domains by the induction of DSBs might influence repair fidelity and the formation of translocations. The radiation-induced local DNA decondensation in the vicinity of DSBs is one factor potentially enhancing the mobility of DSB-containing chromatin domains. Therefore in this study we focus on the influence of different chromatin modifying proteins, known to be activated by the DNA damage response, on the mobility of DSBs. IRIF (ionizing radiation induced foci) in U2OS cells stably expressing 53BP1-GFP were used as a surrogate marker of DSBs. Low angle charged particle irradiation, known to trigger a pronounced DNA decondensation, was used for the defined induction of linear tracks of IRIF. Our results show that movement of IRIF is independent of the investigated chromatin modifying proteins like ACF1 or PARP1 and PARG. Also depletion of proteins that tether DNA strands like MRE11 and cohesin did not alter IRIF dynamics significantly. Inhibition of ATM, a key component of DNA damage response signaling, resulted in a pronounced confinement of DSB mobility, which might be attributed to a diminished radiation induced decondensation. This confinement following ATM inhibition was confirmed using X-rays, proving that this effect is not restricted to densely ionizing radiation. In conclusion, repair sites of DSBs exhibit a limited mobility on a small spatial scale that is mainly unaffected by depletion of single remodeling or DNA tethering proteins. However, it relies on functional ATM kinase which is considered to influence the chromatin structure after irradiation.	[Becker, Annabelle; Durante, Marco; Taucher-Scholz, Gisela; Jakob, Burkhard] GSI Darmstadt, Helmholtzzentrum Schwerionenforsch GmbH, Darmstadt, Germany; [Durante, Marco; Taucher-Scholz, Gisela] Tech Univ Darmstadt, Darmstadt, Germany	Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Technical University of Darmstadt	Jakob, B (corresponding author), GSI Darmstadt, Helmholtzzentrum Schwerionenforsch GmbH, Darmstadt, Germany.	b.jakob@gsi.de	Durante, Marco/L-4795-2017; Jakob, Burkhard/D-2047-2013; Durante, Marco/K-1315-2014	Durante, Marco/0000-0002-4615-553X; Jakob, Burkhard/0000-0003-2404-377X; Durante, Marco/0000-0002-4615-553X	DFG [GRK 1657]; Helmholtz graduate school for hadron and ion research	DFG(German Research Foundation (DFG)); Helmholtz graduate school for hadron and ion research	This work was supported by DFG funded GRK 1657 and the Helmholtz graduate school for hadron and ion research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bauerschmidt C, 2010, NUCLEIC ACIDS RES, V38, P477, DOI 10.1093/nar/gkp976; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bermudez VP, 2012, P NATL ACAD SCI USA, V109, P9366, DOI 10.1073/pnas.1206840109; BURKLE A, 1993, CARCINOGENESIS, V14, P559, DOI 10.1093/carcin/14.4.559; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dion V, 2013, EMBO REP, V14, P984, DOI 10.1038/embor.2013.142; Dion V, 2013, CELL, V152, P1355, DOI 10.1016/j.cell.2013.02.010; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Dorsett D, 2012, CURR BIOL, V22, pR240, DOI 10.1016/j.cub.2012.02.046; Falk M, 2007, BBA-MOL CELL RES, V1773, P1534, DOI 10.1016/j.bbamcr.2007.07.002; Falk M, 2010, MUTAT RES-REV MUTAT, V704, P88, DOI 10.1016/j.mrrev.2010.01.013; Fournier C, 2004, RADIAT RES, V161, P675, DOI 10.1667/RR3182; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Girst S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02511; Gontijo AMDC, 2003, BIOCHIMIE, V85, P1133, DOI 10.1016/j.biochi.2003.10.018; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2012, INT J MOL SCI, V13, P11844, DOI 10.3390/ijms130911844; Guigas G, 2007, FEBS LETT, V581, P5094, DOI 10.1016/j.febslet.2007.09.054; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Jakob B, 2006, NUCL INSTRUM METH B, V245, P292, DOI 10.1016/j.nimb.2005.11.117; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Jakob B, 2009, RADIAT RES, V171, P405, DOI 10.1667/RR1520.1; Jakob B, 2009, P NATL ACAD SCI USA, V106, P3172, DOI 10.1073/pnas.0810987106; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Jegou T, 2009, MOL BIOL CELL, V20, P2070, DOI 10.1091/mbc.E08-02-0108; Jezkova L, 2014, APPL RADIAT ISOTOPES, V83, P128; Kase Y, 2008, PHYS MED BIOL, V53, P37, DOI 10.1088/0031-9155/53/1/003; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Krawczyk PM, 2012, J CELL SCI, V125, P2127, DOI 10.1242/jcs.089847; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; Lee JH, 2013, J BIOL CHEM, V288, P12840, DOI 10.1074/jbc.M113.460378; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Meyer B, 2013, NUCLEIC ACIDS RES, V41, P6109, DOI 10.1093/nar/gkt304; Mine-Hattab J, 2013, TRENDS CELL BIOL, V23, P529, DOI 10.1016/j.tcb.2013.05.006; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Muller I, 2013, MUTAT RES-GEN TOX EN, V756, P30, DOI 10.1016/j.mrgentox.2013.04.006; Muller I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011560; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6; Platani M, 2002, NAT CELL BIOL, V4, P502, DOI 10.1038/ncb809; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Sanchez-Molina S, 2011, NUCLEIC ACIDS RES, V39, P8445, DOI 10.1093/nar/gkr435; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shi L, 2012, BBA-GENE REGUL MECH, V1819, P811, DOI 10.1016/j.bbagrm.2012.01.002; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sjogren C, 2010, EXP CELL RES, V316, P1445, DOI 10.1016/j.yexcr.2009.12.018; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Sulli G, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3344; Thomas C, 2013, MOL ASPECTS MED, V34, P1124, DOI 10.1016/j.mam.2013.04.001; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Tommasino F, 2013, RADIAT RES, V180, P524, DOI 10.1667/RR13389.1; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Wu N, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-5; Zha S, 2009, NAT STRUCT MOL BIOL, V16, P798, DOI 10.1038/nsmb0809-798	82	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92640	10.1371/journal.pone.0092640	http://dx.doi.org/10.1371/journal.pone.0092640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651490	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800137
J	Fujiwara, T; Kanazawa, S; Ichibori, R; Tanigawa, T; Magome, T; Shingaki, K; Miyata, S; Tohyama, M; Hosokawa, K				Fujiwara, Takashi; Kanazawa, Shigeyuki; Ichibori, Ryoko; Tanigawa, Tomoko; Magome, Takuya; Shingaki, Kenta; Miyata, Shingo; Tohyama, Masaya; Hosokawa, Ko			L-Arginine Stimulates Fibroblast Proliferation through the GPRC6A-ERK1/2 and PI3K/Akt Pathway	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAY; CELL-CYCLE PROGRESSION; NITRIC-OXIDE; GROWTH-FACTORS; AMINO-ACID; MIGRATION; IMMUNE; REGENERATION; SECRETION; APOPTOSIS	L-Arginine is considered a conditionally essential amino acid and has been shown to enhance wound healing. However, the molecular mechanisms through which arginine stimulates cutaneous wound repair remain unknown. Here, we evaluated the effects of arginine supplementation on fibroblast proliferation, which is a key process required for new tissue formation. We also sought to elucidate the signaling pathways involved in mediating the effects of arginine on fibroblasts by evaluation of extracellular signal-related kinase (ERK) 1/2 activation, which is important for cell growth, survival, and differentiation. Our data demonstrated that addition of 6 mM arginine significantly enhanced fibroblast proliferation, while arginine deprivation increased apoptosis, as observed by enhanced DNA fragmentation. In vitro kinase assays demonstrated that arginine supplementation activated ERK1/2, Akt, PKA and its downstream target, cAMP response element binding protein (CREB). Moreover, knockdown of GPRC6A using siRNA blocked fibroblast proliferation and decreased phosphorylation of ERK1/2, Akt and CREB. The present experiments demonstrated a critical role for the GPRC6A-ERK1/2 and PI3K/Akt signaling pathway in arginine-mediated fibroblast survival. Our findings provide novel mechanistic insights into the positive effects of arginine on wound healing.	[Fujiwara, Takashi; Kanazawa, Shigeyuki; Ichibori, Ryoko; Tanigawa, Tomoko; Hosokawa, Ko] Osaka Univ, Grad Sch Med, Dept Plast Surg, Suita, Osaka, Japan; [Magome, Takuya] Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Suita, Osaka, Japan; [Shingaki, Kenta] Noevir Co Ltd, Dept Res & Dev, Higashiomi, Shiga, Japan; [Miyata, Shingo; Tohyama, Masaya] Kinki Univ, Res Inst Tradit Asian Med, Div Mol Brain Sci, Osakasayama, Osaka, Japan	Osaka University; Osaka University; Kindai University (Kinki University)	Kanazawa, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Plast Surg, Suita, Osaka, Japan.	kanazawa@psurg.med.osaka-u.ac.jp						Angele MK, 1999, SURGERY, V126, P279, DOI 10.1067/msy.1999.98743; BARBUL A, 1990, SURGERY, V108, P331; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Chang FM, 2003, INT J ONCOL, V22, P469; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; COLLINS MKL, 1994, BIOESSAYS, V16, P133, DOI 10.1002/bies.950160210; DALY JM, 1988, ANN SURG, V208, P512, DOI 10.1097/00000658-198810000-00013; Du M, 1997, BIOCHEM MOL BIOL INT, V41, P625; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Jones SM, 2001, FEBS LETT, V490, P110, DOI 10.1016/S0014-5793(01)02113-5; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kim JY, 2011, BIOL REPROD, V84, P62, DOI 10.1095/biolreprod.110.085738; KIRK SJ, 1993, SURGERY, V114, P155; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; LANDER HM, 1993, J IMMUNOL, V151, P7182; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; Lovicu FJ, 2001, DEVELOPMENT, V128, P5075; Luiking YC, 2007, CRIT CARE MED, V35, pS557, DOI 10.1097/01.CCM.0000279191.44730.A2; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Oya M, 2013, J BIOL CHEM, V288, P4513, DOI 10.1074/jbc.M112.402677; Pi M, 2012, ENDOCRINOLOGY, V153, P4608, DOI 10.1210/en.2012-1301; Rhoads JM, 2006, AM J PHYSIOL-GASTR L, V291, pG510, DOI 10.1152/ajpgi.00189.2005; ROSE WC, 1949, FED PROC, V8, P546; Schaffer MR, 1996, J SURG RES, V63, P237, DOI 10.1006/jsre.1996.0254; Schaffer MR, 1997, J IMMUNOL, V158, P2375; SEIFTER E, 1978, SURGERY, V84, P224; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tan B, 2010, AMINO ACIDS, V38, P1227, DOI 10.1007/s00726-009-0334-8; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Yatabe J, 2011, J NUTR HEALTH AGING, V15, P282, DOI 10.1007/s12603-010-0306-4; Zheng J, 2006, BIOL REPROD, V74, P375, DOI 10.1095/biolreprod.105.043190; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	37	51	52	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92168	10.1371/journal.pone.0092168	http://dx.doi.org/10.1371/journal.pone.0092168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651445	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800076
J	Moreno-Santos, I; Pavon, FJ; Romero-Cuevas, M; Serrano, A; Cano, C; Suardiaz, M; Decara, J; Suarez, J; de Fonseca, FR; Macias-Gonzalez, M				Moreno-Santos, Inmaculada; Javier Pavon, Francisco; Romero-Cuevas, Miguel; Serrano, Antonia; Cano, Carolina; Suardiaz, Margarita; Decara, Juan; Suarez, Juan; Rodriguez de Fonseca, Fernando; Macias-Gonzalez, Manuel			Computational and Biological Evaluation of N-octadecyl-N '-propylsulfamide, a Selective PPAR alpha Agonist Structurally Related to N-acylethanolamines	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; BODY-WEIGHT; INVERSE-AGONIST; OLEOYLETHANOLAMIDE; SULFAMIDE; ANALOGS	To further understand the pharmacological properties of N-oleoylethanolamine (OEA), a naturally occurring lipid that activates peroxisome proliferator-activated receptor alpha (PPAR alpha), we designed sulfamoyl analogs based on its structure. Among the compounds tested, N-octadecyl-N'-propylsulfamide (CC7) was selected for functional comparison with OEA. The performed studies include the following computational and biological approaches: 1) molecular docking analyses; 2) molecular biology studies with PPAR alpha; 3) pharmacological studies on feeding behavior and visceral analgesia. For the docking studies, we compared OEA and CC7 data with crystallization data obtained with the reference PPAR alpha agonist GW409544. OEA and CC7 interacted with the ligand-binding domain of PPAR alpha in a similar manner to GW409544. Both compounds produced similar transcriptional activation by in vitro assays, including the GST pull-down assay and reporter gene analysis. In addition, CC7 and OEA induced the mRNA expression of CPT1a in HpeG2 cells through PPARa and the induction was avoided with PPAR alpha-specific siRNA. In vivo studies in rats showed that OEA and CC7 had anorectic and antiobesity activity and induced both lipopenia and decreases in hepatic fat content. However, different effects were observed when measuring visceral pain; OEA produced visceral analgesia whereas CC7 showed no effects. These results suggest that OEA activity on the PPARa receptor (e. g., lipid metabolism and feeding behavior) may be dissociated from other actions at alternative targets (e. g., pain) because other non cannabimimetic ligands that interact with PPARa, such as CC7, do not reproduce the full spectrum of the pharmacological activity of OEA. These results provide new opportunities for the development of specific PPAR alpha-activating drugs focused on sulfamide derivatives with a long alkyl chain for the treatment of metabolic dysfunction.	[Moreno-Santos, Inmaculada; Macias-Gonzalez, Manuel] Hosp Univ Virgen Victoria, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Endocrinol & Nutr, Malaga, Spain; [Moreno-Santos, Inmaculada; Javier Pavon, Francisco; Serrano, Antonia; Suarez, Juan; Rodriguez de Fonseca, Fernando; Macias-Gonzalez, Manuel] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, CIBERobn, CB06 03, Santiago De Compostela, Spain; [Javier Pavon, Francisco; Romero-Cuevas, Miguel; Serrano, Antonia; Suardiaz, Margarita; Decara, Juan; Suarez, Juan; Rodriguez de Fonseca, Fernando] Hosp Reg Univ Malaga, Inst IBIMA, Unidad Gest Clin Salud Mental, Malaga, Spain; [Cano, Carolina] CSIC, Ctr Quim Organ Manuel Lora Tamayo, Inst Quim Med, Grp Moduladores Receptores Cannabinoides & PPARs, Madrid, Spain	Hospital Virgen de la Victoria; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); Organic Chemistry Centre Lora-Tamayo (CENQUIOR)	de Fonseca, FR (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, CIBERobn, CB06 03, Santiago De Compostela, Spain.	fernando.rodriguez@fundacionimabis.org; mmacias.manuel@gmail.com	Romero-Cuevas, Miguel/M-3461-2016; Pavón Morón, Francisco Javier/AAG-9721-2020; Suarez, Juan/I-5188-2015; Decara Del Olmo, Juan Manuel/I-1931-2015; MACIAS-GONZALEZ, MANUEL/E-7584-2016	Romero-Cuevas, Miguel/0000-0002-8323-0893; Pavón Morón, Francisco Javier/0000-0002-5256-8904; Suarez, Juan/0000-0001-5254-9802; Serrano, Antonia/0000-0002-8017-9754; Decara Del Olmo, Juan Manuel/0000-0002-9868-015X; MACIAS-GONZALEZ, MANUEL/0000-0002-6475-4704	Research Stabilization Program of the Instituto de Salud Carlos III [CES 10/004]; European Union [Health-F2-2008-223713]; Spanish Ministry of Science and Innovation [SAF2010-20521]; Ministry of Economy and Competitivity [CP12/03109]; Instituto de Salud 'Carlos III' [PI07/0953, PI11/01661]; Red de Trastornos Adictivos EU-ERDF [RD06/0001/0000, RD12/0028/0001]; CIBERobn EU-ERDF [CB06/03/1008]; Andalusian Ministry of Economy, Innovation, Science; Employment EU-ERDF [CTS-8221, CTS-433]; Fundacio La Marato de TV3	Research Stabilization Program of the Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy and Competitivity; Instituto de Salud 'Carlos III'(Instituto de Salud Carlos IIIEuropean Commission); Red de Trastornos Adictivos EU-ERDF; CIBERobn EU-ERDF; Andalusian Ministry of Economy, Innovation, Science; Employment EU-ERDF; Fundacio La Marato de TV3	MM-G was supported by the Research Stabilization Program of the Instituto de Salud Carlos III (CES 10/004). The present work has been supported by the European Union's 7th Framework Programme (Health-F2-2008-223713, Reprobesity), the Spanish Ministry of Science and Innovation (SAF2010-20521), Ministry of Economy and Competitivity (CP12/03109), Instituto de Salud 'Carlos III' (PI07/0953 and PI11/01661), Red de Trastornos Adictivos EU-ERDF (RD06/0001/0000, RD12/0028/0001), CIBERobn EU-ERDF (CB06/03/1008), the Andalusian Ministry of Economy, Innovation, Science and Employment EU-ERDF (CTS-8221 and CTS-433), and Fundacio La Marato de TV3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2003, J BIOL CHEM, V278, P30429, DOI 10.1074/jbc.M305051200; Ali HI, 2008, EUR J MED CHEM, V43, P1376, DOI 10.1016/j.ejmech.2007.10.011; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cano C, 2007, J MED CHEM, V50, P389, DOI 10.1021/jm0601102; Leite LFCD, 2007, EUR J MED CHEM, V42, P1263, DOI 10.1016/j.ejmech.2007.02.015; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Gomez R, 2002, J NEUROSCI, V22, P9612; Gonzalez MM, 2003, MOL ENDOCRINOL, V17, P2028, DOI 10.1210/me.2003-0072; Gonzalez MM, 2002, J BIOL CHEM, V277, P18501, DOI 10.1074/jbc.M200205200; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Kostadinova R, 2005, CURR MED CHEM, V12, P2995, DOI 10.2174/092986705774462905; Lempiainen H, 2005, MOL ENDOCRINOL, V19, P2258, DOI 10.1210/me.2004-0534; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Decara JM, 2012, DIS MODEL MECH, V5, P660, DOI 10.1242/dmm.009233; MARCUS SL, 1993, P NATL ACAD SCI USA, V90, P5723, DOI 10.1073/pnas.90.12.5723; Molnar F, 2005, J BIOL CHEM, V280, P26543, DOI 10.1074/jbc.M502463200; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Nagasawa M, 2007, BIOCHEM PHARMACOL, V74, P1738, DOI 10.1016/j.bcp.2007.08.020; ONATE SA, 1995, SCIENCE, V270, P1354; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Pavon FJ, 2010, DRUG DISCOV TODAY DI, V7, pe175; Reyes-Cabello C, 2012, PHARMACOL BIOCHEM BE, V101, P1, DOI 10.1016/j.pbb.2011.11.011; Serrano A, 2008, OBES METAB-MILAN, V4, P76; Serrano A, 2008, NEUROPHARMACOLOGY, V54, P226, DOI 10.1016/j.neuropharm.2007.03.007; Singh JP, 2005, MOL PHARMACOL, V68, P763, DOI 10.1124/mol.105.010991; Staels B, 2008, NAT CLIN PRACT CARD, V5, P542, DOI 10.1038/ncpcardio1278; Suardiaz M, 2007, PAIN, V133, P99, DOI 10.1016/j.pain.2007.03.008; Thabuis C, 2008, LIPIDS, V43, P887, DOI 10.1007/s11745-008-3217-y; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Yu ST, 2007, BBA-MOL CELL BIOL L, V1771, P936, DOI 10.1016/j.bbalip.2007.01.008; Yu ST, 2003, CURR MOL MED, V3, P561, DOI 10.2174/1566524033479537	34	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92195	10.1371/journal.pone.0092195	http://dx.doi.org/10.1371/journal.pone.0092195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651609	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800082
J	Wizert, A; Iskander, DR; Cwiklik, L				Wizert, Alicja; Iskander, D. Robert; Cwiklik, Lukasz			Organization of Lipids in the Tear Film: A Molecular-Level View	PLOS ONE			English	Article							COARSE-GRAINED MODEL; DRY EYE DISEASE; MEIBOMIAN GLAND; LAYER; DYNAMICS; SURFACE; DYSFUNCTION; EVAPORATION; PREVALENCE; CURVATURE	Biophysical properties of the tear film lipid layer are studied at the molecular level employing coarse grain molecular dynamics (MD) simulations with a realistic model of the human tear film. In this model, polar lipids are chosen to reflect the current knowledge on the lipidome of the tear film whereas typical Meibomian-origin lipids are included in the thick non-polar lipids subphase. Simulation conditions mimic those experienced by the real human tear film during blinks. Namely, thermodynamic equilibrium simulations at different lateral compressions are performed to model varying surface pressure, and the dynamics of the system during a blink is studied by non-equilibrium MD simulations. Polar lipids separate their non-polar counterparts from water by forming a monomolecular layer whereas the non-polar molecules establish a thick outermost lipid layer. Under lateral compression, the polar layer undulates and a sorting of polar lipids occurs. Moreover, formation of three-dimensional aggregates of polar lipids in both non-polar and water subphases is observed. We suggest that these three-dimensional structures are abundant under dynamic conditions caused by the action of eye lids and that they act as reservoirs of polar lipids, thus increasing stability of the tear film.	[Wizert, Alicja; Iskander, D. Robert] Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland; [Cwiklik, Lukasz] Acad Sci Czech Republ, J Heyrovsky Inst Phys Chem, Vvi, Prague, Czech Republic; [Cwiklik, Lukasz] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Prague, Czech Republic; [Cwiklik, Lukasz] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland	Wroclaw University of Science & Technology; Czech Academy of Sciences; J. Heyrovsky Institute of Physical Chemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Tampere University	Cwiklik, L (corresponding author), Acad Sci Czech Republ, J Heyrovsky Inst Phys Chem, Vvi, Prague, Czech Republic.	lukasz.cwiklik@jh-inst.cas.cz	Cwiklik, Lukasz/A-7206-2008; Iskander, D Robert/E-3576-2017	Cwiklik, Lukasz/0000-0002-2083-8738; Iskander, D Robert/0000-0002-5962-6206				Baoukina S, 2008, P NATL ACAD SCI USA, V105, P10803, DOI 10.1073/pnas.0711563105; Begley CG, 2000, OPTOMETRY VISION SCI, V77, P40, DOI 10.1097/00006324-200001000-00012; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Borchman D, 2007, BIOPOLYMERS, V87, P124, DOI 10.1002/bip.20798; Borchman D, 2007, CHEM PHYS LIPIDS, V147, P87, DOI 10.1016/j.chemphyslip.2007.04.001; Borchman D, 2013, LIPIDS, V48, P1269, DOI 10.1007/s11745-013-3844-9; Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; Bron AJ, 2007, OCUL SURF, V5, P108; Butovich IA, 2008, INVEST OPHTH VIS SCI, V49, P3779, DOI 10.1167/iovs.08-1889; Craig JP, 1997, OPTOMETRY VISION SCI, V74, P8, DOI 10.1097/00006324-199701000-00014; Dartt DA, 2011, OCUL SURF, V9, P126, DOI 10.1016/S1542-0124(11)70022-2; Doane M. G., 1980, BER DTSCH OPHTHALMOL, V77, P13; Doughty MJ, 2002, OPTOMETRY VISION SCI, V79, P439, DOI 10.1097/00006324-200207000-00013; Du Toit R, 2001, OPTOMETRY VISION SCI, V78, P455, DOI 10.1097/00006324-200106000-00020; Fonn D, 1999, OPTOMETRY VISION SCI, V76, P700, DOI 10.1097/00006324-199910000-00021; Glasgow BJ, 2010, INVEST OPHTH VIS SCI, V51, P1981, DOI 10.1167/iovs.09-4622; Glasgow BJ, 1999, INVEST OPHTH VIS SCI, V40, P3100; Goto E, 2003, ARCH OPHTHALMOL-CHIC, V121, P173; Guo W, 1996, BIOPHYS J, V71, P2857, DOI 10.1016/S0006-3495(96)79482-1; HAMILTON JA, 1977, J BIOL CHEM, V252, P8071; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOLLY FJ, 1985, T OPHTHAL SOC UK, V104, P374; HOLLY FJ, 1973, EXP EYE RES, V15, P515, DOI 10.1016/0014-4835(73)90064-X; Hu MY, 2012, BIOPHYS J, V102, P1403, DOI 10.1016/j.bpj.2012.02.013; JESTER JV, 1981, INVEST OPHTH VIS SCI, V20, P537; Kamal MM, 2009, P NATL ACAD SCI USA, V106, P22245, DOI 10.1073/pnas.0907354106; KARABORNI S, 1994, MOL PHYS, V83, P345, DOI 10.1080/00268979400101301; Khanal S, 2010, NANOMED-NANOTECHNOL, V6, P707, DOI 10.1016/j.nano.2010.06.002; King-Smith PE, 2008, OPTOMETRY VISION SCI, V85, P623, DOI 10.1097/OPX.0b013e318181ae60; King-Smith PE, 2013, OCUL SURF, V11, P236, DOI 10.1016/j.jtos.2013.05.003; King-Smith PE, 2009, INVEST OPHTH VIS SCI, V50, P2747, DOI 10.1167/iovs.08-2459; Korb DR, 1996, OPTOMETRY VISION SCI, V73, P189, DOI 10.1097/00006324-199603000-00011; Kulovesi P, 2012, SOFT MATTER, V8, P5826, DOI 10.1039/c2sm25210d; Kulovesi P, 2010, BIOPHYS J, V99, P2559, DOI 10.1016/j.bpj.2010.08.001; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; McCulley James P, 2003, Ocul Surf, V1, P97; Millar TJ, 2013, CURR EYE RES, V38, P220, DOI 10.3109/02713683.2012.721045; Nagyova B, 1999, CURR EYE RES, V19, P4, DOI 10.1076/ceyr.19.1.4.5341; NICOLAIDES N, 1989, INVEST OPHTH VIS SCI, V30, P946; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Perera MN, 2012, BIOCHEM J, V445, P81, DOI 10.1042/BJ20112103; Rantamaki A, 2011, PROG RETIN EYE RES, V30, P204, DOI 10.1016/j.preteyeres.2011.02.002; Rantamaki AH, 2012, INVEST OPHTH VIS SCI, V53, P6442, DOI 10.1167/iovs.12-10487; Rantamaki AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019553; Rolando M, 2001, SURV OPHTHALMOL, V45, pS203, DOI 10.1016/S0039-6257(00)00203-4; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Shaw AJ, 2009, CORNEA, V28, P181, DOI 10.1097/ICO.0b013e31818a7d61; Shine WE, 1998, ARCH OPHTHALMOL-CHIC, V116, P849, DOI 10.1001/archopht.116.7.849; SMABY JM, 1978, J LIPID RES, V19, P325; Svitova TF, 2010, OPTOMETRY VISION SCI, V87, P10, DOI 10.1097/OPX.0b013e3181c07908; Szczesna DH, 2010, OPTOMETRY VISION SCI, V87, P513, DOI 10.1097/OPX.0b013e3181e17279; Szczesna-Iskander DH, 2012, OPTOMETRY VISION SCI, V89, P749, DOI 10.1097/OPX.0b013e318250192d; Telenius J, 2012, LANGMUIR, V28, P17092, DOI 10.1021/la304366d; Tomlinson A, 2005, OCUL SURF, V3, P81, DOI 10.1016/S1542-0124(12)70157-X; Tragoulias ST, 2005, CORNEA, V24, P189, DOI 10.1097/01.ico.0000138837.52694.37; Tutt R, 2000, INVEST OPHTH VIS SCI, V41, P4117; Vuorela T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000964; WOLLENSAK G, 1990, GRAEF ARCH CLIN EXP, V228, P78, DOI 10.1007/BF02764296	61	32	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92461	10.1371/journal.pone.0092461	http://dx.doi.org/10.1371/journal.pone.0092461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651175	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800111
J	Zhao, X; Yu, Q; Huang, L; Liu, QX				Zhao, Xiao; Yu, Qi; Huang, Ling; Liu, Qing-Xin			Patterns of Positive Selection of the Myogenic Regulatory Factor Gene Family in Vertebrates	PLOS ONE			English	Article							MYOD-FAMILY; PHYLOGENETIC ANALYSIS; MUSCLE DEVELOPMENT; BHLH GENE; EVOLUTION; EXPRESSION; DUPLICATIONS; DIVERGENCE; PROTEINS; ORIGIN	The functional divergence of transcriptional factors is critical in the evolution of transcriptional regulation. However, the mechanism of functional divergence among these factors remains unclear. Here, we performed an evolutionary analysis for positive selection in members of the myogenic regulatory factor (MRF) gene family of vertebrates. We selected 153 complete vertebrate MRF nucleotide sequences from our analyses, which revealed substantial evidence of positive selection. Here, we show that sites under positive selection were more frequently detected and identified from the genes encoding the myogenic differentiation factors (MyoG and Myf6) than the genes encoding myogenic determination factors (Myf5 and MyoD). Additionally, the functional divergence within the myogenic determination factors or differentiation factors was also under positive selection pressure. The positive selection sites were more frequently detected from MyoG and MyoD than Myf6 and Myf5, respectively. Amino acid residues under positive selection were identified mainly in their transcription activation domains and on the surface of protein three-dimensional structures. These data suggest that the functional gain and divergence of myogenic regulatory factors were driven by distinct positive selection of their transcription activation domains, whereas the function of the DNA binding domains was conserved in evolution. Our study evaluated the mechanism of functional divergence of the transcriptional regulation factors within a family, whereby the functions of their transcription activation domains diverged under positive selection during evolution.	[Zhao, Xiao; Yu, Qi; Huang, Ling; Liu, Qing-Xin] Shandong Agr Univ, Lab Dev Genet, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Liu, QX (corresponding author), Shandong Agr Univ, Lab Dev Genet, Tai An, Shandong, Peoples R China.	liuqingxin@sdau.edu.cn	yu, qi/Q-5819-2018	yu, qi/0000-0003-2605-5328	National Basic Research Program of China [2012CB114600]; National Natural Science Foundation of China [31240037, 31301951]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2012CB114600) and National Natural Science Foundation of China (31240037, 31301951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki I, 1996, GENE, V171, P231, DOI 10.1016/0378-1119(96)00174-6; ATCHLEY WR, 1994, P NATL ACAD SCI USA, V91, P11522, DOI 10.1073/pnas.91.24.11522; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Clark NL, 2005, PLOS GENET, V1, P335, DOI 10.1371/journal.pgen.0010035; Della Gaspera B, 2012, DEV DYNAM, V241, P995, DOI 10.1002/dvdy.23780; Fujisawa-Sehara A, 2000, Tanpakushitsu Kakusan Koso, V45, P2228; Goodsell David S, 2005, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0504s11; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; HOLLAND PWH, 1994, DEVELOPMENT, P125; Innocenzi A, 2011, EMBO REP, V12, P164, DOI 10.1038/embor.2010.195; Jin W, 2012, MOL BIOL EVOL, V29, P3161, DOI 10.1093/molbev/mss123; Kablar B, 1998, BIOCHEM CELL BIOL, V76, P1079, DOI 10.1139/bcb-76-6-1079; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOUMANS JTM, 1995, COMP BIOCHEM PHYS A, V110, P3, DOI 10.1016/0300-9629(94)00150-R; KRAUSE M, 1990, CELL, V63, P907, DOI 10.1016/0092-8674(90)90494-Y; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Meedel TH, 2002, DEV BIOL, V241, P238, DOI 10.1006/dbio.2001.0511; Meedel TH, 1997, DEVELOPMENT, V124, P1711; Meedel TH, 2007, DEV BIOL, V302, P333, DOI 10.1016/j.ydbio.2006.09.043; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; MICHELSON AM, 1990, GENE DEV, V4, P2086, DOI 10.1101/gad.4.12a.2086; Mok GF, 2011, REPRODUCTION, V141, P301, DOI 10.1530/REP-10-0394; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Rescan PY, 2001, COMP BIOCHEM PHYS B, V130, P1, DOI 10.1016/S1096-4959(01)00412-2; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schubert M, 2003, GENE EXPR PATTERNS, V3, P199, DOI 10.1016/S1567-133X(02)00099-6; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urano A, 2003, EVOL DEV, V5, P447, DOI 10.1046/j.1525-142X.2003.03051.x; VENUTI JM, 1991, P NATL ACAD SCI USA, V88, P6219, DOI 10.1073/pnas.88.14.6219; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokoyama S, 2011, CELL MOL LIFE SCI, V68, P1843, DOI 10.1007/s00018-011-0629-2; Yuan JD, 2003, BIOCHEM BIOPH RES CO, V301, P960, DOI 10.1016/S0006-291X(03)00081-0; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]	48	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92873	10.1371/journal.pone.0092873	http://dx.doi.org/10.1371/journal.pone.0092873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651579	gold, Green Submitted, Green Published			2022-12-25	WOS:000333352800161
J	Mogami, H; Keller, PW; Shi, HL; Word, RA				Mogami, Haruta; Keller, Patrick W.; Shi, Haolin; Word, R. Ann			Effect of Thrombin on Human Amnion Mesenchymal Cells, Mouse Fetal Membranes, and Preterm Birth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclooxygenase (COX) Pathway; Fibronectin; Matrix Metalloproteinase (MMP); Prostaglandins; Thrombin; Amnion; Decidua; Fetal Membrane; Protease-activated Receptor-1	PREMATURE RUPTURE; MECHANISMS; EXPRESSION; MICE; MATRIX-METALLOPROTEINASE-9; TRIMESTER; PREGNANCY; ENDOTOXIN; REMOVAL; LABOR	Background: Bleeding during pregnancy is a risk factor for premature rupture of the fetal membranes. Results: Thrombin causes preterm birth in mice and activates PAR-1 and TLR4 to increase MMPs and COX-2. Conclusion: Thrombin acts through multiple mechanisms to increase MMPs and PGE(2) in amnion. Significance: Thrombin plays a pivotal role in the pathogenesis of preterm labor and rupture of the membranes. Here, we investigated the effects of thrombin on matrix metalloproteinases (MMPs) and prostaglandin (PG) synthesis in fetal membranes. Thrombin activity was increased in human amnion from preterm deliveries. Treatment of mesenchymal, but not epithelial, cells with thrombin resulted in increased MMP-1 and MMP-9 mRNA and enzymatic activity. Thrombin also increased COX2 mRNA and PGE(2) in these cells. Protease-activated receptor-1 (PAR-1) was localized to amnion mesenchymal and decidual cells. PAR-1-specific inhibitors and activating peptides indicated that thrombin-induced up-regulation of MMP-9 was mediated via PAR-1. In contrast, thrombin-induced up-regulation of MMP-1 and COX-2 was mediated through Toll-like receptor-4, possibly through thrombin-induced release of soluble fetal fibronectin. In vivo, thrombin-injected pregnant mice delivered preterm. Mmp8, Mmp9, and Mmp13, and PGE(2) content was increased significantly in fetal membranes from thrombin-injected animals. These results indicate that thrombin acts through multiple mechanisms to activate MMPs and PGE2 synthesis in amnion.	[Mogami, Haruta; Keller, Patrick W.; Shi, Haolin; Word, R. Ann] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Word, RA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Div Reprod Endocrinol & Urogynecol, Cecil H & Ida Green Ctr Reprod Biol Sci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ruth.word@utsouthwestern.edu			National Institutes of Health [HD11149]; SUMITOMO Life Social Welfare Service Foundation; Human Tissue and Biologic Fluid Core Laboratory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD011149] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD011149] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25861488, 24119004] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SUMITOMO Life Social Welfare Service Foundation; Human Tissue and Biologic Fluid Core Laboratory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant HD11149. This work was also supported by a fellowship from SUMITOMO Life Social Welfare Service Foundation and the Human Tissue and Biologic Fluid Core Laboratory.	ADAM O, 1995, ANAL BIOCHEM, V225, P321, DOI 10.1006/abio.1995.1161; Athayde N, 1998, AM J OBSTET GYNECOL, V179, P1248, DOI 10.1016/S0002-9378(98)70141-3; Balbin M, 1998, J BIOL CHEM, V273, P23959, DOI 10.1074/jbc.273.37.23959; Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; BRAVERMAN MB, 1984, J CLIN ENDOCR METAB, V58, P521, DOI 10.1210/jcem-58-3-521; Casey ML, 1996, BIOL REPROD, V55, P1253, DOI 10.1095/biolreprod55.6.1253; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V11, P368, DOI 10.1080/713605566; Challis JRG, 2002, REPRODUCTION, V124, P1; DRAPER D, 1995, AM J OBSTET GYNECOL, V173, P1506, DOI 10.1016/0002-9378(95)90640-1; DUCHESNE MJ, 1978, PROSTAG OTH LIPID M, V15, P19, DOI 10.1016/S0090-6980(78)80003-3; Economopoulos P, 1996, MOL CELL ENDOCRINOL, V117, P141, DOI 10.1016/0303-7207(95)03739-X; Elovitz MA, 2000, AM J OBSTET GYNECOL, V183, P799, DOI 10.1067/mob.2000.108897; Erez O, 2009, J MATERN-FETAL NEO M, V22, P971, DOI 10.3109/14767050902994762; FUNDERBURK SJ, 1980, BRIT J OBSTET GYNAEC, V87, P100, DOI 10.1111/j.1471-0528.1980.tb04500.x; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; ISSEKUTZ AC, 1983, J IMMUNOL METHODS, V61, P275, DOI 10.1016/0022-1759(83)90221-1; Kumar D, 2011, PLACENTA, V32, P206, DOI 10.1016/j.placenta.2011.01.006; LOCKWOOD CJ, 1994, ANN NY ACAD SCI, V734, P57, DOI 10.1111/j.1749-6632.1994.tb21736.x; Mackenzie AP, 2004, AM J OBSTET GYNECOL, V191, P1996, DOI 10.1016/j.ajog.2004.08.003; Maymon E, 2000, AM J OBSTET GYNECOL, V183, P914, DOI 10.1067/mob.2000.108879; Mogami H, 2013, J BIOL CHEM, V288, P1953, DOI 10.1074/jbc.M112.424366; Moore RM, 2010, PLACENTA, V31, P886, DOI 10.1016/j.placenta.2010.07.012; Nagy S, 2003, OBSTET GYNECOL, V102, P94, DOI 10.1016/S0029-7844(03)00403-4; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Puthiyachirakkal M, 2013, PLACENTA, V34, P924, DOI 10.1016/j.placenta.2013.07.064; Rahn DD, 2009, AM J PATHOL, V174, P206, DOI 10.2353/ajpath.2009.080212; Rosen T, 2001, J Matern Fetal Med, V10, P297, DOI 10.1080/714904361; Rosen T, 2002, J Matern Fetal Neonatal Med, V11, P11, DOI 10.1080/713605444; Signore CC, 1998, AM J OBSTET GYNECOL, V178, P336, DOI 10.1016/S0002-9378(98)80022-7; Stephenson CD, 2005, J MATERN-FETAL NEO M, V18, P17, DOI 10.1080/14767050500123632; VADILLOORTEGA F, 1995, AM J PATHOL, V146, P148; Wieslander CK, 2008, BIOL REPROD, V78, P521, DOI 10.1095/biolreprod.107.063024; Wu NJ, 2003, J INVEST DERMATOL, V121, P926, DOI 10.1046/j.1523-1747.2003.12497.x	34	26	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13295	13307		10.1074/jbc.M114.550541	http://dx.doi.org/10.1074/jbc.M114.550541			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652285	Green Published, hybrid			2022-12-25	WOS:000335522800029
J	Sheng, JH; Luo, C; Jiang, YX; Hinds, PW; Xu, ZP; Hu, GF				Sheng, Jinghao; Luo, Chi; Jiang, Yuxiang; Hinds, Philip W.; Xu, Zhengping; Hu, Guo-fu			Transcription of Angiogenin and Ribonuclease 4 Is Regulated by RNA Polymerase III Elements and a CCCTC Binding Factor ( CTCF)-dependent Intragenic Chromatin Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Promoters; Ribonuclease; RNA Polymerase; Transcription; Angiogenin; Rinonuclease 4	AMYOTROPHIC-LATERAL-SCLEROSIS; TISSUE-SPECIFIC EXPRESSION; GENOME-WIDE; CELL-PROLIFERATION; PROSTATE-CANCER; POL II; CTCF; STRESS; GENES; SURVIVAL	Background: Angiogenin and ribonuclease 4 share genetic regions with promoter activities, and both have growth and survival activity. Results: RNA polymerase III elements and CTCF-dependent intragenic chromatin loop regulate the transcription. Conclusion: Multiple layers of transcription regulation of this gene locus encode two functionally similar but distinctive proteins. Significance: Elucidating how angiogenin and ribonuclease 4 are differentially transcribed help understand their biological activities. Angiogenin (ANG) and ribonuclease 4 (RNASE4), two members of the secreted and vertebrate-specific ribonuclease superfamily, play important roles in cancers and neurodegenerative diseases. The ANG and RNASE4 genes share genetic regions with promoter activities, but the structure and regulation of these putative promotes are unknown. We have characterized the promoter regions, defined the transcription start site, and identified a mechanism of transcription regulation that involves both RNA polymerase III (Pol III) elements and CCCTC binding factor (CTCF) sites. We found that two Pol III elements within the promoter region influence ANG and RNASE4 expression in a position- and orientation-dependent manner. We also provide evidence for the presence of an intragenic chromatin loop between the two CTCF binding sites located in two introns flanking the ANG coding exon. We found that formation of this intragenic loop preferentially enhances ANG transcription. These results suggest a multilayer transcriptional regulation of ANG and RNASE4 gene locus. These data also add more direct evidence to the notion that Pol III elements are able to directly influence Pol II gene transcription. Furthermore, our data indicate that a CTCF-dependent chromatin loop is able to differentially regulate transcription of genes that share the same promoters.	[Sheng, Jinghao; Luo, Chi; Jiang, Yuxiang; Hinds, Philip W.; Hu, Guo-fu] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Sheng, Jinghao; Xu, Zhengping] Zhejiang Univ, Sch Med, Inst Environm Med, Hangzhou 310058, Zhejiang, Peoples R China	Tufts Medical Center; Zhejiang University	Xu, ZP (corresponding author), Zhejiang Univ, Sch Med, Inst Environm Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	zpxu@zju.edu.cn; ghu@tuftsmedicalcenter.org		LUO, CHI/0000-0001-7669-9506	National Institutes of Health [R01CA105241, R01NS065237]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA105241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA105241 and R01NS065237 (to G.-f. H.). This work was also supported by the China Scholarship Council (to J. S.).	Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; berg U W., 2011, PLOS ONE, V6; Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dyer KD, 2005, NUCLEIC ACIDS RES, V33, P1077, DOI 10.1093/nar/gki250; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fay A, 2011, CURR BIOL, V21, P1624, DOI 10.1016/j.cub.2011.08.036; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Ibaragi S, 2009, CLIN CANCER RES, V15, P1981, DOI 10.1158/1078-0432.CCR-08-2593; Ibaragi S, 2009, MOL CANCER RES, V7, P415, DOI 10.1158/1541-7786.MCR-08-0137; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katona TM, 2005, CLIN CANCER RES, V11, P8358, DOI 10.1158/1078-0432.CCR-05-0962; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim YN, 2012, PROG NEURO-PSYCHOPH, V38, P116, DOI 10.1016/j.pnpbp.2012.02.010; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; Lee BK, 2012, GENOME RES, V22, P9, DOI 10.1101/gr.127597.111; Li SP, 2013, ANGIOGENESIS, V16, P387, DOI 10.1007/s10456-012-9322-9; Li SP, 2011, CURR CANCER THER REV, V7, P83, DOI 10.2174/1573394711107020083; Li SP, 2012, J CELL PHYSIOL, V227, P2822, DOI 10.1002/jcp.23051; Li Shuping, 2010, Int J Biochem Mol Biol, V1, P26; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; McLaughlin RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015402; Nilsson UW, 2010, CLIN CANCER RES, V16, P3659, DOI 10.1158/1078-0432.CCR-10-0501; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Riordan JF, 2001, METHOD ENZYMOL, V341, P263, DOI 10.1016/S0076-6879(01)41157-8; SHAPIRO R, 1986, BIOCHEMISTRY-US, V25, P7255, DOI 10.1021/bi00371a002; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Steidinger TU, 2011, J NEUROCHEM, V116, P334, DOI 10.1111/j.1471-4159.2010.07112.x; Strydom DJ, 1998, CELL MOL LIFE SCI, V54, P811, DOI 10.1007/s000180050210; Subramanian V, 2007, HUM MOL GENET, V16, P1445, DOI 10.1093/hmg/ddm095; Tello-Montoliu A, 2006, J THROMB HAEMOST, V4, P1864, DOI 10.1111/j.1538-7836.2006.01995.x; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; van Bortle K, 2012, TRANSCR-AUSTIN, V3, P277, DOI 10.4161/trns.21579; van Es MA, 2011, ANN NEUROL, V70, P964, DOI 10.1002/ana.22611; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yang WL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-456; Yoshioka N, 2006, P NATL ACAD SCI USA, V103, P14519, DOI 10.1073/pnas.0606708103; Zambelli F, 2012, NUCLEIC ACIDS RES, V40, pW510, DOI 10.1093/nar/gks483	52	21	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12520	12534		10.1074/jbc.M114.551762	http://dx.doi.org/10.1074/jbc.M114.551762			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24659782	Green Published, hybrid			2022-12-25	WOS:000335581400027
J	Xie, YY; Li, J; Fan, GB; Qi, SH; Li, B				Xie, Yuying; Li, Jun; Fan, Guibo; Qi, Sihua; Li, Bing			Reperfusion Promotes Mitochondrial Biogenesis following Focal Cerebral Ischemia in Rats	PLOS ONE			English	Article							NEURONAL CELL-DEATH; BRAIN-INJURY; GENE-EXPRESSION; PERMEABILITY TRANSITION; OXIDATIVE STRESS; DNA CONTENT; NUCLEAR; PROTEIN; TRANSCRIPTION; COACTIVATORS	Background and Purpose: Reperfusion after transient cerebral ischemia causes severe damage to mitochondria; however, little is known regarding the continuous change in mitochondrial biogenesis during reperfusion. Mitochondrial biogenesis causes an increase in the individual mitochondrial mass of neurons and maintains their aerobic set-point in the face of declining function. The aim of this study was to examine mitochondrial biogenesis in the cortex during reperfusion following focal cerebral ischemia. Methods: Male Wistar rats were subjected to transient focal cerebral ischemia. The relative amount of cortical mitochondrial DNA was analyzed using quantitative real-time PCR at 0 h, 24 h, 72 h, and 7 d after reperfusion. Three critical transcriptional regulators of mitochondrial biogenesis were measured by semi-quantitative reverse-transcription PCR. The protein expression of cytochrome C oxidase subunits I and IV was detected by Western blotting. Results: Evidence of increased mitochondrial biogenesis was observed after reperfusion. The cortical mitochondrial DNA content increased after 24 h, peaked after 72 h, and maintained a high level for 7 d. The cortical expression of three critical genes for the transcriptional regulation of mitochondrial biogenesis, namely, peroxisome proliferator-activated receptor coactivator-1 alpha, nuclear respiratory factor-1, and mitochondrial transcription factor A, also increased at 24 h and 72 h. The expression of peroxisome proliferator-activated receptor coactivator-1a returned to the baseline level at 7 d, but two other factors maintained higher levels compared with the controls. Moreover, the expression of cytochrome C oxidase subunits I and IV was increased in the cortex. Conclusions: These results indicate that reperfusion increased mitochondrial biogenesis following focal cerebral ischemia, and this tendency was exacerbated as the reperfusion time was extended. Reperfusion-induced mitochondrial biogenesis was mediated through up-regulation of critical transcriptional regulators of mitochondrial biogenesis.	[Xie, Yuying; Li, Jun; Fan, Guibo; Qi, Sihua] Harbin Med Univ, Affiliated Hosp 4, Dept Anesthesiol, Harbin, Peoples R China; [Li, Bing] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Qi, SH (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Anesthesiol, Harbin, Peoples R China.	sihuaqi_2013@163.com; bingliqi_2013@126.com			Natural Science Foundation of China [81271456]; Nature Science Foundation of Heilongjiang Province [ZD201017]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This project was supported by grants from the Natural Science Foundation of China (No. 81271456) and the Nature Science Foundation of Heilongjiang Province (ZD201017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Anderson MF, 1999, J NEUROCHEM, V73, P1189, DOI 10.1046/j.1471-4159.1999.0731189.x; Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Canevari L, 1997, J CEREBR BLOOD F MET, V17, P1166, DOI 10.1097/00004647-199711000-00005; Cannino G, 2007, MITOCHONDRION, V7, P359, DOI 10.1016/j.mito.2007.07.001; Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x; Chen H, 2001, STROKE, V32, P2382, DOI 10.1161/hs1001.097099; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Chen SD, 2010, J NEUROSCI RES, V88, P3144, DOI 10.1002/jnr.22469; Diaz F, 2008, CELL CALCIUM, V44, P24, DOI 10.1016/j.ceca.2007.12.004; Edwards JL, 2010, DIABETOLOGIA, V53, P160, DOI 10.1007/s00125-009-1553-y; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Escriva H, 1999, BIOCHIMIE, V81, P965, DOI 10.1016/S0300-9084(99)00223-0; Ferrer I, 2009, J BIOENERG BIOMEMBR, V41, P425, DOI 10.1007/s10863-009-9243-5; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Garcia-Roves PM, 2006, AM J PHYSIOL-ENDOC M, V290, pE1172, DOI 10.1152/ajpendo.00633.2005; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hota KB, 2012, HIPPOCAMPUS, V22, P723, DOI 10.1002/hipo.20934; JALC P, 1995, MOL CHEM NEUROPATHOL, V25, P143, DOI 10.1007/BF02960909; Jones AWE, 2012, MITOCHONDRION, V12, P86, DOI 10.1016/j.mito.2011.09.009; Kao TK, 2006, NEUROCHEM INT, V48, P166, DOI 10.1016/j.neuint.2005.10.008; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Kumari S, 2012, TRANSL STROKE RES, V3, P296, DOI 10.1007/s12975-012-0158-9; Kutik S, 2009, BBA-GEN SUBJECTS, V1790, P409, DOI 10.1016/j.bbagen.2009.04.004; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee HM, 2008, FREE RADICAL BIO MED, V44, P807, DOI 10.1016/j.freeradbiomed.2007.11.005; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046498; Lin Tsu-Kung, 2009, Chang Gung Med J, V32, P589; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443; Manoli I, 2007, TRENDS ENDOCRIN MET, V18, P190, DOI 10.1016/j.tem.2007.04.004; Matsumori Y, 2005, J CEREBR BLOOD F MET, V25, P899, DOI 10.1038/sj.jcbfm.9600080; Mattingly KA, 2008, MOL ENDOCRINOL, V22, P609, DOI 10.1210/me.2007-0029; Nagata T, 2006, THESCIENTIFICWORLDJO, V6, P1583, DOI 10.1100/tsw.2006.265; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Onyango IG, 2010, BBA-MOL BASIS DIS, V1802, P228, DOI 10.1016/j.bbadis.2009.07.014; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Peinado MA, 1997, ANAT REC, V247, P420; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; Pundik S, 2012, NEUROLOGY, V79, pS44, DOI 10.1212/WNL.0b013e3182695a14; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shimamura N, 2006, J NEUROSCI METH, V156, P161, DOI 10.1016/j.jneumeth.2006.02.017; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Valerio A, 2011, J NEUROCHEM, V116, P1148, DOI 10.1111/j.1471-4159.2011.07171.x; Villa RF, 2006, J NEURAL TRANSM, V113, P1659, DOI 10.1007/s00702-006-0569-4; VILLA RF, 1981, BIOCHEM PHARMACOL, V30, P2399, DOI 10.1016/0006-2952(81)90333-6; Villa RF, 2013, NEUROCHEM INT, V63, P765, DOI 10.1016/j.neuint.2013.10.004; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yaffe MP, 1999, NAT CELL BIOL, V1, pE149, DOI 10.1038/14101; Yin W, 2006, NEUROBIOL DIS, V21, P358, DOI 10.1016/j.nbd.2005.07.015; Yin W, 2008, STROKE, V39, P3057, DOI 10.1161/STROKEAHA.108.520114; Zaidan E, 1997, BRAIN RES, V772, P23, DOI 10.1016/S0006-8993(97)00833-0; Zhang Q, 2012, NEUROSCIENCE, V205, P10, DOI 10.1016/j.neuroscience.2011.12.053	60	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92443	10.1371/journal.pone.0092443	http://dx.doi.org/10.1371/journal.pone.0092443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667167	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600040
J	Chiang, KC; Tsui, KH; Chung, LC; Yeh, CN; Chen, WT; Chang, PL; Juang, HH				Chiang, Kun-Chun; Tsui, Ke-Hung; Chung, Li-Chuan; Yeh, Chun-Nan; Chen, Wen-Tsung; Chang, Phei-Lang; Juang, Horng-Heng			Celastrol Blocks Interleukin-6 Gene Expression via Downregulation of NF-kappa B in Prostate Carcinoma Cells	PLOS ONE			English	Article							CANCER-SPECIFIC SURVIVAL; ANDROGEN-RECEPTOR; UP-REGULATION; GOD VINE; GROWTH; INHIBITION; PATHWAYS; THERAPY; KINASE; IL-6	Interleukin-6 (IL-6), a multifunctional cytokine, contributes to proliferation or differentiation of prostate carcinoma cells in a highly cell type-specific manner. Celastrol (3-hydroxy-24-nor-2oxo-1(10), 3,5,7-friedelatetrane-29-oic acid), also named as tripterine, is extracted from root of Chinese traditional herb Tripterygiumwilfordii Hook f with potent anti-inflammatory and anti-cancer activities. In this study, we evaluated the molecular mechanisms of celastrol on cell proliferation and IL-6 gene expression in prostate carcinoma cells. 3 H-thymidine incorporation and flow cytometric analysis indicated that celastrol treatments arrested the cell cycle at the G0/ G1 phase, thus attenuating cell proliferation in prostate carcinoma PC-3 cells; moreover, celastrol induced cell apoptosis at higher dosage. Knockdown of IL-6 attenuated the anti-proliferative effect of celastrol on PC-3 cells. Results from ELISA and 5'-deletion transient gene expression assays indicated that celastrol treatment decreased IL-6 secretion and gene expression, and this effect is dependent on the NF-kappa B response element within IL-6 promoter area since mutation of the NF-kappa B response element from AAATGTCCCATTTTCCC to AAATGTTACATTTTCCC by site-directed mutagenesis abolished the inhibition of celastrol on the IL-6 promoter activity. Celastrol also attenuated the activation of PMA and TNF alpha on the gene expression and secretion of IL-6 in PC-3 cells. Immunoblot assays revealed that celastrol treatment downregulated the expressions of IKK alpha, p50 and p65, supporting the 5'-deletion transient gene expression assay result that celastrol blocked IL-6 expression through the NF-kappa B pathway in PC-3 cells. For the first time, our results concluded that celastrol attenuates PC-3 cell proliferation via downregulation of IL-6 gene expression through the NF-kappa B-dependent pathway.	[Chiang, Kun-Chun] Chang Gung Mem Hosp, Dept Gen Surg, Keelung, Taiwan; [Tsui, Ke-Hung] Chang Gung Mem Hosp, Dept Urol, Tao Yuan, Taiwan; [Chung, Li-Chuan; Juang, Horng-Heng] Chang Gung Univ, Sch Med, Dept Anat, Tao Yuan, Taiwan; [Yeh, Chun-Nan] Chang Gung Mem Hosp, Dept Gen Surg, Tao Yuan, Taiwan; [Chen, Wen-Tsung] Natl Kaohsiung Univ Hosp & Tourism, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Kaohsiung University of Hospitality & Tourism	Juang, HH (corresponding author), Chang Gung Univ, Sch Med, Dept Anat, Tao Yuan, Taiwan.	hhj143@mail.cgu.edu.tw	Juang, Horng-Heng/AAG-7683-2020; Tsui, Ke hung/O-3551-2016; Juang, Horng-Heng/G-2313-2012	Tsui, Ke hung/0000-0001-9814-0914; Juang, Horng-Heng/0000-0002-8524-8253	Chang Gung Memorial Hospital [CMRP-D190543, CMRP-D190613, CMRP-G3B1891, D1D0201, CMRP-G3D0311]; National Science Council [101-2314-B-182A-099-MY3, 102-2320-B-182-003 -MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council(Ministry of Science and Technology, Taiwan)	This Research was supported by Chang Gung Memorial Hospital (CMRP-D190543, -D190613, -G3B1891, D1D0201, and -G3D0311) and Taiwan National Science Council (101-2314-B-182A-099-MY3 and 102-2320-B-182-003 -MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bellone S, 2005, GYNECOL ONCOL, V98, P92, DOI 10.1016/j.ygyno.2005.03.016; Cardillo MR, 2006, ANTICANCER RES, V26, P3409; Chung LC, 2012, AM J PHYSIOL-CELL PH, V302, pC676, DOI 10.1152/ajpcell.00180.2011; Collett NP, 2010, SEMIN ONCOL, V37, P258, DOI 10.1053/j.seminoncol.2010.06.014; Conze D, 2001, CANCER RES, V61, P8851; Cozen W, 2004, BLOOD, V103, P3216, DOI 10.1182/blood-2003-08-2860; D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061; Dai Y, 2009, INT J RADIAT ONCOL, V74, P1217, DOI 10.1016/j.ijrobp.2009.03.057; Edwards J, 2005, BJU INT, V95, P1327, DOI 10.1111/j.1464-410X.2005.05527.x; George DJ, 2005, CLIN CANCER RES, V11, P1815, DOI 10.1158/1078-0432.CCR-04-1560; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; He D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-343; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Jee SH, 2004, J INVEST DERMATOL, V123, P1169, DOI 10.1111/j.0022-202X.2004.23497.x; Jia L, 2004, CANCER RES, V64, P2619, DOI 10.1158/0008-5472.CAN-03-3486; Juang HH, 2013, PROSTATE, V73, P1495, DOI 10.1002/pros.22697; Kannaiyan R, 2011, CANCER LETT, V303, P9, DOI 10.1016/j.canlet.2010.10.025; Keller ET, 1996, J BIOL CHEM, V271, P26267, DOI 10.1074/jbc.271.42.26267; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Steiner H, 2006, PROSTATE, V66, P1744, DOI 10.1002/pros.20492; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Tsui KH, 2008, ACTA PHARMACOL SIN, V29, P1334, DOI 10.1111/j.1745-7254.2008.00887.x; Tsui KH, 2008, ANTICANCER RES, V28, P1969; Tsui KH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/791212; Tsui KH, 2012, J MOL ENDOCRINOL, V49, P153, DOI 10.1530/JME-11-0149; Xiao WH, 2004, PROSTATE, V61, P354, DOI 10.1002/pros.20113; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhu H, 2010, CANCER LETT, V297, P155, DOI 10.1016/j.canlet.2010.04.030	38	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93151	10.1371/journal.pone.0093151	http://dx.doi.org/10.1371/journal.pone.0093151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664372	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900159
J	Hedge, LH; Johnston, EL				Hedge, Luke H.; Johnston, Emma L.			Colonisation of the Non-Indigenous Pacific Oyster Crassostrea gigas Determined by Predation, Size and Initial Settlement Densities	PLOS ONE			English	Article							SYDNEY ROCK OYSTERS; PROPAGULE PRESSURE; HABITAT COMPLEXITY; BIOTIC RESISTANCE; NONNATIVE OYSTERS; BALLAST WATER; INVASION; COMMUNITIES; DISTURBANCE; DIVERSITY	Survival of incipient non-indigenous populations is dramatically altered by early predation on new colonisers. These effects can be influenced by morphological traits, such as coloniser size and density. The Australian non-native Pacific Oyster Crassostrea gigas is generally more fecund and faster growing compared to the native Saccostrea glomerata found in the same habitat. It is therefore important to quantify how the two species differ in survival across coloniser density and predation gradients. This information could become pertinent to the management of wild and aquaculture populations of the non-native C. gigas. Using a field-based factorial experiment we model the survival of incipient populations of both the native S. glomerata and the non-indigenous C. gigas as a function of coloniser density, predator reduction and individual size. Unexpectedly, survival of the non-indigenous C. gigas increased compared to S. glomerata when individuals were larger. The proportional survival of newly colonised oyster populations also increased with larger initial populations, regardless of species identity. Further, predator reduction resulted in increased survival of both oyster species, irrespective of coloniser size or initial density. Here we quantitatively demonstrate the effects of recruit density and size on enhancing the survivability of incipient oyster populations.	[Hedge, Luke H.] Univ New S Wales, Sydney Inst Marine Sci, Sydney, NSW, Australia; Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	Sydney Institute of Marine Science; University of New South Wales Sydney; University of New South Wales Sydney	Hedge, LH (corresponding author), Univ New S Wales, Sydney Inst Marine Sci, Sydney, NSW, Australia.	l.hedge@unsw.edu.au	Johnston, Emma L/B-7210-2009; Johnston, Emma/AAC-2878-2022	Johnston, Emma L/0000-0002-2117-366X; Johnston, Emma/0000-0002-2117-366X	Australian Research Foundation Discovery Grant	Australian Research Foundation Discovery Grant	This work partially funded from an Australian Research Foundation Discovery Grant. No additional external funding was received for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 1999, MAR ECOL PROG SER, V187, P203, DOI 10.3354/meps187203; Bishop MJ, 2010, MAR FRESHWATER RES, V61, P714, DOI 10.1071/MF09177; Bishop MJ, 2006, ECOL APPL, V16, P718, DOI 10.1890/1051-0761(2006)016[0718:WRMNPI]2.0.CO;2; BUTMAN CA, 1994, LIMNOL OCEANOGR, V39, P1755, DOI 10.4319/lo.1994.39.7.1755; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clark GF, 2005, MAR ECOL PROG SER, V298, P9, DOI 10.3354/meps298009; Clark GF, 2009, OIKOS, V118, P1679, DOI 10.1111/j.1600-0706.2009.17564.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Costello C, 2007, ECOL APPL, V17, P655, DOI 10.1890/06-0190; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; CRAWLEY MJ, 2006, R BOOK; Drake JM, 2006, BIOL INVASIONS, V8, P365, DOI 10.1007/s10530-004-8122-6; Drake JM, 2005, BIOL LETTERS, V1, P480, DOI 10.1098/rsbl.2005.0375; Drake JM, 2007, CAN J FISH AQUAT SCI, V64, P530, DOI 10.1139/F07-029; Drake LM, 2004, P ROYAL SOC, V271, P575; Dutertre M, 2010, MAR ENVIRON RES, V69, P1, DOI 10.1016/j.marenvres.2009.07.002; Eschtruth AK, 2009, ECOL MONOGR, V79, P265, DOI 10.1890/08-0221.1; Grabowski JH, 2004, MAR ECOL PROG SER, V277, P291, DOI 10.3354/meps277291; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; Grabowski JH, 2008, ECOLOGY, V89, P3413, DOI 10.1890/07-1057.1; Green TJ, 2008, AQUACULTURE, V280, P35, DOI 10.1016/j.aquaculture.2008.04.004; Hedge LH, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-000375.1; Holling C. S., 1959, Canadian Entomologist, V91, P385; Hughes AR, 2006, OECOLOGIA, V149, P256, DOI 10.1007/s00442-006-0439-7; Jonsson PR, 2005, LIMNOL OCEANOGR, V50, P1989, DOI 10.4319/lo.2005.50.6.1989; Krassoi FR, 2008, J ANIM ECOL, V77, P5, DOI 10.1111/j.1365-2656.2007.01316.x; Lambrinos JG, 2006, OECOLOGIA, V147, P327, DOI 10.1007/s00442-005-0259-1; Leung B, 2004, ECOLOGY, V85, P1651, DOI 10.1890/02-0571; Liu W, 2009, AQUACULTURE, V299, P99; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Lopez MS, 2010, MAR ECOL PROG SER, V403, P101, DOI 10.3354/meps08409; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Range P, 2008, J EXP MAR BIOL ECOL, V365, P23, DOI 10.1016/j.jembe.2008.07.031; Rico-Villa B, 2009, AQUACULTURE, V287, P395, DOI 10.1016/j.aquaculture.2008.10.054; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; Ruesink JL, 2007, MAR ECOL PROG SER, V331, P1, DOI 10.3354/meps331001; Ruesink JL, 2005, ANNU REV ECOL EVOL S, V36, P643, DOI 10.1146/annurev.ecolsys.36.102003.152638; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Schmidt A, 2008, HELGOLAND MAR RES, V62, P367, DOI 10.1007/s10152-008-0125-8; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Smith IR, 2000, AQUACULTURE, V185, P197, DOI 10.1016/S0044-8486(99)00350-6; Taylor JJ, 1998, J SHELLFISH RES, V17, P281; Troost K, 2010, J SEA RES, V64, P145, DOI 10.1016/j.seares.2010.02.004; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Wilkie EM, 2012, MAR FRESHWATER RES, V63, P1201, DOI 10.1071/MF12078; Wilkie EM, 2012, J EXP MAR BIOL ECOL, V420, P16, DOI 10.1016/j.jembe.2012.03.018; Zuur Alain F., 2009, P1	48	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90621	10.1371/journal.pone.0090621	http://dx.doi.org/10.1371/journal.pone.0090621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663029	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900009
J	Remy, S; Govarts, E; Bruckers, L; Paulussen, M; Wens, B; Den Hond, E; Nelen, V; Baeyens, W; van Larebeke, N; Loots, I; Sioen, I; Schoeters, G				Remy, Sylvie; Govarts, Eva; Bruckers, Liesbeth; Paulussen, Melissa; Wens, Britt; Den Hond, Elly; Nelen, Vera; Baeyens, Willy; van Larebeke, Nicolas; Loots, Ilse; Sioen, Isabelle; Schoeters, Greet			Expression of the sFLT1 Gene in Cord Blood Cells Is Associated to Maternal Arsenic Exposure and Decreased Birth Weight	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-1; DNA METHYLATION; REACTIVE OXYGEN; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; HYPERTENSION; CHINESE; VASCULOGENESIS; ANGIOGENESIS; METABOLITES	There is increasing epidemiologic evidence that arsenic exposure in utero is associated with adverse pregnancy outcomes and may contribute to long-term health effects. These effects may occur at low environmental exposures but the underlying molecular mechanism is not clear. We collected cord blood samples of 183 newborns to identify associations between arsenic levels and birth anthropometric parameters in an area with very low arsenic exposure. Our core research aim was to screen for transcriptional marks that mechanistically explain these associations. Multiple regression analyses showed that birth weight decreased with 47 g (95% CI: 16-78 g) for an interquartile range increase of 0.99 mg/L arsenic. The model was adjusted for child's sex, maternal smoking during pregnancy, gestational age, and parity. Higher arsenic concentrations and reduced birth weight were positively associated with changes in expression of the sFLT1 (soluble fms-like tyrosine kinase-1) gene in cord blood cells in girls. The protein product of sFLT1 is a scavenger of vascular endothelial growth factor (VEGF) in the extracellular environment and plays a key role in the inhibition of placental angiogenesis. In terms of fetal development, inhibition of placental angiogenesis leads to impaired nutrition and hence to growth retardation. Various genes related to DNA methylation and oxidative stress showed also changed expression in relation to arsenic exposure but were not related to birth outcome parameters. In conclusion, this study suggests that increased expression of sFLT1 is an intermediate marker that points to placental angiogenesis as a pathway linking prenatal arsenic exposure to reduced birth weight.	[Remy, Sylvie; Govarts, Eva; Paulussen, Melissa; Wens, Britt; Den Hond, Elly; Schoeters, Greet] Flemish Inst Technol Res VITO, Mol, Belgium; [Bruckers, Liesbeth] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium; [Remy, Sylvie; Wens, Britt; Schoeters, Greet] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Nelen, Vera] Prov Inst Hyg, Dept Hlth, Antwerp, Belgium; [Baeyens, Willy; van Larebeke, Nicolas] Vrije Univ Brussel, Dept Analyt Environm & Geochem AEGC, Brussels, Belgium; [van Larebeke, Nicolas] Univ Ghent, Dept Radiotherapy & Expt Canc Res, B-9000 Ghent, Belgium; [Loots, Ilse] Univ Antwerp, Dept Sociol, Fac Polit & Social Sci, B-2020 Antwerp, Belgium; [Sioen, Isabelle] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Sioen, Isabelle] FWO Res Fdn, Brussels, Belgium; [Schoeters, Greet] Univ Southern Denmark, Dept Environm Med, Odense, Denmark	VITO; Hasselt University; University of Antwerp; Vrije Universiteit Brussel; Ghent University; University of Antwerp; Ghent University; University of Southern Denmark	Remy, S (corresponding author), Flemish Inst Technol Res VITO, Mol, Belgium.	sylvie.remy@vito.be		Schoeters, Greta/0000-0002-6556-4814; Baeyens, Willy/0000-0002-5281-903X; van Larebeke, Nik/0000-0002-3183-3369; Remy, Sylvie/0000-0003-0322-9620	Ministry of the Flemish Community; European Community [OBELIX 227391]; Research Foundation - Flanders [1.2.683.11.N.00]	Ministry of the Flemish Community; European Community(European Commission); Research Foundation - Flanders(FWO)	The studies of the Flemish Center of Expertise on Environment and Health were commissioned, financed and steered by the Ministry of the Flemish Community (Department of Economics, Science and Innovation; Flemish Agency for Care and Health; and Department of Environment, Nature and Energy). The research received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement OBELIX 227391. Isabelle Sioen is financially supported by the Research Foundation - Flanders (Grant no: 1.2.683.11.N.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Alam MGM, 2002, INT J ENVIRON HEAL R, V12, P236, DOI 10.1080/0960312021000000998; Alexander BT, 2003, HYPERTENSION, V41, P457, DOI 10.1161/01.HYP.0000053448.95913.3D; Arroyo JA, 2008, SEMIN PERINATOL, V32, P172, DOI 10.1053/j.semperi.2008.02.006; Barchowsky A, 1999, FREE RADICAL BIO MED, V27, P1405, DOI 10.1016/S0891-5849(99)00186-0; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bodwell JE, 2006, CHEM RES TOXICOL, V19, P1619, DOI 10.1021/tx060122q; Bos I, 2012, NEUROSCIENCE, V223, P131, DOI 10.1016/j.neuroscience.2012.07.057; Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954; Cheng TF, 2012, J APPL TOXICOL, V32, P643, DOI 10.1002/jat.2717; Concha G, 1998, TOXICOL SCI, V44, P185, DOI 10.1006/toxs.1998.2486; Fangstrom B, 2008, ENVIRON HEALTH PERSP, V116, P963, DOI 10.1289/ehp.11094; Fei DL, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-58; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Furuya M, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/123717; Gosse JA, 2014, J APPL TOXICOL, V34, P498, DOI 10.1002/jat.2898; Guan H, 2012, BIOL TRACE ELEM RES, V149, P10, DOI 10.1007/s12011-012-9396-7; He WJ, 2007, TOXICOL SCI, V99, P244, DOI 10.1093/toxsci/kfm162; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hsueh YM, 1998, ATHEROSCLEROSIS, V141, P249, DOI 10.1016/S0021-9150(98)00178-6; Illsley NP, 2000, PLACENTA, V21, P14, DOI 10.1053/plac.1999.0448; Intarasunanont P, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-31; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Jebbink J, 2011, HYPERTENSION, V58, P70, DOI 10.1161/HYPERTENSIONAHA.110.164079; Kile ML, 2012, ENVIRON HEALTH PERSP, V120, P1061, DOI 10.1289/ehp.1104173; Leonce J, 2006, PLACENTA, V27, pS103, DOI 10.1016/j.placenta.2006.02.006; Liu J, 2001, TOXICOL SCI, V61, P314, DOI 10.1093/toxsci/61.2.314; Liu J, 2007, TOXICOL APPL PHARM, V220, P284, DOI 10.1016/j.taap.2007.01.018; Lu FX, 2007, AM J OBSTET GYNECOL, V197, pS141, DOI 10.1016/j.ajog.2007.10.558; Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175; McDermott S, 2012, SPAT SPATIO-TEMPORAL, V3, P265, DOI 10.1016/j.sste.2012.05.001; Muralimanoharan S, 2013, PLACENTA, V34, P1183, DOI 10.1016/j.placenta.2013.09.015; Neter J., 1996, APPL LINEAR REGRESSI; Ojeda NB, 2007, AM J PHYSIOL-REG I, V292, pR758, DOI 10.1152/ajpregu.00311.2006; Pi JB, 2002, ENVIRON HEALTH PERSP, V110, P331, DOI 10.1289/ehp.02110331; Pi JB, 2000, FREE RADICAL BIO MED, V28, P1137, DOI 10.1016/S0891-5849(00)00209-4; Pilsner JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037147; Rahman M, 1999, HYPERTENSION, V33, P74, DOI 10.1161/01.HYP.33.1.74; Rajakumar A, 2005, PLACENTA, V26, P563, DOI 10.1016/j.placenta.2004.09.001; Schoeters G, 2012, INT J HYG ENVIR HEAL, V215, P102, DOI 10.1016/j.ijheh.2011.11.006; Schroijen C, 2008, CHEMOSPHERE, V71, P1317, DOI 10.1016/j.chemosphere.2007.11.053; States JC, 2009, TOXICOL SCI, V107, P312, DOI 10.1093/toxsci/kfn236; Tchounwou PB, 2003, TOXICOL PATHOL, V31, P575, DOI 10.1080/01926230390242007; Tsai SH, 2001, TOXICOL LETT, V123, P11, DOI 10.1016/S0378-4274(01)00373-3; Tseng CH, 2007, J ENVIRON BIOL, V28, P349; Vahter M, 2002, TOXICOLOGY, V181, P211, DOI 10.1016/S0300-483X(02)00285-8; Vahter ME, 2007, J NUTR, V137, P2798, DOI 10.1093/jn/137.12.2798; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang CH, 2002, CIRCULATION, V105, P1804, DOI 10.1161/01.CIR.0000015862.64816.B2; Wang TS, 1996, J CELL PHYSIOL, V169, P256, DOI 10.1002/(SICI)1097-4652(199611)169:2<256::AID-JCP5>3.0.CO;2-N; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wilson D, 2012, J ENVIRON HEALTH, V75, P14; Xie YX, 2007, TOXICOLOGY, V236, P7, DOI 10.1016/j.tox.2007.03.021; Xu Lei, 2011, Nihon Koshu Eisei Zasshi, V58, P89; Zhong CXY, 2001, TOXICOL LETT, V122, P223, DOI 10.1016/S0378-4274(01)00365-4	55	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92677	10.1371/journal.pone.0092677	http://dx.doi.org/10.1371/journal.pone.0092677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664213	Green Published, gold			2022-12-25	WOS:000333459900096
J	Clark, CJ; Everson-Rose, SA; Alonso, A; Spencer, RA; Brady, SS; Resnick, MD; Borowsky, IW; Connett, JE; Krueger, RF; Suglia, SF				Clark, Cari Jo; Everson-Rose, Susan A.; Alonso, Alvaro; Spencer, Rachael A.; Brady, Sonya S.; Resnick, Michael D.; Borowsky, Iris W.; Connett, John E.; Krueger, Robert F.; Suglia, Shakira F.			Effect of Partner Violence in Adolescence and Young Adulthood on Blood Pressure and Incident Hypertension	PLOS ONE			English	Article							PHYSICAL HEALTH CONSEQUENCES; SEX-DIFFERENCES; HELP-SEEKING; INTIMATE; WOMEN; AMERICAN; STRESS; REACTIVITY; DISEASE; FORMS	Intimate partner violence has adverse health consequences, but little is known about its association with hypertension. This study investigates sex differences in the relationship between intimate partner violence and blood pressure outcomes. Data included 9,699 participants from waves 3 (2001-02) and 4 (2008-09) of the National Longitudinal Study of Adolescent Health (51% female). Systolic (SBP) and diastolic (DBP) blood pressure and incident hypertension (SBP >= 140 mmHg, DBP >= 90 mmHg, or taking antihypertensive medication) were ascertained at wave 4. Intimate partner violence was measured at wave 3 with 8 items from the revised Conflict Tactics Scales. Separate victimization and perpetration scores were calculated. Sex-specific indicators of severe victimization and perpetration were created using the 66th percentile among those exposed as a cut point. Sex-specific, linear and logistic regression models were developed adjusting for age, race, financial stress, and education. Thirty-three percent of men and 47% of women reported any intimate partner violence exposure; participants were categorized as having: no exposure, moderate victimization and / or perpetration only, severe victimization, severe perpetration, and severe victimization and perpetration. Men experiencing severe perpetration and victimization had a 2.66 mmHg (95% CI: 0.05, 5.28) higher SBP and a 59% increased odds (OR: 1.59, 95% CI: 1.07, 2.37) of incident hypertension compared to men not exposed to intimate partner violence. No other category of violence was associated with blood pressure outcomes in men. Intimate partner violence was not associated with blood pressure outcomes in women. Intimate partner violence may have long-term consequences for men's hemodynamic health. Screening men for victimization and perpetration may assist clinicians to identify individuals at increased risk of hypertension.	[Clark, Cari Jo; Everson-Rose, Susan A.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Clark, Cari Jo; Alonso, Alvaro; Brady, Sonya S.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Clark, Cari Jo; Everson-Rose, Susan A.] Univ Minnesota, Program Hlth Dispar Res, Minneapolis, MN USA; [Spencer, Rachael A.] Independent Researcher, Atlanta, GA USA; [Resnick, Michael D.; Borowsky, Iris W.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Connett, John E.] Univ Minnesota, Biostat Design & Anal Ctr, Div Biostat, Minneapolis, MN USA; [Krueger, Robert F.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Suglia, Shakira F.] Columbia Univ, Dept Epidemiol, New York, NY USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Columbia University	Clark, CJ (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	cjclark@umn.edu	Clark, Cari Jo/P-1856-2018; Alonso, Alvaro/A-4917-2010; Everson-Rose, Susan A/L-7582-2017	Clark, Cari Jo/0000-0002-9959-5221; Alonso, Alvaro/0000-0002-2225-8323; Everson-Rose, Susan/0000-0002-9839-2537; Brady, Sonya/0000-0001-8660-9308; Borowsky, Iris/0000-0001-6451-7779	National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) [8UL1TR000114-02]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R03HD068045-02, P01-HD31921]; Centers for Disease Control and Prevention [5U48DP001939]; National Institute on Minority Health and Health Disparities [1P60MD003422]; Program in Health Disparities Research; Applied Clinical Research Program at the University of Minnesota; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD068045, P01HD031921] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114, KL2TR000113] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001939] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD003422] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Program in Health Disparities Research; Applied Clinical Research Program at the University of Minnesota; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH), Award Number 8UL1TR000114-02 (Drs. Clark and Connett). Dr. Clark was additionally funded in part by grant number R03HD068045-02 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Dr. Resnick was supported in part by Cooperative Agreement Number 5U48DP001939 from the Centers for Disease Control and Prevention. Dr. Everson-Rose was supported in part by grant 1P60MD003422 from the National Institute on Minority Health and Health Disparities. Additional support was provided by the Program in Health Disparities Research and the Applied Clinical Research Program (Drs. Clark and Dr. Everson-Rose) at the University of Minnesota. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Centers for Disease Control and Prevention. The National Longitudinal Study of Adolescent Health was funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackard Diann M, 2003, J Gend Specif Med, V6, P39; Archer J, 2000, PSYCHOL BULL, V126, P651, DOI 10.1037//0033-2909.126.5.651; Barnett RC, 2005, ANN BEHAV MED, V30, P36, DOI 10.1207/s15324796abm3001_5; Black M., 2011, NATL INTIMATE PARTNE; Bonomi AE, 2009, ARCH INTERN MED, V169, P1692, DOI 10.1001/archinternmed.2009.292; Breiding MJ, 2008, ANN EPIDEMIOL, V18, P538, DOI 10.1016/j.annepidem.2008.02.005; Campbell J, 2002, ARCH INTERN MED, V162, P1157, DOI 10.1001/archinte.162.10.1157; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Catalano S, 2011, INTIMATE PARTNER VIO; Chantala K., 2010, STRATEGIES PERFORM D, P19; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chyu L, 2011, BIODEMOGR SOC BIOL, V57, P184, DOI 10.1080/19485565.2011.614572; Coker AL, 2000, AM J PREV MED, V19, P316, DOI 10.1016/S0749-3797(00)00239-7; Coker AL, 2000, ARCH FAM MED, V9, P451, DOI 10.1001/archfami.9.5.451; Din-Dzietham R, 2007, CIRCULATION, V116, P1488, DOI 10.1161/CIRCULATIONAHA.106.683243; Entzel P., 2009, ADD HLTH WAVE 4 DOCU, DOI 10.17615/C6HM11; Flicker SM, 2011, VIOLENCE AGAINST WOM, V17, P1067, DOI 10.1177/1077801211414846; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Halpern CT, 2009, J ADOLESCENT HEALTH, V45, P508, DOI 10.1016/j.jadohealth.2009.03.011; Hamby S, 2009, PSYCHOL TRAUMA-US, V1, P24, DOI 10.1037/a0015066; Harris K.M., 2008, NATL LONGITUDINAL ST; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lown EA, 2001, PSYCHOSOM MED, V63, P352, DOI 10.1097/00006842-200105000-00004; Mason SM, 2012, ANN EPIDEMIOL, V22, P562, DOI 10.1016/j.annepidem.2012.05.003; Nealey-Moore JB, 2007, J BEHAV MED, V30, P505, DOI 10.1007/s10865-007-9124-5; Ordaz S, 2012, PSYCHONEUROENDOCRINO, V37, P1135, DOI 10.1016/j.psyneuen.2012.01.002; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Ruiz-Perez I, 2007, EUR J PUBLIC HEALTH, V17, P437, DOI 10.1093/eurpub/ckl280; Straus M A, 1999, Clin Child Fam Psychol Rev, V2, P55, DOI 10.1023/A:1021891529770; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Suglia SF, 2008, J TRAUMA STRESS, V21, P479, DOI 10.1002/jts.20362; Suglia SF, 2010, PSYCHOL TRAUMA-US, V2, P326, DOI 10.1037/a0018953; Tabor J, 2010, ADD HLTH WAVE 4 DOCU; Tjaden P., 2000, 183781 NCJ US DEP JU; Tjaden P.G., 2000, FULL REPORT PREVALEN; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Vives-Cases C, 2011, J PUBLIC HEALTH-UK, V33, P15, DOI 10.1093/pubmed/fdq101; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; Whitaker DJ, 2007, AM J PUBLIC HEALTH, V97, P941, DOI 10.2105/AJPH.2005.079020; Williams SL, 2005, SEX ROLES, V52, P771, DOI 10.1007/s11199-005-4198-4; Wright RJ, 2010, J EPIDEMIOL COMMUN H, V64, P630, DOI 10.1136/jech.2009.090795	44	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92204	10.1371/journal.pone.0092204	http://dx.doi.org/10.1371/journal.pone.0092204			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6GL	24658452	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300060
J	Badole, SL; Jangam, GB; Chaudhari, SM; Ghule, AE; Zanwar, AA				Badole, Sachin L.; Jangam, Ganesh B.; Chaudhari, Swapnil M.; Ghule, Arvindkumar E.; Zanwar, Anand A.			L-Glutamine Supplementation Prevents the Development of Experimental Diabetic Cardiomyopathy in Streptozotocin-Nicotinamide Induced Diabetic Rats	PLOS ONE			English	Article							GLP-1; EXPRESSION; TISSUES; DAMAGE	The objective of the present investigation was to evaluate the effect of L-glutamine on cardiac myopathy in streptozotocin-nicotinamide induced diabetic rats. Diabetes was induced in overnight fasted Sprague Dawely rats by using intraperitonial injection of streptozotocin (55 mg/kg). Nicotinamide (100 mg/kg, i.p.) was administered 20 min before administration of streptozotocin. Experimental rats were divided into Group I: non-diabetic control (distilled water; 10 ml/kg, p.o.), II: diabetic control (distilled water, 10 ml/kg, p.o.), III: L-glutamine (500 mg/kg, p.o.) and IV: L-glutamine (1000 mg/kg, p.o.). All groups were diabetic except group I. The plasma glucose level, body weight, electrocardiographic abnormalities, hemodynamic changes and left ventricular contractile function, biological markers of cardiotoxicity, antioxidant markers were determined after 4 months after STZ with nicotinamide injection. Histopathological changes of heart tissue were carried out by using H and E stain. L-glutamine treatment improved the electrocardiographic, hemodynamic changes; LV contractile function; biological markers; oxidative stress parameters and histological changes in STZ induced diabetic rats. Results from the present investigation demonstrated that L-glutamine has seemed a cardioprotective activity.	[Badole, Sachin L.; Jangam, Ganesh B.; Chaudhari, Swapnil M.] PESs Modern Coll Pharm, Dept Pharmacol, Pune, Maharashtra, India; [Ghule, Arvindkumar E.] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmacol, Pune, Maharashtra, India; [Zanwar, Anand A.] Bharati Vidyapeeth Deemed Univ, Interact Res Sch Hlth Affairs, Ctr Innovat Nutr Hlth Dis, Pune, Maharashtra, India	Bharati Vidyapeeth Deemed University; Poona College of Pharmacy; Bharati Vidyapeeth Deemed University	Badole, SL (corresponding author), PESs Modern Coll Pharm, Dept Pharmacol, Pune, Maharashtra, India.	sachinbadole@rediffmail.com	Zanwar, Anand/AAK-6051-2020; Bodhankar, Sunhash/AAQ-4624-2020	Zanwar, Anand/0000-0002-0858-7075; Chaudhari, Swapnil/0000-0002-6547-8596				Akula A, 2003, PHARMACOL RES, V48, P429, DOI 10.1016/S1043-6618(03)00191-9; Alnahdi HS., 2012, J HLTH SCI, V2, P33, DOI DOI 10.5923/J.HEALTH.20120204.03; Badole SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072817; Badole SL, 2013, CHEM-BIOL INTERACT, V203, P530, DOI 10.1016/j.cbi.2013.02.006; Badole SL, 2010, EUR J PHARMACOL, V632, P103, DOI 10.1016/j.ejphar.2010.01.019; BALAZS T, 1978, ENVIRON HEALTH PERSP, V26, P181, DOI 10.2307/3428841; Borges GR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-26; El-Sheikh NM, 2011, FOOD CHEM TOXICOL, V49, P758, DOI 10.1016/j.fct.2010.11.039; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Galera SC, 2010, NUTRITION, V26, P375, DOI 10.1016/j.nut.2009.05.013; Hausenloy DJ, 2008, CIRC-HEART FAIL, V1, P147, DOI 10.1161/CIRCHEARTFAILURE.108.810887; Jia J, 2009, FOOD CHEM, V115, P32, DOI 10.1016/j.foodchem.2008.11.043; Kumar SHS, 2007, J CLIN BIOCHEM NUTR, V40, P49, DOI 10.3164/jcbn.40.49; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao Y, 2011, INT J CARDIOL, V146, P432, DOI 10.1016/j.ijcard.2010.10.102; Maya L, 2010, J MOL CELL CARDIOL, V48, P524, DOI 10.1016/j.yjmcc.2009.06.021; Menge BA, 2010, REGUL PEPTIDES, V160, P75, DOI 10.1016/j.regpep.2009.08.001; MISRA HP, 1972, J BIOL CHEM, V247, P3170; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; Murarka S, 2010, J CARD FAIL, V16, P971, DOI 10.1016/j.cardfail.2010.07.249; Ravassa S, 2012, CARDIOVASC RES, V94, P316, DOI 10.1093/cvr/cvs123; Roth E, 2008, J NUTR, V138, p2025S, DOI 10.1093/jn/138.10.2025S; SLATER TF, 1971, BIOCHEM J, V123, P805, DOI 10.1042/bj1230805; Todorova VK, 2010, J NUTR, V140, P44, DOI 10.3945/jn.109.113415; Tsai PH, 2011, CLIN NUTR, V30, P124, DOI 10.1016/j.clnu.2010.07.005; Ugurlucan M, 2010, EXPERT OPIN THER TAR, V14, P1143, DOI 10.1517/14728222.2010.521500; Xi SG, 2009, EXP MOL MED, V41, P538, DOI 10.3858/emm.2009.41.8.059; Yan H, 2012, INT J CLIN EXP PATHO, V5, P651; Yao P, 2006, FOOD CHEM, V99, P305, DOI 10.1016/j.foodchem.2005.07.047	29	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92697	10.1371/journal.pone.0092697	http://dx.doi.org/10.1371/journal.pone.0092697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651718	Green Submitted, gold, Green Published			2022-12-25	WOS:000333352800144
J	Boberg, JB; Finlay, RD; Stenlid, J; Ekblad, A; Lindahl, BD				Boberg, Johanna B.; Finlay, Roger D.; Stenlid, Jan; Ekblad, Alf; Lindahl, Bjorn D.			Nitrogen and Carbon Reallocation in Fungal Mycelia during Decomposition of Boreal Forest Litter	PLOS ONE			English	Article							LONG-TERM DECOMPOSITION; ORGANIC-MATTER; HUMIC SUBSTANCES; PINE FORESTS; SOIL; WOOD; DYNAMICS; NUTRIENT; ROOTS; MINERALIZATION	Boreal forests are characterized by spatially heterogeneous soils with low N availability. The decomposition of coniferous litter in these systems is primarily performed by basidiomycete fungi, which often form large mycelia with a well-developed capacity to reallocate resources spatially-an advantageous trait in heterogeneous environments. In axenic microcosm systems we tested whether fungi increase their biomass production by reallocating N between Pinus sylvestris (Scots pine) needles at different stages of decomposition. We estimated fungal biomass production by analysing the accumulation of the fungal cell wall compound chitin. Monospecific systems were compared with systems with interspecific interactions. We found that the fungi reallocated assimilated N and mycelial growth away from well-degraded litter towards fresh litter components. This redistribution was accompanied by reduced decomposition of older litter. Interconnection of substrates increased over-all fungal C use efficiency (i.e. the allocation of assimilated C to biomass rather than respiration), presumably by enabling fungal translocation of growth-limiting N to litter with higher C quality. Fungal connection between different substrates also restricted N-mineralization and production of dissolved organic N, suggesting that litter saprotrophs in boreal forest ecosystems primarily act to redistribute rather than release N. This spatial integration of different resource qualities was hindered by interspecific interactions, in which litters of contrasting quality were colonised by two different basidiomycete species. The experiments provide a detailed picture of how resource reallocation in two decomposer fungi leads to a more efficient utilisation of spatially separated resources under N-limitation. From an ecosystem point of view, such economic fungal behaviour could potentially contribute to organic matter accumulation in the litter layers of boreal forests.	[Boberg, Johanna B.; Finlay, Roger D.; Stenlid, Jan; Lindahl, Bjorn D.] Swedish Univ Agr Sci, Uppsala BioCtr, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden; [Ekblad, Alf] Univ Orebro, Sch Sci & Technol, Orebro Isotope Lab, SE-70182 Orebro, Sweden	Swedish University of Agricultural Sciences; Orebro University	Boberg, JB (corresponding author), Swedish Univ Agr Sci, Uppsala BioCtr, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden.	Johanna.Boberg@slu.se	Ekblad, Alf/AAG-2632-2019; Finlay, Roger D/B-4731-2009; Stenlid, Jan/K-5909-2019; Lindahl, Björn D./AAH-4538-2019; Finlay, Roger/Q-7796-2019	Finlay, Roger D/0000-0002-3652-2930; Finlay, Roger/0000-0002-3652-2930; Stenlid, Jan/0000-0002-5344-2094; Boberg, Johanna/0000-0002-1300-8883	Swedish University of Agricultural Sciences [2007-1365, 2011-1747]; Swedish Research Council FORMAS	Swedish University of Agricultural Sciences; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	Strategic grant to JS and RDF from Swedish University of Agricultural Sciences (http://www.slu.se/en/) Grants (2007-1365 and 2011-1747) to BL from The Swedish Research Council FORMAS (http://www.formas.se/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2006, AM NAT, V167, P619, DOI 10.1086/503443; Allison SD, 2009, SOIL BIOL BIOCHEM, V41, P293, DOI 10.1016/j.soilbio.2008.10.032; Appuhn A, 2006, SOIL BIOL BIOCHEM, V38, P1040, DOI 10.1016/j.soilbio.2005.09.002; Axelsson B., 1980, Ecological Bulletins, V32, P25; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Berg B, 2000, FOREST ECOL MANAG, V133, P13, DOI 10.1016/S0378-1127(99)00294-7; Berg B., 1981, Ecological Bulletins, V33, P163; BERG B, 1982, CAN J BOT, V60, P1310, DOI 10.1139/b82-167; Boberg J, 2009, LITTER DECOMPOSING F; Boberg J, 2008, SOIL BIOL BIOCHEM, V40, P995, DOI 10.1016/j.soilbio.2007.11.005; Boberg JB, 2011, FUNGAL ECOL, V4, P408, DOI 10.1016/j.funeco.2011.03.004; Boberg JB, 2011, FUNGAL ECOL, V4, P110, DOI 10.1016/j.funeco.2010.09.002; Boberg JB, 2010, FUNCT ECOL, V24, P454, DOI 10.1111/j.1365-2435.2009.01616.x; Boddy L, 1999, MYCOLOGIA, V91, P13, DOI 10.2307/3761190; BODDY L, 1995, CAN J BOT, V73, pS1377, DOI 10.1139/b95-400; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Chadwick DR, 1998, SOIL BIOL BIOCHEM, V30, P47, DOI 10.1016/S0038-0717(97)00090-4; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; DOWSON CG, 1989, NEW PHYTOL, V111, P501, DOI 10.1111/j.1469-8137.1989.tb00713.x; Ekblad A, 1996, PLANT SOIL, V178, P29, DOI 10.1007/BF00011160; Ekschmitt K, 2005, GEODERMA, V128, P167, DOI 10.1016/j.geoderma.2004.12.024; FAHEY TJ, 1985, BIOGEOCHEMISTRY, V1, P257, DOI 10.1007/BF02187202; Frankland JC, 1998, MYCOL RES, V102, P1, DOI 10.1017/S0953756297005364; FRANKLAND JC, 1978, SOIL BIOL BIOCHEM, V10, P323, DOI 10.1016/0038-0717(78)90030-5; Frey SD, 2000, SOIL BIOL BIOCHEM, V32, P689, DOI 10.1016/S0038-0717(99)00205-9; Fry B., 2006, STABLE ISOTOPE ECOLO; Gebauer G, 2000, ECOL STU AN, V142, P144; Hart S.C., 1990, BIOGEOCHEMISTRY, V12, P73; JOHANSSON MB, 1995, CAN J BOT, V73, P1509, DOI 10.1139/b95-163; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lenoir L, 2007, BIOL FERT SOILS, V43, P281, DOI 10.1007/s00374-006-0103-8; LEVI MP, 1969, PHYTOPATHOLOGY, V59, P460; Lindahl BD, 2006, NEW PHYTOL, V169, P389, DOI 10.1111/j.1469-8137.2005.01581.x; LINDAHL BD, 2004, MYCOLOGIST, V18, P79, DOI DOI 10.1017/S0269915X04002046; Lindahl B, 2008, BR MYCOL SY, V28, P183; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Lindahl BO, 2002, PLANT SOIL, V242, P123, DOI 10.1023/A:1019650226585; MELILLO JM, 1989, PLANT SOIL, V115, P189, DOI 10.1007/BF02202587; Moore TR, 2006, ECOSYSTEMS, V9, P46, DOI 10.1007/s10021-004-0026-x; NEWELL K, 1984, SOIL BIOL BIOCHEM, V16, P235, DOI 10.1016/0038-0717(84)90007-5; NORTHUP RR, 1995, NATURE, V377, P227, DOI 10.1038/377227a0; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Paul E.A., 2007, SOIL MICROBIOLOGY EC; Piccolo A, 1996, CHEMOSPHERE, V33, P595, DOI 10.1016/0045-6535(96)00210-X; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; ROBINSON CH, 1993, PLANT SOIL, V151, P139, DOI 10.1007/BF00010794; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Simpson AJ, 2002, NATURWISSENSCHAFTEN, V89, P84, DOI 10.1007/s00114-001-0293-8; Tamm C., 1991, NITROGEN TERRESTRIAL, DOI DOI 10.2307/2260680; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; VENABLES CE, 1989, MYCOL RES, V92, P273, DOI 10.1016/S0953-7562(89)80065-6; Wallander H, 2003, SOIL BIOL BIOCHEM, V35, P997, DOI 10.1016/S0038-0717(03)00121-4; Woodward S, 2008, BR MYCOL SY, V28, P125; Zeller B, 1998, ANN SCI FOREST, V55, P375, DOI 10.1051/forest:19980308	55	47	47	0	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92897	10.1371/journal.pone.0092897	http://dx.doi.org/10.1371/journal.pone.0092897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651625	Green Submitted, gold, Green Published			2022-12-25	WOS:000333352800162
J	Cadby, JA; Buehler, E; Godbout, C; van Weeren, PR; Snedeker, JG				Cadby, Jennifer A.; Buehler, Evelyne; Godbout, Charles; van Weeren, P. Rene; Snedeker, Jess G.			Differences between the Cell Populations from the Peritenon and the Tendon Core with Regard to Their Potential Implication in Tendon Repair	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SMOOTH MUSCLE ACTIN; IN-VITRO; ACHILLES-TENDON; GENE-EXPRESSION; SYNOVIAL SHEATH; FLEXOR TENDONS; DIFFERENTIATION; MATRIX; BONE	The role of intrinsic and extrinsic healing in injured tendons is still debated. In this study, we characterized cell plasticity, proliferative capacity, and migration characteristics as proxy measures of healing potential in cells derived from the peritenon (extrinsic healing) and compared these to cells from the tendon core (intrinsic healing). Both cell populations were extracted from horse superficial digital flexor tendon and characterized for tenogenic and matrix remodeling markers as well as for rates of migration and replication. Furthermore, colony-forming unit assays, multipotency assays, and real-time quantitative polymerase chain reaction analyses of markers of osteogenic and adipogenic differentiation after culture in induction media were performed. Finally, cellular capacity for differentiation towards a myofibroblastic phenotype was assessed. Our results demonstrate that both tendon-and peritenon-derived cell populations are capable of adipogenic and osteogenic differentiation, with higher expression of progenitor cell markers in peritenon cells. Cells from the peritenon also migrated faster, replicate more quickly, and show higher differentiation potential toward a myofibroblastic phenotype when compared to cells from the tendon core. Based on these data, we suggest that cells from the peritenon have substantial potential to influence tendon-healing outcome, warranting further scrutiny of their role.	[Cadby, Jennifer A.; Buehler, Evelyne; Snedeker, Jess G.] Univ Zurich, Dept Orthopaed, Balgrist Hosp, Zurich, Switzerland; [Cadby, Jennifer A.; Buehler, Evelyne; Snedeker, Jess G.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Cadby, Jennifer A.; van Weeren, P. Rene] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands; [Godbout, Charles] Univ Montreal Hosp, Res Ctr CRCHUM, Osteoarthritis Res Unit, Montreal, PQ, Canada	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Utrecht University; Universite de Montreal	Snedeker, JG (corresponding author), Univ Zurich, Dept Orthopaed, Balgrist Hosp, Zurich, Switzerland.	snedeker@ethz.ch	Snedeker, Jess/C-2105-2009; Snedeker, Jess G./X-2098-2019	Snedeker, Jess/0000-0002-8115-0275; Snedeker, Jess G./0000-0002-8115-0275; Godbout, Charles/0000-0003-4805-3454	Bonizzi-Theler Stiftung; Utrecht University, NL	Bonizzi-Theler Stiftung; Utrecht University, NL	The funding was provided in part by the Bonizzi-Theler Stiftung and in part by internal funds of Utrecht University, NL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIEL D, 1991, MATRIX, V11, P184, DOI 10.1016/S0934-8832(11)80157-5; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Cui QB, 2011, EUR J APPL PHYSIOL, V111, P1457, DOI 10.1007/s00421-010-1764-4; de Mos M, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-16; EIKEN O, 1975, SCAND J PLAST RECONS, V9, P182, DOI 10.3109/02844317509022864; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; FURLOW LT, 1976, PLAST RECONSTR SURG, V57, P39, DOI 10.1097/00006534-197601000-00009; GELBERMAN RH, 1992, J HAND SURG-AM, V17A, P551, DOI 10.1016/0363-5023(92)90370-5; Gohr CM, 2007, CONNECT TISSUE RES, V48, P286, DOI 10.1080/03008200701692362; Guest DJ, 2008, STEM CELLS CLONING, V1, P1, DOI 10.2147/SCCAA.S3824; Harris MT, 2004, J ORTHOP RES, V22, P998, DOI 10.1016/j.orthres.2004.02.012; Harrison RK, 2003, J HAND SURG-AM, V28A, P987, DOI 10.1016/S0363-5023(03)00380-0; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hoynowski SM, 2007, BIOCHEM BIOPH RES CO, V362, P347, DOI 10.1016/j.bbrc.2007.07.182; Jarvinen M, 1997, SCAND J MED SCI SPOR, V7, P86; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Jones ME, 2003, J HAND SURG-AM, V28A, P221, DOI 10.1053/jhsu.2003.50044; Jung H.J, 2009, SPORTS MED ARTHROSC, V1, P1; Kajikawa Y, 2007, J CELL PHYSIOL, V210, P684, DOI 10.1002/jcp.20876; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; KVIST M, 1985, PATHOL RES PRACT, V180, P416; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovati A B, 2011, J Biol Regul Homeost Agents, V25, pS75; Lundborg G, 1978, J Hand Surg Am, V3, P21; MATTHEWS P, 1974, J BONE JOINT SURG BR, VB 56, P618; Mienaltowski MJ, 2013, TISSUE ENG PT A, V19, P199, DOI [10.1089/ten.tea.2012.0182, 10.1089/ten.TEA.2012.0182]; Mos Md, 2008, TENDON CELL BEHAV MA; Ohberg L, 2002, BRIT J SPORT MED, V36, P173, DOI 10.1136/bjsm.36.3.173; Ohberg L, 2003, KNEE SURG SPORT TR A, V11, P339, DOI 10.1007/s00167-003-0402-7; Patterson-Kane JC, 2012, J COMP PATHOL, V147, P227, DOI 10.1016/j.jcpa.2012.05.010; Penny J, 2012, FRONT BIOSCI-LANDMRK, V17, P892, DOI 10.2741/3963; Pierre-Jerome C, 2010, ACTA RADIOL, V51, P438, DOI 10.3109/02841851003627809; POTENZA AD, 1964, JAMA-J AM MED ASSOC, V187, P187; Reed SA, 2008, J CELL PHYSIOL, V215, P329, DOI 10.1002/jcp.21312; Rees JD, 2009, AM J SPORT MED, V37, P1855, DOI 10.1177/0363546508324283; Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Sharma RI, 2010, BIOMATERIALS, V31, P7695, DOI 10.1016/j.biomaterials.2010.06.046; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; SKOOG T, 1954, PLAST RECONSTR SURG, V13, P384, DOI 10.1097/00006534-195405000-00005; Taylor SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016337; Violini S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-29; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhang YWW, 2009, VET IMMUNOL IMMUNOP, V130, P114, DOI 10.1016/j.vetimm.2009.01.012	47	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92474	10.1371/journal.pone.0092474	http://dx.doi.org/10.1371/journal.pone.0092474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651449	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000333352800116
J	Deo, S; Patel, TR; Dzananovic, E; Booy, EP; Zeid, K; McEleney, K; Harding, SE; McKenna, SA				Deo, Soumya; Patel, Trushar R.; Dzananovic, Edis; Booy, Evan P.; Zeid, Khalid; McEleney, Kevin; Harding, Stephen E.; McKenna, Sean A.			Activation of 2 ' 5 '-Oligoadenylate Synthetase by Stem Loops at the 5 '-End of the West Nile Virus Genome	PLOS ONE			English	Article							RNASE-L; INTERFERON; REPLICATION; EXPRESSION; SEDIMENTATION; RESISTANCE; CYCLIZATION; SYSTEM; SPREAD; SHAPE	West Nile virus (WNV) has a positive sense RNA genome with conserved structural elements in the 5' and 3'-untranslated regions required for polyprotein production. Antiviral immunity to WNV is partially mediated through the production of a cluster of proteins known as the interferon stimulated genes (ISGs). The 2' 5'-oligoadenylate synthetases (OAS) are key ISGs that help to amplify the innate immune response. Upon interaction with viral double stranded RNA, OAS enzymes become activated and enable the host cell to restrict viral propagation. Studies have linked mutations in the OAS1 gene to increased susceptibility to WNV infection, highlighting the importance of OAS1 enzyme. Here we report that the region at the 5'-end of the WNV genome comprising both the 5'-UTR and initial coding region is capable of OAS1 activation in vitro. This region contains three RNA stem loops (SLI, SLII, and SLIII), whose relative contribution to OAS1 binding affinity and activation were investigated using electrophoretic mobility shift assays and enzyme kinetics experiments. Stem loop I, comprising nucleotides 1-73, is dispensable for maximum OAS1 activation, as a construct containing only SLII and SLIII was capable of enzymatic activation. Mutations to the RNA binding site of OAS1 confirmed the specificity of the interaction. The purity, monodispersity and homogeneity of the 5'-end (SLI/II/III) and OAS1 were evaluated using dynamic light scattering and analytical ultra-centrifugation. Solution conformations of both the 5'-end RNA of WNV and OAS1 were then elucidated using small-angle x-ray scattering. In the context of purified components in vitro, these data demonstrate the recognition of conserved secondary structural elements of the WNV genome by a member of the interferon-mediated innate immune response.	[Deo, Soumya; Patel, Trushar R.; Dzananovic, Edis; Booy, Evan P.; Zeid, Khalid; McEleney, Kevin; McKenna, Sean A.] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Harding, Stephen E.] Univ Nottingham, Natl Ctr Macromol Hydrodynam, Sutton, Bonington, England; [McKenna, Sean A.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [McEleney, Kevin] Univ Manitoba, Manitoba Inst Mat, Winnipeg, MB, Canada	University of Manitoba; University of Nottingham; University of Manitoba; University of Manitoba	McKenna, SA (corresponding author), Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada.	Sean.mckenna@umanitoba.ca	Patel, Trushar R./AAB-6250-2020; Patel, Trushar R/F-2776-2011	Patel, Trushar R./0000-0003-0627-2923; Patel, Trushar R/0000-0003-0627-2923; McKenna, Sean/0000-0002-9407-7257; Harding, Stephen E./0000-0002-7798-9692	Natural Sciences and Engineering Research Council of Canada (NSERC); Manitoba Health Research Council (MHRC); University of Manitoba GETS program; Manitoba Health Research Council Postdoctoral Fellowship; University of Manitoba; NSERC USRA program; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Health Research Council (MHRC); University of Manitoba GETS program; Manitoba Health Research Council Postdoctoral Fellowship; University of Manitoba; NSERC USRA program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Manitoba Health Research Council (MHRC). ED was partially supported by the University of Manitoba GETS program. EPB was support by a Manitoba Health Research Council Postdoctoral Fellowship. SD was supported by a University of Manitoba Graduate Fellowship and Faculty of Science Scholarships. KZ was supported by the NSERC USRA program. TRP was supported by a Canadian Institutes of Health Research Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737; Bigham AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024745; Booy Evan P, 2012, Methods Mol Biol, V941, P69, DOI 10.1007/978-1-62703-113-4_6; Borisevich V, 2006, VIROLOGY, V349, P371, DOI 10.1016/j.virol.2006.02.013; Brinton MA, 2001, ANN NY ACAD SCI, V951, P207; Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654; Calisher CH, 2000, VIRAL IMMUNOL, V13, P411, DOI 10.1089/vim.2000.13.411; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; CHEBATH J, 1987, NATURE, V330, P587, DOI 10.1038/330587a0; Dam J, 2004, METHOD ENZYMOL, V384, P185; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Dzananovic E, 2013, RNA, V19, P333, DOI 10.1261/rna.035931.112; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10; Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Han YC, 2012, CELL REP, V2, P902, DOI 10.1016/j.celrep.2012.09.004; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Hartmann R, 1998, J BIOL CHEM, V273, P3236, DOI 10.1074/jbc.273.6.3236; Hovanessian AG, 2007, BIOCHIMIE, V89, P779, DOI 10.1016/j.biochi.2007.02.003; Ivanyi-Nagy R, 2012, VIRUS RES, V167, P226, DOI 10.1016/j.virusres.2012.05.003; Kajaste-Rudnitski A, 2006, J BIOL CHEM, V281, P4624, DOI 10.1074/jbc.M508649200; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321; Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728; Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08; Markoff L, 2003, ADV VIRUS RES, V59, P177, DOI 10.1016/S0065-3527(03)59006-6; McKenna SA, 2007, NAT PROTOC, V2, P3270, DOI 10.1038/nprot.2007.480; Meng H, 2012, J MOL BIOL, V422, P635, DOI 10.1016/j.jmb.2012.06.017; Patel TR, 2012, MATRIX BIOL, V31, P135, DOI 10.1016/j.matbio.2011.11.004; Patel TR, 2010, MATRIX BIOL, V29, P565, DOI 10.1016/j.matbio.2010.07.004; Patel TR, 2008, MACROMOL BIOSCI, V8, P1108, DOI 10.1002/mabi.200800064; Peisley A, 2012, CELL MOL LIFE SCI; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; Polacek C, 2009, J VIROL, V83, P1161, DOI 10.1128/JVI.01362-08; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; SANGSTER MY, 1994, J VIROL, V68, P448, DOI 10.1128/JVI.68.1.448-452.1994; Savage HM, 1999, AM J TROP MED HYG, V61, P600, DOI 10.4269/ajtmh.1999.61.600; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WATHELET M, 1986, FEBS LETT, V196, P113, DOI 10.1016/0014-5793(86)80224-1; Yakub I, 2005, J INFECT DIS, V192, P1741, DOI 10.1086/497340; Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D	55	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92545	10.1371/journal.pone.0092545	http://dx.doi.org/10.1371/journal.pone.0092545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651762	gold, Green Published			2022-12-25	WOS:000333352800125
J	Shaw, AD; Tiwari, Y; Kaplan, W; Heath, A; Mitchell, PB; Schofield, PR; Fullerton, JM				Shaw, Alex D.; Tiwari, Yash; Kaplan, Warren; Heath, Anna; Mitchell, Philip B.; Schofield, Peter R.; Fullerton, Janice M.			Characterisation of Genetic Variation in ST8SIA2 and Its Interaction Region in NCAM1 in Patients with Bipolar Disorder	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; DNA-SEQUENCING DATA; GENOME-WIDE SCAN; POLYSIALIC-ACID; PSA-NCAM; HUMAN POLYSIALYLTRANSFERASE; SUSCEPTIBILITY LOCUS; PREFRONTAL CORTEX; SCHIZOPHRENIA; EXPRESSION	Alpha-2,8-sialyltransferase 2 (ST8SIA2) is an enzyme responsible for the transfer of polysialic acid (PSA) to glycoproteins, principally the neuronal cell adhesion molecule (NCAM1), and is involved in neuronal plasticity. Variants within ST8SIA2 have previously shown association with bipolar disorder, schizophrenia and autism. In addition, altered PSA-NCAM expression in brains of patients with schizophrenia or bipolar disorder indicates a functional dysregulation of glycosylation in mental illness. To explore the role of sequence variation affecting PSA-NCAM formation, we conducted a targeted re-sequencing study of a similar to 100 kb region - including the entire ST8SIA2 gene and its region of interaction with NCAM1 - in 48 Caucasian cases with bipolar disorder using the Roche 454 platform. We identified over 400 DNA variants, including 47 putative novel variants not described in dbSNP. Validation of a subset of variants via Sequenom showed high reliability of Roche 454 genotype calls (97% genotype concordance, with 80% of novel variants independently verified). We did not observe major loss-of-function mutations that would affect PSA-NCAM formation, either by ablating ST8SIA2 function or by affecting the ability of NCAM1 to be glycosylated. However, we identified 13 SNPs in the UTRs of ST8SIA2, a synonymous coding SNP in exon 5 (rs2305561, P207P) and many additional non-coding variants that may influence splicing or regulation of ST8SIA2 expression. We calculated nucleotide diversity within ST8SIA2 on specific haplotypes, finding that the diversity on the specific "risk" and "protective" haplotypes was lower than other non-disease-associated haplotypes, suggesting that putative functional variation may have arisen on a spectrum of haplotypes. We have identified common and novel variants (rs11074064, rs722645, 15:92961050) that exist on a spectrum of haplotypes, yet are plausible candidates for conferring the effect of risk and protective haplotypes via multiple enhancer elements. A Galaxy workflow/pipeline for sequence analysis used herein is available at: https://main.g2.bx.psu.edu/u/a-shaw-neura/p/next-generation-resources.	[Shaw, Alex D.; Tiwari, Yash; Heath, Anna; Schofield, Peter R.; Fullerton, Janice M.] Neurosci Res Australia, Sydney, NSW, Australia; [Shaw, Alex D.; Tiwari, Yash; Schofield, Peter R.; Fullerton, Janice M.] Schizophrenia Res Inst, Sydney, NSW, Australia; [Tiwari, Yash; Schofield, Peter R.; Fullerton, Janice M.] Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW, Australia; [Kaplan, Warren] Garvan Inst, Peter Wills Bioinformat Ctr, Sydney, NSW, Australia; [Mitchell, Philip B.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Mitchell, Philip B.] Black Dog Inst, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney; Black Dog Institute	Fullerton, JM (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	j.fullerton@neura.edu.au	Fullerton, Janice/F-8485-2013; Schofield, Peter/C-9669-2011	Fullerton, Janice/0000-0003-4014-4490; Mitchell, Philip/0000-0002-7954-5235; Shaw, Alex/0000-0001-7548-1329; Schofield, Peter/0000-0003-2967-9662	Australian National Medical and Health Research Council [630574, 510135, 1037196]; Schizophrenia Research Institute; NSW Health; Australian National Health and Medical Research Council [401184]; Cancer Institute NSW [11/REG/1-10]; Australian Postgraduate Award	Australian National Medical and Health Research Council(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute; NSW Health; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; Australian Postgraduate Award(Australian Government)	This work was supported by the Australian National Medical and Health Research Council (project grant 630574, and program grants 510135 and 1037196) and by the Schizophrenia Research Institute, utilizing infrastructure funding from NSW Health. Genetic Repositories Australia is supported by an Australian National Health and Medical Research Council (Grant # 401184). The authors used Garvan Galaxy, funded by a Cancer Institute NSW grant (11/REG/1-10). Mr Yash Tiwari was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; America N, 2011, NATURE, V467, P1026; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Arai M, 2004, BIOL PSYCHIAT, V55, P804, DOI 10.1016/j.biopsych.2004.01.009; Atz ME, 2007, PSYCHIAT GENET, V17, P55, DOI 10.1097/YPG.0b013e328012d850; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Castillo-Gomez E, 2008, EXP NEUROL, V214, P97, DOI 10.1016/j.expneurol.2008.07.018; Chazal G, 2000, J NEUROSCI, V20, P1446; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Darnell JC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012344; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; FINNE J, 1982, J BIOL CHEM, V257, P1966; Foley DA, 2010, J BIOL CHEM, V285, P27360, DOI 10.1074/jbc.M110.140038; Foley DA, 2009, J BIOL CHEM, V284, P15505, DOI 10.1074/jbc.M809696200; Frasca A, 2008, INT J NEUROPSYCHOPH, V11, P591, DOI 10.1017/S1461145708009061; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Harismendy O, 2009, BIOTECHNIQUES, V46, P229, DOI 10.2144/000113082; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Kamien B, 2014, AM J MED GENET A, V164, P782, DOI 10.1002/ajmg.a.36345; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Krocher T, 2015, BRAIN STRUCT FUNCT, V220, P71, DOI 10.1007/s00429-013-0638-z; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mackowiak M, 2009, EUR NEUROPSYCHOPHARM, V19, P125, DOI 10.1016/j.euroneuro.2008.10.001; Maheu ME, 2013, J PSYCHIATR RES, V47, P384, DOI 10.1016/j.jpsychires.2012.11.013; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; McAuley EZ, 2009, MOL PSYCHIATR, V14, P492, DOI 10.1038/sj.mp.4002146; McAuley EZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038172; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mikkonen M, 1998, ANN NEUROL, V44, P923, DOI 10.1002/ana.410440611; Muhlenhoff M, 2013, NEUROCHEM RES, V38, P1134, DOI 10.1007/s11064-013-0979-2; Muhleisen T, 2014, NAT COMMUN IN PRESS; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nakayama J, 1996, J BIOL CHEM, V271, P1829, DOI 10.1074/jbc.271.4.1829; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Park N, 2004, MOL PSYCHIATR, V9, P1091, DOI 10.1038/sj.mp.4001541; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; R Core Team, 2012, R LANG ENV STAT COMP; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Roy-Engel AM, 2002, GENOME RES, V12, P1333, DOI 10.1101/gr.384802; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00061; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P902, DOI 10.1016/j.biopsych.2006.07.036; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; van Baren MJ, 2004, BIOINFORMATICS, V20, P591, DOI 10.1093/bioinformatics/btg473; Varea E, 2012, J PSYCHIATR RES, V46, P189, DOI 10.1016/j.jpsychires.2011.10.011; Vazza G, 2007, MOL PSYCHIATR, V12, P87, DOI 10.1038/sj.mp.4001895	63	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92556	10.1371/journal.pone.0092556	http://dx.doi.org/10.1371/journal.pone.0092556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651862	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800128
J	Venturini, G; Di Gioia, SA; Harper, S; Weigel-DiFranco, C; Rivolta, C; Berson, EL				Venturini, Giulia; Di Gioia, Silvio Alessandro; Harper, Shyana; Weigel-DiFranco, Carol; Rivolta, Carlo; Berson, Eliot L.			Molecular Genetics of FAM161A in North American Patients with Early-Onset Retinitis Pigmentosa	PLOS ONE			English	Article							MUTATIONS; PRPF31	Retinitis pigmentosa (RP) is a hereditary disease that leads to the progressive degeneration of retinal photoreceptor cells and to blindness. It is caused by mutations in several distinct genes, including the ciliary gene FAM161A, which is associated with a recessive form of this disorder. Recent investigations have revealed that defects in FAM161A represent a rather prevalent cause of hereditary blindness in Israel and the Palestinian territories, whereas they seem to be rarely present within patients from Germany. Genetic or clinical data are currently not available for other countries. In this work, we screened a cohort of patients with recessive RP from North America to determine the frequency of FAM161A mutations in this ethnically-mixed population and to assess the phenotype of positive cases. Out of 273 unrelated patients, only 3 subjects had defects in FAM161A. A fourth positive patient, the sister of one of these index cases, was also identified following pedigree analysis. They were all homozygous for the p.T452Sfx3 mutation, which was previously reported as a founder DNA variant in the Israeli and Palestinian populations. Analysis of cultured lymphoblasts from patients revealed that mutant FAM161A transcripts were actively degraded by nonsense-mediated mRNA decay. Electroretinographic testing showed 30 Hz cone flicker responses in the range of 0.10 to 0.60 microvolts in all cases at their first visit (age 12 to 23) (lower norm = 50 mu V) and of 0.06 to 0.32 microvolts at their most recent examination (age 27 to 43), revealing an early-onset of this progressive disease. Our data indicate that mutations in FAM161A are responsible for 1% of recessive RP cases in North America, similar to the prevalence detected in Germany and unlike the data from Israel and the Palestinian territories. We also show that, at the molecular level, the disease is likely caused by FAM161A protein deficiency.	[Venturini, Giulia; Di Gioia, Silvio Alessandro; Rivolta, Carlo] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Harper, Shyana; Weigel-DiFranco, Carol; Berson, Eliot L.] Harvard Univ, Sch Med, Berman Gund Lab Study Retinal Degenerat, Massachusetts Eye & Ear, Boston, MA USA	University of Lausanne; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Rivolta, C (corresponding author), Univ Lausanne, Dept Med Genet, Lausanne, Switzerland.	carlo.rivolta@unil.ch		Rivolta, Carlo/0000-0002-0733-9950; Di Gioia, Silvio Alessandro/0000-0002-7235-5682	Swiss National Science Foundation [310030_138346]; Gebert Ruf Foundation, Switzerland; Foundation Fighting Blindness, Columbia, Maryland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gebert Ruf Foundation, Switzerland; Foundation Fighting Blindness, Columbia, Maryland	This work was supported by the Swiss National Science Foundation (Grant 310030_138346), the Gebert Ruf Foundation, Switzerland (Rare Diseases - New Technologies grant), and a Center Grant to the Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, to Dr. Berson from The Foundation Fighting Blindness, Columbia, Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P382, DOI 10.1016/j.ajhg.2010.07.022; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Di Gioia SA, 2012, HUM MOL GENET, V21, P5174, DOI 10.1093/hmg/dds368; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Frio TR, 2008, J CLIN INVEST, V118, P1519, DOI 10.1172/JCI34211; Gu SM, 1999, J MED GENET, V36, P705; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Langmann T, 2010, AM J HUM GENET, V87, P376, DOI 10.1016/j.ajhg.2010.07.018; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Rivolta C, 2006, HUM MUTAT, V27, P644, DOI 10.1002/humu.20325; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Zach F, 2012, HUM MOL GENET, V21, P4573, DOI 10.1093/hmg/dds268	17	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92479	10.1371/journal.pone.0092479	http://dx.doi.org/10.1371/journal.pone.0092479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651477	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000333352800117
J	Veselits, M; Tanaka, A; Lipkowitz, S; O'Neill, S; Sciammas, R; Finnegan, A; Zhang, J; Clark, MR				Veselits, Margaret; Tanaka, Azusa; Lipkowitz, Stanley; O'Neill, Shannon; Sciammas, Roger; Finnegan, Alison; Zhang, Jian; Clark, Marcus R.			Recruitment of Cbl-b to B Cell Antigen Receptor Couples Antigen Recognition to Toll-Like Receptor 9 Activation in Late Endosomes	PLOS ONE			English	Article							MHC CLASS-II; LIGHT-CHAIN RECOMBINATION; UBIQUITIN LIGASE CBL; C-CBL; NEGATIVE REGULATION; IG-BETA; PROTEINS; CIN85; COMPARTMENTS; DEGRADATION	Casitas B-lineage lymphoma-b (Cbl-b) is a ubiquitin ligase (E3) that modulates signaling by tagging molecules for degradation. It is a complex protein with multiple domains and binding partners that are not involved in ubiquitinating substrates. Herein, we demonstrate that Cbl-b, but not c-Cbl, is recruited to the clustered B cell antigen receptor (BCR) and that Cbl-b is required for entry of endocytosed BCRs into late endosomes. The E3 activity of Cbl-b is not necessary for BCR endocytic trafficking. Rather, the ubiquitin associated (UBA) domain is required. Furthermore, the Cbl-b UBA domain is sufficient to confer the receptor trafficking functions of Cbl-b on c-Cbl. Cbl-b is also required for entry of the Toll-like receptor 9 (TLR9) into late endosomes and for the in vitro activation of TLR9 by BCR-captured ligands. These data indicate that Cbl-b acts as a scaffolding molecule to coordinate the delivery of the BCR and TLR9 into subcellular compartments required for productively delivering BCR-captured ligands to TLR9.	[Veselits, Margaret; Tanaka, Azusa; Sciammas, Roger; Clark, Marcus R.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Veselits, Margaret; Tanaka, Azusa; Sciammas, Roger; Clark, Marcus R.] Univ Chicago, Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Lipkowitz, Stanley] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [O'Neill, Shannon] Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO USA; [O'Neill, Shannon] Univ Colorado, Denver, CO 80202 USA; [O'Neill, Shannon] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Finnegan, Alison] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Finnegan, Alison] Rush Univ, Med Ctr, Dept Internal Med, Rheumatol Sect, Chicago, IL 60612 USA; [Zhang, Jian] Univ Chicago, Dept Med, Nephrol Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Jewish Health; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Rush University; Rush University; University of Chicago	Clark, MR (corresponding author), Univ Chicago, Dept Med, Rheumatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mclark@medicine.bsd.uchicago.edu	Zhang, Jian/A-2564-2008	Zhang, Jian/0000-0002-9523-5296	National Institutes of Health [GM088847, GM101090, AI090901]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101090, R01GM088847, R01GM067772, R21GM076601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (MRC, GM088847 and GM101090 and JZ, AI090901). This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bustelo XR, 1997, ONCOGENE, V15, P2511, DOI 10.1038/sj.onc.1201430; Cascalho M, 2007, CRIT REV IMMUNOL, V27, P141, DOI 10.1615/CritRevImmunol.v27.i2.20; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Clark MR, 2004, CURR OPIN IMMUNOL, V16, P382, DOI 10.1016/j.coi.2004.03.007; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Ferrari G, 1997, J CELL BIOL, V139, P1433, DOI 10.1083/jcb.139.6.1433; Haglund K, 2002, P NATL ACAD SCI USA, V99, P12191, DOI 10.1073/pnas.192462299; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hou P, 2006, PLOS BIOL, V4, P1147, DOI 10.1371/journal.pbio.0040200; Hunt SD, 2011, BIOCHEM SOC T, V39, P1179, DOI 10.1042/BST0391179; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Kitaura Y, 2007, IMMUNITY, V26, P567, DOI 10.1016/j.immuni.2007.03.015; Kowanetz K, 2004, MOL BIOL CELL, V15, P3155, DOI 10.1091/mbc.E03-09-0683; Lankar D, 2002, J EXP MED, V195, P461, DOI 10.1084/jem.20011543; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Li C, 2002, INT IMMUNOL, V14, P1179, DOI 10.1093/intimm/dxf083; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Luisiri P, 1996, J BIOL CHEM, V271, P5158; Mandal M, 2009, NAT IMMUNOL, V10, P1110, DOI 10.1038/ni.1785; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; O'Neill SK, 2009, P NATL ACAD SCI USA, V106, P6262, DOI 10.1073/pnas.0812922106; Oksvold MP, 2008, MOL IMMUNOL, V45, P925, DOI 10.1016/j.molimm.2007.08.002; Paolino M, 2010, SEMIN IMMUNOPATHOL, V32, P137, DOI 10.1007/s00281-010-0197-9; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Qiao GL, 2007, J IMMUNOL, V179, P4473, DOI 10.4049/jimmunol.179.7.4473; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; RIBERDY JM, 1994, J CELL BIOL, V125, P1225, DOI 10.1083/jcb.125.6.1225; Schnyder T, 2011, IMMUNITY, V34, P905, DOI 10.1016/j.immuni.2011.06.001; Siemasko K, 1998, J IMMUNOL, V160, P5203; Siemasko K, 2001, CURR OPIN IMMUNOL, V13, P32, DOI 10.1016/S0952-7915(00)00178-3; Smit GDV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000217; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; Yasuda T, 2000, J EXP MED, V191, P641, DOI 10.1084/jem.191.4.641; Zhang J, 2009, CELL RES, V19, P733, DOI 10.1038/cr.2009.51; Zhang M, 2007, J IMMUNOL, V179, P4435, DOI 10.4049/jimmunol.179.7.4435	50	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e89792	10.1371/journal.pone.0089792	http://dx.doi.org/10.1371/journal.pone.0089792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651487	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800004
J	Wilken, PM; Steenkamp, ET; Wingfield, MJ; de Beer, ZW; Wingfield, BD				Wilken, P. Markus; Steenkamp, Emma T.; Wingfield, Michael J.; de Beer, Z. Wilhelm; Wingfield, Brenda D.			DNA Loss at the Ceratocystis fimbriata Mating Locus Results in Self- Sterility	PLOS ONE			English	Article							ASCOSPORE DIMORPHISM; NEUROSPORA-CRASSA; GENES; SEQUENCE; SEX; EVOLUTION; STRAINS; PATHOGEN; BEHAVIOR; SYSTEMS	Fungi have evolved a remarkable diversity of reproductive strategies. Some of these, most notably those of the model fungi, have been well studied but others are poorly understood. The latter is also true for uni-directional mating type switching, which has been reported in only five fungal genera, including Ceratocystis. Mating type switching allows a self-fertile fungal isolate to produce both self-fertile and self-sterile offspring. This study considered the molecular nature of uni-directional mating type switching in the type species of Ceratocystis, C. fimbriata. To do this, the genome of C. fimbriata was first examined for the presence of mating type genes. Three mating genes (MAT1-1-1, MAT1-2-1 and MAT1-1-2) were found in an atypical organisation of the mating type locus. To study the effect that uni-directional switching has on this locus, several self-sterile offspring were analysed. Using a combination of next generation and conventional Sanger sequencing, it was shown that a 3581 base pair (bp) region had been completely deleted from the MAT locus. This deletion, which includes the entire MAT1-2-1 gene, results in the permanent loss of self-fertility, rendering these isolates exclusively self-sterile. Our data also suggest that the deletion mechanism is tightly controlled and that it always occurs at the same genomic position. Two 260 bp direct repeats flanking the deleted region are strongly implicated in the process, although the exact mechanism behind the switching remains unclear.	[Wilken, P. Markus; Wingfield, Michael J.; Wingfield, Brenda D.] Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Genet, ZA-0002 Pretoria, South Africa; [Steenkamp, Emma T.; de Beer, Z. Wilhelm] Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria	Wingfield, BD (corresponding author), Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Genet, ZA-0002 Pretoria, South Africa.	brenda.wingfield@up.ac.za	de Beer, Z. Wilhelm/B-6353-2008; Wilken, Markus/B-2049-2010; Steenkamp, Emma T/B-7958-2009; Wingfield, Michael J/A-9473-2008; de Beer, Wilhelm/AAK-9266-2020; de Beer, Z. Wilhelm/O-3194-2019; Wingfield, Brenda D./B-1376-2008	de Beer, Z. Wilhelm/0000-0001-9758-8987; Wilken, Markus/0000-0003-0827-6098; Steenkamp, Emma T/0000-0003-0217-8219; de Beer, Z. Wilhelm/0000-0001-9758-8987; Wingfield, Brenda D./0000-0002-6189-1519	National Research Foundation (NRF); Centres of Excellence and the Technology and Human Resources Programmes of the South African Departments of Science and Technology (DST); Trade Industry (DTI); University of Pretoria; National Research Foundation of South Africa [83924]	National Research Foundation (NRF); Centres of Excellence and the Technology and Human Resources Programmes of the South African Departments of Science and Technology (DST); Trade Industry (DTI); University of Pretoria; National Research Foundation of South Africa(National Research Foundation - South Africa)	The authors thank the following institutions and programmes for financial support: the National Research Foundation (NRF) and the Centres of Excellence and the Technology and Human Resources Programmes of the South African Departments of Science and Technology (DST) and Trade Industry (DTI), respectively, as well as the University of Pretoria and members of the Tree Pathology Co-operative Programme (TPCP). This work is based on research supported in part by a number of grants from the National Research Foundation of South Africa (includes Grant specific unique reference number (UID) 83924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Arie T, 1997, FUNGAL GENET BIOL, V21, P118, DOI 10.1006/fgbi.1997.0961; Aronstein KA, 2007, MYCOLOGIA, V99, P553, DOI 10.3852/mycologia.99.4.553; ASTELL CR, 1981, CELL, V27, P15, DOI 10.1016/0092-8674(81)90356-1; Barnes I, 2001, PLANT DIS, V85, P317, DOI [10.1094/PDIS.2001.85.3.317, 10.1094/PDIS.2001.85.9.1029B]; BARNETT HL, 1947, MYCOLOGIA, V39, P699, DOI 10.2307/3755220; Betley JN, 2002, CURR BIOL, V12, P1756, DOI 10.1016/S0960-9822(02)01220-4; Bidard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021476; Billiard S, 2012, J EVOLUTION BIOL, V25, P1020, DOI 10.1111/j.1420-9101.2012.02495.x; Bobrowicz P, 2002, MOL MICROBIOL, V45, P795, DOI 10.1046/j.1365-2958.2002.03052.x; BUTLER ET, 1982, J BIOL CHEM, V257, P5772; Butler G, 2010, CLIN MICROBIOL REV, V23, P140, DOI 10.1128/CMR.00053-09; Chitrampalam P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056895; Conde-Ferraez L, 2007, MOL PLANT PATHOL, V8, P111, DOI [10.1111/j.1364-3703.2006.00376.x, 10.1111/J.1364-3703.2006.00376.X]; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; COPPINRAYNAL E, 1989, MOL GEN GENET, V219, P270, DOI 10.1007/BF00261187; Cozijnsen AJ, 2003, CURR GENET, V43, P351, DOI 10.1007/s00294-003-0391-6; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; FARETRA F, 1988, J GEN MICROBIOL, V134, P2543; Fraser JA, 2005, CURR OPIN GENET DEV, V15, P645, DOI 10.1016/j.gde.2005.09.002; Gioti A, 2012, MOL BIOL EVOL, V29, P3215, DOI 10.1093/molbev/mss132; GLASS NL, 1990, P NATL ACAD SCI USA, V87, P4912, DOI 10.1073/pnas.87.13.4912; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Harrington TC, 1997, CURR GENET, V32, P52, DOI 10.1007/s002940050247; Harrington TC, 1995, INOCULUM, V46, P18; Heitman J., 2007, SEX FUNGI MOL DETERM; Heitman J, 2013, MYCOLOGIA, V105, P1, DOI 10.3852/12-253; Kanematsu S, 2007, CURR GENET, V52, P11, DOI 10.1007/s00294-007-0132-3; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; LABARERE J, 1992, GENETICS, V131, P307; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Li WJ, 2010, EUKARYOT CELL, V9, P46, DOI 10.1128/EC.00259-09; Lin Xiaorong, 2007, P35; Martin SH, 2011, FUNGAL GENET BIOL, V48, P731, DOI 10.1016/j.fgb.2011.03.005; MATHIESON MJ, 1952, ANN BOT-LONDON, V16, P449, DOI 10.1093/oxfordjournals.aob.a083327; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; Nelson MA, 1996, TRENDS GENET, V12, P69, DOI 10.1016/0168-9525(96)81403-X; Ni M, 2011, ANNU REV GENET, V45, P405, DOI 10.1146/annurev-genet-110410-132536; NICKOLOFF JA, 1986, P NATL ACAD SCI USA, V83, P7831, DOI 10.1073/pnas.83.20.7831; Nygren K, 2012, MOL BIOL EVOL, V29, P3827, DOI 10.1093/molbev/mss193; OLSON EO, 1949, PHYTOPATHOLOGY, V39, P548; PERKINS DD, 1987, GENETICS, V115, P215; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2001, MOL CLONING LAB MANU; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Turgeon B. Gillian, 2007, P93; Turgeon BG, 1998, ANNU REV PHYTOPATHOL, V36, P115, DOI 10.1146/annurev.phyto.36.1.115; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; UHM JY, 1983, PHYTOPATHOLOGY, V73, P565, DOI 10.1094/Phyto-73-565; van Wyk M, 2004, STUD MYCOL, P273; Waalwijk C, 2002, FUNGAL GENET BIOL, V35, P277, DOI 10.1006/fgbi.2001.1322; Wada R, 2012, APPL ENVIRON MICROB, V78, P2819, DOI 10.1128/AEM.07034-11; WEBSTER RK, 1967, MYCOLOGIA, V59, P212, DOI 10.2307/3756794; Wik L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-109; Wilken PM, 2013, IMA FUNGUS, V4, P357, DOI 10.5598/imafungus.2013.04.02.14; Witthuhn RC, 2000, CURR GENET, V38, P48, DOI 10.1007/s002940000131; Yokoyama E, 2003, APPL ENVIRON MICROB, V69, P5019, DOI 10.1128/AEM.69.8.5019-5022.2003; Yokoyama E, 2005, FEMS MICROBIOL LETT, V250, P145, DOI 10.1016/j.femsle.2005.07.004; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	66	38	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92180	10.1371/journal.pone.0092180	http://dx.doi.org/10.1371/journal.pone.0092180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651494	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800079
J	Aga, M; Bentz, GL; Raffa, S; Torrisi, MR; Kondo, S; Wakisaka, N; Yoshizaki, T; Pagano, JS; Shackelford, J				Aga, M.; Bentz, G. L.; Raffa, S.; Torrisi, M. R.; Kondo, S.; Wakisaka, N.; Yoshizaki, T.; Pagano, J. S.; Shackelford, J.			Exosomal HIF1 alpha supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes	ONCOGENE			English	Article							INDUCIBLE FACTOR 1-ALPHA; MULTIVESICULAR BODIES; MESSENGER-RNAS; HYPOXIA; MICROVESICLES; MECHANISM; RELEASE; CELLS; PALMITOYLATION; INHIBITION	It has emerged recently that exosomes are potential carriers of pro-tumorigenic factors that participate in oncogenesis. However, whether oncogenic transcription factors are transduced by exosomes is unknown. Hypoxia-inducible factor-1 alpha (HIF1 alpha) transcriptionally regulates numerous key aspects of tumor development and progression by promoting a more aggressive tumor phenotype, characterized by increased proliferation and invasiveness coupled with neoangiogenesis. It has been shown that the principal oncoprotein of Epstein-Barr virus (EBV), latent membrane protein 1 (LMP1), drives oncogenic processes and tumor progression of the highly invasive EBV malignancy, nasopharyngeal carcinoma (NPC). We now demonstrate that endogenous HIF1 alpha is detectable in exosomes and that LMP1 significantly increases levels of HIF1 alpha in exosomes. HIF1 recovered from exosomes retains DNA-binding activity and is transcriptionally active in recipient cells after exosome uptake. We also show that treatment of EBV-negative cells with LMP1-exosomes increases migration and invasiveness of NP cell lines in functional assays, which correlates with the phenotype associated with epithelial-mesenchymal transition (EMT). In addition, we provide evidence that HIF1 alpha itself participates in exosome-mediated pro-metastatic effects in recipient cells, as exosome-mediated delivery of active and inactive forms of HIF1 alpha results in reciprocal changes in the expression of E- and N-cadherins associated with EMT. Further, immunohistochemical analysis of NPC tumor tissues revealed direct correlation between protein levels of LMP1 and of the endosome/exosome marker tetraspanin, CD63, which suggests an increase in exosome formation in this EBV-positive malignancy. We hypothesize that exosome-mediated transfer of functional pro-metastatic factors by LMP1-positive NPC cells to surrounding tumor cells promotes cancer progression.	[Aga, M.; Bentz, G. L.; Pagano, J. S.; Shackelford, J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Aga, M.; Kondo, S.; Wakisaka, N.; Yoshizaki, T.] Kanazawa Univ, Grad Sch Med, Div Otolaryngol, Kanazawa, Ishikawa, Japan; [Raffa, S.; Torrisi, M. R.] Univ Roma La Sapienza, Dipartimento Med Clin & Mol, I-00185 Rome, Italy; [Shackelford, J.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Kanazawa University; Sapienza University Rome; University of North Carolina; University of North Carolina Chapel Hill	Pagano, JS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	joseph_pagano@med.unc.edu	Raffa, Salvatore/GPX-5723-2022; RAFFA, SALVATORE/AAL-5514-2020; Raffa, Salvatore/AAW-7060-2020	Raffa, Salvatore/0000-0001-9501-7638; 	National Cancer Institute [2P01-CA19014-26]; International Training Program of Cancer Research Institute of Kanazawa University; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25670713] Funding Source: KAKEN	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); International Training Program of Cancer Research Institute of Kanazawa University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Meckes DG Jr. and Raab-Traub N (University of North Carolina, Chapel Hill, NC, USA) for providing helpful advice on the further experimental strategies and Richard DE (Centre de Recherche en Cancerologie de l'Universite Laval, Quebec, QC, Canada) for the HA-DN HIF1a plasmid. This work was supported by a grant from the National Cancer Institute 2P01-CA19014-26 and International Training Program of Cancer Research Institute of Kanazawa University.	Ceccarelli S, 2007, INT J CANCER, V121, P1494, DOI 10.1002/ijc.22844; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Corrado C, 2013, INT J MOL SCI, V14, P5338, DOI 10.3390/ijms14035338; Daker M, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-34; Denzer K, 2000, J CELL SCI, V113, P3365; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Gourzones C, 2012, SEMIN CANCER BIOL, V22, P127, DOI 10.1016/j.semcancer.2012.01.002; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hendrix A, 2011, INT J DEV BIOL, V55, P879, DOI 10.1387/ijdb.113391ah; Hong BS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-556; Houali K, 2007, CLIN CANCER RES, V13, P4993, DOI 10.1158/1078-0432.CCR-06-2945; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; Kondo S, 2006, CANCER RES, V66, P9870, DOI 10.1158/0008-5472.CAN-06-1679; Kovalenko OV, 2004, BIOCHEM J, V377, P407, DOI 10.1042/BJ20031037; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Le Bras GF, 2012, CELL ADHES MIGR, V6, P365, DOI 10.4161/cam.21326; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Meckes Jr DG, P NATL ACAD IN PRESS, V110, pE2925; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Raab-Traub N, 2012, CURR OPIN VIROL, V2, P453, DOI 10.1016/j.coviro.2012.07.001; Rana S, 2011, BIOCHEM SOC T, V39, P559, DOI 10.1042/BST0390559; Richard DE, 2000, J BIOL CHEM, V275, P26765; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079636; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Staubach S, 2009, PROTEOMICS, V9, P2820, DOI 10.1002/pmic.200800793; Sund M, 2009, CANCER METAST REV, V28, P177, DOI 10.1007/s10555-008-9175-2; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wakisaka N, 2004, MOL CELL BIOL, V24, P5223, DOI 10.1128/MCB.24.12.5223-5234.2004; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Yoshizaki T, 2005, EPSTEIN-BARR VIRUS, P171; Yoshizaki T, 2013, CANCER LETT, V337, P1, DOI 10.1016/j.canlet.2013.05.018; Yu X, 2012, J MOL CELL CARDIOL, V53, P848, DOI 10.1016/j.yjmcc.2012.10.002	43	218	239	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 11	2014	33	37					4613	4622		10.1038/onc.2014.66	http://dx.doi.org/10.1038/onc.2014.66			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3UZ	24662828	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-25	WOS:000342004800008
J	Yang, WJ; Liu, PD; Wei, DT; Li, WF; Hitchman, G; Li, XP; Qiu, J; Zhang, QL				Yang, Wenjing; Liu, Peiduo; Wei, Dongtao; Li, Wenfu; Hitchman, Glenn; Li, Xueping; Qiu, Jiang; Zhang, Qinglin			Females and Males Rely on Different Cortical Regions in Raven's Matrices Reasoning Capacity: Evidence from a Voxel-Based Morphometry Study	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; ADVANCED PROGRESSIVE MATRICES; SEX-DIFFERENCES; GENERAL INTELLIGENCE; MENTAL ROTATION; FUNCTIONAL MRI; MEMORY; LANGUAGE; FLUID; PERFORMANCE	Raven's Matrices test (RMT) is a non-verbal test designed to assess individuals' ability to reason and solve new problems without relying extensively on declarative knowledge derived from schooling or previous experience. Despite a large number of behavioral studies that demonstrated gender differences in Raven's Matrices reasoning ability, no neural evidence supported this difference. In this study, voxel-based morphometry (VBM) was used in an attempt to uncover the gender-specific neural basis of Raven's Matrices reasoning ability as measured by the combined Raven's Matrices test (CRT) in 370 healthy young adults. The behavioral results showed no difference between males and females. However, the VBM results showed that the relationship between reasoning ability and regional gray matter volume (rGMV) differed between sexes. The association between CRT scores and rGMV in the dorsolateral prefrontal cortex (associated with visuospatial ability) was significantly greater in males than in females, whereas the reverse was true for the inferior frontal cortex (relating to verbal reasoning ability) and the medial frontal cortex (engaged in information binding) where the association was greater in females. These findings suggest that males and females use differently structured brains in different ways to achieve similar levels of overall Raven's Matrices reasoning ability.	[Yang, Wenjing; Liu, Peiduo; Wei, Dongtao; Li, Wenfu; Hitchman, Glenn; Qiu, Jiang; Zhang, Qinglin] Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; [Yang, Wenjing; Liu, Peiduo; Wei, Dongtao; Li, Wenfu; Hitchman, Glenn; Qiu, Jiang; Zhang, Qinglin] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Li, Xueping] China West Normal Univ, Inst Educ, Nanchong, Peoples R China	Southwest University - China; China West Normal University	Qiu, J (corresponding author), Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China.	qiuj318@swu.edu.cn; zhangql@swu.edu.cn	Hitchman, Glenn/F-6974-2014	Hitchman, Glenn/0000-0003-3268-5246	National Natural Science Foundation of China [31170983]; Fundamental Research Funds for the Central Universities [SWU1309433]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (31170983) and the Fundamental Research Funds for the Central Universities (SWU1309433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad FJ, 2004, PERS INDIV DIFFER, V36, P1459, DOI 10.1016/S0191-8869(03)00241-1; Abdel-Khalek AM, 2006, PERS INDIV DIFFER, V40, P175, DOI 10.1016/j.paid.2005.06.020; ALDERTON DL, 1990, EDUC PSYCHOL MEAS, V50, P887, DOI 10.1177/0013164490504019; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Astur RS, 1998, BEHAV BRAIN RES, V93, P185, DOI 10.1016/S0166-4328(98)00019-9; BERMAN KF, 1988, ARCH GEN PSYCHIAT, V45, P616; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; BRAINE MDS, 1978, PSYCHOL REV, V85, P1, DOI 10.1037//0033-295X.85.1.1; Brown MRG, 2004, J NEUROPHYSIOL, V91, P873, DOI 10.1152/jn.00382.2003; Butler T, 2006, NEUROIMAGE, V32, P445, DOI 10.1016/j.neuroimage.2006.03.030; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Clements AM, 2006, BRAIN LANG, V98, P150, DOI 10.1016/j.bandl.2006.04.007; Colom R, 2002, PERS INDIV DIFFER, V32, P445, DOI 10.1016/S0191-8869(01)00040-X; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Curtis CE, 2006, J NEUROPHYSIOL, V95, P3923, DOI 10.1152/jn.01120.2005; D'Esposito M, 2000, NEUROIMAGE, V11, P400, DOI 10.1006/nimg.2000.0571; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Desco M, 2011, NEUROIMAGE, V57, P281, DOI 10.1016/j.neuroimage.2011.03.063; DeShon RP, 1995, INTELLIGENCE, V21, P135, DOI 10.1016/0160-2896(95)90023-3; Diwadkar VA, 2000, NEUROIMAGE, V12, P85, DOI 10.1006/nimg.2000.0586; Funahashi S, 2013, PROG NEUROBIOL, V103, P131, DOI 10.1016/j.pneurobio.2012.04.002; Gauthier CT, 2009, CORTEX, V45, P164, DOI 10.1016/j.cortex.2007.09.006; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; Haier RJ, 2003, INTELLIGENCE, V31, P429, DOI 10.1016/S0160-2896(03)00025-4; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; HYDE JS, 1975, MULTIVAR BEHAV RES, V10, P289, DOI 10.1207/s15327906mbr1003_3; Irwing P, 2005, BRIT J PSYCHOL, V96, P505, DOI 10.1348/000712605X53542; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Just MA, 2001, J EXP PSYCHOL GEN, V130, P493, DOI 10.1037/0096-3445.130.3.493; Kaiser A, 2007, INT J PSYCHOPHYSIOL, V63, P192, DOI 10.1016/j.ijpsycho.2006.03.008; Kalbfleisch ML, 2007, COGN NEURODYNAMICS, V1, P71, DOI 10.1007/s11571-006-9007-4; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Khaleefa O, 2008, MANKIND QUART, V49, P58; KIMURA D, 1992, SCI AM, V267, P119; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Lee KH, 2006, NEUROIMAGE, V29, P578, DOI 10.1016/j.neuroimage.2005.07.036; Lewin C, 2001, NEUROPSYCHOLOGY, V15, P165, DOI 10.1037//0894-4105.15.2.165; Li D., 1988, PSYCHOL SCI, V4, P27, DOI DOI 10.16719/J.CNKI.1671-6981.1988.04.007; LIM TK, 1994, INTELLIGENCE, V19, P179, DOI 10.1016/0160-2896(94)90012-4; Lynn R, 1998, J BIOSOC SCI, V30, P529, DOI 10.1017/S002193209800529X; Lynn R, 2004, INTELLIGENCE, V32, P411, DOI 10.1016/j.intell.2004.06.007; Lynn R, 2004, PERS INDIV DIFFER, V36, P779, DOI 10.1016/S0191-8869(03)00132-6; Mackintosh NJ, 2005, INTELLIGENCE, V33, P663, DOI 10.1016/j.intell.2005.03.004; Markowska AL, 1999, J NEUROSCI, V19, P8122; McGrew K.S., 1998, INTELLIGENCE TEST DE; Meyer GF, 2011, J COGNITIVE NEUROSCI, V23, P2291, DOI 10.1162/jocn.2010.21593; Mitchell JP, 2004, J NEUROSCI, V24, P4912, DOI 10.1523/JNEUROSCI.0481-04.2004; Newton JH, 2010, PSYCHOL SCHOOLS, V47, P621, DOI 10.1002/pits.20495; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Postle BR, 2000, J COGNITIVE NEUROSCI, V12, P2, DOI 10.1162/089892900564028; Postma A, 2004, BRAIN COGNITION, V54, P24, DOI 10.1016/S0278-2626(03)00238-0; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Qin SZ, 2007, NEUROIMAGE, V38, P212, DOI 10.1016/j.neuroimage.2007.07.020; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Raven J.C., 1938, PROGR MATRICES PERCE; RISBERG J, 1986, NEUROPSYCHOLOGIA, V24, P135, DOI 10.1016/0028-3932(86)90047-3; Rodriguez-Moreno D, 2009, NEUROPSYCHOLOGIA, V47, P949, DOI 10.1016/j.neuropsychologia.2008.08.030; Rubia K, 2010, NEUROIMAGE, V51, P817, DOI 10.1016/j.neuroimage.2010.02.058; Rushton JP, 2010, INTELLIGENCE, V38, P213, DOI 10.1016/j.intell.2009.12.002; Rushton JP, 2000, INTELLIGENCE, V28, P251, DOI 10.1016/S0160-2896(00)00035-0; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Takeuchi H, 2014, BRAIN STRUCT FUNCT, V219, P71, DOI 10.1007/s00429-012-0485-3; van der Ven AHGS, 2000, PERS INDIV DIFFER, V29, P45, DOI 10.1016/S0191-8869(99)00177-4; Wagner AD, 1999, NEURON, V22, P19, DOI 10.1016/S0896-6273(00)80674-1; Wallentin M, 2009, BRAIN LANG, V108, P175, DOI 10.1016/j.bandl.2008.07.001; WANG D, 1989, REPORTS PSYCHOL SCI, V5, P23; [王栋 WANG Dong], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P559; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254	73	11	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93104	10.1371/journal.pone.0093104	http://dx.doi.org/10.1371/journal.pone.0093104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667298	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600140
J	Han, Q; Wang, RN; Sun, CK; Jin, X; Liu, DJ; Zhao, X; Wang, LL; Ji, N; Li, J; Zhou, Y; Ye, L; Liang, XH; Jiang, L; Liao, G; Dan, HX; Zeng, X; Chen, QM				Han, Qi; Wang, Ruinan; Sun, Chongkui; Jin, Xin; Liu, Dongjuan; Zhao, Xin; Wang, Lili; Ji, Ning; Li, Jing; Zhou, Yu; Ye, Ling; Liang, Xinhua; Jiang, Lu; Liao, Ga; Dan, Hongxia; Zeng, Xin; Chen, Qianming			Human Beta-Defensin-1 Suppresses Tumor Migration and Invasion and Is an Independent Predictor for Survival of Oral Squamous Cell Carcinoma Patients	PLOS ONE			English	Article							BETA-DEFENSIN 1; ANTIMICROBIAL PEPTIDE; EPITHELIAL-CELLS; MESSENGER-RNA; EXPRESSION; CANCER; METASTASIS; INDUCTION; PATTERN; GLANDS	Background: Human beta-defensin-1 (hBD-1) has recently been considered as a candidate tumor suppressor in renal and prostate cancer. The aim of this study was to investigate the role of hBD-1 in the progression of oral squamous cell carcinoma (OSCC) and its potential as diagnostic/prognostic biomarker and therapeutic target for OSCC. Methods: HBD-1 expression in tissues at different stages of oral carcinogenesis, as well as OSCC cell lines was examined. HBD-1 was overexpressed in HSC-3, UM1, SCC-9 and SCC-25 cells and subjected to cell growth, apoptosis, migration and invasion assays. Tissue microarray constructed with tissues from 175 patients was used to examine clinicopathological significance of hBD-1 expression in OSCC. Results: HBD-1 expression decreased from oral precancerous lesions to OSCC and was lower in OSCC with lymph node metastasis than those without metastasis. In vitro, the expression of hBD-1 was related to the invasive potential of OSCC cell lines. Induction of exogenous expression of hBD-1 inhibited migration and invasion of OSCC cells, probably by regulation of RhoA, RhoC and MMP-2; but had no significant effect on proliferation or apoptosis. In a cohort of patients with primary OSCC, cases with no expression of hBD-1 had more chance to be involved in lymph node metastasis. Eventually, the positive expression of hBD-1 was associated with longer survival of patients with OSCC, and multivariate analysis and ROC curve analysis confirmed hBD-1 positivity to be an independent prognostic factor of OSCC, especially OSCC at early stage. Conclusions: Overall, these data indicated that hBD-1 suppressed tumor migration and invasion of OSCC and was likely to be a prognostic biomarker and a potential target for treatment of OSCC.	[Han, Qi; Wang, Ruinan; Sun, Chongkui; Jin, Xin; Liu, Dongjuan; Zhao, Xin; Wang, Lili; Ji, Ning; Li, Jing; Zhou, Yu; Ye, Ling; Liang, Xinhua; Jiang, Lu; Liao, Ga; Dan, Hongxia; Zeng, Xin; Chen, Qianming] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China	Sichuan University	Dan, HX (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.	hxdan@foxmail.com; zengxin22@163.com	Sun, Chongkui/Q-1534-2019	Sun, Chongkui/0000-0003-0362-4129; Dan, Hongxia/0000-0002-9765-0012	National Natural Science Foundation of China [81321002, 30772424, 81200791, 81102060, 81072218]; Doctoral Program of the Ministry of Education of China [20110181110055, 20120181120011]; ISTCPC [2012DFA31370]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of the Ministry of Education of China(Ministry of Education, China); ISTCPC	This work was supported by grants from the National Natural Science Foundation of China (No. 81321002, 30772424, 81200791, 81102060, 81072218), the Doctoral Program of the Ministry of Education of China (No. 20110181110055, 20120181120011) and the ISTCPC (2012DFA31370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko Y, 1999, CANCER LETT, V143, P37, DOI 10.1016/S0304-3835(99)00171-8; Ai JY, 2012, INT J ORAL SCI, V4, P85, DOI 10.1038/ijos.2012.26; Ali RS, 2001, J INVEST DERMATOL, V117, P106; Bissell J, 2004, J ORAL PATHOL MED, V33, P278, DOI 10.1111/j.0904-2512.2004.00143.x; Bose SK, 2009, MOL IMMUNOL, V46, P1140, DOI 10.1016/j.molimm.2008.11.004; Bullard RS, 2008, MOL IMMUNOL, V45, P839, DOI 10.1016/j.molimm.2006.11.026; Dale BA, 2001, J PERIODONTAL RES, V36, P285, DOI 10.1034/j.1600-0765.2001.360503.x; Donald CD, 2003, LAB INVEST, V83, P501, DOI 10.1097/01.LAB.0000063929.61760.F6; Duits LA, 2002, IMMUNOLOGY, V106, P517, DOI 10.1046/j.1365-2567.2002.01430.x; Gambichler T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-163; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Iiizumi M, 2008, CANCER RES, V68, P7613, DOI 10.1158/0008-5472.CAN-07-6700; Islam M, 2009, MOL CANCER RES, V7, P1771, DOI 10.1158/1541-7786.MCR-08-0512; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joly S, 2005, MOL IMMUNOL, V42, P1073, DOI 10.1016/j.molimm.2004.11.001; Joly S, 2009, ORAL MICROBIOL IMMUN, V24, P353, DOI 10.1111/j.1399-302X.2009.00512.x; Krisanaprakornkit S, 1998, INFECT IMMUN, V66, P4222; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033860; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Mendes O, 2007, CLIN EXP METASTAS, V24, P341, DOI 10.1007/s10585-007-9071-0; Messadi DV, 2013, INT J ORAL SCI, V5, P59, DOI 10.1038/ijos.2013.24; Nakayama Shuko, 1998, Invasion and Metastasis, V18, P219, DOI 10.1159/000024515; Nishimura M, 2004, J DERMATOL SCI, V36, P87, DOI 10.1016/j.jdermsci.2004.07.001; Nishitani Junko, 2002, Cellular and Molecular Biology Online Papers, V48, pOL331; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Sahasrabudhe KS, 2000, J DENT RES, V79, P1669, DOI 10.1177/00220345000790090601; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Sorensen OE, 2005, J IMMUNOL, V174, P4870, DOI 10.4049/jimmunol.174.8.4870; Struckhoff AP, 2011, FRONT BIOSCI-LANDMRK, V16, P1915, DOI 10.2741/3830; Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Wang Z, 2008, MOL CELL PROTEOMICS, V7, P1639, DOI 10.1074/mcp.M700520-MCP200; Wang Z, 2009, EUR J CANCER, V45, P490, DOI 10.1016/j.ejca.2008.11.012; Wenghoefer M, 2008, INT J ORAL MAX SURG, V37, P660, DOI 10.1016/j.ijom.2008.02.003; Winter J, 2011, CANCER INVEST, V29, P196, DOI 10.3109/07357907.2010.543210; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4; Zhou Y, 2012, ORAL ONCOL, V48, P110, DOI 10.1016/j.oraloncology.2011.09.007	40	30	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91867	10.1371/journal.pone.0091867	http://dx.doi.org/10.1371/journal.pone.0091867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658581	gold, Green Submitted, Green Published			2022-12-25	WOS:000333355300042
J	Lanzerstorfer, P; Borgmann, D; Schutz, G; Winkler, SM; Hoglinger, O; Weghuber, J				Lanzerstorfer, Peter; Borgmann, Daniela; Schuetz, Gerhard; Winkler, Stephan M.; Hoeglinger, Otmar; Weghuber, Julian			Quantification and Kinetic Analysis of Grb2-EGFR Interaction on Micro-Patterned Surfaces for the Characterization of EGFR-Modulating Substances	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; TYROSINE KINASE INHIBITORS; ERBB RECEPTORS; LUNG-CANCER; GROWTH; GRB2; INTERNALIZATION; DOMAIN; PHOSPHORYLATION; ACTIVATION	The identification of the epidermal growth factor receptor (EGFR) as an oncogene has led to the development of several anticancer therapeutics directed against this receptor tyrosine kinase. However, drug resistance and low efficacy remain a severe challenge, and have led to a demand for novel systems for an efficient identification and characterization of new substances. Here we report on a technique which combines micro-patterned surfaces and total internal reflection fluorescence (TIRF) microscopy (m-patterning assay) for the quantitative analysis of EGFR activity. It does not simply measure the phosphorylation of the receptor, but instead quantifies the interaction of the key signal transmitting protein Grb2 (growth factor receptor-bound protein 2) with the EGFR in a live cell context. It was possible to demonstrate an EGF dependent recruitment of Grb2 to the EGFR, which was significantly inhibited in the presence of clinically tested EGFR inhibitors, including small tyrosine kinase inhibitors and monoclonal antibodies targeting the EGF binding site. Importantly, in addition to its potential use as a screening tool, our experimental setup offers the possibility to provide insight into the molecular mechanisms of bait-prey interaction. Recruitment of the EGFR together with Grb2 to clathrin coated pits (CCPs) was found to be a key feature in our assay. Application of bleaching experiments enabled calculation of the Grb2 exchange rate, which significantly changed upon stimulation or the presence of EGFR activity inhibiting drugs.	[Lanzerstorfer, Peter; Hoeglinger, Otmar; Weghuber, Julian] Univ Appl Sci Upper Austria, Wels, Austria; [Borgmann, Daniela; Winkler, Stephan M.] Univ Appl Sci Upper Austria, Hagenberg, Austria; [Schuetz, Gerhard] Vienna Univ Technol, Inst Appl Phys, A-1040 Vienna, Austria	Technische Universitat Wien	Weghuber, J (corresponding author), Univ Appl Sci Upper Austria, Wels, Austria.	julian.weghuber@fh-wels.at	Schuetz, Gerhard/B-1243-2008	Schuetz, Gerhard/0000-0003-1542-1089; Weghuber, Julian/0000-0001-6312-4666; Lanzerstorfer, Peter/0000-0003-4512-7964	Regionale Wettbewerbsfahigkeit; European fund for regional development	Regionale Wettbewerbsfahigkeit; European fund for regional development(European Commission)	This work was funded by the program "Regionale Wettbewerbsfahigkeit OO2007-2013" with financial means of the European fund for regional development as well as the country of Upper Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RA, 2012, CARDIOVASC RES, V94, P125, DOI 10.1093/cvr/cvs017; Antczak C, 2012, ASSAY DRUG DEV TECHN, V10, P24, DOI 10.1089/adt.2011.423; Arteaga CL, 2002, ONCOLOGIST, V7, P31; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Borgmann DM, 2012, P 24 EUR MOD SIM S; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Chen MM, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807605; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Ferraro DA, 2013, P NATL ACAD SCI USA, V110, P1815, DOI 10.1073/pnas.1220763110; Fortian A, 2013, J CELL SCI; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Giocanti N, 2004, BRIT J CANCER, V91, P2026, DOI 10.1038/sj.bjc.6602242; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Grecco HE, 2010, NAT METHODS, V7, P467, DOI [10.1038/NMETH.1458, 10.1038/nmeth.1458]; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; Heukers R, 2013, J CELL SCI; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083; Lanzerstorfer P, 2013, PROTEIN PUR IN PRESS; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Morimatsu M, 2007, P NATL ACAD SCI USA, V104, P18013, DOI 10.1073/pnas.0701330104; Narayanan R, 2012, INT J ONCOL, V40, P13, DOI 10.3892/ijo.2011.1211; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Oh D, 2012, P NATL ACAD SCI USA, V109, P14024, DOI 10.1073/pnas.1203397109; Olive DM, 2004, EXPERT REV PROTEOMIC, V1, P327, DOI 10.1586/14789450.1.3.327; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Pennucci J, 2010, J BIOMOL SCREEN, V15, P644, DOI 10.1177/1087057110370893; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Schwarzenbacher M, 2008, NAT METHODS, V5, P1053, DOI 10.1038/nmeth.1268; Sequist LV, 2008, ANNU REV MED, V59, P429, DOI 10.1146/annurev.med.59.090506.202405; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sorkina T, 2002, J BIOL CHEM, V277, P27433, DOI 10.1074/jbc.M201595200; Sunzenauer S, 2013, CYTOM PART A, V83, P847, DOI 10.1002/cyto.a.22225; Thomas SM, 2004, CANCER TREAT REV, V30, P255, DOI 10.1016/j.ctrv.2003.10.003; Walker F, 2009, HUM PATHOL, V40, P1517, DOI 10.1016/j.humpath.2009.05.010; Weghuber J, 2010, J VIS EXP; Weghuber J, 2010, ANAL BIOANAL CHEM, V397, P3339, DOI 10.1007/s00216-010-3854-x; Weghuber J, 2010, METHOD ENZYMOL, V472, P133, DOI 10.1016/S0076-6879(10)72012-7; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Yamazaki T, 2002, J CELL SCI, V115, P1791; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278	47	38	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92151	10.1371/journal.pone.0092151	http://dx.doi.org/10.1371/journal.pone.0092151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658383	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300058
J	Montagud-Romero, S; Daza-Losada, M; Vidal-Infer, A; Maldonado, C; Aguilar, MA; Minarro, J; Rodriguez-Arias, M				Montagud-Romero, Sandra; Daza-Losada, Manuel; Vidal-Infer, Antonio; Maldonado, Concepcion; Aguilar, Maria A.; Minarro, Jose; Rodriguez-Arias, Marta			The Novelty-Seeking Phenotype Modulates the Long-Lasting Effects of Intermittent Ethanol Administration during Adolescence	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; ELEVATED PLUS-MAZE; TRIAL OBJECT RECOGNITION; SENSATION-SEEKING; INDIVIDUAL-DIFFERENCES; SOCIAL-BEHAVIOR; ANIMAL-MODELS; RISK-TAKING; ADULT RATS; DRUG-ADDICTION	The aim of the present study was to investigate if a novelty-seeking phenotype mediates the long-lasting consequences of intermittent EtOH intoxication during adolescence. The hole board test was employed to classify adolescent mice as High-or Low-Novelty Seekers. Subsequently, animals were administered ethanol (1.25 or 2.5 g/kg) on two consecutive days at 48-h intervals over a 14-day period. Anxiety levels - measured using the elevated plus maze-spontaneous motor activity and social interaction test were studied 3 weeks later. A different set of mice underwent the same procedure, but received only the 2.5 g/kg dose of ethanol. Three weeks later, in order to induce CPP, the same animals were administered 1 or 6 mg/kg of cocaine or 1 or 2.5 mg/kg MDMA. The results revealed a decrease in aggressive behaviors and an anxiolytic profile in HNS mice and longer latency to explore the novel object by LNS mice. Ethanol exposure enhanced the reinforcing effects of cocaine and MDMA in both groups when CPP was induced with a sub-threshold dose of the drugs. The extinguished cocaine-induced CPP (1 and 6 mg/kg) was reinstated after a priming dose in HNS animals only. Our results confirm that intermittent EtOH administration during adolescence induces long-lasting effects that are manifested in adult life, and that there is an association between these effects and the novelty-seeking phenotype.	[Montagud-Romero, Sandra; Daza-Losada, Manuel; Vidal-Infer, Antonio; Maldonado, Concepcion; Aguilar, Maria A.; Minarro, Jose; Rodriguez-Arias, Marta] Univ Valencia, Fac Psicol, Dept Psicobiol, Unidad Invest Psicobiol Drogodependencias, Valencia, Spain	University of Valencia	Rodriguez-Arias, M (corresponding author), Univ Valencia, Fac Psicol, Dept Psicobiol, Unidad Invest Psicobiol Drogodependencias, Valencia, Spain.	marta.rodriguez@uv.es	Aguilar, Maria A/D-3416-2011; Vidal-Infer, Antonio/AAR-6567-2021; Minarro, Jose/B-4414-2011; Romero, Sandra Montagud/AAF-9408-2021; Montagud-Romero, Sandra/E-6537-2017; Rodriguez-Arias, Marta/B-5163-2011; Vidal-Infer, Antonio/D-2314-2015	Aguilar, Maria A/0000-0002-1935-6619; Minarro, Jose/0000-0002-5731-7821; Romero, Sandra Montagud/0000-0002-3380-7252; Montagud-Romero, Sandra/0000-0002-3380-7252; Vidal-Infer, Antonio/0000-0002-7860-8652	Ministerio de Economia y Competitividad, Direccion General de Investigacion [PSI2011-24762]; Generalidad Valenciana, Consejeria de Educacion [PROMETEO/2009/072]; Instituto de Salud 'Carlos III' (FIS), Redes Telematicas de Investigacion Cooperativa en Salud (RETICS), Red de Trastornos Adictivos (RTA), fondos FEDER [RD06/001/0016, RD12/0028/005]	Ministerio de Economia y Competitividad, Direccion General de Investigacion; Generalidad Valenciana, Consejeria de Educacion; Instituto de Salud 'Carlos III' (FIS), Redes Telematicas de Investigacion Cooperativa en Salud (RETICS), Red de Trastornos Adictivos (RTA), fondos FEDER	This work was supported by the following grants: Ministerio de Economia y Competitividad, Direccion General de Investigacion (PSI2011-24762); Generalidad Valenciana, Consejeria de Educacion (PROMETEO/2009/072); and Instituto de Salud 'Carlos III' (FIS), Redes Telematicas de Investigacion Cooperativa en Salud (RETICS), Red de Trastornos Adictivos (RTA), fondos FEDER (RD06/001/0016, RD12/0028/005). The funding organisms had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MA, 2009, BRAIN RES REV, V59, P253, DOI 10.1016/j.brainresrev.2008.08.002; Alfonso-Loeches S, 2011, CRIT REV CL LAB SCI, V48, P19, DOI 10.3109/10408363.2011.580567; Bahi A, 2013, PHARMACOL BIOCHEM BE, V105, P83, DOI 10.1016/j.pbb.2013.01.023; Ballaz SJ, 2007, NEUROSCIENCE, V149, P192, DOI 10.1016/j.neuroscience.2007.07.043; Ballaz SJ, 2007, BEHAV NEUROSCI, V121, P1113, DOI 10.1037/0735-7044.121.5.1113; Bardo MT, 1996, BEHAV BRAIN RES, V77, P23, DOI 10.1016/0166-4328(95)00203-0; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Bird J, 2013, ADDICT BIOL, V18, P654, DOI 10.1111/j.1369-1600.2012.00477.x; BLANCHARD RJ, 1987, PHARMACOL BIOCHEM BE, V27, P641, DOI 10.1016/0091-3057(87)90187-0; BRAIN PF, 1981, BEHAV PROCESS, V6, P319, DOI 10.1016/0376-6357(81)90049-8; Brain PF, 1989, NEUROMETHODS, V13, P687; Brown SA, 2008, PEDIATRICS, V121, pS290, DOI 10.1542/peds.2007-2243D; Busse GD, 2005, PHARMACOL BIOCHEM BE, V81, P459, DOI 10.1016/j.pbb.2005.04.003; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P489, DOI 10.1080/10408440802014238; Conrad KL, 2011, ALCOHOL, V45, P585, DOI 10.1016/j.alcohol.2010.11.002; Daza-Losada M, 2007, NEUROPSYCHOPHARMACOL, V32, P1750, DOI 10.1038/sj.npp.1301309; Daza-Losada M, 2009, ADDICT BIOL, V14, P447, DOI 10.1111/j.1369-1600.2009.00173.x; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Doremus TL, 2003, PHARMACOL BIOCHEM BE, V75, P411, DOI 10.1016/S0091-3057(03)00134-5; EDADES, 2010, DEL GOB PLAN NAC DRO; EMCDDA, 2011, ANN REP 2011 STAT DR; EMCDDA-European Monitoring Centre for Drugs and Drug Addiction, 2009, POL US PATT RESP SEL; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; ESTUDES, 2010, INF ENC EST US DROG; EVERILL B, 1987, PHYSIOL BEHAV, V39, P45, DOI 10.1016/0031-9384(87)90342-8; Fillmore MT, 2009, DRUG ALCOHOL DEPEN, V100, P91, DOI 10.1016/j.drugalcdep.2008.09.007; Forbes A, 2013, ALCOHOL, V47, P95, DOI 10.1016/j.alcohol.2012.12.007; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Fukushiro DF, 2012, PHARMACOL BIOCHEM BE, V101, P132, DOI 10.1016/j.pbb.2011.12.013; Grimm JW, 1997, PHYSIOL BEHAV, V61, P755, DOI 10.1016/S0031-9384(96)00532-X; Guerri C, 2002, NEUROTOX RES, V4, P327, DOI 10.1080/1029842021000010884; Harper C, 2005, CURR OPIN PHARMACOL, V5, P73, DOI 10.1016/j.coph.2004.06.011; Hefner K, 2007, BEHAV BRAIN RES, V176, P210, DOI 10.1016/j.bbr.2006.10.001; HILAKIVI LA, 1989, ALCOHOL CLIN EXP RES, V13, P622, DOI 10.1111/j.1530-0277.1989.tb00393.x; Hutchison MA, 2012, PHARMACOL BIOCHEM BE, V101, P458, DOI 10.1016/j.pbb.2012.02.007; Kankaanpaa A, 1998, PHARMACOL BIOCHEM BE, V59, P1003, DOI 10.1016/S0091-3057(97)00527-3; Kelley AE, 2004, ANN NY ACAD SCI, V1021, P27, DOI 10.1196/annals.1308.003; Kelly TH, 2006, PSYCHOPHARMACOLOGY, V189, P17, DOI 10.1007/s00213-006-0487-z; Kerman IA, 2011, BRAIN RES, V1419, P34, DOI 10.1016/j.brainres.2011.08.038; Kliethermes CL, 2007, GENES BRAIN BEHAV, V6, P608, DOI 10.1111/j.1601-183X.2006.00289.x; KRSIAK M, 1973, PSYCHOPHARMACOLOGIA, V32, P201, DOI 10.1007/BF00428691; Kushner MG, 2000, CLIN PSYCHOL REV, V20, P149, DOI 10.1016/S0272-7358(99)00027-6; Laviola G, 1999, NEUROSCI BIOBEHAV R, V23, P993, DOI 10.1016/S0149-7634(99)00032-9; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Le Pen G, 1998, NEUROREPORT, V9, P2887, DOI 10.1097/00001756-199808240-00038; MacPherson L, 2010, ALCOHOL CLIN EXP RES, V34, P1400, DOI 10.1111/j.1530-0277.2010.01223.x; Maldonado C, 2006, BEHAV PHARMACOL, V17, P119, DOI 10.1097/01.fbp.0000190685.84984.ec; Mantsch JR, 2001, PSYCHOPHARMACOLOGY, V157, P31, DOI 10.1007/s002130100744; Manzanedo C, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-19; Marinelli M, 2000, J NEUROSCI, V20, P8876; Marquez C, 2005, PSYCHONEUROENDOCRINO, V30, P179, DOI 10.1016/j.psyneuen.2004.05.012; Martin CA, 2002, J AM ACAD CHILD PSY, V41, P1495, DOI 10.1097/00004583-200212000-00022; Martin CA, 2004, PSYCHOL REP, V94, P1075; McClain JA, 2013, ADDICT BIOL IN PRESS; Milivojevic D, 2012, AM J ADDICTION, V21, P462, DOI 10.1111/j.1521-0391.2012.00251.x; MUGFORD RA, 1970, NATURE, V226, P967, DOI 10.1038/226967a0; National Institute on Alcohol Abuse and Alcoholism, 2004, NIAAA NEWSLETTER; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Piazza PV, 2000, J NEUROSCI, V20, P4226; Do Couto BR, 2012, ADDICT BIOL, V17, P588, DOI 10.1111/j.1369-1600.2011.00382.x; Rodgers RJ, 1997, PHARMACOL BIOCHEM BE, V57, P127, DOI 10.1016/S0091-3057(96)00134-7; Rodriguez-Arias M, 1998, EUR NEUROPSYCHOPHARM, V8, P95, DOI 10.1016/S0924-977X(97)00051-5; Rodriguez-Arias M, 2011, PSYCHOPHARMACOLOGY, V218, P429, DOI 10.1007/s00213-011-2329-x; Rodriguez-Arias M, 2010, PROG NEURO-PSYCHOPH, V34, P166, DOI 10.1016/j.pnpbp.2009.10.019; Schramm-Sapyta NL, 2008, ALCOHOL CLIN EXP RES, V32, P754, DOI 10.1111/j.1530-0277.2008.00631.x; Schramm-Sapyta NL, 2009, PSYCHOPHARMACOLOGY, V206, P1, DOI 10.1007/s00213-009-1585-5; Schramm-Sapyta NL, 2004, PSYCHOPHARMACOLOGY, V173, P41, DOI 10.1007/s00213-003-1696-3; SMOOTHY R, 1986, PHYSIOL BEHAV, V37, P689, DOI 10.1016/0031-9384(86)90173-3; Spear HJ, 2004, PUBLIC HEALTH NURS, V21, P144, DOI 10.1111/j.0737-1209.2004.021208.x; Spear Linda Patia, 2005, Recent Dev Alcohol, V17, P143, DOI 10.1007/0-306-48626-1_7; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Spear LP, 2004, ANN NY ACAD SCI, V1021, P23, DOI 10.1196/annals.1308.002; Spear LP, 2002, ALCOHOL RES HEALTH, V26, P287; Stansfield KH, 2007, PHARMACOL BIOCHEM BE, V86, P637, DOI 10.1016/j.pbb.2007.02.008; Stoops WW, 2007, ADDICT BEHAV, V32, P1177, DOI 10.1016/j.addbeh.2006.08.006; Tur JA, 2003, ALCOHOL ALCOHOLISM, V38, P243, DOI 10.1093/alcalc/agg061; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Varlinskaya EI, 2002, ALCOHOL CLIN EXP RES, V26, P1502, DOI 10.1097/01.ALC.0000034033.95701.E3; Vidal-Infer A, 2012, PHARMACOL BIOCHEM BE, V102, P124, DOI 10.1016/j.pbb.2012.03.031; White AM, 2006, ALCOHOL CLIN EXP RES, V30, P1006, DOI 10.1111/j.1530-0277.2006.00122.x; YANAI J, 1977, PSYCHOPHARMACOLOGY, V52, P31, DOI 10.1007/BF00426596	82	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92576	10.1371/journal.pone.0092576	http://dx.doi.org/10.1371/journal.pone.0092576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658541	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300101
J	Nagarajan, R; Gromiha, MM				Nagarajan, R.; Gromiha, M. Michael			Prediction of RNA Binding Residues: An Extensive Analysis Based on Structure and Function to Select the Best Predictor	PLOS ONE			English	Article							PROTEIN; SITES; DNA; INFORMATION; SEQUENCE; REPLICATION; DATABASE; SERVER; SVM	Protein-RNA complexes play key roles in several cellular processes by the interactions of amino acids with RNA. To understand the recognition mechanism, it is important to identify the specific amino acids involved in RNA binding. Various computational methods have been developed for predicting RNA binding residues from protein sequence. However, their performances mainly depend on the training dataset, feature selection for developing a model and learning capacity of the model. Hence, it is important to reveal the correspondence between the performance of methods and properties of RNA-binding proteins (RBPs). In this work, we have collected all available RNA binding residues prediction methods and revealed their performances on unbiased, stringent and diverse datasets for RBPs with less than 25% sequence identity based on structural class, fold, superfamily, family, protein function, RNA type, RNA strand and RNA conformation. The best methods for each type of RBPs and the type of RBPs, which require further refinement in prediction, have been brought out. We also analyzed the performance of these methods for the disordered regions, structures which are not included in the training dataset and recently solved structures. The reliability of prediction is better than randomly choosing any method or combination of methods. This approach would be a valuable resource for biologists to choose the best method based on the type of RBPs for designing their experiments and the tool is freely accessible online at www.iitm.ac.in/bioinfo/RNA-protein/.	[Nagarajan, R.; Gromiha, M. Michael] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Gromiha, MM (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	gromiha@iitm.ac.in	Gromiha, Michael/H-8493-2019; Raju, Nagarajan/H-9157-2013	Raju, Nagarajan/0000-0003-3851-5520; Michael, Gromiha/0000-0002-1776-4096	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	Funding came from the Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Anderson JSJ, 2000, NUCLEIC ACIDS RES, V28, P1604, DOI 10.1093/nar/28.7.1604; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bahadur RP, 2008, NUCLEIC ACIDS RES, V36, P2705, DOI 10.1093/nar/gkn102; Beaudoin ME, 2008, NUCLEIC ACIDS RES, V36, P6835, DOI 10.1093/nar/gkn792; Berman HM, 2012, STRUCTURE, V20, P391, DOI 10.1016/j.str.2012.01.010; BERMAN HM, 1992, BIOPHYS J, V63, P751, DOI 10.1016/S0006-3495(92)81649-1; Carson MB, 2010, NUCLEIC ACIDS RES, V38, pW431, DOI 10.1093/nar/gkq361; Cheng CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S6; Ellis JJ, 2007, PROTEINS, V66, P903, DOI 10.1002/prot.21211; Gromiha MM, 2013, ADV PROTEIN CHEM STR, V91, P65, DOI 10.1016/B978-0-12-411637-5.00003-2; Gromiha MM, 2010, LECT NOTES COMPUT SC, V6215, P626, DOI 10.1007/978-3-642-14922-1_78; Hertel KJ, 2005, TRENDS BIOCHEM SCI, V30, P115, DOI 10.1016/j.tibs.2005.01.002; Jeong Euna, 2004, Genome Inform, V15, P105; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Ma X, 2011, PROTEINS, V79, P1230, DOI 10.1002/prot.22958; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagarajan R, 2013, NUCLEIC ACIDS RES, V41, P7606, DOI 10.1093/nar/gkt544; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; Puton T, 2012, J STRUCT BIOL, V179, P261, DOI 10.1016/j.jsb.2011.10.001; Saunus JM, 2008, CANCER RES, V68, P9469, DOI 10.1158/0008-5472.CAN-08-1159; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Tjong H, 2007, NUCLEIC ACIDS RES, V35, P1465, DOI 10.1093/nar/gkm008; Walia RR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-89; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wang Y, 2008, AMINO ACIDS, V35, P295, DOI 10.1007/s00726-007-0634-9; Wang Y, 2013, MOL BIOSYST, V9, P133, DOI 10.1039/c2mb25292a; Yu Z, 2005, P NATL ACAD SCI USA, V102, P4027, DOI 10.1073/pnas.0408889102	32	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91140	10.1371/journal.pone.0091140	http://dx.doi.org/10.1371/journal.pone.0091140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658593	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300025
J	Nordgreen, J; Tahamtani, FM; Janczak, AM; Horsberg, TE				Nordgreen, Janicke; Tahamtani, Fernanda M.; Janczak, Andrew M.; Horsberg, Tor Einar			Behavioural Effects of the Commonly Used Fish Anaesthetic Tricaine Methanesulfonate (MS-222) on Zebrafish (Danio rerio) and Its Relevance for the Acetic Acid Pain Test	PLOS ONE			English	Article							MORPHINE; NOCICEPTION; RESPONSES; SALMON; EUGENOL; STRESS	The pros and cons of using anaesthesia when handling fish in connection with experiments are debated. A widely adopted practice is to wait thirty minutes after anaesthesia before behavioural observations are initiated, but information about immediate effects of a treatment is then lost. This is pertinent for responses to acute stressors, such as acid injection in the acetic acid pain test. However, omission of anaesthetics in order to obtain data on immediate responses will compromise the welfare of fish and contribute to experimental noise due to stress. We therefore tested the effect of tricaine methanesulfonate on the behaviour of zebrafish. We predicted that tricaine (MS 222) would decrease swimming velocity and that the control fish would show an increased level of anxiety-and stress-related behaviours compared to the tricaine group. Following acclimatization to the test tank, baseline behaviour was recorded before immersion in either tricaine (168 mgl(-1), treatment group, N = 8) or tank water (control group, N = 7). Latencies to lose equilibrium and to lose response to touch were registered. The fish was then returned to the test tank, and the latency to regain equilibrium was registered in anaesthetized fish. When equilibrium was regained, and at five, thirty and sixty minutes after the fish had been returned to the test tank, behaviour was recorded. The tricaine fish showed the following responses (mean +/- sd): latency to lose equilibrium 22.6 s +/- 3.9; latency to lose response to touch 101.9 s +/- 26.8; latency to regain equilibrium 92.0 s +/- 54.4. Contrary to our predictions, neither treatment caused a change in any of the behaviours registered. This indicates that tricaine has no effect on several commonly used behavioural parameters, and that it may be unnecessary to postpone behavioural observations to 30 min after anaesthesia.	[Nordgreen, Janicke; Horsberg, Tor Einar] NMBU, Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway; [Tahamtani, Fernanda M.; Janczak, Andrew M.] NMBU, Sch Vet Sci, Dept Prod Anim Clin Sci, Anim Welf Res Grp, Oslo, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences	Nordgreen, J (corresponding author), NMBU, Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway.	janicke.nordgreen@nmbu.no	Nordgreen, Janicke/H-9442-2017; Tahamtani, Fernanda/J-6339-2019; Janczak, Andrew M/B-4113-2013	Tahamtani, Fernanda/0000-0002-4439-9733; Janczak, Andrew M/0000-0002-1141-8272	Norwegian School of Veterinary Science	Norwegian School of Veterinary Science	This study was funded by the Norwegian School of Veterinary Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnolds DEW, 2002, BIOL BULL, V203, P188, DOI 10.2307/1543388; Ashley PJ, 2007, BRAIN RES, V1166, P47, DOI 10.1016/j.brainres.2007.07.011; Bakke MJ, 2010, AQUAT TOXICOL, V99, P1, DOI 10.1016/j.aquatox.2010.03.013; Brydges NM, 2009, APPL ANIM BEHAV SCI, V116, P295, DOI 10.1016/j.applanim.2008.09.003; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Correia AD, 2011, PHARMACEUTICALS, V4, P665, DOI 10.3390/ph4040665; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; FRAZIER DT, 1975, EUR J PHARMACOL, V33, P313, DOI 10.1016/0014-2999(75)90175-2; Godwin J., 2012, ZEBRAFISH PROTOCOLS, P181, DOI [10.1007/978-1-61779-597-8_13, 10.3389/fnbeh.2022.744533, DOI 10.3389/FNBEH.2022.744533]; HIKASA Y, 1986, JPN J VET SCI, V48, P341; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Lopez-Olmeda JF, 2012, FISH PHYSIOL BIOCHEM, V38, P143, DOI 10.1007/s10695-011-9523-y; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Newby NC, 2009, CAN J ZOOL, V87, P388, DOI 10.1139/Z09-023; Newby NC, 2007, T AM FISH SOC, V136, P341, DOI 10.1577/T06-110.1; Newby NC, 2009, APPL ANIMAL BEHAV SC, V116, P96; Nordgreen J, 2013, APPL ANIM BEHAV SCI, V145, P129, DOI 10.1016/j.applanim.2013.03.002; Nordgreen J, 2009, APPL ANIM BEHAV SCI, V119, P101, DOI 10.1016/j.applanim.2009.03.015; Palmer LM, 2004, J NEUROPHYSIOL, V92, P1034, DOI 10.1152/jn.01151.2003; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; Raymond J, 2012, ZEBRAFISH PROTOCOLS, P273; Readman GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073773; Reilly SC, 2008, APPL ANIM BEHAV SCI, V114, P248, DOI 10.1016/j.applanim.2008.01.016; Sanchez-Vazquez FJ, 2011, CHRONOBIOL INT, V28, P109, DOI 10.3109/07420528.2010.538105; Sneddon LU, 2003, J PAIN, V4, P431, DOI 10.1067/S1526-5900(03)00717-X; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Sneddon LU, 2009, APPL ANIM BEHAV SCI, V116, P96, DOI 10.1016/j.applanim.2008.07.006; Summerfelt R.C., 1990, P213; TAYLOR PB, 1988, J FISH BIOL, V32, P161, DOI 10.1111/j.1095-8649.1988.tb05349.x; Vindas MA, 2012, ANIM COGN, V15, P903, DOI 10.1007/s10071-012-0517-7; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zahl IH, 2009, AQUACULTURE, V295, P52, DOI 10.1016/j.aquaculture.2009.06.019	33	34	34	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92116	10.1371/journal.pone.0092116	http://dx.doi.org/10.1371/journal.pone.0092116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658262	gold, Green Submitted, Green Published			2022-12-25	WOS:000333355300055
J	Sward, K; Albinsson, S; Rippe, C				Sward, Karl; Albinsson, Sebastian; Rippe, Catarina			Arterial Dysfunction but Maintained Systemic Blood Pressure in Cavin-1-Deficient Mice	PLOS ONE			English	Article							MESENTERIC SMALL ARTERIES; CAVEOLIN-1-DEFICIENT MICE; CAVEOLAE; KNOCKOUT; CAVIN; RAT; ABNORMALITIES; CONTRACTILITY; HYPERTENSION; ENDOTHELIUM	Caveolae are omega-shaped plasma membrane micro-domains that are abundant in cells of the vascular system. Formation of caveolae depends on caveolin-1 and cavin-1 and lack of either protein leads to loss of caveolae. Mice with caveolin-1 deficiency have dysfunctional blood vessels, but whether absence of cavin-1 similarly leads to vascular dysfunction is not known. Here we addressed this hypothesis using small mesenteric arteries from cavin-1-deficient mice. Cavin-1-reporter staining was intense in mesenteric arteries, brain arterioles and elsewhere in the vascular system, with positive staining of both endothelial and smooth muscle cells. Arterial expression of cavin-1, -2 and -3 was reduced in knockout (KO) arteries as was expression of caveolin-1, -2 and -3. Caveolae were absent in the endothelial and smooth muscle layers of small mesenteric arteries as determined by electron microscopy. Arginase, a negative regulator of nitric oxide production, was elevated in cavin-1 deficient arteries as was contraction in response to the alpha(1)-adrenergic agonist cirazoline. Detailed assessment of vascular dimensions revealed increased media thickness and reduced distensibility, arguing that enhanced contraction was due to increased muscle mass. Contrasting with increased alpha(1)-adrenergic contraction, myogenic tone was essentially absent and this appeared to be due in part to increased nitric oxide production. Vasomotion was less frequent in the knock-out vessels. In keeping with the opposing influences on arterial resistance of increased agonist-induced contractility and reduced myogenic tone, arterial blood pressure was unchanged in vivo. We conclude that deficiency of cavin-1 affects the function of small arteries, but that opposing influences on arterial resistance balance each other such that systemic blood pressure in unstressed mice is well maintained.	[Sward, Karl; Albinsson, Sebastian; Rippe, Catarina] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Rippe, C (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	catarina.rippe@med.lu.se	Albinsson, Sebastian/B-4105-2010; Rippe, Catarina/B-4110-2010	Albinsson, Sebastian/0000-0001-6936-3967; Rippe, Catarina/0000-0001-8621-9836; Sward, Karl/0000-0002-7255-5510	Crafoord Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Olle Engqvist Byggmastare the Swedish Research Council [K2009-65X-4955-01-3, K2011-67P-20608-02-4, 524-2009-7774]; Faculty of Medicine at Lund University	Crafoord Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Olle Engqvist Byggmastare the Swedish Research Council(Swedish Research Council); Faculty of Medicine at Lund University	The authors' work is supported by Grants from the Crafoord Foundation, the Ake Wiberg Foundation, the Magnus Bergvall Foundation, Olle Engqvist Byggmastare the Swedish Research Council (K2009-65X-4955-01-3, K2011-67P-20608-02-4, 524-2009-7774), and the Faculty of Medicine at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2011, ACTA PHYSIOL, V202, P253, DOI 10.1111/j.1748-1716.2011.02320.x; Adebiyi A, 2007, AM J PHYSIOL-HEART C, V292, pH1584, DOI 10.1152/ajpheart.00584.2006; Albinsson S, 2007, AM J PHYSIOL-REG I, V293, pR1222, DOI 10.1152/ajpregu.00092.2007; Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004; Aung CS, 2011, EUR J CELL BIOL, V90, P136, DOI 10.1016/j.ejcb.2010.06.004; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; BUUS NH, 1994, BRIT J PHARMACOL, V112, P579, DOI 10.1111/j.1476-5381.1994.tb13114.x; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Desjardins F, 2008, CARDIOVASC RES, V79, P527, DOI 10.1093/cvr/cvn080; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Govender P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062045; GUSTAFSSON H, 1993, ACTA PHYSIOL SCAND, V148, P153, DOI 10.1111/j.1748-1716.1993.tb09545.x; Haddock RE, 2006, AM J PHYSIOL-HEART C, V291, pH2047, DOI 10.1152/ajpheart.00484.2006; Hansen CG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2808; Hassan GS, 2006, AM J PHYSIOL-HEART C, V290, pH2393, DOI 10.1152/ajpheart.01161.2005; Hausman N, 2012, J CELL MOL MED, V16, P1720, DOI 10.1111/j.1582-4934.2011.01457.x; Heagerty AM, 2010, J CELL MOL MED, V14, P1037, DOI 10.1111/j.1582-4934.2010.01080.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hill MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043041; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Jhun BS, 2012, CIRC RES, V110, P59, DOI 10.1161/CIRCRESAHA.111.254672; Karbalaei MS, 2012, EUR J PHARMACOL, V689, P179, DOI 10.1016/j.ejphar.2012.05.023; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Magyar J, 2012, CHANNELS, V6, P166, DOI 10.4161/chan.20192; Neidhold S, 2007, BRIT J PHARMACOL, V150, P261, DOI 10.1038/sj.bjp.0706980; Rahman A, 2009, ACTA PHYSIOL, V195, P231, DOI 10.1111/j.1748-1716.2008.01907.x; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P38121; Saliez J, 2008, CIRCULATION, V117, P1065, DOI 10.1161/CIRCULATIONAHA.107.731679; Schubert R, 2008, CARDIOVASC RES, V77, P8, DOI 10.1016/j.cardiores.2007.07.018; Shakirova Y, 2006, AM J PHYSIOL-CELL PH, V291, pC1326, DOI 10.1152/ajpcell.00046.2006; Sward K, 2003, CURR HYPERTENS REP, V5, P66, DOI 10.1007/s11906-003-0013-1; Sward K, 2002, CIRC RES, V90, P792, DOI 10.1161/01.RES.0000015214.40360.84; Sward K, 2013, PHYSL REPORTS, V1; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	37	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92428	10.1371/journal.pone.0092428	http://dx.doi.org/10.1371/journal.pone.0092428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658465	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300082
J	Vargas, LM; Leal, N; Estrada, LD; Gonzalez, A; Serrano, F; Araya, K; Gysling, K; Inestrosa, NC; Pasquale, EB; Alvarez, AR				Vargas, Lina M.; Leal, Nancy; Estrada, Lisbell D.; Gonzalez, Adrian; Serrano, Felipe; Araya, Katherine; Gysling, Katia; Inestrosa, Nibaldo C.; Pasquale, Elena B.; Alvarez, Alejandra R.			EphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-beta Oligomers	PLOS ONE			English	Article							DENDRITIC SPINE MORPHOLOGY; A-BETA; TYROSINE KINASE; MOLECULAR-BASIS; FAMILY KINASES; EPHRIN-BINDING; KEY ROLE; RECEPTORS; APOPTOSIS; PREVENTS	The early stages of Alzheimer's disease are characterised by impaired synaptic plasticity and synapse loss. Here, we show that amyloid-beta oligomers (A beta Os) activate the c-Abl kinase in dendritic spines of cultured hippocampal neurons and that c-Abl kinase activity is required for A beta Os-induced synaptic loss. We also show that the EphA4 receptor tyrosine kinase is upstream of c-Abl activation by A beta Os. EphA4 tyrosine phosphorylation (activation) is increased in cultured neurons and synaptoneurosomes exposed to A beta Os, and in Alzheimer-transgenic mice brain. We do not detect c-Abl activation in EphA4-knockout neurons exposed to A beta Os. More interestingly, we demonstrate EphA4/c-Abl activation is a key-signalling event that mediates the synaptic damage induced by A beta Os. According to this results, the EphA4 antagonistic peptide KYL and c-Abl inhibitor STI prevented i) dendritic spine reduction, ii) the blocking of LTP induction and iii) neuronal apoptosis caused by A beta Os. Moreover, EphA4-/- neurons or sh-EphA4-transfected neurons showed reduced synaptotoxicity by A beta Os. Our results are consistent with EphA4 being a novel receptor that mediates synaptic damage induced by A beta Os. EphA4/c-Abl signalling could be a relevant pathway involved in the early cognitive decline observed in Alzheimer's disease patients.	[Vargas, Lina M.; Leal, Nancy; Estrada, Lisbell D.; Gonzalez, Adrian; Alvarez, Alejandra R.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Lab Senalizac Celular, Santiago, Chile; [Araya, Katherine; Gysling, Katia] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago, Chile; [Serrano, Felipe; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Envejecimiento & Regenerac CARE, Dept Biol Celular & Mol, Santiago, Chile; [Pasquale, Elena B.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Sanford Burnham Prebys Medical Discovery Institute	Alvarez, AR (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Lab Senalizac Celular, Alameda 340, Santiago, Chile.	aalvarez@bio.puc.cl	estrada, lisbell/S-8188-2019	estrada, lisbell/0000-0002-8594-4072; Alvarez Rojas, Alejandra/0000-0002-8129-9280; Serrano, Felipe/0000-0003-1362-8561	FONDECYT [3120015, 1120512, 11130561]; FONDEF [D10I1077]; National Institutes of Health [CA138390, HD025938]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA138390] Funding Source: NIH RePORTER	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDEF; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants from FONDECYT 3120015 (LV), FONDECYT 1120512 and FONDEF D10I1077 (AA), FONDECYT 11130561 (LE) and National Institutes of Health grants CA138390 and HD025938 (EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AR, 2008, FASEB J, V22, P3617, DOI 10.1096/fj.07-102715; Alvarez AR, 2004, NEUROBIOL DIS, V17, P326, DOI 10.1016/j.nbd.2004.06.007; Araya KA, 2007, EUR J PHARMACOL, V572, P32, DOI 10.1016/j.ejphar.2007.06.013; Arimon M, 2005, FASEB J, V19, P1344, DOI 10.1096/fj.04-3137fje; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Beazely MA, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-20; Bittner T, 2012, ACTA NEUROPATHOL, V124, P797, DOI 10.1007/s00401-012-1047-8; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cancino GI, 2008, BRAIN, V131, P2425, DOI 10.1093/brain/awn125; Cancino GI, 2011, NEUROBIOL AGING, V32, P1249, DOI 10.1016/j.neurobiolaging.2009.07.007; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Cerpa W, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-3; Cesa R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019160; Chen Y, 2012, CELL SIGNAL, V24, P606, DOI 10.1016/j.cellsig.2011.11.016; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Clifford MA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-21; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Estrada LD, 2011, CURR ALZHEIMER RES, V8, P643; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fu AKY, 2011, NAT NEUROSCI, V14, P181, DOI 10.1038/nn.2715; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Genua M, 2009, VITAM HORM, V80, P77, DOI 10.1016/S0083-6729(08)00604-3; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Gonfloni S, 2012, INT J CELL BIOL; Harbott LK, 2005, MOL CELL NEUROSCI, V30, P1, DOI 10.1016/j.mcn.2005.05.002; Ikonomovic MD, 1997, J NEUROPATH EXP NEUR, V56, P1018, DOI 10.1097/00005072-199709000-00007; Inoue E, 2009, J CELL BIOL, V185, P551, DOI 10.1083/jcb.200809151; Jing Z, 2009, J ALZHEIMERS DIS, V17, P409, DOI 10.3233/JAD-2009-1062; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lamberto I, 2012, BIOCHEM J, V445, P47, DOI 10.1042/BJ20120408; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li JG, 2012, NEUROSCI LETT, V518, P92, DOI 10.1016/j.neulet.2012.04.060; Simon AM, 2009, J ALZHEIMERS DIS, V17, P773, DOI 10.3233/JAD-2009-1096; Moresco EMY, 2003, CURR OPIN NEUROBIOL, V13, P535, DOI 10.1016/j.conb.2003.08.002; Moresco EMY, 2003, J NEUROPHYSIOL, V89, P1678, DOI 10.1152/jn.00892.2002; Munro KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055948; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Patel AN, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002134; Peng YR, 2013, NEUROPHARMACOLOGY, V65, P232, DOI 10.1016/j.neuropharm.2012.10.012; de Arce KP, 2010, J NEUROSCI, V30, P3728, DOI 10.1523/JNEUROSCI.2024-09.2010; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Schlatterer SD, 2011, J MOL NEUROSCI, V45, P445, DOI 10.1007/s12031-011-9588-1; Schlatterer SD, 2011, J ALZHEIMERS DIS, V25, P119, DOI 10.3233/JAD-2011-102025; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Spanevello MD, 2013, J NEUROTRAUM, V30, P1023, DOI 10.1089/neu.2012.2729; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936; Xu QL, 2000, PHILOS T ROY SOC B, V355, P993, DOI 10.1098/rstb.2000.0635; Yu HH, 2001, ONCOGENE, V20, P3995, DOI 10.1038/sj.onc.1204524; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182; Zhou L, 2007, J NEUROSCI, V27, P5127, DOI 10.1523/JNEUROSCI.1170-07.2007	71	56	57	8	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92309	10.1371/journal.pone.0092309	http://dx.doi.org/10.1371/journal.pone.0092309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658113	Green Submitted, Green Published, gold			2022-12-25	WOS:000333355300072
J	Wan, SW; Lu, YT; Huang, CH; Lin, CF; Anderson, R; Liu, HS; Yeh, TM; Yen, YT; Wu-Hsieh, BA; Lin, YS				Wan, Shu-Wen; Lu, Yi-Tien; Huang, Chia-Hui; Lin, Chiou-Feng; Anderson, Robert; Liu, Hsiao-Sheng; Yeh, Trai-Ming; Yen, Yu-Ting; Wu-Hsieh, Betty A.; Lin, Yee-Shin			Protection against Dengue Virus Infection in Mice by Administration of Antibodies against Modified Nonstructural Protein 1	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; C-TERMINAL REGION; DEPENDENT ENHANCEMENT; ENDOTHELIAL-CELLS; NS1 PROTEIN; ENCEPHALITIS; IMMUNIZATION; IMMUNITY; VACCINE; GLYCOPROTEIN	Background: Infection with dengue virus (DENV) may cause life-threatening disease with thrombocytopenia and vascular leakage which are related to dysfunction of platelets and endothelial cells. We previously showed that antibodies (Abs) against DENV nonstructural protein 1 (NS1) cross-react with human platelets and endothelial cells, leading to functional disturbances. Based on sequence homology analysis, the C-terminal region of DENV NS1 protein contains cross-reactive epitopes. For safety in vaccine development, the cross-reactive epitopes of DENV NS1 protein should be deleted or modified. Methodology/Principal Findings: We tested the protective effects of Abs against full-length DENV NS1, NS1 lacking the C-terminal amino acids (a.a.) 271-352 (designated DC NS1), and chimeric DJ NS1 consisting of N-terminal DENV NS1 (a.a. 1-270) and C-terminal Japanese encephalitis virus NS1 (a.a. 271-352). The anti-Delta C NS1 and anti-DJ NS1 Abs showed a lower binding activity to endothelial cells and platelets than that of anti-DENV NS1 Abs. Passive immunization with anti-Delta C NS1 and anti-DJ NS1 Abs reduced DENV-induced prolonged mouse tail bleeding time. Treatment with anti-DENV NS1, anti-Delta C NS1 and anti-DJ NS1 Abs reduced local skin hemorrhage, controlled the viral load of DENV infection in vivo, synergized with complement to inhibit viral replication in vitro, as well as abolished DENV-induced macrophage infiltration to the site of skin inoculation. Moreover, active immunization with modified NS1 protein, but not with unmodified DENV NS1 protein, reduced DENV-induced prolonged bleeding time, local skin hemorrhage, and viral load. Conclusions/Significance: These results support the idea that modified NS1 proteins may represent an improved strategy for safe and effective vaccine development against DENV infection.	[Wan, Shu-Wen; Lin, Chiou-Feng; Liu, Hsiao-Sheng; Yeh, Trai-Ming; Lin, Yee-Shin] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Lin, Chiou-Feng] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Lin, Chiou-Feng] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Anderson, Robert] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Yeh, Trai-Ming] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Yen, Yu-Ting; Wu-Hsieh, Betty A.] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Dalhousie University; National Cheng Kung University; National Taiwan University	Wu-Hsieh, BA (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.	bwh@ntu.edu.tw; yslin1@mail.ncku.edu.tw	Yeh, Trai-Ming/C-7193-2011	Yeh, Trai-Ming/0000-0003-3172-7432; WU-HSIEH, BETTY AN-YE/0000-0003-1522-2055; Liu, Hsiao-Sheng/0000-0003-0576-7203	National Science Council, Taiwan [NSC101-2325-B-006-006, NSC101-2321-B-006-002, NSC101-2321-B-006-031, NSC 101-2321-B-002-062]; Multidisciplinary Center of Excellence for Clinical Trial and Research, Department of Health, Taiwan [DOH102-TD-B-111-002]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Multidisciplinary Center of Excellence for Clinical Trial and Research, Department of Health, Taiwan	This work was supported by Grants NSC101-2325-B-006-006, NSC101-2321-B-006-002, NSC101-2321-B-006-031 (to YSL), and NSC 101-2321-B-002-062 (to BAWH) from National Science Council, Taiwan; and DOH102-TD-B-111-002 from Multidisciplinary Center of Excellence for Clinical Trial and Research, Department of Health, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Amorim JH, 2012, VACCINE, V30, P837, DOI 10.1016/j.vaccine.2011.12.034; Anderson R, 1997, J VIROL, V71, P4226, DOI 10.1128/JVI.71.6.4226-4232.1997; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; Chen MC, 2009, J IMMUNOL, V183, P1797, DOI 10.4049/jimmunol.0800672; Cheng HJ, 2009, MOL IMMUNOL, V47, P398, DOI 10.1016/j.molimm.2009.08.033; Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147; Chuang YC, 2013, THROMB HAEMOSTASIS, V110, P358, DOI 10.1160/TH13-02-0149; Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006; Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07; Coller BAG, 2011, CURR OPIN IMMUNOL, V23, P391, DOI 10.1016/j.coi.2011.03.005; Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127; Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06; FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Halstead SB, 2002, CURR OPIN INFECT DIS, V15, P471, DOI 10.1097/00001432-200210000-00003; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114; HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101; Henriques HR, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002330, 10.1371/journal.pntd.0002469]; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; Huang KJ, 2000, J GEN VIROL, V81, P2177, DOI 10.1099/0022-1317-81-9-2177; Kitai Y, 2010, CLIN VACCINE IMMUNOL, V17, P875, DOI 10.1128/CVI.00217-09; Krishna VD, 2009, J VIROL, V83, P4766, DOI 10.1128/JVI.01850-08; Li PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001636; Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395; Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657; Lin CW, 2008, BIOTECHNOL LETT, V30, P205, DOI 10.1007/s10529-007-9529-9; Lin CF, 2008, AM J INFECT DIS, V4, P69, DOI 10.3844/ajidsp.2008.69.75; Lin YS, 2011, EXP BIOL MED, V236, P515, DOI 10.1258/ebm.2011.010339; Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998; Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008; Perng GC, 2011, WORLD J VACCIN, V1, P109; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015; SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853; SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805; Severin S, 2007, J CLIN INVEST, V117, P944, DOI 10.1172/JCI29967; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Swaminathan S, 2010, EXPERT OPIN THER PAT, V20, P819, DOI 10.1517/13543771003767476; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Thomas SJ, 2011, CURR OPIN INFECT DIS, V24, P442, DOI 10.1097/QCO.0b013e32834a1b0b; Wan SW, 2008, AM J INFECT DIS, V4, P85, DOI 10.3844/ajidsp.2008.85.91; Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4; Wu-Hsieh BA, 2009, ANN NY ACAD SCI, V1171, pE42, DOI 10.1111/j.1749-6632.2009.05053.x; Yauch LE, 2008, ANTIVIR RES, V80, P87, DOI 10.1016/j.antiviral.2008.06.010; Yen YT, 2008, J VIROL, V82, P12312, DOI 10.1128/JVI.00968-08	56	26	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92495	10.1371/journal.pone.0092495	http://dx.doi.org/10.1371/journal.pone.0092495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658118	Green Submitted, gold, Green Published			2022-12-25	WOS:000333355300090
J	Burk, D; Ingram, JN; Franklin, DW; Shadlen, MN; Wolpert, DM				Burk, Diana; Ingram, James N.; Franklin, David W.; Shadlen, Michael N.; Wolpert, Daniel M.			Motor Effort Alters Changes of Mind in Sensorimotor Decision Making	PLOS ONE			English	Article							DEVELOPING OCULOMOTOR COMMANDS; PERCEPTUAL DECISION; NEURAL BASIS; DISCRIMINATION; REPRESENTATION; TIME	After committing to an action, a decision-maker can change their mind to revise the action. Such changes of mind can even occur when the stream of information that led to the action is curtailed at movement onset. This is explained by the time delays in sensory processing and motor planning which lead to a component at the end of the sensory stream that can only be processed after initiation. Such post-initiation processing can explain the pattern of changes of mind by asserting an accumulation of additional evidence to a criterion level, termed change-of-mind bound. Here we test the hypothesis that physical effort associated with the movement required to change one's mind affects the level of the change-of-mind bound and the time for post-initiation deliberation. We varied the effort required to change from one choice target to another in a reaching movement by varying the geometry of the choice targets or by applying a force field between the targets. We show that there is a reduction in the frequency of change of mind when the separation of the choice targets would require a larger excursion of the hand from the initial to the opposite choice. The reduction is best explained by an increase in the evidence required for changes of mind and a reduced time period of integration after the initial decision. Thus the criteria to revise an initial choice is sensitive to energetic costs.	[Burk, Diana; Ingram, James N.; Franklin, David W.; Wolpert, Daniel M.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England; [Burk, Diana] Howard Hughes Med Inst, Ashburn, VA USA; [Burk, Diana] NIDA, Intramural Res Program, Baltimore, MD USA; [Shadlen, Michael N.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst, New York, NY 10032 USA; [Shadlen, Michael N.] Columbia Univ, Zuckerman Mind Brain Behav Inst, Dept Neurosci, New York, NY USA	University of Cambridge; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Columbia University; Howard Hughes Medical Institute; Columbia University	Wolpert, DM (corresponding author), Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England.	wolpert@eng.cam.ac.uk	Shadlen, Michael Neil/AAL-1870-2020; Franklin, David/A-2371-2009	Franklin, David/0000-0001-9530-0820; Wolpert, Daniel/0000-0003-2011-2790	Human Frontiers Science Program; Wellcome Trust; Howard Hughes Medical Institute; NIH [R01EY11378]; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Human Frontiers Science Program, the Wellcome Trust, Howard Hughes Medical Institute and the NIH (R01EY11378). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Laming DR, 1968, INFORM THEORY CHOICE; LINK SW, 1975, J MATH PSYCHOL, V12, P114, DOI 10.1016/0022-2496(75)90053-X; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McCullagh P, 1989, GEN LINEAR MODELS; O'Sullivan I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000345; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Roitman JD, 2002, J NEUROSCI, V22, P9475; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Selen LPJ, 2012, J NEUROSCI, V32, P2276, DOI 10.1523/JNEUROSCI.5273-11.2012; Shadlen MN, 2013, NEURON, V80, P791, DOI 10.1016/j.neuron.2013.10.047; Shadlen MN, 2008, BETTER CONSCIOUS DEC, P71, DOI 10.7551/mitpress/9780262195805.003.0004; SMITH PL, 1988, J MATH PSYCHOL, V32, P135, DOI 10.1016/0022-2496(88)90043-0; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963	26	45	45	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92681	10.1371/journal.pone.0092681	http://dx.doi.org/10.1371/journal.pone.0092681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651615	Green Published, gold			2022-12-25	WOS:000333352800141
J	Haward, SJ				Haward, Simon J.			Synovial Fluid Response to Extensional Flow: Effects of Dilution and Intermolecular Interactions	PLOS ONE			English	Article							SODIUM HYALURONATE; POLYMER-SOLUTIONS; VISCOSITY; SHEAR; BEHAVIOR; MACROMOLECULES; RHEOMETRY	In this study, a microfluidic cross-slot device is used to examine the extensional flow response of diluted porcine synovial fluid (PSF) samples using flow-induced birefringence (FIB) measurements. The PSF sample is diluted to 10x20x and 30x its original mass in a phosphate-buffered saline and its FIB response measured as a function of the strain rate at the stagnation point of the cross-slots. Equivalent experiments are also carried out using trypsin-treated PSF (t-PSF) in which the protein content is digested away using an enzyme. The results show that, at the synovial fluid concentrations tested, the protein content plays a negligible role in either the fluid's bulk shear or extensional flow behaviour. This helps support the validity of the analysis of synovial fluid HA content, either by microfluidic or by other techniques where the synovial fluid is first diluted, and suggests that the HA and protein content in synovial fluid must be higher than a certain minimum threshold concentration before HA-protein or protein-protein interactions become significant. However a systematic shift in the FIB response as the PSF and t-PSF samples are progressively diluted indicates that HA-HA interactions remain significant at the concentrations tested. These interactions influence FIB-derived macromolecular parameters such as the relaxation time and the molecular weight distribution and therefore must be minimized for the best validity of this method as an analytical technique, in which non-interaction between molecules is assumed.	Univ Porto, Ctr Estudos Fenomenos Transporte, Fac Engn, Dept Engn Quim, P-4100 Oporto, Portugal	Universidade do Porto	Haward, SJ (corresponding author), Univ Porto, Ctr Estudos Fenomenos Transporte, Fac Engn, Dept Engn Quim, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	shaward@fe.up.pt	Haward, Simon James/H-8700-2013	Haward, Simon James/0000-0002-1884-4100	Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme [298220]	Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme(European Commission)	This research was supported by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme, FP7-PEOPLE-2011-IIF, grant 298220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlAssaf S, 1996, BIORHEOLOGY, V33, P319, DOI 10.1016/0006-355X(96)00025-X; Arratia PE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.144502; Backus C, 2002, HYALURONAN, V1, P209, DOI DOI 10.1533/9781845693121.209; BALAZS EA, 1993, J RHEUMATOL, V20, P3; Bingol AO, 2010, BIORHEOLOGY, V47, P205, DOI 10.3233/BIR-2010-0572; Clasen C, 2006, J RHEOL, V50, P849, DOI 10.1122/1.2357595; DEGENNES PG, 1974, J CHEM PHYS, V60, P5030, DOI 10.1063/1.1681018; Elsaid KA, 2005, ARTHRITIS RHEUM-US, V52, P1746, DOI 10.1002/art.21038; FOUISSAC E, 1993, MACROMOLECULES, V26, P6945, DOI 10.1021/ma00077a036; GILSON MK, 1985, J MOL BIOL, V184, P503, DOI 10.1016/0022-2836(85)90297-9; Haward SJ, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4816708; Haward SJ, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4818151; Haward SJ, 2012, SOFT MATTER, V8, P536, DOI 10.1039/c1sm06494k; Haward SJ, 2014, BIOPOLYMERS, V101, P287, DOI 10.1002/bip.22357; Haward SJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128301; Haward SJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.031502; Haward SJ, 2011, SOFT MATTER, V7, P9908, DOI 10.1039/c1sm05493g; Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104; KELLER A, 1985, COLLOID POLYM SCI, V263, P181, DOI 10.1007/BF01415506; LARSON RG, 1989, MACROMOLECULES, V22, P3004, DOI 10.1021/ma00197a022; McCarty D. J., 1997, ARTHRITIS ALLIED CON, V1, P81; Mendichi R, 2003, BIOMACROMOLECULES, V4, P1805, DOI 10.1021/bm0342178; Meyer F, 2009, J RHEOL, V53, P799, DOI 10.1122/1.3122985; Moon YU, 2000, J SOLUTION CHEM, V29, P699, DOI 10.1023/A:1005112927213; Oates KMN, 2006, J R SOC INTERFACE, V3, P167, DOI 10.1098/rsif.2005.0086; Oates KMN, 2002, MATER RES SOC SYMP P, V711, P53; Odell JA, 2006, J NON-NEWTON FLUID, V137, P110, DOI 10.1016/j.jnnfm.2006.03.010; ODELL JA, 1989, ADV CHEM SER, P193; PALFREY AJ, 1968, J APPL PHYSIOL, V25, P672, DOI 10.1152/jappl.1968.25.6.672; Poole RJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.164503; RIDDIFORD CL, 1970, J PHYS D APPL PHYS, V3, P1314, DOI 10.1088/0022-3727/3/9/311; Sharma V, 2011, SOFT MATTER, V7, P5150, DOI 10.1039/c0sm01312a	32	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92867	10.1371/journal.pone.0092867	http://dx.doi.org/10.1371/journal.pone.0092867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651529	gold, Green Submitted, Green Published			2022-12-25	WOS:000333352800159
J	Pfortmueller, CA; Funk, GC; Leichtle, AB; Fiedler, GM; Schwarz, C; Exadaktylos, AK; Lindner, G				Pfortmueller, Carmen A.; Funk, Georg-Christian; Leichtle, Alexander B.; Fiedler, Georg M.; Schwarz, Christoph; Exadaktylos, Aristomenis K.; Lindner, Gregor			Electrolyte Disorders and In-Hospital Mortality during Prolonged Heat Periods: A Cross-Sectional Analysis	PLOS ONE			English	Article							HYPONATREMIA; DEHYDRATION; EXERCISE; HYPERNATREMIA; ADMISSION	Background: Heat periods during recent years were associated with excess hospitalization and mortality rates, especially in the elderly. We intended to study whether prolonged warmth/heat periods are associated with an increased prevalence of disorders of serum sodium and potassium and an increased hospital mortality. Methods: In this cross-sectional analysis all patients admitted to the Department of Emergency Medicine of a large tertiary care facility between January 2009 and December 2010 with measurements of serum sodium were included. Demographic data along with detailed data on diuretic medication, length of hospital stay and hospital mortality were obtained for all patients. Data on daily temperatures (maximum, mean, minimum) and humidity were retrieved by Meteo Swiss. Results: A total of 22.239 patients were included in the study. 5 periods with a temperature exceeding 25 degrees C for 3 to 5 days were noticed and 2 periods with temperatures exceeding 25 degrees C for more than 5 days were noted. Additionally, 2 periods with 3 to 5 days with daily temperatures exceeding 30 degrees C were noted during the study period. We found a significantly increased prevalence of hyponatremia during heat periods. However, in the Cox regression analysis, prolonged heat was not associated with the prevalence of disorders of serum sodium or potassium. Admission during a heat period was an independent predictor for hospital mortality. Conclusions: Although we found an increased prevalence of hyponatremia during heat periods, no convincing connection could be found for hypernatremia or disorders of serum potassium.	[Pfortmueller, Carmen A.; Exadaktylos, Aristomenis K.; Lindner, Gregor] Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.] Univ Hosp Bern, Inselspital, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Funk, Georg-Christian] Otto Wagner Spital Vienna, Dept Resp & Crit Care Med, Vienna, Austria; [Funk, Georg-Christian] Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria; [Leichtle, Alexander B.; Fiedler, Georg M.] Univ Hosp Bern, Inselspital, Ctr Lab Med, CH-3010 Bern, Switzerland; [Schwarz, Christoph] Landeskrankenhaus Steyr, Dept Nephrol, Steyr, Austria	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Ludwig Boltzmann Institute; University of Bern; University Hospital of Bern	Lindner, G (corresponding author), Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland.	lindner.gregor@gmail.com	Fiedler, Georg Martin/C-8341-2011; Leichtle, Alexander/C-7262-2011; Lindner, Gregor/AAR-6761-2020	Fiedler, Georg Martin/0000-0001-5689-4574; Lindner, Gregor/0000-0001-5551-8227; Pfortmueller, Carmen/0000-0003-0326-2770				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Almond CSD, 2005, NEW ENGL J MED, V352, P1550, DOI 10.1056/NEJMoa043901; Arampatzis S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-83; ARMSTRONG LE, 1993, MED SCI SPORT EXER, V25, P543; Flinn SD, 2000, PHYSICIAN SPORTSMED, V28, P61, DOI 10.3810/psm.2000.09.1207; Funk GC, 2010, INTENS CARE MED, V36, P304, DOI 10.1007/s00134-009-1692-0; Grandjean AC, 2007, J AM COLL NUTR, V26, p549S, DOI 10.1080/07315724.2007.10719657; Hawkins RC, 2003, CLIN CHIM ACTA, V337, P169, DOI 10.1016/j.cccn.2003.08.001; Hayes LD, 2010, EUR J APPL PHYSIOL, V108, P701, DOI 10.1007/s00421-009-1288-y; HIMMELSTEIN DU, 1983, J AM GERIATR SOC, V31, P466, DOI 10.1111/j.1532-5415.1983.tb05118.x; Knechtle B, 2011, CLIN J SPORT MED, V21, P226, DOI 10.1097/JSM.0b013e31820cb021; Lindner G, 2013, J CRIT CARE, V28, p[216, e211]; Nayha S, 2007, INT J CIRCUMPOL HEAL, V66, P418; O'Neill MS, 2009, J OCCUP ENVIRON MED, V51, P13, DOI 10.1097/JOM.0b013e318173e122; Palmisano P, 2013, INT J BIOMETEOROL; Rikkert MGMO, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2663; Robine J, 2003, REPORT EXCESS MORTAL; ROSE DB, 2001, CLIN PHYSL ACID BASE	18	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92150	10.1371/journal.pone.0092150	http://dx.doi.org/10.1371/journal.pone.0092150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651296	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800074
J	Shin, YJ; Kumarasamy, V; Camacho, D; Sun, D				Shin, Y-J; Kumarasamy, V.; Camacho, D.; Sun, D.			Involvement of G-quadruplex structures in regulation of human RET gene expression by small molecules in human medullary thyroid carcinoma TT cells	ONCOGENE			English	Article							PROXIMAL PROMOTER REGION; POLYPYRIMIDINE/POLYPURINE TRACT; DNA; PROTOONCOGENE; TRANSCRIPTION; TRANSITION; ONCOGENE; PATHWAY; PROTEIN; SYSTEM	The RET (rearranged during transfection) proto-oncogene encodes a receptor tyrosine kinase for members of the glial cell line-derived neurotrophic factor family of extracellular signaling molecules. The activating germline point mutations in the RET, which are known to induce oncogenic activation of RET tyrosine kinase, are associated with the development of medullary thyroid carcinoma (MTC) and pathogenesis of multiple endocrine neoplasia type 2 (MEN2). The polypurine/ polypyrimidine tract in the proximal promoter region of the human RET gene (similar to 51 to similar to 33 relative to transcription start site) is essential for basal transcriptional activity of this gene. This tract consists of a guanine-rich sequence containing five runs of at least three contiguous guanines separated by one or more bases, conforming to a general motif capable of forming an intramolecular G-quadruplex. Here, we show that specific G-quadruplex structures formed in the RET promoter region act to repress the transcription of this gene, and transcription of this gene can be controlled by ligand-mediated G-quadruplex stabilization. In this study, NSC194598, a derivative of indeno[1,2,3-de] quinazoline, was found to be a novel G-quadruplex interactive agent that interfered with transcriptional activation of mutated RET gene in human medullary thyroid carcinoma TT cells. This compound significantly reduced endogenous RET protein levels and increased apoptosis in these cells. Our results provide further support for the idea that G-quadruplex structures may have a critical role in transcriptional regulation of the RET gene in vivo, providing insight into a novel strategy for transcriptional repression of this gene by small molecules.	[Shin, Y-J; Kumarasamy, V.; Camacho, D.; Sun, D.] Univ Arizona, Dept Pharmacol & Toxicol, Coll Pharm, Tucson, AZ 85721 USA; [Sun, D.] BIO5 Inst, Tucson, AZ USA; [Sun, D.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA	University of Arizona; Arizona Center Cancer Care; University of Arizona	Sun, D (corresponding author), Univ Arizona, Dept Pharmacol & Toxicol, Coll Pharm, 1657 E Helen St, Tucson, AZ 85721 USA.	sun@pharmacy.arizona.edu			American Cancer Society [RSGM-12-046-01-CDD]	American Cancer Society(American Cancer Society)	We thank the American Cancer Society for support of this work (RSGM-12-046-01-CDD).	Andrew SD, 2000, GENE, V256, P283, DOI 10.1016/S0378-1119(00)00302-4; Andrew SD, 2002, GENE, V298, P9, DOI 10.1016/S0378-1119(02)00919-8; Bachetti T, 2005, GENE EXPRESSION, V12, P137, DOI 10.3727/000000005783992106; BELLOC F, 1994, CYTOMETRY, V17, P59, DOI 10.1002/cyto.990170108; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Carter MT, 2001, CYTOGENET CELL GENET, V95, P169, DOI 10.1159/000059341; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; de Groot JWB, 2006, ENDOCR REV, V27, P535, DOI 10.1210/er.2006-0017; EVANS T, 1986, J BIOL CHEM, V261, P4771; Gray DM, 2002, ENANTIOMER, V7, P49, DOI 10.1080/10242430212192; Guo K, 2007, J AM CHEM SOC, V129, P10220, DOI 10.1021/ja072185g; Han HY, 1999, NUCLEIC ACIDS RES, V27, P537, DOI 10.1093/nar/27.2.537; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lodish MB, 2008, EXPERT REV ANTICANC, V8, P625, DOI 10.1586/14737140.8.4.625; Massoll N, 2004, CLIN LAB MED, V24, P49, DOI 10.1016/j.cll.2004.01.006; MCCARTHY JG, 1987, NUCLEIC ACIDS RES, V15, P8069, DOI 10.1093/nar/15.19.8069; Nair RR, 2008, MOL PHARMACOL, V73, P919, DOI 10.1124/mol.107.042606; Niccoli-Sire P, 2007, ANN ENDOCRINOL-PARIS, V68, P317, DOI 10.1016/j.ando.2007.04.005; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Phan AT, 2004, J AM CHEM SOC, V126, P8710, DOI 10.1021/ja048805k; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Rahman KM, 2012, BIOORG MED CHEM LETT, V22, P3006, DOI 10.1016/j.bmcl.2012.02.020; Runeberg-Roos P, 2007, ANN MED, V39, P572, DOI 10.1080/07853890701646256; Rustighi A, 2002, BIOCHEMISTRY-US, V41, P1229, DOI 10.1021/bi011666o; Sassano Maria Florencia, 2012, Open Med Chem J, V6, P20, DOI 10.2174/1874104501206010020; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simonsson T, 2001, BIOL CHEM, V382, P621, DOI 10.1515/BC.2001.073; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Todd AK, 2008, NUCLEIC ACIDS RES, V36, P2700, DOI 10.1093/nar/gkn078; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742; Yan CH, 2004, FASEB J, V18, P540, DOI 10.1096/fj.03-0960fje	33	30	31	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2015	34	10					1292	1299		10.1038/onc.2014.65	http://dx.doi.org/10.1038/onc.2014.65			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC9JX	24662821				2022-12-25	WOS:000350687100009
J	Hancer, NJ; Qiu, W; Cherella, C; Li, YD; Copps, KD; White, MF				Hancer, Nancy J.; Qiu, Wei; Cherella, Christine; Li, Yedan; Copps, Kyle D.; White, Morris F.			Insulin and Metabolic Stress Stimulate Multisite Serine/Threonine Phosphorylation of Insulin Receptor Substrate 1 and Inhibit Tyrosine Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Insulin Resistance; Phosphotyrosine Signaling; Protein Phosphorylation; Signal Transduction; CHO Cells; IRS1; Insulin Signaling; Metabolic Stress; Monoclonal Antibodies	PROTEIN-KINASE-C; PLECKSTRIN-HOMOLOGY-DOMAIN; IRS-1 SERINE PHOSPHORYLATION; DIET-INDUCED OBESITY; SKELETAL-MUSCLE; PHOSPHOPROTEOME REVEALS; REGULATORY ROLE; IN-VITRO; RESISTANCE; MTOR	Background: Metabolic stresses, including hyperinsulinemia, promote insulin resistance. Results: Monoclonal antibodies raised against Ser(P)/Thr(P) residues in IRS1 were used to quantify phosphorylation in response to insulin or agents that model metabolic stress. Conclusion: Similar IRS1 Ser(P)/Thr(P) residues are increased by insulin or metabolic stress, and some correlate significantly with reduced IRS1 tyrosine phosphorylation. Significance: Metabolic stress co-opts insulin-dependent IRS1 phosphorylation to aggravate insulin resistance. IRS1 and IRS2 are key substrates of the insulin receptor tyrosine kinase. Mass spectrometry reveals more than 50 phosphorylated IRS1 serine and threonine residues (Ser(P)/Thr(P) residues) in IRS1 from insulin-stimulated cells or human tissues. We investigated a subset of IRS1 Ser(P)/Thr(P) residues using a newly developed panel of 25 phospho-specific monoclonal antibodies (pS/TmAb(Irs1)). CHO cells overexpressing the human insulin receptor and rat IRS1 were stimulated with insulin in the absence or presence of inhibitors of the PI3K Akt mechanistic target of rapamycin (mTOR) S6 kinase or MEK pathways. Nearly all IRS1 Ser(P)/Thr(P) residues were stimulated by insulin and significantly suppressed by PI3K inhibition; fewer were suppressed by Akt or mTOR inhibition, and none were suppressed by MEK inhibition. Insulin-stimulated Irs1 tyrosine phosphorylation (Tyr(P)(Irs1)) was enhanced by inhibition of the PI3K Akt mTOR pathway and correlated with decreased Ser(P)-302(Irs1), Ser(P)-307(Irs1), Ser(P)-318(Irs1), Ser(P)-325(Irs1), and Ser(P)-346(Irs1). Metabolic stress modeled by anisomycin, thapsigargin, or tunicamycin increased many of the same Ser(P)/Thr(P) residues as insulin, some of which (Ser(P)-302(Irs1), Ser(P)-307(Irs1), and four others) correlated significantly with impaired insulin-stimulated Tyr(P)(Irs1). Thus, IRS1 Ser(P)/Thr(P) is an integrated response to insulin stimulation and metabolic stress, which associates with reduced Tyr(P)(Irs1) in CHOIR/IRS1 cells.	[Hancer, Nancy J.; Qiu, Wei; Cherella, Christine; Li, Yedan; Copps, Kyle D.; White, Morris F.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol,Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	White, MF (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol,Dept Med,Ctr Life Sci, Rm 16020,3 Blackfan Circle, Boston, MA 02115 USA.	morris.white@childrens.harvard.edu			National Institutes of Health [DK38712, DK55326, DK098655, GM021700]; Juvenile Diabetes Foundation International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055326, R29DK038712, R01DK038712, R01DK098655, R55DK038712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021700] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Foundation International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK38712, DK55326, DK098655 and GM021700 (to M. F. W.). This work was also supported by an award from the Juvenile Diabetes Foundation International.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Blattler SM, 2012, CELL METAB, V15, P505, DOI 10.1016/j.cmet.2012.03.008; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Bouzakri K, 2006, DIABETES, V55, P785, DOI 10.2337/diabetes.55.03.06.db05-0796; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Ersoy BA, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004111; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Giraud J, 2007, MOL ENDOCRINOL, V21, P2294, DOI 10.1210/me.2007-0159; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Gual P, 2003, DIABETOLOGIA, V46, P1532, DOI 10.1007/s00125-003-1223-4; Gupta A, 2012, MOL BIOL CELL, V23, P3882, DOI 10.1091/mbc.E12-05-0337; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hennige AM, 2006, FASEB J, V20, P1206, DOI 10.1096/fj.05-4635fje; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Jiang GQ, 2004, BIOCHEM J, V377, P339, DOI 10.1042/BJ20031207; Karlsson HKR, 2007, CELL BIOCHEM BIOPHYS, V48, P103, DOI 10.1007/s12013-007-0030-9; Kim JA, 2005, J BIOL CHEM, V280, P23173, DOI 10.1074/jbc.M501439200; Kim SJ, 2012, MOL CELL, V48, P875, DOI 10.1016/j.molcel.2012.09.029; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Langlais P, 2011, DIABETOLOGIA, V54, P2878, DOI 10.1007/s00125-011-2271-9; Levkovitz Y, 2007, MOL CELL NEUROSCI, V36, P305, DOI 10.1016/j.mcn.2007.05.009; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Liu YF, 2004, MOL CELL BIOL, V24, P9668, DOI 10.1128/MCB.24.21.9668-9681.2004; Luo ML, 2005, ENDOCRINOLOGY, V146, P4410, DOI 10.1210/en.2005-0260; Mandavia C, 2012, CARDIORENAL MED, V2, P308, DOI 10.1159/000343889; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Nawaratne R, 2006, MOL ENDOCRINOL, V20, P1838, DOI 10.1210/me.2005-0536; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Paz K, 1999, J BIOL CHEM, V274, P28816, DOI 10.1074/jbc.274.40.28816; Qiao LY, 2002, J BIOL CHEM, V277, P26530, DOI 10.1074/jbc.M201494200; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scheufele F, 2014, CELL SIGNAL, V26, P233, DOI 10.1016/j.cellsig.2013.11.005; SEGER R, 1995, J BIOL CHEM, V270, P28325; Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Waraich RS, 2008, J BIOL CHEM, V283, P11226, DOI 10.1074/jbc.M708588200; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Xie JL, 2013, NAT CELL BIOL, V15, P1263, DOI 10.1038/ncb2877; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Xu XS, 2012, J BIOL CHEM, V287, P40758, DOI 10.1074/jbc.M112.405209; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yi ZP, 2007, DIABETES, V56, P1508, DOI 10.2337/db06-1355; Yi ZP, 2006, J AM SOC MASS SPECTR, V17, P562, DOI 10.1016/j.jasms.2005.12.010; Yi ZP, 2005, ANAL CHEM, V77, P5693, DOI 10.1021/ac050760y; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4; ZINCK R, 1995, MOL CELL BIOL, V15, P4930; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	91	63	66	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12467	12484		10.1074/jbc.M114.554162	http://dx.doi.org/10.1074/jbc.M114.554162			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24652289	Green Published, hybrid			2022-12-25	WOS:000335581400023
J	Dhanwani, R; Khan, M; Lomash, V; Rao, PVL; Ly, H; Parida, M				Dhanwani, Rekha; Khan, Mohsin; Lomash, Vinay; Rao, Putcha Venkata Lakshmana; Ly, Hinh; Parida, Manmohan			Characterization of Chikungunya Virus Induced Host Response in a Mouse Model of Viral Myositis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; PYRUVATE-KINASE; SYNOVIAL-FLUID; ARTHRITIS; CELLS; INFECTION; DISEASE; STRESS; INFLAMMATION; EXPRESSION	While a number of studies have documented the persistent presence of chikungunya virus (CHIKV) in muscle tissue with primary fibroblast as the preferable cell target, little is known regarding the alterations that take place in muscle tissue in response to CHIKV infection. Hence, in the present study a permissive mouse model of CHIKV infection was established and characterized in order to understand the pathophysiology of the disease. The two dimensional electrophoresis of muscle proteome performed for differential analysis indicated a drastic reprogramming of the proteins from various classes like stress, inflammation, cytoskeletal, energy and lipid metabolism. The roles of the affected proteins were explained in relation to virus induced myopathy which was further supported by the histopathological and behavioural experiments proving the lack of hind limb coordination and other loco-motor abnormalities in the infected mice. Also, the level of various pro-inflammatory mediators like IL-6, MCP-1, Rantes and TNF-alpha was significantly elevated in muscles of infected mice. Altogether this comprehensive study of characterizing CHIKV induced mouse myopathy provides many potential targets for further evaluation and biomarker study.	[Dhanwani, Rekha; Khan, Mohsin; Parida, Manmohan] DRDE, Dept Virol, Gwalior, India; [Lomash, Vinay] DRDE, Dept Pharmacol & Toxicol, Gwalior, India; [Rao, Putcha Venkata Lakshmana] Bharathiar Univ Campus, DRDO BU Ctr Life Sci, Coimbatore, Tamil Nadu, India; [Ly, Hinh] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN USA	Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE); Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE); Bharathiar University; Defence Research & Development Organisation (DRDO); DRDO BU Center Life Sciences; University of Minnesota System; University of Minnesota Twin Cities	Parida, M (corresponding author), DRDE, Dept Virol, Gwalior, India.	paridamm@rediffmail.com	Khan, Mohsin/O-2827-2013	Khan, Mohsin/0000-0002-4142-2213; LOMASH, VINAY/0000-0001-9556-0366	Defence Research and Development Organisation (DRDO), Govt. of India	Defence Research and Development Organisation (DRDO), Govt. of India(Defence Research & Development Organisation (DRDO))	The study was funded by Defence Research and Development Organisation (DRDO), Govt. of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abere B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034800; AlShamma MRR, 1997, THORAX, V52, P1056, DOI 10.1136/thx.52.12.1056; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Baatartsogt O., 2009, Biotechnology, V8, P13; Butt RH, 2005, J PROTEOME RES, V4, P982, DOI 10.1021/pr050054d; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Dash PK, 2007, VECTOR-BORNE ZOONOT, V7, P519, DOI 10.1089/vbz.2007.7272; Dhanwani R, 2012, VIRUS RES, V163, P563, DOI 10.1016/j.virusres.2011.12.009; Dhanwani R, 2011, PROTEOMICS, V11, P1936, DOI 10.1002/pmic.201000500; Dong WJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2588; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Escobedo J, 2004, FREE RADICAL BIO MED, V37, P1455, DOI 10.1016/j.freeradbiomed.2004.07.024; Fernandez-Arenas E, 2007, MOL CELL PROTEOMICS, V6, P460, DOI 10.1074/mcp.M600210-MCP200; FRANKE WW, 1979, EXP CELL RES, V123, P25, DOI 10.1016/0014-4827(79)90418-X; FRASER JRE, 1981, AUST NZ J MED, V11, P168, DOI 10.1111/j.1445-5994.1981.tb04226.x; Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09; Geiben-Lynn R, 2003, J BIOL CHEM, V278, P1569, DOI 10.1074/jbc.M209964200; Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001; HAZELTON RA, 1985, AUST NZ J MED, V15, P336, DOI 10.1111/j.1445-5994.1985.tb04048.x; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; HIRUMA M, 1990, JPN J VET SCI, V52, P767; Ho PP, 2010, J IMMUNOL, V184, P379, DOI 10.4049/jimmunol.0901639; Jain M, 2008, TROP DOCT, V38, P70, DOI 10.1258/td.2007.070019; Koh TJ, 2004, AM J PHYSIOL-CELL PH, V286, pC713, DOI 10.1152/ajpcell.00341.2003; Liu YF, 2001, FRONT BIOSCI-LANDMRK, V6, pD12, DOI 10.2741/Liu; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARINKOVIC S, 1989, J IMMUNOL, V142, P808; Miller I, 1999, ELECTROPHORESIS, V20, P836, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<836::AID-ELPS836>3.0.CO;2-6; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190; Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006; Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018; Naito H, 2000, J APPL PHYSIOL, V88, P359, DOI 10.1152/jappl.2000.88.1.359; Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631; NIEDERMEIER W, 1965, ARTHRITIS RHEUM-US, V8, P355, DOI 10.1002/art.1780080303; Oliviero F, 2009, CLIN EXP RHEUMATOL, V27, P79; Oremek GM, 2003, ANTICANCER RES, V23, P1131; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Patil DR, 2012, MICROBES INFECT, V14, P457, DOI 10.1016/j.micinf.2011.12.008; Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; RITTLING SR, 1987, MOL CELL BIOL, V7, P3908, DOI 10.1128/MCB.7.11.3908; Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151; Rulli NE, 2011, J INFECT DIS, V204, P1026, DOI 10.1093/infdis/jir470; Sam I-C, 2006, Med J Malaysia, V61, P264; Santhosh SR, 2008, VIRUS RES, V135, P36, DOI 10.1016/j.virusres.2008.02.004; Santhosh SR, 2007, J CLIN VIROL, V39, P188, DOI 10.1016/j.jcv.2007.04.015; Seematter G, 2004, CURR OPIN CLIN NUTR, V7, P169, DOI 10.1097/00075197-200403000-00011; Selsby JT, 2005, AM J PHYSIOL-REG I, V289, pR134, DOI 10.1152/ajpregu.00497.2004; Sharma JN, 1976, INFLAMM RES, V6, P147; Shrivastav M, 2002, CLIN RHEUMATOL, V21, P505, DOI 10.1007/s100670200124; SKALLI O, 1991, CELL MOTIL CYTOSKEL, V19, P67, DOI 10.1002/cm.970190202; Soden M, 2000, ARTHRITIS RHEUM, V43, P365, DOI 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E; TESH RB, 1982, ANNU REV MED, V33, P31, DOI 10.1146/annurev.me.33.020182.000335; Trgovcich J, 1996, VIROLOGY, V224, P73, DOI 10.1006/viro.1996.0508; Villoing S, 2000, J VIROL, V74, P173, DOI 10.1128/JVI.74.1.173-183.2000; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Wu XY, 2008, FEBS LETT, V582, P2155, DOI 10.1016/j.febslet.2008.05.033; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	60	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92813	10.1371/journal.pone.0092813	http://dx.doi.org/10.1371/journal.pone.0092813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667237	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600080
J	Choi, H; Kim, YK; Oh, SW; Im, HJ; Hwang, DW; Kang, H; Lee, B; Lee, YS; Jeong, JM; Kim, EE; Chung, JK; Lee, DS				Choi, Hongyoon; Kim, Yu Kyeong; Oh, So Won; Im, Hyung-Jun; Hwang, Do Won; Kang, Hyejin; Lee, Boeun; Lee, Yun-Sang; Jeong, Jae Min; Kim, E. Edmund; Chung, June-Key; Lee, Dong Soo			In Vivo Imaging of mGluR5 Changes during Epileptogenesis Using [C-11]ABP688 PET in Pilocarpine-Induced Epilepsy Rat Model	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; INDUCED STATUS-EPILEPTICUS; UP-REGULATION; EXPRESSION; C-11-ABP688; DEPRESSION; REDUCTION; SUBTYPE-5; BINDING; ROLES	Introduction: Metabotropic glutamate receptor 5 (mGluR5) that regulates glutamatergic neurotransmission contributes to pathophysiology of epilepsy. In this study, we monitored the changes of mGluR5 in vivo using [C-11]ABP688 PET during the epileptogenesis in a pilocarpine-induced epilepsy rat model. Methods: In vivo mGluR5 images were acquired using [C-11]ABP688 microPET/CT in pilocarpine-induced chronic epilepsy rat models and controls. We also acquired microPET/CT at acute, subacute as well as chronic periods after status epilepticus. Non-displaceable binding potential (BPND) of [C-11]ABP688 was calculated using simplified reference tissue model in a voxel-based manner. mGluR5 BPND of the rat brains of epilepsy models and controls were compared. Results: Status epilepticus developed after pilocarpine administration and was followed by recurrent spontaneous seizures for more than 3 weeks. In chronic epilepsy rat model, BPND in hippocampus and amygdala was reduced on a voxel-based analysis. Temporal changes of mGluR5 BPND was also found. In acute period after status epilepticus, mGluR5 BPND was reduced in the whole brain. BPND of caudate-putamen was restored in subacute period, while BPND of the rest of the brain was still lower. In chronic period, global BPND was normalized except in hippocampus and amygdala. Conclusions: In vivo imaging of mGluR5 using [C-11]ABP688 microPET/CT could successfully reveal the regional changes of mGluR5 binding potential of the rat brain in a pilocarpine-induced epilepsy model. The temporal and spatial changes in mGluR5 availability suggest [C-11]ABP688 PET imaging in epilepsy provide abnormal glutamatergic network during epileptogenesis.	[Choi, Hongyoon; Kim, Yu Kyeong; Oh, So Won; Im, Hyung-Jun; Hwang, Do Won; Kang, Hyejin; Lee, Boeun; Lee, Yun-Sang; Jeong, Jae Min; Kim, E. Edmund; Chung, June-Key; Lee, Dong Soo] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea; [Kim, Yu Kyeong; Oh, So Won] Seoul Natl Univ, Boramae Med Ctr, Dept Nucl Med, Seoul, South Korea; [Hwang, Do Won] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Choi, Hongyoon; Im, Hyung-Jun; Lee, Boeun; Kim, E. Edmund; Lee, Dong Soo] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, YK (corresponding author), Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea.	yk3181@snu.ac.kr; dsl@plaza.snu.ac.kr	Im, Hyung-jun/AAY-1309-2020; Im, Hyung-Jun/D-7588-2017; Hong, Juyeon/G-2059-2010; Lee, Boeun/AAG-4646-2022; Lee, Boeun/ADT-1205-2022; Jeong, Jae Min/E-2102-2012	Lee, Boeun/0000-0002-7525-7164; Lee, Boeun/0000-0002-7525-7164; Jeong, Jae Min/0000-0003-2611-6020; Choi, Hongyoon/0000-0002-8895-2449	Nano-Biotechnology Project (Regenomics) [20100002086]; WCU [R31-2008-000-10103-0]; future-based technology development program [20100028755]; Basic Science Research Program through the National Research Foundation of Korea (NRF) [2012R1A1A2008799, 2011-0030815, 2008-0060169]; Ministry of Education, Science and Technology (MEST); Korea Research Council of Fundamental Science & Technology (KRCF), Korea [kiom-2010-2]	Nano-Biotechnology Project (Regenomics); WCU; future-based technology development program; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Council of Fundamental Science & Technology (KRCF), Korea	This work was supported by the Nano-Biotechnology Project (Regenomics, 20100002086), WCU project (R31-2008-000-10103-0), the future-based technology development program (20100028755), Basic Science Research Program (2012R1A1A2008799, No. 2011-0030815, and No. 2008-0060169) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) and a grant (kiom-2010-2) from the Inter-Institutional Collaboration Research Program provided by the Korea Research Council of Fundamental Science & Technology (KRCF), Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkus F, 2013, P NATL ACAD SCI USA, V110, P737, DOI 10.1073/pnas.1210984110; Ametamey SM, 2007, J NUCL MED, V48, P247; Ametamey SM, 2006, J NUCL MED, V47, P698; Aronica E, 2003, EPILEPSIA, V44, P785, DOI 10.1046/j.1528-1157.2003.54802.x; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bianchi R., 2012, JASPERS BASIC MECH E; Blumcke I, 2000, J NEUROPATH EXP NEUR, V59, P1; Cavarsan CF, 2012, EPILEPSY RES, V101, P253, DOI 10.1016/j.eplepsyres.2012.04.011; Costa MS, 2004, NEUROSCI LETT, V356, P41, DOI 10.1016/j.neulet.2003.11.019; Deschwanden A, 2011, AM J PSYCHIAT, V168, P727, DOI 10.1176/appi.ajp.2011.09111607; Doherty J, 2002, CNS NEUROL DISORD-DR, V1, P251, DOI 10.2174/1568007023339355; Elmenhorst D, 2010, J CEREBR BLOOD F MET, V30, P1538, DOI 10.1038/jcbfm.2010.65; Enz R, 2012, CURR DRUG TARGETS, V13, P145, DOI 10.2174/138945012798868452; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Kirschstein T, 2007, J NEUROSCI, V27, P7696, DOI 10.1523/JNEUROSCI.4572-06.2007; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lee H, 2009, KOREAN J PATHOL, V43, P43, DOI 10.4132/KoreanJPathol.2009.43.1.43; Lojkova-Janeckova D, 2009, EPILEPSIA, V50, P2123, DOI 10.1111/j.1528-1167.2009.02091.x; Merlin Lisa R, 2008, Epilepsy Curr, V8, P43, DOI 10.1111/j.1535-7511.2008.00232.x; Merlin LR, 2002, J NEUROPHYSIOL, V87, P621, DOI 10.1152/jn.00579.2001; Miyake N, 2011, BIOL PSYCHIAT, V69, P822, DOI 10.1016/j.biopsych.2010.12.023; Nairismagi J, 2006, EPILEPSIA, V47, P479, DOI 10.1111/j.1528-1167.2006.00455.x; Niessen HG, 2005, EPILEPSIA, V46, P1021, DOI 10.1111/j.1528-1167.2005.60704.x; Notenboom RGE, 2006, BRAIN, V129, P96, DOI 10.1093/brain/awh673; RACINE R, 1972, ELECTROEN CLIN NEURO, V32, P295, DOI 10.1016/0013-4694(72)90178-2; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Sakagami Y, 2005, EUR J NEUROSCI, V21, P3229, DOI 10.1111/j.1460-9568.2005.04165.x; Schiffer WK, 2006, J NEUROSCI METH, V155, P272, DOI 10.1016/j.jneumeth.2006.01.027; Tang FR, 2007, NEUROPHARMACOLOGY, V53, P821, DOI 10.1016/j.neuropharm.2007.08.012; Ure J, 2006, J NEUROL SCI, V247, P1, DOI 10.1016/j.jns.2006.03.018; Wang JQ, 2007, SYNAPSE, V61, P951, DOI 10.1002/syn.20445; Watabe AM, 2002, J NEUROPHYSIOL, V87, P1395, DOI 10.1152/jn.00723.2001	32	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92765	10.1371/journal.pone.0092765	http://dx.doi.org/10.1371/journal.pone.0092765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663806	Green Submitted, Green Published, gold			2022-12-25	WOS:000333459900111
J	Lennon, FE; Mirzapoiazova, T; Mambetsariev, B; Poroyko, VA; Salgia, R; Moss, J; Singleton, PA				Lennon, Frances E.; Mirzapoiazova, Tamara; Mambetsariev, Bolot; Poroyko, Valeriy A.; Salgia, Ravi; Moss, Jonathan; Singleton, Patrick A.			The Mu Opioid Receptor Promotes Opioid and Growth Factor-Induced Proliferation, Migration and Epithelial Mesenchymal Transition (EMT) in Human Lung Cancer	PLOS ONE			English	Article							FACTOR-I RECEPTOR; ANESTHETIC TECHNIQUE; SUBSTANCE-P; GRB2-ASSOCIATED BINDER-1; BREAST-CANCER; RECURRENCE; SURGERY; ACTIVATION; EGFR; SURVIVAL	Recent epidemiologic studies implying differences in cancer recurrence based on anesthetic regimens raise the possibility that the mu opioid receptor (MOR) can influence cancer progression. Based on our previous observations that overexpression of MOR in human non-small cell lung cancer (NSCLC) cells increased tumor growth and metastasis, this study examined whether MOR regulates growth factor receptor signaling and epithelial mesenchymal transition (EMT) in human NSCLC cells. We utilized specific siRNA, shRNA, chemical inhibitors and overexpression vectors in human H358 NSCLC cells that were either untreated or treated with various concentrations of DAMGO, morphine, fentanyl, EGF or IGF. Cell function assays, immunoblot and immunoprecipitation assays were then performed. Our results indicate MOR regulates opioid and growth factor-induced EGF receptor signaling (Src, Gab-1, PI3K, Akt and STAT3 activation) which is crucial for consequent human NSCLC cell proliferation and migration. In addition, human NSCLC cells treated with opioids, growth factors or MOR overexpression exhibited an increase in snail, slug and vimentin and decrease ZO-1 and claudin-1 protein levels, results consistent with an EMT phenotype. Further, these effects were reversed with silencing (shRNA) or chemical inhibition of MOR, Src, Gab-1, PI3K, Akt and STAT3 (p < 0.05). Our data suggest a possible direct effect of MOR on opioid and growth factor-signaling and consequent proliferation, migration and EMT transition during lung cancer progression. Such an effect provides a plausible explanation for the epidemiologic findings.	[Lennon, Frances E.; Mirzapoiazova, Tamara; Mambetsariev, Bolot; Singleton, Patrick A.] Univ Chicago, Pritzker Sch Med, Dept Med, Sect Pulm & Crit Care, Chicago, IL 60637 USA; [Poroyko, Valeriy A.] Univ Chicago, Pritzker Sch Med, Dept Surg, Chicago, IL 60637 USA; [Salgia, Ravi] Univ Chicago, Pritzker Sch Med, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Moss, Jonathan; Singleton, Patrick A.] Univ Chicago, Pritzker Sch Med, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Singleton, PA (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Med, Sect Pulm & Crit Care, Chicago, IL 60637 USA.	psinglet@medicine.bsd.uchicago.edu			National Institutes of Health [CTSA UL1 TR000430]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Support was provided from institutional and/or departmental sources and National Institutes of Health grant CTSA UL1 TR000430. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsharimani B, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00046; Afsharimani B, 2011, CANCER METAST REV, V30, P225, DOI 10.1007/s10555-011-9285-0; Aicher SA, 2000, J NEUROSCI, V20, P4345; Akca H, 2006, LUNG CANCER, V54, P25, DOI 10.1016/j.lungcan.2006.06.007; Beland MD, 2010, RADIOLOGY, V254, P301, DOI 10.1148/radiol.2541090174; Belcheva MM, 2001, J BIOL CHEM, V276, P33847, DOI 10.1074/jbc.M101535200; Belcheva MM, 2003, MOL PHARMACOL, V64, P1391, DOI 10.1124/mol.64.6.1391; Bigliardi-Qi M, 2007, J INVEST DERMATOL, V127, P1479, DOI 10.1038/sj.jid.5700661; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Bovill JG, 2010, ANESTH ANALG, V110, P1524, DOI 10.1213/ANE.0b013e3181d8d183; Cannito S, 2009, ANTIOXID REDOX SIGNA; Carlson Josh J, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P409, DOI 10.1586/erp.09.49; Chan PC, 2003, J BIOL CHEM, V278, P44075, DOI 10.1074/jbc.M305745200; Charpidou A, 2008, IN VIVO, V22, P529; Choi EJ, 2010, MOL CANCER RES, V8, P1027, DOI 10.1158/1541-7786.MCR-09-0507; Chow G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/485468; Christopherson R, 2008, ANESTH ANALG, V107, P325, DOI 10.1213/ane.0b013e3181770f55; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; De Greve J, 2008, B CANCER, V95, P358, DOI 10.1684/bdc.2008.0591; Debruyne D, 2010, ANTICANCER RES, V30, P9; Denlinger CE, 2010, J THORAC CARDIOV SUR, V140, P505, DOI 10.1016/j.jtcvs.2010.02.061; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Frank JW, 2014, PAIN MED; Fujioka N, 2011, ANESTH ANALG, V113, P1353, DOI 10.1213/ANE.0b013e318232b35a; Ganjoo KN, 2007, BIOL-TARGETS THER, V1, P335; Garcia-Recio S, 2013, CANCER RES, V73, P6424, DOI 10.1158/0008-5472.CAN-12-4573; Giubellino A, 2008, EXPERT OPIN THER TAR, V12, P1021, DOI 10.1517/14728222.12.8.1021 ; Gridelli C, 2010, EXPERT OPIN INV DRUG, V19, P631, DOI 10.1517/13543781003767434; Gridelli C, 2010, LUNG CANCER, V67, P86, DOI 10.1016/j.lungcan.2009.03.021; Gualberto A, 2009, CLIN LUNG CANCER, V10, P273, DOI 10.3816/CLC.2009.n.038; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hart JR, 2011, P NATL ACAD SCI USA, V108, P13247, DOI 10.1073/pnas.1110486108; Holz C, 2011, RADIOTHER ONCOL, V101, P158, DOI 10.1016/j.radonc.2011.05.042; Illing S, 2013, BRIT J PHARM; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Lee K, 2012, INT REV CEL MOL BIO, V294, P171, DOI 10.1016/B978-0-12-394305-7.00004-5; Lee MW, 2011, CANC SCI; Lennon FE, 2012, ANESTHESIOLOGY, V116, P857, DOI 10.1097/ALN.0b013e31824babe2; Lennon FE, 2012, ANESTHESIOLOGY, V116, P940, DOI 10.1097/ALN.0b013e31824b9512; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Maione P, 2010, EXPERT OPIN PHARMACO, V11, P2997, DOI 10.1517/14656566.2010.511615; Mathew B, 2011, ANESTH ANALG, V112, P558, DOI 10.1213/ANE.0b013e31820568af; Mercadante S, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-013-0395-y; Myles PS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1491; Ng R, 2008, LUNG CANCER, V61, P262, DOI 10.1016/j.lungcan.2008.02.002; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Pene F, 2002, ONCOGENE, V21, P6587, DOI 10.1038/sj.onc.1205923; Perez S, 2007, J NEUROCHEM, V103, P2153, DOI 10.1111/j.1471-4159.2007.04944.x; Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Singleton PA, 2008, MOL CANCER THER, V7, P1669, DOI 10.1158/1535-7163.MCT-07-2217; Singleton PA, 2010, FUTURE ONCOL, V6, P1237, DOI 10.2217/FON.10.99; Singleton Patrick A, 2010, J Angiogenes Res, V2, P5, DOI 10.1186/2040-2384-2-5; Snyder GL, 2010, BRIT J ANAESTH, V105, P106, DOI 10.1093/bja/aeq164; Spiro SG, 2010, RESPIROLOGY, V15, P44, DOI 10.1111/j.1440-1843.2009.01674.x; Stinchcombe TE, 2011, J THORAC ONCOL, V6, P1443, DOI 10.1097/JTO.0b013e3182246413; Subramanian J, 2010, J THORAC ONCOL, V5, P1116, DOI 10.1097/JTO.0b013e3181e76159; Tavare AN, 2011, INT J CANC; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tiseo M, 2011, LUNG CANCER, V71, P241, DOI 10.1016/j.lungcan.2010.11.014; Uramoto H, 2010, ANTICANCER RES, V30, P2513; Vogt PK, 2011, CANCER DISCOV, V1, P481, DOI 10.1158/2159-8290.CD-11-0218; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wan Q, 2006, J NEUROSCI RES, V84, P1588, DOI 10.1002/jnr.21053; Xu J, 2009, J NEUROCHEM, V108, P962, DOI 10.1111/j.1471-4159.2008.05833.x; Yeager MP, 2010, REGION ANESTH PAIN M, V35, P483, DOI 10.1097/AAP.0b013e3181fa11a9; Yin M, 2009, AM J TRANSL RES, V1, P101; Yin ZJ, 2010, J SURG RES; Yu YJ, 2009, J NEUROSCI, V29, P222, DOI 10.1523/JNEUROSCI.4315-08.2009	74	129	133	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91577	10.1371/journal.pone.0091577	http://dx.doi.org/10.1371/journal.pone.0091577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662916	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900025
J	Menet, MC; Marchal, J; Dal-Pan, A; Taghi, M; Nivet-Antoine, V; Dargere, D; Laprevote, O; Beaudeux, JL; Aujard, F; Epelbaum, J; Cottart, CH				Menet, Marie-Claude; Marchal, Julia; Dal-Pan, Alexandre; Taghi, Meryam; Nivet-Antoine, Valerie; Dargere, Delphine; Laprevote, Olivier; Beaudeux, Jean-Louis; Aujard, Fabienne; Epelbaum, Jacques; Cottart, Charles-Henry			Resveratrol Metabolism in a Non-Human Primate, the Grey Mouse Lemur (Microcebus murinus), Using Ultra-High-Performance Liquid Chromatography-Quadrupole Time of Flight	PLOS ONE			English	Article							CANCER CHEMOPREVENTIVE AGENT; TRANS-RESVERATROL; CALORIE RESTRICTION; DIETARY RESVERATROL; HEALTHY-VOLUNTEERS; HUMAN PLASMA; RED WINE; HUMANS; BIOAVAILABILITY; TOXICITY	The grey mouse lemur (Microcebus murinus) is a non-human primate used to study the ageing process. Resveratrol is a polyphenol that may increase lifespan by delaying age-associated pathologies. However, no information about resveratrol absorption and metabolism is available for this primate. Resveratrol and its metabolites were qualitatively and quantitatively analyzed in male mouse-lemur plasma (after 200 mg.kg(-1) of oral resveratrol) by ultra-high performance liquid chromatography (UHPLC), coupled to a quadrupole-time-of-flight (Q-TOF) mass spectrometer used in full-scan mode. Data analyses showed, in MSE mode, an ion common to resveratrol and all its metabolites: m/z 227.072, and an ion common to dihydro-resveratrol metabolites: m/z 229.08. A semi-targeted study enabled us to identify six hydrophilic resveratrol metabolites (one diglucurono-conjugated, two monoglucurono-conjugated, one monosulfo-conjugated and two both sulfo-and glucurono-conjugated derivatives) and three hydrophilic metabolites of dihydro-resveratrol (one monoglucurono- conjugated, one monosulfo-conjugated, and one both sulfo-and glucurono-conjugated derivatives). The presence of such metabolites has been already detected in the mouse, rat, pig, and humans. Free resveratrol was measurable for several hours in mouse-lemur plasma, and its two main metabolites were trans-resveratrol-3-O-glucuronide and trans-resveratrol-3-sulfate. Free dihydro-resveratrol was not measurable whatever the time of plasma collection, while its hydrophilic metabolites were present at 24 h after intake. These data will help us interpret the effect of resveratrol in mouse lemurs and provide further information on the inter-species characteristics of resveratrol metabolism.	[Menet, Marie-Claude; Taghi, Meryam; Dargere, Delphine; Laprevote, Olivier] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, EA 4463, Paris, France; [Marchal, Julia; Dal-Pan, Alexandre; Aujard, Fabienne] Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France; [Nivet-Antoine, Valerie; Beaudeux, Jean-Louis; Cottart, Charles-Henry] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, EA 4466, Paris, France; [Nivet-Antoine, Valerie] Hop Europeen Georges Pompidou, AP HP, Serv Biochim, Paris, France; [Laprevote, Olivier] GH Lariboisiere St Louis Fernand Widal, AP HP, Serv Toxicol Biol, Paris, France; [Beaudeux, Jean-Louis; Cottart, Charles-Henry] AP HP, GH Necker Enfants Malad, Serv Biochim A, Paris, France; [Epelbaum, Jacques] Univ Paris 05, Fac Med, INSERM, Ctr Psychiat & Neurosci,UMR 894, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Menet, MC (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, EA 4463, Paris, France.	marie-claude.menet@parisdescartes.fr	Menet, Marie Claude/N-4723-2017; Epelbaum, Jacques/B-2263-2013; Menet, Marie-Claude/ABB-3019-2020; Dargere, Delphine/G-5004-2013; Nivet-Antoine, Valerie/R-1981-2017; Taghi, Meryam/ABE-4982-2020	Menet, Marie Claude/0000-0002-3180-9588; Nivet-Antoine, Valerie/0000-0003-2490-0428; Taghi, Meryam/0000-0001-7543-0409; Cottart, Charles-Henry/0000-0003-3776-957X	Paris Descartes University	Paris Descartes University	This study was supported by a "BQR'' grant from the Paris Descartes University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 2011, ANN NY ACAD SCI, V1215, P138, DOI 10.1111/j.1749-6632.2010.05850.x; Amiot MJ, 2013, BIOCHIMIE, V95, P1233, DOI 10.1016/j.biochi.2013.01.008; Andres-Lacueva C, 2012, J AGR FOOD CHEM, V60, P4833, DOI 10.1021/jf3001108; Azorin-Ortuno M, 2011, MOL NUTR FOOD RES, V55, P1154, DOI 10.1002/mnfr.201100140; Azorin-Ortuno M, 2010, J AGR FOOD CHEM, V58, P11165, DOI 10.1021/jf102799m; Barbara JE, 2012, DRUG METAB DISPOS, V40, P1966, DOI 10.1124/dmd.112.047027; Beaudeux JL, 2010, CURR OPIN CLIN NUTR, V13, P729, DOI 10.1097/MCO.0b013e32833ef291; Bode LM, 2013, AM J CLIN NUTR, V97, P295, DOI 10.3945/ajcn.112.049379; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Boocock DJ, 2007, J CHROMATOGR B, V848, P182, DOI 10.1016/j.jchromb.2006.10.017; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Burkon A, 2008, MOL NUTR FOOD RES, V52, P549, DOI 10.1002/mnfr.200700290; Camont L, 2009, ANAL CHIM ACTA, V634, P121, DOI 10.1016/j.aca.2008.12.003; Chow HHS, 2010, CANCER PREV RES, V3, P1168, DOI 10.1158/1940-6207.CAPR-09-0155; Cottart CH, 2014, MOL NUTR FOOD RES, V58, P7, DOI 10.1002/mnfr.201200589; Cottart CH, 2010, MOL NUTR FOOD RES, V54, P7, DOI 10.1002/mnfr.200900437; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; Dal-Pan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016581; Dal-Pan Alexandre, 2010, BMC Physiology, V10, P11, DOI 10.1186/1472-6793-10-11; Dal-Pan A, 2011, AGE, V33, P15, DOI 10.1007/s11357-010-9156-6; Delmas D, 2011, ANN NY ACAD SCI, V1215, P48, DOI 10.1111/j.1749-6632.2010.05871.x; Juan ME, 2010, J AGR FOOD CHEM, V58, P7472, DOI 10.1021/jf100836j; Juan ME, 2010, J PHARMACEUT BIOMED, V51, P391, DOI 10.1016/j.jpba.2009.03.026; Frombaum M, 2012, BIOCHIMIE, V94, P269, DOI 10.1016/j.biochi.2011.11.001; Howells LM, 2011, CANCER PREV RES, V4, P1419, DOI 10.1158/1940-6207.CAPR-11-0148; Hu Y, 2011, FREE RADICAL BIO MED, V51, P250, DOI 10.1016/j.freeradbiomed.2011.04.034; Johnson WD, 2011, FOOD CHEM TOXICOL, V49, P3319, DOI 10.1016/j.fct.2011.08.023; Jung CM, 2009, FEMS MICROBIOL LETT, V297, P266, DOI 10.1111/j.1574-6968.2009.01691.x; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Li F, 2012, CURR PHARM DESIGN, V18, P27, DOI 10.2174/138161212798919075; Maier-Salamon A, 2011, DRUG METAB PHARMACOK, V26, P364, DOI 10.2133/dmpk.DMPK-11-RG-006; Marchal J, 2013, EXP GERONTOL, V48, P992, DOI 10.1016/j.exger.2013.07.002; Marchal J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034289; Marier JF, 2002, J PHARMACOL EXP THER, V302, P369, DOI 10.1124/jpet.102.033340; Menet MC, 2013, ANAL CHIM ACTA, V761, P128, DOI 10.1016/j.aca.2012.11.048; Muzzio M, 2012, J PHARMACEUT BIOMED, V59, P201, DOI 10.1016/j.jpba.2011.10.023; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Pifferi F, 2012, CHRONOBIOL INT, V29, P261, DOI 10.3109/07420528.2011.654019; Planas JM, 2012, ARCH BIOCHEM BIOPHYS, V527, P67, DOI 10.1016/j.abb.2012.06.004; Richard T, 2011, ANN NY ACAD SCI, V1215, P103, DOI 10.1111/j.1749-6632.2010.05865.x; Rotches-Ribalta M, 2012, PHARMACOL RES, V66, P375, DOI 10.1016/j.phrs.2012.08.001; Shu XH, 2010, BIOCHEM PHARMACOL, V79, P1516, DOI 10.1016/j.bcp.2010.01.022; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Stark T, 2011, ANAL CHEM, V83, P3398, DOI 10.1021/ac103305s; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Urpi-Sarda M, 2007, CLIN CHEM, V53, P292, DOI 10.1373/clinchem.2006.071936; Vitaglione P, 2005, MOL NUTR FOOD RES, V49, P495, DOI 10.1002/mnfr.200500002; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang DG, 2005, J CHROMATOGR B, V829, P97, DOI 10.1016/j.jchromb.2005.09.040; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P482, DOI 10.1002/mnfr.200500003; Williams LD, 2009, FOOD CHEM TOXICOL, V47, P2170, DOI 10.1016/j.fct.2009.06.002; Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015; Zamora-Ros R, 2006, CLIN CHEM, V52, P1373, DOI 10.1373/clinchem.2005.065870; Zhu WZ, 2012, NUTR CANCER, V64, P393, DOI 10.1080/01635581.2012.654926	56	11	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91932	10.1371/journal.pone.0091932	http://dx.doi.org/10.1371/journal.pone.0091932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663435	gold, Green Submitted, Green Published			2022-12-25	WOS:000333459900033
J	Pires, FV; da Cunha, MDRD; Abraao, LM; Martins, PYF; Camargo, CH; Fortaleza, CMCB				Pires, Fabiana Venegas; Ribeiro de Souza da Cunha, Maria de Lourdes; Abraao, Ligia Maria; Martins, Patricia Y. F.; Camargo, Carlos Henrique; Castelo Branco Fortaleza, Carlos Magno			Nasal Carriage of Staphylococcus aureus in Botucatu, Brazil: A Population-Based Survey	PLOS ONE			English	Article							METHICILLIN-RESISTANT STRAINS; UNITED-STATES; SKIN INFECTIONS; CA-MRSA; COLONIZATION; PREVALENCE; EPIDEMIOLOGY; CHILDREN; EMERGENCE; IDENTIFICATION	Recent increases in the incidence and severity of staphylococcal infections renewed interest in studies that assess the burden of asymptomatic carriage of Staphylococcus aureus in the community setting. We conducted a population-based survey in the city of Botucatu, Brazil (122,000 inhabitants), in order to identify the prevalence of nasal carriage of Staphylococcus aureus (including methicillin-resistant strains). Nasal swabs were obtained from 686 persons over one year of age. Resistance to methicillin was assessed through phenotypic methods, identification of the mecA gene and typing of the Staphylococcal Chromosome Cassette mec (SCCmec). Methicillin-resistant S. aureus (MRSA) isolates were characterized using Pulsed-Field Gel Electrophoresis (PFGE), Multilocus Sequence Typing (MLST) and spa typing. Polymerase chain reaction was applied to identify genes coding for Panton-Valentine Leukocidin (PVL) in isolates. The prevalence of overall S. aureus carriage was 32.7% (95% CI, 29.2%-36.2%). Carriers were significantly younger (mean age, 28.1 versus 36.3 for non-carriers; OR for age, 0.98; 95% CI, 0.97-0.99) and likely to report recent skin infection (OR, 1.85; 95% CI, 1.03-3.34). Carriage of methicillin-resistant S. aureus (MRSA) was found in 0.9% of study subjects (95% CI, 0.4%-1.8%). All MRSA isolates harbored SCCmec type IV, and belonged to spa types t002 or t021, but none among them harbored genes coding for PLV. In MLST, most isolates belonged to clones ST5 or ST1776. However, we found one subject who carried a novel clone, ST2594. Two out of six MRSA carriers had household contacts colonized with isolates similar to theirs. Our study pointed to dissemination of community-associated MRSA among the Brazilian population.	[Pires, Fabiana Venegas; Abraao, Ligia Maria; Castelo Branco Fortaleza, Carlos Magno] Univ Estadual Paulista, Fac Med Botucatu, Dept Doencas Tropicais, Botucatu, SP, Brazil; [Ribeiro de Souza da Cunha, Maria de Lourdes; Martins, Patricia Y. F.; Camargo, Carlos Henrique] Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Microbiol & Imunol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista	Fortaleza, CMCB (corresponding author), Univ Estadual Paulista, Fac Med Botucatu, Dept Doencas Tropicais, Botucatu, SP, Brazil.	cmfortaleza@uol.com.br	de Lourdes Ribeiro de Souza da Cunha, Maria/A-6287-2008; Fortaleza, Carlos Magno C. B./C-3807-2013; Camargo, Carlos/E-6448-2010; ABRAÃO, LIGIA/CAA-6140-2022	de Lourdes Ribeiro de Souza da Cunha, Maria/0000-0001-9079-2723; Fortaleza, Carlos Magno C. B./0000-0003-4120-1258; Camargo, Carlos/0000-0001-6834-0085; 	"Fundacao de Amparo a Pesquisa do Estado de Sao Paulo'' (FAPESP) [2011/06988-2]	"Fundacao de Amparo a Pesquisa do Estado de Sao Paulo'' (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo'' (FAPESP, grant #2011/06988-2, www.fapesp.br). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2010, J CLIN MICROBIOL, V48, P531, DOI 10.1128/JCM.02290-08; Bassetti M, 2009, INT J ANTIMICROB AG, V34, pS15, DOI 10.1016/S0924-8579(09)70544-8; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P633, DOI 10.1111/j.1469-0691.2010.03320.x; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P160, DOI 10.1111/j.1469-0691.2010.03219.x; Camargo CH, 2013, DIAGN MICR INFEC DIS, V76, P372, DOI 10.1016/j.diagmicrobio.2013.03.013; Carmo MS, 2011, BRAZ J MED BIOL RES, V44, P1013, DOI 10.1590/S0100-879X2011007500114; Casey JA, 2013, EPIDEMIOL INFECT, V141, P1166, DOI 10.1017/S0950268812001872; Cesar CLG, 2005, SAUDE CONDICAO VIDA; Chen CJ, 2011, J CLIN MICROBIOL, V49, P131, DOI 10.1128/JCM.01774-10; Chuang YY, 2013, LANCET INFECT DIS, V13, P698, DOI 10.1016/S1473-3099(13)70136-1; Clinical and Laboratory Standards Institute, 2009, M02A10 CLSI; Demos M, 2012, BRIT J DERMATOL, V167, P725, DOI 10.1111/j.1365-2133.2012.11151.x; Durupt F, 2007, BRIT J DERMATOL, V157, P1161, DOI 10.1111/j.1365-2133.2007.08197.x; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Ertam I, 2007, J EUR ACAD DERMATOL, V21, P777, DOI 10.1111/j.1468-3083.2006.02083.x; Fritz SA, 2012, ARCH PEDIAT ADOL MED, V166, P551, DOI 10.1001/archpediatrics.2011.900; Fritz SA, 2012, CLIN INFECT DIS, V54, P743, DOI 10.1093/cid/cir919; Fritz SA, 2009, J INFECTION, V59, P394, DOI 10.1016/j.jinf.2009.09.001; Gardella N, 2011, INFECT GENET EVOL, V11, P1066, DOI 10.1016/j.meegid.2011.03.019; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Goud R, 2011, REV SOC BRAS MED TRO, V44, P309, DOI 10.1590/S0037-86822011005000035; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hamdan-Partida A, 2010, J CLIN MICROBIOL, V48, P1701, DOI 10.1128/JCM.01929-09; Hayward A, 2008, EMERG INFECT DIS, V14, P720, DOI 10.3201/eid1405.070153; Johnson AP, 2011, J ANTIMICROB CHEMOTH, V66, pIV43, DOI 10.1093/jac/dkr076; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Lear A, 2011, J AM BOARD FAM MED, V24, P429, DOI 10.3122/jabfm.2011.04.100286; Lee CJ, 2011, CLIN INFECT DIS, V52, P775, DOI 10.1093/cid/cir026; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Malik S, 2009, EPIDEMIOL INFECT, V137, P1237, DOI 10.1017/S0950268809002222; Martineau F, 1998, J CLIN MICROBIOL, V36, P618, DOI 10.1128/JCM.36.3.618-623.1998; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Melles DC, 2008, J CLIN MICROBIOL, V46, P235, DOI 10.1128/JCM.00887-07; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Miller M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006708; Mithoe D, 2012, EUR J CLIN MICROBIOL, V31, P349, DOI 10.1007/s10096-011-1316-9; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Munckhof WJ, 2009, CLIN MICROBIOL INFEC, V15, P149, DOI 10.1111/j.1469-0691.2008.02652.x; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Ngoa UA, 2012, ACTA TROP, V124, P42, DOI 10.1016/j.actatropica.2012.06.005; O'Brien FG, 2009, J ANTIMICROB CHEMOTH, V64, P684, DOI 10.1093/jac/dkp285; Olsen K, 2013, EPIDEMIOL INFECT, V141, P143, DOI 10.1017/S0950268812000465; Onanuga A, 2011, AFR HEALTH SCI, V11, P176; Pacheco RL, 2011, CLINICS, V66, P2071, DOI 10.1590/S1807-59322011001200012; Petry V, 2014, INT J DERMATOL, V53, P731, DOI 10.1111/ijd.12020; Qu F, 2010, J CLIN MICROBIOL, V48, P64, DOI 10.1128/JCM.01572-09; Rahimian J, 2007, INFECT CONT HOSP EP, V28, P1415, DOI 10.1086/523273; Reinert C, 2008, BRAZ J INFECT DIS, V12, P213, DOI 10.1590/S1413-86702008000300010; Ribeiro A, 2007, DIAGN MICR INFEC DIS, V59, P339, DOI 10.1016/j.diagmicrobio.2007.05.007; Rim JY, 2007, INFECT CONT HOSP EP, V28, P1044, DOI 10.1086/519934; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Saxena S, 2010, EMERG INFECT DIS, V16, P530, DOI 10.3201/eid1603.090809; Scerri J, 2013, J EPIDEMIOL GLOB HEA, V3, P165, DOI 10.1016/j.jegh.2013.05.003; Schaumburg F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001150; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Silva-Carvalho MC, 2009, DIAGN MICR INFEC DIS, V65, P300, DOI 10.1016/j.diagmicrobio.2009.07.023; Smith CH, 2012, CAN FAM PHYSICIAN, V58, P1350; Talpur R, 2008, BRIT J DERMATOL, V159, P105, DOI 10.1111/j.1365-2133.2008.08612.x; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Weems J. John, 2002, Curr Infect Dis Rep, V4, P420, DOI 10.1007/s11908-002-0009-z; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; Winn W. C., 2005, KONEMANS COLOR ATLAS, V1; Wu DJ, 2010, DIAGN MICR INFEC DIS, V67, P1, DOI 10.1016/j.diagmicrobio.2009.12.006	71	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92537	10.1371/journal.pone.0092537	http://dx.doi.org/10.1371/journal.pone.0092537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663818	Green Published, gold, Green Submitted			2022-12-25	WOS:000333459900072
J	Song, YL; Yu, JJ; Huang, B				Song, Yali; Yu, Jingjin; Huang, Bingru			Elevated CO2-Mitigation of High Temperature Stress Associated with Maintenance of Positive Carbon Balance and Carbohydrate Accumulation in Kentucky Bluegrass	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; AIR CO2 ENRICHMENT; ACUTE HEAT-STRESS; PHYSIOLOGICAL-RESPONSES; ATMOSPHERIC CO2; PHOTOSYNTHETIC ACCLIMATION; METABOLIC-RESPONSES; GROWTH TEMPERATURE; DARK RESPIRATION; PERENNIAL GRASS	Elevated CO2 concentration may promote plant growth while high temperature is inhibitory for C-3 plant species. The interactive effects of elevated CO2 and high temperatures on C-3 perennial grass growth and carbon metabolism are not well documented. Kentucky bluegrass (Poa pratensis) plants were exposed to two CO2 levels (400 and 800 mu mol mol(-1)) and five temperatures (15/12, 20/17, 25/22, 30/27, 35/32 degrees C, day/night) in growth chambers. Increasing temperatures to 25 degrees C and above inhibited leaf photosynthetic rate (Pn) and shoot and root growth, but increased leaf respiration rate (R), leading to a negative carbon balance and a decline in soluble sugar content under ambient CO2. Elevated CO2 did not cause shift of optimal temperatures in Kentucky bluegrass, but promoted Pn, shoot and root growth under all levels of temperature (15, 20, 25, 30, and 35 degrees C) and mitigated the adverse effects of severe high temperatures (30 and 35 degrees C). Elevated CO2-mitigation of adverse effects of high temperatures on Kentucky bluegrass growth could be associated with the maintenance of a positive carbon balance and the accumulation of soluble sugars and total nonstructural carbohydrates through stimulation of Pn and suppression of R and respiratory organic acid metabolism.	[Song, Yali] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Yu, Jingjin] Nanjing Agr Univ, Coll Agro Grassland Sci, Nanjing, Jiangsu, Peoples R China; [Song, Yali; Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA	Beijing Forestry University; Nanjing Agricultural University; Rutgers State University New Brunswick	Huang, B (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA.	huang@aesop.rutgers.edu			Chinese Scholarship Council; Center for Turfgrass Science at Rutgers University; Chinese Natural Science Foundation [720700003]	Chinese Scholarship Council(China Scholarship Council); Center for Turfgrass Science at Rutgers University; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Chinese Scholarship Council for providing stipend to Y. Song to conduct the research project at Rutgers University and Center for Turfgrass Science at Rutgers University for funding support of research expenses, as well as Chinese Natural Science Foundation (No. 720700003) for funding support of metabolite analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert KR, 2011, J EXP BOT, V62, P4253, DOI 10.1093/jxb/err133; Albert KR, 2011, J PLANT PHYSIOL, V168, P1550, DOI 10.1016/j.jplph.2011.02.011; BAKER JT, 1992, PLANT CELL ENVIRON, V15, P231, DOI 10.1111/j.1365-3040.1992.tb01477.x; Beard J. B., 1972, TURFGRASS SCI CULTUR; Bencze S, 2005, CEREAL RES COMMUN, V33, P385, DOI 10.1556/CRC.33.2005.1.95; Bernacchi CJ, 2005, PLANTA, V220, P434, DOI 10.1007/s00425-004-1320-8; BOWES G, 1991, PLANT CELL ENVIRON, V14, P795, DOI 10.1111/j.1365-3040.1991.tb01443.x; Campbell C, 2007, NEW PHYTOL, V176, P375, DOI 10.1111/j.1469-8137.2007.02183.x; Cannell MGR, 1998, ANN BOT-LONDON, V82, P883, DOI 10.1006/anbo.1998.0777; Casella E, 1997, J EXP BOT, V48, P1309, DOI 10.1093/jxb/48.6.1309; Centritto M, 2011, TREE PHYSIOL, V31, P275, DOI 10.1093/treephys/tpq112; Cowling SA, 1998, PLANT CELL ENVIRON, V21, P427, DOI 10.1046/j.1365-3040.1998.00290.x; Cui LJ, 2006, BOT STUD, V47, P61; DIPAOLA J.M., 1992, AGRON MONOGR, V32, P231, DOI DOI 10.2134/AGRONMONOGR32.C7; Drake BG, 1999, PLANT CELL ENVIRON, V22, P649, DOI 10.1046/j.1365-3040.1999.00438.x; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Du HM, 2011, PHYSIOL PLANTARUM, V141, P251, DOI 10.1111/j.1399-3054.2010.01432.x; Erice G, 2006, PLANT SCI, V170, P1059, DOI 10.1016/j.plantsci.2005.12.018; Fares S, 2011, ATMOS ENVIRON, V45, P155, DOI 10.1016/j.atmosenv.2010.09.036; Faria T, 1996, J EXP BOT, V47, P1755, DOI 10.1093/jxb/47.11.1755; FARRAR JF, 1991, PLANT CELL ENVIRON, V14, P819, DOI 10.1111/j.1365-3040.1991.tb01445.x; Foss AR, 2013, ENVIRON ENTOMOL, V42, P503, DOI 10.1603/EN12074; Fry J., 2004, APPL TURFGRASS SCI P; Fukayama H, 2009, PLANT SCI, V177, P203, DOI 10.1016/j.plantsci.2009.05.014; Ge ZM, 2011, PHOTOSYNTHETICA, V49, P172, DOI 10.1007/s11099-011-0029-8; Ge ZM, 2012, PHOTOSYNTHETICA, V50, P141, DOI 10.1007/s11099-012-0014-x; Ge ZM, 2012, BIOMASS BIOENERG, V46, P251, DOI 10.1016/j.biombioe.2012.08.019; Gifford RM, 1995, GLOBAL CHANGE BIOL, V1, P385, DOI 10.1111/j.1365-2486.1995.tb00037.x; GonzalezMeler MA, 1996, PLANT PHYSIOL, V112, P1349, DOI 10.1104/pp.112.3.1349; Grunzweig JM, 2003, FUNCT ECOL, V17, P766, DOI 10.1111/j.1365-2435.2003.00797.x; Hamilton EW, 2008, J INTEGR PLANT BIOL, V50, P1375, DOI 10.1111/j.1744-7909.2008.00747.x; Hoagland DR, 1950, 347 CAL AGR EXP STAT, DOI DOI 10.1016/S0140-6736(00)73482-9; Hu WH, 2010, BIOL PLANTARUM, V54, P761, DOI 10.1007/s10535-010-0137-5; Huang BR, 2003, CROP SCI, V43, P258, DOI 10.2135/cropsci2003.0258; Huang BR, 2000, PLANT SOIL, V227, P17, DOI 10.1023/A:1026512212113; Hunt HW, 1996, GLOB CHANGE BIOL, V2, P35, DOI 10.1111/j.1365-2486.1996.tb00047.x; IDSO KE, 1994, AGR FOREST METEOROL, V69, P153, DOI 10.1016/0168-1923(94)90025-6; Kirkham MB, 2011, ELEVATED CARBON DIOX; Leakey ADB, 2006, PLANT PHYSIOL, V140, P779, DOI 10.1104/pp.105.073957; Leakey ADB, 2009, P NATL ACAD SCI USA, V106, P3597, DOI 10.1073/pnas.0810955106; Lee TD, 2011, GLOBAL CHANGE BIOL, V17, P2893, DOI 10.1111/j.1365-2486.2011.02435.x; Liu XZ, 2008, J PLANT PHYSIOL, V165, P1947, DOI 10.1016/j.jplph.2008.05.001; Liu XZ, 2001, HORTSCIENCE, V36, P1131, DOI 10.21273/HORTSCI.36.6.1131; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Luo Y, 2006, ANNU REV PLANT BIOL, V55, P591, DOI [10.1890/04-1724, DOI 10.1890/04-1724]; Lyons EM, 2007, ENVIRON EXP BOT, V59, P307, DOI 10.1016/j.envexpbot.2006.04.002; Majeau N, 1996, PLANT PHYSIOL, V112, P569, DOI 10.1104/pp.112.2.569; Moore BD, 1998, PLANT CELL ENVIRON, V21, P905, DOI 10.1046/j.1365-3040.1998.00324.x; Morison JIL, 1999, PLANT CELL ENVIRON, V22, P659, DOI 10.1046/j.1365-3040.1999.00443.x; Morison JIL, 1998, J EXP BOT, V49, P443, DOI 10.1093/jexbot/49.suppl_1.443; Nobel PS, 1996, J ARID ENVIRON, V34, P187, DOI 10.1006/jare.1996.0100; Ow LF, 2008, NEW PHYTOL, V178, P123, DOI 10.1111/j.1469-8137.2007.02357.x; PEET MM, 1986, PLANT PHYSIOL, V80, P63, DOI 10.1104/pp.80.1.63; Pote J, 2006, J AM SOC HORTIC SCI, V131, P608, DOI 10.21273/JASHS.131.5.608; Prasad PVV, 2009, FUNCT PLANT BIOL, V36, P761, DOI 10.1071/FP09043; Qaderi MM, 2006, PHYSIOL PLANTARUM, V128, P710, DOI 10.1111/j.1399-3054.2006.00804.x; Qiu Y, 2007, ANAL CHIM ACTA, V583, P277, DOI 10.1016/j.aca.2006.10.025; Rachmilevitch S, 2006, NEW PHYTOL, V170, P479, DOI 10.1111/j.1469-8137.2006.01684.x; Reddy AR, 2010, CURR SCI INDIA, V99, P46; Rodriguez-Calcerrada J, 2010, TREE PHYSIOL, V30, P214, DOI 10.1093/treephys/tpp104; RUSSELL JB, 1986, BRIT J NUTR, V56, P153, DOI 10.1079/BJN19860095; Salvucci ME, 2004, PHYSIOL PLANTARUM, V120, P179, DOI 10.1111/j.0031-9317.2004.0173.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tan KY, 2013, CHINESE SCI BULL, V58, P1795, DOI 10.1007/s11434-012-5605-1; TING SV, 1956, J AGR FOOD CHEM, V4, P263, DOI 10.1021/jf60061a009; Turgeon A. J., 2011, TURFGRASS MANAGEMENT; Wang D, 2008, AM J BOT, V95, P165, DOI 10.3732/ajb.95.2.165; Wang XZ, 2002, PLANT ECOL, V161, P251, DOI 10.1023/A:1020305006949; Winter K, 1997, PLANTA, V201, P389, DOI 10.1007/s004250050081; Woodward FI, 2002, CURR OPIN PLANT BIOL, V5, P207, DOI 10.1016/S1369-5266(02)00253-4; Xu QZ, 2000, CROP SCI, V40, P1363, DOI 10.2135/cropsci2000.4051363x; Yu JJ, 2012, J AM SOC HORTIC SCI, V137, P221, DOI 10.21273/JASHS.137.4.221; Yu JJ, 2012, CROP SCI, V52, P1848, DOI 10.2135/cropsci2012.01.0030	73	76	76	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e89725	10.1371/journal.pone.0089725	http://dx.doi.org/10.1371/journal.pone.0089725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662768	gold, Green Published, Green Submitted			2022-12-25	WOS:000333459900004
J	Zhu, WB; Cromie, MM; Cai, QS; Lv, TF; Singh, K; Gao, WM				Zhu, Wenbin; Cromie, Meghan M.; Cai, Qingsong; Lv, Tangfeng; Singh, Kamaleshwar; Gao, Weimin			Curcumin and Vitamin E Protect against Adverse Effects of Benzo[a]pyrene in Lung Epithelial Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; DNA-ADDUCTS; FLUOROMETRIC ASSAY; CARCINOMA-CELLS; BETA-CAROTENE; BREAST-CANCER; IN-VIVO; EXPRESSION; P53; DAMAGE	Benzo[a] pyrene (BaP), a well-known environmental carcinogen, promotes oxidative stress and DNA damage. Curcumin and vitamin E (VE) have potent antioxidative activity that protects cells from oxidative stress and cellular damage. The objectives of the present study were to investigate the adverse effects of BaP on normal human lung epithelial cells (BEAS-2B), the potential protective effects of curcumin and VE against BaP-induced cellular damage, and the molecular mechanisms of action. MTT assay, flow cytometry, fluorescence microplate assay, HPLC, qRT-PCR, and western blot were performed to analyze cytotoxicity, cell cycle, reactive oxygen species (ROS), BaP diol-epoxidation (BPDE)-DNA adducts, gene expression, and protein expression, respectively. Curcumin or VE prevented cells from BaP-induced cell cycle arrest and growth inhibition, significantly suppressed BaP-induced ROS levels, and decreased BPDE-DNA adducts. While CYP1A1 and 1B1 were induced by BaP, these inductions were not significantly reduced by curcumin or VE. Moreover, the level of activated p53 and PARP-1 were significantly induced by BaP, whereas this induction was markedly reduced after curcumin and VE cotreatment. Survivin was significantly down-regulated by BaP, and curcumin significantly restored survivin expression in BaP-exposed cells. The ratio of Bax/Bcl-2 was also significantly increased in cells exposed to BaP and this increase was reversed by VE co-treatment. Taken together, BaP-induced cytotoxicity occurs through DNA damage, cell cycle arrest, ROS production, modulation of metabolizing enzymes, and the expression/activation of p53, PARP-1, survivin, and Bax/Bcl-2. Curcumin and VE could reverse some of these BaP-mediated alterations and therefore be effective natural compounds against the adverse effects of BaP in lung cells.	[Zhu, Wenbin; Cromie, Meghan M.; Cai, Qingsong; Lv, Tangfeng; Singh, Kamaleshwar; Gao, Weimin] Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Gao, WM (corresponding author), Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth, Lubbock, TX 79409 USA.	weimin.gao@ttu.edu	Singh, Kamaleshwar Prasad/AAE-9166-2020					Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; ALEXANDROV K, 1992, CANCER RES, V52, P6248; American Cancer Society, 2013, CANCER FACTS FIGURES; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Castell JV, 2005, EXP TOXICOL PATHOL, V57, P189, DOI 10.1016/j.etp.2005.05.008; Chan MMY, 1998, BIOCHEM PHARMACOL, V55, P1955, DOI 10.1016/S0006-2952(98)00114-2; Chen LX, 2010, TOXICOL SCI, V116, P206, DOI 10.1093/toxsci/kfq123; Chen YH, 2013, TOXICOLOGY, V304, P167, DOI 10.1016/j.tox.2013.01.003; CHENG KC, 1992, J BIOL CHEM, V267, P166; Chhunchha B, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.121; Ciolino HP, 1998, BIOCHEM PHARMACOL, V56, P197, DOI 10.1016/S0006-2952(98)00143-9; Deng B, 2013, OXIDATIVE MEDICINE A, V2013, P11; Garner RC, 1998, MUTAT RES-FUND MOL M, V402, P67; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Graziewicz M, 1996, CARCINOGENESIS, V17, P2501, DOI 10.1093/carcin/17.11.2501; HECHT SS, 1993, J CELL BIOCHEM, P27; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Jeffy BD, 2000, NEOPLASIA, V2, P460, DOI 10.1038/sj.neo.7900104; Jin Q, 2008, CARCINOGENESIS, V29, P1614, DOI 10.1093/carcin/bgm234; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740; Kim JH, 2004, TOXICOL APPL PHARM, V199, P210, DOI 10.1016/j.taap.2003.11.015; Krishnan R, 2004, J AGR FOOD CHEM, V52, P4261, DOI 10.1021/jf049979o; Li CY, 2012, ASIAN PAC J CANCER P, V13, P3757, DOI 10.7314/APJCP.2012.13.8.3757; Lin MT, 2001, J BIOL CHEM, V276, P48997, DOI 10.1074/jbc.M107829200; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Luch A, 1999, CARCINOGENESIS, V20, P859, DOI 10.1093/carcin/20.5.859; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; Mattson MP, 2008, AGEING RES REV, V7, P43, DOI 10.1016/j.arr.2007.08.004; Mattson MP, 2006, TRENDS NEUROSCI, V29, P632, DOI 10.1016/j.tins.2006.09.001; Mcclean MD, 2004, ANN OCCUP HYG, V48, P565, DOI 10.1093/annhyg/meh044; Melchini A, 2011, CELL BIOL TOXICOL, V27, P371, DOI 10.1007/s10565-011-9194-6; Messarah M, 2013, TOXICOL IND HEALTH, V29, P77, DOI 10.1177/0748233712446726; Numakawa Y, 2006, J NEUROCHEM, V97, P1191, DOI 10.1111/j.1471-4159.2006.03827.x; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pan MH, 2008, CHEM SOC REV, V37, P2558, DOI 10.1039/b801558a; Penning TM, 1996, CHEM RES TOXICOL, V9, P84, DOI 10.1021/tx950055s; Perocco P, 2000, MUTAT RES-GEN TOX EN, V465, P151, DOI 10.1016/S1383-5718(99)00223-5; Poirier MC, 2004, NAT REV CANCER, V4, P630, DOI 10.1038/nrc1410; REDDY ACP, 1994, ANN NUTR METAB, V38, P349, DOI 10.1159/000177833; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rietjens IMCM, 2002, ENVIRON TOXICOL PHAR, V11, P321, DOI 10.1016/S1382-6689(02)00003-0; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; ROJAS M, 1994, CARCINOGENESIS, V15, P557, DOI 10.1093/carcin/15.3.557; Sehgal A, 2012, HUM EXP TOXICOL, V31, P473, DOI 10.1177/0960327111421943; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sinha D, 2012, CURR DRUG TARGETS, V13, P1799, DOI 10.2174/138945012804545632; Sithanandam G, 2005, AM J RESP CELL MOL, V33, P490, DOI 10.1165/rcmb.2005-0049OC; Tao GH, 2009, MOL BIOL REP, V36, P2413, DOI 10.1007/s11033-009-9472-z; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; Vakharia DD, 2001, DRUG METAB DISPOS, V29, P999; Zhang L, 2011, J BIOL CHEM, V286, P25644, DOI 10.1074/jbc.M111.240739; Zheng Z, 2011, J KOREAN MED SCI, V26, P222, DOI 10.3346/jkms.2011.26.2.222	57	54	57	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92992	10.1371/journal.pone.0092992	http://dx.doi.org/10.1371/journal.pone.0092992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664296	gold, Green Submitted, Green Published			2022-12-25	WOS:000333459900139
J	Moriyama, T; Tanaka, K; Iwasaki, C; Oshima, Y; Ochi, A; Kataoka, H; Itabashi, M; Takei, T; Uchida, K; Nitta, K				Moriyama, Takahito; Tanaka, Kayu; Iwasaki, Chihiro; Oshima, Yasuko; Ochi, Ayami; Kataoka, Hiroshi; Itabashi, Mitsuyo; Takei, Takashi; Uchida, Keiko; Nitta, Kosaku			Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; IMPAIRED RENAL-FUNCTION; RANDOMIZED CONTROLLED-TRIAL; STEROID PULSE THERAPY; SERUM URIC-ACID; OXFORD CLASSIFICATION; COMBINATION THERAPY; RISK-FACTORS; FOLLOW-UP; COHORT	Background: Little is known about the long-term prognosis of patients with IgA nephropathy (IgAN). Methods: This retrospective cohort analysis evaluated clinical and histological findings at the time of renal biopsy, initial treatment, patient outcomes over 30 years, and risk factors associated with progression in 1,012 patients diagnosed with IgAN at our center since 1974. Results: Of the 1,012 patients, 40.5% were male. Mean patient age was 33612 years and mean blood pressure was 122 +/- 17/75 +/- 13 mmHg. Mean serum creatinine concentration was 0.89 +/- 0.42 mg/dL, and mean estimated glomerular filtration rate (eGFR) was 78.5 +/- 26.2 ml/min/1.73 m(2). Mean proteinuria was 1.19 +/- 1.61 g/day, and mean urinary red blood cells were 36.6 +/- 35.3/high-powered field. Histologically, mesangial hypercellularity was present in 47.6% of patients, endothelial hypercellularity in 44.3%, segmental sclerosis in 74.6%, and tubular atrophy/interstitial fibrosis in 28.8% by Oxford classification. Initial treatment consisted of corticosteroids in 26.9% of patients, renin-angiotensin-aldosterone system inhibitor in 28.9%, and tonsillectomy plus steroids in 11.7%. The 10-, 20-, and 30-year renal survival rates were 84.3, 66.6, and 50.3%, respectively. Tonsillectomy plus steroids dramatically improved renal outcome. Cox multivariate regression analysis showed that higher proteinuria, lower eGFR, and higher uric acid at the time of renal biopsy were independent risk factors for the development of end stage renal disease (ESRD). Conclusions: IgAN is not a benign disease, with about 50% of patients progressing to ESRD within 30 years despite treatment.	[Moriyama, Takahito; Tanaka, Kayu; Iwasaki, Chihiro; Oshima, Yasuko; Ochi, Ayami; Kataoka, Hiroshi; Itabashi, Mitsuyo; Takei, Takashi; Uchida, Keiko; Nitta, Kosaku] Tokyo Womens Med Univ, Kidney Ctr, Dept Med, Tokyo, Japan	Tokyo Women's Medical University	Moriyama, T (corresponding author), Tokyo Womens Med Univ, Kidney Ctr, Dept Med, Tokyo, Japan.	takamori@kc.twmu.ac.jp	Kataoka, Hiroshi/AAL-8850-2021; Kataoka, Hiroshi/AAD-1531-2019	Kataoka, Hiroshi/0000-0001-9543-7608; Moriyama, Takahito/0000-0002-9459-4924				ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12, DOI 10.1016/S0272-6386(12)80284-8; Alamartine E, 2011, CLIN J AM SOC NEPHRO, V6, P2384, DOI 10.2215/CJN.01170211; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Cheng GY, 2013, CLIN NEPHROL, V80, P40, DOI 10.5414/CN107813; Hotta O, 2001, AM J KIDNEY DIS, V38, P736, DOI 10.1053/ajkd.2001.27690; Kamei D, 2013, CLIN EXP NE IN PRESS; Katafuchi R, 2011, CLIN J AM SOC NEPHRO, V6, P2806, DOI 10.2215/CJN.02890311; Kobayashi Y, 1996, NEPHRON, V72, P237, DOI 10.1159/000188848; Komatsu H, 2009, AM J NEPHROL, V30, P19, DOI 10.1159/000197116; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051225; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsuzaki K, 2013, CLIN EXP NE IN PRESS; Miura N, 2009, CLIN EXP NEPHROL, V13, P460, DOI 10.1007/s10157-009-0179-1; Moriyama T, 2013, REN FAIL IN PRESS; Moriyama Takahito, 2004, Clin Exp Nephrol, V8, P237; Moriyama T, 2013, INTERNAL MED, V52, P193, DOI 10.2169/internalmedicine.52.8323; Moriyama T, 2012, INT UROL NEPHROL, V44, P1177, DOI 10.1007/s11255-011-0109-5; Moriyama T, 2012, CLIN EXP NEPHROL, V16, P231, DOI 10.1007/s10157-011-0545-7; Moriyama T, 2011, CLIN EXP NEPHROL, V15, P700, DOI 10.1007/s10157-011-0455-8; Moriyama T, 2011, AM J NEPHROL, V34, P233, DOI 10.1159/000330189; Moriyama T, 2010, NEPHRON CLIN PRACT, V115, pC227, DOI 10.1159/000313040; Myllymaki J, 2005, NEPHROL DIAL TRANSPL, V20, P89, DOI 10.1093/ndt/gfh584; Ochi A, 2013, INT UROL NEPHROL, V45, P469, DOI 10.1007/s11255-012-0251-8; Ohno I, 2001, NEPHRON, V87, P333, DOI 10.1159/000045939; Pozzi C, 2004, J AM SOC NEPHROL, V15, P157, DOI 10.1097/01.ASN.0000103869.08096.4F; Pozzi C, 1999, LANCET, V353, P883, DOI 10.1016/S0140-6736(98)03563-6; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Shi YJ, 2012, KIDNEY BLOOD PRESS R, V35, P153, DOI 10.1159/000331453; Yau T, 2011, AM J NEPHROL, V34, P435, DOI 10.1159/000332223	32	126	141	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91756	10.1371/journal.pone.0091756	http://dx.doi.org/10.1371/journal.pone.0091756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658533	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300040
J	Zhao, JL; Chen, L; Shu, B; Tang, JM; Zhang, LJ; Xie, JL; Qi, SH; Xu, YB				Zhao, Jingling; Chen, Lei; Shu, Bin; Tang, Jinming; Zhang, Lijun; Xie, Julin; Qi, Shaohai; Xu, Yingbin			Granulocyte/Macrophage Colony-Stimulating Factor Influences Angiogenesis by Regulating the Coordinated Expression of VEGF and the Ang/Tie System	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; BLOOD-VESSEL MATURATION; NON-HODGKINS-LYMPHOMA; ENDOTHELIAL-CELLS; GROWTH-FACTOR; TUMOR ANGIOGENESIS; WOUND REPAIR; LEG ULCERS; GM-CSF; ANGIOPOIETIN-1	Granulocyte/macrophage colony-stimulating factor (GM-CSF) can accelerate wound healing by promoting angiogenesis. The biological effects of GM-CSF in angiogenesis and the corresponding underlying molecular mechanisms, including in the early stages of primitive endothelial tubule formation and the later stages of new vessel maturation, have only been partially clarified. This study aimed to investigate the effects of GM-CSF on angiogenesis and its regulatory mechanisms. Employing a self-controlled model (Sprague-Dawley rats with deep partial-thickness burn wounds), we determined that GMCSF can increase VEGF expression and decrease the expression ratio of Ang-1/Ang-2 and the phosphorylation of Tie-2 in the early stages of the wound healing process, which promotes the degradation of the basement membrane and the proliferation of endothelial cells. At later stages of wound healing, GM-CSF can increase the expression ratio of Ang-1/Ang-2 and the phosphorylation of Tie-2 and maintain a high VEGF expression level. Consequently, pericyte coverages were higher, and the basement membrane became more integrated in new blood vessels, which enhanced the barrier function of blood vessels. In summary, we report here that increased angiogenesis is associated with GM-CSF treatment, and we indicate that VEGF and the Ang/Tie system may act as angiogenic mediators of the healing effect of GM-CSF on burn wounds.	[Zhao, Jingling; Chen, Lei; Shu, Bin; Tang, Jinming; Zhang, Lijun; Xie, Julin; Qi, Shaohai; Xu, Yingbin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Burns, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xu, YB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Burns, Guangzhou 510275, Guangdong, Peoples R China.	79951927@qq.com	Chen, Lei/AAF-8797-2020; Qi, Shaohai/AAF-7703-2020	Chen, Lei/0000-0001-7146-4636; Qi, Shaohai/0000-0002-6945-4137	National Natural Science Foundation [81272153]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The research was funded by the National Natural Science Foundation (81272153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Benest AV, 2006, MICROCIRCULATION, V13, P423, DOI 10.1080/10739680600775940; Benest AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070459; Bhushan M, 2002, BRIT J DERMATOL, V147, P418, DOI 10.1046/j.1365-2133.2002.05003.x; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; BUSSOLINO F, 1991, BLOOD, V78, P2475; Canturk NZ, 1999, ENDOCR RES, V25, P105, DOI 10.3109/07435809909066133; Cianfarani F, 2006, BRIT J DERMATOL, V154, P34, DOI 10.1111/j.1365-2133.2005.06925.x; Davidson JM, 1998, ARCH DERMATOL RES, V290, pS1, DOI 10.1007/PL00007448; Eberhard A, 2000, CANCER RES, V60, P1388; Etoh T, 2001, CANCER RES, V61, P2145; Fang Y, 2007, BRIT J DERMATOL, V157, P458, DOI 10.1111/j.1365-2133.2007.07979.x; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Goede V, 1998, LAB INVEST, V78, P1385; GORIN NC, 1992, BLOOD, V80, P1149; Groves R W, 2000, Adv Skin Wound Care, V13, P107; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; Imokawa G, 1996, BIOCHEM J, V313, P625, DOI 10.1042/bj3130625; Jeon BH, 2003, CIRC RES, V92, P586, DOI 10.1161/01.RES.0000066881.04116.45; KAPLAN G, 1992, J EXP MED, V175, P1717, DOI 10.1084/jem.175.6.1717; Karagiannis ED, 2006, J THEOR BIOL, V238, P124, DOI 10.1016/j.jtbi.2005.05.020; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kutcher ME, 2009, MICROVASC RES, V77, P235, DOI 10.1016/j.mvr.2009.01.007; Lee HJ, 2004, FASEB J, V18, P1200, DOI 10.1096/fj.03-1466com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mann A, 2001, J INVEST DERMATOL, V117, P1382, DOI 10.1046/j.0022-202x.2001.01600.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mery L, 2004, DERMATOLOGY, V208, P135, DOI 10.1159/000076487; Reiss Y, 2007, CIRC RES, V101, P88, DOI 10.1161/CIRCRESAHA.106.143594; SCHRIBER JR, 1993, LEUKEMIA, V7, P1491; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Somerville RPT, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-216; Staton CA, 2010, BRIT J DERMATOL, V163, P920, DOI 10.1111/j.1365-2133.2010.09940.x; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Ure I, 1998, BRIT J DERMATOL, V138, P277; Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904; VISANI G, 1990, HAEMATOLOGICA, V75, P551; Voskaridou E, 1999, BLOOD, V93, P3568; WAKUI S, 1993, MICROVASC RES, V46, P19, DOI 10.1006/mvre.1993.1032; Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D; Yan H, 2012, BURNS, V38, P877, DOI 10.1016/j.burns.2012.02.001; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhang SX, 2004, DIABETOLOGIA, V47, P124, DOI 10.1007/s00125-003-1276-4	48	43	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92691	10.1371/journal.pone.0092691	http://dx.doi.org/10.1371/journal.pone.0092691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658178	gold, Green Submitted, Green Published			2022-12-25	WOS:000333355300115
J	Hiz, MC; Canher, B; Niron, H; Turet, M				Hiz, Mahmut Can; Canher, Balkan; Niron, Harun; Turet, Muge			Transcriptome Analysis of Salt Tolerant Common Bean (Phaseolus vulgaris L.) under Saline Conditions	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; GENE-EXPRESSION; ABIOTIC STRESS; ARABIDOPSIS-THALIANA; FUNCTIONAL GENOMICS; GLYCINE-MAX; SHORT READS; WEB TOOL; RNA-SEQ; DROUGHT	Salinity is one of the important abiotic stress factors that limit crop production. Common bean, Phaseolus vulgaris L., a major protein source in developing countries, is highly affected by soil salinity and the information on genes that play a role in salt tolerance is scarce. We aimed to identify differentially expressed genes (DEGs) and related pathways by comprehensive analysis of transcriptomes of both root and leaf tissues of the tolerant genotype grown under saline and control conditions in hydroponic system. We have generated a total of 158 million high-quality reads which were assembled into 83,774 all-unigenes with a mean length of 813 bp and N50 of 1,449 bp. Among the all-unigenes, 58,171 were assigned with Nr annotations after homology analyses. It was revealed that 6,422 and 4,555 all-unigenes were differentially expressed upon salt stress in leaf and root tissues respectively. Validation of the RNA-seq quantifications (RPKM values) was performed by qRT-PCR (Quantitative Reverse Transcription PCR) analyses. Enrichment analyses of DEGs based on GO and KEGG databases have shown that both leaf and root tissues regulate energy metabolism, transmembrane transport activity, and secondary metabolites to cope with salinity. A total of 2,678 putative common bean transcription factors were identified and classified under 59 transcription factor families; among them 441 were salt responsive. The data generated in this study will help in understanding the fundamentals of salt tolerance in common bean and will provide resources for functional genomic studies.	[Hiz, Mahmut Can; Canher, Balkan; Niron, Harun; Turet, Muge] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey	Bogazici University	Hiz, MC (corresponding author), Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey.	mcanhiz@boun.edu.tr	türet, müge/AAM-1132-2020	türet, müge/0000-0003-1927-7918; Niron, Harun/0000-0001-5303-7024	Scientific and Technological Research Council of Turkey [TUBITAK 110T922]; Bogazici University [BAP 6674]	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Bogazici University(Bogazici University)	This work was financially supported by The Scientific and Technological Research Council of Turkey (TUBITAK 110T922) and Bogazici University Research Funds (BAP 6674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aydi S, 2008, PLANT SOIL, V312, P59, DOI 10.1007/s11104-008-9656-7; Benjamini Y, 2001, ANN STAT, V29, P1165; Borges A, 2012, PLANT CELL REP, V31, P827, DOI 10.1007/s00299-011-1204-x; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Carillo P, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, P21; Chen Y, 2013, J PLANT PHYSIOL, V170, P93, DOI 10.1016/j.jplph.2012.08.019; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Dasgan HY, 2009, J FOOD AGRIC ENVIRON, V7, P363; Campos Mariana Lins de Oliveira, 2012, Braz. J. Plant Physiol., V24, P55, DOI 10.1590/S1677-04202012000100008; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; Faical B, 2012, ISRN MOL BIOL, V2012; Fan XD, 2013, GENE, V512, P392, DOI 10.1016/j.gene.2012.09.100; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; Gama PBS, 2007, AFR J BIOTECHNOL, V6, P79; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Ge Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-153; Ghosh D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00006; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gulduren S., 2012, Ziraat Fakultesi Dergisi, Ataturk Universitesi, V43, P29; Guo KM, 2008, PHYSIOL PLANTARUM, V134, P499, DOI 10.1111/j.1399-3054.2008.01157.x; HIDE J, 1954, DIAGNOSIS IMPROVEMEN; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Horie T, 2012, RICE, V5, DOI 10.1186/1939-8433-5-11; Huang JZ, 2012, DNA RES, V19, P195, DOI 10.1093/dnares/dss004; Huang L, 2003, J BIOL CHEM, V278, P51085, DOI 10.1074/jbc.M308321200; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jacoby RP, 2011, TRENDS PLANT SCI, V16, P614, DOI 10.1016/j.tplants.2011.08.002; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; Jiang YQ, 2009, MOL GENET GENOMICS, V282, P503, DOI 10.1007/s00438-009-0481-3; Kalavacharla V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-135; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Leng Q, 2002, PLANT PHYSIOL, V128, P400, DOI 10.1104/pp.010832; Li HM, 2007, PLANT MOL BIOL, V65, P655, DOI 10.1007/s11103-007-9230-3; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li-Chao Z, 2009, ACTA AGRON SIN, V35, P1181; Liao D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00060; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Liu ZJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-42; Madakbas SY, 2005, HASAD BITKISEL URETI, V21, P80; Magnan F, 2008, PLANT J, V56, P575, DOI 10.1111/j.1365-313X.2008.03622.x; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Melotto M, 2005, GENOME, V48, P562, DOI 10.1139/G05-010; Mochida K, 2010, BIOINFORMATICS, V26, P290, DOI 10.1093/bioinformatics/btp645; Mochida K, 2009, DNA RES, V16, P353, DOI 10.1093/dnares/dsp023; Moe KT, 2011, J INTEGR PLANT BIOL, V53, P63, DOI 10.1111/j.1744-7909.2010.01012.x; Molina C, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-31; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Muzna Zahur, 2013, Advances in Bioscience and Biotechnology, V4, P15; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Ni YX, 2008, ACTA BIOCH BIOPH SIN, V40, P78, DOI 10.1111/j.1745-7270.2008.00371.x; Pang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-488; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Parra-Gonzalez LB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-425; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Qin YX, 2012, MOL BIOL REP, V39, P7183, DOI 10.1007/s11033-012-1550-y; Qing DJ, 2009, PLANT CELL PHYSIOL, V50, P889, DOI 10.1093/pcp/pcp038; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Ramirez M, 2005, PLANT PHYSIOL, V137, P1211, DOI 10.1104/pp.104.054999; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Sanchez DH, 2008, PLANT J, V53, P973, DOI 10.1111/j.1365-313X.2007.03381.x; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shavrukov Y, 2013, J EXP BOT, V64, P119, DOI 10.1093/jxb/ers316; Silva P, 2009, PLANT SIGNAL BEHAV, V4, P718, DOI 10.4161/psb.4.8.9236; Skowyra D, 2001, J BIOL CHEM, V276, P8734, DOI 10.1074/jbc.M007664200; Sun JQ, 2007, PLANT CELL PHYSIOL, V48, P1148, DOI 10.1093/pcp/pcm088; Teakle NL, 2007, J EXP BOT, V58, P2169, DOI 10.1093/jxb/erm102; Teakle NL, 2010, PLANT CELL ENVIRON, V33, P566, DOI 10.1111/j.1365-3040.2009.02060.x; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Touchette BW, 2009, ESTUAR COAST, V32, P917, DOI 10.1007/s12237-009-9178-4; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Walia H, 2007, PLANT MOL BIOL, V63, P609, DOI 10.1007/s11103-006-9112-0; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039856; Wang H, 2003, PLANT MOL BIOL, V52, P873, DOI 10.1023/A:1025029026375; Wang HH, 2009, PLANTA, V230, P293, DOI 10.1007/s00425-009-0946-y; Wei W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007209; Wu N, 2013, THEOR APPL GENET, V126, P1145, DOI 10.1007/s00122-013-2042-8; Xu P, 2009, PLANT PHYSIOL, V149, P760, DOI 10.1104/pp.108.132217; Xu P, 2013, GENE, V525, P26, DOI 10.1016/j.gene.2013.04.066; YAMAGUCHISHINOZAKI K, 1992, PLANT CELL PHYSIOL, V33, P217, DOI 10.1093/oxfordjournals.pcp.a078243; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Yuen CYL, 2010, SIGNAL COMMUN PLANTS, P137, DOI 10.1007/978-3-642-10494-7_7; Zahaf O, 2012, MOL PLANT, V5, P1068, DOI 10.1093/mp/sss009; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90	102	72	74	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92598	10.1371/journal.pone.0092598	http://dx.doi.org/10.1371/journal.pone.0092598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651267	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800131
J	Snapp-Childs, W; Flatters, I; Fath, A; Mon-Williams, M; Bingham, GP				Snapp-Childs, Winona; Flatters, Ian; Fath, Aaron; Mon-Williams, Mark; Bingham, Geoffrey P.			Training Compliance Control Yields Improvements in Drawing as a Function of Beery Scores	PLOS ONE			English	Article							DEVELOPMENTAL COORDINATION DISORDER; VISUAL-MOTOR INTEGRATION; ROBOT-ASSISTED THERAPY; CHILDREN; VARIABILITY; MOVEMENT; PERFORMANCE; STRATEGIES; FORCE; NOISE	Many children have difficulty producing movements well enough to improve in sensori-motor learning. Previously, we developed a training method that supports active movement generation to allow improvement at a 3D tracing task requiring good compliance control. Here, we tested 7-8 year old children from several 2nd grade classrooms to determine whether 3D tracing performance could be predicted using the Beery VMI. We also examined whether 3D tracing training lead to improvements in drawing. Baseline testing included Beery, a drawing task on a tablet computer, and 3D tracing. We found that baseline performance in 3D tracing and drawing co-varied with the visual perception (VP) component of the Beery. Differences in 3D tracing between children scoring low versus high on the Beery VP replicated differences previously found between children with and without motor impairments, as did post-training performance that eliminated these differences. Drawing improved as a result of training in the 3D tracing task. The training method improved drawing and reduced differences predicted by Beery scores.	[Snapp-Childs, Winona; Fath, Aaron; Bingham, Geoffrey P.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Flatters, Ian; Mon-Williams, Mark] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Flatters, Ian] Univ Leeds, Sch Mech Engn, Leeds, W Yorkshire, England	Indiana University System; Indiana University Bloomington; University of Leeds; University of Leeds	Snapp-Childs, W (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	wsnappch@indiana.edu		Snapp-Childs, Winona/0000-0003-4354-7092; Fath, Aaron J/0000-0003-3451-2306; Mon-Williams, Mark/0000-0001-7595-8545; Flatters, Ian John/0000-0002-3789-0487	NIH NIDCD [T32DC00012]; NIH NICHD [R01HD070832]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000012] Funding Source: NIH RePORTER	NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH NIDCD Training Grant T32DC00012 and NIH NICHD R01HD070832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bastin J, 2006, HUM MOVEMENT SCI, V25, P718, DOI 10.1016/j.humov.2006.04.001; Beets IAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037687; Ben-Pazi H, 2010, J CHILD NEUROL, V25, P674, DOI 10.1177/0883073809342592; Bo J, 2008, NEUROSCI LETT, V431, P215, DOI 10.1016/j.neulet.2007.11.040; Clark F.J., 1986, HDB PERCEPTION PERFO, V1, P1; Cornhill H, 1996, AM J OCCUP THER, V50, P732, DOI 10.5014/ajot.50.9.732; Culmer PR, 2009, J NEUROSCI METH, V184, P184, DOI 10.1016/j.jneumeth.2009.07.025; Daly CJ, 2003, AM J OCCUP THER, V57, P459, DOI 10.5014/ajot.57.4.459; Davidson PR, 2003, CURR OPIN NEUROBIOL, V13, P232, DOI 10.1016/S0959-4388(03)00038-2; Dessing JC, 2002, NEURAL NETWORKS, V15, P163, DOI 10.1016/S0893-6080(01)00136-8; Deutsch KM, 2001, J EXP CHILD PSYCHOL, V80, P392, DOI 10.1006/jecp.2001.2642; FELDMAN AG, 1966, BIOPHYS-USSR, V11, P565; GETCHELL N, 1989, DEV PSYCHOL, V25, P920, DOI 10.1037/0012-1649.25.6.920; Gonzalez C, 2011, EXP BRAIN RES, V208, P459, DOI 10.1007/s00221-010-2482-1; Goodwin G M, 1976, Exerc Sport Sci Rev, V4, P87; Kaiser ML, 2009, J OCC THER SCH EARLY, V2, P87, DOI 10.1080/19411240903146228; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Lee DN, 1993, ECOLOGICAL INTERPERS, P68; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Marchal-Crespo L, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-20; MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P763, DOI 10.1152/physrev.1978.58.4.763; McCloskey DI, 1980, SPINAL SUPRASPINAL M; Montagne G, 2005, INT J SPORT PSYCHOL, V36, P127; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; NELSON JK, 1986, RES Q EXERCISE SPORT, V57, P280, DOI 10.1080/02701367.1986.10608088; NEWELL KM, 1991, ANNU REV PSYCHOL, V42, P213, DOI 10.1146/annurev.ps.42.020191.001241; Reinkensmeyer DJ, 2009, EXERC SPORT SCI REV, V37, P43, DOI 10.1097/JES.0b013e3181912108; Rodger S., 2007, NZ J PHYSIOTHERAPY, V35, P99; Smits-Engelsman BCM, 2008, HUM MOVEMENT SCI, V27, P296, DOI 10.1016/j.humov.2008.02.005; Snapp-Childs W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077609; Snapp-Childs W, 2013, J CHILD NEUROL, V28, P204, DOI 10.1177/0883073812461945; Snapp-Childs W, 2009, EXP BRAIN RES, V198, P527, DOI 10.1007/s00221-009-1944-9; Studenka BE, 2013, J EXP PSYCHOL HUMAN, V39, P1557, DOI 10.1037/a0031744; Sugden D., 2006, LEEDS CONSENSUS STAT; Takahashi CD, 2003, J NEUROPHYSIOL, V90, P703, DOI 10.1152/jn.01173.2002; THELEN E, 1993, CHILD DEV, V64, P1058, DOI 10.2307/1131327; Turvey M. T., 1992, ECOL PSYCHOL, V4, P173, DOI [10.1207/s15326969eco0403_3, DOI 10.1207/S15326969EC00403_]; Van Waelvelde H, 2004, DEV MED CHILD NEUROL, V46, P661, DOI 10.1017/s0012162204001112; Volman MJM, 2006, AM J OCCUP THER, V60, P451, DOI 10.5014/ajot.60.4.451; VONHOFSTEN C, 1993, HUM DEV, V36, P253, DOI 10.1159/000278212; Wild MR, 1938, RES QUART, V9, P20, DOI 10.1080/23267429.1938.11802445; Wilson AD, 2010, J EXP PSYCHOL HUMAN, V36, P1508, DOI 10.1037/a0020412; Wilson BN, 2009, PHYS OCCUP THER PEDI, V29, P182, DOI 10.1080/01942630902784761; Wong JD, 2012, J NEUROPHYSIOL, V108, P3313, DOI 10.1152/jn.00122.2012	46	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92464	10.1371/journal.pone.0092464	http://dx.doi.org/10.1371/journal.pone.0092464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651280	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800113
J	Watanabe, H; Takayama, K; Inamura, M; Tachibana, M; Mimura, N; Katayama, K; Tashiro, K; Nagamoto, Y; Sakurai, F; Kawabata, K; Furue, MK; Mizuguchi, H				Watanabe, Hitoshi; Takayama, Kazuo; Inamura, Mitsuru; Tachibana, Masashi; Mimura, Natsumi; Katayama, Kazufumi; Tashiro, Katsuhisa; Nagamoto, Yasuhito; Sakurai, Fuminori; Kawabata, Kenji; Furue, Miho Kusuda; Mizuguchi, Hiroyuki			HHEX Promotes Hepatic-Lineage Specification through the Negative Regulation of Eomesodermin	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HOMEOBOX GENE HEX; HEMATOPOIETIC-CELLS; EFFICIENT DIFFERENTIATION; FUNCTIONAL HEPATOCYTES; DEFINITIVE ENDODERM; LIVER; TRANSCRIPTION; GENERATION; ORGANOGENESIS	Human embryonic stem cells (hESCs) could provide a major window into human developmental biology, because the differentiation methods from hESCs mimic human embryogenesis. We previously reported that the overexpression of hematopoietically expressed homeobox (HHEX) in the hESC-derived definitive endoderm (DE) cells markedly promotes hepatic specification. However, it remains unclear how HHEX functions in this process. To reveal the molecular mechanisms of hepatic specification by HHEX, we tried to identify the genes directly targeted by HHEX. We found that HHEX knockdown considerably enhanced the expression level of eomesodermin (EOMES). In addition, HHEX bound to the HHEX response element located in the first intron of EOMES. Loss-of-function assays of EOMES showed that the gene expression levels of hepatoblast markers were significantly upregulated, suggesting that EOMES has a negative role in hepatic specification from the DE cells. Furthermore, EOMES exerts its effects downstream of HHEX in hepatic specification from the DE cells. In conclusion, the present results suggest that HHEX promotes hepatic specification by repressing EOMES expression.	[Watanabe, Hitoshi; Takayama, Kazuo; Inamura, Mitsuru; Tachibana, Masashi; Katayama, Kazufumi; Nagamoto, Yasuhito; Sakurai, Fuminori; Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Osaka, Japan; [Takayama, Kazuo; Mimura, Natsumi; Nagamoto, Yasuhito; Mizuguchi, Hiroyuki] Natl Inst Biomed Innovat, Lab Hepatocyte Differentiat, Osaka, Japan; [Takayama, Kazuo; Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, iPS Cell Based Res Project Hepat Tox & Metab, Osaka, Japan; [Tashiro, Katsuhisa; Kawabata, Kenji] Natl Inst Biomed Innovat, Lab Stem Cell Regulat, Osaka, Japan; [Furue, Miho Kusuda] Natl Inst Biomed Innovat, Dept Dis Bioresources Res, Lab Embryon Stem Cell Cultures, Osaka, Japan; [Furue, Miho Kusuda] Kyoto Univ, Inst Frontier Med Sci, Field Stem Cell Res, Dept Embryon Stem Cell Res, Kyoto, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Ctr Adv Med Engn & Informat, Osaka, Japan	Osaka University; National Institute of Health Sciences - Japan; Osaka University; National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; Kyoto University; Osaka University	Mizuguchi, H (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Osaka, Japan.	mizuguch@phs.osaka-u.ac.jp	Takayama, Kazuo/U-2360-2019; TASHIRO, KOHJI/AAM-1198-2020	Furue, Miho/0000-0001-5032-9953; Tachibana, Masashi/0000-0002-0376-508X; Mizuguchi, Hiroyuki/0000-0003-0594-8178; Takayama, Kazuo/0000-0002-1132-2457	Ministry of Health Labor and Welfare of Japan; Uehara Memorial Foundation; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)	Ministry of Health Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	HM and MKF were supported by grants from the Ministry of Health Labor and Welfare of Japan. HM was also supported by The Uehara Memorial Foundation. FS were supported by Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). K. Takayama and YN are supported by a Grant-in-aid for the Japan Society for the Promotion of Science Fellows. The funders had no role in study design data collection and analysis decision to publish or preparation of the manuscript.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Bogue CW, 2000, DEV DYNAM, V219, P84, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1028>3.0.CO;2-5; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Cong R, 2006, BIOCHEM BIOPH RES CO, V346, P535, DOI 10.1016/j.bbrc.2006.05.153; CROMPTON MR, 1992, NUCLEIC ACIDS RES, V20, P5661, DOI 10.1093/nar/20.21.5661; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Guiral M, 2001, J BIOL CHEM, V276, P2961, DOI 10.1074/jbc.M004948200; Inamura M, 2011, MOL THER, V19, P400, DOI 10.1038/mt.2010.241; Keng VW, 2000, BIOCHEM BIOPH RES CO, V276, P1155, DOI 10.1006/bbrc.2000.3548; Kubo A, 2010, HEPATOLOGY, V51, P633, DOI 10.1002/hep.23293; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Nagamoto Y, 2012, BIOMATERIALS, V33, P4526, DOI 10.1016/j.biomaterials.2012.03.011; Noy P, 2010, MOL CELL BIOL, V30, P2120, DOI 10.1128/MCB.01511-09; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Takayama K, 2013, STEM CELL REP, V1, P322, DOI 10.1016/j.stemcr.2013.08.006; Takayama K, 2014, DEVELOPMENT, V141, P91, DOI 10.1242/dev.103168; Takayama K, 2013, BIOMATERIALS, V34, P1781, DOI 10.1016/j.biomaterials.2012.11.029; Takayama K, 2012, J HEPATOL, V57, P628, DOI 10.1016/j.jhep.2012.04.038; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Takayama K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021780; Tanaka H, 2005, ARCH BIOCHEM BIOPHYS, V442, P117, DOI 10.1016/j.abb.2005.08.001; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	28	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90791	10.1371/journal.pone.0090791	http://dx.doi.org/10.1371/journal.pone.0090791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651531	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800024
J	Zhao, YJ; Selvaraj, JN; Xing, FG; Zhou, L; Wang, Y; Song, HM; Tan, XX; Sun, LC; Sangare, L; Folly, YME; Liu, Y				Zhao, Yueju; Selvaraj, Jonathan Nimal; Xing, Fuguo; Zhou, Lu; Wang, Yan; Song, Huimin; Tan, Xinxin; Sun, Lichao; Sangare, Lancine; Folly, Yawa Minnie Elodie; Liu, Yang			Antagonistic Action of Bacillus subtilis Strain SG6 on Fusarium graminearum	PLOS ONE			English	Article							HEAD BLIGHT; BIOLOGICAL-CONTROL; MYCOTOXIN DEOXYNIVALENOL; WHEAT GERMPLASM; GIBBERELLA-ZEAE; WINTER-WHEAT; BIOCONTROL; BACTERIA; ANTIBIOTICS; FENGYCIN	Fusarium graminearum causes Fusarium head blight (FHB), a devastating disease that leads to extensive yield and quality loss of wheat and barley. Bacteria isolated from wheat kernels and plant anthers were screened for antagonistic activity against F. graminearum. Based on its in vitro effectiveness, strain SG6 was selected for characterization and identified as Bacillus subtilis. B. subtilis SG6 exhibited a high antifungal effect on the mycelium growth, sporulation and DON production of F. graminearum with the inhibition rate of 87.9%, 95.6% and 100%, respectively. In order to gain insight into biological control effect in situ, we applied B. subtilis SG6 at anthesis through the soft dough stage of kernel development in field test. It was revealed that B. subtilis SG6 significantly reduced disease incidence (DI), FHB index and DON (P <= 0.05). Further, ultrastructural examination shows that B. subtilis SG6 strain induced stripping of F. graminearum hyphal surface by destroying the cellular structure. When hypha cell wall was damaged, the organelles and cytoplasm inside cell would exude, leading to cell death. The antifungal activity of SG6 could be associated with the coproduction of chitinase, fengycins and surfactins.	[Zhao, Yueju; Selvaraj, Jonathan Nimal; Xing, Fuguo; Zhou, Lu; Wang, Yan; Song, Huimin; Tan, Xinxin; Sun, Lichao; Sangare, Lancine; Folly, Yawa Minnie Elodie; Liu, Yang] Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Beijing 100193, Peoples R China; [Zhao, Yueju; Selvaraj, Jonathan Nimal; Xing, Fuguo; Zhou, Lu; Wang, Yan; Song, Huimin; Tan, Xinxin; Sun, Lichao; Sangare, Lancine; Folly, Yawa Minnie Elodie; Liu, Yang] Minist Agr, Key Lab Agroprod Proc, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Liu, Y (corresponding author), Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Beijing 100193, Peoples R China.	liuyang01@caas.cn	Xing, Fuguo/HGD-3209-2022		Ministry of Sciences and Technology of China (973 Program) [2013CB127805]; Ministry of Agriculture of China [201203037]; Ministry of Sciences and Technology of China [2013FY113400]	Ministry of Sciences and Technology of China (973 Program)(National Basic Research Program of China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the Ministry of Sciences and Technology of China (973 Program, 2013CB127805), from the Ministry of Agriculture of China (Special Fund for Agro-scientific Research in the Public Interest, 201203037), from the Ministry of Sciences and Technology of China (National Program of China Basic Science and Technology Research, 2013FY113400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baysal O, 2008, PHYSIOL MOL PLANT P, V73, P25, DOI 10.1016/j.pmpp.2008.11.002; Bie XM, 2009, J MICROBIOL METH, V79, P272, DOI 10.1016/j.mimet.2009.09.013; Bleakley BH, 2012, TRIAL PERFORMANCE SE, P7; Bluhm BH, 2007, MOL PLANT MICROBE IN, V20, P627, DOI 10.1094/MPMI-20-6-0627; Chan YK, 2003, CAN J MICROBIOL, V49, P253, DOI 10.1139/W03-033; Cohen-Kupiec R, 1998, CURR OPIN BIOTECH, V9, P270, DOI 10.1016/S0958-1669(98)80058-X; Crane JM, 2013, PHYTOPATHOLOGY, V103, P146, DOI 10.1094/PHYTO-07-12-0154-R; Dihazi A, 2012, PLANT PHYSIOL BIOCH, V55, P7, DOI 10.1016/j.plaphy.2012.03.003; Dunlap CA, 2011, J MICROBIOL, V49, P603, DOI 10.1007/s12275-011-1044-y; Gajbhiye A, 2010, WORLD J MICROB BIOT, V26, P1187, DOI 10.1007/s11274-009-0287-9; Gonzalez-Sanchez MA, 2010, J APPL MICROBIOL, V109, P65, DOI 10.1111/j.1365-2672.2009.04628.x; Groth JV, 1999, PLANT DIS, V83, P1033, DOI 10.1094/PDIS.1999.83.11.1033; Hao CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046444; Hartnett DJ, 2002, J I BREWING, V108, P169, DOI 10.1002/j.2050-0416.2002.tb00537.x; He J, 2009, J APPL MICROBIOL, V106, P1805, DOI 10.1111/j.1365-2672.2009.04147.x; HIRAOKA H, 1992, J GEN APPL MICROBIOL, V38, P635, DOI 10.2323/jgam.38.635; Jochum CC, 2006, BIOL CONTROL, V39, P336, DOI 10.1016/j.biocontrol.2006.05.004; Joshi R, 2006, PHYTOPATHOLOGY, V96, P145, DOI 10.1094/PHYTO-96-0145; Kang ZS, 2000, MYCOL RES, V104, P1083, DOI 10.1017/S0953756200002495; Khan NI, 2004, BIOL CONTROL, V29, P245, DOI 10.1016/S1049-9644(03)00157-9; Khan NI, 2001, PLANT DIS, V85, P1253, DOI 10.1094/PDIS.2001.85.12.1253; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Leelasuphakul W, 2008, POSTHARVEST BIOL TEC, V48, P113, DOI 10.1016/j.postharvbio.2007.09.024; Li DQ, 2007, APPL MICROBIOL BIOT, V75, P1401, DOI 10.1007/s00253-007-0951-7; Liu SX, 2003, CROP SCI, V43, P760, DOI 10.2135/cropsci2003.0760; Liu Y, 2005, J AGR FOOD CHEM, V53, P6864, DOI 10.1021/jf050831u; Mannanov RN, 2001, CHEM NAT COMPD, V37, P117, DOI 10.1023/A:1012314516354; Maragos CM, 2002, J AGR FOOD CHEM, V50, P1827, DOI 10.1021/jf011487d; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Marten P, 2000, J APPL MICROBIOL, V89, P463, DOI 10.1046/j.1365-2672.2000.01136.x; Montesinos E, 2007, FEMS MICROBIOL LETT, V270, P1, DOI 10.1111/j.1574-6968.2007.00683.x; Mora I, 2011, INT MICROBIOL, V14, P213, DOI 10.2436/20.1501.01.151; MORSY E. M., 2009, EGYPTIAN J PHYTOPATH, V37, P47; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; Palazzinia JM, 2007, CROP PROT, V26, P1702, DOI 10.1016/j.cropro.2007.03.004; Ramarathnam R, 2007, CAN J MICROBIOL, V53, P901, DOI 10.1139/W07-049; Romanenko LA, 2008, MICROBIOL RES, V163, P633, DOI 10.1016/j.micres.2006.10.001; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; Schisler DA, 2002, PLANT DIS, V86, P1350, DOI 10.1094/PDIS.2002.86.12.1350; Schisler DA, 2002, ADV EXP MED BIOL, V504, P53; Schisler DA, 2003, GOOGLE PATENTS; Siddiqui S, 2005, WORLD J MICROB BIOT, V21, P729, DOI 10.1007/s11274-004-4799-z; Snedecor G.W., 1989, AMES IOWA STATE U PR; Snijders C, 1995, BREEDING RESISTANCE; SNIJDERS CHA, 1990, NETH J PLANT PATHOL, V96, P187, DOI 10.1007/BF01974256; Starkey DE, 2007, FUNGAL GENET BIOL, V44, P1191, DOI 10.1016/j.fgb.2007.03.001; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Stein T, 2008, RAPID COMMUN MASS SP, V22, P1146, DOI 10.1002/rcm.3481; Stockwell CA, 2001, BIOL CONTROL FUSARIU, V1448, P91; TUITE J, 1990, PLANT DIS, V74, P959, DOI 10.1094/PD-74-0959; VANITTANAKOM N, 1986, J ANTIBIOT, V39, P888, DOI 10.7164/antibiotics.39.888; WITT MF, 1985, J AGR FOOD CHEM, V33, P745, DOI 10.1021/jf00064a046; Xue AG, 2009, CAN J PLANT PATHOL, V31, P169; Xue AG, 2009, WORLD MYCOTOXIN J, V2, P193, DOI 10.3920/WMJ2008.1121; Xue YF, 2006, INT J SYST EVOL MICR, V56, P1217, DOI 10.1099/ijs.0.64105-0; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995; Yu JB, 2008, CROP SCI, V48, P1090, DOI 10.2135/cropsci2007.10.0554; Zhou XH, 2011, J FOOD SCI, V76, pM254, DOI 10.1111/j.1750-3841.2011.02160.x	61	101	112	5	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92486	10.1371/journal.pone.0092486	http://dx.doi.org/10.1371/journal.pone.0092486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651513	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800119
J	Machova, I; Snasel, J; Zimmermann, M; Laubitz, D; Plocinski, P; Oehlmann, W; Singh, M; Dostal, J; Sauer, U; Pichova, I				Machova, Iva; Snasel, Jan; Zimmermann, Michael; Laubitz, Daniel; Plocinski, Przemyslaw; Oehlmann, Wulf; Singh, Mahavir; Dostal, Jiri; Sauer, Uwe; Pichova, Iva			Mycobacterium tuberculosis Phosphoenolpyruvate Carboxykinase Is Regulated by Redox Mechanisms and Interaction with Thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Hypoxia; Metabolism; Mycobacterium Tuberculosis; Oxidation-Reduction; Thioredoxin; Phosphoenolpyruvate Carboxykinase	MACROPHAGES; EXPRESSION; CATALYSIS; SMEGMATIS; CYCLE	Background: Phosphoenolpyruvate carboxykinase (Pck) catalyzes the interconversion of phosphoenolpyruvate and oxaloacetate but typically prefers gluconeogenic formation of phosphoenolpyruvate. Results: Interactions of Mycobacterium tuberculosis (MTb) Pck with thioredoxin and reducing environments favor the anaplerotic oxaloacetate synthesis. Conclusion: A mechanism explaining the regulation of Pck functions is proposed. Significance: Regulation of Pck is important for the MTb non-replicative state associated with latent tuberculosis infection. Tuberculosis remains a major health concern worldwide. Eradication of its causative agent, the bacterial pathogen Mycobacterium tuberculosis, is particularly challenging due to a vast reservoir of latent carriers of the disease. Despite the misleading terminology of a so-called dormant state associated with latent infections, the bacteria have to maintain basic metabolic activities. Hypoxic conditions have been widely used as an in vitro system to study this dormancy. Such studies identified a rearrangement of central carbon metabolism to exploit fermentative processes caused by the lack of oxygen. Phosphoenolpyruvate carboxykinase (Pck; EC 4.1.1.32) is the enzyme at the center of these metabolic rearrangements. Although Pck is associated with gluconeogenesis under standard growth conditions, the enzyme can catalyze the reverse reaction, supporting anaplerosis of the tricarboxylic acid cycle, under conditions leading to slowed or stopped bacterial replication. To study the mechanisms that regulate the switch between two Pck functions, we systematically investigated factors influencing the gluconeogenic and anaplerotic reaction kinetics. We demonstrate that a reducing environment, as found under hypoxia-triggered non-replicating conditions, accelerates the reaction in the anaplerotic direction. Furthermore, we identified proteins that interact with Pck. The interaction between Pck and the reduced form of mycobacterial thioredoxin, gene expression of which is increased under hypoxic conditions, also increased the Pck anaplerotic activity. We thus propose that a reducing environment and the protein-protein interaction with thioredoxin in particular enable the Pck anaplerotic function under fermentative growth conditions.	[Machova, Iva; Snasel, Jan; Dostal, Jiri; Pichova, Iva] Acad Sci Czech Republic, Inst Organ Chem & Biochem, CR-16610 Prague, Czech Republic; [Zimmermann, Michael; Sauer, Uwe] Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Laubitz, Daniel; Plocinski, Przemyslaw] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Oehlmann, Wulf; Singh, Mahavir] Lionex, D-38126 Braunschweig, Germany	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Pichova, I (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Flemingovo Nam 2, CR-16610 Prague, Czech Republic.	iva.pichova@uochb.cas.cz	Płociński, Przemysław A/S-5587-2017; Sauer, Uwe/Y-3556-2019; Snasel, Jan/G-8921-2014; Machova, Iva/AAH-7522-2020; Pichova, Iva/G-7917-2014; Dostal, Jiri/E-9584-2012; Machova, Iva/G-5578-2014	Płociński, Przemysław A/0000-0002-6623-3494; Machova, Iva/0000-0003-3231-4509; Machova, Iva/0000-0003-3231-4509; Laubitz, Daniel/0000-0002-7482-8500; Zimmermann, Michael/0000-0002-5797-3589	EU [241587]; RVO [61388963]; Operacni program Praha-Konkurenceschopnost (OPPK) Project [CZ.2.16/3.1.00/24016]	EU(European Commission); RVO; Operacni program Praha-Konkurenceschopnost (OPPK) Project	This work was supported by EU-PF7 SysteMtb Collaborative Project 241587, RVO 61388963, and by Operacni program Praha-Konkurenceschopnost (OPPK) Project CZ.2.16/3.1.00/24016.	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; Akif M, 2008, J BACTERIOL, V190, P7087, DOI 10.1128/JB.00159-08; BALLARD F J, 1970, Biochemical Journal, V120, P809; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Dharmarajan L, 2008, FEBS J, V275, P5810, DOI 10.1111/j.1742-4658.2008.06702.x; DYSON JED, 1969, J BIOL CHEM, V244, P560; Holyoak T, 2006, BIOCHEMISTRY-US, V45, P8254, DOI 10.1021/bi060269g; Jaeger T, 2004, ARCH BIOCHEM BIOPHYS, V423, P182, DOI 10.1016/j.abb.2003.11.021; Johnson TA, 2012, BIOCHEMISTRY-US, V51, P9547, DOI 10.1021/bi301278t; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; MAKINEN AL, 1989, J BIOL CHEM, V264, P12148; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Mukhopadhyay B, 2001, J BIOL CHEM, V276, P16137, DOI 10.1074/jbc.M008960200; Pocinski P., 2014, PLOS ONE, V9; Rios SE, 2002, ARCH BIOCHEM BIOPHYS, V404, P25, DOI 10.1016/S0003-9861(02)00236-9; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Srinivasan V, 2006, BIOL BULL-US, V210, P1, DOI 10.2307/4134531; Sturm N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000383; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Waddell SJ, 2007, CURR MOL MED, V7, P287, DOI 10.2174/156652407780598548; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zamboni N, 2004, METAB ENG, V6, P277, DOI 10.1016/j.ymben.2004.03.001	35	18	19	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13066	13078		10.1074/jbc.M113.536748	http://dx.doi.org/10.1074/jbc.M113.536748			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24659783	Green Published, hybrid			2022-12-25	WOS:000335522800010
J	Hart, LA; Bowker, MB; Tarboton, W; Downs, CT				Hart, Lorinda A.; Bowker, Meyrick B.; Tarboton, Warwick; Downs, Colleen T.			Species Composition, Distribution and Habitat Types of Odonata in the iSimangaliso Wetland Park, KwaZulu-Natal, South Africa and the Associated Conservation Implications	PLOS ONE			English	Article							FRESH-WATER BIODIVERSITY; DRAGONFLIES ODONATA; RED LIST; ASSEMBLAGES; INDICATORS; HOTSPOTS; TAXA	Maputaland-Pondoland-Albany, South Africa has been identified as a biodiversity hotspot and centre for endemism. Odonata make good indicators of freshwater ecosystem health. Consequently we compiled a list of Odonata species recorded to date in the iSimangaliso Wetland Park. We then detailed important species in terms of endemism, conservation status, and potential as indicator species. Finally, we compared Odonata assemblages of different sites sampled within the park to illustrate habitat importance. Species identified during two formal surveys and incidental observations made during the study period were combined with an existing database to compile an accurate and up to date species list for the iSimangaliso Wetland Park. Data from this study were then analyzed to determine which water bodies had the most similar species composition. The Dragonfly Biotic Index (DBI) value of each study area was also determined. We recorded 68 odonate species in the iSimangaliso Wetland Park, adding 13 species to the Ezemvelo KwaZulu-Natal Wildlife database for the area. This brings the total number of Odonata species for the iSimangaliso Wetland Park to 86. Eight species are red-listed, 12 are restricted in South Africa to the coastal plains of northern KwaZulu-Natal, and the remainder occurs widely across the southern African savanna. Analyses indicate that species odonate assemblages were most similar in water bodies with comparable habitats. iSimangaliso Wetland Park is identified as an important area for Odonata diversity and endemism, a trend also reflected by the DBI values. Shifts in the existing species assemblages would indicate changes within the ecosystem and thus this species account provides necessary baseline data for the area. Species Conservation efforts should thus target water bodies of varying habitat types to protect greater species diversity.	[Hart, Lorinda A.; Bowker, Meyrick B.; Tarboton, Warwick; Downs, Colleen T.] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa	University of Kwazulu Natal	Downs, CT (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa.	Downs@ukzn.ac.za	Downs, Colleen T./A-7770-2010; Hart, Lorinda A/A-8391-2019	Downs, Colleen T./0000-0001-8334-1510; Hart, Lorinda/0000-0002-3942-0374				BALINSKY B. I., 1961, JOUR ENT SOC SOUTHERN AFRICA, V24, P72; Balinsky B. I., 1965, Koedoe Pretoria, Vno. 8, P95; BALINSKY B. I., 1967, J ENTOMOL SOC S AFR, V29, P3; Bried JT, 2005, SOUTHEAST NAT, V4, P731, DOI 10.1656/1528-7092(2005)004[0731:DOAOAL]2.0.CO;2; Bruton MN, 1980, STUDIES ECOLOGY MAPU, pxvii; CLARK TE, 1994, AFR ENTOMOL, V2, P61; Clausnitzer V, 2012, FRONT ECOL ENVIRON, V10, P129, DOI 10.1890/110247; Clausnitzer V, 2009, BIOL CONSERV, V142, P1864, DOI 10.1016/j.biocon.2009.03.028; Dolny A, 2011, TROP ZOOL, V24, P63; Dolny A, 2012, BIOL CONSERV, V145, P109, DOI 10.1016/j.biocon.2011.10.020; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Grant PBC, 2011, BIOL CONSERV, V144, P772, DOI 10.1016/j.biocon.2010.11.008; Harabis F, 2012, J INSECT CONSERV, V16, P121, DOI 10.1007/s10841-011-9400-0; Humphries MS, 2013, CHEMOSPHERE, V93, P1494, DOI 10.1016/j.chemosphere.2013.07.047; Kalkman VJ, 2008, HYDROBIOLOGIA, V363, P595; Kati V, 2004, CONSERV BIOL, V18, P667, DOI 10.1111/j.1523-1739.2004.00465.x; Kinvig RG, 2000, ODONATOLOGICA, V29, P195; Magoba RN, 2010, J INSECT CONSERV, V14, P627, DOI 10.1007/s10841-010-9291-5; Maud R.R., 1980, STUDIES ECOLOGY MAPU, P1; Mucina L, 2006, VEGETATION S AFRICA, P584; Oertli B, 2002, BIOL CONSERV, V104, P59, DOI 10.1016/S0006-3207(01)00154-9; PICKER M., 2002, FIELD GUIDE INSECTS; PINHEY E, 1985, J ENTOMOL SOC S AFR, V48, P1; PINHEY E, 1984, J ENTOMOL SOC S AFR, V47, P147; Samways MJ, 2006, ODONATOLOGICA, V35, P341; Samways MJ, 2007, BIODIVERS CONSERV, V16, P2575, DOI 10.1007/s10531-006-9023-z; Samways Michael J., 2010, BioRisk, V5, P73; Samways Michael J., 2008, P97; Samways MJ, 2004, S AFR J SCI, V100, P78; Simaika JP, 2013, BIOL CONSERV, V157, P245, DOI 10.1016/j.biocon.2012.08.039; Simaika JP, 2012, ORG DIVERS EVOL, V12, P251, DOI 10.1007/s13127-012-0104-4; Simaika JP, 2011, ECOL INDIC, V11, P370, DOI 10.1016/j.ecolind.2010.06.005; Simaika JP, 2009, BIODIVERS CONSERV, V18, P1171, DOI 10.1007/s10531-008-9484-3; Simaika John P., 2008, P109; Simaika JP, 2009, BIOL CONSERV, V142, P638, DOI 10.1016/j.biocon.2008.11.012; Simaika JP, 2008, THESIS STELLENDOSCH; Smith J, 2007, BIODIVERS CONSERV, V16, P2695, DOI 10.1007/s10531-006-9081-2; Steenkamp Y., 2004, HOTSPOTS REVISITED E; Stewart DAB, 1998, CONSERV BIOL, V12, P683, DOI 10.1046/j.1523-1739.1998.96465.x; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Suhling F, 2006, BIODIVERS CONSERV, V15, P311, DOI 10.1007/s10531-005-2007-6; Taylor R. H., 1995, ST LUCIA WETLAND PAR; WISSINGER S A, 1988, Journal of the North American Benthological Society, V7, P13, DOI 10.2307/1467827	43	14	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92588	10.1371/journal.pone.0092588	http://dx.doi.org/10.1371/journal.pone.0092588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662948	Green Published, Green Submitted, gold			2022-12-25	WOS:000333459900081
J	Graciotti, M; Alam, M; Solyakov, L; Schmid, R; Burley, G; Bottrill, AR; Doerig, C; Cullis, P; Tobin, AB				Graciotti, Michele; Alam, Mahmood; Solyakov, Lev; Schmid, Ralf; Burley, Glenn; Bottrill, Andrew R.; Doerig, Christian; Cullis, Paul; Tobin, Andrew B.			Malaria Protein Kinase CK2 (PfCK2) Shows Novel Mechanisms of Regulation	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TYROSINE KINASE; FUNCTIONAL-ANALYSIS; TRYPANOSOMA-BRUCEI; GLOBAL ANALYSIS; PARASITE; PHOSPHORYLATION; KINOME; INHIBITOR; INSIGHTS	Casein kinase 2 (protein kinase CK2) is a conserved eukaryotic serine/theronine kinase with multiple substrates and roles in the regulation of cellular processes such as cellular stress, cell proliferation and apoptosis. Here we report a detailed analysis of the Plasmodium falciparum CK2, PfCK2, demonstrating that this kinase, like the mammalian orthologue, is a dual specificity kinase able to phosphorylate at both serine and tyrosine. However, unlike the human orthologue that is auto-phosphorylated on tyrosine within the activation loop, PfCK2 shows no activation loop auto-phosphorylation but rather is auto-phosphorylated at threonine 63 within subdomain I. Phosphorylation at this site in PfCK2 is shown here to regulate the intrinsic kinase activity of PfCK2. Furthermore, we generate an homology model of PfCK2 in complex with the known selective protein kinase CK2 inhibitor, quinalizarin, and in so doing identify key co-ordinating residues in the ATP binding pocket that could aid in designing selective inhibitors to PfCK2.	[Graciotti, Michele] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Alam, Mahmood; Solyakov, Lev; Tobin, Andrew B.] Univ Leicester, Med Res Council Toxicol Unit, Leicester, Leics, England; [Schmid, Ralf] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Burley, Glenn] Univ Strathclyde, Dept Pure & Appl Chem, Glasgow, Lanark, Scotland; [Bottrill, Andrew R.] Univ Leicester, Prot Nucle Acid Chem Lab, Leicester, Leics, England; [Doerig, Christian] Monash Univ, Sch Biomed Sci, Dept Microbiol, Clayton, Vic, Australia; [Cullis, Paul] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England	University of Leicester; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Leicester; University of Leicester; University of Strathclyde; University of Leicester; Monash University; University of Leicester	Tobin, AB (corresponding author), Univ Leicester, Med Res Council Toxicol Unit, Leicester, Leics, England.	tba@le.ac.uk	Doerig, Christian/Q-9900-2019; Burley, Glenn/AAV-8541-2021; Bottrill, Andrew/ABD-1459-2021; Alam, Mahmood/GQQ-9664-2022; Schmid, Ralf/E-6722-2011; Schmid, Ralf/ABE-1065-2020; Bottrill, Andrew/C-6367-2013; Cullis, Paul/B-1151-2016	Bottrill, Andrew/0000-0002-5182-3643; Schmid, Ralf/0000-0002-0203-4023; Schmid, Ralf/0000-0002-0203-4023; Bottrill, Andrew/0000-0002-5182-3643; Doerig, Christian/0000-0002-3188-094X; Burley, Glenn/0000-0002-4896-113X; Cullis, Paul/0000-0003-3583-0162; Alam, Mahmood M/0000-0003-2148-4887	MRC; University of Leicester; MRC [G1100712, MC_UP_A600_1110] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1653478] Funding Source: researchfish; Medical Research Council [MC_UP_A600_1110, G1100712] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Leicester; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Sources of funding: MRC and University of Leicester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2005, ANTI-CANCER DRUG, V16, P1037, DOI 10.1097/00001813-200511000-00001; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cozza G, 2009, BIOCHEM J, V421, P387, DOI 10.1042/BJ20090069; Dastidar EG, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-5; Doerig C, 2010, BBA-PROTEINS PROTEOM, V1804, P604, DOI 10.1016/j.bbapap.2009.10.009; Donella-Deana A, 2001, BIOCHEM J, V357, P563, DOI 10.1042/0264-6021:3570563; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gazarini ML, 2003, BRAZ J MED BIOL RES, V36, P1465, DOI 10.1590/S0100-879X2003001100003; Holland Z, 2009, EUKARYOT CELL, V8, P388, DOI 10.1128/EC.00334-08; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Lasonder E, 2012, J PROTEOME RES, V11, P5323, DOI 10.1021/pr300557m; Lasonder E, 2012, MICROBES INFECT, V14, P811, DOI 10.1016/j.micinf.2012.04.008; Leroy D, 2008, TRENDS PHARMACOL SCI, V29, P241, DOI 10.1016/j.tips.2008.02.005; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Low HY, 2012, CELL MOL LIFE SCI, V69, P1523, DOI 10.1007/s00018-011-0888-y; Lucet IS, 2012, FUTURE MED CHEM, V4, P2295, DOI [10.4155/FMC.12.183, 10.4155/fmc.12.183]; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mishra Neerad C., 1999, Indian Journal of Experimental Biology, V37, P418; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Pagano MA, 2004, J MED CHEM, V47, P6239, DOI 10.1021/jm049854a; Pantaleo A, 2010, PROTEOMICS, V10, P3469, DOI 10.1002/pmic.201000269; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; PARSONS M, 1993, P NATL ACAD SCI USA, V90, P2656, DOI 10.1073/pnas.90.7.2656; Pease BN, 2013, J PROTEOME RES, V12, P4028, DOI 10.1021/pr400394g; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Pierre F, 2011, MOL CELL BIOCHEM, V356, P37, DOI 10.1007/s11010-011-0956-5; Sarno S, 2003, BIOCHEM J, V374, P639, DOI 10.1042/BJ20030674; Shiu SH, 2004, MOL BIOL EVOL, V21, P828, DOI 10.1093/molbev/msh077; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Talevich E, 2012, PHILOS T R SOC B, V367, P2607, DOI 10.1098/rstb.2012.0014; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e85391	10.1371/journal.pone.0085391	http://dx.doi.org/10.1371/journal.pone.0085391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658579	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300001
J	Hotson, JR				Hotson, John R.			Noninvasive Peroneal Sensory and Motor Nerve Conduction Recordings in the Rabbit Distal Hindlimb: Feasibility, Variability and Neuropathy Measure	PLOS ONE			English	Article							OXALIPLATIN-INDUCED NEUROTOXICITY; PERIPHERAL NEUROPATHY; PHYLOGENETIC ANALYSIS; AXONAL NEUROPATHY; FIBER DENSITY; ANIMAL-MODELS; VINCRISTINE; RELIABILITY; TRANSPORT; MEDICINE	The peroneal nerve anatomy of the rabbit distal hindlimb is similar to humans, but reports of distal peroneal nerve conduction studies were not identified with a literature search. Distal sensorimotor recordings may be useful for studying rabbit models of length-dependent peripheral neuropathy. Surface electrodes were adhered to the dorsal rabbit foot overlying the extensor digitorum brevis muscle and the superficial peroneal nerve. The deep and superficial peroneal nerves were stimulated above the ankle and the common peroneal nerve was stimulated at the knee. The nerve conduction studies were repeated twice with a one-week intertest interval to determine measurement variability. Intravenous vincristine was used to produce a peripheral neuropathy. Repeat recordings measured the response to vincristine. A compound muscle action potential and a sensory nerve action potential were evoked in all rabbits. The compound muscle action potential mean amplitude was 0.29 mV (SD +/- 0.12) and the fibula head to ankle mean motor conduction velocity was 46.5 m/s (SD +/- 2.9). The sensory nerve action potential mean amplitude was 22.8 mu V (SD +/- 2.8) and the distal sensory conduction velocity was 38.8 m/s (SD +/- 2.2). Sensorimotor latencies and velocities were least variable between two test sessions (coefficient of variation = 2.6-5.9%), sensory potential amplitudes were intermediate (coefficient of variation = 11.1%) and compound potential amplitudes were the most variable (coefficient of variation = 19.3%). Vincristine abolished compound muscle action potentials and reduced sensory nerve action potential amplitudes by 42-57% while having little effect on velocity. Rabbit distal hindlimb nerve conduction studies are feasible with surface recordings and stimulation. The evoked distal sensory potentials have amplitudes, configurations and recording techniques that are similar to humans and may be valuable for measuring large sensory fiber function in chronic models of peripheral neuropathies.	[Hotson, John R.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Hotson, John R.] Calif Inst Med Res, San Jose, CA 95128 USA	Stanford University	Hotson, JR (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	hotson@stanford.edu			California Institute for Medical Research	California Institute for Medical Research	The study was supported by internal funds of the California Institute for Medical Research, (http://www.cimr.org). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albers JW, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005228.pub3; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; BABA M, 1983, J NEUROL SCI, V60, P235, DOI 10.1016/0022-510X(83)90065-5; BABA M, 1982, J NEUROL SCI, V54, P197, DOI 10.1016/0022-510X(82)90182-4; BRADLEY WG, 1970, J NEUROL SCI, V10, P107, DOI 10.1016/0022-510X(70)90013-4; Brigo F, 2012, J CHILD NEUROL, V27, P867, DOI 10.1177/0883073811428379; CASEY EB, 1973, BRAIN, V96, P69, DOI 10.1093/brain/96.1.69; David WS, 2010, MUSCLE NERVE, V41, P794, DOI 10.1002/mus.21590; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; Duranthon V, 2012, TRANSGENIC RES, V21, P699, DOI 10.1007/s11248-012-9599-x; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; FIORI MG, 1995, TOXICOL PATHOL, V23, P248, DOI 10.1177/019262339502300302; Gomber S, 2010, INDIAN J PEDIATR, V77, P97, DOI 10.1007/s12098-009-0254-3; Graur D, 1996, NATURE, V379, P333, DOI 10.1038/379333a0; Hoke A, 2013, J PERIPHER NERV SYST, V18, P1, DOI 10.1111/jns5.12000; Hoke A, 2012, NEUROTHERAPEUTICS, V9, P262, DOI 10.1007/s13311-012-0116-y; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hotson JR, 2013, J PERIPHER NERV SYST, V18, P48; JOHNSTONE EM, 1991, MOL BRAIN RES, V10, P299, DOI 10.1016/0169-328X(91)90088-F; Kimura J, 2001, ELECTRODIAGNOSIS DIS; Krishnan AV, 2005, MUSCLE NERVE, V32, P51, DOI 10.1002/mus.20340; Kurokawa K, 2004, CLIN NEUROPHYSIOL, V115, P1677, DOI 10.1016/j.clinph.2004.02.007; Lauria G, 2005, J PERIPHER NERV SYST, V10, P202, DOI 10.1111/j.1085-9489.2005.0010210.x; Leandri M, 2012, J NEUROSCI METH, V209, P403, DOI 10.1016/j.jneumeth.2012.07.005; Lehky RJ, 2004, MUSCLE NERVE, V29, P387, DOI 10.1002/mus.10559; LOUIS AA, 1986, ELECTROEN CLIN NEURO, V63, P371, DOI 10.1016/0013-4694(86)90022-2; Misawa K, 2003, MOL PHYLOGENET EVOL, V28, P320, DOI 10.1016/S1055-7903(03)00079-4; Nishimoto Y, 2004, NEUROLOGY, V62, P1939, DOI 10.1212/01.WNL.0000129917.28461.0C; NORIDO F, 1988, TOXICOL APPL PHARM, V93, P433, DOI 10.1016/0041-008X(88)90046-4; Ogawa T, 2000, NEUROTOXICOLOGY, V21, P501; Park SB, 2009, BRAIN, V132, P2712, DOI 10.1093/brain/awp219; POPESKO P, 2003, COLOUR ATLAS ANATOMY; SANDLER SG, 1969, NEUROLOGY, V19, P367, DOI 10.1212/WNL.19.4.367; Shevalye H, 2012, DIABETES, V61, P2126, DOI 10.2337/db11-1524; Sprowl JA, 2013, P NATL ACAD SCI USA, V110, P11199, DOI 10.1073/pnas.1305321110; Staff NP, 2013, NEUROTOXICOLOGY, V39, P124, DOI 10.1016/j.neuro.2013.09.001; STOKES M, 1985, Physiotherapy Practice, V1, P71; Susuki K, 2003, ANN NEUROL, V54, P383, DOI 10.1002/ana.33333; VALENSI P, 1993, DIABETIC MED, V10, P933, DOI 10.1111/j.1464-5491.1993.tb00009.x; Vuillaumier S, 1997, MOL BIOL EVOL, V14, P372, DOI 10.1093/oxfordjournals.molbev.a025773; Woodruff-Pak DS, 2008, J ALZHEIMERS DIS, V15, P507; Zhu J, 2013, ANN NEUROL, V74, P893, DOI 10.1002/ana.24004	42	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92694	10.1371/journal.pone.0092694	http://dx.doi.org/10.1371/journal.pone.0092694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658286	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300116
J	Kang, YG; Shin, JW; Park, SH; Oh, MJ; Park, HS; Shin, JW; Kim, SH				Kang, Yun Gyeong; Shin, Ji Won; Park, So Hee; Oh, Min-Jae; Park, Hyo Soon; Shin, Jung-Woog; Kim, Su-Hyang			Effects of Flow-Induced Shear Stress on Limbal Epithelial Stem Cell Growth and Enrichment	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; IN-VITRO; DIFFERENTIATION; CORNEA; EXPRESSION; PHENOTYPE; ABSENCE; MATRIX; LINES	The roles of limbal epithelial stem cells (LESCs) are widely recognized, but for these cells to be utilized in basic research and potential clinical applications, researchers must be able to efficiently isolate them and subsequently maintain their stemness in vitro. We aimed to develop a biomimetic environment for LESCs involving cells from their in vivo niche and the principle of flow-induced shear stress, and to subsequently demonstrate the potential of this novel paradigm. LESCs, together with neighboring cells, were isolated from the minced limbal tissues of rabbits. At days 8 and 9 of culture, the cells were exposed to a steady flow or intermittent flow for 2 h per day in a custom-designed bioreactor. The responses of LESCs and epithelial cells were assessed at days 12 and 14. LESCs and epithelial cells responded to both types of flow. Proliferation of LESCs, as assessed using a BrdU assay, was increased to a greater extent under steady flow conditions. Holoclones were found under intermittent flow, indicating that differentiation into transient amplifying cells had occurred. Immunofluorescent staining of Bmi-1 suggested that steady flow has a positive effect on the maintenance of stemness. This finding was confirmed by real-time PCR. Notch-1 and p63 were more sensitive to intermittent flow, but this effect was transient. K3 and K12 expression, indicative of differentiation of LESCs into epithelial cells, was induced by flow and lasted longer under intermittent flow conditions. In summary, culture of LESCs in a bioreactor under a steady flow paradigm, rather than one of intermittent flow, is beneficial for both increasing proliferation and maintaining stemness. Conversely, intermittent flow appears to induce differentiation of LESCs. This novel experimental method introduces micro-mechanical stimuli to traditional culture techniques, and has potential for regulating the proliferation and differentiation of LESCs in vitro, thereby facilitating research in this field.	[Kang, Yun Gyeong; Park, So Hee; Oh, Min-Jae; Shin, Jung-Woog; Kim, Su-Hyang] Inje Univ, Dept Biomed Engn, Gyeongnam, South Korea; [Shin, Ji Won; Shin, Jung-Woog] Inje Univ, Cardiovasc & Metab Dis Ctr, Pusan, South Korea; [Park, Hyo Soon] Nunevit Eye Clin, Pusan, South Korea; [Shin, Jung-Woog] Inje Univ, UHRC, Inst Aged Life Redesign, Dept Hlth Sci & Technol, Gyeongnam, South Korea	Inje University; Inje University; Inje University	Shin, JW (corresponding author), Inje Univ, Dept Biomed Engn, Gyeongnam, South Korea.	biomechshin@gmail.com; jacky1231@paran.com			Bio & Medical Technology Development Program of the National Research Foundation (NRF); Ministry of Science [NRF-2012M3A9C6050370]; Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family, Republic of Korea [A091807]; Nunevit Eye Clinic	Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family, Republic of Korea; Nunevit Eye Clinic	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science (NRF-2012M3A9C6050370) and a grant of the Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family, Republic of Korea (A091807). Nunevit Eye Clinic provided support in the form of a salary for author HSP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647; Chee KYH, 2006, CLIN EXP OPHTHALMOL, V34, P64, DOI 10.1111/j.1442-9071.2006.01147.x; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.TEC.2010.0609, 10.1089/ten.tec.2010.0609]; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Grueterich M, 2002, INVEST OPHTH VIS SCI, V43, P63; HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96; Jang JY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/860652; Jones MB, 2008, B MATH BIOL, V70, P323, DOI 10.1007/s11538-007-9252-7; Kisiday JD, 2009, TISSUE ENG PT A, V15, P2817, DOI [10.1089/ten.tea.2008.0357, 10.1089/ten.TEA.2008.0357]; Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Lee SW, 2010, TISSUE ENG REGEN MED, V7, P255; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Mathers WD, 1996, OPHTHALMOLOGY, V103, P664, DOI 10.1016/S0161-6420(96)30637-4; Meyer-Blazejewska EA, 2010, INVEST OPHTH VIS SCI, V51, P765, DOI 10.1167/iovs.09-4109; Park KS, 2006, INVEST OPHTH VIS SCI, V47, P892, DOI 10.1167/iovs.05-1006; Sato M, 2000, J BIOMECH, V33, P127, DOI 10.1016/S0021-9290(99)00178-5; Sumanasinghe RD, 2009, J BIOMED MATER RES A, V88A, P778, DOI 10.1002/jbm.a.31913; Thorpe SD, 2010, ANN BIOMED ENG, V38, P2896, DOI 10.1007/s10439-010-0059-6; Wray LS, 2009, TISSUE ENG PT A, V15, P1463, DOI 10.1089/ten.tea.2008.0239; Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004	25	19	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e93023	10.1371/journal.pone.0093023	http://dx.doi.org/10.1371/journal.pone.0093023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658122	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300151
J	Ma, JY; Chen, J; Ming, DL; Tian, JW				Ma, Jiayi; Chen, Jun; Ming, Delie; Tian, Jinwen			A Mixture Model for Robust Point Matching under Multi-Layer Motion	PLOS ONE			English	Article							VECTOR; APPROXIMATION	This paper proposes an efficient mixture model for establishing robust point correspondences between two sets of points under multi-layer motion. Our algorithm starts by creating a set of putative correspondences which can contain a number of false correspondences, or outliers, in addition to the true correspondences (inliers). Next we solve for correspondence by interpolating a set of spatial transformations on the putative correspondence set based on a mixture model, which involves estimating a consensus of inlier points whose matching follows a non-parametric geometrical constraint. We formulate this as a maximum a posteriori (MAP) estimation of a Bayesian model with hidden/latent variables indicating whether matches in the putative set are outliers or inliers. We impose non-parametric geometrical constraints on the correspondence, as a prior distribution, in a reproducing kernel Hilbert space (RKHS). MAP estimation is performed by the EM algorithm which by also estimating the variance of the prior model (initialized to a large value) is able to obtain good estimates very quickly (e. g., avoiding many of the local minima inherent in this formulation). We further provide a fast implementation based on sparse approximation which can achieve a significant speed-up without much performance degradation. We illustrate the proposed method on 2D and 3D real images for sparse feature correspondence, as well as a public available dataset for shape matching. The quantitative results demonstrate that our method is robust to non-rigid deformation and multi-layer/large discontinuous motion.	[Ma, Jiayi; Ming, Delie; Tian, Jinwen] Huazhong Univ Sci & Technol, Sch Automat, Natl Key Lab Sci & Technol Multispectral Informat, Wuhan 430074, Hubei, Peoples R China; [Chen, Jun] Huazhong Univ Sci & Technol, Elect & Informat Engn Dept, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Ming, DL (corresponding author), Huazhong Univ Sci & Technol, Sch Automat, Natl Key Lab Sci & Technol Multispectral Informat, Wuhan 430074, Hubei, Peoples R China.	mingdelie@hust.edu.cn	Ma, Jiayi/Y-2470-2019	Ma, Jiayi/0000-0003-3264-3265	National Natural Science Foundation of China [61273279, 61273241]; China Scholarship Council [201206160008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work is supported by the National Natural Science Foundation of China (Nos. 61273279 and 61273241, http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) and China Scholarship Council (No. 201206160008, http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSZAJN N, 1950, T AM MATH SOC, V68, P337, DOI 10.1090/s0002-9947-1950-0051437-7; Baldassarre L, 2011, TECHNICAL REPORT; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bishop C.M., 2006, PATTERN RECOGNITION; Carmeli C, 2006, ANAL APPL, V4, P377, DOI 10.1142/S0219530506000838; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Chum O, 2005, PROC CVPR IEEE, P772; Chum O, 2005, PROC CVPR IEEE, P220, DOI 10.1109/cvpr.2005.221; Chum O, 2003, LECT NOTES COMPUT SC, V2781, P236; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Gold S, 1998, PATTERN RECOGN, V31, P1019, DOI 10.1016/S0031-3203(98)80010-1; Hartley R., 2003, MULTIPLE VIEW GEOMET, V2nd second; Horaud R, 2011, IEEE T PATTERN ANAL, V33, P587, DOI 10.1109/TPAMI.2010.94; Huber PJ, 1981, ROBUST STAT; Jian B, 2011, IEEE T PATTERN ANAL, V33, P1633, DOI 10.1109/TPAMI.2010.223; Kim VG, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964974; Leordeanu M., 2005, P INT C COMP VIS; Li XR, 2010, INT J COMPUT VISION, V89, P1, DOI 10.1007/s11263-010-0318-x; Liu C., 2011, IEEE T PATTERN ANAL, V33; Liu H., 2010, ICML, P671; Liu HR, 2010, PROC CVPR IEEE, P1609, DOI 10.1109/CVPR.2010.5539780; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Ma JY, 2014, IEEE T IMAGE PROCESS, V23, P1706, DOI 10.1109/TIP.2014.2307478; Ma JY, 2013, PROC CVPR IEEE, P2147, DOI 10.1109/CVPR.2013.279; Ma JY, 2013, PATTERN RECOGN, V46, P3519, DOI 10.1016/j.patcog.2013.05.017; Ma JY, 2012, IEEE IMAGE PROC, P1, DOI 10.1109/ICIP.2012.6466780; Micchelli CA, 2005, NEURAL COMPUT, V17, P177, DOI 10.1162/0899766052530802; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; POGGIO T, 1990, P IEEE, V78, P1481, DOI 10.1109/5.58326; Raguram R, 2008, LECT NOTES COMPUT SC, V5303, P500, DOI 10.1007/978-3-540-88688-4_37; Rangarajan A, 1997, LECT NOTES COMPUT SC, V1230, P29; Rousseeuw P. J., 1987, ROBUST REGRESSION OU; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Torr PHS, 2000, COMPUT VIS IMAGE UND, V78, P138, DOI 10.1006/cviu.1999.0832; Torresani L, 2008, LECT NOTES COMPUT SC, V5303, P596, DOI 10.1007/978-3-540-88688-4_44; Tsin Y, 2004, LECT NOTES COMPUT SC, V3023, P558; Tuytelaars T, 2004, INT J COMPUT VISION, V59, P61, DOI 10.1023/B:VISI.0000020671.28016.e8; Ullman S., 1979, INTERPRETATION VISUA, V28; YUILLE AL, 1988, NATURE, V333, P71, DOI 10.1038/333071a0; YUILLE AL, 1989, INT J COMPUT VISION, V3, P155, DOI 10.1007/BF00126430; Zaharescu A, 2009, PROC CVPR IEEE, P373, DOI 10.1109/CVPRW.2009.5206748; Zhao J, 2011, PROC CVPR IEEE, P2977, DOI 10.1109/CVPR.2011.5995336	44	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92282	10.1371/journal.pone.0092282	http://dx.doi.org/10.1371/journal.pone.0092282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658087	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300069
J	Romeo, R; Foglieni, B; Casazza, G; Spreafico, M; Colombo, M; Prati, D				Romeo, Raffaella; Foglieni, Barbara; Casazza, Giovanni; Spreafico, Marta; Colombo, Massimo; Prati, Daniele			High Serum Levels of HDV RNA Are Predictors of Cirrhosis and Liver Cancer in Patients with Chronic Hepatitis Delta	PLOS ONE			English	Article							B-VIRUS; HEPATOCELLULAR-CARCINOMA; VANISHING DISEASE; INFECTION; MANAGEMENT	Chronic infection with the hepatitis delta virus (HDV) is a risk factor for cirrhosis and hepatocellular carcinoma (HCC), but little is known whether the outcome of hepatitis is predicted by serum markers of HDV and hepatitis B virus (HBV) infection. The aim of the study was to investigate these correlations in 193 patients with chronic HDV infection who had been followed up for a median of 9.5 years (4.8-19.3). HDV-RNA was first measured by qualitative in-house nested RT-PCR and quantified by in-house real-time PCR. HDV RNA levels only appeared significantly associated to HCC (univariate analysis: OR 1.32, 95% CI 1.02-1.71; p = 0.037; multivariate analysis: OR 1.42, 95% CI 1.04-1.95; p = 0.03). In non-cirrhotics at first presentation (n = 105), HDV RNA levels were associated with progression to cirrhosis (univariate analysis: OR = 1.57, 95% CI 1.20-2.05, p<0.001; multivariate analysis: OR = 1.60, 95% CI 1.20-2.12, p = 0.007) and development of HCC (univariate analysis: OR = 1.66, 95% CI 1.04-2.65, p = 0.033; multivariate analysis: OR = 1.88, 95% CI 1.11-3.19, p = 0.019). ROC analysis showed that approximately 600,000 HDV RNA copies/mL was the optimal cut-off value in our cohort of patients for discriminating the development of cirrhosis. High levels of HDV viremia in non-cirrhotic patients are associated with a considerable likelihood of progression to cirrhosis and the development of HCC. Once cirrhosis has developed, the role of HDV replication as a predictor of a negative outcome lessens.	[Romeo, Raffaella; Colombo, Massimo] Univ Milan, IRCCS, Fdn Ca Granda Osped Maggiore Policlin, AM & A Migliavacca Ctr Liver Dis,Div Gastroentero, Milan, Italy; [Foglieni, Barbara; Spreafico, Marta; Prati, Daniele] Osped A Manzoni, Dept Transfus Med & Hematol, Lecce, Italy; [Casazza, Giovanni] Univ Milan, Dipartimento Sci Biomed Clin L Sacco, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan	Romeo, R (corresponding author), Univ Milan, IRCCS, Fdn Ca Granda Osped Maggiore Policlin, AM & A Migliavacca Ctr Liver Dis,Div Gastroentero, Milan, Italy.	raffaella.romeo@policlinico.mi.it	Casazza, Giovanni/G-3661-2012; Prati, Daniele/P-8215-2019; Spreafico, Marta/C-5945-2014	Casazza, Giovanni/0000-0003-3718-1784; Prati, Daniele/0000-0002-2281-7498; Spreafico, Marta/0000-0003-3378-5513	Merck; Roche; BMS; Novartis; Bayer; Tibotec; Vertex; Janssen Cilag; Achillion; Lundbeck; Abbott; Boehringer Ingelheim; GSK; GenSpera; AbbVie Speaking and teaching	Merck(Merck & Company); Roche(Roche Holding); BMS(Bristol-Myers Squibb); Novartis(Novartis); Bayer(Bayer AG); Tibotec; Vertex(Vertex Pharmaceuticals); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Achillion; Lundbeck(Lundbeck Corporation); Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); GSK(GlaxoSmithKline); GenSpera; AbbVie Speaking and teaching(AbbVie)	MC has the following interests: Grant and research support: Merck, Roche, BMS, Gilead Science Advisory committees: Merck, Roche, Novartis, Bayer, BMS, Gilead Science, Tibotec, Vertex, Janssen Cilag, Achillion, Lundbeck, Abbott, Boehringer Ingelheim, GSK, GenSpera, AbbVie Speaking and teaching: Tibotec, Roche, Novartis, Bayer, BMS, Gilead Science, Vertex. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aslan N, 2003, J HEPATOL, V38, P15, DOI 10.1016/S0168-8278(03)80457-9; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; COLOMBO M, 1983, GASTROENTEROLOGY, V85, P235; COLOMBO M, 1991, NEW ENGL J MED, V325, P675, DOI 10.1056/NEJM199109053251002; Cross TJS, 2008, J MED VIROL, V80, P277, DOI 10.1002/jmv.21078; De Franchis R, 2001, P 3 BAV INT CONS WOR; Erhardt A, 2003, Z GASTROENTEROL, V41, P523, DOI 10.1055/s-2003-39648; Farci P, 2003, J HEPATOL, V39, pS212, DOI 10.1016/S0168-8278(03)00331-3; Gaeta GB, 2000, HEPATOLOGY, V32, P824, DOI 10.1053/jhep.2000.17711; Hadziyannis SJ, 1997, J GASTROEN HEPATOL, V12, P289, DOI 10.1111/j.1440-1746.1997.tb00424.x; HADZIYANNIS SJ, 1985, HEPATOLOGY, V5, P544, DOI 10.1002/hep.1840050404; Heidrich B, 2012, LIVER INT; Huang YH, 2004, J GEN VIROL, V85, P3089, DOI 10.1099/vir.0.80183-0; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Kodani M, 2013, J VIROL METHODS, V193, P531, DOI 10.1016/j.jviromet.2013.07.033; Niro GA, 1997, HEPATOLOGY, V25, P728, DOI 10.1002/hep.510250339; OTTOBRELLI A, 1991, GASTROENTEROLOGY, V101, P1649, DOI 10.1016/0016-5085(91)90404-9; Peters RL, 1976, HEPATOCELLULAR CARCI; Pollicino T, 2011, J VIROL, V85, P432, DOI 10.1128/JVI.01609-10; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; RIZZETTO M, 1983, HEPATOLOGY, V3, P729; Romeo R, 2009, GASTROENTEROLOGY, V136, P1629, DOI 10.1053/j.gastro.2009.01.052; Sakugawa H, 2001, J MED VIROL, V65, P478, DOI 10.1002/jmv.2061; Salerno F, 1999, ITAL J GASTROENTEROL, V31, P626; Schaper M, 2010, J HEPATOL, V52, P658, DOI 10.1016/j.jhep.2009.10.036; Taylor JM, 2006, VIROLOGY, V344, P71, DOI 10.1016/j.virol.2005.09.033; Wedemeyer H, 2007, HEPATOLOGY, V45, P1331, DOI 10.1002/hep.21590; Williams V, 2009, J GEN VIROL, V90, P2759, DOI 10.1099/vir.0.011239-0; WU JC, 1995, GASTROENTEROLOGY, V108, P796, DOI 10.1016/0016-5085(95)90453-0; Zachou K, 2010, LIVER INT, V30, P430, DOI 10.1111/j.1478-3231.2009.02140.x	31	50	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92062	10.1371/journal.pone.0092062	http://dx.doi.org/10.1371/journal.pone.0092062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658127	Green Published, Green Submitted, gold			2022-12-25	WOS:000333355300052
J	Erb, CD; Sobel, DM				Erb, Christopher D.; Sobel, David M.			The Development of Diagnostic Reasoning about Uncertain Events between Ages 4-7	PLOS ONE			English	Article							YOUNG-CHILDREN; EXPLORATORY PLAY; CAUSAL; PRESCHOOLERS; KNOWLEDGE; SCIENCE; PROBABILITY; ACQUISITION; EXPLANATION; INFERENCES	The present investigation examines the development of children's diagnostic reasoning abilities when such inferences involve belief revision about uncertain potential causes. Four-to 7-year-olds observed an event occur that was due to one of four potential causes. Some of those potential causes were revealed to be efficacious; others were revealed to be inefficacious, but there was always one potential cause presented with unknown efficacy. While all children could make appropriate predictive inferences about this situation, 4- and 5-year-olds were less capable of making correct diagnostic inferences about the cause of the event under these circumstances than older children. We discuss possible mechanisms for this development, as well as speculate on the relation between these findings and literature in children's scientific reasoning.	[Erb, Christopher D.; Sobel, David M.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA	Brown University	Sobel, DM (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA.	Dave_Sobel@brown.edu	Erb, Christopher/I-8241-2019	Erb, Christopher/0000-0002-1649-2324	National Science Foundation [1223777]	National Science Foundation(National Science Foundation (NSF))	This research was funded by National Science Foundation 1223777 to DMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck SR, 2006, CHILD DEV, V77, P413, DOI 10.1111/j.1467-8624.2006.00879.x; BINDRA D, 1980, J EXP PSYCHOL GEN, V109, P422, DOI 10.1037/0096-3445.109.4.422; Bullock M., 1982, DEV PSYCHOL TIME, P209; Chen Z, 1999, CHILD DEV, V70, P1098, DOI 10.1111/1467-8624.00081; Cook C, 2011, COGNITION, V120, P341, DOI 10.1016/j.cognition.2011.03.003; Fernbach PM, 2012, COGNITIVE DEV, V27, P39, DOI 10.1016/j.cogdev.2011.10.002; Fischbein E., 1975, INTUITIVE SOURCES PR; Gopnik A, 2000, CHILD DEV, V71, P1205, DOI 10.1111/1467-8624.00224; Gopnik A, 2001, DEV PSYCHOL, V37, P620, DOI 10.1037//0012-1649.37.5.620; HARMAN GH, 1965, PHILOS REV, V74, P88, DOI 10.2307/2183532; HOEMANN HW, 1971, CHILD DEV, V42, P221, DOI 10.1111/j.1467-8624.1971.tb03631.x; Klahr D, 2004, PSYCHOL SCI, V15, P661, DOI 10.1111/j.0956-7976.2004.00737.x; Kuhn D, 1995, MONOGR SOC RES CHILD, V60, P1; Kuhn D, 2009, J EXP CHILD PSYCHOL, V103, P268, DOI 10.1016/j.jecp.2009.01.009; Legare CH, 2012, CHILD DEV, V83, P173, DOI 10.1111/j.1467-8624.2011.01691.x; Lehrer R, 2000, J APPL DEV PSYCHOL, V21, P39, DOI 10.1016/S0193-3973(99)00049-0; Muentener P, 2010, COGNITIVE PSYCHOL, V61, P63, DOI 10.1016/j.cogpsych.2010.02.001; PERNER J, 1979, CHILD DEV, V50, P1121; Piaget J., 1975, ORIGIN IDEA CHANCE C; RUFFMAN T, 1993, CHILD DEV, V64, P1617, DOI 10.2307/1131459; Saxe R, 2005, PSYCHOL SCI, V16, P995, DOI 10.1111/j.1467-9280.2005.01649.x; Schauble L, 1996, DEV PSYCHOL, V32, P102, DOI 10.1037/0012-1649.32.1.102; Schulz LE, 2007, DEV PSYCHOL, V43, P1045, DOI 10.1037/0012-1649.43.4.1045; Schulz LE, 2007, DEVELOPMENTAL SCI, V10, P322, DOI 10.1111/j.1467-7687.2007.00587.x; Sobel DM, 2007, DEVELOPMENTAL SCI, V10, P298, DOI 10.1111/j.1467-7687.2007.00589.x; Sobel DM, 2009, DEV PSYCHOL, V45, P511, DOI 10.1037/a0014944; Sobel DM, 2004, COGNITIVE SCI, V28, P303, DOI 10.1016/j.cogsci.2003.11.001; SODIAN B, 1991, CHILD DEV, V62, P753, DOI 10.2307/1131175	28	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92285	10.1371/journal.pone.0092285	http://dx.doi.org/10.1371/journal.pone.0092285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651366	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800094
J	Zhang, P; Guan, P; Bai, XL; Song, ZP				Zhang, Pen; Guan, Ping; Bai, Xiao-Lu; Song, Zhi-Ping			New Aspects of HERG K+ Channel Function Depending upon Cardiac Spatial Heterogeneity	PLOS ONE			English	Article							RECTIFIER POTASSIUM CURRENTS; I-KR; OUTWARD CURRENT; TRANSIENT; REPOLARIZATION; IMPAIRMENT; DEPENDENCE; ARRHYTHMIA; MYOCYTES; CELLS	HERG K+ channel, the genetic counterpart of rapid delayed rectifier K+ current in cardiac cells, is responsible for many cases of inherited and drug-induced long QT syndromes. HERG has unusual biophysical properties distinct from those of other K+ channels. While the conventional pulse protocols in patch-clamp studies have helped us elucidate these properties, their limitations in assessing HERG function have also been progressively noticed. We employed AP-clamp techniques using physiological action potential waveforms recorded from various regions of canine heart to study HERG function in HEK293 cells and identified several novel aspects of HERG function. We showed that under AP-clamp IHERG increased gradually with membrane repolarization, peaked at potentials around 20-30 mV more negative than revealed by pulse protocols and at action potential duration (APD) to 60%-70% full repolarization, and fell rapidly at the terminal phase of repolarization. We found that the rising phase of IHERG was conferred by removal of inactivation and the decaying phase resulted from a fall in driving force, which were all determined by the rate of membrane repolarization. We identified regional heterogeneity and transmural gradient of IHERG when quantified with the area covered by IHERG trace. In addition, we observed regional and transmural differences of IHERG in response to dofetilide blockade. Finally, we characterized the influence of HERG function by selective inhibition of other ion currents. Based on our results, we conclude that the distinct biophysical properties of HERG reported by AP-clamp confer its unique function in cardiac repolarization thereby in antiarrhythmia and arrhythmogenesis.	[Zhang, Pen; Guan, Ping; Bai, Xiao-Lu; Song, Zhi-Ping] Minhang Cent Hosp, Dept Cardiol, Shanghai, Peoples R China		Song, ZP (corresponding author), Minhang Cent Hosp, Dept Cardiol, Shanghai, Peoples R China.	zpsong.dcmch@sina.com						Anson BD, 2004, AM J PHYSIOL-HEART C, V286, pH2434, DOI 10.1152/ajpheart.00891.2003; Antzelevitch C, 2001, BASIC RES CARDIOL, V96, P517, DOI 10.1007/s003950170002; Berecki G, 2005, BIOPHYS J, V88, P566, DOI 10.1529/biophysj.104.047290; BOYDEN PA, 1995, CARDIOVASC RES, V29, P312, DOI 10.1016/S0008-6363(96)88586-5; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Corr PB, 1995, CARDIAC ELECTROPHYSI, P182; Di Diego JM, 2003, CIRCULATION, V108, P1027, DOI 10.1161/01.CIR.0000085066.05180.40; Gintant GA, 2000, AM J PHYSIOL-HEART C, V278, pH806, DOI 10.1152/ajpheart.2000.278.3.H806; Goldhaber, 1998, J Cardiovasc Pharmacol Ther, V3, P37, DOI 10.1177/107424849800300105; Hancox JC, 1998, PFLUG ARCH EUR J PHY, V436, P843, DOI 10.1007/s004240050713; Hua F, 2004, AM J PHYSIOL-HEART C, V286, pH2342, DOI 10.1152/ajpheart.00793.2003; Hua F, 2004, CIRC RES, V94, P810, DOI 10.1161/01.RES.0000121102.24277.89; LITOVSKY SH, 1989, J AM COLL CARDIOL, V14, P1053, DOI 10.1016/0735-1097(89)90490-7; LIU DW, 1995, CIRC RES, V76, P351, DOI 10.1161/01.RES.76.3.351; Lu Y, 2003, J PHYSIOL-LONDON, V551, P253, DOI 10.1113/jphysiol.2003.046045; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; SICOURI S, 1991, CIRC RES, V68, P1729, DOI 10.1161/01.RES.68.6.1729; Taglialatela M, 1998, BIOCHEM PHARMACOL, V55, P1741, DOI 10.1016/S0006-2952(98)00002-1; Tsuji Y, 2000, CARDIOVASC RES, V48, P300, DOI 10.1016/S0008-6363(00)00180-2; Wang HZ, 2000, CIRCULATION, V102, P1165, DOI 10.1161/01.CIR.102.10.1165; Wang JX, 2004, J BIOL CHEM, V279, P13289, DOI 10.1074/jbc.C400025200; Wang JX, 2001, CIRCULATION, V104, P2645, DOI 10.1161/hc4701.100513; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; WANG ZG, 1993, CIRC RES, V73, P276, DOI 10.1161/01.RES.73.2.276; Yue LX, 1999, CIRC RES, V84, P776; Yue LX, 2000, CARDIOVASC RES, V46, P151, DOI 10.1016/S0008-6363(99)00430-7; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	31	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e72181	10.1371/journal.pone.0072181	http://dx.doi.org/10.1371/journal.pone.0072181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475014	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300001
J	Johnson, SN; Lopaticki, G; Hartley, SE				Johnson, Scott N.; Lopaticki, Goran; Hartley, Susan E.			Elevated Atmospheric CO2 Triggers Compensatory Feeding by Root Herbivores on a C-3 but Not a C-4 Grass	PLOS ONE			English	Article							RISING CO2; CARBON; PERFORMANCE; NITROGEN; GROWTH	Predicted increases in atmospheric carbon dioxide (CO2) concentrations often reduce nutritional quality for herbivores by increasing the C:N ratio of plant tissue. This frequently triggers compensatory feeding by aboveground herbivores, whereby they consume more shoot material in an attempt to meet their nutritional needs. Little, however, is known about how root herbivores respond to such changes. Grasslands are particularly vulnerable to root herbivores, which can collectively exceed the mass of mammals grazing aboveground. Here we provide novel evidence for compensatory feeding by a grass root herbivore, Sericesthis nigrolineata, under elevated atmospheric CO2 (600 mmol mol(-1)) on a C-3 (Microlaena stipoides) but not a C-4 (Cymbopogon refractus) grass species. At ambient CO2 (400 mu mol mol(-1)) M. stipoides roots were 44% higher in nitrogen (N) and 7% lower in carbon (C) concentrations than C. refractus, with insects performing better on M. stipoides. Elevated CO2 decreased N and increased C: N in M. stipoides roots, but had no impact on C. refractus roots. Root-feeders displayed compensatory feeding on M. stipoides at elevated CO2, consuming 118% more tissue than at ambient atmospheric CO2. Despite this, root feeder biomass remained depressed by 24%. These results suggest that compensatory feeding under elevated atmospheric CO2 may make some grass species particularly vulnerable to attack, potentially leading to future shifts in the community composition of grasslands.	[Johnson, Scott N.; Lopaticki, Goran] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia; [Hartley, Susan E.] Univ York, Dept Biol, York Environm Sustainabil Inst, York YO10 5DD, N Yorkshire, England	Western Sydney University; University of York - UK	Johnson, SN (corresponding author), Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia.	Scott.Johnson@uws.edu.au	Johnson, Scott/HDN-6310-2022; Johnson, Scott N/B-2268-2012; Gemmell, Neil/C-6774-2009	Johnson, Scott/0000-0002-8388-8345; Rosengrave, Patrice/0000-0001-8421-3094; Gemmell, Neil/0000-0003-0671-3637; Carne, Alan/0000-0003-3665-1940; Hartley, Sue/0000-0002-5117-687X; Kleffmann, Torsten/0000-0001-9305-5980	Hawkesbury Institute for the Environment	Hawkesbury Institute for the Environment	The authors are grateful to the Hawkesbury Institute for the Environment for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Barbehenn RV, 2004, GLOBAL CHANGE BIOL, V10, P1565, DOI 10.1111/j.1365-2486.2004.00833.x; Barbehenn RV, 2004, OECOLOGIA, V140, P86, DOI 10.1007/s00442-004-1572-9; Barbehenn RV, 2004, OECOLOGIA, V140, P96, DOI 10.1007/s00442-004-1555-x; Barnett K, 2013, ADV INSECT PHYSIOL, V45, P1, DOI 10.1016/B978-0-12-417165-7.00001-5; Barton CVM, 2010, AGR FOREST METEOROL, V150, P941, DOI 10.1016/j.agrformet.2010.03.001; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; BRITTON EB, 1978, AUST J ZOOL, P1; CASWELL H, 1973, AM NAT, V107, P465, DOI 10.1086/282851; Dawson LA, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P3, DOI 10.1079/9781845934613.0003; DeLucia EH, 2012, PLANT PHYSIOL, V160, P1677, DOI 10.1104/pp.112.204750; Frew A, 2013, FOREST ECOL MANAG, V306, P275, DOI 10.1016/j.foreco.2013.06.051; Hovenden MJ, 2010, AUSTRAL ECOL, V35, P665, DOI 10.1111/j.1442-9993.2009.02074.x; Johnson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079479; Johnson SN, 2012, ECOLOGY, V93, P2208, DOI 10.1890/11-2272.1; Johnson SN, 2011, GLOBAL CHANGE BIOL, V17, P688, DOI 10.1111/j.1365-2486.2010.02264.x; Johnson SN, 2010, OECOLOGIA, V162, P209, DOI 10.1007/s00442-009-1428-4; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MURRAY PJ, 1992, ANN APPL BIOL, V121, P715, DOI 10.1111/j.1744-7348.1992.tb03480.x; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Salt DT, 1996, OIKOS, V77, P326, DOI 10.2307/3546072; Scheirs J, 2001, ECOLOGY, V82, P410, DOI 10.1890/0012-9658(2001)082[0410:ATOTCC]2.0.CO;2; Seastedt TR, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P54, DOI 10.1079/9781845934613.0054; Simpson S.J., 1990, P111; Staley JT, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P192, DOI 10.1079/9781845934613.0192; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Trumper K, 2009, UNEP RAPID RESPONSE; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; WILLIAMS RE, 1968, J RANGE MANAGE, V21, P355, DOI 10.2307/3896081	30	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90251	10.1371/journal.pone.0090251	http://dx.doi.org/10.1371/journal.pone.0090251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651855	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800012
J	Jeon, SJ; Oh, M; Yeo, WS; Galvao, KN; Jeong, KC				Jeon, Soo Jin; Oh, Manhwan; Yeo, Won-Sik; Galvao, Klibs N.; Jeong, Kwang Cheol			Underlying Mechanism of Antimicrobial Activity of Chitosan Microparticles and Implications for the Treatment of Infectious Diseases	PLOS ONE			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; ANTIBACTERIAL ACTIVITY; CELL-MEMBRANE; DAIRY-COWS; NANOPARTICLES; PROTEIN; PATHOGENS; TRANSPORT; CEFTIOFUR	The emergence of antibiotic resistant microorganisms is a great public health concern and has triggered an urgent need to develop alternative antibiotics. Chitosan microparticles (CM), derived from chitosan, have been shown to reduce E. coli O157:H7 shedding in a cattle model, indicating potential use as an alternative antimicrobial agent. However, the underlying mechanism of CM on reducing the shedding of this pathogen remains unclear. To understand the mode of action, we studied molecular mechanisms of antimicrobial activity of CM using in vitro and in vivo methods. We report that CM are an effective bactericidal agent with capability to disrupt cell membranes. Binding assays and genetic studies with an ompA mutant strain demonstrated that outer membrane protein OmpA of E. coli O157:H7 is critical for CM binding, and this binding activity is coupled with a bactericidal effect of CM. This activity was also demonstrated in an animal model using cows with uterine diseases. CM treatment effectively reduced shedding of intrauterine pathogenic E. coli (IUPEC) in the uterus compared to antibiotic treatment. Since Shiga-toxins encoded in the genome of bacteriophage is often overexpressed during antibiotic treatment, antibiotic therapy is generally not recommended because of high risk of hemolytic uremic syndrome. However, CM treatment did not induce bacteriophage or Shiga-toxins in E. coli O157:H7; suggesting that CM can be a potential candidate to treat infections caused by this pathogen. This work establishes an underlying mechanism whereby CM exert antimicrobial activity in vitro and in vivo, providing significant insight for the treatment of diseases caused by a broad spectrum of pathogens including antibiotic resistant microorganisms.	[Jeon, Soo Jin; Oh, Manhwan; Yeo, Won-Sik; Jeong, Kwang Cheol] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Jeon, Soo Jin; Oh, Manhwan; Yeo, Won-Sik; Jeong, Kwang Cheol] Univ Florida, Inst Food & Agr Sci, Dept Anim Sci, Gainesville, FL 32611 USA; [Galvao, Klibs N.] Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32610 USA; [Galvao, Klibs N.] Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Jeong, KC (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	kcjeong@ufl.edu		Lee, Inhee/0000-0001-5723-9678; Jeon, Soo Jin/0000-0001-7473-3184	USDA-AFRI Grants program (Nanotechnology for Agricultural and Food Systems) [2014-67021-21597]; Milk Check-Off grants [F003431]; USDA-NIFA-CRIS program [FLA-VME-005176]	USDA-AFRI Grants program (Nanotechnology for Agricultural and Food Systems); Milk Check-Off grants; USDA-NIFA-CRIS program	This work was supported by USDA-AFRI Grants program (Nanotechnology for Agricultural and Food Systems, 2014-67021-21597) to KCJ. This work was also supported in part by Milk Check-Off grants (F003431) and USDA-NIFA-CRIS program (FLA-VME-005176) to KNG and KCJ. The funders had not role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung YC, 2003, BIORESOURCE TECHNOL, V88, P179, DOI 10.1016/S0960-8524(03)00002-6; DARMADJI P, 1994, MEAT SCI, V38, P243, DOI 10.1016/0309-1740(94)90114-7; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davydova VN, 2008, BIOPHYS CHEM, V136, P1, DOI 10.1016/j.bpc.2008.03.006; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; Galvao KN, 2009, J DAIRY SCI, V92, P1532, DOI 10.3168/jds.2008-1615; Grif K, 1998, EUR J CLIN MICROBIOL, V17, P761, DOI 10.1007/s100960050181; Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2; Jeong KC, 2011, APPL ENVIRON MICROB, V77, P2611, DOI 10.1128/AEM.02587-10; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; KILLMANN H, 1993, EMBO J, V12, P3007, DOI 10.1002/j.1460-2075.1993.tb05969.x; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; KLEBBA PE, 1994, EMBO J, V13, P4670, DOI 10.1002/j.1460-2075.1994.tb06790.x; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koebnik R, 1999, J BACTERIOL, V181, P3688, DOI 10.1128/JB.181.12.3688-3694.1999; Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012; Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022; Lopez-Leon T, 2005, J COLLOID INTERF SCI, V283, P344, DOI 10.1016/j.jcis.2004.08.186; Mahae N., 2011, International Food Research Journal, V18, P1543; McDougall S, 2007, ANIM REPROD SCI, V99, P9, DOI 10.1016/j.anireprosci.2006.03.017; McLaughlin CL, 2012, J DAIRY SCI, V95, P4363, DOI 10.3168/jds.2011-5111; Ozenc E, 2010, J ANIM VET ADV, V9, P3000, DOI 10.3923/javaa.2010.3000.3004; PAPINEAU AM, 1991, FOOD BIOTECHNOL, V5, P45, DOI 10.1080/08905439109549790; Park D, 2013, APPL ENVIRON MICROB, V79, P1563, DOI 10.1128/AEM.03158-12; Pascal TA, 2010, J BIOL CHEM, V285, P37753, DOI 10.1074/jbc.M110.122804; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Prasadarao NV, 2003, INFECT IMMUN, V71, P1680, DOI 10.1128/IAI.71.4.1680-1688.2003; Prasadarao NV, 2002, INFECT IMMUN, V70, P6513, DOI 10.1128/IAI.70.11.6513.2002; Qi LF, 2004, CARBOHYD RES, V339, P2693, DOI 10.1016/j.carres.2004.09.007; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; ROWE PM, 1993, LANCET, V342, P110, DOI 10.1016/0140-6736(93)91308-9; Serna A, 2008, CURR OPIN GASTROEN, V24, P38, DOI 10.1097/MOG.0b013e3282f2dfb8; Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; Shu XZ, 2001, J MICROENCAPSUL, V18, P237; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; SUDARSHAN NR, 1992, FOOD BIOTECHNOL, V6, P257, DOI 10.1080/08905439209549838; US Food and Drug Administration, 2012, SHRIMP DER CHIT GRAS; van der Lubben IM, 2001, BIOMATERIALS, V22, P687, DOI 10.1016/S0142-9612(00)00231-3; Xing K, 2009, INT J FOOD MICROBIOL, V132, P127, DOI 10.1016/j.ijfoodmicro.2009.04.013; Yoh M, 1997, EPIDEMIOL INFECT, V119, P101, DOI 10.1017/S0950268897007541	43	127	129	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92723	10.1371/journal.pone.0092723	http://dx.doi.org/10.1371/journal.pone.0092723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	26778895	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300121
J	Wang, ST; Sun, XL; Hoshino, Y; Yu, Y; Jia, B; Sun, ZW; Sun, MZ; Duan, XB; Zhu, YM				Wang, Sun-ting; Sun, Xiao-li; Hoshino, Yoichiro; Yu, Yang; Jia, Bei; Sun, Zhong-wen; Sun, Ming-zhe; Duan, Xiang-bo; Zhu, Yan-ming			MicroRNA319 Positively Regulates Cold Tolerance by Targeting OsPCF6 and OsTCP21 in Rice (Oryza sativa L.)	PLOS ONE			English	Article							APOPLASTIC OXIDATIVE BURST; PLANT MICRORNAS; TRANSCRIPTION FACTORS; LOW-TEMPERATURE; GENE-REGULATION; SMALL RNAS; STRESS; ARABIDOPSIS; EXPRESSION; LANCEOLATE	The microRNA319 (miR319) family is conserved among diverse plant species. In rice (Oryza sativa L.), the miR319 gene family is comprised of two members, Osa-miR319a and Osa-miR319b. We found that overexpressing Osa-miR319b in rice resulted in wider leaf blades and delayed development. Here, we focused on the biological function and potential molecular mechanism of the Osa-miR319b gene in response to cold stress in rice. The expression of Osa-miR319b was down-regulated by cold stress, and the overexpression of Osa-miR319b led to an enhanced tolerance to cold stress, as evidenced by higher survival rates and proline content. Also, the expression of a handful of cold stress responsive genes, such as DREB1A/B/C, DREB2A, TPP1/2, was increased in Osa-miR319b transgenic lines. Furthermore, we demonstrated the nuclear localization of the transcription factors, OsPCF6 and OsTCP21, which may be Osa-miR319b-targeted genes. We also showed that OsPCF6 and OsTCP21 expression was largely induced by cold stress, and the degree of induction was obviously repressed in plants overexpressing Osa-miR319b. As expected, the down-regulation of OsPCF6 and OsTCP21 resulted in enhanced tolerance to cold stress, partially by modifying active oxygen scavenging. Taken together, our findings suggest that Osa-miR319b plays an important role in plant response to cold stress, maybe by targeting OsPCF6 and OsTCP21.	[Wang, Sun-ting; Sun, Xiao-li; Yu, Yang; Jia, Bei; Sun, Zhong-wen; Sun, Ming-zhe; Duan, Xiang-bo; Zhu, Yan-ming] Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China; [Hoshino, Yoichiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Kita Ku, Sapporo, Hokkaido, Japan	Northeast Agricultural University - China; Hokkaido University	Zhu, YM (corresponding author), Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China.	ymzhu2001@neau.edu.cn	Hoshino, Yoichiro/A-5115-2012; han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020	Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Xiaoli/0000-0003-1134-3976; Sun, Mingzhe/0000-0001-7557-623X	National Natural Science Foundation of China [31171578]; "863" project [2008AA10Z153]; Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program [2011TD005]; National basic scientific talent training fund projects [J1210069]; Graduate student innovation research project in Heilongjiang province [YJSCX2012-047HLJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "863" project(National High Technology Research and Development Program of China); Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program; National basic scientific talent training fund projects; Graduate student innovation research project in Heilongjiang province	This work was supported by the National Natural Science Foundation of China (31171578), the "863" project (2008AA10Z153), Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program (2011TD005), National basic scientific talent training fund projects (J1210069), Graduate student innovation research project in Heilongjiang province (YJSCX2012-047HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Armengaud P, 2004, PHYSIOL PLANTARUM, V120, P442, DOI 10.1111/j.0031-9317.2004.00251.x; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Ben-Gera H, 2012, PLANT SIGNAL BEHAV, V7, P1255, DOI 10.4161/psb.21550; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Efroni I, 2008, PLANT CELL, V20, P2293, DOI 10.1105/tpc.107.057521; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; GLASZMANN JC, 1990, EUPHYTICA, V45, P95; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hsieh TH, 2002, PLANT PHYSIOL, V129, P1086, DOI 10.1104/pp.003442; Huang J, 2009, BIOCHEM BIOPH RES CO, V389, P556, DOI 10.1016/j.bbrc.2009.09.032; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Lou QJ, 2007, EUPHYTICA, V158, P87, DOI 10.1007/s10681-007-9431-5; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mao DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047275; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Nonogaki H, 2010, PLANT CELL PHYSIOL, V51, P1840, DOI 10.1093/pcp/pcq154; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Ozhuner E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059543; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Peyman S, 2010, RICE SCI, V1, P77; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Saini A., 2012, MICRORNAS PLANT DEV, P219, DOI [10.1016/j.tplants.2012.01.010, DOI 10.1016/J.TPLANTS.2012.01.010]; Schommer C., 2012, SIGNAL COMMUN PLANTS, V15, P29, DOI [DOI 10.1007/978-3-642-27384-1_2, 10.1007/978-3-642-27384-1_2]; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Sharma R., 2010, J PLANT MOL BIOL BIO, V1, P24; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Talmor-Neiman M, 2006, PLANT J, V47, P25, DOI 10.1111/j.1365-313X.2006.02768.x; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Ueno M, 2003, PLANT J, V36, P215, DOI 10.1046/j.1365-313X.2003.01875.x; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Xin Z, 2000, PLANT CELL ENVIRON, V23, P893, DOI 10.1046/j.1365-3040.2000.00611.x; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yanai O, 2011, PLANT J, V68, P571, DOI 10.1111/j.1365-313X.2011.04716.x; Yang CH, 2013, PLANT CELL ENVIRON, V36, P2207, DOI 10.1111/pce.12130; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhao K, 2013, PLANT CELL PHYSIOL, V54, P1415, DOI 10.1093/pcp/pct087	61	207	241	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91357	10.1371/journal.pone.0091357	http://dx.doi.org/10.1371/journal.pone.0091357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24595136	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600005
J	Wang, S; Han, XH; Wang, JF; Yao, JR; Shi, YK				Wang, Shuai; Han, Xiaohong; Wang, Jianfei; Yao, Jiarui; Shi, Yuankai			Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; SELECTIVE INHIBITORS; PROGNOSTIC-FACTOR; TRANSPORT; RECEPTOR; APOPTOSIS; EGFR	Background: Chromosome Region Maintenance 1 (CRM1) is a nuclear exporter and its inhibitor has anti-tumor activity in various cancers. This study assessed the therapeutic efficiency of the novel CRM1 inhibitor KPT-185 on non-small cell lung cancer (NSCLC). Methods: NSCLC cell lines were treated with KPT-185 to assess changes in cell viability, cell cycle, apoptosis, and protein expression. NOD-SCID mice carrying NSCLC cell xenografts were orally treated with KPT-276, a clinical analog of KPT-185, to examine the efficacy and side effects of KPT-276 in vivo. Results: KPT-185 significantly reduced the viability of six NSCLC cell lines in a time-and dose-dependent manner, including epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-resistant H1975 and H1650GR cell lines. In addition, KPT-185 induced these NSCLC cells to arrest at G1 phase of the cell cycle and caused apoptosis in a dose-dependent manner. KPT-185 treatment also reduced CRM1 protein levels in six NSCLC cell lines, and the reduction could be completely abolished by the proteasome inhibitor bortezomib. KPT-185 activated caspase 3, 8, and 9, but inhibited survivin expression in NSCLC cells. In a mouse H1975 cell xenograft model, tumor growth was significantly inhibited by oral KPT-276 administration, and there was no significant mouse body weight loss or other side effects. Conclusions: The current study demonstrated the anti-tumor effects of KPT-185 in NSCLC cells, including EGFR-TKI-resistant NSCLC cell lines. Further studies will assess anti-tumor activity of KPT-185 in a clinical trial for NSCLC patients.	[Shi, Yuankai] Chinese Acad Med Sci, Dept Med Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China; Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shi, YK (corresponding author), Chinese Acad Med Sci, Dept Med Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China.	syuankai@cicams.ac.cn	Hoshino, Yoichiro/A-5115-2012; han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020	Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Xiaoli/0000-0003-1134-3976; Sun, Mingzhe/0000-0001-7557-623X				Azmi AS, 2013, GASTROENTEROLOGY, V144, P447, DOI 10.1053/j.gastro.2012.10.036; Bartholomeusz G, 2006, MOL CARCINOGEN, V45, P73, DOI 10.1002/mc.20156; Bonazzi S, 2010, J AM CHEM SOC, V132, P1432, DOI 10.1021/ja9097093; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Keller Shannon A., 2000, Blood, V96, P2537; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Meissner T, 2004, FEBS LETT, V576, P27, DOI 10.1016/j.febslet.2004.08.056; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Murakami N, 2002, BIOORG MED CHEM LETT, V12, P2807, DOI 10.1016/S0960-894X(02)00624-8; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Newlands ES, 1996, BRIT J CANCER, V74, P648, DOI 10.1038/bjc.1996.415; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Noske A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-294; Phelps RM, 1996, J CELL BIOCHEM, P32; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Sakakibara K, 2011, BLOOD, V118, P3922, DOI 10.1182/blood-2011-01-333138; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Turner JG, 2012, BIOCHEM PHARMACOL, V83, P1021, DOI 10.1016/j.bcp.2011.12.016; Van Neck T, 2008, BIOORGAN MED CHEM, V16, P9487, DOI 10.1016/j.bmc.2008.09.051; Wach JY, 2010, BIOORG MED CHEM LETT, V20, P2843, DOI 10.1016/j.bmcl.2010.03.049; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zhang KJ, 2013, EXP HEMATOL, V41, P67, DOI 10.1016/j.exphem.2012.09.002	31	207	241	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89848	10.1371/journal.pone.0089848	http://dx.doi.org/10.1371/journal.pone.0089848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595136	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500025
J	Wang, SL; Yang, H; Yu, LJ; Jin, JL; Qian, L; Zhao, H; Xu, Y; Zhu, XL				Wang, Sulei; Yang, Hui; Yu, Linjie; Jin, Jiali; Qian, Lai; Zhao, Hui; Xu, Yun; Zhu, Xiaolei			Oridonin Attenuates A beta(1-42)-Induced Neuroinflammation and Inhibits NF-kappa B Pathway	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; IN-VITRO; PROINFLAMMATORY CYTOKINES; INFLAMMATION; ACTIVATION; HYPOTHESIS; PROTECTS; NEURONS	Neuroinflammation induced by beta-amyloid (A beta) plays a critical role in the pathogenesis of Alzheimer's disease (AD), and inhibiting A beta-induced neuroinflammation serves as a potential strategy for the treatment of AD. Oridonin (Ori), a compound of Rabdosia rubescens, has been shown to exert anti-inflammatory effects. In this study, we demonstrated that Ori inhibited glial activation and decreased the release of inflammatory cytokines in the hippocampus of A beta(1-42)-induced AD mice. In addition, Ori inhibited the NF-kappa B pathway and A beta(1-42)-induced apoptosis. Furthermore, Ori could attenuate memory deficits in A beta(1-42)-induced AD mice. In conclusion, our study demonstrated that Ori inhibited the neuroinflammation and attenuated memory deficits induced by A beta(1-42), suggesting that Ori might be a promising candidate for AD treatment.	[Wang, Sulei; Yang, Hui; Xu, Yun] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Yu, Linjie; Jin, Jiali; Qian, Lai; Zhao, Hui; Xu, Yun; Zhu, Xiaolei] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University of Chinese Medicine; Nanjing University	Xu, Y (corresponding author), Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	xuyun20042001@aliyun.com; zhuquelee@126.com	Hoshino, Yoichiro/A-5115-2012; han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020	Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Xiaoli/0000-0003-1134-3976; Sun, Mingzhe/0000-0001-7557-623X	National Nature Science Foundation of China [81200839, 81230026, 81171085]; Natural Science Foundation [BL2012013]; Bureau of Health of the Jiangsu Province of China [LJ201101]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Bureau of Health of the Jiangsu Province of China	This study was supported by the National Nature Science Foundation of China (81200839, 81230026, and 81171085), the Natural Science Foundation (BL2012013) and the Bureau of Health (LJ201101) of the Jiangsu Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2014, INT J MOL MED, V33, P185, DOI 10.3892/ijmm.2013.1561; Batsch N., 2012, WORLD ALZHEIMER REPO; Boissiere F, 1997, NEUROREPORT, V8, P2849, DOI 10.1097/00001756-199709080-00009; Bu HQ, 2014, ONCOL REP, V31, P975, DOI 10.3892/or.2013.2888; Capiralla H, 2012, J NEUROCHEM, V120, P461, DOI 10.1111/j.1471-4159.2011.07594.x; Couturier J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-72; Fan H, 2013, J BIOMED RES, V27, P296, DOI 10.7555/JBR.27.20120100; Gubandru M, 2013, FOOD CHEM TOXICOL, V61, P209, DOI 10.1016/j.fct.2013.07.013; Han LJ, 2013, NEUROCHEM INT, V62, P913, DOI 10.1016/j.neuint.2013.03.003; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Huang Y, 2005, NEUROSCI LETT, V373, P115, DOI 10.1016/j.neulet.2004.09.074; Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim HG, 2014, NEUROTOXICOLOGY, V40, P23, DOI 10.1016/j.neuro.2013.10.004; Ku CM, 2013, FOOD CHEM, V141, P1104, DOI 10.1016/j.foodchem.2013.04.044; Kurt MA, 1997, NEUROSCI LETT, V239, P41, DOI 10.1016/S0304-3940(97)00876-8; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Leung CH, 2005, MOL PHARMACOL, V68, P286, DOI 10.1124/mol.105.012765; Llano DA, 2012, ALZ DIS ASSOC DIS, V26, P322, DOI 10.1097/WAD.0b013e31823b2728; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; Meng QH, 2013, PHARMAZIE, V68, P904, DOI 10.1691/ph.2013.3571; Overmyer M, 1999, DEMENT GERIATR COGN, V10, P252, DOI 10.1159/000017128; Paris D, 2007, NEUROSCI LETT, V415, P11, DOI 10.1016/j.neulet.2006.12.029; PRICE DL, 1995, CURR OPIN NEUROL, V8, P268, DOI 10.1097/00019052-199508000-00004; Rozemuller AJM, 2012, NEURODEGENER DIS, V10, P301, DOI 10.1159/000335380; Thangavel R, 2012, NEUROPATH APPL NEURO, V38, P572, DOI 10.1111/j.1365-2990.2011.01232.x; Valerio A, 2006, EUR J NEUROSCI, V23, P1711, DOI 10.1111/j.1460-9568.2006.04722.x; Wang C, 2011, NEUROSCI LETT, V491, P127, DOI 10.1016/j.neulet.2011.01.022; Wu J, 2011, BIOCHEM BIOPH RES CO, V408, P382, DOI 10.1016/j.bbrc.2011.04.013; Xu Y, 2009, INT IMMUNOPHARMACOL, V9, P360, DOI 10.1016/j.intimp.2009.01.002; Zhang J, 2013, BEHAV BRAIN RES, V244, P70, DOI 10.1016/j.bbr.2013.01.037; Zhang YY, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S40405; Zhao H, 2013, CNS NEUROSCI THER, V19, P117, DOI 10.1111/cns.12043; Zhu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035823	37	207	241	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104745	10.1371/journal.pone.0104745	http://dx.doi.org/10.1371/journal.pone.0104745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	24595136	gold, Green Submitted, Green Published			2022-12-25	WOS:000341017000058
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24941042	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon R. T., 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/NCLIMATE1958, 10.1038/nclimate1958]; R Core Team, 2021, R LANG ENV STAT COMP; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24941042	Green Published, gold, Green Accepted			2022-12-25	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000343943100017
